Citrus Sinensis ID: 003185
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 840 | 2.2.26 [Sep-21-2011] | |||||||
| Q54R82 | 942 | Mitogen-activated protein | no | no | 0.266 | 0.237 | 0.277 | 2e-19 | |
| Q39008 | 608 | Mitogen-activated protein | no | no | 0.294 | 0.406 | 0.314 | 6e-18 | |
| Q5R8Z4 | 681 | Serine/threonine-protein | yes | no | 0.244 | 0.301 | 0.269 | 8e-18 | |
| Q8BTW9 | 593 | Serine/threonine-protein | yes | no | 0.208 | 0.295 | 0.300 | 9e-18 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.254 | 0.160 | 0.299 | 9e-18 | |
| Q9NQU5 | 681 | Serine/threonine-protein | yes | no | 0.244 | 0.301 | 0.269 | 1e-17 | |
| P38692 | 1080 | Serine/threonine-protein | yes | no | 0.244 | 0.189 | 0.307 | 1e-17 | |
| Q3ULB5 | 682 | Serine/threonine-protein | no | no | 0.207 | 0.255 | 0.293 | 1e-17 | |
| Q54XJ4 | 1495 | Probable serine/threonine | no | no | 0.191 | 0.107 | 0.330 | 2e-17 | |
| O96013 | 591 | Serine/threonine-protein | no | no | 0.258 | 0.367 | 0.274 | 2e-17 |
| >sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 98.6 bits (244), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 81/292 (27%), Positives = 128/292 (43%), Gaps = 68/292 (23%)
Query: 535 VRTLKVCGSSAD-EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 593
V+ L++ ++D +++N S E+ ++ +LRH IV G + +L
Sbjct: 198 VKQLEIVDINSDPKLKNMILSFSKEIEVMRSLRHDNIVRYLGTSLDQSFL---------- 247
Query: 594 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 653
++F+EY+ GGS+ + + K E + V + + L LH+ I+HRDI
Sbjct: 248 ----SVFLEYIPGGSISSLLGKFGAFSENVIKV-----YTKQILQGLSFLHANSIIHRDI 298
Query: 654 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV-GTPRWMA 712
K NILID K +VKL DF C + GI + + GTP WMA
Sbjct: 299 KGANILIDT-------KGIVKLSDFG-----------CSKSFSGIVSQFKSMQGTPYWMA 340
Query: 713 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL 772
PEV+ K +G DIWS GC+++E+ T Q P+ ++EL
Sbjct: 341 PEVI----KQTGHGRSSDIWSLGCVIVEMATAQPPWSNITEL------------------ 378
Query: 773 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 824
+ + +A S S P + + +F D C + +P ERP A L
Sbjct: 379 ----AAVMYHIASSNSIPNIP-SHMSQEAF--DFLNLCFKRDPKERPDANQL 423
|
Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5 |
| >sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 93.6 bits (231), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 101/321 (31%), Positives = 139/321 (43%), Gaps = 74/321 (23%)
Query: 514 GKSVSSSLFRCKFGSADA-AAKVRTLKVCGSSADE-IRNFEYSCLGEVRMLGALRHSCIV 571
G+ S++ G D A K +L GS A E I+ E GE+++L L+H IV
Sbjct: 340 GRGSFGSVYEGISGDGDFFAVKEVSLLDQGSQAQECIQQLE----GEIKLLSQLQHQNIV 395
Query: 572 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALF 631
G + DG+ + IF+E V GS + KL + + SV ++L+
Sbjct: 396 RYRGT--------AKDGSNLY------IFLELVTQGS----LLKLYQRYQLRDSV-VSLY 436
Query: 632 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 691
Q + L LH K +HRDIK NIL+D A+G VKL DF A + F
Sbjct: 437 TRQ-ILDGLKYLHDKGFIHRDIKCANILVD-----ANG--AVKLADFGLA-KVSKFNDIK 487
Query: 692 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL 751
C GTP WMAPEV+ + YG DIWS GC +LE+ T Q+PY L
Sbjct: 488 S-----------CKGTPFWMAPEVINRKDS-DGYGSPADIWSLGCTVLEMCTGQIPYSDL 535
Query: 752 SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 811
++ I G P + D L L+ F++ +C
Sbjct: 536 EPVQALFRIGRGTLPEVPDTL-----------------------SLDARLFIL----KCL 568
Query: 812 EENPTERPTAGDLYEM-FVAR 831
+ NP ERPTA +L FV R
Sbjct: 569 KVNPEERPTAAELLNHPFVRR 589
|
Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q5R8Z4|PAK6_PONAB Serine/threonine-protein kinase PAK 6 OS=Pongo abelii GN=PAK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 93.2 bits (230), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 73/271 (26%), Positives = 121/271 (44%), Gaps = 66/271 (24%)
Query: 556 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 615
EV ++ +H +VEMY + + L + ME+++GG++ + + +
Sbjct: 450 FNEVVIMRDYQHFNVVEMYKSYLVGEEL--------------WVLMEFLQGGALTDIVSQ 495
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
+ E+ +V + V AL LH++ ++HRDIKS++IL+ L DG+ VKL
Sbjct: 496 VRLNEEQIATV------CEAVLQALAYLHAQGVIHRDIKSDSILLTL-----DGR--VKL 542
Query: 676 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735
DF C + +P VGTP WMAPEV+ +LY EVDIWS G
Sbjct: 543 SDFG----------FCAQISKDVPKRKSLVGTPYWMAPEVISR----SLYATEVDIWSLG 588
Query: 736 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 795
+++E++ + PY S ++ ++ P+L + H+V+
Sbjct: 589 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN---------SHKVS----------- 628
Query: 796 ELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
L D R +P ER TA +L +
Sbjct: 629 -----PVLRDFLERMLVRDPQERATAQELLD 654
|
Serine/threonine protein kinase that plays a role in the regulation of gene transcription. The kinase activity is induced by various effectors including AR or MAP2K6/MAPKK6. Phosphorylates the DNA-binding domain of androgen receptor/AR and thereby inhibits AR-mediated transcription. Inhibits also ESR1-mediated transcription. May play a role in cytoskeleton regulation by interacting with IQGAP1. May protect cells from apoptosis through phosphorylation of BAD. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8BTW9|PAK4_MOUSE Serine/threonine-protein kinase PAK 4 OS=Mus musculus GN=Pak4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 93.2 bits (230), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 41/216 (18%)
Query: 555 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 614
EV ++ RH +VEMY + L + ME+++GG++ + +
Sbjct: 365 LFNEVVIMRDYRHENVVEMYNSYLVGDEL--------------WVVMEFLEGGALTDIVT 410
Query: 615 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 674
E+ +V LA V AL LH++ ++HRDIKS++IL+ DG+ VK
Sbjct: 411 HTRMNEEQIAAVCLA------VLQALAVLHAQGVIHRDIKSDSILLT-----HDGR--VK 457
Query: 675 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 734
L DF C + +P VGTP WMAPE++ + YG EVDIWS
Sbjct: 458 LSDFG----------FCAQVSKEVPRRKSLVGTPYWMAPELISRLP----YGPEVDIWSL 503
Query: 735 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 770
G +++E++ + PY L+ +I+ PRL +
Sbjct: 504 GVMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKN 539
|
Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell migration, growth, proliferation or cell survival. Activation by various effectors including growth factor receptors or active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues. Phosphorylates and inactivates the protein phosphatase SSH1, leading to increased inhibitory phosphorylation of the actin binding/depolymerizing factor cofilin. Decreased cofilin activity may lead to stabilization of actin filaments. Phosphorylates LIMK1, a kinase that also inhibits the activity of cofilin. Phosphorylates integrin beta5/ITGB5 and thus regulates cell motility. Phosphorylates ARHGEF2 and activates the downstream target RHOA that plays a role in the regulation of assembly of focal adhesions and actin stress fibers. Stimulates cell survival by phosphorylating the BCL2 antagonist of cell death BAD. Alternatively, inhibits apoptosis by preventing caspase-8 binding to death domain receptors in a kinase independent manner. Plays a role in cell-cycle progression by controlling levels of the cell-cycle regulatory protein CDKN1A and by phosphorylating RAN. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 92.8 bits (229), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 79/264 (29%), Positives = 121/264 (45%), Gaps = 50/264 (18%)
Query: 512 EAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV 571
E GK S + + + D A K + + I+ F+ EV +LG+L+H +V
Sbjct: 1078 EIGKGHFSKVLKGNWKGKDVAVKKLNSNKDKAREEMIQEFK----AEVELLGSLQHPNLV 1133
Query: 572 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKL--- 628
YG+ + NP I ME++ G++ I S+ E+ S+KL
Sbjct: 1134 TCYGYSL----------NP------MCIVMEFLPSGNLFELIH--SKPSEQQQSIKLDST 1175
Query: 629 -ALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSF 687
L IA D+A + LH+++I+HRD+KS N+L+D +K+ D A SF
Sbjct: 1176 LILAIAFDIARGMQHLHTRNIIHRDLKSSNLLMDKHFN-------IKIADLGIARE-TSF 1227
Query: 688 LHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 747
T +GT W APE+LR H+ Y + D++SY +L ELLT + P
Sbjct: 1228 TQTMT-----------TIGTVAWTAPEILR--HES--YNQKADVYSYAIVLYELLTGEEP 1272
Query: 748 YMGLSELEIHDLI-QMGKRPRLTD 770
Y G+ + L+ G RP L D
Sbjct: 1273 YQGIPPMNAGILVASKGLRPELPD 1296
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9NQU5|PAK6_HUMAN Serine/threonine-protein kinase PAK 6 OS=Homo sapiens GN=PAK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 92.8 bits (229), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 73/271 (26%), Positives = 121/271 (44%), Gaps = 66/271 (24%)
Query: 556 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 615
EV ++ +H +VEMY + + L + ME+++GG++ + + +
Sbjct: 450 FNEVVIMRDYQHFNVVEMYKSYLVGEEL--------------WVLMEFLQGGALTDIVSQ 495
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
+ E+ +V + V AL LH++ ++HRDIKS++IL+ L DG+ VKL
Sbjct: 496 VRLNEEQIATV------CEAVLQALAYLHAQGVIHRDIKSDSILLTL-----DGR--VKL 542
Query: 676 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735
DF C + +P VGTP WMAPEV+ +LY EVDIWS G
Sbjct: 543 SDFG----------FCAQISKDVPKRKSLVGTPYWMAPEVISR----SLYATEVDIWSLG 588
Query: 736 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 795
+++E++ + PY S ++ ++ P+L + H+V+
Sbjct: 589 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN---------SHKVS----------- 628
Query: 796 ELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
L D R +P ER TA +L +
Sbjct: 629 -----PVLRDFLERMLVRDPQERATAQELLD 654
|
Serine/threonine protein kinase that plays a role in the regulation of gene transcription. The kinase activity is induced by various effectors including AR or MAP2K6/MAPKK6. Phosphorylates the DNA-binding domain of androgen receptor/AR and thereby inhibits AR-mediated transcription. Inhibits also ESR1-mediated transcription. May play a role in cytoskeleton regulation by interacting with IQGAP1. May protect cells from apoptosis through phosphorylation of BAD. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P38692|KIC1_YEAST Serine/threonine-protein kinase KIC1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=KIC1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 92.4 bits (228), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 83/270 (30%), Positives = 120/270 (44%), Gaps = 65/270 (24%)
Query: 519 SSLF-------RCKFGSADAAAKVRTLKVCG-------SSADEIRNFEYSCLGEVRMLGA 564
SSLF R KFG V+T +V S +DE+ + + E++ L +
Sbjct: 20 SSLFKRTEVIGRGKFGVVYKGYNVKTGRVYAIKVLNLDSDSDEVEDVQR----EIQFLAS 75
Query: 565 LRH-SCIVEMYGH--KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE 621
L+ S I YG K +S W I ME+ GGS+++ + + + E
Sbjct: 76 LKQISNITRYYGSYLKDTSLW----------------IIMEHCAGGSLRSLL-RPGKIDE 118
Query: 622 KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA 681
K++ V I +++ AL +H +++HRDIK+ N+LI E VKLCDF A
Sbjct: 119 KYIGV-----IMRELLVALKCIHKDNVIHRDIKAANVLITNEGN-------VKLCDFGVA 166
Query: 682 VPL-RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740
+ ++ L +A GTP WMAPEV+ Y +VDIWS G E
Sbjct: 167 AQVNQTSLRRQTMA-----------GTPYWMAPEVIMEGV---YYDTKVDIWSLGITTYE 212
Query: 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTD 770
+ T PY + L LI K PRL D
Sbjct: 213 IATGNPPYCDVEALRAMQLIIKSKPPRLED 242
|
Protein kinase involved in morphogenesis and cell integrity. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3ULB5|PAK6_MOUSE Serine/threonine-protein kinase PAK 6 OS=Mus musculus GN=Pak6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 92.4 bits (228), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 41/215 (19%)
Query: 556 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 615
EV ++ +H +VEMY + + L + ME+++GG++ + I +
Sbjct: 451 FNEVVIMRDYQHLNVVEMYKSYLVGEEL--------------WVLMEFLQGGALTDIISQ 496
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
+ E+ +V + V AL LH++ ++HRDIKS++IL+ L DG+ VKL
Sbjct: 497 VRLNEEQIATV------CEAVLQALAYLHAQGVIHRDIKSDSILLTL-----DGR--VKL 543
Query: 676 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735
DF C + +P VGTP WMAPEV+ +LY EVDIWS G
Sbjct: 544 SDFG----------FCAQISKDVPKRKSLVGTPYWMAPEVISR----SLYATEVDIWSLG 589
Query: 736 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 770
+++E++ + PY S ++ ++ P+L +
Sbjct: 590 IMVIEMVDGEPPYFSDSPVQAMKRLRDSAPPKLKN 624
|
Serine/threonine protein kinase that plays a role in the regulation of gene transcription. The kinase activity is induced by various effectors including AR or MAP2K6/MAPKK6. Phosphorylates the DNA-binding domain of androgen receptor/AR and thereby inhibits AR-mediated transcription. Inhibits also ESR1-mediated transcription. May play a role in cytoskeleton regulation by interacting with IQGAP1. May protect cells from apoptosis through phosphorylation of BAD. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54XJ4|Y8901_DICDI Probable serine/threonine-protein kinase DDB_G0278901 OS=Dictyostelium discoideum GN=DDB_G0278901 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 92.0 bits (227), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 67/203 (33%), Positives = 97/203 (47%), Gaps = 42/203 (20%)
Query: 552 EYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 611
+ S + E+ +L L H IV Y H +PS+ S I ME+++ GS++
Sbjct: 66 QISLMAEINLLKVLSHHNIVRYYEH------IPSSS--------HSYIVMEFIENGSLEK 111
Query: 612 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 671
I++ E V+V +IAQ V L LH + ++HRDIK+ N+LI DG
Sbjct: 112 IIKRHGLLPESLVTV----YIAQ-VLNGLEYLHRQGVIHRDIKAANLLIS-----TDGS- 160
Query: 672 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV-- 729
+KL DF A + D GTP WMAPEV++ + G+
Sbjct: 161 -IKLADFGVATKVSDL--------SSDNPDDTFAGTPYWMAPEVIQ------MQGISTAC 205
Query: 730 DIWSYGCLLLELLTLQVPYMGLS 752
D+WS GC ++ELLT PY GL+
Sbjct: 206 DVWSLGCTIIELLTGTPPYFGLA 228
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O96013|PAK4_HUMAN Serine/threonine-protein kinase PAK 4 OS=Homo sapiens GN=PAK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 92.0 bits (227), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 78/284 (27%), Positives = 124/284 (43%), Gaps = 67/284 (23%)
Query: 555 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 614
EV ++ +H +VEMY + L + ME+++GG++ + +
Sbjct: 363 LFNEVVIMRDYQHENVVEMYNSYLVGDEL--------------WVVMEFLEGGALTDIVT 408
Query: 615 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 674
E+ +V LA V AL LH++ ++HRDIKS++IL+ DG+ VK
Sbjct: 409 HTRMNEEQIAAVCLA------VLQALSVLHAQGVIHRDIKSDSILL-----THDGR--VK 455
Query: 675 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 734
L DF C + +P VGTP WMAPE++ + YG EVDIWS
Sbjct: 456 LSDFG----------FCAQVSKEVPRRKSLVGTPYWMAPELISRLP----YGPEVDIWSL 501
Query: 735 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 794
G +++E++ + PY L+ +I+ PRL + H+V+ S GF
Sbjct: 502 GIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKN---------LHKVSPSLKGF---- 548
Query: 795 AELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSSIS 837
R +P +R TA +L + F+A+ S
Sbjct: 549 ------------LDRLLVRDPAQRATAAELLKHPFLAKAGPPAS 580
|
Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell migration, growth, proliferation or cell survival. Activation by various effectors including growth factor receptors or active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues. Phosphorylates and inactivates the protein phosphatase SSH1, leading to increased inhibitory phosphorylation of the actin binding/depolymerizing factor cofilin. Decreased cofilin activity may lead to stabilization of actin filaments. Phosphorylates LIMK1, a kinase that also inhibits the activity of cofilin. Phosphorylates integrin beta5/ITGB5 and thus regulates cell motility. Phosphorylates ARHGEF2 and activates the downstream target RHOA that plays a role in the regulation of assembly of focal adhesions and actin stress fibers. Stimulates cell survival by phosphorylating the BCL2 antagonist of cell death BAD. Alternatively, inhibits apoptosis by preventing caspase-8 binding to death domain receptors in a kinase independent manner. Plays a role in cell-cycle progression by controlling levels of the cell-cycle regulatory protein CDKN1A and by phosphorylating RAN. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 840 | ||||||
| 225432806 | 1117 | PREDICTED: uncharacterized protein LOC10 | 0.979 | 0.736 | 0.682 | 0.0 | |
| 255552033 | 1152 | ATP binding protein, putative [Ricinus c | 0.988 | 0.720 | 0.644 | 0.0 | |
| 449525764 | 970 | PREDICTED: uncharacterized protein LOC10 | 0.971 | 0.841 | 0.591 | 0.0 | |
| 449433293 | 1131 | PREDICTED: uncharacterized protein LOC10 | 0.971 | 0.721 | 0.589 | 0.0 | |
| 356534187 | 1109 | PREDICTED: uncharacterized protein LOC10 | 0.966 | 0.732 | 0.604 | 0.0 | |
| 224099855 | 1214 | predicted protein [Populus trichocarpa] | 0.871 | 0.602 | 0.643 | 0.0 | |
| 15219675 | 1112 | leucine-rich repeat protein kinase-like | 0.969 | 0.732 | 0.555 | 0.0 | |
| 297843232 | 1115 | leucine-rich repeat family protein [Arab | 0.970 | 0.730 | 0.549 | 0.0 | |
| 356574435 | 1021 | PREDICTED: uncharacterized protein LOC10 | 0.841 | 0.692 | 0.609 | 0.0 | |
| 218193736 | 1112 | hypothetical protein OsI_13471 [Oryza sa | 0.926 | 0.699 | 0.475 | 0.0 |
| >gi|225432806|ref|XP_002279386.1| PREDICTED: uncharacterized protein LOC100249467 [Vitis vinifera] gi|297737117|emb|CBI26318.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1131 bits (2925), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 576/844 (68%), Positives = 679/844 (80%), Gaps = 21/844 (2%)
Query: 1 MDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQR 59
MDV E E D ++ + GS +TSSS T SSNSR AR S K WKR ++LQQR
Sbjct: 291 MDVLETTNQEIDESICCN----GSPNTSSSTLTGPSSNSRCFVARMSQKGWKRRYYLQQR 346
Query: 60 ARQERLNNSRKWRGEGHAQT-SMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQLL 118
ARQERLNNSRKW+ E HA+ ++K ++ + G L L E+ +E A DI+ LD+DDKQLL
Sbjct: 347 ARQERLNNSRKWKSEDHAEVLTIKAAEKCEHGKLAVLHPESLAEHAPDIVVLDNDDKQLL 406
Query: 119 SPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTG--KEGNDECSKHDSSSLSTANG 176
S EAESENLL SVED + G SCA L+S + EC+ D+S S + G
Sbjct: 407 SEEAESENLLNSVEDAESGPRKG------SCAVLDSIAINQGSKSECNDDDASLSSLSKG 460
Query: 177 ATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDR 236
A+E++EGSSSE SK+ K+KRHSDRDLDNPKPCK+R+ + E+SN S KYS +S+C+IEDR
Sbjct: 461 ASEKNEGSSSEVSKSTPKSKRHSDRDLDNPKPCKARRPVNEHSNLSCKYSKISYCNIEDR 520
Query: 237 LPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLN 296
LPDGFYDAGRDRPFM LT YEQ H DSREVIL+DR+ DEELDAI LSAQALV LKQLN
Sbjct: 521 LPDGFYDAGRDRPFMPLTVYEQNFHFDSREVILLDRERDEELDAITLSAQALVSQLKQLN 580
Query: 297 GLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTG 356
GLTK+ DNLQIA LLALFVSDHFGGSD+S ++ERTRK+VSGSNY+KPFVC+CSTG
Sbjct: 581 GLTKERKQVTDDNLQIASLLALFVSDHFGGSDKSALIERTRKSVSGSNYQKPFVCSCSTG 640
Query: 357 NSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKY 416
N ++ +TS KQ LD VEDIV+SDLCEKSLRSIK++RNS++VPIG++QFGVCRHRAVL+KY
Sbjct: 641 NRNNISTSNKQNLDTVEDIVVSDLCEKSLRSIKARRNSIIVPIGTLQFGVCRHRAVLMKY 700
Query: 417 LCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIR 476
LCDR+EPPVPCELVRGYLDF PHAWN + K+GDSW+RMIVDACRPHDIREE DPEYF R
Sbjct: 701 LCDRMEPPVPCELVRGYLDFLPHAWNVVHTKRGDSWVRMIVDACRPHDIREETDPEYFCR 760
Query: 477 YIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVR 536
YIPL R P ST+S +P +G GSFPSLS+CDE + SSSL +CKFGS +AAAKVR
Sbjct: 761 YIPLSRINVPLSTQS--TPVTG---GSFPSLSACDEIANAPSSSLIQCKFGSVEAAAKVR 815
Query: 537 TLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQ 596
L+VCG S DE+RNFEY CLGEVR+LGAL+HSCIVE+YGH+ISSKW+P++DGN EH +LQ
Sbjct: 816 ILEVCGDSVDEVRNFEYCCLGEVRILGALKHSCIVEIYGHQISSKWIPASDGNLEHRVLQ 875
Query: 597 SAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656
SAI ME+VKGGS+K+Y+EKLSE GEKHV V+LAL IA+DVA+AL ELHSKHI+HRDIKSE
Sbjct: 876 SAILMEHVKGGSLKSYLEKLSEAGEKHVPVELALCIARDVASALAELHSKHIIHRDIKSE 935
Query: 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 716
NILIDL++K+ADG PVVKLCDFDRAVPLRSFLH+CCIAH GIP PDVCVGTPRWMAPEVL
Sbjct: 936 NILIDLDKKRADGTPVVKLCDFDRAVPLRSFLHSCCIAHIGIPPPDVCVGTPRWMAPEVL 995
Query: 717 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG 776
RAMHK +YGLEVDIWSYGCLLLELLTLQVPY LSE + HD +QMGKRP+L +ELEALG
Sbjct: 996 RAMHKREIYGLEVDIWSYGCLLLELLTLQVPYFELSESQFHDQLQMGKRPQLPEELEALG 1055
Query: 777 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSI 836
S E E+AQSG E PE E+E L FLVD+ R CT+ NPT+RPTA +LY+M + +T +
Sbjct: 1056 S-QEPEMAQSGKE-EGPETEVEKLGFLVDLVRWCTKGNPTDRPTAENLYKMLLTQTRTFT 1113
Query: 837 SSRS 840
SSRS
Sbjct: 1114 SSRS 1117
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255552033|ref|XP_002517061.1| ATP binding protein, putative [Ricinus communis] gi|223543696|gb|EEF45224.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1087 bits (2810), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 546/847 (64%), Positives = 654/847 (77%), Gaps = 17/847 (2%)
Query: 1 MDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQR 59
MDVYE + + S + GS++ +SS+ T SNS+ AR+ +K+WKR H+LQQR
Sbjct: 316 MDVYETTIQSDHTKFSCN----GSQNATSSLLTGPPSNSKCFAARRLNKRWKRRHYLQQR 371
Query: 60 ARQERLNNSRKWRGEGHAQTSM-KEGQRYKSGNLDALASETPSEEASDIIGL-----DDD 113
ARQERLNNSRKW+GEG A S KE + KS NLD L SET + SDIIGL D +
Sbjct: 372 ARQERLNNSRKWKGEGRADLSTPKESKNCKSDNLDLLTSETCEDGTSDIIGLVDNNEDKE 431
Query: 114 DKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECSKHDSSSLST 173
DK + S E E+ENLL S +DD++ S G ++++CS ES DEC H+ S T
Sbjct: 432 DKVVPSSEVEAENLLVSGKDDRMNSKKGFYIKSCS-HNPESVSNGEEDECCVHEKSLALT 490
Query: 174 ANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSI 233
NG + +DEGSSSEN+K + K+KRH D LDNPKPCK R+ ++ + S KYS +SFCS
Sbjct: 491 QNGVSGEDEGSSSENTKFILKSKRHFDGALDNPKPCKCRRPTEDSLSLSHKYSDLSFCST 550
Query: 234 EDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLK 293
ED LPDGFYDAGRDRPFM L YEQ HLDSREVIL+DR+ DE+LDA LSAQALV LK
Sbjct: 551 EDHLPDGFYDAGRDRPFMPLRRYEQILHLDSREVILLDREKDEKLDATVLSAQALVCRLK 610
Query: 294 QLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTC 353
+LNG ++G + VD LQIA LLALFVSDHFGGSDRS +ERTRK VSGSNY+KPFVCTC
Sbjct: 611 RLNGFFEEGNKDAVDVLQIASLLALFVSDHFGGSDRSFTIERTRKAVSGSNYKKPFVCTC 670
Query: 354 STGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVL 413
STGN +S NTS KQIL + EDIV SDLCEKSLRS+K+KRNS++VP+G++QFGVCRHRA+L
Sbjct: 671 STGNDESINTSTKQILGSAEDIVFSDLCEKSLRSVKAKRNSIIVPLGNLQFGVCRHRALL 730
Query: 414 LKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEY 473
KYLCDR++PP+PCELVRGYLDF PHAWNTILVK+GDSW+RM+VDACRPHDIREE DPEY
Sbjct: 731 FKYLCDRMDPPIPCELVRGYLDFIPHAWNTILVKRGDSWVRMLVDACRPHDIREETDPEY 790
Query: 474 FIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAA 533
F RY+PL T P STES HSP S S S+ DE K+V S++ +CKF S +AAA
Sbjct: 791 FCRYVPLSHTRVPLSTESIHSPGC-----SITSFSTHDELEKTVLSTVIQCKFESVEAAA 845
Query: 534 KVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 593
KVRTL++C + DEIRNFEYSC+GEVR+L ALRH CIVE+YGH+ISSKW+ + DG P H
Sbjct: 846 KVRTLEICETPVDEIRNFEYSCIGEVRILRALRHPCIVELYGHQISSKWIHAEDGKPPHQ 905
Query: 594 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 653
+L+S I ME+VKGGS+K+YIEK+S+T +KHV + AL IA+D++ A+ +LHSKHI+HRD+
Sbjct: 906 ILRSTILMEHVKGGSLKSYIEKMSKTSKKHVPMDFALCIARDISCAMADLHSKHIIHRDV 965
Query: 654 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 713
KSENILIDL+ K+ADG PVVKLCDFDRAVPLRSFLHTCCIAH GIP PDVCVGTPRWMAP
Sbjct: 966 KSENILIDLDSKRADGMPVVKLCDFDRAVPLRSFLHTCCIAHNGIPPPDVCVGTPRWMAP 1025
Query: 714 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 773
EVLRAMHK N YGLEVDIWS+GCLLLELLTLQ+PY GLSE I +L+QMG+RP LTDELE
Sbjct: 1026 EVLRAMHKRNPYGLEVDIWSFGCLLLELLTLQIPYSGLSEFHIKELLQMGERPPLTDELE 1085
Query: 774 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 833
L S +E QSGS PEAE ETL FLVD+FRRCTE NP RPTA ++YE+ + +S
Sbjct: 1086 TLVSMNEPVATQSGSDVAAPEAESETLRFLVDLFRRCTEANPASRPTAAEIYELLLGCSS 1145
Query: 834 SSISSRS 840
+ SSRS
Sbjct: 1146 AFTSSRS 1152
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449525764|ref|XP_004169886.1| PREDICTED: uncharacterized protein LOC101227936, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 962 bits (2486), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/840 (59%), Positives = 637/840 (75%), Gaps = 24/840 (2%)
Query: 1 MDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQR 59
MDVYE + +N+ + G R+ SS++ S+NSRS +++S K+W+R H+LQQ+
Sbjct: 136 MDVYEATVQDNENSFPLK----GMRNISSNLLMGPSTNSRSFASKRSGKRWRRRHYLQQK 191
Query: 60 ARQERLNNSRKWRGEGHAQTSMKEGQRYKSGNLD-ALASETPSEEASDIIGLDDDDKQLL 118
ARQERLN+SRKW+G H T +K + + LD A SET ++S I L D K+
Sbjct: 192 ARQERLNSSRKWKGVDH-HTEVKIHENQEPERLDSASISETTVGDSSAIDELFDS-KETC 249
Query: 119 SPEAESENLLFSVEDDKIRSGTGLHVENCS--CAGLESTGKEGNDECSKHDSSSLSTANG 176
+ AE EN + S E+D VE+CS C T +EC + + T NG
Sbjct: 250 AVGAERENHIESHENDNFDPKKEFPVEDCSSICDAAAETMTRDENECCETSKTLPLTGNG 309
Query: 177 ATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDR 236
A +Q EGSSS+ SK K KR S+R+LDNPKPCKSRK + +S+ S KY+S SFC++ED
Sbjct: 310 AHDQ-EGSSSQVSKDNAKLKRCSERELDNPKPCKSRKPVEYSSSLSCKYNSTSFCNVEDY 368
Query: 237 LPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLN 296
LPDGFYDAGRDRPFM L YEQ HLDSREVI+V+R+ DE LD+I ++A++LVL LKQ+N
Sbjct: 369 LPDGFYDAGRDRPFMPLRNYEQNFHLDSREVIIVNREHDEVLDSITIAAKSLVLRLKQIN 428
Query: 297 GLT--KDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCS 354
LT +D VI D++ IA LLALFVSDHFGGSDRS +VE+TR+ VSGS Y+KPFVCTCS
Sbjct: 429 QLTQERDQVI---DDVYIAQLLALFVSDHFGGSDRSAMVEKTRRAVSGSKYQKPFVCTCS 485
Query: 355 TGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLL 414
TG+ D+ +S K +D EDI+ +D+CEKSLRSIK+ RNS++VP+G++QFGVCRHRA+LL
Sbjct: 486 TGDRDNLTSSTKLTVDNYEDILFTDICEKSLRSIKASRNSIIVPLGALQFGVCRHRALLL 545
Query: 415 KYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYF 474
KYLCDR+EPPVPCELVRGYLDF PHAWN ILV++G++ +RM+VDACRP+DIREEADPEYF
Sbjct: 546 KYLCDRMEPPVPCELVRGYLDFLPHAWNVILVQRGNTLVRMVVDACRPNDIREEADPEYF 605
Query: 475 IRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAK 534
RYIPL R P S SP G+ SFPSLS+CDE K+ SSS+ +CK S +AAAK
Sbjct: 606 CRYIPLSRAKLPISFGVTSSP--GI---SFPSLSNCDEIEKAPSSSVIKCKLASVEAAAK 660
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
+R +VC SS +EIRNFE+SCLGEVR+LGAL+HSCIV+MYGH+ISS+W+PS +G P+ L
Sbjct: 661 LRKREVCESSFEEIRNFEFSCLGEVRILGALKHSCIVQMYGHQISSEWIPSENGKPKRRL 720
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
L+SAIF+E+VKGGS+K+Y++KL + G++HV + LAL +A+DVA+ALVELHSKHI+HRDIK
Sbjct: 721 LRSAIFLEHVKGGSLKSYMDKLYKAGKEHVPMDLALHVARDVASALVELHSKHIIHRDIK 780
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714
SENIL+D + +K+DG P+VKLCDFDRAVPLRS LHTCCIAH GIP PDVCVGTPRWMAPE
Sbjct: 781 SENILMDFD-EKSDGVPIVKLCDFDRAVPLRSLLHTCCIAHTGIPPPDVCVGTPRWMAPE 839
Query: 715 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL-E 773
VLRAMH PN+YGLEVDIWS+GCLLLELLTLQ+P++GL+EL+I D +QMGKRP L +L E
Sbjct: 840 VLRAMHTPNVYGLEVDIWSFGCLLLELLTLQIPFLGLTELQIFDHLQMGKRPELAGDLEE 899
Query: 774 ALGSCHEHEVAQSG-SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 832
LG+ + ++QS E E + ET + L+D+FR+CT+ENP +RPTA +L+ + + T
Sbjct: 900 ELGTIKQSTMSQSSVQESEGQEKDQETKALLIDLFRKCTQENPNDRPTAEELHRILLEHT 959
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449433293|ref|XP_004134432.1| PREDICTED: uncharacterized protein LOC101218031 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 957 bits (2473), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 495/840 (58%), Positives = 635/840 (75%), Gaps = 24/840 (2%)
Query: 1 MDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQR 59
MDVYE +N+ + G R+ SS++ S+NSRS +++S K+W+R H+LQQ+
Sbjct: 297 MDVYEATDQDNENSFPLK----GMRNISSNLLMGPSTNSRSFASKRSGKRWRRRHYLQQK 352
Query: 60 ARQERLNNSRKWRGEGHAQTSMKEGQRYKSGNLD-ALASETPSEEASDIIGLDDDDKQLL 118
ARQERLN+SRKW+G H T +K + + LD A SET ++S I L D K+
Sbjct: 353 ARQERLNSSRKWKGVDH-HTEVKIHENQEPERLDSASISETTVGDSSAIDELFDS-KETC 410
Query: 119 SPEAESENLLFSVEDDKIRSGTGLHVENCS--CAGLESTGKEGNDECSKHDSSSLSTANG 176
AE EN + S E+D VE+CS C T +EC + + T NG
Sbjct: 411 DVGAERENHIESHENDNFDPKKEFPVEDCSSICDAAAETMTRDENECCETSKTLPLTGNG 470
Query: 177 ATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDR 236
A +Q EGSSS+ SK K KR S+++LDNPKPCKSRK + +S+ S KY+S SFC++ED
Sbjct: 471 AHDQ-EGSSSQVSKDNAKLKRCSEKELDNPKPCKSRKPVEYSSSLSCKYNSTSFCNVEDY 529
Query: 237 LPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLN 296
LPDGFYDAGRDRPFM L YEQ HLDSREVI+V+R+ DE LD+I ++A++LVL LKQ+N
Sbjct: 530 LPDGFYDAGRDRPFMPLRNYEQNFHLDSREVIIVNREHDEVLDSITIAAKSLVLRLKQIN 589
Query: 297 GLT--KDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCS 354
LT +D VI D++ IA LLALFVSDHFGGSDRS +VE+TR+ VSGS Y+KPFVCTCS
Sbjct: 590 QLTQERDQVI---DDVYIAQLLALFVSDHFGGSDRSAMVEKTRRVVSGSKYQKPFVCTCS 646
Query: 355 TGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLL 414
TG+ D+ +S K +D EDI+ +D+CEKSLRSIK+ RNS++VP+G++QFGVCRHRA+LL
Sbjct: 647 TGDRDNLTSSTKLTVDNYEDILFTDICEKSLRSIKASRNSIIVPLGALQFGVCRHRALLL 706
Query: 415 KYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYF 474
KYLCDR+EPPVPCELVRGYLDF PHAWN ILV++G++ +RM+VDACRP+DIREEADPEYF
Sbjct: 707 KYLCDRMEPPVPCELVRGYLDFLPHAWNVILVQRGNTLVRMVVDACRPNDIREEADPEYF 766
Query: 475 IRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAK 534
RYIPL R P S SP G+ SFPSLS+CDE K+ SSS+ +CK S +AAAK
Sbjct: 767 CRYIPLSRAKLPISFGVTSSP--GI---SFPSLSNCDEIEKAPSSSVIKCKLASVEAAAK 821
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
+R +VC SS +EIRNFE+SCLGEVR+LGAL+HSCIV+MYGH+ISS+W+PS +G P+ L
Sbjct: 822 LRKREVCESSFEEIRNFEFSCLGEVRILGALKHSCIVQMYGHQISSEWIPSENGKPKRRL 881
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
L+SAIF+E+VKGGS+K+Y++KL + G++HV + LAL +A+DVA+ALVELHSKHI+HRDIK
Sbjct: 882 LRSAIFLEHVKGGSLKSYMDKLYKAGKEHVPMDLALHVARDVASALVELHSKHIIHRDIK 941
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714
SENIL+D + +K+DG P+VKLCDFDRAVPLRS LHTCCIAH GIP PDVCVGTPRWMAPE
Sbjct: 942 SENILMDFD-EKSDGVPIVKLCDFDRAVPLRSLLHTCCIAHTGIPPPDVCVGTPRWMAPE 1000
Query: 715 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL-E 773
VLRAMH P++YGLEVDIWS+GCLLLELLTLQ+P++GL+EL+I D +QMGKRP L +L E
Sbjct: 1001 VLRAMHTPHVYGLEVDIWSFGCLLLELLTLQIPFLGLTELQIFDHLQMGKRPELAGDLEE 1060
Query: 774 ALGSCHEHEVAQSG-SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 832
LG+ + ++QS E E + ET + L+D+FR+CT+ENP +RPTA +L+ + + T
Sbjct: 1061 ELGTIKQSTMSQSSVQESEGQEKDQETKALLIDLFRKCTQENPNDRPTAEELHRILLEHT 1120
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356534187|ref|XP_003535639.1| PREDICTED: uncharacterized protein LOC100819959 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 942 bits (2434), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 505/835 (60%), Positives = 622/835 (74%), Gaps = 23/835 (2%)
Query: 1 MDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQR 59
MD+YE END +S G +TSSS+ T SSS+SR +RKS K+WKR HHLQQ+
Sbjct: 290 MDLYESNFQENDETLS-----DGPHNTSSSMLTSSSSSSRCFASRKSGKRWKRRHHLQQK 344
Query: 60 ARQERLNNSRKWRGEGHA-QTSMKEGQRY-KSGNLDALASETPSEEASDIIGLDDDDKQL 117
ARQERLNNSRKW+ H Q K+ R + N D+LASE+ +E S+ LDD++K++
Sbjct: 345 ARQERLNNSRKWKAVDHDDQLLSKKIHRISEPENHDSLASESCAEIVSENGSLDDNNKRI 404
Query: 118 LSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECSKHDSSSLSTANGA 177
S A ++N + + +D++ + E+C E DE + S S
Sbjct: 405 SSERAVNDNAIDNDNNDEVITEKQFSGEDCCTT-------ESKDE---KEESLCSLDKRP 454
Query: 178 TEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRL 237
+EQDE S E + V K+KRH DRDLDNPKPCKSRKS+ +S S KYS +SFC IED L
Sbjct: 455 SEQDEASCLELLECVSKSKRHLDRDLDNPKPCKSRKSISSSSLLSCKYSKISFCGIEDHL 514
Query: 238 PDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNG 297
DGFYDAGRDR FM L YEQ L SREVIL+DRK DEELDA+ L+AQALV +LK+LNG
Sbjct: 515 SDGFYDAGRDRLFMPLECYEQNHCLASREVILLDRKIDEELDAVMLAAQALVYNLKKLNG 574
Query: 298 LTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGN 357
L++ G + VDNLQ+A LLALFVSDHFGGSDRSGIVERTRK+VSGSNY KPFVCTCS G+
Sbjct: 575 LSRYGNQDGVDNLQMASLLALFVSDHFGGSDRSGIVERTRKSVSGSNYNKPFVCTCSAGS 634
Query: 358 SDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYL 417
S S ++ + + + +EDI LS + EKSL SIK +RNS+++PIGSVQ+GVCRHRA+L KYL
Sbjct: 635 STSISSPTEPVANTIEDITLSKMSEKSLDSIKKRRNSIIIPIGSVQYGVCRHRALLFKYL 694
Query: 418 CDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRY 477
CD +EPPVPCELVRGYLDF PHAWN IL+K+G +W+RM++DACRP DIREE DPEYF RY
Sbjct: 695 CDHMEPPVPCELVRGYLDFSPHAWNIILIKRGATWVRMLIDACRPLDIREEKDPEYFCRY 754
Query: 478 IPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRT 537
IPL RT P S+ P SFPSL++CDE S++L +CKFGS +AAAKVRT
Sbjct: 755 IPLNRTTIPISSIGSPGP-----DYSFPSLTTCDELETKASTTLVKCKFGSVEAAAKVRT 809
Query: 538 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 597
L+ GSSAD+I+NFEY+CLGE+R+LGAL+H CIVEMYGH+IS +W SADGNPEH +L+S
Sbjct: 810 LEEQGSSADKIKNFEYNCLGEIRILGALKHPCIVEMYGHQISCQWSVSADGNPEHRVLRS 869
Query: 598 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657
AIFMEYV+GGS+KNY+EKLSE GEKHV V+LAL IA+DV+ AL ELHSKHI+HRDIKSEN
Sbjct: 870 AIFMEYVEGGSLKNYLEKLSEAGEKHVPVELALHIAKDVSCALSELHSKHIIHRDIKSEN 929
Query: 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717
IL +L+RK+ DG P VKLCDFD AVPLRS LH CCIAH G P P +CVGTPRWMAPEV+R
Sbjct: 930 ILFNLDRKRDDGTPTVKLCDFDSAVPLRSTLHVCCIAHAGTPPPCICVGTPRWMAPEVMR 989
Query: 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 777
M+K N YGLE DIWS+GCLLLE+LTLQ+PY GLS+ D +QMGKRP+LTDEL L S
Sbjct: 990 TMYKKNSYGLEADIWSFGCLLLEMLTLQIPYSGLSDSHFLDSLQMGKRPQLTDELRVLSS 1049
Query: 778 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 832
+ + SG EK +A ++ L FLVD+F +C EENP++RPTA ++++M +A T
Sbjct: 1050 MNGPTMIPSGEELEKSDAGVDMLKFLVDLFHKCVEENPSKRPTAEEIHKMVLAHT 1104
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099855|ref|XP_002311646.1| predicted protein [Populus trichocarpa] gi|222851466|gb|EEE89013.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 934 bits (2413), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 491/763 (64%), Positives = 576/763 (75%), Gaps = 31/763 (4%)
Query: 1 MDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKRHHLQQRA 60
MDVYE E+D S + GS H+ SSI T SSN + R S + +RH+LQQ+A
Sbjct: 309 MDVYETSFQEDDRKFSCN----GSNHSMSSIVTGPSSNRSFASRRSSKRWKRRHYLQQKA 364
Query: 61 RQERLNNSRKWRGEGHAQT-SMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQL-L 118
RQERLNNSRKW+GEG A+ ++KE + +KS NLD L E SD++G+DDD++++ L
Sbjct: 365 RQERLNNSRKWKGEGCAEALALKESESFKSNNLDVLTPEVHEGGTSDVVGVDDDNEKVEL 424
Query: 119 SPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECSKHDSSSLSTANGAT 178
S EAE ENL SVEDDKI S VE+CSC L S K + C D ST + A
Sbjct: 425 SVEAEGENLHTSVEDDKISSKKVFSVESCSC-DLGSINKSEEEVCCVQDEPLASTRDEAA 483
Query: 179 EQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLP 238
QDE SSSE SK K+KRH DRD+DNPKPCK R+ ++SN S KYS +SFCSIEDRLP
Sbjct: 484 SQDESSSSEKSKITYKSKRHHDRDIDNPKPCKCRRPTEDSSNFSCKYSELSFCSIEDRLP 543
Query: 239 DGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGL 298
DGFYDAGRDRPFM L +EQ LDSREVIL+DR+ DE+LDA+ALSAQALV K+ NG
Sbjct: 544 DGFYDAGRDRPFMPLRRFEQILPLDSREVILLDREKDEQLDAVALSAQALVFRFKRSNGS 603
Query: 299 TKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNS 358
TK+ VDNLQIA LLALFVSDHFGGSDRSG VERTRK VSGSNYRKPFVCTC TGN+
Sbjct: 604 TKERNKVAVDNLQIASLLALFVSDHFGGSDRSGAVERTRKAVSGSNYRKPFVCTCPTGNN 663
Query: 359 DSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLC 418
+S + + KQ L+ VEDI+ SDLCE+SLRSIK++R S+V+P+GS+QFGVCRHRA+L+KYLC
Sbjct: 664 ESISLAGKQALETVEDIIFSDLCERSLRSIKARRGSIVIPLGSLQFGVCRHRALLMKYLC 723
Query: 419 DRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYI 478
DR++PPVPCELVRGYLDF PHAWN IL ++GDS +RM+VDAC PHDIREE DPEYF RYI
Sbjct: 724 DRMDPPVPCELVRGYLDFMPHAWNVILRRRGDSLVRMVVDACHPHDIREETDPEYFCRYI 783
Query: 479 PLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTL 538
PL RT P STES P SFP++S+ D+ K+ SS+L RCKFGS +AAAKVRTL
Sbjct: 784 PLSRTKVPLSTESVPGPGC-----SFPTMSTSDKIEKAGSSTLIRCKFGSVEAAAKVRTL 838
Query: 539 KVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA 598
+VC +SADEIRNFEY CLGE +SSKW+PS DGNPE +LQS
Sbjct: 839 EVCEASADEIRNFEYICLGE-------------------LSSKWVPSEDGNPERRILQSV 879
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
I MEYV GGS+KNY+E++S+TGEKHV V++AL IA+DVA AL E+HSK I+HRDIKSENI
Sbjct: 880 ILMEYVDGGSLKNYLEEVSKTGEKHVPVEMALCIARDVACALAEIHSKDIIHRDIKSENI 939
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718
LIDL+ +ADG PVVKLCDFDRAVP +SFLHTCCIAHRGI PDVCVGTPRWMAPEVLR
Sbjct: 940 LIDLDDTRADGMPVVKLCDFDRAVPRKSFLHTCCIAHRGIAPPDVCVGTPRWMAPEVLRT 999
Query: 719 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 761
M K N Y LEVDIWSYGCLLLELLTLQVPY GL E IH+L+Q
Sbjct: 1000 MDKRNTYALEVDIWSYGCLLLELLTLQVPYAGLPESRIHELLQ 1042
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15219675|ref|NP_171917.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|3142291|gb|AAC16742.1| Contains similarity to adenylate cyclase gb|AF012921 from Magnaporthe grisae. EST gb|Z24512 comes from this gene [Arabidopsis thaliana] gi|20466532|gb|AAM20583.1| unknown protein [Arabidopsis thaliana] gi|34365545|gb|AAQ65084.1| At1g04210 [Arabidopsis thaliana] gi|332189549|gb|AEE27670.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 906 bits (2341), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 464/835 (55%), Positives = 590/835 (70%), Gaps = 21/835 (2%)
Query: 1 MDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKR--HHLQQ 58
MDV+E P N V GS ++ST SS SR +ARKSSK+WKR ++ QQ
Sbjct: 291 MDVFETPYENNVITVPHK----GSHRNPLNMSTGISSISRCFSARKSSKRWKRRQYYFQQ 346
Query: 59 RARQERLNNSRKWRGEGHAQTSMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQLL 118
RARQERLNNSRKW+GE + + + ++G + + D D++DK
Sbjct: 347 RARQERLNNSRKWKGEVPPEGLSLKMEVEETGKQGMKVPQNTDRGSVDNSCSDENDKLF- 405
Query: 119 SPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECSKHDSSSLSTANGAT 178
E + + E+++ + +N C + T + N E + +SS S+ +
Sbjct: 406 -----EEASVITSEEEESSLKADVVSDNSQCVETQLTSERDNYESCEIKTSSPSSGDAPG 460
Query: 179 EQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLP 238
D SSSE K K+KR S++ LDNPK K K + +N S+KYSS SFCS ED LP
Sbjct: 461 TVDYNSSSERKKPNNKSKRCSEKYLDNPKGSKCHKLSTDITNLSRKYSSNSFCSTEDSLP 520
Query: 239 DGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGL 298
DGF+DAGRDRPFM L+ YE+ LDSREVIL+DR DE LDAI LSA+ALV LK+LN L
Sbjct: 521 DGFFDAGRDRPFMTLSKYEKVLPLDSREVILLDRAKDEVLDAITLSARALVARLKKLNCL 580
Query: 299 TKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNS 358
T D +DNLQ+A LALFVSDHFGGSDR+ I+ERTRK VSG+NY+KPF+CTC TGN
Sbjct: 581 TPDVDQVSIDNLQVASFLALFVSDHFGGSDRTAIIERTRKAVSGTNYQKPFICTCLTGNQ 640
Query: 359 DSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLC 418
D KQ+ ED +LSD+CEKSLRSIKSKRNS+VVP+G +QFG+CRHRA+L+KYLC
Sbjct: 641 DDLAALNKQVSTTAEDAILSDVCEKSLRSIKSKRNSIVVPLGKLQFGICRHRALLMKYLC 700
Query: 419 DRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYI 478
DR+EPPVPCELVRGYLDF PHAWN + VK+G SW+RM+VDACRPHDIRE+ D EYF RYI
Sbjct: 701 DRMEPPVPCELVRGYLDFMPHAWNIVPVKQGSSWVRMVVDACRPHDIREDTDQEYFCRYI 760
Query: 479 PLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTL 538
PL R + L+PG S S + + +SSL RCK GS +A K+RTL
Sbjct: 761 PLNRLNESIRIKEK------LEPGCSVSSLSTGKGVERANSSLIRCKLGSTEAVVKMRTL 814
Query: 539 KVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA 598
+V G+S D+IR FEY+CLGEVR+LGAL+H CIVE+YGH+ISSKW+ S +GN EH +LQS+
Sbjct: 815 EVSGASLDDIRTFEYTCLGEVRILGALKHDCIVELYGHEISSKWITSENGN-EHRVLQSS 873
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
I ME++KGGS+K +IEKLSE G+ HV + LAL IA+D++ AL+ELHSK I+HRDIKSEN+
Sbjct: 874 ILMEHIKGGSLKGHIEKLSEAGKHHVPMDLALSIARDISGALMELHSKDIIHRDIKSENV 933
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718
LIDL+ + A+G+P+VKLCDFDRAVPLRS LH CCIAH GIP P++CVGTPRWM+PEV RA
Sbjct: 934 LIDLDNQSANGEPIVKLCDFDRAVPLRSHLHGCCIAHVGIPPPNICVGTPRWMSPEVFRA 993
Query: 719 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 778
MH+ N YGLEVDIWS+GCL+ ELLTLQ PY LSEL+IH+ +Q GKRP+L +LE L S
Sbjct: 994 MHEQNFYGLEVDIWSFGCLIFELLTLQNPYFDLSELQIHESLQNGKRPKLPKKLETLISE 1053
Query: 779 HEHEVAQS--GSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 831
E E + + F+ E++L+T+ FL+DVF +CTEE+P++R AGDL+EM ++R
Sbjct: 1054 TEEEESTNKLSEVFDLTESDLDTMRFLIDVFHQCTEESPSDRLNAGDLHEMILSR 1108
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297843232|ref|XP_002889497.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] gi|297335339|gb|EFH65756.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 902 bits (2332), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 461/839 (54%), Positives = 587/839 (69%), Gaps = 24/839 (2%)
Query: 1 MDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKR--HHLQQ 58
MDV+E P N + + GS ++ST SS SR +ARKSSK+WKR H+ QQ
Sbjct: 291 MDVFETPYENN----TITVPHKGSHRNPLNMSTGISSISRCFSARKSSKRWKRRQHYFQQ 346
Query: 59 RARQERLNNSRKWRGE---GHAQTSMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDK 115
RARQERLNNSRKW+GE G M+ + K G E + D D+DK
Sbjct: 347 RARQERLNNSRKWKGEVPPGGLSLKMEVEETGKQG---MKVPENTDRGSVDSTYSGDNDK 403
Query: 116 QLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECSKHDSSSLSTAN 175
L E+ + E+++ +N + T + N+E + +SS S+ +
Sbjct: 404 LL----EEASVITSEEEEEESSLKAKFASDNSRFVETQLTSERDNNESCEIKASSPSSGD 459
Query: 176 GATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIED 235
D SSSE K K+KR S++ LDNPK K + + +N S KYS SFCS ED
Sbjct: 460 APGTADYNSSSERKKPNNKSKRCSEKYLDNPKGSKCHRPSTDFANLSHKYSRNSFCSTED 519
Query: 236 RLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQL 295
LPDGF+DAGRDRPFM L+ YE+ LDSREVIL+DR DE LDAI LSA+ LV LK+L
Sbjct: 520 SLPDGFFDAGRDRPFMSLSKYEEILPLDSREVILLDRAKDEVLDAITLSARTLVARLKKL 579
Query: 296 NGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCST 355
N LT D +DNLQ+A LALFVSDHFGGSDR+ I+ERTRK VSG+NY+KPF+CTC T
Sbjct: 580 NCLTPDVDQVSIDNLQVASFLALFVSDHFGGSDRTAIIERTRKAVSGTNYQKPFICTCLT 639
Query: 356 GNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLK 415
GN D KQ+ ED++LSD+CEKSLRSIKSKRNS+VVP+G +QFG+CRHRA+L+K
Sbjct: 640 GNQDDLAALNKQVSTTAEDVILSDVCEKSLRSIKSKRNSIVVPLGKLQFGICRHRALLMK 699
Query: 416 YLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFI 475
YLCDR+EPPVPCELVRGYLDF PHAWN + VK+G SW+RM+VDACRPHDIRE+ D EYF
Sbjct: 700 YLCDRMEPPVPCELVRGYLDFMPHAWNIVPVKQGSSWVRMVVDACRPHDIREDTDQEYFC 759
Query: 476 RYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKV 535
RYIPL R T+ + L+PG S + + +SSL RCK GS +A K+
Sbjct: 760 RYIPLNRLNESIRTKEN------LEPGCSVSSLLTGKGVERANSSLIRCKLGSTEAVVKM 813
Query: 536 RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLL 595
RTL+V G+S D+IR FEY+CLGEVR+LGAL+H CIVE+YGH+ISSKW+ S +G+ +L
Sbjct: 814 RTLEVSGASLDDIRTFEYTCLGEVRILGALKHDCIVELYGHEISSKWITSENGDEHRRVL 873
Query: 596 QSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 655
QS+I ME++KGGS+K +IEKLSE G+ HV + LAL IA+D++ AL+ELHSK I+HRDIKS
Sbjct: 874 QSSILMEHIKGGSLKGHIEKLSEAGKHHVPMDLALSIARDISGALMELHSKDIIHRDIKS 933
Query: 656 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 715
EN+LIDL+ + A+G+ +VKLCDFDRAVPLRS LH CCIAH GIP P++CVGTPRWM+PEV
Sbjct: 934 ENVLIDLDNQSANGEAIVKLCDFDRAVPLRSHLHGCCIAHVGIPPPNICVGTPRWMSPEV 993
Query: 716 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL 775
RAMH+ N YGLEVDIWS+GCL+ ELLTLQ PY LSEL+IH+ +Q GKRP+L +LE L
Sbjct: 994 FRAMHEQNFYGLEVDIWSFGCLIFELLTLQNPYFDLSELQIHESLQKGKRPKLPKKLETL 1053
Query: 776 GSCHEHEVAQSG--SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 832
S E + + + F+ E++L+T+ FL+DVF +CTEE+P++R AGDL+EM ++RT
Sbjct: 1054 SSETEEDESTNKLCEEFDLTESDLDTMRFLIDVFHQCTEESPSDRLNAGDLHEMILSRT 1112
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574435|ref|XP_003555353.1| PREDICTED: uncharacterized protein LOC100811118 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 826 bits (2133), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 445/730 (60%), Positives = 545/730 (74%), Gaps = 23/730 (3%)
Query: 1 MDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQR 59
MD+YE END +S G +TSSS+ T SS+SR +RKS K+WKR ++LQQ+
Sbjct: 290 MDLYESNFQENDETLS-----DGPHNTSSSMLTSPSSSSRCFASRKSGKRWKRRYYLQQK 344
Query: 60 ARQERLNNSRKWRGEGHAQT--SMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQL 117
ARQERLNNSRKW+ H S K + +SGN D+LASE+ +E S+ LDD++K++
Sbjct: 345 ARQERLNNSRKWKAVDHDDLLLSKKIHRISESGNHDSLASESCAEIESENGSLDDNNKRI 404
Query: 118 LSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECSKHDSSSLSTANGA 177
S A ++N + + +D++ + E+C E DE D+S S
Sbjct: 405 FSERAVNDNAIDNDNNDEVITEKQFSGEDCCTT-------ESKDE---KDASLCSLEKRQ 454
Query: 178 TEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRL 237
+EQ+E S E ++V K+KRH DRDLDNPKPCKSRKS+ +S S KYS +SFC ED L
Sbjct: 455 SEQEEASCLELLESVSKSKRHLDRDLDNPKPCKSRKSISSSSLLSCKYSKISFCGTEDHL 514
Query: 238 PDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNG 297
DGFYDAGRDRPFM L YEQ L SREVIL+DRK DEELDA+ L+AQALV +LK+LNG
Sbjct: 515 SDGFYDAGRDRPFMPLESYEQNQCLASREVILLDRKRDEELDAVMLAAQALVYNLKKLNG 574
Query: 298 LTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGN 357
L + G VDNLQ A LLALFVSDHFGGSDRS IVERTRK+VSGSNY KPFVCTCS G+
Sbjct: 575 LNRHGNQVGVDNLQTASLLALFVSDHFGGSDRSAIVERTRKSVSGSNYNKPFVCTCSAGS 634
Query: 358 SDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYL 417
S S ++ + + + +EDI LS + EKSL S+K ++NS+++PIGSVQ+GVCRHRA+L KYL
Sbjct: 635 STSISSPTEPVANTIEDITLSKMSEKSLDSMKKRQNSIIIPIGSVQYGVCRHRALLFKYL 694
Query: 418 CDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRY 477
CD +EPPVPCELVRGYLDF PHAWN IL+K+G +W+RM++DAC+P DIREE DPEYF RY
Sbjct: 695 CDHMEPPVPCELVRGYLDFSPHAWNIILIKRGATWVRMLIDACQPLDIREEKDPEYFCRY 754
Query: 478 IPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRT 537
IPL RT P ST C G D SFPSL++CDE S+SL +CKFGS +AAAKVRT
Sbjct: 755 IPLNRTTIPLSTIG----CPGPD-YSFPSLTTCDELETKASTSLVKCKFGSVEAAAKVRT 809
Query: 538 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 597
L+ GSSAD+I+NF+Y+CLGE+R+LGAL+H CIVEMYGH+IS +W SADGNPEH +L+S
Sbjct: 810 LEEQGSSADKIKNFKYNCLGEIRILGALKHPCIVEMYGHQISCQWSVSADGNPEHRVLRS 869
Query: 598 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657
AIFMEYV+GGS+K+Y+EKLSE GEKHV V+LAL IA+DV+ AL ELHS+HI+HRDIKSEN
Sbjct: 870 AIFMEYVEGGSLKSYLEKLSEAGEKHVPVELALLIAKDVSCALSELHSRHIIHRDIKSEN 929
Query: 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717
IL DL+RK+ DG P VKLCDFD AVPLRS LH CCIAH G P P VCVGTPRWMAPEV+R
Sbjct: 930 ILFDLDRKRDDGTPTVKLCDFDSAVPLRSTLHACCIAHAGTPPPCVCVGTPRWMAPEVMR 989
Query: 718 AMHKPNLYGL 727
M+K N YGL
Sbjct: 990 TMYKKNSYGL 999
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|218193736|gb|EEC76163.1| hypothetical protein OsI_13471 [Oryza sativa Indica Group] | Back alignment and taxonomy information |
|---|
Score = 701 bits (1810), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/821 (47%), Positives = 519/821 (63%), Gaps = 43/821 (5%)
Query: 35 SSSNSRSLTARKSSKQWKRHH-LQQRARQERLNNSRKWRGEGHAQT-------------S 80
+S+N + +K+ K WKR LQQ+ARQERL +SR + +
Sbjct: 302 ASANLKVHPTQKTKKGWKRRDCLQQQARQERLESSRSKLNDDYVDEMAVNMTEDESPLHD 361
Query: 81 MKEGQRYKSGNLDALASETPSEEAS---DIIGLDDDDKQLLSPEAESENLLFSVEDDKIR 137
M+ K + +A + P E +S D+ + DDD + ++ +++ +
Sbjct: 362 MENKSEMKGIDEEASLQDLPKETSSISEDLSCIVDDDSY---GHIKDSGMMLQDHNEEEK 418
Query: 138 SGTGLHVE-NCSCAG----LESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAV 192
G + NCSC + S + + E DS+S + + A E + SE SK
Sbjct: 419 PGLSMKSHGNCSCISGNTDILSRRRIRSVENELEDSAS--SVHDAAVVVEENPSETSKHS 476
Query: 193 CKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQ 252
K+KRH D D NPKP K + E S S KYS SFCSI+D LPDGFYDAGRD PFM
Sbjct: 477 WKSKRHPDMDC-NPKPSKCPRPFDECSKLSYKYSVQSFCSIDDHLPDGFYDAGRDMPFMP 535
Query: 253 LTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQI 312
L YE++ L +REVIL+DR+ DEELDAIA SAQ L+ +LK + D + +L
Sbjct: 536 LEEYERSIGLYAREVILLDREQDEELDAIASSAQILLSNLKMPSCFVADE--DAGQDLLR 593
Query: 313 ALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAV 372
A +LALFVSD FGG DRS + RTR+ + +PFVCTCS G+ + + K+I +
Sbjct: 594 ASVLALFVSDCFGGCDRSASLSRTRRAIVSLRKEQPFVCTCSAGSICDSIEASKRINNLY 653
Query: 373 EDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG 432
+ LC+KS+ IK +RNS +VPIG++QFGVCRHRAVL+KYLCDR +PP+PCELVRG
Sbjct: 654 GHFDFTGLCDKSIHIIKERRNSGIVPIGALQFGVCRHRAVLMKYLCDRADPPIPCELVRG 713
Query: 433 YLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPFSTESD 492
+LD+ PHAWN + V+KG++W+RMIVDAC P +I+EE DPEYF RY+PL R +
Sbjct: 714 HLDYTPHAWNVVPVRKGNTWVRMIVDACYPTNIKEETDPEYFCRYVPLSRLQIILDDQ-- 771
Query: 493 HSPCSGLDPGS-FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNF 551
G P S FPS+S C E + SSS++ CK G+ DAAAKVR L +S+DE++NF
Sbjct: 772 -----GYTPRSPFPSVSLCKEIETTASSSVYYCKIGAVDAAAKVRYLDTRCASSDEVKNF 826
Query: 552 EYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVK 610
EY L EVRMLGALR H IVE+YGH++ SKW+ AD + E+ +LQS I MEYVKGGS+K
Sbjct: 827 EYKLLAEVRMLGALRKHQSIVEIYGHQLYSKWV-QADDDKEYKILQSTIMMEYVKGGSLK 885
Query: 611 NYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 670
Y+ KL + G+KH + LA +I ++VA AL+ELH K ++HRDIKSEN+L+DL+ +++DG
Sbjct: 886 GYLTKLLKEGKKHAPIDLAFYIVREVACALLELHKKLVIHRDIKSENVLVDLDLERSDGT 945
Query: 671 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 730
PVVKL DFD A+PL S HTCCIAH G P+VCVGTP WMAPEVLRAM N YGLEVD
Sbjct: 946 PVVKLSDFDNAIPLHSLSHTCCIAHLGTYPPNVCVGTPCWMAPEVLRAMRDKNQYGLEVD 1005
Query: 731 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSG 789
IWS+GC LLE+LTL++PY GL + EI+DLI K RPRLT ELEA + + + + G
Sbjct: 1006 IWSFGCFLLEMLTLRIPYQGLPDSEIYDLIMRKKQRPRLTQELEAFWTL-DKPITRLELG 1064
Query: 790 FEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 830
+A E L L+D+F +CT+ +ERP A +Y + +
Sbjct: 1065 ITS-DAHAEKLRLLIDLFYQCTKGIASERPKAEAVYNLLCS 1104
|
Source: Oryza sativa Indica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 840 | ||||||
| TAIR|locus:2020220 | 1112 | AT1G04210 [Arabidopsis thalian | 0.969 | 0.732 | 0.548 | 2.1e-235 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.077 | 0.065 | 0.420 | 1.5e-19 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.077 | 0.063 | 0.420 | 1.5e-18 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.104 | 0.1 | 0.320 | 3.2e-15 | |
| TAIR|locus:2076416 | 809 | AT3G58640 [Arabidopsis thalian | 0.238 | 0.247 | 0.243 | 2e-14 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.084 | 0.076 | 0.448 | 4.1e-14 | |
| UNIPROTKB|F5H1S7 | 184 | ULK1 "Serine/threonine-protein | 0.185 | 0.847 | 0.305 | 3.9e-13 | |
| TAIR|locus:2133559 | 608 | MEKK1 "MAPK/ERK kinase kinase | 0.080 | 0.111 | 0.434 | 6.7e-13 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.079 | 0.163 | 0.402 | 8.2e-13 | |
| UNIPROTKB|F1N1A8 | 324 | MKNK1 "MAP kinase-interacting | 0.164 | 0.425 | 0.348 | 8.9e-13 |
| TAIR|locus:2020220 AT1G04210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2270 (804.1 bits), Expect = 2.1e-235, P = 2.1e-235
Identities = 458/835 (54%), Positives = 581/835 (69%)
Query: 1 MDVYEGPMLENDGNVSFSESDAGXXXXXXXXXXXXXXXXXXXXXXXXXKQWKR--HHLQQ 58
MDV+E P EN NV + G K+WKR ++ QQ
Sbjct: 291 MDVFETPY-EN--NV-ITVPHKGSHRNPLNMSTGISSISRCFSARKSSKRWKRRQYYFQQ 346
Query: 59 RARQERLNNSRKWRGEGHAQTSMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQLL 118
RARQERLNNSRKW+GE + + + ++G + + D D++DK L
Sbjct: 347 RARQERLNNSRKWKGEVPPEGLSLKMEVEETGKQGMKVPQNTDRGSVDNSCSDENDK--L 404
Query: 119 SPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECSKHDSSSLSTANGAT 178
EA + + E+++ + +N C + T + N E + +SS S+ +
Sbjct: 405 FEEAS----VITSEEEESSLKADVVSDNSQCVETQLTSERDNYESCEIKTSSPSSGDAPG 460
Query: 179 EQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLP 238
D SSSE K K+KR S++ LDNPK K K + +N S+KYSS SFCS ED LP
Sbjct: 461 TVDYNSSSERKKPNNKSKRCSEKYLDNPKGSKCHKLSTDITNLSRKYSSNSFCSTEDSLP 520
Query: 239 DGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGL 298
DGF+DAGRDRPFM L+ YE+ LDSREVIL+DR DE LDAI LSA+ALV LK+LN L
Sbjct: 521 DGFFDAGRDRPFMTLSKYEKVLPLDSREVILLDRAKDEVLDAITLSARALVARLKKLNCL 580
Query: 299 TKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNS 358
T D +DNLQ+A LALFVSDHFGGSDR+ I+ERTRK VSG+NY+KPF+CTC TGN
Sbjct: 581 TPDVDQVSIDNLQVASFLALFVSDHFGGSDRTAIIERTRKAVSGTNYQKPFICTCLTGNQ 640
Query: 359 DSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLC 418
D KQ+ ED +LSD+CEKSLRSIKSKRNS+VVP+G +QFG+CRHRA+L+KYLC
Sbjct: 641 DDLAALNKQVSTTAEDAILSDVCEKSLRSIKSKRNSIVVPLGKLQFGICRHRALLMKYLC 700
Query: 419 DRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYI 478
DR+EPPVPCELVRGYLDF PHAWN + VK+G SW+RM+VDACRPHDIRE+ D EYF RYI
Sbjct: 701 DRMEPPVPCELVRGYLDFMPHAWNIVPVKQGSSWVRMVVDACRPHDIREDTDQEYFCRYI 760
Query: 479 PLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTL 538
PL R ES L+PG S S + + +SSL RCK GS +A K+RTL
Sbjct: 761 PLNRL-----NESIRIK-EKLEPGCSVSSLSTGKGVERANSSLIRCKLGSTEAVVKMRTL 814
Query: 539 KVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA 598
+V G+S D+IR FEY+CLGEVR+LGAL+H CIVE+YGH+ISSKW+ S +GN EH +LQS+
Sbjct: 815 EVSGASLDDIRTFEYTCLGEVRILGALKHDCIVELYGHEISSKWITSENGN-EHRVLQSS 873
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
I ME++KGGS+K +IEKLSE G+ HV + LAL IA+D++ AL+ELHSK I+HRDIKSEN+
Sbjct: 874 ILMEHIKGGSLKGHIEKLSEAGKHHVPMDLALSIARDISGALMELHSKDIIHRDIKSENV 933
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718
LIDL+ + A+G+P+VKLCDFDRAVPLRS LH CCIAH GIP P++CVGTPRWM+PEV RA
Sbjct: 934 LIDLDNQSANGEPIVKLCDFDRAVPLRSHLHGCCIAHVGIPPPNICVGTPRWMSPEVFRA 993
Query: 719 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 778
MH+ N YGLEVDIWS+GCL+ ELLTLQ PY LSEL+IH+ +Q GKRP+L +LE L S
Sbjct: 994 MHEQNFYGLEVDIWSFGCLIFELLTLQNPYFDLSELQIHESLQNGKRPKLPKKLETLISE 1053
Query: 779 HEHEVAQS--GSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 831
E E + + F+ E++L+T+ FL+DVF +CTEE+P++R AGDL+EM ++R
Sbjct: 1054 TEEEESTNKLSEVFDLTESDLDTMRFLIDVFHQCTEESPSDRLNAGDLHEMILSR 1108
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 127 (49.8 bits), Expect = 1.5e-19, Sum P(5) = 1.5e-19
Identities = 29/69 (42%), Positives = 41/69 (59%)
Query: 387 SIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG--YLDFQPHAWNTI 444
S+K+ S+V+P+GS+ G+ RHRA+L K LCD V VPC +V+G Y A N+I
Sbjct: 282 SLKATLRSMVLPLGSLTIGLARHRALLFKVLCDSVG--VPCRIVKGQQYTGSDDVAMNSI 339
Query: 445 LVKKGDSWI 453
G +I
Sbjct: 340 KTDDGREYI 348
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 126 (49.4 bits), Expect = 1.5e-18, Sum P(4) = 1.5e-18
Identities = 29/69 (42%), Positives = 41/69 (59%)
Query: 387 SIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG--YLDFQPHAWNTI 444
S+K+ S+V+P+GS+ G+ RHRA+L K LCD V VPC +V+G Y + A N I
Sbjct: 306 SLKATLGSMVLPLGSLTIGLARHRALLFKVLCDSVG--VPCRIVKGQQYTGSEDVAMNFI 363
Query: 445 LVKKGDSWI 453
G +I
Sbjct: 364 KADDGREYI 372
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 123 (48.4 bits), Expect = 3.2e-15, Sum P(4) = 3.2e-15
Identities = 33/103 (32%), Positives = 56/103 (54%)
Query: 672 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 731
VVK+CDF L H ++ + GTP WMAPEVLR ++P + D+
Sbjct: 745 VVKVCDFG----LSRMKHHTYLSSKST------AGTPEWMAPEVLR--NEPA--NEKCDV 790
Query: 732 WSYGCLLLELLTLQVPYMGLSELEIHDLIQM-GKRPRLTDELE 773
+S+G +L EL T +VP+ GL+ +++ + +R + D+++
Sbjct: 791 YSFGVILWELATSRVPWKGLNPMQVVGAVGFQNRRLEIPDDID 833
|
|
| TAIR|locus:2076416 AT3G58640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 111 (44.1 bits), Expect = 2.0e-14, Sum P(4) = 2.0e-14
Identities = 54/222 (24%), Positives = 94/222 (42%)
Query: 346 RKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFG 405
+K + +G + T K+I V D+ + +S +S N + +G ++ G
Sbjct: 126 QKQLITKLVSGLNSKPATIIKKIAGLVADVYKQSTLQSPAKSTQSFENCGIQLLGQIKHG 185
Query: 406 VCRHRAVLLKYLCD------RVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDA 459
CR RA+L K L D R+ +P + +D H T+L+ + M+VD
Sbjct: 186 SCRPRAILFKVLADTVGLQSRLVVGLPSDGAAESVDSYSHISVTVLLNS----VEMLVDL 241
Query: 460 CR-PHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPC-SGLDPGS----FPSLSSCDEA 513
R P + + F+ +I + A S +++ C S L+P S +P + A
Sbjct: 242 MRFPGQLIPLSTKAIFMSHI----SAAGESDSAENDSCDSPLEPNSPMFGYPEKFDHENA 297
Query: 514 GKSVSSSLFRCKFGSADAAAKV-RTLKVCGSSADEIRNFEYS 554
K + SL R GS + + R + + +SA E R +S
Sbjct: 298 EKDENLSLHRKLDGSPNTSGPPSRNMLLRSASALE-RKLSFS 338
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 126 (49.4 bits), Expect = 4.1e-14, Sum P(3) = 4.1e-14
Identities = 35/78 (44%), Positives = 45/78 (57%)
Query: 371 AVED--IVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCE 428
+ ED IVL+ EKS K+ N+ V PIG V+ G+ RHRA+L K L D V +PC
Sbjct: 233 SAEDSSIVLARWTEKS-SEFKAALNTCVFPIGFVKIGISRHRALLFKVLADSVR--LPCR 289
Query: 429 LVRG--YLDFQPHAWNTI 444
LV+G Y + A NTI
Sbjct: 290 LVKGSHYTGNEDDAVNTI 307
|
|
| UNIPROTKB|F5H1S7 ULK1 "Serine/threonine-protein kinase ULK1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 184 (69.8 bits), Expect = 3.9e-13, P = 3.9e-13
Identities = 55/180 (30%), Positives = 91/180 (50%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+ MEY GG + +Y+ + E + LF+ Q +A A+ LHSK I+HRD+K +NI
Sbjct: 7 LVMEYCNGGDLADYLHAMRTLSEDTIR----LFL-QQIAGAMRLLHSKGIIHRDLKPQNI 61
Query: 659 LIDLER-KKADGKPV-VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 716
L+ ++A+ + VK+ DF A L+S + A +C G+P +MAPEV+
Sbjct: 62 LLSNPAGRRANPNSIRVKIADFGFARYLQS----------NMMAATLC-GSPMYMAPEVI 110
Query: 717 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR--PRLTDELEA 774
+ H Y + D+WS G ++ + LT + P+ S ++ + K P + E A
Sbjct: 111 MSQH----YDGKADLWSIGTIVYQCLTGKAPFQASSPQDLRLFYEKNKTLVPTIPRETSA 166
|
|
| TAIR|locus:2133559 MEKK1 "MAPK/ERK kinase kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 144 (55.7 bits), Expect = 6.7e-13, Sum P(4) = 6.7e-13
Identities = 30/69 (43%), Positives = 37/69 (53%)
Query: 704 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG 763
C GTP WMAPEV+ YG DIWS GC +LE+ T Q+PY L ++ I G
Sbjct: 489 CKGTPFWMAPEVINRKDSDG-YGSPADIWSLGCTVLEMCTGQIPYSDLEPVQALFRIGRG 547
Query: 764 KRPRLTDEL 772
P + D L
Sbjct: 548 TLPEVPDTL 556
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 125 (49.1 bits), Expect = 8.2e-13, Sum P(4) = 8.2e-13
Identities = 29/72 (40%), Positives = 45/72 (62%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
I EY KGGSV+ + L+ + V +KLA+ A DVA + +H ++ +HRD+KS+N+
Sbjct: 206 IVTEYAKGGSVRQF---LTRRQNRAVPLKLAVKQALDVARGMAYVHGRNFIHRDLKSDNL 262
Query: 659 LIDLER--KKAD 668
LI ++ K AD
Sbjct: 263 LISADKSIKIAD 274
|
|
| UNIPROTKB|F1N1A8 MKNK1 "MAP kinase-interacting serine/threonine-protein kinase 1" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 197 (74.4 bits), Expect = 8.9e-13, P = 8.9e-13
Identities = 54/155 (34%), Positives = 85/155 (54%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+ E ++GGS+ +I+K +KH + + A + +DVAAAL LH+K I HRD+K ENI
Sbjct: 110 LVFEKLQGGSILAHIQK-----QKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENI 164
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV--GTPRWMAPEVL 716
L + K + PV K+CDFD ++ L+ C I P++ G+ +MAPEV+
Sbjct: 165 LCESPEKVS---PV-KICDFDLGSGVK--LNNSCTP---ITTPELTTPCGSAEYMAPEVV 215
Query: 717 RAM-HKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 750
+ Y D+WS G +L +L+ P++G
Sbjct: 216 EVFTDEATFYDKRCDLWSLGVVLYIMLSGYPPFVG 250
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 840 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-40 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-40 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-34 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-32 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-31 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-25 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-21 | |
| pfam14381 | 203 | pfam14381, EDR1, Ethylene-responsive protein kinas | 7e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-17 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-17 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-16 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-15 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-15 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-14 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-10 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-06 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-06 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.001 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.001 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.001 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.002 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 83/282 (29%), Positives = 117/282 (41%), Gaps = 71/282 (25%)
Query: 546 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 605
+I+ L E+++L L+H IV +Y E L + MEY +
Sbjct: 35 KKIKKDRERILREIKILKKLKHPNIVRLYDV-----------FEDEDKLY---LVMEYCE 80
Query: 606 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 665
GG + + ++K +S A F + + +AL LHSK I+HRD+K ENIL+
Sbjct: 81 GGDLFDLLKK-----RGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILL----- 130
Query: 666 KADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 723
D VKL DF R + L T GTP +MAPEVL
Sbjct: 131 --DEDGHVKLADFGLARQLDPGEKLTTFV-------------GTPEYMAPEVLLGKG--- 172
Query: 724 LYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHE 782
YG VDIWS G +L ELLT + P+ G +L E+ I K P E +
Sbjct: 173 -YGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDI-------- 223
Query: 783 VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 824
PEA D+ R+ ++P +R TA +
Sbjct: 224 ---------SPEA--------KDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 7e-40
Identities = 77/281 (27%), Positives = 118/281 (41%), Gaps = 60/281 (21%)
Query: 546 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 605
E + + E+R+L L H IV + A + +H + MEY +
Sbjct: 36 SEKSKKDQTARREIRILRRLSHPNIVRLID----------AFEDKDH----LYLVMEYCE 81
Query: 606 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 665
GG + +Y+ + +S A IA + L LHS I+HRD+K ENIL+
Sbjct: 82 GGDLFDYLSR-----GGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILL----- 131
Query: 666 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 725
D VVK+ DF A + + VGTP +MAPEVL N Y
Sbjct: 132 --DENGVVKIADFGLA----------KKLLKSSSSLTTFVGTPWYMAPEVLL---GGNGY 176
Query: 726 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 785
G +VD+WS G +L ELLT + P+ G + L+ LI+ P L
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL----------------- 219
Query: 786 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
+ E + ++C ++P++RPTA ++ +
Sbjct: 220 EFDEPKWSSGSEEAKDLI----KKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 1e-38
Identities = 65/230 (28%), Positives = 94/230 (40%), Gaps = 46/230 (20%)
Query: 514 GKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV 571
G+ +++ + A K+ + S +E+ E+ +L L H IV
Sbjct: 2 GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLR-------EIEILKKLNHPNIV 54
Query: 572 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALF 631
++YG L + MEY +GGS+K+ +++ E +S L
Sbjct: 55 KLYGVFEDENHL--------------YLVMEYCEGGSLKDLLKEN----EGKLSEDEILR 96
Query: 632 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 691
I + L LHS I+HRD+K ENIL+D VKL DF + L S
Sbjct: 97 ILLQILEGLEYLHSNGIIHRDLKPENILLD------SDNGKVKLADFGLSKLLTSDKSLL 150
Query: 692 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741
VGTP +MAPEVL Y + DIWS G +L EL
Sbjct: 151 K----------TIVGTPAYMAPEVLLGKGY---YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 92/297 (30%), Positives = 131/297 (44%), Gaps = 79/297 (26%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+++++ G S +E+ + E+R+L +L+H IV YG + ++ L
Sbjct: 30 VKSVELSGDSEEELE----ALEREIRILSSLQHPNIVRYYGSERD---------EEKNTL 76
Query: 595 LQSAIFMEYVKGGSVKNYIEK---LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 651
IF+EYV GGS+ + ++K L E + + + L LHS I+HR
Sbjct: 77 N---IFLEYVSGGSLSSLLKKFGKLPEPVIRKY--------TRQILEGLAYLHSNGIVHR 125
Query: 652 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 711
DIK NIL+D +DG VVKL DF A L GTP WM
Sbjct: 126 DIKGANILVD-----SDG--VVKLADFGCAKRLGDIETGEGTGSV--------RGTPYWM 170
Query: 712 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP--RLT 769
APEV+R YG DIWS GC ++E+ T GK P L
Sbjct: 171 APEVIRGE----EYGRAADIWSLGCTVIEMAT-------------------GKPPWSELG 207
Query: 770 DELEALGSCHEHEVAQSGSGFEKPEAEL--ETLSFLVDVFRRCTEENPTERPTAGDL 824
+ + AL +++ SG E PE L E FL R+C +P +RPTA +L
Sbjct: 208 NPMAAL-----YKIGSSGEPPEIPE-HLSEEAKDFL----RKCLRRDPKKRPTADEL 254
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 85/306 (27%), Positives = 126/306 (41%), Gaps = 81/306 (26%)
Query: 523 RCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISS 580
R K + A KV L+ I E+++L +H IV+ YG K
Sbjct: 20 RHKRTGKEVAIKVIKLESKEKKEKIIN--------EIQILKKCKHPNIVKYYGSYLKKDE 71
Query: 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-GEKHVSVKLALFIAQDVAAA 639
W I ME+ GGS+K+ ++ ++T E ++ ++ +++
Sbjct: 72 LW----------------IVMEFCSGGSLKDLLKSTNQTLTESQIA-----YVCKELLKG 110
Query: 640 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP 699
L LHS I+HRDIK+ NIL+ +DG+ VKL DF + L
Sbjct: 111 LEYLHSNGIIHRDIKAANILL-----TSDGE--VKLIDFGLSAQLSD-----------TK 152
Query: 700 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 759
A + VGTP WMAPEV+ Y + DIWS G +EL + PY SEL
Sbjct: 153 ARNTMVGTPYWMAPEVINGKP----YDYKADIWSLGITAIELAEGKPPY---SELPPMKA 205
Query: 760 IQMGKRPRLTDELEALGSCHEHEVAQSGS-GFEKPEAELETLSFLVDVFRRCTEENPTER 818
+ +A +G G P E + F D ++C ++NP +R
Sbjct: 206 LFK--------------------IATNGPPGLRNP--EKWSDEF-KDFLKKCLQKNPEKR 242
Query: 819 PTAGDL 824
PTA L
Sbjct: 243 PTAEQL 248
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 77/297 (25%), Positives = 125/297 (42%), Gaps = 74/297 (24%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+TLK +S +I F L E R++ L H IV++ G + ++ E +
Sbjct: 33 VKTLKE-DASEQQIEEF----LREARIMRKLDHPNIVKLLG--VCTE--------EEPLM 77
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
+ MEY+ GG + +Y L + K +S+ L A +A + L SK+ +HRD+
Sbjct: 78 IV----MEYMPGGDLLDY---LRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLA 130
Query: 655 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 712
+ N L+ VVK+ DF R + + +P RWMA
Sbjct: 131 ARNCLVGENL-------VVKISDFGLSRDLYDDDYYKV---KGGKLPI--------RWMA 172
Query: 713 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 771
PE L+ + + D+WS+G LL E+ TL + PY G+S E+ + ++ G R
Sbjct: 173 PESLKE----GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYR------ 222
Query: 772 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
L +C L + +C E+P +RPT +L E+
Sbjct: 223 LPKPPNCPPE---------------------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 76/297 (25%), Positives = 125/297 (42%), Gaps = 75/297 (25%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+TLK +S +I F L E R++ L H +V++ G + ++ E
Sbjct: 33 VKTLKE-DASEQQIEEF----LREARIMRKLDHPNVVKLLG--VCTE--------EEPLY 77
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
+ MEY++GG + +Y+ K +S+ L A +A + L SK+ +HRD+
Sbjct: 78 IV----MEYMEGGDLLSYLRKN----RPKLSLSDLLSFALQIARGMEYLESKNFIHRDLA 129
Query: 655 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 712
+ N L+ VVK+ DF R + + +P RWMA
Sbjct: 130 ARNCLV-------GENLVVKISDFGLSRDLYDDDYYRK---RGGKLPI--------RWMA 171
Query: 713 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 771
PE L+ + + D+WS+G LL E+ TL + PY G+S E+ + ++ G R
Sbjct: 172 PESLKEGK----FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYR------ 221
Query: 772 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
L +C L D+ +C E+P +RPT +L E+
Sbjct: 222 LPQPPNCPPE---------------------LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 76/297 (25%), Positives = 125/297 (42%), Gaps = 74/297 (24%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+TLK G+S +E F L E ++ L H IV + G + ++ L
Sbjct: 33 VKTLK-EGASEEEREEF----LEEASIMKKLSHPNIVRLLG--VCTQ---------GEPL 76
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
I EY+ GG + +++ K E +++K L +A +A + L SK+ +HRD+
Sbjct: 77 Y---IVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYLESKNFVHRDLA 129
Query: 655 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 712
+ N L+ VVK+ DF R + + G P +WMA
Sbjct: 130 ARNCLV-------TENLVVKISDFGLSRDIYEDDYYR----KRGGGKLP------IKWMA 172
Query: 713 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 771
PE L+ + + D+WS+G LL E+ TL + PY G+S E+ +L++ G R
Sbjct: 173 PESLKDGK----FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYR------ 222
Query: 772 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
L +C + L ++ +C +P +RPT +L E
Sbjct: 223 LPRPENCPDE---------------------LYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 78/286 (27%), Positives = 118/286 (41%), Gaps = 67/286 (23%)
Query: 542 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 601
S E + L EV++L L H I++ Y L I M
Sbjct: 37 NMSEKERED----ALNEVKILKKLNHPNIIKYYESFEEKG-----------KLC---IVM 78
Query: 602 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661
EY GG + I+K + G K + L + AL LHS+ I+HRDIK +NI +
Sbjct: 79 EYADGGDLSQKIKKQKKEG-KPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT 137
Query: 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 721
++G +VKL DF + + T +A VGTP +++PE+ + +K
Sbjct: 138 -----SNG--LVKLGDFGIS---KVLSSTVDLAK-------TVVGTPYYLSPELCQ--NK 178
Query: 722 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH 781
P Y + DIWS GC+L EL TL+ P+ G + LE+ I G+ P +
Sbjct: 179 P--YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI------------- 223
Query: 782 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 827
P L LV +++P ERP+ + +
Sbjct: 224 -----------PSQYSSELRNLVS---SLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 78/274 (28%), Positives = 115/274 (41%), Gaps = 74/274 (27%)
Query: 557 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 616
E+ +L L+H IV+ G + L IF+E V GGS+ ++K
Sbjct: 51 QEIALLSKLQHPNIVQYLGTEREEDNL--------------YIFLELVPGGSLAKLLKKY 96
Query: 617 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 676
E + L+ Q + L LH ++ +HRDIK NIL+D +G VVKL
Sbjct: 97 GSFPEPVIR----LYTRQ-ILLGLEYLHDRNTVHRDIKGANILVD-----TNG--VVKLA 144
Query: 677 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736
DF A + F G+P WMAPEV+ + YGL DIWS GC
Sbjct: 145 DFGMAKQVVEFSFA-----------KSFKGSPYWMAPEVIA---QQGGYGLAADIWSLGC 190
Query: 737 LLLELLTLQVPYMGLSELE----IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 792
+LE+ T + P+ S+LE + + + + P + D L
Sbjct: 191 TVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPIPDHLS------------------- 228
Query: 793 PEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
EA+ D +C + +P+ RPTA +L E
Sbjct: 229 DEAK--------DFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 77/299 (25%), Positives = 127/299 (42%), Gaps = 70/299 (23%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+TLK +S +E ++F L E R++ L H +V + G + ++ E L
Sbjct: 28 VKTLK-EDASEEERKDF----LKEARVMKKLGHPNVVRLLG--VCTE---------EEPL 71
Query: 595 LQSAIFMEYVKGGSVKNYIEK----LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 650
+ +EY++GG + +Y+ K + +S+K L A +A + L SK +H
Sbjct: 72 Y---LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVH 128
Query: 651 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 710
RD+ + N L+ VVK+ DF + + + +P RW
Sbjct: 129 RDLAARNCLV-------GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI--------RW 173
Query: 711 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 769
MAPE L K ++ + D+WS+G LL E+ TL PY GLS E+ + ++ G R
Sbjct: 174 MAPESL----KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL--- 226
Query: 770 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
KPE + L ++ C + +P +RPT +L E
Sbjct: 227 ---------------------PKPEYCPDELY---ELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 72/281 (25%), Positives = 118/281 (41%), Gaps = 88/281 (31%)
Query: 556 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGS----V 609
+ E+ ++ +H IV+ Y + +L+ ++ MEY+ GGS +
Sbjct: 63 INEILIMKDCKHPNIVDYY----------------DSYLVGDELWVVMEYMDGGSLTDII 106
Query: 610 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 669
+++E ++ ++ ++V L LHS++++HRDIKS+NIL+ DG
Sbjct: 107 TQNFVRMNEP---QIA-----YVCREVLQGLEYLHSQNVIHRDIKSDNILLSK-----DG 153
Query: 670 KPVVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 723
VKL DF + R+ + VGTP WMAPEV++
Sbjct: 154 --SVKLADFGFAAQLTKEKSKRNSV----------------VGTPYWMAPEVIKR----K 191
Query: 724 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV 783
YG +VDIWS G + +E+ + PY+ L LI P L +
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNP------------ 239
Query: 784 AQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 824
EK E FL +C ++P +RP+A +L
Sbjct: 240 -------EKWSPEF--KDFL----NKCLVKDPEKRPSAEEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 69/211 (32%), Positives = 92/211 (43%), Gaps = 52/211 (24%)
Query: 554 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 613
S + E+ +L L+H IV+ G +S L I +EY + GS++ I
Sbjct: 45 SIMQEIDLLKNLKHPNIVKYIGSIETSDSL--------------YIILEYAENGSLRQII 90
Query: 614 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 673
+K E V+V ++ Q V L LH + ++HRDIK+ NIL DG VV
Sbjct: 91 KKFGPFPESLVAV----YVYQ-VLQGLAYLHEQGVIHRDIKAANILT-----TKDG--VV 138
Query: 674 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV--DI 731
KL DF A L VGTP WMAPEV+ + G DI
Sbjct: 139 KLADFGVATKLNDVSKD----------DASVVGTPYWMAPEVI------EMSGASTASDI 182
Query: 732 WSYGCLLLELLTLQVPYMGLSELEIHDLIQM 762
WS GC ++ELLT PY +DL M
Sbjct: 183 WSLGCTVIELLTGNPPY--------YDLNPM 205
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 7e-27
Identities = 59/164 (35%), Positives = 81/164 (49%), Gaps = 26/164 (15%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
+EY GG + +++ K E S + A F A ++ AL LHS I++RD+K ENIL+
Sbjct: 72 LEYAPGGELFSHLSK-----EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL 126
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720
D ADG +KL DF A L S + GTP ++APEVL +
Sbjct: 127 D-----ADGH--IKLTDFGLAKELSSEGSRT----------NTFCGTPEYLAPEVL--LG 167
Query: 721 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
K YG VD WS G LL E+LT + P+ EI++ I
Sbjct: 168 KG--YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP 209
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 81/269 (30%), Positives = 120/269 (44%), Gaps = 59/269 (21%)
Query: 557 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 616
E+++L L+H +V+ YG E H + IFMEY GG+ +E+L
Sbjct: 48 DEMKVLELLKHPNLVKYYG--------------VEVHREKVYIFMEYCSGGT----LEEL 89
Query: 617 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 676
E G + ++ Q + L LHS I+HRDIK NI +D +G V+KL
Sbjct: 90 LEHGRILDEHVIRVYTLQ-LLEGLAYLHSHGIVHRDIKPANIFLD-----HNG--VIKLG 141
Query: 677 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736
DF AV L++ +T + GTP +MAPEV+ K +G DIWS GC
Sbjct: 142 DFGCAVKLKN--NTTTMGEEV----QSLAGTPAYMAPEVITG-GKGKGHGRAADIWSLGC 194
Query: 737 LLLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 795
++LE+ T + P+ L +E +I + G +P + D L+
Sbjct: 195 VVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK---------------- 238
Query: 796 ELETLSFLVDVFRRCTEENPTERPTAGDL 824
D RC E +P +RPTA +L
Sbjct: 239 ---------DFLDRCLESDPKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 77/271 (28%), Positives = 115/271 (42%), Gaps = 69/271 (25%)
Query: 557 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK- 615
E+++L L+H IV+ YG + E +IFMEY+ GGSVK+ ++
Sbjct: 53 CEIQLLKNLQHERIVQYYG----------CLRDDET----LSIFMEYMPGGSVKDQLKAY 98
Query: 616 --LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 673
L+ET V+ K I + V LHS I+HRDIK NIL D V
Sbjct: 99 GALTET----VTRKYTRQILEGVEY----LHSNMIVHRDIKGANILRDSAGN-------V 143
Query: 674 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 733
KL DF + L T C + G+ + GTP WM+PEV+ YG + D+WS
Sbjct: 144 KLGDFGAS----KRLQTICSSGTGMKS---VTGTPYWMSPEVISG----EGYGRKADVWS 192
Query: 734 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP 793
GC ++E+LT + P+ + + ++ +P P
Sbjct: 193 VGCTVVEMLTEKPPWAEFEAMAA--IFKIATQP------------------------TNP 226
Query: 794 EAELETLSFLVDVFRRCTEENPTERPTAGDL 824
+ + RR EN +RP+A +L
Sbjct: 227 QLPSHVSPDARNFLRRTFVENAKKRPSAEEL 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 78/269 (28%), Positives = 110/269 (40%), Gaps = 71/269 (26%)
Query: 558 EVRMLGALRHSCIVEMYGH--KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 615
E++ L R I + YG K S W I MEY GGS + + K
Sbjct: 49 EIQFLSQCRSPYITKYYGSFLKGSKLW----------------IIMEYCGGGSCLDLL-K 91
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
+ E +++ FI ++V L LH + +HRDIK+ NIL+ +G VKL
Sbjct: 92 PGKLDETYIA-----FILREVLLGLEYLHEEGKIHRDIKAANILLS-----EEGD--VKL 139
Query: 676 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735
DF + L S ++ R + VGTP WMAPEV+ K + Y + DIWS G
Sbjct: 140 ADFGVSGQLTS-----TMSKR-----NTFVGTPFWMAPEVI----KQSGYDEKADIWSLG 185
Query: 736 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 795
+EL + P L + + LI P L G+ F KP
Sbjct: 186 ITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE-----------------GNKFSKP-- 226
Query: 796 ELETLSFLVDVFRRCTEENPTERPTAGDL 824
D C ++P ERP+A +L
Sbjct: 227 -------FKDFVSLCLNKDPKERPSAKEL 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 66/219 (30%), Positives = 93/219 (42%), Gaps = 45/219 (20%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
EV +L L+H IV Y I + + L I MEY +GG + I+K
Sbjct: 49 EVNILRELKHPNIVRYYDRII----------DRSNQTLY--IVMEYCEGGDLAQLIQKCK 96
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELH-----SKHIMHRDIKSENILIDLERKKADGKPV 672
+ + + + I + AL E H ++HRD+K NI +D
Sbjct: 97 KERKY-IEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD-------ANNN 148
Query: 673 VKLCDFDRAVPL---RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 729
VKL DF A L SF T VGTP +M+PE L M Y +
Sbjct: 149 VKLGDFGLAKILGHDSSFAKTY-------------VGTPYYMSPEQLNHMS----YDEKS 191
Query: 730 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 768
DIWS GCL+ EL L P+ ++L++ I+ GK R+
Sbjct: 192 DIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI 230
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 76/293 (25%), Positives = 108/293 (36%), Gaps = 43/293 (14%)
Query: 549 RNFEYSCLGEVRMLGALRH-SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG 607
L E+++L +L H IV++Y + MEYV GG
Sbjct: 38 SKEVERFLREIQILASLNHPPNIVKLYDFFQDEG--------------SLYLVMEYVDGG 83
Query: 608 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667
S+++ ++K+ G +S ALFI + +AL LHSK I+HRDIK ENIL+D + +
Sbjct: 84 SLEDLLKKIGRKGP--LSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRV- 140
Query: 668 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 727
VKL DF L L P VGTP +MAPEVL +
Sbjct: 141 -----VKLIDF----GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAY-ASS 190
Query: 728 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG 787
DIWS G L ELLT P+ G T L
Sbjct: 191 SSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL--------------- 235
Query: 788 SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSISSRS 840
+ P D+ ++ ++P R ++ + S
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDL 288
|
Length = 384 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 71/229 (31%), Positives = 95/229 (41%), Gaps = 52/229 (22%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
I MEY +GGSV+ + K EK++SV I ++V AL +H ++HRDIK+ NI
Sbjct: 79 IIMEYAEGGSVRT-LMKAGPIAEKYISV-----IIREVLVALKYIHKVGVIHRDIKAANI 132
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718
L+ VKLCDF A L VGTP WMAPEV+
Sbjct: 133 LVTNTGN-------VKLCDFGVAALLNQ----------NSSKRSTFVGTPYWMAPEVIT- 174
Query: 719 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 778
+ Y + DIWS G + E+ T PY + LI K PRL D
Sbjct: 175 --EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDN------- 225
Query: 779 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 827
G+ K L + C +E P ER +A +L +
Sbjct: 226 ----------GYSK---------LLREFVAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 4e-22
Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 43/210 (20%)
Query: 555 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 614
L E R+L ++RH +V +YG L +L+ MEYV GG + +++
Sbjct: 48 VLNEKRILQSIRHPFLVNLYGSFQDDSNL---------YLV-----MEYVPGGELFSHLR 93
Query: 615 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 674
K E A F A V AL LHS I++RD+K EN+L+D +DG +K
Sbjct: 94 KSGRFPEPV-----ARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD-----SDGY--IK 141
Query: 675 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 734
+ DF A ++ +T C GTP ++APE++ K YG VD W+
Sbjct: 142 ITDFGFAKRVKGRTYTLC-------------GTPEYLAPEIIL--SKG--YGKAVDWWAL 184
Query: 735 GCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
G L+ E+L P+ + ++I++ I GK
Sbjct: 185 GILIYEMLAGYPPFFDDNPIQIYEKILEGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 76/272 (27%), Positives = 107/272 (39%), Gaps = 67/272 (24%)
Query: 557 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 616
E+ ML RH IV +G + L I MEY GGS+++ +
Sbjct: 49 QEISMLKECRHPNIVAYFGSYLRRDKL--------------WIVMEYCGGGSLQDIYQVT 94
Query: 617 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 676
+S ++ ++ L LH +HRDIK NIL+ DG VKL
Sbjct: 95 RG----PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL-----TEDGD--VKLA 143
Query: 677 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736
DF + L T IA R +GTP WMAPEV A+ + Y + DIW+ G
Sbjct: 144 DFGVSAQL-----TATIAKR-----KSFIGTPYWMAPEVA-AVERKGGYDGKCDIWALGI 192
Query: 737 LLLELLTLQVPYMGLSELEIHDLIQMGKR----PRLTDELEALGSCHEHEVAQSGSGFEK 792
+EL LQ P L + L + K P+L D+
Sbjct: 193 TAIELAELQPPMFDLHPMRA--LFLISKSNFPPPKLKDK--------------------- 229
Query: 793 PEAELETLSFLVDVFRRCTEENPTERPTAGDL 824
E + F D ++C ++P +RPTA L
Sbjct: 230 ---EKWSPVF-HDFIKKCLTKDPKKRPTATKL 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 75/302 (24%), Positives = 113/302 (37%), Gaps = 70/302 (23%)
Query: 531 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGN 589
A K+ + + +EI+ E +L H I YG I N
Sbjct: 34 VAIKI--MDIIEDEEEEIKE-------EYNILRKYSNHPNIATFYGAFIKK--------N 76
Query: 590 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAALVELHS 645
P + Q + ME GGSV + ++ L + G E+ ++ +I ++ L LH
Sbjct: 77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA-----YILRETLRGLAYLHE 131
Query: 646 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV 705
++HRDIK +NIL+ K A+ VKL DF + L S L + +
Sbjct: 132 NKVIHRDIKGQNILLT---KNAE----VKLVDFGVSAQLDSTLG----------RRNTFI 174
Query: 706 GTPRWMAPEVLRAMHKPNL-YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
GTP WMAPEV+ +P+ Y D+WS G +EL + P + + I
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP 234
Query: 765 RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 824
P L E + F D C +N +RP +L
Sbjct: 235 PPTLK------------------------SPENWSKKF-NDFISECLIKNYEQRPFMEEL 269
Query: 825 YE 826
E
Sbjct: 270 LE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (234), Expect = 5e-21
Identities = 60/217 (27%), Positives = 91/217 (41%), Gaps = 57/217 (26%)
Query: 554 SCLGEVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSV 609
+ L E+ +L L+H IV++ H +L +F + +
Sbjct: 44 TALREISLLKELKHPNIVKLLDVIHTERKLYL---------------VFEYCDM----DL 84
Query: 610 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 669
K Y++K +S L I + L HS I+HRD+K +NILI +
Sbjct: 85 KKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI-------NR 133
Query: 670 KPVVKLCDFD--RA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 725
V+KL DF RA +PLR++ H V T + APE+L Y
Sbjct: 134 DGVLKLADFGLARAFGIPLRTYTHE--------------VVTLWYRAPEILLGSKH---Y 176
Query: 726 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 762
VDIWS GC+ E++T + + G S EI L ++
Sbjct: 177 STAVDIWSVGCIFAEMITGKPLFPGDS--EIDQLFKI 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 5e-21
Identities = 75/269 (27%), Positives = 118/269 (43%), Gaps = 70/269 (26%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 615
EV ++ +H IVEMY +L+ ++ ME+++GG++ + +
Sbjct: 66 EVVIMRDYQHPNIVEMYSS----------------YLVGDELWVVMEFLEGGALTDIVTH 109
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
E+ +V LA V AL LH++ ++HRDIKS++IL+ +DG VKL
Sbjct: 110 TRMNEEQIATVCLA------VLKALSFLHAQGVIHRDIKSDSILL-----TSDG--RVKL 156
Query: 676 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735
DF F C + +P VGTP WMAPEV+ + YG EVDIWS G
Sbjct: 157 SDF-------GF---CAQVSKEVPRRKSLVGTPYWMAPEVISRL----PYGTEVDIWSLG 202
Query: 736 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 795
+++E++ + PY L+ I+ P+L + H+V+ F
Sbjct: 203 IMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK---------NLHKVSPRLRSF----- 248
Query: 796 ELETLSFLVDVFRRCTEENPTERPTAGDL 824
R +P +R TA +L
Sbjct: 249 -----------LDRMLVRDPAQRATAAEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|222722 pfam14381, EDR1, Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 7e-21
Identities = 69/255 (27%), Positives = 93/255 (36%), Gaps = 75/255 (29%)
Query: 219 SNASQKYSSVSFCSIEDRLPDGFYD---------AGRDRPFMQLTGYEQTPHLD-SREVI 268
S +Y S +D++PDGFYD L + P D S EV+
Sbjct: 5 EALSHRYWVYGCLSYDDKIPDGFYDIYGMDPCSDLKEFGRIPSLEDLQAVPPGDSSFEVV 64
Query: 269 LVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSD 328
LVDR++D +L + A+ LV + + LA VSDH GG
Sbjct: 65 LVDRRTDPKLKELEQLARCLVSGC-------------GTNTAALVQKLAGLVSDHMGGP- 110
Query: 329 RSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSI 388
V + S L S
Sbjct: 111 -----------VKDAE---------------------------------SMLARWKECSN 126
Query: 389 KSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG--YLDFQPHAWNTILV 446
+ K NS VVP+GS++ G+CRHRA+L K L D + +PC LV+G Y A N LV
Sbjct: 127 ELKENSGVVPLGSLKIGLCRHRALLFKVLADSIG--LPCRLVKGCKYCGSDDDASN--LV 182
Query: 447 KKGDSWIRMIVDACR 461
K D +VD
Sbjct: 183 KFDDG-REYLVDLMG 196
|
EDR1 regulates disease resistance and ethylene-induced senescence, and is also involved in stress response signalling and cell death regulation. Length = 203 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 7e-21
Identities = 51/171 (29%), Positives = 76/171 (44%), Gaps = 26/171 (15%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
+EY G + YI K + K F A ++ AL LHSK I+HRD+K ENIL+
Sbjct: 81 LEYAPNGELLQYIRKYGS-----LDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL 135
Query: 661 DLERKKADGKPVVKLCDFDRA-------VPLRSFLHTCCIAHRGIPAPDVC---VGTPRW 710
D D +K+ DF A P + I + VGT +
Sbjct: 136 D-----KDMH--IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEY 188
Query: 711 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 761
++PE+L KP G D+W+ GC++ ++LT + P+ G +E I
Sbjct: 189 VSPELLN--EKP--AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 82/308 (26%), Positives = 136/308 (44%), Gaps = 74/308 (24%)
Query: 531 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY-GHKISSK-WLPSADG 588
AAAK+ ++ S +E+ +F + E+ +L +H IV +Y + +K W
Sbjct: 33 AAAKIIQIE----SEEELEDF----MVEIDILSECKHPNIVGLYEAYFYENKLW------ 78
Query: 589 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHI 648
I +E+ GG++ + + +L E+ ++ ++ + + AL LHS +
Sbjct: 79 ----------ILIEFCDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHSHKV 124
Query: 649 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 708
+HRD+K+ NIL+ L+ VKL DF + +S L D +GTP
Sbjct: 125 IHRDLKAGNILLTLDGD-------VKLADFGVSAKNKSTLQK----------RDTFIGTP 167
Query: 709 RWMAPEVLRA-MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPR 767
WMAPEV+ K N Y + DIWS G L+EL ++ P+ L+ + + I + P
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPT 227
Query: 768 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 827
L Q S + SF D + C ++P +RPTA +L +
Sbjct: 228 L---------------DQP-SKWSS--------SF-NDFLKSCLVKDPDDRPTAAELLKH 262
Query: 828 -FVARTSS 834
FV+ S
Sbjct: 263 PFVSDQSD 270
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 68/268 (25%), Positives = 104/268 (38%), Gaps = 66/268 (24%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+ +L IV+ YG + L I MEY GSV + ++ +
Sbjct: 48 EISILKQCDSPYIVKYYGSYFKNT-----------DLW---IVMEYCGAGSVSDIMKITN 93
Query: 618 ET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 676
+T E+ ++ I L LHS +HRDIK+ NIL++ +G KL
Sbjct: 94 KTLTEEEIAA-----ILYQTLKGLEYLHSNKKIHRDIKAGNILLN-----EEG--QAKLA 141
Query: 677 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736
DF + L + A R +GTP WMAPEV+ + Y + DIWS G
Sbjct: 142 DFGVSGQLTDTM-----AKRN-----TVIGTPFWMAPEVI----QEIGYNNKADIWSLGI 187
Query: 737 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 796
+E+ + PY +IH + + P + PE
Sbjct: 188 TAIEMAEGKPPYS-----DIHPMRAIFMIPN-----------------KPPPTLSDPE-- 223
Query: 797 LETLSFLVDVFRRCTEENPTERPTAGDL 824
+ D ++C ++P ERP+A L
Sbjct: 224 -KWSPEFNDFVKKCLVKDPEERPSAIQL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 77/285 (27%), Positives = 117/285 (41%), Gaps = 90/285 (31%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+ L L H IV+ G E +IF+EYV GGS+ + +
Sbjct: 58 EIETLKDLDHLNIVQYLGF--------------ETTEEYLSIFLEYVPGGSIGSCLRTYG 103
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
E+ V F + V L LHSK I+HRD+K++N+L+D ADG + K+ D
Sbjct: 104 RFEEQLVR-----FFTEQVLEGLAYLHSKGILHRDLKADNLLVD-----ADG--ICKISD 151
Query: 678 F------------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 725
F D+ + ++ G+ WMAPEV+ + + Y
Sbjct: 152 FGISKKSDDIYDNDQNMSMQ--------------------GSVFWMAPEVIHSYSQG--Y 189
Query: 726 GLEVDIWSYGCLLLELLTLQVPYMGLSELE-IHDLIQMG---KRPRLTDELEALGSCHEH 781
+VDIWS GC++LE+ + P+ S+ E I + ++G P + ++ S
Sbjct: 190 SAKVDIWSLGCVVLEMFAGRRPW---SDEEAIAAMFKLGNKRSAPPIPPDVSMNLS---- 242
Query: 782 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
P A L FL C NP RPTA +L +
Sbjct: 243 -----------PVA----LDFL----NACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 76/321 (23%), Positives = 125/321 (38%), Gaps = 69/321 (21%)
Query: 511 DEAGKSVSSSLFR--CKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS 568
+ G ++ ++ C + A K L+ C +S DE+R EV+ + H
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRK-------EVQAMSQCNHP 59
Query: 569 CIVEMYGHKI--SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE-KLSETGEKHVS 625
+V+ Y + W + M Y+ GGS+ + ++ G
Sbjct: 60 NVVKYYTSFVVGDELW----------------LVMPYLSGGSLLDIMKSSYPRGGLDEAI 103
Query: 626 VKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 685
+ + ++V L LHS +HRDIK+ NIL+ DG VK+ DF +
Sbjct: 104 IA---TVLKEVLKGLEYLHSNGQIHRDIKAGNILLG-----EDGS--VKIADFGVSA--- 150
Query: 686 SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 745
S + VGTP WMAPEV M + + Y + DIWS+G +EL T
Sbjct: 151 SLADGGDRTRK---VRKTFVGTPCWMAPEV---MEQVHGYDFKADIWSFGITAIELATGA 204
Query: 746 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 805
PY +++ L P L + + F K ++
Sbjct: 205 APYSKYPPMKVLMLTLQNDPPSLE---------TGADYKKYSKSFRK----------MIS 245
Query: 806 VFRRCTEENPTERPTAGDLYE 826
C +++P++RPTA +L +
Sbjct: 246 ---LCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 5e-20
Identities = 75/278 (26%), Positives = 122/278 (43%), Gaps = 67/278 (24%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
EV ++ +H +VEMY + + L + ME+++GG++ + + +
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEEL--------------WVLMEFLQGGALTDIVSQTR 113
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
E+ +V + V AL LHS+ ++HRDIKS++IL+ L DG+ VKL D
Sbjct: 114 LNEEQIATV------CESVLQALCYLHSQGVIHRDIKSDSILLTL-----DGR--VKLSD 160
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F C + +P VGTP WMAPEV+ YG EVDIWS G +
Sbjct: 161 FG----------FCAQISKDVPKRKSLVGTPYWMAPEVI----SRTPYGTEVDIWSLGIM 206
Query: 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 797
++E++ + PY S ++ ++ P+L + H+++
Sbjct: 207 VIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN---------AHKIS------------- 244
Query: 798 ETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSS 834
L D R P ER TA +L + F+ +T
Sbjct: 245 ---PVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 73/290 (25%), Positives = 116/290 (40%), Gaps = 58/290 (20%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+ + +++ E + E+R++ L H I+ M G A H
Sbjct: 30 VKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLG----------ATCEDSHF- 78
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
+F+E++ GGSV + + K E V + + + L LH I+HRD+K
Sbjct: 79 ---NLFVEWMAGGSVSHLLSKYGAFKEA-VIINYTEQLLR----GLSYLHENQIIHRDVK 130
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714
N+LID + G+ +++ DF A L + T +G +GT +MAPE
Sbjct: 131 GANLLID-----STGQ-RLRIADFGAAARLAAKG-TGAGEFQG-----QLLGTIAFMAPE 178
Query: 715 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEA 774
VLR YG D+WS GC+++E+ T K P ++
Sbjct: 179 VLRGEQ----YGRSCDVWSVGCVIIEMAT-------------------AKPPWNAEKH-- 213
Query: 775 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 824
S H + + S P L DV RC E P +RP + +L
Sbjct: 214 --SNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 74/234 (31%), Positives = 110/234 (47%), Gaps = 46/234 (19%)
Query: 541 CGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF 600
++ E+ E C E+++L LRH IV+ YG +PE L +IF
Sbjct: 41 SQETSKEVNALE--C--EIQLLKNLRHDRIVQYYG----------CLRDPEEKKL--SIF 84
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
+EY+ GGS+K+ ++ E V+ + I Q V+ LHS I+HRDIK NIL
Sbjct: 85 VEYMPGGSIKDQLKAYGALTEN-VTRRYTRQILQGVSY----LHSNMIVHRDIKGANIL- 138
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720
D VKL DF + + T C++ GI + GTP WM+PEV+
Sbjct: 139 ------RDSAGNVKLGDFGAS----KRIQTICMSGTGIKS---VTGTPYWMSPEVISG-- 183
Query: 721 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE----IHDLIQMGKRPRLTD 770
YG + D+WS C ++E+LT + P+ +E E I + +P L D
Sbjct: 184 --EGYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPMLPD 232
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 61/207 (29%), Positives = 88/207 (42%), Gaps = 37/207 (17%)
Query: 555 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 614
CL E+ +L L H +++ I + L I +E G + I+
Sbjct: 49 CLKEIDLLKQLDHPNVIKYLASFIENNEL--------------NIVLELADAGDLSRMIK 94
Query: 615 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 674
+ + + Q + +AL +HSK IMHRDIK N+ I A G VVK
Sbjct: 95 HFKKQKRLIPERTIWKYFVQ-LCSALEHMHSKRIMHRDIKPANVFIT-----ATG--VVK 146
Query: 675 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 734
L D R F AH VGTP +M+PE + N Y + DIWS
Sbjct: 147 LGDLGLG---RFFSSKTTAAHS-------LVGTPYYMSPERIHE----NGYNFKSDIWSL 192
Query: 735 GCLLLELLTLQVPYMGLSELEIHDLIQ 761
GCLL E+ LQ P+ G ++ ++ L +
Sbjct: 193 GCLLYEMAALQSPFYG-DKMNLYSLCK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 71/227 (31%), Positives = 104/227 (45%), Gaps = 38/227 (16%)
Query: 531 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 590
A +V V SS D R+ + E+ +L L+H IV+ G + + L
Sbjct: 29 AVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL------- 81
Query: 591 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 650
IF+EYV GGSV + E V F+ Q + L LH++ I+H
Sbjct: 82 -------NIFLEYVPGGSVAALLNNYGAFEETLVRN----FVRQ-ILKGLNYLHNRGIIH 129
Query: 651 RDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 708
RDIK NIL+D K +K+ DF + + S L T R P + G+
Sbjct: 130 RDIKGANILVD-------NKGGIKISDFGISKKLEANS-LSTKTNGAR----PSL-QGSV 176
Query: 709 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 755
WMAPEV+ K Y + DIWS GCL++E+LT + P+ ++L+
Sbjct: 177 FWMAPEVV----KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 9e-19
Identities = 57/168 (33%), Positives = 80/168 (47%), Gaps = 22/168 (13%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+ MEY+ GG + + +E + E ++IA+ + AL LHS I+HRD+K +NI
Sbjct: 70 LVMEYLPGGDLASLLENVGSLDEDVA----RIYIAE-IVLALEYLHSNGIIHRDLKPDNI 124
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSF-LHTCCIAHRGIPAPDV-CVGTPRWMAPEVL 716
LID ++G +KL DF L L I D VGTP ++APEV+
Sbjct: 125 LID-----SNGH--LKLTDFG----LSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 717 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
+ VD WS GC+L E L P+ G + EI I GK
Sbjct: 174 LGQG----HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK 217
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 74/267 (27%), Positives = 118/267 (44%), Gaps = 66/267 (24%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
EV ++ +H +VEMY + L + ME+++GG++ + +
Sbjct: 67 EVVIMRDYQHENVVEMYNSYLVGDEL--------------WVVMEFLEGGALTDIVTHTR 112
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
E+ +V LA V AL LH++ ++HRDIKS++IL+ DG+ VKL D
Sbjct: 113 MNEEQIAAVCLA------VLKALSVLHAQGVIHRDIKSDSILL-----THDGR--VKLSD 159
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F C + +P VGTP WMAPE++ + YG EVDIWS G +
Sbjct: 160 FG----------FCAQVSKEVPRRKSLVGTPYWMAPELISRLP----YGPEVDIWSLGIM 205
Query: 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 797
++E++ + PY L+ +I+ P+L + H+V+ S GF
Sbjct: 206 VIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKN---------LHKVSPSLKGF------- 249
Query: 798 ETLSFLVDVFRRCTEENPTERPTAGDL 824
R +P +R TA +L
Sbjct: 250 ---------LDRLLVRDPAQRATAAEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 65/191 (34%), Positives = 93/191 (48%), Gaps = 35/191 (18%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+++L L H IV+ YG E L +IFME++ GGS+K+ ++
Sbjct: 54 EIQLLKNLLHERIVQYYG---------CLRDPMERTL---SIFMEHMPGGSIKDQLKSYG 101
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
E V+ K I + V+ LHS I+HRDIK NIL D VKL D
Sbjct: 102 ALTEN-VTRKYTRQILEGVSY----LHSNMIVHRDIKGANIL-------RDSVGNVKLGD 149
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F + L T C++ G+ + GTP WM+PEV+ YG + DIWS GC
Sbjct: 150 FGAS----KRLQTICLSGTGMKS---VTGTPYWMSPEVISG----EGYGRKADIWSVGCT 198
Query: 738 LLELLTLQVPY 748
++E+LT + P+
Sbjct: 199 VVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 65/276 (23%), Positives = 111/276 (40%), Gaps = 67/276 (24%)
Query: 553 YSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 612
L E+ +L L+H I+ Y H + L I MEY GG
Sbjct: 44 RDALNEIVILSLLQHPNIIAYYNHFMDDNTL--------------LIEMEYANGG---TL 86
Query: 613 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 672
+K+ + ++ L+ + +A+ +H I+HRDIK+ NI + KA +
Sbjct: 87 YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT----KAG---L 139
Query: 673 VKLCDFDRAVPLRS-FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 731
+KL DF + L S + + VGTP +M+PE+ + + Y + DI
Sbjct: 140 IKLGDFGISKILGSEYSMA-----------ETVVGTPYYMSPELCQGVK----YNFKSDI 184
Query: 732 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 791
W+ GC+L ELLTL+ + + L + I G + V+ S
Sbjct: 185 WALGCVLYELLTLKRTFDATNPLNLVVKIVQGN--------------YTPVVSVYSSE-- 228
Query: 792 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 827
L+ + +++P +RPTA ++ +
Sbjct: 229 -----------LISLVHSLLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 80/297 (26%), Positives = 126/297 (42%), Gaps = 63/297 (21%)
Query: 544 SADEIRNFEYSCLGEVRMLGALRHSCIVEMY-GHKISSKWLPSADGNPEHHLLQSAIFME 602
++++ + L EV++L LRH IV + + + +L+ E
Sbjct: 39 DDEDVKK---TALREVKVLRQLRHENIVNLKEAFRRKGRL----------YLV-----FE 80
Query: 603 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662
YV ++ +E S G +V+ ++ + A+ HS +I+HRDIK ENIL+
Sbjct: 81 YV-ERTLLELLEA-SPGGLPPDAVRSYIW---QLLQAIAYCHSHNIIHRDIKPENILVSE 135
Query: 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHK 721
V+KLCDF A LR+ R V T RW APE+L
Sbjct: 136 SG-------VLKLCDFGFARALRA---------RPASPLTDYVAT-RWYRAPELLV---G 175
Query: 722 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ--MGKRPRLTDELEALGSCH 779
YG VD+W+ GC++ ELL + + G S+++ LIQ +G P EL
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF------ 229
Query: 780 EHEVAQSGSGFEKPEAELETL---------SFLVDVFRRCTEENPTERPTAGDLYEM 827
+G F +P + E+L S +D + C +P ER T +L +
Sbjct: 230 SSNPRFAGVAFPEPS-QPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 6e-18
Identities = 65/191 (34%), Positives = 92/191 (48%), Gaps = 35/191 (18%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+++L L+H IV+ YG E L IFMEY+ GGSVK+ ++
Sbjct: 54 EIQLLKNLQHERIVQYYG---------CLRDRAEKTL---TIFMEYMPGGSVKDQLKAYG 101
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
E V+ K + + + LHS I+HRDIK NIL D VKL D
Sbjct: 102 ALTES-VTRKYT----RQILEGMSYLHSNMIVHRDIKGANIL-------RDSAGNVKLGD 149
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F + L T C++ GI + GTP WM+PEV+ YG + D+WS GC
Sbjct: 150 FGAS----KRLQTICMSGTGIRS---VTGTPYWMSPEVISG----EGYGRKADVWSLGCT 198
Query: 738 LLELLTLQVPY 748
++E+LT + P+
Sbjct: 199 VVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 7e-18
Identities = 55/172 (31%), Positives = 89/172 (51%), Gaps = 27/172 (15%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+ ME+++GG++ + + E+ +V L+ V AL LH++ ++HRDIKS++I
Sbjct: 96 VVMEFLEGGALTDIVTHTRMNEEQIATVCLS------VLRALSYLHNQGVIHRDIKSDSI 149
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718
L+ +DG+ +KL DF C + +P VGTP WMAPEV+
Sbjct: 150 LL-----TSDGR--IKLSDFG----------FCAQVSKEVPKRKSLVGTPYWMAPEVISR 192
Query: 719 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 770
+ YG EVDIWS G +++E++ + PY L+ I+ PR+ D
Sbjct: 193 LP----YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKD 240
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 58/217 (26%), Positives = 87/217 (40%), Gaps = 45/217 (20%)
Query: 546 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 605
+RN L E R+L L H +V ++ + + E+ L ++ +
Sbjct: 42 GSVRNV----LNERRILQELNHPFLVNLW----------YSFQDEENMYL----VVDLLL 83
Query: 606 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 665
GG ++ ++ + + E+ V F ++ AL LHSK I+HRDIK +NIL+D
Sbjct: 84 GGDLRYHLSQKVKFSEEQVK-----FWICEIVLALEYLHSKGIIHRDIKPDNILLD---- 134
Query: 666 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 725
G V + DF+ A GTP +MAPEVL Y
Sbjct: 135 -EQGH--VHITDFNIA----------TKVTPDTLTTSTS-GTPGYMAPEVLCR----QGY 176
Query: 726 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 762
+ VD WS G E L + PY G S +
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK 213
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 53/162 (32%), Positives = 74/162 (45%), Gaps = 29/162 (17%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
MEY GG + + E A F V A LH++ I++RD+K EN+L+
Sbjct: 72 MEYCLGGELWTILRDRGLFDEYT-----ARFYIACVVLAFEYLHNRGIIYRDLKPENLLL 126
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720
D ++G VKL DF A L+S T GTP ++APE++
Sbjct: 127 D-----SNG--YVKLVDFGFAKKLKSGQKTWTF-----------CGTPEYVAPEIILNKG 168
Query: 721 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE--LEIHDLI 760
Y VD WS G LL ELLT + P+ E +EI++ I
Sbjct: 169 ----YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI 206
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 59/184 (32%), Positives = 80/184 (43%), Gaps = 38/184 (20%)
Query: 591 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 650
E HL + MEY+ GG + N + + E+ A F ++ AL +H +H
Sbjct: 73 EEHLY---LVMEYMPGGDLMNLLIRKDVFPEET-----ARFYIAELVLALDSVHKLGFIH 124
Query: 651 RDIKSENILIDLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPA 700
RDIK +NILID ADG +KL DF DR L + + +
Sbjct: 125 RDIKPDNILID-----ADGH--IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 701 PD---------VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL 751
D VGTP ++APEVLR YGLE D WS G +L E+L P+
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTP----YGLECDWWSLGVILYEMLYGFPPFYSD 233
Query: 752 SELE 755
+ E
Sbjct: 234 TLQE 237
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 43/207 (20%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E R+L + H I+ ++ + + L + MEYV GG + +Y+
Sbjct: 51 EKRVLKEVSHPFIIRLF-----------WTEHDQRFLY---MLMEYVPGGELFSYLR--- 93
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
S LF A ++ AL LHSK I++RD+K ENIL+D +G +KL D
Sbjct: 94 --NSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD-----KEGH--IKLTD 144
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F A LR T C GTP ++APEV+++ + VD W+ G L
Sbjct: 145 FGFAKKLRDRTWTLC-------------GTPEYLAPEVIQSKG----HNKAVDWWALGIL 187
Query: 738 LLELLTLQVPYMGLSELEIHDLIQMGK 764
+ E+L P+ + I++ I GK
Sbjct: 188 IYEMLVGYPPFFDDNPFGIYEKILAGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 38/215 (17%)
Query: 554 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 613
+ E+R+L ++ H I+ + DGN + I MEY G + I
Sbjct: 45 DAVNEIRILASVNHPNIISYKEAFL--------DGN------KLCIVMEYAPFGDLSKAI 90
Query: 614 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 673
K + K + + I + L LH + I+HRD+KS NIL+ +V
Sbjct: 91 SKRKKKR-KLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL------VAND-LV 142
Query: 674 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 733
K+ D + L+ + I GTP +MAPEV + +P Y + DIWS
Sbjct: 143 KIGDLGISKVLKKNMAKTQI------------GTPHYMAPEVWKG--RP--YSYKSDIWS 186
Query: 734 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 768
GCLL E+ T P+ S ++ +Q GK P +
Sbjct: 187 LGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI 221
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 67/204 (32%), Positives = 97/204 (47%), Gaps = 42/204 (20%)
Query: 599 IFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657
+ MEY+ GGS+ + + E + G+ + ++ AL LHS ++HRDIKS+N
Sbjct: 93 VVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQALEFLHSNQVIHRDIKSDN 145
Query: 658 ILIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714
IL+ + DG VKL DF + P +S T VGTP WMAPE
Sbjct: 146 ILLGM-----DGS--VKLTDFGFCAQITPEQSKRST-------------MVGTPYWMAPE 185
Query: 715 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT--DEL 772
V+ YG +VDIWS G + +E++ + PY+ + L LI P L ++L
Sbjct: 186 VVTRKA----YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241
Query: 773 EA-----LGSCHEHEVAQSGSGFE 791
A L C E +V + GS E
Sbjct: 242 SAIFRDFLNRCLEMDVEKRGSAKE 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 50/165 (30%), Positives = 75/165 (45%), Gaps = 32/165 (19%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
MEYV GG + +I++ E A F A ++ L LH + I++RD+K +N+L+
Sbjct: 75 MEYVNGGDLMFHIQRSGRFDEPR-----ARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL 129
Query: 661 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717
D ++G +K+ DF + T C GTP ++APE+L
Sbjct: 130 D-----SEGH--IKIADFGMCKEGILGGVTTSTFC-------------GTPDYIAPEILS 169
Query: 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 762
YG VD W+ G LL E+L Q P+ G E E+ I
Sbjct: 170 YQ----PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 61/238 (25%), Positives = 98/238 (41%), Gaps = 70/238 (29%)
Query: 598 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSE 656
+I +EY+ GGS+ + ++K+ + E ++ +IA+ + L LH+K HI+HRDIK
Sbjct: 75 SIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLHTKRHIIHRDIKPS 129
Query: 657 NILIDLERKKADGKPVVKLCDF-------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 709
N+LI+ K VK+ DF + +F VGT
Sbjct: 130 NLLINS-------KGEVKIADFGISKVLENTLDQCNTF-----------------VGTVT 165
Query: 710 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL---IQMGKRP 766
+M+PE ++ Y DIWS G LLE + P++ + +L I G P
Sbjct: 166 YMSPERIQGES----YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP 221
Query: 767 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 824
L E E E F+ C +++P +RP+A +L
Sbjct: 222 SLPAE----------------------EFSPEFRDFI----SACLQKDPKKRPSAAEL 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 66/227 (29%), Positives = 102/227 (44%), Gaps = 52/227 (22%)
Query: 524 CKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583
C+ + ++ + V + DE + E ++L L H I+E Y + + K L
Sbjct: 19 CRRKADQKLVIIKQIPVEQMTKDE----RLAAQNECQVLKLLSHPNIIEYYENFLEDKAL 74
Query: 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK-----LSETGEKHVSVKLALFIAQDVAA 638
I MEY GG++ YI+K L E H V++ L
Sbjct: 75 --------------MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILL-------- 112
Query: 639 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 698
AL +H+K I+HRD+K++NIL+D + K VVK+ DF + L S
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLD--KHKM----VVKIGDFGISKILSS-----------K 155
Query: 699 PAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 745
VGTP +++PE+ KP Y + DIW+ GC+L EL +L+
Sbjct: 156 SKAYTVVGTPCYISPELCEG--KP--YNQKSDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 4e-17
Identities = 54/158 (34%), Positives = 85/158 (53%), Gaps = 30/158 (18%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
MEYV GG + +I+++ + E H A+F A ++A L LHSK I++RD+K +N+++
Sbjct: 80 MEYVNGGDLMYHIQQVGKFKEPH-----AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVLRA 718
D A+G +K+ DF C + G C GTP ++APE++
Sbjct: 135 D-----AEGH--IKIADFGM-----------CKENIFGGKTTRTFC-GTPDYIAPEII-- 173
Query: 719 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEI 756
++P YG VD W++G LL E+L Q P+ G E E+
Sbjct: 174 AYQP--YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 70/283 (24%), Positives = 106/283 (37%), Gaps = 77/283 (27%)
Query: 556 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYI 613
L E ++ +L H ++ +YG +L + M E GS+ +
Sbjct: 44 LKEAAIMHSLDHENLIRLYGV-----------------VLTHPLMMVTELAPLGSL---L 83
Query: 614 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 673
++L + H + A +A + L SK +HRD+ + NIL+ + K V
Sbjct: 84 DRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK-------V 136
Query: 674 KLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM---HKPNLYGLE 728
K+ DF RA+P H H +P W APE LR H
Sbjct: 137 KIGDFGLMRALPQNE-DHYVMEEHLKVPFA--------WCAPESLRTRTFSHAS------ 181
Query: 729 VDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG 787
D+W +G L E+ T + P+ GLS +I I E E L
Sbjct: 182 -DVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID--------KEGERL------------ 220
Query: 788 SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 830
E+PEA + + +V +C NP +RPT L E
Sbjct: 221 ---ERPEACPQD---IYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 72/235 (30%), Positives = 101/235 (42%), Gaps = 52/235 (22%)
Query: 598 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657
I MEY +GGS+ + +K+ + G + + K+ IA+ V L LHS+ I+HRDIK N
Sbjct: 77 GIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSN 135
Query: 658 ILIDLERKKADGKPVVKLCDFDRAVPL-RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 716
IL+ K VKLCDF + L S T GT +MAPE
Sbjct: 136 ILLTR-------KGQVKLCDFGVSGELVNSLAGT-------------FTGTSFYMAPE-- 173
Query: 717 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY-----MGLSELEIHDLIQMGKRPRLTDE 771
R KP Y + D+WS G LLE+ + P+ L +E+ I P L DE
Sbjct: 174 RIQGKP--YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE 231
Query: 772 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
P ++ D ++C E++PT RPT D+ E
Sbjct: 232 ---------------------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 84/320 (26%), Positives = 127/320 (39%), Gaps = 67/320 (20%)
Query: 511 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYS--CLGEVRMLGALRHS 568
DE G+ V L + +G AA + T R+ Y E+ + L+H
Sbjct: 8 DENGERVV--LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 569 CIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKL 628
IV+ G + + IFME V GGS+ + S+ G + +
Sbjct: 66 NIVQYLGSDSENGFF--------------KIFMEQVPGGSLSALLR--SKWGPLKDNEQT 109
Query: 629 ALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFL 688
+F + + L LH I+HRDIK +N+L++ VVK+ DF
Sbjct: 110 IIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSG------VVKISDFG--------- 154
Query: 689 HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 748
T P + GT ++MAPEV+ P YG DIWS GC ++E+ T + P+
Sbjct: 155 -TSKRLAGINPCTETFTGTLQYMAPEVID--KGPRGYGAPADIWSLGCTIVEMATGKPPF 211
Query: 749 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL-ETLSFLVDVF 807
I++G E + A G K E+ E+LS F
Sbjct: 212 -----------IELG----------------EPQAAMFKVGMFKIHPEIPESLSAEAKNF 244
Query: 808 -RRCTEENPTERPTAGDLYE 826
RC E +P +R +A DL +
Sbjct: 245 ILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 9e-17
Identities = 55/174 (31%), Positives = 78/174 (44%), Gaps = 33/174 (18%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
MEYV GG + + L E H A F ++ A+ LH +HRD+K EN LI
Sbjct: 80 MEYVPGGDFRTLLNNLGVLSEDH-----ARFYMAEMFEAVDALHELGYIHRDLKPENFLI 134
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720
D A G +KL DF + + ++ ++ VG+P +MAPEVLR
Sbjct: 135 D-----ASGH--IKLTDFGLSKGIVTYANS-------------VVGSPDYMAPEVLRGKG 174
Query: 721 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI----QMGKRPRLTD 770
Y VD WS GC+L E L P+ G + E + + + +RP D
Sbjct: 175 ----YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD 224
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 66/235 (28%), Positives = 96/235 (40%), Gaps = 59/235 (25%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSEN 657
I MEY+ GGS ++K+ + + + ++ IA V L LH KH I+HRD+K N
Sbjct: 76 ICMEYMDGGS----LDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSN 131
Query: 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717
IL++ + G+ +KLCDF + L +A VGT +MAPE ++
Sbjct: 132 ILVN-----SRGQ--IKLCDFGVSGQL-----VNSLA-------KTFVGTSSYMAPERIQ 172
Query: 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG-----LSELEIHDLIQMGKRPRLTDEL 772
N Y ++ DIWS G L+EL T + PY E+ I PRL
Sbjct: 173 ----GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP--- 225
Query: 773 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 827
F D C ++P ERP+ +L E
Sbjct: 226 --------------SGKFSPD---------FQDFVNLCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 54/162 (33%), Positives = 83/162 (51%), Gaps = 30/162 (18%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
MEYV GG + I+++ E H A+F A ++A L LHSK I++RD+K +N+++
Sbjct: 80 MEYVNGGDLMYQIQQVGRFKEPH-----AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVLRA 718
D E +K+ DF C + G+ C GTP ++APE++
Sbjct: 135 DSEGH-------IKIADFGM-----------CKENMWDGVTTKTFC-GTPDYIAPEIIA- 174
Query: 719 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 760
++P YG VD W++G LL E+L Q P+ G E E+ I
Sbjct: 175 -YQP--YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 63/297 (21%)
Query: 527 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 586
GS V+TL+ G++ E + F L E ++ H IV++ G
Sbjct: 23 GSGPIRVAVKTLRK-GATDQEKKEF----LKEAHLMSNFNHPNIVKLLG--------VCL 69
Query: 587 DGNPEHHLLQSAIFMEYVKGGSVKNYIE--KLSETGEKHVSVKLALFIAQDVAAALVELH 644
P++ I ME ++GG + +Y+ ++ G +++K L I DVA V L
Sbjct: 70 LNEPQY------IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE 123
Query: 645 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC 704
H +HRD+ + N L+ K D VVK+ DF A + + +P
Sbjct: 124 QMHFIHRDLAARNCLV--SEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV---- 177
Query: 705 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMG 763
RWMAPE L + + D+WS+G L+ E+LTL Q PY L+ E+ + G
Sbjct: 178 ----RWMAPESL----LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG 229
Query: 764 KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820
R L+ +C + + + C ++P+ERPT
Sbjct: 230 GR------LQKPENCPDK---------------------IYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-16
Identities = 52/162 (32%), Positives = 83/162 (51%), Gaps = 30/162 (18%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
MEYV GG + +I+++ + E A+F A +++ L LH + I++RD+K +N+++
Sbjct: 80 MEYVNGGDLMYHIQQVGKFKEPQ-----AVFYAAEISVGLFFLHRRGIIYRDLKLDNVML 134
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVLRA 718
D E +K+ DF C H G+ C GTP ++APE++
Sbjct: 135 DSEGH-------IKIADFGM-----------CKEHMVDGVTTRTFC-GTPDYIAPEII-- 173
Query: 719 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 760
++P YG VD W+YG LL E+L Q P+ G E E+ I
Sbjct: 174 AYQP--YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 556 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 615
L E +L H IV++ G P + I ME V GGS+ ++ K
Sbjct: 40 LQEAEILKQYDHPNIVKLIG--------VCVQKQPIY------IVMELVPGGSLLTFLRK 85
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
+ ++VK L ++ D AA + L SK+ +HRD+ + N L+ V+K+
Sbjct: 86 ----KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-------VLKI 134
Query: 676 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735
DF + ++T + IP +W APE L Y E D+WSYG
Sbjct: 135 SDFGMSREEEGGIYTVSDGLKQIPI--------KWTAPEALNY----GRYTSESDVWSYG 182
Query: 736 CLLLELLTL-QVPYMGLSELEIHDLIQMGKR---PRLTDE 771
LL E +L PY G+S + + I+ G R P+L E
Sbjct: 183 ILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPE 222
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 40/203 (19%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+ MEY+ GGS+ + + +ET + + ++ AL LH+ ++HRDIKS+N+
Sbjct: 93 VVMEYLAGGSLTDVV---TETCMDEAQIAA---VCRECLQALEFLHANQVIHRDIKSDNV 146
Query: 659 LIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 715
L+ ++ VKL DF + P +S T VGTP WMAPEV
Sbjct: 147 LLGMDGS-------VKLTDFGFCAQITPEQSKRST-------------MVGTPYWMAPEV 186
Query: 716 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE---- 771
+ YG +VDIWS G + +E++ + PY+ + L LI P L +
Sbjct: 187 VTR----KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242
Query: 772 ---LEALGSCHEHEVAQSGSGFE 791
+ L C E +V + GS E
Sbjct: 243 PIFRDFLNRCLEMDVEKRGSAKE 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 53/162 (32%), Positives = 74/162 (45%), Gaps = 26/162 (16%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
MEY+ GG + +I+ E A F A ++ L LH K I++RD+K +N+L+
Sbjct: 75 MEYLNGGDLMFHIQSSGRFDEAR-----ARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL 129
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720
D DG +K+ DF C G GTP ++APE+L
Sbjct: 130 D-----KDGH--IKIADFG----------MCKENMNGEGKASTFCGTPDYIAPEIL---- 168
Query: 721 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 762
K Y VD WS+G LL E+L Q P+ G E E+ D I
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 2e-15
Identities = 71/234 (30%), Positives = 107/234 (45%), Gaps = 49/234 (20%)
Query: 599 IFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657
+ MEY+ GGS+ + + E + G+ + ++ AL LHS ++HRDIKS+N
Sbjct: 94 VVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQALEFLHSNQVIHRDIKSDN 146
Query: 658 ILIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714
IL+ + DG VKL DF + P +S VGTP WMAPE
Sbjct: 147 ILLGM-----DGS--VKLTDFGFCAQITPEQS-------------KRSTMVGTPYWMAPE 186
Query: 715 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT--DEL 772
V+ YG +VDIWS G + +E++ + PY+ + L LI P L ++L
Sbjct: 187 VVTR----KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242
Query: 773 EA-----LGSCHEHEVAQSGSG-------FEKPEAELETLSFLVDVFRRCTEEN 814
A L C + +V + GS F K L +L+ L+ + T+ N
Sbjct: 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKNN 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 72/272 (26%), Positives = 104/272 (38%), Gaps = 69/272 (25%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
EV +L +L+H IV+ G + + +IFME+V GGS+ + + +
Sbjct: 52 EVDLLKSLKHVNIVQYLGTCLDDNTI--------------SIFMEFVPGGSISSILNRFG 97
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
E V K I VA LH+ ++HRDIK N+++ +G ++KL D
Sbjct: 98 PLPEP-VFCKYTKQILDGVAY----LHNNCVVHRDIKGNNVML-----MPNG--IIKLID 145
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCV---GTPRWMAPEVLRAMHKPNLYGLEVDIWSY 734
F A L ++ GTP WMAPEV+ YG + DIWS
Sbjct: 146 FGCARRL-------AWVGLHGTHSNMLKSMHGTPYWMAPEVINESG----YGRKSDIWSI 194
Query: 735 GCLLLELLTLQVPYMGLSELEIHDLI--QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 792
GC + E+ T + P + L I G PRL D A
Sbjct: 195 GCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA---------------- 238
Query: 793 PEAELETLSFLVDVFRRCTEENPTERPTAGDL 824
+D C + ERP+A L
Sbjct: 239 -----------IDFVTSCLTRDQHERPSALQL 259
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 73/244 (29%), Positives = 106/244 (43%), Gaps = 44/244 (18%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+ M+ +H IV +G +S + L I MEY GGS+++
Sbjct: 56 EIFMVKECKHCNIVAYFGSYLSREKL--------------WICMEYCGGGSLQDIYHVTG 101
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
E ++ ++ ++ L LHSK MHRDIK NIL+ D VKL D
Sbjct: 102 PLSELQIA-----YVCRETLQGLAYLHSKGKMHRDIKGANILLT---DNGD----VKLAD 149
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F A + T IA R +GTP WMAPEV A+ K Y DIW+ G
Sbjct: 150 FGVAAKI-----TATIAKR-----KSFIGTPYWMAPEV-AAVEKNGGYNQLCDIWAVGIT 198
Query: 738 LLELLTLQVPYMGLSELEIHDLIQMGKR----PRLTDELEALGSCHEH-EVAQSGSGFEK 792
+EL LQ P L + L M K P+L D+ + + H +++ + + ++
Sbjct: 199 AIELAELQPPMFDLHPMRA--LFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKR 256
Query: 793 PEAE 796
P AE
Sbjct: 257 PTAE 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 53/162 (32%), Positives = 78/162 (48%), Gaps = 30/162 (18%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
ME+V GG + +I+K E A F A ++ +AL+ LH K I++RD+K +N+L+
Sbjct: 75 MEFVNGGDLMFHIQKSRRFDEAR-----ARFYAAEITSALMFLHDKGIIYRDLKLDNVLL 129
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA--HRGIPAPDVCVGTPRWMAPEVLRA 718
D E KL DF C G C GTP ++APE+L+
Sbjct: 130 DHEGH-------CKLADFGM-----------CKEGIFNGKTTSTFC-GTPDYIAPEILQE 170
Query: 719 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 760
M LYG VD W+ G LL E+L P+ +E ++ + I
Sbjct: 171 M----LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-15
Identities = 70/245 (28%), Positives = 101/245 (41%), Gaps = 51/245 (20%)
Query: 529 ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK------- 581
AA K+ L++ D I+ GEV+++ RH ++Y K+ SK
Sbjct: 29 EKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLV---RHKSSKQVYAMKLLSKFEMIKRS 85
Query: 582 -----WLPS---ADGNPE-----HHLLQSA----IFMEYVKGGSVKNYIEKLSETGEKHV 624
W A N E H+ Q + MEY+ GG + N +
Sbjct: 86 DSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNL------MSNYDI 139
Query: 625 SVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 684
K A F +V AL +HS +HRD+K +N+L+D G +KL DF
Sbjct: 140 PEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-----KSGH--LKLADFG----- 187
Query: 685 RSFLHTCCIAHR-GIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743
TC G+ D VGTP +++PEVL++ YG E D WS G L E+L
Sbjct: 188 -----TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 242
Query: 744 LQVPY 748
P+
Sbjct: 243 GDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 64/277 (23%), Positives = 108/277 (38%), Gaps = 58/277 (20%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+ +L L H IV+ G + G L+ MEY+ GS+++Y+++
Sbjct: 56 EIEILRTLDHENIVKYKG-------VCEKPGGRSLRLI-----MEYLPSGSLRDYLQRHR 103
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
+ +++K L + + + L S+ +HRD+ + NIL++ E VK+ D
Sbjct: 104 D----QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL-------VKISD 152
Query: 678 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735
F + +P + P W APE LR + + D+WS+G
Sbjct: 153 FGLAKVLPEDKDYYY-VKEPGESPI--------FWYAPECLRT----SKFSSASDVWSFG 199
Query: 736 CLLLELLTL----QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 791
L EL T Q P + QM +T LE L + G
Sbjct: 200 VTLYELFTYGDPSQSPPAEFLRMIGIAQGQM----IVTRLLELL---------KEGERLP 246
Query: 792 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
+P + + D+ + C E P +RP+ DL +
Sbjct: 247 RPPS---CPDEVYDLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 3e-15
Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 42/204 (20%)
Query: 599 IFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657
+ MEY+ GGS+ + + E + G+ + ++ AL LHS ++HRDIKS+N
Sbjct: 93 VVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQALDFLHSNQVIHRDIKSDN 145
Query: 658 ILIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714
IL+ + DG VKL DF + P +S T VGTP WMAPE
Sbjct: 146 ILLGM-----DGS--VKLTDFGFCAQITPEQSKRST-------------MVGTPYWMAPE 185
Query: 715 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT--DEL 772
V+ YG +VDIWS G + +E++ + PY+ + L LI P L + L
Sbjct: 186 VVTR----KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241
Query: 773 EA-----LGSCHEHEVAQSGSGFE 791
A L C E +V + GS E
Sbjct: 242 SAVFRDFLNRCLEMDVDRRGSAKE 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 7e-15
Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 59/270 (21%)
Query: 504 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLG 563
FP+L K++ + L R K D K+R L++ + ++ GEV+++
Sbjct: 12 FPAL----RKNKNIDNFLNRYK----DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLV- 62
Query: 564 ALRHSCIVEMYGHKISSKW--LPSADGN---PEHHLLQSA-------------------I 599
RH ++Y K+ SK+ + +D E ++ A +
Sbjct: 63 --RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120
Query: 600 FMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659
MEY+ GG + N + V K A F +V AL +HS +HRD+K +N+L
Sbjct: 121 VMEYMPGGDLVNLMSNYD------VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 174
Query: 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR-GIPAPDVCVGTPRWMAPEVLRA 718
+D +KL DF TC ++ G+ D VGTP +++PEVL++
Sbjct: 175 LDKSGH-------LKLADFG----------TCMKMNKEGMVRCDTAVGTPDYISPEVLKS 217
Query: 719 MHKPNLYGLEVDIWSYGCLLLELLTLQVPY 748
YG E D WS G L E+L P+
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 63/311 (20%), Positives = 115/311 (36%), Gaps = 71/311 (22%)
Query: 523 RCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582
G + ++T+ S E F L E ++ +V + G + S
Sbjct: 29 GVVKGEPETRVAIKTVNENASM-RERIEF----LNEASVMKEFNCHHVVRLLG--VVST- 80
Query: 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH-----VSVKLALFIAQDVA 637
G P + + ME + G +K+Y+ E + +++ + +A ++A
Sbjct: 81 -----GQP------TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 638 AALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG 697
+ L +K +HRD+ + N ++ + VK+ DF + +
Sbjct: 130 DGMAYLAAKKFVHRDLAARNCMVAEDL-------TVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 698 IPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEI 756
+P RWMAPE L K ++ + D+WS+G +L E+ TL + PY GLS E+
Sbjct: 183 LPV--------RWMAPESL----KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV 230
Query: 757 HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816
+ G L + L+++ R C + NP
Sbjct: 231 LKFVIDGGHLDLPENCP---------------------------DKLLELMRMCWQYNPK 263
Query: 817 ERPTAGDLYEM 827
RPT ++
Sbjct: 264 MRPTFLEIVSS 274
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 58/215 (26%), Positives = 86/215 (40%), Gaps = 57/215 (26%)
Query: 632 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 691
I + L +H HRD+K EN+L+ G VVK+ DF A +RS
Sbjct: 104 IIYQILQGLAHIHKHGFFHRDLKPENLLV-------SGPEVVKIADFGLAREIRS----- 151
Query: 692 CIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 750
P V T RW APE+L + + Y VDIW+ GC++ EL TL+ + G
Sbjct: 152 ------RPPYTDYVST-RWYRAPEIL--LRSTS-YSSPVDIWALGCIMAELYTLRPLFPG 201
Query: 751 LSELEIHDLIQMGKRPRLTDEL----EALGSCHE------HEVAQSGSGFEKPEAE---L 797
SE D+L LG+ + +++A GF P+ L
Sbjct: 202 SSE---------------IDQLYKICSVLGTPTKQDWPEGYKLASK-LGFRFPQFAPTSL 245
Query: 798 ETL-----SFLVDVFRRCTEENPTERPTAGDLYEM 827
L +D+ + +P +RPTA +
Sbjct: 246 HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 60/213 (28%), Positives = 86/213 (40%), Gaps = 56/213 (26%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE--- 614
E+++L LRH IV + S + +I+M V Y++
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKG--------------KGSIYM-------VFEYMDHDL 86
Query: 615 -KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 673
L ++ E + + + L LHS I+HRDIK NILI+ DG V+
Sbjct: 87 TGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN-----NDG--VL 139
Query: 674 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG-TPR----WM-APEVLRAMHKPNLYGL 727
KL DF A R + T R W PE+L + YG
Sbjct: 140 KLADFGLA---RPY------------TKRNSADYTNRVITLWYRPPELL--LGATR-YGP 181
Query: 728 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 760
EVD+WS GC+L EL + + G +ELE + I
Sbjct: 182 EVDMWSVGCILAELFLGKPIFQGSTELEQLEKI 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 66/206 (32%), Positives = 92/206 (44%), Gaps = 54/206 (26%)
Query: 639 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 698
L LHS I+HRD+K N+LI +DG V+KL DF A RSF
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIA-----SDG--VLKLADFGLA---RSF----------- 152
Query: 699 PAPDVCVGTP----RWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM-GLS 752
+P+ T RW APE+L YG+ VD+WS GC+ ELL L+VP++ G S
Sbjct: 153 GSPNR-KMTHQVVTRWYRAPELLFG---ARHYGVGVDMWSVGCIFAELL-LRVPFLPGDS 207
Query: 753 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ-----SGSGFEK-PEAELETL-----S 801
+++ Q+GK EALG+ E F+ P L+ +
Sbjct: 208 DID-----QLGKI------FEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASD 256
Query: 802 FLVDVFRRCTEENPTERPTAGDLYEM 827
+D+ +R NP +R TA E
Sbjct: 257 DALDLLQRLLTLNPNKRITARQALEH 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 51/162 (31%), Positives = 75/162 (46%), Gaps = 26/162 (16%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
MEY+ GG + +I+ + + A F A ++ L LHSK I++RD+K +NIL+
Sbjct: 75 MEYLNGGDLMFHIQSCHK-----FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL 129
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720
D + +K+ DF C G GTP ++APE+L
Sbjct: 130 DTDGH-------IKIADFG----------MCKENMLGDAKTCTFCGTPDYIAPEILLGQK 172
Query: 721 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 762
Y VD WS+G LL E+L Q P+ G E E+ I+M
Sbjct: 173 ----YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-14
Identities = 65/240 (27%), Positives = 103/240 (42%), Gaps = 51/240 (21%)
Query: 534 KVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW--LPSADGN-- 589
K+R L++ D ++ GEV+++ RH ++Y K+ SK+ + +D
Sbjct: 34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLV---RHKSSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 590 -PEHHLLQSA-------------------IFMEYVKGGSVKNYIEKLSETGEKHVSVKLA 629
E ++ A + MEY+ GG + N + V K A
Sbjct: 91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD------VPEKWA 144
Query: 630 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 689
F +V AL +HS ++HRD+K +N+L+D +KL DF
Sbjct: 145 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH-------LKLADFG---------- 187
Query: 690 TCC-IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 748
TC + G+ D VGTP +++PEVL++ YG E D WS G L E+L P+
Sbjct: 188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 78/285 (27%), Positives = 125/285 (43%), Gaps = 68/285 (23%)
Query: 558 EVRMLGALRHSCIV---EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 614
E+RML LRH +V E++ K + +L+ E+V +V + +E
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRK--KRL----------YLV-----FEFVDH-TVLDDLE 91
Query: 615 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 674
K G V+ LF + + HS +I+HRDIK ENIL+ VVK
Sbjct: 92 KY-PNGLDESRVRKYLF---QILRGIEFCHSHNIIHRDIKPENILVSQSG-------VVK 140
Query: 675 LCDFDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 732
LCDF A L + ++T +A R AP++ VG + YG VDIW
Sbjct: 141 LCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK---------------YGRAVDIW 185
Query: 733 SYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS--GSGF 790
+ GCL+ E+LT + + G S++ D + + L L H+ ++ +G
Sbjct: 186 AVGCLVTEMLTGEPLFPGDSDI---DQLY-----HIIKCLGNLIPRHQEIFQKNPLFAGM 237
Query: 791 EKPEA-ELETL--------SFLVDVFRRCTEENPTERPTAGDLYE 826
PE E+E L ++D+ ++C +P +RP++ L
Sbjct: 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 59/193 (30%), Positives = 91/193 (47%), Gaps = 37/193 (19%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
EV +L ++H IV + A L I MEY GG + I +
Sbjct: 49 EVILLAKMKHPNIVTFF-----------ASFQENGRLF---IVMEYCDGGDLMKRINR-- 92
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
+ G ++ + Q ++ L +H + I+HRDIKS+NI + +G V KL D
Sbjct: 93 QRGVLFSEDQILSWFVQ-ISLGLKHIHDRKILHRDIKSQNIFL-----SKNGM-VAKLGD 145
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F A R + +A+ CVGTP +++PE+ + ++P Y + DIWS GC+
Sbjct: 146 FGIA---RQLNDSMELAY-------TCVGTPYYLSPEICQ--NRP--YNNKTDIWSLGCV 191
Query: 738 LLELLTLQVPYMG 750
L EL TL+ P+ G
Sbjct: 192 LYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 60/236 (25%), Positives = 95/236 (40%), Gaps = 57/236 (24%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
I ME V+GG ++ T + VK + + ++ AA + L SKH +HRD+ + N
Sbjct: 70 IVMELVQGGDFLTFLR----TEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNC 125
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718
L+ K V+K+ DF + ++ + IP +W APE L
Sbjct: 126 LV-------TEKNVLKISDFGMSREEEDGVYASTGGMKQIPV--------KWTAPEALNY 170
Query: 719 MHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 777
Y E D+WS+G LL E +L VPY LS + + I+ G R L
Sbjct: 171 ----GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR------LPCPEL 220
Query: 778 CHEHEVAQSGSGFEKPEAELETLSFLVDVFR---RCTEENPTERPTAGDLYEMFVA 830
C + V+R RC E +P +RP+ +++ +
Sbjct: 221 CPD------------------------AVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 73/278 (26%), Positives = 119/278 (42%), Gaps = 73/278 (26%)
Query: 556 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 615
L E +++ LRH +V++Y + S + P + I EY+ GS+ ++++
Sbjct: 49 LQEAQIMKKLRHDKLVQLYA--VCS------EEEPIY------IVTEYMSKGSLLDFLK- 93
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
S G+K +L AQ +A + L S++ +HRD+ + NIL+ V K+
Sbjct: 94 -SGEGKKLRLPQLVDMAAQ-IAEGMAYLESRNYIHRDLAARNILV-------GENLVCKI 144
Query: 676 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIW 732
DF A R A G P +W APE YG ++ D+W
Sbjct: 145 ADFGLA---RLIEDDEYTAREGAKFP------IKWTAPEAA-------NYGRFTIKSDVW 188
Query: 733 SYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGF 790
S+G LL E++T +VPY G++ E+ + ++ G R PR + C
Sbjct: 189 SFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPN-------C------------ 229
Query: 791 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
PE L D+ +C +++P ERPT L
Sbjct: 230 --PEE-------LYDLMLQCWDKDPEERPTFEYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 8e-14
Identities = 82/311 (26%), Positives = 135/311 (43%), Gaps = 70/311 (22%)
Query: 531 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 590
AAAKV K S +E+ ++ + E+ +L H IV++ G + W DG
Sbjct: 40 AAAKVIETK----SEEELEDY----MVEIEILATCNHPYIVKLLG---AFYW----DG-- 82
Query: 591 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 650
+ I +E+ GG+V + +L + G +++ I + + AL LHS I+H
Sbjct: 83 -----KLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQV---ICRQMLEALQYLHSMKIIH 133
Query: 651 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 710
RD+K+ N+L+ L DG +KL DF V ++ + + D +GTP W
Sbjct: 134 RDLKAGNVLLTL-----DGD--IKLADF--GVSAKNV--------KTLQRRDSFIGTPYW 176
Query: 711 MAPEVLRA-MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT 769
MAPEV+ K Y + DIWS G L+E+ ++ P+ L+ + + I + P L+
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLS 236
Query: 770 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-F 828
K E D + +++P RP+A L E F
Sbjct: 237 QP-------------------SKWSMEFR------DFLKTALDKHPETRPSAAQLLEHPF 271
Query: 829 VARTSSSISSR 839
V+ +S+ R
Sbjct: 272 VSSVTSNRPLR 282
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 62/256 (24%), Positives = 101/256 (39%), Gaps = 35/256 (13%)
Query: 514 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 573
G +++ + A ++ + V G +EI+ E+ ML H +
Sbjct: 15 GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ-------EINMLKKYSHHRNIAT 67
Query: 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 633
Y K P D Q + ME+ GSV + I+ T + + +I
Sbjct: 68 YYGAFIKKNPPGMDD-------QLWLVMEFCGAGSVTDLIKN---TKGNTLKEEWIAYIC 117
Query: 634 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 693
+++ L LH ++HRDIK +N+L+ + VKL DF + L
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAE-------VKLVDFGVSAQL--------- 161
Query: 694 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPN-LYGLEVDIWSYGCLLLELLTLQVPYMGLS 752
R + + +GTP WMAPEV+ P+ Y + D+WS G +E+ P +
Sbjct: 162 -DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220
Query: 753 ELEIHDLIQMGKRPRL 768
+ LI PRL
Sbjct: 221 PMRALFLIPRNPAPRL 236
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 25/174 (14%)
Query: 592 HHLLQSAIF----MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 647
H+ Q M+Y GG + + K E + +A F ++ A+ +H
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 648 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 707
+HRDIK +N+L+D ++L DF + L + G +V VGT
Sbjct: 123 YVHRDIKPDNVLLDKNGH-------IRLADFGSCLRLLA---------DGTVQSNVAVGT 166
Query: 708 PRWMAPEVLRAMHK-PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 760
P +++PE+L+AM YG E D WS G + E+L + P+ S +E + I
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 65/231 (28%), Positives = 100/231 (43%), Gaps = 50/231 (21%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENIL 659
ME++ GS+ +K + V++ IA V L L++ H IMHRDIK NIL
Sbjct: 82 MEFMDCGSLDRIYKKGGP-----IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNIL 136
Query: 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 719
+ + + +KLCDF + L + IA D VGT +M+PE ++
Sbjct: 137 V-------NSRGQIKLCDFGVSGELIN-----SIA-------DTFVGTSTYMSPERIQG- 176
Query: 720 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 779
K Y ++ D+WS G ++EL + P+ + + MG L+ L
Sbjct: 177 GK---YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI-------LDLL---- 222
Query: 780 EHEVAQSGSGFEKPEAELETLSF---LVDVFRRCTEENPTERPTAGDLYEM 827
++ Q +P L + F L D C ++PTERPT L M
Sbjct: 223 -QQIVQ------EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 71/244 (29%), Positives = 106/244 (43%), Gaps = 44/244 (18%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+ M+ +HS IV +G + L I ME+ GGS+++
Sbjct: 56 EIIMMKDCKHSNIVAYFGSYLRRDKL--------------WICMEFCGGGSLQDIYHVTG 101
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
E ++ +++++ L LHSK MHRDIK NIL+ VKL D
Sbjct: 102 PLSESQIA-----YVSRETLQGLYYLHSKGKMHRDIKGANILL-------TDNGHVKLAD 149
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F + + T IA R +GTP WMAPEV A+ + Y DIW+ G
Sbjct: 150 FGVSAQI-----TATIAKR-----KSFIGTPYWMAPEV-AAVERKGGYNQLCDIWAVGIT 198
Query: 738 LLELLTLQVPYMGLSELEIHDLIQMGKR----PRLTDELEALGSCHEH-EVAQSGSGFEK 792
+EL LQ P L + L M K P+L D+++ S H ++A + + ++
Sbjct: 199 AIELAELQPPMFDLHPMRA--LFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKR 256
Query: 793 PEAE 796
P AE
Sbjct: 257 PTAE 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 61/238 (25%), Positives = 96/238 (40%), Gaps = 37/238 (15%)
Query: 533 AKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPE 591
A ++ + V +EI+ E+ ML H I YG I +P
Sbjct: 44 AAIKVMDVTEDEEEEIKL-------EINMLKKYSHHRNIATYYGAFIKK--------SPP 88
Query: 592 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 651
H Q + ME+ GSV + ++ K + +I +++ L LH+ ++HR
Sbjct: 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA---YICREILRGLAHLHAHKVIHR 145
Query: 652 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 711
DIK +N+L+ + VKL DF + L R + + +GTP WM
Sbjct: 146 DIKGQNVLLTENAE-------VKLVDFGVSAQL----------DRTVGRRNTFIGTPYWM 188
Query: 712 APEVLRAMHKPN-LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 768
APEV+ P+ Y DIWS G +E+ P + + LI P+L
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 35/203 (17%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+ M+Y GG + + K E + +A F ++ A+ +H H +HRDIK +NI
Sbjct: 78 LVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 133
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718
L+D+ ++L DF + L G V VGTP +++PE+L+A
Sbjct: 134 LMDMNGH-------IRLADFGSCLKL---------MEDGTVQSSVAVGTPDYISPEILQA 177
Query: 719 MHK-PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL--------- 768
M YG E D WS G + E+L + P+ S +E + I M + R
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI-MNHKERFQFPAQVTDV 236
Query: 769 ----TDELEALGSCHEHEVAQSG 787
D + L EH + Q+G
Sbjct: 237 SEDAKDLIRRLICSREHRLGQNG 259
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 57/208 (27%), Positives = 85/208 (40%), Gaps = 55/208 (26%)
Query: 556 LGEVRMLGALRHSCIV---EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 612
L E+++L L H I+ +++ HK L + E++
Sbjct: 46 LREIKLLKELNHPNIIKLLDVFRHK--------------GDL---YLVFEFMDTD----- 83
Query: 613 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 672
+ KL + ++ + L + L HS I+HRD+K EN+LI +G V
Sbjct: 84 LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI-----NTEG--V 136
Query: 673 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP----RWM-APEVLRAMHKPNLYGL 727
+KL DF A RSF V T RW APE+L Y
Sbjct: 137 LKLADFGLA---RSF------------GSPVRPYTHYVVTRWYRAPELLLGD---KGYST 178
Query: 728 EVDIWSYGCLLLELLTLQVPYMGLSELE 755
VDIWS GC+ ELL+ + + G SE++
Sbjct: 179 PVDIWSVGCIFAELLSRRPLFPGKSEID 206
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 61/275 (22%), Positives = 97/275 (35%), Gaps = 75/275 (27%)
Query: 555 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 614
+ E R+L L S I+ Y + L I MEY + G + ++
Sbjct: 46 AIDEARVLAKLDSSYIIRYYESFLDKGKL--------------NIVMEYAENGDLHKLLK 91
Query: 615 K-----LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 669
L E +++ L L LHSK I+HRDIKS N+ +D D
Sbjct: 92 MQRGRPLPEDQVWRFFIQILL--------GLAHLHSKKILHRDIKSLNLFLD----AYDN 139
Query: 670 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 729
VK+ D A L I VGTP +++PE+ KP Y +
Sbjct: 140 ---VKIGDLGVA----KLLSDNTNFANTI------VGTPYYLSPELCE--DKP--YNEKS 182
Query: 730 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG 789
D+W+ G +L E T + P+ ++ + I G P +
Sbjct: 183 DVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV------------------SQM 224
Query: 790 FEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 824
+ + L + +C ++ +RP L
Sbjct: 225 YSQQ---------LAQLIDQCLTKDYRQRPDTFQL 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 56/231 (24%), Positives = 107/231 (46%), Gaps = 51/231 (22%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
I E++ G N ++ L E + V+ + L++A +++A+ L K+ +HRD+ + N
Sbjct: 79 IITEFMTYG---NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 135
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718
L+ E +VK+ DF + + +T AH G P +W APE L
Sbjct: 136 LVG-ENH------LVKVADFGLSRLMTGDTYT---AHAGAKFP------IKWTAPESLAY 179
Query: 719 MHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGS 777
N + ++ D+W++G LL E+ T + PY G+ ++++L++ G R
Sbjct: 180 ----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR------------ 223
Query: 778 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
E+PE + ++ R C + NP++RP+ ++++ F
Sbjct: 224 ------------MERPEGCPPK---VYELMRACWQWNPSDRPSFAEIHQAF 259
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 34/100 (34%), Positives = 45/100 (45%), Gaps = 19/100 (19%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 702
+H+ IMHRD+K N+LI ADG V+K+ DF A
Sbjct: 115 MHANGIMHRDLKPANLLIS-----ADG--VLKIADFGLARLFSE---------EEPRLYS 158
Query: 703 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742
V T + APE+L K Y VD+W+ GC+ ELL
Sbjct: 159 HQVATRWYRAPELLYGARK---YDPGVDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 59/196 (30%), Positives = 84/196 (42%), Gaps = 36/196 (18%)
Query: 555 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 614
C+ E+ +L L H +++ Y I L I +E G + I+
Sbjct: 49 CIKEIDLLKQLNHPNVIKYYASFIEDNEL--------------NIVLELADAGDLSRMIK 94
Query: 615 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 674
+ + + Q + +AL +HS+ +MHRDIK N+ I A G VVK
Sbjct: 95 HFKKQKRLIPEKTVWKYFVQ-LCSALEHMHSRRVMHRDIKPANVFI-----TATG--VVK 146
Query: 675 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 734
L D R F AH VGTP +M+PE +H+ N Y + DIWS
Sbjct: 147 LGDLGLG---RFFSSKTTAAHS-------LVGTPYYMSPE---RIHE-NGYNFKSDIWSL 192
Query: 735 GCLLLELLTLQVPYMG 750
GCLL E+ LQ P+ G
Sbjct: 193 GCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 67/248 (27%), Positives = 102/248 (41%), Gaps = 52/248 (20%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSEN 657
I ME++ GGS+ ++K E + I+ V L L KH IMHRD+K N
Sbjct: 76 ICMEHMDGGSLDQVLKKAGRIPENILGK-----ISIAVLRGLTYLREKHKIMHRDVKPSN 130
Query: 658 ILIDLERKKADGKPVVKLCDFDRAVPL-----RSFLHTCCIAHRGIPAPDVCVGTPRWMA 712
IL++ + G+ +KLCDF + L SF VGT +M+
Sbjct: 131 ILVN-----SRGE--IKLCDFGVSGQLIDSMANSF-----------------VGTRSYMS 166
Query: 713 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL 772
PE L+ H Y ++ DIWS G L+E+ + P E+ + E
Sbjct: 167 PERLQGTH----YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKES 222
Query: 773 EALGSCHEHEVAQSGSGFE-------KPEAELETLSF---LVDVFRRCTEENPTERPTAG 822
S H + + + FE +P +L + +F D +C ++NP ER
Sbjct: 223 HRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERA--- 279
Query: 823 DLYEMFVA 830
DL E+
Sbjct: 280 DLKELTKH 287
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 57/192 (29%), Positives = 86/192 (44%), Gaps = 30/192 (15%)
Query: 639 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 698
AL +HS +++HRD+K NIL++ + + VKL DF A RS + +
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCR-------VKLADFGLA---RSL--SELEENPEN 166
Query: 699 PAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIH 757
P V T RW APE+L + Y VD+WS GC+L E+L + + G S L
Sbjct: 167 PVLTDYVAT-RWYRAPEILLGSTR---YTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQL 222
Query: 758 DLIQMGKRPRLTDE-LEALGSCHEHEV-AQSGSGFEKPEAEL------ETLSFLVDVFRR 809
+ I + + E +E++ S + S KP EL + L L ++
Sbjct: 223 EKI-IEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLL----KK 277
Query: 810 CTEENPTERPTA 821
NP +R TA
Sbjct: 278 LLVFNPNKRLTA 289
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 50/163 (30%), Positives = 68/163 (41%), Gaps = 33/163 (20%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
MEY GG + +I S A+F A V L LH I++RD+K +N+L+
Sbjct: 81 MEYAAGGDLMMHIH------TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL 134
Query: 661 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717
D E VK+ DF + T C GTP ++APEVL
Sbjct: 135 DTE-------GFVKIADFGLCKEGMGFGDRTSTFC-------------GTPEFLAPEVLT 174
Query: 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 760
Y VD W G L+ E+L + P+ G E E+ D I
Sbjct: 175 ETS----YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI 213
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 77/287 (26%), Positives = 113/287 (39%), Gaps = 80/287 (27%)
Query: 556 LGEVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 613
+ EVR L LRH +E G + + WL MEY G S + +
Sbjct: 63 IKEVRFLQQLRHPNTIEYKGCYLREHTAWL----------------VMEYCLG-SASDIL 105
Query: 614 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 673
E + ++ V++A I L LHS +HRDIK+ NIL+ G V
Sbjct: 106 EVHKKPLQE---VEIAA-ICHGALQGLAYLHSHERIHRDIKAGNILL-----TEPG--TV 154
Query: 674 KLCDFDRAV---PLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 730
KL DF A P SF VGTP WMAPEV+ AM + Y +VD
Sbjct: 155 KLADFGSASLVSPANSF-----------------VGTPYWMAPEVILAMDEGQ-YDGKVD 196
Query: 731 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS-G 789
+WS G +EL + P + + + AL + +AQ+ S
Sbjct: 197 VWSLGITCIELAERKPPLFNM------------------NAMSAL-----YHIAQNDSPT 233
Query: 790 FEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSSS 835
+ +F+ C ++ P +RP++ +L + FV R
Sbjct: 234 LSSNDWSDYFRNFV----DSCLQKIPQDRPSSEELLKHRFVLRERPP 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 68/240 (28%), Positives = 101/240 (42%), Gaps = 55/240 (22%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
I MEY+ GGS + + K E +++ I +++ L LHS+ +HRDIK+ N+
Sbjct: 79 IIMEYLGGGSALDLL-KPGPLEETYIAT-----ILREILKGLDYLHSERKIHRDIKAANV 132
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718
L+ ++ D VKL DF A L T R + VGTP WMAPEV+
Sbjct: 133 LLS---EQGD----VKLADFGVAGQL-----TDTQIKR-----NTFVGTPFWMAPEVI-- 173
Query: 719 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 778
K + Y + DIWS G +EL + P L + + LI P L +
Sbjct: 174 --KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQ------- 224
Query: 779 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSSIS 837
+ KP + C ++P RPTA +L + F+ R + S
Sbjct: 225 -----------YSKP---------FKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTS 264
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 69/251 (27%), Positives = 111/251 (44%), Gaps = 61/251 (24%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+TLK +S D ++FE E +L +H IV+ YG +G+P
Sbjct: 40 VKTLKE-TASNDARKDFER----EAELLTNFQHENIVKFYG--------VCTEGDPPI-- 84
Query: 595 LQSAIFMEYVKGGSVKNYIEK-------LSETGEKHVSVKLA--LFIAQDVAAALVELHS 645
+F EY++ G + ++ L + L+ L IA +A+ +V L S
Sbjct: 85 ---MVF-EYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS 140
Query: 646 KHIMHRDIKSENILI--DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 703
+H +HRD+ + N L+ DL VVK+ DF + + + + H +P
Sbjct: 141 QHFVHRDLATRNCLVGYDL---------VVKIGDFGMSRDVYTTDYYRVGGHTMLPI--- 188
Query: 704 CVGTPRWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDL 759
RWM PE + +Y E D+WS+G +L E+ T + P+ GLS E+ +
Sbjct: 189 -----RWMPPESI-------MYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236
Query: 760 IQMGK---RPR 767
I G+ RPR
Sbjct: 237 ITQGRLLQRPR 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 81/353 (22%), Positives = 145/353 (41%), Gaps = 107/353 (30%)
Query: 512 EAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV 571
E GK V ++ FR K + V+ LK +S+ E+R+ L E +L + H ++
Sbjct: 12 EFGKVVKATAFRLKGRAGYTTVAVKMLKE-NASSSELRDL----LSEFNLLKQVNHPHVI 66
Query: 572 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI------------------ 613
++YG S DG + +EY K GS+++++
Sbjct: 67 KLYG-------ACSQDGPL-------LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112
Query: 614 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 672
L E+ +++ + A ++ + L ++HRD+ + N+L+ A+G+
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV------AEGR-K 165
Query: 673 VKLCDF--------DRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAPEVLRAMHKPN 723
+K+ DF + + RS +G IP +WMA E L H
Sbjct: 166 MKISDFGLSRDVYEEDSYVKRS---------KGRIPV--------KWMAIESL-FDH--- 204
Query: 724 LYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE 782
+Y + D+WS+G LL E++TL PY G++ + +L++ G R
Sbjct: 205 IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYR----------------- 247
Query: 783 VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT----AGDLYEMFVAR 831
E+PE E + L+ C ++ P +RPT + +L +M V
Sbjct: 248 -------MERPENCSEEMYNLM---LTCWKQEPDKRPTFADISKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 9e-13
Identities = 49/162 (30%), Positives = 79/162 (48%), Gaps = 26/162 (16%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
ME++ GG + +I+ + + A F A ++ L LHSK I++RD+K +N+++
Sbjct: 75 MEFLNGGDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML 129
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720
D DG +K+ DF C G GTP ++APE+L+ +
Sbjct: 130 D-----RDGH--IKIADFG----------MCKENVFGDNRASTFCGTPDYIAPEILQGLK 172
Query: 721 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 762
Y VD WS+G LL E+L Q P+ G E E+ + I++
Sbjct: 173 ----YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 9e-13
Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 32/153 (20%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+ +EYV GG + ++++ + E+H A F A ++ AL LH + I++RD+K +N+
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLPEEH-----ARFYAAEICIALNFLHERGIIYRDLKLDNV 127
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEV 715
L+D ADG +KL D+ + G+ D GTP ++APE+
Sbjct: 128 LLD-----ADGH--IKLTDYG-------------MCKEGLGPGDTTSTFCGTPNYIAPEI 167
Query: 716 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 748
LR YG VD W+ G L+ E++ + P+
Sbjct: 168 LRGEE----YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 21/163 (12%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+ M+Y GG + + K E + +A F ++ A+ +H H +HRDIK +N+
Sbjct: 78 LVMDYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV 133
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718
L+D+ ++L DF + + G V VGTP +++PE+L+A
Sbjct: 134 LLDMNGH-------IRLADFGSCLKMNQ---------DGTVQSSVAVGTPDYISPEILQA 177
Query: 719 MHKP-NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 760
M YG E D WS G + E+L + P+ S +E + I
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 44/230 (19%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E +++ L H +V++YG + +K P I EY+ G + NY+ +
Sbjct: 49 EAKVMMKLSHPNLVQLYG--VCTKQRPIF------------IVTEYMANGCLLNYLRERK 94
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
+ L + DV A+ L S +HRD+ + N L+ + VVK+ D
Sbjct: 95 GKLGT----EWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN-------VVKVSD 143
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F A R L + +G P +W PEV + + + + D+WS+G L
Sbjct: 144 FGLA---RYVLDDQYTSSQGTKFP------VKWAPPEVF--DY--SRFSSKSDVWSFGVL 190
Query: 738 LLELLTL-QVPYMGLSELEIHDLIQMG---KRPRL--TDELEALGSCHEH 781
+ E+ + ++PY S E+ + + G RP+L T+ + SC
Sbjct: 191 MWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHE 240
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 56/226 (24%), Positives = 98/226 (43%), Gaps = 55/226 (24%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+ EY G + N++ + E+ ++++ L + VA + L SK+ +HRD+ + N+
Sbjct: 116 VITEYCCYGDLLNFLRRKRES---FLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNV 172
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG---IPAPDVCVGTPRWMAPEV 715
L+ GK +VK+CDF A R ++ +G +P +WMAPE
Sbjct: 173 LL------THGK-IVKICDFGLA---RDIMNDSNYVVKGNARLPV--------KWMAPES 214
Query: 716 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEA 774
+ +Y E D+WSYG LL E+ +L PY G+ D
Sbjct: 215 IFN----CVYTFESDVWSYGILLWEIFSLGSNPYPGM----------------PVDSK-- 252
Query: 775 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820
+++ + G +PE + D+ + C + +P +RPT
Sbjct: 253 -----FYKLIKEGYRMAQPEHAPAE---IYDIMKTCWDADPLKRPT 290
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 48/174 (27%), Positives = 79/174 (45%), Gaps = 27/174 (15%)
Query: 579 SSKWLPSADG--NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDV 636
+S W+P + +L + MEY GG + + + + + ++ +A F ++
Sbjct: 59 NSPWIPQLQYAFQDKDNLY---LVMEYQPGGDLLSLLNRYEDQFDE----DMAQFYLAEL 111
Query: 637 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR 696
A+ +H +HRDIK EN+LID +KL DF A L +
Sbjct: 112 VLAIHSVHQMGYVHRDIKPENVLIDRTGH-------IKLADFGSAARLTANKMV------ 158
Query: 697 GIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGCLLLELLTLQVPY 748
+ VGTP ++APEVL M+ YG+E D WS G + E++ + P+
Sbjct: 159 ---NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 33/168 (19%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+E+V GG + ++ K +A F ++ A LHSK I++RD+K EN+
Sbjct: 95 FLLEFVVGGELFTHLRKAGRFPND-----VAKFYHAELVLAFEYLHSKDIIYRDLKPENL 149
Query: 659 LIDLERKKADGKPVVKLCDFDRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 716
L+ D K VK+ DF A VP R+F T C GTP ++APEV+
Sbjct: 150 LL-------DNKGHVKVTDFGFAKKVPDRTF--TLC-------------GTPEYLAPEVI 187
Query: 717 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
++ +G VD W+ G LL E + P+ + I++ I G+
Sbjct: 188 QSKG----HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR 231
|
Length = 329 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 63/287 (21%), Positives = 115/287 (40%), Gaps = 72/287 (25%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+TLK + L E +++ LRH ++++Y P +
Sbjct: 35 VKTLKPGTMDPKDF-------LAEAQIMKKLRHPKLIQLYA--------VCTLEEPIY-- 77
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
I E +K GS+ Y++ + + + + +A VA+ + L +++ +HRD+
Sbjct: 78 ----IVTELMKYGSLLEYLQG---GAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLA 130
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714
+ N+L+ + + K+ DF A R A G P +W APE
Sbjct: 131 ARNVLV------GENN-ICKVADFGLA---RVIKEDIYEAREGAKFP------IKWTAPE 174
Query: 715 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 773
N + ++ D+WS+G LL E++T ++PY G++ E+ + G R +
Sbjct: 175 AALY----NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR------MP 224
Query: 774 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820
C P+ L D+ C +E+P +RPT
Sbjct: 225 CPPGC--------------PKE-------LYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 50/164 (30%), Positives = 79/164 (48%), Gaps = 34/164 (20%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
MEYV GG + I++ + E + F A +V AL+ LH +++RD+K +NIL+
Sbjct: 75 MEYVNGGDLMFQIQRSRKFDEPR-----SRFYAAEVTLALMFLHRHGVIYRDLKLDNILL 129
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV----GTPRWMAPEVL 716
D A+G KL DF + GI V GTP ++APE+L
Sbjct: 130 D-----AEGH--CKLADFG-------------MCKEGI-LNGVTTTTFCGTPDYIAPEIL 168
Query: 717 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 760
+ + YG VD W+ G L+ E++ Q P+ +E ++ + I
Sbjct: 169 QELE----YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 59/184 (32%), Positives = 86/184 (46%), Gaps = 37/184 (20%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+ +EY+ GG + ++E+ E A F +++ AL LH + I++RD+K ENI
Sbjct: 77 LILEYLSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENI 131
Query: 659 LIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 715
L+D A G VKL DF ++ + HT C GT +MAPE+
Sbjct: 132 LLD-----AQGH--VKLTDFGLCKESIHEGTVTHTFC-------------GTIEYMAPEI 171
Query: 716 L-RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK---RPRLTDE 771
L R+ H G VD WS G L+ ++LT P+ + + D I GK P LT E
Sbjct: 172 LMRSGH-----GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPE 226
Query: 772 LEAL 775
L
Sbjct: 227 ARDL 230
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 71/274 (25%), Positives = 111/274 (40%), Gaps = 62/274 (22%)
Query: 555 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 614
C+ E+ +L L H ++ K+L S + E + I +E G + I+
Sbjct: 49 CVKEIDLLKQLNHPNVI---------KYLDSFIEDNELN-----IVLELADAGDLSQMIK 94
Query: 615 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 674
+ + + Q + +A+ +HS+ +MHRDIK N+ I A G VVK
Sbjct: 95 YFKKQKRLIPERTVWKYFVQ-LCSAVEHMHSRRVMHRDIKPANVFI-----TATG--VVK 146
Query: 675 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 734
L D R F AH VGTP +M+PE +H+ N Y + DIWS
Sbjct: 147 LGDLGLG---RFFSSKTTAAHS-------LVGTPYYMSPE---RIHE-NGYNFKSDIWSL 192
Query: 735 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 794
GCLL E+ LQ P+ G D++ C + E + P
Sbjct: 193 GCLLYEMAALQSPFYG-------------------DKMNLFSLCQKIEQC------DYPP 227
Query: 795 AELETLS-FLVDVFRRCTEENPTERPTAGDLYEM 827
E S L ++ C +P +RP G ++++
Sbjct: 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 22/171 (12%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
I +E+ GG+V + +L E+ ++ + + AL LH I+HRD+K+ NI
Sbjct: 79 ILIEFCAGGAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNI 134
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718
L L DG +KL DF + R I D +GTP WMAPEV+
Sbjct: 135 LFTL-----DGD--IKLADFGVSAK----------NTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 719 -MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 768
K Y + D+WS G L+E+ ++ P+ L+ + + I + P L
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL 228
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 57/174 (32%), Positives = 90/174 (51%), Gaps = 28/174 (16%)
Query: 587 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 646
D ++L A+ ++Y G ++ I+ ++T + L Q V A+ +HSK
Sbjct: 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ-VLLAVHHVHSK 162
Query: 647 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV--- 703
H++HRDIKS NIL+ ++G +VKL DF + + + T + DV
Sbjct: 163 HMIHRDIKSANILL-----CSNG--LVKLGDFGFS---KMYAATV--------SDDVGRT 204
Query: 704 -CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEI 756
C GTP ++APE+ R KP Y + D++S G LL ELLTL+ P+ G + E+
Sbjct: 205 FC-GTPYYVAPEIWR--RKP--YSKKADMFSLGVLLYELLTLKRPFDGENMEEV 253
|
Length = 496 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 67/235 (28%), Positives = 98/235 (41%), Gaps = 62/235 (26%)
Query: 554 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVK---GGS 608
S L E+ +L LRH IVE+ + K L S IF MEY +
Sbjct: 52 SSLREITLLLNLRHPNIVELK-EVVVGKHLDS-------------IFLVMEYCEQDLASL 97
Query: 609 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 668
+ N SE+ VK + + L LH I+HRD+K N+L+
Sbjct: 98 LDNMPTPFSES-----QVKC---LMLQLLRGLQYLHENFIIHRDLKVSNLLL-------T 142
Query: 669 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV--CVGTPRWMAPEVLRAMHKPNLYG 726
K +K+ DF A R++ G+PA + V T + APE+L Y
Sbjct: 143 DKGCLKIADFGLA---RTY---------GLPAKPMTPKVVTLWYRAPELLLGCTT---YT 187
Query: 727 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH 781
+D+W+ GC+L ELL + G SE+E DLI ++ LG+ +E
Sbjct: 188 TAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLI-----------IQLLGTPNES 231
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 32/151 (21%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
+E+V GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 75 IEFVSGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNFLHERGIIYRDLKLDNVLL 129
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEVLR 717
D A+G +KL D+ + GI D GTP ++APE+LR
Sbjct: 130 D-----AEGH--IKLTDYG-------------MCKEGIRPGDTTSTFCGTPNYIAPEILR 169
Query: 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 748
YG VD W+ G L+ E++ + P+
Sbjct: 170 GED----YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 67/267 (25%)
Query: 556 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 615
L E ++ L+H +V +Y + +K P I EY+ GS+ ++++
Sbjct: 49 LEEANLMKTLQHDKLVRLYA--VVTKEEPIY------------IITEYMAKGSLLDFLK- 93
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
S+ G K + KL F AQ +A + + K+ +HRD+++ N+L+ + K+
Sbjct: 94 -SDEGGKVLLPKLIDFSAQ-IAEGMAYIERKNYIHRDLRAANVLVS-------ESLMCKI 144
Query: 676 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735
DF A + +T A G P +W APE + + ++ D+WS+G
Sbjct: 145 ADFGLARVIEDNEYT---AREGAKFP------IKWTAPEAINF----GSFTIKSDVWSFG 191
Query: 736 CLLLELLTL-QVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKP 793
LL E++T ++PY G+S ++ +Q G R PR+ + C +
Sbjct: 192 ILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMEN-------CPDE------------ 232
Query: 794 EAELETLSFLVDVFRRCTEENPTERPT 820
L D+ + C +E ERPT
Sbjct: 233 ---------LYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 71/319 (22%), Positives = 113/319 (35%), Gaps = 82/319 (25%)
Query: 516 SVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 575
SV ++ K G A V+TLK + I + L E ++ L H CIV + G
Sbjct: 10 SVVKGVYLMKSGKEVEVA-VKTLK-----QEHIAAGKKEFLREASVMAQLDHPCIVRLIG 63
Query: 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQD 635
+ + ME G + Y++K + + V +A
Sbjct: 64 VCKGEPLM---------------LVMELAPLGPLLKYLKK-----RREIPVSDLKELAHQ 103
Query: 636 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCI 693
VA + L SKH +HRD+ + N+L L + K+ DF RA+ S +
Sbjct: 104 VAMGMAYLESKHFVHRDLAARNVL--LVNRHQ-----AKISDFGMSRALGAGSDYYR--- 153
Query: 694 AHRGIPAPDVCVGTPRWMAPEVL---RAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYM 749
A P +W APE + + K D+WSYG L E + PY
Sbjct: 154 ATTAGRWP------LKWYAPECINYGKFSSKS-------DVWSYGVTLWEAFSYGAKPYG 200
Query: 750 GLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 809
+ E+ +++ G+R L C + + +
Sbjct: 201 EMKGAEVIAMLESGER------LPRPEECPQE---------------------IYSIMLS 233
Query: 810 CTEENPTERPTAGDLYEMF 828
C + P +RPT +L F
Sbjct: 234 CWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 33/161 (20%)
Query: 588 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 647
+ H+L M+Y+K G + + ++K E +S I + + AL +LH +
Sbjct: 79 TTLKGHVL----IMDYIKDGDLFDLLKK-----EGKLSEAEVKKIIRQLVEALNDLHKHN 129
Query: 648 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 707
I+H DIK EN+L D + + + LCD+ C I P GT
Sbjct: 130 IIHNDIKLENVLYDRAKDR------IYLCDYG----------LCKIIG----TPSCYDGT 169
Query: 708 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 748
+ +PE ++ Y + D W+ G L ELLT + P+
Sbjct: 170 LDYFSPEKIK--GHN--YDVSFDWWAVGVLTYELLTGKHPF 206
|
Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 52/228 (22%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---- 613
E +L L+H IV+ YG DG+P + EY+K G + ++
Sbjct: 57 EAELLTNLQHEHIVKFYG--------VCGDGDP------LIMVFEYMKHGDLNKFLRAHG 102
Query: 614 ---------EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 664
+ GE + + L IA +A+ +V L S+H +HRD+ + N L+
Sbjct: 103 PDAMILVDGQPRQAKGE--LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---- 156
Query: 665 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 724
+VK+ DF + + S + H +P RWM PE + M++
Sbjct: 157 ---GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI--------RWMPPESI--MYRK-- 201
Query: 725 YGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGK---RPRL 768
+ E D+WS+G +L E+ T + P+ LS E+ + I G+ RPR+
Sbjct: 202 FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRV 249
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 56/191 (29%), Positives = 87/191 (45%), Gaps = 37/191 (19%)
Query: 639 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 698
+L +H I HRDIK ENILI + ++KL DF +C +
Sbjct: 112 SLDHMHRNGIFHRDIKPENILIKDD--------ILKLADFG----------SCRGIYSKP 153
Query: 699 PAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE-- 755
P + + T RW APE L YG ++DIW+ GC+ E+L+L + G +EL+
Sbjct: 154 PYTEY-IST-RWYRAPECLLTD---GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI 208
Query: 756 --IHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEK--PEAELETLSFLVDVFRRC 810
IHD+ +G + + + + ++ G+G K P A E L D+ ++
Sbjct: 209 AKIHDV--LGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGL----DLLKKL 262
Query: 811 TEENPTERPTA 821
+P ER TA
Sbjct: 263 LAYDPDERITA 273
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 44/148 (29%), Positives = 66/148 (44%), Gaps = 30/148 (20%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
MEY+ GG + I+ L E +A +V + +LH + I+HRDIK EN+LI
Sbjct: 76 MEYLNGGDCASLIKTLGGLPEDWAKQYIA-----EVVLGVEDLHQRGIIHRDIKPENLLI 130
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720
D G +KL DF ++ G+ VGTP ++APE + +
Sbjct: 131 D-----QTGH--LKLTDFG-------------LSRNGLENKKF-VGTPDYLAPETI--LG 167
Query: 721 KPNLYGLEVDIWSYGCLLLELLTLQVPY 748
+ D WS GC++ E L P+
Sbjct: 168 VGDDK--MSDWWSLGCVIFEFLFGYPPF 193
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 51/154 (33%), Positives = 70/154 (45%), Gaps = 24/154 (15%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
I MEY GG + ++K+ K L + + +H K ++HRDIKS+NI
Sbjct: 75 IVMEYCDGGDL---MQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNI 131
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718
+ +GK VKL DF A L S C VGTP ++ PE+
Sbjct: 132 FL-----TQNGK--VKLGDFGSARLLTSPGAYAC----------TYVGTPYYVPPEIWEN 174
Query: 719 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS 752
M Y + DIWS GC+L EL TL+ P+ S
Sbjct: 175 MP----YNNKSDIWSLGCILYELCTLKHPFQANS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 51/150 (34%), Positives = 72/150 (48%), Gaps = 23/150 (15%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+ ++YV GG + ++ + E V V +A ++ AL LH I++RDIK ENI
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVYIA-----EIVLALDHLHQLGIIYRDIKLENI 136
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718
L+D ++G V L DF + + FL A A C GT +MAPEV+R
Sbjct: 137 LLD-----SEGH--VVLTDFGLS---KEFL-----AEEEERAYSFC-GTIEYMAPEVIRG 180
Query: 719 MHKPNLYGLEVDIWSYGCLLLELLTLQVPY 748
+ VD WS G L ELLT P+
Sbjct: 181 --GSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 62/206 (30%), Positives = 91/206 (44%), Gaps = 34/206 (16%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
I ME + G++ N+ L G VSV L + DVA + L SK ++HRD+ + NI
Sbjct: 75 IVMELMSKGNLVNF---LRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNI 131
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718
L+ DG V K+ DF +A G D +W APE L
Sbjct: 132 LV-----SEDG--VAKVSDFG-------------LARVGSMGVDNSKLPVKWTAPEAL-- 169
Query: 719 MHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEA--- 774
K + + D+WSYG LL E+ + + PY +S E+ + ++ G R + A
Sbjct: 170 --KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVY 227
Query: 775 --LGSCHEHEVAQSGSGFEKPEAELE 798
+ SC E E + S F K +LE
Sbjct: 228 VLMTSCWETEPKKRPS-FHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 74/311 (23%), Positives = 111/311 (35%), Gaps = 94/311 (30%)
Query: 551 FEYSCLGEVRMLGALRHSCIV---EMY--GHKISSKWLPS---------AD-----GNPE 591
F + L E+++L L+H +V +M S + S D NP
Sbjct: 50 FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPS 109
Query: 592 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 651
L +S I K Y+ +L E G + LH HI+HR
Sbjct: 110 VKLTESQI----------KCYMLQLLE-GINY-------------------LHENHILHR 139
Query: 652 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-----CVG 706
DIK+ NILI D + ++K+ DF A R + +G V
Sbjct: 140 DIKAANILI-------DNQGILKIADFGLA---RPY-DGPPPNPKGGGGGGTRKYTNLVV 188
Query: 707 TPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR 765
T RW PE+L + + Y VDIW GC+ E+ T + G S+++ LI
Sbjct: 189 T-RWYRPPELL--LGERR-YTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI----- 239
Query: 766 PRLTDELEALGSCHEHE--VAQSGSGFEKPEAELETLSFLVDVFRRCTEE---------- 813
+ G+ E +S G E + L + F + E
Sbjct: 240 ------FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLS 293
Query: 814 -NPTERPTAGD 823
+P +R TA D
Sbjct: 294 LDPYKRLTASD 304
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 33/152 (21%)
Query: 609 VKNYIEKLSETGEKHVSVKLALF-IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667
+K +++ +G +K LF + Q +A HS ++HRD+K +N+LI+
Sbjct: 85 LKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC----HSHRVLHRDLKPQNLLIN-----T 135
Query: 668 DGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 723
+G +KL DF A VP+R++ H V T + APE+L
Sbjct: 136 EGA--IKLADFGLARAFGVPVRTYTHE--------------VVTLWYRAPEILLGC---K 176
Query: 724 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 755
Y VDIWS GC+ E++T + + G SE++
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 6e-12
Identities = 53/164 (32%), Positives = 79/164 (48%), Gaps = 34/164 (20%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
++YV GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 75 LDYVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL 129
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWMAPEVL 716
D + G V L DF + GI C GTP ++APEVL
Sbjct: 130 D-----SQGH--VVLTDFG-------------LCKEGIEHSKTTSTFC-GTPEYLAPEVL 168
Query: 717 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 760
R +P Y VD W G +L E+L P+ E++D I
Sbjct: 169 R--KQP--YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 58/226 (25%), Positives = 100/226 (44%), Gaps = 57/226 (25%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
I E++ GS+ ++++ S+ G K KL F AQ +A + + ++ +HRD+++ NI
Sbjct: 77 IITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQ-IAEGMAFIEQRNYIHRDLRAANI 133
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718
L+ V K+ DF A + +T A G P +W APE +
Sbjct: 134 LVS-------ASLVCKIADFGLARVIEDNEYT---AREGAKFP------IKWTAPEAIN- 176
Query: 719 MHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEA 774
+G ++ D+WS+G LL+E++T ++PY G+S E+ ++ G R +
Sbjct: 177 ------FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE---- 226
Query: 775 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820
+C E L ++ RC + P ERPT
Sbjct: 227 --NCPEE---------------------LYNIMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 26/163 (15%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
M + GG +K +I GE A+F A + L LH + I++RD+K EN+L+
Sbjct: 72 MTLMNGGDLKYHI---YNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL 128
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720
D G V++ D AV L +G GTP +MAPEVL
Sbjct: 129 D-----DHGN--VRISDLGLAVEL-----------KGGKKIKGRAGTPGYMAPEVL---- 166
Query: 721 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE-LEIHDLIQM 762
+ +Y VD ++ GC L E++ + P+ E +E +L +
Sbjct: 167 QGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 9e-12
Identities = 71/242 (29%), Positives = 103/242 (42%), Gaps = 59/242 (24%)
Query: 599 IFMEYVKGGSVKNYIEK--LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656
I MEY+ GGS + +E L ET ++A I +++ L LHS+ +HRDIK+
Sbjct: 79 IIMEYLGGGSALDLLEPGPLDET-------QIAT-ILREILKGLDYLHSEKKIHRDIKAA 130
Query: 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 716
N+L+ + VKL DF A L T R + VGTP WMAPEV+
Sbjct: 131 NVLLSEHGE-------VKLADFGVAGQL-----TDTQIKR-----NTFVGTPFWMAPEVI 173
Query: 717 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG 776
K + Y + DIWS G +EL + P+ L +++ LI P L
Sbjct: 174 ----KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLE------- 222
Query: 777 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSS 835
+ KP L + C + P+ RPTA +L + F+ R +
Sbjct: 223 -----------GNYSKP---------LKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK 262
Query: 836 IS 837
S
Sbjct: 263 TS 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 26/148 (17%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
+EYV GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 75 IEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNYLHERGIIYRDLKLDNVLL 129
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720
D E +KL D+ C R GTP ++APE+LR
Sbjct: 130 DSEGH-------IKLTDYG----------MCKEGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 721 KPNLYGLEVDIWSYGCLLLELLTLQVPY 748
YG VD W+ G L+ E++ + P+
Sbjct: 173 ----YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 52/181 (28%), Positives = 90/181 (49%), Gaps = 35/181 (19%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
MEY GG + ++ + E+ + + A F ++ +AL LHS+ +++RDIK EN+++
Sbjct: 74 MEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 128
Query: 661 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717
D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 129 D-----KDGH--IKITDFGLCKEGISDGATMKTFC-------------GTPEYLAPEVL- 167
Query: 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG--KRPR-LTDELEA 774
+ N YG VD W G ++ E++ ++P+ + +LI M + PR L+ E ++
Sbjct: 168 ---EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 224
Query: 775 L 775
L
Sbjct: 225 L 225
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 49/149 (32%), Positives = 76/149 (51%), Gaps = 28/149 (18%)
Query: 599 IFMEYVKGGSVKNYI--EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656
I M+Y +GG + I ++ E + L F+ + AL +H + I+HRDIKS+
Sbjct: 76 IVMDYCEGGDLYKKINAQRGVLFPEDQI---LDWFV--QICLALKHVHDRKILHRDIKSQ 130
Query: 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 716
NI + DG +KL DF A L S T +A C+GTP +++PE+
Sbjct: 131 NIFL-----TKDG--TIKLGDFGIARVLNS---TVELAR-------TCIGTPYYLSPEIC 173
Query: 717 RAMHKPNLYGLEVDIWSYGCLLLELLTLQ 745
++P Y + DIW+ GC+L E+ TL+
Sbjct: 174 E--NRP--YNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 75/274 (27%), Positives = 103/274 (37%), Gaps = 77/274 (28%)
Query: 556 LGEVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 613
+ EV+ L L+H +E G K + WL MEY G +
Sbjct: 69 IKEVKFLQQLKHPNTIEYKGCYLKEHTAWL----------------VMEYCLGSA----- 107
Query: 614 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 673
L E +K + I L LHS +++HRDIK+ NIL+ + V
Sbjct: 108 SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ-------V 160
Query: 674 KLCDFDRAV---PLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 730
KL DF A P SF VGTP WMAPEV+ AM + Y +VD
Sbjct: 161 KLADFGSASKSSPANSF-----------------VGTPYWMAPEVILAMDEGQ-YDGKVD 202
Query: 731 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 790
+WS G +EL + P ++ + I P L +E S GF
Sbjct: 203 VWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL----------QSNEWTDSFRGF 252
Query: 791 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 824
VD C ++ P ERP + +L
Sbjct: 253 -------------VDY---CLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 53/178 (29%), Positives = 87/178 (48%), Gaps = 29/178 (16%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
MEY GG + ++ + E+ S A F ++ +AL LHS +++RD+K EN+++
Sbjct: 74 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML 128
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720
D DG +K+ DF S G C GTP ++APEVL
Sbjct: 129 D-----KDGH--IKITDFGLCKEGISD---------GATMKTFC-GTPEYLAPEVL---- 167
Query: 721 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG--KRPR-LTDELEAL 775
+ N YG VD W G ++ E++ ++P+ ++ +LI M + PR L+ E ++L
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSL 225
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 58/298 (19%), Positives = 119/298 (39%), Gaps = 68/298 (22%)
Query: 535 VRTLKVCGSSADEIRNF--EYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEH 592
V+T+K+ + EI F E +C+ + H ++++ G + S+
Sbjct: 32 VKTMKLDIHTYSEIEEFLSEAACMKD------FDHPNVMKLIGVCFEA----SSLQKIPK 81
Query: 593 HLLQSAIFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 651
+ + + ++K G + +++ + + ++ L D+A + L +++ +HR
Sbjct: 82 PM----VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHR 137
Query: 652 DIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 709
D+ + N ++ + V + DF + + + IA +P +
Sbjct: 138 DLAARNCMLREDMT-------VCVADFGLSKKIYSGDYYRQGRIAK--MPV--------K 180
Query: 710 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRL 768
W+A E L +Y + D+W++G + E+ T Q PY G+ EI+D ++ G R
Sbjct: 181 WIAIESL----ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR--- 233
Query: 769 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
++PE + L L D+ C +P +RPT L E
Sbjct: 234 ---------------------LKQPE---DCLDELYDLMYSCWRADPKDRPTFTKLRE 267
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 47/212 (22%)
Query: 535 VRTLKV-CGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 593
V+TLK CG E+ +L L H IV+ G ++ +
Sbjct: 38 VKTLKRECGQQNTS------GWKKEINILKTLYHENIVKYKG--------CCSEQGGKGL 83
Query: 594 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 653
L MEYV GS+++Y+ K +++ L AQ + + LHS+H +HRD+
Sbjct: 84 QL----IMEYVPLGSLRDYLPKHK------LNLAQLLLFAQQICEGMAYLHSQHYIHRDL 133
Query: 654 KSENILIDLERKKADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 711
+ N+L+D +R +VK+ DF +AVP +R D V W
Sbjct: 134 AARNVLLDNDR-------LVKIGDFGLAKAVP------EGHEYYRVREDGDSPV---FWY 177
Query: 712 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743
A E L K N + D+WS+G L ELLT
Sbjct: 178 AVECL----KENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 87/298 (29%), Positives = 123/298 (41%), Gaps = 88/298 (29%)
Query: 556 LGEVRMLGALRHSCIV---EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 612
L E+RML L+H +V E++ K + L HL+ EY +V N
Sbjct: 48 LREIRMLKQLKHPNLVNLIEVFRRK---RKL---------HLV-----FEYCDH-TVLNE 89
Query: 613 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 672
+EK +H+ K+ Q V H + +HRD+K ENILI K
Sbjct: 90 LEKNPRGVPEHLIKKIIWQTLQAVNFC----HKHNCIHRDVKPENILI----TKQG---Q 138
Query: 673 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWM-APEVLRAMHKPNLYGL 727
+KLCDF A R + P V T RW APE+L + YG
Sbjct: 139 IKLCDFGFA--------------RILTGPGDDYTDYVAT-RWYRAPELLVGDTQ---YGP 180
Query: 728 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ--MGKR-PRLTDELEALGSCHEHEVA 784
VD+W+ GC+ ELLT Q + G S+++ LI+ +G PR H+ +
Sbjct: 181 PVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR-----------HQQIFS 229
Query: 785 QSG--SGFEKPEAE----LE---------TLSFLVDVFRRCTEENPTERPTAGDLYEM 827
+ G PE E LE LSFL + C + +PTER + +L E
Sbjct: 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFL----KGCLQMDPTERLSCEELLEH 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 72/301 (23%), Positives = 117/301 (38%), Gaps = 92/301 (30%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+ LK ++A + L E ++ LRH +V++ G GNP +
Sbjct: 34 VKCLKDDSTAAQ-------AFLAEASVMTTLRHPNLVQLLG--------VVLQGNPLY-- 76
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
I EY+ GS+ +Y L G +++ L A DV + L K+ +HRD+
Sbjct: 77 ----IVTEYMAKGSLVDY---LRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLA 129
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 708
+ N+L+ + V K+ DF G+ A + G
Sbjct: 130 ARNVLVSEDL-------VAKVSDF------------------GL-AKEASQGQDSGKLPV 163
Query: 709 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPY--MGLSELEIHDLIQMGKR 765
+W APE LR + + D+WS+G LL E+ + +VPY + L ++ H ++ G R
Sbjct: 164 KWTAPEALRE----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH--VEKGYR 217
Query: 766 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 825
+EA C + V + C E +P +RPT L
Sbjct: 218 ------MEAPEGCPPE---------------------VYKVMKDCWELDPAKRPTFKQLR 250
Query: 826 E 826
E
Sbjct: 251 E 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 65/240 (27%), Positives = 104/240 (43%), Gaps = 45/240 (18%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E +++ L H +V++YG + +K P I EY+ G + NY L
Sbjct: 49 EAKVMMKLSHEKLVQLYG--VCTKQRPIY------------IVTEYMSNGCLLNY---LR 91
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
E G++ +L L + +DV + L SK +HRD+ + N L+D G VK+ D
Sbjct: 92 EHGKRFQPSQL-LEMCKDVCEGMAYLESKQFIHRDLAARNCLVD-----DQG--CVKVSD 143
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F + R L + G P RW PEVL + + D+W++G L
Sbjct: 144 FGLS---RYVLDDEYTSSVGSKFP------VRWSPPEVLLYSK----FSSKSDVWAFGVL 190
Query: 738 LLELLTL-QVPYMGLSELEIHDLIQMGK---RPRLTDE--LEALGSCHEHEVAQSGSGFE 791
+ E+ +L ++PY + E + + G RP L E + SC HE A+ F+
Sbjct: 191 MWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCW-HEKAEERPTFQ 249
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 65/229 (28%), Positives = 97/229 (42%), Gaps = 62/229 (27%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+ +++++GG + + K E+ V LA ++A AL LHS I++RD+K ENI
Sbjct: 75 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-----ELALALDHLHSLGIIYRDLKPENI 129
Query: 659 LIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 715
L+D +G +KL DF ++ ++ C GT +MAPEV
Sbjct: 130 LLD-----EEGH--IKLTDFGLSKESIDHEKKAYSFC-------------GTVEYMAPEV 169
Query: 716 L-RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEA 774
+ R H D WS+G L+ E+LT +P+ G E +I K
Sbjct: 170 VNRRGHT-----QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK---------- 214
Query: 775 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823
LG F PEA+ S L +F+R NP R AG
Sbjct: 215 LGMPQ----------FLSPEAQ----SLLRALFKR----NPANRLGAGP 245
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-11
Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 38/209 (18%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+ L A H IV+ + D + LL + MEY GG + I++
Sbjct: 115 ELHCLAACDHFGIVKHFD-----------DFKSDDKLL---LIMEYGSGGDLNKQIKQRL 160
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP--VVKL 675
+ ++ L Q + AL E+HS+ +MHRD+KS NI + P ++KL
Sbjct: 161 KEHLPFQEYEVGLLFYQ-IVLALDEVHSRKMMHRDLKSANIFL---------MPTGIIKL 210
Query: 676 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735
DF + + + + + A C GTP ++APE+ Y + D+WS G
Sbjct: 211 GDFGFS---KQYSDSVSLD----VASSFC-GTPYYLAPELWERKR----YSKKADMWSLG 258
Query: 736 CLLLELLTLQVPYMGLSELEIHDLIQMGK 764
+L ELLTL P+ G S+ EI + GK
Sbjct: 259 VILYELLTLHRPFKGPSQREIMQQVLYGK 287
|
Length = 478 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 39/209 (18%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
EV+ L LRH ++ + + S G P + I E ++ GS+ + L
Sbjct: 52 EVQALKRLRHKHLISL--FAVCSV------GEPVY------IITELMEKGSLLAF---LR 94
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
+ + V + +A VA + L ++ +HRD+ + NIL+ + V K+ D
Sbjct: 95 SPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL-------VCKVAD 147
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F A ++ ++ + + IP +W APE + + D+WS+G L
Sbjct: 148 FGLARLIKEDVYLS--SDKKIPY--------KWTAPEAASHGT----FSTKSDVWSFGIL 193
Query: 738 LLELLTL-QVPYMGLSELEIHDLIQMGKR 765
L E+ T QVPY G++ E++D I G R
Sbjct: 194 LYEMFTYGQVPYPGMNNHEVYDQITAGYR 222
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 50/234 (21%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
MEYV+GG ++ + + V +A + AL LH+ I+HRD+K +N+LI
Sbjct: 80 MEYVEGGDCATLLKNIGA-----LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI 134
Query: 661 DLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPE 714
+ G +KL DF + + L + L+ I R VC GTP ++APE
Sbjct: 135 -----TSMGH--IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC-GTPEYIAPE 186
Query: 715 V-LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 773
V LR YG VD W+ G +L E L VP+ G + E+ + ++D++E
Sbjct: 187 VILRQG-----YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV-------ISDDIE 234
Query: 774 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 827
G E A+ + D+ R +NP ER G +E+
Sbjct: 235 WPE------------GDEALPADAQ------DLISRLLRQNPLERLGTGGAFEV 270
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 72/271 (26%), Positives = 108/271 (39%), Gaps = 45/271 (16%)
Query: 503 SFPSLSSCDEA----GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGE 558
SFP S E GK +F+ + A V+ L D I + + E
Sbjct: 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL-------DPIHDIDEEIEAE 64
Query: 559 VRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
+L AL H +V+ YG K + + D Q + +E GGSV + ++
Sbjct: 65 YNILKALSDHPNVVKFYG-MYYKKDVKNGD--------QLWLVLELCNGGSVTDLVKGFL 115
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
+ GE+ + + +I + L LH +HRD+K NIL+ E VKL D
Sbjct: 116 KRGER-MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG-------VKLVD 167
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVDIWSYGC 736
F + L S + VGTP WMAPEV+ + + Y D+WS G
Sbjct: 168 FGVSAQLTSTRLR----------RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGI 217
Query: 737 LLLELLTLQVPYMGLSELEIHDLIQMGKRPR 767
+EL P ++H + + K PR
Sbjct: 218 TAIELGDGDPPLA-----DLHPMRALFKIPR 243
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 64/247 (25%), Positives = 93/247 (37%), Gaps = 72/247 (29%)
Query: 599 IFMEYVKGGSVKNYI-------EKLS-----ETGEKHVSVKLALFIAQDVAAALVELHSK 646
+ +EY G++++++ E S E L F Q VA + L SK
Sbjct: 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQ-VARGMEFLASK 151
Query: 647 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 706
+HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 152 KCIHRDLAARNVLVTEDH-------VMKIADFGLA--------------RDIHHIDYYRK 190
Query: 707 TPR------WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ-VPYMGLSELEIHDL 759
T WMAPE L +Y + D+WS+G LL E+ TL PY G+ E+ L
Sbjct: 191 TTNGRLPVKWMAPEALFD----RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246
Query: 760 IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819
++ G R EKP L + R C E P++RP
Sbjct: 247 LKEGYR------------------------MEKP---QNCTQELYHLMRDCWHEVPSQRP 279
Query: 820 TAGDLYE 826
T L E
Sbjct: 280 TFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 5e-11
Identities = 61/232 (26%), Positives = 87/232 (37%), Gaps = 47/232 (20%)
Query: 538 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 597
LKV RN L E +L L H + +Y + +L L+
Sbjct: 31 LKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYL---------CLV-- 79
Query: 598 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657
M+Y GG L K +S ++A F A +V AL LH I++RD+K EN
Sbjct: 80 ---MDYCPGG---ELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPEN 133
Query: 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLH-TCCIAHRGIPAPDV------------- 703
IL+ G + L DFD + +G V
Sbjct: 134 ILL-----HESGH--IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 704 -----CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 750
VGT ++APEV+ + +G VD W+ G LL E+L P+ G
Sbjct: 187 FRSNSFVGTEEYIAPEVISG----DGHGSAVDWWTLGILLYEMLYGTTPFKG 234
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 67/245 (27%), Positives = 109/245 (44%), Gaps = 51/245 (20%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+TLK +S + ++F E +L L+H IV+ YG +G+P
Sbjct: 40 VKTLK--DASDNARKDFHR----EAELLTNLQHEHIVKFYG--------VCVEGDP---- 81
Query: 595 LQSAIFMEYVKGGSVKNYIEK------LSETGE--KHVSVKLALFIAQDVAAALVELHSK 646
+ EY+K G + ++ L G ++ L IAQ +AA +V L S+
Sbjct: 82 --LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ 139
Query: 647 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 706
H +HRD+ + N L+ +VK+ DF + + S + H +P
Sbjct: 140 HFVHRDLATRNCLV-------GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI------ 186
Query: 707 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGK- 764
RWM PE + M++ + E D+WS G +L E+ T + P+ LS E+ + I G+
Sbjct: 187 --RWMPPESI--MYRK--FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 240
Query: 765 --RPR 767
RPR
Sbjct: 241 LQRPR 245
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 6e-11
Identities = 71/304 (23%), Positives = 120/304 (39%), Gaps = 85/304 (27%)
Query: 546 DEIRNFEYSCLGEVRMLGALRHSCIVEM----YGHKISSKWLPSADGNPEHHLLQSAIF- 600
E F + L E+ +L L+H IV + G + I+
Sbjct: 42 KEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK------------------IYM 83
Query: 601 -MEYVKGGSVKNYIEKLSE---TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656
MEYV+ +K+ +E + + E VK + + + + LH I+HRD+K+
Sbjct: 84 VMEYVEH-DLKSLMETMKQPFLQSE----VK---CLMLQLLSGVAHLHDNWILHRDLKTS 135
Query: 657 NILIDLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 712
N+L++ + ++K+CDF A PL+ + V T + A
Sbjct: 136 NLLLN-------NRGILKICDFGLAREYGSPLKPYTQL--------------VVTLWYRA 174
Query: 713 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL---- 768
PE+L + Y +D+WS GC+ ELLT + + G SE++ Q+ K +L
Sbjct: 175 PELLLGAKE---YSTAIDMWSVGCIFAELLTKKPLFPGKSEID-----QLNKIFKLLGTP 226
Query: 769 TDE-------LEALGSCH--EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819
T++ L ++ Q F P L F D+ R +P +R
Sbjct: 227 TEKIWPGFSELPGAKKKTFTKYPYNQLRKKF--PALSLSDNGF--DLLNRLLTYDPAKRI 282
Query: 820 TAGD 823
+A D
Sbjct: 283 SAED 286
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 6e-11
Identities = 53/226 (23%), Positives = 86/226 (38%), Gaps = 58/226 (25%)
Query: 612 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 671
Y+ K + G + + + + + + LHS I+HRD+K +NIL+ + +
Sbjct: 95 YLSKCPKPG---LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ------ 145
Query: 672 VVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 725
VK+ DF + L S V T + APEVL + Y
Sbjct: 146 -VKIADFGLARIYSFEMALTS-----------------VVVTLWYRAPEVL--LQSS--Y 183
Query: 726 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE--- 782
VD+WS GC+ EL + + G SE + D I + +G E E
Sbjct: 184 ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI-----------FDVIGLPSEEEWPR 232
Query: 783 -VAQSGSGFE----KPEAEL--ETLSFLVDVFRRCTEENPTERPTA 821
V+ S F + E +D+ ++ NP +R +A
Sbjct: 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-11
Identities = 51/172 (29%), Positives = 83/172 (48%), Gaps = 34/172 (19%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
MEYV GG + ++ + E+ S F ++ +AL LHS I++RD+K EN+++
Sbjct: 74 MEYVNGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML 128
Query: 661 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717
D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 129 D-----KDGH--IKITDFGLCKEGITDAATMKTFC-------------GTPEYLAPEVL- 167
Query: 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG--KRPR 767
+ N YG VD W G ++ E++ ++P+ ++ +LI M K PR
Sbjct: 168 ---EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR 216
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 41/115 (35%), Positives = 52/115 (45%), Gaps = 23/115 (20%)
Query: 639 ALVELHSKH-IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG 697
AL L KH ++HRD+K NIL+D A G VKLCDF I+ R
Sbjct: 126 ALHYLKEKHGVIHRDVKPSNILLD-----ASG--NVKLCDFG-------------ISGRL 165
Query: 698 IP--APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 750
+ A G +MAPE + Y + D+WS G L+EL T Q PY
Sbjct: 166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 74/309 (23%), Positives = 114/309 (36%), Gaps = 83/309 (26%)
Query: 532 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 591
V+TL S DE +F L E ++ H IV + G S + P
Sbjct: 38 QVAVKTLPESCSEQDES-DF----LMEALIMSKFNHQNIVRLIG--------VSFERLPR 84
Query: 592 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA--LFIAQDVAAALVELHSKHIM 649
I +E + GG +K+++ + E+ S+ + LF A+DVA L H +
Sbjct: 85 F------ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFI 138
Query: 650 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-----C 704
HRDI + N L+ K G+ V K+ DF A R I
Sbjct: 139 HRDIAARNCLLT---CKGPGR-VAKIADFGMA--------------RDIYRASYYRKGGR 180
Query: 705 VGTP-RWMAPEVLRAMHKPNLYGL---EVDIWSYGCLLLELLTL-QVPYMGLSELEIHDL 759
P +WM PE L G+ + D+WS+G LL E+ +L +PY G + E+ +
Sbjct: 181 AMLPIKWMPPEAF-------LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233
Query: 760 IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819
+ G R L+ C P + + C + P +RP
Sbjct: 234 VTGGGR------LDPPKGC--------------PGP-------VYRIMTDCWQHTPEDRP 266
Query: 820 TAGDLYEMF 828
+ E
Sbjct: 267 NFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 8e-11
Identities = 60/267 (22%), Positives = 108/267 (40%), Gaps = 64/267 (23%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E ++L L H IV+ + + I EY +G + +E+L
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAF--------------CIITEYCEGRDLDCKLEELK 97
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
TG+ ++ + Q + + +H + I+HRD+K++NI + ++K+ D
Sbjct: 98 HTGKTLSENQVCEWFIQ-LLLGVHYMHQRRILHRDLKAKNIFLK--------NNLLKIGD 148
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F + R + +C +A GTP +M+PE L+ H+ Y + DIWS GC+
Sbjct: 149 FGVS---RLLMGSCDLA-------TTFTGTPYYMSPEALK--HQG--YDSKSDIWSLGCI 194
Query: 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 797
L E+ L + G + L + I G P L PE
Sbjct: 195 LYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL------------------------PETYS 230
Query: 798 ETLSFLVDVFRRCTEENPTERPTAGDL 824
L+ ++ ++P+ RP+A ++
Sbjct: 231 RQLNSIMQ---SMLNKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 66/256 (25%), Positives = 102/256 (39%), Gaps = 41/256 (16%)
Query: 514 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVE 572
GK +++ + A V+ L D I + + E +L +L H +V+
Sbjct: 31 GKGTYGKVYKVTNKKDGSLAAVKIL-------DPISDVDEEIEAEYNILQSLPNHPNVVK 83
Query: 573 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFI 632
YG + L Q + +E GGSV ++ L G++ ++ +I
Sbjct: 84 FYGMFYKADKLVGG---------QLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS-YI 133
Query: 633 AQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCC 692
L LH+ I+HRD+K NIL+ E VKL DF + L T
Sbjct: 134 LYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG-------VKLVDFGVSAQL-----TST 181
Query: 693 IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL-YGLEVDIWSYGCLLLELLTLQVPYMGL 751
R + VGTP WMAPEV+ + + Y D+WS G +EL P
Sbjct: 182 RLRR-----NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL--- 233
Query: 752 SELEIHDLIQMGKRPR 767
++H + + K PR
Sbjct: 234 --FDMHPVKTLFKIPR 247
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 9e-11
Identities = 38/118 (32%), Positives = 57/118 (48%), Gaps = 29/118 (24%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRA--VPLRSFLHTCCIAHRGI 698
H +MHRD+K +N+L+D K ++K+ D RA +P++S+ H
Sbjct: 126 CHKHGVMHRDLKPQNLLVD------KQKGLLKIADLGLGRAFSIPVKSYTHE-------- 171
Query: 699 PAPDVCVGTPRWMAPEVLR-AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 755
+ T + APEVL + H Y VDIWS GC+ E+ Q + G SEL+
Sbjct: 172 ------IVTLWYRAPEVLLGSTH----YSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 51/198 (25%), Positives = 78/198 (39%), Gaps = 46/198 (23%)
Query: 632 IAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 690
IA + AL LHSK ++HRD+K N+LI+ + VKLCDF + L +
Sbjct: 108 IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ-------VKLCDFGISGYLVDSV-- 158
Query: 691 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 750
A + G +MAPE + Y ++ D+WS G ++EL T + PY
Sbjct: 159 ---------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY-- 207
Query: 751 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRR 809
+ L +V + S P+ E S D +
Sbjct: 208 ---------------DSWKTPFQQL-----KQVVEEPS----PQLPAEKFSPEFQDFVNK 243
Query: 810 CTEENPTERPTAGDLYEM 827
C ++N ERP +L +
Sbjct: 244 CLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 47/158 (29%), Positives = 73/158 (46%), Gaps = 31/158 (19%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+ + + GG +K +I + G + + ALF A ++ L +LH ++ ++RD+K ENI
Sbjct: 77 LVLTIMNGGDLKFHIYNMGNPGFEE---ERALFYAAEILCGLEDLHRENTVYRDLKPENI 133
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEV 715
L+D G +++ D AV IP + VGT +MAPEV
Sbjct: 134 LLD-----DYGH--IRISDLGLAVK--------------IPEGESIRGRVGTVGYMAPEV 172
Query: 716 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE 753
L Y L D W GCL+ E++ Q P+ G E
Sbjct: 173 L----NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 43/148 (29%), Positives = 67/148 (45%), Gaps = 25/148 (16%)
Query: 606 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 665
GG +K +I + G + A+F A ++ L +LH + I++RD+K ENIL+D
Sbjct: 84 GGDLKFHIYNMGNPGFDE---ERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD---- 136
Query: 666 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 725
+++ D AV + I R VGT +MAPEV+ K Y
Sbjct: 137 ---DYGHIRISDLGLAVEIPE---GETIRGR--------VGTVGYMAPEVV----KNERY 178
Query: 726 GLEVDIWSYGCLLLELLTLQVPYMGLSE 753
D W GCL+ E++ + P+ E
Sbjct: 179 TFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 58/240 (24%), Positives = 90/240 (37%), Gaps = 56/240 (23%)
Query: 595 LQSAIF--MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHR 651
++ A++ MEY+ GS+ T V L I V L L +H I+HR
Sbjct: 70 IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDV-LR-RITYAVVKGLKFLKEEHNIIHR 127
Query: 652 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 711
D+K N+L+ +G VKLCDF + L + L I G +M
Sbjct: 128 DVKPTNVLV-------NGNGQVKLCDFGVSGNLVASLAKTNI------------GCQSYM 168
Query: 712 APEVLRA--MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM---GKRP 766
APE +++ ++ Y ++ D+WS G +LE+ + PY + I + G P
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP 228
Query: 767 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
L +A+ D +C + P RPT L E
Sbjct: 229 TLPSGYS-------------------DDAQ--------DFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 39/117 (33%), Positives = 61/117 (52%), Gaps = 30/117 (25%)
Query: 644 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA----VPLRSFLH-TCCIAHRGI 698
HS+ ++HRD+K +N+LI D K V+KL DF A +P+R + H + +R
Sbjct: 118 HSRRVLHRDLKPQNLLI-------DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYR-- 168
Query: 699 PAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 755
AP+V +G+PR+ P VDIWS G + E+ T + + G SE++
Sbjct: 169 -APEVLLGSPRYSTP---------------VDIWSIGTIFAEMATKKPLFHGDSEID 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 44/150 (29%), Positives = 69/150 (46%), Gaps = 31/150 (20%)
Query: 610 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 669
K Y++ TG +K ++ Q + + HS ++HRD+K +N+LID E
Sbjct: 85 KKYMDSSPLTGLDPPLIKS--YLYQ-LLQGIAYCHSHRVLHRDLKPQNLLIDREG----- 136
Query: 670 KPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 725
+KL DF A VP+R++ H V T + APE+L Y
Sbjct: 137 --ALKLADFGLARAFGVPVRTYTHE--------------VVTLWYRAPEILLGSR---QY 177
Query: 726 GLEVDIWSYGCLLLELLTLQVPYMGLSELE 755
VDIWS GC+ E++ + + G SE++
Sbjct: 178 STPVDIWSIGCIFAEMVNRRPLFPGDSEID 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 67/249 (26%), Positives = 106/249 (42%), Gaps = 57/249 (22%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+ LK SA + +F+ E +L L+H IV YG +G P
Sbjct: 40 VKALKEASESARQ--DFQR----EAELLTVLQHQHIVRFYG--------VCTEGRP---- 81
Query: 595 LQSAIFMEYVKGGSVKNYIE------KLSETGEKHVSVKLAL----FIAQDVAAALVELH 644
+ EY++ G + ++ K+ GE +L L IA +A+ +V L
Sbjct: 82 --LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA 139
Query: 645 SKHIMHRDIKSENILI--DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 702
S H +HRD+ + N L+ L VVK+ DF + + S + +P
Sbjct: 140 SLHFVHRDLATRNCLVGQGL---------VVKIGDFGMSRDIYSTDYYRVGGRTMLPI-- 188
Query: 703 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQ 761
RWM PE + +++ + E DIWS+G +L E+ T + P+ LS E + I
Sbjct: 189 ------RWMPPESI--LYRK--FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238
Query: 762 MGK---RPR 767
G+ RPR
Sbjct: 239 QGRELERPR 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-10
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 35/205 (17%)
Query: 556 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI-- 613
L E ++ L H IV +Y I S DG+P ++ M Y++G ++K+ +
Sbjct: 50 LREAKIAADLIHPGIVPVY--SICS------DGDPVYYT------MPYIEGYTLKSLLKS 95
Query: 614 ----EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 669
E LS+ + SV L I + A + +HSK ++HRD+K +NIL+ L G
Sbjct: 96 VWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF-----G 150
Query: 670 KPVV------KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 723
+ V+ + L + I + + P VGTP +MAPE L
Sbjct: 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG----V 206
Query: 724 LYGLEVDIWSYGCLLLELLTLQVPY 748
DI++ G +L ++LTL PY
Sbjct: 207 PASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 1e-10
Identities = 57/205 (27%), Positives = 87/205 (42%), Gaps = 62/205 (30%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI-PAP 701
LHS +++HRD+K NIL++ +K+CDF A RG+ P
Sbjct: 119 LHSANVIHRDLKPSNILVNSN-------CDLKICDFGLA--------------RGVDPDE 157
Query: 702 DVC------VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 754
D V T RW APE+L + + Y +DIWS GC+ ELLT + + G +
Sbjct: 158 DEKGFLTEYVVT-RWYRAPELLLSSSR---YTKAIDIWSVGCIFAELLTRKPLFPGRDYI 213
Query: 755 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-----LVDVFRR 809
+ +LI +E LG+ E ++ S EK L++L L +F
Sbjct: 214 DQLNLI-----------VEVLGTPSEEDLKFITS--EKARNYLKSLPKKPKKPLSKLFPG 260
Query: 810 CTEE-----------NPTERPTAGD 823
+ E +P +R TA +
Sbjct: 261 ASPEAIDLLEKMLVFDPKKRITADE 285
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 47/203 (23%), Positives = 80/203 (39%), Gaps = 59/203 (29%)
Query: 630 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 689
L IA+ VAA + L + +HRD+ + N L+ VVK+ DF +
Sbjct: 133 LCIAKQVAAGMAYLSERKFVHRDLATRNCLV-------GENMVVKIADFGLS-------- 177
Query: 690 TCCIAHRGIPAPDVCVGTP------RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743
R I + D + RWM PE + N Y E D+W+YG +L E+ +
Sbjct: 178 ------RNIYSADYYKASENDAIPIRWMPPESIFY----NRYTTESDVWAYGVVLWEIFS 227
Query: 744 LQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 802
+ PY G++ E+ ++ G + SC ++
Sbjct: 228 YGMQPYYGMAHEEVIYYVRDGN----------VLSCPDN-----------------CPLE 260
Query: 803 LVDVFRRCTEENPTERPTAGDLY 825
L ++ R C + P++RP+ +
Sbjct: 261 LYNLMRLCWSKLPSDRPSFASIN 283
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 51/189 (26%), Positives = 86/189 (45%), Gaps = 37/189 (19%)
Query: 603 YVKGGSVKNYIEK---LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659
Y+ G++K ++++ + +S + + +A +A + LH + ++H+DI + N +
Sbjct: 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCV 149
Query: 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT----P-RWMAPE 714
ID E + VK+ D A+ F P C+G P +WMA E
Sbjct: 150 IDEELQ-------VKITD--NALSRDLF-----------PMDYHCLGDNENRPVKWMALE 189
Query: 715 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR----PRLT 769
L Y D+WS+G LL EL+TL Q PY+ + E+ ++ G R
Sbjct: 190 SL----VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCP 245
Query: 770 DELEALGSC 778
DEL A+ +C
Sbjct: 246 DELFAVMAC 254
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 88/324 (27%), Positives = 127/324 (39%), Gaps = 97/324 (29%)
Query: 526 FGSADAAAKVRTLKVCGSSADEIRNFEYS----------CLGEVRMLGALRHSCIVEMYG 575
FG+ A VRT +V I+ YS + EV+ L ++H +E G
Sbjct: 38 FGAVYFARDVRTNEVVA-----IKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQD 635
+ EH + + MEY G + L E +K + I
Sbjct: 93 CYLR-----------EH---TAWLVMEYCLGSA-----SDLLEVHKKPLQEVEIAAITHG 133
Query: 636 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV---PLRSFLHTCC 692
L LHS +++HRDIK+ NIL+ + VKL DF A P SF
Sbjct: 134 ALQGLAYLHSHNMIHRDIKAGNILLTEPGQ-------VKLADFGSASIASPANSF----- 181
Query: 693 IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS 752
VGTP WMAPEV+ AM + Y +VD+WS G +EL + P +
Sbjct: 182 ------------VGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPLFNM- 227
Query: 753 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR--- 809
+ + AL + +AQ+ E P + S D FR
Sbjct: 228 -----------------NAMSAL-----YHIAQN----ESPTLQSNEWS---DYFRNFVD 258
Query: 810 -CTEENPTERPTAGDLYE-MFVAR 831
C ++ P +RPT+ +L + MFV R
Sbjct: 259 SCLQKIPQDRPTSEELLKHMFVLR 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 57/226 (25%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
I EY++ GS+ ++++ + G K KL AQ +A + + K+ +HRD+++ NI
Sbjct: 77 IITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQ-IAEGMAFIERKNYIHRDLRAANI 133
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718
L+ K+ DF A R A G P +W APE +
Sbjct: 134 LVSETL-------CCKIADFGLA---RLIEDNEYTAREGAKFP------IKWTAPEAIN- 176
Query: 719 MHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEA 774
YG ++ D+WS+G LL E++T ++PY G++ E+ ++ G R D
Sbjct: 177 ------YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPD---- 226
Query: 775 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820
+C PE L ++ R C +E P ERPT
Sbjct: 227 --NC--------------PEE-------LYELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 37/276 (13%)
Query: 554 SCLGEVRMLGALRHSCIVEMYGHKI--SSKWLPSADGNPEHHLLQSA-IFMEYVKGGSVK 610
L E++++ L H IV++Y + S L G+ L S I EY++ +
Sbjct: 48 HALREIKIIRRLDHDNIVKVY-EVLGPSGSDLTEDVGSLTE--LNSVYIVQEYMET-DLA 103
Query: 611 NYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 670
N +E+ E+H LF+ Q + L +HS +++HRD+K N+ I+ E
Sbjct: 104 NVLEQ-GPLSEEHAR----LFMYQ-LLRGLKYIHSANVLHRDLKPANVFINTE------D 151
Query: 671 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEV 729
V+K+ DF A + +H+G + + +W +P +L + PN Y +
Sbjct: 152 LVLKIGDFGLARIVDPHY-----SHKGYLSEGL---VTKWYRSPRLLLS---PNNYTKAI 200
Query: 730 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP--RLTDELEALGSCHEHEVAQSG 787
D+W+ GC+ E+LT + + G ELE LI + P R D E L + V G
Sbjct: 201 DMWAAGCIFAEMLTGKPLFAGAHELEQMQLI-LESVPVVREEDRNELL-NVIPSFVRNDG 258
Query: 788 SGFEKPEAEL--ETLSFLVDVFRRCTEENPTERPTA 821
+P +L +D + NP +R TA
Sbjct: 259 GEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 48/166 (28%), Positives = 72/166 (43%), Gaps = 31/166 (18%)
Query: 602 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661
+Y+ GG + +++K E S A F ++ AL LH I++RD+K ENIL+D
Sbjct: 76 DYMSGGELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD 130
Query: 662 LERKKADGKPVVKLCDFDRAVPLRS---FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718
A G + LCDF + + +T C GT ++APEVL
Sbjct: 131 -----ATGH--IALCDFGLSKANLTDNKTTNTFC-------------GTTEYLAPEVLL- 169
Query: 719 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
Y VD WS G L+ E+ P+ +++ I GK
Sbjct: 170 --DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK 213
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 39/115 (33%), Positives = 53/115 (46%), Gaps = 27/115 (23%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKP--VVKLCDFDRA----VPLRSFLHTCCIAHR 696
LHS ++HRD+K NIL+ +G VVK+ D A PL+
Sbjct: 124 LHSNWVLHRDLKPANILV-----MGEGPERGVVKIGDLGLARLFNAPLKPLADL------ 172
Query: 697 GIPAPDVCVGTPRWMAPEVLR-AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 750
D V T + APE+L A H Y +DIW+ GC+ ELLTL+ + G
Sbjct: 173 -----DPVVVTIWYRAPELLLGARH----YTKAIDIWAIGCIFAELLTLEPIFKG 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 61/217 (28%), Positives = 87/217 (40%), Gaps = 53/217 (24%)
Query: 558 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 615
EVR L LRH ++ G + + WL MEY G +
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWL----------------VMEYCLGSA-----SD 103
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP-VVK 674
L E +K + + L LHS +++HRD+K+ NIL+ +P +VK
Sbjct: 104 LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS--------EPGLVK 155
Query: 675 LCDFDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 731
L DF A P F VGTP WMAPEV+ AM + Y +VD+
Sbjct: 156 LGDFGSASIMAPANXF-----------------VGTPYWMAPEVILAMDEGQ-YDGKVDV 197
Query: 732 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 768
WS G +EL + P ++ + I + P L
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 234
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 56/178 (31%), Positives = 81/178 (45%), Gaps = 42/178 (23%)
Query: 592 HHLLQSA----IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 647
H+ Q+A ++YV GG + ++++ E+ A F A +VA+A+ LHS +
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHSLN 116
Query: 648 IMHRDIKSENILIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVC 704
I++RD+K ENIL+D + V L DF V T C
Sbjct: 117 IIYRDLKPENILLDSQGH-------VVLTDFGLCKEGVEPEETTSTFC------------ 157
Query: 705 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 762
GTP ++APEVLR +P Y VD W G +L E+L GL D+ QM
Sbjct: 158 -GTPEYLAPEVLR--KEP--YDRTVDWWCLGAVLYEML------YGLPPFYSRDVSQM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 50/146 (34%), Positives = 71/146 (48%), Gaps = 23/146 (15%)
Query: 607 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 666
VKN LS+ G + ++ L VA + L SK+ +HRD+ + N+L+
Sbjct: 220 SEVKNL---LSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL------ 270
Query: 667 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 726
A GK +VK+CDF A R +H +G V +WMAPE + NLY
Sbjct: 271 AQGK-IVKICDFGLA---RDIMHDSNYVSKGSTFLPV-----KWMAPESIF----DNLYT 317
Query: 727 LEVDIWSYGCLLLELLTL-QVPYMGL 751
D+WSYG LL E+ +L PY G+
Sbjct: 318 TLSDVWSYGILLWEIFSLGGTPYPGM 343
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 51/163 (31%), Positives = 79/163 (48%), Gaps = 32/163 (19%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
+++V GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 75 LDFVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL 129
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV---GTPRWMAPEVLR 717
D + G V L DF + GI D GTP ++APEV+R
Sbjct: 130 D-----SQGHVV--LTDFG-------------LCKEGIAQSDTTTTFCGTPEYLAPEVIR 169
Query: 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 760
+P Y VD W G +L E+L P+ E++D I
Sbjct: 170 --KQP--YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 70/276 (25%), Positives = 106/276 (38%), Gaps = 78/276 (28%)
Query: 556 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 615
L E R+L H IV++ G + ++ P I ME V GG +++ K
Sbjct: 40 LSEARILKQYDHPNIVKLIG--VCTQRQPIY------------IVMELVPGGDFLSFLRK 85
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
+ + VK AL D AA + L SK+ +HRD+ + N L+ V+K+
Sbjct: 86 KKDELKTKQLVKFAL----DAAAGMAYLESKNCIHRDLAARNCLVGENN-------VLKI 134
Query: 676 CDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 729
DF D + S L + IP +W APE L Y E
Sbjct: 135 SDFGMSRQEDDGIYSSSGL-------KQIPI--------KWTAPEALNY----GRYSSES 175
Query: 730 DIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 788
D+WSYG LL E +L V PY G++ + + ++ G R + C +
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR------MSCPQKCPDD------- 222
Query: 789 GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 824
+ V +RC + P RP +L
Sbjct: 223 --------------VYKVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 65/247 (26%), Positives = 103/247 (41%), Gaps = 53/247 (21%)
Query: 514 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 573
G+ + +C+ ++ K ++E + + L E++ML L+ IVE+
Sbjct: 10 GEGAYGVVLKCRHKETKEIVAIKKFK----DSEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 574 YGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYIEKLSETGEKHVSVKLALF 631
E + +++ EYV+ KN +E L E K+ +
Sbjct: 66 ----------------KEAFRRRGKLYLVFEYVE----KNMLELLEEMPNGVPPEKVRSY 105
Query: 632 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFL--- 688
I Q + A+ H I+HRDIK EN+LI V+KLCDF A L
Sbjct: 106 IYQ-LIKAIHWCHKNDIVHRDIKPENLLIS-------HNDVLKLCDFGFARNLSEGSNAN 157
Query: 689 HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 748
+T +A R +P++ +G P YG VD+WS GC+L EL Q +
Sbjct: 158 YTEYVATRWYRSPELLLGAP----------------YGKAVDMWSVGCILGELSDGQPLF 201
Query: 749 MGLSELE 755
G SE++
Sbjct: 202 PGESEID 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 28/128 (21%)
Query: 644 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIP 699
HS ++HRD+K +N+LID +KL DF A +P+R+F H
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTN------ALKLADFGLARAFGIPVRTFTHE--------- 163
Query: 700 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHD 758
V T + APE+L Y VDIWS GC+ E++ + + G SE+ E+
Sbjct: 164 -----VVTLWYRAPEILLGSRH---YSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK 215
Query: 759 LIQMGKRP 766
+ ++ P
Sbjct: 216 IFRILGTP 223
|
Length = 294 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 33/166 (19%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENIL 659
MEY GG + ++ + E+ S A F ++ +AL LHS K++++RD+K EN++
Sbjct: 74 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 128
Query: 660 IDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 716
+D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 129 LD-----KDGH--IKITDFGLCKEGIKDGATMKTFC-------------GTPEYLAPEVL 168
Query: 717 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 762
+ N YG VD W G ++ E++ ++P+ ++ +LI M
Sbjct: 169 ----EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 67/235 (28%), Positives = 113/235 (48%), Gaps = 52/235 (22%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+TLK G+ + E S L E +++ LRH +V++Y + S+ P +
Sbjct: 35 VKTLKP-GTMSPE------SFLEEAQIMKKLRHDKLVQLYA--VVSE-------EPIY-- 76
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
I EY+ GS+ ++ L + + + + + +A VAA + + + +HRD++
Sbjct: 77 ----IVTEYMSKGSLLDF---LKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLR 129
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714
S NIL+ DG V K+ DF A + +T A +G P +W APE
Sbjct: 130 SANILV------GDGL-VCKIADFGLARLIEDNEYT---ARQGAKFP------IKWTAPE 173
Query: 715 VLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 765
LYG ++ D+WS+G LL EL+T +VPY G++ E+ + ++ G R
Sbjct: 174 AA-------LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR 221
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 9e-10
Identities = 54/232 (23%), Positives = 98/232 (42%), Gaps = 43/232 (18%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
++TLK GSS + +F L E ++G H I+ + G S+ +
Sbjct: 37 IKTLKA-GSSDKQRLDF----LTEASIMGQFDHPNIIRLEGVVTKSRPV----------- 80
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
I EY++ GS+ + L E K +L + + + +A+ + L + +HRD+
Sbjct: 81 ---MIITEYMENGSLDKF---LRENDGKFTVGQL-VGMLRGIASGMKYLSEMNYVHRDLA 133
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714
+ NIL++ V K+ DF + L T IP RW APE
Sbjct: 134 ARNILVNSNL-------VCKVSDFGLSRRLEDSEATYTTKGGKIPI--------RWTAPE 178
Query: 715 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 765
+ + D+WS+G ++ E+++ + PY +S ++ ++ G R
Sbjct: 179 AIAYRK----FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR 226
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 9e-10
Identities = 54/195 (27%), Positives = 75/195 (38%), Gaps = 63/195 (32%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
M+Y+ GG + + + +L E LA F ++ A+ +H +HRDIK +NILI
Sbjct: 80 MDYIPGGDMMSLLIRLGIFEED-----LARFYIAELTCAIESVHKMGFIHRDIKPDNILI 134
Query: 661 DLERKKADGKPVVKLCDF-----------------------------------DRAVP-- 683
D DG +KL DF DR
Sbjct: 135 DR-----DGH--IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKP 187
Query: 684 ---LRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740
R H C+AH VGTP ++APEVL Y D WS G +L E
Sbjct: 188 LERRRKRQHQRCLAHS-------LVGTPNYIAPEVLLRTG----YTQLCDWWSVGVILYE 236
Query: 741 LLTLQVPYMGLSELE 755
+L Q P++ + E
Sbjct: 237 MLVGQPPFLADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 59/234 (25%), Positives = 88/234 (37%), Gaps = 65/234 (27%)
Query: 598 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657
+I E++ GGS+ Y K+ E HV + IA V L L S I+HRD+K N
Sbjct: 75 SICTEFMDGGSLDVY-RKIPE----HVLGR----IAVAVVKGLTYLWSLKILHRDVKPSN 125
Query: 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717
+L++ + VKLCDF + L + + VGT +MAPE +
Sbjct: 126 MLVNTRGQ-------VKLCDFGVSTQLVNSIAK------------TYVGTNAYMAPERIS 166
Query: 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM-------GLSELEIHDLIQMGKRPRLTD 770
YG+ D+WS G +EL + PY L L++ I P L
Sbjct: 167 GEQ----YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV 222
Query: 771 ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 824
+ ++ V +C + P ERP +L
Sbjct: 223 ----------GQFSEK----------------FVHFITQCMRKQPKERPAPENL 250
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 70/292 (23%), Positives = 122/292 (41%), Gaps = 69/292 (23%)
Query: 543 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 602
S+A+ +R+FE E+ +L +L+H IV+ G S+ G L+ ME
Sbjct: 44 STAEHLRDFER----EIEILKSLQHDNIVKYKGVCYSA-------GRRNLRLV-----ME 87
Query: 603 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662
Y+ GS+++Y++K E+ KL L+ +Q + + L SK +HRD+ + NIL++
Sbjct: 88 YLPYGSLRDYLQK---HRERLDHRKLLLYASQ-ICKGMEYLGSKRYVHRDLATRNILVES 143
Query: 663 ERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR-----WMAPEV 715
E + VK+ DF + +P + V P W APE
Sbjct: 144 ENR-------VKIGDFGLTKVLPQDKEYYK--------------VREPGESPIFWYAPES 182
Query: 716 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL 775
L + + + D+WS+G +L EL T + MG D+ +
Sbjct: 183 L----TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMR---MMGN-----DKQGQM 230
Query: 776 GSCHEHEVAQSGSGFEKPE---AELETLSFLVDVFRRCTEENPTERPTAGDL 824
H E+ ++ P AE+ + + C +P++RP+ +L
Sbjct: 231 IVYHLIELLKNNGRLPAPPGCPAEIYAI------MKECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 66/269 (24%), Positives = 115/269 (42%), Gaps = 72/269 (26%)
Query: 556 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 615
L E +++ LRH +V +Y P + I E++ GS+ ++
Sbjct: 49 LQEAQIMKKLRHDKLVPLYA---------VVSEEPIY------IVTEFMGKGSLLDF--- 90
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
L E K++ + + +A +A + + + +HRD+++ NIL+ D V K+
Sbjct: 91 LKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV------GDNL-VCKI 143
Query: 676 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIW 732
DF A + +T A +G P +W APE LYG ++ D+W
Sbjct: 144 ADFGLARLIEDNEYT---ARQGAKFP------IKWTAPEAA-------LYGRFTIKSDVW 187
Query: 733 SYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 791
S+G LL EL+T +VPY G+ E+ + ++ G R + C
Sbjct: 188 SFGILLTELVTKGRVPYPGMVNREVLEQVERGYR------MPCPQGC------------- 228
Query: 792 KPEAELETLSFLVDVFRRCTEENPTERPT 820
PE+ L ++ + C +++P ERPT
Sbjct: 229 -PES-------LHELMKLCWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 53/160 (33%), Positives = 80/160 (50%), Gaps = 26/160 (16%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
++Y+ GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 75 LDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL 129
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720
D + G V L DF L I H G + GTP ++APEVL H
Sbjct: 130 D-----SQGHIV--LTDFG--------LCKENIEHNGTTS--TFCGTPEYLAPEVL---H 169
Query: 721 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 760
K Y VD W G +L E+L P+ + E++D I
Sbjct: 170 K-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 67/240 (27%), Positives = 100/240 (41%), Gaps = 55/240 (22%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
I MEY+ GGS + + + E ++ L +++ L LHS+ +HRDIK+ N+
Sbjct: 79 IIMEYLGGGSALDLL-RAGPFDEFQIATML-----KEILKGLDYLHSEKKIHRDIKAANV 132
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718
L+ + VKL DF A L T R + VGTP WMAPEV++
Sbjct: 133 LLSEQGD-------VKLADFGVAGQL-----TDTQIKR-----NTFVGTPFWMAPEVIQQ 175
Query: 719 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 778
+ Y + DIWS G +EL + P + + + LI P LT E
Sbjct: 176 ----SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGE------- 224
Query: 779 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSSIS 837
F KP E C ++P+ RPTA +L + F+ + + S
Sbjct: 225 -----------FSKPFKEF---------IDACLNKDPSFRPTAKELLKHKFIVKNAKKTS 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 53/188 (28%), Positives = 90/188 (47%), Gaps = 37/188 (19%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E ++L L+H IV Y W DG I M + +GG + + +++
Sbjct: 49 EAQLLSQLKHPNIV-AY----RESW-EGEDG-------LLYIVMGFCEGGDLYHKLKE-- 93
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
+ G+ ++ + Q +A AL LH KHI+HRD+K++N+ L R ++K+ D
Sbjct: 94 QKGKLLPENQVVEWFVQ-IAMALQYLHEKHILHRDLKTQNVF--LTRTN-----IIKVGD 145
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
A R + C +A +GTP +M+PE+ +KP Y + D+W+ GC
Sbjct: 146 LGIA---RVLENQCDMA-------STLIGTPYYMSPELFS--NKP--YNYKSDVWALGCC 191
Query: 738 LLELLTLQ 745
+ E+ TL+
Sbjct: 192 VYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 68/255 (26%), Positives = 105/255 (41%), Gaps = 58/255 (22%)
Query: 598 AIFMEYVKGGSVKNYIEKLSETGEKHV-SVKLALFIAQDVAAALVELHSKH-IMHRDIKS 655
+I ME++ GGS+ ++K E+ + V +A V L L KH IMHRD+K
Sbjct: 79 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA------VIKGLTYLREKHKIMHRDVKP 132
Query: 656 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 715
NIL+ + + +KLCDF + L + + VGT +M+PE
Sbjct: 133 SNILV-------NSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPER 173
Query: 716 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL 775
L+ H Y ++ DIWS G L+E+ + P + + +L M P D E+
Sbjct: 174 LQGTH----YSVQSDIWSMGLSLVEMAIGRYP---IPPPDAKELELMFGCPVEGDPAESE 226
Query: 776 GSCHEHEVAQSGSGF----EKPEAELETLSFLV-----------------DVFRRCTEEN 814
S + S + P A E L ++V D +C +N
Sbjct: 227 TSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKN 286
Query: 815 PTERPTAGDLYEMFV 829
P ER DL ++ V
Sbjct: 287 PAER---ADLKQLMV 298
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 50/156 (32%), Positives = 71/156 (45%), Gaps = 28/156 (17%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 702
LHS I+HRDIK N+L+ + V+K+CDF A + + +
Sbjct: 119 LHSAGILHRDIKPGNLLV-------NSNCVLKICDFGLA-RVEEPDESKHMTQE------ 164
Query: 703 VCVGTPRWMAPEVLR-AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 761
V T + APE+L + H Y VDIWS GC+ ELL ++ + S ++ DLI
Sbjct: 165 --VVTQYYRAPEILMGSRH----YTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218
Query: 762 --MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 795
+G T LEA+ S E A G KP +
Sbjct: 219 DLLG-----TPSLEAMRSACEGARAHILRGPHKPPS 249
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 66/271 (24%), Positives = 99/271 (36%), Gaps = 78/271 (28%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
M+Y+ GG + + + ++ E LA F ++ A+ +H +HRDIK +NILI
Sbjct: 80 MDYIPGGDMMSLLIRMEVFPEV-----LARFYIAELTLAIESVHKMGFIHRDIKPDNILI 134
Query: 661 DLERKKADGKPVVKLCDF-----------------------------------------D 679
DL DG +KL DF D
Sbjct: 135 DL-----DGH--IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGD 187
Query: 680 RAVPLRSFL---HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736
R L H C+AH VGTP ++APEVL + K Y D WS G
Sbjct: 188 RLKTLEQRATKQHQRCLAHS-------LVGTPNYIAPEVL--LRKG--YTQLCDWWSVGV 236
Query: 737 LLLELLTLQVPYMGLSELE-----------IHDLIQMGKRPRLTDELEALGSCHEHEVAQ 785
+L E+L Q P++ + E +H Q+ P D + L E + +
Sbjct: 237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGR 296
Query: 786 SGSGFEKPEAELETLSFLVDVFRRCTEENPT 816
+G+ K + F D+ + P
Sbjct: 297 NGADDIKAHPFFSEVDFSSDIRTQPAPYVPK 327
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 51/195 (26%), Positives = 85/195 (43%), Gaps = 50/195 (25%)
Query: 636 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 695
VA + L SK+ +HRD+ + NIL+ R + K+CDF A +R+ + +
Sbjct: 223 VAKGMSFLASKNCIHRDLAARNILLTHGR-------ITKICDFGLARDIRNDSNYVVKGN 275
Query: 696 RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLS-E 753
+P +WMAPE + +Y E D+WSYG LL E+ +L PY G+ +
Sbjct: 276 ARLPV--------KWMAPESIFNC----VYTFESDVWSYGILLWEIFSLGSSPYPGMPVD 323
Query: 754 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE-AELETLSFLVDVFRRCTE 812
+ + +I+ G R PE A E + D+ + C +
Sbjct: 324 SKFYKMIKEGYR------------------------MLSPECAPSE----MYDIMKSCWD 355
Query: 813 ENPTERPTAGDLYEM 827
+P +RPT + ++
Sbjct: 356 ADPLKRPTFKQIVQL 370
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 45/214 (21%)
Query: 556 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 615
L E +++ LRH +V++Y P + I EY+ GS+ ++++
Sbjct: 49 LQEAQVMKKLRHEKLVQLYA---------VVSEEPIY------IVTEYMSKGSLLDFLK- 92
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
E G+ +L AQ +A+ + + + +HRD+++ NIL+ V K+
Sbjct: 93 -GEMGKYLRLPQLVDMAAQ-IASGMAYVERMNYVHRDLRAANILVG-------ENLVCKV 143
Query: 676 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIW 732
DF A + +T A +G P +W APE LYG ++ D+W
Sbjct: 144 ADFGLARLIEDNEYT---ARQGAKFP------IKWTAPEAA-------LYGRFTIKSDVW 187
Query: 733 SYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 765
S+G LL EL T +VPY G+ E+ D ++ G R
Sbjct: 188 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 221
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 67/271 (24%), Positives = 102/271 (37%), Gaps = 78/271 (28%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
M+Y+ GG + + + ++ E LA F ++ A+ +H +HRDIK +NILI
Sbjct: 80 MDYIPGGDMMSLLIRMGIFPED-----LARFYIAELTCAVESVHKMGFIHRDIKPDNILI 134
Query: 661 DLERKKADGKPVVKLCDF-----------------------------------------D 679
D DG +KL DF D
Sbjct: 135 D-----RDGH--IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGD 187
Query: 680 RAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736
R PL + H C+AH VGTP ++APEVL L D WS G
Sbjct: 188 RLKPLERRAARQHQRCLAHS-------LVGTPNYIAPEVLLRTGYTQL----CDWWSVGV 236
Query: 737 LLLELLTLQVPYMGLSELE-----------IHDLIQMGKRPRLTDELEALGSCHEHEVAQ 785
+L E+L Q P++ + LE +H Q P +D + L E + +
Sbjct: 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGK 296
Query: 786 SGSGFEKPEAELETLSFLVDVFRRCTEENPT 816
+G+ K +T+ F D+ ++ P
Sbjct: 297 NGADEIKAHPFFKTIDFSSDLRQQSAPYIPK 327
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 31/153 (20%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+ + + GG +K +I + E G + A+F A ++ L +LH + I++RD+K ENI
Sbjct: 77 LVLTLMNGGDLKFHIYHMGEAGFEE---GRAVFYAAEICCGLEDLHQERIVYRDLKPENI 133
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEV 715
L+D G +++ D AV +P VGT +MAPEV
Sbjct: 134 LLD-----DHGH--IRISDLGLAV--------------HVPEGQTIKGRVGTVGYMAPEV 172
Query: 716 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 748
+ K Y D W+ GCLL E++ Q P+
Sbjct: 173 V----KNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 35/154 (22%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALF-IAQDVAAALVELHSKHIMHRDIKSEN 657
+ +E++ GGS++ H++ + L +A+ + + + LH +HI+HRDIK N
Sbjct: 149 VLLEFMDGGSLEG----------THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSN 198
Query: 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717
+LI+ + VK+ DF + L + C + VGT +M+PE +
Sbjct: 199 LLINSAKN-------VKIADFGVSRILAQTMDPC----------NSSVGTIAYMSPERIN 241
Query: 718 AMHKPNLY-GLEVDIWSYGCLLLELLTLQVPYMG 750
Y G DIWS G +LE Y+G
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEF------YLG 269
|
Length = 353 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 58/240 (24%), Positives = 99/240 (41%), Gaps = 58/240 (24%)
Query: 599 IFMEYVKGGSVKNYIEKLSETG-----------EKHVSVKLALFIAQDVAAALVELHSKH 647
+ +EY G+++ Y+ G E+ ++ K + A VA + L S+
Sbjct: 95 VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK 154
Query: 648 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 707
+HRD+ + N+L+ + V+K+ DF A + + + + +P
Sbjct: 155 CIHRDLAARNVLVTEDN-------VMKIADFGLARDVHNIDYYKKTTNGRLPV------- 200
Query: 708 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 766
+WMAPE L +Y + D+WS+G LL E+ TL PY G+ E+ L++ G R
Sbjct: 201 -KWMAPEALF----DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR- 254
Query: 767 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
++ +C HE L + R C P++RPT L E
Sbjct: 255 -----MDKPANC-THE--------------------LYMIMRECWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 69/296 (23%), Positives = 115/296 (38%), Gaps = 78/296 (26%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+T K C +S F L E ++ H IV++ G + ++ NP
Sbjct: 39 VKTCKNC-TSPSVREKF----LQEAYIMRQFDHPHIVKLIG--VITE-------NP---- 80
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
I ME G +++Y++ + + L L+ Q ++ AL L SK +HRDI
Sbjct: 81 --VWIVMELAPLGELRSYLQVNKYSLD---LASLILYSYQ-LSTALAYLESKRFVHRDIA 134
Query: 655 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWM 711
+ N+L+ VKL DF R + S+ A +G +P +WM
Sbjct: 135 ARNVLV-------SSPDCVKLGDFGLSRYLEDESYYK----ASKGKLPI--------KWM 175
Query: 712 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTD 770
APE + + D+W +G + E+L L V P+ G+ ++ I+ G+R
Sbjct: 176 APESINFRR----FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---- 227
Query: 771 ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
P TL L+ +C +P++RP +L
Sbjct: 228 --------------------PMPPNCPPTLYSLM---TKCWAYDPSKRPRFTELKA 260
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 59/272 (21%), Positives = 104/272 (38%), Gaps = 65/272 (23%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---- 613
E+ M L H +V + G + P + +L EY G +K ++
Sbjct: 58 ELDMFRKLSHKNVVRLLGL--------CREAEPHYMIL------EYTDLGDLKQFLRATK 103
Query: 614 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 673
K + +S K + + +A + L + +HRD+ + N L+ +R+
Sbjct: 104 SKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL-- 161
Query: 674 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 733
L + V + R P RW+APE ++ + + + D+WS
Sbjct: 162 SLS---KDVYNSEYYK-----LRNALIP------LRWLAPEAVQE----DDFSTKSDVWS 203
Query: 734 YGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 792
+G L+ E+ T ++P+ GLS+ E+ + +Q GK E
Sbjct: 204 FGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK-------------------------LEL 238
Query: 793 PEAELETLSFLVDVFRRCTEENPTERPTAGDL 824
P E S L + RC NP +RP+ +L
Sbjct: 239 PVPE-GCPSRLYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 60/246 (24%), Positives = 100/246 (40%), Gaps = 70/246 (28%)
Query: 599 IFMEYVKGGSVKNYIE-----------KLSETGEKHVSVKLALFIAQDVAAALVELHSKH 647
+ +EY G+++ ++ +++ E+ +S K + A VA + L S+
Sbjct: 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR 154
Query: 648 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 707
+HRD+ + N+L+ + V+K+ DF A RG+ D T
Sbjct: 155 CIHRDLAARNVLVTEDN-------VMKIADFGLA--------------RGVHDIDYYKKT 193
Query: 708 P------RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLI 760
+WMAPE L +Y + D+WS+G L+ E+ TL PY G+ E+ L+
Sbjct: 194 SNGRLPVKWMAPEALF----DRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL 249
Query: 761 QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820
+ G R ++ +C HE L + R C PT+RPT
Sbjct: 250 REGHR------MDKPSNC-THE--------------------LYMLMRECWHAVPTQRPT 282
Query: 821 AGDLYE 826
L E
Sbjct: 283 FKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 59/240 (24%), Positives = 96/240 (40%), Gaps = 58/240 (24%)
Query: 599 IFMEYVKGGSVKNYIEKLSETG-----------EKHVSVKLALFIAQDVAAALVELHSKH 647
+ +EY G+++ Y+ G E+ +S K + A VA + L SK
Sbjct: 101 VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK 160
Query: 648 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 707
+HRD+ + N+L+ + V+K+ DF A + + + +P
Sbjct: 161 CIHRDLAARNVLVTEDN-------VMKIADFGLARDIHHIDYYKKTTNGRLPV------- 206
Query: 708 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 766
+WMAPE L +Y + D+WS+G LL E+ TL PY G+ E+ L++ G R
Sbjct: 207 -KWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR- 260
Query: 767 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
+KP L ++ R C P++RPT L E
Sbjct: 261 -----------------------MDKPSNCTNELYMMM---RDCWHAVPSQRPTFKQLVE 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 7e-09
Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 26/148 (17%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
+ ++ GG + +++++ E + A F ++ AL LH ++++RD+K ENIL+
Sbjct: 72 LAFINGGELFHHLQR-----EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL 126
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720
D + A LCDF C + + + GTP ++APE+L
Sbjct: 127 DYQGHIA-------LCDFG----------LCKLNMKDDDKTNTFCGTPEYLAPELLLGHG 169
Query: 721 KPNLYGLEVDIWSYGCLLLELLTLQVPY 748
Y VD W+ G LL E+LT P+
Sbjct: 170 ----YTKAVDWWTLGVLLYEMLTGLPPF 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 61/273 (22%), Positives = 102/273 (37%), Gaps = 72/273 (26%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E +++ L H +V++YG K L I E+++ G + NY+ +
Sbjct: 49 EAKVMMKLSHPKLVQLYGVCTQQKPL--------------YIVTEFMENGCLLNYLRQ-- 92
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
+ +S + L + QDV + L +HRD+ + N L+ VVK+ D
Sbjct: 93 --RQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG-------VVKVSD 143
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F R L + G P +W PEV + Y + D+WS+G L
Sbjct: 144 FGMT---RYVLDDEYTSSSGAKFP------VKWSPPEVFNF----SKYSSKSDVWSFGVL 190
Query: 738 LLELLTL-QVPYMGLSELEIHDLIQMGKR---PRLTDELEALGSCHEHEVAQSGSGFEKP 793
+ E+ T ++P+ S E+ ++I G R P+L +
Sbjct: 191 MWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKL--------ASM-------------- 228
Query: 794 EAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
+ +V C E P RPT +L
Sbjct: 229 --------TVYEVMYSCWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 45/175 (25%), Positives = 80/175 (45%), Gaps = 28/175 (16%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+ M + GG +K +I + GE+ + ++ + + + ++ LHS I++RD+K EN+
Sbjct: 70 LVMSLMNGGDLKYHIYNV---GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENV 126
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718
L+D + +L D AV L+ A GT +MAPE+L
Sbjct: 127 LLDDQGN-------CRLSDLGLAVELKDGKTITQRA-----------GTNGYMAPEIL-- 166
Query: 719 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 773
K Y VD ++ GC + E++ + P+ E + + KR L DE++
Sbjct: 167 --KEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL---KRRTLEDEVK 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 45/158 (28%), Positives = 63/158 (39%), Gaps = 36/158 (22%)
Query: 600 FMEYVKGGSVKN-----YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
M Y GS ++ + E L E FI +DV AL +HSK +HR +K
Sbjct: 80 LMAY---GSCEDLLKTHFPEGLPEL--------AIAFILKDVLNALDYIHSKGFIHRSVK 128
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPL--RSFLHTCCIAHRGIPAPDVCVGTPRWMA 712
+ +IL+ DGK V L +V + P V W++
Sbjct: 129 ASHILLS-----GDGK--VVLSGLRYSVSMIKHGKRQRVVHDF-----PKSSVKNLPWLS 176
Query: 713 PEVLRAMHKPNL--YGLEVDIWSYGCLLLELLTLQVPY 748
PEVL+ NL Y + DI+S G EL VP+
Sbjct: 177 PEVLQQ----NLQGYNEKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 50/180 (27%), Positives = 78/180 (43%), Gaps = 26/180 (14%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+ ++Y+ GG + ++ + E+ V + ++ AL LH I++RDIK ENI
Sbjct: 82 LILDYINGGELFTHLSQRERFKEQEVQIYSG-----EIVLALEHLHKLGIIYRDIKLENI 136
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718
L+D ++G V L DF + + F A C GT +MAP+++R
Sbjct: 137 LLD-----SNGHVV--LTDFGLS---KEFH-----EDEVERAYSFC-GTIEYMAPDIVRG 180
Query: 719 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ---MGKRPRLTDELEAL 775
+ VD WS G L+ ELLT P+ E I + P E+ AL
Sbjct: 181 GDGG--HDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 238
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 44/137 (32%), Positives = 66/137 (48%), Gaps = 28/137 (20%)
Query: 630 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 689
L IA +AA + L S H +HRD+ + N L+ +G VK+ DF + + S +
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLV------GEGL-TVKISDFGLSRDIYSADY 179
Query: 690 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLT--L 744
+ +P RWM PE + LYG E DIWS+G +L E+ + L
Sbjct: 180 YRVQSKSLLPV--------RWMPPEAI-------LYGKFTTESDIWSFGVVLWEIFSYGL 224
Query: 745 QVPYMGLSELEIHDLIQ 761
Q PY G S E+ ++I+
Sbjct: 225 Q-PYYGFSNQEVIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 34/100 (34%), Positives = 48/100 (48%), Gaps = 23/100 (23%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 702
+HS ++HRD+K NILI+ + D +K+CDF A P
Sbjct: 124 VHSAGVVHRDLKPSNILIN---ENCD----LKICDFGLARIQD-------------PQMT 163
Query: 703 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742
V T + APE++ K Y +EVDIWS GC+ E+L
Sbjct: 164 GYVSTRYYRAPEIMLTWQK---YDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 47/152 (30%), Positives = 72/152 (47%), Gaps = 31/152 (20%)
Query: 598 AIFMEYVKGGSVKNYIEKLSETGEKHV-SVKLALFIAQDVAAALVELHSKH-IMHRDIKS 655
+I ME++ GGS+ +++ E+ + V +A V L L KH IMHRD+K
Sbjct: 79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA------VLRGLAYLREKHQIMHRDVKP 132
Query: 656 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 715
NIL+ + + +KLCDF + L + + VGT +M+PE
Sbjct: 133 SNILV-------NSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPER 173
Query: 716 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 747
L+ H Y ++ DIWS G L+EL + P
Sbjct: 174 LQGTH----YSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 42/173 (24%), Positives = 63/173 (36%), Gaps = 50/173 (28%)
Query: 601 MEYVKGGSVKNYIEK---LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657
MEY+ GG + + K +E + F + A+ +H +HRDIK +N
Sbjct: 80 MEYLPGGDMMTLLMKKDTFTE--------EETRFYIAETILAIDSIHKLGYIHRDIKPDN 131
Query: 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSF---LHTCCIAHRGIPAPDV----------- 703
+L+D A G +KL DF L+ ++H
Sbjct: 132 LLLD-----AKGH--IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184
Query: 704 --------------CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742
VGTP ++APEV Y E D WS G ++ E+L
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVF----LQTGYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 38/157 (24%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+ ++YV GG + ++ + E V F + ++ AL LH I++RDIK ENI
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFSEDEVR-----FYSGEIILALEHLHKLGIVYRDIKLENI 136
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFL-------HTCCIAHRGIPAPDVCVGTPRWM 711
L+D ++G V L DF + + FL ++ C GT +M
Sbjct: 137 LLD-----SEGHVV--LTDFGLS---KEFLSEEKERTYSFC-------------GTIEYM 173
Query: 712 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 748
APE++R +G VD WS G L+ ELLT P+
Sbjct: 174 APEIIRGKGG---HGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 62/230 (26%), Positives = 93/230 (40%), Gaps = 60/230 (26%)
Query: 605 KGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 664
K S E+ E ++ ++++ + + VA + L S+ +HRD+ + NIL+
Sbjct: 151 KSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS--- 207
Query: 665 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI-PAPD-VCVGTPR----WMAPEVLRA 718
VVK+CDF A R I PD V G R WMAPE +
Sbjct: 208 ----ENNVVKICDFGLA--------------RDIYKDPDYVRKGDARLPLKWMAPESIF- 248
Query: 719 MHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGS 777
+Y + D+WS+G LL E+ +L PY G+ E + + K
Sbjct: 249 ---DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCRRLKE------------ 291
Query: 778 CHEHEVAQSGSGFEKPE-AELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
G+ PE A E S ++D C NP +RPT +L E
Sbjct: 292 ---------GTRMRAPEYATPEIYSIMLD----CWHNNPEDRPTFSELVE 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 61/232 (26%)
Query: 601 MEYVKGGSVKNYIEK-----------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 649
+EY G++ +++ K ++ + +S + L A DVA + L K +
Sbjct: 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI 146
Query: 650 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 709
HRD+ + NIL+ V K+ DF + ++ +P R
Sbjct: 147 HRDLAARNILVGENY-------VAKIADFGLSRGQEVYVKK---TMGRLPV--------R 188
Query: 710 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRL 768
WMA E L ++Y D+WSYG LL E+++L PY G++ E+++ + G R
Sbjct: 189 WMAIESLNY----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--- 241
Query: 769 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820
EKP L + D+ R+C E P ERP+
Sbjct: 242 ---------------------LEKP---LNCDDEVYDLMRQCWREKPYERPS 269
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 22/148 (14%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
M + GG ++ +I + E A F + + L LH + I++RD+K EN+L+
Sbjct: 72 MTIMNGGDLRYHIYNVDEENPG-FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL 130
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720
D DG V++ D AV L+ G GTP +MAPE+L+
Sbjct: 131 D-----NDGN--VRISDLGLAVELKD----------GQSKTKGYAGTPGFMAPELLQGEE 173
Query: 721 KPNLYGLEVDIWSYGCLLLELLTLQVPY 748
Y VD ++ G L E++ + P+
Sbjct: 174 ----YDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 49/207 (23%), Positives = 83/207 (40%), Gaps = 77/207 (37%)
Query: 554 SCLGEVRMLGALRHSCIVEMYG-----HKIS----------SKWLPSADGNPEHHLLQSA 598
S L E+ +L L+H IV +Y K++ K+ S +G+ + +++S
Sbjct: 45 SALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSF 104
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+F + +KG L HS +++HRD+K +N+
Sbjct: 105 MF-QLLKG---------------------------------LAFCHSHNVLHRDLKPQNL 130
Query: 659 LIDLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714
LI+ +G+ +KL DF A +P+R + V T + P+
Sbjct: 131 LIN-----KNGE--LKLADFGLARAFGIPVRCYSAE--------------VVTLWYRPPD 169
Query: 715 VLRAMHKPNLYGLEVDIWSYGCLLLEL 741
VL LY +D+WS GC+ EL
Sbjct: 170 VLFG---AKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-08
Identities = 50/158 (31%), Positives = 74/158 (46%), Gaps = 38/158 (24%)
Query: 636 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 695
VA + L SK+ +HRD+ + N+LI +GK +VK+CDF A R +
Sbjct: 248 VANGMEFLASKNCVHRDLAARNVLI------CEGK-LVKICDFGLA---RDIMRDSNYIS 297
Query: 696 RG---IPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGL 751
+G +P +WMAPE + NLY D+WS+G LL E+ TL PY
Sbjct: 298 KGSTFLPL--------KWMAPESIFN----NLYTTLSDVWSFGILLWEIFTLGGTPY--- 342
Query: 752 SELEIHDLI--------QMGKRPRLTDEL-EALGSCHE 780
EL +++ +M K +DE+ E + C E
Sbjct: 343 PELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWE 380
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 52/236 (22%), Positives = 90/236 (38%), Gaps = 52/236 (22%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
+E+ G +KNY+ + + +A +VA+ L+ LH +H D+ N +
Sbjct: 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL 133
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP----APDVCVGTP-RWMAPEV 715
AD VK+ D+ +A P C P RW+APE+
Sbjct: 134 -----TADLS--VKIGDYG-------------LALEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 716 LRAMH---KPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDE 771
+ P + +IWS G + EL T PY LS+ ++ + + +L
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL--- 230
Query: 772 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 827
KP+ +L+ +V + C + P RPTA +++E+
Sbjct: 231 -------------------PKPQLDLKYSDRWYEVMQFCWLD-PETRPTAEEVHEL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 50/208 (24%), Positives = 84/208 (40%), Gaps = 43/208 (20%)
Query: 556 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 615
E ++L + H V +YG +L + +E+V GG ++ +
Sbjct: 79 FSERKILNYINHPFCVNLYGSFKDESYL--------------YLVLEFVIGGEFFTFLRR 124
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
K + F A + L S +I++RD+K EN+L+D DG +K+
Sbjct: 125 -----NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD-----KDG--FIKM 172
Query: 676 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735
DF A + + +T C GTP ++APE+L + +G D W+ G
Sbjct: 173 TDFGFAKVVDTRTYTLC-------------GTPEYIAPEILLNVG----HGKAADWWTLG 215
Query: 736 CLLLELLTLQVPYMGLSELEIHDLIQMG 763
+ E+L P+ L I+ I G
Sbjct: 216 IFIYEILVGCPPFYANEPLLIYQKILEG 243
|
Length = 340 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 60/274 (21%), Positives = 106/274 (38%), Gaps = 72/274 (26%)
Query: 556 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYI 613
L E ++ LRHS +V++ G + K +++ EY+ GS+ +Y
Sbjct: 47 LAEASVMTQLRHSNLVQLLGVIVEEK---------------GGLYIVTEYMAKGSLVDY- 90
Query: 614 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 673
L G + L + DV A+ L + + +HRD+ + N+L+ + V
Sbjct: 91 --LRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN-------VA 141
Query: 674 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 733
K+ DF S T +P +W APE LR + + D+WS
Sbjct: 142 KVSDFGLTKEASSTQDTG-----KLPV--------KWTAPEALRE----KKFSTKSDVWS 184
Query: 734 YGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 792
+G LL E+ + +VPY + ++ ++ G + ++A C
Sbjct: 185 FGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------MDAPDGC-------------- 224
Query: 793 PEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
P + DV ++C + RP+ L E
Sbjct: 225 PPV-------VYDVMKQCWHLDAATRPSFLQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 41/154 (26%), Positives = 73/154 (47%), Gaps = 30/154 (19%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKL-ALFIAQDVAAALVELH-SKHIMHRDIKSE 656
I M+ ++G + + L E ++ ++ +F+ + AL LH K I+HRD+
Sbjct: 86 IVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV--QMVLALRYLHKEKRIVHRDLTPN 143
Query: 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV--CVGTPRWMAPE 714
NI++ E K V + DF +A + P + VGT + PE
Sbjct: 144 NIMLG-EDDK------VTITDFG-------------LAKQKQPESKLTSVVGTILYSCPE 183
Query: 715 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 748
+++ P YG + D+W++GC+L ++ TLQ P+
Sbjct: 184 IVKNE--P--YGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 8e-08
Identities = 44/172 (25%), Positives = 79/172 (45%), Gaps = 41/172 (23%)
Query: 599 IFMEYVKGGSVKNYIEKLSETG---EKHVSVKLALFIAQDVAAALVELHS-------KHI 648
I ME+ G + I+K + E+H V I + + AL H+ + +
Sbjct: 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD----ITRQLLHALAYCHNLKDGPNGERV 146
Query: 649 MHRDIKSENIL----------IDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHR 696
+HRD+K +NI I + +G+P+ K+ DF + + + S H+C
Sbjct: 147 LHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSC----- 201
Query: 697 GIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 748
VGTP + +PE+L +H+ Y + D+W+ GC++ EL + + P+
Sbjct: 202 --------VGTPYYWSPELL--LHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 64/314 (20%), Positives = 127/314 (40%), Gaps = 67/314 (21%)
Query: 516 SVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 575
SV + + + GS A V+ LK S+ +I F L E + H ++++ G
Sbjct: 14 SVREAQLKSEDGSFQKVA-VKMLKADIFSSSDIEEF----LREAACMKEFDHPNVIKLIG 68
Query: 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFI--A 633
+ S+ + L + + ++K G + ++ +S GE+ ++ L +
Sbjct: 69 VSLRSR--------AKGRLPIPMVILPFMKHGDLHTFL-LMSRIGEEPFTLPLQTLVRFM 119
Query: 634 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS--FLHTC 691
D+A+ + L SK+ +HRD+ + N +++ V + DF + + S +
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMT-------VCVADFGLSKKIYSGDYYRQG 172
Query: 692 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMG 750
C + +P +W+A E L N+Y D+W++G + E++T Q PY G
Sbjct: 173 CASK--LPV--------KWLALESL----ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218
Query: 751 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 810
+ EI++ + G R ++P + L + ++ +C
Sbjct: 219 VENSEIYNYLIKGNR------------------------LKQP---PDCLEDVYELMCQC 251
Query: 811 TEENPTERPTAGDL 824
P RP+ L
Sbjct: 252 WSPEPKCRPSFQHL 265
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 9e-08
Identities = 39/128 (30%), Positives = 59/128 (46%), Gaps = 33/128 (25%)
Query: 631 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 690
FI Q + L +HS +++HRD+K N+L++ AD + +K+CDF A
Sbjct: 110 FIYQ-ILCGLKYIHSANVLHRDLKPGNLLVN-----ADCE--LKICDFGLA--------- 152
Query: 691 CCIAHRGI-PAPDVCVG------TPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742
RG P G RW APE++ + Y +D+WS GC+L ELL
Sbjct: 153 -----RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQS---YTKAIDVWSVGCILAELL 204
Query: 743 TLQVPYMG 750
+ + G
Sbjct: 205 GRKPVFKG 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 38/132 (28%), Positives = 60/132 (45%), Gaps = 22/132 (16%)
Query: 631 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 690
F A ++ L +H++ +++RD+K NIL+D E + CDF + P S
Sbjct: 101 FYAAEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHAS---- 155
Query: 691 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 750
VGT +MAPEVL+ K Y D +S GC+L +LL P+
Sbjct: 156 --------------VGTHGYMAPEVLQ---KGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 198
Query: 751 LSELEIHDLIQM 762
+ H++ +M
Sbjct: 199 HKTKDKHEIDRM 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 42/162 (25%), Positives = 72/162 (44%), Gaps = 27/162 (16%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
++ + GG + ++ + EK + F A ++ L +H++ +++RD+K NIL+
Sbjct: 76 LDLMNGGDLHYHLSQHGVFSEKEMR-----FYATEIILGLEHMHNRFVVYRDLKPANILL 130
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720
D E + CDF + P S VGT +MAPEVL+
Sbjct: 131 D-EHGHVRISDLGLACDFSKKKPHAS------------------VGTHGYMAPEVLQ--- 168
Query: 721 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 762
K Y D +S GC+L +LL P+ + H++ +M
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 31/148 (20%)
Query: 604 VKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663
+ GG +K +I + G + A+F A ++ L +L + I++RD+K ENIL+
Sbjct: 82 MNGGDLKFHIYNMGNPG---FDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL--- 135
Query: 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEVLRAMH 720
D + +++ D AV IP + VGT +MAPEV+
Sbjct: 136 ----DDRGHIRISDLGLAVQ--------------IPEGETVRGRVGTVGYMAPEVI---- 173
Query: 721 KPNLYGLEVDIWSYGCLLLELLTLQVPY 748
Y D W GCL+ E++ Q P+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 30/148 (20%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+ ME++ +V Y++ + + L+ Q + AL +HSK I HRD+K +N+
Sbjct: 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQ-LCRALAYIHSKFICHRDLKPQNL 201
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPL----RSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714
LID +KLCDF A L RS + C +R AP++ +G
Sbjct: 202 LIDPNTH------TLKLCDFGSAKNLLAGQRSVSYICSRFYR---APELMLGATN----- 247
Query: 715 VLRAMHKPNLYGLEVDIWSYGCLLLELL 742
Y +D+WS GC++ E++
Sbjct: 248 ----------YTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 50/206 (24%), Positives = 83/206 (40%), Gaps = 41/206 (19%)
Query: 537 TLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQ 596
LKV GS + F + ++ L H +V++YG + D N
Sbjct: 34 VLKVLGSDHRDSLAFFET----ASLMSQLSHKHLVKLYG-------VCVRDEN------- 75
Query: 597 SAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656
+ EYVK G + ++ + +VS+ L +A+ +A+AL L K ++H ++ +
Sbjct: 76 -IMVEEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGK 130
Query: 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 716
NIL+ P +KL D + + S R P W+APE +
Sbjct: 131 NILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIP--------WIAPECI 176
Query: 717 RAMH-KPNLYGLEVDIWSYGCLLLEL 741
R + D WS+G LLE+
Sbjct: 177 RNGQASLTIAA---DKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 60/275 (21%), Positives = 106/275 (38%), Gaps = 78/275 (28%)
Query: 552 EYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 611
E++C VR+LG + + G P + + ME + G +K+
Sbjct: 65 EFNCHHVVRLLGVV--------------------SQGQP------TLVIMELMTRGDLKS 98
Query: 612 YIEKL-----SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 666
Y+ L + + S+K + +A ++A + L++ +HRD+ + N ++ +
Sbjct: 99 YLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-- 156
Query: 667 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 726
VK+ DF R T G V RWM+PE L K ++
Sbjct: 157 -----TVKIGDFGMT---RDIYETDYYRKGGKGLLPV-----RWMSPESL----KDGVFT 199
Query: 727 LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 785
D+WS+G +L E+ TL + PY G+S ++ +
Sbjct: 200 TYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV------------------------M 235
Query: 786 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820
G +KP+ L ++ R C + NP RP+
Sbjct: 236 EGGLLDKPD---NCPDMLFELMRMCWQYNPKMRPS 267
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 38/133 (28%), Positives = 54/133 (40%), Gaps = 27/133 (20%)
Query: 640 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--------DRAVPLRSFLHTC 691
L LH + MHRD+ NI I+ K + K+ DF S T
Sbjct: 132 LNVLHKWYFMHRDLSPANIFIN-------SKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 692 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL 751
V T + APE+L K Y VD+WS GC+ ELLT + + G
Sbjct: 185 QRREEMTSK----VVTLWYRAPELLMGAEK---YHFAVDMWSVGCIFAELLTGKPLFPGE 237
Query: 752 SELEIHDLIQMGK 764
+E++ Q+G+
Sbjct: 238 NEID-----QLGR 245
|
Length = 335 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 54/236 (22%), Positives = 98/236 (41%), Gaps = 52/236 (22%)
Query: 599 IFMEYVKGGSVKNYIEKL-----SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 653
+ ME + G +K+Y+ L + G +++ + +A ++A + L++K +HRD+
Sbjct: 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDL 145
Query: 654 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 713
+ N ++ + VK+ DF R T G V RWMAP
Sbjct: 146 AARNCMVAHDF-------TVKIGDFGMT---RDIYETDYYRKGGKGLLPV-----RWMAP 190
Query: 714 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDEL 772
E L K ++ D+WS+G +L E+ +L + PY GLS ++ +
Sbjct: 191 ESL----KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV------------ 234
Query: 773 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
G ++P+ E ++ D+ R C + NP RPT ++ +
Sbjct: 235 ------------MDGGYLDQPDNCPERVT---DLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 58/241 (24%), Positives = 104/241 (43%), Gaps = 44/241 (18%)
Query: 527 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 586
G + A ++TLK G + + ++F L E ++G H I+ + G + +K+ P+
Sbjct: 30 GRKEVAVAIKTLKP-GYTEKQRQDF----LSEASIMGQFSHHNIIRLEG--VVTKFKPAM 82
Query: 587 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 646
I EY++ G++ Y L + + S +L + + +AA + L
Sbjct: 83 ------------IITEYMENGALDKY---LRDHDGEFSSYQLVGML-RGIAAGMKYLSDM 126
Query: 647 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCV 705
+ +HRD+ + NIL+ + K+ DF + L G IP
Sbjct: 127 NYVHRDLAARNILV-------NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI----- 174
Query: 706 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGK 764
RW APE + A K + D+WS+G ++ E+++ + PY +S E+ I G
Sbjct: 175 ---RWTAPEAI-AYRK---FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF 227
Query: 765 R 765
R
Sbjct: 228 R 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 42/179 (23%), Positives = 80/179 (44%), Gaps = 31/179 (17%)
Query: 599 IFMEYVKGGSVKNYIE-----------KLSETGEKHVSVKLALFIAQDVAAALVELHSKH 647
+ +EY G+++ Y+ ++ ++ ++ K + VA + L S+
Sbjct: 98 VIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK 157
Query: 648 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 707
+HRD+ + N+L+ V+K+ DF A + + + + +P
Sbjct: 158 CIHRDLAARNVLVTENN-------VMKIADFGLARDVNNIDYYKKTTNGRLPV------- 203
Query: 708 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 765
+WMAPE L +Y + D+WS+G L+ E+ TL PY G+ E+ L++ G R
Sbjct: 204 -KWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 257
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 39/117 (33%), Positives = 61/117 (52%), Gaps = 20/117 (17%)
Query: 636 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 695
VA + L SK+ +HRD+ + N+L+ DG+ V K+CDF A R ++
Sbjct: 221 VAQGMDFLASKNCIHRDVAARNVLL------TDGR-VAKICDFGLA---RDIMNDSNYVV 270
Query: 696 RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGL 751
+G V +WMAPE + +Y ++ D+WSYG LL E+ +L + PY G+
Sbjct: 271 KGNARLPV-----KWMAPESIFDC----VYTVQSDVWSYGILLWEIFSLGKSPYPGI 318
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 46/156 (29%), Positives = 74/156 (47%), Gaps = 30/156 (19%)
Query: 609 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 668
++ Y++K+ G ++K + + L LH+ I+HRD+K ENIL+ +
Sbjct: 93 LRTYLDKVPPPGLPAETIK---DLMRQFLRGLDFLHANCIVHRDLKPENILV-----TSG 144
Query: 669 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 728
G+ VKL DF A +++C +A V T + APEVL + Y
Sbjct: 145 GQ--VKLADFGLAR-----IYSCQMAL------TPVVVTLWYRAPEVLLQ----STYATP 187
Query: 729 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
VD+WS GC+ E+ + + G SE + Q+GK
Sbjct: 188 VDMWSVGCIFAEMFRRKPLFCGNSEAD-----QLGK 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 8e-07
Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 37/208 (17%)
Query: 551 FEYSCLGEVRMLGALRHSCIVEMYGHKI-SSKWLPSADGNPEHHLLQSAIFMEYVKGGSV 609
F + L E+++L L+H +V + +I +K P +L+ F E+ G +
Sbjct: 54 FPITALREIKILQLLKHENVVNLI--EICRTKATPYNRYKGSFYLVFE--FCEHDLAGLL 109
Query: 610 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 669
N K + E +K+ L L +H I+HRD+K+ NILI DG
Sbjct: 110 SNKNVKFTL-SEIKKVMKMLL-------NGLYYIHRNKILHRDMKAANILIT-----KDG 156
Query: 670 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEVLRAMHKPNLYG 726
++KL DF A R+F + P+ V T + PE+L YG
Sbjct: 157 --ILKLADFGLA---RAF------SLSKNSKPNRYTNRVVTLWYRPPELLLGERD---YG 202
Query: 727 LEVDIWSYGCLLLELLTLQVPYM-GLSE 753
+D+W GC++ E+ T P M G +E
Sbjct: 203 PPIDMWGAGCIMAEMWTRS-PIMQGNTE 229
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 51/204 (25%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM-EYVKGGSVKNYIEKL 616
E +L L+H+ IV + H I H ++ + EY+ +K Y++
Sbjct: 53 EASLLKDLKHANIVTL--HDII-------------HTKKTLTLVFEYLDT-DLKQYMDDC 96
Query: 617 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 676
G +V+L LF + L H + ++HRD+K +N+LI ER + +KL
Sbjct: 97 G-GGLSMHNVRLFLF---QLLRGLAYCHQRRVLHRDLKPQNLLIS-ERGE------LKLA 145
Query: 677 DFDRA----VPLRSFLH-TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 731
DF A VP +++ + + +R PDV +G+ Y +D+
Sbjct: 146 DFGLARAKSVPSKTYSNEVVTLWYR---PPDVLLGSTE---------------YSTSLDM 187
Query: 732 WSYGCLLLELLTLQVPYMGLSELE 755
W GC+ E+ T + + G +++E
Sbjct: 188 WGVGCIFYEMATGRPLFPGSTDVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 45/191 (23%), Positives = 67/191 (35%), Gaps = 61/191 (31%)
Query: 647 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP------- 699
I+HRD+K NIL+ D +KLCDF GI
Sbjct: 128 KIIHRDVKPSNILL-------DRNGNIKLCDF------------------GISGQLVDSI 162
Query: 700 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 759
A G +MAPE + + Y + D+WS G L E+ T + PY + + D
Sbjct: 163 AKTRDAGCRPYMAPERI-DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQ 219
Query: 760 IQM---GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816
+ G P L + E E + S V+ C ++ +
Sbjct: 220 LTQVVKGDPPI-------LSNSEEREFSPS----------------FVNFINLCLIKDES 256
Query: 817 ERPTAGDLYEM 827
+RP +L E
Sbjct: 257 KRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 57/241 (23%), Positives = 101/241 (41%), Gaps = 44/241 (18%)
Query: 527 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 586
G + ++TLK G + + R+F L E ++G H I+ + G SK +
Sbjct: 29 GKREIPVAIKTLKA-GYTEKQRRDF----LSEASIMGQFDHPNIIHLEGVVTKSKPV--- 80
Query: 587 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 646
I EY++ GS+ ++ K + +V + + + +A+ + L
Sbjct: 81 -----------MIVTEYMENGSLDAFLRK----HDGQFTVIQLVGMLRGIASGMKYLSDM 125
Query: 647 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCV 705
+HRD+ + NIL++ V K+ DF + L G IP
Sbjct: 126 GYVHRDLAARNILVN-------SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI----- 173
Query: 706 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGK 764
RW APE + A K + D+WSYG ++ E+++ + PY +S ++ I+ G
Sbjct: 174 ---RWTAPEAI-AYRK---FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY 226
Query: 765 R 765
R
Sbjct: 227 R 227
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 39/132 (29%), Positives = 61/132 (46%), Gaps = 22/132 (16%)
Query: 636 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 695
+A + L K ++HRD+ + N+L+ + VK+ DF A L A
Sbjct: 118 IAKGMSYLEEKRLVHRDLAARNVLVKTPQH-------VKITDFGLA-KLLDVDEKEYHAE 169
Query: 696 RGIPAPDVCVGTP-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSE 753
G P +WMA E + +Y + D+WSYG + EL+T PY G+
Sbjct: 170 GGK--------VPIKWMALESILH----RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217
Query: 754 LEIHDLIQMGKR 765
+EI DL++ G+R
Sbjct: 218 VEIPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 40/126 (31%), Positives = 54/126 (42%), Gaps = 36/126 (28%)
Query: 624 VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 683
+ + AL I + + L LH++ I+HRD+K+ENI I+ D D
Sbjct: 154 LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN---------------DVD---- 194
Query: 684 LRSFLHTCCIAHRG-----IPAPDV--CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736
CI G + AP GT APEVL A K Y + DIWS G
Sbjct: 195 ------QVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVL-ARDK---YNSKADIWSAGI 244
Query: 737 LLLELL 742
+L E+L
Sbjct: 245 VLFEML 250
|
Length = 357 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 60/300 (20%), Positives = 118/300 (39%), Gaps = 72/300 (24%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG---HKISSKWLPSADGNPE 591
V+T+K+ + E+ +F L E + H ++ + G + S+ PS
Sbjct: 31 VKTMKIAICTRSEMEDF----LSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP----- 81
Query: 592 HHLLQSAIFMEYVKGGSVKNYI--EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 649
+ + ++K G + +++ +L + + + L F+ D+A+ + L SK +
Sbjct: 82 ------VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT-DIASGMEYLSSKSFI 134
Query: 650 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS--FLHTCCIAHRGIPAPDVCVGT 707
HRD+ + N +++ V + DF + + + + IA +
Sbjct: 135 HRDLAARNCMLNENMN-------VCVADFGLSKKIYNGDYYRQGRIAKMPV--------- 178
Query: 708 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 766
+W+A E L +Y + D+WS+G + E+ T Q PY G+ EI+D ++ G R
Sbjct: 179 -KWIAIESL----ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR- 232
Query: 767 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
++P + L L + C NP +RP+ L
Sbjct: 233 -----------------------LKQPP---DCLDGLYSLMSSCWLLNPKDRPSFETLRC 266
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 47/169 (27%), Positives = 75/169 (44%), Gaps = 24/169 (14%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657
+ + Y+K G ++N+I E H +VK + VA + L SK +HRD+ + N
Sbjct: 74 VVLPYMKHGDLRNFIRS-----ETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARN 128
Query: 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717
++D VK+ DF A + + H G P +WMA E L+
Sbjct: 129 CMLD-------ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP------VKWMALESLQ 175
Query: 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKR 765
K + + D+WS+G LL EL+T PY + +I + G+R
Sbjct: 176 T-QK---FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR 220
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 55/207 (26%), Positives = 84/207 (40%), Gaps = 43/207 (20%)
Query: 538 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 597
LKV S RN+ S M+ L H +V YG + E ++Q
Sbjct: 32 LKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD---------ESIMVQ- 78
Query: 598 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657
EYVK GS+ Y++K +++ L +A+ +A AL L K + H ++ ++N
Sbjct: 79 ----EYVKFGSLDTYLKKNKNL----INISWKLEVAKQLAWALHFLEDKGLTHGNVCAKN 130
Query: 658 ILIDLERKKADGK-PVVKLCD--FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714
+L+ E + G P +KL D V + L R IP W+ PE
Sbjct: 131 VLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL-----LER-IP----------WVPPE 174
Query: 715 VLRAMHKPNLYGLEVDIWSYGCLLLEL 741
+ P L D WS+G L E+
Sbjct: 175 CIE---NPQNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 39/117 (33%), Positives = 51/117 (43%), Gaps = 31/117 (26%)
Query: 631 FIAQDVAAALVELHSKHIMHRDIKSENILI--DLERKKADGKPVVKLCDFDRAVPLRSFL 688
F+ + L +HS I+HRD+K NI + D E +K+ DF A +
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE---------LKILDFGLARHTDDEM 172
Query: 689 HTCCIAHRGIPAPDVCVGTPRW-MAPEV-LRAMHKPNLYGLEVDIWSYGCLLLELLT 743
V T RW APE+ L MH Y VDIWS GC++ ELLT
Sbjct: 173 TG-------------YVAT-RWYRAPEIMLNWMH----YNQTVDIWSVGCIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 36/110 (32%), Positives = 49/110 (44%), Gaps = 27/110 (24%)
Query: 639 ALVELHSKHIMHRDIKSENILI----DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA 694
L +HS +++HRD+K N+L+ DL K+CDF A R
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDL-----------KICDFGLA---RI--ADPEHD 161
Query: 695 HRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743
H G V RW APE+ M Y +DIWS GC+L E+L+
Sbjct: 162 HTGFLTEYVAT---RWYRAPEI---MLNSKGYTKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 33/102 (32%), Positives = 49/102 (48%), Gaps = 24/102 (23%)
Query: 644 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 703
H ++HRD+K +N+LI+ + +KL DF A R+F GIP
Sbjct: 117 HENRVLHRDLKPQNLLIN-------KRGELKLADFGLA---RAF---------GIPVNTF 157
Query: 704 C--VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743
V T + AP+VL Y +DIWS GC++ E++T
Sbjct: 158 SNEVVTLWYRAPDVLLG---SRTYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 6e-06
Identities = 30/101 (29%), Positives = 47/101 (46%), Gaps = 20/101 (19%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 702
+HS +++HRD+K N+L++ D +K+CDF A T +
Sbjct: 124 IHSANVLHRDLKPSNLLLN---ANCD----LKICDFGLA-------RTTSEKGDFMTE-- 167
Query: 703 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743
V T + APE+L + Y +D+WS GC+ ELL
Sbjct: 168 -YVVTRWYRAPELLLNCSE---YTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 46/156 (29%), Positives = 71/156 (45%), Gaps = 36/156 (23%)
Query: 612 YIEKLSETGEKHVSVK---LALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 668
Y++K+ E G ++K L D LHS ++HRD+K +NIL+ +
Sbjct: 98 YLDKVPEPGVPTETIKDMMFQLLRGLDF------LHSHRVVHRDLKPQNILV-----TSS 146
Query: 669 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 728
G+ +KL DF A + SF A V T + APEVL + Y
Sbjct: 147 GQ--IKLADFGLA-RIYSFQ----------MALTSVVVTLWYRAPEVLLQ----SSYATP 189
Query: 729 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
VD+WS GC+ E+ + + G S+++ Q+GK
Sbjct: 190 VDLWSVGCIFAEMFRRKPLFRGSSDVD-----QLGK 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 61/254 (24%), Positives = 92/254 (36%), Gaps = 57/254 (22%)
Query: 600 FMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659
FM Y GS + ++ G + LF A L LH +HR+IK+ +IL
Sbjct: 80 FMAY---GSANSLLKTYFPEGMSEALIGNILFGA---LRGLNYLHQNGYIHRNIKASHIL 133
Query: 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA------PDVCVGTPRWMAP 713
I DG V L H + G A P W++P
Sbjct: 134 I-----SGDG-----------LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSP 177
Query: 714 EVLRAMHKPNLYGLEV--DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE 771
E+LR +LYG V DI+S G EL T +VP+ + ++ L+Q K P +
Sbjct: 178 ELLRQ----DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPL 231
Query: 772 LEALGSCHEHEVAQSGSGFEKPEAELETLSF---------------------LVDVFRRC 810
C E + S SG + E + ++ C
Sbjct: 232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELC 291
Query: 811 TEENPTERPTAGDL 824
+++P +RP+A L
Sbjct: 292 LQQDPEKRPSASSL 305
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 53/233 (22%), Positives = 98/233 (42%), Gaps = 61/233 (26%)
Query: 599 IFMEYVKGGSVKNYIEK--LSET----GEKH-----VSVKLALFIAQDVAAALVELHSKH 647
I +EY G++ +++ K + ET ++H ++ + L A DVA + L K
Sbjct: 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ 139
Query: 648 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 707
+HRD+ + N+L+ K+ DF + ++ +P
Sbjct: 140 FIHRDLAARNVLVG-------ENLASKIADFGLSRGEEVYVKK---TMGRLPV------- 182
Query: 708 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 766
RWMA E L ++Y + D+WS+G LL E+++L PY G++ E+++ + G R
Sbjct: 183 -RWMAIESLNY----SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR- 236
Query: 767 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819
+E +C + + ++ R+C + P ERP
Sbjct: 237 -----MEKPRNCDDE---------------------VYELMRQCWRDRPYERP 263
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 57/200 (28%), Positives = 80/200 (40%), Gaps = 58/200 (29%)
Query: 636 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 695
VA + L S+ +HRD+ + NIL+ VVK+CDF A
Sbjct: 183 VARGMEFLASRKCIHRDLAARNILLSENN-------VVKICDFGLA-------------- 221
Query: 696 RGI-PAPD-VCVGTPR----WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PY 748
R I PD V G+ R WMAPE + +Y + D+WS+G LL E+ +L PY
Sbjct: 222 RDIYKDPDYVRKGSARLPLKWMAPESIF----DKVYTTQSDVWSFGVLLWEIFSLGASPY 277
Query: 749 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 808
G+ E + Q RL D G+ PE + +
Sbjct: 278 PGVQINE--EFCQ-----RLKD----------------GTRMRAPE---NATPEIYRIML 311
Query: 809 RCTEENPTERPTAGDLYEMF 828
C + +P ERPT L E+
Sbjct: 312 ACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 39/122 (31%), Positives = 56/122 (45%), Gaps = 30/122 (24%)
Query: 636 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 695
VA + L S+ +HRD+ + NIL+ VVK+CDF +A
Sbjct: 188 VAKGMEFLASRKCIHRDLAARNILLS-------ENNVVKICDFG-------------LAR 227
Query: 696 RGIPAPD-VCVGTPR----WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYM 749
PD V G R WMAPE + +Y ++ D+WS+G LL E+ +L PY
Sbjct: 228 DIYKDPDYVRKGDARLPLKWMAPETIF----DRVYTIQSDVWSFGVLLWEIFSLGASPYP 283
Query: 750 GL 751
G+
Sbjct: 284 GV 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 38/117 (32%), Positives = 55/117 (47%), Gaps = 19/117 (16%)
Query: 644 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 703
H K+ +HRDIK NIL+ + K +KL DF A R + + P +
Sbjct: 133 HKKNFLHRDIKCSNILL-------NNKGQIKLADFGLA---RLY-----NSEESRPYTNK 177
Query: 704 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 760
V T + PE+L + YG +D+WS GC+L EL T + + EL +LI
Sbjct: 178 -VITLWYRPPELLLGEER---YGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 41/140 (29%), Positives = 63/140 (45%), Gaps = 26/140 (18%)
Query: 612 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 671
Y+++ + ++ A+ I + + AL LH + I+HRD+K+ENI +D +P
Sbjct: 175 YVDRSGP-----LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD--------EP 221
Query: 672 V-VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 730
L DF A L AH P GT +PE+L A+ + Y + D
Sbjct: 222 ENAVLGDFGAACKLD--------AHPDTPQCYGWSGTLETNSPELL-AL---DPYCAKTD 269
Query: 731 IWSYGCLLLELLTLQVPYMG 750
IWS G +L E+ V G
Sbjct: 270 IWSAGLVLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 57/241 (23%), Positives = 98/241 (40%), Gaps = 52/241 (21%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+ ME++ GS+K Y+ + + +++K L A + + L S+ +HRD+ + N+
Sbjct: 85 LIMEFLPSGSLKEYLPR----NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNV 140
Query: 659 LIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 716
L++ E + VK+ DF +A+ +T D W APE L
Sbjct: 141 LVESEHQ-------VKIGDFGLTKAIETDKEYYT---------VKDDLDSPVFWYAPECL 184
Query: 717 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG 776
+ + + D+WS+G L ELLT Y + ++M +G
Sbjct: 185 --IQSK--FYIASDVWSFGVTLYELLT----YCDSESSPMTLFLKM------------IG 224
Query: 777 SCHEH-------EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 829
H V + G +P E + L+ R+C E P++R T +L E F
Sbjct: 225 PTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLM---RKCWEFQPSKRTTFQNLIEGFE 281
Query: 830 A 830
A
Sbjct: 282 A 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 48/212 (22%), Positives = 88/212 (41%), Gaps = 41/212 (19%)
Query: 556 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 615
L E ++ L + IV M G + W+ + ME + G + +++K
Sbjct: 44 LREANVMQQLDNPYIVRMIGICEAESWM---------------LVMELAELGPLNKFLQK 88
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
KHV+ K + V+ + L + +HRD+ + N+L+ + K+
Sbjct: 89 -----NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH-------YAKI 136
Query: 676 CDFDRAVPLRSFL-HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 734
DF + L + + H P +W APE + +K + + D+WS+
Sbjct: 137 SDFGLSKALGADENYYKAKTHGKWPV--------KWYAPECMN-YYK---FSSKSDVWSF 184
Query: 735 GCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 765
G L+ E + Q PY G+ E+ +I+ G+R
Sbjct: 185 GVLMWEAFSYGQKPYKGMKGNEVTQMIESGER 216
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 60/240 (25%), Positives = 97/240 (40%), Gaps = 75/240 (31%)
Query: 599 IFMEYVKGGSVKNYIEK--LSET----GEKH-----VSVKLALFIAQDVAAALVELHSKH 647
+ +EY G++ +++ K + ET + +S + L A DVA + L K
Sbjct: 73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 132
Query: 648 IMHRDIKSENILI--DLERKKAD-----GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA 700
+HRD+ + NIL+ + K AD G+ V R +P+R
Sbjct: 133 FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR-LPVR--------------- 176
Query: 701 PDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDL 759
WMA E L ++Y D+WSYG LL E+++L PY G++ E+++
Sbjct: 177 ---------WMAIESLNY----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 223
Query: 760 IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819
+ G R LE +C + + D+ R+C E P ERP
Sbjct: 224 LPQGYR------LEKPLNCDDE---------------------VYDLMRQCWREKPYERP 256
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-05
Identities = 38/109 (34%), Positives = 53/109 (48%), Gaps = 24/109 (22%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA-VPLRSFLHTCCIAHRGIPAP 701
LHS I+HRD+K NI++ K+D +K+ DF A SF+ T P
Sbjct: 134 LHSAGIIHRDLKPSNIVV-----KSDC--TLKILDFGLARTAGTSFMMT----------P 176
Query: 702 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 750
V T + APEV+ M Y VDIWS GC++ E++ V + G
Sbjct: 177 YVV--TRYYRAPEVILGMG----YKENVDIWSVGCIMGEMIRGTVLFPG 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 47/220 (21%)
Query: 538 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 597
LKV +E ++ + E +L L+H+ IV + H I H ++
Sbjct: 35 LKVISMKTEE--GVPFTAIREASLLKGLKHANIVLL--HDII-------------HTKET 77
Query: 598 AIF-MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656
F EY+ + I+ G H + LF+ Q + L +H +HI+HRD+K +
Sbjct: 78 LTFVFEYMHTDLAQYMIQ---HPGGLH-PYNVRLFMFQ-LLRGLAYIHGQHILHRDLKPQ 132
Query: 657 NILIDLERKKADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714
N+LI + +KL DF RA + S ++ + PDV +G
Sbjct: 133 NLLISYLGE-------LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD----- 180
Query: 715 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 754
Y +DIW GC+ +E+L Q + G+S++
Sbjct: 181 ----------YSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 38/113 (33%), Positives = 53/113 (46%), Gaps = 22/113 (19%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 702
LHS I+HRD+K NI++ K+D +K+ DF A T C P
Sbjct: 139 LHSAGIIHRDLKPSNIVV-----KSDC--TLKILDFGLA-------RTACTNFMMTPY-- 182
Query: 703 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 755
V T + APEV+ M Y VDIWS GC++ EL+ V + G ++
Sbjct: 183 --VVTRYYRAPEVILGMG----YKENVDIWSVGCIMGELVKGSVIFQGTDHID 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 47/158 (29%), Positives = 69/158 (43%), Gaps = 36/158 (22%)
Query: 607 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 666
G+ N I K + + HV F+ + L +HS I+HRD+K N+ ++ + +
Sbjct: 105 GADLNNIVKCQKLTDDHVQ-----FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE- 158
Query: 667 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG--TPRWM-APEV-LRAMHKP 722
+K+ DF A HT D G RW APE+ L MH
Sbjct: 159 ------LKILDFGLA------RHT----------DDEMTGYVATRWYRAPEIMLNWMH-- 194
Query: 723 NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 760
Y VDIWS GC++ ELLT + + G ++ LI
Sbjct: 195 --YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 34/109 (31%), Positives = 50/109 (45%), Gaps = 19/109 (17%)
Query: 632 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 691
+A+ + +A+ +H + I+HRDIK+EN+L+ +G + L DF A R
Sbjct: 265 VARQLLSAIDYIHGEGIIHRDIKTENVLV-------NGPEDICLGDFGAACFAR------ 311
Query: 692 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740
P GT APEVL + Y VDIWS G ++ E
Sbjct: 312 --GSWSTPFHYGIAGTVDTNAPEVLAG----DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 49/191 (25%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
EV +L L+H+ IV + H I H + EY+ +K Y++
Sbjct: 53 EVSLLKNLKHANIVTL--HDII------------HTERCLTLVFEYLDS-DLKQYLDNCG 97
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
H +VK+ +F + L H + I+HRD+K +N+LI + K +KL D
Sbjct: 98 NLMSMH-NVKIFMF---QLLRGLSYCHKRKILHRDLKPQNLLI-------NEKGELKLAD 146
Query: 678 FD----RAVPLRSFLH-TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 732
F ++VP +++ + + +R PDV +G+ + P +D+W
Sbjct: 147 FGLARAKSVPTKTYSNEVVTLWYR---PPDVLLGSTEYSTP---------------IDMW 188
Query: 733 SYGCLLLELLT 743
GC+L E+ T
Sbjct: 189 GVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 37/110 (33%), Positives = 52/110 (47%), Gaps = 26/110 (23%)
Query: 639 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 698
AL +H+ ++ HRD+K +NIL + AD K +K+CDF A +F T
Sbjct: 115 ALKYIHTANVFHRDLKPKNILAN-----ADCK--LKICDFGLARV--AFNDT-------- 157
Query: 699 PAPDVCVGT----PRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743
P T RW APE+ + Y +DIWS GC+ E+LT
Sbjct: 158 --PTAIFWTDYVATRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAEVLT 203
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 29/101 (28%), Positives = 49/101 (48%), Gaps = 18/101 (17%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 702
+HS +++HRD+K N+L++ +++ DF A L S H+
Sbjct: 123 IHSANVIHRDLKPSNLLVN-------EDCELRIGDFGMARGLSSS----PTEHKYFMTEY 171
Query: 703 VCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742
V RW APE+L ++ + Y +D+WS GC+ E+L
Sbjct: 172 V---ATRWYRAPELLLSLPE---YTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 6e-05
Identities = 65/309 (21%), Positives = 118/309 (38%), Gaps = 75/309 (24%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+ L+ +S + +F EV++L L I + G L
Sbjct: 51 VKVLR-PDASDNAREDFL----KEVKILSRLSDPNIARLLGVCTVDPPL----------- 94
Query: 595 LQSAIFMEYVKGGSVKNYIEK------LSETGEKHVSVKLALFIAQDVAAALVELHSKHI 648
+ MEY++ G + +++K K +S L++A +A+ + L S +
Sbjct: 95 ---CMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF 151
Query: 649 MHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVG 706
+HRD+ + N L+ +K+ DF R + + + R P P
Sbjct: 152 VHRDLATRNCLVGKNYT-------IKIADFGMSRNLYSSDY---YRVQGRA-PLP----- 195
Query: 707 TPRWMAPE-VLRAMHKPNLYGLEVDIWSYGCLLLELLTL--QVPYMGLSELEIHDLIQ-M 762
RWMA E VL + K + + D+W++G L E+LTL + PY L +I+
Sbjct: 196 -IRWMAWESVL--LGK---FTTKSDVWAFGVTLWEILTLCREQPY---EHLTDQQVIENA 246
Query: 763 GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822
G R L +P + + ++ C + +RPT
Sbjct: 247 GHFFRDDGRQIYLP---------------RPPNCPKD---IYELMLECWRRDEEDRPTFR 288
Query: 823 DLYEMFVAR 831
+++ +F+ R
Sbjct: 289 EIH-LFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 46/217 (21%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYIEK 615
E +++ L H +V++YG +S I + E+++ G + +Y+
Sbjct: 49 EAQVMMKLSHPKLVQLYGVCTE----------------RSPICLVFEFMEHGCLSDYLR- 91
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
++ G+ S + L + DV + L S +++HRD+ + N L+ + VVK+
Sbjct: 92 -AQRGK--FSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ-------VVKV 141
Query: 676 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735
DF R L + G P +W +PEV + Y + D+WS+G
Sbjct: 142 SDFGMT---RFVLDDQYTSSTGTKFP------VKWSSPEVF----SFSKYSSKSDVWSFG 188
Query: 736 CLLLELLTL-QVPYMGLSELEIHDLIQMGKR---PRL 768
L+ E+ + + PY S E+ + I G R PRL
Sbjct: 189 VLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRL 225
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 37/137 (27%), Positives = 67/137 (48%), Gaps = 28/137 (20%)
Query: 630 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 689
+ I +AA + L S H++H+D+ + N+L+ K VK+ D + + +
Sbjct: 127 VHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF-------DKLNVKISDLGLFREVYAADY 179
Query: 690 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLT--L 744
+ + +P RWM+PE + +YG ++ DIWSYG +L E+ + L
Sbjct: 180 YKLMGNSLLPI--------RWMSPEAI-------MYGKFSIDSDIWSYGVVLWEVFSYGL 224
Query: 745 QVPYMGLSELEIHDLIQ 761
Q PY G S ++ ++I+
Sbjct: 225 Q-PYCGYSNQDVIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 35/131 (26%), Positives = 61/131 (46%), Gaps = 20/131 (15%)
Query: 636 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 695
+A + L + ++HRD+ + N+L+ VK+ DF A L +
Sbjct: 118 IAKGMNYLEERRLVHRDLAARNVLVK-------TPQHVKITDFGLAKLLGADEKEYHAEG 170
Query: 696 RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSEL 754
+P +WMA E + +H+ +Y + D+WSYG + EL+T PY G+
Sbjct: 171 GKVPI--------KWMALESI--LHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 218
Query: 755 EIHDLIQMGKR 765
EI +++ G+R
Sbjct: 219 EISSILEKGER 229
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 50/215 (23%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
EV +L L+H+ IV ++ + K L + EY+ +K Y++
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSL--------------TLVFEYLDK-DLKQYMDDCG 98
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
H +VK+ L+ + L H + ++HRD+K +N+LI+ ER + +KL D
Sbjct: 99 NIMSMH-NVKIFLY---QILRGLAYCHRRKVLHRDLKPQNLLIN-ERGE------LKLAD 147
Query: 678 FD----RAVPLRSFLH-TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 732
F ++VP +++ + + +R PDV +G+ Y ++D+W
Sbjct: 148 FGLARAKSVPTKTYSNEVVTLWYR---PPDVLLGSSE---------------YSTQIDMW 189
Query: 733 SYGCLLLELLTLQVPYMGLS-ELEIHDLIQMGKRP 766
GC+ E+ + + + G + E E+H + ++ P
Sbjct: 190 GVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTP 224
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 7e-05
Identities = 37/122 (30%), Positives = 55/122 (45%), Gaps = 13/122 (10%)
Query: 636 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 695
V AL H++ I+HRD+K +NI++ + +P K+ DF L
Sbjct: 88 VLDALACAHNQGIVHRDLKPQNIMV----SQTGVRPHAKVLDFGIGTLLPGVRD---ADV 140
Query: 696 RGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 754
+ +GTP + APE LR PN D++++G + LE LT Q G S
Sbjct: 141 ATLTRTTEVLGTPTYCAPEQLRGEPVTPN-----SDLYAWGLIFLECLTGQRVVQGASVA 195
Query: 755 EI 756
EI
Sbjct: 196 EI 197
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 8e-05
Identities = 37/146 (25%), Positives = 64/146 (43%), Gaps = 20/146 (13%)
Query: 621 EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDR 680
+ ++ +L L +A ++ L + ++HRD+ + N+L+ VK+ DF
Sbjct: 103 KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH-------VKITDFGL 155
Query: 681 AVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740
A L +P +WMA E + + + D+WSYG + E
Sbjct: 156 ARLLEGDEKEYNADGGKMPI--------KWMALECIHYRK----FTHQSDVWSYGVTIWE 203
Query: 741 LLTL-QVPYMGLSELEIHDLIQMGKR 765
L+T PY G+ EI DL++ G+R
Sbjct: 204 LMTFGGKPYDGIPTREIPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 50/215 (23%), Positives = 98/215 (45%), Gaps = 50/215 (23%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
EV +L L+H+ IV ++ + K L + EY+ +K Y++
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSL--------------TLVFEYLDK-DLKQYLDDCG 98
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
+ H +VKL LF + L H + ++HRD+K +N+LI+ ER + +KL D
Sbjct: 99 NSINMH-NVKLFLF---QLLRGLNYCHRRKVLHRDLKPQNLLIN-ERGE------LKLAD 147
Query: 678 FD----RAVPLRSFLH-TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 732
F +++P +++ + + +R PD+ +G+ Y ++D+W
Sbjct: 148 FGLARAKSIPTKTYSNEVVTLWYR---PPDILLGSTD---------------YSTQIDMW 189
Query: 733 SYGCLLLELLTLQVPYMGLS-ELEIHDLIQMGKRP 766
GC+ E+ T + + G + E ++H + ++ P
Sbjct: 190 GVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTP 224
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 35/133 (26%), Positives = 60/133 (45%), Gaps = 20/133 (15%)
Query: 630 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 689
L IA +AA + L S +H+D+ + NILI + VK+ D + + S +
Sbjct: 127 LHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH-------VKISDLGLSREIYSADY 179
Query: 690 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PY 748
+P RWM PE + + + DIWS+G +L E+ + + PY
Sbjct: 180 YRVQPKSLLPI--------RWMPPEAIMY----GKFSSDSDIWSFGVVLWEIFSFGLQPY 227
Query: 749 MGLSELEIHDLIQ 761
G S E+ ++++
Sbjct: 228 YGFSNQEVIEMVR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-04
Identities = 32/88 (36%), Positives = 45/88 (51%), Gaps = 16/88 (18%)
Query: 595 LQSA----IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 650
LQSA + MEY+ GG VK+ + E+ +A+ +VA AL LH I+H
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEE-----MAVKYISEVALALDYLHRHGIIH 127
Query: 651 RDIKSENILIDLERKKADGKPVVKLCDF 678
RD+K +N+LI E +KL DF
Sbjct: 128 RDLKPDNMLISNEGH-------IKLTDF 148
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 39/202 (19%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA-VPLRSFLHTCCIAHRGIPAP 701
LHS I+HRD+K NI++ K+D +K+ DF A SF+ T P
Sbjct: 142 LHSAGIIHRDLKPSNIVV-----KSDC--TLKILDFGLARTAGTSFMMT----------P 184
Query: 702 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI- 760
V T + APEV+ M Y VDIWS GC++ E++ V + G ++ + +
Sbjct: 185 YVV--TRYYRAPEVILGMG----YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238
Query: 761 -QMGKR-PRLTDELEALGSCH-EHEVAQSGSGFEKPEAELETLSFLVDV-FRRCTEENPT 816
Q+G P +L+ + E+ +G FEK DV F +E N
Sbjct: 239 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEK---------LFPDVLFPADSEHNKL 289
Query: 817 ERPTAGDLY-EMFVARTSSSIS 837
+ A DL +M V S IS
Sbjct: 290 KASQARDLLSKMLVIDASKRIS 311
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 40/133 (30%), Positives = 58/133 (43%), Gaps = 32/133 (24%)
Query: 628 LALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPV-----------VKL 675
LA I Q AL H++ H+MH D+K ENIL++ D PV V++
Sbjct: 233 LAQIIFQ-TGVALDYFHTELHLMHTDLKPENILMETSDTVVD--PVTNRALPPDPCRVRI 289
Query: 676 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735
CD L CC A V T + +PEV+ + + D+WS G
Sbjct: 290 CD----------LGGCCDERHSRTA---IVSTRHYRSPEVVLGLG----WMYSTDMWSMG 332
Query: 736 CLLLELLTLQVPY 748
C++ EL T ++ Y
Sbjct: 333 CIIYELYTGKLLY 345
|
Length = 467 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 55/243 (22%), Positives = 105/243 (43%), Gaps = 46/243 (18%)
Query: 527 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 586
G + ++TLK G + + R+F L E ++G H I+ + G + +K P
Sbjct: 29 GKREIFVAIKTLKS-GYTEKQRRDF----LSEASIMGQFDHPNIIHLEG--VVTKSRPVM 81
Query: 587 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 646
I E+++ G++ +++ + + +V + + + +AA + L
Sbjct: 82 ------------IITEFMENGALDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLSEM 125
Query: 647 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 706
+ +HRD+ + NIL+ + V K+ DF L FL P +G
Sbjct: 126 NYVHRDLAARNILV-------NSNLVCKVSDFG----LSRFLED----DTSDPTYTSSLG 170
Query: 707 TP---RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQM 762
RW APE + A K + D+WSYG ++ E+++ + PY +S ++ + I+
Sbjct: 171 GKIPIRWTAPEAI-AYRK---FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ 226
Query: 763 GKR 765
R
Sbjct: 227 DYR 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 34/109 (31%), Positives = 52/109 (47%), Gaps = 24/109 (22%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA-VPLRSFLHTCCIAHRGIPAP 701
LHS I+HRD+K NI++ K+D +K+ DF A SF+ T + R AP
Sbjct: 135 LHSAGIIHRDLKPSNIVV-----KSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 702 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 750
+V +G Y VDIWS GC++ E++ ++ + G
Sbjct: 188 EVILGMG----------------YKENVDIWSVGCIMGEMVRHKILFPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 57/256 (22%), Positives = 107/256 (41%), Gaps = 48/256 (18%)
Query: 502 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM 561
G S ++ G+ +++++ G + K+ LKV +E ++ + E +
Sbjct: 2 GKADSYEKLEKLGEGSYATVYK---GKSKVNGKLVALKVIRLQEEE--GTPFTAIREASL 56
Query: 562 LGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE 621
L L+H+ IV + H I H + EYV + Y++K G
Sbjct: 57 LKGLKHANIVLL--HDII------------HTKETLTLVFEYVHT-DLCQYMDK-HPGGL 100
Query: 622 KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFD-- 679
+VKL LF + L +H ++I+HRD+K +N+LI + +KL DF
Sbjct: 101 HPENVKLFLF---QLLRGLSYIHQRYILHRDLKPQNLLISDTGE-------LKLADFGLA 150
Query: 680 RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739
RA + S ++ + PDV +G+ Y +D+W GC+ +
Sbjct: 151 RAKSVPSHTYSNEVVTLWYRPPDVLLGSTE---------------YSTCLDMWGVGCIFV 195
Query: 740 ELLTLQVPYMGLSELE 755
E++ + G+ +++
Sbjct: 196 EMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 35/140 (25%), Positives = 65/140 (46%), Gaps = 21/140 (15%)
Query: 602 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661
E+V+ G + ++ + S+ ++ +A+ +A+AL L K ++H ++ ++NIL+
Sbjct: 84 EFVEFGPLDLFMHRKSDV----LTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLA 139
Query: 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 721
E + P +KL D +P+ C+ IP W+APE +
Sbjct: 140 REGIDGECGPFIKLS--DPGIPITVLSRQECVER--IP----------WIAPECVE--DS 183
Query: 722 PNLYGLEVDIWSYGCLLLEL 741
NL + D WS+G L E+
Sbjct: 184 KNL-SIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 36/112 (32%), Positives = 52/112 (46%), Gaps = 20/112 (17%)
Query: 632 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 691
I + + A+ +H K ++HRDIK ENI ++ DGK V L DF A+P
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLN-----CDGKIV--LGDFGTAMPFEK----- 319
Query: 692 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743
VGT +PE+L + Y DIWS G +LL++L+
Sbjct: 320 ----EREAFDYGWVGTVATNSPEILAG----DGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 41/116 (35%), Positives = 49/116 (42%), Gaps = 20/116 (17%)
Query: 630 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 689
L I + V A+ LH I+HRDIK+ENI I+ D V L DF A
Sbjct: 185 LAIERSVLRAIQYLHENRIIHRDIKAENIFIN---HPGD----VCLGDFGAA-------- 229
Query: 690 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 745
C GT APE+L P YG VDIWS G +L E+ T
Sbjct: 230 -CFPVDINANKYYGWAGTIATNAPELL--ARDP--YGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 57/197 (28%), Positives = 86/197 (43%), Gaps = 37/197 (18%)
Query: 602 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661
E+V+ G + + K E G V V + +AQ +A+AL L K+++H ++ ++NIL
Sbjct: 96 EFVEHGPLDVCLRK--EKG--RVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNIL-- 149
Query: 662 LERKK-ADG-KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 719
L R A+G P +KL D P SF + + V W+APE +
Sbjct: 150 LARLGLAEGTSPFIKLSD-----PGVSF---------TALSREERVERIPWIAPECV--- 192
Query: 720 HKPNLYGLE--VDIWSYGCLLLEL-LTLQVPYMGLSELEIHDLIQMGKRPRLTD----EL 772
P L D WS+G LLE+ +VP + E + K+ RL + EL
Sbjct: 193 --PGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE--KKHRLPEPSCKEL 248
Query: 773 EAL-GSCHEHEVAQSGS 788
L C +E Q S
Sbjct: 249 ATLISQCLTYEPTQRPS 265
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 22/132 (16%)
Query: 636 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 695
+A + L ++HRD+ + N+L+ VK+ DF A L T A
Sbjct: 118 IAKGMSYLEEVRLVHRDLAARNVLVKSPNH-------VKITDFGLA-RLLDIDETEYHAD 169
Query: 696 RG-IPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSE 753
G +P +WMA E + +H+ + + D+WSYG + EL+T PY G+
Sbjct: 170 GGKVPI--------KWMALESI--LHRR--FTHQSDVWSYGVTVWELMTFGAKPYDGIPA 217
Query: 754 LEIHDLIQMGKR 765
EI DL++ G+R
Sbjct: 218 REIPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 65/265 (24%), Positives = 95/265 (35%), Gaps = 74/265 (27%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+ ME++ GG + + K E+ +IA+ V A + +H +HRDIK +N+
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLTEEETQ----FYIAETVLA-IDSIHQLGFIHRDIKPDNL 132
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR---------GIPAPDV------ 703
L+ D K VKL DF L+ AHR +P+
Sbjct: 133 LL-------DSKGHVKLSDFGLCTGLKK-------AHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 704 -----------------CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 746
VGTP ++APEV Y D WS G ++ E+L
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ----TGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 747 PYMGLSELEIHDLIQMGKRPRLTDELEA----------LGSCHEHEVAQSGSGFEKPEAE 796
P+ + E + + M + L E L C E E G E E
Sbjct: 235 PFCSETPQETYKKV-MNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVE----E 289
Query: 797 LETLSFLVDVFRRCTEENPTERPTA 821
++T F F E+ ERP A
Sbjct: 290 IKTNPF----FEGVDWEHIRERPAA 310
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 36/127 (28%), Positives = 57/127 (44%), Gaps = 27/127 (21%)
Query: 631 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 690
F+ + L +H+ I+HRD+K N+ ++ + + +K+ DF A S +
Sbjct: 122 FLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE-------LKILDFGLARQTDSEMTG 174
Query: 691 CCIAHRGIPAPDVCVGTPRWM-APEV-LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 748
+ RW APEV L MH Y VDIWS GC++ E+LT + +
Sbjct: 175 YVVT--------------RWYRAPEVILNWMH----YTQTVDIWSVGCIMAEMLTGKPLF 216
Query: 749 MGLSELE 755
G L+
Sbjct: 217 KGHDHLD 223
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 35/110 (31%), Positives = 50/110 (45%), Gaps = 27/110 (24%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 702
+HS I+HRD+K N+ ++ + + +K+ DF A R A
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCE-------LKILDFGLA--------------RHADAEM 171
Query: 703 VCVGTPRWM-APEV-LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 750
RW APEV L MH Y VDIWS GC++ E+LT + + G
Sbjct: 172 TGYVVTRWYRAPEVILNWMH----YNQTVDIWSVGCIMAEMLTGKTLFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 9e-04
Identities = 64/255 (25%), Positives = 95/255 (37%), Gaps = 66/255 (25%)
Query: 537 TLKVCGSSA-DEIRNFEYSCLGEVRMLGALRHSCIVE--MYGH-KISSKWLPSADGNPEH 592
+LKV G A E+R + G + + LR + ++E H + L ADG
Sbjct: 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVV 64
Query: 593 HLLQS-------AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS 645
+ S + ME++ GG + + K E+ +IA+ V A + +H
Sbjct: 65 KMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQ----FYIAETVLA-IDAIHQ 119
Query: 646 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI------- 698
+HRDIK +N+L+ D K VKL DF L+ AHR
Sbjct: 120 LGFIHRDIKPDNLLL-------DAKGHVKLSDFGLCTGLKK-------AHRTEFYRNLTH 165
Query: 699 -PAPDV------------------------CVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 733
P D VGTP ++APEV Y D WS
Sbjct: 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG----YNKLCDWWS 221
Query: 734 YGCLLLELLTLQVPY 748
G ++ E+L P+
Sbjct: 222 LGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 39/144 (27%), Positives = 65/144 (45%), Gaps = 28/144 (19%)
Query: 607 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 666
G+ N I K + ++HV F+ + L +HS I+HRD+K N+ ++ + +
Sbjct: 103 GADLNNIVKCQKLSDEHVQ-----FLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE- 156
Query: 667 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 726
+++ DF A + T +A R AP++ +L MH Y
Sbjct: 157 ------LRILDFGLARQADDEM-TGYVATRWYRAPEI-----------MLNWMH----YN 194
Query: 727 LEVDIWSYGCLLLELLTLQVPYMG 750
VDIWS GC++ ELL + + G
Sbjct: 195 QTVDIWSVGCIMAELLKGKALFPG 218
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 13/101 (12%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 702
LH+ ++HRD+K NIL+ E + + VK+ D A S L + + D
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPE---RGRVKIADMGFARLFNSPL-------KPLADLD 173
Query: 703 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743
V T + APE+L Y +DIW+ GC+ ELLT
Sbjct: 174 PVVVTFWYRAPELLLGARH---YTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 47/181 (25%), Positives = 67/181 (37%), Gaps = 53/181 (29%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+ ME++ GG + + K E + F + A+ +H +HRDIK +NI
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSED-----VTRFYMAECVLAIEAVHKLGFIHRDIKPDNI 132
Query: 659 LIDLERKKADGKPVVKLCDF----------DRAV---PLRSFLHTCCIAHRGIPAPDV-- 703
LID G +KL DF D A L+ + I +R A D
Sbjct: 133 LID-----RGGH--IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSIN 185
Query: 704 ----------------------CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741
VGTP ++APE+ YG E D WS G ++ E
Sbjct: 186 LTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG----YGQECDWWSLGAIMFEC 241
Query: 742 L 742
L
Sbjct: 242 L 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 13/101 (12%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 702
LH+ ++HRD+K NIL+ E + + VK+ D A S L + + D
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPE---RGRVKIADMGFARLFNSPL-------KPLADLD 173
Query: 703 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743
V T + APE+L Y +DIW+ GC+ ELLT
Sbjct: 174 PVVVTFWYRAPELLLGARH---YTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 41/208 (19%), Positives = 87/208 (41%), Gaps = 40/208 (19%)
Query: 555 CLGEVRMLGALRHSCIVEMYGHKIS-SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 613
E++ L + + I+++YG I LP ++ +EY G ++ +
Sbjct: 65 TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRL-----------SLILEYCTRGYLREVL 113
Query: 614 EKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPV 672
+K EK +S K L +A D L L+ + ++++ S + L+ + K
Sbjct: 114 DK-----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT-----ENYKLK 163
Query: 673 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 732
+ ++ + F + + + + ++L + Y ++ DI+
Sbjct: 164 IICHGLEKILSSPPFKNVNFMVYF---------------SYKMLNDIFSE--YTIKDDIY 206
Query: 733 SYGCLLLELLTLQVPYMGLSELEIHDLI 760
S G +L E+ T ++P+ L+ EI+DLI
Sbjct: 207 SLGVVLWEIFTGKIPFENLTTKEIYDLI 234
|
Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 48/210 (22%), Positives = 93/210 (44%), Gaps = 49/210 (23%)
Query: 562 LGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE 621
+G+L H+ IV + G P A LQ + + GS+ +++ + ++
Sbjct: 63 MGSLDHAYIVRLLG------ICPGAS-------LQ--LVTQLSPLGSLLDHVRQHRDS-- 105
Query: 622 KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA 681
+ + L +A + L ++HR++ + NIL+ K+D +V++ DF A
Sbjct: 106 --LDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL-----KSDS--IVQIADFGVA 156
Query: 682 VPL----RSFLHTCCIAHRGIPAPDVCVGTP-RWMAPEVLRAMHKPNLYGLEVDIWSYGC 736
L + + ++ TP +WMA L ++ Y + D+WSYG
Sbjct: 157 DLLYPDDKKYFYSE-------------HKTPIKWMA---LESILFGR-YTHQSDVWSYGV 199
Query: 737 LLLELLTLQV-PYMGLSELEIHDLIQMGKR 765
+ E+++ PY G+ E+ DL++ G+R
Sbjct: 200 TVWEMMSYGAEPYAGMRPHEVPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 26/84 (30%), Positives = 35/84 (41%), Gaps = 17/84 (20%)
Query: 632 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 691
I + + AL LHS I+HRD+K +NI+ K+ D A LR
Sbjct: 260 IMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGS------FKIIDLGAAADLRV----- 308
Query: 692 CIAHRGIP-APDVCVGTPRWMAPE 714
GI P + PR+ APE
Sbjct: 309 -----GINYIPKEFLLDPRYAAPE 327
|
Length = 566 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 840 | |||
| PF14381 | 204 | EDR1: Ethylene-responsive protein kinase Le-CTR1 | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.63 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.54 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.26 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.24 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.24 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.23 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.23 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.17 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.17 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.96 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.89 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.87 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.86 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.69 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.64 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.63 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.54 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.39 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.39 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.33 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.29 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.09 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.97 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.91 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.88 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.85 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.8 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.73 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.69 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.6 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.59 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.49 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.3 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.29 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.07 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.0 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.92 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.92 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.89 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.87 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.76 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.59 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.44 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.36 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.21 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.94 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.91 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.66 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.13 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.02 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.83 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.79 | |
| PLN02236 | 344 | choline kinase | 93.96 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.96 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 93.95 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 92.31 | |
| smart00460 | 68 | TGc Transglutaminase/protease-like homologues. Tra | 90.85 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 90.77 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 90.36 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 90.02 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 88.9 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 88.52 | |
| PF01841 | 113 | Transglut_core: Transglutaminase-like superfamily; | 85.88 | |
| PTZ00296 | 442 | choline kinase; Provisional | 85.32 |
| >PF14381 EDR1: Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-49 Score=400.14 Aligned_cols=189 Identities=35% Similarity=0.516 Sum_probs=161.8
Q ss_pred CcccccccccccccccCCCCCCCCccccCCCCC----------CCcccccccc-CCCCCceEEEEEcCCCCHHHHHHHHH
Q 003185 216 GENSNASQKYSSVSFCSIEDRLPDGFYDAGRDR----------PFMQLTGYEQ-TPHLDSREVILVDRKSDEELDAIALS 284 (840)
Q Consensus 216 ~~~~~~s~~~~~~~~~~~~d~~~dgfy~~~~~~----------~~~~l~~~~~-~~~~~~~evilvdr~~d~~l~~~~~~ 284 (840)
++++++|||||++|||+|+|||||||||++++. .+++|++|+. .+...++|||||||.+|+.|++|++.
T Consensus 1 ~~~e~lS~r~W~~~~L~y~dki~DGFYdi~g~~~~~~l~~~~~~~Psl~~L~~~~~~~~~~EvIlVDr~~D~~L~~L~~~ 80 (204)
T PF14381_consen 1 SSAESLSHRYWVNGCLSYDDKIPDGFYDIYGMDCTNSLKEEFGRMPSLEDLQAVPPDDSSREVILVDRRRDPSLKELEQR 80 (204)
T ss_pred CcHHHHHHHHHHcCCCCCCCcCCCCCcccccCCCccccccccCCCCCHHHHhcCCCCCCCeeEEEEccccCHHHHHHHHH
Confidence 367999999999999999999999999999873 3558999994 46689999999999999999999999
Q ss_pred HHHHHHHhhhccCcccCCccCccchHHHHHHHHHHHHhhcCCCCcccccccccccccCCCCCCCcccccCCCCCCCcccc
Q 003185 285 AQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTS 364 (840)
Q Consensus 285 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~la~~v~~~~gg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (840)
|+.++..+. .+..+++++||+|||++|||++..+
T Consensus 81 a~~~~~~~~-------------~~~~~~v~~LA~lVa~~MGG~~~~~--------------------------------- 114 (204)
T PF14381_consen 81 AHELSKGLS-------------TNTKELVQKLAKLVADRMGGPVSDA--------------------------------- 114 (204)
T ss_pred HHHHHhccc-------------cCHHHHHHHHHHHHHHHhCCCCCcc---------------------------------
Confidence 999995432 1345699999999999999987332
Q ss_pred hhhhhcccchhhhhhHHHHHHHHHHhhcCceEEeccceeeeccccceeeeeeeccccCCCccccccccccccCC-CCcce
Q 003185 365 QKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQP-HAWNT 443 (840)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~v~pig~l~~g~~~~rallfk~l~d~~~~~lpcrlvrG~~~~~~-~a~~s 443 (840)
+ .....|+..++.||. ++++||||+|++|+|||||||||+|||+|+ ||||||||+|||.. +..+.
T Consensus 115 ---------~-~~~~~w~~~s~~lk~--~s~~vplG~l~~G~~rhRALLFKvLAD~ig--lpCrLvrG~~y~g~~~~~a~ 180 (204)
T PF14381_consen 115 ---------E-DMLFRWELRSEKLKE--NSGVVPLGSLRIGLCRHRALLFKVLADRIG--LPCRLVRGCYYCGWDDDDAS 180 (204)
T ss_pred ---------h-hhhHHHHHHHHHHHh--CCCeEEEeeecccchHHHHHHHHHHHHhcC--CCceEEeeccCCccCCCCce
Confidence 1 133479998888888 899999999999999999999999999999 99999999999976 45556
Q ss_pred eEEeeCCceEEEEeccc-CCCcc
Q 003185 444 ILVKKGDSWIRMIVDAC-RPHDI 465 (840)
Q Consensus 444 ~lvr~G~~~~~~lvd~~-~p~~~ 465 (840)
+.|+.++.+ +|+||++ .||.+
T Consensus 181 ~~V~~~~~~-eyiVDLm~~PG~L 202 (204)
T PF14381_consen 181 NLVKFDDGR-EYIVDLMGAPGQL 202 (204)
T ss_pred EEEEcCCCc-EEEEEcCCCCCCc
Confidence 788877765 8999998 57765
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=409.24 Aligned_cols=267 Identities=30% Similarity=0.449 Sum_probs=223.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCee-EEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGSAD-AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
+.+..+.+.+.||+|+||+||+|.|.+.. ||+|++.... ..... .+.|.+|+.+|.+|+|||||+++|++...
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~--~~~~~----~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPD--FDDES----RKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchh--cChHH----HHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 56777788888999999999999999998 9999965332 22222 34559999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eecccCCCCcEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENIL 659 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~g-IVHRDLKPeNIL 659 (840)
.. .++|||||+++|+|.+++... ....+++..++.|+.||++||.|||+++ ||||||||+|||
T Consensus 112 ~~-------------~~~iVtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiL 175 (362)
T KOG0192|consen 112 PG-------------SLCIVTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNIL 175 (362)
T ss_pred CC-------------ceEEEEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEE
Confidence 41 359999999999999999862 3467999999999999999999999999 999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
|+.+. .++||+|||+++....... ..+...||+.|||||++.+. ...|+.|+||||||++||
T Consensus 176 v~~~~------~~~KI~DFGlsr~~~~~~~----------~~~~~~GT~~wMAPEv~~~~--~~~~~~K~DvySFgIvlW 237 (362)
T KOG0192|consen 176 VDLKG------KTLKIADFGLSREKVISKT----------SMTSVAGTYRWMAPEVLRGE--KSPYTEKSDVYSFGIVLW 237 (362)
T ss_pred EcCCC------CEEEECCCccceeeccccc----------cccCCCCCccccChhhhcCC--CCcCCccchhhhHHHHHH
Confidence 99872 3799999999987654211 11225799999999999853 367999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHH-cCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~-~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
||+||+.||.+..+.++...+. ++.+|.++.. +++.+..||.+||..||..|
T Consensus 238 El~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~---------------------------~~~~l~~l~~~CW~~dp~~R 290 (362)
T KOG0192|consen 238 ELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKE---------------------------CPPHLSSLMERCWLVDPSRR 290 (362)
T ss_pred HHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCcc---------------------------CCHHHHHHHHHhCCCCCCcC
Confidence 9999999999998888777765 5577776642 35579999999999999999
Q ss_pred CCHHHHHHHHHhhcCCC
Q 003185 819 PTAGDLYEMFVARTSSS 835 (840)
Q Consensus 819 PSa~ELLehLe~l~~~~ 835 (840)
|++.+|+..|+.+....
T Consensus 291 P~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 291 PSFLEIVSRLESIMSHI 307 (362)
T ss_pred CCHHHHHHHHHHHHHhh
Confidence 99999999999876543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=404.57 Aligned_cols=272 Identities=22% Similarity=0.270 Sum_probs=222.2
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
..+.|.+.+.||+|+||.|-+|.. .++.||+|++.............. ...+.+|+++|++|+|||||+++++|...
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~-~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAK-TRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccc-hhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 345678899999999999999985 788999999865543332211111 12357999999999999999999999987
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
+.. ||||||++||.|.+++-. .+.+.+..-+.+++||+.|+.|||++||+||||||+|||+
T Consensus 249 ds~--------------YmVlE~v~GGeLfd~vv~-----nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl 309 (475)
T KOG0615|consen 249 DSS--------------YMVLEYVEGGELFDKVVA-----NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILL 309 (475)
T ss_pred Cce--------------EEEEEEecCccHHHHHHh-----ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEe
Confidence 754 999999999999999976 4678888889999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
..+. ....+||+|||+|+....... ..+.+|||.|.|||++.... ...+..++||||+||+||-
T Consensus 310 ~~~~----e~~llKItDFGlAK~~g~~sf-----------m~TlCGTpsYvAPEVl~~kg-~~~~~~kVDiWSlGcvLfv 373 (475)
T KOG0615|consen 310 SNDA----EDCLLKITDFGLAKVSGEGSF-----------MKTLCGTPSYVAPEVLASKG-VEYYPSKVDIWSLGCVLFV 373 (475)
T ss_pred ccCC----cceEEEecccchhhcccccee-----------hhhhcCCccccChhheecCC-eecccchheeeeccceEEE
Confidence 8763 347899999999998764322 35578999999999998622 1234469999999999999
Q ss_pred HHhCCCCCCCCCHHH-HHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLTLQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLTG~~PF~~~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+++|.+||.+..... +.++|.++.....+..| ..++++.++||.+||..||++||
T Consensus 374 cLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w------------------------~~Iseea~dlI~~mL~VdP~~R~ 429 (475)
T KOG0615|consen 374 CLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW------------------------DRISEEALDLINWMLVVDPENRP 429 (475)
T ss_pred EeccCCCcccccCCccHHHHHhcCcccccChhh------------------------hhhhHHHHHHHHHhhEeCcccCc
Confidence 999999998765444 88899988766554333 34578899999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 003185 820 TAGDLYEMFVARTSS 834 (840)
Q Consensus 820 Sa~ELLehLe~l~~~ 834 (840)
|++|+|+|.+-...+
T Consensus 430 s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 430 SADEALNHPWFKDAP 444 (475)
T ss_pred CHHHHhcChhhhccc
Confidence 999999998766444
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=395.60 Aligned_cols=256 Identities=29% Similarity=0.440 Sum_probs=221.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
+...+++.++.||+|..|+||++++ ++.-+|+|++.+.. .. .+.+++.+|+++++..+|||||.+||+|..
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~---~~----~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI---DP----ALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC---CH----HHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 5567889999999999999999998 47788999874332 22 334556999999999999999999999997
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCCCcE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENI 658 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs-~gIVHRDLKPeNI 658 (840)
... ..+|+||||++|||+.++.. .+++++....+|+.+|++||.|||+ ++||||||||+||
T Consensus 149 ~~~-------------~isI~mEYMDgGSLd~~~k~-----~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNl 210 (364)
T KOG0581|consen 149 NGE-------------EISICMEYMDGGSLDDILKR-----VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNL 210 (364)
T ss_pred CCc-------------eEEeehhhcCCCCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHe
Confidence 652 25999999999999999986 3679999999999999999999996 8999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
||+..| .|||||||.+..+.... .++++||..|||||.+.+ ..|+.++||||||++|
T Consensus 211 LvNskG-------eVKicDFGVS~~lvnS~------------a~tfvGT~~YMsPERi~g----~~Ys~~sDIWSLGLsl 267 (364)
T KOG0581|consen 211 LVNSKG-------EVKICDFGVSGILVNSI------------ANTFVGTSAYMSPERISG----ESYSVKSDIWSLGLSL 267 (364)
T ss_pred eeccCC-------CEEeccccccHHhhhhh------------cccccccccccChhhhcC----CcCCcccceecccHHH
Confidence 999884 59999999998876531 356789999999999997 7899999999999999
Q ss_pred HHHHhCCCCCCCC-----CHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 003185 739 LELLTLQVPYMGL-----SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 813 (840)
Q Consensus 739 ~ELLTG~~PF~~~-----~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~ 813 (840)
+|+++|+.||... ...+++..|..+..|.++.. ..++++.+||..||++
T Consensus 268 lE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~--------------------------~fS~ef~~FV~~CL~K 321 (364)
T KOG0581|consen 268 LELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG--------------------------EFSPEFRSFVSCCLRK 321 (364)
T ss_pred HHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc--------------------------cCCHHHHHHHHHHhcC
Confidence 9999999999763 67888888988877777742 1366899999999999
Q ss_pred CCCCCCCHHHHHHHHHhh
Q 003185 814 NPTERPTAGDLYEMFVAR 831 (840)
Q Consensus 814 DP~eRPSa~ELLehLe~l 831 (840)
||.+||++.|+++|.+-.
T Consensus 322 dp~~R~s~~qLl~Hpfi~ 339 (364)
T KOG0581|consen 322 DPSERPSAKQLLQHPFIK 339 (364)
T ss_pred CcccCCCHHHHhcCHHHh
Confidence 999999999999996654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=384.83 Aligned_cols=262 Identities=27% Similarity=0.436 Sum_probs=220.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEe-
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI- 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~- 578 (840)
.++.+|++.++||+|+||.||++.. .+..+|.|-+... ...... ++.+..|+.+|++|+|||||++|++-.
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~--~md~k~----rq~~v~Ei~lLkQL~HpNIVqYy~~~f~ 89 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG--MMDAKA----RQDCVKEISLLKQLNHPNIVQYYAHSFI 89 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh--hccHHH----HHHHHHHHHHHHhcCCchHHHHHHHhhh
Confidence 5788999999999999999999985 6777777764432 222222 345699999999999999999999433
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--eecccCC
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS--KH--IMHRDIK 654 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs--~g--IVHRDLK 654 (840)
.+.. .++||||||.+|+|.++|+.+.+ ....+++.++|+++.|++.||.++|. .. |+|||||
T Consensus 90 ~~~e-------------vlnivmE~c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIK 155 (375)
T KOG0591|consen 90 EDNE-------------VLNIVMELCDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIK 155 (375)
T ss_pred ccch-------------hhHHHHHhhcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCc
Confidence 3322 25999999999999999987544 45789999999999999999999999 45 9999999
Q ss_pred CCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHH
Q 003185 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 734 (840)
Q Consensus 655 PeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSL 734 (840)
|.||+|+.+ +.|||+|||+++.+..... .....+|||.||+||.+.+ ..|++||||||+
T Consensus 156 PaNIFl~~~-------gvvKLGDfGL~r~l~s~~t----------fA~S~VGTPyYMSPE~i~~----~~Y~~kSDiWsl 214 (375)
T KOG0591|consen 156 PANIFLTAN-------GVVKLGDFGLGRFLSSKTT----------FAHSLVGTPYYMSPERIHE----SGYNFKSDIWSL 214 (375)
T ss_pred chheEEcCC-------CceeeccchhHhHhcchhH----------HHHhhcCCCcccCHHHHhc----CCCCcchhHHHH
Confidence 999999977 5799999999998865432 2356789999999999997 889999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003185 735 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 814 (840)
Q Consensus 735 GvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~D 814 (840)
||++|||+.-++||.+.+-.++...|.++..|++|+.. .+..+..||..|+..|
T Consensus 215 GCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~--------------------------YS~~l~~li~~ci~vd 268 (375)
T KOG0591|consen 215 GCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEH--------------------------YSTDLRELINMCIAVD 268 (375)
T ss_pred HHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHH--------------------------hhhHHHHHHHHHccCC
Confidence 99999999999999999999999999999888777533 3668999999999999
Q ss_pred CCCCCCHHHHHHHHHh
Q 003185 815 PTERPTAGDLYEMFVA 830 (840)
Q Consensus 815 P~eRPSa~ELLehLe~ 830 (840)
|..||+.-.++..+..
T Consensus 269 ~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 269 PEQRPDTVPYVQDIQS 284 (375)
T ss_pred cccCCCcchHHHHHHH
Confidence 9999996666665554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=407.31 Aligned_cols=257 Identities=26% Similarity=0.377 Sum_probs=221.7
Q ss_pred CCCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEE
Q 003185 500 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 577 (840)
Q Consensus 500 ~p~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~ 577 (840)
|+.. .+|...+.||+|||+.||++++ .+..||+|++..+...... . .+++.+||+|.+.|+|||||+++++|
T Consensus 14 D~~~-~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~-~----reKv~~EIeIHr~L~HpnIV~f~~~F 87 (592)
T KOG0575|consen 14 DPRS-KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPK-Q----REKVLNEIEIHRSLKHPNIVQFYHFF 87 (592)
T ss_pred cCCc-ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcc-h----HHHHHHHHHHHHhcCCCcEEeeeeEe
Confidence 4455 7899999999999999999986 7899999998754433222 2 33458999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
++.+++ |||+|+|+.++|..+++. ++.+++.+++.+++||+.||.|||+++|||||||..|
T Consensus 88 EDs~nV--------------YivLELC~~~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGN 148 (592)
T KOG0575|consen 88 EDSNNV--------------YIVLELCHRGSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGN 148 (592)
T ss_pred ecCCce--------------EEEEEecCCccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhh
Confidence 988866 999999999999999986 5789999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
|||+.+ ..|||+|||+|..+..... ...+.+|||.|.|||++.. ...++.+||||+|||
T Consensus 149 lfL~~~-------~~VKIgDFGLAt~le~~~E----------rk~TlCGTPNYIAPEVl~k----~gHsfEvDiWSlGcv 207 (592)
T KOG0575|consen 149 LFLNEN-------MNVKIGDFGLATQLEYDGE----------RKKTLCGTPNYIAPEVLNK----SGHSFEVDIWSLGCV 207 (592)
T ss_pred eeecCc-------CcEEecccceeeeecCccc----------ccceecCCCcccChhHhcc----CCCCCchhhhhhhhH
Confidence 999988 5699999999988764321 2355689999999999985 678999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
||-||+|++||...+..+.+..|...... +|. ..+..+++||.+||+.||.+
T Consensus 208 mYtLL~G~PPFetk~vkety~~Ik~~~Y~-~P~---------------------------~ls~~A~dLI~~lL~~~P~~ 259 (592)
T KOG0575|consen 208 MYTLLVGRPPFETKTVKETYNKIKLNEYS-MPS---------------------------HLSAEAKDLIRKLLRPNPSE 259 (592)
T ss_pred HHhhhhCCCCcccchHHHHHHHHHhcCcc-ccc---------------------------ccCHHHHHHHHHHhcCCccc
Confidence 99999999999999999999999876431 121 22457899999999999999
Q ss_pred CCCHHHHHHHHHh
Q 003185 818 RPTAGDLYEMFVA 830 (840)
Q Consensus 818 RPSa~ELLehLe~ 830 (840)
|||+++|+.|-.-
T Consensus 260 Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 260 RPSLDEVLDHPFF 272 (592)
T ss_pred CCCHHHHhcCHhh
Confidence 9999999999665
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=388.58 Aligned_cols=258 Identities=27% Similarity=0.452 Sum_probs=208.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|.+.++||+|+||+||+|++ .+..||||.+..+.. .....+. +..|+.+|+.|+|||||++++++..
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~----L~~Ei~iLkel~H~nIV~l~d~~~~ 80 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVEL----LLSEIKILKELKHPNIVRLLDCIED 80 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHH----HHHHHHHHHhcCCcceeeEEEEEec
Confidence 5678999999999999999999997 557888887654432 2333333 4899999999999999999999998
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.+.+ |||||||.||+|..||+. .+.+++.+++.++.||+.||++||+++||||||||+|||
T Consensus 81 ~~~i--------------~lVMEyC~gGDLs~yi~~-----~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiL 141 (429)
T KOG0595|consen 81 DDFI--------------YLVMEYCNGGDLSDYIRR-----RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNIL 141 (429)
T ss_pred CCeE--------------EEEEEeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEE
Confidence 7754 999999999999999997 458999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
|+..... .....+||+|||+|+.+..... ..+.+|++.|||||+++. ..|+.|+|+||+|+|||
T Consensus 142 Ls~~~~~-~~~~~LKIADFGfAR~L~~~~~-----------a~tlcGSplYMAPEV~~~----~~YdAKADLWSiG~Ily 205 (429)
T KOG0595|consen 142 LSTTARN-DTSPVLKIADFGFARFLQPGSM-----------AETLCGSPLYMAPEVIMS----QQYDAKADLWSIGTILY 205 (429)
T ss_pred eccCCCC-CCCceEEecccchhhhCCchhH-----------HHHhhCCccccCHHHHHh----ccccchhhHHHHHHHHH
Confidence 9876221 1127899999999998865322 234579999999999986 78999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCC--CCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGK--RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~--~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
+|++|+.||...+..+++..+.++. .+.++..+ +..+.+|+...|..+|.+
T Consensus 206 q~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~---------------------------s~~~~~Ll~~ll~~~~~~ 258 (429)
T KOG0595|consen 206 QCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAEL---------------------------SNPLRELLISLLQRNPKD 258 (429)
T ss_pred HHHhCCCCccccCHHHHHHHHhccccccCchhhhc---------------------------cCchhhhhhHHHhcCccc
Confidence 9999999999999999998887762 22222221 223445666666666666
Q ss_pred CCCHHHHHHH
Q 003185 818 RPTAGDLYEM 827 (840)
Q Consensus 818 RPSa~ELLeh 827 (840)
|.++.+-+.|
T Consensus 259 ~~~~~~~~~~ 268 (429)
T KOG0595|consen 259 RISFEDFFDH 268 (429)
T ss_pred cCchHHhhhh
Confidence 6666665554
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=368.48 Aligned_cols=279 Identities=24% Similarity=0.334 Sum_probs=218.5
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
|+.|+.+.++|+|+||+||+|+. .++-||||.+. ..... ..+ .+-.+||+++|++|+|||+|.++.+|....
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~--Esedd-~~V---kKIAlREIrmLKqLkH~NLVnLiEVFrrkr 74 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFV--ESEDD-PVV---KKIALREIRMLKQLKHENLVNLIEVFRRKR 74 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeec--cCCcc-HHH---HHHHHHHHHHHHhcccchHHHHHHHHHhcc
Confidence 46899999999999999999996 56777777763 22221 222 233499999999999999999999998665
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. ++||+|||+. ++.+-|.. . ...++...+.++++|++.|+.|+|++++|||||||+||||+
T Consensus 75 k--------------lhLVFE~~dh-TvL~eLe~---~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit 135 (396)
T KOG0593|consen 75 K--------------LHLVFEYCDH-TVLHELER---Y-PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT 135 (396)
T ss_pred e--------------eEEEeeecch-HHHHHHHh---c-cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe
Confidence 4 4999999997 55555554 1 34589999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +++||||||+|+.+..+... .+.++.|..|.|||.+.+ ...|+..+||||+||++.||
T Consensus 136 ~~-------gvvKLCDFGFAR~L~~pgd~----------YTDYVATRWYRaPELLvG---DtqYG~pVDiWAiGCv~aEl 195 (396)
T KOG0593|consen 136 QN-------GVVKLCDFGFARTLSAPGDN----------YTDYVATRWYRAPELLVG---DTQYGKPVDIWAIGCVFAEL 195 (396)
T ss_pred cC-------CcEEeccchhhHhhcCCcch----------hhhhhhhhhccChhhhcc---cCcCCCcccchhhhHHHHHH
Confidence 87 67999999999987642221 345689999999999987 46799999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCc---cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH---EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~---~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
++|++.|++.++.+.+..|.+...+-++.-..-+.... .-.++.....-......+..+..+.+|+..||+.||.+|
T Consensus 196 ~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R 275 (396)
T KOG0593|consen 196 LTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDR 275 (396)
T ss_pred hcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCcccc
Confidence 99999999999999999998876655665443332111 001111111111223344556789999999999999999
Q ss_pred CCHHHHHHH
Q 003185 819 PTAGDLYEM 827 (840)
Q Consensus 819 PSa~ELLeh 827 (840)
++.+++++|
T Consensus 276 ~sc~qll~H 284 (396)
T KOG0593|consen 276 LSCEQLLHH 284 (396)
T ss_pred ccHHHHhcC
Confidence 999999987
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=385.62 Aligned_cols=286 Identities=23% Similarity=0.236 Sum_probs=223.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~ 578 (840)
..+++|.++++||.|+||.||+|+. .+..||+|. ++.....-++.-. +||+..|++|. |||||++.+++.
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~--MK~Kf~s~ee~~n-----LREvksL~kln~hpniikL~Evi~ 79 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKK--MKKKFYSWEECMN-----LREVKSLRKLNPHPNIIKLKEVIR 79 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHH--HHhhhccHHHHHH-----HHHHHHHHhcCCCCcchhhHHHhh
Confidence 4578999999999999999999986 566677776 4444444443333 79999999999 999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
+... .+|+|||||+ .+|+++++. .+..|++..++.|++||++||+|+|.+|+.||||||+||
T Consensus 80 d~~~-------------~L~fVfE~Md-~NLYqLmK~----R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENi 141 (538)
T KOG0661|consen 80 DNDR-------------ILYFVFEFMD-CNLYQLMKD----RNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENI 141 (538)
T ss_pred ccCc-------------eEeeeHHhhh-hhHHHHHhh----cCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhhe
Confidence 6652 4699999998 599999987 257899999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|+... ..+||+|||+|+.+..... .+.++.|..|+|||++.. ...|+.+.||||+|||+
T Consensus 142 Li~~~-------~~iKiaDFGLARev~SkpP-----------YTeYVSTRWYRAPEvLLr---s~~Ys~pvD~wA~GcI~ 200 (538)
T KOG0661|consen 142 LISGN-------DVIKIADFGLAREVRSKPP-----------YTEYVSTRWYRAPEVLLR---SGYYSSPVDMWAVGCIM 200 (538)
T ss_pred Eeccc-------ceeEecccccccccccCCC-----------cchhhhcccccchHHhhh---ccccCCchHHHHHHHHH
Confidence 99854 5799999999998865432 355789999999999986 57899999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCc---cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 739 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH---EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~---~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
+|+.+-++.|+|.+..+.+.+|......+..+.+....... .-.++. ..+..........+.++.+||.+||.+||
T Consensus 201 aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~-~~~~~l~~L~p~~s~~~~~li~~ll~WDP 279 (538)
T KOG0661|consen 201 AELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQ-VKPSPLKDLLPNASSEAASLIERLLAWDP 279 (538)
T ss_pred HHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCc-CCCCChHHhCcccCHHHHHHHHHHhcCCC
Confidence 99999999999999988888876652222222221100000 000000 01111122233467889999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCC
Q 003185 816 TERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 816 ~eRPSa~ELLehLe~l~~~ 834 (840)
.+||||.++++|.......
T Consensus 280 ~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 280 DKRPTASQALQHPFFQVGR 298 (538)
T ss_pred ccCccHHHHhcCccccccc
Confidence 9999999999997655433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=370.06 Aligned_cols=255 Identities=28% Similarity=0.352 Sum_probs=217.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
...++|++.+.||+|+||.||.++. .++-+|+|+.+.+..... .+.+ .+..|..||.+++||.||.++..|++
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-~e~~----~~~~Er~IL~~v~hPFiv~l~ysFQt 96 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-KEVR----HTKAERNILSKIKHPFIVKLIYSFQT 96 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-hhHH----HHHHHHHHHHhCCCCcEeeeEEeccc
Confidence 5578899999999999999999985 678899999765443322 2233 34899999999999999999999997
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
...+ |+|+||+.||.|...|++ ...+++..+..++..|+.||.|||++|||||||||+|||
T Consensus 97 ~~kL--------------ylVld~~~GGeLf~hL~~-----eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENIL 157 (357)
T KOG0598|consen 97 EEKL--------------YLVLDYLNGGELFYHLQR-----EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENIL 157 (357)
T ss_pred CCeE--------------EEEEeccCCccHHHHHHh-----cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHee
Confidence 7754 999999999999999986 578999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
|+.+ +.++|+|||+++....... ...+++||+.|||||++.+ ..|+..+|.||||+++|
T Consensus 158 Ld~~-------GHi~LtDFgL~k~~~~~~~----------~t~tfcGT~eYmAPEil~~----~gy~~~vDWWsLGillY 216 (357)
T KOG0598|consen 158 LDEQ-------GHIKLTDFGLCKEDLKDGD----------ATRTFCGTPEYMAPEILLG----KGYDKAVDWWSLGILLY 216 (357)
T ss_pred ecCC-------CcEEEeccccchhcccCCC----------ccccccCCccccChHHHhc----CCCCcccchHhHHHHHH
Confidence 9988 5699999999985433221 1345789999999999997 68999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
||++|.+||.+.+...+.+.|.++..+..+..+ +...++|+.++|..||.+|.
T Consensus 217 eML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~l---------------------------s~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 217 EMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYL---------------------------SEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred HHhhCCCCCcCccHHHHHHHHhcCcCCCCCccC---------------------------CHHHHHHHHHHhccCHHHhc
Confidence 999999999999999999999988754444321 44789999999999999995
Q ss_pred ----CHHHHHHHH
Q 003185 820 ----TAGDLYEMF 828 (840)
Q Consensus 820 ----Sa~ELLehL 828 (840)
++.+|-+|.
T Consensus 270 g~~~d~~~ik~Hp 282 (357)
T KOG0598|consen 270 GGPGDAEEIKRHP 282 (357)
T ss_pred CCCCChHHhhcCc
Confidence 677777763
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=381.10 Aligned_cols=266 Identities=24% Similarity=0.316 Sum_probs=219.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~ 578 (840)
....+|.+++.||+|+|++|++|+. .+..+|+||...+.. ......+ -+.+|-.+|.+| .||.||++|-.|.
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~I-ike~Kvk----YV~~Ek~~l~~L~~hPgivkLy~TFQ 144 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYI-IKEKKVK----YVTREKEALTQLSGHPGIVKLYFTFQ 144 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHH-Hhhcccc----hhhHHHHHHHHhhCCCCeEEEEEEee
Confidence 5678899999999999999999986 678999999643321 1112222 347888899999 6999999999999
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
++..+ |+|+||+++|+|.++|.+ .+.|++..++.++.+|+.||+|||++|||||||||+||
T Consensus 145 D~~sL--------------YFvLe~A~nGdll~~i~K-----~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENI 205 (604)
T KOG0592|consen 145 DEESL--------------YFVLEYAPNGDLLDLIKK-----YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENI 205 (604)
T ss_pred cccce--------------EEEEEecCCCcHHHHHHH-----hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhhe
Confidence 88755 999999999999999998 36799999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCccccccccccccc-ccC--CCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI-AHR--GIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~-~~~--~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLG 735 (840)
||+.+ +.+||+|||.|+.+......... ... .......++||..|.+||+|.. ...++.+|||+||
T Consensus 206 LLd~d-------mhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~----~~~~~~sDiWAlG 274 (604)
T KOG0592|consen 206 LLDKD-------GHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND----SPAGPSSDLWALG 274 (604)
T ss_pred eEcCC-------CcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC----CCCCcccchHHHH
Confidence 99988 56999999999988664332110 011 1111256899999999999987 7789999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 736 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 736 vIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
||||+|+.|++||.+.++.-+++.|...... +++ ..++.+.+||.++|..||
T Consensus 275 CilyQmlaG~PPFra~NeyliFqkI~~l~y~-fp~---------------------------~fp~~a~dLv~KLLv~dp 326 (604)
T KOG0592|consen 275 CILYQMLAGQPPFRAANEYLIFQKIQALDYE-FPE---------------------------GFPEDARDLIKKLLVRDP 326 (604)
T ss_pred HHHHHHhcCCCCCccccHHHHHHHHHHhccc-CCC---------------------------CCCHHHHHHHHHHHccCc
Confidence 9999999999999999999999998775332 111 124578999999999999
Q ss_pred CCCCCHHHHHHHHHh
Q 003185 816 TERPTAGDLYEMFVA 830 (840)
Q Consensus 816 ~eRPSa~ELLehLe~ 830 (840)
.+|+|+++|.+|...
T Consensus 327 ~~Rlt~~qIk~HpFF 341 (604)
T KOG0592|consen 327 SDRLTSQQIKAHPFF 341 (604)
T ss_pred cccccHHHHhhCccc
Confidence 999999999999654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=381.00 Aligned_cols=258 Identities=29% Similarity=0.434 Sum_probs=219.4
Q ss_pred CCceeeeeecccCceEEEEEEECCe-eEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKFGSA-DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~-~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
..+.+++.||+|-||.||.|.|++. +||+|..+-. ... .+.| .+|+.+|++|+|+|||+++|++..+..+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~--~m~---~~~f----~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG--SMS---PEAF----LREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc--ccC---hhHH----HHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 3467889999999999999999776 9999986533 222 1233 8999999999999999999999976644
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
||||||++.|+|.+||+. ..+..+.....+.++.|||.||+||+++++|||||-+.||||+.+
T Consensus 277 --------------yIVtE~m~~GsLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~ 339 (468)
T KOG0197|consen 277 --------------YIVTEYMPKGSLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDED 339 (468)
T ss_pred --------------EEEEEecccCcHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccC
Confidence 999999999999999986 345779999999999999999999999999999999999999988
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
..+||+|||+|+.+.+..... .. ...-...|.|||.+.. ..++.|||||||||+||||+|
T Consensus 340 -------~~vKIsDFGLAr~~~d~~Y~~---~~------~~kfPIkWtAPEa~~~----~~FS~kSDVWSFGVlL~E~fT 399 (468)
T KOG0197|consen 340 -------LVVKISDFGLARLIGDDEYTA---SE------GGKFPIKWTAPEALNY----GKFSSKSDVWSFGVLLWELFT 399 (468)
T ss_pred -------ceEEEcccccccccCCCceee---cC------CCCCCceecCHHHHhh----CCcccccceeehhhhHHHHhc
Confidence 579999999999654433221 11 1113468999999986 789999999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 744 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 744 -G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
|+.||.+++..+++..+.++.+.+-|+ .+++.+.+||..||+.+|++|||++
T Consensus 400 ~G~~py~~msn~ev~~~le~GyRlp~P~---------------------------~CP~~vY~lM~~CW~~~P~~RPtF~ 452 (468)
T KOG0197|consen 400 YGRVPYPGMSNEEVLELLERGYRLPRPE---------------------------GCPDEVYELMKSCWHEDPEDRPTFE 452 (468)
T ss_pred cCCCCCCCCCHHHHHHHHhccCcCCCCC---------------------------CCCHHHHHHHHHHhhCCcccCCCHH
Confidence 999999999999999999998755443 2467899999999999999999999
Q ss_pred HHHHHHHhhcCCC
Q 003185 823 DLYEMFVARTSSS 835 (840)
Q Consensus 823 ELLehLe~l~~~~ 835 (840)
.+...|+.+....
T Consensus 453 ~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 453 TLREVLEDFFTST 465 (468)
T ss_pred HHHHHHHHhhhcc
Confidence 9999998876543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=350.19 Aligned_cols=288 Identities=21% Similarity=0.228 Sum_probs=230.7
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
.+|...++||+|.||.||+|++ +++.||+|.+++..... .+....+|||+.|+.++|+||+.++++|.....
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd------Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~ 75 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD------GINRTALREIKLLQELKHPNIIELIDVFPHKSN 75 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc------CccHHHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence 4788999999999999999997 67788888876653222 223344899999999999999999999987765
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
+ .||+||++ .+|+..|+. ....++...++.++.++++||+|||.+.|+||||||.|+||+.
T Consensus 76 l--------------~lVfEfm~-tdLe~vIkd----~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~ 136 (318)
T KOG0659|consen 76 L--------------SLVFEFMP-TDLEVVIKD----KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISS 136 (318)
T ss_pred e--------------EEEEEecc-ccHHHHhcc----cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcC
Confidence 4 99999998 599999986 4567899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||+|+.+...... ....+-|..|.|||.+.| ...|+..+||||.|||+.||+
T Consensus 137 ~-------g~lKiADFGLAr~f~~p~~~----------~~~~V~TRWYRAPELLfG---sr~Yg~~VDmWavGCI~AELl 196 (318)
T KOG0659|consen 137 D-------GQLKIADFGLARFFGSPNRI----------QTHQVVTRWYRAPELLFG---SRQYGTGVDMWAVGCIFAELL 196 (318)
T ss_pred C-------CcEEeecccchhccCCCCcc----------cccceeeeeccChHHhcc---chhcCCcchhhhHHHHHHHHH
Confidence 8 56999999999988764432 122267999999999997 578999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
-|.+.|+|.++.+.+..|.+....+.++.|+.+...++....+..+..........++.++.+|+.+||.+||.+|+++.
T Consensus 197 lr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~ 276 (318)
T KOG0659|consen 197 LRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITAS 276 (318)
T ss_pred ccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHH
Confidence 99999999999888888877654455555655544443222221111111223445567789999999999999999999
Q ss_pred HHHHHHHhhcCCCCC
Q 003185 823 DLYEMFVARTSSSIS 837 (840)
Q Consensus 823 ELLehLe~l~~~~~s 837 (840)
|+++|---...+.+.
T Consensus 277 qaL~~~yf~~~P~pt 291 (318)
T KOG0659|consen 277 QALKHPYFKSLPLPT 291 (318)
T ss_pred HHhcchhhhcCCCCC
Confidence 999996665555444
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=365.24 Aligned_cols=272 Identities=26% Similarity=0.375 Sum_probs=224.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
.....|++.+.||.|..++||+|+. .+..||+|++.++.+... ++.+ .+|+..|+.++||||++++..|..
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~---ld~l----~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND---LDAL----RKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh---HHHH----HHHHHHhhhcCCCCcceEEEEEEe
Confidence 5567899999999999999999986 678999999988766443 3444 899999999999999999999998
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
+..+ |+||+||.+||+.++++.....+ +++..+..|++++++||.|||.+|.||||||+.|||
T Consensus 96 ~~~L--------------WvVmpfMa~GS~ldIik~~~~~G---l~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnIL 158 (516)
T KOG0582|consen 96 DSEL--------------WVVMPFMAGGSLLDIIKTYYPDG---LEEASIATILREVLKALDYLHQNGHIHRDVKAGNIL 158 (516)
T ss_pred ccee--------------EEeehhhcCCcHHHHHHHHcccc---ccHHHHHHHHHHHHHHHHHHHhcCceecccccccEE
Confidence 8765 99999999999999999876655 999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
|+.+ +.|||+|||.+-.+.... . +.....+.++||+.|||||+++. .-..|+.|+||||||++..
T Consensus 159 i~~d-------G~VkLadFgvsa~l~~~G-~-----R~~~rf~tfvgtp~wmAPEvl~q--~~~GYdfKaDIwSfGITA~ 223 (516)
T KOG0582|consen 159 IDSD-------GTVKLADFGVSASLFDSG-D-----RQVTRFNTFVGTPCWMAPEVLMQ--QLHGYDFKADIWSFGITAC 223 (516)
T ss_pred EcCC-------CcEEEcCceeeeeecccC-c-----eeeEeeccccCcccccChHHhhh--cccCccchhhhhhhhHHHH
Confidence 9988 469999999887665422 1 11111166789999999999764 2357899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
||.+|..||....+.+++..-.++..|.+. . +....+.....+..+..+|..||..||.+||
T Consensus 224 ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~--t----------------~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRp 285 (516)
T KOG0582|consen 224 ELAHGHAPFSKYPPMKVLLLTLQNDPPTLL--T----------------SGLDKDEDKKFSKSFREMIALCLVKDPSKRP 285 (516)
T ss_pred HHhcCCCCcccCChHHHHHHHhcCCCCCcc--c----------------ccCChHHhhhhcHHHHHHHHHHhhcCcccCC
Confidence 999999999999998887666666554322 0 1112223334455899999999999999999
Q ss_pred CHHHHHHHHHh
Q 003185 820 TAGDLYEMFVA 830 (840)
Q Consensus 820 Sa~ELLehLe~ 830 (840)
||+++++|-+.
T Consensus 286 tAskLlkh~FF 296 (516)
T KOG0582|consen 286 TASKLLKHAFF 296 (516)
T ss_pred CHHHHhccHHH
Confidence 99999998543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=377.73 Aligned_cols=294 Identities=20% Similarity=0.231 Sum_probs=228.4
Q ss_pred CCCCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeE
Q 003185 499 LDPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 576 (840)
Q Consensus 499 ~~p~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~ 576 (840)
+-+...+.|+.+++||+|+||.||+|++ .+..||+|.+.+.... ..|.....|||.||++|.|||||++.+.
T Consensus 111 w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~------~~~~~t~~REI~ILr~l~HpNIikL~ei 184 (560)
T KOG0600|consen 111 WGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK------EGFPITAIREIKILRRLDHPNIIKLEEI 184 (560)
T ss_pred ccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC------CcchHHHHHHHHHHHhcCCCcccceeeE
Confidence 3456778899999999999999999997 5667999987765422 2333445899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
..... ...+|||+|||+. +|..++.. +.-.|++.+++.+++||+.||+|||.+||+|||||.+
T Consensus 185 vt~~~------------~~siYlVFeYMdh-DL~GLl~~----p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~S 247 (560)
T KOG0600|consen 185 VTSKL------------SGSIYLVFEYMDH-DLSGLLSS----PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGS 247 (560)
T ss_pred EEecC------------CceEEEEEecccc-hhhhhhcC----CCcccChHHHHHHHHHHHHHHHHHhhcCeeecccccc
Confidence 88652 1246999999996 99999875 4568999999999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
||||+.+ +.+||+|||+|+++...... ..+..+-|..|.|||+|.| ...|+.++|+||.||
T Consensus 248 NiLidn~-------G~LKiaDFGLAr~y~~~~~~---------~~T~rVvTLWYRpPELLLG---~t~Yg~aVDlWS~GC 308 (560)
T KOG0600|consen 248 NILIDNN-------GVLKIADFGLARFYTPSGSA---------PYTSRVVTLWYRPPELLLG---ATSYGTAVDLWSVGC 308 (560)
T ss_pred ceEEcCC-------CCEEeccccceeeccCCCCc---------ccccceEEeeccChHHhcC---CcccccceeehhhhH
Confidence 9999988 56999999999987653322 1344578999999999998 567999999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCC--CCCCchhhhhhHHHHHHHHHHhcccC
Q 003185 737 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS--GFEKPEAELETLSFLVDVFRRCTEEN 814 (840)
Q Consensus 737 IL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~L~dLI~rCL~~D 814 (840)
||.||++|++.|++.+..+.+..|.+....+-.+.|. ...++.....+... .....+.....+....+|+..||..|
T Consensus 309 Il~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ld 387 (560)
T KOG0600|consen 309 ILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLD 387 (560)
T ss_pred HHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccC
Confidence 9999999999999999988888887753333333333 11111000000000 11122334455678899999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCCC
Q 003185 815 PTERPTAGDLYEMFVARTSSS 835 (840)
Q Consensus 815 P~eRPSa~ELLehLe~l~~~~ 835 (840)
|.+|.||.++|++=..-..+.
T Consensus 388 P~kR~tA~~aL~seyF~t~p~ 408 (560)
T KOG0600|consen 388 PDKRGTASSALQSEYFTTEPL 408 (560)
T ss_pred ccccccHHHHhcCcccccCCC
Confidence 999999999998755433333
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=382.27 Aligned_cols=255 Identities=27% Similarity=0.443 Sum_probs=220.3
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
+...|....+||+|+.|.||.|.. .+..||+|.+.+..+... +.+++|+.+|+.++|+|||.+++.|...
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k--------eLilnEi~Vm~~~~H~NiVnfl~Sylv~ 342 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK--------ELLLNEILVMRDLHHPNIVNFLDSYLVG 342 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch--------hhhHHHHHHHHhccchHHHHHHHHhccc
Confidence 456788899999999999999986 566788888766654322 2348999999999999999999998866
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
+. +|+||||++||+|.+.+.. ..+++.++..|++.+++||+|||.+||+|||||.+|||+
T Consensus 343 de--------------LWVVMEym~ggsLTDvVt~------~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL 402 (550)
T KOG0578|consen 343 DE--------------LWVVMEYMEGGSLTDVVTK------TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL 402 (550)
T ss_pred ce--------------eEEEEeecCCCchhhhhhc------ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe
Confidence 54 4999999999999999986 569999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.++ .+||+|||++..+..... .....+|||.|||||++.. ..|++|.||||||++++|
T Consensus 403 ~~~g-------~vKltDFGFcaqi~~~~~----------KR~TmVGTPYWMAPEVvtr----k~YG~KVDIWSLGIMaIE 461 (550)
T KOG0578|consen 403 TMDG-------SVKLTDFGFCAQISEEQS----------KRSTMVGTPYWMAPEVVTR----KPYGPKVDIWSLGIMAIE 461 (550)
T ss_pred ccCC-------cEEEeeeeeeeccccccC----------ccccccCCCCccchhhhhh----cccCccccchhhhhHHHH
Confidence 9885 499999999987765332 2466789999999999986 789999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|+-|++||-..++...+..|.....|.+.. ....+..+++|+.+||+.||.+|++
T Consensus 462 MveGEPPYlnE~PlrAlyLIa~ng~P~lk~-------------------------~~klS~~~kdFL~~cL~~dv~~Ras 516 (550)
T KOG0578|consen 462 MVEGEPPYLNENPLRALYLIATNGTPKLKN-------------------------PEKLSPELKDFLDRCLVVDVEQRAS 516 (550)
T ss_pred HhcCCCCccCCChHHHHHHHhhcCCCCcCC-------------------------ccccCHHHHHHHHHHhhcchhcCCC
Confidence 999999999999999999998887776552 1223668999999999999999999
Q ss_pred HHHHHHHHHhh
Q 003185 821 AGDLYEMFVAR 831 (840)
Q Consensus 821 a~ELLehLe~l 831 (840)
|.|||+|..-.
T Consensus 517 A~eLL~HpFl~ 527 (550)
T KOG0578|consen 517 AKELLEHPFLK 527 (550)
T ss_pred HHHHhcChhhh
Confidence 99999996543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=367.89 Aligned_cols=264 Identities=33% Similarity=0.446 Sum_probs=208.2
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
..+|...+.||+|+||+||++... +...|||...+.. ....+ .+.+|+.+|.+|+|||||+++|......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~----~~~~~----~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED----SPTSE----SLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc----chhHH----HHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 456899999999999999999985 5899999876551 11123 3489999999999999999999754332
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. ..++|+|||+++|+|.+++.+ .+. .+++..++.+++||+.||.|||++|||||||||+||||+
T Consensus 88 ~------------~~~~i~mEy~~~GsL~~~~~~---~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~ 151 (313)
T KOG0198|consen 88 N------------DEYNIFMEYAPGGSLSDLIKR---YGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD 151 (313)
T ss_pred C------------eeeEeeeeccCCCcHHHHHHH---cCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe
Confidence 1 246999999999999999987 232 699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.. .+.+||+|||+++....... .........||+.|||||++.. +....+++|||||||++.||
T Consensus 152 ~~------~~~~KlaDFG~a~~~~~~~~-------~~~~~~~~~Gtp~~maPEvi~~---g~~~~~~sDiWSlGCtVvEM 215 (313)
T KOG0198|consen 152 PS------NGDVKLADFGLAKKLESKGT-------KSDSELSVQGTPNYMAPEVIRN---GEVARRESDIWSLGCTVVEM 215 (313)
T ss_pred CC------CCeEEeccCccccccccccc-------cccccccccCCccccCchhhcC---CCcCCccchhhhcCCEEEec
Confidence 83 14699999999987653110 0111234679999999999984 12334699999999999999
Q ss_pred HhCCCCCCC-CCHHHHHHHHHcC-CCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 742 LTLQVPYMG-LSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 742 LTG~~PF~~-~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+||..||.. ....+....+... ..|.++.. .+..+.++|.+|+..||.+||
T Consensus 216 ~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~---------------------------ls~~a~~Fl~~C~~~~p~~Rp 268 (313)
T KOG0198|consen 216 LTGKPPWSEFFEEAEALLLIGREDSLPEIPDS---------------------------LSDEAKDFLRKCFKRDPEKRP 268 (313)
T ss_pred cCCCCcchhhcchHHHHHHHhccCCCCCCCcc---------------------------cCHHHHHHHHHHhhcCcccCc
Confidence 999999987 4444444444433 34444432 356789999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 003185 820 TAGDLYEMFVARTSS 834 (840)
Q Consensus 820 Sa~ELLehLe~l~~~ 834 (840)
||+++|+|.......
T Consensus 269 ta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 269 TAEELLEHPFLKQNS 283 (313)
T ss_pred CHHHHhhChhhhccc
Confidence 999999998776543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=371.96 Aligned_cols=264 Identities=23% Similarity=0.284 Sum_probs=215.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~ 578 (840)
...++|.+.+.||+|+||.|++|.+ .+..||+|+...+...... ....+.+.+|+.++++++ ||||++++.++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~---~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~ 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS---QKLDELIKREISILRRLRSHPNIIRLLEVFA 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc---cccchhhHHHHHHHHHhccCCCEeEEEEEEe
Confidence 5678999999999999999999986 6789999976543221111 122233478999999999 999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
.... .||||||+.||+|.++|.+ ..++.+..+..+++||+.|++|||++||+||||||+||
T Consensus 91 t~~~--------------~~ivmEy~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENi 151 (370)
T KOG0583|consen 91 TPTK--------------IYIVMEYCSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENI 151 (370)
T ss_pred cCCe--------------EEEEEEecCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHE
Confidence 7664 4999999999999999986 46799999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.+. +.+||+|||++...... .......+||+.|+|||++.+.. ..-+.++||||+||+|
T Consensus 152 lld~~~------~~~Kl~DFG~s~~~~~~----------~~~l~t~cGsp~Y~aPEvl~~~~--~Y~g~~aDvWS~GViL 213 (370)
T KOG0583|consen 152 LLDGNE------GNLKLSDFGLSAISPGE----------DGLLKTFCGSPAYAAPEVLSGKG--TYSGKAADVWSLGVIL 213 (370)
T ss_pred EecCCC------CCEEEeccccccccCCC----------CCcccCCCCCcccCCHHHhCCCC--CcCCchhhhhhhHHHH
Confidence 999871 34999999999876310 11134568999999999998721 1346999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 739 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
|.|++|+.||...+...++..|.++.. .++..+ . +..+.+|+.+||..||.+|
T Consensus 214 y~ml~G~~PF~d~~~~~l~~ki~~~~~-~~p~~~-------------------------~-S~~~~~Li~~mL~~~P~~R 266 (370)
T KOG0583|consen 214 YVLLCGRLPFDDSNVPNLYRKIRKGEF-KIPSYL-------------------------L-SPEARSLIEKMLVPDPSTR 266 (370)
T ss_pred HHHHhCCCCCCCccHHHHHHHHhcCCc-cCCCCc-------------------------C-CHHHHHHHHHHcCCCcccC
Confidence 999999999999888888888777643 222111 0 4478999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 003185 819 PTAGDLYEMFVART 832 (840)
Q Consensus 819 PSa~ELLehLe~l~ 832 (840)
+|+.+|++|-+-..
T Consensus 267 ~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 267 ITLLEILEHPWFQK 280 (370)
T ss_pred CCHHHHhhChhhcc
Confidence 99999999877665
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=377.57 Aligned_cols=266 Identities=24% Similarity=0.382 Sum_probs=221.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
++.+.+.+.+.||+|+||+||+|.|.|. ||||+.... ....+..+.| .+|+.++++-+|.||+-|+|++....
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whGd-VAVK~Lnv~--~pt~~qlqaF----KnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHGD-VAVKLLNVD--DPTPEQLQAF----KNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cCHHHhhccceeccccccceeecccccc-eEEEEEecC--CCCHHHHHHH----HHHHHHHhhcchhhheeeehhhcCCc
Confidence 6778889999999999999999999874 899996544 4455566666 99999999999999999999987543
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
..||+.+|+|.+|+.+|+. ....|.+...+.|++||++||.|||.++|||||||..|||+.
T Consensus 462 ---------------~AIiTqwCeGsSLY~hlHv----~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~ 522 (678)
T KOG0193|consen 462 ---------------LAIITQWCEGSSLYTHLHV----QETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLH 522 (678)
T ss_pred ---------------eeeeehhccCchhhhhccc----hhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEc
Confidence 3899999999999999986 246799999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
++ .+|||+|||++..-..... ..+. ..--|...|||||+++. ....+|++.+||||||+++|||
T Consensus 523 ~~-------~kVkIgDFGLatvk~~w~g-----~~q~---~qp~gsilwmAPEvIRm-qd~nPfS~qSDVYaFGiV~YEL 586 (678)
T KOG0193|consen 523 ED-------LKVKIGDFGLATVKTRWSG-----EQQL---EQPHGSLLWMAPEVIRM-QDDNPFSFQSDVYAFGIVWYEL 586 (678)
T ss_pred cC-------CcEEEecccceeeeeeecc-----cccc---CCCccchhhhcHHHHhh-cccCCCCcccchhhhhHHHHHH
Confidence 87 5699999999975433211 1111 22247889999999984 4467899999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCC-CCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
+||..||......+++..+.++.. +.+. .....++.++++|+..||.+++++||.
T Consensus 587 ltg~lPysi~~~dqIifmVGrG~l~pd~s------------------------~~~s~~pk~mk~Ll~~C~~~~~~eRP~ 642 (678)
T KOG0193|consen 587 LTGELPYSIQNRDQIIFMVGRGYLMPDLS------------------------KIRSNCPKAMKRLLSDCWKFDREERPL 642 (678)
T ss_pred HhCcCCcCCCChhheEEEecccccCccch------------------------hhhccCHHHHHHHHHHHHhcCcccCcc
Confidence 999999997778888888777732 2221 112345778999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 003185 821 AGDLYEMFVARTS 833 (840)
Q Consensus 821 a~ELLehLe~l~~ 833 (840)
+.+|+..|+.+..
T Consensus 643 F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 643 FPQLLSKLEELLP 655 (678)
T ss_pred HHHHHHHHHHhhh
Confidence 9999998888776
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=353.58 Aligned_cols=293 Identities=24% Similarity=0.268 Sum_probs=224.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
.++++|+.++.|++|+||.||+|+++ +.-||+|.++.+. +...|....+|||.+|.+++|||||.+-.+...
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek------ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG 146 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK------EKEGFPITSLREINILLKARHPNIVEVKEVVVG 146 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc------ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec
Confidence 57889999999999999999999984 5566666655443 233455556999999999999999999998875
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.+. ...|||||||+. +|..++.. -.++|...+++.++.|+++||+|||.+.|+||||||+|+|
T Consensus 147 ~~~------------d~iy~VMe~~Eh-DLksl~d~----m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLL 209 (419)
T KOG0663|consen 147 SNM------------DKIYIVMEYVEH-DLKSLMET----MKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLL 209 (419)
T ss_pred ccc------------ceeeeeHHHHHh-hHHHHHHh----ccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhhee
Confidence 432 247999999996 99999987 2368999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.. +.+||+|||+|+.+...... .+..+-|..|.|||.+.+ ...|+++.|+||+|||+.
T Consensus 210 m~~~-------G~lKiaDFGLAR~ygsp~k~----------~T~lVVTLWYRaPELLLG---~~tyst~iDMWSvGCI~a 269 (419)
T KOG0663|consen 210 LSHK-------GILKIADFGLAREYGSPLKP----------YTPLVVTLWYRAPELLLG---AKTYSTAVDMWSVGCIFA 269 (419)
T ss_pred eccC-------CcEEecccchhhhhcCCccc----------CcceEEEeeecCHHHhcC---CcccCcchhhhhHHHHHH
Confidence 9987 56999999999998765322 244567999999999998 567999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcccc---ccccCCC-CCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE---VAQSGSG-FEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~---~~~~~~~-~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
||+++++.|+|....+.+..|.+....+-...|+.+...+... +...... ..........++.-.+|+..+|.+||
T Consensus 270 E~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP 349 (419)
T KOG0663|consen 270 ELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDP 349 (419)
T ss_pred HHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCc
Confidence 9999999999999888888877653333333333322221110 0000000 00000001145778899999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCCCC
Q 003185 816 TERPTAGDLYEMFVARTSSSIS 837 (840)
Q Consensus 816 ~eRPSa~ELLehLe~l~~~~~s 837 (840)
.+|.||.+.|+|=.....+.+.
T Consensus 350 ~kR~tA~~~L~h~~F~e~P~p~ 371 (419)
T KOG0663|consen 350 GKRITAEDGLKHEYFRETPLPI 371 (419)
T ss_pred cccccHHHhhcccccccCCCCC
Confidence 9999999999996655544443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=371.73 Aligned_cols=251 Identities=28% Similarity=0.409 Sum_probs=215.8
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+++|.+.+.||+|+||.||+|+. ....||+|. +.+......+++.+ .+|++|++.|+|||||.++++|++..
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~--i~K~gr~~k~l~~l----~~ev~i~r~lkHpniv~m~esfEt~~ 74 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKF--IDKSGRNEKELKNL----RQEVRILRSLKHPNIVEMLESFETSA 74 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEE--ehhcCCchHHHHHH----HHHHHHHHhcCCcchhhHHHhhcccc
Confidence 47899999999999999999986 456777777 55666666677776 99999999999999999999999776
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. +|+|+||+.| +|..+|.. ...++++.+..|+.|++.||.|||+++|+|||+||.|||+.
T Consensus 75 ~--------------~~vVte~a~g-~L~~il~~-----d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~ 134 (808)
T KOG0597|consen 75 H--------------LWVVTEYAVG-DLFTILEQ-----DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE 134 (808)
T ss_pred e--------------EEEEehhhhh-hHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec
Confidence 4 4999999986 99999986 57899999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.. +++|+||||+|+........ ...+.|||.|||||++.+ .+|+..+|+||+|||+|||
T Consensus 135 ~~-------~~~KlcdFg~Ar~m~~~t~v----------ltsikGtPlYmAPElv~e----~pyd~~sDlWslGcilYE~ 193 (808)
T KOG0597|consen 135 KG-------GTLKLCDFGLARAMSTNTSV----------LTSIKGTPLYMAPELVEE----QPYDHTSDLWSLGCILYEL 193 (808)
T ss_pred CC-------CceeechhhhhhhcccCcee----------eeeccCcccccCHHHHcC----CCccchhhHHHHHHHHHHH
Confidence 77 67999999999876542221 244579999999999986 8899999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
++|++||...+..++...|.....+... ..+..+.+|++.+|.+||.+|.|.
T Consensus 194 ~~G~PPF~a~si~~Lv~~I~~d~v~~p~----------------------------~~S~~f~nfl~gLL~kdP~~RltW 245 (808)
T KOG0597|consen 194 YVGQPPFYARSITQLVKSILKDPVKPPS----------------------------TASSSFVNFLQGLLIKDPAQRLTW 245 (808)
T ss_pred hcCCCCchHHHHHHHHHHHhcCCCCCcc----------------------------cccHHHHHHHHHHhhcChhhcccH
Confidence 9999999988888888888765322111 225578999999999999999999
Q ss_pred HHHHHHHH
Q 003185 822 GDLYEMFV 829 (840)
Q Consensus 822 ~ELLehLe 829 (840)
.+++.|..
T Consensus 246 ~~Ll~HpF 253 (808)
T KOG0597|consen 246 TDLLGHPF 253 (808)
T ss_pred HHHhcChH
Confidence 99999854
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=358.82 Aligned_cols=266 Identities=23% Similarity=0.349 Sum_probs=203.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCccee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 573 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l 573 (840)
++.++|++.+.||+|+||.||+|.+ .+..||+|+.... ....... .+.+|+.+|..+ +|||||++
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~E~~~l~~l~~h~niv~~ 76 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG---ATASEHK----ALMSELKILIHIGNHLNVVNL 76 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc---cchHHHH----HHHHHHHHHHHhccCcceeeE
Confidence 4567899999999999999999974 2356899985421 1222223 348999999999 79999999
Q ss_pred eeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc----------------------------------
Q 003185 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---------------------------------- 619 (840)
Q Consensus 574 ~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~---------------------------------- 619 (840)
++++..... ..++||||+++|+|.+++......
T Consensus 77 ~~~~~~~~~-------------~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (338)
T cd05102 77 LGACTKPNG-------------PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQAS 143 (338)
T ss_pred EeEecCCCC-------------ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCC
Confidence 998864332 359999999999999999752110
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEe
Q 003185 620 -----------------------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 676 (840)
Q Consensus 620 -----------------------~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~ 676 (840)
....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~-------~~~kl~ 216 (338)
T cd05102 144 VLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-------NVVKIC 216 (338)
T ss_pred ccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC-------CcEEEe
Confidence 01347888999999999999999999999999999999999876 469999
Q ss_pred ecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH-
Q 003185 677 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSEL- 754 (840)
Q Consensus 677 DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~- 754 (840)
|||+++........ .......+++.|||||++.+ ..++.++|||||||+||||++ |..||.+....
T Consensus 217 DfG~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~ 284 (338)
T cd05102 217 DFGLARDIYKDPDY--------VRKGSARLPLKWMAPESIFD----KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE 284 (338)
T ss_pred ecccccccccCcch--------hcccCCCCCccccCcHHhhc----CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH
Confidence 99999865332111 01122346788999999975 668899999999999999997 99999876433
Q ss_pred HHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003185 755 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 833 (840)
Q Consensus 755 el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~ 833 (840)
.+...+..+..+..+ ...++.+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus 285 ~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 285 EFCQRLKDGTRMRAP---------------------------ENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHhcCCCCCCC---------------------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 333333333222111 1124578999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=348.40 Aligned_cols=278 Identities=20% Similarity=0.241 Sum_probs=208.1
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.+++|++.+.||.|+||.||+|.. .+..+|+|+........ .. ..+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG---AP----CTAIREVSLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC---cc----hhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 577899999999999999999987 56789999875432111 11 2337899999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .++||||+++ +|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 76 ~~--------------~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~ 136 (288)
T cd07871 76 RC--------------LTLVFEYLDS-DLKQYLDN----CGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI 136 (288)
T ss_pred Ce--------------EEEEEeCCCc-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 43 5999999985 99998875 23457899999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||+++........ .....||+.|+|||++.+ ...++.++|||||||++|+
T Consensus 137 ~~~-------~~~kl~DfG~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~~l~~ 196 (288)
T cd07871 137 NEK-------GELKLADFGLARAKSVPTKT----------YSNEVVTLWYRPPDVLLG---STEYSTPIDMWGVGCILYE 196 (288)
T ss_pred CCC-------CCEEECcCcceeeccCCCcc----------ccCceecccccChHHhcC---CcccCcHHHHHHHHHHHHH
Confidence 877 45999999998754321111 122358999999999864 2457899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccC-CCC---CCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG-SGF---EKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~-~~~---~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
|+||+.||.+.+..+....+.........+.+...... ..+.... ... .........+..+++||.+||.+||.
T Consensus 197 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~ 274 (288)
T cd07871 197 MATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN--EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETK 274 (288)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc--hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcc
Confidence 99999999988877776666554333333333222110 0000000 000 00011123456789999999999999
Q ss_pred CCCCHHHHHHHH
Q 003185 817 ERPTAGDLYEMF 828 (840)
Q Consensus 817 eRPSa~ELLehL 828 (840)
+|||++|+++|.
T Consensus 275 ~R~t~~~~l~hp 286 (288)
T cd07871 275 SRISAEAALRHS 286 (288)
T ss_pred cCCCHHHHhcCC
Confidence 999999999884
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=366.25 Aligned_cols=278 Identities=23% Similarity=0.249 Sum_probs=216.9
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCCh-----HHHH-HhHHhHHHHHHHHHhCCCCCcce
Q 003185 501 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSA-----DEIR-NFEYSCLGEVRMLGALRHSCIVE 572 (840)
Q Consensus 501 p~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~-----~~~~-~f~~~~~rEi~iL~~L~HpNIV~ 572 (840)
...++.|++++.||+|.||.|-+|+. .+..||+||+..+...... .... .-.+++.+||.||++|.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 36789999999999999999999997 6789999997644322110 0000 00135699999999999999999
Q ss_pred eeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Q 003185 573 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRD 652 (840)
Q Consensus 573 l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRD 652 (840)
++.+..+... ..+|||+|||..|.+...= .....+++.++++++++++.||+|||.+||||||
T Consensus 173 LiEvLDDP~s------------~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRD 235 (576)
T KOG0585|consen 173 LIEVLDDPES------------DKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRD 235 (576)
T ss_pred EEEeecCccc------------CceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccc
Confidence 9999765432 3579999999988765432 2223389999999999999999999999999999
Q ss_pred CCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHH
Q 003185 653 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 732 (840)
Q Consensus 653 LKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVW 732 (840)
|||+|+||+.+ ++|||+|||.+..+........ ... -...+|||.|||||.+.+.......+++.|||
T Consensus 236 IKPsNLLl~~~-------g~VKIsDFGVs~~~~~~~~~~~----d~~-L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiW 303 (576)
T KOG0585|consen 236 IKPSNLLLSSD-------GTVKISDFGVSNEFPQGSDEGS----DDQ-LSRTVGTPAFFAPELCSGGNSFSYSGFALDIW 303 (576)
T ss_pred cchhheEEcCC-------CcEEeeccceeeecccCCcccc----HHH-HhhcCCCccccchHhhcCCCCccccchhhhhh
Confidence 99999999988 5799999999986633211100 000 11257999999999998744445568999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 003185 733 SYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 812 (840)
Q Consensus 733 SLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~ 812 (840)
|+||+||.|+.|+.||.+....+++.+|.+... .++. ..+..+.+++||.+||.
T Consensus 304 alGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL-~fP~-------------------------~pe~~e~~kDli~~lL~ 357 (576)
T KOG0585|consen 304 ALGVTLYCLLFGQLPFFDDFELELFDKIVNDPL-EFPE-------------------------NPEINEDLKDLIKRLLE 357 (576)
T ss_pred hhhhhHHHhhhccCCcccchHHHHHHHHhcCcc-cCCC-------------------------cccccHHHHHHHHHHhh
Confidence 999999999999999999999999999987632 1111 11345689999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcC
Q 003185 813 ENPTERPTAGDLYEMFVARTS 833 (840)
Q Consensus 813 ~DP~eRPSa~ELLehLe~l~~ 833 (840)
+||.+|++..+|..|++--..
T Consensus 358 KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 358 KDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred cChhheeehhhheecceeccC
Confidence 999999999999999875543
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=373.53 Aligned_cols=250 Identities=25% Similarity=0.395 Sum_probs=211.0
Q ss_pred CCCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 501 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 501 p~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.++|+...-++-||.|+.|.||+|++.+..||||.++ +++ ..+|+-|++|+||||+.|.|+|...
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~---------elk------ETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVR---------ELK------ETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeeccCceehhHHHh---------hhh------hhhHHHHHhccCcceeeEeeeecCC
Confidence 3778888888999999999999999999999998643 111 3478889999999999999999855
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.- .|||||||..|-|..+|+. +..+.......|..+||.||.|||.+.|||||||..||||
T Consensus 185 Pc--------------yCIiMEfCa~GqL~~VLka-----~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLI 245 (904)
T KOG4721|consen 185 PC--------------YCIIMEFCAQGQLYEVLKA-----GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILI 245 (904)
T ss_pred ce--------------eEEeeeccccccHHHHHhc-----cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEe
Confidence 43 4999999999999999986 5678999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
..+ ..|||+|||.++....... ...+.||..|||||+++. .+.++|+|||||||+|||
T Consensus 246 s~~-------d~VKIsDFGTS~e~~~~ST-----------kMSFaGTVaWMAPEvIrn----ePcsEKVDIwSfGVVLWE 303 (904)
T KOG4721|consen 246 SYD-------DVVKISDFGTSKELSDKST-----------KMSFAGTVAWMAPEVIRN----EPCSEKVDIWSFGVVLWE 303 (904)
T ss_pred ecc-------ceEEeccccchHhhhhhhh-----------hhhhhhhHhhhCHHHhhc----CCcccccceehhHHHHHH
Confidence 988 4699999999988765422 245789999999999986 788999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
||||..||...+...++.-+..+.. .......+++.++-||+.||+-.|..||+
T Consensus 304 mLT~EiPYkdVdssAIIwGVGsNsL--------------------------~LpvPstcP~GfklL~Kqcw~sKpRNRPS 357 (904)
T KOG4721|consen 304 MLTGEIPYKDVDSSAIIWGVGSNSL--------------------------HLPVPSTCPDGFKLLLKQCWNSKPRNRPS 357 (904)
T ss_pred HHhcCCCccccchheeEEeccCCcc--------------------------cccCcccCchHHHHHHHHHHhcCCCCCcc
Confidence 9999999988777666555443311 11122345678899999999999999999
Q ss_pred HHHHHHHHHhhc
Q 003185 821 AGDLYEMFVART 832 (840)
Q Consensus 821 a~ELLehLe~l~ 832 (840)
|.+|+.||.-..
T Consensus 358 Frqil~HldIa~ 369 (904)
T KOG4721|consen 358 FRQILLHLDIAS 369 (904)
T ss_pred HHHHHHHHhhcC
Confidence 999999997543
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=344.87 Aligned_cols=282 Identities=22% Similarity=0.254 Sum_probs=204.4
Q ss_pred CCceeeeeecccCceEEEEEEE---CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC---CCCCcceeeeEEe
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF---GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKI 578 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~---~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L---~HpNIV~l~g~~~ 578 (840)
.+|++.+.||+|+||.||+|.+ ++..+|+|+......... ... .+.+|+.+++.+ .||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~--~~~----~~~~e~~~l~~l~~~~hpniv~~~~~~~ 74 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPL----STIREVAVLRHLETFEHPNVVRLFDVCT 74 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC--chH----HHHHHHHHHHhhcccCCCCcceEEEEEe
Confidence 3799999999999999999986 356789998764432211 111 225677776665 6999999999986
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
..... .....++||||+. ++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 75 ~~~~~---------~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Ni 141 (290)
T cd07862 75 VSRTD---------RETKLTLVFEHVD-QDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 141 (290)
T ss_pred cccCC---------CCCcEEEEEccCC-CCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHE
Confidence 43211 1234699999997 599999875 2234589999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.+ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 142 l~~~~-------~~~kl~Dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~il 199 (290)
T cd07862 142 LVTSS-------GQIKLADFGLARIYSFQM-----------ALTSVVVTLWYRAPEVLLQ----SSYATPVDLWSVGCIF 199 (290)
T ss_pred EEcCC-------CCEEEccccceEeccCCc-----------ccccccccccccChHHHhC----CCCCCccchHHHHHHH
Confidence 99877 459999999997653321 1123468999999999975 5678899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 739 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
|||++|.+||.+.+..+....+........+..+..........+ ...............+..+.+|+.+||+.||++|
T Consensus 200 ~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 278 (290)
T cd07862 200 AEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF-HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 278 (290)
T ss_pred HHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhc-cCCCCCCHHHHccCCCHHHHHHHHHHhccCchhc
Confidence 999999999998887777766655432222222221111100000 0000000111122346678999999999999999
Q ss_pred CCHHHHHHHH
Q 003185 819 PTAGDLYEMF 828 (840)
Q Consensus 819 PSa~ELLehL 828 (840)
||+.++++|.
T Consensus 279 ~s~~~~l~hp 288 (290)
T cd07862 279 ISAYSALSHP 288 (290)
T ss_pred CCHHHHhcCC
Confidence 9999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=350.53 Aligned_cols=250 Identities=28% Similarity=0.361 Sum_probs=204.6
Q ss_pred CCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||.||+|.+. +..+|+|+....... .. .....+.+|+.++++++||||+++++++....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RL----KQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR- 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hh----HHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC-
Confidence 47899999999999999999974 788999987543211 01 11234588999999999999999998877554
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
..|+||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~ 136 (291)
T cd05612 75 -------------FLYMLMEYVPGGELFSYLRN-----SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDK 136 (291)
T ss_pred -------------eEEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC
Confidence 35999999999999999976 356899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||+++...... ....||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 137 ~-------~~~kl~Dfg~~~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~~l~ 192 (291)
T cd05612 137 E-------GHIKLTDFGFAKKLRDRT-------------WTLCGTPEYLAPEVIQS----KGHNKAVDWWALGILIYEML 192 (291)
T ss_pred C-------CCEEEEecCcchhccCCc-------------ccccCChhhcCHHHHcC----CCCCchhhHHHHHHHHHHHH
Confidence 6 459999999987653211 12368999999999976 56789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC--
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT-- 820 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS-- 820 (840)
+|+.||.+.+..++...+..... .++. ..+..+.+||.+||+.||.+||+
T Consensus 193 ~g~~pf~~~~~~~~~~~i~~~~~-~~~~---------------------------~~~~~~~~li~~~l~~dp~~R~~~~ 244 (291)
T cd05612 193 VGYPPFFDDNPFGIYEKILAGKL-EFPR---------------------------HLDLYAKDLIKKLLVVDRTRRLGNM 244 (291)
T ss_pred hCCCCCCCCCHHHHHHHHHhCCc-CCCc---------------------------cCCHHHHHHHHHHcCCCHHHccCCc
Confidence 99999998888877777765432 1111 11446899999999999999995
Q ss_pred ---HHHHHHHHHh
Q 003185 821 ---AGDLYEMFVA 830 (840)
Q Consensus 821 ---a~ELLehLe~ 830 (840)
++++++|.+-
T Consensus 245 ~~~~~~~l~h~~~ 257 (291)
T cd05612 245 KNGADDVKNHRWF 257 (291)
T ss_pred cCCHHHHhcCccc
Confidence 9999999644
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=356.43 Aligned_cols=252 Identities=23% Similarity=0.283 Sum_probs=207.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++.+.||+|+||.||+|++ .+..+|+|++...... .. .....+.+|+.++++++||||+++++++..
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 89 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KM----KQVQHVAQEKSILMELSHPFIVNMMCSFQD 89 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hh----hhHHHHHHHHHHHHhCCCCCCCcEEEEEEc
Confidence 4678999999999999999999997 4678999987533211 11 112345899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .|+||||+.+|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 90 ~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIl 150 (329)
T PTZ00263 90 ENR--------------VYFLLEFVVGGELFTHLRK-----AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLL 150 (329)
T ss_pred CCE--------------EEEEEcCCCCChHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEE
Confidence 653 4999999999999999976 356889999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
|+.+ +.+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 151 l~~~-------~~~kl~Dfg~~~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ 206 (329)
T PTZ00263 151 LDNK-------GHVKVTDFGFAKKVPDRT-------------FTLCGTPEYLAPEVIQS----KGHGKAVDWWTMGVLLY 206 (329)
T ss_pred ECCC-------CCEEEeeccCceEcCCCc-------------ceecCChhhcCHHHHcC----CCCCCcceeechHHHHH
Confidence 9877 459999999997653311 12468999999999986 56789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|++|..||.+.+..+....+..+.. .++. ..+..+.+||.+||+.||.+||
T Consensus 207 elltg~~pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~~~~~~~li~~~L~~dP~~R~ 258 (329)
T PTZ00263 207 EFIAGYPPFFDDTPFRIYEKILAGRL-KFPN---------------------------WFDGRARDLVKGLLQTDHTKRL 258 (329)
T ss_pred HHHcCCCCCCCCCHHHHHHHHhcCCc-CCCC---------------------------CCCHHHHHHHHHHhhcCHHHcC
Confidence 99999999998888777777765422 1121 1234689999999999999999
Q ss_pred C-----HHHHHHHHH
Q 003185 820 T-----AGDLYEMFV 829 (840)
Q Consensus 820 S-----a~ELLehLe 829 (840)
+ +++|++|..
T Consensus 259 ~~~~~~~~~ll~hp~ 273 (329)
T PTZ00263 259 GTLKGGVADVKNHPY 273 (329)
T ss_pred CCCCCCHHHHhcCCc
Confidence 7 799998853
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=342.47 Aligned_cols=277 Identities=24% Similarity=0.264 Sum_probs=203.1
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||.||+|++ .+..+|+|++..... ... ....+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEE----VKETTLRELKMLRTLKQENIVELKEAFRRRGK 74 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc--ccc----chhhHHHHHHHHHhCCCccccchhhhEecCCE
Confidence 4799999999999999999998 467889998754321 111 22334889999999999999999999876553
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.++||||++++.|..+... ...+++..++.++.||+.||.|||+.||+||||||+|||++.
T Consensus 75 --------------~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~ 135 (287)
T cd07848 75 --------------LYLVFEYVEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISH 135 (287)
T ss_pred --------------EEEEEecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 5999999998766554432 346899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 136 ~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslGvil~el~ 195 (287)
T cd07848 136 N-------DVLKLCDFGFARNLSEGSNA---------NYTEYVATRWYRSPELLLG----APYGKAVDMWSVGCILGELS 195 (287)
T ss_pred C-------CcEEEeeccCcccccccccc---------cccccccccccCCcHHHcC----CCCCCchhHHhHHHHHHHHH
Confidence 7 45999999999865432111 1123468999999999975 56789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCC-CCC-----CchhhhhhHHHHHHHHHHhcccCCC
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS-GFE-----KPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
+|++||.+.+..+....+.....+.....+....... .+..... ... ........+..+.+||.+||+.||.
T Consensus 196 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~ 273 (287)
T cd07848 196 DGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP--RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPT 273 (287)
T ss_pred hCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc--hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcc
Confidence 9999999877666555544432222222221111100 0000000 000 0011122466899999999999999
Q ss_pred CCCCHHHHHHHH
Q 003185 817 ERPTAGDLYEMF 828 (840)
Q Consensus 817 eRPSa~ELLehL 828 (840)
+|||++++++|.
T Consensus 274 ~R~s~~~~l~hp 285 (287)
T cd07848 274 DRYLTEQCLNHP 285 (287)
T ss_pred cCCCHHHHhcCC
Confidence 999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=370.70 Aligned_cols=259 Identities=21% Similarity=0.307 Sum_probs=219.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..++-|.+++.||.|+.|.|-+|++ +|+.+|||++...... .... .+.+.+||.||+.|.||||+++|+++..
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~-s~s~----~~~IerEIviMkLi~HpnVl~LydVwe~ 83 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSEL-SSSQ----PAGIEREIVIMKLIEHPNVLRLYDVWEN 83 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeecccccc-cccc----ccchhhhhHHHHHhcCCCeeeeeeeecc
Confidence 4567899999999999999999997 7899999998655322 1112 2345899999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... +|+|.||++||-|.+++-. ++++++.++.++++||+.|+.|+|..+|+||||||+|+|
T Consensus 84 ~~~--------------lylvlEyv~gGELFdylv~-----kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlL 144 (786)
T KOG0588|consen 84 KQH--------------LYLVLEYVPGGELFDYLVR-----KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLL 144 (786)
T ss_pred Cce--------------EEEEEEecCCchhHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhh
Confidence 664 5999999999999999986 578999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
|+..+ .+||+|||+|..-..... -.+.+|+|.|+|||++++ ....+.++||||.|||||
T Consensus 145 Ld~~~-------nIKIADFGMAsLe~~gkl-----------LeTSCGSPHYA~PEIV~G---~pYdG~~sDVWSCGVILf 203 (786)
T KOG0588|consen 145 LDVKN-------NIKIADFGMASLEVPGKL-----------LETSCGSPHYAAPEIVSG---RPYDGRPSDVWSCGVILF 203 (786)
T ss_pred hhccc-------CEeeeccceeecccCCcc-----------ccccCCCcccCCchhhcC---CCCCCCccccchhHHHHH
Confidence 99884 399999999975433221 133479999999999998 345589999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
.||||++||.+.+...++.+++++... +|. .++.++++||.+||..||.+|+
T Consensus 204 ALLtG~LPFdDdNir~LLlKV~~G~f~-MPs---------------------------~Is~eaQdLLr~ml~VDp~~Ri 255 (786)
T KOG0588|consen 204 ALLTGKLPFDDDNIRVLLLKVQRGVFE-MPS---------------------------NISSEAQDLLRRMLDVDPSTRI 255 (786)
T ss_pred HHHhCCCCCCCccHHHHHHHHHcCccc-CCC---------------------------cCCHHHHHHHHHHhccCccccc
Confidence 999999999999999999999988542 221 2356899999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 003185 820 TAGDLYEMFVARTS 833 (840)
Q Consensus 820 Sa~ELLehLe~l~~ 833 (840)
|.+||++|.+-..-
T Consensus 256 T~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 256 TTEEILKHPFLSGY 269 (786)
T ss_pred cHHHHhhCchhhcC
Confidence 99999999776543
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=348.88 Aligned_cols=288 Identities=20% Similarity=0.237 Sum_probs=205.0
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|++.+.||+|+||.||+|.. .+..||+|+..... ....... ++.+|+.++++++||||+++++++......
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDAT----RILREIKLLRLLRHPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh--ccchhHH----HHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence 589999999999999999987 56789999864221 1112222 348999999999999999999988644321
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.....|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 75 ---------~~~~~~lv~e~~~-~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~ 139 (338)
T cd07859 75 ---------EFKDIYVVFELME-SDLHQVIKA-----NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD 139 (338)
T ss_pred ---------CCceEEEEEecCC-CCHHHHHHh-----cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC
Confidence 1235799999996 699999875 3468999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.+||+|||+++......... .......||+.|+|||++.+. ...++.++|||||||++|||++
T Consensus 140 -------~~~kL~Dfg~~~~~~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~--~~~~~~~~DvwSlGvvl~el~t 203 (338)
T cd07859 140 -------CKLKICDFGLARVAFNDTPTA-------IFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLT 203 (338)
T ss_pred -------CcEEEccCccccccccccCcc-------ccccCCCCCCCcCCHHHHhcc--ccccCchhHHHHHHHHHHHHHc
Confidence 569999999997643221110 011234699999999998642 1457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccc---cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ---SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|+.||.+.+.......+...........+............. ..............+..+.+||.+||..||.+|||
T Consensus 204 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 283 (338)
T cd07859 204 GKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT 283 (338)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC
Confidence 999998877655544443322111122111110000000000 00000011111234567899999999999999999
Q ss_pred HHHHHHHHHh
Q 003185 821 AGDLYEMFVA 830 (840)
Q Consensus 821 a~ELLehLe~ 830 (840)
++++++|..-
T Consensus 284 ~~e~l~hp~f 293 (338)
T cd07859 284 AEEALADPYF 293 (338)
T ss_pred HHHHhcCchh
Confidence 9999999543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=353.11 Aligned_cols=280 Identities=21% Similarity=0.248 Sum_probs=217.0
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
.|.-.+.+|.|+||.||+|.. .+..+|+|....+.. .+ .+|+.+|+.+.|||||++.-+|......
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YK------NRELQIMRKLDHPNIVRLLYFFSSSTES 92 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cC------cHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence 578899999999999999986 567888887643321 11 5699999999999999999988754421
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
+.....+||||++ .+|.++++.+... +..++...++-+.+||.+||.|||+.||+||||||+|||+|.+
T Consensus 93 ---------d~~~lnlVleymP-~tL~~~~r~~~~~-~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~ 161 (364)
T KOG0658|consen 93 ---------DEVYLNLVLEYMP-ETLYRVIRHYTRA-NQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPD 161 (364)
T ss_pred ---------chhHHHHHHHhch-HHHHHHHHHHhhc-CCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCC
Confidence 1335689999998 5999999864433 4678999999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
. +.+||||||.|+.+...... .....|..|+|||.+.+ ...|+.+.||||.||++.||+-
T Consensus 162 t------g~LKicDFGSAK~L~~~epn-----------iSYicSRyYRaPELifg---a~~Yt~~IDiWSaGCV~aELl~ 221 (364)
T KOG0658|consen 162 T------GVLKICDFGSAKVLVKGEPN-----------ISYICSRYYRAPELIFG---ATEYTTSIDIWSAGCVMAELLK 221 (364)
T ss_pred C------CeEEeccCCcceeeccCCCc-----------eeEEEeccccCHHHHcC---ccccCceeEEhhhhHHHHHHhc
Confidence 3 78999999999987653322 34568999999999997 5679999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccC-ccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC-HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
|++.|+|.+..+.+..|.+....+-.+.+..+... .+..+++.....-..-.....++++.+|+.++|.++|.+|.++.
T Consensus 222 g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~ 301 (364)
T KOG0658|consen 222 GQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSAL 301 (364)
T ss_pred CCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHH
Confidence 99999999888877777766433334444333211 11111111111100113344567899999999999999999999
Q ss_pred HHHHHH
Q 003185 823 DLYEMF 828 (840)
Q Consensus 823 ELLehL 828 (840)
|++.|-
T Consensus 302 ~~l~h~ 307 (364)
T KOG0658|consen 302 EALAHP 307 (364)
T ss_pred HHhcch
Confidence 999883
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=343.57 Aligned_cols=253 Identities=20% Similarity=0.247 Sum_probs=203.6
Q ss_pred eeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 590 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g~~ 590 (840)
..||+|++|.||+|.+++..||+|++.... .. .+.+.+.+.+|+.+|++++|||||+++|++.....
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~--~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~-------- 92 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFH--KG---HKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD-------- 92 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccc--cc---cHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc--------
Confidence 578999999999999999999999864321 11 11222345899999999999999999999875110
Q ss_pred ccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCCCcEEEecccccCCC
Q 003185 591 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADG 669 (840)
Q Consensus 591 ~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~-gIVHRDLKPeNILLd~~~~~~~~ 669 (840)
.....++||||+++|+|.+++.. ...+++.....++.|++.||.|||+. +++||||||+|||++.+
T Consensus 93 --~~~~~~lv~Ey~~~g~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~------ 159 (283)
T PHA02988 93 --DLPRLSLILEYCTRGYLREVLDK-----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN------ 159 (283)
T ss_pred --CCCceEEEEEeCCCCcHHHHHhh-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCC------
Confidence 12246999999999999999976 35688999999999999999999985 99999999999999877
Q ss_pred CCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003185 670 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 749 (840)
Q Consensus 670 ~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~ 749 (840)
+.+||+|||+++...... ....||..|+|||++.+. ...++.++|||||||++|||++|+.||.
T Consensus 160 -~~~kl~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~~--~~~~~~k~Di~SlGvil~el~~g~~Pf~ 223 (283)
T PHA02988 160 -YKLKIICHGLEKILSSPP-------------FKNVNFMVYFSYKMLNDI--FSEYTIKDDIYSLGVVLWEIFTGKIPFE 223 (283)
T ss_pred -CcEEEcccchHhhhcccc-------------ccccCcccccCHHHhhhc--cccccchhhhhHHHHHHHHHHHCCCCCC
Confidence 569999999987653311 123588999999998752 1467899999999999999999999999
Q ss_pred CCCHHHHHHHHHcC-CCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003185 750 GLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828 (840)
Q Consensus 750 ~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehL 828 (840)
+.+..++...+... .++.++ ...+..+.+|+.+||+.||.+|||+.+|++.|
T Consensus 224 ~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l 276 (283)
T PHA02988 224 NLTTKEIYDLIINKNNSLKLP---------------------------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276 (283)
T ss_pred CCCHHHHHHHHHhcCCCCCCC---------------------------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 88887777766543 222221 12355799999999999999999999999999
Q ss_pred Hhhc
Q 003185 829 VART 832 (840)
Q Consensus 829 e~l~ 832 (840)
+.+.
T Consensus 277 ~~~~ 280 (283)
T PHA02988 277 SLYK 280 (283)
T ss_pred HHHH
Confidence 8764
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=339.58 Aligned_cols=263 Identities=22% Similarity=0.350 Sum_probs=208.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 574 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~ 574 (840)
..+++|++.+.||+|+||.||+|.+.+ ..+++|..... ..... ...+.+|+.++.+++||||++++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~---~~~~~----~~~~~~ei~~l~~l~h~~i~~~~ 74 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN---AEPKV----QQEFRQEAELMSDLQHPNIVCLL 74 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC---CCHHH----HHHHHHHHHHHHhcCCcccceEE
Confidence 356789999999999999999998633 35777764322 11222 23458999999999999999999
Q ss_pred eEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccC-----------CCCCCHHHHHHHHHHHHHHHHHH
Q 003185 575 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG-----------EKHVSVKLALFIAQDVAAALVEL 643 (840)
Q Consensus 575 g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~-----------~~~ls~~~~~~Ia~QIa~AL~yL 643 (840)
+++..... .+++|||+++++|.+++....... ...+++..++.++.||+.||.||
T Consensus 75 ~~~~~~~~--------------~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~l 140 (283)
T cd05048 75 GVCTKEQP--------------TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL 140 (283)
T ss_pred EEEcCCCc--------------eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHH
Confidence 99876543 499999999999999997632211 14688899999999999999999
Q ss_pred HhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCC
Q 003185 644 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 723 (840)
Q Consensus 644 Hs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~ 723 (840)
|++||+|+||||+|||++.+ +.++|+|||++......... .......+++.|+|||.+.+ .
T Consensus 141 H~~~i~H~dlkp~Nil~~~~-------~~~~L~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~ 201 (283)
T cd05048 141 SSHHFVHRDLAARNCLVGEG-------LTVKISDFGLSRDIYSADYY--------RVQSKSLLPVRWMPPEAILY----G 201 (283)
T ss_pred HhCCeeccccccceEEEcCC-------CcEEECCCcceeeccccccc--------cccCCCcccccccCHHHhcc----C
Confidence 99999999999999999876 46999999999765332111 00122356889999999875 5
Q ss_pred CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHH
Q 003185 724 LYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 802 (840)
Q Consensus 724 ~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 802 (840)
.++.++|||||||++|||++ |..||.+....++...+.....+..+ ...+..
T Consensus 202 ~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~ 254 (283)
T cd05048 202 KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCP---------------------------EDCPAR 254 (283)
T ss_pred cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCc---------------------------ccCCHH
Confidence 67899999999999999998 99999988888887777665433222 123568
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 003185 803 LVDVFRRCTEENPTERPTAGDLYEMFVAR 831 (840)
Q Consensus 803 L~dLI~rCL~~DP~eRPSa~ELLehLe~l 831 (840)
+.+|+.+||+.||.+||++.+|+++|+++
T Consensus 255 ~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 255 VYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 99999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=335.17 Aligned_cols=258 Identities=19% Similarity=0.292 Sum_probs=204.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeE
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 576 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~ 576 (840)
+...+|++.+.||+|+||.||+|.+. +..+|+|+.... ....... .+.+|+.++++++||||++++++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~---~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~ 74 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG---CSDKQRR----GFLAEALTLGQFDHSNIVRLEGV 74 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC---CCHHHHH----HHHHHHHHHhcCCCCCcCeEEEE
Confidence 34568999999999999999999752 457777775432 1222222 34899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
+..... .++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++|++||||||+
T Consensus 75 ~~~~~~--------------~~lv~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~ 136 (266)
T cd05064 75 ITRGNT--------------MMIVTEYMSNGALDSFLRK----HEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAH 136 (266)
T ss_pred EecCCC--------------cEEEEEeCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHh
Confidence 876553 4999999999999999975 2246899999999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
|||++.+ +.++|+|||.+......... ......++..|+|||.+.+ ..++.++|||||||
T Consensus 137 nili~~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~ 196 (266)
T cd05064 137 KVLVNSD-------LVCKISGFRRLQEDKSEAIY---------TTMSGKSPVLWAAPEAIQY----HHFSSASDVWSFGI 196 (266)
T ss_pred hEEEcCC-------CcEEECCCcccccccccchh---------cccCCCCceeecCHHHHhh----CCccchhHHHHHHH
Confidence 9999876 56999999987653221110 0112235678999999876 67889999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 737 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 737 IL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
++|||++ |..||...+..++...+..+..+..+. ..+..+.+++.+||+.+|
T Consensus 197 ~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~c~~~~p 249 (266)
T cd05064 197 VMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPR---------------------------NCPNLLHQLMLDCWQKER 249 (266)
T ss_pred HHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCc
Confidence 9999775 999999888887777776553322221 134578999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 003185 816 TERPTAGDLYEMFVAR 831 (840)
Q Consensus 816 ~eRPSa~ELLehLe~l 831 (840)
.+||++.+|++.|..+
T Consensus 250 ~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 250 GERPRFSQIHSILSKM 265 (266)
T ss_pred hhCCCHHHHHHHHHhh
Confidence 9999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=352.74 Aligned_cols=245 Identities=25% Similarity=0.350 Sum_probs=197.9
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 588 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g 588 (840)
+.||+|+||.||+|.. .+..+|+|+....... ..... ..+.+|+.++++++||||+++++++.....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~------ 69 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVII-AKDEV----AHTLTESRVLQNTRHPFLTALKYSFQTHDR------ 69 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhHHH----HHHHHHHHHHHhCCCCCCCCEEEEEEcCCE------
Confidence 4699999999999986 5778999987543211 11122 234889999999999999999999886653
Q ss_pred CCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCC
Q 003185 589 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 668 (840)
Q Consensus 589 ~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~ 668 (840)
.||||||+++++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~----- 131 (323)
T cd05571 70 --------LCFVMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD----- 131 (323)
T ss_pred --------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-----
Confidence 4999999999999999875 3568999999999999999999999999999999999999877
Q ss_pred CCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003185 669 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 748 (840)
Q Consensus 669 ~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF 748 (840)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 132 --~~~kl~DfG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltg~~Pf 195 (323)
T cd05571 132 --GHIKITDFGLCKEGISDGA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPF 195 (323)
T ss_pred --CCEEEeeCCCCcccccCCC----------cccceecCccccChhhhcC----CCCCccccCcccchhhhhhhcCCCCC
Confidence 4599999999875322111 1123469999999999976 66889999999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHH
Q 003185 749 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGD 823 (840)
Q Consensus 749 ~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP-----Sa~E 823 (840)
...+...+...+..... .++. ..+..+.+||.+||..||.+|| ++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~-~~p~---------------------------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (323)
T cd05571 196 YNQDHEKLFELILMEEI-RFPR---------------------------TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKE 247 (323)
T ss_pred CCCCHHHHHHHHHcCCC-CCCC---------------------------CCCHHHHHHHHHHccCCHHHcCCCCCCCHHH
Confidence 88877776666654321 1111 1245789999999999999999 8999
Q ss_pred HHHHH
Q 003185 824 LYEMF 828 (840)
Q Consensus 824 LLehL 828 (840)
+++|-
T Consensus 248 ll~h~ 252 (323)
T cd05571 248 IMEHR 252 (323)
T ss_pred HHcCC
Confidence 99883
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=347.72 Aligned_cols=284 Identities=20% Similarity=0.249 Sum_probs=218.3
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
.|...+.||.|+||.|+.|.+ ++..||+|.. ........ ..++..||+++|+.++|+||+.+++++....
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi--~~~F~~~~----~akRtlRElklLr~~~HeNIi~l~di~~p~~-- 94 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKI--LNPFENQI----DAKRTLRELKLLRHLRHENIIGLLDIFRPPS-- 94 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhh--hhhhhchH----HHHHHHHHHHHHHHhcCCCcceEEeeccccc--
Confidence 455579999999999999987 5567777753 32222222 3345599999999999999999999987522
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.......|+|+|+|+ .+|.+.|+. +..++...+..+++||++||.|+|+.+|+||||||.|+|++.+
T Consensus 95 -------~~~f~DvYiV~elMe-tDL~~iik~-----~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~ 161 (359)
T KOG0660|consen 95 -------RDKFNDVYLVFELME-TDLHQIIKS-----QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNAD 161 (359)
T ss_pred -------ccccceeEEehhHHh-hHHHHHHHc-----CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccC
Confidence 123456899999996 699999986 3459999999999999999999999999999999999999988
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.+||+|||+|+...... .....+..+.|..|.|||++.. ...|+.+.||||.||||.||++
T Consensus 162 -------c~lKI~DFGLAR~~~~~~--------~~~~mTeYVaTRWYRAPElll~---~~~Yt~aiDiWSvGCI~AEmL~ 223 (359)
T KOG0660|consen 162 -------CDLKICDFGLARYLDKFF--------EDGFMTEYVATRWYRAPELLLN---SSEYTKAIDIWSVGCILAEMLT 223 (359)
T ss_pred -------CCEEeccccceeeccccC--------cccchhcceeeeeecCHHHHhc---cccccchhhhhhhhHHHHHHHc
Confidence 459999999999875431 1111245678999999999975 4679999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCC---CCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS---GFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|++.|+|.+....+..|......+-++.+..+.......+.+... ........+...+...+|+++||..||.+|+|
T Consensus 224 gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRit 303 (359)
T KOG0660|consen 224 GKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRIT 303 (359)
T ss_pred CCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCC
Confidence 999999999888888887764443444444332111111111111 11223334456778999999999999999999
Q ss_pred HHHHHHHH
Q 003185 821 AGDLYEMF 828 (840)
Q Consensus 821 a~ELLehL 828 (840)
++|+|+|.
T Consensus 304 a~eAL~hP 311 (359)
T KOG0660|consen 304 AEEALAHP 311 (359)
T ss_pred HHHHhcCh
Confidence 99999985
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=359.15 Aligned_cols=269 Identities=23% Similarity=0.324 Sum_probs=216.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++++.||+|+||.||+|+- .+..+|+|+.+.... ....+++.. +.|-.+|....+|+||++|..|.+
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M-~~~~Qv~hV----~aERdiL~~~ds~~vVKLyYsFQD 212 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEM-LKKNQVEHV----RAERDILAEVDSPWVVKLYYSFQD 212 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHH-HhhhhHHHH----HHHHHHhhhcCCCcEEEEEEEecC
Confidence 5788999999999999999999984 788999999653322 222333333 889999999999999999999998
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
..++ ||||||++||++..+|.+ ...|++..++.++.+++.|+..||+.|+|||||||+|+|
T Consensus 213 ~~~L--------------YLiMEylPGGD~mTLL~~-----~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlL 273 (550)
T KOG0605|consen 213 KEYL--------------YLIMEYLPGGDMMTLLMR-----KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLL 273 (550)
T ss_pred CCee--------------EEEEEecCCccHHHHHHh-----cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhhee
Confidence 7765 999999999999999987 468999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccc---------------cccCC----------------------CCCCC
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCC---------------IAHRG----------------------IPAPD 702 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~---------------~~~~~----------------------~~~~~ 702 (840)
||.. +++||+|||++..+........ ..... .....
T Consensus 274 iD~~-------GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~ 346 (550)
T KOG0605|consen 274 IDAK-------GHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAY 346 (550)
T ss_pred ecCC-------CCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhh
Confidence 9988 5699999999975433111100 00000 00112
Q ss_pred cccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCcchHHhhhccCccc
Q 003185 703 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEH 781 (840)
Q Consensus 703 ~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~ 781 (840)
..+|||.|||||++.+ ..|+..+|.||||||+||||.|.+||.+.++.+.+..|.+... ..+|.
T Consensus 347 StVGTPDYiAPEVll~----kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~----------- 411 (550)
T KOG0605|consen 347 STVGTPDYIAPEVLLG----KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE----------- 411 (550)
T ss_pred cccCCccccchHHHhc----CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-----------
Confidence 4589999999999997 6799999999999999999999999999999999999876521 11111
Q ss_pred cccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHHHHHHHhh
Q 003185 782 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP---TAGDLYEMFVAR 831 (840)
Q Consensus 782 ~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP---Sa~ELLehLe~l 831 (840)
....+.+++|||.+||. ||.+|. .++||.+|....
T Consensus 412 --------------~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~ 449 (550)
T KOG0605|consen 412 --------------EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFK 449 (550)
T ss_pred --------------cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccc
Confidence 11224689999999999 999996 599998885543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=341.88 Aligned_cols=267 Identities=19% Similarity=0.263 Sum_probs=200.8
Q ss_pred CCCCceeeeeecccCceEEEEEEEC------------------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHh
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFG------------------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGA 564 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~------------------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~ 564 (840)
+.++|.+.++||+|+||.||+|.+. +..+|+|+..... ..... ..+.+|+.+|.+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~----~~~~~E~~~l~~ 75 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNAR----NDFLKEVKILSR 75 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHH----HHHHHHHHHHhh
Confidence 3468999999999999999999752 2358888864321 22222 344899999999
Q ss_pred CCCCCcceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc--------------cCCCCCCHHHHH
Q 003185 565 LRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE--------------TGEKHVSVKLAL 630 (840)
Q Consensus 565 L~HpNIV~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~--------------~~~~~ls~~~~~ 630 (840)
++||||+++++++..... .++||||+++++|.+++..... .....+++..++
T Consensus 76 l~h~niv~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (304)
T cd05096 76 LKDPNIIRLLGVCVDEDP--------------LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLL 141 (304)
T ss_pred cCCCCeeEEEEEEecCCc--------------eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHH
Confidence 999999999999986553 4999999999999999975211 111346788999
Q ss_pred HHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcc
Q 003185 631 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 710 (840)
Q Consensus 631 ~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y 710 (840)
.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.+....... ......++..|
T Consensus 142 ~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~-------~~~kl~DfG~~~~~~~~~~~~--------~~~~~~~~~~y 206 (304)
T cd05096 142 HVALQIASGMKYLSSLNFVHRDLATRNCLVGEN-------LTIKIADFGMSRNLYAGDYYR--------IQGRAVLPIRW 206 (304)
T ss_pred HHHHHHHHHHHHHHHCCccccCcchhheEEcCC-------ccEEECCCccceecccCceeE--------ecCcCCCCccc
Confidence 999999999999999999999999999999876 469999999997653321110 01223467899
Q ss_pred cchhhhhcccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCC
Q 003185 711 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 788 (840)
Q Consensus 711 mAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT--G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~ 788 (840)
||||++.. ..++.++|||||||++|||++ +..||.+.+..++...+...........
T Consensus 207 ~aPE~~~~----~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~----------------- 265 (304)
T cd05096 207 MAWECILM----GKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQV----------------- 265 (304)
T ss_pred cCHHHHhc----CCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccc-----------------
Confidence 99999875 568999999999999999987 6688887776666554432211000000
Q ss_pred CCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003185 789 GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 789 ~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe 829 (840)
.......++..+.+|+.+||..||.+|||+.+|.+.|+
T Consensus 266 ---~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 266 ---YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred ---cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 00001123567999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=343.16 Aligned_cols=256 Identities=23% Similarity=0.299 Sum_probs=197.4
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
.|++.+.||+|+||.||+|.+ .+..+|+|+........ ... ...+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~----~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~- 74 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKG----EAMALNEKRILEKVNSRFVVSLAYAYETKDA- 74 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-hhh----HHHHHHHHHHHHhcCCCcEEEEEEEEccCCe-
Confidence 478899999999999999986 57889999865332111 111 1234789999999999999999999876553
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.++||||+++|+|..++.. .....+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 75 -------------~~lv~e~~~~g~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~ 138 (285)
T cd05631 75 -------------LCLVLTIMNGGDLKFHIYN---MGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR 138 (285)
T ss_pred -------------EEEEEEecCCCcHHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC
Confidence 4999999999999988864 223468999999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.+||+|||++........ .....||+.|||||++.+ ..++.++|||||||+||+|++
T Consensus 139 -------~~~kl~Dfg~~~~~~~~~~-----------~~~~~g~~~y~aPE~~~~----~~~~~~~DvwslGvil~el~~ 196 (285)
T cd05631 139 -------GHIRISDLGLAVQIPEGET-----------VRGRVGTVGYMAPEVINN----EKYTFSPDWWGLGCLIYEMIQ 196 (285)
T ss_pred -------CCEEEeeCCCcEEcCCCCe-----------ecCCCCCCCccCHhhhcC----CCCCcccCchhHHHHHHHHHh
Confidence 4699999999976532111 122468999999999986 678899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC---
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT--- 820 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS--- 820 (840)
|+.||.+.........+......... ......+..+.+||.+||+.||.+||+
T Consensus 197 g~~pf~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~s~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05631 197 GQSPFRKRKERVKREEVDRRVKEDQE------------------------EYSEKFSEDAKSICRMLLTKNPKERLGCRG 252 (285)
T ss_pred CCCCCCCCCcchhHHHHHHHhhcccc------------------------cCCccCCHHHHHHHHHHhhcCHHHhcCCCC
Confidence 99999876543222222211000000 000123557899999999999999997
Q ss_pred --HHHHHHHHH
Q 003185 821 --AGDLYEMFV 829 (840)
Q Consensus 821 --a~ELLehLe 829 (840)
++++++|..
T Consensus 253 ~~~~~~~~h~~ 263 (285)
T cd05631 253 NGAAGVKQHPI 263 (285)
T ss_pred CCHHHHhcCHh
Confidence 899999843
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=341.29 Aligned_cols=261 Identities=26% Similarity=0.326 Sum_probs=218.0
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.-+.|++.+.||+|.|+.||++.. .++.+|+|++..+..... ..+.+ .+|++|.+.|+|||||++.+.+...
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~--~~e~l----~rEarIC~~LqHP~IvrL~~ti~~~ 82 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKL----EREARICRKLQHPNIVRLHDSIQEE 82 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc--cHHHH----HHHHHHHHhcCCCcEeehhhhhccc
Confidence 346799999999999999999976 678899999776654333 33444 8999999999999999999988766
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .|||+|++.|++|..-|-. +..+++..+-..++||+.||.|+|.+||||||+||+|+|+
T Consensus 83 ~~--------------~ylvFe~m~G~dl~~eIV~-----R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllL 143 (355)
T KOG0033|consen 83 SF--------------HYLVFDLVTGGELFEDIVA-----REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLL 143 (355)
T ss_pred ce--------------eEEEEecccchHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheee
Confidence 54 4999999999999876654 2568899999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
.... ...-+||+|||+|..+..... ....+|||.|||||++.. .+|+..+|||+.|||||-
T Consensus 144 ASK~----~~A~vKL~~FGvAi~l~~g~~-----------~~G~~GtP~fmaPEvvrk----dpy~kpvDiW~cGViLfi 204 (355)
T KOG0033|consen 144 ASKA----KGAAVKLADFGLAIEVNDGEA-----------WHGFAGTPGYLSPEVLKK----DPYSKPVDIWACGVILYI 204 (355)
T ss_pred eecc----CCCceeecccceEEEeCCccc-----------cccccCCCcccCHHHhhc----CCCCCcchhhhhhHHHHH
Confidence 8764 235699999999988763221 234689999999999986 789999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|+.|.+||.+.+...+++.|.++....-+..| ..+.+..++|+.+||..||.+|+|
T Consensus 205 LL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w------------------------~~is~~Ak~LvrrML~~dP~kRIt 260 (355)
T KOG0033|consen 205 LLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW------------------------DTVTPEAKSLIRRMLTVNPKKRIT 260 (355)
T ss_pred HHhCCCCCCCccHHHHHHHHhccccCCCCccc------------------------CcCCHHHHHHHHHHhccChhhhcc
Confidence 99999999999999999999988542222111 234568899999999999999999
Q ss_pred HHHHHHHHHhh
Q 003185 821 AGDLYEMFVAR 831 (840)
Q Consensus 821 a~ELLehLe~l 831 (840)
+.|.|+|.+-.
T Consensus 261 a~EAL~HpWi~ 271 (355)
T KOG0033|consen 261 ADEALKHPWIC 271 (355)
T ss_pred HHHHhCCchhc
Confidence 99999996543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=362.71 Aligned_cols=250 Identities=30% Similarity=0.435 Sum_probs=213.3
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
.|...+.||+|+||.||+|.+ .++.||+|+..+... .++++.+ .+|+.+|..++++||.++|+.|.....+
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~---~deIedi----qqei~~Ls~~~~~~it~yygsyl~g~~L 86 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA---EDEIEDI----QQEISVLSQCDSPNITEYYGSYLKGTKL 86 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhc---chhhHHH----HHHHHHHHhcCcchHHhhhhheeecccH
Confidence 467779999999999999997 567899999876643 3344444 8899999999999999999999977654
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
+|+||||.||++.+.++. ...+.+..+..++++++.||.|||.++.+|||||+.|||+..+
T Consensus 87 --------------wiiMey~~gGsv~~lL~~-----~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~ 147 (467)
T KOG0201|consen 87 --------------WIIMEYCGGGSVLDLLKS-----GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES 147 (467)
T ss_pred --------------HHHHHHhcCcchhhhhcc-----CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEecc
Confidence 999999999999999975 3445888899999999999999999999999999999999988
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+ .|||+|||.+..+..... ...+++||+.|||||++.+ ..|+.|+||||||++.+||++
T Consensus 148 g-------~vkl~DfgVa~ql~~~~~----------rr~tfvGTPfwMAPEVI~~----~~Y~~KADIWSLGITaiEla~ 206 (467)
T KOG0201|consen 148 G-------DVKLADFGVAGQLTNTVK----------RRKTFVGTPFWMAPEVIKQ----SGYDTKADIWSLGITAIELAK 206 (467)
T ss_pred C-------cEEEEecceeeeeechhh----------ccccccccccccchhhhcc----ccccchhhhhhhhHHHHHHhc
Confidence 4 599999999987655332 2356799999999999986 789999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~E 823 (840)
|.+||....++.++..|-+...|.+.. ..++.+++||..||.+||+.||+|.+
T Consensus 207 GePP~s~~hPmrvlflIpk~~PP~L~~---------------------------~~S~~~kEFV~~CL~k~P~~RpsA~~ 259 (467)
T KOG0201|consen 207 GEPPHSKLHPMRVLFLIPKSAPPRLDG---------------------------DFSPPFKEFVEACLDKNPEFRPSAKE 259 (467)
T ss_pred CCCCCcccCcceEEEeccCCCCCcccc---------------------------ccCHHHHHHHHHHhhcCcccCcCHHH
Confidence 999999998877777776665554442 23557999999999999999999999
Q ss_pred HHHHHH
Q 003185 824 LYEMFV 829 (840)
Q Consensus 824 LLehLe 829 (840)
+++|-.
T Consensus 260 LLKh~F 265 (467)
T KOG0201|consen 260 LLKHKF 265 (467)
T ss_pred HhhhHH
Confidence 999843
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=342.16 Aligned_cols=281 Identities=19% Similarity=0.256 Sum_probs=199.3
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
.++|++.+.||+|+||.||+|.. .+..+|+|+........ .. ..+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG---TP----FTAIREASLLKGLKHANIVLLHDIIHTKE 76 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc---cc----hhHHHHHHHHhhCCCCCcCeEEEEEecCC
Confidence 46899999999999999999997 57789999875432111 11 12378999999999999999999988655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .++||||+. ++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 77 ~--------------~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~ 137 (303)
T cd07869 77 T--------------LTLVFEYVH-TDLCQYMDK----HPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS 137 (303)
T ss_pred e--------------EEEEEECCC-cCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence 3 499999996 688888865 234688999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||++......... .....||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 138 ~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l 197 (303)
T cd07869 138 DT-------GELKLADFGLARAKSVPSHT----------YSNEVVTLWYRPPDVLLG---STEYSTCLDMWGVGCIFVEM 197 (303)
T ss_pred CC-------CCEEECCCCcceeccCCCcc----------CCCCcccCCCCChHHHcC---CCCCCcHHHHHHHHHHHHHH
Confidence 76 45999999998754321111 122458999999999864 24578899999999999999
Q ss_pred HhCCCCCCCCCH-HHHHHHHHcCCCCCcchHHhhhc---cCccccccccC-CCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 742 LTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALG---SCHEHEVAQSG-SGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 742 LTG~~PF~~~~~-~el~~~I~~~~~p~l~~~l~~~~---~~~~~~~~~~~-~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
++|..||.+... .+....+...........+.... ......+.... ............+..+.+|+.+||+.||.
T Consensus 198 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~ 277 (303)
T cd07869 198 IQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPK 277 (303)
T ss_pred HhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCch
Confidence 999999987543 23333332211111111110000 00000000000 00000000011245788999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 003185 817 ERPTAGDLYEMFVA 830 (840)
Q Consensus 817 eRPSa~ELLehLe~ 830 (840)
+|||+.++++|-.-
T Consensus 278 ~R~s~~~~l~h~~f 291 (303)
T cd07869 278 NRLSAQAALSHEYF 291 (303)
T ss_pred hccCHHHHhcCccc
Confidence 99999999998554
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=352.83 Aligned_cols=252 Identities=21% Similarity=0.295 Sum_probs=206.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC---eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~ 578 (840)
..+++|++.+.||+|+||.||+|.+.+ ..+|+|++...... ..... ..+.+|+.+++.++||||+++++++.
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-~~~~~----~~~~~E~~~l~~l~hp~Iv~~~~~~~ 101 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-KQKQV----DHVFSERKILNYINHPFCVNLYGSFK 101 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-hhhhH----HHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 678899999999999999999998632 47899987533211 11122 23488999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
.... .|+||||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 102 ~~~~--------------~~lv~Ey~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NI 162 (340)
T PTZ00426 102 DESY--------------LYLVLEFVIGGEFFTFLRR-----NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENL 162 (340)
T ss_pred eCCE--------------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHE
Confidence 6553 5999999999999999976 35689999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.+ +.+||+|||++....... ....||+.|||||++.+ ..++.++|||||||++
T Consensus 163 Ll~~~-------~~ikL~DFG~a~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvil 218 (340)
T PTZ00426 163 LLDKD-------GFIKMTDFGFAKVVDTRT-------------YTLCGTPEYIAPEILLN----VGHGKAADWWTLGIFI 218 (340)
T ss_pred EECCC-------CCEEEecCCCCeecCCCc-------------ceecCChhhcCHHHHhC----CCCCccccccchhhHH
Confidence 99876 469999999997653211 22469999999999976 5678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 739 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
|||++|..||.+.++......+..+.. .++. ..+..+.++|.+||+.||.+|
T Consensus 219 ~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~~~~~~~li~~~l~~dp~~R 270 (340)
T PTZ00426 219 YEILVGCPPFYANEPLLIYQKILEGII-YFPK---------------------------FLDNNCKHLMKKLLSHDLTKR 270 (340)
T ss_pred HHHhcCCCCCCCCCHHHHHHHHhcCCC-CCCC---------------------------CCCHHHHHHHHHHcccCHHHc
Confidence 999999999998888777777665422 1111 123468899999999999999
Q ss_pred C-----CHHHHHHHHH
Q 003185 819 P-----TAGDLYEMFV 829 (840)
Q Consensus 819 P-----Sa~ELLehLe 829 (840)
+ +++++++|..
T Consensus 271 ~~~~~~~~~~~~~hp~ 286 (340)
T PTZ00426 271 YGNLKKGAQNVKEHPW 286 (340)
T ss_pred CCCCCCCHHHHHcCCC
Confidence 5 8999999854
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=350.68 Aligned_cols=256 Identities=24% Similarity=0.337 Sum_probs=206.1
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||.||+|.+ .+..+|+|++...... .... ...+.+|+.++..++||||+++++++.....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~----~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-KLNE----VRHVLTERDILTTTKSEWLVKLLYAFQDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhH----HHHHHHHHHHHHhCCCCCCccEEEEEEcCCE
Confidence 4799999999999999999997 4678999997543211 1112 2345889999999999999999999886553
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.||||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~ 136 (333)
T cd05600 76 --------------LYLAMEYVPGGDFRTLLNN-----LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDA 136 (333)
T ss_pred --------------EEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC
Confidence 5999999999999999975 356899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||+||||+
T Consensus 137 ~-------~~~kL~Dfg~a~~~~~~-------------~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell 192 (333)
T cd05600 137 S-------GHIKLTDFGLSKGIVTY-------------ANSVVGSPDYMAPEVLRG----KGYDFTVDYWSLGCMLYEFL 192 (333)
T ss_pred C-------CCEEEEeCcCCcccccc-------------cCCcccCccccChhHhcC----CCCCCccceecchHHHhhhh
Confidence 7 46999999999765331 123469999999999986 57889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCC-CcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRP-RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p-~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
+|..||.+.+..+....+...... ..+. . .......+..+.+||.+||..+|.+||++
T Consensus 193 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------------~---------~~~~~~~s~~~~~li~~~l~~~~~rr~s~ 251 (333)
T cd05600 193 CGFPPFSGSTPNETWENLKYWKETLQRPV------------Y---------DDPRFNLSDEAWDLITKLINDPSRRFGSL 251 (333)
T ss_pred hCCCCCCCCCHHHHHHHHHhccccccCCC------------C---------CccccccCHHHHHHHHHHhhChhhhcCCH
Confidence 999999988887777666543210 0000 0 00002235678999999999999999999
Q ss_pred HHHHHHHH
Q 003185 822 GDLYEMFV 829 (840)
Q Consensus 822 ~ELLehLe 829 (840)
.++++|..
T Consensus 252 ~~ll~h~~ 259 (333)
T cd05600 252 EDIKNHPF 259 (333)
T ss_pred HHHHhCcc
Confidence 99999843
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=340.00 Aligned_cols=282 Identities=19% Similarity=0.264 Sum_probs=209.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|.+.+.||+|+||.||+|++ .+..+|+|......... .. ..+.+|+.++++++||||+++++++..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~ 75 (309)
T cd07872 3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG---AP----CTAIREVSLLKDLKHANIVTLHDIVHT 75 (309)
T ss_pred CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC---cc----hhHHHHHHHHHhCCCCCcceEEEEEee
Confidence 4678899999999999999999987 56778999865432211 11 123789999999999999999999886
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .++||||+++ +|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 76 ~~~--------------~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nil 136 (309)
T cd07872 76 DKS--------------LTLVFEYLDK-DLKQYMDD----CGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLL 136 (309)
T ss_pred CCe--------------EEEEEeCCCC-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 553 4999999985 89888865 2345889999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++......... .....+|+.|+|||++.+ ...++.++|||||||++|
T Consensus 137 l~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 196 (309)
T cd07872 137 INER-------GELKLADFGLARAKSVPTKT----------YSNEVVTLWYRPPDVLLG---SSEYSTQIDMWGVGCIFF 196 (309)
T ss_pred ECCC-------CCEEECccccceecCCCccc----------cccccccccccCCHHHhC---CCCCCcHHHHHHHHHHHH
Confidence 9877 45999999998754322111 122357899999999875 245788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccC-CCCC---CchhhhhhHHHHHHHHHHhcccCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG-SGFE---KPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~-~~~~---~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
+|+||+.||.+.+..+....+...........+........ +.... .... ........+..+.+||.+||..||
T Consensus 197 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 274 (309)
T cd07872 197 EMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE--FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYES 274 (309)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh--hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCCh
Confidence 99999999998877766666655433222332222111000 00000 0000 001112346678999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 003185 816 TERPTAGDLYEMFVAR 831 (840)
Q Consensus 816 ~eRPSa~ELLehLe~l 831 (840)
.+|||+.|+++|..-.
T Consensus 275 ~~R~t~~e~l~h~~~~ 290 (309)
T cd07872 275 KKRISAEEAMKHAYFR 290 (309)
T ss_pred hhCCCHHHHhcChhhh
Confidence 9999999999986544
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=334.60 Aligned_cols=252 Identities=26% Similarity=0.352 Sum_probs=213.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++.+.||.|+||.|.+++. ++..+|+|+...... ...... +...+|..+|+.+.||.|+++++.+.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~v-VklKQv----eH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKV-VKLKQV----EHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHH-HHHHHH----HHHhhHHHHHhhccCceeEEEEEeecc
Confidence 6789999999999999999999986 788999999653321 111222 334889999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... +|+||||++||-|..++++ .++|++..++.++.||+.||+|||+.+|++|||||+|||
T Consensus 116 ~~~--------------lymvmeyv~GGElFS~Lrk-----~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiL 176 (355)
T KOG0616|consen 116 NSN--------------LYMVMEYVPGGELFSYLRK-----SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLL 176 (355)
T ss_pred CCe--------------EEEEEeccCCccHHHHHHh-----cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHee
Confidence 665 4999999999999999987 478999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
||.+ +.+||+|||+|+...... -+.+|||.|+|||++.. ..++.++|.|||||++|
T Consensus 177 lD~~-------G~iKitDFGFAK~v~~rT-------------~TlCGTPeYLAPEii~s----k~ynkavDWWalGVLIY 232 (355)
T KOG0616|consen 177 LDQN-------GHIKITDFGFAKRVSGRT-------------WTLCGTPEYLAPEIIQS----KGYNKAVDWWALGVLIY 232 (355)
T ss_pred eccC-------CcEEEEeccceEEecCcE-------------EEecCCccccChHHhhc----CCCCcchhHHHHHHHHH
Confidence 9988 569999999999876532 23579999999999987 78999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC-
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER- 818 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR- 818 (840)
||+.|.+||...++.+++++|..+... +|.. .+.++++||.++|+.|-.+|
T Consensus 233 EMlaG~pPF~~~~~~~iY~KI~~~~v~-fP~~---------------------------fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 233 EMLAGYPPFYDDNPIQIYEKILEGKVK-FPSY---------------------------FSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred HHHcCCCCCcCCChHHHHHHHHhCccc-CCcc---------------------------cCHHHHHHHHHHHhhhhHhhh
Confidence 999999999999999999999887431 2211 14478999999999999999
Q ss_pred ----CCHHHHHHHHH
Q 003185 819 ----PTAGDLYEMFV 829 (840)
Q Consensus 819 ----PSa~ELLehLe 829 (840)
....+|.+|-+
T Consensus 285 gnlknG~~dIk~H~w 299 (355)
T KOG0616|consen 285 GNLKNGVEDIKNHPW 299 (355)
T ss_pred cCcCCCccccccCcc
Confidence 34556666643
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=361.15 Aligned_cols=288 Identities=19% Similarity=0.238 Sum_probs=205.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..-.+|++.+.||+|+||.||+|.. .+..+|+|.+.... .. ..+|+.+|+.++|||||++++++..
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~----~~~Ei~il~~l~h~niv~l~~~~~~ 130 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QY----KNRELLIMKNLNHINIIFLKDYYYT 130 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------ch----HHHHHHHHHhcCCCCCcceeeeEee
Confidence 3456899999999999999999987 56789999763211 11 1579999999999999999998764
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.... .......+++||||++ ++|.+++..... ....+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 131 ~~~~------~~~~~~~l~lvmE~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NIL 202 (440)
T PTZ00036 131 ECFK------KNEKNIFLNVVMEFIP-QTVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLL 202 (440)
T ss_pred cccc------cCCCceEEEEEEecCC-ccHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEE
Confidence 3211 0112234689999998 588888765322 2357899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
|+.++ ..+||+|||+|+.+..... .....||+.|+|||++.+ ...++.++|||||||+||
T Consensus 203 l~~~~------~~vkL~DFGla~~~~~~~~-----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlGvil~ 262 (440)
T PTZ00036 203 IDPNT------HTLKLCDFGSAKNLLAGQR-----------SVSYICSRFYRAPELMLG---ATNYTTHIDLWSLGCIIA 262 (440)
T ss_pred EcCCC------CceeeeccccchhccCCCC-----------cccCCCCcCccCHHHhcC---CCCCCcHHHHHHHHHHHH
Confidence 98652 3699999999986543211 123468999999999875 246889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhcc-CccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS-CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
||++|.+||.+.+..+.+..+.........+.+..... .....+................+.++.+||.+||.+||.+|
T Consensus 263 elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R 342 (440)
T PTZ00036 263 EMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKR 342 (440)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHC
Confidence 99999999998877666555544322222222211100 00000000000000000011235689999999999999999
Q ss_pred CCHHHHHHHHH
Q 003185 819 PTAGDLYEMFV 829 (840)
Q Consensus 819 PSa~ELLehLe 829 (840)
||+.|+++|..
T Consensus 343 ~ta~e~l~hp~ 353 (440)
T PTZ00036 343 LNPIEALADPF 353 (440)
T ss_pred cCHHHHhCChh
Confidence 99999999865
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=342.29 Aligned_cols=288 Identities=21% Similarity=0.263 Sum_probs=220.0
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCC-cceeeeEEecC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC-IVEMYGHKISS 580 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpN-IV~l~g~~~~~ 580 (840)
+..|...++||+|+||+||+|+. .+..||+|...+...... ......+|+.+|+.|+|+| ||.+++++...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG------~P~taiREisllk~L~~~~~iv~L~dv~~~~ 83 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG------VPSTAIREISLLKRLSHANHIVRLHDVIHTS 83 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC------CCchhhHHHHHHHHhCCCcceEEEEeeeeec
Confidence 66788999999999999999986 678899999887654211 2223489999999999999 99999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
+.. .....+++||||++ .+|..++....+.. ..++...++.+++||+.||+|||+++|+||||||+||||
T Consensus 84 ~~~--------~~~~~l~lvfe~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi 153 (323)
T KOG0594|consen 84 NNH--------RGIGKLYLVFEFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI 153 (323)
T ss_pred ccc--------cccceEEEEEEeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE
Confidence 631 12335799999997 59999998743221 457779999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||+|+.+.-.... ....++|..|.|||++.+ ...|+...||||+|||++|
T Consensus 154 ~~~-------G~lKlaDFGlAra~~ip~~~----------yt~evvTlWYRaPEvLlG---s~~Ys~~vDiWs~GcIfaE 213 (323)
T KOG0594|consen 154 SSS-------GVLKLADFGLARAFSIPMRT----------YTPEVVTLWYRAPEVLLG---STSYSTSVDIWSLGCIFAE 213 (323)
T ss_pred CCC-------CcEeeeccchHHHhcCCccc----------ccccEEEeeccCHHHhcC---CCcCCCCcchHhHHHHHHH
Confidence 987 56999999999965432221 234578999999999997 3468999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcccc--ccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE--VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
|+++++.|++.+..+....|......+-.+.|+......... +.....................+|+.+||+++|.+|
T Consensus 214 m~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R 293 (323)
T KOG0594|consen 214 MFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKR 293 (323)
T ss_pred HHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccC
Confidence 999999999999888888887653333333343332222111 111110111111112223578999999999999999
Q ss_pred CCHHHHHHH
Q 003185 819 PTAGDLYEM 827 (840)
Q Consensus 819 PSa~ELLeh 827 (840)
.|+..++.|
T Consensus 294 ~Sa~~al~h 302 (323)
T KOG0594|consen 294 ISAKGALTH 302 (323)
T ss_pred cCHHHHhcC
Confidence 999999999
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=352.30 Aligned_cols=264 Identities=22% Similarity=0.267 Sum_probs=204.5
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||.||+|.+ .+..+|+|++...... . ......+.+|+.+|..++||||+++++++.....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~----~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-E----KEQVAHVRAERDILAEADNPWVVKLYYSFQDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-h----hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCe
Confidence 4799999999999999999997 5678999997543211 1 1122344889999999999999999999986654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.||||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~E~~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~ 136 (364)
T cd05599 76 --------------LYLIMEYLPGGDMMTLLMK-----KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDA 136 (364)
T ss_pred --------------EEEEECCCCCcHHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC
Confidence 4999999999999999976 346899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccc---c-------------------------CCCCCCCcccCCCcccchh
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA---H-------------------------RGIPAPDVCVGTPRWMAPE 714 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~---~-------------------------~~~~~~~~~vGT~~YmAPE 714 (840)
+ +.+||+|||++..+.......... . .........+||+.|+|||
T Consensus 137 ~-------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 209 (364)
T cd05599 137 K-------GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE 209 (364)
T ss_pred C-------CCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHH
Confidence 7 469999999987653221100000 0 0000011246999999999
Q ss_pred hhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCcchHHhhhccCccccccccCCCCCCc
Q 003185 715 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKP 793 (840)
Q Consensus 715 vL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~ 793 (840)
++.. ..++.++|||||||++|||++|..||.+.+..+....+..... ..++.
T Consensus 210 ~~~~----~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~----------------------- 262 (364)
T cd05599 210 VFLQ----TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPD----------------------- 262 (364)
T ss_pred HHcC----CCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCC-----------------------
Confidence 9875 5688999999999999999999999998888777666654321 11110
Q ss_pred hhhhhhHHHHHHHHHHhcccCCCCCCC---HHHHHHHHH
Q 003185 794 EAELETLSFLVDVFRRCTEENPTERPT---AGDLYEMFV 829 (840)
Q Consensus 794 ~~~~~~s~~L~dLI~rCL~~DP~eRPS---a~ELLehLe 829 (840)
....++.+.+||.+||. +|.+|++ +.++++|.+
T Consensus 263 --~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~ 298 (364)
T cd05599 263 --EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF 298 (364)
T ss_pred --CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCC
Confidence 01224578999999997 9999998 999999853
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=342.05 Aligned_cols=279 Identities=23% Similarity=0.303 Sum_probs=204.7
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
..++|++.+.||+|+||.||++.+ .+..+|+|+..... ... ....+.+|+.+|++++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 75 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPA----IRNQIIRELQVLHECNSPYIVGFYGAFYSD 75 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHH----HHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence 357899999999999999999998 46678888865431 112 233458999999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCCCcEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENIL 659 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~-gIVHRDLKPeNIL 659 (840)
.. .++||||+++++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||
T Consensus 76 ~~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil 136 (331)
T cd06649 76 GE--------------ISICMEHMDGGSLDQVLKE-----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNIL 136 (331)
T ss_pred CE--------------EEEEeecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEE
Confidence 53 5999999999999999976 34689999999999999999999986 6999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++....... .....||+.|+|||++.+ ..++.++|||||||+||
T Consensus 137 ~~~~-------~~~kl~Dfg~~~~~~~~~------------~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~il~ 193 (331)
T cd06649 137 VNSR-------GEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYSVQSDIWSMGLSLV 193 (331)
T ss_pred EcCC-------CcEEEccCcccccccccc------------cccCCCCcCcCCHhHhcC----CCCCchHhHHHHHHHHH
Confidence 9877 459999999987653211 123468999999999976 56889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCc-------------cc------cccccCCC-CCCchhhhhh
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH-------------EH------EVAQSGSG-FEKPEAELET 799 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~-------------~~------~~~~~~~~-~~~~~~~~~~ 799 (840)
||++|+.||...+..++...+.......-........... .. ........ ..........
T Consensus 194 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
T cd06649 194 ELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVF 273 (331)
T ss_pred HHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccc
Confidence 9999999998777665544432211000000000000000 00 00000000 0000001124
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003185 800 LSFLVDVFRRCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 800 s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~ 830 (840)
+..+++||.+||..||++|||+.+|++|.+-
T Consensus 274 ~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 274 TPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 6689999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=345.20 Aligned_cols=243 Identities=24% Similarity=0.303 Sum_probs=195.0
Q ss_pred ecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCCCC
Q 003185 513 AGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 590 (840)
Q Consensus 513 LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g~~ 590 (840)
||+|+||.||+|.+ .+..+|+|+...... ....... .+.+|+.++++++||||+++++++.....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-------- 67 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-VSRSEVT----HTLAERTVLAQVNCPFIVPLKFSFQSPEK-------- 67 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHH----HHHHHHHHHHhCCCCcEeceeeEEecCCe--------
Confidence 79999999999997 466799998653211 1112222 34889999999999999999999876543
Q ss_pred ccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCCC
Q 003185 591 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 670 (840)
Q Consensus 591 ~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~ 670 (840)
.|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 68 ------~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~------- 129 (312)
T cd05585 68 ------LYLVLAFINGGELFHHLQR-----EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ------- 129 (312)
T ss_pred ------EEEEEcCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCC-------
Confidence 5999999999999999975 3568999999999999999999999999999999999999877
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003185 671 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 750 (840)
Q Consensus 671 ~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~ 750 (840)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+
T Consensus 130 ~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 130 GHIALCDFGLCKLNMKDDD----------KTNTFCGTPEYLAPELLLG----HGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred CcEEEEECcccccCccCCC----------ccccccCCcccCCHHHHcC----CCCCCccceechhHHHHHHHhCCCCcCC
Confidence 4599999999875322111 1233469999999999976 5688999999999999999999999998
Q ss_pred CCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 003185 751 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP---TAGDLYEM 827 (840)
Q Consensus 751 ~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP---Sa~ELLeh 827 (840)
.+..++...+..... .++ ...+..+.+||.+||..||.+|| ++.+++.|
T Consensus 196 ~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 196 ENVNEMYRKILQEPL-RFP---------------------------DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCHHHHHHHHHcCCC-CCC---------------------------CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 877777666654321 111 11245789999999999999997 57888887
Q ss_pred H
Q 003185 828 F 828 (840)
Q Consensus 828 L 828 (840)
.
T Consensus 248 p 248 (312)
T cd05585 248 P 248 (312)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=350.38 Aligned_cols=262 Identities=20% Similarity=0.215 Sum_probs=201.5
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||+||+|.. .+..+|+|+...... ........+.+|+.++.+++||||+++++.+.....
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM-----LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH-----HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCe
Confidence 4789999999999999999987 567899999753211 011122345889999999999999999999886654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.||||||++||+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+||||+.
T Consensus 76 --------------~~lv~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~ 136 (363)
T cd05628 76 --------------LYLIMEFLPGGDMMTLLMK-----KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDS 136 (363)
T ss_pred --------------EEEEEcCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC
Confidence 4999999999999999976 356899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccc-------------------------cCCCCCCCcccCCCcccchhhhh
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-------------------------HRGIPAPDVCVGTPRWMAPEVLR 717 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~-------------------------~~~~~~~~~~vGT~~YmAPEvL~ 717 (840)
+ +.+||+|||+++.+.......... ..........+||+.|+|||++.
T Consensus 137 ~-------~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~ 209 (363)
T cd05628 137 K-------GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM 209 (363)
T ss_pred C-------CCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc
Confidence 6 469999999997653211100000 00000112357999999999997
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCcchHHhhhccCccccccccCCCCCCchhh
Q 003185 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 796 (840)
Q Consensus 718 ~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 796 (840)
+ ..++.++|||||||+||||++|..||.+.+..+....+.... ...++..
T Consensus 210 ~----~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~------------------------- 260 (363)
T cd05628 210 Q----TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPE------------------------- 260 (363)
T ss_pred C----CCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCc-------------------------
Confidence 6 568899999999999999999999999888888777776532 1111110
Q ss_pred hhhHHHHHHHHHHhcccCCC---CCCCHHHHHHH
Q 003185 797 LETLSFLVDVFRRCTEENPT---ERPTAGDLYEM 827 (840)
Q Consensus 797 ~~~s~~L~dLI~rCL~~DP~---eRPSa~ELLeh 827 (840)
...++.+.+||.+|+. +|. .||+++||++|
T Consensus 261 ~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 261 VPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 1124578889988765 444 56899999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=346.68 Aligned_cols=248 Identities=26% Similarity=0.319 Sum_probs=197.9
Q ss_pred eeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCC
Q 003185 510 CDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 584 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p 584 (840)
.+.||+|+||.||+++. .+..+|+|+............ ...+.+|+.+|+.++||||+++++++.....
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~----~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~-- 74 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKD----TAHTKAERNILEAVKHPFIVDLIYAFQTGGK-- 74 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhh----HHHHHHHHHHHHhCCCCchhceeeEEecCCe--
Confidence 36899999999999985 467899998753221111111 2234789999999999999999999886553
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEeccc
Q 003185 585 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 664 (840)
Q Consensus 585 ~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~ 664 (840)
.|+||||+++++|.+++.. ...+.+..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 75 ------------~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~- 136 (323)
T cd05584 75 ------------LYLILEYLSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ- 136 (323)
T ss_pred ------------EEEEEeCCCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-
Confidence 4999999999999999876 3568889999999999999999999999999999999999877
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 003185 665 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 744 (840)
Q Consensus 665 ~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG 744 (840)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||+||||++|
T Consensus 137 ------~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~G 196 (323)
T cd05584 137 ------GHVKLTDFGLCKESIHEGT----------VTHTFCGTIEYMAPEILMR----SGHGKAVDWWSLGALMYDMLTG 196 (323)
T ss_pred ------CCEEEeeCcCCeecccCCC----------cccccCCCccccChhhccC----CCCCCcceecccHHHHHHHhcC
Confidence 4699999999875322111 1123469999999999976 5578899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----
Q 003185 745 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP----- 819 (840)
Q Consensus 745 ~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP----- 819 (840)
+.||.+.+.......+..+.. .++. ..+..+.+||.+||+.||.+||
T Consensus 197 ~~pf~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~li~~~l~~~p~~R~~~~~~ 248 (323)
T cd05584 197 APPFTAENRKKTIDKILKGKL-NLPP---------------------------YLTPEARDLLKKLLKRNPSSRLGAGPG 248 (323)
T ss_pred CCCCCCCCHHHHHHHHHcCCC-CCCC---------------------------CCCHHHHHHHHHHcccCHhHcCCCCCC
Confidence 999998887776666655422 1111 1245789999999999999999
Q ss_pred CHHHHHHHHH
Q 003185 820 TAGDLYEMFV 829 (840)
Q Consensus 820 Sa~ELLehLe 829 (840)
+++++++|..
T Consensus 249 ~~~~l~~h~~ 258 (323)
T cd05584 249 DAAEVQSHPF 258 (323)
T ss_pred CHHHHhcCCC
Confidence 8999999853
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=358.92 Aligned_cols=255 Identities=27% Similarity=0.350 Sum_probs=219.8
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.+++|..++++|+|+||.++++++ .+..+++|.+.+...... ..+. ..+|+.++++++|||||.+.+.|..+
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~--~r~~----A~~E~~lis~~~hP~iv~y~ds~~~~ 75 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP--ERRS----AIQEMDLLSKLLHPNIVEYKDSFEED 75 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch--hhHH----HHHHHHHHHhccCCCeeeeccchhcC
Confidence 367899999999999999999886 566888888776654332 2223 38999999999999999999999977
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
+.+ ++|||+||+||+|.+.|... .+..++++.++.|+.||+.|+.|||+++|+|||||+.|||+
T Consensus 76 ~~~-------------l~Ivm~Y~eGg~l~~~i~~~---k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl 139 (426)
T KOG0589|consen 76 GQL-------------LCIVMEYCEGGDLAQLIKEQ---KGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL 139 (426)
T ss_pred Cce-------------EEEEEeecCCCCHHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc
Confidence 652 59999999999999999873 24679999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.++ .|+|+|||+|+.+...... ..+++||+.||.||++.+ .+|+.|+|||||||++||
T Consensus 140 tk~~-------~VkLgDfGlaK~l~~~~~~----------a~tvvGTp~YmcPEil~d----~pYn~KSDiWsLGC~~yE 198 (426)
T KOG0589|consen 140 TKDK-------KVKLGDFGLAKILNPEDSL----------ASTVVGTPYYMCPEILSD----IPYNEKSDIWSLGCCLYE 198 (426)
T ss_pred cccC-------ceeecchhhhhhcCCchhh----------hheecCCCcccCHHHhCC----CCCCccCcchhhcchHHH
Confidence 9884 4899999999988664311 245689999999999997 789999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|++-+++|...+...+...|.+....+++.. .+.++..||..||..+|..||+
T Consensus 199 m~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~---------------------------ys~el~~lv~~~l~~~P~~RPs 251 (426)
T KOG0589|consen 199 MCTLKPAFKASNMSELILKINRGLYSPLPSM---------------------------YSSELRSLVKSMLRKNPEHRPS 251 (426)
T ss_pred HHhcccccCccchHHHHHHHhhccCCCCCcc---------------------------ccHHHHHHHHHHhhcCCccCCC
Confidence 9999999999999999999988765544432 3568999999999999999999
Q ss_pred HHHHHHH
Q 003185 821 AGDLYEM 827 (840)
Q Consensus 821 a~ELLeh 827 (840)
+.++|.+
T Consensus 252 a~~LL~~ 258 (426)
T KOG0589|consen 252 ALELLRR 258 (426)
T ss_pred HHHHhhC
Confidence 9999987
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=347.52 Aligned_cols=245 Identities=24% Similarity=0.348 Sum_probs=196.7
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 588 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g 588 (840)
+.||+|+||.||++.. .+..+|+|+....... ..... ..+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~----~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~------ 69 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVII-AKDEV----AHTLTESRVLKNTRHPFLTSLKYSFQTKDR------ 69 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHH----HHHHHHHHHHHhCCCCCCcceEEEEEcCCE------
Confidence 4699999999999986 5778999987533211 11222 344889999999999999999999886553
Q ss_pred CCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCC
Q 003185 589 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 668 (840)
Q Consensus 589 ~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~ 668 (840)
.||||||+++|+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~lv~Ey~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~----- 131 (328)
T cd05593 70 --------LCFVMEYVNGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD----- 131 (328)
T ss_pred --------EEEEEeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCC-----
Confidence 4999999999999998875 3568999999999999999999999999999999999999877
Q ss_pred CCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003185 669 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 748 (840)
Q Consensus 669 ~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF 748 (840)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||+||+|++|+.||
T Consensus 132 --~~~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~elltG~~Pf 195 (328)
T cd05593 132 --GHIKITDFGLCKEGITDAA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPF 195 (328)
T ss_pred --CcEEEecCcCCccCCCccc----------ccccccCCcCccChhhhcC----CCCCccCCccccchHHHHHhhCCCCC
Confidence 4599999999875322111 1123469999999999975 56789999999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHH
Q 003185 749 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGD 823 (840)
Q Consensus 749 ~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP-----Sa~E 823 (840)
.+.+..+....+..... .++ ...+..+.+||.+||..||.+|| ++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~-~~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (328)
T cd05593 196 YNQDHEKLFELILMEDI-KFP---------------------------RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKE 247 (328)
T ss_pred CCCCHHHHHHHhccCCc-cCC---------------------------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHH
Confidence 88777766655543321 111 11245789999999999999997 8999
Q ss_pred HHHHH
Q 003185 824 LYEMF 828 (840)
Q Consensus 824 LLehL 828 (840)
+++|.
T Consensus 248 il~h~ 252 (328)
T cd05593 248 IMRHS 252 (328)
T ss_pred HhcCC
Confidence 99884
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=346.20 Aligned_cols=253 Identities=23% Similarity=0.340 Sum_probs=214.3
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
-.+|++.+.||.|.||.|-+|.. .++.||+|.++....... .++- .+.+||+||..|+||||+++|.+|...+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkde-qDlv----hIRREIeIMSsLNHPhII~IyEVFENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDE-QDLV----HIRREIEIMSSLNHPHIIQIYEVFENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccH-HHHH----HHHHHHHHHhhcCCCceeehhhhhcCCc
Confidence 35799999999999999999985 678899998654433322 2222 3489999999999999999999999777
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
.+ .|||||..+|.|++||.. ...+++.++..+++||+.|+.|+|.++++|||||.+|||+|
T Consensus 127 KI--------------vivMEYaS~GeLYDYiSe-----r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD 187 (668)
T KOG0611|consen 127 KI--------------VIVMEYASGGELYDYISE-----RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD 187 (668)
T ss_pred eE--------------EEEEEecCCccHHHHHHH-----hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec
Confidence 54 999999999999999987 47899999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+++ +||+|||++..+..... -.+++|++.|.+||++.+ ...-++.+|.|||||+||-|
T Consensus 188 ~N~N-------iKIADFGLSNly~~~kf-----------LqTFCGSPLYASPEIvNG---~PY~GPEVDsWsLGvLLYtL 246 (668)
T KOG0611|consen 188 QNNN-------IKIADFGLSNLYADKKF-----------LQTFCGSPLYASPEIVNG---TPYKGPEVDSWSLGVLLYTL 246 (668)
T ss_pred CCCC-------eeeeccchhhhhccccH-----------HHHhcCCcccCCccccCC---CCCCCCccchhhHHHHHHHH
Confidence 8854 99999999987755332 245689999999999987 23347899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
+.|..||.+.+...+..+|.++..-+-+ .+....-||..||..||.+|.|+
T Consensus 247 VyGtMPFDG~Dhk~lvrQIs~GaYrEP~-----------------------------~PSdA~gLIRwmLmVNP~RRATi 297 (668)
T KOG0611|consen 247 VYGTMPFDGRDHKRLVRQISRGAYREPE-----------------------------TPSDASGLIRWMLMVNPERRATI 297 (668)
T ss_pred hhcccccCCchHHHHHHHhhcccccCCC-----------------------------CCchHHHHHHHHHhcCcccchhH
Confidence 9999999999999999999888321111 12246779999999999999999
Q ss_pred HHHHHHHHh
Q 003185 822 GDLYEMFVA 830 (840)
Q Consensus 822 ~ELLehLe~ 830 (840)
.+|..|++-
T Consensus 298 eDiAsHWWv 306 (668)
T KOG0611|consen 298 EDIASHWWV 306 (668)
T ss_pred HHHhhhhee
Confidence 999999874
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.13 Aligned_cols=257 Identities=23% Similarity=0.362 Sum_probs=206.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
+..++|++.++||+|+||.||+|.. .+..+++|..... ....+ .+.+|+.++++++||||+++++.+...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-----~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-----TMSVQ----AFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-----chhHH----HHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 5678999999999999999999986 4566888874321 11223 348999999999999999999988755
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .++||||+++++|.+++... ....+++..++.++.||+.||+|||+.+++||||||+||++
T Consensus 74 ~~--------------~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili 136 (261)
T cd05072 74 EP--------------IYIITEYMAKGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV 136 (261)
T ss_pred CC--------------cEEEEecCCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe
Confidence 43 49999999999999999752 23468889999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.++|+|||++......... ......++..|+|||++.+ ..++.++|||||||++|+
T Consensus 137 ~~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~ 196 (261)
T cd05072 137 SES-------LMCKIADFGLARVIEDNEYT---------AREGAKFPIKWTAPEAINF----GSFTIKSDVWSFGILLYE 196 (261)
T ss_pred cCC-------CcEEECCCccceecCCCcee---------ccCCCccceecCCHHHhcc----CCCChhhhhhhhHHHHHH
Confidence 876 56999999999865432111 0112245678999999875 567889999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|+| |..||...........+......... ...+..+.+|+.+||..+|++||
T Consensus 197 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 249 (261)
T cd05072 197 IVTYGKIPYPGMSNSDVMSALQRGYRMPRM---------------------------ENCPDELYDIMKTCWKEKAEERP 249 (261)
T ss_pred HHccCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHccCCcccCc
Confidence 998 99999888777777766654322111 11245789999999999999999
Q ss_pred CHHHHHHHHHhh
Q 003185 820 TAGDLYEMFVAR 831 (840)
Q Consensus 820 Sa~ELLehLe~l 831 (840)
+++++++.|+.+
T Consensus 250 ~~~~i~~~l~~~ 261 (261)
T cd05072 250 TFDYLQSVLDDF 261 (261)
T ss_pred CHHHHHHHHhcC
Confidence 999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=345.86 Aligned_cols=254 Identities=25% Similarity=0.267 Sum_probs=196.4
Q ss_pred CceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEec
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 579 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~ 579 (840)
+|++.+.||+|+||.||+++. .+..+|+|++......... .....+.+|+.++..++ ||||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKA----KTVEHTRTERNVLEHVRQSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhh----hHHHHHHHHHHHHHhccCCCCcccEEEEEec
Confidence 589999999999999999875 4678999987532211111 12234488999999995 9999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 77 ~~~--------------~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil 137 (332)
T cd05614 77 EAK--------------LHLILDYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENIL 137 (332)
T ss_pred CCE--------------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeE
Confidence 553 4999999999999999975 356899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||+++........ ......||+.|||||++.+ ...++.++|||||||+||
T Consensus 138 i~~~-------~~~kl~DfG~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 198 (332)
T cd05614 138 LDSE-------GHVVLTDFGLSKEFLSEEKE---------RTYSFCGTIEYMAPEIIRG---KGGHGKAVDWWSLGILIF 198 (332)
T ss_pred ECCC-------CCEEEeeCcCCccccccCCC---------ccccccCCccccCHHHhcC---CCCCCCccccccchhhhh
Confidence 9877 45999999998764322111 1123469999999999975 234678999999999999
Q ss_pred HHHhCCCCCCCCC----HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 740 ELLTLQVPYMGLS----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 740 ELLTG~~PF~~~~----~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
||+||..||.... ...+...+.... +.++ ...+..+.+||.+||..||
T Consensus 199 elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~~li~~~l~~dp 250 (332)
T cd05614 199 ELLTGASPFTLEGERNTQSEVSRRILKCD-PPFP---------------------------SFIGPEAQDLLHKLLRKDP 250 (332)
T ss_pred hhhcCCCCCCCCCCCCCHHHHHHHHhcCC-CCCC---------------------------CCCCHHHHHHHHHHcCCCH
Confidence 9999999996432 222323222211 1111 1124578999999999999
Q ss_pred CCCC-----CHHHHHHHHH
Q 003185 816 TERP-----TAGDLYEMFV 829 (840)
Q Consensus 816 ~eRP-----Sa~ELLehLe 829 (840)
.+|| +++++++|.+
T Consensus 251 ~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 251 KKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred HHcCCCCCCCHHHHHcCCC
Confidence 9999 8889998853
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.38 Aligned_cols=265 Identities=20% Similarity=0.332 Sum_probs=203.1
Q ss_pred ceeeeeecccCceEEEEEEECCe----eEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKFGSA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~~----~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
|.+.+.||+|+||.||+|.+... .+|+|..... .......+.+ .+|+.+++.++||||+++++++.....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA--ICTRSEMEDF----LSEAVCMKEFDHPNVMRLIGVCLQTVE 74 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccC--cCCHHHHHHH----HHHHHHHHhCCCCCcceEEEEEccCCc
Confidence 45778999999999999987432 5777775433 2223333444 889999999999999999998764321
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHh-ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS-ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~-~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. ......++||||+.+|+|.+++.... ......+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 75 ~--------~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~ 146 (272)
T cd05075 75 S--------EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN 146 (272)
T ss_pred c--------cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc
Confidence 1 01224699999999999999885321 12234588999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||+++.+....... ......+++.|+|||++.. ..++.++|||||||++|||
T Consensus 147 ~~-------~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~----~~~~~~~Di~slG~il~el 207 (272)
T cd05075 147 EN-------MNVCVADFGLSKKIYNGDYYR--------QGRIAKMPVKWIAIESLAD----RVYTTKSDVWSFGVTMWEI 207 (272)
T ss_pred CC-------CCEEECCCCcccccCccccee--------cCCcccCCcccCCHHHccC----CCcChHHHHHHHHHHHHHH
Confidence 76 469999999998664322110 0122246778999999875 5678999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 742 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 742 LT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
++ |+.||.+....+....+..+..+..+. ..+..+.++|.+||+.||.+|||
T Consensus 208 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rps 260 (272)
T cd05075 208 ATRGQTPYPGVENSEIYDYLRQGNRLKQPP---------------------------DCLDGLYSLMSSCWLLNPKDRPS 260 (272)
T ss_pred HcCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCcccCcC
Confidence 99 899998887777777666553322111 12456899999999999999999
Q ss_pred HHHHHHHHHhh
Q 003185 821 AGDLYEMFVAR 831 (840)
Q Consensus 821 a~ELLehLe~l 831 (840)
+.+|+++|+.+
T Consensus 261 ~~~l~~~l~~~ 271 (272)
T cd05075 261 FETLRCELEKA 271 (272)
T ss_pred HHHHHHHHHhh
Confidence 99999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=353.23 Aligned_cols=264 Identities=22% Similarity=0.269 Sum_probs=201.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|.+.+.||+|+||.||+|.. .+..+|+|+...... .... ....+.+|+.++++++|||||++++++.....
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~----~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-FKKD----QLAHVKAERDVLAESDSPWVVSLYYSFQDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH-HHhH----HHHHHHHHHHHHHhCCCCCcceEEEEEEcCCe
Confidence 4789999999999999999987 677899998643211 1111 22345889999999999999999999986654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.||||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~ 136 (377)
T cd05629 76 --------------LYLIMEFLPGGDLMTMLIK-----YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDR 136 (377)
T ss_pred --------------eEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC
Confidence 4999999999999999975 356899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCccccccccccccc--------ccCC-----------------------------CCCCCccc
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCI--------AHRG-----------------------------IPAPDVCV 705 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~--------~~~~-----------------------------~~~~~~~v 705 (840)
+ +.+||+|||+++.+......... .... .......+
T Consensus 137 ~-------~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (377)
T cd05629 137 G-------GHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTV 209 (377)
T ss_pred C-------CCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccC
Confidence 6 46999999999643221100000 0000 00001246
Q ss_pred CCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCcchHHhhhccCcccccc
Q 003185 706 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVA 784 (840)
Q Consensus 706 GT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~ 784 (840)
||+.|+|||++.+ ..++.++|||||||+||||++|..||.+.+..+....+.... ...++.
T Consensus 210 gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------- 271 (377)
T cd05629 210 GTPDYIAPEIFLQ----QGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPD-------------- 271 (377)
T ss_pred CCccccCHHHHcc----CCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCC--------------
Confidence 9999999999975 568899999999999999999999998887777666665421 111110
Q ss_pred ccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC---CCHHHHHHHHH
Q 003185 785 QSGSGFEKPEAELETLSFLVDVFRRCTEENPTER---PTAGDLYEMFV 829 (840)
Q Consensus 785 ~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR---PSa~ELLehLe 829 (840)
....+..+.+||.+||. +|.+| +++.+++.|..
T Consensus 272 -----------~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~ 307 (377)
T cd05629 272 -----------DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPF 307 (377)
T ss_pred -----------CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCC
Confidence 01124578999999998 77765 59999999854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=326.85 Aligned_cols=257 Identities=22% Similarity=0.379 Sum_probs=206.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
+...+|.+.+.||+|+||.||+|.+ .+..+++|+.... ...... +.+|+.++++++||||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEE----FLKEAAVMKEIKHPNLVQLLGVCTR 73 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHH----HHHHHHHHHhCCCCChhheEEEEcC
Confidence 4556799999999999999999987 4677888875421 122233 3889999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .++||||+++++|.+++.. .....+++..++.++.|++.||+|||++||+||||||+|||
T Consensus 74 ~~~--------------~~lv~e~~~~~~L~~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil 136 (263)
T cd05052 74 EPP--------------FYIITEFMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 136 (263)
T ss_pred CCC--------------cEEEEEeCCCCcHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEE
Confidence 554 3999999999999999975 22346889999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|
T Consensus 137 ~~~~-------~~~kl~df~~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~ 196 (263)
T cd05052 137 VGEN-------HLVKVADFGLSRLMTGDTYT---------AHAGAKFPIKWTAPESLAY----NKFSIKSDVWAFGVLLW 196 (263)
T ss_pred EcCC-------CcEEeCCCccccccccceee---------ccCCCCCccccCCHHHhcc----CCCCchhHHHHHHHHHH
Confidence 9876 46999999999766432211 0111234678999999876 56788999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 740 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 740 ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
||++ |..||.+.+..+....+.....+..+ ...+..+.+|+.+||..||.+|
T Consensus 197 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~cl~~~p~~R 249 (263)
T cd05052 197 EIATYGMSPYPGIDLSQVYELLEKGYRMERP---------------------------EGCPPKVYELMRACWQWNPSDR 249 (263)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---------------------------CCCCHHHHHHHHHHccCCcccC
Confidence 9998 99999888777776666554332222 1124579999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 003185 819 PTAGDLYEMFVAR 831 (840)
Q Consensus 819 PSa~ELLehLe~l 831 (840)
|++.++++.|+.+
T Consensus 250 p~~~~l~~~l~~~ 262 (263)
T cd05052 250 PSFAEIHQAFETM 262 (263)
T ss_pred CCHHHHHHHHHhh
Confidence 9999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=345.82 Aligned_cols=245 Identities=25% Similarity=0.352 Sum_probs=196.7
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 588 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g 588 (840)
+.||+|+||.||++.. .+..+|+|+....... ..... ..+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~----~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~------ 69 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEV----AHTVTESRVLQNTRHPFLTALKYAFQTHDR------ 69 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHH----HHHHHHHHHHHhCCCCCCcceeeEEecCCE------
Confidence 4699999999999986 5778999987543211 11122 234789999999999999999999886553
Q ss_pred CCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCC
Q 003185 589 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 668 (840)
Q Consensus 589 ~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~ 668 (840)
.||||||+++|+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 --------~~lv~E~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~----- 131 (323)
T cd05595 70 --------LCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD----- 131 (323)
T ss_pred --------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC-----
Confidence 5999999999999998875 3568999999999999999999999999999999999999877
Q ss_pred CCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003185 669 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 748 (840)
Q Consensus 669 ~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF 748 (840)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||
T Consensus 132 --~~~kL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~ell~g~~Pf 195 (323)
T cd05595 132 --GHIKITDFGLCKEGISDGA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPF 195 (323)
T ss_pred --CCEEecccHHhccccCCCC----------ccccccCCcCcCCcccccC----CCCCchhchhhhHHHHHHHHhCCCCC
Confidence 4599999999875322111 1123469999999999975 56789999999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHH
Q 003185 749 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGD 823 (840)
Q Consensus 749 ~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP-----Sa~E 823 (840)
...+.......+..... .++ ...++.+.+||.+||..||.+|| ++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~-~~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (323)
T cd05595 196 YNQDHERLFELILMEEI-RFP---------------------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 247 (323)
T ss_pred CCCCHHHHHHHHhcCCC-CCC---------------------------CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHH
Confidence 88877766666543321 111 11245789999999999999998 8999
Q ss_pred HHHHH
Q 003185 824 LYEMF 828 (840)
Q Consensus 824 LLehL 828 (840)
+++|-
T Consensus 248 ~l~h~ 252 (323)
T cd05595 248 VMEHR 252 (323)
T ss_pred HHcCC
Confidence 99874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=361.43 Aligned_cols=267 Identities=24% Similarity=0.316 Sum_probs=211.7
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.-.+|++.+.||+|+||+||+|.+ .+..+|+|++.... ........ +.+|+.++..++|+||+++++.+...
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~--~~~~~~~~----~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG--MSEADKNR----AQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEeccc--CCHHHHHH----HHHHHHHHhcCCCCcEEEeecceecc
Confidence 447999999999999999999986 67899999975442 22333333 48899999999999999999877643
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
... ........++||||+++|+|.++|..... ....+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 104 ~~~------~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl 176 (496)
T PTZ00283 104 DPR------NPENVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL 176 (496)
T ss_pred ccc------CcccceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE
Confidence 211 11122346899999999999999975322 23568999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||+++.+...... .......||+.|+|||++.+ ..++.++|||||||+|||
T Consensus 177 ~~~-------~~vkL~DFGls~~~~~~~~~--------~~~~~~~Gt~~Y~aPE~~~~----~~~s~k~DVwSlGvilye 237 (496)
T PTZ00283 177 CSN-------GLVKLGDFGFSKMYAATVSD--------DVGRTFCGTPYYVAPEIWRR----KPYSKKADMFSLGVLLYE 237 (496)
T ss_pred eCC-------CCEEEEecccCeeccccccc--------cccccccCCcceeCHHHhCC----CCCCcHHHHHHHHHHHHH
Confidence 877 46999999999865432111 01233569999999999976 668999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|++|+.||.+.+..++...+..+....++. ..++.+.+|+.+||+.||.+||+
T Consensus 238 LltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~L~~dP~~RPs 290 (496)
T PTZ00283 238 LLTLKRPFDGENMEEVMHKTLAGRYDPLPP---------------------------SISPEMQEIVTALLSSDPKRRPS 290 (496)
T ss_pred HHHCCCCCCCCCHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHcccChhhCcC
Confidence 999999999888877777766554332221 12457899999999999999999
Q ss_pred HHHHHHHH
Q 003185 821 AGDLYEMF 828 (840)
Q Consensus 821 a~ELLehL 828 (840)
+.++++|.
T Consensus 291 ~~ell~~p 298 (496)
T PTZ00283 291 SSKLLNMP 298 (496)
T ss_pred HHHHHhCH
Confidence 99999873
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=332.53 Aligned_cols=281 Identities=21% Similarity=0.211 Sum_probs=200.1
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC---CCCCcceeeeEEecC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKISS 580 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L---~HpNIV~l~g~~~~~ 580 (840)
+|++.+.||+|+||.||+|.+ ++..+|+|+.......... . ..+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~--~----~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL--P----LSTVREVALLKRLEAFDHPNIVRLMDVCATS 74 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC--c----hHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence 589999999999999999987 5678999987543222111 1 1225677766665 699999999988643
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
... .....++||||+. ++|..++.. .....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 75 ~~~---------~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili 141 (288)
T cd07863 75 RTD---------RETKVTLVFEHVD-QDLRTYLDK---VPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV 141 (288)
T ss_pred cCC---------CCceEEEEEcccc-cCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 211 2235799999998 499998875 223458999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||++........ .....||..|+|||++.+ ..++.++|||||||++|+
T Consensus 142 ~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~~l~~ 199 (288)
T cd07863 142 TSG-------GQVKLADFGLARIYSCQMA-----------LTPVVVTLWYRAPEVLLQ----STYATPVDMWSVGCIFAE 199 (288)
T ss_pred CCC-------CCEEECccCccccccCccc-----------CCCccccccccCchHhhC----CCCCCcchhhhHHHHHHH
Confidence 877 4599999999976543211 122468999999999975 568899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|++|.+||.+....+....+...........+..........+.. .............+..+.+||.+||++||.+|||
T Consensus 200 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 278 (288)
T cd07863 200 MFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSP-RGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS 278 (288)
T ss_pred HHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCC-CCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC
Confidence 999999998877666555544321111111111000000000000 0000011122344667899999999999999999
Q ss_pred HHHHHHHH
Q 003185 821 AGDLYEMF 828 (840)
Q Consensus 821 a~ELLehL 828 (840)
+.+++.|.
T Consensus 279 ~~~~l~hp 286 (288)
T cd07863 279 AFRALQHP 286 (288)
T ss_pred HHHHhcCC
Confidence 99999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=325.83 Aligned_cols=251 Identities=25% Similarity=0.373 Sum_probs=201.4
Q ss_pred CCCceeeeeecccCceEEEEEEECC-eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
.++|++.+.||+|+||.||++.++. ..+|+|..... ... ... +.+|+.++++++||||+++++++.....
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~--~~~---~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG--AMS---EED----FIEEAKVMMKLSHPKLVQLYGVCTQQKP 73 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccC--Ccc---HHH----HHHHHHHHHHCCCCCceeEEEEEccCCC
Confidence 4678999999999999999999854 47888875321 111 123 3889999999999999999999876543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 74 --------------~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~ 135 (256)
T cd05114 74 --------------LYIVTEFMENGCLLNYLRQ----RQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS 135 (256)
T ss_pred --------------EEEEEEcCCCCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcC
Confidence 4999999999999999875 1235889999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||+++........ ......++..|+|||++.+ ..++.++||||||+++|||+
T Consensus 136 ~-------~~~kl~d~g~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~s~G~~l~el~ 195 (256)
T cd05114 136 T-------GVVKVSDFGMTRYVLDDEYT---------SSSGAKFPVKWSPPEVFNF----SKYSSKSDVWSFGVLMWEVF 195 (256)
T ss_pred C-------CeEEECCCCCccccCCCcee---------ccCCCCCchhhCChhhccc----CccchhhhhHHHHHHHHHHH
Confidence 6 56999999998765322111 0112235678999999875 56788999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 743 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 743 T-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
+ |+.||...+..+....+..+..+..+. ..+..+.+|+.+||..+|.+||++
T Consensus 196 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~~~li~~c~~~~p~~Rps~ 248 (256)
T cd05114 196 TEGKMPFEKKSNYEVVEMISRGFRLYRPK---------------------------LASMTVYEVMYSCWHEKPEGRPTF 248 (256)
T ss_pred cCCCCCCCCCCHHHHHHHHHCCCCCCCCC---------------------------CCCHHHHHHHHHHccCCcccCcCH
Confidence 9 999998888877777776654332221 013468999999999999999999
Q ss_pred HHHHHHH
Q 003185 822 GDLYEMF 828 (840)
Q Consensus 822 ~ELLehL 828 (840)
++|++.|
T Consensus 249 ~~l~~~l 255 (256)
T cd05114 249 AELLRAI 255 (256)
T ss_pred HHHHHhh
Confidence 9999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=360.03 Aligned_cols=255 Identities=26% Similarity=0.362 Sum_probs=204.6
Q ss_pred CCCceeeeeecccCceEEEEEEEC---CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~---~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
...|.+.+.||+|+||.||+|... +..+++|..... ...... .+.+|+.+|+.++|||||++++++...
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~----~~~~E~~~l~~l~Hpniv~~~~~~~~~ 137 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAA----YARSELHCLAACDHFGIVKHFDDFKSD 137 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHH----HHHHHHHHHHhCCCCCEeEEEEEEEEC
Confidence 445999999999999999999862 456777764322 122222 347899999999999999999999866
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .||||||+++|+|.+++..... ....+++..+..++.||+.||.|||++||+||||||+||||
T Consensus 138 ~~--------------~~lv~E~~~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll 202 (478)
T PTZ00267 138 DK--------------LLLIMEYGSGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL 202 (478)
T ss_pred CE--------------EEEEEECCCCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE
Confidence 53 5999999999999999875322 23468899999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||+++.+...... .......||+.|+|||++.+ ..++.++|||||||++||
T Consensus 203 ~~~-------~~~kL~DFgla~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~~l~e 263 (478)
T PTZ00267 203 MPT-------GIIKLGDFGFSKQYSDSVSL--------DVASSFCGTPYYLAPELWER----KRYSKKADMWSLGVILYE 263 (478)
T ss_pred CCC-------CcEEEEeCcCceecCCcccc--------ccccccCCCccccCHhHhCC----CCCCcHHhHHHHHHHHHH
Confidence 876 46999999999866432111 11233569999999999976 668999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|++|+.||.+.+..++...+..+..+.++. ..+..+.+||.+||..||.+||+
T Consensus 264 l~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~s~~~~~li~~~L~~dP~~Rps 316 (478)
T PTZ00267 264 LLTLHRPFKGPSQREIMQQVLYGKYDPFPC---------------------------PVSSGMKALLDPLLSKNPALRPT 316 (478)
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCCCc---------------------------cCCHHHHHHHHHHhccChhhCcC
Confidence 999999999888877777776554332221 12457899999999999999999
Q ss_pred HHHHHHH
Q 003185 821 AGDLYEM 827 (840)
Q Consensus 821 a~ELLeh 827 (840)
+.+++.+
T Consensus 317 ~~~~l~~ 323 (478)
T PTZ00267 317 TQQLLHT 323 (478)
T ss_pred HHHHHhC
Confidence 9999875
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=352.27 Aligned_cols=263 Identities=22% Similarity=0.294 Sum_probs=208.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++.+.||+|+||.||+|.. .+..+|+|+....... ..... ..+.+|+.+++.++||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~~~~e~~il~~~~h~~iv~~~~~~~~ 114 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDS----AFFWEERDIMAHANSEWIVQLHYAFQD 114 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhhH----HHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 4678999999999999999999987 5678999986432111 11111 234789999999999999999999886
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 115 ~~~--------------~~lv~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIL 174 (370)
T cd05596 115 DKY--------------LYMVMEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 174 (370)
T ss_pred CCE--------------EEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 553 5999999999999999875 35888999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++........ .......||+.|||||++.+......++.++|||||||+||
T Consensus 175 l~~~-------~~~kL~DfG~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvily 238 (370)
T cd05596 175 LDKS-------GHLKLADFGTCMKMDANGM---------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 238 (370)
T ss_pred EcCC-------CCEEEEeccceeeccCCCc---------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHH
Confidence 9877 4699999999976543211 11133569999999999976433345789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCC-CCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC-
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE- 817 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e- 817 (840)
||++|..||.+.+....+..+..... ..++. ....+..+.+||.+||..+|.+
T Consensus 239 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~~p~r~ 293 (370)
T cd05596 239 EMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD-------------------------DIEISKQAKDLICAFLTDREVRL 293 (370)
T ss_pred HHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCC-------------------------cCCCCHHHHHHHHHHccChhhcc
Confidence 99999999998887777766654321 11111 0123567899999999999988
Q ss_pred -CCCHHHHHHHHHh
Q 003185 818 -RPTAGDLYEMFVA 830 (840)
Q Consensus 818 -RPSa~ELLehLe~ 830 (840)
||+++++++|.+-
T Consensus 294 ~R~s~~ell~h~~~ 307 (370)
T cd05596 294 GRNGVDEIKSHPFF 307 (370)
T ss_pred CCCCHHHHhcCccc
Confidence 9999999998643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=345.21 Aligned_cols=283 Identities=17% Similarity=0.209 Sum_probs=207.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++.+.||+|+||.||+|.+ .+..+|+|++.... ....... .+.+|+.+++.++||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~----~~~~E~~~l~~l~h~~ii~~~~~~~~ 94 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAK----RAYRELVLMKCVNHKNIIGLLNVFTP 94 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc--cCchhHH----HHHHHHHHHHhcCCCCccccceeecc
Confidence 3468999999999999999999986 56778999864322 1222222 34889999999999999999998865
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.... ......|+||||++ ++|..++.. .+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 95 ~~~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIl 158 (364)
T cd07875 95 QKSL--------EEFQDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158 (364)
T ss_pred cccc--------cccCeEEEEEeCCC-CCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEE
Confidence 4322 12234699999997 488887753 4788999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||+||
T Consensus 159 l~~~-------~~~kL~DfG~a~~~~~~~~-----------~~~~~~t~~y~aPE~~~~----~~~~~~~DiwSlG~il~ 216 (364)
T cd07875 159 VKSD-------CTLKILDFGLARTAGTSFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMG 216 (364)
T ss_pred ECCC-------CcEEEEeCCCccccCCCCc-----------ccCCcccCCcCCHHHHhC----CCCCchhhHHhHHHHHH
Confidence 9877 4699999999976533211 123468999999999976 66889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccc------c---------ccccCCCCCCchhhhhhHHHHH
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH------E---------VAQSGSGFEKPEAELETLSFLV 804 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~------~---------~~~~~~~~~~~~~~~~~s~~L~ 804 (840)
+|++|+.||.+.+..+....+........++.+......... . +.+..... ...........+.
T Consensus 217 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 295 (364)
T cd07875 217 EMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPA-DSEHNKLKASQAR 295 (364)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccc-cccccccccHHHH
Confidence 999999999988877776666554332223222211100000 0 00000000 0011112345789
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHH
Q 003185 805 DVFRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 805 dLI~rCL~~DP~eRPSa~ELLehLe 829 (840)
+||.+||..||.+|||+.++++|..
T Consensus 296 dll~~mL~~dP~~R~t~~e~L~hp~ 320 (364)
T cd07875 296 DLLSKMLVIDASKRISVDEALQHPY 320 (364)
T ss_pred HHHHHhcCcCcccCCCHHHHhcCcc
Confidence 9999999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=348.31 Aligned_cols=264 Identities=24% Similarity=0.308 Sum_probs=206.5
Q ss_pred CCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|.+.+.||+|+||.||+|.+. +..+|+|++....... ... ...+.+|+.++..++||||+++++++.....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK-RNQ----IAHVRAERDILADADSPWIVKLYYSFQDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh-ccH----HHHHHHHHHHHHhcCCCCccchhhheecCCe
Confidence 47999999999999999999985 7889999975432111 111 2344889999999999999999999876553
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.|+||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||||+.
T Consensus 76 --------------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~ 136 (350)
T cd05573 76 --------------LYLVMEYMPGGDLMNLLIR-----KDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDA 136 (350)
T ss_pred --------------EEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC
Confidence 5999999999999999986 257899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCccccccccccccc-------------------ccCCCCCCCcccCCCcccchhhhhcccCCC
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCI-------------------AHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 723 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~-------------------~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~ 723 (840)
+ +.+||+|||++............ ............||+.|+|||++.+ .
T Consensus 137 ~-------~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~ 205 (350)
T cd05573 137 D-------GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG----T 205 (350)
T ss_pred C-------CCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcC----C
Confidence 7 45999999999866543200000 0000011234569999999999986 5
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCcchHHhhhccCccccccccCCCCCCchhhhhhHHH
Q 003185 724 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 802 (840)
Q Consensus 724 ~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 802 (840)
.++.++|||||||+||||++|+.||...+.......+.... ...++. ....++.
T Consensus 206 ~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------------------~~~~~~~ 260 (350)
T cd05573 206 PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPP-------------------------DPPVSPE 260 (350)
T ss_pred CCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCC-------------------------CCCCCHH
Confidence 78999999999999999999999998888776666665421 111110 0113567
Q ss_pred HHHHHHHhcccCCCCCCC-HHHHHHHHH
Q 003185 803 LVDVFRRCTEENPTERPT-AGDLYEMFV 829 (840)
Q Consensus 803 L~dLI~rCL~~DP~eRPS-a~ELLehLe 829 (840)
+.+||.+||. ||.+||+ +.++++|..
T Consensus 261 ~~~li~~ll~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 261 AIDLICRLLC-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred HHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence 8999999998 9999999 999999854
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=324.76 Aligned_cols=253 Identities=25% Similarity=0.387 Sum_probs=205.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
..+.+|++.+.||+|+||.||++...+..+++|..... ...+ .+.+|+.++++++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~------~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND------ATAQ----AFLAEASVMTQLRHSNLVQLLGVIVEEK 72 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCC------chHH----HHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence 45678999999999999999999999999999986422 1122 3488999999999999999999865432
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. ..++||||+++++|.+++.. .....+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 73 ~-------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~ 136 (256)
T cd05082 73 G-------------GLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS 136 (256)
T ss_pred C-------------ceEEEEECCCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc
Confidence 1 25999999999999999975 2234588999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||++....... ....++..|+|||++.. ..++.++|||||||++|+|
T Consensus 137 ~~-------~~~kl~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~i~~~l 192 (256)
T cd05082 137 ED-------NVAKVSDFGLTKEASSTQ-------------DTGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEI 192 (256)
T ss_pred CC-------CcEEecCCccceeccccC-------------CCCccceeecCHHHHcc----CCCCchhhhHHHHHHHHHH
Confidence 77 469999999987543211 11234678999999875 5678899999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 742 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 742 LT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
++ |..||......++...+.+...+..++ ..+..+.+|+.+||..+|.+|||
T Consensus 193 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rpt 245 (256)
T cd05082 193 YSFGRVPYPRIPLKDVVPRVEKGYKMDAPD---------------------------GCPPVVYDVMKQCWHLDAATRPS 245 (256)
T ss_pred HhCCCCCCCCCCHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHhcCChhhCcC
Confidence 97 999998877777776665543322221 12457899999999999999999
Q ss_pred HHHHHHHHHhh
Q 003185 821 AGDLYEMFVAR 831 (840)
Q Consensus 821 a~ELLehLe~l 831 (840)
+.+++++|+.+
T Consensus 246 ~~~l~~~l~~~ 256 (256)
T cd05082 246 FLQLREQLEHI 256 (256)
T ss_pred HHHHHHHHhcC
Confidence 99999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=342.89 Aligned_cols=248 Identities=27% Similarity=0.365 Sum_probs=197.3
Q ss_pred ceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHH---HhCCCCCcceeeeEEecCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRML---GALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL---~~L~HpNIV~l~g~~~~~~ 581 (840)
|++.+.||+|+||.||+|.+ .+..+|+|+....... ..... +.+.+|+.++ +.++||||+++++++....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-ARDEV----ESLMCEKRIFETANSERHPFLVNLFACFQTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHH----HHHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence 68899999999999999987 5678999997533211 11122 2336666554 5667999999999988655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
..|+||||+++++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 76 --------------~~~lv~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~ 135 (324)
T cd05589 76 --------------HVCFVMEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD 135 (324)
T ss_pred --------------EEEEEEcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC
Confidence 35999999999999988864 4689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||+++....... ......||+.|||||++.+ ..++.++|||||||++|||
T Consensus 136 ~~-------~~~kL~Dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~il~el 194 (324)
T cd05589 136 TE-------GFVKIADFGLCKEGMGFGD----------RTSTFCGTPEFLAPEVLTE----TSYTRAVDWWGLGVLIYEM 194 (324)
T ss_pred CC-------CcEEeCcccCCccCCCCCC----------cccccccCccccCHhHhcC----CCCCcccchhhHHHHHHHH
Confidence 77 4699999999864322111 1123569999999999976 5678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC--
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-- 819 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP-- 819 (840)
++|+.||.+.+..++...+...... ++. ..+..+.+||.+||..||.+||
T Consensus 195 ~~G~~pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 195 LVGESPFPGDDEEEVFDSIVNDEVR-YPR---------------------------FLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCC-CCC---------------------------CCCHHHHHHHHHHhhcCHhHcCCC
Confidence 9999999988887777766554221 111 1245789999999999999999
Q ss_pred ---CHHHHHHHH
Q 003185 820 ---TAGDLYEMF 828 (840)
Q Consensus 820 ---Sa~ELLehL 828 (840)
++.++++|.
T Consensus 247 ~~~~~~~l~~~~ 258 (324)
T cd05589 247 GEKDAEDVKKQP 258 (324)
T ss_pred CCCCHHHHhhCC
Confidence 688998874
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=349.32 Aligned_cols=263 Identities=24% Similarity=0.371 Sum_probs=201.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCccee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 573 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l 573 (840)
.+.++|++.+.||+|+||.||+|.+ .+..+|+|+..... ..... +.+.+|+.+|..+ +|||||++
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~----~~~~~Ei~il~~l~~HpnIv~l 104 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTER----EALMSELKVLSYLGNHINIVNL 104 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHH----HHHHHHHHHHHHhcCCcceeee
Confidence 4566899999999999999999974 34578898854221 11222 2348999999999 79999999
Q ss_pred eeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----------------------------------
Q 003185 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE----------------------------------- 618 (840)
Q Consensus 574 ~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~----------------------------------- 618 (840)
++++..... .++||||+++|+|.+++.....
T Consensus 105 ~~~~~~~~~--------------~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 170 (375)
T cd05104 105 LGACTVGGP--------------TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMD 170 (375)
T ss_pred eeeeccCCc--------------ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhh
Confidence 999876654 3999999999999999975210
Q ss_pred -----------------------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 619 -----------------------------------TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 619 -----------------------------------~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.....+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~ 250 (375)
T cd05104 171 MKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG 250 (375)
T ss_pred cCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECC
Confidence 011257888999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
..+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|||++
T Consensus 251 -------~~~kl~DfG~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~sDi~slG~~l~ellt 311 (375)
T cd05104 251 -------RITKICDFGLARDIRNDSNY--------VVKGNARLPVKWMAPESIFN----CVYTFESDVWSYGILLWEIFS 311 (375)
T ss_pred -------CcEEEecCccceeccCcccc--------cccCCCCCCcceeChhHhcC----CCCCCCCCHHHHHHHHHHHHh
Confidence 46999999999765432211 00112335678999999976 678899999999999999998
Q ss_pred -CCCCCCCCCHH-HHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 744 -LQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 744 -G~~PF~~~~~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
|..||...... .....+..+.++..+. ..+.++.+||.+||+.||.+||++
T Consensus 312 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~RPs~ 364 (375)
T cd05104 312 LGSSPYPGMPVDSKFYKMIKEGYRMLSPE---------------------------CAPSEMYDIMKSCWDADPLKRPTF 364 (375)
T ss_pred cCCCCCCCCCchHHHHHHHHhCccCCCCC---------------------------CCCHHHHHHHHHHccCChhHCcCH
Confidence 89999776533 3344443333221110 124478999999999999999999
Q ss_pred HHHHHHHHhh
Q 003185 822 GDLYEMFVAR 831 (840)
Q Consensus 822 ~ELLehLe~l 831 (840)
.+|++.|+..
T Consensus 365 ~eil~~l~~~ 374 (375)
T cd05104 365 KQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHhh
Confidence 9999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=344.83 Aligned_cols=285 Identities=18% Similarity=0.218 Sum_probs=204.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++.+.||+|+||.||+|.+ .+..+|+|++.... ....... .+.+|+.+++.++||||+++++++..
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF--QNQTHAK----RAYRELVLLKCVNHKNIISLLNVFTP 91 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc--cchhHHH----HHHHHHHHHHhCCCCCEeeeeeeecc
Confidence 3568999999999999999999987 56789999864332 1222222 34889999999999999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.... ......|+||||+.+ +|.+.+.. .++...+..++.||+.||.|||++||+||||||+|||
T Consensus 92 ~~~~--------~~~~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl 155 (359)
T cd07876 92 QKSL--------EEFQDVYLVMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 155 (359)
T ss_pred CCCc--------cccceeEEEEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence 4422 112346999999975 77777643 4788999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 156 ~~~~-------~~~kl~Dfg~a~~~~~~~~-----------~~~~~~t~~y~aPE~~~~----~~~~~~~DiwSlG~il~ 213 (359)
T cd07876 156 VKSD-------CTLKILDFGLARTACTNFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMG 213 (359)
T ss_pred ECCC-------CCEEEecCCCccccccCcc-----------CCCCcccCCCCCchhccC----CCCCcchhhHHHHHHHH
Confidence 9877 4699999999975432111 122468999999999976 56889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhc-------c----CccccccccCCCCC---CchhhhhhHHHHHH
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG-------S----CHEHEVAQSGSGFE---KPEAELETLSFLVD 805 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~-------~----~~~~~~~~~~~~~~---~~~~~~~~s~~L~d 805 (840)
+|++|+.||.+.+.......+...........+.... . .....+......+. ........+..+.+
T Consensus 214 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (359)
T cd07876 214 ELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARD 293 (359)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHH
Confidence 9999999998877655444443321111111111000 0 00000000000000 00111123467899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHh
Q 003185 806 VFRRCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 806 LI~rCL~~DP~eRPSa~ELLehLe~ 830 (840)
||.+||..||.+|||+.|+++|.+-
T Consensus 294 li~~mL~~dP~~R~t~~e~l~hp~~ 318 (359)
T cd07876 294 LLSKMLVIDPDKRISVDEALRHPYI 318 (359)
T ss_pred HHHHHhccCcccCCCHHHHhcCchh
Confidence 9999999999999999999999653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=331.80 Aligned_cols=268 Identities=24% Similarity=0.348 Sum_probs=228.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~ 578 (840)
..+..|.-.+.||.|..++|-++.. ++..+|+|++.........+...++.+...+|+.||+++. ||||+++.++|.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 4567888999999999999999876 6678888887665555555556677777799999999995 999999999999
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
.+..+ ++|+|.|+.|-|.++|.. ...++++...+|++|+..|+.|||.++||||||||+||
T Consensus 94 s~sF~--------------FlVFdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENI 154 (411)
T KOG0599|consen 94 SDAFV--------------FLVFDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENI 154 (411)
T ss_pred Ccchh--------------hhhhhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhhe
Confidence 88766 999999999999999986 46799999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc--CCCCCCchhhHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGC 736 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~--~~~~~s~kSDVWSLGv 736 (840)
|++.+ ..+||+|||+|..+...... ...+|||+|+|||.+.+.. ....|+..+|+||+||
T Consensus 155 Llddn-------~~i~isDFGFa~~l~~GekL-----------relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GV 216 (411)
T KOG0599|consen 155 LLDDN-------MNIKISDFGFACQLEPGEKL-----------RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGV 216 (411)
T ss_pred eeccc-------cceEEeccceeeccCCchhH-----------HHhcCCCcccChhheeeecccCCCCccchhhHHHHHH
Confidence 99988 45999999999887653322 3457999999999997643 3356889999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 737 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 737 IL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
|||.|+.|.+||......-++..|+.+....-...| .+.+...++||.+||+.||.
T Consensus 217 ImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW------------------------adis~~~KdLIsrlLqVdp~ 272 (411)
T KOG0599|consen 217 IMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW------------------------ADISATVKDLISRLLQVDPT 272 (411)
T ss_pred HHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch------------------------hhccccHHHHHHHHHeeCch
Confidence 999999999999988888888999888664433333 33466889999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 003185 817 ERPTAGDLYEMFVA 830 (840)
Q Consensus 817 eRPSa~ELLehLe~ 830 (840)
+|.|++|+|.|..-
T Consensus 273 ~Ritake~LaHpff 286 (411)
T KOG0599|consen 273 KRITAKEALAHPFF 286 (411)
T ss_pred hcccHHHHhcChHH
Confidence 99999999999765
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=330.94 Aligned_cols=265 Identities=23% Similarity=0.344 Sum_probs=208.7
Q ss_pred CCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 575 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g 575 (840)
...+|.+.+.||+|+||.||++.. .+..+++|... .. ...... .+.+|+.++++++||||+++++
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~--~~--~~~~~~----~~~~e~~~l~~l~h~~i~~~~~ 74 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLK--DA--SDNARK----DFHREAELLTNLQHEHIVKFYG 74 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecC--Cc--CHHHHH----HHHHHHHHHHhCCCCCcceEEE
Confidence 456899999999999999999975 12346666543 21 122222 3489999999999999999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc--------cCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE--------TGEKHVSVKLALFIAQDVAAALVELHSKH 647 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~--------~~~~~ls~~~~~~Ia~QIa~AL~yLHs~g 647 (840)
++..... .++||||+++++|.+++..... .....+++..++.++.||+.||+|||++|
T Consensus 75 ~~~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~ 140 (288)
T cd05093 75 VCVEGDP--------------LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH 140 (288)
T ss_pred EEecCCc--------------cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9886554 4999999999999999975321 11235899999999999999999999999
Q ss_pred eecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCc
Q 003185 648 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 727 (840)
Q Consensus 648 IVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~ 727 (840)
|+||||||+|||++.+ +.+||+|||++.......... ......++..|+|||++.+ ..++.
T Consensus 141 i~H~dlkp~Nili~~~-------~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~ 201 (288)
T cd05093 141 FVHRDLATRNCLVGEN-------LLVKIGDFGMSRDVYSTDYYR--------VGGHTMLPIRWMPPESIMY----RKFTT 201 (288)
T ss_pred eeecccCcceEEEccC-------CcEEeccCCccccccCCceee--------cCCCCCccccccCHHHhcc----CCCCc
Confidence 9999999999999876 469999999997653321110 0122346788999999975 56789
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHH
Q 003185 728 EVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 806 (840)
Q Consensus 728 kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dL 806 (840)
++|||||||++|+|++ |..||...........+..+..+..+. ..+..+.+|
T Consensus 202 ~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~l 254 (288)
T cd05093 202 ESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPR---------------------------TCPKEVYDL 254 (288)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHHHHH
Confidence 9999999999999998 999998888777777776654322221 124478999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 003185 807 FRRCTEENPTERPTAGDLYEMFVARTSSS 835 (840)
Q Consensus 807 I~rCL~~DP~eRPSa~ELLehLe~l~~~~ 835 (840)
+.+||+.||.+|||+.++++.|+.+...+
T Consensus 255 i~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 255 MLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred HHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 99999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=350.18 Aligned_cols=264 Identities=23% Similarity=0.270 Sum_probs=199.6
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
.|++++.||+|+||+||+|.+ .+..+|+|++...... .... ...+.+|+.+++.++||||+++++++.....
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~----~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~- 75 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-NRNQ----VAHVKAERDILAEADNEWVVKLYYSFQDKDN- 75 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHH----HHHHHHHHHHHHhcCCCCeeeeEEEEecCCE-
Confidence 589999999999999999987 5678999987543211 1112 2345899999999999999999999986553
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.|+||||++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||||+.+
T Consensus 76 -------------~~lv~E~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~ 137 (381)
T cd05626 76 -------------LYFVMDYIPGGDMMSLLIR-----MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD 137 (381)
T ss_pred -------------EEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCC
Confidence 5999999999999999976 3568899999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCccccccccccccc-------------------------------------ccCCCCCCCcccC
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCI-------------------------------------AHRGIPAPDVCVG 706 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~vG 706 (840)
+.+||+|||++..+......... ...........+|
T Consensus 138 -------~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 210 (381)
T cd05626 138 -------GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVG 210 (381)
T ss_pred -------CCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccC
Confidence 46999999998644211100000 0000001123579
Q ss_pred CCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCcchHHhhhccCccccccc
Q 003185 707 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQ 785 (840)
Q Consensus 707 T~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~ 785 (840)
|+.|+|||++.+ ..++.++|||||||+||||++|..||...+..+....+... ....++.
T Consensus 211 t~~Y~aPE~~~~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------------- 271 (381)
T cd05626 211 TPNYIAPEVLLR----KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPP--------------- 271 (381)
T ss_pred CccccCHHHHcC----CCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCC---------------
Confidence 999999999975 56789999999999999999999999887766655554432 1111110
Q ss_pred cCCCCCCchhhhhhHHHHHHHHHHhc--ccCCCCCCCHHHHHHHHH
Q 003185 786 SGSGFEKPEAELETLSFLVDVFRRCT--EENPTERPTAGDLYEMFV 829 (840)
Q Consensus 786 ~~~~~~~~~~~~~~s~~L~dLI~rCL--~~DP~eRPSa~ELLehLe 829 (840)
....+.++.+||.+|+ ..+|..||++.+|++|..
T Consensus 272 ----------~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~ 307 (381)
T cd05626 272 ----------QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307 (381)
T ss_pred ----------CCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcc
Confidence 0113457889999855 555666999999999954
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=370.28 Aligned_cols=269 Identities=25% Similarity=0.364 Sum_probs=221.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 574 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~ 574 (840)
++..+..+.+.||+|+||.||+|.. ...-||||. ++... ... .++.|.||+++|..|+|||||+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~--LKd~a-~~~----~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKA--LKDKA-ENQ----ARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhh--hcccc-cHH----HHHHHHHHHHHHHhccCCCeEEEE
Confidence 4556778899999999999999985 234556655 54321 122 234559999999999999999999
Q ss_pred eEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHHh
Q 003185 575 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG---------EKHVSVKLALFIAQDVAAALVELHS 645 (840)
Q Consensus 575 g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~---------~~~ls~~~~~~Ia~QIa~AL~yLHs 645 (840)
|+|...+.+ ++|+|||..|+|.+||....... ...++..+.+.|+.|||.||.||-+
T Consensus 556 GVC~~~~P~--------------~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~ 621 (774)
T KOG1026|consen 556 GVCREGDPL--------------CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS 621 (774)
T ss_pred EEEccCCee--------------EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999987755 99999999999999998643321 2338899999999999999999999
Q ss_pred CCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCC
Q 003185 646 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 725 (840)
Q Consensus 646 ~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~ 725 (840)
+.+|||||-..|+||..+ .+|||+|||+++.+-....... . ....-.++|||||.++. +.|
T Consensus 622 ~~FVHRDLATRNCLVge~-------l~VKIsDfGLsRdiYssDYYk~---~-----~~t~lPIRWMppEsIly----~kF 682 (774)
T KOG1026|consen 622 HHFVHRDLATRNCLVGEN-------LVVKISDFGLSRDIYSSDYYKV---R-----GNTLLPIRWMPPESILY----GKF 682 (774)
T ss_pred Ccccccchhhhhceeccc-------eEEEecccccchhhhhhhhhcc---c-----CCceeeeecCCHHHhhc----Ccc
Confidence 999999999999999987 7899999999997755443311 0 01123579999999997 889
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHH
Q 003185 726 GLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 804 (840)
Q Consensus 726 s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~ 804 (840)
+.+||||||||+|||+++ |.+||.+.+..++++.|.++....-+ ..++..++
T Consensus 683 TteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL~~P---------------------------e~CP~~vY 735 (774)
T KOG1026|consen 683 TTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLLSCP---------------------------ENCPTEVY 735 (774)
T ss_pred cchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcccCC---------------------------CCCCHHHH
Confidence 999999999999999998 99999999999999999988653333 23577899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhcCCCCC
Q 003185 805 DVFRRCTEENPTERPTAGDLYEMFVARTSSSIS 837 (840)
Q Consensus 805 dLI~rCL~~DP~eRPSa~ELLehLe~l~~~~~s 837 (840)
+||..||+.+|.+||++.||-..|+...+.++.
T Consensus 736 ~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 736 SLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred HHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 999999999999999999999999998877654
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=330.05 Aligned_cols=251 Identities=29% Similarity=0.486 Sum_probs=197.7
Q ss_pred eeeeeecccCceEEEEEEEC------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 508 SSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 508 ~i~~~LG~G~fG~Vy~a~~~------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
.+.+.||.|+||.||+|.+. +..|+||+... .......+.+ .+|+.++++++||||++++|++....
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~---~~~~~~~~~~----~~e~~~l~~l~h~ni~~~~g~~~~~~ 74 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP---SSSEEEEEEF----LNEIQILRKLRHPNIVKLYGFCIENE 74 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST---TSSHHHHHHH----HHHHHHHHTHSBTTBE-EEEEEESSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc---ccccccceee----eecccccccccccccccccccccccc
Confidence 57889999999999999987 67888888632 2223334444 89999999999999999999998544
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .++||||+++|+|.++|... ....+++..++.|+.||+.||.|||+++|+|++|++.|||++
T Consensus 75 ~--------------~~lv~e~~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~ 137 (259)
T PF07714_consen 75 P--------------LFLVMEYCPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD 137 (259)
T ss_dssp S--------------EEEEEE--TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE
T ss_pred c--------------cccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccc
Confidence 2 49999999999999999872 235789999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||++........... .....+...|+|||.+.. ..++.++||||||+++|||
T Consensus 138 ~~-------~~~Kl~~f~~~~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~----~~~~~ksDVysfG~~l~ei 198 (259)
T PF07714_consen 138 SN-------GQVKLSDFGLSRPISEKSKYKN--------DSSQQLPLRYLAPEVLKD----GEYTKKSDVYSFGMLLYEI 198 (259)
T ss_dssp TT-------TEEEEESTTTGEETTTSSSEEE--------STTSESGGGGS-HHHHHH----SEESHHHHHHHHHHHHHHH
T ss_pred cc-------cccccccccccccccccccccc--------cccccccccccccccccc----ccccccccccccccccccc
Confidence 87 5699999999987632211100 122346789999999987 5589999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 742 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 742 LT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
++ |+.||...+..++...+..+.++..+.. .+..+.+||.+||..||.+|||
T Consensus 199 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~li~~C~~~~p~~RPs 251 (259)
T PF07714_consen 199 LTLGKFPFSDYDNEEIIEKLKQGQRLPIPDN---------------------------CPKDIYSLIQQCWSHDPEKRPS 251 (259)
T ss_dssp HTTSSGTTTTSCHHHHHHHHHTTEETTSBTT---------------------------SBHHHHHHHHHHT-SSGGGS--
T ss_pred cccccccccccccccccccccccccceeccc---------------------------hhHHHHHHHHHHcCCChhhCcC
Confidence 99 7899999888888888866654433321 2457899999999999999999
Q ss_pred HHHHHHHH
Q 003185 821 AGDLYEMF 828 (840)
Q Consensus 821 a~ELLehL 828 (840)
+.+|++.|
T Consensus 252 ~~~i~~~L 259 (259)
T PF07714_consen 252 FQEILQEL 259 (259)
T ss_dssp HHHHHHHH
T ss_pred HHHHHhcC
Confidence 99999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=335.77 Aligned_cols=261 Identities=19% Similarity=0.307 Sum_probs=204.4
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCe----eEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeE
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 576 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~----~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~ 576 (840)
...+|++.+.||+|+||.||+|.+ .+. .+|+|+.... ...... +.+.+|+.+++.++||||++++|+
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~----~~~~~e~~~l~~l~h~niv~~~g~ 77 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKAN----KEILDEAYVMASVDNPHVCRLLGI 77 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc---CCHHHH----HHHHHHHHHHHhCCCCCCCeEEEE
Confidence 456799999999999999999986 233 3788875321 112222 334889999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
+.... .++|+||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+
T Consensus 78 ~~~~~---------------~~~v~e~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~ 138 (316)
T cd05108 78 CLTST---------------VQLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAAR 138 (316)
T ss_pred EcCCC---------------ceeeeecCCCCCHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchh
Confidence 87532 3899999999999999975 2345888999999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
|||++.+ +.+||+|||+++......... ......++..|+|||++.. ..++.++|||||||
T Consensus 139 Nill~~~-------~~~kl~DfG~a~~~~~~~~~~--------~~~~~~~~~~y~apE~~~~----~~~~~~~Di~slGv 199 (316)
T cd05108 139 NVLVKTP-------QHVKITDFGLAKLLGADEKEY--------HAEGGKVPIKWMALESILH----RIYTHQSDVWSYGV 199 (316)
T ss_pred heEecCC-------CcEEEccccccccccCCCcce--------eccCCccceeecChHHhcc----CCCCchhhhHHHHH
Confidence 9999876 459999999998764322110 0111234678999999975 66889999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 737 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 737 IL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
++|||++ |..||.+....++...+.....+..+. .++..+.+++.+||..+|
T Consensus 200 ~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~cl~~~p 252 (316)
T cd05108 200 TVWELMTFGSKPYDGIPASEISSILEKGERLPQPP---------------------------ICTIDVYMIMVKCWMIDA 252 (316)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCC---------------------------CCCHHHHHHHHHHccCCh
Confidence 9999998 999998887776655554443322111 123468899999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCC
Q 003185 816 TERPTAGDLYEMFVARTSSS 835 (840)
Q Consensus 816 ~eRPSa~ELLehLe~l~~~~ 835 (840)
.+||++.+++.+|..+....
T Consensus 253 ~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 253 DSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred hhCcCHHHHHHHHHHHHcCC
Confidence 99999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=324.11 Aligned_cols=248 Identities=22% Similarity=0.333 Sum_probs=198.2
Q ss_pred eecccCceEEEEEEE----CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCC
Q 003185 512 EAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 587 (840)
Q Consensus 512 ~LG~G~fG~Vy~a~~----~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~ 587 (840)
+||+|+||.||+|.+ .+..+|+|+.... ...... .+.+.+|+.+++.+.||||+++++++....
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~--~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 69 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND--NNDPAL----KDELLREANVMQQLDNPYIVRMIGICEAES------ 69 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCC--CCcHHH----HHHHHHHHHHHHhCCCCCcceEEEEEcCCC------
Confidence 689999999999975 4678899985432 222222 234489999999999999999999875332
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccC
Q 003185 588 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667 (840)
Q Consensus 588 g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~ 667 (840)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||.|||++.+
T Consensus 70 ---------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~---- 131 (257)
T cd05116 70 ---------WMLVMELAELGPLNKFLQK-----NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ---- 131 (257)
T ss_pred ---------cEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC----
Confidence 3899999999999999975 3468999999999999999999999999999999999999876
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCC
Q 003185 668 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQV 746 (840)
Q Consensus 668 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT-G~~ 746 (840)
+.+||+|||++........... ......++..|+|||.+.. ..++.++|||||||++|||++ |..
T Consensus 132 ---~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~t~g~~ 197 (257)
T cd05116 132 ---HYAKISDFGLSKALGADENYYK-------AKTHGKWPVKWYAPECMNY----YKFSSKSDVWSFGVLMWEAFSYGQK 197 (257)
T ss_pred ---CeEEECCCccccccCCCCCeee-------ecCCCCCCccccCHhHhcc----CCcCchhHHHHHHHHHHHHHhCCCC
Confidence 5699999999986643221100 0111234679999999865 567889999999999999998 999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003185 747 PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826 (840)
Q Consensus 747 PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLe 826 (840)
||......++...+.++..+.++. ..+..+.+||.+||+.||.+||++++|.+
T Consensus 198 p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 198 PYKGMKGNEVTQMIESGERMECPQ---------------------------RCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred CCCCCCHHHHHHHHHCCCCCCCCC---------------------------CCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 998888877777777654433331 12457899999999999999999999999
Q ss_pred HHHh
Q 003185 827 MFVA 830 (840)
Q Consensus 827 hLe~ 830 (840)
.|+.
T Consensus 251 ~l~~ 254 (257)
T cd05116 251 RLRN 254 (257)
T ss_pred HHhc
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=328.75 Aligned_cols=262 Identities=21% Similarity=0.342 Sum_probs=205.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 575 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g 575 (840)
.++.+|++.+.||+|+||.||+|.+ .+..+++|..... ....... .+.+|+.++++++||||+++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~----~~~~E~~~l~~l~h~niv~~~~ 74 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI---NNPQQWG----EFQQEASLMAELHHPNIVCLLG 74 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC---CCHHHHH----HHHHHHHHHhhCCCCCeeeEEE
Confidence 4578899999999999999999985 3356777765321 1222223 3488999999999999999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc------------cCCCCCCHHHHHHHHHHHHHHHHHH
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE------------TGEKHVSVKLALFIAQDVAAALVEL 643 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~------------~~~~~ls~~~~~~Ia~QIa~AL~yL 643 (840)
++..... .|+||||+++++|.+++..... .....+++..+..++.||+.||.||
T Consensus 75 ~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 140 (283)
T cd05090 75 VVTQEQP--------------VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL 140 (283)
T ss_pred EEecCCc--------------eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 9876554 4999999999999999864211 0123578889999999999999999
Q ss_pred HhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCC
Q 003185 644 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 723 (840)
Q Consensus 644 Hs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~ 723 (840)
|++||+||||||+|||++.+ ..+||+|||+++........ .......++..|+|||++.+ .
T Consensus 141 H~~~i~H~dlkp~nili~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~ 201 (283)
T cd05090 141 SSHFFVHKDLAARNILIGEQ-------LHVKISDLGLSREIYSADYY--------RVQPKSLLPIRWMPPEAIMY----G 201 (283)
T ss_pred HhcCeehhccccceEEEcCC-------CcEEeccccccccccCCcce--------ecccCCCccceecChHHhcc----C
Confidence 99999999999999999876 45999999999765432111 01122346778999999875 5
Q ss_pred CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHH
Q 003185 724 LYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 802 (840)
Q Consensus 724 ~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 802 (840)
.++.++|||||||+||||++ |..||.+.....+...+.....+..+. ..+..
T Consensus 202 ~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 254 (283)
T cd05090 202 KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSE---------------------------DCPPR 254 (283)
T ss_pred CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCC---------------------------CCCHH
Confidence 67899999999999999998 999998887777766665543322221 12457
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003185 803 LVDVFRRCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 803 L~dLI~rCL~~DP~eRPSa~ELLehLe~ 830 (840)
+.+++.+||+.||.+||++.+|+++|.+
T Consensus 255 ~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 255 MYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 8999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=324.87 Aligned_cols=265 Identities=22% Similarity=0.364 Sum_probs=206.3
Q ss_pred ceeeeeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
|.+.+.||+|+||.||+|... ...+|+|+.... .........+ .+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD--IHTYSEIEEF----LSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccC--cCCHHHHHHH----HHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 578899999999999999863 256889886533 2222333344 89999999999999999999887544
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. ......++||||+++++|..++..... .....+++..++.++.||+.||.|||+++|+||||||+||++
T Consensus 75 ~~--------~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~ 146 (273)
T cd05035 75 SL--------QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML 146 (273)
T ss_pred cc--------ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE
Confidence 21 112346999999999999999865321 223468999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||+++......... ......++..|+|||.+.. ..++.++|||||||++||
T Consensus 147 ~~~-------~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~SlG~il~e 207 (273)
T cd05035 147 RED-------MTVCVADFGLSKKIYSGDYYR--------QGRIAKMPVKWIAIESLAD----RVYTSKSDVWAFGVTMWE 207 (273)
T ss_pred CCC-------CeEEECCccceeecccccccc--------ccccccCCccccCHhhccc----CCCCcccchHHHHHHHHH
Confidence 876 469999999998654322110 0111235678999999865 567899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|++ |..||.+....++...+..+..+..+. ..+..+.+++.+||+.||.+||
T Consensus 208 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp 260 (273)
T cd05035 208 IATRGQTPYPGVENHEIYDYLRHGNRLKQPE---------------------------DCLDELYDLMYSCWRADPKDRP 260 (273)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------CCCHHHHHHHHHHcCCChhhCc
Confidence 999 999998888777777766554332221 1245789999999999999999
Q ss_pred CHHHHHHHHHhh
Q 003185 820 TAGDLYEMFVAR 831 (840)
Q Consensus 820 Sa~ELLehLe~l 831 (840)
++.+++++|+.+
T Consensus 261 ~~~e~~~~l~~~ 272 (273)
T cd05035 261 TFTKLREVLENI 272 (273)
T ss_pred CHHHHHHHHHhh
Confidence 999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=360.09 Aligned_cols=254 Identities=28% Similarity=0.367 Sum_probs=213.1
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEE
Q 003185 501 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHK 577 (840)
Q Consensus 501 p~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~ 577 (840)
+..+++|.++++||+|+||.|+++.. ++..+|+|+.+..... ..++++.. +.|.+|+.... ||.++.++..|
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il-~~d~Ve~~----~~EkrI~~la~~HPFL~~L~~~f 438 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDIL-QRDEVESL----MCEKRIFELANRHPFLVNLFSCF 438 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeecccee-ccccHHHH----HHHHHHHHHhccCCeEeeccccc
Confidence 56789999999999999999999987 5679999997654433 33445554 78888888776 99999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
.+..++ |+||||+.||++..+++ ...|++..+..++..|+.||+|||++||||||||.+|
T Consensus 439 QT~~~l--------------~fvmey~~Ggdm~~~~~------~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdN 498 (694)
T KOG0694|consen 439 QTKEHL--------------FFVMEYVAGGDLMHHIH------TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDN 498 (694)
T ss_pred ccCCeE--------------EEEEEecCCCcEEEEEe------cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhh
Confidence 987754 99999999999555443 3679999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
||||.+ +.+||+|||+++....... ...+++|||.|||||++.+ ..|+.++|.|||||+
T Consensus 499 iLLD~e-------Gh~kiADFGlcKe~m~~g~----------~TsTfCGTpey~aPEil~e----~~Yt~aVDWW~lGVL 557 (694)
T KOG0694|consen 499 LLLDTE-------GHVKIADFGLCKEGMGQGD----------RTSTFCGTPEFLAPEVLTE----QSYTRAVDWWGLGVL 557 (694)
T ss_pred eEEccc-------CcEEecccccccccCCCCC----------ccccccCChhhcChhhhcc----CcccchhhHHHHHHH
Confidence 999988 5699999999986432111 2356789999999999997 789999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
|||||.|+.||.+.+..++++.|.+... ..|.. .+.+..+||.++|..+|++
T Consensus 558 lyeML~Gq~PF~gddEee~FdsI~~d~~-~yP~~---------------------------ls~ea~~il~~ll~k~p~k 609 (694)
T KOG0694|consen 558 LYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRF---------------------------LSKEAIAIMRRLLRKNPEK 609 (694)
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCc---------------------------ccHHHHHHHHHHhccCccc
Confidence 9999999999999999999999987632 12211 2557899999999999999
Q ss_pred CCC-----HHHHHHHH
Q 003185 818 RPT-----AGDLYEMF 828 (840)
Q Consensus 818 RPS-----a~ELLehL 828 (840)
|.. +.+|.+|.
T Consensus 610 RLG~~e~d~~~i~~hp 625 (694)
T KOG0694|consen 610 RLGSGERDAEDIKKHP 625 (694)
T ss_pred ccCCCCCCchhhhhCC
Confidence 974 57777764
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=323.74 Aligned_cols=262 Identities=24% Similarity=0.399 Sum_probs=206.0
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+++|++.+.||+|+||.||+|+. .+..+|+|....... ...... ..+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKAR----QDCVKEIDLLKQLNHPNVIKYLDSFIEDN 75 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHH----HHHHHHHHHHHhCCCcceeeeeeeEEECC
Confidence 46899999999999999999986 678899997643221 122222 23488999999999999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .++||||+++++|.+++..... ....+++..++.++.||+.||.|||++||+|+||||+|||++
T Consensus 76 ~--------------~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~ 140 (267)
T cd08228 76 E--------------LNIVLELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT 140 (267)
T ss_pred e--------------EEEEEEecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc
Confidence 3 4999999999999999875322 234588999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.++|+|||++......... .....|++.|+|||.+.+ ..++.++||||||+++|||
T Consensus 141 ~~-------~~~~l~d~g~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~----~~~~~~~Di~slG~~l~el 199 (267)
T cd08228 141 AT-------GVVKLGDLGLGRFFSSKTTA----------AHSLVGTPYYMSPERIHE----NGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred CC-------CCEEECccccceeccchhHH----------HhcCCCCccccChhhhcc----CCCCchhhHHHHHHHHHHH
Confidence 76 45999999998765432111 122358899999999875 5578899999999999999
Q ss_pred HhCCCCCCCCC--HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 742 LTLQVPYMGLS--ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 742 LTG~~PF~~~~--~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
++|..||.... .......+.....+..+. ...+..+.+||.+||..+|.+||
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~li~~cl~~~p~~Rp 253 (267)
T cd08228 200 AALQSPFYGDKMNLFSLCQKIEQCDYPPLPT--------------------------EHYSEKLRELVSMCIYPDPDQRP 253 (267)
T ss_pred hcCCCCCccccccHHHHHHHHhcCCCCCCCh--------------------------hhcCHHHHHHHHHHCCCCcccCc
Confidence 99999996543 334444444433222211 12345789999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 003185 820 TAGDLYEMFVART 832 (840)
Q Consensus 820 Sa~ELLehLe~l~ 832 (840)
++.+|++.|+.+.
T Consensus 254 ~~~~vl~~~~~~~ 266 (267)
T cd08228 254 DIGYVHQIAKQMH 266 (267)
T ss_pred CHHHHHHHHHHhc
Confidence 9999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=328.68 Aligned_cols=261 Identities=24% Similarity=0.362 Sum_probs=206.6
Q ss_pred CCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 575 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g 575 (840)
...+|.+.+.||+|+||.||+|.+. ...+|+|+.... ...... ..+.+|+.+|+.++||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~ 75 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET---ASNDAR----KDFEREAELLTNFQHENIVKFYG 75 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc---CCHHHH----HHHHHHHHHHHhcCCCCchheee
Confidence 3567899999999999999999862 357888886422 111122 34489999999999999999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHh---------ccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS---------ETGEKHVSVKLALFIAQDVAAALVELHSK 646 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~---------~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~ 646 (840)
++..... .++||||+++++|.+++.... ......+++..+..++.||+.||.|||++
T Consensus 76 ~~~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~ 141 (280)
T cd05049 76 VCTEGDP--------------PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ 141 (280)
T ss_pred EEecCCC--------------eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC
Confidence 9886543 499999999999999997631 11224578899999999999999999999
Q ss_pred CeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCC
Q 003185 647 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 726 (840)
Q Consensus 647 gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s 726 (840)
||+||||||+|||++.+ +.+||+|||++......... .......+++.|+|||++.+ ..++
T Consensus 142 ~i~h~dlkp~nili~~~-------~~~kl~d~g~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~ 202 (280)
T cd05049 142 HFVHRDLATRNCLVGYD-------LVVKIGDFGMSRDVYTTDYY--------RVGGHTMLPIRWMPPESIMY----RKFT 202 (280)
T ss_pred CeeccccccceEEEcCC-------CeEEECCcccceecccCcce--------ecCCCCcccceecChhhhcc----CCcc
Confidence 99999999999999877 56999999998754322110 01122346789999999976 6688
Q ss_pred chhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHH
Q 003185 727 LEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 805 (840)
Q Consensus 727 ~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~d 805 (840)
.++|||||||++|||++ |..||...+..+....+..+..+..+. ..+..+.+
T Consensus 203 ~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~ 255 (280)
T cd05049 203 TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPR---------------------------TCPSEVYD 255 (280)
T ss_pred hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHHHH
Confidence 99999999999999998 999998888777777776553322221 12457899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHh
Q 003185 806 VFRRCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 806 LI~rCL~~DP~eRPSa~ELLehLe~ 830 (840)
|+.+||..||.+||++.||++.|++
T Consensus 256 li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 256 IMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHcCCCcccCCCHHHHHHHhhC
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=325.00 Aligned_cols=257 Identities=22% Similarity=0.348 Sum_probs=205.2
Q ss_pred CCCceeeeeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEe
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 578 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~ 578 (840)
.++|++.+.||+|+||.||+|.+. ...+++|+.... ....... .+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~---~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG---SSDKQRL----DFLTEASIMGQFDHPNIIRLEGVVT 75 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC---CChHHHH----HHHHHHHHHHhCCCCCcceEeEEEe
Confidence 457899999999999999999873 346788875322 1222223 3488999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
.... .++||||+++++|.+++.. ....+++..++.++.|++.||.|||++||+|+||||+||
T Consensus 76 ~~~~--------------~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~ni 137 (266)
T cd05033 76 KSRP--------------VMIITEYMENGSLDKFLRE----NDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNI 137 (266)
T ss_pred cCCc--------------eEEEEEcCCCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceE
Confidence 6543 4999999999999999975 224689999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.+ +.++|+|||++.......... ......++..|+|||.+.+ ..++.++||||||+++
T Consensus 138 li~~~-------~~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~~Pe~~~~----~~~~~~~Dv~slG~~l 198 (266)
T cd05033 138 LVNSN-------LVCKVSDFGLSRRLEDSEATY--------TTKGGKIPIRWTAPEAIAY----RKFTSASDVWSFGIVM 198 (266)
T ss_pred EEcCC-------CCEEECccchhhcccccccce--------eccCCCCCccccChhhhcc----CCCccccchHHHHHHH
Confidence 99876 469999999998764211110 0111235678999999875 5678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 739 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 739 ~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
|+|++ |..||......++...+........+ ...+..+.+|+.+||+.+|.+
T Consensus 199 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~~p~~ 251 (266)
T cd05033 199 WEVMSYGERPYWDMSNQDVIKAVEDGYRLPPP---------------------------MDCPSALYQLMLDCWQKDRNE 251 (266)
T ss_pred HHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHcCCCccc
Confidence 99998 99999888777777777655332211 112457899999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 003185 818 RPTAGDLYEMFVAR 831 (840)
Q Consensus 818 RPSa~ELLehLe~l 831 (840)
||++.+|+++|.++
T Consensus 252 Rp~~~ei~~~l~~~ 265 (266)
T cd05033 252 RPTFSQIVSTLDKM 265 (266)
T ss_pred CcCHHHHHHHHHhh
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=341.09 Aligned_cols=249 Identities=25% Similarity=0.329 Sum_probs=198.4
Q ss_pred CceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCC-CcceeeeEEecCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKW 582 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~Hp-NIV~l~g~~~~~~~ 582 (840)
+|++.+.||+|+||.||+|.+. +..+|+|++...... .....+ .+..|+.++..+.|+ +|+.+++++...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~----~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII-QDDDVE----CTMVEKRVLALPGKPPFLTQLHSCFQTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHH----HHHHHHHHHHhcCCCCceeeeEEEEEcCCE
Confidence 5899999999999999999874 568999987543211 112222 347899999999865 58888888876543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.|+||||+++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~ 136 (324)
T cd05587 76 --------------LYFVMEYVNGGDLMYHIQQ-----VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA 136 (324)
T ss_pred --------------EEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcC
Confidence 5999999999999999875 356899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 137 ~-------~~~kL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~ell 195 (324)
T cd05587 137 E-------GHIKIADFGMCKENIFGGK----------TTRTFCGTPDYIAPEIIAY----QPYGKSVDWWAFGVLLYEML 195 (324)
T ss_pred C-------CCEEEeecCcceecCCCCC----------ceeeecCCccccChhhhcC----CCCCcccchhhhHHHHHHHH
Confidence 7 4599999999864321111 1123469999999999986 56789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA- 821 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa- 821 (840)
||+.||.+.+..++...+..... .++. ..+..+.+|+.+||..||.+|+++
T Consensus 196 tG~~pf~~~~~~~~~~~i~~~~~-~~~~---------------------------~~~~~~~~li~~~l~~~P~~R~~~~ 247 (324)
T cd05587 196 AGQPPFDGEDEDELFQSIMEHNV-SYPK---------------------------SLSKEAVSICKGLLTKHPAKRLGCG 247 (324)
T ss_pred hCCCCCCCCCHHHHHHHHHcCCC-CCCC---------------------------CCCHHHHHHHHHHhhcCHHHcCCCC
Confidence 99999998888777777655421 1111 124578999999999999999976
Q ss_pred ----HHHHHH
Q 003185 822 ----GDLYEM 827 (840)
Q Consensus 822 ----~ELLeh 827 (840)
+++++|
T Consensus 248 ~~~~~~~~~h 257 (324)
T cd05587 248 PTGERDIREH 257 (324)
T ss_pred CCCHHHHhcC
Confidence 788877
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=348.72 Aligned_cols=267 Identities=28% Similarity=0.383 Sum_probs=202.1
Q ss_pred CCceeeeeecccCceEEEEEEECC-eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
++|.-...||+|+||.||+|...+ ..+|||.. ....... ..+| .+|+.++.+++|||||+++|||.+...
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~--~~~~~~~--~~eF----~~Ei~~ls~l~H~Nlv~LlGyC~e~~~- 145 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRL--SSNSGQG--EREF----LNEVEILSRLRHPNLVKLLGYCLEGGE- 145 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEEe--cCCCCcc--hhHH----HHHHHHHhcCCCcCcccEEEEEecCCc-
Confidence 577778899999999999999865 78999953 3222211 2335 999999999999999999999986652
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCCCcEEE
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHRDIKSENILI 660 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~---gIVHRDLKPeNILL 660 (840)
+.+||+||+++|+|.++|... ... .++|..+++|+.++|+||+|||.. .||||||||+||||
T Consensus 146 ------------~~~LVYEym~nGsL~d~L~~~--~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL 210 (361)
T KOG1187|consen 146 ------------HRLLVYEYMPNGSLEDHLHGK--KGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL 210 (361)
T ss_pred ------------eEEEEEEccCCCCHHHHhCCC--CCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence 249999999999999999751 111 789999999999999999999986 49999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccc-cccccccccCCCCCCCcc-cCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRS-FLHTCCIAHRGIPAPDVC-VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~-~~~~~~~~~~~~~~~~~~-vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|.+ +.+||+|||+|+.... .... ... .||.+|+|||++.. +..+.|+|||||||+|
T Consensus 211 D~~-------~~aKlsDFGLa~~~~~~~~~~-----------~~~~~gt~gY~~PEy~~~----g~lt~KsDVySFGVvl 268 (361)
T KOG1187|consen 211 DED-------FNAKLSDFGLAKLGPEGDTSV-----------STTVMGTFGYLAPEYAST----GKLTEKSDVYSFGVVL 268 (361)
T ss_pred CCC-------CCEEccCccCcccCCccccce-----------eeecCCCCccCChhhhcc----CCcCcccccccchHHH
Confidence 987 6699999999965543 1111 111 69999999999975 6789999999999999
Q ss_pred HHHHhCCCCCCCCC---HHHHHH----HHHcCCCCCcchHHhhhccCccccccccCCC-CCCchhhhhhHHHHHHHHHHh
Q 003185 739 LELLTLQVPYMGLS---ELEIHD----LIQMGKRPRLTDELEALGSCHEHEVAQSGSG-FEKPEAELETLSFLVDVFRRC 810 (840)
Q Consensus 739 ~ELLTG~~PF~~~~---~~el~~----~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~L~dLI~rC 810 (840)
.||+||+.|..... ...+.. .+..+ .+. .+.+.... ..... ......+..+..+|
T Consensus 269 lElitgr~~~d~~~~~~~~~l~~w~~~~~~~~---~~~------------eiiD~~l~~~~~~~--~~~~~~~~~~a~~C 331 (361)
T KOG1187|consen 269 LELITGRKAVDQSRPRGELSLVEWAKPLLEEG---KLR------------EIVDPRLKEGEYPD--EKEVKKLAELALRC 331 (361)
T ss_pred HHHHhCCcccCCCCCcccccHHHHHHHHHHCc---chh------------heeCCCccCCCCCh--HHHHHHHHHHHHHH
Confidence 99999998876432 111222 11111 111 11222211 11110 14556688999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhcCC
Q 003185 811 TEENPTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 811 L~~DP~eRPSa~ELLehLe~l~~~ 834 (840)
++.+|.+||++.+|++.|+.+...
T Consensus 332 ~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 332 LRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred cCcCCCcCcCHHHHHHHHHhhccc
Confidence 999999999999999999776544
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=351.96 Aligned_cols=264 Identities=22% Similarity=0.258 Sum_probs=200.7
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
.+|++.+.||+|+||.||+|.. .+..+|+|++..... ........+.+|+.+|++++||||+++++.+.....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADV-----LMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHH-----HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCE
Confidence 3699999999999999999987 567899998643211 011122345889999999999999999999986553
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.||||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~E~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~ 136 (376)
T cd05598 76 --------------LYFVMDYIPGGDMMSLLIR-----LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR 136 (376)
T ss_pred --------------EEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECC
Confidence 5999999999999999976 356889999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCccccccccccccc---------------------------------ccCCCCCCCcccCCCc
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCI---------------------------------AHRGIPAPDVCVGTPR 709 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~---------------------------------~~~~~~~~~~~vGT~~ 709 (840)
+ +.+||+|||+|..+......... ...........+||+.
T Consensus 137 ~-------~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 209 (376)
T cd05598 137 D-------GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN 209 (376)
T ss_pred C-------CCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCcc
Confidence 7 46999999998543210000000 0000001123579999
Q ss_pred ccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCcchHHhhhccCccccccccCC
Q 003185 710 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGS 788 (840)
Q Consensus 710 YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~ 788 (840)
|||||++.+ ..++.++|||||||+||||++|+.||.+.+..+....+..... ..++
T Consensus 210 y~aPE~~~~----~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------- 266 (376)
T cd05598 210 YIAPEVLLR----TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIP------------------- 266 (376)
T ss_pred ccCHHHHcC----CCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCC-------------------
Confidence 999999976 5678999999999999999999999998877666555543211 1111
Q ss_pred CCCCchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHHHHHHH
Q 003185 789 GFEKPEAELETLSFLVDVFRRCTEENPTERP---TAGDLYEMFV 829 (840)
Q Consensus 789 ~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP---Sa~ELLehLe 829 (840)
.....+..+.+||.+|+ .+|.+|+ ++.++++|..
T Consensus 267 ------~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~ 303 (376)
T cd05598 267 ------SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPF 303 (376)
T ss_pred ------CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCC
Confidence 00123457888999977 5999999 9999999944
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=334.62 Aligned_cols=265 Identities=25% Similarity=0.415 Sum_probs=203.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~ 578 (840)
+.|++|++.+.||+|+||.||+|.+. +..++++++.++.. ....... .+.+|+.++.++ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~----~~~~Ei~~l~~l~~h~~iv~~~~~~~ 78 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHR----DFAGELEVLCKLGHHPNIINLLGACE 78 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHH----HHHHHHHHHHHhcCCCCcceEEEEEC
Confidence 56889999999999999999999863 34444444433321 1222223 348899999999 7999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELHSKH 647 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----------~~~~~ls~~~~~~Ia~QIa~AL~yLHs~g 647 (840)
.... .|+||||+++++|.+++..... .....+++..++.++.||+.||+|||++|
T Consensus 79 ~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g 144 (303)
T cd05088 79 HRGY--------------LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 144 (303)
T ss_pred CCCC--------------ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 6654 3999999999999999975211 11235889999999999999999999999
Q ss_pred eecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCc
Q 003185 648 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 727 (840)
Q Consensus 648 IVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~ 727 (840)
|+||||||+|||++.+ +.+||+|||++........ .....++..|+|||++.+ ..++.
T Consensus 145 i~H~dlkp~Nili~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~ 202 (303)
T cd05088 145 FIHRDLAARNILVGEN-------YVAKIADFGLSRGQEVYVK-----------KTMGRLPVRWMAIESLNY----SVYTT 202 (303)
T ss_pred ccccccchheEEecCC-------CcEEeCccccCcccchhhh-----------cccCCCcccccCHHHHhc----cCCcc
Confidence 9999999999999876 4699999999864321110 111234678999999875 56789
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHH
Q 003185 728 EVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 806 (840)
Q Consensus 728 kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dL 806 (840)
++|||||||++|||+| |..||.+.+..+....+.....+..+ ...+..+.+|
T Consensus 203 ~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l 255 (303)
T cd05088 203 NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP---------------------------LNCDDEVYDL 255 (303)
T ss_pred cccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCCCC---------------------------CCCCHHHHHH
Confidence 9999999999999998 99999887776666555433221111 1124578999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 003185 807 FRRCTEENPTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 807 I~rCL~~DP~eRPSa~ELLehLe~l~~~ 834 (840)
+.+||+.+|.+||++++++.+|..+...
T Consensus 256 i~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 256 MRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=348.73 Aligned_cols=264 Identities=23% Similarity=0.347 Sum_probs=201.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCccee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 573 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l 573 (840)
.+.++|++.+.||+|+||.||+|.+. ...||+|+..... ...... .+.+|+.+++.+ +|||||++
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~----~~~~E~~il~~l~~h~nIv~~ 107 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDERE----ALMSELKILSHLGQHKNIVNL 107 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHH----HHHHHHHHHHhhccCCceeeE
Confidence 45668999999999999999999852 2368888864321 122222 348999999999 79999999
Q ss_pred eeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----------------------------------
Q 003185 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE----------------------------------- 618 (840)
Q Consensus 574 ~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~----------------------------------- 618 (840)
++++..... .++||||+++|+|.+++.....
T Consensus 108 ~~~~~~~~~--------------~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (374)
T cd05106 108 LGACTHGGP--------------VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGF 173 (374)
T ss_pred eeEecCCCC--------------eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccc
Confidence 999876654 4999999999999999865211
Q ss_pred ------------------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCC
Q 003185 619 ------------------------------TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 668 (840)
Q Consensus 619 ------------------------------~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~ 668 (840)
.....+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~----- 248 (374)
T cd05106 174 SSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDG----- 248 (374)
T ss_pred cccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCC-----
Confidence 011347888999999999999999999999999999999999866
Q ss_pred CCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 003185 669 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVP 747 (840)
Q Consensus 669 ~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT-G~~P 747 (840)
..+||+|||+++........ .......+++.|||||++.. ..++.++|||||||++|||++ |..|
T Consensus 249 --~~~kL~DfGla~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwSlGvil~ellt~G~~P 314 (374)
T cd05106 249 --RVAKICDFGLARDIMNDSNY--------VVKGNARLPVKWMAPESIFD----CVYTVQSDVWSYGILLWEIFSLGKSP 314 (374)
T ss_pred --CeEEEeeceeeeeccCCcce--------eeccCCCCccceeCHHHhcC----CCCCccccHHHHHHHHHHHHhCCCCC
Confidence 56999999999765332111 01122235678999999875 668999999999999999997 9999
Q ss_pred CCCCCHHHHH-HHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003185 748 YMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826 (840)
Q Consensus 748 F~~~~~~el~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLe 826 (840)
|......... ..+.....+..+. ..+..+.+|+.+||+.||.+|||+.+|++
T Consensus 315 f~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 315 YPGILVNSKFYKMVKRGYQMSRPD---------------------------FAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred CccccccHHHHHHHHcccCccCCC---------------------------CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9776543333 2222222211110 12457899999999999999999999999
Q ss_pred HHHhhc
Q 003185 827 MFVART 832 (840)
Q Consensus 827 hLe~l~ 832 (840)
.|+.+.
T Consensus 368 ~l~~~~ 373 (374)
T cd05106 368 LIQRQL 373 (374)
T ss_pred HHHHHh
Confidence 998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=330.60 Aligned_cols=266 Identities=23% Similarity=0.353 Sum_probs=208.8
Q ss_pred CCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 575 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g 575 (840)
.+.+|.+.+.||+|+||.||+|.+. ...+++|... . ......+ .+.+|+.++++++||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~--~--~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~ 74 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK--D--PTLAARK----DFQREAELLTNLQHEHIVKFYG 74 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecC--C--ccHHHHH----HHHHHHHHHhcCCCCCcceEEE
Confidence 4567999999999999999999852 2346666532 1 1112222 3489999999999999999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----------cCCCCCCHHHHHHHHHHHHHHHHHHH
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELH 644 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----------~~~~~ls~~~~~~Ia~QIa~AL~yLH 644 (840)
++..... .++||||+++++|.+++..... .....+++..++.++.||+.||+|||
T Consensus 75 ~~~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 140 (291)
T cd05094 75 VCGDGDP--------------LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA 140 (291)
T ss_pred EEccCCc--------------eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9876543 4999999999999999975211 11235889999999999999999999
Q ss_pred hCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCC
Q 003185 645 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 724 (840)
Q Consensus 645 s~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~ 724 (840)
++||+||||||+|||++.+ +.++|+|||++......... .......++..|+|||++.+ ..
T Consensus 141 ~~~i~H~dlkp~Nil~~~~-------~~~~l~dfg~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~ 201 (291)
T cd05094 141 SQHFVHRDLATRNCLVGAN-------LLVKIGDFGMSRDVYSTDYY--------RVGGHTMLPIRWMPPESIMY----RK 201 (291)
T ss_pred hCCeeecccCcceEEEccC-------CcEEECCCCcccccCCCcee--------ecCCCCCcceeecChHHhcc----CC
Confidence 9999999999999999877 46999999999765432111 00122357889999999876 56
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHH
Q 003185 725 YGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 803 (840)
Q Consensus 725 ~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L 803 (840)
++.++|||||||++|||+| |..||...+..++...+..+..+..+. ..+..+
T Consensus 202 ~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~ 254 (291)
T cd05094 202 FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPR---------------------------VCPKEV 254 (291)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCCCCCc---------------------------cCCHHH
Confidence 7889999999999999999 999998887777776665553332221 124578
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 003185 804 VDVFRRCTEENPTERPTAGDLYEMFVARTSSSI 836 (840)
Q Consensus 804 ~dLI~rCL~~DP~eRPSa~ELLehLe~l~~~~~ 836 (840)
.+|+.+||+.+|.+||++.+|++.|+.+..+.+
T Consensus 255 ~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 255 YDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred HHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=331.95 Aligned_cols=280 Identities=19% Similarity=0.242 Sum_probs=207.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++.+.||.|+||.||+|.+ .+..+|+|.+........ ...+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~nI~~~~~~~~~ 75 (301)
T cd07873 3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA-------PCTAIREVSLLKDLKHANIVTLHDIIHT 75 (301)
T ss_pred ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc-------hhHHHHHHHHHHhcCCCCcceEEEEEec
Confidence 5678999999999999999999987 467889998754432111 1123789999999999999999999886
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .++||||+. ++|.+++.. ....+++..+..++.||+.||.|||++||+|+||||+|||
T Consensus 76 ~~~--------------~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil 136 (301)
T cd07873 76 EKS--------------LTLVFEYLD-KDLKQYLDD----CGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLL 136 (301)
T ss_pred CCe--------------EEEEEeccc-cCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEE
Confidence 553 599999997 599998875 2346889999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.++|+|||++......... .....+++.|+|||++.+ ...++.++|||||||++|
T Consensus 137 ~~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~~l~ 196 (301)
T cd07873 137 INER-------GELKLADFGLARAKSIPTKT----------YSNEVVTLWYRPPDILLG---STDYSTQIDMWGVGCIFY 196 (301)
T ss_pred ECCC-------CcEEECcCcchhccCCCCCc----------ccccceeecccCcHHHhC---CCCCccHHHHHHHHHHHH
Confidence 9877 45999999998754321111 122357899999999875 245788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCC-CCC---CchhhhhhHHHHHHHHHHhcccCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS-GFE---KPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~-~~~---~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
+|+||++||.+.+..+....+...........+...... ..+..... ... ........+..+.+||.+||+.||
T Consensus 197 el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp 274 (301)
T cd07873 197 EMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN--EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEG 274 (301)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc--ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCc
Confidence 999999999988776666555443222222222211100 00000000 000 011122346678999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 003185 816 TERPTAGDLYEMFV 829 (840)
Q Consensus 816 ~eRPSa~ELLehLe 829 (840)
.+|||++++++|.+
T Consensus 275 ~~R~t~~eil~h~~ 288 (301)
T cd07873 275 RKRISAEEAMKHPY 288 (301)
T ss_pred ccCcCHHHHhcCcc
Confidence 99999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=327.22 Aligned_cols=260 Identities=21% Similarity=0.344 Sum_probs=202.3
Q ss_pred CCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeE
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 576 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~ 576 (840)
-++|++.+.||+|+||.||+|.+. +..+|+|+.... ....... .+.+|+.+++.++||||++++++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~---~~~~~~~----~~~~e~~~l~~l~~~~iv~~~~~ 77 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA---ASMRERI----EFLNEASVMKEFNCHHVVRLLGV 77 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc---CCHHHHH----HHHHHHHHHHhCCCCCeeeEEEE
Confidence 457999999999999999999863 346888874321 1112222 34899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----GEKHVSVKLALFIAQDVAAALVELHSKHIMHR 651 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-----~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHR 651 (840)
+..... .++||||+++++|.+++...... ....+++..+..++.|++.||.|||+.|++|+
T Consensus 78 ~~~~~~--------------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~ 143 (277)
T cd05062 78 VSQGQP--------------TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHR 143 (277)
T ss_pred EcCCCC--------------eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 875543 49999999999999999763211 01346788899999999999999999999999
Q ss_pred cCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhH
Q 003185 652 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 731 (840)
Q Consensus 652 DLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDV 731 (840)
||||+|||++.+ +.++|+|||+++......... ......+++.|||||++.+ ..++.++||
T Consensus 144 dlkp~Nil~~~~-------~~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di 204 (277)
T cd05062 144 DLAARNCMVAED-------FTVKIGDFGMTRDIYETDYYR--------KGGKGLLPVRWMSPESLKD----GVFTTYSDV 204 (277)
T ss_pred CcchheEEEcCC-------CCEEECCCCCccccCCcceee--------cCCCCccCHhhcChhHhhc----CCcCchhHH
Confidence 999999999876 469999999987654322110 0111245788999999875 668899999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 003185 732 WSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 810 (840)
Q Consensus 732 WSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rC 810 (840)
|||||++|||++ |..||.+.........+.....+.++. ..+..+.+|+.+|
T Consensus 205 ~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~ 257 (277)
T cd05062 205 WSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPD---------------------------NCPDMLFELMRMC 257 (277)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHHHHHHHHH
Confidence 999999999999 789998888777776665543322221 1245789999999
Q ss_pred cccCCCCCCCHHHHHHHHHh
Q 003185 811 TEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 811 L~~DP~eRPSa~ELLehLe~ 830 (840)
|+.||.+|||+.+++++|+.
T Consensus 258 l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 258 WQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCCChhhCcCHHHHHHHhhC
Confidence 99999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=344.05 Aligned_cols=245 Identities=26% Similarity=0.357 Sum_probs=196.4
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 588 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g 588 (840)
+.||+|+||.||++.. .+..+|+|+....... ..... ..+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~----~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~------ 69 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEV----AHTLTENRVLQNSRHPFLTALKYSFQTHDR------ 69 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHH----HHHHHHHHHHHhCCCCCCCceEEEEEcCCE------
Confidence 4699999999999986 6778999997543211 11122 234789999999999999999999876553
Q ss_pred CCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCCCcEEEecccccC
Q 003185 589 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLERKKA 667 (840)
Q Consensus 589 ~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs-~gIVHRDLKPeNILLd~~~~~~ 667 (840)
.||||||+++|+|..++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.+
T Consensus 70 --------~~lv~E~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~---- 132 (325)
T cd05594 70 --------LCFVMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD---- 132 (325)
T ss_pred --------EEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC----
Confidence 5999999999999998875 3568999999999999999999997 799999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003185 668 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 747 (840)
Q Consensus 668 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~P 747 (840)
+.+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||+||+|++|..|
T Consensus 133 ---~~~kL~Dfg~~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~tG~~P 195 (325)
T cd05594 133 ---GHIKITDFGLCKEGIKDGAT----------MKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLP 195 (325)
T ss_pred ---CCEEEecCCCCeecCCCCcc----------cccccCCcccCCHHHHcc----CCCCCccccccccceeeeeccCCCC
Confidence 45999999998753221110 123469999999999976 5678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHH
Q 003185 748 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAG 822 (840)
Q Consensus 748 F~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP-----Sa~ 822 (840)
|.+.+.......+..... .++. ..+..+.+||.+||+.||.+|+ ++.
T Consensus 196 f~~~~~~~~~~~i~~~~~-~~p~---------------------------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 247 (325)
T cd05594 196 FYNQDHEKLFELILMEEI-RFPR---------------------------TLSPEAKSLLSGLLKKDPKQRLGGGPDDAK 247 (325)
T ss_pred CCCCCHHHHHHHHhcCCC-CCCC---------------------------CCCHHHHHHHHHHhhcCHHHhCCCCCCCHH
Confidence 988877776666544321 1111 1245789999999999999997 999
Q ss_pred HHHHHH
Q 003185 823 DLYEMF 828 (840)
Q Consensus 823 ELLehL 828 (840)
++++|.
T Consensus 248 ~il~h~ 253 (325)
T cd05594 248 EIMQHK 253 (325)
T ss_pred HHhcCC
Confidence 999884
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=346.37 Aligned_cols=284 Identities=19% Similarity=0.205 Sum_probs=205.7
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|++.+.||+|+||.||+|.+ .+..+|+|..... .......+ ++.+|+.+++.++||||+++++++......
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV--FQNLVSCK----RVFRELKMLCFFKHDNVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc--ccchHHHH----HHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence 478899999999999999996 5778999975322 11222222 348999999999999999999998754311
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.....|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 75 ---------~~~~~~lv~e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~ 139 (372)
T cd07853 75 ---------PFEEIYVVTELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN 139 (372)
T ss_pred ---------ccceEEEEeeccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCC
Confidence 1225699999997 588888764 3568999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.+||+|||+++........ ......+|+.|+|||++.+ ...++.++|||||||++|||++
T Consensus 140 -------~~~kL~Dfg~a~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~~ 200 (372)
T cd07853 140 -------CVLKICDFGLARVEEPDESK---------HMTQEVVTQYYRAPEILMG---SRHYTSAVDIWSVGCIFAELLG 200 (372)
T ss_pred -------CCEEeccccceeecccCccc---------cCCCCCcCCCcCCHHHHcC---CCCCCcHHHHHhHHHHHHHHHc
Confidence 46999999999764322111 1122358899999999875 2457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCC----CchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE----KPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~----~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|+.||.+.++.+....+...........+..........+........ ........++.+.+||.+||+.||.+||
T Consensus 201 g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~ 280 (372)
T cd07853 201 RRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRI 280 (372)
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCc
Confidence 999999888877776665532222122221110000000000000000 0001122356789999999999999999
Q ss_pred CHHHHHHHHH
Q 003185 820 TAGDLYEMFV 829 (840)
Q Consensus 820 Sa~ELLehLe 829 (840)
|+.++++|..
T Consensus 281 t~~e~l~hp~ 290 (372)
T cd07853 281 SAADALAHPY 290 (372)
T ss_pred CHHHHhcCHh
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=341.54 Aligned_cols=245 Identities=27% Similarity=0.373 Sum_probs=195.9
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEecCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 587 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~~~~~~p~~~ 587 (840)
+.||+|+||.||+|.+ .+..+|+|+....... .....+ .+..|+.++..+ +||||+++++++.....
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~----- 70 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-QDDDVE----CTMTEKRILSLARNHPFLTQLYCCFQTPDR----- 70 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hccHHH----HHHHHHHHHHhccCCCchhceeeEEEcCCE-----
Confidence 4699999999999997 4678999987533211 111222 337888888877 59999999999886553
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccC
Q 003185 588 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667 (840)
Q Consensus 588 g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~ 667 (840)
.||||||+++|+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 71 ---------~~iv~Ey~~~g~L~~~i~~-----~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~---- 132 (320)
T cd05590 71 ---------LFFVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE---- 132 (320)
T ss_pred ---------EEEEEcCCCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC----
Confidence 5999999999999999876 3568999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003185 668 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 747 (840)
Q Consensus 668 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~P 747 (840)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~P 195 (320)
T cd05590 133 ---GHCKLADFGMCKEGIFNGK----------TTSTFCGTPDYIAPEILQE----MLYGPSVDWWAMGVLLYEMLCGHAP 195 (320)
T ss_pred ---CcEEEeeCCCCeecCcCCC----------cccccccCccccCHHHHcC----CCCCCccchhhhHHHHHHHhhCCCC
Confidence 4599999999875322111 1123469999999999975 5678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH------
Q 003185 748 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA------ 821 (840)
Q Consensus 748 F~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa------ 821 (840)
|.+.+..++...+..... .++. ..+..+.+||.+||+.||.+||++
T Consensus 196 f~~~~~~~~~~~i~~~~~-~~~~---------------------------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 247 (320)
T cd05590 196 FEAENEDDLFEAILNDEV-VYPT---------------------------WLSQDAVDILKAFMTKNPTMRLGSLTLGGE 247 (320)
T ss_pred CCCCCHHHHHHHHhcCCC-CCCC---------------------------CCCHHHHHHHHHHcccCHHHCCCCCCCCCH
Confidence 998888887777765422 1111 124578999999999999999998
Q ss_pred HHHHHHH
Q 003185 822 GDLYEMF 828 (840)
Q Consensus 822 ~ELLehL 828 (840)
+++++|.
T Consensus 248 ~~~~~h~ 254 (320)
T cd05590 248 EAILRHP 254 (320)
T ss_pred HHHHcCC
Confidence 8888874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=320.66 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=205.4
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|.+.+.||+|+||.||+|.+ ++..+++|....... ...... .+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRRERE----EAIDEARVLAKLDSSYIIRYYESFLDKG-- 72 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC--CHHHHH----HHHHHHHHHHhcCCCCeehheeeeccCC--
Confidence 588999999999999999987 567889998654322 222333 3489999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
..++||||+++++|.+++... ....+++..++.++.||+.||.|||+.||+|+||||+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~ 137 (256)
T cd08529 73 ------------KLNIVMEYAENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY 137 (256)
T ss_pred ------------EEEEEEEeCCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC
Confidence 359999999999999999862 23568899999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.++|+|||+++.+...... .....|++.|+|||++.. ..++.++|||||||++|+|++
T Consensus 138 -------~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~~ 196 (256)
T cd08529 138 -------DNVKIGDLGVAKLLSDNTNF----------ANTIVGTPYYLSPELCED----KPYNEKSDVWALGVVLYECCT 196 (256)
T ss_pred -------CCEEEcccccceeccCccch----------hhccccCccccCHHHhcC----CCCCCccchHHHHHHHHHHHh
Confidence 45999999998866432211 122358899999999976 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~E 823 (840)
|+.||...+.......+.....+.++. ..+..+.++|.+||+.+|++||++.+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~Rp~~~~ 249 (256)
T cd08529 197 GKHPFDANNQGALILKIIRGVFPPVSQ---------------------------MYSQQLAQLIDQCLTKDYRQRPDTFQ 249 (256)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCcc---------------------------ccCHHHHHHHHHHccCCcccCcCHHH
Confidence 999998888777666666554443332 12457899999999999999999999
Q ss_pred HHHH
Q 003185 824 LYEM 827 (840)
Q Consensus 824 LLeh 827 (840)
++++
T Consensus 250 ll~~ 253 (256)
T cd08529 250 LLRN 253 (256)
T ss_pred HhhC
Confidence 9987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=342.11 Aligned_cols=245 Identities=26% Similarity=0.312 Sum_probs=192.9
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHH-HHHhCCCCCcceeeeEEecCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKISSKWLPSAD 587 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~-iL~~L~HpNIV~l~g~~~~~~~~p~~~ 587 (840)
+.||+|+||.||+|.+ .+..+|+|++........ ... ..+..|.. +++.++||||+++++++.....
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~----~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~----- 70 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK-KEQ----KHIMAERNVLLKNVKHPFLVGLHYSFQTADK----- 70 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh-hHH----HHHHHHHHHHHhhCCCCCCCCeeEEEEeCCE-----
Confidence 4699999999999997 578899999754321111 111 22355554 5678999999999999876553
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccC
Q 003185 588 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667 (840)
Q Consensus 588 g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~ 667 (840)
.|+||||+++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~---- 132 (323)
T cd05575 71 ---------LYFVLDYVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ---- 132 (323)
T ss_pred ---------EEEEEcCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC----
Confidence 5999999999999999875 3568999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003185 668 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 747 (840)
Q Consensus 668 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~P 747 (840)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|..|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell~g~~p 195 (323)
T cd05575 133 ---GHVVLTDFGLCKEGIEHSK----------TTSTFCGTPEYLAPEVLRK----QPYDRTVDWWCLGAVLYEMLYGLPP 195 (323)
T ss_pred ---CcEEEeccCCCcccccCCC----------ccccccCChhhcChhhhcC----CCCCccccccccchhhhhhhcCCCC
Confidence 4599999999875322111 1223469999999999976 5688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH----HH
Q 003185 748 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA----GD 823 (840)
Q Consensus 748 F~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa----~E 823 (840)
|...+..++...+...... ++ ...+..+.+||.+||+.||.+||++ .+
T Consensus 196 f~~~~~~~~~~~i~~~~~~-~~---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (323)
T cd05575 196 FYSRDTAEMYDNILNKPLR-LK---------------------------PNISVSARHLLEGLLQKDRTKRLGAKDDFLE 247 (323)
T ss_pred CCCCCHHHHHHHHHcCCCC-CC---------------------------CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHH
Confidence 9988877777766554211 11 1124578999999999999999987 57
Q ss_pred HHHHH
Q 003185 824 LYEMF 828 (840)
Q Consensus 824 LLehL 828 (840)
+++|.
T Consensus 248 il~~~ 252 (323)
T cd05575 248 IKNHV 252 (323)
T ss_pred HHcCC
Confidence 77763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=349.05 Aligned_cols=260 Identities=29% Similarity=0.353 Sum_probs=218.3
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEec
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 579 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~ 579 (840)
.-..|++.+.||+|.||.||+++. ++..+|+|++..+...... ..+ .+.+|+.+|++|. |||||.++++|.+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~-~~~----~v~~Ev~il~~l~~hpniv~l~~~~e~ 107 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE-DRE----DVRREVAILQQLSGHPNIVQLKDAFED 107 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc-cHH----HHHHHHHHHHhccCCCCEEEEEEEEEc
Confidence 345799999999999999999997 5788999998655432221 222 3489999999999 9999999999998
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
...+ ++|||++.||.|.+.|... .+++..+..++.||+.|++|||+.||+||||||+|+|
T Consensus 108 ~~~~--------------~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L 167 (382)
T KOG0032|consen 108 PDSV--------------YLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLL 167 (382)
T ss_pred CCeE--------------EEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHee
Confidence 7754 9999999999999999872 3999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
+..... +.+.+|++|||++........ ....+||+.|+|||++.. ..|+..+||||+||++|
T Consensus 168 ~~~~~~---~~~~ik~~DFGla~~~~~~~~-----------~~~~~Gtp~y~APEvl~~----~~y~~~~DiWS~Gvi~y 229 (382)
T KOG0032|consen 168 LASKDE---GSGRIKLIDFGLAKFIKPGER-----------LHTIVGTPEYVAPEVLGG----RPYGDEVDVWSIGVILY 229 (382)
T ss_pred eccccC---CCCcEEEeeCCCceEccCCce-----------EeeecCCccccCchhhcC----CCCCcccchhHHHHHHH
Confidence 987632 235799999999988765211 244689999999999986 68999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
.|++|.+||.+.+.......|..+...... +.+...+..+.++|.+||..||.+|+
T Consensus 230 iLL~G~~PF~~~~~~~~~~~i~~~~~~f~~------------------------~~w~~is~~akd~i~~ll~~dp~~R~ 285 (382)
T KOG0032|consen 230 ILLSGVPPFWGETEFEIFLAILRGDFDFTS------------------------EPWDDISESAKDFIRKLLEFDPRKRL 285 (382)
T ss_pred HHhhCCCCCcCCChhHHHHHHHcCCCCCCC------------------------CCccccCHHHHHHHHHhcccCcccCC
Confidence 999999999999988888888877542211 12233467899999999999999999
Q ss_pred CHHHHHHHHH
Q 003185 820 TAGDLYEMFV 829 (840)
Q Consensus 820 Sa~ELLehLe 829 (840)
|+.++|+|.+
T Consensus 286 ta~~~L~HpW 295 (382)
T KOG0032|consen 286 TAAQALQHPW 295 (382)
T ss_pred CHHHHhcCcc
Confidence 9999999965
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=340.70 Aligned_cols=246 Identities=24% Similarity=0.324 Sum_probs=197.0
Q ss_pred eeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEecCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 587 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~~~~~~p~~~ 587 (840)
+.||+|+||.||+|.+. +..+|+|++...... .....+ .+..|+.++..+ +||||+++++++.....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~e~~il~~~~~hp~i~~~~~~~~~~~~----- 70 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL-QDDDVD----CTMTEKRILALAAKHPFLTALHCCFQTKDR----- 70 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHH----HHHHHHHHHHhccCCCCccceeeEEEcCCe-----
Confidence 46999999999999874 568999987543211 112222 337788888876 69999999999986553
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccC
Q 003185 588 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667 (840)
Q Consensus 588 g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~ 667 (840)
.||||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~E~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~---- 132 (321)
T cd05591 71 ---------LFFVMEYVNGGDLMFQIQR-----SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE---- 132 (321)
T ss_pred ---------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC----
Confidence 4999999999999999875 3568999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003185 668 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 747 (840)
Q Consensus 668 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~P 747 (840)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 133 ---~~~kL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~tg~~P 195 (321)
T cd05591 133 ---GHCKLADFGMCKEGILNGV----------TTTTFCGTPDYIAPEILQE----LEYGPSVDWWALGVLMYEMMAGQPP 195 (321)
T ss_pred ---CCEEEeecccceecccCCc----------cccccccCccccCHHHHcC----CCCCCccceechhHHHHHHhcCCCC
Confidence 4699999999875322111 1123468999999999975 5688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-------C
Q 003185 748 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-------T 820 (840)
Q Consensus 748 F~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP-------S 820 (840)
|...+..+....+...... ++. ..+..+.+||.+||..||.+|| +
T Consensus 196 f~~~~~~~~~~~i~~~~~~-~p~---------------------------~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~ 247 (321)
T cd05591 196 FEADNEDDLFESILHDDVL-YPV---------------------------WLSKEAVSILKAFMTKNPNKRLGCVASQGG 247 (321)
T ss_pred CCCCCHHHHHHHHHcCCCC-CCC---------------------------CCCHHHHHHHHHHhccCHHHcCCCCCCCCC
Confidence 9998888887777654221 110 1245789999999999999999 8
Q ss_pred HHHHHHHHH
Q 003185 821 AGDLYEMFV 829 (840)
Q Consensus 821 a~ELLehLe 829 (840)
++++++|..
T Consensus 248 ~~~~~~hp~ 256 (321)
T cd05591 248 EDAIKQHPF 256 (321)
T ss_pred HHHHhcCCc
Confidence 999998853
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=323.71 Aligned_cols=252 Identities=24% Similarity=0.335 Sum_probs=201.9
Q ss_pred CCCceeeeeecccCceEEEEEEECC-eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
..+|.+.+.||+|+||.||+|.+.+ ..+|+|..... ... ... +.+|+.++++++||||+++++++.....
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~--~~~---~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMS---EDE----FIEEAKVMMKLSHEKLVQLYGVCTKQRP 73 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC--ccc---HHH----HHHHHHHHhcCCCCCeeeEEEEEccCCC
Confidence 4578999999999999999998754 45888875422 111 123 3889999999999999999999875543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.++||||+.+++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||.|||++.
T Consensus 74 --------------~~lv~e~~~~~~l~~~i~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~ 135 (256)
T cd05113 74 --------------IYIVTEYMSNGCLLNYLRE----HGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD 135 (256)
T ss_pred --------------cEEEEEcCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC
Confidence 3999999999999999975 1236899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||+++........ ......++..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 136 ~-------~~~kl~d~g~~~~~~~~~~~---------~~~~~~~~~~y~~pe~~~~----~~~~~~~Di~slG~~l~~l~ 195 (256)
T cd05113 136 Q-------GCVKVSDFGLSRYVLDDEYT---------SSVGSKFPVRWSPPEVLLY----SKFSSKSDVWAFGVLMWEVY 195 (256)
T ss_pred C-------CCEEECCCccceecCCCcee---------ecCCCccChhhCCHHHHhc----CcccchhHHHHHHHHHHHHh
Confidence 6 46999999998765332111 0111235678999999975 56788999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 743 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 743 T-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
+ |..||...+..++...+.++.++..+. ..+..+.+++.+||+.+|.+||++
T Consensus 196 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~cl~~~p~~Rp~~ 248 (256)
T cd05113 196 SLGKMPYERFNNSETVEKVSQGLRLYRPH---------------------------LASEKVYAIMYSCWHEKAEERPTF 248 (256)
T ss_pred cCCCCCcCcCCHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCcccCCCH
Confidence 9 999998887777777776654332221 124578999999999999999999
Q ss_pred HHHHHHHH
Q 003185 822 GDLYEMFV 829 (840)
Q Consensus 822 ~ELLehLe 829 (840)
.+|++.|+
T Consensus 249 ~~ll~~~~ 256 (256)
T cd05113 249 QQLLSSIE 256 (256)
T ss_pred HHHHHhhC
Confidence 99998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=341.61 Aligned_cols=283 Identities=17% Similarity=0.220 Sum_probs=204.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++.+.||+|+||.||+|.+ .+..+|+|+..... ....... .+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~ 87 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAK----RAYRELVLMKCVNHKNIISLLNVFTP 87 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc--cChHHHH----HHHHHHHHHHHhCCCchhceeeeeec
Confidence 3578999999999999999999986 56788888754321 2222222 34789999999999999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.... ......|+||||+++ +|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 88 ~~~~--------~~~~~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nil 151 (355)
T cd07874 88 QKSL--------EEFQDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151 (355)
T ss_pred cccc--------cccceeEEEhhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEE
Confidence 4322 122346999999975 78777753 4788999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 152 l~~~-------~~~kl~Dfg~~~~~~~~~~-----------~~~~~~t~~y~aPE~~~~----~~~~~~~DiwslG~il~ 209 (355)
T cd07874 152 VKSD-------CTLKILDFGLARTAGTSFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMG 209 (355)
T ss_pred ECCC-------CCEEEeeCcccccCCCccc-----------cCCccccCCccCHHHHcC----CCCCchhhHHHHHHHHH
Confidence 9876 4699999999976533211 123468999999999976 56889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCc------ccc-----ccccCCCC---CCchhhhhhHHHHHH
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH------EHE-----VAQSGSGF---EKPEAELETLSFLVD 805 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~------~~~-----~~~~~~~~---~~~~~~~~~s~~L~d 805 (840)
+|++|+.||.+.+..+....+........++.+....... ... +....... ............+.+
T Consensus 210 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (355)
T cd07874 210 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 289 (355)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHH
Confidence 9999999998887665554443332212222111110000 000 00000000 001111223467899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHH
Q 003185 806 VFRRCTEENPTERPTAGDLYEMF 828 (840)
Q Consensus 806 LI~rCL~~DP~eRPSa~ELLehL 828 (840)
||.+||..||.+|||+.|+++|.
T Consensus 290 li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 290 LLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred HHHHHhcCCchhcCCHHHHhcCc
Confidence 99999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=348.98 Aligned_cols=262 Identities=23% Similarity=0.280 Sum_probs=200.0
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
.|++++.||+|+||.||+|+. .+..+|+|+...... ........+.+|+.++++++|||||++++.+.....
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-----~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~- 75 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-----LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN- 75 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-----hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCE-
Confidence 589999999999999999987 567889998653211 111222345899999999999999999999986653
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.||||||+++|+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 76 -------------~~lv~E~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~ 137 (382)
T cd05625 76 -------------LYFVMDYIPGGDMMSLLIR-----MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD 137 (382)
T ss_pred -------------EEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 5999999999999999975 2468899999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCccccccccccccc-------------------------------------ccCCCCCCCcccC
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCI-------------------------------------AHRGIPAPDVCVG 706 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~vG 706 (840)
+.+||+|||++..+......... ...........+|
T Consensus 138 -------g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 210 (382)
T cd05625 138 -------GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVG 210 (382)
T ss_pred -------CCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccc
Confidence 46999999998643211000000 0000001123579
Q ss_pred CCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCcchHHhhhccCccccccc
Q 003185 707 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQ 785 (840)
Q Consensus 707 T~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~ 785 (840)
|+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.++.+....+.... ...++.
T Consensus 211 t~~Y~aPE~~~~----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--------------- 271 (382)
T cd05625 211 TPNYIAPEVLLR----TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPP--------------- 271 (382)
T ss_pred CcccCCHHHhcC----CCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCC---------------
Confidence 999999999976 568899999999999999999999999887776665554421 111110
Q ss_pred cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC---HHHHHHHH
Q 003185 786 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT---AGDLYEMF 828 (840)
Q Consensus 786 ~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS---a~ELLehL 828 (840)
....++.+.+||.+|+ .+|.+|++ ++++++|.
T Consensus 272 ----------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp 306 (382)
T cd05625 272 ----------QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHP 306 (382)
T ss_pred ----------cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCC
Confidence 0122457889998876 59999997 99999884
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=325.44 Aligned_cols=264 Identities=22% Similarity=0.360 Sum_probs=203.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 574 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~ 574 (840)
...++|.+.+.||+|+||.||+|.+.. ..+++|.. .... ....... +.+|+.+++.++|+||++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~--~~~~-~~~~~~~----~~~e~~~l~~l~~~~i~~~~ 75 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--PESC-SEQDESD----FLMEALIMSKFNHQNIVRLI 75 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEc--CCCC-CHHHHHH----HHHHHHHHHhCCCCCEeeEE
Confidence 455789999999999999999999854 45555553 3221 1222223 48899999999999999999
Q ss_pred eEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Q 003185 575 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHIMHRD 652 (840)
Q Consensus 575 g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~--~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRD 652 (840)
+++..... .++||||+++++|.+++...... ....+++..++.++.||+.||+|||+++++|||
T Consensus 76 ~~~~~~~~--------------~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~d 141 (277)
T cd05036 76 GVSFERLP--------------RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRD 141 (277)
T ss_pred EEEccCCC--------------cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecc
Confidence 98876553 39999999999999999763211 123588999999999999999999999999999
Q ss_pred CCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHH
Q 003185 653 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 732 (840)
Q Consensus 653 LKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVW 732 (840)
|||+|||++..+. ...+||+|||+++.+....... .......+..|+|||++.+ ..++.++|||
T Consensus 142 lkp~nil~~~~~~----~~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~Diw 205 (277)
T cd05036 142 IAARNCLLTCKGP----GRVAKIADFGMARDIYRASYYR--------KGGRAMLPIKWMPPEAFLD----GIFTSKTDVW 205 (277)
T ss_pred cchheEEEeccCC----CcceEeccCccccccCCcccee--------cCCCCCccHhhCCHHHHhc----CCcCchhHHH
Confidence 9999999986531 2469999999998663221110 0111234568999999975 5689999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 003185 733 SYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 811 (840)
Q Consensus 733 SLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL 811 (840)
||||++|||++ |..||.+.+...+...+.....+..+ ...+..+.+++.+||
T Consensus 206 slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~cl 258 (277)
T cd05036 206 SFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPP---------------------------KGCPGPVYRIMTDCW 258 (277)
T ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHc
Confidence 99999999997 99999888777766666544322211 112457899999999
Q ss_pred ccCCCCCCCHHHHHHHHH
Q 003185 812 EENPTERPTAGDLYEMFV 829 (840)
Q Consensus 812 ~~DP~eRPSa~ELLehLe 829 (840)
+.+|.+||++.+|++||.
T Consensus 259 ~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 259 QHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCcccCcCHHHHHHHhh
Confidence 999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=348.90 Aligned_cols=263 Identities=22% Similarity=0.306 Sum_probs=206.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
...++|++.+.||+|+||.||++.+ .+..+|+|+....... ..... ..+.+|+.+++.++||||+++++++..
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDS----AFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhH----HHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 3457899999999999999999997 4678999986432111 11112 234789999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 115 ~~~--------------~~lv~Ey~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NIL 174 (370)
T cd05621 115 DKY--------------LYMVMEYMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNML 174 (370)
T ss_pred CCE--------------EEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEE
Confidence 653 5999999999999999975 35889999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++......... ......||+.|||||++.+......++.++|||||||+||
T Consensus 175 l~~~-------~~~kL~DFG~a~~~~~~~~~---------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ily 238 (370)
T cd05621 175 LDKH-------GHLKLADFGTCMKMDETGMV---------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLF 238 (370)
T ss_pred ECCC-------CCEEEEecccceecccCCce---------ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHH
Confidence 9877 46999999999865432111 1134569999999999976333345789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCC-CCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC-
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE- 817 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e- 817 (840)
||++|..||.+.+.......+.... ...++. ....+..+.+|+.+||..+|.+
T Consensus 239 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------------------~~~~s~~~~~li~~~L~~~~~r~ 293 (370)
T cd05621 239 EMLVGDTPFYADSLVGTYSKIMDHKNSLNFPE-------------------------DVEISKHAKNLICAFLTDREVRL 293 (370)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCcccCCCC-------------------------cccCCHHHHHHHHHHccCchhcc
Confidence 9999999999888777766665432 111111 0123557899999999865544
Q ss_pred -CCCHHHHHHHHHh
Q 003185 818 -RPTAGDLYEMFVA 830 (840)
Q Consensus 818 -RPSa~ELLehLe~ 830 (840)
|+++.++++|.+-
T Consensus 294 ~R~~~~e~l~hp~~ 307 (370)
T cd05621 294 GRNGVEEIKQHPFF 307 (370)
T ss_pred CCCCHHHHhcCccc
Confidence 8999999999654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=343.51 Aligned_cols=258 Identities=21% Similarity=0.300 Sum_probs=196.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+.+|++.+.||+|+||.||+|.+ .+..||+|+..... .. .....+.+|+.+++.++|+||+++++++..
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 143 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---ED----TVRRQICREIEILRDVNHPNVVKCHDMFDH 143 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cH----HHHHHHHHHHHHHHhCCCCCcceeeeEecc
Confidence 5678899999999999999999997 46789999864321 11 223345899999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .++||||+++++|... ....+..+..++.||+.||.|||++||+||||||+|||
T Consensus 144 ~~~--------------~~lv~e~~~~~~L~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 200 (353)
T PLN00034 144 NGE--------------IQVLLEFMDGGSLEGT---------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLL 200 (353)
T ss_pred CCe--------------EEEEEecCCCCccccc---------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEE
Confidence 553 4999999999998643 23567788899999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~kSDVWSLGvIL 738 (840)
|+.+ +.+||+|||+++.+...... .....||..|+|||++.... .....+.++|||||||+|
T Consensus 201 l~~~-------~~~kL~DfG~~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil 263 (353)
T PLN00034 201 INSA-------KNVKIADFGVSRILAQTMDP----------CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSI 263 (353)
T ss_pred EcCC-------CCEEEcccccceeccccccc----------ccccccCccccCccccccccccCcCCCcchhHHHHHHHH
Confidence 9877 45999999999865432111 12346999999999985321 123346799999999999
Q ss_pred HHHHhCCCCCCCCCHHH---HHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 739 LELLTLQVPYMGLSELE---IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~e---l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
|||++|+.||......+ +...+.....+..+ ...+..+.+||.+||..||
T Consensus 264 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~~P 316 (353)
T PLN00034 264 LEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAP---------------------------ATASREFRHFISCCLQREP 316 (353)
T ss_pred HHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCC---------------------------CccCHHHHHHHHHHccCCh
Confidence 99999999997432222 22222221111111 1235579999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 003185 816 TERPTAGDLYEMFVARTS 833 (840)
Q Consensus 816 ~eRPSa~ELLehLe~l~~ 833 (840)
.+||++.||++|.+-...
T Consensus 317 ~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 317 AKRWSAMQLLQHPFILRA 334 (353)
T ss_pred hhCcCHHHHhcCcccccC
Confidence 999999999999654443
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=339.30 Aligned_cols=249 Identities=25% Similarity=0.328 Sum_probs=198.7
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEecCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 582 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~~~~ 582 (840)
+|.+.+.||+|+||.||+|.+ .+..+|+|+....... .....+ .+..|..++..+. |++|+++++++...+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVE----CTMVEKRVLALSGKPPFLTQLHSCFQTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHH----HHHHHHHHHHhccCCCeEeeEEEEEecCCE
Confidence 588999999999999999987 4568999987543211 111222 2367888888774 8999999999876553
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.||||||+++|+|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~ 136 (323)
T cd05616 76 --------------LYFVMEYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS 136 (323)
T ss_pred --------------EEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECC
Confidence 5999999999999999875 356899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 137 ~-------~~~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~ell 195 (323)
T cd05616 137 E-------GHIKIADFGMCKENMWDGV----------TTKTFCGTPDYIAPEIIAY----QPYGKSVDWWAFGVLLYEML 195 (323)
T ss_pred C-------CcEEEccCCCceecCCCCC----------ccccCCCChhhcCHHHhcC----CCCCCccchhchhHHHHHHH
Confidence 7 4699999999875322111 1123469999999999986 66889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA- 821 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa- 821 (840)
||+.||.+.+..++...+..... .++. ..+..+.+|+.+||+.||.+|+++
T Consensus 196 tg~~Pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05616 196 AGQAPFEGEDEDELFQSIMEHNV-AYPK---------------------------SMSKEAVAICKGLMTKHPGKRLGCG 247 (323)
T ss_pred hCCCCCCCCCHHHHHHHHHhCCC-CCCC---------------------------cCCHHHHHHHHHHcccCHHhcCCCC
Confidence 99999998888877777665422 1111 124578999999999999999984
Q ss_pred ----HHHHHH
Q 003185 822 ----GDLYEM 827 (840)
Q Consensus 822 ----~ELLeh 827 (840)
.++++|
T Consensus 248 ~~~~~~i~~h 257 (323)
T cd05616 248 PEGERDIKEH 257 (323)
T ss_pred CCCHHHHhcC
Confidence 788776
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=328.13 Aligned_cols=262 Identities=21% Similarity=0.352 Sum_probs=204.1
Q ss_pred CceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEe
Q 003185 506 SLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 578 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~ 578 (840)
+|++.+.||+|+||.||+|.... ..+++|+.... ....... .+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN---ASSSELR----DLLSEFNLLKQVNHPHVIKLYGACS 73 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC---CCHHHHH----HHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 47889999999999999998632 35777764321 1222233 3489999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-------------------cCCCCCCHHHHHHHHHHHHHH
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------------TGEKHVSVKLALFIAQDVAAA 639 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-------------------~~~~~ls~~~~~~Ia~QIa~A 639 (840)
.... .++||||+.+++|.+++..... .....+++..++.++.||+.|
T Consensus 74 ~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~ 139 (290)
T cd05045 74 QDGP--------------LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRG 139 (290)
T ss_pred cCCC--------------cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHH
Confidence 6553 3999999999999999875211 112357889999999999999
Q ss_pred HHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcc
Q 003185 640 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 719 (840)
Q Consensus 640 L~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~ 719 (840)
|.|||++||+||||||+|||++.+ ..+||+|||+++......... ......++..|+|||++.+
T Consensus 140 l~~LH~~~ivH~dikp~nill~~~-------~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~apE~~~~- 203 (290)
T cd05045 140 MQYLAEMKLVHRDLAARNVLVAEG-------RKMKISDFGLSRDVYEEDSYV--------KRSKGRIPVKWMAIESLFD- 203 (290)
T ss_pred HHHHHHCCeehhhhhhheEEEcCC-------CcEEeccccccccccCccchh--------cccCCCCCccccCHHHHcc-
Confidence 999999999999999999999876 469999999997653321110 0112235678999999875
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhh
Q 003185 720 HKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 798 (840)
Q Consensus 720 ~~~~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 798 (840)
..++.++||||||+++|||++ |..||.+..+..+...+........+ ..
T Consensus 204 ---~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~ 253 (290)
T cd05045 204 ---HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERP---------------------------EN 253 (290)
T ss_pred ---CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCC---------------------------CC
Confidence 567899999999999999998 99999888887777666554322211 11
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 003185 799 TLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 799 ~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~~ 834 (840)
.+..+.+|+.+||+.+|.+||++.++++.|+.+...
T Consensus 254 ~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 254 CSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred CCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 245789999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=339.42 Aligned_cols=244 Identities=26% Similarity=0.386 Sum_probs=191.9
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEecCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 587 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~~~~~~p~~~ 587 (840)
+.||+|+||.||+|.+ .+..||+|++....... ....+ .+..|..++..+ +||||+++++++....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~----~~~~e~~~l~~~~~hp~i~~~~~~~~~~~------ 69 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE-DDDVE----CTMVERRVLALAWEHPFLTHLFCTFQTKE------ 69 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhhHH----HHHHHHHHHHhccCCCCccceeeEEEcCC------
Confidence 4699999999999987 45679999876432111 11122 225666676654 7999999999987654
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccC
Q 003185 588 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667 (840)
Q Consensus 588 g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~ 667 (840)
..|+||||++||+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~gg~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~---- 132 (316)
T cd05592 70 --------HLFFVMEYLNGGDLMFHIQS-----SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD---- 132 (316)
T ss_pred --------EEEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC----
Confidence 35999999999999999875 3568999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003185 668 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 747 (840)
Q Consensus 668 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~P 747 (840)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..|
T Consensus 133 ---~~~kL~Dfg~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell~G~~P 195 (316)
T cd05592 133 ---GHIKIADFGMCKENMNGEG----------KASTFCGTPDYIAPEILKG----QKYNESVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred ---CCEEEccCcCCeECCCCCC----------ccccccCCccccCHHHHcC----CCCCCcccchhHHHHHHHHHhCCCC
Confidence 4599999999975432111 1233569999999999976 5678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 003185 748 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG-DLYE 826 (840)
Q Consensus 748 F~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~-ELLe 826 (840)
|.+.+..++...+.... +.++. ..+..+.+||.+||..||.+||++. ++++
T Consensus 196 f~~~~~~~~~~~i~~~~-~~~~~---------------------------~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 196 FHGEDEDELFDSILNDR-PHFPR---------------------------WISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHcCC-CCCCC---------------------------CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 99888877777665432 22221 1244688999999999999999864 6776
Q ss_pred H
Q 003185 827 M 827 (840)
Q Consensus 827 h 827 (840)
|
T Consensus 248 h 248 (316)
T cd05592 248 H 248 (316)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=325.11 Aligned_cols=262 Identities=22% Similarity=0.349 Sum_probs=206.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 574 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~ 574 (840)
+..++|++.+.||+|+||.||+|.+.+ ..+++|+.... ....... .+.+|+.+++.++||||++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~---~~~~~~~----~~~~e~~~l~~~~~~~i~~~~ 75 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN---ASMRERI----EFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc---cCHHHHH----HHHHHHHHHHhCCCCceeEEE
Confidence 456789999999999999999998743 56888885321 1112222 348899999999999999999
Q ss_pred eEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Q 003185 575 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----GEKHVSVKLALFIAQDVAAALVELHSKHIM 649 (840)
Q Consensus 575 g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-----~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIV 649 (840)
+++..... .++||||+++++|.+++...... ....+++..++.++.||+.||.|||+++|+
T Consensus 76 ~~~~~~~~--------------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 141 (277)
T cd05032 76 GVVSTGQP--------------TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFV 141 (277)
T ss_pred EEEcCCCC--------------cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 99876553 49999999999999999753221 123478889999999999999999999999
Q ss_pred cccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchh
Q 003185 650 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 729 (840)
Q Consensus 650 HRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kS 729 (840)
||||||+|||++.+ +.+||+|||+++.+...... .......++..|+|||.+.. ..++.++
T Consensus 142 H~di~p~nill~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~ 202 (277)
T cd05032 142 HRDLAARNCMVAED-------LTVKIGDFGMTRDIYETDYY--------RKGGKGLLPVRWMAPESLKD----GVFTTKS 202 (277)
T ss_pred ccccChheEEEcCC-------CCEEECCcccchhhccCccc--------ccCCCCCccccccCHHHHhc----CCCCccc
Confidence 99999999999877 45999999998765432211 01122346789999999875 5678999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHH
Q 003185 730 DIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 808 (840)
Q Consensus 730 DVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~ 808 (840)
|||||||++|||++ |..||...+..+....+.....+.++. ..+..+.+|+.
T Consensus 203 Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~ 255 (277)
T cd05032 203 DVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPE---------------------------NCPDKLLELMR 255 (277)
T ss_pred chHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHH
Confidence 99999999999998 999998888877777666443332221 12457899999
Q ss_pred HhcccCCCCCCCHHHHHHHHHh
Q 003185 809 RCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 809 rCL~~DP~eRPSa~ELLehLe~ 830 (840)
+||+.+|.+|||+.+|++.|+.
T Consensus 256 ~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 256 MCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHcCCChhhCCCHHHHHHHhcC
Confidence 9999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=326.12 Aligned_cols=262 Identities=20% Similarity=0.283 Sum_probs=204.3
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCe----eEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeE
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 576 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~----~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~ 576 (840)
...+|++.+.||+|+||.||+|.+ .+. .+++|..... ...... ..+..|+.+++++.||||++++++
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~----~~~~~~~~~l~~l~h~~iv~~~~~ 77 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR---SGRQTF----QEITDHMLAMGSLDHAYIVRLLGI 77 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc---cchHHH----HHHHHHHHHHhcCCCCCcceEEEE
Confidence 456889999999999999999997 333 3555553211 111122 234788889999999999999998
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
+... ..+++|||+++|+|.+++.. ....+++..++.|+.||+.||.|||++|++||||||+
T Consensus 78 ~~~~---------------~~~~i~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~ 138 (279)
T cd05111 78 CPGA---------------SLQLVTQLSPLGSLLDHVRQ----HRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAAR 138 (279)
T ss_pred ECCC---------------ccEEEEEeCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcc
Confidence 7432 23899999999999999975 2346899999999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
|||++.+ +.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||
T Consensus 139 nili~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slG~ 199 (279)
T cd05111 139 NILLKSD-------SIVQIADFGVADLLYPDDKK--------YFYSEHKTPIKWMALESILF----GRYTHQSDVWSYGV 199 (279)
T ss_pred eEEEcCC-------CcEEEcCCccceeccCCCcc--------cccCCCCCcccccCHHHhcc----CCcCchhhHHHHHH
Confidence 9999876 56999999999765332111 01122347788999999975 56889999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 737 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 737 IL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
++|||++ |..||.+.....+...+..+..+..+. .++..+.+++.+||..||
T Consensus 200 il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~c~~~~p 252 (279)
T cd05111 200 TVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQ---------------------------ICTIDVYMVMVKCWMIDE 252 (279)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCC---------------------------CCCHHHHHHHHHHcCCCc
Confidence 9999998 999998887777666666554332221 113467889999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCCC
Q 003185 816 TERPTAGDLYEMFVARTSSSI 836 (840)
Q Consensus 816 ~eRPSa~ELLehLe~l~~~~~ 836 (840)
.+|||+.++++.|..+..+++
T Consensus 253 ~~Rps~~el~~~l~~~~~~~~ 273 (279)
T cd05111 253 NVRPTFKELANEFTRMARDPP 273 (279)
T ss_pred ccCcCHHHHHHHHHHHHhCCc
Confidence 999999999999998876654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=343.17 Aligned_cols=260 Identities=23% Similarity=0.276 Sum_probs=204.6
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|.+.+.||+|+||.||+|.. .+..+|+|+....... .. .....+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~----~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-AQ----ETVSFFEEERDILSISNSPWIPQLQYAFQDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh-hh----hHHHHHHHHHHHHHhCCCCCCcceeeEEecCCe
Confidence 4799999999999999999987 5778999987643211 11 122345889999999999999999999876543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.||||||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~ 137 (330)
T cd05601 76 --------------LYLVMEYQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR 137 (330)
T ss_pred --------------EEEEECCCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECC
Confidence 59999999999999999762 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC--CCCCCchhhHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK--PNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~--~~~~s~kSDVWSLGvIL~E 740 (840)
+ +.+||+|||++..+...... ......||+.|+|||++..... ...++.++|||||||++||
T Consensus 138 ~-------~~~kL~Dfg~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~e 201 (330)
T cd05601 138 T-------GHIKLADFGSAARLTANKMV---------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYE 201 (330)
T ss_pred C-------CCEEeccCCCCeECCCCCce---------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeee
Confidence 7 45999999999765432111 1123468999999999874221 2457889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCC-CCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|++|..||...+....+..+..... ..++. ....+..+.+||.+||. +|.+||
T Consensus 202 l~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~~~~~~~li~~ll~-~p~~R~ 255 (330)
T cd05601 202 MIYGRSPFHEGTSAKTYNNIMNFQRFLKFPE-------------------------DPKVSSDFLDLIQSLLC-GQKERL 255 (330)
T ss_pred eccCCCCCCCCCHHHHHHHHHcCCCccCCCC-------------------------CCCCCHHHHHHHHHHcc-ChhhCC
Confidence 9999999988877776666654321 11110 01235578999999998 999999
Q ss_pred CHHHHHHHHH
Q 003185 820 TAGDLYEMFV 829 (840)
Q Consensus 820 Sa~ELLehLe 829 (840)
+++++++|..
T Consensus 256 t~~~l~~h~~ 265 (330)
T cd05601 256 GYEGLCCHPF 265 (330)
T ss_pred CHHHHhCCCC
Confidence 9999998843
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=320.46 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=206.5
Q ss_pred CCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
..++|++.+.||.|+||.||+|...+..+++|....... ..+ ++.+|+.+++.++|+||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-----~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 74 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-----AAQ----AFLAEASVMTTLRHPNLVQLLGVVLQGNP 74 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-----HHH----HHHHHHHHHHhcCCcceeeeEEEEcCCCC
Confidence 467899999999999999999999999999998753321 223 34899999999999999999999876443
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.++||||+++++|.+++.. .....+++..++.++.|++.||.|||++||+|+||||+|||++.
T Consensus 75 --------------~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~ 137 (256)
T cd05039 75 --------------LYIVTEYMAKGSLVDYLRS---RGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSE 137 (256)
T ss_pred --------------eEEEEEecCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeC
Confidence 4999999999999999976 22236899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.++|+|||.++....... ...++..|+|||++.. ..++.++||||||+++|+|+
T Consensus 138 ~-------~~~~l~d~g~~~~~~~~~~-------------~~~~~~~~~ape~~~~----~~~~~~~Di~slG~il~~l~ 193 (256)
T cd05039 138 D-------LVAKVSDFGLAKEASQGQD-------------SGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEIY 193 (256)
T ss_pred C-------CCEEEcccccccccccccc-------------cCCCcccccCchhhcC----CcCCcHHHHHHHHHHHHHHH
Confidence 6 4699999999976532111 1234568999999875 56788999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 743 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 743 T-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
+ |..||......++...+.....+..+ ...++.+.+||.+||..+|.+||++
T Consensus 194 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~ 246 (256)
T cd05039 194 SFGRVPYPRIPLKDVVPHVEKGYRMEAP---------------------------EGCPPEVYKVMKDCWELDPAKRPTF 246 (256)
T ss_pred hcCCCCCCCCCHHHHHHHHhcCCCCCCc---------------------------cCCCHHHHHHHHHHhccChhhCcCH
Confidence 7 99999888777776666554332221 1124578999999999999999999
Q ss_pred HHHHHHHHhh
Q 003185 822 GDLYEMFVAR 831 (840)
Q Consensus 822 ~ELLehLe~l 831 (840)
.++++.|+.+
T Consensus 247 ~~l~~~l~~~ 256 (256)
T cd05039 247 KQLREQLALI 256 (256)
T ss_pred HHHHHHHhcC
Confidence 9999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=328.95 Aligned_cols=260 Identities=23% Similarity=0.389 Sum_probs=201.3
Q ss_pred CCCceeeeeecccCceEEEEEEECC--e--eEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEe
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFGS--A--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 578 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~--~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~ 578 (840)
|++|++.+.||+|+||.||+|.... . .+++|... .. ......+ .+.+|+.++.++ +||||+++++++.
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~--~~-~~~~~~~----~~~~E~~~l~~l~~hp~iv~~~~~~~ 73 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EF-ASENDHR----DFAGELEVLCKLGHHPNIINLLGACE 73 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcc--cc-CCHHHHH----HHHHHHHHHHhhcCCCchhheEEEEc
Confidence 5789999999999999999998733 2 34666533 21 1122222 348899999999 6999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVELHSKH 647 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-----------~~~~ls~~~~~~Ia~QIa~AL~yLHs~g 647 (840)
.... .++||||+++++|.+++...... ....+++..++.++.||+.||+|||++|
T Consensus 74 ~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ 139 (297)
T cd05089 74 NRGY--------------LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ 139 (297)
T ss_pred cCCc--------------ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 6553 49999999999999999752110 1135889999999999999999999999
Q ss_pred eecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCc
Q 003185 648 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 727 (840)
Q Consensus 648 IVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~ 727 (840)
|+||||||+|||++.+ ..+||+|||++........ ......+..|+|||++.+ ..++.
T Consensus 140 ivH~dlkp~Nill~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~ 197 (297)
T cd05089 140 FIHRDLAARNVLVGEN-------LASKIADFGLSRGEEVYVK-----------KTMGRLPVRWMAIESLNY----SVYTT 197 (297)
T ss_pred cccCcCCcceEEECCC-------CeEEECCcCCCccccceec-----------cCCCCcCccccCchhhcc----CCCCc
Confidence 9999999999999876 4699999999864321100 011123567999999875 56789
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHH
Q 003185 728 EVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 806 (840)
Q Consensus 728 kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dL 806 (840)
++|||||||++|||++ |..||......++...+.....+..+. ..+..+.+|
T Consensus 198 ~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l 250 (297)
T cd05089 198 KSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPR---------------------------NCDDEVYEL 250 (297)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHH
Confidence 9999999999999997 999998888777776665543322221 124578999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003185 807 FRRCTEENPTERPTAGDLYEMFVARTS 833 (840)
Q Consensus 807 I~rCL~~DP~eRPSa~ELLehLe~l~~ 833 (840)
+.+||..+|.+||++++|++.|+.+..
T Consensus 251 i~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 251 MRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 999999999999999999999887765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=345.57 Aligned_cols=277 Identities=22% Similarity=0.238 Sum_probs=198.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
+...+|++.+.||+|+||.||+|.+ .+..+|+|... .. .+.+|+.+|++|+|||||++++++..
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----------~~----~~~~E~~il~~l~HpnIv~~~~~~~~ 154 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----------RG----GTATEAHILRAINHPSIIQLKGTFTY 154 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----------hh----hhHHHHHHHHhCCCCCCCCEeEEEEE
Confidence 4456899999999999999999997 56678888532 11 23789999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .++|||++. ++|..++.. ...+++..++.++.||+.||.|||++|||||||||+|||
T Consensus 155 ~~~--------------~~lv~e~~~-~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIl 214 (391)
T PHA03212 155 NKF--------------TCLILPRYK-TDLYCYLAA-----KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIF 214 (391)
T ss_pred CCe--------------eEEEEecCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEE
Confidence 553 499999996 699998875 356889999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||+|+........ ......||+.|+|||++.+ ..++.++|||||||+||
T Consensus 215 l~~~-------~~vkL~DFG~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~ 274 (391)
T PHA03212 215 INHP-------GDVCLGDFGAACFPVDINAN---------KYYGWAGTIATNAPELLAR----DPYGPAVDIWSAGIVLF 274 (391)
T ss_pred EcCC-------CCEEEEeCCccccccccccc---------ccccccCccCCCChhhhcC----CCCCcHHHHHHHHHHHH
Confidence 9877 45999999999754321110 1123469999999999976 56899999999999999
Q ss_pred HHHhCCCCCCCCC-------HHHHHHHHHcC-C-CC-Ccch----HHhhhccCccccccccCCCCCCchhhhhhHHHHHH
Q 003185 740 ELLTLQVPYMGLS-------ELEIHDLIQMG-K-RP-RLTD----ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 805 (840)
Q Consensus 740 ELLTG~~PF~~~~-------~~el~~~I~~~-~-~p-~l~~----~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~d 805 (840)
||++|..||.... ....+..+... . .+ .++. .+...........................+..+.+
T Consensus 275 elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 354 (391)
T PHA03212 275 EMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEY 354 (391)
T ss_pred HHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHH
Confidence 9999998875421 12222222221 1 11 1110 00000000000000000000011112234668999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhhc
Q 003185 806 VFRRCTEENPTERPTAGDLYEMFVART 832 (840)
Q Consensus 806 LI~rCL~~DP~eRPSa~ELLehLe~l~ 832 (840)
||.+||++||.+|||+.|+++|-.-..
T Consensus 355 Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 355 LICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred HHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 999999999999999999999866543
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=336.82 Aligned_cols=278 Identities=24% Similarity=0.303 Sum_probs=201.6
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
-++|++.++||+|+||.||++.+ .+..+|+|+..... ..... ..+.+|++++++++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIR----NQIIRELQVLHECNSPYIVGFYGAFYSDG 76 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHH----HHHHHHHHHHHHCCCCcccceeEEEEECC
Confidence 46899999999999999999998 46678888765432 12222 33489999999999999999999998665
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCCCcEEE
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILI 660 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~-gIVHRDLKPeNILL 660 (840)
. .++||||+++++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||+
T Consensus 77 ~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili 137 (333)
T cd06650 77 E--------------ISICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 137 (333)
T ss_pred E--------------EEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE
Confidence 3 5999999999999999975 34688999999999999999999975 79999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||++..+.... .....||..|+|||++.+ ..++.++|||||||++|+
T Consensus 138 ~~~-------~~~kL~Dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~~ 194 (333)
T cd06650 138 NSR-------GEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYSVQSDIWSMGLSLVE 194 (333)
T ss_pred cCC-------CCEEEeeCCcchhhhhhc------------cccCCCCccccCHHHhcC----CCCCcHHHHHHHHHHHHH
Confidence 876 459999999987553211 122468999999999976 567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHH--hh-------hccCccc--------cccccCCCCC-CchhhhhhHHH
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL--EA-------LGSCHEH--------EVAQSGSGFE-KPEAELETLSF 802 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l--~~-------~~~~~~~--------~~~~~~~~~~-~~~~~~~~s~~ 802 (840)
|++|+.||......++...+............ .. ....... .......... ........+.+
T Consensus 195 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (333)
T cd06650 195 MAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAE 274 (333)
T ss_pred HHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHH
Confidence 99999999876655544333211000000000 00 0000000 0000000000 00000123567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003185 803 LVDVFRRCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 803 L~dLI~rCL~~DP~eRPSa~ELLehLe~ 830 (840)
+.+||.+||++||.+|||+.+++.|..-
T Consensus 275 ~~~li~~~L~~~P~~Rpt~~ell~h~~~ 302 (333)
T cd06650 275 FQDFVNKCLIKNPAERADLKQLMVHAFI 302 (333)
T ss_pred HHHHHHHhccCCcccCcCHHHHhhCHHH
Confidence 8999999999999999999999998554
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=327.99 Aligned_cols=261 Identities=20% Similarity=0.318 Sum_probs=206.1
Q ss_pred CCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 575 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g 575 (840)
.+.+|.+.+.||.|+||.||+|.+. +..+|+|+...+. ... +...+.+|+.++..++||||+++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~----~~~~~~~e~~~~~~l~h~~iv~~~~ 75 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGP----LREEFKHEAMMRSRLQHPNIVCLLG 75 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHH----HHHHHHHHHHHHhcCCCCCcCeEEE
Confidence 4567899999999999999999863 3578888864321 111 2234589999999999999999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----------cCCCCCCHHHHHHHHHHHHHHHHHHH
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELH 644 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----------~~~~~ls~~~~~~Ia~QIa~AL~yLH 644 (840)
++..... .++++||+.+++|.+++..... .....+++..++.++.|++.||.|||
T Consensus 76 ~~~~~~~--------------~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH 141 (283)
T cd05091 76 VVTKEQP--------------LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS 141 (283)
T ss_pred EEcCCCc--------------eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 9876553 4999999999999999863110 11235788899999999999999999
Q ss_pred hCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCC
Q 003185 645 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 724 (840)
Q Consensus 645 s~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~ 724 (840)
++||+||||||+|||++.+ ..+||+|||+++........ .......+++.|+|||++.+ ..
T Consensus 142 ~~gi~H~dlkp~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~ 202 (283)
T cd05091 142 SHHVVHKDLATRNVLVFDK-------LNVKISDLGLFREVYAADYY--------KLMGNSLLPIRWMSPEAIMY----GK 202 (283)
T ss_pred HcCccccccchhheEecCC-------CceEecccccccccccchhe--------eeccCccCCccccCHHHHhc----CC
Confidence 9999999999999999876 45999999998865432111 00122346789999999875 56
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHH
Q 003185 725 YGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 803 (840)
Q Consensus 725 ~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L 803 (840)
++.++|||||||++|||++ |..||.+....++...+........+. ..+..+
T Consensus 203 ~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~ 255 (283)
T cd05091 203 FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPD---------------------------DCPAWV 255 (283)
T ss_pred CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHH
Confidence 7899999999999999998 889998888888877777654332221 234578
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003185 804 VDVFRRCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 804 ~dLI~rCL~~DP~eRPSa~ELLehLe~ 830 (840)
.+|+.+||+.+|.+||++.+|+..|+.
T Consensus 256 ~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 256 YTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=340.18 Aligned_cols=283 Identities=18% Similarity=0.215 Sum_probs=204.2
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
.++|++.+.||.|+||.||+|.+ .+..||+|+..... ..... ...+.+|+.+|++++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF--QSLIH----ARRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh--hhhHH----HHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 46899999999999999999986 55678888864221 11111 223478999999999999999999876433
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
.. ......|++|+++ +++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 88 ~~--------~~~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~ 152 (343)
T cd07878 88 SI--------ENFNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN 152 (343)
T ss_pred cc--------cccCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC
Confidence 11 1223469999998 6799988763 4699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||+++..... .....||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 153 ~~-------~~~kl~Dfg~~~~~~~~-------------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el 209 (343)
T cd07878 153 ED-------CELRILDFGLARQADDE-------------MTGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAEL 209 (343)
T ss_pred CC-------CCEEEcCCccceecCCC-------------cCCccccccccCchHhcC---CccCCchhhhHhHHHHHHHH
Confidence 77 45999999999765331 122468999999999875 24578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCC---CchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE---KPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
++|+.||.+.+..+....+........+..+..........+........ .........+.+.+||.+||..||.+|
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R 289 (343)
T cd07878 210 LKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKR 289 (343)
T ss_pred HHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhC
Confidence 99999998877666655554432222222221111000000000000000 001111234568899999999999999
Q ss_pred CCHHHHHHHHHh
Q 003185 819 PTAGDLYEMFVA 830 (840)
Q Consensus 819 PSa~ELLehLe~ 830 (840)
||+.++++|..-
T Consensus 290 ~s~~ell~hp~~ 301 (343)
T cd07878 290 ISASEALAHPYF 301 (343)
T ss_pred CCHHHHhcCcch
Confidence 999999999543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=340.21 Aligned_cols=245 Identities=24% Similarity=0.303 Sum_probs=190.9
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHH-HHHHhCCCCCcceeeeEEecCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEV-RMLGALRHSCIVEMYGHKISSKWLPSAD 587 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi-~iL~~L~HpNIV~l~g~~~~~~~~p~~~ 587 (840)
+.||+|+||.||+|.+ .+..+|+|+...+..... ... ..+..|. .+++.++||||+++++++.....
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~----~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~----- 70 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK-KEE----KHIMSERNVLLKNVKHPFLVGLHFSFQTADK----- 70 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh-hHH----HHHHHHHHHHHHhCCCCCCCceeEEEEcCCe-----
Confidence 4799999999999997 456799998754321111 111 1224444 45678899999999999886653
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccC
Q 003185 588 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667 (840)
Q Consensus 588 g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~ 667 (840)
.|+||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~---- 132 (325)
T cd05602 71 ---------LYFVLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ---- 132 (325)
T ss_pred ---------EEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC----
Confidence 4999999999999999975 3568889999999999999999999999999999999999876
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003185 668 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 747 (840)
Q Consensus 668 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~P 747 (840)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 133 ---~~~kl~DfG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~p 195 (325)
T cd05602 133 ---GHIVLTDFGLCKENIEHNG----------TTSTFCGTPEYLAPEVLHK----QPYDRTVDWWCLGAVLYEMLYGLPP 195 (325)
T ss_pred ---CCEEEccCCCCcccccCCC----------CcccccCCccccCHHHHcC----CCCCCccccccccHHHHHHhcCCCC
Confidence 4599999999875322111 1233569999999999976 6688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH----H
Q 003185 748 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG----D 823 (840)
Q Consensus 748 F~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~----E 823 (840)
|.+.+..+.+..+...... +. ...+..+.+||.+||+.||.+||++. +
T Consensus 196 f~~~~~~~~~~~i~~~~~~-~~---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 196 FYSRNTAEMYDNILNKPLQ-LK---------------------------PNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCCCHHHHHHHHHhCCcC-CC---------------------------CCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 9988877777666543211 00 11245789999999999999999876 5
Q ss_pred HHHHH
Q 003185 824 LYEMF 828 (840)
Q Consensus 824 LLehL 828 (840)
+++|.
T Consensus 248 i~~~~ 252 (325)
T cd05602 248 IKNHI 252 (325)
T ss_pred HhcCc
Confidence 55553
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=338.00 Aligned_cols=245 Identities=25% Similarity=0.376 Sum_probs=193.1
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEecCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 587 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~~~~~~p~~~ 587 (840)
+.||+|+||.||+|.+ .+..+|+|+......... .... .+..|..++..+ +||||+++++++.....
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-~~~~----~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~----- 70 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLID-DDVE----CTMVEKRVLALAWENPFLTHLYCTFQTKEH----- 70 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhc-chHH----HHHHHHHHHHhccCCCCccCeeEEEEeCCE-----
Confidence 4799999999999997 567899998754321111 1122 236788887765 79999999999986653
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccC
Q 003185 588 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667 (840)
Q Consensus 588 g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~ 667 (840)
.|+||||+.+|+|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~E~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~---- 132 (316)
T cd05620 71 ---------LFFVMEFLNGGDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD---- 132 (316)
T ss_pred ---------EEEEECCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC----
Confidence 5999999999999999875 3568999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003185 668 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 747 (840)
Q Consensus 668 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~P 747 (840)
+.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|..|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~el~~g~~P 195 (316)
T cd05620 133 ---GHIKIADFGMCKENVFGD----------NRASTFCGTPDYIAPEILQG----LKYTFSVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred ---CCEEeCccCCCeecccCC----------CceeccCCCcCccCHHHHcC----CCCCcccchhhhHHHHHHHHhCCCC
Confidence 469999999986432111 01233569999999999986 5688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-HHHHH
Q 003185 748 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA-GDLYE 826 (840)
Q Consensus 748 F~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa-~ELLe 826 (840)
|.+.+..++...+.... +.++. ..+..+.+||.+||..||.+||++ +++++
T Consensus 196 f~~~~~~~~~~~~~~~~-~~~~~---------------------------~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 196 FHGDDEDELFESIRVDT-PHYPR---------------------------WITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred CCCCCHHHHHHHHHhCC-CCCCC---------------------------CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 99888777776665432 11211 124578999999999999999997 57776
Q ss_pred HH
Q 003185 827 MF 828 (840)
Q Consensus 827 hL 828 (840)
|.
T Consensus 248 h~ 249 (316)
T cd05620 248 HP 249 (316)
T ss_pred CC
Confidence 63
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=345.58 Aligned_cols=263 Identities=21% Similarity=0.286 Sum_probs=205.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
...++|++.+.||+|+||.||+|.+ .+..+|+|+....... .... ...+.+|+.+++.++||||+++++++..
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~----~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSD----SAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-hhHH----HHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4568999999999999999999997 5678899986432111 1111 2234789999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.. ..|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 115 ~~--------------~~~lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIl 174 (371)
T cd05622 115 DR--------------YLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 174 (371)
T ss_pred CC--------------EEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEE
Confidence 55 35999999999999999875 35889999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++......... ......||+.|||||++........++.++|||||||+||
T Consensus 175 l~~~-------~~ikL~DfG~a~~~~~~~~~---------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvily 238 (371)
T cd05622 175 LDKS-------GHLKLADFGTCMKMNKEGMV---------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 238 (371)
T ss_pred ECCC-------CCEEEEeCCceeEcCcCCcc---------cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHH
Confidence 9876 46999999999765432111 1234569999999999976333345789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCC-CCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC-
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE- 817 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e- 817 (840)
||++|..||...+.......+..... ..++. ....+..+.+||.+||..++.+
T Consensus 239 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~~~~r~ 293 (371)
T cd05622 239 EMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD-------------------------DNDISKEAKNLICAFLTDREVRL 293 (371)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCcccCCC-------------------------cCCCCHHHHHHHHHHcCChhhhc
Confidence 99999999998888777777654321 11111 1123567899999999844433
Q ss_pred -CCCHHHHHHHHHh
Q 003185 818 -RPTAGDLYEMFVA 830 (840)
Q Consensus 818 -RPSa~ELLehLe~ 830 (840)
|+++++|++|..-
T Consensus 294 ~r~~~~ei~~h~~~ 307 (371)
T cd05622 294 GRNGVEEIKRHLFF 307 (371)
T ss_pred CCCCHHHHhcCccc
Confidence 7899999998643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.42 Aligned_cols=261 Identities=28% Similarity=0.395 Sum_probs=205.0
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCC-hHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~-~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
+|.+...||.|+||.||+|.. .+..+++|.+........ ......+.+.+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 478889999999999999986 567899998755433222 12223344566899999999999999999999886654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||++|++||||||+|||++.
T Consensus 81 --------------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~ 141 (267)
T cd06628 81 --------------LNIFLEYVPGGSVAALLNN-----YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDN 141 (267)
T ss_pred --------------cEEEEEecCCCCHHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcC
Confidence 3999999999999999976 346888999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.++|+|||+++.......... .........|+..|+|||.+.+ ..++.++|||||||++|+|+
T Consensus 142 ~-------~~~~l~dfg~~~~~~~~~~~~~----~~~~~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~il~~l~ 206 (267)
T cd06628 142 K-------GGIKISDFGISKKLEANSLSTK----TNGARPSLQGSVFWMAPEVVKQ----TSYTRKADIWSLGCLVVEML 206 (267)
T ss_pred C-------CCEEecccCCCcccccccccCC----ccccccccCCCcCccChhHhcc----CCCCchhhhHHHHHHHHHHh
Confidence 6 4699999999987653221100 0011123458899999999875 56788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
+|+.||...+.......+.....+.++. ..+..+.++|.+||+.||.+||++.
T Consensus 207 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp~~~ 259 (267)
T cd06628 207 TGKHPFPDCTQLQAIFKIGENASPEIPS---------------------------NISSEAIDFLEKTFEIDHNKRPTAA 259 (267)
T ss_pred hCCCCCCCccHHHHHHHHhccCCCcCCc---------------------------ccCHHHHHHHHHHccCCchhCcCHH
Confidence 9999998776555544444433332221 1245789999999999999999999
Q ss_pred HHHHH
Q 003185 823 DLYEM 827 (840)
Q Consensus 823 ELLeh 827 (840)
+|++|
T Consensus 260 ~il~~ 264 (267)
T cd06628 260 ELLKH 264 (267)
T ss_pred HHhhC
Confidence 99986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=322.63 Aligned_cols=261 Identities=20% Similarity=0.302 Sum_probs=204.6
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCe----eEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeE
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 576 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~----~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~ 576 (840)
...+|++.+.||+|+||+||+|.+ .+. .||+|+.... ...... ..+.+|+.+++.+.||||++++++
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~---~~~~~~----~~~~~e~~~l~~~~~~~i~~~~~~ 77 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN---TSPKAN----KEILDEAYVMAGVGSPYVCRLLGI 77 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC---CCHHHH----HHHHHHHHHHHhcCCCCCceEEEE
Confidence 456789999999999999999986 332 4788875422 122222 344889999999999999999998
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
+.... .+++|||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+
T Consensus 78 ~~~~~---------------~~l~~~~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~ 138 (279)
T cd05109 78 CLTST---------------VQLVTQLMPYGCLLDYVRE----NKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAAR 138 (279)
T ss_pred EcCCC---------------cEEEEEcCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 86432 3899999999999999875 2346899999999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
|||++.+ ..+||+|||+++......... ......+++.|+|||.+.+ ..++.++|||||||
T Consensus 139 Nil~~~~-------~~~kL~dfG~~~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~ 199 (279)
T cd05109 139 NVLVKSP-------NHVKITDFGLARLLDIDETEY--------HADGGKVPIKWMALESILH----RRFTHQSDVWSYGV 199 (279)
T ss_pred eEEEcCC-------CcEEECCCCceeeccccccee--------ecCCCccchhhCCHHHhcc----CCCCchhHHHHHHH
Confidence 9999866 459999999998764321110 0111235678999999875 56889999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 737 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 737 IL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
++|||++ |..||.......+...+.....+..+ ...+..+.+++.+||..||
T Consensus 200 ~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~dp 252 (279)
T cd05109 200 TVWELMTFGAKPYDGIPAREIPDLLEKGERLPQP---------------------------PICTIDVYMIMVKCWMIDS 252 (279)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC---------------------------ccCCHHHHHHHHHHcCCCh
Confidence 9999998 99999887776666666554332221 1124578999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCC
Q 003185 816 TERPTAGDLYEMFVARTSSS 835 (840)
Q Consensus 816 ~eRPSa~ELLehLe~l~~~~ 835 (840)
.+||++.++++.|..+...+
T Consensus 253 ~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 253 ECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred hhCcCHHHHHHHHHHhhcCC
Confidence 99999999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=318.51 Aligned_cols=248 Identities=26% Similarity=0.394 Sum_probs=194.5
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 588 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g 588 (840)
+.||+|+||.||+|.+ .+..+|+|+.... ...... ..+.+|+.++++++||||+++++++.....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~---~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------ 67 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET---LPPDLK----AKFLQEARILKQYSHPNIVRLIGVCTQKQP------ 67 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc---CCHHHH----HHHHHHHHHHHhCCCCCcceEEEEEcCCCC------
Confidence 4699999999999987 5778899875321 122222 344899999999999999999999876553
Q ss_pred CCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCC
Q 003185 589 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 668 (840)
Q Consensus 589 ~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~ 668 (840)
.++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 68 --------~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~----- 130 (252)
T cd05084 68 --------IYIVMELVQGGDFLTFLRT----EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK----- 130 (252)
T ss_pred --------eEEEEeeccCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCC-----
Confidence 4999999999999999875 23458899999999999999999999999999999999999876
Q ss_pred CCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 003185 669 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVP 747 (840)
Q Consensus 669 ~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT-G~~P 747 (840)
+.+||+|||++......... .. .....++..|+|||.+.+ ..++.++|||||||++|||++ |..|
T Consensus 131 --~~~kl~dfg~~~~~~~~~~~---~~-----~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~e~~~~~~~p 196 (252)
T cd05084 131 --NVLKISDFGMSREEEDGVYA---ST-----GGMKQIPVKWTAPEALNY----GRYSSESDVWSFGILLWEAFSLGAVP 196 (252)
T ss_pred --CcEEECccccCccccccccc---cc-----CCCCCCceeecCchhhcC----CCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 45999999998754321110 00 011123467999999875 567899999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003185 748 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 827 (840)
Q Consensus 748 F~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLeh 827 (840)
|...........+........+. ..+..+.+|+.+||+.+|.+|||+.+|++.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rps~~~~~~~ 249 (252)
T cd05084 197 YANLSNQQTREAIEQGVRLPCPE---------------------------LCPDAVYRLMERCWEYDPGQRPSFSTVHQE 249 (252)
T ss_pred ccccCHHHHHHHHHcCCCCCCcc---------------------------cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 98777666665555443222211 124578999999999999999999999998
Q ss_pred HH
Q 003185 828 FV 829 (840)
Q Consensus 828 Le 829 (840)
|+
T Consensus 250 l~ 251 (252)
T cd05084 250 LQ 251 (252)
T ss_pred Hh
Confidence 86
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=327.35 Aligned_cols=264 Identities=23% Similarity=0.359 Sum_probs=207.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCccee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 573 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l 573 (840)
...++|++.+.||+|+||.||++.+.+ ..+|+|+.... ........ +.+|+.+++++ +||||+++
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~----~~~E~~~l~~l~~h~~i~~~ 81 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD---ATEKDLSD----LVSEMEMMKMIGKHKNIINL 81 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC---CCHHHHHH----HHHHHHHHHhhcCCCCeeeE
Confidence 456789999999999999999998632 46788875422 12222233 48999999999 79999999
Q ss_pred eeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----------cCCCCCCHHHHHHHHHHHHHHHHH
Q 003185 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVE 642 (840)
Q Consensus 574 ~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----------~~~~~ls~~~~~~Ia~QIa~AL~y 642 (840)
++++..... .++||||+++|+|..++..... .....+++..++.++.||+.||+|
T Consensus 82 ~~~~~~~~~--------------~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~ 147 (293)
T cd05053 82 LGVCTQEGP--------------LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEF 147 (293)
T ss_pred EEEEcCCCC--------------eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 999876543 4999999999999999975210 223568899999999999999999
Q ss_pred HHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC
Q 003185 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 722 (840)
Q Consensus 643 LHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~ 722 (840)
||++||+||||||+|||++.+ +.+||+|||+++.+........ .....++..|+|||++.+
T Consensus 148 LH~~~ivH~dlkp~Nil~~~~-------~~~kL~Dfg~~~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~---- 208 (293)
T cd05053 148 LASKKCIHRDLAARNVLVTED-------HVMKIADFGLARDIHHIDYYRK--------TTNGRLPVKWMAPEALFD---- 208 (293)
T ss_pred HHHCCccccccceeeEEEcCC-------CeEEeCccccccccccccceec--------cCCCCCCccccCHHHhcc----
Confidence 999999999999999999876 5699999999987643221100 011234678999999875
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHH
Q 003185 723 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 801 (840)
Q Consensus 723 ~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 801 (840)
..++.++|||||||++|||++ |..||.+....++...+.....+..+ ...+.
T Consensus 209 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 261 (293)
T cd05053 209 RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKP---------------------------QNCTQ 261 (293)
T ss_pred CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCH
Confidence 567899999999999999997 99999888877777766555332221 11245
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 003185 802 FLVDVFRRCTEENPTERPTAGDLYEMFVART 832 (840)
Q Consensus 802 ~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~ 832 (840)
.+.+|+.+||..||.+|||+.+++++|+.+.
T Consensus 262 ~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 262 ELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 7899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=321.96 Aligned_cols=256 Identities=22% Similarity=0.328 Sum_probs=206.1
Q ss_pred CCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+-.+|++.+.||.|+||.||+|.+ .+..+++|+..... ..... .+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~----~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 75 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD----LLKQQ----DFQKEVQALKRLRHKHLISLFAVCSVGE 75 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc----hhhHH----HHHHHHHHHhcCCCcchhheeeeEecCC
Confidence 345799999999999999999997 45778888854321 11222 3488999999999999999999987655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .++||||+++++|.+++.. .....+++..++.++.||+.||.|||++||+|+||||+|||++
T Consensus 76 ~--------------~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~ 138 (261)
T cd05148 76 P--------------VYIITELMEKGSLLAFLRS---PEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG 138 (261)
T ss_pred C--------------eEEEEeecccCCHHHHHhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc
Confidence 3 4999999999999999975 2234689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||++......... .....++..|+|||.+.. ..++.++||||||+++|+|
T Consensus 139 ~~-------~~~kl~d~g~~~~~~~~~~~----------~~~~~~~~~~~~PE~~~~----~~~~~~~DiwslG~~l~~l 197 (261)
T cd05148 139 ED-------LVCKVADFGLARLIKEDVYL----------SSDKKIPYKWTAPEAASH----GTFSTKSDVWSFGILLYEM 197 (261)
T ss_pred CC-------ceEEEccccchhhcCCcccc----------ccCCCCceEecCHHHHcc----CCCCchhhHHHHHHHHHHH
Confidence 77 46999999999765432111 112235778999999875 5678899999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 742 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 742 LT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
++ |..||...+..+....+.....+..+ ...++.+.+++.+||..||.+|||
T Consensus 198 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rpt 250 (261)
T cd05148 198 FTYGQVPYPGMNNHEVYDQITAGYRMPCP---------------------------AKCPQEIYKIMLECWAAEPEDRPS 250 (261)
T ss_pred HcCCCCCCCcCCHHHHHHHHHhCCcCCCC---------------------------CCCCHHHHHHHHHHcCCCchhCcC
Confidence 98 89999888877777776654332221 122457899999999999999999
Q ss_pred HHHHHHHHHhh
Q 003185 821 AGDLYEMFVAR 831 (840)
Q Consensus 821 a~ELLehLe~l 831 (840)
+.+|++.|+.+
T Consensus 251 ~~~l~~~L~~~ 261 (261)
T cd05148 251 FKALREELDNI 261 (261)
T ss_pred HHHHHHHHhcC
Confidence 99999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.85 Aligned_cols=250 Identities=26% Similarity=0.333 Sum_probs=202.3
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|++.+.||.|+||.||++.+ .+..+++|.+..... ....+ .+.+|+.+++.++||||+++++.+.....
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 72 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS---SSAVE----DSRKEAVLLAKMKHPNIVAFKESFEADGH- 72 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc---hHHHH----HHHHHHHHHHhCCCCCcceEEEEEEECCE-
Confidence 588999999999999999987 567889998654321 12223 33789999999999999999999886553
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.|+||||+++++|.+++.. .....+++..++.++.||+.||.|||++||+|+||||+|||++.+
T Consensus 73 -------------~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~ 136 (255)
T cd08219 73 -------------LYIVMEYCDGGDLMQKIKL---QRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN 136 (255)
T ss_pred -------------EEEEEeeCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC
Confidence 5999999999999999875 223458899999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.++|+|||++......... .....|++.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 137 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~----~~~~~~~Dv~slG~i~~~l~~ 195 (255)
T cd08219 137 -------GKVKLGDFGSARLLTSPGAY----------ACTYVGTPYYVPPEIWEN----MPYNNKSDIWSLGCILYELCT 195 (255)
T ss_pred -------CcEEEcccCcceeecccccc----------cccccCCccccCHHHHcc----CCcCchhhhhhhchhheehhh
Confidence 45999999998765432111 123468899999999876 567899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~E 823 (840)
|..||...+.......+..+....++. ..+..+.+||.+||+.||.+||++.+
T Consensus 196 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~P~~Rp~~~~ 248 (255)
T cd08219 196 LKHPFQANSWKNLILKVCQGSYKPLPS---------------------------HYSYELRSLIKQMFKRNPRSRPSATT 248 (255)
T ss_pred ccCCCCCCCHHHHHHHHhcCCCCCCCc---------------------------ccCHHHHHHHHHHHhCCcccCCCHHH
Confidence 999998887777666665554333221 12346889999999999999999999
Q ss_pred HHHH
Q 003185 824 LYEM 827 (840)
Q Consensus 824 LLeh 827 (840)
|+..
T Consensus 249 il~~ 252 (255)
T cd08219 249 ILSR 252 (255)
T ss_pred Hhhc
Confidence 9864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.94 Aligned_cols=255 Identities=23% Similarity=0.372 Sum_probs=203.8
Q ss_pred CCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+.++|++.+.||+|+||.||+|.+ .+..+|+|...... . ..+. +.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~---~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--M---DPKD----FLAEAQIMKKLRHPKLIQLYAVCTLEE 74 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--c---cHHH----HHHHHHHHHHCCCCCccceeEEEecCC
Confidence 456799999999999999999987 44578888754321 1 1223 388999999999999999999987655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .++||||+++++|.+++... ....+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus 75 ~--------------~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~ 137 (261)
T cd05068 75 P--------------IYIVTELMKYGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG 137 (261)
T ss_pred C--------------eeeeeecccCCcHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc
Confidence 3 49999999999999999751 234689999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.++|+|||++......... .......+..|+|||++.+ ..++.++||||||+++|||
T Consensus 138 ~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el 197 (261)
T cd05068 138 EN-------NICKVADFGLARVIKEDIYE---------AREGAKFPIKWTAPEAALY----NRFSIKSDVWSFGILLTEI 197 (261)
T ss_pred CC-------CCEEECCcceEEEccCCccc---------ccCCCcCceeccCcccccc----CCCCchhhHHHHHHHHHHH
Confidence 77 45999999999876532111 0011123468999999875 5678999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 742 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 742 LT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
++ |+.||.+.....+...+........+ ...+..+.+++.+||+.+|.+||+
T Consensus 198 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~P~~Rp~ 250 (261)
T cd05068 198 VTYGRMPYPGMTNAEVLQQVDQGYRMPCP---------------------------PGCPKELYDIMLDCWKEDPDDRPT 250 (261)
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CcCCHHHHHHHHHHhhcCcccCCC
Confidence 99 99999988877777766554322111 112457899999999999999999
Q ss_pred HHHHHHHHHh
Q 003185 821 AGDLYEMFVA 830 (840)
Q Consensus 821 a~ELLehLe~ 830 (840)
+.+|++.|+.
T Consensus 251 ~~~l~~~l~~ 260 (261)
T cd05068 251 FETLQWKLED 260 (261)
T ss_pred HHHHHHHHhc
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=330.62 Aligned_cols=267 Identities=24% Similarity=0.356 Sum_probs=207.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC---------eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcc
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIV 571 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV 571 (840)
+..++|.+.+.||+|+||.||+|.+.+ ..+|+|+.... ....... .+.+|+.+++.+ +||||+
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~----~~~~e~~~l~~l~~h~~i~ 87 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD---ATEKDLS----DLISEMEMMKMIGKHKNII 87 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC---CChHHHH----HHHHHHHHHHHhcCCCCEe
Confidence 446789999999999999999998622 35888875422 1222223 348899999999 799999
Q ss_pred eeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHH
Q 003185 572 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAAL 640 (840)
Q Consensus 572 ~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-----------~~~~ls~~~~~~Ia~QIa~AL 640 (840)
++++++..... .|+||||+++++|.+++...... ....+++..++.++.||+.||
T Consensus 88 ~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL 153 (307)
T cd05098 88 NLLGACTQDGP--------------LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGM 153 (307)
T ss_pred eEEEEEecCCc--------------eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHH
Confidence 99999876553 49999999999999999763211 123588899999999999999
Q ss_pred HHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003185 641 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720 (840)
Q Consensus 641 ~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~ 720 (840)
+|||++|++||||||+|||++.+ +.+||+|||++.......... ......+++.|+|||++.+
T Consensus 154 ~~lH~~gi~H~dlkp~Nill~~~-------~~~kL~dfg~a~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-- 216 (307)
T cd05098 154 EYLASKKCIHRDLAARNVLVTED-------NVMKIADFGLARDIHHIDYYK--------KTTNGRLPVKWMAPEALFD-- 216 (307)
T ss_pred HHHHHCCcccccccHHheEEcCC-------CcEEECCCcccccccccchhh--------ccccCCCccceeChHHhcc--
Confidence 99999999999999999999876 469999999987654321110 0011124578999999876
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhh
Q 003185 721 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 799 (840)
Q Consensus 721 ~~~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 799 (840)
..++.++|||||||++|||++ |..||.+....++...+........+. ..
T Consensus 217 --~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~ 267 (307)
T cd05098 217 --RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS---------------------------NC 267 (307)
T ss_pred --CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCCCCCCC---------------------------cC
Confidence 567899999999999999998 899998877777776665543322221 12
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 003185 800 LSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 835 (840)
Q Consensus 800 s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~~~ 835 (840)
+..+.+|+.+||..+|.+||++.+|+++|+.+....
T Consensus 268 ~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 268 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 457899999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=340.72 Aligned_cols=243 Identities=24% Similarity=0.304 Sum_probs=195.2
Q ss_pred eeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 585 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~ 585 (840)
+.||+|+||.||++.. .+..+|+|++..... .... ...+.+|+.+|++++||||+++++++.....
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 72 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRD----RVRTKMERDILAEVNHPFIVKLHYAFQTEGK--- 72 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhh----HHHHHHHHHHHHhCCCCCcccEEEEEEcCCE---
Confidence 6799999999999875 467899998754321 1111 1234789999999999999999999886553
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccc
Q 003185 586 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 665 (840)
Q Consensus 586 ~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~ 665 (840)
.|+||||+++|+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 73 -----------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-- 134 (318)
T cd05582 73 -----------LYLILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-- 134 (318)
T ss_pred -----------EEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCC--
Confidence 5999999999999999875 3568999999999999999999999999999999999999877
Q ss_pred cCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCC
Q 003185 666 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 745 (840)
Q Consensus 666 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~ 745 (840)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 135 -----~~~kL~Dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~il~el~tg~ 195 (318)
T cd05582 135 -----GHIKLTDFGLSKESIDHEK----------KAYSFCGTVEYMAPEVVNR----RGHTQSADWWSFGVLMFEMLTGS 195 (318)
T ss_pred -----CcEEEeeccCCcccCCCCC----------ceecccCChhhcCHHHHcC----CCCCCccceeccceEeeeeccCC
Confidence 4599999999875433211 1123468999999999976 56788999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC-----
Q 003185 746 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT----- 820 (840)
Q Consensus 746 ~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS----- 820 (840)
.||...+..+....+..... .++. ..+..+.+||.+||+.||.+||+
T Consensus 196 ~p~~~~~~~~~~~~i~~~~~-~~p~---------------------------~~~~~~~~li~~~l~~~P~~R~~a~~~~ 247 (318)
T cd05582 196 LPFQGKDRKETMTMILKAKL-GMPQ---------------------------FLSPEAQSLLRALFKRNPANRLGAGPDG 247 (318)
T ss_pred CCCCCCCHHHHHHHHHcCCC-CCCC---------------------------CCCHHHHHHHHHHhhcCHhHcCCCCCCC
Confidence 99998887777766654422 1111 12457899999999999999999
Q ss_pred HHHHHHH
Q 003185 821 AGDLYEM 827 (840)
Q Consensus 821 a~ELLeh 827 (840)
+.+++.|
T Consensus 248 ~~~~~~~ 254 (318)
T cd05582 248 VEEIKRH 254 (318)
T ss_pred HHHHhCC
Confidence 6667766
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=336.49 Aligned_cols=245 Identities=26% Similarity=0.340 Sum_probs=195.7
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEecCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 587 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~~~~~~p~~~ 587 (840)
+.||+|+||.||+|.+ .+..+|+|++...... ...... .+.+|+.++..+ +||||+++++++.....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~e~~il~~~~~h~~i~~~~~~~~~~~~----- 70 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL-QDDDVE----CTMTEKRVLALAGKHPFLTQLHSCFQTKDR----- 70 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHH----HHHHHHHHHHhccCCCCccceeeEEEcCCE-----
Confidence 4699999999999987 4568999987543211 111222 337888999888 69999999999876553
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccC
Q 003185 588 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667 (840)
Q Consensus 588 g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~ 667 (840)
.|+||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~---- 132 (318)
T cd05570 71 ---------LFFVMEYVNGGDLMFHIQR-----SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE---- 132 (318)
T ss_pred ---------EEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC----
Confidence 5999999999999999876 3468999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003185 668 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 747 (840)
Q Consensus 668 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~P 747 (840)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslGvil~~l~~G~~p 195 (318)
T cd05570 133 ---GHIKIADFGMCKEGILGGV----------TTSTFCGTPDYIAPEILSY----QPYGPAVDWWALGVLLYEMLAGQSP 195 (318)
T ss_pred ---CcEEecccCCCeecCcCCC----------cccceecCccccCHHHhcC----CCCCcchhhhhHHHHHHHHhhCCCC
Confidence 4599999999864321111 1123468999999999976 6688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-----H
Q 003185 748 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA-----G 822 (840)
Q Consensus 748 F~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa-----~ 822 (840)
|.+.+...+...+..... .++. ..+..+.+||.+||..||.+||++ .
T Consensus 196 f~~~~~~~~~~~i~~~~~-~~~~---------------------------~~~~~~~~li~~~l~~dP~~R~s~~~~~~~ 247 (318)
T cd05570 196 FEGDDEDELFQSILEDEV-RYPR---------------------------WLSKEAKSILKSFLTKNPEKRLGCLPTGEQ 247 (318)
T ss_pred CCCCCHHHHHHHHHcCCC-CCCC---------------------------cCCHHHHHHHHHHccCCHHHcCCCCCCCHH
Confidence 988887777666654321 1110 124578999999999999999999 9
Q ss_pred HHHHHH
Q 003185 823 DLYEMF 828 (840)
Q Consensus 823 ELLehL 828 (840)
++++|.
T Consensus 248 ~ll~~~ 253 (318)
T cd05570 248 DIKGHP 253 (318)
T ss_pred HHhcCC
Confidence 998873
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=320.31 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=200.4
Q ss_pred CCCCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+..+|++.+.||+|+||.||++.+. +..+|+|+.... ... ... +.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~--~~~---~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG--AMS---EDD----FIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccC--CCC---HHH----HHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 3457899999999999999999874 447888885321 111 122 378999999999999999999987554
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .|+||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 73 ~--------------~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~ 134 (256)
T cd05059 73 P--------------IFIVTEYMANGCLLNYLRE----RKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG 134 (256)
T ss_pred c--------------eEEEEecCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC
Confidence 3 4999999999999999975 123689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||+++........ ......++..|+|||.+.+ ..++.++||||||+++|+|
T Consensus 135 ~~-------~~~kl~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~Pe~~~~----~~~~~~~Di~slG~il~~l 194 (256)
T cd05059 135 ED-------NVVKVSDFGLARYVLDDQYT---------SSQGTKFPVKWAPPEVFDY----SRFSSKSDVWSFGVLMWEV 194 (256)
T ss_pred CC-------CcEEECCcccceeccccccc---------ccCCCCCCccccCHHHhcc----CCCCchhhHHHHHHHHHHH
Confidence 76 46999999998765432111 0111124568999999876 5678899999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 742 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 742 LT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
++ |..||...+..+....+.....+..+ ...+..+.+|+.+||..+|.+|||
T Consensus 195 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~cl~~~p~~Rpt 247 (256)
T cd05059 195 FSEGKMPYERFSNSEVVESVSAGYRLYRP---------------------------KLAPTEVYTIMYSCWHEKPEDRPA 247 (256)
T ss_pred hccCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHhcCChhhCcC
Confidence 99 89999887777776666554332211 113557999999999999999999
Q ss_pred HHHHHHHH
Q 003185 821 AGDLYEMF 828 (840)
Q Consensus 821 a~ELLehL 828 (840)
+.++++.|
T Consensus 248 ~~~~l~~l 255 (256)
T cd05059 248 FKKLLSQL 255 (256)
T ss_pred HHHHHHHh
Confidence 99999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=336.30 Aligned_cols=244 Identities=27% Similarity=0.368 Sum_probs=192.7
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEecCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 587 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~~~~~~p~~~ 587 (840)
+.||+|+||.||+|.+ .+..+|+|+........ ..... .+..|..++..+ +||||+++++++.....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~----~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~----- 70 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM-DDDVE----CTMVEKRVLSLAWEHPFLTHLYCTFQTKEN----- 70 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-cchHH----HHHHHHHHHHhccCCCcCcceEEEEEeCCE-----
Confidence 4699999999999997 45679999876432111 11112 236777887764 89999999999986653
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccC
Q 003185 588 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667 (840)
Q Consensus 588 g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~ 667 (840)
.+|||||+++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~ey~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~---- 132 (316)
T cd05619 71 ---------LFFVMEYLNGGDLMFHIQS-----CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD---- 132 (316)
T ss_pred ---------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC----
Confidence 4999999999999999975 3568899999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003185 668 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 747 (840)
Q Consensus 668 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~P 747 (840)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|..|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~G~~p 195 (316)
T cd05619 133 ---GHIKIADFGMCKENMLGDA----------KTCTFCGTPDYIAPEILLG----QKYNTSVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred ---CCEEEccCCcceECCCCCC----------ceeeecCCccccCHHHHcC----CCCCchhhhhhHHHHHHHHHhCCCC
Confidence 4599999999874322111 1123468999999999976 5688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 003185 748 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG-DLYE 826 (840)
Q Consensus 748 F~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~-ELLe 826 (840)
|.+.+..++...+.... +.++. ..+..+.+||.+||..||.+||++. ++++
T Consensus 196 f~~~~~~~~~~~i~~~~-~~~~~---------------------------~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 196 FHGHDEEELFQSIRMDN-PCYPR---------------------------WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHhCC-CCCCc---------------------------cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 99888777776665432 11111 1234689999999999999999996 7777
Q ss_pred H
Q 003185 827 M 827 (840)
Q Consensus 827 h 827 (840)
|
T Consensus 248 h 248 (316)
T cd05619 248 H 248 (316)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=330.05 Aligned_cols=255 Identities=22% Similarity=0.289 Sum_probs=197.1
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
.|++.+.||+|+||.||++.+ .+..+|+|+....... . ......+.+|+.+++.++||||+++++.+.....
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 74 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-K----RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA- 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-h----hhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCe-
Confidence 488999999999999999987 4678999986432211 1 1112234789999999999999999999876543
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.++||||+++|+|..++.. .....+++..+..++.||+.||.|||+.||+||||||+|||++.+
T Consensus 75 -------------~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~ 138 (285)
T cd05605 75 -------------LCLVLTLMNGGDLKFHIYN---MGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY 138 (285)
T ss_pred -------------EEEEEeccCCCcHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC
Confidence 5999999999999998865 223468999999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.++|+|||++........ .....|++.|+|||++.+ ..++.++|||||||++|||++
T Consensus 139 -------~~~~l~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Diws~G~~l~el~~ 196 (285)
T cd05605 139 -------GHIRISDLGLAVEIPEGET-----------IRGRVGTVGYMAPEVVKN----ERYTFSPDWWGLGCLIYEMIE 196 (285)
T ss_pred -------CCEEEeeCCCceecCCCCc-----------cccccCCCCccCcHHhcC----CCCCccccchhHHHHHHHHHH
Confidence 4699999999876532111 122368999999999975 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC----
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP---- 819 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP---- 819 (840)
|+.||.+.........+......... ......+..+.+||.+||..||.+||
T Consensus 197 g~~pf~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05605 197 GKSPFRQRKEKVKREEVERRVKEDQE------------------------EYSEKFSEAARSICRQLLTKDPGFRLGCRG 252 (285)
T ss_pred CCCCCCCCchhhHHHHHHHHhhhccc------------------------ccCcccCHHHHHHHHHHccCCHHHhcCCCC
Confidence 99999876544332222211000000 00012355789999999999999999
Q ss_pred -CHHHHHHHH
Q 003185 820 -TAGDLYEMF 828 (840)
Q Consensus 820 -Sa~ELLehL 828 (840)
+++++++|.
T Consensus 253 ~~~~~l~~~~ 262 (285)
T cd05605 253 EGAEEVKAHP 262 (285)
T ss_pred CCHHHHhcCc
Confidence 899998883
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=338.75 Aligned_cols=246 Identities=22% Similarity=0.327 Sum_probs=189.4
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEecCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 587 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~~~~~~p~~~ 587 (840)
+.||+|+||.||+|.+ .+..+|+|+....... ..... ..+.+|+.++..+ +||||+++++++.....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~-~~~~~----~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~----- 70 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN-DDEDI----DWVQTEKHVFETASNHPFLVGLHSCFQTESR----- 70 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHH----HHHHHHHHHHHhccCCCCCCceEEEEEcCCE-----
Confidence 4699999999999997 5678999997543211 11122 2347899999998 69999999999886653
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccC
Q 003185 588 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667 (840)
Q Consensus 588 g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~ 667 (840)
.||||||+++|+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~e~~~~g~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~---- 132 (329)
T cd05588 71 ---------LFFVIEFVSGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE---- 132 (329)
T ss_pred ---------EEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC----
Confidence 4999999999999998875 3579999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003185 668 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 747 (840)
Q Consensus 668 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~P 747 (840)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~~l~el~~g~~P 195 (329)
T cd05588 133 ---GHIKLTDYGMCKEGIRPGD----------TTSTFCGTPNYIAPEILRG----EDYGFSVDWWALGVLMFEMMAGRSP 195 (329)
T ss_pred ---CCEEECcCccccccccCCC----------ccccccCCccccCHHHHcC----CCCCCccceechHHHHHHHHHCCCC
Confidence 4699999999864321111 1123469999999999976 6678999999999999999999999
Q ss_pred CCCCCH---------HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 748 YMGLSE---------LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 748 F~~~~~---------~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
|..... ..+...+... ...++ ...+..+.+||.+||+.||.+|
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~p---------------------------~~~~~~~~~li~~~L~~dP~~R 247 (329)
T cd05588 196 FDIVGMSDNPDQNTEDYLFQVILEK-QIRIP---------------------------RSLSVKASSVLKGFLNKDPKER 247 (329)
T ss_pred cccccccccccccchHHHHHHHHcC-CCCCC---------------------------CCCCHHHHHHHHHHhccCHHHc
Confidence 963211 1112222211 11111 1124578999999999999999
Q ss_pred CC------HHHHHHHHH
Q 003185 819 PT------AGDLYEMFV 829 (840)
Q Consensus 819 PS------a~ELLehLe 829 (840)
|+ ++++++|.+
T Consensus 248 ~~~~~~~~~~~i~~hp~ 264 (329)
T cd05588 248 LGCHPQTGFRDIKSHPF 264 (329)
T ss_pred CCCCCCCCHHHHhcCCC
Confidence 97 789998843
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=337.59 Aligned_cols=267 Identities=24% Similarity=0.349 Sum_probs=203.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCccee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 573 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l 573 (840)
.+.++|++.+.||+|+||.||+|... +..||+|++... ......+. +.+|+.++.++ +||||+++
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~----~~~E~~~~~~l~~h~niv~~ 76 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG---ATASEYKA----LMTELKILIHIGHHLNVVNL 76 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCC---CCHHHHHH----HHHHHHHHHhhccCcchhhe
Confidence 34568999999999999999999742 357999986422 12222333 38899999999 79999999
Q ss_pred eeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc----------------------------------
Q 003185 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---------------------------------- 619 (840)
Q Consensus 574 ~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~---------------------------------- 619 (840)
++++..... ..+++|||+++++|.+++......
T Consensus 77 ~~~~~~~~~-------------~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (337)
T cd05054 77 LGACTKPGG-------------PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSA 143 (337)
T ss_pred eeeEecCCC-------------CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCcccccc
Confidence 998875432 358999999999999998642110
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEee
Q 003185 620 ----------------------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677 (840)
Q Consensus 620 ----------------------~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~D 677 (840)
....+++..+..++.||+.||+|||++||+||||||+|||++.+ +.++|+|
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~-------~~vkL~D 216 (337)
T cd05054 144 SSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-------NVVKICD 216 (337)
T ss_pred ccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCC-------CcEEEec
Confidence 01367899999999999999999999999999999999999876 4699999
Q ss_pred cCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-
Q 003185 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELE- 755 (840)
Q Consensus 678 FGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~e- 755 (840)
||++..+...... .......++..|+|||++.+ ..++.++|||||||+||||++ |..||.+....+
T Consensus 217 fG~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~ 284 (337)
T cd05054 217 FGLARDIYKDPDY--------VRKGDARLPLKWMAPESIFD----KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE 284 (337)
T ss_pred cccchhcccCcch--------hhccCCCCCccccCcHHhcC----CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH
Confidence 9999876432111 01123356788999999976 678999999999999999998 999997754333
Q ss_pred HHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 003185 756 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 756 l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~~ 834 (840)
....+..+..+..+ ...+..+.+|+.+||+.+|.+||++.+|+++|..+...
T Consensus 285 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 285 FCRRLKEGTRMRAP---------------------------EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHHhccCCCCCC---------------------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 22333332222111 11245789999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=338.18 Aligned_cols=245 Identities=26% Similarity=0.293 Sum_probs=190.8
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHH-HHHhCCCCCcceeeeEEecCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKISSKWLPSAD 587 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~-iL~~L~HpNIV~l~g~~~~~~~~p~~~ 587 (840)
+.||+|+||.||+|++ .+..+|+|++....... . .....+.+|.. +++.++||||+++++++.....
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~----~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~----- 70 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK-K----KEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEK----- 70 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-h----hHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCE-----
Confidence 4699999999999997 56789999875332111 1 11122355554 6788999999999999876553
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccC
Q 003185 588 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667 (840)
Q Consensus 588 g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~ 667 (840)
.|+||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.+
T Consensus 71 ---------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~---- 132 (321)
T cd05603 71 ---------LYFVLDYVNGGELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ---- 132 (321)
T ss_pred ---------EEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC----
Confidence 5999999999999988865 3568899999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003185 668 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 747 (840)
Q Consensus 668 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~P 747 (840)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~p 195 (321)
T cd05603 133 ---GHVVLTDFGLCKEGVEPEE----------TTSTFCGTPEYLAPEVLRK----EPYDRTVDWWCLGAVLYEMLYGLPP 195 (321)
T ss_pred ---CCEEEccCCCCccCCCCCC----------ccccccCCcccCCHHHhcC----CCCCCcCcccccchhhhhhhcCCCC
Confidence 4599999999875322111 1123468999999999875 5678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH----HH
Q 003185 748 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA----GD 823 (840)
Q Consensus 748 F~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa----~E 823 (840)
|.+.+..++...+..... .++ ...+..+.++|.+||+.||.+||++ .+
T Consensus 196 f~~~~~~~~~~~i~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (321)
T cd05603 196 FYSRDVSQMYDNILHKPL-QLP---------------------------GGKTVAACDLLVGLLHKDQRRRLGAKADFLE 247 (321)
T ss_pred CCCCCHHHHHHHHhcCCC-CCC---------------------------CCCCHHHHHHHHHHccCCHhhcCCCCCCHHH
Confidence 998887777666654321 111 1124578999999999999999875 46
Q ss_pred HHHHH
Q 003185 824 LYEMF 828 (840)
Q Consensus 824 LLehL 828 (840)
+++|.
T Consensus 248 ~~~~~ 252 (321)
T cd05603 248 IKNHV 252 (321)
T ss_pred HhCCC
Confidence 66653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=369.30 Aligned_cols=268 Identities=25% Similarity=0.407 Sum_probs=218.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE---CCe--eEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeE
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF---GSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 576 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~---~~~--~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~ 576 (840)
.+....++...||+|+||.||.|.. .+. ++.|+++.++... ...+...| ++|..+|+.++|||||+++|+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~F----l~Ea~~m~~f~HpNiv~liGv 763 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDF----LKEALLMSKFDHPNIVSLIGV 763 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHH----HHHHHHHhcCCCcceeeEEEe
Confidence 4566788999999999999999986 222 4555655565432 33445555 999999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~--~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLK 654 (840)
+..... .+|++|||+||+|..||++.+.. ....++....+.++.|||+|+.||+++++|||||-
T Consensus 764 ~l~~~~--------------~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLA 829 (1025)
T KOG1095|consen 764 CLDSGP--------------PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLA 829 (1025)
T ss_pred ecCCCC--------------cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchh
Confidence 987553 39999999999999999973221 14568899999999999999999999999999999
Q ss_pred CCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHH
Q 003185 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 734 (840)
Q Consensus 655 PeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSL 734 (840)
..|+||+.. .+|||+|||+|+.+....... ..+ ...-...|||||.+.. ..++.|+|||||
T Consensus 830 aRNCLL~~~-------r~VKIaDFGlArDiy~~~yyr---~~~-----~a~lPvkWm~PEsl~d----~iFtskSDvWsF 890 (1025)
T KOG1095|consen 830 ARNCLLDER-------RVVKIADFGLARDIYDKDYYR---KHG-----EAMLPVKWMPPESLKD----GIFTSKSDVWSF 890 (1025)
T ss_pred hhheeeccc-------CcEEEcccchhHhhhhchhee---ccC-----ccccceecCCHHHHhh----cccccccchhhh
Confidence 999999987 679999999999544333221 111 1123468999999997 789999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 003185 735 GCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 813 (840)
Q Consensus 735 GvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~ 813 (840)
||+|||++| |..||.+.+..+++..+..+.+...|. .+++.+++||..||+.
T Consensus 891 GVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~---------------------------~CP~~ly~lM~~CW~~ 943 (1025)
T KOG1095|consen 891 GVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPS---------------------------YCPEKLYQLMLQCWKH 943 (1025)
T ss_pred HHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCC---------------------------CCChHHHHHHHHHccC
Confidence 999999999 899999999999998777776544442 2466789999999999
Q ss_pred CCCCCCCHHHHHHHHHhhcCC
Q 003185 814 NPTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 814 DP~eRPSa~ELLehLe~l~~~ 834 (840)
+|++||++..|++.+..+.+.
T Consensus 944 ~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 944 DPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred ChhhCccHHHHHhhhhhhhhh
Confidence 999999999999998887754
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=315.20 Aligned_cols=253 Identities=22% Similarity=0.338 Sum_probs=201.4
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|++.+.||.|+||.||++.. .+..+++|....+.. .....+ .+.+|+.++++++||||+++++.+.....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~~- 73 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--SRRERK----AAEQEAQLLSQLKHPNIVAYRESWEGEDG- 73 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc--CHHHHH----HHHHHHHHHHhCCCCCeeeeeeeecCCCC-
Confidence 589999999999999999987 456789888654321 222222 34889999999999999999987753321
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
..++||||+++++|.+++.. .....+++..++.++.||+.||.|||++||+|+||||+||+++.+
T Consensus 74 ------------~~~lv~e~~~~~~l~~~l~~---~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~ 138 (257)
T cd08223 74 ------------LLYIVMGFCEGGDLYHKLKE---QKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT 138 (257)
T ss_pred ------------EEEEEecccCCCcHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC
Confidence 35999999999999999975 223458999999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.++|+|||++........ ......+++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 139 -------~~~~l~df~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~~l~~ 197 (257)
T cd08223 139 -------NIIKVGDLGIARVLENQCD----------MASTLIGTPYYMSPELFSN----KPYNYKSDVWALGCCVYEMAT 197 (257)
T ss_pred -------CcEEEecccceEEecccCC----------ccccccCCcCccChhHhcC----CCCCchhhhHHHHHHHHHHHc
Confidence 4699999999876533211 1123458899999999876 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~E 823 (840)
|+.||...+.......+..+..+.++ ...+..+.+|+.+||+.||.+||++.+
T Consensus 198 g~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~ 250 (257)
T cd08223 198 LKHAFNAKDMNSLVYRIIEGKLPPMP---------------------------KDYSPELGELIATMLSKRPEKRPSVKS 250 (257)
T ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCc---------------------------cccCHHHHHHHHHHhccCcccCCCHHH
Confidence 99999877766665555544332222 123457899999999999999999999
Q ss_pred HHHHH
Q 003185 824 LYEMF 828 (840)
Q Consensus 824 LLehL 828 (840)
+++|.
T Consensus 251 ~l~~~ 255 (257)
T cd08223 251 ILRQP 255 (257)
T ss_pred HhcCC
Confidence 99873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.00 Aligned_cols=262 Identities=26% Similarity=0.415 Sum_probs=204.3
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+++|++.+.||+|+||.||+|.. .+..+++|....... ...... ..+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~----~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 75 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-MDAKAR----ADCIKEIDLLKQLNHPNVIKYYASFIEDN 75 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-hhHHHH----HHHHHHHHHHHHccCCchhhhhheeEeCC
Confidence 46899999999999999999996 677889887543221 111122 34589999999999999999999988655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .++||||+++++|.+++..... ....+++..++.++.||+.||.|||++||+|+||||+||+++
T Consensus 76 ~--------------~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~ 140 (267)
T cd08229 76 E--------------LNIVLELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT 140 (267)
T ss_pred e--------------EEEEEEecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc
Confidence 3 4999999999999999875322 235689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.++|+|||++......... .....|+..|+|||++.+ ..++.++||||||+++|+|
T Consensus 141 ~~-------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~~~ape~~~~----~~~~~~~Dv~slG~il~~l 199 (267)
T cd08229 141 AT-------GVVKLGDLGLGRFFSSKTTA----------AHSLVGTPYYMSPERIHE----NGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred CC-------CCEEECcchhhhccccCCcc----------cccccCCcCccCHHHhcC----CCccchhhHHHHHHHHHHH
Confidence 76 45999999998765432111 122358899999999975 5678899999999999999
Q ss_pred HhCCCCCCCCCH--HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 742 LTLQVPYMGLSE--LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 742 LTG~~PF~~~~~--~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
++|..||.+... ......+.....+.++ ....+..+.+|+.+||..||.+||
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~~p~~Rp 253 (267)
T cd08229 200 AALQSPFYGDKMNLYSLCKKIEQCDYPPLP--------------------------SDHYSEELRQLVNMCINPDPEKRP 253 (267)
T ss_pred HhCCCCcccccchHHHHhhhhhcCCCCCCC--------------------------cccccHHHHHHHHHhcCCCcccCC
Confidence 999999965532 2333333322221111 012356799999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 003185 820 TAGDLYEMFVART 832 (840)
Q Consensus 820 Sa~ELLehLe~l~ 832 (840)
|+.+|++.+.++.
T Consensus 254 t~~~i~~~~~~~~ 266 (267)
T cd08229 254 DITYVYDVAKRMH 266 (267)
T ss_pred CHHHHHHHHhhhc
Confidence 9999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=324.58 Aligned_cols=267 Identities=21% Similarity=0.298 Sum_probs=202.8
Q ss_pred CCCCceeeeeecccCceEEEEEEECC------------------eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHh
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFGS------------------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGA 564 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~------------------~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~ 564 (840)
...+|++.+.||+|+||.||+|.+.. ..+|+|+..... ..... ..+.+|+.++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~----~~~~~e~~~l~~ 75 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNAR----EDFLKEVKILSR 75 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHH----HHHHHHHHHHHh
Confidence 45689999999999999999998632 347788754321 12222 344899999999
Q ss_pred CCCCCcceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc------CCCCCCHHHHHHHHHHHHH
Q 003185 565 LRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------GEKHVSVKLALFIAQDVAA 638 (840)
Q Consensus 565 L~HpNIV~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~------~~~~ls~~~~~~Ia~QIa~ 638 (840)
++||||+++++++..... .++||||+++++|.+++...... ....+++..++.++.||+.
T Consensus 76 l~~~~i~~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 141 (296)
T cd05051 76 LSDPNIARLLGVCTVDPP--------------LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIAS 141 (296)
T ss_pred cCCCCEeEEEEEEecCCC--------------cEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHH
Confidence 999999999999876553 49999999999999999763211 1236899999999999999
Q ss_pred HHHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhc
Q 003185 639 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718 (840)
Q Consensus 639 AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~ 718 (840)
||.|||++||+|+||||+|||++.+ +.++|+|||++......... .......+++.|+|||++.+
T Consensus 142 al~~LH~~~i~H~dlkp~Nili~~~-------~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~ 206 (296)
T cd05051 142 GMRYLESLNFVHRDLATRNCLVGKN-------YTIKIADFGMSRNLYSSDYY--------RVQGRAPLPIRWMAWESVLL 206 (296)
T ss_pred HHHHHHHcCccccccchhceeecCC-------CceEEccccceeecccCcce--------eecCcCCCCceecCHHHhhc
Confidence 9999999999999999999999877 56999999998765332111 01123346789999999875
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhh
Q 003185 719 MHKPNLYGLEVDIWSYGCLLLELLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 796 (840)
Q Consensus 719 ~~~~~~~s~kSDVWSLGvIL~ELLT--G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 796 (840)
..++.++|||||||++|||++ +..||...+..+++..+.......-... .....
T Consensus 207 ----~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~ 262 (296)
T cd05051 207 ----GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQI--------------------YLPRP 262 (296)
T ss_pred ----CCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccc--------------------cCCCc
Confidence 568899999999999999998 7888887776666555543211000000 00001
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003185 797 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 797 ~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe 829 (840)
...+..+.+|+.+||+.||.+|||+.+|++.|+
T Consensus 263 ~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 263 PNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred cCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 123467999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=338.61 Aligned_cols=244 Identities=25% Similarity=0.301 Sum_probs=191.6
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHH-HHHhCCCCCcceeeeEEecCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKISSKWLPSAD 587 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~-iL~~L~HpNIV~l~g~~~~~~~~p~~~ 587 (840)
+.||+|+||.||+|.. .+..+|+|++..+.... .... ..+..|.. +++.++||||+++++++.....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~----~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~----- 70 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN-RKEQ----KHIMAERNVLLKNVKHPFLVGLHYSFQTTEK----- 70 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHH----HHHHHHHHHHHHhCCCCCCccEEEEEecCCE-----
Confidence 4699999999999987 57789999975432211 1111 22355554 4677999999999999886553
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccC
Q 003185 588 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667 (840)
Q Consensus 588 g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~ 667 (840)
.|+||||+++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~---- 132 (325)
T cd05604 71 ---------LYFVLDFVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ---- 132 (325)
T ss_pred ---------EEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC----
Confidence 4999999999999988875 3568999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003185 668 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 747 (840)
Q Consensus 668 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~P 747 (840)
+.+||+|||+++....... ......||+.|||||++.+ ..++.++|||||||++|||++|..|
T Consensus 133 ---~~~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~G~~p 195 (325)
T cd05604 133 ---GHVVLTDFGLCKEGIAQSD----------TTTTFCGTPEYLAPEVIRK----QPYDNTVDWWCLGAVLYEMLYGLPP 195 (325)
T ss_pred ---CCEEEeecCCcccCCCCCC----------CcccccCChhhCCHHHHcC----CCCCCcCccccccceehhhhcCCCC
Confidence 4599999999875322111 1233469999999999976 6678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH----H
Q 003185 748 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG----D 823 (840)
Q Consensus 748 F~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~----E 823 (840)
|...+..++...+....... . ...+..+.++|.+||..+|.+||++. +
T Consensus 196 f~~~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 196 FYCRDVAEMYDNILHKPLVL-R---------------------------PGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred CCCCCHHHHHHHHHcCCccC-C---------------------------CCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 99888777776665432110 0 01244688999999999999999774 6
Q ss_pred HHHH
Q 003185 824 LYEM 827 (840)
Q Consensus 824 LLeh 827 (840)
+++|
T Consensus 248 i~~h 251 (325)
T cd05604 248 IQEH 251 (325)
T ss_pred HhcC
Confidence 7665
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=318.05 Aligned_cols=255 Identities=26% Similarity=0.384 Sum_probs=202.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
+..++|++.+.||+|+||.||+|.+ .+..+|+|....... . .+ .+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~---~~----~~~~E~~~l~~l~~~~i~~~~~~~~~~ 73 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--S---PE----SFLEEAQIMKKLRHDKLVQLYAVVSEE 73 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--C---HH----HHHHHHHHHHhcCCCceEEEEeEECCC
Confidence 4567899999999999999999987 445788887643221 1 12 348899999999999999999987432
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
..++||||+++++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 74 ---------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili 135 (260)
T cd05070 74 ---------------PIYIVTEYMSKGSLLDFLKD---GEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV 135 (260)
T ss_pred ---------------CcEEEEEecCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE
Confidence 13899999999999999975 223458999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.++|+|||++......... ......++..|+|||++.+ ..++.++||||||+++|+
T Consensus 136 ~~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~ 195 (260)
T cd05070 136 GDG-------LVCKIADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTE 195 (260)
T ss_pred eCC-------ceEEeCCceeeeeccCcccc---------cccCCCCCccccChHHHhc----CCCcchhhhHHHHHHHHH
Confidence 876 56999999999765432111 0111235678999999875 567899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|++ |..||.+.+..+....+.....+..+ ...+..+.+|+.+||..+|.+||
T Consensus 196 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 248 (260)
T cd05070 196 LVTKGRVPYPGMNNREVLEQVERGYRMPCP---------------------------QDCPISLHELMLQCWKKDPEERP 248 (260)
T ss_pred HHhcCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CcCCHHHHHHHHHHcccCcccCc
Confidence 999 89999888777777766554332222 11245799999999999999999
Q ss_pred CHHHHHHHHHh
Q 003185 820 TAGDLYEMFVA 830 (840)
Q Consensus 820 Sa~ELLehLe~ 830 (840)
|+.++.+.|+.
T Consensus 249 t~~~l~~~l~~ 259 (260)
T cd05070 249 TFEYLQSFLED 259 (260)
T ss_pred CHHHHHHHHhc
Confidence 99999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.62 Aligned_cols=258 Identities=28% Similarity=0.435 Sum_probs=201.8
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|.+.+.||+|++|.||+|.. .+..+++|+........ .. ......+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~--~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSP--ET-KKEVNALECEIQLLKNLQHERIVQYYGCLRDDE- 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccch--hh-HHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC-
Confidence 4689999999999999999986 56889999875432211 11 111234589999999999999999999998655
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||||+||+++.
T Consensus 78 -------------~~~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~ 139 (263)
T cd06625 78 -------------TLSIFMEYMPGGSVKDQLKA-----YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDS 139 (263)
T ss_pred -------------eEEEEEEECCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 35999999999999999976 246889999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.++|+|||+++........ ........|+..|+|||++.+ ..++.++||||||+++|+|+
T Consensus 140 ~-------~~~~l~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~el~ 201 (263)
T cd06625 140 A-------GNVKLGDFGASKRLQTICSS-------GTGMKSVTGTPYWMSPEVISG----EGYGRKADVWSVGCTVVEML 201 (263)
T ss_pred C-------CCEEEeecccceeccccccc-------cccccCCCcCccccCcceecc----CCCCchhhhHHHHHHHHHHH
Confidence 6 45999999998765432111 000122457889999999986 45789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcC-CCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 743 TLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
+|+.||...+.......+... ..+.++ ...+..+.+||.+||..+|.+|||+
T Consensus 202 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rpt~ 254 (263)
T cd06625 202 TEKPPWAEFEAMAAIFKIATQPTNPQLP---------------------------SHVSPDARNFLRRTFVENAKKRPSA 254 (263)
T ss_pred hCCCCccccchHHHHHHHhccCCCCCCC---------------------------ccCCHHHHHHHHHHhhcCcccCCCH
Confidence 999999776555444333322 111111 1234578999999999999999999
Q ss_pred HHHHHHHH
Q 003185 822 GDLYEMFV 829 (840)
Q Consensus 822 ~ELLehLe 829 (840)
.++++|..
T Consensus 255 ~~ll~~~~ 262 (263)
T cd06625 255 EELLRHFF 262 (263)
T ss_pred HHHhhCCC
Confidence 99998853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=327.96 Aligned_cols=250 Identities=22% Similarity=0.274 Sum_probs=189.9
Q ss_pred ecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCCCC
Q 003185 513 AGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 590 (840)
Q Consensus 513 LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g~~ 590 (840)
||+|+||+||++.+ .+..+|+|+....... ..... ..+..|+.+++.++||||+++++++.....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~----~~~~~E~~il~~l~~~~i~~~~~~~~~~~~-------- 67 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-KRKGY----EGAMVEKRILAKVHSRFIVSLAYAFQTKTD-------- 67 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-hhHHH----HHHHHHHHHHHhCCCCcEeeeeEEEcCCCe--------
Confidence 79999999999987 5678999986432211 11111 334789999999999999999998876543
Q ss_pred ccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCCC
Q 003185 591 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 670 (840)
Q Consensus 591 ~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~ 670 (840)
.++||||+++|+|..++..... ....+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 68 ------~~lv~e~~~~g~L~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~------- 133 (280)
T cd05608 68 ------LCLVMTIMNGGDLRYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND------- 133 (280)
T ss_pred ------EEEEEeCCCCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-------
Confidence 5999999999999988864222 23568999999999999999999999999999999999999876
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003185 671 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 750 (840)
Q Consensus 671 ~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~ 750 (840)
+.++|+|||++..+..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 134 ~~~~l~dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~g~~pf~~ 199 (280)
T cd05608 134 GNVRISDLGLAVELKDGQS----------KTKGYAGTPGFMAPELLQG----EEYDFSVDYFALGVTLYEMIAARGPFRA 199 (280)
T ss_pred CCEEEeeCccceecCCCCc----------cccccCCCcCccCHHHhcC----CCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 4599999999976543211 1123468999999999986 5678999999999999999999999976
Q ss_pred CCHHHHHHHHHcC-CCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHHH
Q 003185 751 LSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGDL 824 (840)
Q Consensus 751 ~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP-----Sa~EL 824 (840)
.........+... ...... .....+..+.+|+.+||+.||.+|| +++++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~ 254 (280)
T cd05608 200 RGEKVENKELKQRILNDSVT-------------------------YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGL 254 (280)
T ss_pred CCcchhHHHHHHhhcccCCC-------------------------CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHH
Confidence 5322111111111 000000 0012356789999999999999999 88999
Q ss_pred HHHH
Q 003185 825 YEMF 828 (840)
Q Consensus 825 LehL 828 (840)
++|.
T Consensus 255 l~h~ 258 (280)
T cd05608 255 RTHP 258 (280)
T ss_pred hcCh
Confidence 9984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=315.24 Aligned_cols=252 Identities=27% Similarity=0.426 Sum_probs=202.4
Q ss_pred eeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 585 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~-----~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~ 585 (840)
+.||+|+||.||+|.+. +..+++|+..... ... ..+ .+.+|+.++..++|+||+++++++.....
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~-~~~----~~~~e~~~l~~~~~~~i~~~~~~~~~~~~--- 70 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--SEE-ERK----DFLKEARVMKKLGHPNVVRLLGVCTEEEP--- 70 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeecccc--chh-HHH----HHHHHHHHHhhcCCCChheeeeeecCCCc---
Confidence 47999999999999975 6788888864332 111 233 34899999999999999999999886543
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 586 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 586 ~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~----~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
.++||||+++++|.+++...... ....+++..++.++.||+.||.|||++||+|+||||+||+++
T Consensus 71 -----------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~ 139 (262)
T cd00192 71 -----------LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG 139 (262)
T ss_pred -----------eEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC
Confidence 49999999999999999862110 026789999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||.+......... .......+++.|+|||.+.. ..++.++|||||||++|+|
T Consensus 140 ~~-------~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 200 (262)
T cd00192 140 ED-------LVVKISDFGLSRDVYDDDYY--------RKKTGGKLPIRWMAPESLKD----GIFTSKSDVWSFGVLLWEI 200 (262)
T ss_pred CC-------CcEEEccccccccccccccc--------ccccCCCcCccccCHHHhcc----CCcchhhccHHHHHHHHHH
Confidence 87 45999999999876543210 11123457889999999876 4678999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 742 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 742 LT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
++ |..||......++...+..+.....+. ..+..+.+++.+||..+|.+|||
T Consensus 201 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rps 253 (262)
T cd00192 201 FTLGATPYPGLSNEEVLEYLRKGYRLPKPE---------------------------YCPDELYELMLSCWQLDPEDRPT 253 (262)
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cCChHHHHHHHHHccCCcccCcC
Confidence 99 699999888888777776643332221 12457999999999999999999
Q ss_pred HHHHHHHHH
Q 003185 821 AGDLYEMFV 829 (840)
Q Consensus 821 a~ELLehLe 829 (840)
+.+++++|+
T Consensus 254 ~~~l~~~l~ 262 (262)
T cd00192 254 FSELVERLE 262 (262)
T ss_pred HHHHHHhhC
Confidence 999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=342.52 Aligned_cols=264 Identities=20% Similarity=0.231 Sum_probs=203.1
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||.||+|.. .+..+|+|+....... .......+.+|+.++..++||||+++++.+.....
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-----EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-----hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 4689999999999999999987 5678999987532111 11122345889999999999999999999886653
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.||||||++||+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+||||+.
T Consensus 76 --------------~~lv~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~ 136 (360)
T cd05627 76 --------------LYLIMEFLPGGDMMTLLMK-----KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDA 136 (360)
T ss_pred --------------EEEEEeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC
Confidence 4999999999999999975 356899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccc-------------------------cCCCCCCCcccCCCcccchhhhh
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-------------------------HRGIPAPDVCVGTPRWMAPEVLR 717 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~-------------------------~~~~~~~~~~vGT~~YmAPEvL~ 717 (840)
+ +.+||+|||++..+.......... ..........+||+.|+|||++.
T Consensus 137 ~-------~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 209 (360)
T cd05627 137 K-------GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM 209 (360)
T ss_pred C-------CCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc
Confidence 6 469999999987553221100000 00000112347999999999997
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCcchHHhhhccCccccccccCCCCCCchhh
Q 003185 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 796 (840)
Q Consensus 718 ~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 796 (840)
+ ..++.++|||||||+||||++|..||.+.++......+.... ...++. .
T Consensus 210 ~----~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------------------~ 260 (360)
T cd05627 210 Q----TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPP-------------------------E 260 (360)
T ss_pred C----CCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCC-------------------------C
Confidence 6 668899999999999999999999999888877777665431 111110 0
Q ss_pred hhhHHHHHHHHHHhcccCCCCCC---CHHHHHHHHH
Q 003185 797 LETLSFLVDVFRRCTEENPTERP---TAGDLYEMFV 829 (840)
Q Consensus 797 ~~~s~~L~dLI~rCL~~DP~eRP---Sa~ELLehLe 829 (840)
...+..+.+||.+|+. ||.+|+ ++.++++|..
T Consensus 261 ~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~ 295 (360)
T cd05627 261 VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPF 295 (360)
T ss_pred CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCC
Confidence 1124578999999874 999998 4899999843
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=315.26 Aligned_cols=262 Identities=26% Similarity=0.396 Sum_probs=205.7
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+++|++.+.||+|+||.||+|.. .+..+++|.+...... ..... ..+.+|+.++++++|+||+++++++....
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~----~~~~~ei~~l~~~~~~~i~~~~~~~~~~~ 75 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-DAKAR----QDCLKEIDLLKQLDHPNVIKYLASFIENN 75 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccccc-chhhH----HHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 36899999999999999999997 5788999986543221 11222 34489999999999999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .++||||+++++|.+++..... ....+++..++.++.||+.||.|||+.||+||||||+||+++
T Consensus 76 ~--------------~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~ 140 (267)
T cd08224 76 E--------------LNIVLELADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT 140 (267)
T ss_pred e--------------EEEEEecCCCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEEC
Confidence 3 4999999999999999975322 235689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.++|+|||++......... .....+++.|+|||.+.+ ..++.++|||||||++|+|
T Consensus 141 ~~-------~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~y~apE~~~~----~~~~~~~Di~slG~il~~l 199 (267)
T cd08224 141 AT-------GVVKLGDLGLGRFFSSKTTA----------AHSLVGTPYYMSPERIHE----NGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred CC-------CcEEEeccceeeeccCCCcc----------cceecCCccccCHHHhcc----CCCCchhcHHHHHHHHHHH
Confidence 77 45999999998765332111 122358889999999875 5678899999999999999
Q ss_pred HhCCCCCCCCC--HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 742 LTLQVPYMGLS--ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 742 LTG~~PF~~~~--~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
++|..||.... ..++...+..+..+.++. ...+..+.++|.+||..+|.+||
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~i~~cl~~~p~~Rp 253 (267)
T cd08224 200 AALQSPFYGDKMNLYSLCKKIEKCDYPPLPA--------------------------DHYSEELRDLVSRCINPDPEKRP 253 (267)
T ss_pred HHCCCCcccCCccHHHHHhhhhcCCCCCCCh--------------------------hhcCHHHHHHHHHHcCCCcccCC
Confidence 99999996543 233444443332222221 12345789999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 003185 820 TAGDLYEMFVART 832 (840)
Q Consensus 820 Sa~ELLehLe~l~ 832 (840)
|+.+|++.|+.+.
T Consensus 254 ~~~~il~~~~~~~ 266 (267)
T cd08224 254 DISYVLQVAKEMH 266 (267)
T ss_pred CHHHHHHHHHHhc
Confidence 9999999998774
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=318.22 Aligned_cols=249 Identities=21% Similarity=0.324 Sum_probs=196.5
Q ss_pred eecccCceEEEEEEEC----CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCC
Q 003185 512 EAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 587 (840)
Q Consensus 512 ~LG~G~fG~Vy~a~~~----~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~ 587 (840)
.||+|+||.||+|.+. +..+|+|+..... .. ...+.+.+|+.++++++||||+++++++...
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~---~~----~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~------- 67 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EK----SVRDEMMREAEIMHQLDNPYIVRMIGVCEAE------- 67 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc---Ch----HHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC-------
Confidence 4899999999999763 3457888754321 11 2223458999999999999999999987532
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccC
Q 003185 588 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667 (840)
Q Consensus 588 g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~ 667 (840)
..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++|++||||||+|||++.+
T Consensus 68 --------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~---- 131 (257)
T cd05115 68 --------ALMLVMEMASGGPLNKFLSG----KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ---- 131 (257)
T ss_pred --------CeEEEEEeCCCCCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCC----
Confidence 24999999999999999874 23568999999999999999999999999999999999999876
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCC
Q 003185 668 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQV 746 (840)
Q Consensus 668 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT-G~~ 746 (840)
..+||+|||++........... ......++..|+|||++.. ..++.++|||||||++|+|++ |..
T Consensus 132 ---~~~kl~dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~~~g~~ 197 (257)
T cd05115 132 ---HYAKISDFGLSKALGADDSYYK-------ARSAGKWPLKWYAPECINF----RKFSSRSDVWSYGITMWEAFSYGQK 197 (257)
T ss_pred ---CcEEeccCCccccccCCcccee-------ccCCCCCCcccCCHHHHcc----CCCCchhhHHHHHHHHHHHhcCCCC
Confidence 4699999999975543221100 0111224578999999875 567889999999999999996 999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003185 747 PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826 (840)
Q Consensus 747 PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLe 826 (840)
||......++...+..+..+..+. ..++++.+||.+||..+|.+||++.+|++
T Consensus 198 p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 198 PYKKMKGPEVMSFIEQGKRLDCPA---------------------------ECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred CcCcCCHHHHHHHHHCCCCCCCCC---------------------------CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999888877777776665433221 12457899999999999999999999999
Q ss_pred HHHhh
Q 003185 827 MFVAR 831 (840)
Q Consensus 827 hLe~l 831 (840)
.|+..
T Consensus 251 ~l~~~ 255 (257)
T cd05115 251 RMRTY 255 (257)
T ss_pred HHhhh
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=342.40 Aligned_cols=264 Identities=25% Similarity=0.335 Sum_probs=202.8
Q ss_pred CCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceee
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMY 574 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~ 574 (840)
+-++|++++.||+|+||.||+|.+. ...||+|++.... ..... +.+.+|+.+|+++. |||||+++
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~----~~~~~Ei~~l~~l~~HpnIv~l~ 107 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEK----QALMSELKIMTHLGPHLNIVNLL 107 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC---ChHHH----HHHHHHHHHHHhcCCCCCeeeEE
Confidence 4568899999999999999999862 2358898864321 12222 34489999999996 99999999
Q ss_pred eEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc------------------------------------
Q 003185 575 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE------------------------------------ 618 (840)
Q Consensus 575 g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~------------------------------------ 618 (840)
+++..... .||||||+++|+|.++|.....
T Consensus 108 ~~~~~~~~--------------~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (400)
T cd05105 108 GACTKSGP--------------IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFEN 173 (400)
T ss_pred EEEccCCc--------------eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcc
Confidence 99976553 4999999999999999875211
Q ss_pred -------------------------------------------------------cCCCCCCHHHHHHHHHHHHHHHHHH
Q 003185 619 -------------------------------------------------------TGEKHVSVKLALFIAQDVAAALVEL 643 (840)
Q Consensus 619 -------------------------------------------------------~~~~~ls~~~~~~Ia~QIa~AL~yL 643 (840)
.....+++..++.++.||+.||+||
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 253 (400)
T cd05105 174 KGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL 253 (400)
T ss_pred cccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence 0113477888999999999999999
Q ss_pred HhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCC
Q 003185 644 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 723 (840)
Q Consensus 644 Hs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~ 723 (840)
|+++|+||||||+|||++.+ ..+||+|||+++........ .......+++.|+|||++.+ .
T Consensus 254 H~~~ivH~dikp~Nill~~~-------~~~kL~DfGla~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~ 314 (400)
T cd05105 254 ASKNCVHRDLAARNVLLAQG-------KIVKICDFGLARDIMHDSNY--------VSKGSTFLPVKWMAPESIFD----N 314 (400)
T ss_pred HhCCeeCCCCChHhEEEeCC-------CEEEEEeCCcceeccccccc--------cccCCcCCCcceEChhhhcC----C
Confidence 99999999999999999876 56999999999765432111 11123357789999999875 5
Q ss_pred CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHH
Q 003185 724 LYGLEVDIWSYGCLLLELLT-LQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 801 (840)
Q Consensus 724 ~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 801 (840)
.++.++|||||||+||||++ |..||....... +...+..+..+..+ ...+.
T Consensus 315 ~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 367 (400)
T cd05105 315 LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKP---------------------------DHATQ 367 (400)
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCC---------------------------ccCCH
Confidence 67899999999999999997 999997764333 33333333222111 12345
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003185 802 FLVDVFRRCTEENPTERPTAGDLYEMFVARTS 833 (840)
Q Consensus 802 ~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~ 833 (840)
.+.+|+.+||+.||.+||++.+|.+.|+.+..
T Consensus 368 ~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 368 EVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 78999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=328.34 Aligned_cols=283 Identities=20% Similarity=0.243 Sum_probs=190.6
Q ss_pred eeeecccCceEEEEEEE----CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCC
Q 003185 510 CDEAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 585 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~----~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~ 585 (840)
.++||+|+||.||+|.. .+..+|+|+.... .. ...+.+|+.+|++++||||+++++++.....
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 72 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GI--------SMSACREIALLRELKHPNVISLQKVFLSHAD--- 72 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CC--------cHHHHHHHHHHHhcCCCCCcceeeeEecCCC---
Confidence 46899999999999985 3467888875422 11 1123789999999999999999998864321
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhc----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 586 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE----TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 586 ~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~----~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
...++||||+. ++|..++..... .....+++..++.++.||+.||.|||++||+||||||+|||+.
T Consensus 73 ---------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~ 142 (317)
T cd07868 73 ---------RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVM 142 (317)
T ss_pred ---------cEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEe
Confidence 24699999996 599988864211 1123588999999999999999999999999999999999996
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.... ..+.+||+|||+++.+...... ........||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 143 ~~~~---~~~~~kl~DfG~a~~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el 209 (317)
T cd07868 143 GEGP---ERGRVKIADMGFARLFNSPLKP-------LADLDPVVVTFWYRAPELLLG---ARHYTKAIDIWAIGCIFAEL 209 (317)
T ss_pred cCCC---CcCcEEEeecCceeccCCCCcc-------ccccCCccccccccCCHHHcC---CCCcCchhhHHHHHHHHHHH
Confidence 4321 2357999999999865432111 011233568999999999875 24578999999999999999
Q ss_pred HhCCCCCCCCCH---------HHHHHHHHcCCCCCcchHHhhhccCccc-----cccccCCC-C----CCchhhhhhHHH
Q 003185 742 LTLQVPYMGLSE---------LEIHDLIQMGKRPRLTDELEALGSCHEH-----EVAQSGSG-F----EKPEAELETLSF 802 (840)
Q Consensus 742 LTG~~PF~~~~~---------~el~~~I~~~~~p~l~~~l~~~~~~~~~-----~~~~~~~~-~----~~~~~~~~~s~~ 802 (840)
++|++||..... ......+...........+......... .+...... . ............
T Consensus 210 ~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (317)
T cd07868 210 LTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 289 (317)
T ss_pred HhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChH
Confidence 999999965432 1222222221111111111111000000 00000000 0 000001112346
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHH
Q 003185 803 LVDVFRRCTEENPTERPTAGDLYEMF 828 (840)
Q Consensus 803 L~dLI~rCL~~DP~eRPSa~ELLehL 828 (840)
+.+||.+||++||.+|||++|+++|-
T Consensus 290 ~~dli~~mL~~dP~~R~t~~e~l~hp 315 (317)
T cd07868 290 AFHLLQKLLTMDPIKRITSEQAMQDP 315 (317)
T ss_pred HHHHHHHHhccCcccCCCHHHHhcCC
Confidence 88999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=318.59 Aligned_cols=260 Identities=24% Similarity=0.330 Sum_probs=189.4
Q ss_pred eeecccCceEEEEEEE-C---CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKF-G---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 586 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~-~---~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~ 586 (840)
+.||+|+||.||+|.. . ...+++|... . ........ .+.+|+.+++.++||||+++++.+.....
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~--~-~~~~~~~~----~~~~e~~~~~~l~h~nii~~~~~~~~~~~---- 69 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELR--A-SATPDEQL----LFLQEVQPYRELNHPNVLQCLGQCIESIP---- 69 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecC--c-cCChHHHH----HHHHHHHHHHhCCCCCcceEEEEECCCCc----
Confidence 3699999999999975 2 2345555432 1 11222222 34889999999999999999999876553
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEeccccc
Q 003185 587 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 666 (840)
Q Consensus 587 ~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~ 666 (840)
.++||||+++|+|.+++..........+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 ----------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~--- 136 (269)
T cd05042 70 ----------YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD--- 136 (269)
T ss_pred ----------eEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC---
Confidence 4999999999999999986322222345678889999999999999999999999999999999877
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc---CCCCCCchhhHHHHHHHHHHHHh
Q 003185 667 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH---KPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 667 ~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~---~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.+||+|||++......... .......+++.|+|||++.... ....++.++|||||||++|||++
T Consensus 137 ----~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 204 (269)
T cd05042 137 ----LSVKIGDYGLALEQYPEDYY--------ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204 (269)
T ss_pred ----CcEEEeccccccccccchhe--------eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHh
Confidence 46999999998654221110 0012234677899999986411 12456889999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 744 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 744 -G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
|..||......+....+.......++. +......+..+.+++..|| .||.+|||++
T Consensus 205 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~ 261 (269)
T cd05042 205 AADQPYPDLSDEQVLKQVVREQDIKLPK----------------------PQLDLKYSDRWYEVMQFCW-LDPETRPTAE 261 (269)
T ss_pred CCCCCCCcCCHHHHHHHHhhccCccCCC----------------------CcccccCCHHHHHHHHHHh-cCcccccCHH
Confidence 788998877666555544433222221 0011223557788999999 5999999999
Q ss_pred HHHHHHH
Q 003185 823 DLYEMFV 829 (840)
Q Consensus 823 ELLehLe 829 (840)
+|++.|.
T Consensus 262 ~v~~~l~ 268 (269)
T cd05042 262 EVHELLT 268 (269)
T ss_pred HHHHHhc
Confidence 9999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=321.71 Aligned_cols=268 Identities=22% Similarity=0.351 Sum_probs=206.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 574 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~ 574 (840)
+..++|++.+.||+|+||.||+|... +..+|+|+.... ....... .+.+|+.+++.++||||++++
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~e~~~l~~l~~~~i~~~~ 75 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES---ASLRERI----EFLNEASVMKGFTCHHVVRLL 75 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc---CCHHHHH----HHHHHHHHHHhCCCCCeeeEE
Confidence 34568999999999999999999753 346788874321 1112222 348899999999999999999
Q ss_pred eEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Q 003185 575 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----GEKHVSVKLALFIAQDVAAALVELHSKHIM 649 (840)
Q Consensus 575 g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-----~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIV 649 (840)
+++..... .++||||+++|+|.+++...... ....++...+..++.||+.||.|||+++|+
T Consensus 76 ~~~~~~~~--------------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~ 141 (288)
T cd05061 76 GVVSKGQP--------------TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFV 141 (288)
T ss_pred EEEcCCCC--------------cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Confidence 99875543 39999999999999999763211 123456788899999999999999999999
Q ss_pred cccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchh
Q 003185 650 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 729 (840)
Q Consensus 650 HRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kS 729 (840)
||||||+|||++.+ +.++|+|||+++......... ......++..|+|||.+.+ ..++.++
T Consensus 142 H~dikp~nili~~~-------~~~~L~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~~pE~~~~----~~~~~~~ 202 (288)
T cd05061 142 HRDLAARNCMVAHD-------FTVKIGDFGMTRDIYETDYYR--------KGGKGLLPVRWMAPESLKD----GVFTTSS 202 (288)
T ss_pred CCCCChheEEEcCC-------CcEEECcCCcccccccccccc--------ccCCCcccccccCHHHhcc----CCCChHh
Confidence 99999999999876 469999999987653321110 0112245678999999875 5678999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHH
Q 003185 730 DIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 808 (840)
Q Consensus 730 DVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~ 808 (840)
|||||||++|||++ |..||.+....++...+..+..+..+. ..+..+.+++.
T Consensus 203 DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~ 255 (288)
T cd05061 203 DMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD---------------------------NCPERVTDLMR 255 (288)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHH
Confidence 99999999999998 789998887777766665443322221 12457999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 003185 809 RCTEENPTERPTAGDLYEMFVARTSSSI 836 (840)
Q Consensus 809 rCL~~DP~eRPSa~ELLehLe~l~~~~~ 836 (840)
+||+.||.+|||+.++++.|+....++-
T Consensus 256 ~~l~~~p~~Rps~~~ll~~l~~~~~~~~ 283 (288)
T cd05061 256 MCWQFNPKMRPTFLEIVNLLKDDLHPSF 283 (288)
T ss_pred HHcCCChhHCcCHHHHHHHHHhhcCCCC
Confidence 9999999999999999999998765543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.43 Aligned_cols=249 Identities=24% Similarity=0.333 Sum_probs=197.3
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEecCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 582 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~~~~ 582 (840)
+|++.+.||+|+||.||+|.. ++..||+|+....... .....+ .+..|+.++..+. |++|+++++++.....
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~----~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVE----CTMVEKRVLALQDKPPFLTQLHSCFQTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHH----HHHHHHHHHHhccCCCchhheeeEEecCCE
Confidence 478899999999999999987 5678999987543211 111222 3377888888886 5778889988876553
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.|+||||+++|+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~Ey~~~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~ 136 (323)
T cd05615 76 --------------LYFVMEYVNGGDLMYHIQQ-----VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS 136 (323)
T ss_pred --------------EEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC
Confidence 5999999999999999875 356899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 137 ~-------~~ikL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~ell 195 (323)
T cd05615 137 E-------GHIKIADFGMCKEHMVDGV----------TTRTFCGTPDYIAPEIIAY----QPYGKSVDWWAYGVLLYEML 195 (323)
T ss_pred C-------CCEEEeccccccccCCCCc----------cccCccCCccccCHHHHcC----CCCCCccchhhhHHHHHHHH
Confidence 7 4599999999875322111 1123468999999999976 56789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC--
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT-- 820 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS-- 820 (840)
+|..||.+.+...+...+..... .++. ..+..+.+|+.+||..+|.+|++
T Consensus 196 tG~~pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 196 AGQPPFDGEDEDELFQSIMEHNV-SYPK---------------------------SLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred hCCCCCCCCCHHHHHHHHHhCCC-CCCc---------------------------cCCHHHHHHHHHHcccCHhhCCCCC
Confidence 99999998888777777655421 1111 12446899999999999999997
Q ss_pred ---HHHHHHH
Q 003185 821 ---AGDLYEM 827 (840)
Q Consensus 821 ---a~ELLeh 827 (840)
..++++|
T Consensus 248 ~~~~~~i~~h 257 (323)
T cd05615 248 PEGERDIREH 257 (323)
T ss_pred CCCHHHHhcC
Confidence 4677776
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=319.19 Aligned_cols=256 Identities=23% Similarity=0.274 Sum_probs=216.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
-.+++|++++.||+|-||.||+|+. +..-+|+||.... .-.......++.+|++|-..|+||||+++|++|.+
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKs-----qi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd 93 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKS-----QILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD 93 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHH-----HHHHhcchhhhhheeEeecccCCccHHhhhhheec
Confidence 5688999999999999999999997 4556788876432 12333445677999999999999999999999998
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
...+ ||++||..+|.|...|.. ....++++..+..++.|+|.||.|+|..+||||||||+|+|
T Consensus 94 ~~ri--------------yLilEya~~gel~k~L~~---~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlL 156 (281)
T KOG0580|consen 94 SKRI--------------YLILEYAPRGELYKDLQE---GRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLL 156 (281)
T ss_pred ccee--------------EEEEEecCCchHHHHHHh---cccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhc
Confidence 7755 999999999999999985 34567999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++..+ .+||+|||-+..... ....+.+||..|.+||+..+ ..++..+|+|++|++.|
T Consensus 157 lg~~~-------~lkiAdfGwsV~~p~------------~kR~tlcgt~dyl~pEmv~~----~~hd~~Vd~w~lgvl~y 213 (281)
T KOG0580|consen 157 LGSAG-------ELKIADFGWSVHAPS------------NKRKTLCGTLDYLPPEMVEG----RGHDKFVDLWSLGVLCY 213 (281)
T ss_pred cCCCC-------CeeccCCCceeecCC------------CCceeeecccccCCHhhcCC----CCccchhhHHHHHHHHH
Confidence 99884 499999998865432 12355689999999999987 77899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|++.|.+||...+..+.+..|.+... .++ ..++..+.+||.+||..+|.+|.
T Consensus 214 eflvg~ppFes~~~~etYkrI~k~~~-~~p---------------------------~~is~~a~dlI~~ll~~~p~~r~ 265 (281)
T KOG0580|consen 214 EFLVGLPPFESQSHSETYKRIRKVDL-KFP---------------------------STISGGAADLISRLLVKNPIERL 265 (281)
T ss_pred HHHhcCCchhhhhhHHHHHHHHHccc-cCC---------------------------cccChhHHHHHHHHhccCccccc
Confidence 99999999998888888888876532 111 12355789999999999999999
Q ss_pred CHHHHHHHHHh
Q 003185 820 TAGDLYEMFVA 830 (840)
Q Consensus 820 Sa~ELLehLe~ 830 (840)
+..|+++|.+-
T Consensus 266 ~l~~v~~hpwI 276 (281)
T KOG0580|consen 266 ALTEVMDHPWI 276 (281)
T ss_pred cHHHHhhhHHH
Confidence 99999999763
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=326.23 Aligned_cols=266 Identities=22% Similarity=0.341 Sum_probs=208.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC---------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcc
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIV 571 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~---------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV 571 (840)
...++|.+.+.||+|+||.||+|.+. ...+|+|+.... ....... .+.+|+.+++.+ +||||+
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~----~~~~E~~~l~~l~~h~~i~ 84 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD---ATEKDLS----DLVSEMEMMKMIGKHKNII 84 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc---cchHHHH----HHHHHHHHHHhhccCCCch
Confidence 45678999999999999999999741 235777775321 1122233 348999999999 799999
Q ss_pred eeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHH
Q 003185 572 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAAL 640 (840)
Q Consensus 572 ~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-----------~~~~ls~~~~~~Ia~QIa~AL 640 (840)
++++++..... .|+||||+++++|.+++...... ....+++..+..++.||+.||
T Consensus 85 ~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al 150 (304)
T cd05101 85 NLLGACTQDGP--------------LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGM 150 (304)
T ss_pred heeEEEecCCc--------------eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHH
Confidence 99999876543 49999999999999999863211 123578889999999999999
Q ss_pred HHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003185 641 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720 (840)
Q Consensus 641 ~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~ 720 (840)
.|||++||+||||||+|||++.+ +.+||+|||+++......... ......+++.|+|||++.+
T Consensus 151 ~~LH~~givH~dlkp~Nili~~~-------~~~kl~D~g~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-- 213 (304)
T cd05101 151 EYLASQKCIHRDLAARNVLVTEN-------NVMKIADFGLARDVNNIDYYK--------KTTNGRLPVKWMAPEALFD-- 213 (304)
T ss_pred HHHHHCCeeecccccceEEEcCC-------CcEEECCCccceecccccccc--------cccCCCCCceeeCchhhcc--
Confidence 99999999999999999999876 469999999998664322110 0111235678999999875
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhh
Q 003185 721 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 799 (840)
Q Consensus 721 ~~~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 799 (840)
..++.++||||||+++|+|++ |..||.+.+..++...+........+ ...
T Consensus 214 --~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~ 264 (304)
T cd05101 214 --RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP---------------------------ANC 264 (304)
T ss_pred --CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCC---------------------------CCC
Confidence 567899999999999999998 88999888888877777655432221 123
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 003185 800 LSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 800 s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~~ 834 (840)
+..+.+|+.+||..+|.+||++.+|++.|+.+...
T Consensus 265 ~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 265 TNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 45789999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=319.17 Aligned_cols=266 Identities=23% Similarity=0.315 Sum_probs=207.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 575 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g 575 (840)
+.-++|++.+.||+|+||.||+|.+. +..+++|+.. . .......+. +.+|+.++++++||||+++++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~--~-~~~~~~~~~----~~~e~~~l~~l~h~ni~~~~~ 75 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK--D-HASEIQVTL----LLQESCLLYGLSHQNILPILH 75 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEcc--C-CCCHHHHHH----HHHHHHHHHhCCCCCCCeEEE
Confidence 34578999999999999999999974 3677777643 1 122233333 489999999999999999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---GEKHVSVKLALFIAQDVAAALVELHSKHIMHRD 652 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~---~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRD 652 (840)
++..... ..++++||+.+++|.+++...... ....+++..++.++.||+.||+|||+++++|||
T Consensus 76 ~~~~~~~-------------~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~d 142 (280)
T cd05043 76 VCIEDGE-------------PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKD 142 (280)
T ss_pred EEecCCC-------------CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecc
Confidence 8775432 249999999999999999763211 114689999999999999999999999999999
Q ss_pred CCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHH
Q 003185 653 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 732 (840)
Q Consensus 653 LKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVW 732 (840)
|||+|||++.+ ..+||+|||+++.+........ .....++..|+|||++.+ ..++.++|||
T Consensus 143 i~p~nil~~~~-------~~~kl~d~g~~~~~~~~~~~~~--------~~~~~~~~~y~apE~~~~----~~~~~~~Di~ 203 (280)
T cd05043 143 IAARNCVIDEE-------LQVKITDNALSRDLFPMDYHCL--------GDNENRPVKWMALESLVN----KEYSSASDVW 203 (280)
T ss_pred cCHhhEEEcCC-------CcEEECCCCCcccccCCceEEe--------CCCCCcchhccCHHHHhc----CCCCchhhHH
Confidence 99999999876 5699999999986543221100 112246778999999975 5678999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 003185 733 SYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 811 (840)
Q Consensus 733 SLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL 811 (840)
||||++||+++ |..||...++.++...+..+..+..+ ...++.+.+++.+||
T Consensus 204 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l 256 (280)
T cd05043 204 SFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP---------------------------INCPDELFAVMACCW 256 (280)
T ss_pred HhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCC---------------------------CcCCHHHHHHHHHHc
Confidence 99999999999 99999888777766665554322111 112457899999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhcC
Q 003185 812 EENPTERPTAGDLYEMFVARTS 833 (840)
Q Consensus 812 ~~DP~eRPSa~ELLehLe~l~~ 833 (840)
..||++|||+.++++.|..+..
T Consensus 257 ~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 257 ALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCChhhCCCHHHHHHHHHHHHh
Confidence 9999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=336.55 Aligned_cols=245 Identities=22% Similarity=0.350 Sum_probs=188.2
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEecCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 587 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~~~~~~p~~~ 587 (840)
+.||+|+||.||+|.. .+..+|+|++...... ...... .+.+|+.++.++ +||||+++++++.....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~----- 70 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN-DDEDID----WVQTEKHVFEQASNHPFLVGLHSCFQTESR----- 70 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc-chhHHH----HHHHHHHHHHhcCCCCcCCceeeEEEeCCE-----
Confidence 4699999999999987 5678999987543221 112222 347888888877 79999999999886553
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccC
Q 003185 588 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667 (840)
Q Consensus 588 g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~ 667 (840)
.|+||||+++|+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~E~~~~~~L~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~---- 132 (329)
T cd05618 71 ---------LFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE---- 132 (329)
T ss_pred ---------EEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC----
Confidence 5999999999999988875 3568999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003185 668 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 747 (840)
Q Consensus 668 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~P 747 (840)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..|
T Consensus 133 ---~~~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~P 195 (329)
T cd05618 133 ---GHIKLTDYGMCKEGLRPGD----------TTSTFCGTPNYIAPEILRG----EDYGFSVDWWALGVLMFEMMAGRSP 195 (329)
T ss_pred ---CCEEEeeCCccccccCCCC----------ccccccCCccccCHHHHcC----CCCCCccceecccHHHHHHhhCCCC
Confidence 4599999999875322111 1123469999999999976 6678999999999999999999999
Q ss_pred CCCCC---------HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 748 YMGLS---------ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 748 F~~~~---------~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
|.... ...+...+... ...++ ...+..+.+||.+||+.||.+|
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p---------------------------~~~~~~~~~ll~~~L~~dP~~R 247 (329)
T cd05618 196 FDIVGSSDNPDQNTEDYLFQVILEK-QIRIP---------------------------RSLSVKAASVLKSFLNKDPKER 247 (329)
T ss_pred CccCCCcCCcccccHHHHHHHHhcC-CCCCC---------------------------CCCCHHHHHHHHHHhcCCHHHc
Confidence 95321 11122222221 11111 1124578999999999999999
Q ss_pred CC------HHHHHHHH
Q 003185 819 PT------AGDLYEMF 828 (840)
Q Consensus 819 PS------a~ELLehL 828 (840)
|+ +.++++|.
T Consensus 248 ~~~~~~~~~~~i~~hp 263 (329)
T cd05618 248 LGCHPQTGFADIQGHP 263 (329)
T ss_pred CCCCCCCCHHHHhcCC
Confidence 98 57888883
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=320.91 Aligned_cols=256 Identities=32% Similarity=0.457 Sum_probs=198.0
Q ss_pred ceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 584 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p 584 (840)
|++.+.||+|+||+||++.. ++..+|+|+...... . ........+|+.++++++||||+++++++.....
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~----~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-- 72 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI----E--EEEREENIREIKILRRLRHPNIVQILDVFQDDNY-- 72 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH----H--HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSE--
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc----c--ccccchhhhhhhcccccccccccccccccccccc--
Confidence 78999999999999999998 445799999764421 1 1111223569999999999999999999987553
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEeccc
Q 003185 585 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 664 (840)
Q Consensus 585 ~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~ 664 (840)
.++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+|||++.+
T Consensus 73 ------------~~~v~~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~- 134 (260)
T PF00069_consen 73 ------------LYIVMEYCPGGSLQDYLQK-----NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN- 134 (260)
T ss_dssp ------------EEEEEEEETTEBHHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT-
T ss_pred ------------ccccccccccccccccccc-----ccccccccccccccccccccccccccccccccccccccccccc-
Confidence 4999999999999999984 2578999999999999999999999999999999999999976
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 003185 665 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 744 (840)
Q Consensus 665 ~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG 744 (840)
+.++|+|||.+........ ......+|..|+|||++.. ...++.++||||||+++|+|++|
T Consensus 135 ------~~~~l~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~~l~~~ 195 (260)
T PF00069_consen 135 ------GEVKLIDFGSSVKLSENNE----------NFNPFVGTPEYMAPEVLQQ---GKKYTRKSDIWSLGIILYELLTG 195 (260)
T ss_dssp ------SEEEESSGTTTEESTSTTS----------EBSSSSSSGGGSCHHHHTT---TSSBSTHHHHHHHHHHHHHHHHS
T ss_pred ------ccccccccccccccccccc----------ccccccccccccccccccc---ccccccccccccccccccccccc
Confidence 4599999999975411111 1123468999999999871 26789999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 003185 745 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 824 (840)
Q Consensus 745 ~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~EL 824 (840)
..||...........+.......+..... ........+.+||.+||+.||.+||++.++
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l 254 (260)
T PF00069_consen 196 KLPFEESNSDDQLEIIEKILKRPLPSSSQ---------------------QSREKSEELRDLIKKMLSKDPEQRPSAEEL 254 (260)
T ss_dssp SSSSTTSSHHHHHHHHHHHHHTHHHHHTT---------------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHH
T ss_pred ccccccccchhhhhhhhhccccccccccc---------------------ccchhHHHHHHHHHHHccCChhHCcCHHHH
Confidence 99998874444333333221111111000 000113689999999999999999999999
Q ss_pred HHHH
Q 003185 825 YEMF 828 (840)
Q Consensus 825 LehL 828 (840)
++|.
T Consensus 255 ~~~~ 258 (260)
T PF00069_consen 255 LKHP 258 (260)
T ss_dssp HTSG
T ss_pred hcCC
Confidence 9874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=321.75 Aligned_cols=259 Identities=27% Similarity=0.383 Sum_probs=199.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
....+|++.+.||+|+||.||+|.. .+..+|+|+...+.. ..... +.+|+.++++++||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~----~~~e~~~l~~~~h~~ii~~~~~~~~ 77 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG----DDFSL----IQQEIFMVKECKHCNIVAYFGSYLS 77 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc----chHHH----HHHHHHHHHhcCCCCeeeeeEEEEe
Confidence 3456899999999999999999996 567889998754321 12222 3789999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.. ..++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+
T Consensus 78 ~~--------------~~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil 138 (267)
T cd06646 78 RE--------------KLWICMEYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANIL 138 (267)
T ss_pred CC--------------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence 54 35999999999999999875 346899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.++|+|||++........ ......|++.|+|||.+.... ...++.++|||||||++|
T Consensus 139 l~~~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~~~-~~~~~~~~Dvws~G~il~ 200 (267)
T cd06646 139 LTDN-------GDVKLADFGVAAKITATIA----------KRKSFIGTPYWMAPEVAAVEK-NGGYNQLCDIWAVGITAI 200 (267)
T ss_pred ECCC-------CCEEECcCccceeeccccc----------ccCccccCccccCHhHccccc-CCCCcchhhHHHHHHHHH
Confidence 9876 4599999999986532211 012345889999999985321 245678999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
||++|+.||....+......+...... .+ ........+..+.+||.+||..+|.+||
T Consensus 201 el~~g~~p~~~~~~~~~~~~~~~~~~~-~~----------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rp 257 (267)
T cd06646 201 ELAELQPPMFDLHPMRALFLMSKSNFQ-PP----------------------KLKDKTKWSSTFHNFVKISLTKNPKKRP 257 (267)
T ss_pred HHHhCCCCccccchhhhheeeecCCCC-CC----------------------CCccccccCHHHHHHHHHHhhCChhhCc
Confidence 999999999765443322222111100 00 0000112345789999999999999999
Q ss_pred CHHHHHHHH
Q 003185 820 TAGDLYEMF 828 (840)
Q Consensus 820 Sa~ELLehL 828 (840)
++++|++||
T Consensus 258 ~~~~il~~l 266 (267)
T cd06646 258 TAERLLTHL 266 (267)
T ss_pred CHHHHhcCC
Confidence 999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=317.39 Aligned_cols=255 Identities=24% Similarity=0.396 Sum_probs=204.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
+..++|++.++||+|+||.||+|.. .+..+|+|...... . .... +.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~--~---~~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~ 73 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS--M---SPEA----FLAEANLMKQLQHPRLVRLYAVVTQE 73 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC--C---cHHH----HHHHHHHHHhcCCcCeeeEEEEEccC
Confidence 4457899999999999999999987 55789999864222 1 1223 48899999999999999999986432
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
..++||||+.+++|.+++.. .....+++..+..++.|++.||+|||+.|++||||||+||++
T Consensus 74 ---------------~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i 135 (260)
T cd05067 74 ---------------PIYIITEYMENGSLVDFLKT---PEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV 135 (260)
T ss_pred ---------------CcEEEEEcCCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE
Confidence 24999999999999999875 233568999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.++|+|||++......... ......++..|+|||++.. ..++.++||||||+++||
T Consensus 136 ~~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~pe~~~~----~~~~~~~Di~slG~~l~e 195 (260)
T cd05067 136 SET-------LCCKIADFGLARLIEDNEYT---------AREGAKFPIKWTAPEAINY----GTFTIKSDVWSFGILLTE 195 (260)
T ss_pred cCC-------CCEEEccCcceeecCCCCcc---------cccCCcccccccCHHHhcc----CCcCcccchHHHHHHHHH
Confidence 877 46999999999765421111 0112346778999999875 567889999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|++ |..||.+.+..+....+.....+..+. ..+..+.+++.+||..+|.+||
T Consensus 196 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp 248 (260)
T cd05067 196 IVTYGRIPYPGMTNPEVIQNLERGYRMPRPD---------------------------NCPEELYELMRLCWKEKPEERP 248 (260)
T ss_pred HHhCCCCCCCCCChHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHccCChhhCC
Confidence 999 999998887777766665543322211 1245799999999999999999
Q ss_pred CHHHHHHHHHh
Q 003185 820 TAGDLYEMFVA 830 (840)
Q Consensus 820 Sa~ELLehLe~ 830 (840)
+++++++.|+.
T Consensus 249 ~~~~l~~~l~~ 259 (260)
T cd05067 249 TFEYLRSVLED 259 (260)
T ss_pred CHHHHHHHhhc
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=321.87 Aligned_cols=278 Identities=21% Similarity=0.248 Sum_probs=199.6
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|++.+.||+|+||.||+|.. .+..+|+|+....... .. ....+.+|+.++++++||||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 73 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE--EG----VPSTAIREISLLKELQHPNIVCLQDVLMQESR- 73 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc--CC----chHHHHHHHHHHHhcCCCCEeeeEEEEeeCCe-
Confidence 588999999999999999987 5778999986543211 11 11234789999999999999999999886553
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.|+||||++ ++|.+++... .....+++..++.++.||+.||.|||++||+|+||||+|||++.+
T Consensus 74 -------------~~~v~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~ 137 (285)
T cd07861 74 -------------LYLIFEFLS-MDLKKYLDSL--PKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK 137 (285)
T ss_pred -------------EEEEEecCC-CCHHHHHhcC--CCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC
Confidence 499999997 6999988652 223568999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.++|+|||++......... .....+++.|+|||++.+ ...++.++|||||||++|+|+|
T Consensus 138 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~~l~t 197 (285)
T cd07861 138 -------GVIKLADFGLARAFGIPVRV----------YTHEVVTLWYRAPEVLLG---SPRYSTPVDIWSIGTIFAEMAT 197 (285)
T ss_pred -------CcEEECcccceeecCCCccc----------ccCCcccccccChHHhcC---CCCcCcHHHHHHHHHHHHHHHH
Confidence 45999999998754322110 122357899999999865 2356889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcc--ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE--HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
|+.||.+.........+...........+........ ..+.. .............++++.+||.+||..||.+|||+
T Consensus 198 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~ 276 (285)
T cd07861 198 KKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPK-WKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISA 276 (285)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccc-cCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCH
Confidence 9999987765544333322211111111110000000 00000 00000011122346788999999999999999999
Q ss_pred HHHHHH
Q 003185 822 GDLYEM 827 (840)
Q Consensus 822 ~ELLeh 827 (840)
.+|++|
T Consensus 277 ~~ll~~ 282 (285)
T cd07861 277 KKALNH 282 (285)
T ss_pred HHHhcC
Confidence 999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=317.28 Aligned_cols=256 Identities=25% Similarity=0.352 Sum_probs=201.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
+..++|++.++||+|+||.||+|.+.+ ..+|+|+..... .. .+ .+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~--~~---~~----~~~~E~~~l~~l~~~~i~~~~~~~~~~ 73 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MS---PE----AFLQEAQVMKKLRHEKLVQLYAVVSEE 73 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc--cC---HH----HHHHHHHHHHhCCCCCcceEEEEECCC
Confidence 345679999999999999999998743 468888754221 11 12 348899999999999999999886432
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
..++||||+++++|.+++.. .....+++..+..++.|++.||+|||+.+|+|+||||+||++
T Consensus 74 ---------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill 135 (262)
T cd05071 74 ---------------PIYIVTEYMSKGSLLDFLKG---EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 135 (262)
T ss_pred ---------------CcEEEEEcCCCCcHHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE
Confidence 23899999999999999975 122457899999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.++|+|||.+..+...... ......++..|+|||++.+ ..++.++|||||||++|+
T Consensus 136 ~~~-------~~~~L~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~----~~~~~~~DvwslG~~l~e 195 (262)
T cd05071 136 GEN-------LVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTE 195 (262)
T ss_pred cCC-------CcEEeccCCceeeccccccc---------cccCCcccceecCHhHhcc----CCCCchhhHHHHHHHHHH
Confidence 876 45999999999765432211 0112346778999999865 567899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|+| |..||.+....++...+......... ...+..+.+|+.+||+.+|.+||
T Consensus 196 llt~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~~p~~Rp 248 (262)
T cd05071 196 LTTKGRVPYPGMVNREVLDQVERGYRMPCP---------------------------PECPESLHDLMCQCWRKEPEERP 248 (262)
T ss_pred HHcCCCCCCCCCChHHHHHHHhcCCCCCCc---------------------------cccCHHHHHHHHHHccCCcccCC
Confidence 999 89999888777666665443221111 12345789999999999999999
Q ss_pred CHHHHHHHHHhh
Q 003185 820 TAGDLYEMFVAR 831 (840)
Q Consensus 820 Sa~ELLehLe~l 831 (840)
++.++++.|+..
T Consensus 249 ~~~~~~~~l~~~ 260 (262)
T cd05071 249 TFEYLQAFLEDY 260 (262)
T ss_pred CHHHHHHHHHHh
Confidence 999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=316.87 Aligned_cols=249 Identities=26% Similarity=0.401 Sum_probs=202.9
Q ss_pred CCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
.+.+|++.+.||+|+||.||++...+..+|+|+..... ... .+.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~------~~~----~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 72 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV------TAQ----AFLEETAVMTKLHHKNLVRLLGVILHNG- 72 (254)
T ss_pred cHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc------hHH----HHHHHHHHHHhCCCCCcCeEEEEEcCCC-
Confidence 46789999999999999999999999999999864321 112 3488999999999999999999876432
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.++||||+++++|.+++.. .....+++..++.++.|++.||.|||++|++||||||+|||++.
T Consensus 73 --------------~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~ 135 (254)
T cd05083 73 --------------LYIVMELMSKGNLVNFLRT---RGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSE 135 (254)
T ss_pred --------------cEEEEECCCCCCHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC
Confidence 3899999999999999975 22345889999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||++....... .....+..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 136 ~-------~~~kl~Dfg~~~~~~~~~-------------~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~~l~el~ 191 (254)
T cd05083 136 D-------GVAKVSDFGLARVGSMGV-------------DNSKLPVKWTAPEALKH----KKFSSKSDVWSYGVLLWEVF 191 (254)
T ss_pred C-------CcEEECCCccceeccccC-------------CCCCCCceecCHHHhcc----CCcCchhhHHHHHHHHHHHH
Confidence 6 459999999987543211 11224568999999875 56789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 743 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 743 T-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
+ |..||...+..+....+..+..+..+ ...+..+.+|+.+||+.+|.+||++
T Consensus 192 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~ 244 (254)
T cd05083 192 SYGRAPYPKMSLKEVKECVEKGYRMEPP---------------------------EGCPADVYVLMTSCWETEPKKRPSF 244 (254)
T ss_pred hCCCCCCccCCHHHHHHHHhCCCCCCCC---------------------------CcCCHHHHHHHHHHcCCChhhCcCH
Confidence 8 99999888777776666554332211 1124578999999999999999999
Q ss_pred HHHHHHHHh
Q 003185 822 GDLYEMFVA 830 (840)
Q Consensus 822 ~ELLehLe~ 830 (840)
++|++.|+.
T Consensus 245 ~~l~~~l~~ 253 (254)
T cd05083 245 HKLREKLEK 253 (254)
T ss_pred HHHHHHHcc
Confidence 999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=349.87 Aligned_cols=276 Identities=23% Similarity=0.283 Sum_probs=215.0
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-C-----CCcceeeeEE
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-H-----SCIVEMYGHK 577 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-H-----pNIV~l~g~~ 577 (840)
+|++.+.||+|+||.|-+|.+ +++.||+||++-+ ..|..+-..|+.+|..|+ | -|||+++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---------k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---------KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---------hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 899999999999999999997 6789999996533 233344478999999997 4 5899999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
...++ +|||+|.+. .+|+++|+. +....++...++.|+.||+.||.+||..||||+||||+|
T Consensus 258 ~fr~H--------------lciVfELL~-~NLYellK~---n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPEN 319 (586)
T KOG0667|consen 258 YFRNH--------------LCIVFELLS-TNLYELLKN---NKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPEN 319 (586)
T ss_pred ccccc--------------eeeeehhhh-hhHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhh
Confidence 87664 599999997 699999987 444569999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
|||...+. ..|||+|||.|........ ..+.+..|+|||++.+ .+|+.+.||||||||
T Consensus 320 ILL~~~~r-----~~vKVIDFGSSc~~~q~vy-------------tYiQSRfYRAPEVILG----lpY~~~IDmWSLGCI 377 (586)
T KOG0667|consen 320 ILLKDPKR-----SRIKVIDFGSSCFESQRVY-------------TYIQSRFYRAPEVILG----LPYDTAIDMWSLGCI 377 (586)
T ss_pred eeeccCCc-----CceeEEecccccccCCcce-------------eeeeccccccchhhcc----CCCCCccceeehhhh
Confidence 99987643 5799999999987655332 2457889999999998 789999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccc--------------------------------
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ-------------------------------- 785 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~-------------------------------- 785 (840)
++||++|.+.|+|.+..+.+..|......+-+..+... ......+..
T Consensus 378 lAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~-~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~ 456 (586)
T KOG0667|consen 378 LAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA-KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLE 456 (586)
T ss_pred HHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc-cccceehhccCCceeeeeeecccccccchhhhhhhhhhccc
Confidence 99999999999999999888888765332222222211 100000000
Q ss_pred -cCC-CCC--CchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 003185 786 -SGS-GFE--KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 831 (840)
Q Consensus 786 -~~~-~~~--~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l 831 (840)
... ..+ ...........++++|.+||.+||.+|+|+.++|+|.+--
T Consensus 457 ~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~ 506 (586)
T KOG0667|consen 457 RRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLT 506 (586)
T ss_pred ccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccc
Confidence 000 000 0011113356789999999999999999999999996644
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=315.24 Aligned_cols=254 Identities=23% Similarity=0.358 Sum_probs=200.9
Q ss_pred CCCCceeeeeecccCceEEEEEEECC-eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
..++|.+.+.||+|+||.||+|.+.+ ..+++|+..... . . .+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~---~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 73 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--M---M----PEAFLQEAQIMKKLRHDKLVPLYAVVSEE- 73 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--c---c----HHHHHHHHHHHHhCCCCCeeeEEEEEcCC-
Confidence 34679999999999999999998744 467888743221 1 1 12348899999999999999999887422
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
..++||||+.+++|.+++.. .....+++..+..++.||+.||.|||+.||+|+||||+|||++
T Consensus 74 --------------~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~ 136 (260)
T cd05069 74 --------------PIYIVTEFMGKGSLLDFLKE---GDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG 136 (260)
T ss_pred --------------CcEEEEEcCCCCCHHHHHhh---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc
Confidence 13899999999999999975 2234578999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.++|+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|
T Consensus 137 ~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~Pe~~~~----~~~~~~~Di~slG~~l~el 196 (260)
T cd05069 137 DN-------LVCKIADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTEL 196 (260)
T ss_pred CC-------CeEEECCCccceEccCCccc---------ccCCCccchhhCCHHHhcc----CCcChHHHHHHHHHHHHHH
Confidence 76 46999999999765432111 0112246778999999875 5678999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 742 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 742 LT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
+| |..||.+....+....+.....+..+. ..+..+.+|+.+||..||.+||+
T Consensus 197 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp~ 249 (260)
T cd05069 197 VTKGRVPYPGMVNREVLEQVERGYRMPCPQ---------------------------GCPESLHELMKLCWKKDPDERPT 249 (260)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------ccCHHHHHHHHHHccCCcccCcC
Confidence 99 999998887777766665543322111 12457899999999999999999
Q ss_pred HHHHHHHHHh
Q 003185 821 AGDLYEMFVA 830 (840)
Q Consensus 821 a~ELLehLe~ 830 (840)
+++|++.|+.
T Consensus 250 ~~~i~~~l~~ 259 (260)
T cd05069 250 FEYIQSFLED 259 (260)
T ss_pred HHHHHHHHhc
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=334.17 Aligned_cols=262 Identities=23% Similarity=0.278 Sum_probs=201.4
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||.||++.. .+..+|+|+...... ..... ...+.+|+.++..++|+||+++++++.....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-LKRAE----TACFREERDVLVNGDRRWITNLHYAFQDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhh----HHHHHHHHHHHHhCCCCCCCceEEEEecCCe
Confidence 4799999999999999999997 467899998753211 11111 2334889999999999999999999986654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.|+||||+++|+|.+++.+ ....+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 137 (331)
T cd05597 76 --------------LYLVMDYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDK 137 (331)
T ss_pred --------------EEEEEecCCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECC
Confidence 4999999999999999975 1346899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC-CCCCCchhhHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~-~~~~s~kSDVWSLGvIL~EL 741 (840)
+ +.+||+|||++..+...... ......||+.|||||++..... ...++.++|||||||++|+|
T Consensus 138 ~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el 201 (331)
T cd05597 138 N-------GHIRLADFGSCLRLLADGTV---------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEM 201 (331)
T ss_pred C-------CCEEEEECCceeecCCCCCc---------cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHH
Confidence 6 45999999998765332111 1122469999999999974221 24578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCC-CCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--C
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE--R 818 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e--R 818 (840)
++|+.||.+.+..+....+.... ...++. .....+..+.+||.+||..++.+ |
T Consensus 202 ~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~~~~~~~~li~~ll~~~~~r~~r 257 (331)
T cd05597 202 LYGETPFYAESLVETYGKIMNHKEHFQFPP------------------------DVTDVSEEAKDLIRRLICSPETRLGR 257 (331)
T ss_pred hhCCCCCCCCCHHHHHHHHHcCCCcccCCC------------------------ccCCCCHHHHHHHHHHccCcccccCC
Confidence 99999998887777666654431 111110 01123567899999988764444 7
Q ss_pred CCHHHHHHHHH
Q 003185 819 PTAGDLYEMFV 829 (840)
Q Consensus 819 PSa~ELLehLe 829 (840)
|++.++++|.+
T Consensus 258 ~~~~~~l~hp~ 268 (331)
T cd05597 258 NGLQDFKDHPF 268 (331)
T ss_pred CCHHHHhcCCC
Confidence 89999999954
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=347.75 Aligned_cols=284 Identities=20% Similarity=0.215 Sum_probs=199.9
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC------CCCcceee
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR------HSCIVEMY 574 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~------HpNIV~l~ 574 (840)
..++|++.+.||+|+||+||+|.+ .+..||||++.... ... ..+..|+.++..++ |++|+.++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-----~~~----~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-----KYT----RDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-----hhH----HHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 347899999999999999999987 56789999864211 111 12255666666665 45688888
Q ss_pred eEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccC
Q 003185 575 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDI 653 (840)
Q Consensus 575 g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs-~gIVHRDL 653 (840)
+++.... .+.+||||++ |++|.+++.+ ...+++..+..|+.||+.||.|||. .|||||||
T Consensus 198 ~~~~~~~-------------~~~~iv~~~~-g~~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDl 258 (467)
T PTZ00284 198 RYFQNET-------------GHMCIVMPKY-GPCLLDWIMK-----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDL 258 (467)
T ss_pred EEEEcCC-------------ceEEEEEecc-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCC
Confidence 8886432 2469999998 6799998875 3568999999999999999999998 59999999
Q ss_pred CCCcEEEecccccC---------CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCC
Q 003185 654 KSENILIDLERKKA---------DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 724 (840)
Q Consensus 654 KPeNILLd~~~~~~---------~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~ 724 (840)
||+|||++.++... .....+||+|||.+...... ....+||+.|||||++.+ ..
T Consensus 259 KP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-------------~~~~~gt~~Y~APE~~~~----~~ 321 (467)
T PTZ00284 259 KPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-------------RTAIVSTRHYRSPEVVLG----LG 321 (467)
T ss_pred CHHHEEEecCCcccccccccccCCCCceEEECCCCccccCccc-------------cccccCCccccCcHHhhc----CC
Confidence 99999998653210 01235999999987532211 133579999999999986 67
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcc-cccccc----CCCC---------
Q 003185 725 YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE-HEVAQS----GSGF--------- 790 (840)
Q Consensus 725 ~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~-~~~~~~----~~~~--------- 790 (840)
++.++|||||||+||||++|+.||.+.+..+....+..... .++..+...+.... ..+... ....
T Consensus 322 ~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (467)
T PTZ00284 322 WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLG-RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIA 400 (467)
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC-CCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhh
Confidence 89999999999999999999999998877776666554322 12222221100000 000000 0000
Q ss_pred -CCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 003185 791 -EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 832 (840)
Q Consensus 791 -~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~ 832 (840)
............+.+||.+||++||.+|||++|+++|.+-..
T Consensus 401 ~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 401 RARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLK 443 (467)
T ss_pred cccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccc
Confidence 000001112456889999999999999999999999965443
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=317.39 Aligned_cols=258 Identities=21% Similarity=0.331 Sum_probs=202.2
Q ss_pred CCCceeeeeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEe
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 578 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~ 578 (840)
..+|++.+.||+|+||.||+|.+. ...+|+|... ... .....+ .+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~--~~~-~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLK--AGY-TEKQRR----DFLSEASIMGQFDHPNIIHLEGVVT 75 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECC--CCC-CHHHHH----HHHHHHHHHHhCCCCCcceEEEEEe
Confidence 457899999999999999999862 2256776643 211 222233 3488999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
.... .++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+||
T Consensus 76 ~~~~--------------~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~ni 137 (267)
T cd05066 76 KSKP--------------VMIVTEYMENGSLDAFLRK----HDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNI 137 (267)
T ss_pred cCCc--------------cEEEEEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcE
Confidence 6554 4999999999999999975 224689999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.+ +.++|+|||++..+....... .......++..|+|||++.+ ..++.++|||||||++
T Consensus 138 li~~~-------~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~~l 199 (267)
T cd05066 138 LVNSN-------LVCKVSDFGLSRVLEDDPEAA-------YTTRGGKIPIRWTAPEAIAY----RKFTSASDVWSYGIVM 199 (267)
T ss_pred EECCC-------CeEEeCCCCccccccccccee-------eecCCCccceeecCHhHhcc----CccCchhhhHHHHHHH
Confidence 99876 569999999998664321110 00111224568999999975 5678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 739 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 739 ~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
||+++ |..||......+....+....++..+ ...+..+.+++.+||+.+|.+
T Consensus 200 ~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~ 252 (267)
T cd05066 200 WEVMSYGERPYWEMSNQDVIKAIEEGYRLPAP---------------------------MDCPAALHQLMLDCWQKDRNE 252 (267)
T ss_pred HHHhcCCCCCcccCCHHHHHHHHhCCCcCCCC---------------------------CCCCHHHHHHHHHHcccCchh
Confidence 99886 99999888777776666654322111 112457899999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 003185 818 RPTAGDLYEMFVAR 831 (840)
Q Consensus 818 RPSa~ELLehLe~l 831 (840)
||++.++++.|.++
T Consensus 253 Rp~~~~i~~~l~~~ 266 (267)
T cd05066 253 RPKFEQIVSILDKL 266 (267)
T ss_pred CCCHHHHHHHHHhh
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=326.84 Aligned_cols=265 Identities=23% Similarity=0.356 Sum_probs=207.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE---------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcc
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF---------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIV 571 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~---------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV 571 (840)
.+.++|.+.+.||+|+||.||+|.. ....+|+|+.... ........ +.+|+.+++++ +||||+
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~----~~~E~~~l~~l~~h~~iv 81 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN---ATDKDLAD----LISEMELMKLIGKHKNII 81 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC---CChHHHHH----HHHHHHHHHhccCCCCee
Confidence 4567899999999999999999975 2346788875422 12222333 48899999999 599999
Q ss_pred eeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----------cCCCCCCHHHHHHHHHHHHHHH
Q 003185 572 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAAL 640 (840)
Q Consensus 572 ~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----------~~~~~ls~~~~~~Ia~QIa~AL 640 (840)
++++++..... .++||||+++|+|.+++..... .....+++..+..++.||+.||
T Consensus 82 ~~~~~~~~~~~--------------~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL 147 (314)
T cd05099 82 NLLGVCTQEGP--------------LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGM 147 (314)
T ss_pred eEEEEEccCCc--------------eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHH
Confidence 99999875543 4999999999999999976321 1124588999999999999999
Q ss_pred HHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003185 641 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720 (840)
Q Consensus 641 ~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~ 720 (840)
.|||++||+||||||+|||++.+ +.+||+|||+++.......... .....++..|||||++.+
T Consensus 148 ~~lH~~gi~H~dlkp~Nill~~~-------~~~kL~Dfg~~~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~-- 210 (314)
T cd05099 148 EYLESRRCIHRDLAARNVLVTED-------NVMKIADFGLARGVHDIDYYKK--------TSNGRLPVKWMAPEALFD-- 210 (314)
T ss_pred HHHHHCCeeeccccceeEEEcCC-------CcEEEccccccccccccccccc--------cccCCCCccccCHHHHcc--
Confidence 99999999999999999999876 4599999999986543211100 011124568999999875
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhh
Q 003185 721 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 799 (840)
Q Consensus 721 ~~~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 799 (840)
..++.++|||||||++|+|++ |..||.+....++...+........+ ..+
T Consensus 211 --~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~ 261 (314)
T cd05099 211 --RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKP---------------------------SNC 261 (314)
T ss_pred --CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCC
Confidence 567899999999999999999 89999888887777776654332221 112
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003185 800 LSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 833 (840)
Q Consensus 800 s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~ 833 (840)
+..+.+|+.+||..+|.+||++.++++.|..+..
T Consensus 262 ~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 262 THELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 4578899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=347.38 Aligned_cols=261 Identities=27% Similarity=0.474 Sum_probs=212.8
Q ss_pred CCceeeeeecccCceEEEEEEEC---C--ee-EEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEe
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKFG---S--AD-AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 578 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~---~--~~-vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~ 578 (840)
++..+.++||+|+||.||+|++. + .. ||+|....+ .....+...+| ++|+++|++++|||||++||+..
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~-~~~~~~~~~e~----m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGS-SELTKEQIKEF----MKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccc-ccccHHHHHHH----HHHHHHHHhCCCCCEEEEEEEEc
Confidence 45567799999999999999862 1 12 677765431 22344555555 99999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
....+ +||||+|.||+|.++|++ ....++..+...++.+.+.||+|||++++|||||-..|+
T Consensus 232 ~~~Pl--------------~ivmEl~~gGsL~~~L~k----~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNc 293 (474)
T KOG0194|consen 232 LEEPL--------------MLVMELCNGGSLDDYLKK----NKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNC 293 (474)
T ss_pred CCCcc--------------EEEEEecCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHh
Confidence 77755 999999999999999987 223699999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.+ .++||+|||+++.-...... .....-...|+|||.+.. ..|++++|||||||++
T Consensus 294 L~~~~-------~~vKISDFGLs~~~~~~~~~----------~~~~klPirWLAPEtl~~----~~~s~kTDV~sfGV~~ 352 (474)
T KOG0194|consen 294 LYSKK-------GVVKISDFGLSRAGSQYVMK----------KFLKKLPIRWLAPETLNT----GIFSFKTDVWSFGVLL 352 (474)
T ss_pred eecCC-------CeEEeCccccccCCcceeec----------cccccCcceecChhhhcc----CccccccchhheeeeE
Confidence 99987 45899999998754311110 001123478999999986 6899999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHH-HcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 739 LELLT-LQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 739 ~ELLT-G~~PF~~~~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
||+++ |..||.+....++...| ..+.+...+. ..+..+..++.+||..+|+
T Consensus 353 ~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~---------------------------~~p~~~~~~~~~c~~~~p~ 405 (474)
T KOG0194|consen 353 WEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS---------------------------KTPKELAKVMKQCWKKDPE 405 (474)
T ss_pred EeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC---------------------------CCHHHHHHHHHHhccCChh
Confidence 99999 88999999999999999 5556554442 1256788999999999999
Q ss_pred CCCCHHHHHHHHHhhcCCCC
Q 003185 817 ERPTAGDLYEMFVARTSSSI 836 (840)
Q Consensus 817 eRPSa~ELLehLe~l~~~~~ 836 (840)
+||++.++.+.|+.+.....
T Consensus 406 ~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 406 DRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred hccCHHHHHHHHHHHHhccc
Confidence 99999999999998876644
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=363.51 Aligned_cols=269 Identities=20% Similarity=0.319 Sum_probs=204.8
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEe
Q 003185 501 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 578 (840)
Q Consensus 501 p~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~ 578 (840)
+..+++|++.+.||.|+||+||+|.+ .+..+|+|++.... ....... .+.+|+.+|++|+|||||+++++|.
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~--l~e~~~~----~~~~EI~IL~~L~HPNIVrl~d~f~ 82 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG--LKEREKS----QLVIEVNVMRELKHKNIVRYIDRFL 82 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccc--cCHHHHH----HHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 36788999999999999999999997 45678888865432 2222233 4489999999999999999999886
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-------Ceecc
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-------HIMHR 651 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~-------gIVHR 651 (840)
.... ..+||||||+++++|.++|...... ...+++..++.|+.||+.||.|||.. +||||
T Consensus 83 de~~------------~~lyIVMEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHR 149 (1021)
T PTZ00266 83 NKAN------------QKLYILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHR 149 (1021)
T ss_pred ecCC------------CEEEEEEeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceec
Confidence 4431 2469999999999999999763322 24699999999999999999999984 59999
Q ss_pred cCCCCcEEEecccc----------cCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC
Q 003185 652 DIKSENILIDLERK----------KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 721 (840)
Q Consensus 652 DLKPeNILLd~~~~----------~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~ 721 (840)
||||+||||+.... .......+||+|||++..+..... .....||+.|+|||++.+.
T Consensus 150 DLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~-----------~~s~vGTp~YmAPEvL~ge-- 216 (1021)
T PTZ00266 150 DLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM-----------AHSCVGTPYYWSPELLLHE-- 216 (1021)
T ss_pred cCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccc-----------ccccCCCccccCHHHHhcc--
Confidence 99999999975321 112345699999999976533211 1234699999999998651
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhH
Q 003185 722 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 800 (840)
Q Consensus 722 ~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s 800 (840)
...++.++||||||||||||+||..||...... .+...+..... ++. ...+
T Consensus 217 ~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~--lpi--------------------------~~~S 268 (1021)
T PTZ00266 217 TKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPD--LPI--------------------------KGKS 268 (1021)
T ss_pred CCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCC--CCc--------------------------CCCC
Confidence 245789999999999999999999999765433 33333332211 110 0124
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003185 801 SFLVDVFRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 801 ~~L~dLI~rCL~~DP~eRPSa~ELLehLe 829 (840)
..+.+||..||..+|.+||++.++|.|..
T Consensus 269 ~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ 297 (1021)
T PTZ00266 269 KELNILIKNLLNLSAKERPSALQCLGYQI 297 (1021)
T ss_pred HHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence 57899999999999999999999997644
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=312.61 Aligned_cols=255 Identities=29% Similarity=0.422 Sum_probs=204.8
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|++.+.||.|+||.||+|.+ .+..+++|+..... ......+ ++..|+.++++++||||+++++++.....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~~- 73 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN--MTEKEKQ----QLVSEVNILRELKHPNIVRYYDRIIDRSN- 73 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEeccc--CCHHHHH----HHHHHHHHHHhcCCCccceeeeeeecCCC-
Confidence 588999999999999999986 55678888764332 2223333 34889999999999999999998764331
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCeecccCCCCcE
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH-----SKHIMHRDIKSENI 658 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLH-----s~gIVHRDLKPeNI 658 (840)
...+++|||+++++|.+++..... ....+++..++.++.||+.||.||| +.+|+|+||||+||
T Consensus 74 -----------~~~~~~~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~ni 141 (265)
T cd08217 74 -----------QTLYIVMEYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANI 141 (265)
T ss_pred -----------CEEEEEehhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHE
Confidence 246999999999999999976432 2357899999999999999999999 88999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
+++.+ +.+||+|||++......... .....|++.|+|||++.. ..++.++||||||+++
T Consensus 142 li~~~-------~~~kl~d~g~~~~~~~~~~~----------~~~~~~~~~~~~pE~~~~----~~~~~~~Dv~slG~il 200 (265)
T cd08217 142 FLDAN-------NNVKLGDFGLAKILGHDSSF----------AKTYVGTPYYMSPEQLNH----MSYDEKSDIWSLGCLI 200 (265)
T ss_pred EEecC-------CCEEEecccccccccCCccc----------ccccccCCCccChhhhcC----CCCCchhHHHHHHHHH
Confidence 99876 46999999999876442210 122358999999999875 5578899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 739 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
|+|++|..||...+...+...+.....+.++. ..+..+.+|+.+||..+|.+|
T Consensus 201 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~~~l~~~p~~R 253 (265)
T cd08217 201 YELCALSPPFTARNQLQLASKIKEGKFRRIPY---------------------------RYSSELNEVIKSMLNVDPDKR 253 (265)
T ss_pred HHHHHCCCcccCcCHHHHHHHHhcCCCCCCcc---------------------------ccCHHHHHHHHHHccCCcccC
Confidence 99999999998887776666666554333221 124578999999999999999
Q ss_pred CCHHHHHHH
Q 003185 819 PTAGDLYEM 827 (840)
Q Consensus 819 PSa~ELLeh 827 (840)
|++.+|++|
T Consensus 254 p~~~~il~~ 262 (265)
T cd08217 254 PSTEELLQL 262 (265)
T ss_pred CCHHHHhhC
Confidence 999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=333.11 Aligned_cols=272 Identities=25% Similarity=0.320 Sum_probs=218.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC--eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+..|++++.||.|.-|+||++...+ ..+|+||+...... .... ..+...|-+||+.+.||.++.+|..|..
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~-~rkK----l~Ra~tE~eIL~~lDHPFlPTLYa~fet 148 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLA-SRKK----LKRAQTEREILSLLDHPFLPTLYASFET 148 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHh-hhhH----HHHHHHHHHHHHhcCCCccchhhheeec
Confidence 457789999999999999999999855 78999996433211 1112 2345789999999999999999999998
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
+.+. |+|||||+||+|..++++ ++...|++..++.++..|+.||+|||-.|||+|||||+|||
T Consensus 149 ~~~~--------------cl~meyCpGGdL~~Lrqk---Qp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENIL 211 (459)
T KOG0610|consen 149 DKYS--------------CLVMEYCPGGDLHSLRQK---QPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENIL 211 (459)
T ss_pred ccee--------------EEEEecCCCccHHHHHhh---CCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeE
Confidence 8865 999999999999999886 56678999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCccccccccccc--------------------c-------c-c-----------------
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTC--------------------C-------I-A----------------- 694 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~--------------------~-------~-~----------------- 694 (840)
|..+ +.+.|+||.++.......... + . .
T Consensus 212 vred-------GHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~ 284 (459)
T KOG0610|consen 212 VRED-------GHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELV 284 (459)
T ss_pred EecC-------CcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhh
Confidence 9988 569999999886542110000 0 0 0
Q ss_pred -cCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHh
Q 003185 695 -HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 773 (840)
Q Consensus 695 -~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~ 773 (840)
.......+.++||-.|.|||++.+ ...+.++|.|+|||+||||+.|..||.+.+..+.+..|..... .++..
T Consensus 285 aep~~~RSnSFVGThEYlAPEvI~G----~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l-~Fp~~-- 357 (459)
T KOG0610|consen 285 AEPTGARSNSFVGTHEYLAPEVIRG----EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPL-KFPEE-- 357 (459)
T ss_pred cCCCCccccccccccccccceeeec----CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCC-cCCCC--
Confidence 011123457899999999999997 6678999999999999999999999999988888877765421 12210
Q ss_pred hhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC----HHHHHHHHHhhc
Q 003185 774 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT----AGDLYEMFVART 832 (840)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS----a~ELLehLe~l~ 832 (840)
...+..++|||.++|.+||.+|.. |+||-+|.....
T Consensus 358 -----------------------~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~g 397 (459)
T KOG0610|consen 358 -----------------------PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEG 397 (459)
T ss_pred -----------------------CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccC
Confidence 133568999999999999999998 999999865443
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=317.82 Aligned_cols=246 Identities=20% Similarity=0.367 Sum_probs=186.7
Q ss_pred eeecccCceEEEEEEEC--------------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeE
Q 003185 511 DEAGKSVSSSLFRCKFG--------------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 576 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~--------------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~ 576 (840)
+.||+|+||.||+|.+. ...+++|+.... .......+.+|+.++..++||||++++++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~~~~l~~l~hp~iv~~~~~ 72 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--------HRDISLAFFETASMMRQVSHKHIVLLYGV 72 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--------hhhHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 46899999999999852 124666653221 11223345889999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
+..... .++||||+++++|..++.. ....+++..++.++.||+.||+|||++||+||||||+
T Consensus 73 ~~~~~~--------------~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 134 (262)
T cd05077 73 CVRDVE--------------NIMVEEFVEFGPLDLFMHR----KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTK 134 (262)
T ss_pred EecCCC--------------CEEEEecccCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcc
Confidence 876553 3999999999999998865 2346899999999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
|||++.++........++++|||++...... ....++..|+|||.+.. ...++.++|||||||
T Consensus 135 Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~--------------~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~ 197 (262)
T cd05077 135 NILLAREGIDGECGPFIKLSDPGIPITVLSR--------------QECVERIPWIAPECVED---SKNLSIAADKWSFGT 197 (262)
T ss_pred cEEEecCCccCCCCceeEeCCCCCCccccCc--------------ccccccccccChhhhcC---CCCCCchhHHHHHHH
Confidence 9999876432333345999999998654321 22357889999998863 256788999999999
Q ss_pred HHHHHH-hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 737 LLLELL-TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 737 IL~ELL-TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
++|||+ +|..||......+...... ..... ....+..+.+||.+||+.||
T Consensus 198 ~l~el~~~~~~p~~~~~~~~~~~~~~-~~~~~----------------------------~~~~~~~~~~li~~cl~~dp 248 (262)
T cd05077 198 TLWEICYNGEIPLKDKTLAEKERFYE-GQCML----------------------------VTPSCKELADLMTHCMNYDP 248 (262)
T ss_pred HHHHHHhCCCCCCCCcchhHHHHHHh-cCccC----------------------------CCCChHHHHHHHHHHcCCCh
Confidence 999998 5888887665443322211 11000 00124578999999999999
Q ss_pred CCCCCHHHHHHHH
Q 003185 816 TERPTAGDLYEMF 828 (840)
Q Consensus 816 ~eRPSa~ELLehL 828 (840)
.+||++.+|+++|
T Consensus 249 ~~Rp~~~~il~~~ 261 (262)
T cd05077 249 NQRPFFRAIMRDI 261 (262)
T ss_pred hhCcCHHHHHHhc
Confidence 9999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=316.84 Aligned_cols=261 Identities=20% Similarity=0.322 Sum_probs=202.6
Q ss_pred CCCCceeeeeecccCceEEEEEEECC-----eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEE
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 577 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~ 577 (840)
....|.+.+.||+|+||.||+|.+.. ..+++|+.... ....... .+..|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~----~~~~e~~~l~~l~h~ni~~~~~~~ 74 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG---YTEKQRR----DFLSEASIMGQFDHPNIIHLEGVV 74 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC---CCHHHHH----HHHHHHHHHHhCCCcCcceEEEEE
Confidence 34678999999999999999998732 35888875322 1222333 348999999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
..... .++||||+++++|.+++.. ....+++..++.++.|++.||.|||++|++|+||||+|
T Consensus 75 ~~~~~--------------~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~n 136 (269)
T cd05065 75 TKSRP--------------VMIITEFMENGALDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARN 136 (269)
T ss_pred CCCCc--------------eEEEEecCCCCcHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChhe
Confidence 76553 4999999999999999875 23468999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
||++.+ ..+||+|||++........... .........+..|+|||++.+ ..++.++|||||||+
T Consensus 137 ili~~~-------~~~kl~dfg~~~~~~~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~----~~~~~~~DvwslG~~ 200 (269)
T cd05065 137 ILVNSN-------LVCKVSDFGLSRFLEDDTSDPT-----YTSSLGGKIPIRWTAPEAIAY----RKFTSASDVWSYGIV 200 (269)
T ss_pred EEEcCC-------CcEEECCCccccccccCccccc-----cccccCCCcceeecCHhHhcc----CcccchhhhhhhHHH
Confidence 999866 5699999999876543221100 000011112457999999875 567899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 738 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 738 L~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
+|||++ |..||...+.......+........+ ...+..+.+++.+||..+|.
T Consensus 201 l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~ 253 (269)
T cd05065 201 MWEVMSYGERPYWDMSNQDVINAIEQDYRLPPP---------------------------MDCPTALHQLMLDCWQKDRN 253 (269)
T ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCc---------------------------ccCCHHHHHHHHHHcCCChh
Confidence 999886 99999888777777666543221111 12245689999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 003185 817 ERPTAGDLYEMFVAR 831 (840)
Q Consensus 817 eRPSa~ELLehLe~l 831 (840)
+||++.+|+..|+.+
T Consensus 254 ~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 254 ARPKFGQIVSTLDKM 268 (269)
T ss_pred hCcCHHHHHHHHHhh
Confidence 999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=321.12 Aligned_cols=246 Identities=21% Similarity=0.341 Sum_probs=186.8
Q ss_pred eecccCceEEEEEEEC--------------------------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC
Q 003185 512 EAGKSVSSSLFRCKFG--------------------------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL 565 (840)
Q Consensus 512 ~LG~G~fG~Vy~a~~~--------------------------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L 565 (840)
.||+|+||.||+|.+. ...+++|+.... .......+.+|+.+++.+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~~~~~~~l 73 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--------HRDIALAFFETASLMSQV 73 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--------HHHHHHHHHHHHHHHhcC
Confidence 6999999999999741 123566654211 112233458899999999
Q ss_pred CCCCcceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 003185 566 RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS 645 (840)
Q Consensus 566 ~HpNIV~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs 645 (840)
+||||+++++++..... .++||||+++|+|..++.. ....+++..+..++.||+.||+|||+
T Consensus 74 ~h~niv~~~~~~~~~~~--------------~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~ 135 (274)
T cd05076 74 SHIHLAFVHGVCVRGSE--------------NIMVEEFVEHGPLDVCLRK----EKGRVPVAWKITVAQQLASALSYLED 135 (274)
T ss_pred CCCCeeeEEEEEEeCCc--------------eEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHc
Confidence 99999999999886553 4999999999999999864 23568899999999999999999999
Q ss_pred CCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCC
Q 003185 646 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 725 (840)
Q Consensus 646 ~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~ 725 (840)
+||+||||||+|||++..+........+||+|||++...... ....++..|+|||.+.+ ...+
T Consensus 136 ~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~--------------~~~~~~~~~~aPe~~~~---~~~~ 198 (274)
T cd05076 136 KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR--------------EERVERIPWIAPECVPG---GNSL 198 (274)
T ss_pred CCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc--------------cccccCCcccCchhhcC---CCCC
Confidence 999999999999999875432233456899999987543221 11247888999999864 2457
Q ss_pred CchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHH
Q 003185 726 GLEVDIWSYGCLLLELL-TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 804 (840)
Q Consensus 726 s~kSDVWSLGvIL~ELL-TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~ 804 (840)
+.++|||||||++|||+ +|..||....+.+....+..... ++. .....+.
T Consensus 199 ~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~---------------------------~~~~~~~ 249 (274)
T cd05076 199 STAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHR--LPE---------------------------PSCKELA 249 (274)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhccC--CCC---------------------------CCChHHH
Confidence 89999999999999995 79999987665544333222111 110 0123689
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHH
Q 003185 805 DVFRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 805 dLI~rCL~~DP~eRPSa~ELLehLe 829 (840)
+||.+||+.+|.+|||+.+|+++|.
T Consensus 250 ~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 250 TLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHHcccChhhCcCHHHHHHhhC
Confidence 9999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=337.54 Aligned_cols=246 Identities=25% Similarity=0.299 Sum_probs=192.5
Q ss_pred ecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC---CCCCcceeeeEEecCCCCCCCC
Q 003185 513 AGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKISSKWLPSAD 587 (840)
Q Consensus 513 LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L---~HpNIV~l~g~~~~~~~~p~~~ 587 (840)
||+|+||.||+|.. .+..+|+|++..+.... .... ..+..|..++..+ .||||+.+++++.....
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~----~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~----- 70 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA-KKEV----AHTIGERNILVRTLLDESPFIVGLKFSFQTDSD----- 70 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh-hhHH----HHHHHHHHHHHHhccCCCCcCcceEEEEecCCe-----
Confidence 79999999999987 57889999875332111 1111 1235677776665 69999999999886654
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccC
Q 003185 588 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667 (840)
Q Consensus 588 g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~ 667 (840)
.|+||||+++|+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~---- 132 (330)
T cd05586 71 ---------LYLVTDYMSGGELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT---- 132 (330)
T ss_pred ---------EEEEEcCCCCChHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC----
Confidence 4999999999999999875 3568999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003185 668 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 747 (840)
Q Consensus 668 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~P 747 (840)
+.+||+|||++........ ......||+.|||||++.+ ...++.++|||||||+||+|++|..|
T Consensus 133 ---~~~kl~Dfg~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslGvil~elltG~~P 196 (330)
T cd05586 133 ---GHIALCDFGLSKANLTDNK----------TTNTFCGTTEYLAPEVLLD---EKGYTKHVDFWSLGVLVFEMCCGWSP 196 (330)
T ss_pred ---CCEEEecCCcCcCCCCCCC----------CccCccCCccccCHHHHcC---CCCCCCccceeccccEEEEeccCCCC
Confidence 4599999999875322111 1123469999999999874 23478899999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC----CHHH
Q 003185 748 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP----TAGD 823 (840)
Q Consensus 748 F~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP----Sa~E 823 (840)
|.+.+..++...+..+... ++. ...+..+.+||.+||..||.+|| ++.+
T Consensus 197 f~~~~~~~~~~~i~~~~~~-~~~--------------------------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 249 (330)
T cd05586 197 FYAEDTQQMYRNIAFGKVR-FPK--------------------------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVE 249 (330)
T ss_pred CCCCCHHHHHHHHHcCCCC-CCC--------------------------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHH
Confidence 9988877777776554221 110 01245788999999999999998 7889
Q ss_pred HHHHHH
Q 003185 824 LYEMFV 829 (840)
Q Consensus 824 LLehLe 829 (840)
+++|..
T Consensus 250 ll~h~~ 255 (330)
T cd05586 250 LKEHPF 255 (330)
T ss_pred HhcCcc
Confidence 988754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=346.68 Aligned_cols=256 Identities=29% Similarity=0.420 Sum_probs=214.8
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
.|.-++.||.|+||.||-|++ +...||+|.. ..... ...+. .+.+++|+.+|.+|+|||+|.+-|+|..+..
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKM--sySGK--Qs~EK-WqDIlKEVrFL~~l~HPntieYkgCyLre~T- 100 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKM--SYSGK--QSNEK-WQDILKEVRFLRQLRHPNTIEYKGCYLREHT- 100 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeec--ccccc--ccHHH-HHHHHHHHHHHHhccCCCcccccceeeccch-
Confidence 467788999999999999997 4556666653 32222 11222 3556999999999999999999999986653
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.|||||||- |+-.+++.-+ ++++.+.++..|..+.+.||+|||+++.||||||..|||++..
T Consensus 101 -------------aWLVMEYCl-GSAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~ 162 (948)
T KOG0577|consen 101 -------------AWLVMEYCL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEP 162 (948)
T ss_pred -------------HHHHHHHHh-ccHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCC
Confidence 599999997 5888888752 4678899999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.|||+|||.|..... .+.++|||.|||||++..+.. +.|+-++||||||++..||..
T Consensus 163 -------g~VKLaDFGSAsi~~P--------------AnsFvGTPywMAPEVILAMDE-GqYdgkvDvWSLGITCIELAE 220 (948)
T KOG0577|consen 163 -------GLVKLADFGSASIMAP--------------ANSFVGTPYWMAPEVILAMDE-GQYDGKVDVWSLGITCIELAE 220 (948)
T ss_pred -------CeeeeccccchhhcCc--------------hhcccCCccccchhHheeccc-cccCCccceeeccchhhhhhh
Confidence 6799999999876543 356799999999999987654 788999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~E 823 (840)
.++|+.+++.+..+..|.++..|.+.. .+.++.+..|+..||+.-|.+|||.++
T Consensus 221 RkPPlFnMNAMSALYHIAQNesPtLqs--------------------------~eWS~~F~~Fvd~CLqKipqeRptse~ 274 (948)
T KOG0577|consen 221 RKPPLFNMNAMSALYHIAQNESPTLQS--------------------------NEWSDYFRNFVDSCLQKIPQERPTSEE 274 (948)
T ss_pred cCCCccCchHHHHHHHHHhcCCCCCCC--------------------------chhHHHHHHHHHHHHhhCcccCCcHHH
Confidence 999999999999999999988777663 123668999999999999999999999
Q ss_pred HHHHHHhhcC
Q 003185 824 LYEMFVARTS 833 (840)
Q Consensus 824 LLehLe~l~~ 833 (840)
++.|..-...
T Consensus 275 ll~H~fv~R~ 284 (948)
T KOG0577|consen 275 LLKHRFVLRE 284 (948)
T ss_pred HhhcchhccC
Confidence 9999765543
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=316.56 Aligned_cols=257 Identities=21% Similarity=0.312 Sum_probs=203.0
Q ss_pred CCCceeeeeecccCceEEEEEEECC-----eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEe
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 578 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~ 578 (840)
-.+|.+.+.||+|+||.||+|.+.. ..+++|...... ..... +.+.+|+.+++++.||||+++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~----~~~~~e~~~l~~~~h~~i~~~~~~~~ 77 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVR----EKFLQEAYIMRQFDHPHIVKLIGVIT 77 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC---CHHHH----HHHHHHHHHHHhCCCCchhceeEEEc
Confidence 4568999999999999999998632 357777654221 12222 34489999999999999999999876
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
... .++||||+++++|.+++.. ....+++..++.++.||+.||+|||++|++|+||||+||
T Consensus 78 ~~~---------------~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~ni 138 (270)
T cd05056 78 ENP---------------VWIVMELAPLGELRSYLQV----NKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNV 138 (270)
T ss_pred CCC---------------cEEEEEcCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheE
Confidence 432 3899999999999999975 224589999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.+ +.++|+|||+++......... .....++..|+|||.+.. ..++.++|||||||++
T Consensus 139 li~~~-------~~~~l~d~g~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il 198 (270)
T cd05056 139 LVSSP-------DCVKLGDFGLSRYLEDESYYK---------ASKGKLPIKWMAPESINF----RRFTSASDVWMFGVCM 198 (270)
T ss_pred EEecC-------CCeEEccCceeeeccccccee---------cCCCCccccccChhhhcc----CCCCchhhhHHHHHHH
Confidence 99876 469999999987654321110 111234568999999865 5678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 739 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 739 ~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
|||++ |..||......+....+.++..+..+. ..+..+.+||.+||..+|.+
T Consensus 199 ~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~P~~ 251 (270)
T cd05056 199 WEILMLGVKPFQGVKNNDVIGRIENGERLPMPP---------------------------NCPPTLYSLMTKCWAYDPSK 251 (270)
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHHHHHHHHHcCCChhh
Confidence 99996 999998887777666665554332221 12457899999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 003185 818 RPTAGDLYEMFVARTS 833 (840)
Q Consensus 818 RPSa~ELLehLe~l~~ 833 (840)
|||+.+++..|..+..
T Consensus 252 Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 252 RPRFTELKAQLSDILQ 267 (270)
T ss_pred CcCHHHHHHHHHHHHh
Confidence 9999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=321.78 Aligned_cols=259 Identities=29% Similarity=0.466 Sum_probs=206.3
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
+.++|++.+.||.|+||.||++.+ .+..+++|+.... .....+. +.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELED----FMVEIDILSECKHPNIVGLYEAYFYE 74 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHH----HHHHHHHHHhCCCCceeEEEEEEecC
Confidence 456799999999999999999987 4678899986533 2223333 48899999999999999999998865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .|+||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+||++
T Consensus 75 ~~--------------~~lv~e~~~~~~L~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili 136 (280)
T cd06611 75 NK--------------LWILIEFCDGGALDSIMLE----LERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL 136 (280)
T ss_pred Ce--------------EEEEeeccCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE
Confidence 53 4999999999999999875 23468999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~kSDVWSLGvIL~ 739 (840)
+.+ +.++|+|||++........ ......|++.|+|||++.... ....++.++|||||||++|
T Consensus 137 ~~~-------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~ 199 (280)
T cd06611 137 TLD-------GDVKLADFGVSAKNKSTLQ----------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLI 199 (280)
T ss_pred CCC-------CCEEEccCccchhhccccc----------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHH
Confidence 877 4699999998865432211 112346899999999986321 1245678999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|++|..||...+.......+.....+.+.. ....+..+.+||.+||..+|.+||
T Consensus 200 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rp 254 (280)
T cd06611 200 ELAQMEPPHHELNPMRVLLKILKSEPPTLDQ-------------------------PSKWSSSFNDFLKSCLVKDPDDRP 254 (280)
T ss_pred HHHhCCCCcccCCHHHHHHHHhcCCCCCcCC-------------------------cccCCHHHHHHHHHHhccChhhCc
Confidence 9999999998887766666665543322210 011245789999999999999999
Q ss_pred CHHHHHHHHH
Q 003185 820 TAGDLYEMFV 829 (840)
Q Consensus 820 Sa~ELLehLe 829 (840)
++.++++|.+
T Consensus 255 s~~~il~~~~ 264 (280)
T cd06611 255 TAAELLKHPF 264 (280)
T ss_pred CHHHHhcChh
Confidence 9999999854
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=314.44 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=196.8
Q ss_pred eeecccCceEEEEEEECC-----eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 585 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~-----~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~ 585 (840)
++||+|+||.||+|.+.. ..+|+|+..... .. ... ..+.+|+.+++.+.||||+++++++...
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~--~~-~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 68 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH--IA-AGK----KEFLREASVMAQLDHPCIVRLIGVCKGE----- 68 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEeccccc--ch-HHH----HHHHHHHHHHHhcCCCCeeeEEEEEcCC-----
Confidence 479999999999998622 467888754322 11 122 3448999999999999999999987532
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccc
Q 003185 586 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 665 (840)
Q Consensus 586 ~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~ 665 (840)
..++||||+++++|.+++.. ...+++..++.++.|++.||+|||.++++|+||||+|||++.+
T Consensus 69 ----------~~~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~-- 131 (257)
T cd05060 69 ----------PLMLVMELAPLGPLLKYLKK-----RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR-- 131 (257)
T ss_pred ----------ceEEEEEeCCCCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC--
Confidence 24999999999999999986 2468999999999999999999999999999999999999877
Q ss_pred cCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-C
Q 003185 666 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 744 (840)
Q Consensus 666 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT-G 744 (840)
+.+||+|||+++.......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |
T Consensus 132 -----~~~kl~df~~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~~~~~g 195 (257)
T cd05060 132 -----HQAKISDFGMSRALGAGSDYYR-------ATTAGRWPLKWYAPECINY----GKFSSKSDVWSYGVTLWEAFSYG 195 (257)
T ss_pred -----CcEEeccccccceeecCCcccc-------cccCccccccccCHHHhcC----CCCCccchHHHHHHHHHHHHcCC
Confidence 4599999999986643221100 0111224568999999875 568899999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 003185 745 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 824 (840)
Q Consensus 745 ~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~EL 824 (840)
..||...+..++...+........+ ...+..+.+||.+||..+|.+||++.+|
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~~p~~Rp~~~~l 248 (257)
T cd05060 196 AKPYGEMKGAEVIAMLESGERLPRP---------------------------EECPQEIYSIMLSCWKYRPEDRPTFSEL 248 (257)
T ss_pred CCCcccCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 9999888877777776554322211 1124578999999999999999999999
Q ss_pred HHHHHhhc
Q 003185 825 YEMFVART 832 (840)
Q Consensus 825 LehLe~l~ 832 (840)
++.|+.+.
T Consensus 249 ~~~l~~~~ 256 (257)
T cd05060 249 ESTFRRDP 256 (257)
T ss_pred HHHHHhcc
Confidence 99998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=320.05 Aligned_cols=260 Identities=23% Similarity=0.342 Sum_probs=202.2
Q ss_pred CCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 575 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g 575 (840)
.+.+|.+.++||+|+||.||++.. .+..+++|... .. ...... .+.+|+.+++.++||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~--~~--~~~~~~----~~~~e~~~l~~l~h~~i~~~~~ 74 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK--EA--SESARQ----DFQREAELLTVLQHQHIVRFYG 74 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecC--cC--CHHHHH----HHHHHHHHHhcCCCCCCceEEE
Confidence 456789999999999999999974 23466777643 21 122223 3489999999999999999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc----------CCCCCCHHHHHHHHHHHHHHHHHHHh
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----------GEKHVSVKLALFIAQDVAAALVELHS 645 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~----------~~~~ls~~~~~~Ia~QIa~AL~yLHs 645 (840)
++..... .++||||+++++|.+++...... ....+++..++.++.||+.||+|||+
T Consensus 75 ~~~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 140 (280)
T cd05092 75 VCTEGRP--------------LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS 140 (280)
T ss_pred EEecCCc--------------eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH
Confidence 9876543 49999999999999999763210 11357899999999999999999999
Q ss_pred CCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCC
Q 003185 646 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 725 (840)
Q Consensus 646 ~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~ 725 (840)
+||+||||||+|||++.+ +.+||+|||++.......... ......+++.|+|||++.+ ..+
T Consensus 141 ~~i~H~dlkp~nil~~~~-------~~~kL~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~ 201 (280)
T cd05092 141 LHFVHRDLATRNCLVGQG-------LVVKIGDFGMSRDIYSTDYYR--------VGGRTMLPIRWMPPESILY----RKF 201 (280)
T ss_pred CCeecccccHhhEEEcCC-------CCEEECCCCceeEcCCCceee--------cCCCccccccccCHHHhcc----CCc
Confidence 999999999999999876 469999999987553221100 0122345788999999876 567
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHH
Q 003185 726 GLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 804 (840)
Q Consensus 726 s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~ 804 (840)
+.++|||||||++|||++ |.+||......+....+..+..+..+. ..+..+.
T Consensus 202 ~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~ 254 (280)
T cd05092 202 TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPR---------------------------TCPPEVY 254 (280)
T ss_pred CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccCCCCC---------------------------CCCHHHH
Confidence 899999999999999998 999998877777666665543322221 1245789
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHh
Q 003185 805 DVFRRCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 805 dLI~rCL~~DP~eRPSa~ELLehLe~ 830 (840)
+||.+||+.||.+||++.+|++.|++
T Consensus 255 ~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 255 AIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHHHccCChhhCCCHHHHHHHHhC
Confidence 99999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=319.90 Aligned_cols=262 Identities=24% Similarity=0.365 Sum_probs=204.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 574 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~ 574 (840)
...++|++.+.||+|+||.||+|.+ .+..+|+|+.... ....... .+.+|+.+++++.||||++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~----~~~~ei~~l~~l~h~~iv~~~ 74 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQA----DFQREAALMAEFDHPNIVKLL 74 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC---cCHHHHH----HHHHHHHHHHhcCCCchheEE
Confidence 3467899999999999999999986 3467888875422 1222223 348899999999999999999
Q ss_pred eEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----------------cCCCCCCHHHHHHHHHHHH
Q 003185 575 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------------TGEKHVSVKLALFIAQDVA 637 (840)
Q Consensus 575 g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----------------~~~~~ls~~~~~~Ia~QIa 637 (840)
+++..... .++||||+++++|.+++..... .....+++..++.++.||+
T Consensus 75 ~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~ 140 (288)
T cd05050 75 GVCAVGKP--------------MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVA 140 (288)
T ss_pred EEEcCCCc--------------cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHH
Confidence 99876553 3999999999999999975211 1123478889999999999
Q ss_pred HHHHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhh
Q 003185 638 AALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717 (840)
Q Consensus 638 ~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~ 717 (840)
.||.|||+++++||||||+|||++.+ +.++|+|||++..+....... ......++..|+|||.+.
T Consensus 141 ~aL~~lH~~~i~H~dl~p~nil~~~~-------~~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~ 205 (288)
T cd05050 141 AGMAYLSERKFVHRDLATRNCLVGEN-------MVVKIADFGLSRNIYSADYYK--------ASENDAIPIRWMPPESIF 205 (288)
T ss_pred HHHHHHHhCCeecccccHhheEecCC-------CceEECccccceecccCcccc--------ccCCCccChhhcCHHHHh
Confidence 99999999999999999999999876 469999999987553321110 011223567899999987
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhh
Q 003185 718 AMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 796 (840)
Q Consensus 718 ~~~~~~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 796 (840)
+ ..++.++|||||||++|||++ |..||.+....+....+..+.....+.
T Consensus 206 ~----~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------- 255 (288)
T cd05050 206 Y----NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPD-------------------------- 255 (288)
T ss_pred c----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC--------------------------
Confidence 5 568899999999999999997 889998888777776665543221111
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003185 797 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 797 ~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~ 830 (840)
..+..+.+|+.+||+.+|.+|||+.||++-|+.
T Consensus 256 -~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 256 -NCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 124578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=321.07 Aligned_cols=278 Identities=21% Similarity=0.256 Sum_probs=199.3
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|++.+.||+|+||.||+|.+ .+..+++|........ .. ....+.+|+.++++++||||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~--~~----~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~- 73 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EG----VPSSALREICLLKELKHKNIVRLYDVLHSDKK- 73 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc--cc----CccchhHHHHHHHhcCCCCeeeHHHHhccCCc-
Confidence 588999999999999999997 5678899987543211 11 12234789999999999999999999876543
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.++||||+. ++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 74 -------------~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~ 135 (284)
T cd07839 74 -------------LTLVFEYCD-QDLKKYFDS----CNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN 135 (284)
T ss_pred -------------eEEEEecCC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC
Confidence 499999997 588888764 23568999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.+||+|||+++........ .....+++.|+|||++.+ ...++.++|||||||++|+|+|
T Consensus 136 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~t 195 (284)
T cd07839 136 -------GELKLADFGLARAFGIPVRC----------YSAEVVTLWYRPPDVLFG---AKLYSTSIDMWSAGCIFAELAN 195 (284)
T ss_pred -------CcEEECccchhhccCCCCCC----------cCCCccccCCcChHHHhC---CcccCcHHHHHHHHHHHHHHHh
Confidence 45999999999765332111 122357899999999875 2456889999999999999999
Q ss_pred CCCCC-CCCCHHHHHHHHHcCCCCCcchHHhhhccCccc-cccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 744 LQVPY-MGLSELEIHDLIQMGKRPRLTDELEALGSCHEH-EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 744 G~~PF-~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
|..|| .+.+..+....+.....+.....+......... .+................+..+.+||.+||..||.+|||+
T Consensus 196 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~ 275 (284)
T cd07839 196 AGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISA 275 (284)
T ss_pred cCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCH
Confidence 98885 444444444444332211111111111100000 0000000000011122346788999999999999999999
Q ss_pred HHHHHHH
Q 003185 822 GDLYEMF 828 (840)
Q Consensus 822 ~ELLehL 828 (840)
+++++|.
T Consensus 276 ~~il~h~ 282 (284)
T cd07839 276 EEALQHP 282 (284)
T ss_pred HHHhcCC
Confidence 9999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=312.64 Aligned_cols=257 Identities=28% Similarity=0.422 Sum_probs=202.4
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
.++|++.+.||.|+||.||+|.. .+..+++|+...... ...+ .+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~----~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG----DDFE----IIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch----hhHH----HHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 46899999999999999999987 457899998764421 1223 3489999999999999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
..|++|||+++++|.+++.. ....+++..++.++.|++.||.|||++||+|+||||+||+++
T Consensus 74 --------------~~~l~~e~~~~~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~ 135 (262)
T cd06613 74 --------------KLWIVMEYCGGGSLQDIYQV----TRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT 135 (262)
T ss_pred --------------EEEEEEeCCCCCcHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC
Confidence 35999999999999999875 125689999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||++......... .....++..|+|||.+..... ..++.++|||||||++|+|
T Consensus 136 ~~-------~~~~l~d~g~~~~~~~~~~~----------~~~~~~~~~y~~Pe~~~~~~~-~~~~~~~Di~slG~~l~~~ 197 (262)
T cd06613 136 ED-------GDVKLADFGVSAQLTATIAK----------RKSFIGTPYWMAPEVAAVERK-GGYDGKCDIWALGITAIEL 197 (262)
T ss_pred CC-------CCEEECccccchhhhhhhhc----------cccccCCccccCchhhccccc-CCcCchhhhHHHHHHHHHH
Confidence 77 45999999998765432111 123468889999999875211 2678899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
++|..||...+.......+......... .......+..+.+||.+||..+|.+|||+
T Consensus 198 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 254 (262)
T cd06613 198 AELQPPMFDLHPMRALFLISKSNFPPPK-----------------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTA 254 (262)
T ss_pred HhCCCCCCCCCHHHHHHHHHhccCCCcc-----------------------ccchhhhhHHHHHHHHHHcCCChhhCCCH
Confidence 9999999887766555444333111000 00012235678999999999999999999
Q ss_pred HHHHHH
Q 003185 822 GDLYEM 827 (840)
Q Consensus 822 ~ELLeh 827 (840)
.+|+.|
T Consensus 255 ~~il~~ 260 (262)
T cd06613 255 TKLLQH 260 (262)
T ss_pred HHHhcC
Confidence 999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=322.29 Aligned_cols=242 Identities=22% Similarity=0.286 Sum_probs=183.6
Q ss_pred ecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCCCC
Q 003185 513 AGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 590 (840)
Q Consensus 513 LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g~~ 590 (840)
||+|+||.||++.. .+..+|+|....+..... ... ..+..|+.++++++||||+++++++.....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-~~~----~~~~~E~~il~~l~hp~i~~~~~~~~~~~~-------- 67 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK-SGE----KMALLEKEILEKVNSPFIVNLAYAFESKTH-------- 67 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc-hhh----HHHHHHHHHHHhcCCCcEEEEEEEEecCCe--------
Confidence 79999999999986 477889888643221111 111 223679999999999999999999876543
Q ss_pred ccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCCC
Q 003185 591 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 670 (840)
Q Consensus 591 ~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~ 670 (840)
.++||||++|++|..++.. .....+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 68 ------~~lv~e~~~g~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~------- 131 (277)
T cd05607 68 ------LCLVMSLMNGGDLKYHIYN---VGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ------- 131 (277)
T ss_pred ------EEEEEecCCCCCHHHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCC-------
Confidence 4999999999999998865 223458899999999999999999999999999999999999876
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003185 671 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 750 (840)
Q Consensus 671 ~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~ 750 (840)
..++|+|||++........ .....||..|+|||++.+ ..++.++|||||||++|||++|..||..
T Consensus 132 ~~~~l~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslGv~l~el~~g~~p~~~ 196 (277)
T cd05607 132 GNCRLSDLGLAVELKDGKT-----------ITQRAGTNGYMAPEILKE----EPYSYPVDWFAMGCSIYEMVAGRTPFKD 196 (277)
T ss_pred CCEEEeeceeeeecCCCce-----------eeccCCCCCccCHHHHcc----CCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 4599999999876543211 122358999999999976 5588999999999999999999999976
Q ss_pred CCHH----HHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 003185 751 LSEL----EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 825 (840)
Q Consensus 751 ~~~~----el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELL 825 (840)
.... ++...+..... . ......+..+.+||.+||+.||.+||++.|++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~---~------------------------~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 197 HKEKVAKEELKRRTLEDEV---K------------------------FEHQNFTEESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred CcchhhHHHHHHHhhcccc---c------------------------cccccCCHHHHHHHHHHhccCHhhCCCCccch
Confidence 4321 12111111100 0 00012355789999999999999999995433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=313.43 Aligned_cols=256 Identities=25% Similarity=0.374 Sum_probs=204.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
+..++|++.+.||+|+||.||+|.+. ...+++|...... . ..+. +.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~--~---~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--M---SPEA----FLQEAQIMKKLRHDKLVQLYAVCSEE 73 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc--c---CHHH----HHHHHHHHhhCCCCCEeeeeeeeecC
Confidence 56678999999999999999999873 4567888754221 1 1223 48899999999999999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .++||||+++++|.+++.. .....+++..+..++.||+.||.|||++||+|+||||+||++
T Consensus 74 ~~--------------~~~v~e~~~~~~L~~~i~~---~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili 136 (261)
T cd05034 74 EP--------------IYIVTEYMSKGSLLDFLKS---GEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV 136 (261)
T ss_pred Cc--------------eEEEEeccCCCCHHHHHhc---cccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE
Confidence 43 4999999999999999975 223468999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.++|+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+
T Consensus 137 ~~~-------~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~il~~ 196 (261)
T cd05034 137 GEN-------LVCKIADFGLARLIEDDEYT---------AREGAKFPIKWTAPEAANY----GRFTIKSDVWSFGILLTE 196 (261)
T ss_pred cCC-------CCEEECccccceeccchhhh---------hhhccCCCccccCHHHhcc----CCcCchhHHHHHHHHHHH
Confidence 877 46999999998766432111 0111234678999999875 567899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|++ |+.||.+.+.......+........+. ..+..+.+++.+||..+|.+||
T Consensus 197 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~Rp 249 (261)
T cd05034 197 IVTYGRVPYPGMTNREVLEQVERGYRMPRPP---------------------------NCPEELYDLMLQCWDKDPEERP 249 (261)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcccCcccCC
Confidence 998 999998887777777765543322211 1245789999999999999999
Q ss_pred CHHHHHHHHHh
Q 003185 820 TAGDLYEMFVA 830 (840)
Q Consensus 820 Sa~ELLehLe~ 830 (840)
+++++++.|+.
T Consensus 250 ~~~~l~~~l~~ 260 (261)
T cd05034 250 TFEYLQSFLED 260 (261)
T ss_pred CHHHHHHHHhc
Confidence 99999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=318.42 Aligned_cols=273 Identities=22% Similarity=0.292 Sum_probs=197.0
Q ss_pred CCc-eeeeeecccCceEEEEEEE------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEE
Q 003185 505 PSL-SSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 577 (840)
Q Consensus 505 ~~y-~i~~~LG~G~fG~Vy~a~~------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~ 577 (840)
++| ++.+.||+|+||+||++.+ .+..+|+|+..... ...... .+.+|+.+|++++||||+++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~----~~~~E~~~l~~l~h~~i~~~~~~~ 75 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTS----GWKKEINILKTLYHENIVKYKGCC 75 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHH----HHHHHHHHHHhCCCCCEeeEEEEE
Confidence 345 8899999999999998763 45678999864331 112222 348899999999999999999987
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
..... ...++||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 76 ~~~~~------------~~~~lv~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~N 137 (283)
T cd05080 76 SEQGG------------KGLQLIMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARN 137 (283)
T ss_pred ecCCC------------ceEEEEecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChhe
Confidence 64321 235999999999999999975 358999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
||++.+ ..++|+|||+++.+........ ......++..|+|||++.+ ..++.++||||||++
T Consensus 138 ili~~~-------~~~~l~dfg~~~~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~----~~~~~~~Di~slG~~ 199 (283)
T cd05080 138 VLLDND-------RLVKIGDFGLAKAVPEGHEYYR-------VREDGDSPVFWYAVECLKE----NKFSYASDVWSFGVT 199 (283)
T ss_pred EEEcCC-------CcEEEeecccccccCCcchhhc-------cCCCCCCCceeeCHhHhcc----cCCCcccccHHHHHH
Confidence 999876 4699999999986643221100 0111235677999999875 567899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
+|||+||..||...... ....+...........+... ..... ........+..+.+|+.+||+.+|.+
T Consensus 200 l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~--------~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~ 267 (283)
T cd05080 200 LYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIEL--------LERGM---RLPCPKNCPQEVYILMKNCWETEAKF 267 (283)
T ss_pred HHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhh--------hhcCC---CCCCCCCCCHHHHHHHHHHhccChhh
Confidence 99999999998654321 11111111000000000000 00000 00111234568999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 003185 818 RPTAGDLYEMFVART 832 (840)
Q Consensus 818 RPSa~ELLehLe~l~ 832 (840)
|||+++|++.|+.+.
T Consensus 268 Rps~~~i~~~l~~~~ 282 (283)
T cd05080 268 RPTFRSLIPILKEMH 282 (283)
T ss_pred CCCHHHHHHHHHHhh
Confidence 999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=328.09 Aligned_cols=265 Identities=23% Similarity=0.365 Sum_probs=206.6
Q ss_pred CCceeeeeecccCceEEEEEEEC---------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceee
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 574 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~---------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~ 574 (840)
.+|++.+.||+|+||.||+|.+. ...+|+|+.... ......+. +.+|+.+++++ +||||++++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~----~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD---ATDKDLSD----LVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc---cCHHHHHH----HHHHHHHHHhhcCCCCeeeee
Confidence 47899999999999999999752 235788875422 12222333 48999999999 799999999
Q ss_pred eEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----------cCCCCCCHHHHHHHHHHHHHHHHHH
Q 003185 575 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVEL 643 (840)
Q Consensus 575 g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----------~~~~~ls~~~~~~Ia~QIa~AL~yL 643 (840)
+++..... .++||||+++|+|.+++..... .....+++..+..++.||+.||.||
T Consensus 85 ~~~~~~~~--------------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L 150 (334)
T cd05100 85 GACTQDGP--------------LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL 150 (334)
T ss_pred EEEccCCc--------------eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence 99876553 4999999999999999976321 1123578889999999999999999
Q ss_pred HhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCC
Q 003185 644 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 723 (840)
Q Consensus 644 Hs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~ 723 (840)
|++||+||||||+|||++.+ ..+||+|||+++......... ......++..|+|||++.+ .
T Consensus 151 H~~givH~dlkp~Nill~~~-------~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~ 211 (334)
T cd05100 151 ASQKCIHRDLAARNVLVTED-------NVMKIADFGLARDVHNIDYYK--------KTTNGRLPVKWMAPEALFD----R 211 (334)
T ss_pred HHCCeeccccccceEEEcCC-------CcEEECCcccceecccccccc--------cccCCCcCceEcCHHHhcc----C
Confidence 99999999999999999876 469999999997654321110 0111234568999999976 5
Q ss_pred CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHH
Q 003185 724 LYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 802 (840)
Q Consensus 724 ~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 802 (840)
.++.++|||||||+||||++ |..||.+.+..+....+.....+..+. ..+..
T Consensus 212 ~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 264 (334)
T cd05100 212 VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPA---------------------------NCTHE 264 (334)
T ss_pred CcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHH
Confidence 67889999999999999998 899999888877777766543322221 12447
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 003185 803 LVDVFRRCTEENPTERPTAGDLYEMFVARTSSSI 836 (840)
Q Consensus 803 L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~~~~ 836 (840)
+.+|+.+||+.+|.+||++.+|+++|+.+...+.
T Consensus 265 l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 265 LYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 8999999999999999999999999998885443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=333.00 Aligned_cols=245 Identities=22% Similarity=0.340 Sum_probs=188.4
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEecCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 587 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~~~~~~p~~~ 587 (840)
+.||+|+||.||+|.. ++..+|+|+....... ..... ..+.+|+.++.++ +||||+++++++.....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~----- 70 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH-DDEDI----DWVQTEKHVFEQASSNPFLVGLHSCFQTTSR----- 70 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHH----HHHHHHHHHHHhhcCCCCEeeEEEEEEeCCE-----
Confidence 4699999999999987 5678999987543211 11222 2348899999888 59999999999876553
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccC
Q 003185 588 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667 (840)
Q Consensus 588 g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~ 667 (840)
.|+||||+++|+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~---- 132 (327)
T cd05617 71 ---------LFLVIEYVNGGDLMFHMQR-----QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD---- 132 (327)
T ss_pred ---------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC----
Confidence 5999999999999998875 3569999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003185 668 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 747 (840)
Q Consensus 668 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~P 747 (840)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||+||||++|..|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~ell~g~~p 195 (327)
T cd05617 133 ---GHIKLTDYGMCKEGLGPGD----------TTSTFCGTPNYIAPEILRG----EEYGFSVDWWALGVLMFEMMAGRSP 195 (327)
T ss_pred ---CCEEEeccccceeccCCCC----------ceecccCCcccCCHHHHCC----CCCCchheeehhHHHHHHHHhCCCC
Confidence 4599999999874322111 0123469999999999976 6678999999999999999999999
Q ss_pred CCCCC------HH-HHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 748 YMGLS------EL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 748 F~~~~------~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|.... .. .+...+... ...++. ..+..+.++|.+||..||.+|++
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~-~~~~p~---------------------------~~~~~~~~li~~~L~~dP~~R~~ 247 (327)
T cd05617 196 FDIITDNPDMNTEDYLFQVILEK-PIRIPR---------------------------FLSVKASHVLKGFLNKDPKERLG 247 (327)
T ss_pred CCccCCCcccccHHHHHHHHHhC-CCCCCC---------------------------CCCHHHHHHHHHHhccCHHHcCC
Confidence 95321 11 222222221 111111 12456899999999999999998
Q ss_pred ------HHHHHHHH
Q 003185 821 ------AGDLYEMF 828 (840)
Q Consensus 821 ------a~ELLehL 828 (840)
++++++|.
T Consensus 248 ~~~~~~~~~i~~h~ 261 (327)
T cd05617 248 CQPQTGFSDIKSHT 261 (327)
T ss_pred CCCCCCHHHHHcCC
Confidence 56888874
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=331.40 Aligned_cols=266 Identities=24% Similarity=0.360 Sum_probs=201.4
Q ss_pred CCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceee
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 574 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~ 574 (840)
+.++|++.+.||+|+||.||+|.+ .+..+|+|+..... ....... +.+|+.+|.++ +||||++++
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~----~~~E~~~l~~l~~h~niv~~~ 77 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRA----LMSELKILIHIGHHLNVVNLL 77 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHH----HHHHHHHHHhccCCccHhhhc
Confidence 346899999999999999999974 35679999864321 2222333 48999999999 589999999
Q ss_pred eEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----------------------------------
Q 003185 575 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----------------------------------- 619 (840)
Q Consensus 575 g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~----------------------------------- 619 (840)
+++..... ..++||||+++|+|.+++......
T Consensus 78 ~~~~~~~~-------------~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (343)
T cd05103 78 GACTKPGG-------------PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSS 144 (343)
T ss_pred ceeecCCC-------------ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccc
Confidence 98865432 258999999999999999752100
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCCCCe
Q 003185 620 ---------------------------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 672 (840)
Q Consensus 620 ---------------------------~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~ 672 (840)
....+++..+..++.||+.||+|||++||+||||||+|||++.+ ..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~-------~~ 217 (343)
T cd05103 145 QSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN-------NV 217 (343)
T ss_pred cccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCC-------Cc
Confidence 01246788889999999999999999999999999999999876 46
Q ss_pred EEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003185 673 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGL 751 (840)
Q Consensus 673 vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~ 751 (840)
+||+|||++......... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||...
T Consensus 218 ~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 218 VKICDFGLARDIYKDPDY--------VRKGDARLPLKWMAPETIFD----RVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred EEEEecccccccccCcch--------hhcCCCCCCcceECcHHhcC----CCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 999999999765332111 00112345678999999875 567899999999999999997 99999765
Q ss_pred CHH-HHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003185 752 SEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 752 ~~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~ 830 (840)
... .....+..+..+..+. ..+..+.+++.+||+.||.+|||+.+|+++|+.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 286 KIDEEFCRRLKEGTRMRAPD---------------------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred cccHHHHHHHhccCCCCCCC---------------------------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 432 3333333333222211 113468999999999999999999999999998
Q ss_pred hcCC
Q 003185 831 RTSS 834 (840)
Q Consensus 831 l~~~ 834 (840)
+.+.
T Consensus 339 ~~~~ 342 (343)
T cd05103 339 LLQA 342 (343)
T ss_pred HHhc
Confidence 8654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=320.31 Aligned_cols=284 Identities=21% Similarity=0.230 Sum_probs=205.8
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|.+.+.||.|+||.||+|.+ .+..+++|.+......... ......+..|+.++++++|+||+++++++....
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAK---DGINFTALREIKLLQELKHPNIIGLLDVFGHKS-- 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccccc---chhhHHHHHHHHHHhhcCCCCChhhhheeecCC--
Confidence 588899999999999999987 4678999987644322111 112234478999999999999999999988654
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
..++||||+ +++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.+
T Consensus 76 ------------~~~lv~e~~-~~~L~~~i~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~ 138 (298)
T cd07841 76 ------------NINLVFEFM-ETDLEKVIKD----KSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD 138 (298)
T ss_pred ------------EEEEEEccc-CCCHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC
Confidence 359999999 8899999975 11368999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.++|+|||++......... .....+++.|+|||.+.+ ...++.++|||||||++|+|++
T Consensus 139 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~e~~~ 198 (298)
T cd07841 139 -------GVLKLADFGLARSFGSPNRK----------MTHQVVTRWYRAPELLFG---ARHYGVGVDMWSVGCIFAELLL 198 (298)
T ss_pred -------CCEEEccceeeeeccCCCcc----------ccccccceeeeCHHHHhC---CCCCCcHHHHHHHHHHHHHHHc
Confidence 45999999999766432111 122346889999999864 2457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~E 823 (840)
|.+||.+.+.......+...........+...........................+..+.+||.+||..||.+|||+.+
T Consensus 199 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e 278 (298)
T cd07841 199 RVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQ 278 (298)
T ss_pred CCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHH
Confidence 99888877766655555433211112111111000000000000111111122334678999999999999999999999
Q ss_pred HHHHHHhh
Q 003185 824 LYEMFVAR 831 (840)
Q Consensus 824 LLehLe~l 831 (840)
+++|-.-.
T Consensus 279 ~l~~~~~~ 286 (298)
T cd07841 279 ALEHPYFS 286 (298)
T ss_pred HhhCcccc
Confidence 99984433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=315.13 Aligned_cols=260 Identities=22% Similarity=0.307 Sum_probs=189.3
Q ss_pred eeecccCceEEEEEEEC----CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 586 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~----~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~ 586 (840)
+.||+|+||.||+|.+. ...+++|..... . ...... .+.+|+.++++++||||+++++++.....
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~--~-~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 69 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVS--A-SVQEQM----KFLEEAQPYRSLQHSNLLQCLGQCTEVTP---- 69 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCC--C-ChHHHH----HHHHHHHHHHhCCCCCEeeEEEEEcCCCC----
Confidence 36899999999999863 235677764322 1 112222 34889999999999999999999876543
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEeccccc
Q 003185 587 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 666 (840)
Q Consensus 587 ~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~ 666 (840)
.++||||+++|+|.+++..........+++..+..++.||+.||.|||++|++|+||||+||+++.+
T Consensus 70 ----------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~--- 136 (269)
T cd05087 70 ----------YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD--- 136 (269)
T ss_pred ----------cEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC---
Confidence 3999999999999999976332223456778888999999999999999999999999999999876
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC---CCCCchhhHHHHHHHHHHHHh
Q 003185 667 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP---NLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 667 ~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~---~~~s~kSDVWSLGvIL~ELLT 743 (840)
.++||+|||++......... .......++..|+|||++.+.... ..++.++|||||||++|||++
T Consensus 137 ----~~~kL~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 204 (269)
T cd05087 137 ----LTVKIGDYGLSHNKYKEDYY--------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFE 204 (269)
T ss_pred ----CcEEECCccccccccCccee--------ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHh
Confidence 56999999998654322110 011223578899999998642111 235789999999999999996
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 744 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 744 -G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
|..||......+............++. +......++.+.+|+.+|| .+|.+|||++
T Consensus 205 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~ 261 (269)
T cd05087 205 LGSQPYRHLSDEQVLTYTVREQQLKLPK----------------------PRLKLPLSDRWYEVMQFCW-LQPEQRPSAE 261 (269)
T ss_pred CCCCCCCCCChHHHHHHHhhcccCCCCC----------------------CccCCCCChHHHHHHHHHh-cCcccCCCHH
Confidence 999998776665543332221111110 0011122456889999999 6899999999
Q ss_pred HHHHHHH
Q 003185 823 DLYEMFV 829 (840)
Q Consensus 823 ELLehLe 829 (840)
+|+..|.
T Consensus 262 ~l~~~l~ 268 (269)
T cd05087 262 EVHLLLS 268 (269)
T ss_pred HHHHHhc
Confidence 9998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.75 Aligned_cols=247 Identities=26% Similarity=0.403 Sum_probs=195.0
Q ss_pred eeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 589 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g~ 589 (840)
+.||+|+||.||+|.. .+..+|+|+.... ..... ...+.+|+.++++++||||+++++++.....
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~---~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------- 66 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKED---LPQEL----KIKFLSEARILKQYDHPNIVKLIGVCTQRQP------- 66 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCc---CCHHH----HHHHHHHHHHHHhCCCCCcCeEEEEEecCCc-------
Confidence 4689999999999986 4567888875322 11221 2245899999999999999999999876554
Q ss_pred CccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCC
Q 003185 590 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 669 (840)
Q Consensus 590 ~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~ 669 (840)
.++||||+++++|.+++.. ....+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 67 -------~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~------ 129 (250)
T cd05085 67 -------IYIVMELVPGGDFLSFLRK----KKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGEN------ 129 (250)
T ss_pred -------cEEEEECCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCC------
Confidence 3999999999999999865 22457899999999999999999999999999999999999876
Q ss_pred CCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 003185 670 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPY 748 (840)
Q Consensus 670 ~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT-G~~PF 748 (840)
+.+||+|||++......... ......++..|+|||++.. ..++.++||||||+++|+|++ |..||
T Consensus 130 -~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~ll~~~~~~g~~p~ 195 (250)
T cd05085 130 -NVLKISDFGMSRQEDDGIYS---------SSGLKQIPIKWTAPEALNY----GRYSSESDVWSYGILLWETFSLGVCPY 195 (250)
T ss_pred -CeEEECCCccceeccccccc---------cCCCCCCcccccCHHHhcc----CCCCchhHHHHHHHHHHHHhcCCCCCC
Confidence 46999999998754322111 0111234678999999875 567889999999999999998 99999
Q ss_pred CCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003185 749 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828 (840)
Q Consensus 749 ~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehL 828 (840)
...........+....+...+ ...+..+.+|+.+||..+|.+||++.++++.|
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 248 (250)
T cd05085 196 PGMTNQQAREQVEKGYRMSCP---------------------------QKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248 (250)
T ss_pred CCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence 888777766666554332211 11245789999999999999999999999987
Q ss_pred H
Q 003185 829 V 829 (840)
Q Consensus 829 e 829 (840)
.
T Consensus 249 ~ 249 (250)
T cd05085 249 A 249 (250)
T ss_pred c
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=315.49 Aligned_cols=252 Identities=27% Similarity=0.438 Sum_probs=192.5
Q ss_pred eeecccCceEEEEEEECC--e--eEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEecCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKFGS--A--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPS 585 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~--~--~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~~~~~~p~ 585 (840)
+.||+|+||.||+|.+.+ . .+++|.. +.. ......+ .+.+|+.++.++ +||||+++++++.....
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~--~~~-~~~~~~~----~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~--- 70 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEY-ASKDDHR----DFAGELEVLCKLGHHPNIINLLGACEHRGY--- 70 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEc--ccc-CCHHHHH----HHHHHHHHHHhhccCCCeeeEEEEEecCCC---
Confidence 368999999999999743 2 3455543 321 1122223 348899999999 79999999999886554
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCC
Q 003185 586 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654 (840)
Q Consensus 586 ~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----------~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLK 654 (840)
.++||||+++++|.+++..... .....+++..++.++.||+.||+|||++|++|||||
T Consensus 71 -----------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dik 139 (270)
T cd05047 71 -----------LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA 139 (270)
T ss_pred -----------ceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccc
Confidence 3999999999999999975211 112357899999999999999999999999999999
Q ss_pred CCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHH
Q 003185 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 734 (840)
Q Consensus 655 PeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSL 734 (840)
|+|||++.+ +.+||+|||++........ ......+..|+|||++.. ..++.++|||||
T Consensus 140 p~nili~~~-------~~~kl~dfgl~~~~~~~~~-----------~~~~~~~~~y~apE~~~~----~~~~~~~Di~sl 197 (270)
T cd05047 140 ARNILVGEN-------YVAKIADFGLSRGQEVYVK-----------KTMGRLPVRWMAIESLNY----SVYTTNSDVWSY 197 (270)
T ss_pred cceEEEcCC-------CeEEECCCCCccccchhhh-----------ccCCCCccccCChHHHcc----CCCCchhhHHHH
Confidence 999999876 5699999999853221100 111124567999999875 567899999999
Q ss_pred HHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 003185 735 GCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 813 (840)
Q Consensus 735 GvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~ 813 (840)
||++|||++ |..||.+.+..+....+........+ ...+..+.+|+.+||..
T Consensus 198 G~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~ 250 (270)
T cd05047 198 GVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP---------------------------LNCDDEVYDLMRQCWRE 250 (270)
T ss_pred HHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCC---------------------------CcCCHHHHHHHHHHccc
Confidence 999999997 99999887776666665443222111 11245789999999999
Q ss_pred CCCCCCCHHHHHHHHHhhc
Q 003185 814 NPTERPTAGDLYEMFVART 832 (840)
Q Consensus 814 DP~eRPSa~ELLehLe~l~ 832 (840)
||.+|||+.++++.|..+.
T Consensus 251 ~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 251 KPYERPSFAQILVSLNRML 269 (270)
T ss_pred ChhhCCCHHHHHHHHHHhh
Confidence 9999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=333.02 Aligned_cols=261 Identities=23% Similarity=0.283 Sum_probs=201.4
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||.||++.+ .+..+|+|+...... ........+.+|+.++..++|+||+++++++.....
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-----LKRAETACFREERDVLVNGDNQWITTLHYAFQDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH-----HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCE
Confidence 4799999999999999999997 456788888642211 011112234789999999999999999999876553
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.|+||||+++|+|.+++.+ ....+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~ey~~~g~L~~~l~~----~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~ 137 (332)
T cd05623 76 --------------LYLVMDYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM 137 (332)
T ss_pred --------------EEEEEeccCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC
Confidence 5999999999999999975 2346899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC-CCCCCchhhHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~-~~~~s~kSDVWSLGvIL~EL 741 (840)
+ +.+||+|||++..+...... ......||+.|+|||++..... ...++.++|||||||+||||
T Consensus 138 ~-------~~~kL~DfG~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~el 201 (332)
T cd05623 138 N-------GHIRLADFGSCLKLMEDGTV---------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEM 201 (332)
T ss_pred C-------CCEEEeecchheecccCCcc---------eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHH
Confidence 6 45999999998754321111 1123469999999999874221 24578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCC-CCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--C
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE--R 818 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e--R 818 (840)
++|+.||...+..+....+..... ..++. .....+..+.+||.+||..++.+ |
T Consensus 202 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~------------------------~~~~~s~~~~~li~~ll~~~~~r~~r 257 (332)
T cd05623 202 LYGETPFYAESLVETYGKIMNHKERFQFPA------------------------QVTDVSEDAKDLIRRLICSREHRLGQ 257 (332)
T ss_pred hcCCCCCCCCCHHHHHHHHhCCCccccCCC------------------------ccccCCHHHHHHHHHHccChhhhcCC
Confidence 999999998888777777654321 11111 11123567899999999765554 6
Q ss_pred CCHHHHHHHH
Q 003185 819 PTAGDLYEMF 828 (840)
Q Consensus 819 PSa~ELLehL 828 (840)
+++.++++|.
T Consensus 258 ~~~~~~~~h~ 267 (332)
T cd05623 258 NGIEDFKQHP 267 (332)
T ss_pred CCHHHHhCCC
Confidence 8999999993
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=311.49 Aligned_cols=251 Identities=22% Similarity=0.349 Sum_probs=200.5
Q ss_pred CCCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
..+|++.+.||+|+||.||+|.+. +..+++|+.... ... ... +.+|+.++++++||||+++++++.....
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~--~~~---~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG--AMS---EED----FIEEAQVMMKLSHPKLVQLYGVCTERSP 73 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC--CCC---HHH----HHHHHHHHHhCCCCCeeeEEEEEccCCc
Confidence 457899999999999999999874 678888875422 111 122 3889999999999999999999875543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.++||||+.+++|.+++.. ....+++..++.++.|++.||+|||+++++|+||||+||+++.
T Consensus 74 --------------~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~ 135 (256)
T cd05112 74 --------------ICLVFEFMEHGCLSDYLRA----QRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE 135 (256)
T ss_pred --------------eEEEEEcCCCCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcC
Confidence 4999999999999999875 2245789999999999999999999999999999999999986
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ ..++|+|||++......... ......++..|+|||++.+ ..++.++||||||+++|||+
T Consensus 136 ~-------~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~~~aPe~~~~----~~~~~~~Dv~slG~~l~el~ 195 (256)
T cd05112 136 N-------QVVKVSDFGMTRFVLDDQYT---------SSTGTKFPVKWSSPEVFSF----SKYSSKSDVWSFGVLMWEVF 195 (256)
T ss_pred C-------CeEEECCCcceeecccCccc---------ccCCCccchhhcCHhHhcc----CCcChHHHHHHHHHHHHHHH
Confidence 6 46999999998765332110 0112235678999999875 56788999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 743 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 743 T-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
+ |..||.......+...+..+..+..+. ..+..+.+|+.+||+.+|.+|||+
T Consensus 196 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~~~l~~~p~~Rp~~ 248 (256)
T cd05112 196 SEGKTPYENRSNSEVVETINAGFRLYKPR---------------------------LASQSVYELMQHCWKERPEDRPSF 248 (256)
T ss_pred cCCCCCCCcCCHHHHHHHHhCCCCCCCCC---------------------------CCCHHHHHHHHHHcccChhhCCCH
Confidence 8 999998877777776665543322111 024578999999999999999999
Q ss_pred HHHHHHH
Q 003185 822 GDLYEMF 828 (840)
Q Consensus 822 ~ELLehL 828 (840)
.+++++|
T Consensus 249 ~~~l~~l 255 (256)
T cd05112 249 SLLLHQL 255 (256)
T ss_pred HHHHHhh
Confidence 9999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.50 Aligned_cols=258 Identities=21% Similarity=0.330 Sum_probs=201.8
Q ss_pred CCCceeeeeecccCceEEEEEEEC--C---eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEe
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFG--S---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 578 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~--~---~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~ 578 (840)
-++|+..+.||+|+||.||+|... + ..+++|...... .....+ .+.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQ----DFLSEASIMGQFSHHNIIRLEGVVT 76 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC---CHHHHH----HHHHHHHHHhcCCCCCeeEEEEEEc
Confidence 357889999999999999999863 2 257777643221 122223 3489999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
.... .++||||+++++|..++.. ....+++..+..++.|++.||+|||+.||+|+||||+||
T Consensus 77 ~~~~--------------~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Ni 138 (268)
T cd05063 77 KFKP--------------AMIITEYMENGALDKYLRD----HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNI 138 (268)
T ss_pred cCCC--------------cEEEEEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhE
Confidence 6553 4999999999999999875 235689999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.+ ..+||+|||++........... .......+..|+|||++.. ..++.++|||||||++
T Consensus 139 li~~~-------~~~kl~dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slG~il 200 (268)
T cd05063 139 LVNSN-------LECKVSDFGLSRVLEDDPEGTY-------TTSGGKIPIRWTAPEAIAY----RKFTSASDVWSFGIVM 200 (268)
T ss_pred EEcCC-------CcEEECCCccceecccccccce-------eccCCCcCceecCHHHhhc----CCcChHhHHHHHHHHH
Confidence 99876 4699999999876543211100 0011123467999999875 5678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 739 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 739 ~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
|||++ |..||...+..++...+........+ ...+..+.+|+.+||..+|.+
T Consensus 201 ~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~~~~li~~c~~~~p~~ 253 (268)
T cd05063 201 WEVMSFGERPYWDMSNHEVMKAINDGFRLPAP---------------------------MDCPSAVYQLMLQCWQQDRAR 253 (268)
T ss_pred HHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCC---------------------------CCCCHHHHHHHHHHcCCCccc
Confidence 99997 99999887777777666554322111 112457899999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 003185 818 RPTAGDLYEMFVAR 831 (840)
Q Consensus 818 RPSa~ELLehLe~l 831 (840)
||++.+|++.|.++
T Consensus 254 Rp~~~~i~~~l~~~ 267 (268)
T cd05063 254 RPRFVDIVNLLDKL 267 (268)
T ss_pred CcCHHHHHHHHHhh
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=321.74 Aligned_cols=254 Identities=25% Similarity=0.428 Sum_probs=200.6
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
...+|++.+.||+|+||.||+|.. .+..+++|....... ...+. +.+|+.+++.+.||||+++++.+...
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~----~~~~~----~~~e~~~l~~~~h~~v~~~~~~~~~~ 89 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKEL----IINEILVMRENKNPNIVNYLDSYLVG 89 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc----chHHH----HHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence 457899999999999999999986 567888887654321 11223 38899999999999999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
. ..|+||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 90 ~--------------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill 149 (296)
T cd06654 90 D--------------ELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149 (296)
T ss_pred C--------------EEEEeecccCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 4 35999999999999999865 457899999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.++|+|||++......... .....|++.|+|||.+.+ ..++.++|||||||++|+
T Consensus 150 ~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~s~Gvil~~ 208 (296)
T cd06654 150 GMD-------GSVKLTDFGFCAQITPEQSK----------RSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIE 208 (296)
T ss_pred cCC-------CCEEECccccchhccccccc----------cCcccCCccccCHHHHcC----CCCCccchHHHHHHHHHH
Confidence 876 46999999998764322110 122358899999999875 567889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|++|+.||....+......+.....+.+. .....+..+.+|+.+||..+|.+||+
T Consensus 209 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt 263 (296)
T cd06654 209 MIEGEPPYLNENPLRALYLIATNGTPELQ-------------------------NPEKLSAIFRDFLNRCLDMDVEKRGS 263 (296)
T ss_pred HHhCCCCCCCCCHHHhHHHHhcCCCCCCC-------------------------CccccCHHHHHHHHHHCcCCcccCcC
Confidence 99999999877654433333222111111 00123457899999999999999999
Q ss_pred HHHHHHHHHh
Q 003185 821 AGDLYEMFVA 830 (840)
Q Consensus 821 a~ELLehLe~ 830 (840)
+.+|++|-.-
T Consensus 264 ~~eil~~~~~ 273 (296)
T cd06654 264 AKELLQHQFL 273 (296)
T ss_pred HHHHhhChhh
Confidence 9999998544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=317.14 Aligned_cols=278 Identities=24% Similarity=0.298 Sum_probs=202.6
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||.||+|.+ .+..+|+|+....... .. ..+.+.+|+.++++++||||+++++++.....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 74 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD--PV----IKKIALREIRMLKQLKHPNLVNLIEVFRRKRK 74 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC--cc----ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE
Confidence 4799999999999999999997 4678999986533211 11 11234789999999999999999999876543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.++||||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 75 --------------~~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~ 135 (286)
T cd07847 75 --------------LHLVFEYCDHTVLNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITK 135 (286)
T ss_pred --------------EEEEEeccCccHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcC
Confidence 4999999999888877653 346899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.++|+|||++......... .....++..|+|||++.+ ...++.++|||||||++|+|+
T Consensus 136 ~-------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~i~~~l~ 195 (286)
T cd07847 136 Q-------GQIKLCDFGFARILTGPGDD----------YTDYVATRWYRAPELLVG---DTQYGPPVDVWAIGCVFAELL 195 (286)
T ss_pred C-------CcEEECccccceecCCCccc----------ccCcccccccCCHHHHhC---CCCcCchhhhHHHHHHHHHHH
Confidence 6 46999999999866432110 122357889999999865 245688999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcc----ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE----HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~----~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
+|..||.+....+....+.......+.... ..+.... ...+...............+..+.+||.+||..+|.+|
T Consensus 196 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 274 (286)
T cd07847 196 TGQPLWPGKSDVDQLYLIRKTLGDLIPRHQ-QIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTER 274 (286)
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCChHHh-hhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCcccc
Confidence 999999887766555544432221111100 0000000 00000000000011122346789999999999999999
Q ss_pred CCHHHHHHHH
Q 003185 819 PTAGDLYEMF 828 (840)
Q Consensus 819 PSa~ELLehL 828 (840)
|++.+++.|.
T Consensus 275 p~~~eil~~~ 284 (286)
T cd07847 275 LSCEELLEHP 284 (286)
T ss_pred CCHHHHhcCC
Confidence 9999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.47 Aligned_cols=262 Identities=23% Similarity=0.336 Sum_probs=205.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--C----eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG--S----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 575 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~----~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g 575 (840)
....+|++.+.||+|+||.||+|.+. + ..+++|+..... ..... ..+.+|+.++++++||||+++++
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~----~~~~~e~~~l~~l~h~~i~~~~~ 76 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKAN----KEILDEAYVMASVDHPHVVRLLG 76 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC---CHHHH----HHHHHHHHHHHhCCCCCcceEEE
Confidence 34578999999999999999999863 2 246777643221 12222 33489999999999999999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCC
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 655 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKP 655 (840)
++.. . ..++||||+++|+|.+++.. ....+++..+..++.||+.||+|||++||+||||||
T Consensus 77 ~~~~-~--------------~~~~v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p 137 (279)
T cd05057 77 ICLS-S--------------QVQLITQLMPLGCLLDYVRN----HKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAA 137 (279)
T ss_pred EEec-C--------------ceEEEEecCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCc
Confidence 9875 2 24999999999999999975 234589999999999999999999999999999999
Q ss_pred CcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003185 656 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735 (840)
Q Consensus 656 eNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLG 735 (840)
+|||++.+ ..+||+|||+++......... ......++..|+|||.+.. ..++.++||||||
T Consensus 138 ~nil~~~~-------~~~kL~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG 198 (279)
T cd05057 138 RNVLVKTP-------QHVKITDFGLAKLLDVDEKEY--------HAEGGKVPIKWMALESILH----RIYTHKSDVWSYG 198 (279)
T ss_pred ceEEEcCC-------CeEEECCCcccccccCcccce--------ecCCCcccccccCHHHhhc----CCcCchhhHHHHH
Confidence 99999876 459999999998764322110 0111224578999999865 5678999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003185 736 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 814 (840)
Q Consensus 736 vIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~D 814 (840)
|++|||++ |..||.+....++...+..+.....+. ..+..+.+++.+||..+
T Consensus 199 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~l~~~ 251 (279)
T cd05057 199 VTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPP---------------------------ICTIDVYMVLVKCWMID 251 (279)
T ss_pred HHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCC---------------------------CCCHHHHHHHHHHcCCC
Confidence 99999998 999999888887777776553322221 12346889999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCCC
Q 003185 815 PTERPTAGDLYEMFVARTSSS 835 (840)
Q Consensus 815 P~eRPSa~ELLehLe~l~~~~ 835 (840)
|.+||++.++++.|..+....
T Consensus 252 p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 252 AESRPTFKELINEFSKMARDP 272 (279)
T ss_pred hhhCCCHHHHHHHHHHHHhCC
Confidence 999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=311.55 Aligned_cols=252 Identities=27% Similarity=0.403 Sum_probs=204.0
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|++.+.||.|+||.||.++. .+..+++|.+..... ....... +.+|+.++++++|+||+++++++.....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~----~~~e~~~l~~~~h~~i~~~~~~~~~~~~- 73 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL--SEKERRD----ALNEIVILSLLQHPNIIAYYNHFMDDNT- 73 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc--chhHHHH----HHHHHHHHHhCCCCCeeEEEeEEecCCe-
Confidence 589999999999999988876 567788888654432 2223333 3899999999999999999999986543
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.++||||+++++|.+++... ....+++..+..++.|++.||.|||+.|++|+||||+||+++.+
T Consensus 74 -------------~~~~~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~ 137 (256)
T cd08221 74 -------------LLIEMEYANGGTLYDKIVRQ---KGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA 137 (256)
T ss_pred -------------EEEEEEecCCCcHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC
Confidence 59999999999999999761 23568999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
..+||+|||++........ ......|++.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 138 -------~~~kl~d~~~~~~~~~~~~----------~~~~~~~~~~y~ape~~~~----~~~~~~~Dv~slG~i~~~l~~ 196 (256)
T cd08221 138 -------GLIKLGDFGISKILGSEYS----------MAETVVGTPYYMSPELCQG----VKYNFKSDIWALGCVLYELLT 196 (256)
T ss_pred -------CCEEECcCcceEEcccccc----------cccccCCCccccCHhhcCC----CCCCCcchhHHHHHHHHHHHH
Confidence 4599999999876543221 1123468999999999875 456789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~E 823 (840)
|..||...+..+....+..+..+... ...+..+.++|.+||..+|.+||++.+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~R~s~~~ 249 (256)
T cd08221 197 LKRTFDATNPLNLVVKIVQGNYTPVV---------------------------SVYSSELISLVHSLLQQDPEKRPTADE 249 (256)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCc---------------------------cccCHHHHHHHHHHcccCcccCCCHHH
Confidence 99999888777777666554332211 122457899999999999999999999
Q ss_pred HHHHH
Q 003185 824 LYEMF 828 (840)
Q Consensus 824 LLehL 828 (840)
+++++
T Consensus 250 ll~~~ 254 (256)
T cd08221 250 VLDQP 254 (256)
T ss_pred HhhCc
Confidence 99985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=332.82 Aligned_cols=261 Identities=22% Similarity=0.296 Sum_probs=201.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||.||+++. .+..+|+|+...... ..... ...+.+|+.++..+.|+||+++++++...+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~----~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM-LKRAE----TACFREERNVLVNGDCQWITTLHYAFQDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HhhHH----HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 4799999999999999999987 556789998643211 01111 2234789999999999999999999986653
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.||||||++||+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~Ey~~gg~L~~~l~~----~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~ 137 (331)
T cd05624 76 --------------LYLVMDYYVGGDLLTLLSK----FEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDM 137 (331)
T ss_pred --------------EEEEEeCCCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcC
Confidence 4999999999999999975 1346899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC-CCCCchhhHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~-~~~s~kSDVWSLGvIL~EL 741 (840)
+ +.+||+|||++......... ......||+.|+|||++.+.... ..++.++|||||||+||+|
T Consensus 138 ~-------~~~kl~DfG~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~el 201 (331)
T cd05624 138 N-------GHIRLADFGSCLKMNQDGTV---------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEM 201 (331)
T ss_pred C-------CCEEEEeccceeeccCCCce---------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhh
Confidence 6 45999999999765432111 11234699999999998753211 3468899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCC-CCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--C
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE--R 818 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e--R 818 (840)
++|+.||...+..+....+.... +..++.. ....++.+.+||.+||..++.+ |
T Consensus 202 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~------------------------~~~~~~~~~~li~~ll~~~~~~~~~ 257 (331)
T cd05624 202 LYGETPFYAESLVETYGKIMNHEERFQFPSH------------------------ITDVSEEAKDLIQRLICSRERRLGQ 257 (331)
T ss_pred hhCCCCccCCCHHHHHHHHHcCCCcccCCCc------------------------cccCCHHHHHHHHHHccCchhhcCC
Confidence 99999998887777666665431 1111111 1123567899999999876655 4
Q ss_pred CCHHHHHHHH
Q 003185 819 PTAGDLYEMF 828 (840)
Q Consensus 819 PSa~ELLehL 828 (840)
++++++++|.
T Consensus 258 ~~~~~~~~h~ 267 (331)
T cd05624 258 NGIEDFKKHA 267 (331)
T ss_pred CCHHHHhcCC
Confidence 6899999884
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=318.01 Aligned_cols=267 Identities=27% Similarity=0.379 Sum_probs=201.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~ 578 (840)
...++|++.+.||+|+||.||+|.. .+..+++|+.... . .... .+.+|+.+++++ +||||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~--~---~~~~----~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI--H---DIDE----EIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc--c---chHH----HHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 4678999999999999999999987 5678899975321 1 1112 237899999999 6999999999886
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
..... .....++||||+++++|.+++...... ...+++..++.++.||+.||.|||+++|+||||||+||
T Consensus 86 ~~~~~---------~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ni 155 (286)
T cd06638 86 KKDVK---------NGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNI 155 (286)
T ss_pred ecccC---------CCCeEEEEEeecCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhE
Confidence 43211 123569999999999999998753222 35688999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~kSDVWSLGvI 737 (840)
+++.+ +.++|+|||++........ ......|++.|+|||++.... ....++.++|||||||+
T Consensus 156 li~~~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi 218 (286)
T cd06638 156 LLTTE-------GGVKLVDFGVSAQLTSTRL----------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGIT 218 (286)
T ss_pred EECCC-------CCEEEccCCceeecccCCC----------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHH
Confidence 99877 4599999999876543211 112346899999999986421 12457889999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
+|||++|+.||...........+.....+.+. .+ ...+..+.+||.+||+.||.+
T Consensus 219 ~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------~~---~~~~~~~~~li~~~l~~~p~~ 273 (286)
T cd06638 219 AIELGDGDPPLADLHPMRALFKIPRNPPPTLH----------------------QP---ELWSNEFNDFIRKCLTKDYEK 273 (286)
T ss_pred HHHHhcCCCCCCCCchhHHHhhccccCCCccc----------------------CC---CCcCHHHHHHHHHHccCCccc
Confidence 99999999999876654433333222111110 00 012346899999999999999
Q ss_pred CCCHHHHHHHHH
Q 003185 818 RPTAGDLYEMFV 829 (840)
Q Consensus 818 RPSa~ELLehLe 829 (840)
|||+.+|++|+.
T Consensus 274 Rps~~ell~~~~ 285 (286)
T cd06638 274 RPTVSDLLQHVF 285 (286)
T ss_pred CCCHHHHhhccc
Confidence 999999999863
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=311.54 Aligned_cols=251 Identities=26% Similarity=0.407 Sum_probs=202.2
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|++.+.||+|+||.||+|.. .+..+++|.+.... ....... .+.+|+.+++.++||||+++++.+....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~----~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 72 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQ--MTKDERL----AAQNECQVLKLLSHPNIIEYYENFLEDK-- 72 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccc--cccHHHH----HHHHHHHHHhhCCCCchhheeeeEecCC--
Confidence 589999999999999999986 67788998865432 2222333 3489999999999999999999887544
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
..++||||+++++|.+++... ....+++..+..++.|++.||.|||++||+|+||||+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~ 137 (256)
T cd08220 73 ------------ALMIVMEYAPGGTLAEYIQKR---CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKH 137 (256)
T ss_pred ------------EEEEEEecCCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 359999999999999999762 23458899999999999999999999999999999999999755
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+ ..++|+|||++........ .....|+..|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 138 ~------~~~~l~d~~~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~~l~~l~~ 196 (256)
T cd08220 138 K------MVVKIGDFGISKILSSKSK-----------AYTVVGTPCYISPELCEG----KPYNQKSDIWALGCVLYELAS 196 (256)
T ss_pred C------CEEEEccCCCceecCCCcc-----------ccccccCCcccCchhccC----CCCCcccchHHHHHHHHHHHh
Confidence 2 4689999999986643211 122458899999999875 557889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~E 823 (840)
|..||...+.......+.......++. ..+..+.+++.+||..+|.+|||+.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rpt~~~ 249 (256)
T cd08220 197 LKRAFEAANLPALVLKIMSGTFAPISD---------------------------RYSPDLRQLILSMLNLDPSKRPQLSQ 249 (256)
T ss_pred CCCCcccCchHHHHHHHHhcCCCCCCC---------------------------CcCHHHHHHHHHHccCChhhCCCHHH
Confidence 999998877666655554443322221 12457899999999999999999999
Q ss_pred HHHH
Q 003185 824 LYEM 827 (840)
Q Consensus 824 LLeh 827 (840)
++.|
T Consensus 250 ll~~ 253 (256)
T cd08220 250 IMAQ 253 (256)
T ss_pred HhhC
Confidence 9987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=314.22 Aligned_cols=259 Identities=26% Similarity=0.361 Sum_probs=201.2
Q ss_pred CceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 584 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p 584 (840)
+|.+.+.||.|+||.||+|.. .+..+|+|+...+.... .........+.+|+.++++++|+||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNV--LAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNT-- 76 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccch--hhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCe--
Confidence 478899999999999999986 66779999866543221 2222223456899999999999999999999886543
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEeccc
Q 003185 585 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 664 (840)
Q Consensus 585 ~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~ 664 (840)
.++||||+++++|.+++.+ ...+++..+..++.||+.||+|||+.+|+|+||||+||+++.+
T Consensus 77 ------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~- 138 (265)
T cd06631 77 ------------ISIFMEFVPGGSISSILNR-----FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN- 138 (265)
T ss_pred ------------EEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCC-
Confidence 4999999999999999975 2468899999999999999999999999999999999999876
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 003185 665 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 744 (840)
Q Consensus 665 ~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG 744 (840)
+.++|+|||++........... .........|+..|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 139 ------~~~~l~dfg~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~slG~~~~~l~~g 204 (265)
T cd06631 139 ------GIIKLIDFGCARRLAWVGLHGT----HSNMLKSMHGTPYWMAPEVINE----SGYGRKSDIWSIGCTVFEMATG 204 (265)
T ss_pred ------CeEEeccchhhHhhhhcccccc----ccccccccCCCccccChhhhcC----CCCcchhhHHHHHHHHHHHHhC
Confidence 4699999999876532111100 0011123458999999999876 5578999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcC--CCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 745 QVPYMGLSELEIHDLIQMG--KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 745 ~~PF~~~~~~el~~~I~~~--~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
..||...+.......+... ..+.++ ...+..+.++|.+||..+|.+||++.
T Consensus 205 ~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~ 257 (265)
T cd06631 205 KPPLASMDRLAAMFYIGAHRGLMPRLP---------------------------DSFSAAAIDFVTSCLTRDQHERPSAL 257 (265)
T ss_pred CCccccCChHHHHHHhhhccCCCCCCC---------------------------CCCCHHHHHHHHHHhcCCcccCCCHH
Confidence 9999876554443333322 111111 12355789999999999999999999
Q ss_pred HHHHH
Q 003185 823 DLYEM 827 (840)
Q Consensus 823 ELLeh 827 (840)
++++|
T Consensus 258 ~~l~~ 262 (265)
T cd06631 258 QLLRH 262 (265)
T ss_pred HHhcC
Confidence 99986
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=317.85 Aligned_cols=257 Identities=26% Similarity=0.397 Sum_probs=198.7
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
..++|.+.+.||+|+||.||+|.+ .+..+|+|+..... ..... .+.+|+.+++.++||||+++++.+...
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~----~~~~e~~~~~~l~h~~ii~~~~~~~~~ 78 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFA----VVQQEIIMMKDCKHSNIVAYFGSYLRR 78 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHH----HHHHHHHHHHhCCCCCeeeEEEEEEeC
Confidence 346899999999999999999987 57789999865432 11222 237899999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||++
T Consensus 79 ~~--------------~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili 139 (267)
T cd06645 79 DK--------------LWICMEFCGGGSLQDIYHV-----TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL 139 (267)
T ss_pred CE--------------EEEEEeccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 53 4999999999999999875 3568999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.++|+|||++........ ......|+..|+|||++... ....++.++|||||||++|+
T Consensus 140 ~~~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~-~~~~~~~~~DvwSlG~il~~ 201 (267)
T cd06645 140 TDN-------GHVKLADFGVSAQITATIA----------KRKSFIGTPYWMAPEVAAVE-RKGGYNQLCDIWAVGITAIE 201 (267)
T ss_pred CCC-------CCEEECcceeeeEccCccc----------ccccccCcccccChhhhccc-cCCCCCchhhhHHHHHHHHH
Confidence 876 4599999999876532111 11234689999999998521 12457889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|++|..||....+......+....... + .+ ......+..+.++|.+||..+|++||+
T Consensus 202 l~~~~~p~~~~~~~~~~~~~~~~~~~~-~-~~---------------------~~~~~~~~~~~~li~~~l~~~P~~R~~ 258 (267)
T cd06645 202 LAELQPPMFDLHPMRALFLMTKSNFQP-P-KL---------------------KDKMKWSNSFHHFVKMALTKNPKKRPT 258 (267)
T ss_pred HhcCCCCcccccchhhHHhhhccCCCC-C-cc---------------------cccCCCCHHHHHHHHHHccCCchhCcC
Confidence 999999997665444333322221100 0 00 000112456899999999999999999
Q ss_pred HHHHHHH
Q 003185 821 AGDLYEM 827 (840)
Q Consensus 821 a~ELLeh 827 (840)
+++|++|
T Consensus 259 ~~~ll~~ 265 (267)
T cd06645 259 AEKLLQH 265 (267)
T ss_pred HHHHhcC
Confidence 9999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=312.56 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=203.9
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|++.+.||+|+||.||++.. .+..+++|....... .....+ .+.+|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKERE----ESRKEVAVLSNMKHPNIVQYQESFEENG-- 72 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHH----HHHHHHHHHHhCCCCCeeeeEeeecCCC--
Confidence 589999999999999999986 567889998654322 222223 3488999999999999999999987554
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
..++||||+.+++|.+++.. .....+++..++.++.||+.||.|||++|++|+||+|+|||++.+
T Consensus 73 ------------~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~ 137 (256)
T cd08218 73 ------------NLYIVMDYCEGGDLYKKINA---QRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD 137 (256)
T ss_pred ------------eEEEEEecCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC
Confidence 35999999999999999875 222457899999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
..++|+|||++......... .....|++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 138 -------~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~slG~i~~~l~~ 196 (256)
T cd08218 138 -------GTIKLGDFGIARVLNSTVEL----------ARTCIGTPYYLSPEICEN----RPYNNKSDIWALGCVLYEMCT 196 (256)
T ss_pred -------CCEEEeeccceeecCcchhh----------hhhccCCccccCHHHhCC----CCCCCccchhHHHHHHHHHHc
Confidence 45999999999765432211 122358899999999875 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~E 823 (840)
|..||......+....+..+..+..+. ..+..+.++|.+||+.+|.+||++.+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08218 197 LKHAFEAGNMKNLVLKIIRGSYPPVSS---------------------------HYSYDLRNLVSQLFKRNPRDRPSVNS 249 (256)
T ss_pred CCCCccCCCHHHHHHHHhcCCCCCCcc---------------------------cCCHHHHHHHHHHhhCChhhCcCHHH
Confidence 999998877777766666554433221 12457899999999999999999999
Q ss_pred HHHHH
Q 003185 824 LYEMF 828 (840)
Q Consensus 824 LLehL 828 (840)
|++|-
T Consensus 250 vl~~~ 254 (256)
T cd08218 250 ILEKN 254 (256)
T ss_pred HhhCc
Confidence 99873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=335.40 Aligned_cols=257 Identities=21% Similarity=0.246 Sum_probs=214.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..-+=|.+.+.||+|.|++|-+|++ .+..|||||+.... ...... ..+.+|++.|+.++|||||++|.+..+
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTK--lD~~st----~hlfqEVRCMKLVQHpNiVRLYEViDT 88 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTK--LDTLST----GHLFQEVRCMKLVQHPNIVRLYEVIDT 88 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccc--cchhhh----hHHHHHHHHHHHhcCcCeeeeeehhcc
Confidence 3445689999999999999999985 99999999965332 222222 234899999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... +|||+|+-.+|+|++||.++ ...+.+..+.+++.||+.|+.|+|+..+|||||||+|+.
T Consensus 89 QTK--------------lyLiLELGD~GDl~DyImKH----e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVV 150 (864)
T KOG4717|consen 89 QTK--------------LYLILELGDGGDLFDYIMKH----EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVV 150 (864)
T ss_pred cce--------------EEEEEEecCCchHHHHHHhh----hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeE
Confidence 553 59999999999999999873 456999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
+.+. .+.|||.|||++..+..... -.+.+|+..|.|||++.+ ...-.+++||||||||||
T Consensus 151 FFEK------lGlVKLTDFGFSNkf~PG~k-----------L~TsCGSLAYSAPEILLG---DsYDAPAVDiWSLGVILy 210 (864)
T KOG4717|consen 151 FFEK------LGLVKLTDFGFSNKFQPGKK-----------LTTSCGSLAYSAPEILLG---DSYDAPAVDIWSLGVILY 210 (864)
T ss_pred Eeee------cCceEeeeccccccCCCcch-----------hhcccchhhccCchhhhc---CccCCcchhhhHHHHHHH
Confidence 8766 36899999999976654322 244579999999999997 234468999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
.|++|++||+..++.+.+..|...+. .+|. ..+.++++||..||..||.+|.
T Consensus 211 MLVCGq~PFqeANDSETLTmImDCKY-tvPs---------------------------hvS~eCrdLI~sMLvRdPkkRA 262 (864)
T KOG4717|consen 211 MLVCGQPPFQEANDSETLTMIMDCKY-TVPS---------------------------HVSKECRDLIQSMLVRDPKKRA 262 (864)
T ss_pred HHHhCCCccccccchhhhhhhhcccc-cCch---------------------------hhhHHHHHHHHHHHhcCchhhc
Confidence 99999999999999998888877643 2222 2466899999999999999999
Q ss_pred CHHHHHHHHHh
Q 003185 820 TAGDLYEMFVA 830 (840)
Q Consensus 820 Sa~ELLehLe~ 830 (840)
+.++|..+-+-
T Consensus 263 slEeI~s~~Wl 273 (864)
T KOG4717|consen 263 SLEEIVSTSWL 273 (864)
T ss_pred cHHHHhccccc
Confidence 99999987543
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=317.66 Aligned_cols=253 Identities=30% Similarity=0.454 Sum_probs=205.5
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||.|+||.||+|.+ .+..+++|+..... ....... +.+|+.+++.++||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~- 72 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIED----IQQEIQFLSQCRSPYITKYYGSFLKGS- 72 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHH----HHHHHHHHHHcCCCCeeeeeEEEEECC-
Confidence 4688999999999999999987 56789999875432 1222233 388999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
..|+||||+++++|.+++.. ..+++..++.++.||+.||.|||+++|+|+||+|+||+++.
T Consensus 73 -------------~~~~v~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~ 133 (274)
T cd06609 73 -------------KLWIIMEYCGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE 133 (274)
T ss_pred -------------eEEEEEEeeCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC
Confidence 35999999999999999975 37899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.++|+|||+++........ .....|++.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 134 ~-------~~~~l~d~g~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~----~~~~~~sDv~slG~il~~l~ 192 (274)
T cd06609 134 E-------GDVKLADFGVSGQLTSTMSK----------RNTFVGTPFWMAPEVIKQ----SGYDEKADIWSLGITAIELA 192 (274)
T ss_pred C-------CCEEEcccccceeecccccc----------cccccCCccccChhhhcc----CCCCchhhHHHHHHHHHHHH
Confidence 7 45999999999876543211 123468899999999986 45889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
||..||...++......+.....+.+... ..+..+.+++.+||..+|.+|||++
T Consensus 193 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~~l~~~p~~Rpt~~ 246 (274)
T cd06609 193 KGEPPLSDLHPMRVLFLIPKNNPPSLEGN--------------------------KFSKPFKDFVSLCLNKDPKERPSAK 246 (274)
T ss_pred hCCCCcccCchHHHHHHhhhcCCCCCccc--------------------------ccCHHHHHHHHHHhhCChhhCcCHH
Confidence 99999987776666555554433322210 0245789999999999999999999
Q ss_pred HHHHHHHhh
Q 003185 823 DLYEMFVAR 831 (840)
Q Consensus 823 ELLehLe~l 831 (840)
++++|-.-.
T Consensus 247 ~il~~~~~~ 255 (274)
T cd06609 247 ELLKHKFIK 255 (274)
T ss_pred HHhhChhhc
Confidence 999985543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=347.00 Aligned_cols=260 Identities=29% Similarity=0.448 Sum_probs=218.0
Q ss_pred CCCceeeeeecccCceEEEEEEECC--eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
-+-|.|+..||.|+||.||+|..+. ...|.|++..+ ..++++.| +-||.||..+.||+||++++.|..++
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk----seEELEDy----lVEIeILa~CdHP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK----SEEELEDY----LVEIEILAECDHPVIVKLLSAYYFEN 102 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc----chhHHhhh----hhhhhhhhcCCChHHHHHHHHHhccC
Confidence 3457899999999999999998643 34566664433 45666666 89999999999999999999988776
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
.+ ||+.|||.||..+.++-.+ ...+.+..+..+++|++.||.|||+++|||||||..|||++
T Consensus 103 kL--------------wiliEFC~GGAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T 164 (1187)
T KOG0579|consen 103 KL--------------WILIEFCGGGAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT 164 (1187)
T ss_pred ce--------------EEEEeecCCchHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE
Confidence 54 9999999999999988763 46799999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~kSDVWSLGvIL~E 740 (840)
.+|+ ++|+|||.+....... .....++|||.|||||+.++.. +..+|..++||||||++|.|
T Consensus 165 ldGd-------irLADFGVSAKn~~t~----------qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIE 227 (1187)
T KOG0579|consen 165 LDGD-------IRLADFGVSAKNKSTR----------QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIE 227 (1187)
T ss_pred ecCc-------EeeecccccccchhHH----------hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHH
Confidence 9954 9999999986543322 1246688999999999987643 33679999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|..+.+|....+++.++-.|.+...|.+-.. ...+..+.+++.+||..||..||+
T Consensus 228 MAqiEPPHhelnpMRVllKiaKSePPTLlqP-------------------------S~Ws~~F~DfLk~cL~Knp~~Rp~ 282 (1187)
T KOG0579|consen 228 MAQIEPPHHELNPMRVLLKIAKSEPPTLLQP-------------------------SHWSRSFSDFLKRCLVKNPRNRPP 282 (1187)
T ss_pred HhccCCCccccchHHHHHHHhhcCCCcccCc-------------------------chhhhHHHHHHHHHHhcCCccCCC
Confidence 9999999999999999999988876655421 112457899999999999999999
Q ss_pred HHHHHHHHHhh
Q 003185 821 AGDLYEMFVAR 831 (840)
Q Consensus 821 a~ELLehLe~l 831 (840)
+++|++|.+--
T Consensus 283 aaqll~Hpfv~ 293 (1187)
T KOG0579|consen 283 AAQLLKHPFVQ 293 (1187)
T ss_pred HHHHhhCcccc
Confidence 99999997643
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=313.24 Aligned_cols=267 Identities=25% Similarity=0.361 Sum_probs=206.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~ 578 (840)
.+.++|++.+.||+|+||.||+|.. .+..+++|+..... ...+ .+.+|+.+++++ .||||+++++++.
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~----~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEE----EIKEEYNILRKYSNHPNIATFYGAFI 73 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHH----HHHHHHHHHHHhcCCCChheEEEEEE
Confidence 5678999999999999999999997 45678998865432 1222 348999999999 6999999999988
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
..... ......++||||+++++|.+++..... ....+++..++.++.||+.||.|||++||+|+||+|+||
T Consensus 74 ~~~~~--------~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni 144 (275)
T cd06608 74 KKNPP--------GNDDQLWLVMELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNI 144 (275)
T ss_pred ecCCC--------CcceEEEEEEEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHE
Confidence 65420 122357999999999999999876322 135689999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~kSDVWSLGvI 737 (840)
+++.+ +.++|+|||++......... .....|+..|+|||++.... ....++.++|||||||+
T Consensus 145 ~~~~~-------~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~i 207 (275)
T cd06608 145 LLTKN-------AEVKLVDFGVSAQLDSTLGR----------RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGIT 207 (275)
T ss_pred EEccC-------CeEEECCCccceecccchhh----------hcCccccccccCHhHhcccccccCCccccccHHHhHHH
Confidence 99877 45999999998765432111 12345899999999986422 12456789999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
||+|++|..||...........+.....+.+.. ....+..+.+||.+||..||.+
T Consensus 208 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~dp~~ 262 (275)
T cd06608 208 AIELADGKPPLCDMHPMRALFKIPRNPPPTLKS-------------------------PENWSKKFNDFISECLIKNYEQ 262 (275)
T ss_pred HHHHHhCCCCccccchHHHHHHhhccCCCCCCc-------------------------hhhcCHHHHHHHHHHhhcChhh
Confidence 999999999998765555444444332221110 0123557899999999999999
Q ss_pred CCCHHHHHHHH
Q 003185 818 RPTAGDLYEMF 828 (840)
Q Consensus 818 RPSa~ELLehL 828 (840)
|||+.+|++|-
T Consensus 263 Rpt~~~ll~~~ 273 (275)
T cd06608 263 RPFMEELLEHP 273 (275)
T ss_pred CcCHHHHhcCC
Confidence 99999999873
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=321.05 Aligned_cols=254 Identities=24% Similarity=0.301 Sum_probs=196.8
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
.|+..+.||+|+||.||+|.+ .+..+|+|+........ ......+.+|+.+|+.++|+||+.+++.+...+.
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~- 74 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK-----RKGESMALNEKQILEKVNSQFVVNLAYAYETKDA- 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhh-----hhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCE-
Confidence 377889999999999999987 46789999864332111 1112234789999999999999999998876553
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.++||||+++++|..++.. .....+++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus 75 -------------~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~ 138 (285)
T cd05632 75 -------------LCLVLTIMNGGDLKFHIYN---MGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY 138 (285)
T ss_pred -------------EEEEEEeccCccHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC
Confidence 4999999999999998865 223469999999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
..++|+|||++........ .....|+..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 139 -------~~~kl~Dfg~~~~~~~~~~-----------~~~~~g~~~~~aPE~~~~----~~~~~~~Di~slG~~l~~l~~ 196 (285)
T cd05632 139 -------GHIRISDLGLAVKIPEGES-----------IRGRVGTVGYMAPEVLNN----QRYTLSPDYWGLGCLIYEMIE 196 (285)
T ss_pred -------CCEEEecCCcceecCCCCc-----------ccCCCCCcCccChHHhcC----CCCCcccchHHHHHHHHHHHh
Confidence 4599999999865432111 122468999999999975 567899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC---
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT--- 820 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS--- 820 (840)
|..||...........+.......... .....+..+.+|+.+||+.||.+||+
T Consensus 197 g~~P~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05632 197 GQSPFRGRKEKVKREEVDRRVLETEEV------------------------YSAKFSEEAKSICKMLLTKDPKQRLGCQE 252 (285)
T ss_pred CCCCCCCCCHHHHHHHHHHhhhccccc------------------------cCccCCHHHHHHHHHHccCCHhHcCCCcc
Confidence 999998776544433332211100000 00112456889999999999999999
Q ss_pred --HHHHHHH
Q 003185 821 --AGDLYEM 827 (840)
Q Consensus 821 --a~ELLeh 827 (840)
+.++++|
T Consensus 253 ~~~~~l~~~ 261 (285)
T cd05632 253 EGAGEVKRH 261 (285)
T ss_pred cChHHHHcC
Confidence 8899988
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=320.08 Aligned_cols=259 Identities=28% Similarity=0.423 Sum_probs=202.0
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
+-+.|++.++||.|+||.||+|.. .+..+++|+.... .....+. +.+|+.+++.++||||+++++.+...
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELED----YMVEIEILATCNHPYIVKLLGAFYWD 81 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHH----HHHHHHHHHhCCCCcEeeeEEEEEeC
Confidence 346799999999999999999997 4577888886432 2223333 48899999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .++||||+++++|..++.+ ....+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 82 ~~--------------~~lv~e~~~~~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili 143 (292)
T cd06644 82 GK--------------LWIMIEFCPGGAVDAIMLE----LDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL 143 (292)
T ss_pred Ce--------------EEEEEecCCCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE
Confidence 53 4999999999999988764 23468999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~kSDVWSLGvIL~ 739 (840)
+.+ +.++|+|||++......... .....+++.|+|||++.+.. ....++.++|||||||++|
T Consensus 144 ~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~ 206 (292)
T cd06644 144 TLD-------GDIKLADFGVSAKNVKTLQR----------RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI 206 (292)
T ss_pred cCC-------CCEEEccCccceeccccccc----------cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHH
Confidence 866 45999999998654321111 12345889999999985321 1245788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|++|..||...+.......+.....+.+.. ....+..+.+||.+||..+|.+||
T Consensus 207 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rp 261 (292)
T cd06644 207 EMAQIEPPHHELNPMRVLLKIAKSEPPTLSQ-------------------------PSKWSMEFRDFLKTALDKHPETRP 261 (292)
T ss_pred HHhcCCCCCccccHHHHHHHHhcCCCccCCC-------------------------CcccCHHHHHHHHHHhcCCcccCc
Confidence 9999999998777665555554433221110 012245789999999999999999
Q ss_pred CHHHHHHHHH
Q 003185 820 TAGDLYEMFV 829 (840)
Q Consensus 820 Sa~ELLehLe 829 (840)
++.++++|..
T Consensus 262 ~~~~il~~~~ 271 (292)
T cd06644 262 SAAQLLEHPF 271 (292)
T ss_pred CHHHHhcCcc
Confidence 9999999854
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.65 Aligned_cols=260 Identities=24% Similarity=0.375 Sum_probs=200.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCccee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 573 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l 573 (840)
...++|.+.+.||+|+||.||+|.+ ....+|+|+..... ..... +.+.+|+.+++++ +||||+++
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~----~~~~~E~~~l~~l~~h~~iv~~ 104 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSER----EALMSELKIMSHLGNHENIVNL 104 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHH----HHHHHHHHHHHhccCCCCcceE
Confidence 4567899999999999999999975 23367777743221 12222 3348999999999 79999999
Q ss_pred eeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccC
Q 003185 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 653 (840)
Q Consensus 574 ~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDL 653 (840)
++++..... .++||||+.+++|.+++.. .....+++..+..++.||+.||+|||+++|+|+||
T Consensus 105 ~~~~~~~~~--------------~~lv~e~~~~~~L~~~i~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dl 167 (302)
T cd05055 105 LGACTIGGP--------------ILVITEYCCYGDLLNFLRR---KRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDL 167 (302)
T ss_pred EEEEecCCc--------------eEEEEEcCCCCcHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhh
Confidence 999876553 4999999999999999975 12234899999999999999999999999999999
Q ss_pred CCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHH
Q 003185 654 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 733 (840)
Q Consensus 654 KPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWS 733 (840)
||+|||++.+ ..++|+|||+++.+....... ......++..|+|||++.+ ..++.++||||
T Consensus 168 kp~Nil~~~~-------~~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~Diws 228 (302)
T cd05055 168 AARNVLLTHG-------KIVKICDFGLARDIMNDSNYV--------VKGNARLPVKWMAPESIFN----CVYTFESDVWS 228 (302)
T ss_pred ccceEEEcCC-------CeEEECCCcccccccCCCcee--------ecCCCCcccccCCHhhhcc----CCCCcHhHHHH
Confidence 9999999866 469999999997654321110 0122346788999999876 56789999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCHHHHH-HHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 003185 734 YGCLLLELLT-LQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 811 (840)
Q Consensus 734 LGvIL~ELLT-G~~PF~~~~~~el~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL 811 (840)
|||++|||++ |..||......... ..+..+..+..+ ...+..+.+|+.+||
T Consensus 229 lGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~cl 281 (302)
T cd05055 229 YGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP---------------------------EHAPAEIYDIMKTCW 281 (302)
T ss_pred HHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHc
Confidence 9999999998 99999876544333 232222211111 112457899999999
Q ss_pred ccCCCCCCCHHHHHHHHHhh
Q 003185 812 EENPTERPTAGDLYEMFVAR 831 (840)
Q Consensus 812 ~~DP~eRPSa~ELLehLe~l 831 (840)
..+|.+|||+.+|++.|+++
T Consensus 282 ~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 282 DADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCchhCcCHHHHHHHHHhh
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.78 Aligned_cols=255 Identities=22% Similarity=0.368 Sum_probs=202.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
+..++|++.+.||+|+||.||++.+ .+..+++|..... ....+ .+.+|+.++++++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-----~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-----SMSVE----AFLAEANVMKTLQHDKLVKLHAVVTK- 72 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-----hhHHH----HHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence 4567899999999999999999986 4456888875321 11223 34889999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
. ..++||||+++++|.+++.. .....+++..+..++.||+.||.|||+.|++|+||||+||++
T Consensus 73 ~--------------~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i 135 (260)
T cd05073 73 E--------------PIYIITEFMAKGSLLDFLKS---DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV 135 (260)
T ss_pred C--------------CeEEEEEeCCCCcHHHHHHh---CCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE
Confidence 2 24999999999999999975 223467888999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.. +.+||+|||++......... ......++..|+|||++.. ..++.++|||||||++|+
T Consensus 136 ~~~-------~~~~l~d~~~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~~l~~ 195 (260)
T cd05073 136 SAS-------LVCKIADFGLARVIEDNEYT---------AREGAKFPIKWTAPEAINF----GSFTIKSDVWSFGILLME 195 (260)
T ss_pred cCC-------CcEEECCCcceeeccCCCcc---------cccCCcccccccCHhHhcc----CCcCccccchHHHHHHHH
Confidence 876 56999999999765432111 1112235678999999875 567889999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|+| |..||.+.+...+...+........+ ...+..+.+++.+||+.+|.+||
T Consensus 196 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rp 248 (260)
T cd05073 196 IVTYGRIPYPGMSNPEVIRALERGYRMPRP---------------------------ENCPEELYNIMMRCWKNRPEERP 248 (260)
T ss_pred HHhcCCCCCCCCCHHHHHHHHhCCCCCCCc---------------------------ccCCHHHHHHHHHHcccCcccCc
Confidence 999 99999888777766666544322111 11245789999999999999999
Q ss_pred CHHHHHHHHHh
Q 003185 820 TAGDLYEMFVA 830 (840)
Q Consensus 820 Sa~ELLehLe~ 830 (840)
++.++++.|+.
T Consensus 249 ~~~~l~~~L~~ 259 (260)
T cd05073 249 TFEYIQSVLDD 259 (260)
T ss_pred CHHHHHHHHhc
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=311.26 Aligned_cols=251 Identities=27% Similarity=0.393 Sum_probs=200.8
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
.++|++.+.||.|+||.||+|.+. +..+++|...... .. ..+.+|+.++++++||||+++++++....
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~----~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DL----QEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HH----HHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 468999999999999999999984 5788888864321 12 34489999999999999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .|++|||+.+++|.+++.. ....+++..++.++.||+.||.|||+.+|+|+||+|.||+++
T Consensus 72 ~--------------~~l~~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~ 133 (256)
T cd06612 72 D--------------LWIVMEYCGAGSVSDIMKI----TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN 133 (256)
T ss_pred c--------------EEEEEecCCCCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC
Confidence 3 5999999999999999875 235689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.++|+|||++........ ......|+..|+|||++.+ ..++.++||||||+++|+|
T Consensus 134 ~~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~s~G~il~~l 192 (256)
T cd06612 134 EE-------GQAKLADFGVSGQLTDTMA----------KRNTVIGTPFWMAPEVIQE----IGYNNKADIWSLGITAIEM 192 (256)
T ss_pred CC-------CcEEEcccccchhcccCcc----------ccccccCCccccCHHHHhc----CCCCchhhHHHHHHHHHHH
Confidence 77 4599999999886643221 1123458899999999876 5678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
++|+.||....+......+.....+.+. .....+..+.++|.+||+.||.+|||+
T Consensus 193 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~i~~~l~~~P~~Rps~ 247 (256)
T cd06612 193 AEGKPPYSDIHPMRAIFMIPNKPPPTLS-------------------------DPEKWSPEFNDFVKKCLVKDPEERPSA 247 (256)
T ss_pred HhCCCCCCCcchhhhhhhhccCCCCCCC-------------------------chhhcCHHHHHHHHHHHhcChhhCcCH
Confidence 9999999876655443333222111111 011234578999999999999999999
Q ss_pred HHHHHHH
Q 003185 822 GDLYEMF 828 (840)
Q Consensus 822 ~ELLehL 828 (840)
.+|++|-
T Consensus 248 ~~il~~~ 254 (256)
T cd06612 248 IQLLQHP 254 (256)
T ss_pred HHHhcCC
Confidence 9999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.75 Aligned_cols=289 Identities=18% Similarity=0.221 Sum_probs=203.0
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEecCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 581 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~~~ 581 (840)
++|++.+.||+|+||.||+|.+ .+..+|+|+....... .. ....+.+|+.+++.+. ||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~--~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 74 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE--EG----IPPTALREISLLQMLSESIYIVRLLDVEHVEE 74 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc--cC----CchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence 4799999999999999999997 5678999986543211 11 1223488999999996 699999999887654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
.. .....|+||||+++ +|.+++..........+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 75 ~~---------~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~ 144 (295)
T cd07837 75 KN---------GKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD 144 (295)
T ss_pred CC---------CCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe
Confidence 31 22346999999985 899998763322235689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ .+.+||+|||++..+...... .....+++.|+|||++.+ ...++.++||||||+++|+|
T Consensus 145 ~~------~~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~l~~l 205 (295)
T cd07837 145 KQ------KGLLKIADLGLGRAFSIPVKS----------YTHEIVTLWYRAPEVLLG---STHYSTPVDIWSVGCIFAEM 205 (295)
T ss_pred cC------CCeEEEeecccceecCCCccc----------cCCcccccCCCChHHhhC---CCCCCchHHHHHHHHHHHHH
Confidence 72 156999999998765332111 112246889999999864 24578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
++|..||.+.+.......+...........+...........................+..+.+||.+||.+||.+||++
T Consensus 206 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~ 285 (295)
T cd07837 206 SRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA 285 (295)
T ss_pred HcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCH
Confidence 99999998877665544443321111111110000000000000000000001112346779999999999999999999
Q ss_pred HHHHHHH
Q 003185 822 GDLYEMF 828 (840)
Q Consensus 822 ~ELLehL 828 (840)
.+++.|-
T Consensus 286 ~eil~~~ 292 (295)
T cd07837 286 KAALTHP 292 (295)
T ss_pred HHHhcCC
Confidence 9999873
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=320.01 Aligned_cols=267 Identities=20% Similarity=0.286 Sum_probs=199.1
Q ss_pred CCCCceeeeeecccCceEEEEEEECC----------------eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFGS----------------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR 566 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~----------------~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~ 566 (840)
+.++|++.+.||+|+||.||+|...+ ..+|+|+.... ....... .+.+|++++++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~ei~~l~~l~ 75 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD---VTKTARN----DFLKEIKIMSRLK 75 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC---CCHHHHH----HHHHHHHHHHhCC
Confidence 45689999999999999999987632 24677775422 1222222 3489999999999
Q ss_pred CCCcceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-------cCCCCCCHHHHHHHHHHHHHH
Q 003185 567 HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------TGEKHVSVKLALFIAQDVAAA 639 (840)
Q Consensus 567 HpNIV~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-------~~~~~ls~~~~~~Ia~QIa~A 639 (840)
||||+++++++..... .++||||+++++|.+++..... .....+++..++.++.||+.|
T Consensus 76 h~~i~~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~a 141 (295)
T cd05097 76 NPNIIRLLGVCVSDDP--------------LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASG 141 (295)
T ss_pred CCCcCeEEEEEcCCCc--------------cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHH
Confidence 9999999999876553 4999999999999999965210 011246788999999999999
Q ss_pred HHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcc
Q 003185 640 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 719 (840)
Q Consensus 640 L~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~ 719 (840)
|+|||++|++|+||||+|||++.+ +.+||+|||++......... .......++..|+|||++..
T Consensus 142 l~~lH~~~i~H~dlkp~Nill~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~- 205 (295)
T cd05097 142 MKYLASLNFVHRDLATRNCLVGNH-------YTIKIADFGMSRNLYSGDYY--------RIQGRAVLPIRWMAWESILL- 205 (295)
T ss_pred HHHHHhcCeeccccChhhEEEcCC-------CcEEecccccccccccCcce--------eccCcCcCceeecChhhhcc-
Confidence 999999999999999999999876 45999999999765322111 00122345788999999875
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhh
Q 003185 720 HKPNLYGLEVDIWSYGCLLLELLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 797 (840)
Q Consensus 720 ~~~~~~s~kSDVWSLGvIL~ELLT--G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 797 (840)
..++.++|||||||++|+|++ +..||...+..+....+........... ......
T Consensus 206 ---~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~ 262 (295)
T cd05097 206 ---GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQI--------------------YLSQTP 262 (295)
T ss_pred ---CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccc--------------------cCCCCC
Confidence 567899999999999999998 6788887776665554432111000000 000011
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003185 798 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 798 ~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe 829 (840)
..+..+.+|+.+||..||.+||++++|++.|+
T Consensus 263 ~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 263 LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 23567999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=309.25 Aligned_cols=255 Identities=24% Similarity=0.345 Sum_probs=193.0
Q ss_pred eeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 585 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~-----~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~ 585 (840)
+.||+|+||.||+|.+. ...+|+|... .. ......+. +.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~--~~-~~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~~~~~--- 70 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLN--RI-TDLEEVEQ----FLKEGIIMKDFSHPNVLSLLGICLPSEG--- 70 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecC--cc-CCHHHHHH----HHHHHHHHccCCCCCcceEEEEeecCCC---
Confidence 46899999999999862 2457777642 11 12222333 4889999999999999999998764332
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccc
Q 003185 586 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 665 (840)
Q Consensus 586 ~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~ 665 (840)
..++||||+.+++|.+++.. ....+++..+..++.||+.||.|||+.+|+||||||+|||++.+
T Consensus 71 ----------~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~-- 134 (262)
T cd05058 71 ----------SPLVVLPYMKHGDLRNFIRS----ETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES-- 134 (262)
T ss_pred ----------CcEEEEecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC--
Confidence 24899999999999999975 22346778889999999999999999999999999999999876
Q ss_pred cCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-C
Q 003185 666 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 744 (840)
Q Consensus 666 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT-G 744 (840)
+.+||+|||+++......... ........++..|+|||++.. ..++.++|||||||++|||++ |
T Consensus 135 -----~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~~~~ 199 (262)
T cd05058 135 -----FTVKVADFGLARDIYDKEYYS------VHNHTGAKLPVKWMALESLQT----QKFTTKSDVWSFGVLLWELMTRG 199 (262)
T ss_pred -----CcEEECCccccccccCCccee------ecccccCcCCccccChhHhcc----CccchHHHHHHHHHHHHHHHcCC
Confidence 469999999997654321100 000112346778999999875 567899999999999999999 5
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 003185 745 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 824 (840)
Q Consensus 745 ~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~EL 824 (840)
.+||...+..+....+..+..+..+. ..+..+.+++.+||..+|.+||++.+|
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i 252 (262)
T cd05058 200 APPYPDVDSFDITVYLLQGRRLLQPE---------------------------YCPDPLYEVMLSCWHPKPEMRPTFSEL 252 (262)
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCCC---------------------------cCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 67777777666665554443222111 124578999999999999999999999
Q ss_pred HHHHHhhcC
Q 003185 825 YEMFVARTS 833 (840)
Q Consensus 825 LehLe~l~~ 833 (840)
++.|+.+..
T Consensus 253 l~~l~~~~~ 261 (262)
T cd05058 253 VSRIEQIFS 261 (262)
T ss_pred HHHHHHHhc
Confidence 999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=336.67 Aligned_cols=264 Identities=24% Similarity=0.316 Sum_probs=203.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCccee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEM 573 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l 573 (840)
++.++|.+.+.||+|+||.||+|++.+ ..||+|+..... .....+ .+.+|+.+|.++. |||||++
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~----~~~~E~~~l~~l~~H~niv~~ 106 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQ----ALMSELKIMSHLGPHLNIVNL 106 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHH----HHHHHHHHHHhcCCCCCeEEE
Confidence 567789999999999999999998643 578999864321 122222 3489999999997 9999999
Q ss_pred eeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----------------------------------
Q 003185 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE----------------------------------- 618 (840)
Q Consensus 574 ~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~----------------------------------- 618 (840)
++++..... .+|||||+++|+|.+++.....
T Consensus 107 ~~~~~~~~~--------------~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (401)
T cd05107 107 LGACTKGGP--------------IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGS 172 (401)
T ss_pred EEEEccCCC--------------cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhh
Confidence 999986554 4999999999999999975211
Q ss_pred ----------------------------------------------------------cCCCCCCHHHHHHHHHHHHHHH
Q 003185 619 ----------------------------------------------------------TGEKHVSVKLALFIAQDVAAAL 640 (840)
Q Consensus 619 ----------------------------------------------------------~~~~~ls~~~~~~Ia~QIa~AL 640 (840)
.....+++..++.++.||+.||
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL 252 (401)
T cd05107 173 ESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGM 252 (401)
T ss_pred ccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHH
Confidence 0112467788899999999999
Q ss_pred HHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003185 641 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720 (840)
Q Consensus 641 ~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~ 720 (840)
.|||+.+|+||||||+|||++.+ ..+||+|||+++.+...... .......+++.|||||++.+
T Consensus 253 ~~LH~~~ivHrdlkp~NiLl~~~-------~~~kL~DfGla~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~-- 315 (401)
T cd05107 253 EFLASKNCVHRDLAARNVLICEG-------KLVKICDFGLARDIMRDSNY--------ISKGSTFLPLKWMAPESIFN-- 315 (401)
T ss_pred HHHhcCCcCcccCCcceEEEeCC-------CEEEEEecCcceeccccccc--------ccCCCcCCCCceeChHHhcC--
Confidence 99999999999999999999876 56999999999765332110 01122357889999999975
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH-HHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhh
Q 003185 721 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 798 (840)
Q Consensus 721 ~~~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el-~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 798 (840)
..++.++|||||||++|||++ |..||......+. ...+..+.++..+ ..
T Consensus 316 --~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p---------------------------~~ 366 (401)
T cd05107 316 --NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKP---------------------------AH 366 (401)
T ss_pred --CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCC---------------------------CC
Confidence 567899999999999999998 8999977654443 3333333332211 11
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 003185 799 TLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 832 (840)
Q Consensus 799 ~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~ 832 (840)
.+..+.+|+.+||..+|.+||++.+|++.|+.+.
T Consensus 367 ~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 367 ASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 2457999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=314.52 Aligned_cols=261 Identities=26% Similarity=0.389 Sum_probs=199.0
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEecCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 581 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~~~~ 581 (840)
+.|++.+.||+|+||.||+|.+ .+..+|+|+..... ..... +.+|+.++.++ +||||+++++++....
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~----~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEE----IKQEINMLKKYSHHRNIATYYGAFIKKN 76 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHH----HHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence 4688899999999999999987 56788888865331 11122 37899999998 6999999999987543
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
.. ......|+||||+.+++|.+++.. .....+++..+..++.||+.||+|||+++|+|+||||+||+++
T Consensus 77 ~~--------~~~~~~~iv~e~~~~~~L~~~l~~---~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~ 145 (272)
T cd06637 77 PP--------GMDDQLWLVMEFCGAGSVTDLIKN---TKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT 145 (272)
T ss_pred CC--------CCCcEEEEEEEcCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC
Confidence 11 012357999999999999999875 2234688999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~kSDVWSLGvIL~E 740 (840)
.+ +.++|+|||++........ ......|++.|+|||++.+.. ....++.++|||||||++||
T Consensus 146 ~~-------~~~~l~Dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~e 208 (272)
T cd06637 146 EN-------AEVKLVDFGVSAQLDRTVG----------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 208 (272)
T ss_pred CC-------CCEEEccCCCceecccccc----------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHH
Confidence 76 4599999999876533211 123346899999999986421 12457889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|++|..||...........+.....+.+. ....+..+.+|+.+||..+|.+|||
T Consensus 209 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~~p~~Rpt 262 (272)
T cd06637 209 MAEGAPPLCDMHPMRALFLIPRNPAPRLK--------------------------SKKWSKKFQSFIESCLVKNHSQRPT 262 (272)
T ss_pred HHhCCCCccccCHHHHHHHHhcCCCCCCC--------------------------CCCcCHHHHHHHHHHcCCChhhCCC
Confidence 99999999766554433333222111100 0112457899999999999999999
Q ss_pred HHHHHHHH
Q 003185 821 AGDLYEMF 828 (840)
Q Consensus 821 a~ELLehL 828 (840)
+.++++|-
T Consensus 263 ~~~il~~~ 270 (272)
T cd06637 263 TEQLMKHP 270 (272)
T ss_pred HHHHhhCC
Confidence 99999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.04 Aligned_cols=278 Identities=20% Similarity=0.252 Sum_probs=205.3
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|++.+.||+|+||.||+|.+ .+..+++|+....... .... ..+.+|+.++++++||||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~--~~~~----~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~- 73 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE--GGIP----NQALREIKALQACQHPYVVKLLDVFPHGSG- 73 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc--chhh----HHHHHHHHHHHhCCCCCCcceeeEEecCCe-
Confidence 589999999999999999997 5778999987544321 1122 234899999999999999999999886543
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.++||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+|+||||+||+++.+
T Consensus 74 -------------~~~v~e~~-~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~ 135 (286)
T cd07832 74 -------------FVLVMEYM-PSDLSEVLRDE----ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD 135 (286)
T ss_pred -------------eEEEeccc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC
Confidence 49999999 89999998752 2568999999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.++|+|||++........ .......|+..|+|||++.+ ...++.++|||||||++|+|++
T Consensus 136 -------~~~~l~dfg~~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~~l~~l~t 196 (286)
T cd07832 136 -------GVLKIADFGLARLFSEEEP---------RLYSHQVATRWYRAPELLYG---ARKYDPGVDLWAVGCIFAELLN 196 (286)
T ss_pred -------CcEEEeeeeecccccCCCC---------CccccccCcccccCceeeec---cccCCchhHHHHHHHHHHHHHc
Confidence 4599999999876543211 01122358999999999864 2456889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccc---cccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH---EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|.+||.+.........+...........++........ .+.. .............+..+.+||.+||..+|.+||+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~ 275 (286)
T cd07832 197 GSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPE-SKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS 275 (286)
T ss_pred CCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCC-CCcchHHHhCCCccHHHHHHHHHHhccChhhCCC
Confidence 99999887766655555443222212122111100000 0000 0000001112234578999999999999999999
Q ss_pred HHHHHHHH
Q 003185 821 AGDLYEMF 828 (840)
Q Consensus 821 a~ELLehL 828 (840)
++++++|.
T Consensus 276 ~~~~l~h~ 283 (286)
T cd07832 276 AAEALRHP 283 (286)
T ss_pred HHHHhhCc
Confidence 99999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=315.21 Aligned_cols=251 Identities=28% Similarity=0.403 Sum_probs=202.5
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
..|+..+.||.|+||.||+|.+ .+..+|+|+..... ...... .+.+|+.+++++.||||+++++++.....
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIE----DIQQEITVLSQCDSPYVTKYYGSYLKGTK 76 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHH----HHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 4578889999999999999987 56789999875432 122233 34899999999999999999999886553
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.
T Consensus 77 --------------~~lv~e~~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~ 136 (277)
T cd06640 77 --------------LWIIMEYLGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSE 136 (277)
T ss_pred --------------EEEEEecCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcC
Confidence 5999999999999999864 45888999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.++|+|||++......... .....++..|+|||++.+ ..++.++|||||||++|||+
T Consensus 137 ~-------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~apE~~~~----~~~~~~~Dv~slG~il~el~ 195 (277)
T cd06640 137 Q-------GDVKLADFGVAGQLTDTQIK----------RNTFVGTPFWMAPEVIQQ----SAYDSKADIWSLGITAIELA 195 (277)
T ss_pred C-------CCEEEcccccceeccCCccc----------cccccCcccccCHhHhcc----CCCccHHHHHHHHHHHHHHH
Confidence 6 45999999999765432110 122357889999999875 56789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
+|..||....+......+.....+.+. ...+..+.+|+.+||..+|.+||++.
T Consensus 196 tg~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ 248 (277)
T cd06640 196 KGEPPNSDMHPMRVLFLIPKNNPPTLT---------------------------GEFSKPFKEFIDACLNKDPSFRPTAK 248 (277)
T ss_pred HCCCCCCCcChHhHhhhhhcCCCCCCc---------------------------hhhhHHHHHHHHHHcccCcccCcCHH
Confidence 999999877766655544333322222 12356789999999999999999999
Q ss_pred HHHHHHHh
Q 003185 823 DLYEMFVA 830 (840)
Q Consensus 823 ELLehLe~ 830 (840)
+++.|..-
T Consensus 249 ~il~~~~~ 256 (277)
T cd06640 249 ELLKHKFI 256 (277)
T ss_pred HHHhChHh
Confidence 99998543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=311.00 Aligned_cols=263 Identities=24% Similarity=0.393 Sum_probs=204.8
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||.|+||+||+|.. ++..+++|+....... ..... +.+|+.+++.++|+||+++++.+....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ---TSVDE----LRKEVQAMSQCNHPNVVKYYTSFVVGD- 72 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc---hHHHH----HHHHHHHHHhcCCCCEEEEEEEEeeCC-
Confidence 4789999999999999999986 5678888886433221 13333 489999999999999999999887654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
..++||||+++++|.+++.... ....+++..+..++.||+.||.|||++||+|+||||+||+++.
T Consensus 73 -------------~~~iv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~ 137 (267)
T cd06610 73 -------------ELWLVMPYLSGGSLLDIMKSSY--PRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGE 137 (267)
T ss_pred -------------EEEEEEeccCCCcHHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC
Confidence 3599999999999999997621 1246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.++|+|||++..+....... ........|+..|+|||++... ..++.++|||||||++|+|+
T Consensus 138 ~-------~~~~l~df~~~~~~~~~~~~~------~~~~~~~~~~~~y~~Pe~~~~~---~~~~~~~Dv~slG~i~~~l~ 201 (267)
T cd06610 138 D-------GSVKIADFGVSASLADGGDRT------RKVRKTFVGTPCWMAPEVMEQV---HGYDFKADIWSFGITAIELA 201 (267)
T ss_pred C-------CCEEEcccchHHHhccCcccc------ccccccccCChhhcChHHHccc---cCcCcccchHhHhHHHHHHH
Confidence 6 459999999987665432210 0112334689999999998752 36788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
+|+.||...+.......+.....+.+... ......+..+.+|+.+||..||.+||++.
T Consensus 202 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 259 (267)
T cd06610 202 TGAAPYSKYPPMKVLMLTLQNDPPSLETG----------------------ADYKKYSKSFRKMISLCLQKDPSKRPTAE 259 (267)
T ss_pred hCCCCccccChhhhHHHHhcCCCCCcCCc----------------------cccccccHHHHHHHHHHcCCChhhCcCHH
Confidence 99999987766655555444322221110 00123356789999999999999999999
Q ss_pred HHHHHH
Q 003185 823 DLYEMF 828 (840)
Q Consensus 823 ELLehL 828 (840)
+|++|.
T Consensus 260 ~ll~~p 265 (267)
T cd06610 260 ELLKHK 265 (267)
T ss_pred HHhhCC
Confidence 999873
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=317.40 Aligned_cols=257 Identities=27% Similarity=0.411 Sum_probs=199.9
Q ss_pred ceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 584 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p 584 (840)
|++.+.||+|+||.||+|.+. +..+++|..... .....+. +.+|+.+++.++||||+++++++....
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~----~~~e~~~l~~l~h~~ii~~~~~~~~~~--- 75 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELED----YMVEIDILASCDHPNIVKLLDAFYYEN--- 75 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHH----HHHHHHHHHHCCCCCeeeEEEEEeeCC---
Confidence 688899999999999999984 455566664322 2223333 388999999999999999999987654
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEeccc
Q 003185 585 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 664 (840)
Q Consensus 585 ~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~ 664 (840)
..++||||+++++|..++.. ....+++..+..++.||+.||.|||+.||+||||||+|||++.+
T Consensus 76 -----------~~~~v~e~~~~~~l~~~~~~----~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~- 139 (282)
T cd06643 76 -----------NLWILIEFCAGGAVDAVMLE----LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD- 139 (282)
T ss_pred -----------EEEEEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC-
Confidence 35999999999999998864 23468999999999999999999999999999999999999876
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHHHHHHh
Q 003185 665 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 665 ~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.+||+|||++........ ......+++.|+|||++.... ....++.++|||||||++|+|++
T Consensus 140 ------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~ 203 (282)
T cd06643 140 ------GDIKLADFGVSAKNTRTIQ----------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQ 203 (282)
T ss_pred ------CCEEEcccccccccccccc----------ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHcc
Confidence 4599999999875432111 112346899999999985321 22457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~E 823 (840)
|++||...+..+....+.....+.+.. ....+..+.+||.+||+.||.+||++.+
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (282)
T cd06643 204 IEPPHHELNPMRVLLKIAKSEPPTLAQ-------------------------PSRWSSEFKDFLKKCLEKNVDARWTTTQ 258 (282)
T ss_pred CCCCccccCHHHHHHHHhhcCCCCCCC-------------------------ccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 999998877766655554443222110 0112457899999999999999999999
Q ss_pred HHHHHHhh
Q 003185 824 LYEMFVAR 831 (840)
Q Consensus 824 LLehLe~l 831 (840)
+++|..-.
T Consensus 259 il~~~~~~ 266 (282)
T cd06643 259 LLQHPFVT 266 (282)
T ss_pred HhcCCCEe
Confidence 99986543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=319.18 Aligned_cols=268 Identities=20% Similarity=0.292 Sum_probs=198.2
Q ss_pred CCCCceeeeeecccCceEEEEEEEC------------------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHh
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFG------------------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGA 564 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~------------------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~ 564 (840)
+.++|++.+.||+|+||.||++.+. ...+|+|+..... ..... ..+.+|+.+|+.
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~----~~~~~E~~~l~~ 75 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNAR----NDFLKEIKIMSR 75 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHH----HHHHHHHHHHHh
Confidence 3467999999999999999998642 2357777754221 11222 344899999999
Q ss_pred CCCCCcceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc------CCCCCCHHHHHHHHHHHHH
Q 003185 565 LRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------GEKHVSVKLALFIAQDVAA 638 (840)
Q Consensus 565 L~HpNIV~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~------~~~~ls~~~~~~Ia~QIa~ 638 (840)
++||||+++++++..... .++||||+++++|.+++...... ....+++..++.++.||+.
T Consensus 76 l~~~~i~~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 141 (296)
T cd05095 76 LKDPNIIRLLAVCITSDP--------------LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIAS 141 (296)
T ss_pred CCCCCcceEEEEEecCCc--------------cEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHH
Confidence 999999999999876654 39999999999999999763211 1134778899999999999
Q ss_pred HHHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhc
Q 003185 639 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718 (840)
Q Consensus 639 AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~ 718 (840)
||+|||++||+|+||||+|||++.+ +.++|+|||+++.+...... .......+++.|+|||...+
T Consensus 142 al~~lH~~~i~H~dlkp~Nili~~~-------~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~ 206 (296)
T cd05095 142 GMKYLSSLNFVHRDLATRNCLVGKN-------YTIKIADFGMSRNLYSGDYY--------RIQGRAVLPIRWMSWESILL 206 (296)
T ss_pred HHHHHHHCCeecccCChheEEEcCC-------CCEEeccCcccccccCCcce--------eccCcCcCccccCCHHHHhc
Confidence 9999999999999999999999876 46999999999765332111 00122235678999998875
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhh
Q 003185 719 MHKPNLYGLEVDIWSYGCLLLELLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 796 (840)
Q Consensus 719 ~~~~~~~s~kSDVWSLGvIL~ELLT--G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 796 (840)
..++.++|||||||++|||++ |..||...+..+............... . .....
T Consensus 207 ----~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----------~----------~~~~~ 262 (296)
T cd05095 207 ----GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQ----------V----------YLPKP 262 (296)
T ss_pred ----CCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhcccc----------c----------cCCCC
Confidence 568899999999999999998 789998776665544332110000000 0 00001
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003185 797 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 797 ~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~ 830 (840)
..++..+.+|+.+||+.||.+||++.+|++.|+.
T Consensus 263 ~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 263 ALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1234678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=320.53 Aligned_cols=254 Identities=23% Similarity=0.283 Sum_probs=195.0
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
.|++.+.||+|+||.||++.+ .+..+|+|........ ... ....+.+|+.++++++|+||+.+++.+.....
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~-~~~----~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~- 74 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRK----GESMALNEKQILEKVNSRFVVSLAYAYETKDA- 74 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc-chH----HHHHHHHHHHHHHhCCCCCeeeeeEEEecCCE-
Confidence 478889999999999999997 4668898876433211 111 12234789999999999999999999876553
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.++||||+++++|.+++.. .....+++..+..++.|++.||.|||+.||+||||||+||+++.+
T Consensus 75 -------------~~lv~e~~~g~~L~~~l~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~ 138 (285)
T cd05630 75 -------------LCLVLTLMNGGDLKFHIYH---MGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH 138 (285)
T ss_pred -------------EEEEEEecCCCcHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC
Confidence 4999999999999999865 223458999999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.++|+|||++........ .....||..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 139 -------~~~~l~Dfg~~~~~~~~~~-----------~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~~l~~l~~ 196 (285)
T cd05630 139 -------GHIRISDLGLAVHVPEGQT-----------IKGRVGTVGYMAPEVVKN----ERYTFSPDWWALGCLLYEMIA 196 (285)
T ss_pred -------CCEEEeeccceeecCCCcc-----------ccCCCCCccccChHHHcC----CCCCCccccHHHHHHHHHHHh
Confidence 4599999999865432111 122368999999999975 568899999999999999999
Q ss_pred CCCCCCCCCHHH---HHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 744 LQVPYMGLSELE---IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 744 G~~PF~~~~~~e---l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|..||....... ....+.......+ ....+..+.+|+.+||+.||.+|||
T Consensus 197 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~li~~~l~~~p~~R~s 249 (285)
T cd05630 197 GQSPFQQRKKKIKREEVERLVKEVQEEY---------------------------SEKFSPDARSLCKMLLCKDPKERLG 249 (285)
T ss_pred CCCCCCCCCccchHHHHHhhhhhhhhhc---------------------------CccCCHHHHHHHHHHhhcCHHHccC
Confidence 999997653221 1111111100000 0112456899999999999999999
Q ss_pred -----HHHHHHHHHh
Q 003185 821 -----AGDLYEMFVA 830 (840)
Q Consensus 821 -----a~ELLehLe~ 830 (840)
++++++|..-
T Consensus 250 ~~~~~~~~~~~h~~~ 264 (285)
T cd05630 250 CQGGGAREVKEHPLF 264 (285)
T ss_pred CCCCchHHHHcChhh
Confidence 9999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.79 Aligned_cols=273 Identities=24% Similarity=0.353 Sum_probs=196.8
Q ss_pred CCceeeeeecccCceEEEEEEE------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEe
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 578 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~ 578 (840)
.+|++.+.||+|+||.||++.. .+..+++|.+... .....+ .+.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~ 75 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLR----DFEREIEILKSLQHDNIVKYKGVCY 75 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHH----HHHHHHHHHHhCCCCCeeEEEEEEc
Confidence 3689999999999999999974 3567888885422 222233 3489999999999999999999875
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
.... ...++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+||
T Consensus 76 ~~~~------------~~~~lv~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~ni 139 (284)
T cd05081 76 SAGR------------RNLRLVMEYLPYGSLRDYLQK----HRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNI 139 (284)
T ss_pred cCCC------------CceEEEEEecCCCCHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhE
Confidence 4321 135999999999999999975 224589999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.+ +.+||+|||++........... ......++..|+|||++.+ ..++.++|||||||++
T Consensus 140 li~~~-------~~~~l~dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l 201 (284)
T cd05081 140 LVESE-------NRVKIGDFGLTKVLPQDKEYYK-------VREPGESPIFWYAPESLTE----SKFSVASDVWSFGVVL 201 (284)
T ss_pred EECCC-------CeEEECCCcccccccCCCccee-------ecCCCCCceEeeCHHHhcc----CCcChHHHHHHHHHHH
Confidence 99876 4699999999986643221100 0011124456999999875 5678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCC-CCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 739 LELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
|||++|..|+..... .....+..... +.....+.... .... ........+..+.+|+.+||..+|.+
T Consensus 202 ~el~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~--------~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~ 269 (284)
T cd05081 202 YELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVYHLIELL--------KNNG---RLPAPPGCPAEIYAIMKECWNNDPSQ 269 (284)
T ss_pred HHHhhcCCcCCCcch-hhhhhcccccccccchHHHHHHH--------hcCC---cCCCCCCCCHHHHHHHHHHccCChhh
Confidence 999999887644322 22222222111 11111111000 0000 00111234567999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 003185 818 RPTAGDLYEMFVAR 831 (840)
Q Consensus 818 RPSa~ELLehLe~l 831 (840)
|||+.+|++.|+.+
T Consensus 270 Rpt~~ei~~~l~~~ 283 (284)
T cd05081 270 RPSFSELALQVEAI 283 (284)
T ss_pred CCCHHHHHHHHHhc
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.66 Aligned_cols=283 Identities=20% Similarity=0.239 Sum_probs=189.2
Q ss_pred eeeecccCceEEEEEEEC----CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCC
Q 003185 510 CDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 585 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~----~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~ 585 (840)
..+||+|+||.||+|... +..+|+|..... .. . ..+.+|+.+++.++||||+++++++.....
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~----~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 72 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GI----S----MSACREIALLRELKHPNVIALQKVFLSHSD--- 72 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC--CC----c----HHHHHHHHHHHhCCCCCeeeEEEEEeccCC---
Confidence 368999999999999863 356888875321 11 1 123789999999999999999999864321
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhc----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 586 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE----TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 586 ~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~----~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
...++||||+. ++|.+++..... .....+++..++.++.||+.||.|||++||+||||||+|||+.
T Consensus 73 ---------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~ 142 (317)
T cd07867 73 ---------RKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVM 142 (317)
T ss_pred ---------CeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEc
Confidence 24699999997 588888764211 1123588999999999999999999999999999999999996
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.++. ..+.+||+|||+++........ ........||+.|+|||++.+ ...++.++|||||||++|||
T Consensus 143 ~~~~---~~~~~kl~DfG~a~~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlG~il~el 209 (317)
T cd07867 143 GEGP---ERGRVKIADMGFARLFNSPLKP-------LADLDPVVVTFWYRAPELLLG---ARHYTKAIDIWAIGCIFAEL 209 (317)
T ss_pred cCCC---CCCcEEEeeccceeccCCCccc-------ccccCcceecccccCcHHhcC---CCccCcHHHHHhHHHHHHHH
Confidence 4321 2357999999999866432211 011233468999999999875 24578999999999999999
Q ss_pred HhCCCCCCCCCHH---------HHHHHHHcCCCCCcchHHhhhccCcc-----ccccccCC---CC--CCchhhhhhHHH
Q 003185 742 LTLQVPYMGLSEL---------EIHDLIQMGKRPRLTDELEALGSCHE-----HEVAQSGS---GF--EKPEAELETLSF 802 (840)
Q Consensus 742 LTG~~PF~~~~~~---------el~~~I~~~~~p~l~~~l~~~~~~~~-----~~~~~~~~---~~--~~~~~~~~~s~~ 802 (840)
+||.+||...... .....+...........+........ ..+..... .. ............
T Consensus 210 ~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (317)
T cd07867 210 LTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSK 289 (317)
T ss_pred HhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChH
Confidence 9999999653221 11111111111111111111100000 00000000 00 000011122456
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHH
Q 003185 803 LVDVFRRCTEENPTERPTAGDLYEMF 828 (840)
Q Consensus 803 L~dLI~rCL~~DP~eRPSa~ELLehL 828 (840)
+.+||.+||..||.+|||+.|+++|.
T Consensus 290 ~~~ll~~~l~~dP~~R~t~~e~l~hp 315 (317)
T cd07867 290 VFLLLQKLLTMDPTKRITSEQALQDP 315 (317)
T ss_pred HHHHHHHHhccCcccccCHHHHhcCC
Confidence 88999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=317.71 Aligned_cols=249 Identities=28% Similarity=0.413 Sum_probs=198.4
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
.|+..+.||+|+||.||+|.+ .+..+|+|+..... ..... ..+.+|+.++++++||||+++++++.....
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 76 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEI----EDIQQEITVLSQCDSPYITRYYGSYLKGTK- 76 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHH----HHHHHHHHHHHcCCCCccHhhhcccccCCc-
Confidence 477888999999999999987 46688998864332 11222 344899999999999999999999875543
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.|+||||+++++|.+++.. ..+++..+..++.||+.||.|||++|++|+||+|+||+++.+
T Consensus 77 -------------~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~ 137 (277)
T cd06642 77 -------------LWIIMEYLGGGSALDLLKP------GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ 137 (277)
T ss_pred -------------eEEEEEccCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC
Confidence 4999999999999998864 468899999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.++|+|||++..+...... .....|+..|+|||++.+ ..++.++|||||||++|||++
T Consensus 138 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~el~t 196 (277)
T cd06642 138 -------GDVKLADFGVAGQLTDTQIK----------RNTFVGTPFWMAPEVIKQ----SAYDFKADIWSLGITAIELAK 196 (277)
T ss_pred -------CCEEEccccccccccCcchh----------hhcccCcccccCHHHhCc----CCCchhhhHHHHHHHHHHHHh
Confidence 45999999998765432111 122358899999999976 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~E 823 (840)
|..||....+......+.....+.+. ...+..+.+||.+||..+|.+||++.+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (277)
T cd06642 197 GEPPNSDLHPMRVLFLIPKNSPPTLE---------------------------GQYSKPFKEFVEACLNKDPRFRPTAKE 249 (277)
T ss_pred CCCCCcccchhhHHhhhhcCCCCCCC---------------------------cccCHHHHHHHHHHccCCcccCcCHHH
Confidence 99999766655544443333222111 112457899999999999999999999
Q ss_pred HHHHHH
Q 003185 824 LYEMFV 829 (840)
Q Consensus 824 LLehLe 829 (840)
+++|..
T Consensus 250 il~~~~ 255 (277)
T cd06642 250 LLKHKF 255 (277)
T ss_pred HHHhHH
Confidence 999854
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=337.09 Aligned_cols=277 Identities=19% Similarity=0.213 Sum_probs=197.9
Q ss_pred CCCceeeeeecccCceEEEEEEEC----CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~----~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
-.+|.+.+.||.|+||.||+|... +..+++|..... .. +.+|+.+|++|+|||||++++++..
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~----~~~E~~il~~l~h~~iv~~~~~~~~ 157 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KT----PGREIDILKTISHRAIINLIHAYRW 157 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------cc----HHHHHHHHHhcCCCCccceeeeEee
Confidence 357999999999999999999753 356777764311 11 2679999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .|+|||++. ++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||
T Consensus 158 ~~~--------------~~lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nil 217 (392)
T PHA03207 158 KST--------------VCMVMPKYK-CDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIF 217 (392)
T ss_pred CCE--------------EEEEehhcC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence 543 499999996 689998854 357899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++..+...... .......||+.|+|||++.+ ..++.++|||||||+||
T Consensus 218 l~~~-------~~~~l~DfG~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvil~ 278 (392)
T PHA03207 218 LDEP-------ENAVLGDFGAACKLDAHPDT--------PQCYGWSGTLETNSPELLAL----DPYCAKTDIWSAGLVLF 278 (392)
T ss_pred EcCC-------CCEEEccCccccccCccccc--------ccccccccccCccCHhHhcC----CCCCchhhHHHHHHHHH
Confidence 9877 45999999999765432211 11223569999999999976 56889999999999999
Q ss_pred HHHhCCCCCCCCCH---HHHHHHHHcC-CC--CCcch-----HHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHH
Q 003185 740 ELLTLQVPYMGLSE---LEIHDLIQMG-KR--PRLTD-----ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 808 (840)
Q Consensus 740 ELLTG~~PF~~~~~---~el~~~I~~~-~~--p~l~~-----~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~ 808 (840)
||++|+.||.+... ...+..+.+. .. ..++. ....+..... ..+..............+..+.+||.
T Consensus 279 el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~ 356 (392)
T PHA03207 279 EMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAI--VLRPPYTIPPVIRKYGMHMDVEYLIA 356 (392)
T ss_pred HHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcc--cccCCccccchhhccCcchhHHHHHH
Confidence 99999999976532 2222222221 11 01110 0000000000 00000000000011123557889999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhcCC
Q 003185 809 RCTEENPTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 809 rCL~~DP~eRPSa~ELLehLe~l~~~ 834 (840)
+||..||.+|||+.+++.|......+
T Consensus 357 ~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 357 KMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred HHhccChhhCCCHHHHhhCchhhccc
Confidence 99999999999999999997665433
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.61 Aligned_cols=258 Identities=26% Similarity=0.394 Sum_probs=197.5
Q ss_pred eeecccCceEEEEEEECC--------eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 511 DEAGKSVSSSLFRCKFGS--------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~--------~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
+.||+|+||.||+|.+.. ..+++|..... ....... .+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~---~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG---ATDQEKK----EFLKEAHLMSNFNHPNIVKLLGVCLLNEP 73 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc---cchhhHH----HHHHHHHHHHhcCCCCeeeEeeeecCCCC
Confidence 368999999999998743 46788875321 1112223 34889999999999999999999875543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~--~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.++||||+++++|.+++...... ....+++..+..++.||+.||.|||+.+++|+||||+|||+
T Consensus 74 --------------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~ 139 (269)
T cd05044 74 --------------QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLV 139 (269)
T ss_pred --------------eEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEE
Confidence 49999999999999999753211 22457889999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.++. +....++|+|||++.......... ......++..|+|||++.+ ..++.++|||||||++|+
T Consensus 140 ~~~~~--~~~~~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~e 205 (269)
T cd05044 140 SEKGY--DADRVVKIGDFGLARDIYKSDYYR--------KEGEGLLPVRWMAPESLLD----GKFTTQSDVWSFGVLMWE 205 (269)
T ss_pred ecCCC--CCCcceEECCcccccccccccccc--------cCcccCCCccccCHHHHcc----CCcccchhHHHHHHHHHH
Confidence 87631 122369999999997654321110 0112246788999999976 567899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|++ |..||...+..+....+........+ ...+..+.+||.+||..+|.+||
T Consensus 206 llt~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 258 (269)
T cd05044 206 ILTLGQQPYPALNNQEVLQHVTAGGRLQKP---------------------------ENCPDKIYQLMTNCWAQDPSERP 258 (269)
T ss_pred HHHcCCCCCcccCHHHHHHHHhcCCccCCc---------------------------ccchHHHHHHHHHHcCCCcccCC
Confidence 998 99999887777766665443322211 11255789999999999999999
Q ss_pred CHHHHHHHHHh
Q 003185 820 TAGDLYEMFVA 830 (840)
Q Consensus 820 Sa~ELLehLe~ 830 (840)
++.+|++.|+.
T Consensus 259 ~~~~i~~~l~~ 269 (269)
T cd05044 259 TFDRIQEILQN 269 (269)
T ss_pred CHHHHHHHHhC
Confidence 99999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=323.97 Aligned_cols=287 Identities=20% Similarity=0.229 Sum_probs=198.8
Q ss_pred eeeeeccc--CceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCC
Q 003185 509 SCDEAGKS--VSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 584 (840)
Q Consensus 509 i~~~LG~G--~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p 584 (840)
+.++||+| +|++||++.. ++..||+|....... ..... ..+.+|+.+++.++||||+++++++.....
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~----~~~~~e~~~l~~l~hpniv~~~~~~~~~~~-- 73 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMV----TFLQGELHVSKLFNHPNIVPYRATFIADNE-- 73 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc--cHHHH----HHHHHHHHHHHhcCCCCeeeEEEEEEECCE--
Confidence 56789999 7889999987 567889988654321 22222 234789999999999999999999986653
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEeccc
Q 003185 585 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 664 (840)
Q Consensus 585 ~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~ 664 (840)
.++||||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 74 ------------~~lv~e~~~~~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~- 137 (327)
T cd08227 74 ------------LWVVTSFMAYGSAKDLICTH---FMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD- 137 (327)
T ss_pred ------------EEEEEeccCCCcHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC-
Confidence 49999999999999999752 12358899999999999999999999999999999999999877
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 003185 665 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 744 (840)
Q Consensus 665 ~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG 744 (840)
+.++++|||.+........... ..........++..|+|||++.+. ...++.++|||||||++|||++|
T Consensus 138 ------~~~~l~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~DiwslG~il~el~~g 206 (327)
T cd08227 138 ------GKVYLSGLRSNLSMINHGQRLR---VVHDFPKYSVKVLPWLSPEVLQQN--LQGYDAKSDIYSVGITACELANG 206 (327)
T ss_pred ------CcEEEcccchhhcccccccccc---ccccccccccceecccChHHhhcc--cCCCCchhhHHHHHHHHHHHHHC
Confidence 4599999987654322111000 000111233577889999999751 13578999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCcchHHh----hhccCcc-----ccccc------cC---CCCCCchhhhhhHHHHHHH
Q 003185 745 QVPYMGLSELEIHDLIQMGKRPRLTDELE----ALGSCHE-----HEVAQ------SG---SGFEKPEAELETLSFLVDV 806 (840)
Q Consensus 745 ~~PF~~~~~~el~~~I~~~~~p~l~~~l~----~~~~~~~-----~~~~~------~~---~~~~~~~~~~~~s~~L~dL 806 (840)
..||......+.......+..+.+.+... ....... ..... .. ............++.+.+|
T Consensus 207 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 286 (327)
T cd08227 207 HVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHF 286 (327)
T ss_pred CCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHH
Confidence 99998766555444433332221111000 0000000 00000 00 0000011122345689999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHh
Q 003185 807 FRRCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 807 I~rCL~~DP~eRPSa~ELLehLe~ 830 (840)
|.+||+.||.+|||+++|++|..-
T Consensus 287 i~~~l~~dP~~Rpt~~ell~~p~f 310 (327)
T cd08227 287 VEQCLQRNPDARPSASTLLNHSFF 310 (327)
T ss_pred HHHHHhhCchhcCCHHHHhcChhh
Confidence 999999999999999999998543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=309.67 Aligned_cols=257 Identities=27% Similarity=0.396 Sum_probs=197.7
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCC-hHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~-~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
.+|++.+.||+|+||.||+|.. .+..+++|+......... ....+ .+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 77 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVN----ALECEIQLLKNLLHERIVQYYGCLRDPM 77 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHH----HHHHHHHHHHhcCCCCeeeEEeEeccCC
Confidence 4789999999999999999986 467899998654332211 12223 4488999999999999999999876432
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. ..+++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++|+|+||||+|||++
T Consensus 78 ~------------~~~~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~ 140 (265)
T cd06652 78 E------------RTLSIFMEHMPGGSIKDQLKS-----YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD 140 (265)
T ss_pred C------------ceEEEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec
Confidence 1 135899999999999999875 24578899999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.++|+|||++.......... .......|+..|+|||++.+ ..++.++|||||||++|+|
T Consensus 141 ~~-------~~~~l~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~el 202 (265)
T cd06652 141 SV-------GNVKLGDFGASKRLQTICLSG-------TGMKSVTGTPYWMSPEVISG----EGYGRKADIWSVGCTVVEM 202 (265)
T ss_pred CC-------CCEEECcCccccccccccccc-------cccccCCCCccccChhhhcC----CCCCcchhHHHHHHHHHHH
Confidence 76 469999999987653321110 01122458899999999875 5578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcC-CCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 742 LTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
++|+.||...........+... ..+.++ ...+..+.++|.+||. +|.+||+
T Consensus 203 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~-~p~~Rp~ 254 (265)
T cd06652 203 LTEKPPWAEFEAMAAIFKIATQPTNPVLP---------------------------PHVSDHCRDFLKRIFV-EAKLRPS 254 (265)
T ss_pred hhCCCCCCccchHHHHHHHhcCCCCCCCc---------------------------hhhCHHHHHHHHHHhc-ChhhCCC
Confidence 9999999876544444333322 111111 1234578899999995 9999999
Q ss_pred HHHHHHHH
Q 003185 821 AGDLYEMF 828 (840)
Q Consensus 821 a~ELLehL 828 (840)
+++|++|.
T Consensus 255 ~~~il~~~ 262 (265)
T cd06652 255 ADELLRHT 262 (265)
T ss_pred HHHHhcCc
Confidence 99999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=307.65 Aligned_cols=249 Identities=27% Similarity=0.407 Sum_probs=196.2
Q ss_pred eeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 589 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g~ 589 (840)
++||+|+||.||+|.+. +..+++|+...... .... ..+.+|+.+++++.||||+++++++.....
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~---~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~------- 66 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP---PDLK----RKFLQEAEILKQYDHPNIVKLIGVCVQKQP------- 66 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCC---HHHH----HHHHHHHHHHHhCCCCCeEEEEEEEecCCC-------
Confidence 47999999999999874 78899987543321 1222 344899999999999999999999886654
Q ss_pred CccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCC
Q 003185 590 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 669 (840)
Q Consensus 590 ~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~ 669 (840)
.++||||+.+++|.+++.. ....+++..+..++.|++.||.|||+++++||||||+|||++.+
T Consensus 67 -------~~~v~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~------ 129 (251)
T cd05041 67 -------IYIVMELVPGGSLLTFLRK----KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGEN------ 129 (251)
T ss_pred -------eEEEEEcCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCC------
Confidence 4999999999999999975 22457899999999999999999999999999999999999876
Q ss_pred CCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 003185 670 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPY 748 (840)
Q Consensus 670 ~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT-G~~PF 748 (840)
..++|+|||++.......... ......++..|+|||++.+ ..++.++|||||||++|+|+| |..||
T Consensus 130 -~~~~l~d~g~~~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~i~~~l~t~~~~p~ 196 (251)
T cd05041 130 -NVLKISDFGMSREEEGGIYTV--------SDGLKQIPIKWTAPEALNY----GRYTSESDVWSYGILLWETFSLGDTPY 196 (251)
T ss_pred -CcEEEeeccccccccCCccee--------ccccCcceeccCChHhhcc----CCCCcchhHHHHHHHHHHHHhccCCCC
Confidence 469999999997654211110 0011224567999999875 567899999999999999999 89999
Q ss_pred CCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003185 749 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828 (840)
Q Consensus 749 ~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehL 828 (840)
...........+........+ ...+..+.+|+.+||..+|.+|||+.+|++.|
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l 249 (251)
T cd05041 197 PGMSNQQTRERIESGYRMPAP---------------------------QLCPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249 (251)
T ss_pred ccCCHHHHHHHHhcCCCCCCC---------------------------ccCCHHHHHHHHHHhccChhhCcCHHHHHHHh
Confidence 887776666655443222111 11245799999999999999999999999998
Q ss_pred Hh
Q 003185 829 VA 830 (840)
Q Consensus 829 e~ 830 (840)
+.
T Consensus 250 ~~ 251 (251)
T cd05041 250 QI 251 (251)
T ss_pred hC
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=319.80 Aligned_cols=256 Identities=26% Similarity=0.441 Sum_probs=204.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
....+|++.+.||.|+||.||+|.. .+..+++|.+..... ...+ .+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~----~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~ 87 (296)
T cd06655 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ----PKKE----LIINEILVMKELKNPNIVNFLDSFLV 87 (296)
T ss_pred CCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC----chHH----HHHHHHHHHHhcCCCceeeeeeeEec
Confidence 3467899999999999999999985 677899998754321 1122 34889999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.. ..++||||+++++|..++.. ..+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 88 ~~--------------~~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nil 147 (296)
T cd06655 88 GD--------------ELFVVMEYLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVL 147 (296)
T ss_pred Cc--------------eEEEEEEecCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 54 35999999999999999875 45899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.++|+|||++......... .....|+..|+|||.+.+ ..++.++|||||||++|
T Consensus 148 i~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slGvil~ 206 (296)
T cd06655 148 LGMD-------GSVKLTDFGFCAQITPEQSK----------RSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAI 206 (296)
T ss_pred ECCC-------CCEEEccCccchhccccccc----------CCCcCCCccccCcchhcC----CCCCchhhHHHHHHHHH
Confidence 9876 45999999998765432111 122358899999999875 56788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|++|..||...++......+.....+.+.. ....+..+.+||.+||..||.+||
T Consensus 207 ~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~dp~~Rp 261 (296)
T cd06655 207 EMVEGEPPYLNENPLRALYLIATNGTPELQN-------------------------PEKLSPIFRDFLNRCLEMDVEKRG 261 (296)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhcCCcccCC-------------------------cccCCHHHHHHHHHHhhcChhhCC
Confidence 9999999998877655444443332211110 012345789999999999999999
Q ss_pred CHHHHHHHHHhh
Q 003185 820 TAGDLYEMFVAR 831 (840)
Q Consensus 820 Sa~ELLehLe~l 831 (840)
++.+|+.|-.-.
T Consensus 262 t~~~il~~~~~~ 273 (296)
T cd06655 262 SAKELLQHPFLK 273 (296)
T ss_pred CHHHHhhChHhh
Confidence 999999985544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=317.25 Aligned_cols=290 Identities=21% Similarity=0.219 Sum_probs=211.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
.++++|++.+.||+|+||.||+|.+ .+..||+|++........ ....+.+|+.++++++|+||+++++++..
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG------IPISSLREITLLLNLRHPNIVELKEVVVG 77 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC------CcchhhHHHHHHHhCCCCCCcceEEEEec
Confidence 4678999999999999999999997 577899998765432111 11123689999999999999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... ...++||||+. ++|.+++... ...+++..++.++.||+.||+|||++|++||||||+||+
T Consensus 78 ~~~------------~~~~lv~e~~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil 140 (309)
T cd07845 78 KHL------------DSIFLVMEYCE-QDLASLLDNM----PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLL 140 (309)
T ss_pred CCC------------CeEEEEEecCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 421 23599999997 4899988751 256899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++......... .....+++.|+|||.+.+ ...++.++|||||||++|
T Consensus 141 ~~~~-------~~~kL~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslG~il~ 200 (309)
T cd07845 141 LTDK-------GCLKIADFGLARTYGLPAKP----------MTPKVVTLWYRAPELLLG---CTTYTTAIDMWAVGCILA 200 (309)
T ss_pred ECCC-------CCEEECccceeeecCCccCC----------CCcccccccccChhhhcC---CCCcCchHHHHHHHHHHH
Confidence 9876 46999999999866432111 112246788999999864 245788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCC-CC-CCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS-GF-EKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~-~~-~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
||++|++||...+..+....+...........+................ .. .........++.+.+||.+||+.||.+
T Consensus 201 el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~ 280 (309)
T cd07845 201 ELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKK 280 (309)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhh
Confidence 9999999999888887777766543222222111110000000000000 00 000111223667899999999999999
Q ss_pred CCCHHHHHHHHHhhcCC
Q 003185 818 RPTAGDLYEMFVARTSS 834 (840)
Q Consensus 818 RPSa~ELLehLe~l~~~ 834 (840)
|||+.+++.|.+-....
T Consensus 281 R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 281 RATAEEALESSYFKEKP 297 (309)
T ss_pred CcCHHHHhcChhhccCC
Confidence 99999999997665433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.37 Aligned_cols=245 Identities=23% Similarity=0.369 Sum_probs=186.3
Q ss_pred eeecccCceEEEEEEECCee------------EEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEe
Q 003185 511 DEAGKSVSSSLFRCKFGSAD------------AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 578 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~~~------------vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~ 578 (840)
+.||+|+||.||+|.+.... +++|+..... ... ..+.+|+.++++++||||+++++++.
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDS----LAFFETASLMSQLSHKHLVKLYGVCV 71 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhH----HHHHHHHHHHHcCCCcchhheeeEEe
Confidence 46999999999999984333 5556543221 112 33488999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
. .. .++||||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 72 ~-~~--------------~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Ni 132 (259)
T cd05037 72 R-DE--------------NIMVEEYVKFGPLDVFLHRE----KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNI 132 (259)
T ss_pred c-CC--------------cEEEEEcCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceE
Confidence 5 32 39999999999999999861 22688999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.++........+||+|||++...... ....++..|+|||++.+. ...++.++|||||||++
T Consensus 133 ll~~~~~~~~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~y~aPE~~~~~--~~~~~~~~Di~slG~~~ 196 (259)
T cd05037 133 LVARYGLNEGYVPFIKLSDPGIPITVLSR--------------EERVERIPWIAPECIRNG--QASLTIAADKWSFGTTL 196 (259)
T ss_pred EEecCccccCCceeEEeCCCCcccccccc--------------cccccCCCccChhhhcCC--CCCcchhhHHHHHHHHH
Confidence 99977532223346999999999765331 123467889999998761 13678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 739 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 739 ~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
|+|++ |..||...+................+ ....+.+||.+||..+|.+
T Consensus 197 ~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~li~~~l~~~p~~ 247 (259)
T cd05037 197 LEICSNGEEPLSTLSSSEKERFYQDQHRLPMP-----------------------------DCAELANLINQCWTYDPTK 247 (259)
T ss_pred HHHHhCCCCCcccCCchhHHHHHhcCCCCCCC-----------------------------CchHHHHHHHHHhccChhh
Confidence 99999 58888666543333222211110000 0147899999999999999
Q ss_pred CCCHHHHHHHH
Q 003185 818 RPTAGDLYEMF 828 (840)
Q Consensus 818 RPSa~ELLehL 828 (840)
|||+.+|++.|
T Consensus 248 Rpt~~~il~~l 258 (259)
T cd05037 248 RPSFRAILRDL 258 (259)
T ss_pred CCCHHHHHHhc
Confidence 99999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=311.76 Aligned_cols=259 Identities=20% Similarity=0.315 Sum_probs=186.6
Q ss_pred eeecccCceEEEEEEE-CCee---EEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKF-GSAD---AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 586 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~-~~~~---vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~ 586 (840)
+.||+|+||.||++.. .+.. +++|.... .......+ .+.+|+.+++.++||||+++++.+.....
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~----~~~~e~~~~~~l~h~~iv~~~~~~~~~~~---- 69 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKA---NASSKEQN----EFLQQGDPYRILQHPNILQCLGQCVEAIP---- 69 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecC---CCChHHHH----HHHHHHHHHhccCCcchhheEEEecCCCc----
Confidence 3699999999999975 3333 33443321 12222223 44899999999999999999999876543
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEeccccc
Q 003185 587 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 666 (840)
Q Consensus 587 ~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~ 666 (840)
.|+||||+++|+|.+++.+... ....++...++.++.||+.||+|||+++|+||||||+|||++.+
T Consensus 70 ----------~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~--- 135 (268)
T cd05086 70 ----------YLLVFEYCELGDLKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD--- 135 (268)
T ss_pred ----------cEEEEecCCCCcHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCC---
Confidence 4999999999999999976211 12346777889999999999999999999999999999999876
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC---CCCCCchhhHHHHHHHHHHHHh
Q 003185 667 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK---PNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 667 ~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~---~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.++|+|||++......... .......++..|+|||++..... ...++.++|||||||++|||++
T Consensus 136 ----~~~~l~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 203 (268)
T cd05086 136 ----LTVKVGDYGIGPSRYKEDYI--------ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFE 203 (268)
T ss_pred ----ccEEecccccccccCcchhh--------hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHh
Confidence 56999999998643211100 01123457899999999853211 1345789999999999999997
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 744 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 744 -G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
|..||......+....+.......+.. +......++.+.+++..|| .+|.+||+++
T Consensus 204 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~ 260 (268)
T cd05086 204 NAAQPYSHLSDREVLNHVIKDQQVKLFK----------------------PQLELPYSERWYEVLQFCW-LSPEKRATAE 260 (268)
T ss_pred CCCCCCCCCCHHHHHHHHHhhcccccCC----------------------CccCCCCcHHHHHHHHHHh-hCcccCCCHH
Confidence 577888777766665554332211110 0001113457888999999 6899999999
Q ss_pred HHHHHHH
Q 003185 823 DLYEMFV 829 (840)
Q Consensus 823 ELLehLe 829 (840)
+|++.|.
T Consensus 261 ~i~~~l~ 267 (268)
T cd05086 261 EVHRLLT 267 (268)
T ss_pred HHHHHhc
Confidence 9998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=310.05 Aligned_cols=257 Identities=27% Similarity=0.408 Sum_probs=196.4
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|++.+.||+|+||.||+|.. .+..+++|+......... .......+.+|+.++++++||||+++++++.....
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 78 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPE---TSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE- 78 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCch---hHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC-
Confidence 688999999999999999986 567889988654332111 11122345899999999999999999998875321
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
...+++|||+++++|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+||+++.+
T Consensus 79 -----------~~~~l~~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~ 142 (266)
T cd06651 79 -----------KTLTIFMEYMPGGSVKDQLKA-----YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSA 142 (266)
T ss_pred -----------CEEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC
Confidence 246899999999999999975 2458899999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.++|+|||++.......... .......++..|+|||++.+ ..++.++|||||||++|||++
T Consensus 143 -------~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~i~~el~~ 204 (266)
T cd06651 143 -------GNVKLGDFGASKRLQTICMSG-------TGIRSVTGTPYWMSPEVISG----EGYGRKADVWSLGCTVVEMLT 204 (266)
T ss_pred -------CCEEEccCCCccccccccccC-------CccccCCccccccCHHHhCC----CCCCchhhhHHHHHHHHHHHH
Confidence 459999999987653211110 00122458899999999875 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcC-CCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 744 LQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
|+.||...........+... ..+.++. ..++.+.+|+ +||..+|.+||+++
T Consensus 205 g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li-~~~~~~p~~Rp~~~ 256 (266)
T cd06651 205 EKPPWAEYEAMAAIFKIATQPTNPQLPS---------------------------HISEHARDFL-GCIFVEARHRPSAE 256 (266)
T ss_pred CCCCccccchHHHHHHHhcCCCCCCCch---------------------------hcCHHHHHHH-HHhcCChhhCcCHH
Confidence 99999876554433333221 2222221 1244677788 68889999999999
Q ss_pred HHHHHH
Q 003185 823 DLYEMF 828 (840)
Q Consensus 823 ELLehL 828 (840)
+|++|-
T Consensus 257 eil~hp 262 (266)
T cd06651 257 ELLRHP 262 (266)
T ss_pred HHhcCc
Confidence 999884
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=351.68 Aligned_cols=270 Identities=22% Similarity=0.326 Sum_probs=204.7
Q ss_pred CceeeeeecccCceEEEEEEE-CC-eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEecCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF-GS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 582 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~-~~-~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~~~~ 582 (840)
++++.+.|.+|||+.||+|.+ ++ ..+|+|..... .....+. +.+||.+|++|. |+|||.+++.......
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~----v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNA----VKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHH----HHHHHHHHHHhcCCCceeeEecccccccc
Confidence 578999999999999999997 33 78999876543 2333333 499999999998 9999999994222110
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCCCcEEE
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILI 660 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~g--IVHRDLKPeNILL 660 (840)
. .....+.+|+||||.||.|-+++..+.. ..|++.++++|++|+++|+.+||... |||||||-+||||
T Consensus 110 ~-------~~~~~EvllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl 179 (738)
T KOG1989|consen 110 S-------NNGVWEVLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL 179 (738)
T ss_pred C-------CCceeEEEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE
Confidence 0 1123568999999999999999987433 34999999999999999999999986 9999999999999
Q ss_pred ecccccCCCCCeEEEeecCCccccccccccc---ccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTC---CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~---~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
..++ ..||||||.|.......... ...... -....|+.|+|||++.- ..+...++|+|||||||+
T Consensus 180 s~~g-------~~KLCDFGSatt~~~~~~~~~e~~~ve~e----I~k~TTp~YRsPEMIDl-ysg~pI~eKsDIWALGcl 247 (738)
T KOG1989|consen 180 SADG-------NYKLCDFGSATTKILSPTSAQEVNYVEEE----IEKYTTPQYRSPEMIDL-YSGLPIGEKSDIWALGCL 247 (738)
T ss_pred cCCC-------CEEeCcccccccccCCCccHHHHHHHHHH----HHhhCCccccChHHHhh-hcCCCCcchhHHHHHHHH
Confidence 9884 59999999986443222100 000001 11247999999999864 334678999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
||-|+....||...... +|.++.. .+| ....++..+.+||..||+.||.+
T Consensus 248 LYkLCy~t~PFe~sg~l----aIlng~Y-~~P-------------------------~~p~ys~~l~~LI~~mL~~nP~~ 297 (738)
T KOG1989|consen 248 LYKLCYFTTPFEESGKL----AILNGNY-SFP-------------------------PFPNYSDRLKDLIRTMLQPNPDE 297 (738)
T ss_pred HHHHHHhCCCcCcCcce----eEEeccc-cCC-------------------------CCccHHHHHHHHHHHHhccCccc
Confidence 99999999999755332 2333311 011 01234778999999999999999
Q ss_pred CCCHHHHHHHHHhhcCCC
Q 003185 818 RPTAGDLYEMFVARTSSS 835 (840)
Q Consensus 818 RPSa~ELLehLe~l~~~~ 835 (840)
||++-++++++..+....
T Consensus 298 RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 298 RPNIYQVLEEIFELANKP 315 (738)
T ss_pred CCCHHHHHHHHHHHhcCC
Confidence 999999999999887654
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=307.95 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=195.6
Q ss_pred eeecccCceEEEEEEECC-----eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 585 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~-----~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~ 585 (840)
+.||+|+||.||+|.+.. ..+|+|+...... . ...+.+.+|+.++++++||||+++++++.. .
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~--~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~---- 68 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--S-----DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-H---- 68 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCccc--H-----HHHHHHHHHHHHHhhcCCCCccceeEEEcC-C----
Confidence 468999999999998732 2578887543221 1 223345899999999999999999999875 3
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccc
Q 003185 586 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 665 (840)
Q Consensus 586 ~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~ 665 (840)
..++||||+++++|.+++... ....+++..++.++.||+.||+|||++|++|+||||+|||++.+
T Consensus 69 ----------~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~-- 133 (257)
T cd05040 69 ----------PLMMVTELAPLGSLLDRLRKD---ALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD-- 133 (257)
T ss_pred ----------eEEEEEEecCCCcHHHHHHhc---ccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC--
Confidence 359999999999999999862 11468999999999999999999999999999999999999977
Q ss_pred cCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-C
Q 003185 666 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 744 (840)
Q Consensus 666 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT-G 744 (840)
+.+||+|||++..+........ ......++..|+|||++.. ..++.++|||||||++|+|++ |
T Consensus 134 -----~~~kl~dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~~pE~~~~----~~~~~~~Di~slG~~l~el~t~g 197 (257)
T cd05040 134 -----DKVKIGDFGLMRALPQNEDHYV-------MEEHLKVPFAWCAPESLRT----RTFSHASDVWMFGVTLWEMFTYG 197 (257)
T ss_pred -----CEEEecccccccccccccccee-------cccCCCCCceecCHHHhcc----cCcCchhhhHHHHHHHHHHHhCC
Confidence 5699999999987644221100 0112347789999999875 567899999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHHcCC-CCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003185 745 QVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823 (840)
Q Consensus 745 ~~PF~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~E 823 (840)
..||...+..++...+.... ....+ ...+..+.+|+.+||..+|.+||++.+
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rps~~~ 250 (257)
T cd05040 198 EEPWAGLSGSQILKKIDKEGERLERP---------------------------EACPQDIYNVMLQCWAHNPADRPTFAA 250 (257)
T ss_pred CCCCCCCCHHHHHHHHHhcCCcCCCC---------------------------ccCCHHHHHHHHHHCCCCcccCCCHHH
Confidence 99998887777666655321 11000 112457899999999999999999999
Q ss_pred HHHHHH
Q 003185 824 LYEMFV 829 (840)
Q Consensus 824 LLehLe 829 (840)
|++.|.
T Consensus 251 ~~~~l~ 256 (257)
T cd05040 251 LREFLP 256 (257)
T ss_pred HHHHhc
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=310.56 Aligned_cols=259 Identities=27% Similarity=0.399 Sum_probs=199.4
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|+..+.||+|+||.||++.. ++..+|+|+........ .........+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~- 77 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTS--SEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSH- 77 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCc--hhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCe-
Confidence 478889999999999999986 67889999875433221 1222233456899999999999999999999875543
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.+
T Consensus 78 -------------~~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~ 139 (268)
T cd06630 78 -------------FNLFVEWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDST 139 (268)
T ss_pred -------------EEEEEeccCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 4999999999999999975 2468899999999999999999999999999999999999765
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+ ..+||+|||.+......... .........|+..|+|||.+.+ ..++.++|||||||++|+|++
T Consensus 140 ~------~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~Dv~slG~~l~~l~~ 203 (268)
T cd06630 140 G------QRLRIADFGAAARLAAKGTG------AGEFQGQLLGTIAFMAPEVLRG----EQYGRSCDVWSVGCVIIEMAT 203 (268)
T ss_pred C------CEEEEccccccccccccccc------CCccccccccccceeCHhHhcc----CCCCcccchHHHHHHHHHHHh
Confidence 3 35999999999776542111 0011223468899999999875 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHH---HcC-CCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 744 LQVPYMGLSELEIHDLI---QMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I---~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|..||...........+ ... ..+.++ ...+..+.+++.+||..+|.+||
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~R~ 256 (268)
T cd06630 204 AKPPWNAEKHSNHLALIFKIASATTAPSIP---------------------------EHLSPGLRDVTLRCLELQPEDRP 256 (268)
T ss_pred CCCCCCCCCCcchHHHHHHHhccCCCCCCc---------------------------hhhCHHHHHHHHHHcCCCcccCc
Confidence 99999654322222211 111 111111 12345789999999999999999
Q ss_pred CHHHHHHHH
Q 003185 820 TAGDLYEMF 828 (840)
Q Consensus 820 Sa~ELLehL 828 (840)
++.++++|.
T Consensus 257 ~~~~ll~~~ 265 (268)
T cd06630 257 PSRELLKHP 265 (268)
T ss_pred CHHHHhcCc
Confidence 999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=312.17 Aligned_cols=278 Identities=19% Similarity=0.247 Sum_probs=198.6
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.+++|++.+.||+|+||.||+|.. .+..+|+|......... ... .+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~---~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG---APF----TAIREASLLKDLKHANIVTLHDIIHTK 75 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC---Cch----hHHHHHHHHhhCCCcceeeEEEEEecC
Confidence 568899999999999999999987 56789999875432211 111 237899999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .++||||+.+ +|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 76 ~~--------------~~lv~e~~~~-~L~~~~~~----~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~ 136 (291)
T cd07844 76 KT--------------LTLVFEYLDT-DLKQYMDD----CGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI 136 (291)
T ss_pred Ce--------------EEEEEecCCC-CHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE
Confidence 53 4999999985 99998875 22468899999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||+++........ .....++..|+|||++.+ ...++.++|||||||++|+
T Consensus 137 ~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Dv~slG~il~~ 196 (291)
T cd07844 137 SER-------GELKLADFGLARAKSVPSKT----------YSNEVVTLWYRPPDVLLG---STEYSTSLDMWGVGCIFYE 196 (291)
T ss_pred cCC-------CCEEECccccccccCCCCcc----------ccccccccccCCcHHhhc---CcccCcHHHHHHHHHHHHH
Confidence 877 45999999998654321110 111246889999999874 2457889999999999999
Q ss_pred HHhCCCCCCCCC-HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCC-CCCch---h--hhhhHHHHHHHHHHhccc
Q 003185 741 LLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG-FEKPE---A--ELETLSFLVDVFRRCTEE 813 (840)
Q Consensus 741 LLTG~~PF~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~-~~~~~---~--~~~~s~~L~dLI~rCL~~ 813 (840)
|++|+.||.+.. ..+....+........+..+......... ...... ..... . .......+.+++.+||+.
T Consensus 197 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 274 (291)
T cd07844 197 MATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF--KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQY 274 (291)
T ss_pred HHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc--ccccccccCChhHHHhCcCCCCchhHHHHHHHHhcc
Confidence 999999997664 33333333322211112221111100000 000000 00000 0 001125788999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 003185 814 NPTERPTAGDLYEMF 828 (840)
Q Consensus 814 DP~eRPSa~ELLehL 828 (840)
+|.+|||+.++++|.
T Consensus 275 ~p~~Rps~~e~l~~~ 289 (291)
T cd07844 275 EPKKRISAAEAMKHP 289 (291)
T ss_pred CcccccCHHHHhcCC
Confidence 999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=318.07 Aligned_cols=266 Identities=25% Similarity=0.303 Sum_probs=204.8
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
.+|++.+.||+|+||.||+|.. .+..+|+|......... ......+..|+.+++.++||||+++++.+....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 74 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK-----RNKVKRVLTEQEILATLDHPFLPTLYASFQTET- 74 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch-----HHHHHHHHHHHHHHHhCCCCCchhheeeeecCC-
Confidence 3689999999999999999997 46889999875432111 112234589999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
..|+||||+.+++|.+++.. .....+++..++.++.||+.||+|||+.|++|+||||+|||++.
T Consensus 75 -------------~~~lv~e~~~~~~L~~~~~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~ 138 (316)
T cd05574 75 -------------YLCLVMDYCPGGELFRLLQR---QPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHE 138 (316)
T ss_pred -------------EEEEEEEecCCCCHHHHHHh---CCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcC
Confidence 35999999999999999875 22356899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCccccccccccccc-------------------ccCCCCCCCcccCCCcccchhhhhcccCCC
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCI-------------------AHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 723 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~-------------------~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~ 723 (840)
+ +.++|+|||++............ ...........+||..|+|||++.+ .
T Consensus 139 ~-------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~ 207 (316)
T cd05574 139 S-------GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG----D 207 (316)
T ss_pred C-------CCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC----C
Confidence 6 45999999998765432111000 0001111234578999999999976 5
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHH
Q 003185 724 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 803 (840)
Q Consensus 724 ~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L 803 (840)
.++.++||||||+++|+|++|..||.+.+.......+..... .++. ....+..+
T Consensus 208 ~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~-------------------------~~~~~~~~ 261 (316)
T cd05574 208 GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEV-TFPG-------------------------SPPVSSSA 261 (316)
T ss_pred CCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCc-cCCC-------------------------ccccCHHH
Confidence 678999999999999999999999988776665554443211 1110 01135689
Q ss_pred HHHHHHhcccCCCCCCC----HHHHHHHHH
Q 003185 804 VDVFRRCTEENPTERPT----AGDLYEMFV 829 (840)
Q Consensus 804 ~dLI~rCL~~DP~eRPS----a~ELLehLe 829 (840)
.+||.+||..||.+||+ ++++++|-+
T Consensus 262 ~~li~~~l~~~p~~R~s~~~~~~~ll~~~~ 291 (316)
T cd05574 262 RDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291 (316)
T ss_pred HHHHHHHccCCHhHCCCchhhHHHHHcCch
Confidence 99999999999999999 999999844
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=315.94 Aligned_cols=249 Identities=27% Similarity=0.364 Sum_probs=202.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||.||++.+ .+..+|+|+...... ... .....+.+|+.++++++||||+++++++.....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-VKL----KQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh-hhh----hHHHHHHHHHHHHHhCCCCCccceeeEEEcCCe
Confidence 4799999999999999999987 568899998653211 111 112345899999999999999999999876553
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+|+||+|.|||++.
T Consensus 76 --------------~~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~ 136 (290)
T cd05580 76 --------------LYLVMEYVPGGELFSHLRK-----SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDS 136 (290)
T ss_pred --------------EEEEEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC
Confidence 4999999999999999976 356899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||++...... .....|++.|+|||.+.+ ...+.++||||||+++|+|+
T Consensus 137 ~-------~~~kl~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~ 192 (290)
T cd05580 137 D-------GYIKITDFGFAKRVKGR-------------TYTLCGTPEYLAPEIILS----KGYGKAVDWWALGILIYEML 192 (290)
T ss_pred C-------CCEEEeeCCCccccCCC-------------CCCCCCCccccChhhhcC----CCCCccccHHHHHHHHHHHH
Confidence 7 45999999998765432 122358899999999875 45788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC---
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP--- 819 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP--- 819 (840)
+|..||...+.......+..+.. .++. ..+..+.++|.+||..||.+||
T Consensus 193 ~g~~p~~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~l~~li~~~l~~~p~~R~~~~ 244 (290)
T cd05580 193 AGYPPFFDDNPIQIYEKILEGKV-RFPS---------------------------FFSPDAKDLIRNLLQVDLTKRLGNL 244 (290)
T ss_pred hCCCCCCCCCHHHHHHHHhcCCc-cCCc---------------------------cCCHHHHHHHHHHccCCHHHccCcc
Confidence 99999988776666666554321 1221 1145789999999999999999
Q ss_pred --CHHHHHHHHH
Q 003185 820 --TAGDLYEMFV 829 (840)
Q Consensus 820 --Sa~ELLehLe 829 (840)
+++++++|..
T Consensus 245 ~~~~~~l~~~~~ 256 (290)
T cd05580 245 KNGVNDIKNHPW 256 (290)
T ss_pred cCCHHHHHcCcc
Confidence 8999998854
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=308.63 Aligned_cols=265 Identities=20% Similarity=0.326 Sum_probs=202.3
Q ss_pred ceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
|.+.+.||+|+||.||+|.+ .+..+|+|++..+. ......+. +.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI--FSSSDIEE----FLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc--CChHHHHH----HHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 57788999999999999986 25789999865332 22233333 388999999999999999999887543
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHh-ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS-ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~-~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. ......++++||+.+|+|..++.... ......++...++.++.||+.||+|||++||+||||||+|||+
T Consensus 75 ~~--------~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili 146 (273)
T cd05074 75 AK--------GRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML 146 (273)
T ss_pred CC--------CcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE
Confidence 11 01223588999999999999885421 1122357889999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||+++........ .......+++.|++||.+.. ..++.++|||||||++|+
T Consensus 147 ~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~----~~~~~~sDi~slG~il~e 207 (273)
T cd05074 147 NEN-------MTVCVADFGLSKKIYSGDYY--------RQGCASKLPVKWLALESLAD----NVYTTHSDVWAFGVTMWE 207 (273)
T ss_pred cCC-------CCEEECcccccccccCCcce--------ecCCCccCchhhcCHhHHhc----CccchhhhhHHHHHHHHH
Confidence 866 46999999999865332111 00112235678999999875 567889999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|++ |..||.+.+..+....+........+ ...+..+.+|+.+||..+|.+||
T Consensus 208 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~~~l~~~p~~Rp 260 (273)
T cd05074 208 IMTRGQTPYAGVENSEIYNYLIKGNRLKQP---------------------------PDCLEDVYELMCQCWSPEPKCRP 260 (273)
T ss_pred HhhCCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHcCCChhhCc
Confidence 999 89999888777666666544321111 11245789999999999999999
Q ss_pred CHHHHHHHHHhh
Q 003185 820 TAGDLYEMFVAR 831 (840)
Q Consensus 820 Sa~ELLehLe~l 831 (840)
++.+++..|+.+
T Consensus 261 s~~~~~~~l~~~ 272 (273)
T cd05074 261 SFQHLRDQLELI 272 (273)
T ss_pred CHHHHHHHHHhh
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.31 Aligned_cols=278 Identities=23% Similarity=0.282 Sum_probs=200.5
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||.||+|.+ .+..+|+|+...... .... ...+.+|+.+++.++||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 73 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMV----KKIAMREIRMLKQLRHENLVNLIEVFRRKK- 73 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC--cchh----hHHHHHHHHHHHhcCCcchhhHHHhcccCC-
Confidence 4789999999999999999998 467899988543221 1111 223488999999999999999999987554
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
..++||||+++++|..++.. ...+++..++.++.||+.||.|||+.||+|+||+|+||+++.
T Consensus 74 -------------~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~ 135 (286)
T cd07846 74 -------------RLYLVFEFVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ 135 (286)
T ss_pred -------------eEEEEEecCCccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC
Confidence 35999999999888887654 245899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.++|+|||++..+..... ......++..|+|||++.+ ...++.++|||||||++|||+
T Consensus 136 ~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~el~ 195 (286)
T cd07846 136 S-------GVVKLCDFGFARTLAAPGE----------VYTDYVATRWYRAPELLVG---DTKYGRAVDIWAVGCLVTEML 195 (286)
T ss_pred C-------CcEEEEeeeeeeeccCCcc----------ccCcccceeeccCcHHhcc---ccccCchHhHHHHHHHHHHHH
Confidence 7 4699999999876533211 1122457899999999864 244678999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcc----ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE----HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~----~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
+|.+||......+....+.......... ......... ...................+..+.+|+.+||..+|.+|
T Consensus 196 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 274 (286)
T cd07846 196 TGEPLFPGDSDIDQLYHIIKCLGNLIPR-HQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDR 274 (286)
T ss_pred cCCCCCCCCchHHHHHHHHHHhCCCchh-hHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccc
Confidence 9999998776555444443221111110 000000000 00000000000001122346789999999999999999
Q ss_pred CCHHHHHHHH
Q 003185 819 PTAGDLYEMF 828 (840)
Q Consensus 819 PSa~ELLehL 828 (840)
|++.+|++|-
T Consensus 275 p~~~~il~~~ 284 (286)
T cd07846 275 PSSSQLLHHE 284 (286)
T ss_pred hhHHHHhcCC
Confidence 9999999873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=315.57 Aligned_cols=249 Identities=25% Similarity=0.417 Sum_probs=193.4
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||.||+|.+ .+..+|+|+..... ...... .+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 73 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQK----QIMSELEILYKCDSPYIIGFYGAFFVENR 73 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHH----HHHHHHHHHHhCCCCCeeeEEEEEEECCE
Confidence 3678899999999999999986 66789999865331 122222 34899999999999999999999986653
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.++||||+++++|..+. .+++..+..++.||+.||.|||+.||+|+||||+|||++.
T Consensus 74 --------------~~lv~e~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~ 130 (279)
T cd06619 74 --------------ISICTEFMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNT 130 (279)
T ss_pred --------------EEEEEecCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECC
Confidence 48999999999996542 3678889999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.++|+|||++..+.... .....||..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 131 ~-------~~~~l~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~~l~~l~ 187 (279)
T cd06619 131 R-------GQVKLCDFGVSTQLVNSI------------AKTYVGTNAYMAPERISG----EQYGIHSDVWSLGISFMELA 187 (279)
T ss_pred C-------CCEEEeeCCcceeccccc------------ccCCCCChhhcCceeecC----CCCCCcchHHHHHHHHHHHH
Confidence 7 469999999997653321 123468999999999875 56789999999999999999
Q ss_pred hCCCCCCCCCHH-------HHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 743 TLQVPYMGLSEL-------EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 743 TG~~PF~~~~~~-------el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
+|..||...... .....+.....+.++ ....+..+.+||.+||+.+|
T Consensus 188 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~~P 241 (279)
T cd06619 188 LGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP--------------------------VGQFSEKFVHFITQCMRKQP 241 (279)
T ss_pred hCCCCchhhcccccccchHHHHHHHhccCCCCCC--------------------------CCcCCHHHHHHHHHHhhCCh
Confidence 999999653211 111111111111100 01124578999999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 003185 816 TERPTAGDLYEMFVART 832 (840)
Q Consensus 816 ~eRPSa~ELLehLe~l~ 832 (840)
.+||+++++++|.+-..
T Consensus 242 ~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 242 KERPAPENLMDHPFIVQ 258 (279)
T ss_pred hhCCCHHHHhcCccccc
Confidence 99999999999965443
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.64 Aligned_cols=247 Identities=23% Similarity=0.389 Sum_probs=186.3
Q ss_pred eeecccCceEEEEEEECC---------eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 511 DEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~---------~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+.||.|+||.||+|.... ..+++|+.... .....+.+..|+.+++.+.||||+++++++....
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~ 72 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--------HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD 72 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--------hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC
Confidence 469999999999998632 23555553211 1122334588999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
.. ++||||+++|+|..++.. ....+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 73 ~~--------------~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~ 134 (258)
T cd05078 73 ES--------------IMVQEYVKFGSLDTYLKK----NKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLI 134 (258)
T ss_pred Cc--------------EEEEecCCCCcHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEe
Confidence 43 999999999999999975 224688999999999999999999999999999999999998
Q ss_pred cccccC-CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 662 LERKKA-DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 662 ~~~~~~-~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
.++... ...+.++|+|||++...... ....+++.|+|||++.+ ...++.++|||||||++|+
T Consensus 135 ~~~~~~~~~~~~~~l~d~g~~~~~~~~--------------~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~~l~~ 197 (258)
T cd05078 135 REEDRKTGNPPFIKLSDPGISITVLPK--------------EILLERIPWVPPECIEN---PQNLSLAADKWSFGTTLWE 197 (258)
T ss_pred cccccccCCCceEEecccccccccCCc--------------hhccccCCccCchhccC---CCCCCchhhHHHHHHHHHH
Confidence 764311 12345899999998654321 22357889999999874 2456889999999999999
Q ss_pred HHhC-CCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLTG-~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|++| ..||...+.......... ...++. .....+.+||.+||+.||.+||
T Consensus 198 l~~g~~~~~~~~~~~~~~~~~~~--~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp 248 (258)
T cd05078 198 IFSGGDKPLSALDSQKKLQFYED--RHQLPA---------------------------PKWTELANLINQCMDYEPDFRP 248 (258)
T ss_pred HHcCCCCChhhccHHHHHHHHHc--cccCCC---------------------------CCcHHHHHHHHHHhccChhhCC
Confidence 9998 466665554443322211 111110 1134689999999999999999
Q ss_pred CHHHHHHHHH
Q 003185 820 TAGDLYEMFV 829 (840)
Q Consensus 820 Sa~ELLehLe 829 (840)
|+++|++.|.
T Consensus 249 s~~~il~~l~ 258 (258)
T cd05078 249 SFRAIIRDLN 258 (258)
T ss_pred CHHHHHHhcC
Confidence 9999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=323.29 Aligned_cols=283 Identities=17% Similarity=0.216 Sum_probs=205.2
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
..++|++.+.||+|+||.||+|.. .+..+|+|+.... ........ .+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP--FQNVTHAK----RAYRELVLMKLVNHKNIIGLLNVFTPQ 87 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcc--ccChhHHH----HHHHHHHHHHhcCCCCCcceeeeeccC
Confidence 467899999999999999999986 5678899975322 11222222 337899999999999999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
... ......|+||||+. ++|.+++.. .++...+..++.||+.||+|||++||+||||||+|||+
T Consensus 88 ~~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~ 151 (353)
T cd07850 88 KSL--------EEFQDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 151 (353)
T ss_pred CCc--------cccCcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE
Confidence 422 11234699999997 599888864 28899999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||+++....... .....++..|+|||++.+ ..++.++|||||||++|+
T Consensus 152 ~~~-------~~~kL~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~~l~~ 209 (353)
T cd07850 152 KSD-------CTLKILDFGLARTAGTSFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGE 209 (353)
T ss_pred CCC-------CCEEEccCccceeCCCCCC-----------CCCCcccccccCHHHHhC----CCCCCchhhHhHHHHHHH
Confidence 877 4599999999976543211 122358899999999976 668899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcccc-----------ccccCCCC----CCchhhhhhHHHHHH
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE-----------VAQSGSGF----EKPEAELETLSFLVD 805 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~-----------~~~~~~~~----~~~~~~~~~s~~L~d 805 (840)
|++|+.||...+.......+.........+.+.......... +....... .........+..+.+
T Consensus 210 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
T cd07850 210 MIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARD 289 (353)
T ss_pred HHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHH
Confidence 999999998877666555554432222221111110000000 00000000 000011234667899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHH
Q 003185 806 VFRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 806 LI~rCL~~DP~eRPSa~ELLehLe 829 (840)
||.+||+.||.+|||+.++++|-.
T Consensus 290 li~~~L~~dP~~R~t~~eiL~~~~ 313 (353)
T cd07850 290 LLSKMLVIDPEKRISVDDALQHPY 313 (353)
T ss_pred HHHHHcCCChhhCcCHHHHhcChh
Confidence 999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=309.95 Aligned_cols=264 Identities=25% Similarity=0.427 Sum_probs=200.7
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCC--hHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSS--ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~--~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+|.+.+.||.|+||.||+|.. .+..+|+|.......... ........+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 578899999999999999975 567899998654322111 1122223345688999999999999999999987554
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .++||||+++++|.+++.. ...++...+..++.||+.||.|||++|++||||||+||+++
T Consensus 82 ~--------------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~ 142 (272)
T cd06629 82 Y--------------LSIFLEYVPGGSIGSCLRT-----YGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD 142 (272)
T ss_pred c--------------eEEEEecCCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc
Confidence 3 4999999999999999976 24688999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.++|+|||++......... .......|+..|+|||.+.... ..++.++||||||+++|+|
T Consensus 143 ~~-------~~~~l~d~~~~~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~--~~~~~~~Dv~slG~~l~~l 205 (272)
T cd06629 143 AD-------GICKISDFGISKKSDDIYDN--------DQNMSMQGSVFWMAPEVIHSYS--QGYSAKVDIWSLGCVVLEM 205 (272)
T ss_pred CC-------CeEEEeeccccccccccccc--------cccccccCCccccCHHHhcccc--CCCCccchhHHHHHHHHHH
Confidence 76 56999999998754321111 0112345889999999987521 2478899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcC-CCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 742 LTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
++|..||...........+... ..+.++.. .....+..+.++|.+||..+|.+||+
T Consensus 206 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rps 262 (272)
T cd06629 206 FAGRRPWSDEEAIAAMFKLGNKRSAPPIPPD-----------------------VSMNLSPVALDFLNACFTINPDNRPT 262 (272)
T ss_pred HhCCCCCcCcchHHHHHHhhccccCCcCCcc-----------------------ccccCCHHHHHHHHHHhcCChhhCCC
Confidence 9999999765544433322211 11111110 11123568999999999999999999
Q ss_pred HHHHHHHH
Q 003185 821 AGDLYEMF 828 (840)
Q Consensus 821 a~ELLehL 828 (840)
+.+|++|.
T Consensus 263 ~~~il~~~ 270 (272)
T cd06629 263 ARELLQHP 270 (272)
T ss_pred HHHHhhCC
Confidence 99999884
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=316.93 Aligned_cols=278 Identities=23% Similarity=0.311 Sum_probs=200.8
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||.||++.+ .+..+++|+...+. ... ....+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 73 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI---KPA----IRNQIIRELKVLHECNSPYIVGFYGAFYSDGE 73 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc---CHH----HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCE
Confidence 4689999999999999999987 45667777654321 122 22345899999999999999999999986653
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCCCcEEEe
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILID 661 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs-~gIVHRDLKPeNILLd 661 (840)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+ .+|+|+||||+|||++
T Consensus 74 --------------~~lv~ey~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~ 134 (308)
T cd06615 74 --------------ISICMEHMDGGSLDQVLKK-----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN 134 (308)
T ss_pred --------------EEEEeeccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe
Confidence 5999999999999999976 2568999999999999999999997 5999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||++....... .....|+..|+|||++.+ ..++.++|||||||++|+|
T Consensus 135 ~~-------~~~~l~dfg~~~~~~~~~------------~~~~~~~~~~~aPE~~~~----~~~~~~~DiwslG~~l~~l 191 (308)
T cd06615 135 SR-------GEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYTVQSDIWSLGLSLVEM 191 (308)
T ss_pred cC-------CcEEEccCCCcccccccc------------cccCCCCcCccChhHhcC----CCCCccchHHHHHHHHHHH
Confidence 76 459999999986543211 123468999999999875 5578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHh-hhcc---Cccc------cccccCCCCCCch-hhhhhHHHHHHHHHHh
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELE-ALGS---CHEH------EVAQSGSGFEKPE-AELETLSFLVDVFRRC 810 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~-~~~~---~~~~------~~~~~~~~~~~~~-~~~~~s~~L~dLI~rC 810 (840)
++|..||...+.......+..... .+..... .... .... ...+.......+. .....+..+.+|+.+|
T Consensus 192 ~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 270 (308)
T cd06615 192 AIGRYPIPPPDAKELEAMFGRPVS-EGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKC 270 (308)
T ss_pred HhCCCCCCCcchhhHHHhhcCccc-cccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHH
Confidence 999999977665544433322111 0000000 0000 0000 0000000000000 0012456799999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhc
Q 003185 811 TEENPTERPTAGDLYEMFVART 832 (840)
Q Consensus 811 L~~DP~eRPSa~ELLehLe~l~ 832 (840)
|..+|.+||++.+|++|..-..
T Consensus 271 l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 271 LKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred ccCChhhCcCHHHHhcChhhhh
Confidence 9999999999999999976544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=338.65 Aligned_cols=273 Identities=19% Similarity=0.238 Sum_probs=194.4
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
...|.+.+.||+|+||.||+|.+. +..||+|.... . .+.+|+.+|++|+|||||++++++....
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~----~~~~E~~iL~~L~HpnIv~l~~~~~~~~ 233 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------A----SSVHEARLLRRLSHPAVLALLDVRVVGG 233 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------c----CHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence 457999999999999999999984 56678775211 1 1278999999999999999999987655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .+||||++. ++|..++.. ....+++..++.|+.||+.||.|||++|||||||||+||||+
T Consensus 234 ~--------------~~lv~e~~~-~~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~ 294 (461)
T PHA03211 234 L--------------TCLVLPKYR-SDLYTYLGA----RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN 294 (461)
T ss_pred E--------------EEEEEEccC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC
Confidence 3 499999996 699998865 224689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||+++........ .......||+.|||||++.+ ..++.++|||||||+||||
T Consensus 295 ~~-------~~vkL~DFGla~~~~~~~~~--------~~~~~~~GT~~Y~APE~~~~----~~~~~~sDvwSlGviL~El 355 (461)
T PHA03211 295 GP-------EDICLGDFGAACFARGSWST--------PFHYGIAGTVDTNAPEVLAG----DPYTPSVDIWSAGLVIFEA 355 (461)
T ss_pred CC-------CCEEEcccCCceeccccccc--------ccccccCCCcCCcCHHHHcC----CCCCchHHHHHHHHHHHHH
Confidence 76 45999999999765332111 01123469999999999976 5688999999999999999
Q ss_pred HhCCCCCCCC--------CHHHHHHHHHcCCC--CCcchH----H-hhhccCccccccccCCCCCCchhhhhhHHHHHHH
Q 003185 742 LTLQVPYMGL--------SELEIHDLIQMGKR--PRLTDE----L-EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 806 (840)
Q Consensus 742 LTG~~PF~~~--------~~~el~~~I~~~~~--p~l~~~----l-~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dL 806 (840)
++|..|+... ...++...+..... ..++.. + ..+...... ....................+.+|
T Consensus 356 ~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~dl 434 (461)
T PHA03211 356 AVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAAR-NRRPAYTRPAWTRYYKLDLDVEYL 434 (461)
T ss_pred HHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhc-ccCCccCCcchhhhccccchHHHH
Confidence 9987665322 12344444443221 111110 0 000000000 000000000001111234578899
Q ss_pred HHHhcccCCCCCCCHHHHHHHHH
Q 003185 807 FRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 807 I~rCL~~DP~eRPSa~ELLehLe 829 (840)
|.+||+.||.+|||+.|||+|-.
T Consensus 435 i~~mL~~DP~~RPsa~elL~hp~ 457 (461)
T PHA03211 435 VCRALTFDGARRPSAAELLRLPL 457 (461)
T ss_pred HHHHcccChhhCcCHHHHhhCcc
Confidence 99999999999999999999954
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.29 Aligned_cols=254 Identities=26% Similarity=0.422 Sum_probs=200.3
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
...+|++.+.||+|+||.||+|.. .+..+|+|.+..... ...+ .+.+|+.+++.++||||+++++++...
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~----~~~~e~~~l~~~~h~~i~~~~~~~~~~ 88 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ----PKKE----LIINEILVMRENKNPNIVNYLDSYLVG 88 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc----chHH----HHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 457899999999999999999986 578899998754321 1122 248899999999999999999998865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
. ..|+||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||+
T Consensus 89 ~--------------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili 148 (297)
T cd06656 89 D--------------ELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL 148 (297)
T ss_pred C--------------EEEEeecccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 4 35999999999999999875 457899999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.++|+|||++......... .....+++.|+|||.+.+ ..++.++|||||||++|+
T Consensus 149 ~~~-------~~~~l~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slGvil~~ 207 (297)
T cd06656 149 GMD-------GSVKLTDFGFCAQITPEQSK----------RSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIE 207 (297)
T ss_pred CCC-------CCEEECcCccceEccCCccC----------cCcccCCccccCHHHHcC----CCCCcHHHHHHHHHHHHH
Confidence 876 45999999998765332111 122358899999999975 567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|++|..||.+.++......+.....+.+. .....+..+.+|+.+||..+|.+||+
T Consensus 208 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~Rps 262 (297)
T cd06656 208 MVEGEPPYLNENPLRALYLIATNGTPELQ-------------------------NPERLSAVFRDFLNRCLEMDVDRRGS 262 (297)
T ss_pred HHhCCCCCCCCCcchheeeeccCCCCCCC-------------------------CccccCHHHHHHHHHHccCChhhCcC
Confidence 99999999766543332222222111111 01123456889999999999999999
Q ss_pred HHHHHHHHHh
Q 003185 821 AGDLYEMFVA 830 (840)
Q Consensus 821 a~ELLehLe~ 830 (840)
+.+|++|-.-
T Consensus 263 ~~~il~~~~~ 272 (297)
T cd06656 263 AKELLQHPFL 272 (297)
T ss_pred HHHHhcCchh
Confidence 9999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=313.62 Aligned_cols=263 Identities=25% Similarity=0.382 Sum_probs=200.0
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEec
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 579 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~~ 579 (840)
+-+.|++.+.||.|+||.||+|.+ .+..+|+|+..... ..... +..|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-----~~~~~----~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-----DEEEE----IKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-----HHHHH----HHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 447899999999999999999997 56788999865331 12222 37899999998 59999999999864
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.... ......|++|||+++|+|.+++... ....+++..++.++.||+.||.|||++||+|+||||+||+
T Consensus 85 ~~~~--------~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nil 153 (282)
T cd06636 85 KSPP--------GHDDQLWLVMEFCGAGSVTDLVKNT---KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVL 153 (282)
T ss_pred cccc--------CCCCEEEEEEEeCCCCcHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 3210 1123579999999999999999752 2345788899999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~kSDVWSLGvIL 738 (840)
++.+ +.++|+|||++........ ......|++.|+|||++.... ....++.++|||||||++
T Consensus 154 i~~~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l 216 (282)
T cd06636 154 LTEN-------AEVKLVDFGVSAQLDRTVG----------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITA 216 (282)
T ss_pred ECCC-------CCEEEeeCcchhhhhcccc----------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHH
Confidence 9876 4599999999876532111 112346899999999986321 124578899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 739 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
|||++|..||....+......+.....+.+. ....+..+.+||.+||..||.+|
T Consensus 217 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~cl~~~p~~R 270 (282)
T cd06636 217 IEMAEGAPPLCDMHPMRALFLIPRNPPPKLK--------------------------SKKWSKKFIDFIEGCLVKNYLSR 270 (282)
T ss_pred HHHHhCCCCccccCHHhhhhhHhhCCCCCCc--------------------------ccccCHHHHHHHHHHhCCChhhC
Confidence 9999999999776554433333222111110 01235579999999999999999
Q ss_pred CCHHHHHHHH
Q 003185 819 PTAGDLYEMF 828 (840)
Q Consensus 819 PSa~ELLehL 828 (840)
|++.+|++|-
T Consensus 271 p~~~ell~~~ 280 (282)
T cd06636 271 PSTEQLLKHP 280 (282)
T ss_pred cCHHHHhcCC
Confidence 9999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=305.46 Aligned_cols=251 Identities=28% Similarity=0.446 Sum_probs=200.9
Q ss_pred ceeeeeecccCceEEEEEEECC------eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 507 LSSCDEAGKSVSSSLFRCKFGS------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~------~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
+++.+.||.|+||.||++.+.. ..+|+|+..... .....+. +.+|+.++..++|+||+++++++...
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~ 73 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA---DEQQIEE----FLREARIMRKLDHPNIVKLLGVCTEE 73 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC---ChHHHHH----HHHHHHHHHhcCCCchheEEEEEcCC
Confidence 4678899999999999999854 678888864321 1112333 48999999999999999999998865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .+++|||+++++|.+++... ....+++..+..++.||+.||.|||+.|++|+||||+||++
T Consensus 74 ~~--------------~~~i~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~ 136 (258)
T smart00219 74 EP--------------LMIVMEYMEGGDLLDYLRKN---RPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV 136 (258)
T ss_pred Ce--------------eEEEEeccCCCCHHHHHHhh---hhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE
Confidence 53 49999999999999999751 11128999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.++|+|||++.......... .....+++.|+|||.+.. ..++.++||||||+++|+
T Consensus 137 ~~~-------~~~~l~dfg~~~~~~~~~~~~---------~~~~~~~~~y~~Pe~~~~----~~~~~~~Di~slG~i~~~ 196 (258)
T smart00219 137 GEN-------LVVKISDFGLSRDLYDDDYYK---------KKGGKLPIRWMAPESLKD----GKFTSKSDVWSFGVLLWE 196 (258)
T ss_pred ccC-------CeEEEcccCCceecccccccc---------cccCCCcccccChHHhcc----CCCCcchhHHHHHHHHHH
Confidence 877 469999999998765432110 011236789999999864 667899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|++ |..||...+...+...+.....+..+. ..+..+.+++.+||..+|.+||
T Consensus 197 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~Rp 249 (258)
T smart00219 197 IFTLGESPYPGMSNEEVLEYLKKGYRLPKPE---------------------------NCPPEIYKLMLQCWAEDPEDRP 249 (258)
T ss_pred HHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC---------------------------cCCHHHHHHHHHHCcCChhhCc
Confidence 998 889998887777777776654432221 1255789999999999999999
Q ss_pred CHHHHHHHH
Q 003185 820 TAGDLYEMF 828 (840)
Q Consensus 820 Sa~ELLehL 828 (840)
|+.++++.|
T Consensus 250 t~~~ll~~l 258 (258)
T smart00219 250 TFSELVEIL 258 (258)
T ss_pred CHHHHHhhC
Confidence 999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=313.76 Aligned_cols=271 Identities=23% Similarity=0.321 Sum_probs=194.6
Q ss_pred CceeeeeecccCceEEEEEEE------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
-|++.+.||+|+||.||+|.+ .+..+|+|..... . ..... ..+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~--~-~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--S-GGNHI----ADLKKEIEILRNLYHENIVKYKGICTE 77 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc--c-cHHHH----HHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 368899999999999999974 3567888875322 1 12222 345899999999999999999998875
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... ...++||||++|++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 78 ~~~------------~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil 141 (284)
T cd05079 78 DGG------------NGIKLIMEFLPSGSLKEYLPR----NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVL 141 (284)
T ss_pred CCC------------CceEEEEEccCCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEE
Confidence 421 135999999999999999865 1235899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.++|+|||+++.+....... .......++..|+|||++.+ ..++.++|||||||++|
T Consensus 142 ~~~~-------~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~apE~~~~----~~~~~~~Di~slG~il~ 203 (284)
T cd05079 142 VESE-------HQVKIGDFGLTKAIETDKEYY-------TVKDDLDSPVFWYAPECLIQ----SKFYIASDVWSFGVTLY 203 (284)
T ss_pred EcCC-------CCEEECCCccccccccCccce-------eecCCCCCCccccCHHHhcc----CCCCccccchhhhhhhh
Confidence 9876 459999999998664322110 01123457788999999875 56788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCC--cchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPR--LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~--l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
||+|++.|+.... ............. ........ ..... .......+..+.+|+.+||+.+|.+
T Consensus 204 ellt~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~ 269 (284)
T cd05079 204 ELLTYCDSESSPM--TLFLKMIGPTHGQMTVTRLVRVL---------EEGKR---LPRPPNCPEEVYQLMRKCWEFQPSK 269 (284)
T ss_pred hhhcCCCCCcccc--chhhhhcccccccccHHHHHHHH---------HcCcc---CCCCCCCCHHHHHHHHHHccCCccc
Confidence 9999887653221 1110000000000 00000000 00000 0011224668999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 003185 818 RPTAGDLYEMFVAR 831 (840)
Q Consensus 818 RPSa~ELLehLe~l 831 (840)
||++.++++.|+.+
T Consensus 270 Rpt~~~il~~l~~~ 283 (284)
T cd05079 270 RTTFQNLIEGFEAI 283 (284)
T ss_pred CcCHHHHHHHHHhh
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=312.44 Aligned_cols=265 Identities=25% Similarity=0.331 Sum_probs=202.9
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEec
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 579 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~~ 579 (840)
..++|.+.+.||+|+||.||++.. .+..+|+|+..... ... ..+.+|+.++.++ +||||+++++++..
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~----~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVD----EEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHH----HHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 468899999999999999999987 56788899864221 111 2337899999999 79999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.... .....++||||+++++|.+++..... ....+++..++.++.||+.||+|||++||+|+||||+||+
T Consensus 91 ~~~~---------~~~~~~lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nil 160 (291)
T cd06639 91 ADKL---------VGGQLWLVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNIL 160 (291)
T ss_pred cccc---------CCCeeEEEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEE
Confidence 4321 12246999999999999999875322 2356899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~kSDVWSLGvIL 738 (840)
++.+ +.+||+|||++......... .....|+..|+|||++.... ....++.++|||||||++
T Consensus 161 i~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~ 223 (291)
T cd06639 161 LTTE-------GGVKLVDFGVSAQLTSTRLR----------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITA 223 (291)
T ss_pred EcCC-------CCEEEeecccchhccccccc----------ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHH
Confidence 9877 45999999998765432111 12245889999999986421 112368899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 739 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
|||++|+.||...........+.....+.+.. .......+.+||.+||+.+|.+|
T Consensus 224 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~p~~R 278 (291)
T cd06639 224 IELGDGDPPLFDMHPVKTLFKIPRNPPPTLLH-------------------------PEKWCRSFNHFISQCLIKDFEAR 278 (291)
T ss_pred HHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCc-------------------------ccccCHHHHHHHHHHhhcChhhC
Confidence 99999999998776655554444432221110 01123468999999999999999
Q ss_pred CCHHHHHHHH
Q 003185 819 PTAGDLYEMF 828 (840)
Q Consensus 819 PSa~ELLehL 828 (840)
|++.+|++|-
T Consensus 279 ps~~~il~~~ 288 (291)
T cd06639 279 PSVTHLLEHP 288 (291)
T ss_pred cCHHHHhcCc
Confidence 9999999884
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=305.38 Aligned_cols=252 Identities=29% Similarity=0.432 Sum_probs=199.1
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCC-hHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~-~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
+|+..+.||+|+||.||+|.. .+..+++|+......... .... +.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~----~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAV----KQLEQEIALLSKLQHPNIVQYLGTEREEDN 76 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHH----HHHHHHHHHHHhcCCCCchheeeeEecCCe
Confidence 477889999999999999987 578899998754432211 2222 344899999999999999999998875543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.++||||+++++|.+++.+ ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.
T Consensus 77 --------------~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~ 137 (258)
T cd06632 77 --------------LYIFLELVPGGSLAKLLKK-----YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDT 137 (258)
T ss_pred --------------EEEEEEecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 4999999999999999976 245889999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||++........ .....|+..|+|||.+.. ...++.++|||||||++|+|+
T Consensus 138 ~-------~~~kl~d~~~~~~~~~~~~-----------~~~~~~~~~y~~pe~~~~---~~~~~~~~D~~slG~~l~~l~ 196 (258)
T cd06632 138 N-------GVVKLADFGMAKQVVEFSF-----------AKSFKGSPYWMAPEVIAQ---QGGYGLAADIWSLGCTVLEMA 196 (258)
T ss_pred C-------CCEEEccCccceecccccc-----------ccccCCCcceeCHHHhcC---CCCCCchhhhHHHHHHHHHHH
Confidence 6 4599999999876543220 123458899999999875 123789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHc-CCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 743 TLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
+|+.||...........+.. ...+.++ ...+..+.+|+.+||..+|.+||++
T Consensus 197 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~ 249 (258)
T cd06632 197 TGKPPWSQLEGVAAVFKIGRSKELPPIP---------------------------DHLSDEAKDFILKCLQRDPSLRPTA 249 (258)
T ss_pred hCCCCcccCcHHHHHHHHHhcccCCCcC---------------------------CCcCHHHHHHHHHHhhcCcccCcCH
Confidence 99999977665444444333 1221111 1124578999999999999999999
Q ss_pred HHHHHHH
Q 003185 822 GDLYEMF 828 (840)
Q Consensus 822 ~ELLehL 828 (840)
.+++.|.
T Consensus 250 ~~~l~~~ 256 (258)
T cd06632 250 AELLEHP 256 (258)
T ss_pred HHHhcCC
Confidence 9999873
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=353.90 Aligned_cols=276 Identities=23% Similarity=0.267 Sum_probs=203.8
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+++|++.++||+|+||.||+|.+ .+..||+|+...... .. .....++.+|+.++++++||||+++++++...+
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~-~~----e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~ 75 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS-EN----PLLKKRFLREAKIAADLIHPGIVPVYSICSDGD 75 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc-cC----HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC
Confidence 57899999999999999999987 467899998653221 11 123345599999999999999999999987655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCC
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 655 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~------~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKP 655 (840)
. .++||||++|++|.+++...... ....++...++.++.||+.||+|||++||+||||||
T Consensus 76 ~--------------lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKP 141 (932)
T PRK13184 76 P--------------VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKP 141 (932)
T ss_pred E--------------EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCch
Confidence 3 49999999999999999753211 123456778899999999999999999999999999
Q ss_pred CcEEEecccccCCCCCeEEEeecCCccccccccccc--------ccccCCCCCCCcccCCCcccchhhhhcccCCCCCCc
Q 003185 656 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC--------CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 727 (840)
Q Consensus 656 eNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~--------~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~ 727 (840)
+|||++.+ +.+||+|||+++......... .............+||+.|||||++.+ ..++.
T Consensus 142 eNILLd~d-------g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g----~~~S~ 210 (932)
T PRK13184 142 DNILLGLF-------GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG----VPASE 210 (932)
T ss_pred heEEEcCC-------CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC----CCCCc
Confidence 99999877 459999999998762211000 000011112234579999999999876 56799
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHH
Q 003185 728 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVF 807 (840)
Q Consensus 728 kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI 807 (840)
++|||||||++|||+||..||.......+........ +..+ ......+..+.+++
T Consensus 211 kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~----P~~~---------------------~p~~~iP~~L~~LI 265 (932)
T PRK13184 211 STDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILS----PIEV---------------------APYREIPPFLSQIA 265 (932)
T ss_pred HhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccC----hhhc---------------------cccccCCHHHHHHH
Confidence 9999999999999999999997754433322110000 0000 00113356789999
Q ss_pred HHhcccCCCCCC-CHHHHHHHHHhhcCC
Q 003185 808 RRCTEENPTERP-TAGDLYEMFVARTSS 834 (840)
Q Consensus 808 ~rCL~~DP~eRP-Sa~ELLehLe~l~~~ 834 (840)
.+||..||.+|| +++++++.|+...+.
T Consensus 266 ~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 266 MKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 999999999996 577777777776543
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=318.28 Aligned_cols=260 Identities=26% Similarity=0.407 Sum_probs=203.1
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
+.|.....||+|+||.||++.. .+..+|+|...... ....+ .+.+|+.+++.++||||+++++.+.....
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~----~~~~e~~~l~~l~h~~ii~~~~~~~~~~~ 93 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK----QQRRE----LLFNEVVIMRDYHHENVVDMYNSYLVGDE 93 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch----HHHHH----HHHHHHHHHHhCCCCcHHHHHHheecCCe
Confidence 3455567899999999999986 56788998764321 12222 34899999999999999999999875543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.++||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 94 --------------~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~ 153 (292)
T cd06658 94 --------------LWVVMEFLEGGALTDIVTH------TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTS 153 (292)
T ss_pred --------------EEEEEeCCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC
Confidence 4999999999999998864 45889999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.++|+|||++........ ......|+..|+|||++.+ ..++.++||||||+++|||+
T Consensus 154 ~-------~~~kL~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slGvil~el~ 212 (292)
T cd06658 154 D-------GRIKLSDFGFCAQVSKEVP----------KRKSLVGTPYWMAPEVISR----LPYGTEVDIWSLGIMVIEMI 212 (292)
T ss_pred C-------CCEEEccCcchhhcccccc----------cCceeecCccccCHHHHcc----CCCCchhhHHHHHHHHHHHH
Confidence 6 4699999999875432211 1123468999999999875 56788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
+|..||...+.......+.....+.+.. ....+..+.+++.+||..||.+|||++
T Consensus 213 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~P~~Rpt~~ 267 (292)
T cd06658 213 DGEPPYFNEPPLQAMRRIRDNLPPRVKD-------------------------SHKVSSVLRGFLDLMLVREPSQRATAQ 267 (292)
T ss_pred hCCCCCCCCCHHHHHHHHHhcCCCcccc-------------------------ccccCHHHHHHHHHHccCChhHCcCHH
Confidence 9999998877666555544332211110 011245789999999999999999999
Q ss_pred HHHHHHHhhcCCCCCC
Q 003185 823 DLYEMFVARTSSSISS 838 (840)
Q Consensus 823 ELLehLe~l~~~~~s~ 838 (840)
++++|..-.....+++
T Consensus 268 ~il~~~~~~~~~~~~~ 283 (292)
T cd06658 268 ELLQHPFLKLAGPPSC 283 (292)
T ss_pred HHhhChhhhccCCccc
Confidence 9999966555444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=340.92 Aligned_cols=251 Identities=27% Similarity=0.448 Sum_probs=201.9
Q ss_pred eeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 590 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g~~ 590 (840)
-.||+|.||+||-|++..+.|-+.|+.+.... .++.+.+..||.+-+.|+|.|||+++|.+...+.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd------sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf-------- 646 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD------SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGF-------- 646 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc------chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCe--------
Confidence 36899999999999986666666555444321 2333455899999999999999999999776554
Q ss_pred ccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCCC
Q 003185 591 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 670 (840)
Q Consensus 591 ~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~ 670 (840)
+-|.||-++||+|.++++. +.+..+-++.++-.+.+||++||.|||.+.|||||||-+|+||+.- .
T Consensus 647 ------~kIFMEqVPGGSLSsLLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTy------S 712 (1226)
T KOG4279|consen 647 ------FKIFMEQVPGGSLSSLLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTY------S 712 (1226)
T ss_pred ------EEEEeecCCCCcHHHHHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeec------c
Confidence 4899999999999999987 3333334789999999999999999999999999999999999754 4
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003185 671 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 750 (840)
Q Consensus 671 ~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~ 750 (840)
+.+||+|||.++.+.... +...++.||..|||||++.. +...|+.++|||||||++.||.||++||..
T Consensus 713 GvlKISDFGTsKRLAgin----------P~TETFTGTLQYMAPEvIDq--G~RGYG~aADIWS~GCT~vEMATGrPPF~E 780 (1226)
T KOG4279|consen 713 GVLKISDFGTSKRLAGIN----------PCTETFTGTLQYMAPEVIDQ--GPRGYGKAADIWSFGCTMVEMATGRPPFVE 780 (1226)
T ss_pred ceEEecccccchhhccCC----------ccccccccchhhhChHhhcc--CCcCCCchhhhhhccceeEeeccCCCCeee
Confidence 789999999998775432 12355779999999999976 346799999999999999999999999976
Q ss_pred CC-HHHHHHHH-HcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003185 751 LS-ELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828 (840)
Q Consensus 751 ~~-~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehL 828 (840)
.. +...+.++ .....|++|+.+ +.+.+.+|.+|+.+||.+||+|.++|...
T Consensus 781 lgspqAAMFkVGmyKvHP~iPeel---------------------------saeak~FilrcFepd~~~R~sA~~LL~Dp 833 (1226)
T KOG4279|consen 781 LGSPQAAMFKVGMYKVHPPIPEEL---------------------------SAEAKNFILRCFEPDPCDRPSAKDLLQDP 833 (1226)
T ss_pred cCChhHhhhhhcceecCCCCcHHH---------------------------HHHHHHHHHHHcCCCcccCccHHHhccCc
Confidence 53 33333333 334566666544 56889999999999999999999999864
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=315.60 Aligned_cols=281 Identities=22% Similarity=0.281 Sum_probs=205.3
Q ss_pred CCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.+++|++.+.||.|+||.||+|.+. +..+++|........ ..+...+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 76 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK------EGFPITSLREINILLKLQHPNIVTVKEVVVGS 76 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc------ccchhhHHHHHHHHHhcCCCCEEEEEEEEEec
Confidence 4578999999999999999999984 667888876543221 12223447899999999999999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
. ....||||||+. ++|.+++.. ....+++..++.++.||+.||+|||++||+|+||||+|||+
T Consensus 77 ~------------~~~~~lv~e~~~-~~L~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili 139 (293)
T cd07843 77 N------------LDKIYMVMEYVE-HDLKSLMET----MKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL 139 (293)
T ss_pred C------------CCcEEEEehhcC-cCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE
Confidence 2 124699999997 499999875 12368999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.++|+|||++......... .....+++.|+|||.+.+ ...++.++||||||+++|+
T Consensus 140 ~~~-------~~~~l~d~g~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~l~~ 199 (293)
T cd07843 140 NNR-------GILKICDFGLAREYGSPLKP----------YTQLVVTLWYRAPELLLG---AKEYSTAIDMWSVGCIFAE 199 (293)
T ss_pred CCC-------CcEEEeecCceeeccCCccc----------cccccccccccCchhhcC---CccccchhhHHHHHHHHHH
Confidence 876 45999999999866442111 122357889999999875 2346889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccc---cccccCCCCCCchhhhh--hHHHHHHHHHHhcccCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH---EVAQSGSGFEKPEAELE--TLSFLVDVFRRCTEENP 815 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~~--~s~~L~dLI~rCL~~DP 815 (840)
|++|..||......+....+...........+......... ......... ....... .++.+.+||.+||+.+|
T Consensus 200 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p 278 (293)
T cd07843 200 LLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQ-LRKKFPALSLSDNGFDLLNRLLTYDP 278 (293)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchh-hhccccccCCChHHHHHHHHHhccCc
Confidence 99999999888777766665543222222222211110000 000000000 0000111 36678999999999999
Q ss_pred CCCCCHHHHHHH
Q 003185 816 TERPTAGDLYEM 827 (840)
Q Consensus 816 ~eRPSa~ELLeh 827 (840)
++|||+.|+++|
T Consensus 279 ~~R~t~~ell~~ 290 (293)
T cd07843 279 AKRISAEDALKH 290 (293)
T ss_pred cccCCHHHHhcC
Confidence 999999999987
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=315.02 Aligned_cols=257 Identities=25% Similarity=0.363 Sum_probs=199.7
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||.||++.+ .+..+|+|.+.... ...... .+.+|+.++++++||||+++++.+.....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~----~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFN----QIIMELDILHKAVSPYIVDFYGAFFIEGA 73 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHH----HHHHHHHHHHhcCCCcHHhhhhheecCCe
Confidence 3689999999999999999998 47788888764321 222223 34899999999999999999998876543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCCCcEEEe
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILID 661 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs-~gIVHRDLKPeNILLd 661 (840)
.++||||+++++|..++... .....+++..+..++.||+.||.|||. .||+|+||||+|||++
T Consensus 74 --------------~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~ 137 (286)
T cd06622 74 --------------VYMCMEYMDAGSLDKLYAGG--VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN 137 (286)
T ss_pred --------------EEEEEeecCCCCHHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC
Confidence 59999999999999998751 112468999999999999999999997 5999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc--CCCCCCchhhHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~--~~~~~s~kSDVWSLGvIL~ 739 (840)
.+ +.+||+|||++..+.... .....+++.|+|||++.+.. ....++.++|||||||++|
T Consensus 138 ~~-------~~~~l~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 198 (286)
T cd06622 138 GN-------GQVKLCDFGVSGNLVASL------------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSIL 198 (286)
T ss_pred CC-------CCEEEeecCCcccccCCc------------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHH
Confidence 76 459999999987653211 12235788999999986422 1134588999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHH---cCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQ---MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~---~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
+|++|..||...........+. ....+.++ ...+..+.+||.+||..+|.
T Consensus 199 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~ 251 (286)
T cd06622 199 EMALGRYPYPPETYANIFAQLSAIVDGDPPTLP---------------------------SGYSDDAQDFVAKCLNKIPN 251 (286)
T ss_pred HHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCC---------------------------cccCHHHHHHHHHHcccCcc
Confidence 9999999997665444433322 22222222 11355789999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 003185 817 ERPTAGDLYEMFVA 830 (840)
Q Consensus 817 eRPSa~ELLehLe~ 830 (840)
+||++.++++|.+-
T Consensus 252 ~Rp~~~~l~~~~~~ 265 (286)
T cd06622 252 RRPTYAQLLEHPWL 265 (286)
T ss_pred cCCCHHHHhcChhh
Confidence 99999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=315.50 Aligned_cols=261 Identities=21% Similarity=0.338 Sum_probs=202.1
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCe----eEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeE
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 576 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~----~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~ 576 (840)
...+|+..+.||+|+||.||+|.+ .+. .+|+|+.... ...... ..+.+|+.+++.++||||++++++
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~----~~~~~e~~~~~~l~h~niv~~~~~ 77 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET---TGPKAN----VEFMDEALIMASMDHPHLVRLLGV 77 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc---CCHHHH----HHHHHHHHHHHhCCCCCcccEEEE
Confidence 446788999999999999999986 333 3566664321 111212 234899999999999999999998
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
+.... .+++|||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+
T Consensus 78 ~~~~~---------------~~~v~e~~~~g~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~ 138 (303)
T cd05110 78 CLSPT---------------IQLVTQLMPHGCLLDYVHE----HKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAAR 138 (303)
T ss_pred EcCCC---------------ceeeehhcCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccc
Confidence 86432 3799999999999999875 2345889999999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
|||++.+ ..+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||
T Consensus 139 Nill~~~-------~~~kL~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~----~~~~~~~DiwslG~ 199 (303)
T cd05110 139 NVLVKSP-------NHVKITDFGLARLLEGDEKE--------YNADGGKMPIKWMALECIHY----RKFTHQSDVWSYGV 199 (303)
T ss_pred eeeecCC-------CceEEccccccccccCcccc--------cccCCCccccccCCHHHhcc----CCCChHHHHHHHHH
Confidence 9999866 45999999999865432211 00112345778999999875 66889999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 737 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 737 IL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
++|||++ |..||.+....+....+..+..+..+. ..+..+.+++.+||..+|
T Consensus 200 ~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~c~~~~p 252 (303)
T cd05110 200 TIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPP---------------------------ICTIDVYMVMVKCWMIDA 252 (303)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCh
Confidence 9999997 999998877666666655443222110 123468899999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCC
Q 003185 816 TERPTAGDLYEMFVARTSSS 835 (840)
Q Consensus 816 ~eRPSa~ELLehLe~l~~~~ 835 (840)
.+||++.++++.|..+....
T Consensus 253 ~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 253 DSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred hhCcCHHHHHHHHHHHHhch
Confidence 99999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=309.50 Aligned_cols=259 Identities=22% Similarity=0.344 Sum_probs=199.4
Q ss_pred CCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeE
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 576 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~ 576 (840)
..+|++...||.|+||.||+|+.. ...+++|+.... ... .+...+.+|+.++++++||||++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~ 76 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT---KDE----NLQSEFRRELDMFRKLSHKNVVRLLGL 76 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc---cch----HHHHHHHHHHHHHHhcCCcceeeeEEE
Confidence 467899999999999999999862 346777764321 111 122344899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAALVELHSKHIMHRD 652 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~----~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRD 652 (840)
+..... .++||||+++++|.+++....... ...+++..+..++.||+.||+|||+++|+|||
T Consensus 77 ~~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~d 142 (275)
T cd05046 77 CREAEP--------------HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRD 142 (275)
T ss_pred ECCCCc--------------ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCc
Confidence 876543 399999999999999997621110 12589999999999999999999999999999
Q ss_pred CCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHH
Q 003185 653 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 732 (840)
Q Consensus 653 LKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVW 732 (840)
|||+|||++.+ +.++|+|||++......... ......++..|+|||.+.+ ..++.++|||
T Consensus 143 lkp~Nili~~~-------~~~~l~~~~~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~ 202 (275)
T cd05046 143 LAARNCLVSSQ-------REVKVSLLSLSKDVYNSEYY---------KLRNALIPLRWLAPEAVQE----DDFSTKSDVW 202 (275)
T ss_pred CccceEEEeCC-------CcEEEcccccccccCccccc---------ccCCceeEEeecChhhhcc----CCCCchhhHH
Confidence 99999999877 45999999998644321110 1122346778999999875 4568899999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 003185 733 SYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 811 (840)
Q Consensus 733 SLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL 811 (840)
|||+++|+|++ |..||.......+...+..+.... + . ....+..+.+++.+||
T Consensus 203 slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~-~----------------------~---~~~~~~~l~~~i~~~l 256 (275)
T cd05046 203 SFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL-P----------------------V---PEGCPSRLYKLMTRCW 256 (275)
T ss_pred HHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC-C----------------------C---CCCCCHHHHHHHHHHc
Confidence 99999999999 888998776666665554332110 0 0 0123457999999999
Q ss_pred ccCCCCCCCHHHHHHHHH
Q 003185 812 EENPTERPTAGDLYEMFV 829 (840)
Q Consensus 812 ~~DP~eRPSa~ELLehLe 829 (840)
+.+|.+||++.+++.+|.
T Consensus 257 ~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 257 AVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCcccCCCHHHHHHHhc
Confidence 999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=329.51 Aligned_cols=269 Identities=18% Similarity=0.192 Sum_probs=189.2
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
-.+|++.+.||+|+||.||+|.+. +..+|+|+.... . ...|+.++++++||||+++++++....
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~----~~~E~~~l~~l~h~~iv~~~~~~~~~~ 130 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------T----TLIEAMLLQNVNHPSVIRMKDTLVSGA 130 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------c----cHHHHHHHHhCCCCCCcChhheEEeCC
Confidence 357999999999999999999984 457888863211 1 156999999999999999999988655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .++||||+. ++|.+++.. ....+++..++.|+.||+.||.|||++|||||||||+|||++
T Consensus 131 ~--------------~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~ 191 (357)
T PHA03209 131 I--------------TCMVLPHYS-SDLYTYLTK----RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN 191 (357)
T ss_pred e--------------eEEEEEccC-CcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence 3 499999996 599998865 235689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ ..+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 192 ~~-------~~~kl~DfG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvvl~el 249 (357)
T PHA03209 192 DV-------DQVCIGDLGAAQFPVVAPA-----------FLGLAGTVETNAPEVLAR----DKYNSKADIWSAGIVLFEM 249 (357)
T ss_pred CC-------CCEEEecCccccccccCcc-----------cccccccccccCCeecCC----CCCCchhhHHHHHHHHHHH
Confidence 77 4599999999874322111 122468999999999976 5688999999999999999
Q ss_pred HhCCCCC-CCCCH----------HHHHHHHHcC--CCCCcc-----hHHhhhccCccccccccCCCCCCchhhhhhHHHH
Q 003185 742 LTLQVPY-MGLSE----------LEIHDLIQMG--KRPRLT-----DELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 803 (840)
Q Consensus 742 LTG~~PF-~~~~~----------~el~~~I~~~--~~p~l~-----~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L 803 (840)
+++..|+ ..... ..+...+... ....++ .....+..... ..+..............+..+
T Consensus 250 l~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 327 (357)
T PHA03209 250 LAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYAS--LERQPYTRYPCFQRVNLPIDG 327 (357)
T ss_pred HHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcc--cCCCcccccHHHhccCCCchH
Confidence 9865554 32111 1112222111 011111 00000000000 000000000000112334567
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHH
Q 003185 804 VDVFRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 804 ~dLI~rCL~~DP~eRPSa~ELLehLe 829 (840)
.+||.+||+.||.+|||+.||++|-+
T Consensus 328 ~~li~~mL~~dP~~Rpta~e~l~hp~ 353 (357)
T PHA03209 328 EFLVHKMLTFDAAMRPSAEEILNYPM 353 (357)
T ss_pred HHHHHHHHcCCcccCcCHHHHhcCch
Confidence 88999999999999999999999854
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=309.66 Aligned_cols=262 Identities=30% Similarity=0.442 Sum_probs=201.2
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|...+.||.|++|.||++.+ .+..+|+|+...... ... ...+.+|++++++++||||+++++++.....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN---PDL----QKQILRELEINKSCKSPYIVKYYGAFLDESS 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc---hHH----HHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence 4689999999999999999997 568899998653311 122 2344899999999999999999999865431
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
...++||||+++++|.+++..... ....++...+..++.||+.||.|||+.|++|+||+|.||+++.
T Consensus 74 ------------~~~~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~ 140 (287)
T cd06621 74 ------------SSIGIAMEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR 140 (287)
T ss_pred ------------CeEEEEEEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEec
Confidence 246999999999999998875332 2356889999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ ..++|+|||++........ ....++..|+|||.+.+ ..++.++|||||||++|+|+
T Consensus 141 ~-------~~~~l~dfg~~~~~~~~~~------------~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slG~il~~l~ 197 (287)
T cd06621 141 K-------GQVKLCDFGVSGELVNSLA------------GTFTGTSFYMAPERIQG----KPYSITSDVWSLGLTLLEVA 197 (287)
T ss_pred C-------CeEEEeecccccccccccc------------ccccCCccccCHHHhcC----CCCCchhhHHHHHHHHHHHH
Confidence 6 4599999999865432111 12347889999999875 56788999999999999999
Q ss_pred hCCCCCCCC-----CHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 743 TLQVPYMGL-----SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 743 TG~~PF~~~-----~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
+|..||... ...+....+.....+.+... .......++.+.+||.+||..+|.+
T Consensus 198 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~li~~~l~~~p~~ 256 (287)
T cd06621 198 QNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE---------------------PGNGIKWSEEFKDFIKQCLEKDPTR 256 (287)
T ss_pred hCCCCCCcccCCCCChHHHHHHHhcCCchhhccC---------------------CCCCCchHHHHHHHHHHHcCCCccc
Confidence 999999755 22333333333222211110 0000113567899999999999999
Q ss_pred CCCHHHHHHHHHh
Q 003185 818 RPTAGDLYEMFVA 830 (840)
Q Consensus 818 RPSa~ELLehLe~ 830 (840)
|||+.||++|.+-
T Consensus 257 Rpt~~eil~~~~~ 269 (287)
T cd06621 257 RPTPWDMLEHPWI 269 (287)
T ss_pred CCCHHHHHhCccc
Confidence 9999999998654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=306.10 Aligned_cols=253 Identities=26% Similarity=0.387 Sum_probs=200.4
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|.+.+.||+|+||.||++.. .+..+|+|....... .....+ .+.+|+.+++.++|+||+++++.+.....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~----~~~~E~~~l~~~~h~~i~~~~~~~~~~~~- 73 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKE----ASKKEVILLAKMKHPNIVTFFASFQENGR- 73 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc--cchhhH----HHHHHHHHHHhCCCCChhhhhheeccCCe-
Confidence 588999999999999999997 467788888654321 112222 34789999999999999999998876543
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.++||||+++++|.+++.. .....+++..+..++.||+.||.|||+.+|+|+||||+||+++.+
T Consensus 74 -------------~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~ 137 (257)
T cd08225 74 -------------LFIVMEYCDGGDLMKRINR---QRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKN 137 (257)
T ss_pred -------------EEEEEecCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCC
Confidence 4999999999999999975 223457899999999999999999999999999999999999866
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+ ..++|+|||.+......... .....|++.|+|||++.. ..++.++||||||+++|+|++
T Consensus 138 ~------~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~~~ape~~~~----~~~~~~~Dv~slG~il~~l~~ 197 (257)
T cd08225 138 G------MVAKLGDFGIARQLNDSMEL----------AYTCVGTPYYLSPEICQN----RPYNNKTDIWSLGCVLYELCT 197 (257)
T ss_pred C------CeEEecccccchhccCCccc----------ccccCCCccccCHHHHcC----CCCCchhhHHHHHHHHHHHHh
Confidence 3 35799999998765432111 122458899999999875 567899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~E 823 (840)
|..||...+..+....+.....+.+. ...+..+.++|.+||..+|.+|||+.+
T Consensus 198 g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 250 (257)
T cd08225 198 LKHPFEGNNLHQLVLKICQGYFAPIS---------------------------PNFSRDLRSLISQLFKVSPRDRPSITS 250 (257)
T ss_pred CCCCCCCccHHHHHHHHhcccCCCCC---------------------------CCCCHHHHHHHHHHhccChhhCcCHHH
Confidence 99999877666555544433222111 112457899999999999999999999
Q ss_pred HHHHH
Q 003185 824 LYEMF 828 (840)
Q Consensus 824 LLehL 828 (840)
|++|.
T Consensus 251 ll~~~ 255 (257)
T cd08225 251 ILKRP 255 (257)
T ss_pred HhhCC
Confidence 99874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=367.71 Aligned_cols=260 Identities=28% Similarity=0.446 Sum_probs=214.1
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|+-..+||.|.||.||-|.. +|.-.|+|-.++.. ....... .+.+|+.+|..|+|||||++||+-...+.+
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~--~~~k~~~----~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQD--SDHKTFK----LIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCc--cccccCc----chHHHHHHHHhccCccccccCceeecHHHH
Confidence 467788999999999999986 66667777654443 2233333 348999999999999999999998766644
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
+|.||||++|+|.+++.. ....++.....+..|++.|+.|||++|||||||||.|||++.+
T Consensus 1310 --------------~IFMEyC~~GsLa~ll~~-----gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~ 1370 (1509)
T KOG4645|consen 1310 --------------YIFMEYCEGGSLASLLEH-----GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFN 1370 (1509)
T ss_pred --------------HHHHHHhccCcHHHHHHh-----cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecC
Confidence 999999999999999986 3456777778889999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.+|++|||.|..+.....+.. ..-+..+||+.|||||++.+... ....-+.|||||||++.||+|
T Consensus 1371 -------g~iK~~DFGsa~ki~~~~~~~~------~el~~~~GT~~YMAPEvit~t~~-kG~~~A~DiWslGCVVlEM~t 1436 (1509)
T KOG4645|consen 1371 -------GLIKYGDFGSAVKIKNNAQTMP------GELQSMMGTPMYMAPEVITGTKG-KGHGGAADIWSLGCVVLEMAT 1436 (1509)
T ss_pred -------CcEEeecccceeEecCchhcCC------HHHHhhcCCchhcCchhhccccc-CCCCcchhhhcccceEEEeec
Confidence 5799999999998876532211 11235689999999999987543 344669999999999999999
Q ss_pred CCCCCCCC-CHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 744 LQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 744 G~~PF~~~-~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
|+.||... +..++...+..+..|.+|+.+ +.+-.++|.+||..||++|.++.
T Consensus 1437 GkrPW~~~dne~aIMy~V~~gh~Pq~P~~l---------------------------s~~g~dFle~Cl~~dP~~Rw~~~ 1489 (1509)
T KOG4645|consen 1437 GKRPWAELDNEWAIMYHVAAGHKPQIPERL---------------------------SSEGRDFLEHCLEQDPKMRWTAS 1489 (1509)
T ss_pred CCCchhhccchhHHHhHHhccCCCCCchhh---------------------------hHhHHHHHHHHHhcCchhhhHHH
Confidence 99999775 567888999999998888653 44678999999999999999999
Q ss_pred HHHHHHHhh
Q 003185 823 DLYEMFVAR 831 (840)
Q Consensus 823 ELLehLe~l 831 (840)
||++|=..-
T Consensus 1490 qlle~~f~~ 1498 (1509)
T KOG4645|consen 1490 QLLEHAFGK 1498 (1509)
T ss_pred HHHHhhccc
Confidence 999985543
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=308.37 Aligned_cols=276 Identities=19% Similarity=0.258 Sum_probs=203.3
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|++.+.||.|++|.||+|.+ .+..+|+|+....... .... .+.+|+.++++++||||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~~~- 72 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE---GTPS----TAIREISLMKELKHENIVRLHDVIHTENK- 72 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc---cchH----HHHHHHHHHHhhcCCCEeeeeeeEeeCCc-
Confidence 589999999999999999997 5778999987544221 1112 23789999999999999999999986654
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.+|||||+++ +|.+++... .....+++..+..++.||+.||.|||+.||+||||||+||+++.+
T Consensus 73 -------------~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~ 136 (284)
T cd07836 73 -------------LMLVFEYMDK-DLKKYMDTH--GVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR 136 (284)
T ss_pred -------------EEEEEecCCc-cHHHHHHhc--CCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC
Confidence 4999999985 999988752 122468999999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.++|+|||++......... .....++..|++||++.+ ...++.++|||||||++|+|++
T Consensus 137 -------~~~~l~d~g~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~~l~~l~~ 196 (284)
T cd07836 137 -------GELKLADFGLARAFGIPVNT----------FSNEVVTLWYRAPDVLLG---SRTYSTSIDIWSVGCIMAEMIT 196 (284)
T ss_pred -------CcEEEeecchhhhhcCCccc----------cccccccccccChHHhcC---CCCCCcHHHHHHHHHHHHHHHh
Confidence 45999999999755332111 122357889999999865 2456889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCC---CchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE---KPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|..||.+.+..+....+...........+....... .+........ ........+..+.++|.+||+.||.+||+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~ 274 (284)
T cd07836 197 GRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP--EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS 274 (284)
T ss_pred CCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc--hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC
Confidence 999998877666655554432222222222211100 0000000000 00111234567899999999999999999
Q ss_pred HHHHHHH
Q 003185 821 AGDLYEM 827 (840)
Q Consensus 821 a~ELLeh 827 (840)
+.++++|
T Consensus 275 ~~~~l~~ 281 (284)
T cd07836 275 AHDALQH 281 (284)
T ss_pred HHHHhcC
Confidence 9999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=313.27 Aligned_cols=255 Identities=28% Similarity=0.404 Sum_probs=199.5
Q ss_pred CCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
..++|++.+.||+|+||+||++.+. +..+|+|+..... ... ....+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSS----VRKQILRELQIMHECRSPYIVSFYGAFLNE 75 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cch----HHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence 3568999999999999999999974 7788999865331 111 233458999999999999999999998865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCCCcEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENIL 659 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs-~gIVHRDLKPeNIL 659 (840)
. ..++||||+++++|..++.. ...+++..+..++.+++.||.|||+ .+|+||||||+||+
T Consensus 76 ~--------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil 136 (284)
T cd06620 76 N--------------NICMCMEFMDCGSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNIL 136 (284)
T ss_pred C--------------EEEEEEecCCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEE
Confidence 4 35999999999999999875 3468999999999999999999997 59999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.++|+|||++....... .....|+..|+|||++.+ ..++.++|||||||++|
T Consensus 137 ~~~~-------~~~~l~d~gl~~~~~~~~------------~~~~~~~~~~~aPE~~~~----~~~~~~~Di~slG~~l~ 193 (284)
T cd06620 137 VNSR-------GQIKLCDFGVSGELINSI------------ADTFVGTSTYMSPERIQG----GKYTVKSDVWSLGISII 193 (284)
T ss_pred ECCC-------CcEEEccCCcccchhhhc------------cCccccCcccCCHHHHcc----CCCCccchHHHHHHHHH
Confidence 9876 469999999986542211 122468999999999875 56788999999999999
Q ss_pred HHHhCCCCCCCCCHH-----------HHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHH
Q 003185 740 ELLTLQVPYMGLSEL-----------EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 808 (840)
Q Consensus 740 ELLTG~~PF~~~~~~-----------el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~ 808 (840)
+|++|..||...... .....+.....+.++ ....+..+.+|+.
T Consensus 194 ~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~ 247 (284)
T cd06620 194 ELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP--------------------------SSDFPEDLRDFVD 247 (284)
T ss_pred HHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC--------------------------chhcCHHHHHHHH
Confidence 999999999765432 111111111111111 0113457899999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhc
Q 003185 809 RCTEENPTERPTAGDLYEMFVART 832 (840)
Q Consensus 809 rCL~~DP~eRPSa~ELLehLe~l~ 832 (840)
+||..||.+|||+.|+++|+.-+.
T Consensus 248 ~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 248 ACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred HHhcCCcccCcCHHHHhcCccccc
Confidence 999999999999999999865544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=313.44 Aligned_cols=292 Identities=21% Similarity=0.243 Sum_probs=201.0
Q ss_pred CceeeeeecccCceEEEEEEE----CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~----~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+|.+.+.||+|+||.||+|.+ .+..+|+|++..... ....+...+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-----QYTGISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-----cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 588999999999999999997 458899998764321 11112233478999999999999999999988652
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. ...++||||++ ++|.+++..........+++..++.++.||+.||.|||+++|+||||||+|||++
T Consensus 76 ~------------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~ 142 (316)
T cd07842 76 D------------KSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVM 142 (316)
T ss_pred C------------ceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEc
Confidence 1 24699999997 4888887654333334789999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.++. ..+.+||+|||++......... ........+|+.|+|||++.+ ...++.++|||||||+||+|
T Consensus 143 ~~~~---~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~~l 209 (316)
T cd07842 143 GEGP---ERGVVKIGDLGLARLFNAPLKP-------LADLDPVVVTIWYRAPELLLG---ARHYTKAIDIWAIGCIFAEL 209 (316)
T ss_pred CCCC---ccceEEECCCccccccCCCccc-------ccccCCccccccccCHHHHhC---CCCCCcHHHHHHHHHHHHHH
Confidence 7321 2367999999999866432211 111233468899999999865 24578899999999999999
Q ss_pred HhCCCCCCCCCHHH---------HHHHHHcCCCCCcchHHhhhccCccc-cc--cccCCCCCCchh----h--hhhHHHH
Q 003185 742 LTLQVPYMGLSELE---------IHDLIQMGKRPRLTDELEALGSCHEH-EV--AQSGSGFEKPEA----E--LETLSFL 803 (840)
Q Consensus 742 LTG~~PF~~~~~~e---------l~~~I~~~~~p~l~~~l~~~~~~~~~-~~--~~~~~~~~~~~~----~--~~~s~~L 803 (840)
++|+.||.+..... ....+........+..+......... .. ............ . ...+..+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (316)
T cd07842 210 LTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQG 289 (316)
T ss_pred HhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHH
Confidence 99999997654321 11111111111111111000000000 00 000000000000 0 1345678
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHH
Q 003185 804 VDVFRRCTEENPTERPTAGDLYEMF 828 (840)
Q Consensus 804 ~dLI~rCL~~DP~eRPSa~ELLehL 828 (840)
.+++.+||..||.+|||+.++++|.
T Consensus 290 ~~~i~~~l~~~P~~Rps~~eil~~~ 314 (316)
T cd07842 290 FDLLRKLLEYDPTKRITAEEALEHP 314 (316)
T ss_pred HHHHHHHhcCCcccCcCHHHHhcCC
Confidence 9999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.59 Aligned_cols=281 Identities=21% Similarity=0.253 Sum_probs=200.9
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+++|++.+.||.|++|.||+|.+ .+..+++|....... .....+ .+.+|+.++++++||||+++++++....
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPS----TAIREISLLKEMQHGNIVRLQDVVHSEK 74 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchH----HHHHHHHHHHhccCCCEeeEEEEEecCC
Confidence 46899999999999999999987 467789988644321 111112 3378999999999999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .|+||||++ ++|.+++.. .....+++..++.++.||+.||+|||++||+|+||||+||+++
T Consensus 75 ~--------------~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~ 136 (294)
T PLN00009 75 R--------------LYLVFEYLD-LDLKKHMDS---SPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID 136 (294)
T ss_pred e--------------EEEEEeccc-ccHHHHHHh---CCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE
Confidence 3 599999996 588888764 2223467889999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
..+ ..+||+|||++......... .....+++.|+|||++.+ ...++.++|||||||++|+|
T Consensus 137 ~~~------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~i~~~l 197 (294)
T PLN00009 137 RRT------NALKLADFGLARAFGIPVRT----------FTHEVVTLWYRAPEILLG---SRHYSTPVDIWSVGCIFAEM 197 (294)
T ss_pred CCC------CEEEEcccccccccCCCccc----------cccCceeecccCHHHHhC---CCCCCcHHHHHHHHHHHHHH
Confidence 542 46999999999755322111 122357899999999865 24578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCC---CCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF---EKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
+||..||...+..+....+...........+........ .......+ .........++.+.+++.+||+.+|.+|
T Consensus 198 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 275 (294)
T PLN00009 198 VNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD--YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKR 275 (294)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh--hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhC
Confidence 999999988776655544433211111111111000000 00000000 0001112345678999999999999999
Q ss_pred CCHHHHHHHHH
Q 003185 819 PTAGDLYEMFV 829 (840)
Q Consensus 819 PSa~ELLehLe 829 (840)
|++.++++|-.
T Consensus 276 ps~~~~l~~~~ 286 (294)
T PLN00009 276 ITARAALEHEY 286 (294)
T ss_pred cCHHHHhcCch
Confidence 99999999854
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=340.43 Aligned_cols=252 Identities=24% Similarity=0.403 Sum_probs=206.9
Q ss_pred eeeeeecccCceEEEEEEECCe--eEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCC
Q 003185 508 SSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 585 (840)
Q Consensus 508 ~i~~~LG~G~fG~Vy~a~~~~~--~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~ 585 (840)
.....||+|+|-+||+|.+... .||--.+.+..........+.| ..|+.+|+.|+|||||++|..+.+....
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~----~~Ev~lLKsL~H~NIirfy~SW~d~~n~-- 116 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERL----YSEVHLLKSLKHPNIIRFYDSWVDTDNK-- 116 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHH----HHHHHHHccCCCCceeeeeeheecCCCc--
Confidence 4567899999999999998444 4443333344444444444555 9999999999999999999999876532
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeecccCCCCcEEEecc
Q 003185 586 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--HIMHRDIKSENILIDLE 663 (840)
Q Consensus 586 ~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~--gIVHRDLKPeNILLd~~ 663 (840)
...+|+|++..|+|..|+++ -+.++.+.++.|++||++||.|||++ .|||||||-+||||+.+
T Consensus 117 ----------~in~iTEL~TSGtLr~Y~kk-----~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~ 181 (632)
T KOG0584|consen 117 ----------TINFITELFTSGTLREYRKK-----HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN 181 (632)
T ss_pred ----------eeeeeeecccCCcHHHHHHH-----hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC
Confidence 45899999999999999998 36788999999999999999999998 69999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
.+.|||+|+|+|....... ...++|||.|||||++. ..|++.+||||||++|+||+|
T Consensus 182 ------~G~VKIGDLGLAtl~r~s~------------aksvIGTPEFMAPEmYE-----E~YnE~VDVYaFGMCmLEMvT 238 (632)
T KOG0584|consen 182 ------LGEVKIGDLGLATLLRKSH------------AKSVIGTPEFMAPEMYE-----ENYNELVDVYAFGMCMLEMVT 238 (632)
T ss_pred ------cCceeecchhHHHHhhccc------------cceeccCccccChHHHh-----hhcchhhhhhhhhHHHHHHHh
Confidence 3789999999998765422 23478999999999997 478999999999999999999
Q ss_pred CCCCCCC-CCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 744 LQVPYMG-LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 744 G~~PF~~-~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
+..||.. .++.+++.++..+..|. .+... ..+++++||.+||.. ..+|||+.
T Consensus 239 ~eYPYsEC~n~AQIYKKV~SGiKP~---sl~kV-----------------------~dPevr~fIekCl~~-~~~R~sa~ 291 (632)
T KOG0584|consen 239 SEYPYSECTNPAQIYKKVTSGIKPA---ALSKV-----------------------KDPEVREFIEKCLAT-KSERLSAK 291 (632)
T ss_pred ccCChhhhCCHHHHHHHHHcCCCHH---Hhhcc-----------------------CCHHHHHHHHHHhcC-chhccCHH
Confidence 9999965 57899999999886542 22111 134789999999999 99999999
Q ss_pred HHHHHHHh
Q 003185 823 DLYEMFVA 830 (840)
Q Consensus 823 ELLehLe~ 830 (840)
|+|++-.-
T Consensus 292 eLL~d~Ff 299 (632)
T KOG0584|consen 292 ELLKDPFF 299 (632)
T ss_pred HHhhChhh
Confidence 99998543
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=320.06 Aligned_cols=283 Identities=20% Similarity=0.258 Sum_probs=203.2
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||.||+|.+ .+..||+|+.... .. . .....+.+|+.++++++||||+++++++.....
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~-~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 77 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EH-Q----TFCQRTLREIKILRRFKHENIIGILDIIRPPSF 77 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--cc-c----hhHHHHHHHHHHHHhCCCCCcCchhheeecccc
Confidence 5899999999999999999986 5678999986421 11 1 122334889999999999999999998765432
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
. .....|+||||+. ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 78 ~---------~~~~~~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~ 141 (336)
T cd07849 78 E---------SFNDVYIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 141 (336)
T ss_pred c---------ccceEEEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC
Confidence 1 2235699999997 588888764 46899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||++......... ........||+.|+|||.+.+ ...++.++|||||||++|+|+
T Consensus 142 ~-------~~~kl~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslGvil~el~ 204 (336)
T cd07849 142 N-------CDLKICDFGLARIADPEHDH-------TGFLTEYVATRWYRAPEIMLN---SKGYTKAIDIWSVGCILAEML 204 (336)
T ss_pred C-------CCEEECcccceeeccccccc-------cCCcCCcCcCCCccChHHhhC---CCCCCcHHHHHHHHHHHHHHH
Confidence 7 45999999998765432111 001123468999999998764 245788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccC---CCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG---SGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|+.||.+.+.......+........++.+..........+.... ............+..+.+||.+||+.+|.+||
T Consensus 205 ~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 284 (336)
T cd07849 205 SNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI 284 (336)
T ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCc
Confidence 999999877665544444332222222222111100000000000 00000111123466799999999999999999
Q ss_pred CHHHHHHH
Q 003185 820 TAGDLYEM 827 (840)
Q Consensus 820 Sa~ELLeh 827 (840)
|+.++++|
T Consensus 285 t~~e~l~h 292 (336)
T cd07849 285 TVEEALAH 292 (336)
T ss_pred CHHHHhcC
Confidence 99999999
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=309.74 Aligned_cols=250 Identities=29% Similarity=0.411 Sum_probs=200.1
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
-|++.+.||.|+||.||+|.+ .+..+|+|+..... ..... ..+.+|+.++.+++||||+++++++.....
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~- 76 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEI----EDIQQEITVLSQCDSPYVTKYYGSYLKDTK- 76 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHH----HHHHHHHHHHHhcCCCCEeEEEEEEEeCCe-
Confidence 367888999999999999986 56788999864321 11222 344889999999999999999999986553
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.++||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.+
T Consensus 77 -------------~~lv~e~~~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~ 137 (277)
T cd06641 77 -------------LWIIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH 137 (277)
T ss_pred -------------EEEEEEeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC
Confidence 4999999999999999864 468899999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.++|+|||++..+...... .....++..|+|||.+.+ ..++.++|||||||++|+|++
T Consensus 138 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slG~~l~~l~~ 196 (277)
T cd06641 138 -------GEVKLADFGVAGQLTDTQIK----------RNTFVGTPFWMAPEVIKQ----SAYDSKADIWSLGITAIELAK 196 (277)
T ss_pred -------CCEEEeecccceecccchhh----------hccccCCccccChhhhcc----CCCCchhhHHHHHHHHHHHHc
Confidence 45999999998765432110 122357889999999875 566889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~E 823 (840)
|..||...........+.....+.+. ...+..+.+++.+||..+|.+||++.+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 249 (277)
T cd06641 197 GEPPHSELHPMKVLFLIPKNNPPTLE---------------------------GNYSKPLKEFVEACLNKEPSFRPTAKE 249 (277)
T ss_pred CCCCCCccchHHHHHHHhcCCCCCCC---------------------------cccCHHHHHHHHHHccCChhhCcCHHH
Confidence 99999877666655555443332222 112457899999999999999999999
Q ss_pred HHHHHHh
Q 003185 824 LYEMFVA 830 (840)
Q Consensus 824 LLehLe~ 830 (840)
+++|..-
T Consensus 250 ~l~~~~~ 256 (277)
T cd06641 250 LLKHKFI 256 (277)
T ss_pred HHhCHHH
Confidence 9998443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=313.92 Aligned_cols=265 Identities=23% Similarity=0.279 Sum_probs=200.5
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||.||++.. .+..+++|....... ........+.+|+.+++.++||||+++++.+.....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-----ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-----hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCE
Confidence 4789999999999999999987 456788887643211 111122345889999999999999999999876543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.++||||++|++|.+++.. ...+++..+..++.|++.||.|||++||+||||||.|||++.
T Consensus 76 --------------~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~ 136 (305)
T cd05609 76 --------------LCMVMEYVEGGDCATLLKN-----IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITS 136 (305)
T ss_pred --------------EEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECC
Confidence 5999999999999999976 346899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCccccccccccccc-----ccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCI-----AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~-----~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
+ +.+||+|||+++........... ............|+..|+|||.+.. ..++.++|||||||+
T Consensus 137 ~-------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~v 205 (305)
T cd05609 137 M-------GHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR----QGYGKPVDWWAMGII 205 (305)
T ss_pred C-------CCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccC----CCCCchhhHHHHHHH
Confidence 6 46999999998742211111000 0000011122457889999999875 567899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
+|||++|..||.+....++...+.....+.... ....+..+.+||.+||+.||.+
T Consensus 206 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~P~~ 260 (305)
T cd05609 206 LYEFLVGCVPFFGDTPEELFGQVISDDIEWPEG-------------------------DEALPADAQDLISRLLRQNPLE 260 (305)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCc-------------------------cccCCHHHHHHHHHHhccChhh
Confidence 999999999998887777666655442211000 0123557899999999999999
Q ss_pred CCC---HHHHHHHHH
Q 003185 818 RPT---AGDLYEMFV 829 (840)
Q Consensus 818 RPS---a~ELLehLe 829 (840)
||+ +.++++|..
T Consensus 261 R~~~~~~~~ll~~~~ 275 (305)
T cd05609 261 RLGTGGAFEVKQHRF 275 (305)
T ss_pred ccCccCHHHHHhCcc
Confidence 998 566676643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.00 Aligned_cols=258 Identities=30% Similarity=0.480 Sum_probs=200.2
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|.+.+.||+|+||.||+|.. .+..+++|+....... .... ..+.+|+.++++++|+||+++++++....
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~----~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-- 72 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND--PKTI----KEIADEMKVLELLKHPNLVKYYGVEVHRE-- 72 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc--hHHH----HHHHHHHHHHHhCCCCChhheeeeEecCC--
Confidence 588999999999999999986 5678999987644321 2223 34599999999999999999999876544
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~ 135 (264)
T cd06626 73 ------------KVYIFMEYCSGGTLEELLEH-----GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN 135 (264)
T ss_pred ------------EEEEEEecCCCCcHHHHHhh-----cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC
Confidence 35999999999999999975 3457899999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.+||+|||++........... .......+++.|+|||++.+.. ...++.++||||||+++|+|++
T Consensus 136 -------~~~kl~d~g~~~~~~~~~~~~~------~~~~~~~~~~~~~~PE~~~~~~-~~~~~~~~Dv~s~G~il~~l~~ 201 (264)
T cd06626 136 -------GVIKLGDFGCAVKLKNNTTTMG------EEVQSLAGTPAYMAPEVITGGK-GKGHGRAADIWSLGCVVLEMAT 201 (264)
T ss_pred -------CCEEEcccccccccCCCCCccc------ccccCCcCCcCccChhhccCCC-CCCCCcccchHHHHHHHHHHHh
Confidence 4599999999987654322110 0011245789999999997621 1237889999999999999999
Q ss_pred CCCCCCCCC-HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 744 LQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 744 G~~PF~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
|+.||.... .......+.....+.++.. ...+..+.++|.+||+.+|.+||++.
T Consensus 202 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~li~~~l~~~p~~R~~~~ 256 (264)
T cd06626 202 GKRPWSELDNEFQIMFHVGAGHKPPIPDS-------------------------LQLSPEGKDFLDRCLESDPKKRPTAS 256 (264)
T ss_pred CCCCccCCcchHHHHHHHhcCCCCCCCcc-------------------------cccCHHHHHHHHHHccCCcccCCCHH
Confidence 999997653 3333333333333222210 11245788999999999999999999
Q ss_pred HHHHH
Q 003185 823 DLYEM 827 (840)
Q Consensus 823 ELLeh 827 (840)
+++.|
T Consensus 257 ~i~~~ 261 (264)
T cd06626 257 ELLQH 261 (264)
T ss_pred HHhcC
Confidence 99876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=306.46 Aligned_cols=261 Identities=23% Similarity=0.345 Sum_probs=202.1
Q ss_pred CceeeeeecccCceEEEEEEEC---CeeEEEEEEecccCCCChH--HHHHhHHhHHHHHHHHHh-CCCCCcceeeeEEec
Q 003185 506 SLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSAD--EIRNFEYSCLGEVRMLGA-LRHSCIVEMYGHKIS 579 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~---~~~vAVKI~~lk~~~~~~~--~~~~f~~~~~rEi~iL~~-L~HpNIV~l~g~~~~ 579 (840)
+|++.+.||+|+||.||+|.+. +..+|+|............ ........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4788999999999999999974 4788999865443221100 111112334788888875 789999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCCCcE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENI 658 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs-~gIVHRDLKPeNI 658 (840)
.. ..++||||+++++|.+++...... ...+++..++.++.|++.||.|||. .+|+|+||||+||
T Consensus 81 ~~--------------~~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~ni 145 (269)
T cd08528 81 ND--------------RLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNI 145 (269)
T ss_pred CC--------------eEEEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHE
Confidence 54 359999999999999998653222 3568999999999999999999996 7899999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.+ +.++|+|||++....... ......|+..|+|||++.+ ..++.++||||||+++
T Consensus 146 l~~~~-------~~~~l~dfg~~~~~~~~~-----------~~~~~~~~~~~~~Pe~~~~----~~~~~~~Dv~slG~ll 203 (269)
T cd08528 146 MLGED-------DKVTITDFGLAKQKQPES-----------KLTSVVGTILYSCPEIVKN----EPYGEKADVWAFGCIL 203 (269)
T ss_pred EECCC-------CcEEEecccceeeccccc-----------ccccccCcccCcChhhhcC----CCCchHHHHHHHHHHH
Confidence 99877 469999999997654321 0123458899999999975 5678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 739 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
|+|++|..||...........+.......... ...+..+.+||.+||+.||.+|
T Consensus 204 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~cl~~~p~~R 257 (269)
T cd08528 204 YQMCTLQPPFYSTNMLSLATKIVEAVYEPLPE--------------------------GMYSEDVTDVITSCLTPDAEAR 257 (269)
T ss_pred HHHHhCCCcccccCHHHHHHHHhhccCCcCCc--------------------------ccCCHHHHHHHHHHCCCCCccC
Confidence 99999999998776666665554443221110 0124578999999999999999
Q ss_pred CCHHHHHHHHH
Q 003185 819 PTAGDLYEMFV 829 (840)
Q Consensus 819 PSa~ELLehLe 829 (840)
|++.|+.+++.
T Consensus 258 p~~~e~~~~~~ 268 (269)
T cd08528 258 PDIIQVSAMIS 268 (269)
T ss_pred CCHHHHHHHhc
Confidence 99999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=305.92 Aligned_cols=275 Identities=23% Similarity=0.284 Sum_probs=198.3
Q ss_pred ceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEecCCCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWL 583 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~~~~~ 583 (840)
|++.+.||+|+||.||+|.. .+..+|+|+..... ...... . ..+|+.++.++. ||||+++++++.....
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~--~~~~~~-~----~~~e~~~l~~l~~h~~i~~~~~~~~~~~~- 72 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF--KSLEQV-N----NLREIQALRRLSPHPNILRLIEVLFDRKT- 72 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhcc--CCchhh-h----HHHHHHHHhhcCCCCCccceEEEEecCCC-
Confidence 67899999999999999987 56788998764322 111111 1 257899999996 9999999999876521
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
...++||||+. ++|.+++.. ....+++..++.++.||+.||.|||+.||+||||||+||+++.
T Consensus 73 -----------~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~- 135 (282)
T cd07831 73 -----------GRLALVFELMD-MNLYELIKG----RKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD- 135 (282)
T ss_pred -----------CcEEEEEecCC-ccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-
Confidence 13599999997 588888865 2246899999999999999999999999999999999999986
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+ .+||+|||++........ .....++..|+|||++.. ...++.++|||||||++|||++
T Consensus 136 ~-------~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slGv~l~el~~ 194 (282)
T cd07831 136 D-------ILKLADFGSCRGIYSKPP-----------YTEYISTRWYRAPECLLT---DGYYGPKMDIWAVGCVFFEILS 194 (282)
T ss_pred C-------CeEEEecccccccccCCC-----------cCCCCCCcccCChhHhhc---CCCCCcchhHHHHHHHHHHHHc
Confidence 3 599999999976533211 122357899999998754 2456889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcccc--ccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE--VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
|..||.+.+..+....+...................... ++.. ............+..+.+||.+||.++|.+||++
T Consensus 195 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 273 (282)
T cd07831 195 LFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSK-KGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA 273 (282)
T ss_pred CCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCccc-ccccHHHHcccccHHHHHHHHHHhccCcccccCH
Confidence 999999887776665554432211111111100000000 0000 0000011122446789999999999999999999
Q ss_pred HHHHHHH
Q 003185 822 GDLYEMF 828 (840)
Q Consensus 822 ~ELLehL 828 (840)
.++++|-
T Consensus 274 ~~~l~~~ 280 (282)
T cd07831 274 KQALRHP 280 (282)
T ss_pred HHHhhCC
Confidence 9999874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=331.19 Aligned_cols=260 Identities=24% Similarity=0.425 Sum_probs=219.1
Q ss_pred CceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 585 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~ 585 (840)
+....++||-|.||.||.|.|+.-...|.++.++.. ..++++| +.|+++|+.++|||+|+++|+|..+..+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEF----LkEAAvMKeikHpNLVqLLGVCT~EpPF-- 338 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTHEPPF-- 338 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHH----HHHHHHHHhhcCccHHHHhhhhccCCCe--
Confidence 456789999999999999999765544444445542 3345566 9999999999999999999999876644
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccc
Q 003185 586 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 665 (840)
Q Consensus 586 ~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~ 665 (840)
|||+|||..|+|.+||+. .++..++.-..+.|+.||..||.||..+++|||||-..|.|+..+
T Consensus 339 ------------YIiTEfM~yGNLLdYLRe---cnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEn-- 401 (1157)
T KOG4278|consen 339 ------------YIITEFMCYGNLLDYLRE---CNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-- 401 (1157)
T ss_pred ------------EEEEecccCccHHHHHHH---hchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccccc--
Confidence 999999999999999987 344567888899999999999999999999999999999999987
Q ss_pred cCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-C
Q 003185 666 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 744 (840)
Q Consensus 666 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT-G 744 (840)
..||++|||+++.+.....+. +.+ ..-.+.|.|||-+.. ..++.|+|||+|||+|||+.| |
T Consensus 402 -----hiVKvADFGLsRlMtgDTYTA---HAG------AKFPIKWTAPEsLAy----NtFSiKSDVWAFGVLLWEIATYG 463 (1157)
T KOG4278|consen 402 -----HIVKVADFGLSRLMTGDTYTA---HAG------AKFPIKWTAPESLAY----NTFSIKSDVWAFGVLLWEIATYG 463 (1157)
T ss_pred -----ceEEeeccchhhhhcCCceec---ccC------ccCcccccCcccccc----cccccchhhHHHHHHHHHHHhcC
Confidence 679999999999887654431 111 123478999999986 678999999999999999998 8
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 003185 745 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 824 (840)
Q Consensus 745 ~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~EL 824 (840)
..||++.+..+++..+.++.+..-++ .+++.+++||..||+++|.+||++.||
T Consensus 464 MsPYPGidlSqVY~LLEkgyRM~~Pe---------------------------GCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 464 MSPYPGIDLSQVYGLLEKGYRMDGPE---------------------------GCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred CCCCCCccHHHHHHHHhccccccCCC---------------------------CCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 99999999999999999987754442 346689999999999999999999999
Q ss_pred HHHHHhhcCCCC
Q 003185 825 YEMFVARTSSSI 836 (840)
Q Consensus 825 LehLe~l~~~~~ 836 (840)
-+.|+.|.++++
T Consensus 517 HqafEtmf~~sS 528 (1157)
T KOG4278|consen 517 HQAFETMFSSSS 528 (1157)
T ss_pred HHHHHHHhcccc
Confidence 999999877654
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=310.71 Aligned_cols=278 Identities=20% Similarity=0.248 Sum_probs=198.9
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|++.+.||.|+||.||+|.+ .+..+++|....+.. .... ...+.+|++++++++||||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~- 73 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGV----PSTAIREISLLKELNHPNIVKLLDVIHTENK- 73 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc--cccc----chHHHHHHHHHHhcCCCCCcchhhhcccCCc-
Confidence 488999999999999999987 567888887654321 1111 1234889999999999999999999875543
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.++||||+. ++|..++.. .....+++..++.++.||+.||+|||++|++|+||+|+||+++.+
T Consensus 74 -------------~~~v~e~~~-~~l~~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~ 136 (284)
T cd07860 74 -------------LYLVFEFLH-QDLKKFMDA---SPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE 136 (284)
T ss_pred -------------EEEEeeccc-cCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC
Confidence 499999996 689998865 233568999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.+||+|||++......... .....+++.|+|||++.+ ...++.++|||||||++|+|+|
T Consensus 137 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~~l~t 196 (284)
T cd07860 137 -------GAIKLADFGLARAFGVPVRT----------YTHEVVTLWYRAPEILLG---CKYYSTAVDIWSLGCIFAEMVT 196 (284)
T ss_pred -------CCEEEeeccchhhcccCccc----------cccccccccccCCeEEec---CCCCCcHHHHHHHHHHHHHHHH
Confidence 45999999998755332111 122246889999998865 2346889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcc--ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE--HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
|+.||.+.+.......+...........++....... ..+..... ..........+..+.++|.+||+.||.+|||+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 275 (284)
T cd07860 197 RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWAR-QDFSKVVPPLDEDGRDLLSQMLHYDPNKRISA 275 (284)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccc-cCHHHHcccCCHHHHHHHHHhcCCCcccCCCH
Confidence 9999987766554444333211111111110000000 00000000 00001112235678899999999999999999
Q ss_pred HHHHHHH
Q 003185 822 GDLYEMF 828 (840)
Q Consensus 822 ~ELLehL 828 (840)
.++++|.
T Consensus 276 ~~~l~~~ 282 (284)
T cd07860 276 KAALAHP 282 (284)
T ss_pred HHHhcCC
Confidence 9999873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=309.48 Aligned_cols=253 Identities=32% Similarity=0.497 Sum_probs=198.9
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC---CCCcceeeeEEecC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKISS 580 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~---HpNIV~l~g~~~~~ 580 (840)
.|++.+.||+|+||.||+|.+ .+..+++|+..... ....... +.+|+.++++++ ||||+++++++...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~----~~~e~~~l~~l~~~~~~~vi~~~~~~~~~ 74 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSD----IQREVALLSQLRQSQPPNITKYYGSYLKG 74 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHH----HHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence 478889999999999999997 56789999865432 1222233 378999999997 99999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
. ..++||||+++++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||+|+||++
T Consensus 75 ~--------------~~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i 134 (277)
T cd06917 75 P--------------RLWIIMEYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV 134 (277)
T ss_pred C--------------EEEEEEecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE
Confidence 4 35999999999999999864 368899999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.++|+|||++......... .....|+..|+|||.+.+ ...++.++|||||||++|+
T Consensus 135 ~~~-------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~~ 194 (277)
T cd06917 135 TNT-------GNVKLCDFGVAALLNQNSSK----------RSTFVGTPYWMAPEVITE---GKYYDTKADIWSLGITIYE 194 (277)
T ss_pred cCC-------CCEEEccCCceeecCCCccc----------cccccCCcceeCHHHhcc---CCccccchhHHHHHHHHHH
Confidence 976 46999999999766432211 122368999999999864 2456889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|++|..||.+.........+.....+.++. ...+..+.+++.+||..||.+||+
T Consensus 195 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~i~~~l~~~p~~R~~ 248 (277)
T cd06917 195 MATGNPPYSDVDAFRAMMLIPKSKPPRLED--------------------------NGYSKLLREFVAACLDEEPKERLS 248 (277)
T ss_pred HHhCCCCCCCCChhhhhhccccCCCCCCCc--------------------------ccCCHHHHHHHHHHcCCCcccCcC
Confidence 999999998776554443332221111110 013457899999999999999999
Q ss_pred HHHHHHHHHhh
Q 003185 821 AGDLYEMFVAR 831 (840)
Q Consensus 821 a~ELLehLe~l 831 (840)
+.+++.|-+-.
T Consensus 249 ~~~il~~~~~~ 259 (277)
T cd06917 249 AEELLKSKWIK 259 (277)
T ss_pred HHHHhhChHhh
Confidence 99999985543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=321.10 Aligned_cols=254 Identities=27% Similarity=0.410 Sum_probs=211.7
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
+-|.++.+||+|+||.||+|.+ .+..+|+|.+.+. .+++++ .+|+.||+++..|++|++||.|.....
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEI----IKEISIMQQC~S~yVVKYYGSYFK~sD 102 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEI----IKEISIMQQCKSKYVVKYYGSYFKHSD 102 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHH----HHHHHHHHHcCCchhhhhhhhhccCCc
Confidence 3478899999999999999987 5667777765443 234444 899999999999999999998875543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
+|||||||..|++.+.++. .++.+++.++..+++..+.||+|||...-||||||..|||++.
T Consensus 103 --------------LWIVMEYCGAGSiSDI~R~----R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT 164 (502)
T KOG0574|consen 103 --------------LWIVMEYCGAGSISDIMRA----RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNT 164 (502)
T ss_pred --------------eEeehhhcCCCcHHHHHHH----hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcc
Confidence 5999999999999999986 3578999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||.|-.+...... .++++|||.|||||++.. ..|+.++||||||++..||.
T Consensus 165 ~-------G~AKLADFGVAGQLTDTMAK----------RNTVIGTPFWMAPEVI~E----IGY~~~ADIWSLGITaIEMA 223 (502)
T KOG0574|consen 165 D-------GIAKLADFGVAGQLTDTMAK----------RNTVIGTPFWMAPEVIEE----IGYDTKADIWSLGITAIEMA 223 (502)
T ss_pred c-------chhhhhhccccchhhhhHHh----------hCccccCcccccHHHHHH----hccchhhhHhhhcchhhhhh
Confidence 8 56999999999877654332 356789999999999986 67899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
.|++||....+...+..|-....|.+. ++ ..-+.++.+++.+||...|++|-||-
T Consensus 224 EG~PPYsDIHPMRAIFMIPT~PPPTF~----------------------KP---E~WS~~F~DFi~~CLiK~PE~R~TA~ 278 (502)
T KOG0574|consen 224 EGRPPYSDIHPMRAIFMIPTKPPPTFK----------------------KP---EEWSSEFNDFIRSCLIKKPEERKTAL 278 (502)
T ss_pred cCCCCcccccccceeEeccCCCCCCCC----------------------Ch---HhhhhHHHHHHHHHhcCCHHHHHHHH
Confidence 999999888777665555444433332 11 12356799999999999999999999
Q ss_pred HHHHHHHhhc
Q 003185 823 DLYEMFVART 832 (840)
Q Consensus 823 ELLehLe~l~ 832 (840)
++++|..-..
T Consensus 279 ~L~~H~Fikn 288 (502)
T KOG0574|consen 279 RLCEHTFIKN 288 (502)
T ss_pred HHhhhhhhcC
Confidence 9999976443
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=302.79 Aligned_cols=251 Identities=28% Similarity=0.443 Sum_probs=201.6
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||.|++|.||+|.. .+..+++|+....... ... ..+.+|+.++.+++||||+++++++....
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~---~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE---EFR----KQLLRELKTLRSCESPYVVKCYGAFYKEG- 72 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch---HHH----HHHHHHHHHHHhcCCCCeeeEEEEEccCC-
Confidence 3689999999999999999987 4778899886543211 222 34489999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCCCcEEEe
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILID 661 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs-~gIVHRDLKPeNILLd 661 (840)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+ .|++|+||+|+||+++
T Consensus 73 -------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~ 134 (264)
T cd06623 73 -------------EISIVLEYMDGGSLADLLKK-----VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN 134 (264)
T ss_pred -------------eEEEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC
Confidence 35999999999999999976 2568999999999999999999999 9999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.++|+|||++......... .....++..|+|||.+.. ..++.++||||||+++|+|
T Consensus 135 ~~-------~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slG~il~~l 193 (264)
T cd06623 135 SK-------GEVKIADFGISKVLENTLDQ----------CNTFVGTVTYMSPERIQG----ESYSYAADIWSLGLTLLEC 193 (264)
T ss_pred CC-------CCEEEccCccceecccCCCc----------ccceeecccccCHhhhCC----CCCCchhhHHHHHHHHHHH
Confidence 77 45999999998766432211 123457899999999876 5678999999999999999
Q ss_pred HhCCCCCCCC---CHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 742 LTLQVPYMGL---SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 742 LTG~~PF~~~---~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
++|..||... ...+....+.....+.++.. ..+..+.++|.+||..+|.+|
T Consensus 194 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~l~~li~~~l~~~p~~R 247 (264)
T cd06623 194 ALGKFPFLPPGQPSFFELMQAICDGPPPSLPAE--------------------------EFSPEFRDFISACLQKDPKKR 247 (264)
T ss_pred HhCCCCCccccccCHHHHHHHHhcCCCCCCCcc--------------------------cCCHHHHHHHHHHccCChhhC
Confidence 9999999766 34444444443322222110 035579999999999999999
Q ss_pred CCHHHHHHHH
Q 003185 819 PTAGDLYEMF 828 (840)
Q Consensus 819 PSa~ELLehL 828 (840)
|++.++++|-
T Consensus 248 ~~~~~ll~~~ 257 (264)
T cd06623 248 PSAAELLQHP 257 (264)
T ss_pred CCHHHHHhCH
Confidence 9999999984
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=312.32 Aligned_cols=259 Identities=27% Similarity=0.396 Sum_probs=203.0
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
+...|.+.+.||+|+||.||+|.. .+..+++|+..... .......+ .+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~----~~~~Ei~~l~~l~h~niv~~~~~~~~~ 87 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQ----DIIKEVRFLQQLRHPNTIEYKGCYLRE 87 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccc-cCcHHHHH----HHHHHHHHHHhCCCCCEEEEEEEEEeC
Confidence 345699999999999999999986 57889999864332 11222223 348999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .++||||+. |+|.+++.. ....+++..+..++.||+.||.|||+.||+||||+|.||++
T Consensus 88 ~~--------------~~lv~e~~~-g~l~~~~~~----~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~ 148 (307)
T cd06607 88 HT--------------AWLVMEYCL-GSASDILEV----HKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL 148 (307)
T ss_pred Ce--------------EEEEHHhhC-CCHHHHHHH----cccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE
Confidence 53 499999997 588887764 12468999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.++|+|||++...... ....+++.|+|||++.+.. ...++.++||||||+++||
T Consensus 149 ~~~-------~~~kL~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~~~-~~~~~~~sDv~s~G~il~e 206 (307)
T cd06607 149 TEP-------GTVKLADFGSASLVSPA--------------NSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIE 206 (307)
T ss_pred CCC-------CCEEEeecCcceecCCC--------------CCccCCccccCceeeeccC-CCCCCcccchHHHHHHHHH
Confidence 877 45999999998654321 2235888999999985321 2557889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|+||..||.+.+.......+.....+.+.. ...+..+.+||.+||..+|.+||+
T Consensus 207 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~li~~~l~~~p~~Rp~ 260 (307)
T cd06607 207 LAERKPPLFNMNAMSALYHIAQNDSPTLSS--------------------------NDWSDYFRNFVDSCLQKIPQDRPS 260 (307)
T ss_pred HHcCCCCCCCccHHHHHHHHhcCCCCCCCc--------------------------hhhCHHHHHHHHHHhcCChhhCcC
Confidence 999999998877666555544432222211 112457899999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 003185 821 AGDLYEMFVARTS 833 (840)
Q Consensus 821 a~ELLehLe~l~~ 833 (840)
+.+|+.|..-...
T Consensus 261 ~~~il~~~~~~~~ 273 (307)
T cd06607 261 SEELLKHRFVLRE 273 (307)
T ss_pred HHHHhcChhhccc
Confidence 9999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=306.47 Aligned_cols=251 Identities=30% Similarity=0.431 Sum_probs=199.2
Q ss_pred CCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||.|+||.||++.+. +..+++|....... .... ..+.+|+.++++++||||+++++.+....
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~----~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 72 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN---EAIQ----KQILRELDILHKCNSPYIVGFYGAFYNNG- 72 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC---hHHH----HHHHHHHHHHHHCCCCchhhhheeeecCC-
Confidence 36888999999999999999984 67888887654321 1222 34489999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCCCcEEEe
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILID 661 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs-~gIVHRDLKPeNILLd 661 (840)
..++||||+++++|.+++... ...+++..+..++.||+.||+|||+ .|++|+||||+||+++
T Consensus 73 -------------~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~ 135 (265)
T cd06605 73 -------------DISICMEYMDGGSLDKILKEV----QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN 135 (265)
T ss_pred -------------EEEEEEEecCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC
Confidence 359999999999999999761 2578999999999999999999999 9999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.++|+|||.+........ ....++..|+|||++.+ ..++.++||||||+++|+|
T Consensus 136 ~~-------~~~~l~d~g~~~~~~~~~~------------~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slG~~l~~l 192 (265)
T cd06605 136 SR-------GQIKLCDFGVSGQLVNSLA------------KTFVGTSSYMAPERIQG----NDYSVKSDIWSLGLSLIEL 192 (265)
T ss_pred CC-------CCEEEeecccchhhHHHHh------------hcccCChhccCHHHHcC----CCCCchhhHHHHHHHHHHH
Confidence 76 4599999999876543211 11458899999999976 5678999999999999999
Q ss_pred HhCCCCCCCCC-----HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 742 LTLQVPYMGLS-----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 742 LTG~~PF~~~~-----~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
++|..||.... ..+....+.....+.++.. ..+..+.++|.+||..||.
T Consensus 193 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~li~~~l~~~p~ 246 (265)
T cd06605 193 ATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSG--------------------------KFSPDFQDFVNLCLIKDPR 246 (265)
T ss_pred HhCCCCCCccccccccHHHHHHHHhcCCCCCCChh--------------------------hcCHHHHHHHHHHcCCCch
Confidence 99999996542 2233333333332222211 1355789999999999999
Q ss_pred CCCCHHHHHHHHH
Q 003185 817 ERPTAGDLYEMFV 829 (840)
Q Consensus 817 eRPSa~ELLehLe 829 (840)
+|||+.+++.|..
T Consensus 247 ~Rpt~~~ll~~~~ 259 (265)
T cd06605 247 ERPSYKELLEHPF 259 (265)
T ss_pred hCcCHHHHhhCch
Confidence 9999999998854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.73 Aligned_cols=261 Identities=24% Similarity=0.348 Sum_probs=196.4
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHH-HHhCCCCCcceeeeEEecCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM-LGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~i-L~~L~HpNIV~l~g~~~~~~ 581 (840)
++|++.+.||+|+||.||++.+ .+..||+|...... ..... .. +..|+.+ ++.+.||||+++++++....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~-~~----~~~e~~~~~~~~~~~~iv~~~~~~~~~~ 73 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV--NSQEQ-KR----LLMDLDISMRSVDCPYTVTFYGALFREG 73 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCC--CcHHH-HH----HHHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence 4789999999999999999997 47889999865432 11121 22 2556665 66678999999999987655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCCCcEEE
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILI 660 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~-gIVHRDLKPeNILL 660 (840)
. .|+||||++ ++|.+++...... ...+++..++.++.||+.||+|||++ +++||||||+|||+
T Consensus 74 ~--------------~~lv~e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~ 137 (283)
T cd06617 74 D--------------VWICMEVMD-TSLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI 137 (283)
T ss_pred c--------------EEEEhhhhc-ccHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE
Confidence 3 499999997 6999998763322 35689999999999999999999998 99999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ ..+||+|||++..+..... .....|+..|+|||++.+......++.++|||||||++|+
T Consensus 138 ~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~ 199 (283)
T cd06617 138 NRN-------GQVKLCDFGISGYLVDSVA-----------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIE 199 (283)
T ss_pred CCC-------CCEEEeecccccccccccc-----------cccccCCccccChhhcCCcccccccCccccchhhHHHHHH
Confidence 877 4599999999876532111 1223588999999998753322456889999999999999
Q ss_pred HHhCCCCCCCC-CHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLTG~~PF~~~-~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|++|+.||... ...+....+.....+.++. ...+..+.+||.+||..+|.+||
T Consensus 200 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~~p~~Rp 253 (283)
T cd06617 200 LATGRFPYDSWKTPFQQLKQVVEEPSPQLPA--------------------------EKFSPEFQDFVNKCLKKNYKERP 253 (283)
T ss_pred HHhCCCCCCccccCHHHHHHHHhcCCCCCCc--------------------------cccCHHHHHHHHHHccCChhhCc
Confidence 99999999643 2223233332222222210 01345789999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 003185 820 TAGDLYEMFVART 832 (840)
Q Consensus 820 Sa~ELLehLe~l~ 832 (840)
++.+|++|..-..
T Consensus 254 ~~~~il~~~~~~~ 266 (283)
T cd06617 254 NYPELLQHPFFEL 266 (283)
T ss_pred CHHHHhcCchhhh
Confidence 9999999855444
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=314.80 Aligned_cols=256 Identities=27% Similarity=0.451 Sum_probs=201.9
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
..|.....||+|+||.||+|.. .+..+++|+...+.. ...+ .+.+|+.++..++||||+++++++.....
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~----~~~~e~~~l~~l~hp~i~~~~~~~~~~~~ 92 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----QRRE----LLFNEVVIMRDYQHQNVVEMYKSYLVGEE 92 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc----chHH----HHHHHHHHHHhCCCCchhhhhhheeeCCe
Confidence 3455566899999999999986 578899998754321 1122 34889999999999999999999876543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.++||||+++++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 93 --------------~~iv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~ 152 (297)
T cd06659 93 --------------LWVLMEFLQGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTL 152 (297)
T ss_pred --------------EEEEEecCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEcc
Confidence 4999999999999998764 45899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||++..+...... .....|+..|+|||++.+ ..++.++|||||||++|||+
T Consensus 153 ~-------~~~kL~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~el~ 211 (297)
T cd06659 153 D-------GRVKLSDFGFCAQISKDVPK----------RKSLVGTPYWMAPEVISR----TPYGTEVDIWSLGIMVIEMV 211 (297)
T ss_pred C-------CcEEEeechhHhhccccccc----------ccceecCccccCHHHHcc----CCCCchhhHHHHHHHHHHHH
Confidence 7 46999999998754332111 123468999999999976 56789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
+|..||......+....+.....+... .....+..+.++|.+||+.+|.+||++.
T Consensus 212 ~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~~i~~~l~~~P~~Rps~~ 266 (297)
T cd06659 212 DGEPPYFSDSPVQAMKRLRDSPPPKLK-------------------------NAHKISPVLRDFLERMLTREPQERATAQ 266 (297)
T ss_pred hCCCCCCCCCHHHHHHHHhccCCCCcc-------------------------ccCCCCHHHHHHHHHHhcCCcccCcCHH
Confidence 999999877766665555433211111 0011245789999999999999999999
Q ss_pred HHHHHHHhhcCC
Q 003185 823 DLYEMFVARTSS 834 (840)
Q Consensus 823 ELLehLe~l~~~ 834 (840)
+|++|..-....
T Consensus 267 ~ll~~~~~~~~~ 278 (297)
T cd06659 267 ELLDHPFLLQTG 278 (297)
T ss_pred HHhhChhhccCC
Confidence 999986555443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=307.77 Aligned_cols=280 Identities=20% Similarity=0.247 Sum_probs=195.5
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
..++|.+.+.||+|+||.||+|.. .+..+++|++..+.... . ...+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 75 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG---V----PFTAIREASLLKGLKHANIVLLHDIIHTK 75 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC---C----cHHHHHHHHHHHhcCCCCEeEEEEEEecC
Confidence 457899999999999999999986 57789999875442111 1 11237899999999999999999998755
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
. ..|+||||+. ++|.+++.. ....+++..+..++.||+.||.|||++||+|+||||+|||+
T Consensus 76 ~--------------~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~ 136 (291)
T cd07870 76 E--------------TLTFVFEYMH-TDLAQYMIQ----HPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI 136 (291)
T ss_pred C--------------eEEEEEeccc-CCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE
Confidence 4 3499999996 688887754 12457888899999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.++|+|||+++........ .....+++.|+|||++.+ ...++.++|||||||++|+
T Consensus 137 ~~~-------~~~~l~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~~ 196 (291)
T cd07870 137 SYL-------GELKLADFGLARAKSIPSQT----------YSSEVVTLWYRPPDVLLG---ATDYSSALDIWGAGCIFIE 196 (291)
T ss_pred cCC-------CcEEEeccccccccCCCCCC----------CCCccccccccCCceeec---CCCCCcHHHHHHHHHHHHH
Confidence 876 45999999998754322111 122357899999999864 2346789999999999999
Q ss_pred HHhCCCCCCCCCH-HHHHHHHHcCCCCCcchHHhhh---ccCcccccccc-CCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 741 LLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEAL---GSCHEHEVAQS-GSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 741 LLTG~~PF~~~~~-~el~~~I~~~~~p~l~~~l~~~---~~~~~~~~~~~-~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
|++|..||..... .+....+...........+... ........... .............+..+.+|+.+||..||
T Consensus 197 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp 276 (291)
T cd07870 197 MLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFP 276 (291)
T ss_pred HHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCc
Confidence 9999999976543 2222222211111111111000 00000000000 00000000001124578899999999999
Q ss_pred CCCCCHHHHHHHH
Q 003185 816 TERPTAGDLYEMF 828 (840)
Q Consensus 816 ~eRPSa~ELLehL 828 (840)
.+|||+.+++.|-
T Consensus 277 ~~R~t~~~~l~h~ 289 (291)
T cd07870 277 KDRISAQDALLHP 289 (291)
T ss_pred ccCcCHHHHhcCC
Confidence 9999999999873
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=308.78 Aligned_cols=294 Identities=17% Similarity=0.210 Sum_probs=204.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++.+.||+|+||.||+|.. .+..+|+|+........ .+...+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE------GFPITALREIKILQLLKHENVVNLIEICRT 82 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC------CchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence 4678999999999999999999997 57789999865432111 112233789999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.... ........++||||+. ++|.+++.. ....+++..++.++.||+.||+|||++||+|+||||+|||
T Consensus 83 ~~~~------~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil 151 (310)
T cd07865 83 KATP------YNRYKGSFYLVFEFCE-HDLAGLLSN----KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANIL 151 (310)
T ss_pred cccc------ccCCCceEEEEEcCCC-cCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 5421 0112335699999997 589888865 2246899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++..+....... ........++..|+|||++.+ ...++.++||||||+++|
T Consensus 152 ~~~~-------~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~~l~ 215 (310)
T cd07865 152 ITKD-------GILKLADFGLARAFSLSKNSK------PNRYTNRVVTLWYRPPELLLG---ERDYGPPIDMWGAGCIMA 215 (310)
T ss_pred ECCC-------CcEEECcCCCcccccCCcccC------CCCccCcccCccccCcHHhcC---CcccCchhhhHHHHHHHH
Confidence 9877 469999999998664322110 011122357889999999865 234678999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcc---ccccccCC-CCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE---HEVAQSGS-GFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~---~~~~~~~~-~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
+|++|..||.+.+.......+........++.++....... ........ ..............+.+||.+||..||
T Consensus 216 el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P 295 (310)
T cd07865 216 EMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDP 295 (310)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCCh
Confidence 99999999988776655544443211111111100000000 00000000 000000000123467899999999999
Q ss_pred CCCCCHHHHHHHH
Q 003185 816 TERPTAGDLYEMF 828 (840)
Q Consensus 816 ~eRPSa~ELLehL 828 (840)
.+|||++++++|.
T Consensus 296 ~~R~t~~e~l~h~ 308 (310)
T cd07865 296 AKRIDADTALNHD 308 (310)
T ss_pred hhccCHHHHhcCC
Confidence 9999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.00 Aligned_cols=274 Identities=23% Similarity=0.351 Sum_probs=197.1
Q ss_pred CCceeeeeecccCceEEEEEEEC------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEe
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 578 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~ 578 (840)
..|++.+.||+|+||.||+|.+. +..+|+|+...... . ... ..+.+|+.+++.+.||||+++++++.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~--~-~~~----~~~~~ei~~l~~l~~~~i~~~~~~~~ 76 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE--E-QHR----SDFEREIEILRTLDHENIVKYKGVCE 76 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc--h-HHH----HHHHHHHHHHHhCCCCChheEEeeee
Confidence 46788899999999999999863 56899998653321 1 122 34489999999999999999999886
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
.... ...++||||+++++|.+++.. ....+++..+..++.||+.||+|||++||+|+||||+||
T Consensus 77 ~~~~------------~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni 140 (284)
T cd05038 77 KPGG------------RSLRLIMEYLPSGSLRDYLQR----HRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNI 140 (284)
T ss_pred cCCC------------CceEEEEecCCCCCHHHHHHh----CccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhE
Confidence 5321 235999999999999999975 123589999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.+ +.++|+|||++........... ......++..|+|||.+.. ..++.++||||||+++
T Consensus 141 l~~~~-------~~~~l~dfg~~~~~~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~----~~~~~~~Di~slG~~l 202 (284)
T cd05038 141 LVESE-------DLVKISDFGLAKVLPEDKDYYY-------VKEPGESPIFWYAPECLRT----SKFSSASDVWSFGVTL 202 (284)
T ss_pred EEcCC-------CCEEEcccccccccccCCccee-------ccCCCCCcccccCcHHHcc----CCCCcccchHHHhhhh
Confidence 99877 5699999999987653211100 0111235567999999875 5678899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 739 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
|||++|..|+......... .............+.... ...... .....++..+.+|+.+||..+|.+|
T Consensus 203 ~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~--------~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~R 270 (284)
T cd05038 203 YELFTYGDPSQSPPAEFLR-MIGIAQGQMIVTRLLELL--------KEGERL---PRPPSCPDEVYDLMKLCWEAEPQDR 270 (284)
T ss_pred heeeccCCCcccccchhcc-ccccccccccHHHHHHHH--------HcCCcC---CCCccCCHHHHHHHHHHhccChhhC
Confidence 9999999998654221110 000000000000000000 000000 0011234679999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 003185 819 PTAGDLYEMFVAR 831 (840)
Q Consensus 819 PSa~ELLehLe~l 831 (840)
||+.+|++.|+.+
T Consensus 271 pt~~ei~~~l~~i 283 (284)
T cd05038 271 PSFADLILIVDRL 283 (284)
T ss_pred CCHHHHHHHHhhc
Confidence 9999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=302.63 Aligned_cols=257 Identities=26% Similarity=0.400 Sum_probs=199.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCC-ChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~-~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
.+|.+.+.||+|+||.||+|.+ .+..+++|+........ ..... ..+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~----~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 77 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEV----NALECEIQLLKNLRHDRIVQYYGCLRDPE 77 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHH----HHHHHHHHHHHHcCCCCcceEEEEEEcCC
Confidence 3689999999999999999986 57789999865432111 11222 34589999999999999999999886532
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. ...++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++
T Consensus 78 ~------------~~~~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~ 140 (264)
T cd06653 78 E------------KKLSIFVEYMPGGSIKDQLKA-----YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD 140 (264)
T ss_pred C------------CEEEEEEEeCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc
Confidence 1 246899999999999999875 24588999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.++|+|||+++........ ........|+..|+|||++.+ ..++.++|||||||++|+|
T Consensus 141 ~~-------~~~~l~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 202 (264)
T cd06653 141 SA-------GNVKLGDFGASKRIQTICMS-------GTGIKSVTGTPYWMSPEVISG----EGYGRKADVWSVACTVVEM 202 (264)
T ss_pred CC-------CCEEECcccccccccccccc-------CccccccCCcccccCHhhhcC----CCCCccccHHHHHHHHHHH
Confidence 76 45999999999865321110 001123458999999999875 5578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcC-CCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 742 LTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
++|+.||...........+... ..+.++. ..++.+.++|.+||. +|..||+
T Consensus 203 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~---------------------------~~~~~~~~~i~~~l~-~~~~r~~ 254 (264)
T cd06653 203 LTEKPPWAEYEAMAAIFKIATQPTKPMLPD---------------------------GVSDACRDFLKQIFV-EEKRRPT 254 (264)
T ss_pred HhCCCCCCccCHHHHHHHHHcCCCCCCCCc---------------------------ccCHHHHHHHHHHhc-CcccCcc
Confidence 9999999877655544443322 2222221 124579999999999 5799999
Q ss_pred HHHHHHHH
Q 003185 821 AGDLYEMF 828 (840)
Q Consensus 821 a~ELLehL 828 (840)
+.+++.|.
T Consensus 255 ~~~~~~~~ 262 (264)
T cd06653 255 AEFLLRHP 262 (264)
T ss_pred HHHHhcCC
Confidence 99999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=306.93 Aligned_cols=248 Identities=26% Similarity=0.338 Sum_probs=196.8
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|++.+.||.|+||.||+|.+ .+..+++|+....... ..... ..+.+|+.++++++||||+++++.+....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-EKGSV----RNVLNERRILQELNHPFLVNLWYSFQDEE-- 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc-chhHH----HHHHHHHHHHHhCCCCChHHHHHhhcCCC--
Confidence 589999999999999999997 4788999987543211 11222 34489999999999999999999887554
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
..++||||+.+++|..++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.+
T Consensus 74 ------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~ 136 (258)
T cd05578 74 ------------NMYLVVDLLLGGDLRYHLSQ-----KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ 136 (258)
T ss_pred ------------eEEEEEeCCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC
Confidence 35999999999999999976 2478999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.++|+|||++........ .....|+..|+|||.+.. ..++.++||||||+++|+|++
T Consensus 137 -------~~~~l~d~~~~~~~~~~~~-----------~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~~l~~l~~ 194 (258)
T cd05578 137 -------GHVHITDFNIATKVTPDTL-----------TTSTSGTPGYMAPEVLCR----QGYSVAVDWWSLGVTAYECLR 194 (258)
T ss_pred -------CCEEEeecccccccCCCcc-----------ccccCCChhhcCHHHHcc----cCCCCcccchhhHHHHHHHHh
Confidence 4599999999876543211 122458889999999876 457899999999999999999
Q ss_pred CCCCCCCCCH---HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 744 LQVPYMGLSE---LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 744 G~~PF~~~~~---~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|..||...+. ..+...... ..+..+ ...+..+.++|.+||..||.+||+
T Consensus 195 g~~p~~~~~~~~~~~~~~~~~~-~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~R~~ 246 (258)
T cd05578 195 GKRPYRGHSRTIRDQIRAKQET-ADVLYP---------------------------ATWSTEAIDAINKLLERDPQKRLG 246 (258)
T ss_pred CCCCCCCCCccHHHHHHHHhcc-ccccCc---------------------------ccCcHHHHHHHHHHccCChhHcCC
Confidence 9999987653 222222211 111111 112467899999999999999999
Q ss_pred H--HHHHHH
Q 003185 821 A--GDLYEM 827 (840)
Q Consensus 821 a--~ELLeh 827 (840)
+ .++++|
T Consensus 247 ~~~~~l~~~ 255 (258)
T cd05578 247 DNLKDLKNH 255 (258)
T ss_pred ccHHHHhcC
Confidence 9 888765
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=330.25 Aligned_cols=262 Identities=22% Similarity=0.337 Sum_probs=196.4
Q ss_pred CCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~~~~ 582 (840)
..|++.++||.||.+.||++... .+.+|+|.+.+. ......+..| .+|+.+|.+|+ |.+||++|+|-..++.
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~--~~D~qtl~gy----~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLL--EADNQTLDGY----RNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHh--hcCHHHHHHH----HHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 46999999999999999999873 344555443332 2233445555 99999999997 9999999999887665
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
+||||||-+ .+|..+|++ ....++...++.+..|++.|+.++|.+||||.||||.|+|+-.
T Consensus 435 --------------lYmvmE~Gd-~DL~kiL~k----~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk 495 (677)
T KOG0596|consen 435 --------------LYMVMECGD-IDLNKILKK----KKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK 495 (677)
T ss_pred --------------EEEEeeccc-ccHHHHHHh----ccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe
Confidence 499999986 599999987 2233444588999999999999999999999999999999864
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC-------CCCCchhhHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-------NLYGLEVDIWSYG 735 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~-------~~~s~kSDVWSLG 735 (840)
+.+||+|||+|..+...... ......+||+.||+||.+..+... -..+.++||||||
T Consensus 496 --------G~LKLIDFGIA~aI~~DTTs--------I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLG 559 (677)
T KOG0596|consen 496 --------GRLKLIDFGIANAIQPDTTS--------IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLG 559 (677)
T ss_pred --------eeEEeeeechhcccCccccc--------eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhh
Confidence 46999999999887654322 112445899999999999865432 1367899999999
Q ss_pred HHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003185 736 CLLLELLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 814 (840)
Q Consensus 736 vIL~ELLTG~~PF~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~D 814 (840)
||||+|+.|+.||.... ...-+..|.. |.-. ++.+... ...+++++++.||..|
T Consensus 560 CILYqMvYgktPf~~~~n~~aKl~aI~~---P~~~--------------------Iefp~~~--~~~~li~~mK~CL~rd 614 (677)
T KOG0596|consen 560 CILYQMVYGKTPFGQIINQIAKLHAITD---PNHE--------------------IEFPDIP--ENDELIDVMKCCLARD 614 (677)
T ss_pred hHHHHHHhcCCchHHHHHHHHHHHhhcC---CCcc--------------------ccccCCC--CchHHHHHHHHHHhcC
Confidence 99999999999996542 2222222222 1110 0011110 0124899999999999
Q ss_pred CCCCCCHHHHHHHHHhhc
Q 003185 815 PTERPTAGDLYEMFVART 832 (840)
Q Consensus 815 P~eRPSa~ELLehLe~l~ 832 (840)
|++||++.+||+|..-..
T Consensus 615 PkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 615 PKKRWSIPELLQHPFLQI 632 (677)
T ss_pred cccCCCcHHHhcCccccc
Confidence 999999999999965443
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=341.92 Aligned_cols=294 Identities=19% Similarity=0.193 Sum_probs=191.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCe---eEEEEEEecccCC---------CChHHHHHhHHhHHHHHHHHHhCCCCC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGSA---DAAAKVRTLKVCG---------SSADEIRNFEYSCLGEVRMLGALRHSC 569 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~---~vAVKI~~lk~~~---------~~~~~~~~f~~~~~rEi~iL~~L~HpN 569 (840)
...++|++++.||+|+||.||+|.+... ..++|.+...... ............+.+|+.+|++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 3467899999999999999999875321 1122210000000 000001122345689999999999999
Q ss_pred cceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Q 003185 570 IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 649 (840)
Q Consensus 570 IV~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIV 649 (840)
||++++++..... .|+||+++. ++|..++...............++.|+.||+.||.|||++|||
T Consensus 225 Iv~l~~~~~~~~~--------------~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIi 289 (501)
T PHA03210 225 ILKIEEILRSEAN--------------TYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLI 289 (501)
T ss_pred cCcEeEEEEECCe--------------eEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 9999999986654 499999996 5888887642111122344677889999999999999999999
Q ss_pred cccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchh
Q 003185 650 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 729 (840)
Q Consensus 650 HRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kS 729 (840)
||||||+||||+.+ +.+||+|||+++.+...... ......||+.|+|||++.+ ..++.++
T Consensus 290 HrDLKP~NILl~~~-------~~vkL~DFGla~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~~~ 349 (501)
T PHA03210 290 HRDIKLENIFLNCD-------GKIVLGDFGTAMPFEKEREA---------FDYGWVGTVATNSPEILAG----DGYCEIT 349 (501)
T ss_pred cCCCCHHHEEECCC-------CCEEEEeCCCceecCccccc---------ccccccCCcCCCCchhhcC----CCCCcHH
Confidence 99999999999877 45999999999866432111 1123469999999999986 5689999
Q ss_pred hHHHHHHHHHHHHhCCCCC-CCC--CH-HHHHHHHHcCC--CCCcchHHhhhccCcc-ccccccCCCCCCchhhhhhHHH
Q 003185 730 DIWSYGCLLLELLTLQVPY-MGL--SE-LEIHDLIQMGK--RPRLTDELEALGSCHE-HEVAQSGSGFEKPEAELETLSF 802 (840)
Q Consensus 730 DVWSLGvIL~ELLTG~~PF-~~~--~~-~el~~~I~~~~--~p~l~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~ 802 (840)
|||||||+||||++|..++ ... .+ .++...+.... ...+++....++.... ..+..........-.....+..
T Consensus 350 DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 429 (501)
T PHA03210 350 DIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPAD 429 (501)
T ss_pred HHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChH
Confidence 9999999999999988654 322 22 22322222111 1111111111100000 0000000000000111123457
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003185 803 LVDVFRRCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 803 L~dLI~rCL~~DP~eRPSa~ELLehLe~ 830 (840)
+.++|.+||.+||.+|||+.|++.|...
T Consensus 430 ~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 430 FEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 8899999999999999999999998653
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=298.95 Aligned_cols=254 Identities=30% Similarity=0.435 Sum_probs=205.1
Q ss_pred CceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|.+.+.||.|+||.||++.+. +..+++|+...... ...... .+.+|+++++.++|||++++++.+....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~----~~~~e~~~l~~l~~~~~~~~~~~~~~~~-- 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM--SEKERE----DALNEVKILKKLNHPNIIKYYESFEEKG-- 72 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC--ChHHHH----HHHHHHHHHHhcCCCChhheEEEEecCC--
Confidence 5889999999999999999985 78899998654322 222223 3488999999999999999999987554
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
..++||||+++++|.+++..... ....+++..+..++.||+.||.|||++|++|+||+|+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~ 139 (258)
T cd08215 73 ------------KLCIVMEYADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN 139 (258)
T ss_pred ------------EEEEEEEecCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC
Confidence 35999999999999999986321 23678999999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.++|+|||++........ ......|++.|+|||.+.. ..++.++||||||+++|+|++
T Consensus 140 -------~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~~~~~l~~ 198 (258)
T cd08215 140 -------GLVKLGDFGISKVLSSTVD----------LAKTVVGTPYYLSPELCQN----KPYNYKSDIWSLGCVLYELCT 198 (258)
T ss_pred -------CcEEECCccceeecccCcc----------eecceeeeecccChhHhcc----CCCCccccHHHHHHHHHHHHc
Confidence 4599999999976544221 1123468899999999875 557889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~E 823 (840)
|..||...+..++...+.....+.++. ..+..+.+++.+||..+|.+|||+.+
T Consensus 199 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~Rp~~~~ 251 (258)
T cd08215 199 LKHPFEGENLLELALKILKGQYPPIPS---------------------------QYSSELRNLVSSLLQKDPEERPSIAQ 251 (258)
T ss_pred CCCCCCCCcHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 999998877776666655443332221 12457899999999999999999999
Q ss_pred HHHHH
Q 003185 824 LYEMF 828 (840)
Q Consensus 824 LLehL 828 (840)
+++|-
T Consensus 252 ll~~~ 256 (258)
T cd08215 252 ILQSP 256 (258)
T ss_pred HhcCC
Confidence 99873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=299.94 Aligned_cols=252 Identities=27% Similarity=0.410 Sum_probs=204.4
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|++.+.||+|+||.||++.+ .+..+++|....... ...... .+.+|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM--SQKERE----DAVNEIRILASVNHPNIISYKEAFLDGN-- 72 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc--cHHHHH----HHHHHHHHHHhCCCCCchhhhhhhccCC--
Confidence 588999999999999999987 566788888653321 222223 3378999999999999999999887553
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
..++||||+++++|.+++..... ....+++..++.++.||+.||.|||+.|++|+||+|.||+++.+
T Consensus 73 ------------~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~ 139 (256)
T cd08530 73 ------------KLCIVMEYAPFGDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAN 139 (256)
T ss_pred ------------EEEEEehhcCCCCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecC
Confidence 45999999999999999876322 23568999999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
..+||+|||++....... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++
T Consensus 140 -------~~~kl~d~g~~~~~~~~~------------~~~~~~~~~~~~Pe~~~~----~~~~~~~D~~slG~~~~~l~~ 196 (256)
T cd08530 140 -------DLVKIGDLGISKVLKKNM------------AKTQIGTPHYMAPEVWKG----RPYSYKSDIWSLGCLLYEMAT 196 (256)
T ss_pred -------CcEEEeeccchhhhccCC------------cccccCCccccCHHHHCC----CCCCchhhHHHHHHHHHHHHh
Confidence 459999999997664421 112357889999999976 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~E 823 (840)
|+.||...+...+...+.....+.++. ..+..+.+++.+||..+|.+||++.+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08530 197 FAPPFEARSMQDLRYKVQRGKYPPIPP---------------------------IYSQDLQNFIRSMLQVKPKLRPNCDK 249 (256)
T ss_pred CCCCCCCCCHHHHHHHHhcCCCCCCch---------------------------hhCHHHHHHHHHHcCCCcccCCCHHH
Confidence 999998888777666665554433332 22457999999999999999999999
Q ss_pred HHHHH
Q 003185 824 LYEMF 828 (840)
Q Consensus 824 LLehL 828 (840)
+++|.
T Consensus 250 ~l~~p 254 (256)
T cd08530 250 ILASP 254 (256)
T ss_pred HhcCC
Confidence 99874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=303.12 Aligned_cols=253 Identities=26% Similarity=0.397 Sum_probs=189.5
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
+.+.....||+|+||.||+|.+ .+..+++|....+ .....+ .+.+|+.++++++|+||+++++++....
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~----~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 78 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER----DSRYVQ----PLHEEIALHSYLKHRNIVQYLGSDSENG- 78 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC----CHHHHH----HHHHHHHHHHhcCCCCeeeeeeeeccCC-
Confidence 3444456899999999999986 4556888875432 122223 3489999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCC--CHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHV--SVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~l--s~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
..++||||+++++|.+++... ...+ +...+..++.||+.||+|||++||+||||||+||++
T Consensus 79 -------------~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~ 141 (268)
T cd06624 79 -------------FFKIFMEQVPGGSLSALLRSK----WGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLV 141 (268)
T ss_pred -------------EEEEEEecCCCCCHHHHHHHh----cccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE
Confidence 359999999999999999751 1234 788889999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+. ..++|+|||++......... .....|++.|+|||++... ...++.++||||||+++|+
T Consensus 142 ~~~~------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~~--~~~~~~~~Dv~slGvvl~~ 203 (268)
T cd06624 142 NTYS------GVVKISDFGTSKRLAGINPC----------TETFTGTLQYMAPEVIDKG--PRGYGAPADIWSLGCTIVE 203 (268)
T ss_pred cCCC------CeEEEecchhheecccCCCc----------cccCCCCccccChhhhccc--cccCCchhhhHHHHHHHHH
Confidence 7632 46999999998755321110 1123578999999998651 1346889999999999999
Q ss_pred HHhCCCCCCCCCHHH-HHHHHH-cCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 741 LLTLQVPYMGLSELE-IHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 741 LLTG~~PF~~~~~~e-l~~~I~-~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
|++|..||....... ....+. ....+.++ ...++.+.+|+.+||..+|.+|
T Consensus 204 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~R 256 (268)
T cd06624 204 MATGKPPFIELGEPQAAMFKVGMFKIHPEIP---------------------------ESLSAEAKNFILRCFEPDPDKR 256 (268)
T ss_pred HHhCCCCCccccChhhhHhhhhhhccCCCCC---------------------------cccCHHHHHHHHHHcCCCchhC
Confidence 999999997543221 111111 11111111 1234578999999999999999
Q ss_pred CCHHHHHHHH
Q 003185 819 PTAGDLYEMF 828 (840)
Q Consensus 819 PSa~ELLehL 828 (840)
||+.+++.|.
T Consensus 257 pt~~~ll~~~ 266 (268)
T cd06624 257 ASAHDLLQDP 266 (268)
T ss_pred CCHHHHHhCC
Confidence 9999999874
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.05 Aligned_cols=255 Identities=26% Similarity=0.420 Sum_probs=200.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
....+|.+.+.||+|+||.||++.. .+..+++|....... ... +.+.+|+.+++.++||||+++++.+..
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~----~~~~~e~~~l~~l~hp~i~~~~~~~~~ 87 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ----PKK----ELIINEILVMRENKHPNIVNYLDSYLV 87 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc----hHH----HHHHHHHHHHhhcCCCCeeehhheeee
Confidence 4568999999999999999999986 567799998643211 112 234889999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .|+||||+++++|.+++.+ ..+++..+..++.||+.||.|||++|++|+||||+||+
T Consensus 88 ~~~--------------~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nil 147 (293)
T cd06647 88 GDE--------------LWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL 147 (293)
T ss_pred CCc--------------EEEEEecCCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEE
Confidence 543 4999999999999999975 45788999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.++|+|||++......... .....|++.|+|||.+.. ..++.++|||||||++|
T Consensus 148 i~~~-------~~~kL~dfg~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slG~ll~ 206 (293)
T cd06647 148 LGMD-------GSVKLTDFGFCAQITPEQSK----------RSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAI 206 (293)
T ss_pred EcCC-------CCEEEccCcceecccccccc----------cccccCChhhcCchhhcc----CCCCchhhHHHHHHHHH
Confidence 9876 45999999988755332111 122458899999999875 56788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|++|..||...+.......+.....+.+. .....+..+.++|.+||..+|.+||
T Consensus 207 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~~p~~Rp 261 (293)
T cd06647 207 EMVEGEPPYLNENPLRALYLIATNGTPELQ-------------------------NPEKLSAIFRDFLNRCLEMDVEKRG 261 (293)
T ss_pred HHHhCCCCCCCCChhhheeehhcCCCCCCC-------------------------CccccCHHHHHHHHHHccCChhhCc
Confidence 999999999876554433322222111111 0111245789999999999999999
Q ss_pred CHHHHHHHHHh
Q 003185 820 TAGDLYEMFVA 830 (840)
Q Consensus 820 Sa~ELLehLe~ 830 (840)
++.+++.|-.-
T Consensus 262 ~~~~il~h~~~ 272 (293)
T cd06647 262 SAKELLQHPFL 272 (293)
T ss_pred CHHHHhcCHHH
Confidence 99999999443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=341.36 Aligned_cols=266 Identities=21% Similarity=0.355 Sum_probs=220.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE---C--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeE
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF---G--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 576 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~---~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~ 576 (840)
++-....|.+.||.|-||.|++|+. . ...||+|. +|.. ........| +.|+.||.++.||||+++.|+
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKT--LK~G-ytekqrrdF----L~EAsIMGQFdHPNIIrLEGV 698 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKT--LKAG-YTEKQRRDF----LSEASIMGQFDHPNIIRLEGV 698 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEee--eccC-ccHHHHhhh----hhhhhhcccCCCCcEEEEEEE
Confidence 4455678999999999999999997 2 34555555 5532 333344444 999999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
......+ +||+|||++|+|+.||++ ....|...+...|++.|+.||+||-+.|+|||||-..
T Consensus 699 VTks~Pv--------------MIiTEyMENGsLDsFLR~----~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAAR 760 (996)
T KOG0196|consen 699 VTKSKPV--------------MIITEYMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAAR 760 (996)
T ss_pred EecCcee--------------EEEhhhhhCCcHHHHHhh----cCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhh
Confidence 9877654 999999999999999987 3356999999999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
||||+.+ ...|++|||+++.+.+......... .-.-...|.|||.+.. ..++.+|||||||+
T Consensus 761 NILVNsn-------LvCKVsDFGLSRvledd~~~~ytt~-------GGKIPiRWTAPEAIa~----RKFTsASDVWSyGI 822 (996)
T KOG0196|consen 761 NILVNSN-------LVCKVSDFGLSRVLEDDPEAAYTTL-------GGKIPIRWTAPEAIAY----RKFTSASDVWSYGI 822 (996)
T ss_pred heeeccc-------eEEEeccccceeecccCCCcccccc-------CCccceeecChhHhhh----cccCchhhccccce
Confidence 9999977 7899999999998765442211110 0112368999999986 78999999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 737 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 737 IL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
+|||.++ |..||..++..+++..|..+.+.+-| .+++..|..|+..||++|-
T Consensus 823 VmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP---------------------------mDCP~aL~qLMldCWqkdR 875 (996)
T KOG0196|consen 823 VMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP---------------------------MDCPAALYQLMLDCWQKDR 875 (996)
T ss_pred EEEEecccCCCcccccchHHHHHHHHhccCCCCC---------------------------CCCcHHHHHHHHHHHHHHh
Confidence 9999877 99999999999999999999764333 3457789999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCCCC
Q 003185 816 TERPTAGDLYEMFVARTSSSIS 837 (840)
Q Consensus 816 ~eRPSa~ELLehLe~l~~~~~s 837 (840)
.+||.+.+|+.+|.++.....|
T Consensus 876 ~~RP~F~qiV~~lDklIrnP~S 897 (996)
T KOG0196|consen 876 NRRPKFAQIVSTLDKLIRNPNS 897 (996)
T ss_pred hcCCCHHHHHHHHHHHhcCchh
Confidence 9999999999999998765433
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=306.31 Aligned_cols=277 Identities=26% Similarity=0.328 Sum_probs=200.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||.||+|.+ .+..+++|+...... . ..+...+.+|+.++++++|+||+++++++....
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 73 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--D----EDVKKTALREVKVLRQLRHENIVNLKEAFRRKG- 73 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--c----ccchhHHHHHHHHHHhcCCCCeeehhheEEECC-
Confidence 4799999999999999999987 467888887643322 1 112234589999999999999999999997654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
..++||||++++.|..++.+ ...+++..++.++.||+.||.|||.+||+|+||+|+||+++.
T Consensus 74 -------------~~~iv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~ 135 (288)
T cd07833 74 -------------RLYLVFEYVERTLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE 135 (288)
T ss_pred -------------EEEEEEecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC
Confidence 35999999998666655543 345899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||++......... ......++..|+|||++.+ ...++.++||||||+++|+|+
T Consensus 136 ~-------~~~kl~d~g~~~~~~~~~~~---------~~~~~~~~~~~~~PE~~~~---~~~~~~~~Dv~slG~~l~~l~ 196 (288)
T cd07833 136 S-------GVLKLCDFGFARALRARPAS---------PLTDYVATRWYRAPELLVG---DTNYGKPVDVWAIGCIMAELL 196 (288)
T ss_pred C-------CCEEEEeeecccccCCCccc---------cccCcccccCCcCCchhcC---CCCcCchhhHHHHHHHHHHHH
Confidence 6 45999999998776443210 1123467899999999976 126789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccc-cCCCCCCc-----hhhhhhHHHHHHHHHHhcccCCC
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ-SGSGFEKP-----EAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
+|+.||.+....+....+........+... ........ +.. ........ ......+..+.+||.+||..+|.
T Consensus 197 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 274 (288)
T cd07833 197 DGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ-ELFSSNPR-FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPK 274 (288)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHh-hhcccCcc-ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCch
Confidence 999999877665544444332111111111 00000000 000 00000000 00112367899999999999999
Q ss_pred CCCCHHHHHHH
Q 003185 817 ERPTAGDLYEM 827 (840)
Q Consensus 817 eRPSa~ELLeh 827 (840)
+||+++++++|
T Consensus 275 ~Rps~~~il~~ 285 (288)
T cd07833 275 ERLTCDELLQH 285 (288)
T ss_pred hcccHHHHhcC
Confidence 99999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=308.30 Aligned_cols=299 Identities=20% Similarity=0.210 Sum_probs=207.5
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.+++|++.+.||.|+||.||+|.+ .+..+++|+......... .. ..+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG--FP----ITALREIKILKKLKHPNVVPLIDMAVER 79 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC--cc----hhHHHHHHHHHhcCCCCccchhhheecc
Confidence 478999999999999999999997 467889998754432111 11 1237899999999999999999987654
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
... .......+++||||+.+ +|...+.. ....+++..+..++.||+.||.|||++||+|+||||+|||+
T Consensus 80 ~~~------~~~~~~~~~lv~~~~~~-~l~~~~~~----~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~ 148 (311)
T cd07866 80 PDK------SKRKRGSVYMVTPYMDH-DLSGLLEN----PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI 148 (311)
T ss_pred ccc------ccccCceEEEEEecCCc-CHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 321 01123357999999974 78777754 23569999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccc-cCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~-~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
+.+ +.++|+|||++............. ...........+++.|+|||++.+ ...++.++|||||||++|
T Consensus 149 ~~~-------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~ 218 (311)
T cd07866 149 DNQ-------GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG---ERRYTTAVDIWGIGCVFA 218 (311)
T ss_pred CCC-------CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhC---CCccCchhHhHHHHHHHH
Confidence 877 469999999998654332211100 001111233467899999999865 245788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcccc--ccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE--VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
||++|++||.+.+.......+........+..+.......... ....................+.++|.+||..||.+
T Consensus 219 el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 298 (311)
T cd07866 219 EMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYK 298 (311)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCccc
Confidence 9999999998887766655554432211111111110000000 00000000001111223467899999999999999
Q ss_pred CCCHHHHHHHH
Q 003185 818 RPTAGDLYEMF 828 (840)
Q Consensus 818 RPSa~ELLehL 828 (840)
|||+.+++.|.
T Consensus 299 R~t~~ell~~~ 309 (311)
T cd07866 299 RLTASDALEHP 309 (311)
T ss_pred CcCHHHHhcCC
Confidence 99999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=301.93 Aligned_cols=244 Identities=27% Similarity=0.331 Sum_probs=195.4
Q ss_pred ecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCCCC
Q 003185 513 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 590 (840)
Q Consensus 513 LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g~~ 590 (840)
||.|+||.||+|... +..+++|++...... ... ....+.+|+.+++.++||||+++++.+.....
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-------- 67 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV-ETG----QQEHIFSEKEILEECNHPFIVKLYRTFKDKKY-------- 67 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcch-hhh----HHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCc--------
Confidence 799999999999985 789999987543211 111 22345899999999999999999999876654
Q ss_pred ccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCCC
Q 003185 591 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 670 (840)
Q Consensus 591 ~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~ 670 (840)
.++||||+++++|.+++.+ ...++...+..++.||+.||.|||++|++|+||||.||+++.+
T Consensus 68 ------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~------- 129 (262)
T cd05572 68 ------IYMLMEYCLGGELWTILRD-----RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN------- 129 (262)
T ss_pred ------cEEEEecCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC-------
Confidence 4999999999999999976 3458999999999999999999999999999999999999877
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003185 671 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 750 (840)
Q Consensus 671 ~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~ 750 (840)
+.++|+|||++........ .....|++.|+|||.+.. ..++.++||||||+++|+|++|..||..
T Consensus 130 ~~~~l~df~~~~~~~~~~~-----------~~~~~~~~~~~~PE~~~~----~~~~~~~Di~slG~il~~l~~g~~p~~~ 194 (262)
T cd05572 130 GYVKLVDFGFAKKLKSGQK-----------TWTFCGTPEYVAPEIILN----KGYDFSVDYWSLGILLYELLTGRPPFGE 194 (262)
T ss_pred CCEEEeeCCcccccCcccc-----------cccccCCcCccChhHhcC----CCCCChhhhhhhHHHHHHHHhCCCCcCC
Confidence 4599999999976643211 122358899999999875 5678899999999999999999999977
Q ss_pred CC--HHHHHHHHHcC-CCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC-----HH
Q 003185 751 LS--ELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT-----AG 822 (840)
Q Consensus 751 ~~--~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS-----a~ 822 (840)
.. +......+... ..+..+. ..+..+.++|.+||..+|.+||+ +.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 247 (262)
T cd05572 195 DDEDPMEIYNDILKGNGKLEFPN---------------------------YIDKAAKDLIKQLLRRNPEERLGNLKGGIK 247 (262)
T ss_pred CCCCHHHHHHHHhccCCCCCCCc---------------------------ccCHHHHHHHHHHccCChhhCcCCcccCHH
Confidence 66 55555554432 1111111 11457899999999999999999 99
Q ss_pred HHHHHHH
Q 003185 823 DLYEMFV 829 (840)
Q Consensus 823 ELLehLe 829 (840)
|+++|..
T Consensus 248 ~l~~~~~ 254 (262)
T cd05572 248 DIKKHKW 254 (262)
T ss_pred HHhcChh
Confidence 9999754
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=330.74 Aligned_cols=256 Identities=21% Similarity=0.380 Sum_probs=212.7
Q ss_pred ceeeeeecccCceEEEEEEE----CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~----~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
..+.+.||.|-||.||.|.+ ++...||.|+..+.. ...+..+.| +.|+.+|+.++|||||+++|+|.+..
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d-~t~d~tekf----lqEa~iMrnfdHphIikLIGv~~e~P- 464 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD-CTPDDTEKF----LQEASIMRNFDHPHIIKLIGVCVEQP- 464 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC-CChhhHHHH----HHHHHHHHhCCCcchhheeeeeeccc-
Confidence 45678899999999999986 344455554444432 233334455 99999999999999999999998654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.|||||+++-|-|..||+. ....++......+++||+.||.|||+.++|||||-..|||+..
T Consensus 465 --------------~WivmEL~~~GELr~yLq~----nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsS 526 (974)
T KOG4257|consen 465 --------------MWIVMELAPLGELREYLQQ----NKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSS 526 (974)
T ss_pred --------------eeEEEecccchhHHHHHHh----ccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecC
Confidence 3999999999999999986 3467899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
. -.|||+|||+++.+........ ....-...|||||.+.- ..++.++|||-|||++||++
T Consensus 527 p-------~CVKLaDFGLSR~~ed~~yYka---------S~~kLPIKWmaPESINf----RrFTtASDVWMFgVCmWEIl 586 (974)
T KOG4257|consen 527 P-------QCVKLADFGLSRYLEDDAYYKA---------SRGKLPIKWMAPESINF----RRFTTASDVWMFGVCMWEIL 586 (974)
T ss_pred c-------ceeeecccchhhhccccchhhc---------cccccceeecCccccch----hcccchhhHHHHHHHHHHHH
Confidence 7 4599999999998876543311 11123468999999976 78999999999999999998
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 743 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 743 T-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
. |..||.+....+++..|.++.+++.|+. +++.+..|+.+||.++|.+||.+
T Consensus 587 ~lGvkPfqgvkNsDVI~~iEnGeRlP~P~n---------------------------CPp~LYslmskcWayeP~kRPrf 639 (974)
T KOG4257|consen 587 SLGVKPFQGVKNSDVIGHIENGERLPCPPN---------------------------CPPALYSLMSKCWAYEPSKRPRF 639 (974)
T ss_pred HhcCCccccccccceEEEecCCCCCCCCCC---------------------------CChHHHHHHHHHhccCcccCCcH
Confidence 7 9999999999999999999988766643 46689999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 003185 822 GDLYEMFVARTS 833 (840)
Q Consensus 822 ~ELLehLe~l~~ 833 (840)
.+|...|..+.+
T Consensus 640 tei~~~lsdv~q 651 (974)
T KOG4257|consen 640 TEIKAILSDVLQ 651 (974)
T ss_pred HHHHHHHHHHHH
Confidence 999998877654
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.65 Aligned_cols=289 Identities=17% Similarity=0.213 Sum_probs=206.2
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
.+|++.+.||+|+||.||+|.. .+..+++|+...... ..... ..+.+|+.+|++++||||+++++++.....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~--~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD--VPTLA----KRTLRELKILRHFKHDNIIAIRDILRPPGA 78 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc--cccch----HHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence 5799999999999999999986 577899998643221 11122 234789999999999999999998764331
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.....++||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 79 ----------~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~ 142 (334)
T cd07855 79 ----------DFKDVYVVMDLME-SDLHHIIHS-----DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNE 142 (334)
T ss_pred ----------CCceEEEEEehhh-hhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 1235699999996 689888864 345899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||++......... .........|+..|+|||++.. ...++.++|||||||++|+|+
T Consensus 143 ~-------~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~~Di~slG~~l~el~ 206 (334)
T cd07855 143 D-------CELRIGDFGMARGLSSSPTE------HKYFMTEYVATRWYRAPELLLS---LPEYTTAIDMWSVGCIFAEML 206 (334)
T ss_pred C-------CcEEecccccceeecccCcC------CCcccccccccccccChHHhcC---CcccccccchHHHHHHHHHHH
Confidence 7 45999999999765432211 0111123468999999999864 235789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcccccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|+.||.+.+.......+...........+............+. .............+..+.++|.+||+.+|.+||
T Consensus 207 ~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 286 (334)
T cd07855 207 GRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERI 286 (334)
T ss_pred cCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCc
Confidence 99999988776655544443211111111111100000000000 000001111233467899999999999999999
Q ss_pred CHHHHHHHHHhh
Q 003185 820 TAGDLYEMFVAR 831 (840)
Q Consensus 820 Sa~ELLehLe~l 831 (840)
++.+++.|.+-.
T Consensus 287 t~~~~l~~~~~~ 298 (334)
T cd07855 287 TVEQALQHPFLA 298 (334)
T ss_pred CHHHHHhChhhh
Confidence 999999986543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=294.19 Aligned_cols=249 Identities=29% Similarity=0.485 Sum_probs=200.1
Q ss_pred CceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|++.+.||+|++|.||++.+. +..+++|+...... ... ..+.+|+.+++.++||||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~- 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKK----EKIINEIQILKKCKHPNIVKYYGSYLKKDE- 71 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHH----HHHHHHHHHHHhCCCCCEeEEEEEEecCCe-
Confidence 4788999999999999999984 77888888654321 122 344899999999999999999999876543
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.+++|||+++++|.+++.. ....+++..+..++.|++.||.|||.+|++||||+|+||+++.+
T Consensus 72 -------------~~l~~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~ 134 (253)
T cd05122 72 -------------LWIVMEFCSGGSLKDLLKS----TNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD 134 (253)
T ss_pred -------------EEEEEecCCCCcHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC
Confidence 4999999999999999876 12468999999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.++|+|||.+........ .....++..|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 135 -------~~~~l~d~~~~~~~~~~~~-----------~~~~~~~~~~~~PE~~~~----~~~~~~~Dv~slG~il~~l~~ 192 (253)
T cd05122 135 -------GEVKLIDFGLSAQLSDTKA-----------RNTMVGTPYWMAPEVING----KPYDYKADIWSLGITAIELAE 192 (253)
T ss_pred -------CeEEEeecccccccccccc-----------ccceecCCcccCHHHHcC----CCCCccccHHHHHHHHHHHHh
Confidence 4599999999876644211 123458899999999876 457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~E 823 (840)
|+.||...+.......+.....+.+... ...+..+.++|.+||..||.+|||+.+
T Consensus 193 g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~i~~~l~~~p~~R~t~~~ 247 (253)
T cd05122 193 GKPPYSELPPMKALFKIATNGPPGLRNP-------------------------EKWSDEFKDFLKKCLQKNPEKRPTAEQ 247 (253)
T ss_pred CCCCCCCCchHHHHHHHHhcCCCCcCcc-------------------------cccCHHHHHHHHHHccCChhhCCCHHH
Confidence 9999987765554444443322222110 112457899999999999999999999
Q ss_pred HHHH
Q 003185 824 LYEM 827 (840)
Q Consensus 824 LLeh 827 (840)
+++|
T Consensus 248 ~l~~ 251 (253)
T cd05122 248 LLKH 251 (253)
T ss_pred HhcC
Confidence 9987
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.69 Aligned_cols=262 Identities=24% Similarity=0.310 Sum_probs=194.4
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEecC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 580 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~~ 580 (840)
..+|...+.||+|+||.||++.+ .+..+|+|....... . ... ..+.+|+.++.++. ||||+++++++...
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~-~~~----~~~~~e~~~l~~~~~~~~iv~~~~~~~~~ 75 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--E-KEQ----KRLLMDLDVVMRSSDCPYIVKFYGALFRE 75 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--h-HHH----HHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence 45677889999999999999997 567888887643221 1 222 23488999999996 99999999988765
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCCCcEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENIL 659 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~-gIVHRDLKPeNIL 659 (840)
.. .+++|||+. ++|.++...........+++..+..++.|++.||+|||+. +|+||||||+|||
T Consensus 76 ~~--------------~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil 140 (288)
T cd06616 76 GD--------------CWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNIL 140 (288)
T ss_pred Cc--------------EEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEE
Confidence 43 499999996 4776655432222335789999999999999999999975 9999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++..+..... .....|++.|+|||++.+.. ...++.++|||||||++|
T Consensus 141 ~~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~ 201 (288)
T cd06616 141 LDRN-------GNIKLCDFGISGQLVDSIA-----------KTRDAGCRPYMAPERIDPSA-RDGYDVRSDVWSLGITLY 201 (288)
T ss_pred EccC-------CcEEEeecchhHHhccCCc-----------cccccCccCccCHHHhcccc-ccCCcchhhhhHHHHHHH
Confidence 9876 4699999999976543211 12235889999999987521 136788999999999999
Q ss_pred HHHhCCCCCCCCCH-HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 740 ELLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 740 ELLTG~~PF~~~~~-~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
+|++|+.||..... .+....+.....+.+.. ......+..+.+||.+||+.+|.+|
T Consensus 202 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~~p~~R 258 (288)
T cd06616 202 EVATGKFPYPKWNSVFDQLTQVVKGDPPILSN-----------------------SEEREFSPSFVNFINLCLIKDESKR 258 (288)
T ss_pred HHHhCCCCchhcchHHHHHhhhcCCCCCcCCC-----------------------cCCCccCHHHHHHHHHHccCChhhC
Confidence 99999999976541 12222222222111110 0012245679999999999999999
Q ss_pred CCHHHHHHHHH
Q 003185 819 PTAGDLYEMFV 829 (840)
Q Consensus 819 PSa~ELLehLe 829 (840)
||+++|++|..
T Consensus 259 pt~~~i~~~~~ 269 (288)
T cd06616 259 PKYKELLEHPF 269 (288)
T ss_pred cCHHHHhcChh
Confidence 99999999844
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=306.47 Aligned_cols=251 Identities=27% Similarity=0.423 Sum_probs=198.8
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
.|...+.||+|++|.||++.. .+..+++|...... ....+ .+.+|+.+++.+.||||+++++++....
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~----~~~~e~~~l~~~~h~~vv~~~~~~~~~~-- 89 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRRE----LLFNEVVIMRDYQHPNIVEMYSSYLVGD-- 89 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc----hhHHH----HHHHHHHHHHHcCCCChheEEEEEEcCC--
Confidence 345567999999999999986 56778888764321 12222 3488999999999999999999987554
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
..++||||+.+++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||+++.+
T Consensus 90 ------------~~~~v~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~ 151 (285)
T cd06648 90 ------------ELWVVMEFLEGGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD 151 (285)
T ss_pred ------------eEEEEEeccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC
Confidence 34999999999999999875 458899999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.++|+|||++........ ......|++.|+|||.+.+ ..++.++|||||||++|+|++
T Consensus 152 -------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slGv~l~ell~ 210 (285)
T cd06648 152 -------GRVKLSDFGFCAQVSKEVP----------RRKSLVGTPYWMAPEVISR----LPYGTEVDIWSLGIMVIEMVD 210 (285)
T ss_pred -------CcEEEcccccchhhccCCc----------ccccccCCccccCHHHhcC----CCCCCcccHHHHHHHHHHHHh
Confidence 4699999998865432111 1123458999999999875 567899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~E 823 (840)
|+.||...++......+.....+.+.. ....+..+.+||.+||..+|.+||++.+
T Consensus 211 g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 265 (285)
T cd06648 211 GEPPYFNEPPLQAMKRIRDNLPPKLKN-------------------------LHKVSPRLRSFLDRMLVRDPAQRATAAE 265 (285)
T ss_pred CCCCCcCCCHHHHHHHHHhcCCCCCcc-------------------------cccCCHHHHHHHHHHcccChhhCcCHHH
Confidence 999998877766665555442221110 0113457999999999999999999999
Q ss_pred HHHHHHh
Q 003185 824 LYEMFVA 830 (840)
Q Consensus 824 LLehLe~ 830 (840)
+++|-.-
T Consensus 266 il~~~~~ 272 (285)
T cd06648 266 LLNHPFL 272 (285)
T ss_pred HccCccc
Confidence 9987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=305.38 Aligned_cols=276 Identities=21% Similarity=0.243 Sum_probs=199.2
Q ss_pred ceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 584 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p 584 (840)
|++.+.||.|++|.||+|.+ .+..+++|+........ .. ...+.+|+.+++.++||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~--~~----~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~-- 72 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE--GV----PSTAIREISLLKELNHPNIVRLLDVVHSENK-- 72 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc--cc----hhHHHHHHHHHHhcCCCCccCHhheeccCCe--
Confidence 67889999999999999986 57889999875442211 11 1233789999999999999999999875543
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEeccc
Q 003185 585 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 664 (840)
Q Consensus 585 ~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~ 664 (840)
.|+||||++ ++|.+++... ....+++..++.++.||+.||+|||+++++||||+|+||+++.+
T Consensus 73 ------------~~iv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~- 135 (283)
T cd07835 73 ------------LYLVFEFLD-LDLKKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE- 135 (283)
T ss_pred ------------EEEEEeccC-cCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-
Confidence 599999996 6999998751 22368999999999999999999999999999999999999876
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 003185 665 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 744 (840)
Q Consensus 665 ~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG 744 (840)
+.++|+|||++......... .....++..|+|||++.+ ...++.++||||||+++|+|++|
T Consensus 136 ------~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~l~~l~~g 196 (283)
T cd07835 136 ------GALKLADFGLARAFGVPVRT----------YTHEVVTLWYRAPEILLG---SRQYSTPVDIWSIGCIFAEMVNR 196 (283)
T ss_pred ------CcEEEeecccccccCCCccc----------cCccccccCCCCCceeec---CcccCcHHHHHHHHHHHHHHHhC
Confidence 45999999998755322111 112246889999998864 23568899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCC---CCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 745 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG---FEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 745 ~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~---~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
+.||...+.......+...........+...... ..+...... ..........+..+.++|.+||+.||.+|||+
T Consensus 197 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 274 (283)
T cd07835 197 RPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL--PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISA 274 (283)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc--hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCH
Confidence 9999887765544444332211111111110000 000000000 00111122345688999999999999999999
Q ss_pred HHHHHHH
Q 003185 822 GDLYEMF 828 (840)
Q Consensus 822 ~ELLehL 828 (840)
.++++|.
T Consensus 275 ~~il~~~ 281 (283)
T cd07835 275 KAALQHP 281 (283)
T ss_pred HHHhcCC
Confidence 9999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=304.46 Aligned_cols=280 Identities=23% Similarity=0.276 Sum_probs=201.6
Q ss_pred ceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 584 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p 584 (840)
|++.+.||.|+||.||+|.+. +..+++|+..... ... .+...+.+|+.+++.++||||+++++++....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKE----GFPITAIREIKLLQKLRHPNIVRLKEIVTSKG--- 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccc----cchHHHHHHHHHHHhccCCCeeeheeeEecCC---
Confidence 678999999999999999974 5789999876543 111 12233488999999999999999999987551
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEeccc
Q 003185 585 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 664 (840)
Q Consensus 585 ~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~ 664 (840)
....++||||+++ +|.+++.. ....+++..++.++.||+.||+|||++|++|+||||+|||++.+
T Consensus 72 ---------~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~- 136 (287)
T cd07840 72 ---------KGSIYMVFEYMDH-DLTGLLDS----PEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND- 136 (287)
T ss_pred ---------CCcEEEEeccccc-cHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC-
Confidence 1135999999974 99988865 12468999999999999999999999999999999999999977
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 003185 665 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 744 (840)
Q Consensus 665 ~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG 744 (840)
+.++|+|||++......... ......++..|+|||.+.+ ...++.++||||||+++|||++|
T Consensus 137 ------~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~~l~el~t~ 198 (287)
T cd07840 137 ------GVLKLADFGLARPYTKRNSA---------DYTNRVITLWYRPPELLLG---ATRYGPEVDMWSVGCILAELFLG 198 (287)
T ss_pred ------CCEEEccccceeeccCCCcc---------cccccccccccCCceeeEc---cccCChHHHHHHHHHHHHHHHhC
Confidence 46999999999866443210 0122346889999998764 24578899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCC--CCCchhhhh-hHHHHHHHHHHhcccCCCCCCCH
Q 003185 745 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG--FEKPEAELE-TLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 745 ~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~-~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
+.||...+.......+...........+................. ......... .+..+.+++.+||..+|.+||++
T Consensus 199 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~ 278 (287)
T cd07840 199 KPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA 278 (287)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCH
Confidence 999988877666555544322111111111100000000000000 000011111 26688999999999999999999
Q ss_pred HHHHHHH
Q 003185 822 GDLYEMF 828 (840)
Q Consensus 822 ~ELLehL 828 (840)
.++++|.
T Consensus 279 ~~~l~~~ 285 (287)
T cd07840 279 DQALQHE 285 (287)
T ss_pred HHHhhCc
Confidence 9999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=295.85 Aligned_cols=249 Identities=31% Similarity=0.454 Sum_probs=200.3
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|++.+.||+|++|.||++.. .+..+++|...... ...... ..+.+|++++.+++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK--IKEEAL----KSIMQEIDLLKNLKHPNIVKYIGSIETSD-- 72 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccc--cCHHHH----HHHHHHHHHHHhCCCCCccEEEEEEEeCC--
Confidence 588999999999999999987 45688999875432 222222 34589999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.+
T Consensus 73 ------------~~~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~ 135 (254)
T cd06627 73 ------------SLYIILEYAENGSLRQIIKK-----FGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD 135 (254)
T ss_pred ------------EEEEEEecCCCCcHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC
Confidence 35999999999999999976 2568999999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.++|+|||++......... .....++..|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 136 -------~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~~lG~~l~~l~~ 194 (254)
T cd06627 136 -------GVVKLADFGVATKLNDVSKD----------DASVVGTPYWMAPEVIEM----SGASTASDIWSLGCTVIELLT 194 (254)
T ss_pred -------CCEEEeccccceecCCCccc----------ccccccchhhcCHhhhcC----CCCCcchhHHHHHHHHHHHHh
Confidence 46999999999876542211 122458899999999875 447889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~E 823 (840)
|..||...........+.....+.++. ..+..+.+++.+||..+|++||++.+
T Consensus 195 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~R~~~~~ 247 (254)
T cd06627 195 GNPPYYDLNPMAALFRIVQDDHPPLPE---------------------------GISPELKDFLMQCFQKDPNLRPTAKQ 247 (254)
T ss_pred CCCCCCCccHHHHHHHHhccCCCCCCC---------------------------CCCHHHHHHHHHHHhCChhhCcCHHH
Confidence 999998766555444443332222221 12457899999999999999999999
Q ss_pred HHHH
Q 003185 824 LYEM 827 (840)
Q Consensus 824 LLeh 827 (840)
++.+
T Consensus 248 ~l~~ 251 (254)
T cd06627 248 LLKH 251 (254)
T ss_pred HhcC
Confidence 9876
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=300.57 Aligned_cols=280 Identities=22% Similarity=0.238 Sum_probs=207.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
+.=++|.+.+.||+|||+.||+++. ++..+|+|.+.... .++.+.. ++|+...++++||||++++++...
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~----~~~~e~~----~rEid~~rkf~s~~vl~l~dh~l~ 89 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS----QEDIEEA----LREIDNHRKFNSPNVLRLVDHQLR 89 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc----hHHHHHH----HHHHHHHHhhCCcchHHHHHHHHH
Confidence 3446899999999999999999984 77788988765432 2344444 899999999999999999998775
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCCCc
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSEN 657 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~g--IVHRDLKPeN 657 (840)
+.. + .....||+++|+..|+|.+.|..... .+..+++..++.|+.+|++||++||... +.||||||.|
T Consensus 90 ~~~----D-----~~~~~yll~Pyy~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~N 159 (302)
T KOG2345|consen 90 EEK----D-----GKHEAYLLLPYYKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPAN 159 (302)
T ss_pred hhc----c-----CceeEEEEeehhccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcce
Confidence 432 1 23357999999999999999987543 3357999999999999999999999998 9999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
||+... +.++|.|||.+....-.........+ ...-..-..|..|.|||.+.. ......++++|||||||+
T Consensus 160 ILls~~-------~~~vl~D~GS~~~a~i~i~~~~~a~~-lQe~a~e~Ct~pyRAPELf~v-k~~~ti~ertDIWSLGCt 230 (302)
T KOG2345|consen 160 ILLSDS-------GLPVLMDLGSATQAPIQIEGSRQALR-LQEWAEERCTIPYRAPELFNV-KSHCTITERTDIWSLGCT 230 (302)
T ss_pred eEecCC-------CceEEEeccCccccceEeechHHHHH-HHHHHHHhCCCcccCchheec-ccCcccccccchhhhhHH
Confidence 999986 56999999998765432211100000 000011236899999999974 334678999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
||.|+.|..||... ..++....+- + ....+..+. ....++.+.+||+.||+.||.+
T Consensus 231 LYa~mf~~sPfe~~--------~~~GgSlaLA-------------v--~n~q~s~P~-~~~yse~l~~lik~mlqvdP~q 286 (302)
T KOG2345|consen 231 LYAMMFGESPFERI--------YQQGGSLALA-------------V--QNAQISIPN-SSRYSEALHQLIKSMLQVDPNQ 286 (302)
T ss_pred HHHHHHcCCcchHH--------hhcCCeEEEe-------------e--eccccccCC-CCCccHHHHHHHHHHhcCCccc
Confidence 99999999999421 0111100000 0 000010111 1225778999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 003185 818 RPTAGDLYEMFVART 832 (840)
Q Consensus 818 RPSa~ELLehLe~l~ 832 (840)
||++.+++.++..+.
T Consensus 287 RP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 287 RPTIPELLSKLDDLI 301 (302)
T ss_pred CCCHHHHHHHHHhhc
Confidence 999999999998764
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=314.48 Aligned_cols=283 Identities=18% Similarity=0.222 Sum_probs=202.6
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
..+|.+.+.||+|+||+||+|.. .+..+|+|...... ....... .+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~----~~~~E~~~l~~l~h~ni~~~~~~~~~~~ 77 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF--DNRIDAK----RTLREIKLLRHLDHENVIAIKDIMPPPH 77 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc--cccchhH----HHHHHHHHHHhcCCCCccchHHheeccc
Confidence 35799999999999999999987 56788998754321 1111222 3378999999999999999999876443
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
.. .....|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+++++||||||+|||++
T Consensus 78 ~~---------~~~~~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~ 142 (337)
T cd07858 78 RE---------AFNDVYIVYELMD-TDLHQIIRS-----SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN 142 (337)
T ss_pred cc---------ccCcEEEEEeCCC-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc
Confidence 11 1224699999996 689988864 35689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||++........ ......++..|+|||.+.. ...++.++|||||||++|+|
T Consensus 143 ~~-------~~~kL~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l 202 (337)
T cd07858 143 AN-------CDLKICDFGLARTTSEKGD----------FMTEYVVTRWYRAPELLLN---CSEYTTAIDVWSVGCIFAEL 202 (337)
T ss_pred CC-------CCEEECcCccccccCCCcc----------cccccccccCccChHHHhc---CCCCCCcccHHHHHHHHHHH
Confidence 76 4599999999976543211 0123357899999999864 13478899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCC---CCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG---FEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~---~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
++|+.||.+.+.......+........++.+..........+.+.... ..........+..+.+||.+||+.+|.+|
T Consensus 203 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 282 (337)
T cd07858 203 LGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKR 282 (337)
T ss_pred HcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhc
Confidence 999999988766554444433221111111110000000000000000 00011123456789999999999999999
Q ss_pred CCHHHHHHH
Q 003185 819 PTAGDLYEM 827 (840)
Q Consensus 819 PSa~ELLeh 827 (840)
||+.++++|
T Consensus 283 ps~~ell~h 291 (337)
T cd07858 283 ITVEEALAH 291 (337)
T ss_pred cCHHHHHcC
Confidence 999999999
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=300.39 Aligned_cols=255 Identities=24% Similarity=0.351 Sum_probs=196.3
Q ss_pred CceeeeeecccCceEEEEEEECC--eeEEEEEEecccC-CCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVC-GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKI~~lk~~-~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
+|.+.+.||+|+||.||++.+.. ..+++|+.+.-.. ........ .+.+|+.+++.++||||+++++++.....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV----QANQEAQLLSKLDHPAIVKFHASFLERDA 76 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHH----HHHHHHHHHHhCCCCcHHHHHHHHhcCCc
Confidence 58899999999999999998743 3455555332111 11111111 23679999999999999999998875543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.++||||+++++|..++..... ....+++..++.++.|++.||.|||++|++|+||||+||+++.
T Consensus 77 --------------~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~ 141 (260)
T cd08222 77 --------------FCIITEYCEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN 141 (260)
T ss_pred --------------eEEEEEeCCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec
Confidence 4999999999999999875322 2356899999999999999999999999999999999999964
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ .++|+|||++......... .....|++.|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 142 ~--------~~~l~d~g~~~~~~~~~~~----------~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~slG~~~~~l~ 199 (260)
T cd08222 142 N--------LLKIGDFGVSRLLMGSCDL----------ATTFTGTPYYMSPEALKH----QGYDSKSDIWSLGCILYEMC 199 (260)
T ss_pred C--------CEeecccCceeecCCCccc----------ccCCCCCcCccCHHHHcc----CCCCchhhHHHHHHHHHHHH
Confidence 3 4999999998765332111 122457889999999865 55678999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
+|..||...........+..+..+.++. ..+..+.++|.+||..+|.+||++.
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp~~~ 252 (260)
T cd08222 200 CLAHAFEGQNFLSVVLRIVEGPTPSLPE---------------------------TYSRQLNSIMQSMLNKDPSLRPSAA 252 (260)
T ss_pred hCCCCCCCccHHHHHHHHHcCCCCCCcc---------------------------hhcHHHHHHHHHHhcCChhhCcCHH
Confidence 9999998766665555554443332221 2245789999999999999999999
Q ss_pred HHHHHH
Q 003185 823 DLYEMF 828 (840)
Q Consensus 823 ELLehL 828 (840)
++++|-
T Consensus 253 ~il~~~ 258 (260)
T cd08222 253 EILRNP 258 (260)
T ss_pred HHhhCC
Confidence 999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=307.64 Aligned_cols=273 Identities=18% Similarity=0.208 Sum_probs=188.3
Q ss_pred CCceeeeeecccCceEEEEEEECC-----eeEEEEEEecccCCCChHHH--HH-hHHhHHHHHHHHHhCCCCCcceeeeE
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEI--RN-FEYSCLGEVRMLGALRHSCIVEMYGH 576 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-----~~vAVKI~~lk~~~~~~~~~--~~-f~~~~~rEi~iL~~L~HpNIV~l~g~ 576 (840)
.+|.+.+.||+|+||.||+|.+.+ ..+++|+..+.......+.. .. .......++..+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 589999999999999999999743 36677765443321111100 00 00112344455667789999999997
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
+..... .....+++|+++. .++.+++.. ....++..++.++.||+.||.|||+++|+||||||+
T Consensus 92 ~~~~~~----------~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~ 155 (294)
T PHA02882 92 GSFKRC----------RMYYRFILLEKLV-ENTKEIFKR-----IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPE 155 (294)
T ss_pred eeEecC----------CceEEEEEEehhc-cCHHHHHHh-----hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 664431 1224588999885 478777764 133578889999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
|||++.+ ..++|+|||+|+.+......... .........||+.|+|||++.+ ..++.++|||||||
T Consensus 156 Nill~~~-------~~~~l~DFGla~~~~~~~~~~~~---~~~~~~~~~gt~~y~ape~~~~----~~~~~~~DiwSlG~ 221 (294)
T PHA02882 156 NIMVDGN-------NRGYIIDYGIASHFIIHGKHIEY---SKEQKDLHRGTLYYAGLDAHNG----ACVTRRGDLESLGY 221 (294)
T ss_pred HEEEcCC-------CcEEEEEcCCceeeccCCccccc---ccccccccCCCccccCHHHhCC----CCCCcHHHHHHHHH
Confidence 9999866 45999999999876432211100 0111233469999999999876 66899999999999
Q ss_pred HHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 737 LLLELLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 737 IL~ELLTG~~PF~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
+||||++|+.||.+.. ...+...........+... . ......+..+.+++..||..+|
T Consensus 222 ~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~---------------~------~~~~~~~~~~~~~~~~~~~~~~ 280 (294)
T PHA02882 222 CMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEG---------------K------IKIKNANKFIYDFIECVTKLSY 280 (294)
T ss_pred HHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhh---------------h------hccCCCCHHHHHHHHHHHhCCC
Confidence 9999999999998763 2222222111000000000 0 0001124679999999999999
Q ss_pred CCCCCHHHHHHHH
Q 003185 816 TERPTAGDLYEMF 828 (840)
Q Consensus 816 ~eRPSa~ELLehL 828 (840)
.+||++++|++.|
T Consensus 281 ~~rp~~~~l~~~~ 293 (294)
T PHA02882 281 EEKPDYDALIKIF 293 (294)
T ss_pred CCCCCHHHHHHhh
Confidence 9999999999876
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=304.66 Aligned_cols=257 Identities=28% Similarity=0.456 Sum_probs=205.5
Q ss_pred CCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
..+.|++.+.||+|+||.||+|.+. +..+++|+...... ..+ .+.+|+.+++.++|+||+++++.+...
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~ 87 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKE----LIINEILIMKDCKHPNIVDYYDSYLVG 87 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHH----HHHHHHHHHHHCCCCCeeEEEEEEEEC
Confidence 4567899999999999999999985 78899998754321 222 348899999999999999999998865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
. ..|+||||+++++|.+++... ...+++..+..++.||+.||.|||+.||+|+||+|+||++
T Consensus 88 ~--------------~~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i 149 (286)
T cd06614 88 D--------------ELWVVMEYMDGGSLTDIITQN----FVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL 149 (286)
T ss_pred C--------------EEEEEEeccCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE
Confidence 4 359999999999999999862 1378999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.++|+|||++........ ......++..|+|||++.+ ..++.++|||||||++|+
T Consensus 150 ~~~-------~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slGvil~~ 208 (286)
T cd06614 150 SKD-------GSVKLADFGFAAQLTKEKS----------KRNSVVGTPYWMAPEVIKR----KDYGPKVDIWSLGIMCIE 208 (286)
T ss_pred cCC-------CCEEECccchhhhhccchh----------hhccccCCcccCCHhHhcC----CCCCCccccHHHHHHHHH
Confidence 876 4599999998865433211 0122357889999999875 567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|++|..||...++......+.....+.+.. ....+..+.+||.+||+.+|.+||+
T Consensus 209 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~p~~Rpt 263 (286)
T cd06614 209 MAEGEPPYLREPPLRALFLITTKGIPPLKN-------------------------PEKWSPEFKDFLNKCLVKDPEKRPS 263 (286)
T ss_pred HHhCCCCCCCCCHHHHHHHHHhcCCCCCcc-------------------------hhhCCHHHHHHHHHHhccChhhCcC
Confidence 999999998777665555544332222111 0113457899999999999999999
Q ss_pred HHHHHHHHHhhc
Q 003185 821 AGDLYEMFVART 832 (840)
Q Consensus 821 a~ELLehLe~l~ 832 (840)
+.+|++|..-..
T Consensus 264 ~~~il~~~~~~~ 275 (286)
T cd06614 264 AEELLQHPFLKK 275 (286)
T ss_pred HHHHhhChHhhc
Confidence 999999865444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=314.90 Aligned_cols=294 Identities=22% Similarity=0.251 Sum_probs=203.8
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
.+|.+.+.||.|+||.||+|.. .+..+++|+...+.. ...+ .+.+|+.++++++||||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~----~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVK----HALREIKIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHH----HHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence 6899999999999999999987 467888888654432 2222 33889999999999999999988765431
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
....+..........|+||||++ ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~ 149 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT 149 (342)
T ss_pred ccccccccccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC
Confidence 10000001112235799999997 599888764 46899999999999999999999999999999999999975
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
++ ..+||+|||++......... ........++..|+|||++.. ...++.++|||||||++|+|+
T Consensus 150 ~~------~~~kl~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwSlGvil~el~ 213 (342)
T cd07854 150 ED------LVLKIGDFGLARIVDPHYSH-------KGYLSEGLVTKWYRSPRLLLS---PNNYTKAIDMWAAGCIFAEML 213 (342)
T ss_pred CC------ceEEECCcccceecCCcccc-------ccccccccccccccCHHHHhC---ccccCchhhHHHHHHHHHHHH
Confidence 42 46899999999765332111 001122357889999998764 245788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccC--CCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG--SGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
+|+.||...++......+........................... ............+..+.+||.+||..||.+|||
T Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 293 (342)
T cd07854 214 TGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293 (342)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC
Confidence 999999888776665555443221111111111000000000000 000001111234567899999999999999999
Q ss_pred HHHHHHHHH
Q 003185 821 AGDLYEMFV 829 (840)
Q Consensus 821 a~ELLehLe 829 (840)
+.+++.|-.
T Consensus 294 ~~ell~h~~ 302 (342)
T cd07854 294 AEEALMHPY 302 (342)
T ss_pred HHHHhCCCc
Confidence 999998843
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=300.61 Aligned_cols=246 Identities=24% Similarity=0.284 Sum_probs=189.0
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHH-HHhCCCCCcceeeeEEecCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM-LGALRHSCIVEMYGHKISSKWLPSAD 587 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~i-L~~L~HpNIV~l~g~~~~~~~~p~~~ 587 (840)
+.||.|+||.||+|.. .+..+|+|+....... ..... ..+..|..+ ...++||||+++++++.....
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~-~~~~~----~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~----- 71 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI-AKNQV----TNVKAERAIMMIQGESPYVAKLYYSFQSKDY----- 71 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh-HHHHH----HHHHHHHHHHhhcCCCCCeeeeeeeEEcCCe-----
Confidence 5799999999999987 5678999986432110 11111 122445444 445579999999999976553
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccC
Q 003185 588 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667 (840)
Q Consensus 588 g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~ 667 (840)
.|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.||+||||+|+|||++.+
T Consensus 72 ---------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~---- 133 (260)
T cd05611 72 ---------LYLVMEYLNGGDCASLIKT-----LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT---- 133 (260)
T ss_pred ---------EEEEEeccCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC----
Confidence 4999999999999999975 2468999999999999999999999999999999999999876
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003185 668 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 747 (840)
Q Consensus 668 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~P 747 (840)
..++|+|||++..... .....|+..|+|||.+.+ ..++.++||||||+++|+|++|..|
T Consensus 134 ---~~~~l~dfg~~~~~~~--------------~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~il~~l~~g~~p 192 (260)
T cd05611 134 ---GHLKLTDFGLSRNGLE--------------NKKFVGTPDYLAPETILG----VGDDKMSDWWSLGCVIFEFLFGYPP 192 (260)
T ss_pred ---CcEEEeecccceeccc--------------cccCCCCcCccChhhhcC----CCCcchhhhHHHHHHHHHHHHCCCC
Confidence 4599999999865432 122358899999999876 4478999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH---HHH
Q 003185 748 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA---GDL 824 (840)
Q Consensus 748 F~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa---~EL 824 (840)
|...+...+...+...... .+. ......+..+.++|.+||..+|.+||++ +|+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~-~~~-----------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 193 FHAETPDAVFDNILSRRIN-WPE-----------------------EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred CCCCCHHHHHHHHHhcccC-CCC-----------------------cccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 9888777766665443211 000 0001235678999999999999999955 688
Q ss_pred HHHHH
Q 003185 825 YEMFV 829 (840)
Q Consensus 825 LehLe 829 (840)
+.|..
T Consensus 249 l~~~~ 253 (260)
T cd05611 249 KSHPF 253 (260)
T ss_pred HcChH
Confidence 77754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=307.81 Aligned_cols=289 Identities=19% Similarity=0.190 Sum_probs=200.2
Q ss_pred ceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 586 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~ 586 (840)
+.+.+.+|.|+++.||++...+..+|+|+..... ......+. +.+|+.+++.++||||+++++++.....
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~----~~~Ei~~l~~l~h~~i~~~~~~~~~~~~---- 73 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS--CSKEDLKL----LQQEIITSRQLQHPNILPYVTSFIVDSE---- 73 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccc--cchhHHHH----HHHHHHHHHhcCCcchhhhhheeecCCe----
Confidence 3456667777787888887788999999976432 22233333 4899999999999999999999886654
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEeccccc
Q 003185 587 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 666 (840)
Q Consensus 587 ~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~ 666 (840)
.+++|||+++++|.+++... ....+++..+..++.||+.||+|||+++|+||||||+|||++.+
T Consensus 74 ----------~~~~~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~--- 137 (314)
T cd08216 74 ----------LYVVSPLMAYGSCEDLLKTH---FPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD--- 137 (314)
T ss_pred ----------EEEEEeccCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC---
Confidence 49999999999999999862 22358899999999999999999999999999999999999876
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 003185 667 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 746 (840)
Q Consensus 667 ~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~ 746 (840)
+.+||+|||.+.......... ...........++..|+|||++... ...++.++|||||||++|||++|..
T Consensus 138 ----~~~kl~d~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Diws~G~il~el~~g~~ 208 (314)
T cd08216 138 ----GKVVLSGLRYSVSMIKHGKRQ---RVVHDFPKSSVKNLPWLSPEVLQQN--LQGYNEKSDIYSVGITACELANGHV 208 (314)
T ss_pred ----CceEEecCccceeeccccccc---cccccccccccccccccCHHHhcCC--CCCCCcchhHHHHHHHHHHHHhCCC
Confidence 459999999987654322110 0001112334578899999998751 1347889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCC-cchH-Hhhhc-cCccc--ccccc-CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 747 PYMGLSELEIHDLIQMGKRPR-LTDE-LEALG-SCHEH--EVAQS-GSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 747 PF~~~~~~el~~~I~~~~~p~-l~~~-l~~~~-~~~~~--~~~~~-~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
||..............+..+. +... ..... ..... ..... .............+..+.+|+.+||..||.+|||
T Consensus 209 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 288 (314)
T cd08216 209 PFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS 288 (314)
T ss_pred CCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcC
Confidence 998765444332222221111 1000 00000 00000 00000 0000011112334568899999999999999999
Q ss_pred HHHHHHHHHh
Q 003185 821 AGDLYEMFVA 830 (840)
Q Consensus 821 a~ELLehLe~ 830 (840)
+.++++|..-
T Consensus 289 ~~~ll~~p~~ 298 (314)
T cd08216 289 ASQLLNHSFF 298 (314)
T ss_pred HHHHhcCchH
Confidence 9999998553
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.75 Aligned_cols=279 Identities=23% Similarity=0.229 Sum_probs=200.6
Q ss_pred ceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC---CCCCcceeeeEEecCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKISSK 581 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L---~HpNIV~l~g~~~~~~ 581 (840)
|++.+.||+|+||.||+|.+. +..+|+|+........ .... .+.+|+.+++++ .||||+++++++....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~----~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE--GIPL----STLREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc--hhhh----hHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 678999999999999999983 6889999976543211 1111 236677777666 5999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
.. .....+++|||+. ++|.+++.. .....+++..++.++.||+.||.|||+.+++|+||+|+||+++
T Consensus 75 ~~---------~~~~~~l~~e~~~-~~l~~~l~~---~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~ 141 (287)
T cd07838 75 TD---------RELKLTLVFEHVD-QDLATYLSK---CPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT 141 (287)
T ss_pred CC---------CCceeEEEehhcc-cCHHHHHHH---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc
Confidence 31 1223699999997 489998875 2223589999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.++|+|||++..+..... .....++..|+|||++.+ ..++.++|||||||++|+|
T Consensus 142 ~~-------~~~~l~dfg~~~~~~~~~~-----------~~~~~~~~~~~~PE~~~~----~~~~~~~Di~s~G~~l~~l 199 (287)
T cd07838 142 SD-------GQVKIADFGLARIYSFEMA-----------LTSVVVTLWYRAPEVLLQ----SSYATPVDMWSVGCIFAEL 199 (287)
T ss_pred cC-------CCEEEeccCcceeccCCcc-----------cccccccccccChHHhcc----CCCCCcchhhhHHHHHHHH
Confidence 77 4699999999876543211 122347889999999976 5678899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
++|.+||......+....+...........+..........+ ...............+..+.+||.+||+.||.+||++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~ 278 (287)
T cd07838 200 FRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSF-PSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA 278 (287)
T ss_pred HhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhc-ccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCH
Confidence 999999988877666655543211111110000000000000 0000111122223456788999999999999999999
Q ss_pred HHHHHH
Q 003185 822 GDLYEM 827 (840)
Q Consensus 822 ~ELLeh 827 (840)
.+++.|
T Consensus 279 ~~il~~ 284 (287)
T cd07838 279 FEALQH 284 (287)
T ss_pred HHHhcC
Confidence 999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=312.38 Aligned_cols=302 Identities=17% Similarity=0.199 Sum_probs=207.0
Q ss_pred CCCCCce-eeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHH------HhHHhHHHHHHHHHhCCCCCcce
Q 003185 502 GSFPSLS-SCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIR------NFEYSCLGEVRMLGALRHSCIVE 572 (840)
Q Consensus 502 ~~~~~y~-i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~------~f~~~~~rEi~iL~~L~HpNIV~ 572 (840)
..-++|. +.+.||.|+||.||+|.+ .+..+|+|+.............. .+...+.+|+.+++.++||||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 3446776 457799999999999986 57789999875433221110000 11124578999999999999999
Q ss_pred eeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Q 003185 573 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRD 652 (840)
Q Consensus 573 l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRD 652 (840)
+++++..... .++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.||+|+|
T Consensus 85 ~~~~~~~~~~--------------~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~d 144 (335)
T PTZ00024 85 LVDVYVEGDF--------------INLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILNGLNVLHKWYFMHRD 144 (335)
T ss_pred eeEEEecCCc--------------EEEEEeccc-cCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 9999886554 499999997 599999875 35689999999999999999999999999999
Q ss_pred CCCCcEEEecccccCCCCCeEEEeecCCccccccccccccccc----CCCCCCCcccCCCcccchhhhhcccCCCCCCch
Q 003185 653 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH----RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 728 (840)
Q Consensus 653 LKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~----~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~k 728 (840)
|||+|||++.+ +.++|+|||++.............. ..........+++.|+|||++.+ ...++.+
T Consensus 145 l~~~nill~~~-------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~ 214 (335)
T PTZ00024 145 LSPANIFINSK-------GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG---AEKYHFA 214 (335)
T ss_pred ccHHHeEECCC-------CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhccc---CCCCCcH
Confidence 99999999876 4699999999976642111100000 00011122346889999999875 2346889
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHH
Q 003185 729 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 808 (840)
Q Consensus 729 SDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~ 808 (840)
+|||||||++|+|++|..||.+.+..+....+...........+...........................+..+.++|.
T Consensus 215 ~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 294 (335)
T PTZ00024 215 VDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQ 294 (335)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHH
Confidence 99999999999999999999888776665555432111111111100000000000000000001111233567899999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhcC
Q 003185 809 RCTEENPTERPTAGDLYEMFVARTS 833 (840)
Q Consensus 809 rCL~~DP~eRPSa~ELLehLe~l~~ 833 (840)
+||..+|.+||++++++.|.+-...
T Consensus 295 ~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 295 SLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHcCCCchhccCHHHHhcCcccCCC
Confidence 9999999999999999998765543
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.70 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=201.9
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
..|...+.||+|+||.||++.+ .+..+++|+...... ...... ..+.+|+.++++++||||+++++++.....
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKW----QDIIKEVKFLQRIKHPNSIEYKGCYLREHT 99 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-CchHHH----HHHHHHHHHHHhCCCCCEEEEEEEEeeCCe
Confidence 4588899999999999999987 567888887643211 122222 334889999999999999999999886553
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.++||||+. |+|.+++.. ....+++..+..++.||+.||.|||++||+||||+|+||+++.
T Consensus 100 --------------~~lv~e~~~-g~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~ 160 (317)
T cd06635 100 --------------AWLVMEYCL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE 160 (317)
T ss_pred --------------EEEEEeCCC-CCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECC
Confidence 499999997 588887754 1346899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.++|+|||++...... ....|++.|+|||++.... ...++.++|||||||++|+|+
T Consensus 161 ~-------~~~kl~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~~~-~~~~~~~~Dv~slGvil~el~ 218 (317)
T cd06635 161 P-------GQVKLADFGSASIASPA--------------NSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELA 218 (317)
T ss_pred C-------CCEEEecCCCccccCCc--------------ccccCCccccChhhhhcCC-CCCCCccccHHHHHHHHHHHH
Confidence 6 45999999988654321 1235889999999985321 245788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
+|..||...........+.....+.... ...+..+.+|+.+||+.+|.+||++.
T Consensus 219 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~~p~~Rpt~~ 272 (317)
T cd06635 219 ERKPPLFNMNAMSALYHIAQNESPTLQS--------------------------NEWSDYFRNFVDSCLQKIPQDRPTSE 272 (317)
T ss_pred hCCCCCCCccHHHHHHHHHhccCCCCCC--------------------------ccccHHHHHHHHHHccCCcccCcCHH
Confidence 9999998776666655555443222110 11245789999999999999999999
Q ss_pred HHHHHHHhhcCC
Q 003185 823 DLYEMFVARTSS 834 (840)
Q Consensus 823 ELLehLe~l~~~ 834 (840)
+|++|+......
T Consensus 273 ~il~~~~~~~~~ 284 (317)
T cd06635 273 ELLKHMFVLRER 284 (317)
T ss_pred HHHhChhhhccC
Confidence 999998765543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=312.11 Aligned_cols=282 Identities=20% Similarity=0.235 Sum_probs=203.5
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
-++|++.+.||+|+||.||+|.. .+..||+|+..... ... .....+.+|+.+|++++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF--QSE----LFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc--cch----HHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 46799999999999999999986 56789999864321 111 12234589999999999999999999987544
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
.. ......++||||+ +++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 88 ~~--------~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~ 152 (343)
T cd07880 88 SL--------DRFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN 152 (343)
T ss_pred cc--------cccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence 22 1123468999999 6799988864 4689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.++|+|||++....... ....+++.|+|||++.+ ...++.++|||||||++|+|
T Consensus 153 ~~-------~~~kl~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~ll~~l 209 (343)
T cd07880 153 ED-------CELKILDFGLARQTDSEM-------------TGYVVTRWYRAPEVILN---WMHYTQTVDIWSVGCIMAEM 209 (343)
T ss_pred CC-------CCEEEeecccccccccCc-------------cccccCCcccCHHHHhC---CCCCCcHHHHHHHHHHHHHH
Confidence 76 459999999987543211 12357899999999864 23478899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCC---CCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF---EKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
++|..||.+.+.......+..............+.......+....... .........+..+.++|.+||..||.+|
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 289 (343)
T cd07880 210 LTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESR 289 (343)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhC
Confidence 9999999877665555444433222111111111100000000000000 0011122345678999999999999999
Q ss_pred CCHHHHHHHHH
Q 003185 819 PTAGDLYEMFV 829 (840)
Q Consensus 819 PSa~ELLehLe 829 (840)
||+.++++|-.
T Consensus 290 ~t~~~~l~~~~ 300 (343)
T cd07880 290 ITAAEALAHPY 300 (343)
T ss_pred CCHHHHhcCcc
Confidence 99999998744
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=305.64 Aligned_cols=293 Identities=20% Similarity=0.213 Sum_probs=204.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
...++|++.+.||+|+||.||+|.+ .+..+++|+......... ....+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~------~~~~~~~e~~~~~~l~h~~i~~~~~~~~~ 77 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG------FPITAIREIKILRQLNHRNIVNLKEIVTD 77 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC------chHHHHHHHHHHHhCCCCCeeeeeheecC
Confidence 3467899999999999999999997 467889998764432111 11234789999999999999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
..... .........++||||+++ +|..++.. ....+++..++.++.||+.||+|||+.||+|+||||+||+
T Consensus 78 ~~~~~----~~~~~~~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nil 148 (302)
T cd07864 78 KQDAL----DFKKDKGAFYLVFEYMDH-DLMGLLES----GLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNIL 148 (302)
T ss_pred cchhh----hccccCCcEEEEEcccCc-cHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 43100 000112257999999985 78777764 2346899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++......... ......++..|+|||.+.+ ...++.++|||||||++|
T Consensus 149 i~~~-------~~~kl~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~---~~~~~~~~Di~slG~~~~ 209 (302)
T cd07864 149 LNNK-------GQIKLADFGLARLYNSEESR---------PYTNKVITLWYRPPELLLG---EERYGPAIDVWSCGCILG 209 (302)
T ss_pred ECCC-------CcEEeCcccccccccCCccc---------ccccceeccCccChHHhcC---CCCCCchhHHHHHHHHHH
Confidence 9876 56999999999765432211 0112246788999998864 234688999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCC--CCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG--FEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
+|++|++||...+..+....+........+..++...........+.... ..........+..+.+|+.+||..||.+
T Consensus 210 el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 289 (302)
T cd07864 210 ELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSK 289 (302)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhh
Confidence 99999999987776665555544321111211111100000000000000 0000111123568999999999999999
Q ss_pred CCCHHHHHHHH
Q 003185 818 RPTAGDLYEMF 828 (840)
Q Consensus 818 RPSa~ELLehL 828 (840)
||++.++++|.
T Consensus 290 Rp~~~~il~~~ 300 (302)
T cd07864 290 RCTAEEALNSP 300 (302)
T ss_pred CCCHHHHhcCC
Confidence 99999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.83 Aligned_cols=254 Identities=32% Similarity=0.491 Sum_probs=199.4
Q ss_pred CceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|.+.+.||+|++|.||+|... +..+++|+...... .....+ .+.+|+.++++++||||+++++.+....
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELE----ALEREIRILSSLQHPNIVRYYGSERDEE-- 72 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHH----HHHHHHHHHHHcCCCCEeeEEEEEecCC--
Confidence 4788999999999999999984 77899998654322 122233 4489999999999999999999988651
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
....++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus 73 ----------~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~ 137 (260)
T cd06606 73 ----------KNTLNIFLEYVSGGSLSSLLKK-----FGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD 137 (260)
T ss_pred ----------CCeEEEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC
Confidence 0135999999999999999986 2378999999999999999999999999999999999999976
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.++|+|||.+......... .......++..|+|||.+.. ...+.++||||||+++|+|++
T Consensus 138 -------~~~~l~d~~~~~~~~~~~~~--------~~~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slG~il~~l~~ 198 (260)
T cd06606 138 -------GVVKLADFGCAKRLGDIETG--------EGTGSVRGTPYWMAPEVIRG----EEYGRAADIWSLGCTVIEMAT 198 (260)
T ss_pred -------CCEEEcccccEEeccccccc--------ccccCCCCCccccCHhhhcC----CCCCchhhHHHHHHHHHHHHh
Confidence 45999999998876543210 00123458899999999876 447899999999999999999
Q ss_pred CCCCCCCCC-HHHHHHHHHc-CCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 744 LQVPYMGLS-ELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 744 G~~PF~~~~-~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
|..||.... .......+.. ...+.++ ...+..+.++|.+||..+|.+||++
T Consensus 199 g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~~i~~~l~~~p~~Rp~~ 251 (260)
T cd06606 199 GKPPWSELGNPMAALYKIGSSGEPPEIP---------------------------EHLSEEAKDFLRKCLRRDPKKRPTA 251 (260)
T ss_pred CCCCCCCCCchHHHHHhccccCCCcCCC---------------------------cccCHHHHHHHHHhCcCChhhCCCH
Confidence 999997765 2222222221 1111111 1124579999999999999999999
Q ss_pred HHHHHHH
Q 003185 822 GDLYEMF 828 (840)
Q Consensus 822 ~ELLehL 828 (840)
.+++.|.
T Consensus 252 ~~ll~~~ 258 (260)
T cd06606 252 DELLQHP 258 (260)
T ss_pred HHHhhCC
Confidence 9999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.17 Aligned_cols=301 Identities=19% Similarity=0.237 Sum_probs=217.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 575 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g 575 (840)
..+..|+++..||+|.||.||+|... ...+|+|.++-.... ..+.....||+.+++.|+|||||.+..
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~------tGiS~SAcREiaL~REl~h~nvi~Lv~ 94 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG------TGISMSACREIALLRELKHPNVISLVK 94 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC------CCcCHHHHHHHHHHHHhcCCcchhHHH
Confidence 45678999999999999999999641 236777765433221 122334489999999999999999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCC
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 655 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKP 655 (840)
+|...+. ..++++||++. +|...|+-........++...++.|++||+.|+.|||++=|+||||||
T Consensus 95 Vfl~~d~-------------~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKP 160 (438)
T KOG0666|consen 95 VFLSHDK-------------KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKP 160 (438)
T ss_pred HHhccCc-------------eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCc
Confidence 9886322 35999999996 999999876666667899999999999999999999999999999999
Q ss_pred CcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003185 656 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735 (840)
Q Consensus 656 eNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLG 735 (840)
.||||..++. ..+.|||+|||+++.+....... ...+.++-|..|.|||.+.+ ...|+.+.||||+|
T Consensus 161 aNIlvmgdgp---erG~VKIaDlGlaR~~~~plkpl-------~s~d~VVVTiWYRAPELLLG---a~hYT~AiDvWAiG 227 (438)
T KOG0666|consen 161 ANILVMGDGP---ERGRVKIADLGLARLFNNPLKPL-------ASLDPVVVTIWYRAPELLLG---ARHYTKAIDVWAIG 227 (438)
T ss_pred ceEEEeccCC---ccCeeEeecccHHHHhhcccccc-------ccCCceEEEEEecChHHhcc---cccccchhhhHHHH
Confidence 9999998854 46789999999999887654432 12344678999999999997 57899999999999
Q ss_pred HHHHHHHhCCCCCCCCC-------H--HHHHHHHHcCCCCCcchHHhhhccCccc--cccccC-CCCCC------chhhh
Q 003185 736 CLLLELLTLQVPYMGLS-------E--LEIHDLIQMGKRPRLTDELEALGSCHEH--EVAQSG-SGFEK------PEAEL 797 (840)
Q Consensus 736 vIL~ELLTG~~PF~~~~-------~--~el~~~I~~~~~p~l~~~l~~~~~~~~~--~~~~~~-~~~~~------~~~~~ 797 (840)
||+.||+|.++.|.+.. + .+.+..|......+-.+.|+.+...++. .+.+.. ..... -....
T Consensus 228 CIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k 307 (438)
T KOG0666|consen 228 CIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHK 307 (438)
T ss_pred HHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhc
Confidence 99999999999986532 1 1233344333221222222222211111 000000 00000 00011
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 003185 798 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 835 (840)
Q Consensus 798 ~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~~~ 835 (840)
..++...+|+.+||.+||.+|.|+++.++|.-....+-
T Consensus 308 ~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~l 345 (438)
T KOG0666|consen 308 VKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPL 345 (438)
T ss_pred CCCchHHHHHHHHhccCchhhccHHHHhcccccccCCC
Confidence 12345789999999999999999999999976665543
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=300.95 Aligned_cols=261 Identities=24% Similarity=0.302 Sum_probs=203.5
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEecCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 581 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~~~ 581 (840)
++|.+.+.||+|+||.||+|.. .+..+++|+....... ..... ..+.+|+.++++++ ||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-KEKKV----KYVKIEKEVLTRLNGHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc-chHHH----HHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence 4799999999999999999987 6788999987543221 11122 33488999999999 999999999887554
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .++||||+++++|.+++.+ ...+++..++.++.||+.||.|||+.|++|+||||+||+++
T Consensus 76 ~--------------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~ 136 (280)
T cd05581 76 N--------------LYFVLEYAPNGELLQYIRK-----YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD 136 (280)
T ss_pred e--------------EEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC
Confidence 3 5999999999999999986 24699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccc----------cccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCC----------IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 731 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~----------~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDV 731 (840)
.+ +.++|+|||++........... .............++..|+|||++.. ..++.++||
T Consensus 137 ~~-------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~----~~~~~~~Di 205 (280)
T cd05581 137 KD-------MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE----KPAGKSSDL 205 (280)
T ss_pred CC-------CCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC----CCCChhhhH
Confidence 76 4599999999986654321100 00001122234568899999999875 557889999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 003185 732 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 811 (840)
Q Consensus 732 WSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL 811 (840)
||||+++|+|++|+.||...........+..... .++ ...++.+.+||.+||
T Consensus 206 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~li~~~l 257 (280)
T cd05581 206 WALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY-SFP---------------------------PNFPPDAKDLIEKLL 257 (280)
T ss_pred HHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC-CCC---------------------------CccCHHHHHHHHHHh
Confidence 9999999999999999988776555555443211 111 112457899999999
Q ss_pred ccCCCCCCCH----HHHHHHH
Q 003185 812 EENPTERPTA----GDLYEMF 828 (840)
Q Consensus 812 ~~DP~eRPSa----~ELLehL 828 (840)
..+|.+||++ .++++|.
T Consensus 258 ~~~p~~R~~~~~~~~~ll~~~ 278 (280)
T cd05581 258 VLDPQDRLGVNEGYDELKAHP 278 (280)
T ss_pred cCCHhhCCCcccCHHHHhcCC
Confidence 9999999999 9998874
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=328.94 Aligned_cols=256 Identities=26% Similarity=0.349 Sum_probs=212.6
Q ss_pred CCCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEE
Q 003185 500 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 577 (840)
Q Consensus 500 ~p~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~ 577 (840)
+...++.|.+.+.||+|.|+.|.+|++ .+..||+|++. ........... +.+|+.+|+.|.|||||+++.+.
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~id--kt~ln~~~~~k----~~rev~imk~l~HPnIvkl~~v~ 124 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIID--KTQLNPSKRQK----LGREVDIMKSLNHPNIVKLFSVI 124 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEeh--hcccChHHHHH----HHHHHHHHHhcCCcceeeeeeee
Confidence 346788999999999999999999996 78899999854 33333333223 48999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
.....+ |+||||+.+|.+.+|+.+ ..++.+..+..++.|+++|++|||+++|||||||++|
T Consensus 125 ~t~~~l--------------ylV~eya~~ge~~~yl~~-----~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eN 185 (596)
T KOG0586|consen 125 ETEATL--------------YLVMEYASGGELFDYLVK-----HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAEN 185 (596)
T ss_pred eeccee--------------EEEEEeccCchhHHHHHh-----cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhh
Confidence 877754 999999999999999987 4567779999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
|||+.+. .+||+|||++..+..... ..+.+|++.|.|||++.+. ...++.+|+||+|++
T Consensus 186 ilL~~~m-------nikIaDfgfS~~~~~~~~-----------lqt~cgsppyAaPEl~~g~---~y~gpe~D~Wslgvv 244 (596)
T KOG0586|consen 186 ILLDENM-------NIKIADFGFSTFFDYGLM-----------LQTFCGSPPYAAPELFNGK---KYDGPEVDIWSLGVV 244 (596)
T ss_pred ccccccc-------ceeeeccccceeeccccc-----------ccccCCCCCccChHhhcCc---ccCCcceehhhhhhh
Confidence 9999884 499999999988764322 2456799999999999972 456899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
||-|+.|.+||.+.+...+...+..+.. .++.. .+.++.+||.++|..+|.+
T Consensus 245 ly~LV~GsLPFDG~~lk~Lr~rvl~gk~-rIp~~---------------------------ms~dce~lLrk~lvl~Psk 296 (596)
T KOG0586|consen 245 LYALVEGSLPFDGQNLKELRPRVLRGKY-RIPFY---------------------------MSCDCEDLLRKFLVLNPSK 296 (596)
T ss_pred heeeeecccccCCcccccccchheeeee-cccce---------------------------eechhHHHHHHhhccCccc
Confidence 9999999999998877666655554422 11111 1346889999999999999
Q ss_pred CCCHHHHHHHHH
Q 003185 818 RPTAGDLYEMFV 829 (840)
Q Consensus 818 RPSa~ELLehLe 829 (840)
|++.++|+++-+
T Consensus 297 r~~~dqim~~~W 308 (596)
T KOG0586|consen 297 RGPCDQIMKDRW 308 (596)
T ss_pred cCCHHHhhhhcc
Confidence 999999998854
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=312.82 Aligned_cols=286 Identities=23% Similarity=0.270 Sum_probs=205.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~ 578 (840)
...++|++.+.||+|+||.||+|.+ .+..+++|...... ....... .+.+|+.+++++ +||||+++++++.
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~----~~~~E~~~l~~l~~h~ni~~~~~~~~ 77 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF--RNATDAQ----RTFREIMFLQELGDHPNIVKLLNVIK 77 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc--Ccchhhh----hhhHHHHHHHHhcCCCCccceeeeec
Confidence 4567899999999999999999987 46788888753221 1112222 237899999999 9999999999886
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
.... ...|+||||+. ++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+||
T Consensus 78 ~~~~------------~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~ni 138 (337)
T cd07852 78 AEND------------KDIYLVFEYME-TDLHAVIRA------NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNI 138 (337)
T ss_pred cCCC------------ceEEEEecccc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 4332 24699999997 599998875 2678889999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.+ +.+||+|||++.......... .........||..|+|||++.+ ...++.++|||||||++
T Consensus 139 ll~~~-------~~~kl~d~g~~~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~sDi~slG~~l 203 (337)
T cd07852 139 LLNSD-------CRVKLADFGLARSLSELEENP-----ENPVLTDYVATRWYRAPEILLG---STRYTKGVDMWSVGCIL 203 (337)
T ss_pred EEcCC-------CcEEEeeccchhccccccccc-----cCcchhcccccccccCceeeec---cccccccchHHHHHHHH
Confidence 99877 569999999998664322110 0111233468999999998764 24567899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcccccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 739 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
|+|++|+.||.+....+....+...........+..+.......+... .............+..+.+||.+||+.||
T Consensus 204 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P 283 (337)
T cd07852 204 GEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNP 283 (337)
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCc
Confidence 999999999988776665555444322111121111100000000000 00000111122246789999999999999
Q ss_pred CCCCCHHHHHHH
Q 003185 816 TERPTAGDLYEM 827 (840)
Q Consensus 816 ~eRPSa~ELLeh 827 (840)
.+|||+.++++|
T Consensus 284 ~~Rps~~~il~~ 295 (337)
T cd07852 284 NKRLTAEEALEH 295 (337)
T ss_pred ccccCHHHHhhC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.60 Aligned_cols=285 Identities=20% Similarity=0.269 Sum_probs=196.0
Q ss_pred eeeeccc--CceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCC
Q 003185 510 CDEAGKS--VSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 585 (840)
Q Consensus 510 ~~~LG~G--~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~ 585 (840)
...||.| +||+||+|.+ .+..||+|+...... .....+ .+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~--~~~~~~----~~~~e~~~~~~l~h~niv~~~~~~~~~~~--- 73 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC--TEEHLK----ALQNEVVLSHFFRHPNIMTSWTVFTTGSW--- 73 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC--CHHHHH----HHHHHHHHHHhCCCCCcceEeeeEecCCc---
Confidence 3466666 9999999987 678999999764422 222233 44889999999999999999999987654
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccc
Q 003185 586 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 665 (840)
Q Consensus 586 ~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~ 665 (840)
.++||||+.+++|.+++... ....+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 74 -----------~~~v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~-- 137 (328)
T cd08226 74 -----------LWVISPFMAYGSANSLLKTY---FPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD-- 137 (328)
T ss_pred -----------eEEEEecccCCCHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC--
Confidence 49999999999999998863 22358899999999999999999999999999999999999876
Q ss_pred cCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCC
Q 003185 666 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 745 (840)
Q Consensus 666 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~ 745 (840)
+.++++|||.+............ .........++..|+|||++.+. ...++.++|||||||++|+|++|.
T Consensus 138 -----~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~DiwslG~~l~el~~g~ 207 (328)
T cd08226 138 -----GLVSLSGLSHLYSLVRNGQKAKV---VYDFPQFSTSVLPWLSPELLRQD--LYGYNVKSDIYSVGITACELATGR 207 (328)
T ss_pred -----CcEEEechHHHhhhhccCccccc---cccccccccCccCccChhhhcCC--CCCCCchhhHHHHHHHHHHHHhCC
Confidence 46999999865433221111000 00001122356789999998751 134688999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCC-CCcch-HHhh---hccCc---------ccccc-----ccCCCCCCchhhhhhHHHHHHH
Q 003185 746 VPYMGLSELEIHDLIQMGKR-PRLTD-ELEA---LGSCH---------EHEVA-----QSGSGFEKPEAELETLSFLVDV 806 (840)
Q Consensus 746 ~PF~~~~~~el~~~I~~~~~-p~l~~-~l~~---~~~~~---------~~~~~-----~~~~~~~~~~~~~~~s~~L~dL 806 (840)
.||................. ..... .... .+... ..... ...............+..+.+|
T Consensus 208 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 287 (328)
T cd08226 208 VPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNL 287 (328)
T ss_pred CCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHH
Confidence 99987765444333322211 00000 0000 00000 00000 0000000111233456789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHH
Q 003185 807 FRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 807 I~rCL~~DP~eRPSa~ELLehLe 829 (840)
|.+||..||.+|||+.++++|..
T Consensus 288 i~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 288 VELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred HHHHccCCcccCCCHHHHhhCHH
Confidence 99999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=303.61 Aligned_cols=249 Identities=25% Similarity=0.326 Sum_probs=189.0
Q ss_pred ecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCCCC
Q 003185 513 AGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 590 (840)
Q Consensus 513 LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g~~ 590 (840)
||+|+||+||+|.. .+..+++|+...+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-------- 67 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK-----RKGEQMALNEKKILEKVSSRFIVSLAYAFETKDD-------- 67 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh-----hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCe--------
Confidence 69999999999986 57789999865332111 1112234789999999999999999999876543
Q ss_pred ccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCCC
Q 003185 591 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 670 (840)
Q Consensus 591 ~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~ 670 (840)
.|+||||+++++|.+++... ....+++..++.++.||+.||.|||+.||+||||+|+|||++.+
T Consensus 68 ------~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~------- 131 (277)
T cd05577 68 ------LCLVMTLMNGGDLKYHIYNV---GEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH------- 131 (277)
T ss_pred ------EEEEEecCCCCcHHHHHHHc---CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-------
Confidence 49999999999999999762 22468999999999999999999999999999999999999877
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003185 671 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 750 (840)
Q Consensus 671 ~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~ 750 (840)
+.++|+|||++........ .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 132 ~~~~l~dfg~~~~~~~~~~-----------~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~il~~l~~g~~p~~~ 196 (277)
T cd05577 132 GNVRISDLGLAVELKGGKK-----------IKGRAGTPGYMAPEVLQG----EVYDFSVDWFALGCTLYEMIAGRSPFRQ 196 (277)
T ss_pred CCEEEccCcchhhhccCCc-----------cccccCCCCcCCHHHhcC----CCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 4599999999876533111 122357889999999875 4578899999999999999999999976
Q ss_pred CCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 003185 751 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGDLY 825 (840)
Q Consensus 751 ~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP-----Sa~ELL 825 (840)
.........+....... + .......++.+.++|.+||+.||.+|| ++.+++
T Consensus 197 ~~~~~~~~~~~~~~~~~-~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll 252 (277)
T cd05577 197 RKEKVEKEELKRRTLEM-A-----------------------VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVR 252 (277)
T ss_pred CcccccHHHHHhccccc-c-----------------------ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHH
Confidence 54321111221111000 0 000011255789999999999999999 888899
Q ss_pred HHHH
Q 003185 826 EMFV 829 (840)
Q Consensus 826 ehLe 829 (840)
+|..
T Consensus 253 ~h~~ 256 (277)
T cd05577 253 EHPL 256 (277)
T ss_pred hChh
Confidence 8743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=328.55 Aligned_cols=258 Identities=24% Similarity=0.360 Sum_probs=212.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC---C--eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeE
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG---S--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 576 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~---~--~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~ 576 (840)
|..+...+.++||+|.||+|++|.|+ + ..||||+.+... ... ....| ++|+.+|.+|+|||+|++||+
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~--l~~-~mddf----lrEas~M~~L~H~hliRLyGv 179 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDS--LNA-IMDDF----LREASHMLKLQHPHLIRLYGV 179 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCc--cch-hHHHH----HHHHHHHHhccCcceeEEeee
Confidence 56677889999999999999999983 3 467777754332 222 34444 999999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
..+.. +.+|||+++.|+|.+.|++ .....|.......++.|||.||.||..+++|||||-..
T Consensus 180 Vl~qp---------------~mMV~ELaplGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAAR 241 (1039)
T KOG0199|consen 180 VLDQP---------------AMMVFELAPLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAAR 241 (1039)
T ss_pred eccch---------------hhHHhhhcccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 88633 3799999999999999987 34467888999999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
||||... -+|||+|||+.+.+............ ..-.+.|+|||.+.. ..++.++|||+|||
T Consensus 242 Nlllasp-------rtVKI~DFGLmRaLg~ned~Yvm~p~-------rkvPfAWCaPEsLrh----~kFShaSDvWmyGV 303 (1039)
T KOG0199|consen 242 NLLLASP-------RTVKICDFGLMRALGENEDMYVMAPQ-------RKVPFAWCAPESLRH----RKFSHASDVWMYGV 303 (1039)
T ss_pred hheeccc-------ceeeeecccceeccCCCCcceEecCC-------CcCcccccCHhHhcc----ccccccchhhhhhh
Confidence 9999876 47999999999988765443211111 112468999999986 78999999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 737 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 737 IL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
+||||+| |+.||.+....++++.|..+.+..-+ ..+++++++++..||..+|
T Consensus 304 TiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRP---------------------------k~csedIY~imk~cWah~p 356 (1039)
T KOG0199|consen 304 TIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRP---------------------------KYCSEDIYQIMKNCWAHNP 356 (1039)
T ss_pred hHHhhhccCCCCCCCCCHHHHHHhccccccCCCC---------------------------CCChHHHHHHHHHhccCCc
Confidence 9999999 89999999999999999866543333 2357899999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 003185 816 TERPTAGDLYEMFV 829 (840)
Q Consensus 816 ~eRPSa~ELLehLe 829 (840)
.+||||..|.+.+-
T Consensus 357 aDRptFsair~~~~ 370 (1039)
T KOG0199|consen 357 ADRPTFSAIREDLV 370 (1039)
T ss_pred cccccHHHHHHhHH
Confidence 99999999975543
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=302.87 Aligned_cols=246 Identities=22% Similarity=0.270 Sum_probs=183.6
Q ss_pred eecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHH---HHHhCCCCCcceeeeEEecCCCCCCC
Q 003185 512 EAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR---MLGALRHSCIVEMYGHKISSKWLPSA 586 (840)
Q Consensus 512 ~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~---iL~~L~HpNIV~l~g~~~~~~~~p~~ 586 (840)
.||+|+||.||++.. .+..+|+|+........... ...+ .+|.. ++....||||+.+++++...+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~---- 71 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLA----LNERIMLSLVSTGDCPFIVCMTYAFHTPDK---- 71 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH-HHHH----HHHHHHHHHHhhCCCCcEeEEEEEEecCCe----
Confidence 489999999999987 56789999875433222211 1111 33433 3344579999999999886553
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEeccccc
Q 003185 587 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 666 (840)
Q Consensus 587 ~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~ 666 (840)
.++||||+++++|..++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus 72 ----------~~lv~e~~~~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~--- 133 (279)
T cd05633 72 ----------LCFILDLMNGGDLHYHLSQ-----HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH--- 133 (279)
T ss_pred ----------EEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC---
Confidence 4999999999999999875 3568999999999999999999999999999999999999876
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 003185 667 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 746 (840)
Q Consensus 667 ~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~ 746 (840)
+.++|+|||++....... .....||+.|+|||.+.. ...++.++|||||||++|+|++|..
T Consensus 134 ----~~~~l~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~ 194 (279)
T cd05633 134 ----GHVRISDLGLACDFSKKK------------PHASVGTHGYMAPEVLQK---GTAYDSSADWFSLGCMLFKLLRGHS 194 (279)
T ss_pred ----CCEEEccCCcceeccccC------------ccCcCCCcCccCHHHhcC---CCCCCchhhhHHHHHHHHHHHhCCC
Confidence 469999999986543211 112358999999999863 2457889999999999999999999
Q ss_pred CCCCCCHHH--HHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----
Q 003185 747 PYMGLSELE--IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP----- 819 (840)
Q Consensus 747 PF~~~~~~e--l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP----- 819 (840)
||....... ............++ ...+..+.++|.+||..||.+||
T Consensus 195 pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~ 247 (279)
T cd05633 195 PFRQHKTKDKHEIDRMTLTVNVELP---------------------------DSFSPELKSLLEGLLQRDVSKRLGCLGR 247 (279)
T ss_pred CcCCCCCcCHHHHHHHhhcCCcCCc---------------------------cccCHHHHHHHHHHhcCCHHHhcCCCCC
Confidence 997543211 11111111111111 12355789999999999999999
Q ss_pred CHHHHHHHHHh
Q 003185 820 TAGDLYEMFVA 830 (840)
Q Consensus 820 Sa~ELLehLe~ 830 (840)
+++++++|...
T Consensus 248 ~~~~~~~h~~~ 258 (279)
T cd05633 248 GAQEVKEHVFF 258 (279)
T ss_pred CHHHHHhCccc
Confidence 69999998543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=311.53 Aligned_cols=282 Identities=20% Similarity=0.220 Sum_probs=202.5
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
.+|.+.+.||+|+||.||+|.+ .+..+|+|+...... .. .+...+.+|+.+++.++||||+++++++.....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 88 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ--SE----IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS 88 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc--cc----cchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence 5899999999999999999986 577899998643211 11 122334889999999999999999999875432
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
. ......++||||+. .+|..++. ..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 89 ~--------~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~ 152 (342)
T cd07879 89 G--------DEFQDFYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNE 152 (342)
T ss_pred C--------CCCceEEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 1 11234699999997 47776642 35889999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||+++..... .....++..|+|||++.+ ...++.++|||||||++|||+
T Consensus 153 ~-------~~~kL~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slGvil~el~ 209 (342)
T cd07879 153 D-------CELKILDFGLARHADAE-------------MTGYVVTRWYRAPEVILN---WMHYNQTVDIWSVGCIMAEML 209 (342)
T ss_pred C-------CCEEEeeCCCCcCCCCC-------------CCCceeeecccChhhhcC---ccccCchHHHHHHHHHHHHHH
Confidence 7 45999999998754221 112357889999999864 235788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCC---CchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE---KPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|+.||.+.+.......+........+.............+........ ........+..+.+||.+||+.||.+||
T Consensus 210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 289 (342)
T cd07879 210 TGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL 289 (342)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCc
Confidence 9999999887666655555433222222221111000000000000000 0011123456789999999999999999
Q ss_pred CHHHHHHH--HHhh
Q 003185 820 TAGDLYEM--FVAR 831 (840)
Q Consensus 820 Sa~ELLeh--Le~l 831 (840)
++.+++.| ++..
T Consensus 290 ~~~e~l~h~~f~~~ 303 (342)
T cd07879 290 TATEALEHPYFDSF 303 (342)
T ss_pred CHHHHhcCcchhhc
Confidence 99999988 4443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=312.46 Aligned_cols=282 Identities=20% Similarity=0.232 Sum_probs=205.3
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.-++|++...||+|+||.||+|.+ .+..+|+|+..... ..... ...+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF--QSAIH----AKRTYRELRLLKHMDHENVIGLLDVFTPA 86 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc--chhhH----HHHHHHHHHHHHhccCCCHHHHHHHhhcc
Confidence 346899999999999999999997 46788999754321 11112 23347899999999999999999887654
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
... ......++||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||++
T Consensus 87 ~~~--------~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill 151 (343)
T cd07851 87 SSL--------EDFQDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 151 (343)
T ss_pred ccc--------cccccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence 321 1122469999999 5699999874 468999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.++|+|||++...... .....++..|+|||.+.+ ...++.++|||||||++|+
T Consensus 152 ~~~-------~~~kL~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslGv~l~e 208 (343)
T cd07851 152 NED-------CELKILDFGLARHTDDE-------------MTGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAE 208 (343)
T ss_pred CCC-------CCEEEcccccccccccc-------------ccCCcccccccCHHHHhC---CCCCCchHhHHHHHHHHHH
Confidence 876 45999999999765331 122357889999999864 2356889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCC---CCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF---EKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
|++|+.||.+.........+........+..+..........+....... .........+..+.+||.+||..+|.+
T Consensus 209 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~ 288 (343)
T cd07851 209 LLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDK 288 (343)
T ss_pred HHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhh
Confidence 99999999888776666665554322222222211100000000000000 001111233678999999999999999
Q ss_pred CCCHHHHHHHH
Q 003185 818 RPTAGDLYEMF 828 (840)
Q Consensus 818 RPSa~ELLehL 828 (840)
|||+.+|++|.
T Consensus 289 Rpt~~ell~h~ 299 (343)
T cd07851 289 RITAAEALAHP 299 (343)
T ss_pred CCCHHHHhcCC
Confidence 99999999984
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=322.37 Aligned_cols=266 Identities=21% Similarity=0.307 Sum_probs=210.0
Q ss_pred CCCCceeeeeecccCceEEEEEEECC-eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+=..+.+.++||+|-||.|.+|...+ ..||||+.+-.. .+..+..|.+|+++|.+|+|||||+++|+|..++
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-------~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De 608 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-------TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD 608 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-------chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence 33457889999999999999999865 899999854221 1122345599999999999999999999999888
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
.+ ++||||+++|+|.+|+..... ..+.......|+.||+.||+||.+.++|||||.+.|+|++
T Consensus 609 Pi--------------cmI~EYmEnGDLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~ 671 (807)
T KOG1094|consen 609 PL--------------CMITEYMENGDLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD 671 (807)
T ss_pred ch--------------HHHHHHHhcCcHHHHHHhccC---cccccchhHHHHHHHHHHHHHHHhhchhhccccccceeec
Confidence 66 999999999999999987321 1234556677999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +++||+|||+++.+-...... ..+..+-...|||||.+.. +.++.++|||+||++|||+
T Consensus 672 ~e-------~~iKiadfgmsR~lysg~yy~--------vqgr~vlpiRwmawEsill----gkFttaSDvWafgvTlwE~ 732 (807)
T KOG1094|consen 672 GE-------FTIKIADFGMSRNLYSGDYYR--------VQGRAVLPIRWMAWESILL----GKFTTASDVWAFGVTLWEV 732 (807)
T ss_pred Cc-------ccEEecCcccccccccCCcee--------eecceeeeeeehhHHHHHh----ccccchhhhhhhHHHHHHH
Confidence 77 679999999998664433221 1233455689999999986 7899999999999999998
Q ss_pred Hh--CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 742 LT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 742 LT--G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
++ .+.||...+..++.+.........-... ......-++..+.+||.+||..|-.+||
T Consensus 733 ~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~--------------------~l~~P~~cp~~lyelml~Cw~~es~~RP 792 (807)
T KOG1094|consen 733 FMLCREQPYSQLTDEQVVENAGEFFRDQGRQV--------------------VLSRPPACPQGLYELMLRCWRRESEQRP 792 (807)
T ss_pred HHHHhhCchhhhhHHHHHHhhhhhcCCCCcce--------------------eccCCCcCcHHHHHHHHHHhchhhhcCC
Confidence 66 7899999888887766544311111100 1112233567889999999999999999
Q ss_pred CHHHHHHHHHhh
Q 003185 820 TAGDLYEMFVAR 831 (840)
Q Consensus 820 Sa~ELLehLe~l 831 (840)
++++|..+|+..
T Consensus 793 sFe~lh~~lq~~ 804 (807)
T KOG1094|consen 793 SFEQLHLFLQED 804 (807)
T ss_pred CHHHHHHHHHHh
Confidence 999999998764
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=298.74 Aligned_cols=276 Identities=22% Similarity=0.282 Sum_probs=202.4
Q ss_pred ceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 584 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p 584 (840)
|.+.+.||+|++|.||+|.. ++..+++|........ .. ....+.+|+.++++++||||+++++++.....
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 72 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES--EG----IPKTALREIKLLKELNHPNIIKLLDVFRHKGD-- 72 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc--ch----hHHHHHHHHHHHHHhcCCCcchHHHhhccCCC--
Confidence 67788999999999999987 5777888876543221 11 12344889999999999999999999875543
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEeccc
Q 003185 585 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 664 (840)
Q Consensus 585 ~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~ 664 (840)
.++||||+++ +|.+++.. ....+++..+..++.||+.||.|||++||+|+||||+||+++.+
T Consensus 73 ------------~~~v~e~~~~-~l~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~- 134 (283)
T cd05118 73 ------------LYLVFEFMDT-DLYKLIKD----RQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE- 134 (283)
T ss_pred ------------EEEEEeccCC-CHHHHHHh----hcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC-
Confidence 5999999975 99888875 12468999999999999999999999999999999999999876
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 003185 665 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 744 (840)
Q Consensus 665 ~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG 744 (840)
+.++|+|||.+......... .....++..|+|||.+.+ ...++.++||||||+++|+|+||
T Consensus 135 ------~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~~~~PE~~~~---~~~~~~~~Di~slG~~l~~l~tg 195 (283)
T cd05118 135 ------GVLKLADFGLARSFGSPVRP----------YTHYVVTRWYRAPELLLG---DKGYSTPVDIWSVGCIFAELLSR 195 (283)
T ss_pred ------CcEEEeeeeeeEecCCCccc----------ccCccCcccccCcHHHhc---CCCCCchhHHHHHHHHHHHHHhC
Confidence 45999999998766442210 122357889999999875 23678999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccC---ccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 745 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC---HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 745 ~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~---~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
+.||...+..+....+........+..+...... ....+... ............+..+.++|.+||..||.+||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~ 274 (283)
T cd05118 196 RPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKK-AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITA 274 (283)
T ss_pred CCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccc-cccCHHHhhhhhCHHHHHHHHHHhccCcccCcCH
Confidence 9999887766655554433221112211111000 00000000 0000112233457789999999999999999999
Q ss_pred HHHHHHH
Q 003185 822 GDLYEMF 828 (840)
Q Consensus 822 ~ELLehL 828 (840)
.+++.|.
T Consensus 275 ~~ll~~~ 281 (283)
T cd05118 275 EQALAHP 281 (283)
T ss_pred HHHhhCC
Confidence 9999874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=307.24 Aligned_cols=286 Identities=20% Similarity=0.243 Sum_probs=202.2
Q ss_pred CceeeeeecccCceEEEEEEEC----CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEecC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 580 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~----~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~~ 580 (840)
+|.+.+.||+|+||.||++.+. +..+|+|...... ..... .+.+.+|+.++++++ ||||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 74 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF--SKKIL----AKRALRELKLLRHFRGHKNITCLYDMDIVF 74 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc--ccchh----HHHHHHHHHHHHHhcCCCChheeeeeeeec
Confidence 5889999999999999999974 5588998754221 11111 233488999999995 99999999876532
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .....+++|||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 75 ~~----------~~~~~~~~~e~~~-~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili 138 (332)
T cd07857 75 PG----------NFNELYLYEELME-ADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV 138 (332)
T ss_pred cc----------cCCcEEEEEeccc-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE
Confidence 10 1124589999996 699998864 3568999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||+++.+...... .........||..|+|||++.+ ...++.++|||||||++|+
T Consensus 139 ~~~-------~~~kl~Dfg~a~~~~~~~~~------~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~~Di~slGv~l~~ 202 (332)
T cd07857 139 NAD-------CELKICDFGLARGFSENPGE------NAGFMTEYVATRWYRAPEIMLS---FQSYTKAIDVWSVGCILAE 202 (332)
T ss_pred cCC-------CCEEeCcCCCceeccccccc------ccccccCcccCccccCcHHHhC---CCCCCcHHHHHHHHHHHHH
Confidence 877 45999999999865432211 0011123468999999999864 2457899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcccccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
|++|.+||...+.......+.........+.+..........+... .............+..+.+|+.+||+.||.+
T Consensus 203 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 282 (332)
T cd07857 203 LLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTK 282 (332)
T ss_pred HHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCccc
Confidence 9999999988776666655554322222222111110000000000 0000011111223567999999999999999
Q ss_pred CCCHHHHHHHHH
Q 003185 818 RPTAGDLYEMFV 829 (840)
Q Consensus 818 RPSa~ELLehLe 829 (840)
|||+.+++.|-.
T Consensus 283 R~t~~~ll~~~~ 294 (332)
T cd07857 283 RISVEEALEHPY 294 (332)
T ss_pred CCCHHHHhcChh
Confidence 999999998854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=295.74 Aligned_cols=253 Identities=27% Similarity=0.335 Sum_probs=195.9
Q ss_pred ecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCCCC
Q 003185 513 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 590 (840)
Q Consensus 513 LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g~~ 590 (840)
||.|+||.||++.+. +..+++|+...... ........+.+|+.++++++||||+++++.+....
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--------- 66 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-----IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK--------- 66 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh-----hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc---------
Confidence 689999999999984 78899998643321 11222345589999999999999999999887554
Q ss_pred ccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCCC
Q 003185 591 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 670 (840)
Q Consensus 591 ~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~ 670 (840)
..|+||||+++++|.+++.+ ...+++..++.++.||+.||+|||++|++|+||+|+||+++.+
T Consensus 67 -----~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~------- 129 (265)
T cd05579 67 -----NLYLVMEYLPGGDLASLLEN-----VGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN------- 129 (265)
T ss_pred -----EEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC-------
Confidence 35999999999999999986 2368999999999999999999999999999999999999977
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003185 671 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 750 (840)
Q Consensus 671 ~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~ 750 (840)
+.++|+|||++.......... ............++..|+|||.+.. ...+.++||||||+++|+|++|..||..
T Consensus 130 ~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~Pe~~~~----~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 203 (265)
T cd05579 130 GHLKLTDFGLSKVGLVRRQIN--LNDDEKEDKRIVGTPDYIAPEVILG----QGHSKTVDWWSLGCILYEFLVGIPPFHG 203 (265)
T ss_pred CCEEEEecccchhcccCcccc--cccccccccCcccCccccCHHHhcC----CCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 459999999987543321100 0000111233468889999999875 4578899999999999999999999988
Q ss_pred CCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 003185 751 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA---GDLYEM 827 (840)
Q Consensus 751 ~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa---~ELLeh 827 (840)
....+....+..+..+ .+.. ...+..+.+++.+||+.+|.+|||+ .++++|
T Consensus 204 ~~~~~~~~~~~~~~~~-~~~~-------------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 204 ETPEEIFQNILNGKIE-WPED-------------------------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCHHHHHHHHhcCCcC-CCcc-------------------------ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 8877776666553221 1110 0024578999999999999999999 777776
Q ss_pred H
Q 003185 828 F 828 (840)
Q Consensus 828 L 828 (840)
-
T Consensus 258 ~ 258 (265)
T cd05579 258 P 258 (265)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=297.82 Aligned_cols=276 Identities=23% Similarity=0.281 Sum_probs=203.6
Q ss_pred ceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 584 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p 584 (840)
|++.+.||+|+||.||+|.. .+..+++|+...... . ..+...+.+|+.++++++||||+++++++.....
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-- 72 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE--E----EGIPSTALREISLLKELKHPNIVKLLDVIHTERK-- 72 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc--c----ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCc--
Confidence 67788999999999999997 478899998764431 1 1122334789999999999999999999876543
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEeccc
Q 003185 585 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 664 (840)
Q Consensus 585 ~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~ 664 (840)
.++||||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||+|+||+++.+
T Consensus 73 ------------~~~v~e~~~-~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~- 134 (282)
T cd07829 73 ------------LYLVFEYCD-MDLKKYLDKR----PGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD- 134 (282)
T ss_pred ------------eEEEecCcC-cCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC-
Confidence 499999998 5999999861 1468999999999999999999999999999999999999876
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 003185 665 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 744 (840)
Q Consensus 665 ~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG 744 (840)
+.++|+|||++......... .....++..|+|||.+.+ ...++.++|||||||++|||++|
T Consensus 135 ------~~~~l~d~g~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Dv~slG~~l~~l~~~ 195 (282)
T cd07829 135 ------GVLKLADFGLARAFGIPLRT----------YTHEVVTLWYRAPEILLG---SKHYSTAVDIWSVGCIFAEMITG 195 (282)
T ss_pred ------CCEEEecCCcccccCCCccc----------cCccccCcCcCChHHhcC---CcCCCccccHHHHHHHHHHHHhC
Confidence 56999999998765432111 112346788999999875 23678899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCc--cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 745 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH--EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 745 ~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
..||.+.+.......+...........+....... ...+... ............+..+.++|.+||..||.+||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~ 274 (282)
T cd07829 196 KPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKF-PPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAK 274 (282)
T ss_pred CCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccccc-CccchHHhcccccHHHHHHHHHhhccCcccCCCHH
Confidence 99998887666655555433222232222221111 0000000 00001111122366899999999999999999999
Q ss_pred HHHHHH
Q 003185 823 DLYEMF 828 (840)
Q Consensus 823 ELLehL 828 (840)
+++.|.
T Consensus 275 ~~l~~p 280 (282)
T cd07829 275 EALKHP 280 (282)
T ss_pred HHhhCc
Confidence 999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=304.33 Aligned_cols=258 Identities=27% Similarity=0.392 Sum_probs=200.9
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
-..|...+.||+|+||.||+|+. ++..+++|....... ....... .+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 88 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQ----DIIKEVRFLQKLRHPNTIQYRGCYLREH 88 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc-cChHHHH----HHHHHHHHHHhCCCCCcccEEEEEEcCC
Confidence 34588889999999999999997 566788887643211 1122222 3478999999999999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .++||||+. |+|.+++.. ....+++..+..++.||+.||.|||+++++||||||+|||++
T Consensus 89 ~--------------~~lv~e~~~-~~l~~~~~~----~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~ 149 (308)
T cd06634 89 T--------------AWLVMEYCL-GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS 149 (308)
T ss_pred e--------------eEEEEEccC-CCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC
Confidence 3 499999997 588887754 234588999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.++|+|||++...... ....|++.|+|||++.+.. ...++.++|||||||++|+|
T Consensus 150 ~~-------~~~kl~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~el 207 (308)
T cd06634 150 EP-------GLVKLGDFGSASIMAPA--------------NXFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIEL 207 (308)
T ss_pred CC-------CcEEECCcccceeecCc--------------ccccCCccccCHHHHhhcc-cCCCCcccchHHHHHHHHHH
Confidence 76 46999999998754321 2235889999999986422 24568899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
++|..||...+.......+.....+.... ...+..+.+||.+||..+|.+||++
T Consensus 208 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~li~~cl~~~P~~Rp~~ 261 (308)
T cd06634 208 AERKPPLFNMNAMSALYHIAQNESPALQS--------------------------GHWSEYFRNFVDSCLQKIPQDRPTS 261 (308)
T ss_pred HcCCCCCccccHHHHHHHHhhcCCCCcCc--------------------------ccccHHHHHHHHHHhhCCcccCCCH
Confidence 99999998776655555554433222110 1124578999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 003185 822 GDLYEMFVARTS 833 (840)
Q Consensus 822 ~ELLehLe~l~~ 833 (840)
.++++|.+.+..
T Consensus 262 ~~ll~~~~~~~~ 273 (308)
T cd06634 262 EVLLKHRFVLRE 273 (308)
T ss_pred HHHhhCcccccc
Confidence 999999776554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=309.14 Aligned_cols=283 Identities=19% Similarity=0.232 Sum_probs=202.6
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
-++|++.+.||+|+||.||+|.. .+..+|+|+..... ...... +.+.+|+.++.+++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~----~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHA----KRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc--hhhHHH----HHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 37899999999999999999986 56788888754221 111112 23478999999999999999999886543
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
.. ......+++++++ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus 90 ~~--------~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~ 154 (345)
T cd07877 90 SL--------EEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 154 (345)
T ss_pred cc--------cccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEc
Confidence 21 0112358899887 6799888764 4589999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||++...... .....++..|+|||.+.+ ...++.++|||||||++|+|
T Consensus 155 ~~-------~~~kl~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslG~il~el 211 (345)
T cd07877 155 ED-------CELKILDFGLARHTDDE-------------MTGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAEL 211 (345)
T ss_pred CC-------CCEEEeccccccccccc-------------ccccccCCCccCHHHHhC---ccCCCchhhHHHHHHHHHHH
Confidence 77 45999999998754321 122357899999999864 24578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcccccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
++|+.||...+.......+........+..+..........+... .............+..+.+||.+||+.||.+|
T Consensus 212 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 291 (345)
T cd07877 212 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 291 (345)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhc
Confidence 999999987776665555544322222222211110000000000 00000111111235678999999999999999
Q ss_pred CCHHHHHHHHHh
Q 003185 819 PTAGDLYEMFVA 830 (840)
Q Consensus 819 PSa~ELLehLe~ 830 (840)
|++.++++|-.-
T Consensus 292 ~t~~e~l~h~~f 303 (345)
T cd07877 292 ITAAQALAHAYF 303 (345)
T ss_pred CCHHHHhcChhh
Confidence 999999998643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=300.84 Aligned_cols=253 Identities=23% Similarity=0.280 Sum_probs=193.1
Q ss_pred CceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEec
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 579 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~ 579 (840)
+|++.+.||.|+||.||+|.. .+..+|+|++........ ....+.+.+|+.++.++. |+||+.+++++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQK----AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhc----chHHHHHHHHHHHHHhcccCCChhceeeEeec
Confidence 488999999999999999986 567899998653221111 112234488999999994 9999999998876
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||
T Consensus 77 ~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil 137 (290)
T cd05613 77 DTK--------------LHLILDYINGGELFTHLSQ-----RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENIL 137 (290)
T ss_pred CCe--------------EEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeE
Confidence 543 4999999999999999976 346889999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++......... ......|+..|+|||.+... ...++.++||||||+++|
T Consensus 138 ~~~~-------~~~kl~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Dv~slG~~l~ 199 (290)
T cd05613 138 LDSN-------GHVVLTDFGLSKEFHEDEVE---------RAYSFCGTIEYMAPDIVRGG--DGGHDKAVDWWSMGVLMY 199 (290)
T ss_pred ECCC-------CCEEEeeCccceeccccccc---------ccccccCCcccCChhhccCC--CCCCCccccHHHHHHHHH
Confidence 9876 46999999999765332111 11234588999999998641 134678999999999999
Q ss_pred HHHhCCCCCCCCCH----HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 740 ELLTLQVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 740 ELLTG~~PF~~~~~----~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
+|++|..||..... ..+...+.... +.++ ...+..+.+|+.+||..||
T Consensus 200 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~~ll~~~l~~~p 251 (290)
T cd05613 200 ELLTGASPFTVDGEKNSQAEISRRILKSE-PPYP---------------------------QEMSALAKDIIQRLLMKDP 251 (290)
T ss_pred HHhcCCCCCCcCCccccHHHHHHHhhccC-CCCC---------------------------ccCCHHHHHHHHHHhcCCH
Confidence 99999999964322 22222222211 1111 1124578999999999999
Q ss_pred CCCC-----CHHHHHHH
Q 003185 816 TERP-----TAGDLYEM 827 (840)
Q Consensus 816 ~eRP-----Sa~ELLeh 827 (840)
.+|| ++.++++|
T Consensus 252 ~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 252 KKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHhcCCCCCCHHHHHcC
Confidence 9997 88999987
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=303.08 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=196.5
Q ss_pred eeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCC
Q 003185 508 SSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 585 (840)
Q Consensus 508 ~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~ 585 (840)
....+||+|+||.||++.. .+..+|+|...... .... ..+.+|+.+++.++||||+++++.+...+.
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--- 91 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK----QQRR----ELLFNEVVIMRDYQHENVVEMYNSYLVGDE--- 91 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc----hhHH----HHHHHHHHHHHhcCCcchhheeeEEEeCCE---
Confidence 3457899999999999987 56788888754321 1122 234889999999999999999999886553
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccc
Q 003185 586 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 665 (840)
Q Consensus 586 ~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~ 665 (840)
.++||||+++++|.+++.. ..+++..+..++.||+.||+|||++||+|+||||+||+++.+
T Consensus 92 -----------~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~-- 152 (292)
T cd06657 92 -----------LWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD-- 152 (292)
T ss_pred -----------EEEEEecCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC--
Confidence 5999999999999998754 458899999999999999999999999999999999999876
Q ss_pred cCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCC
Q 003185 666 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 745 (840)
Q Consensus 666 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~ 745 (840)
+.++|+|||++........ ......|++.|+|||.+.+ ..++.++||||||+++|+|++|.
T Consensus 153 -----~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slGvil~el~tg~ 213 (292)
T cd06657 153 -----GRVKLSDFGFCAQVSKEVP----------RRKSLVGTPYWMAPELISR----LPYGPEVDIWSLGIMVIEMVDGE 213 (292)
T ss_pred -----CCEEEcccccceecccccc----------cccccccCccccCHHHhcC----CCCCchhhHHHHHHHHHHHHhCC
Confidence 4599999998875532111 1123458899999999865 55788999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 003185 746 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 825 (840)
Q Consensus 746 ~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELL 825 (840)
.||.+....+....+.....+.+.. ....+..+.+++.+||..+|.+||++.+++
T Consensus 214 ~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~P~~R~~~~~ll 268 (292)
T cd06657 214 PPYFNEPPLKAMKMIRDNLPPKLKN-------------------------LHKVSPSLKGFLDRLLVRDPAQRATAAELL 268 (292)
T ss_pred CCCCCCCHHHHHHHHHhhCCcccCC-------------------------cccCCHHHHHHHHHHHhCCcccCcCHHHHh
Confidence 9998877666555554332211110 011245688999999999999999999999
Q ss_pred HHHHhh
Q 003185 826 EMFVAR 831 (840)
Q Consensus 826 ehLe~l 831 (840)
+|-.-.
T Consensus 269 ~~~~~~ 274 (292)
T cd06657 269 KHPFLA 274 (292)
T ss_pred cChHHh
Confidence 984433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=301.68 Aligned_cols=259 Identities=23% Similarity=0.337 Sum_probs=197.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~ 578 (840)
..+++|++.+.||+|+||.||+|.+. +..+|+|+..... . ..... .+.+|+.++.++. ||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~-~~~~~----~~~~e~~~~~~~~~~~~i~~~~~~~~ 84 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--N-KEENK----RILMDLDVVLKSHDCPYIVKCYGYFI 84 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC--C-hHHHH----HHHHHHHHHHhccCCCchHhhheeee
Confidence 67889999999999999999999985 7889999865322 1 11222 2366777777775 999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCCCc
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSEN 657 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs-~gIVHRDLKPeN 657 (840)
.... .|+||||+. ++|..++... ...+++..+..++.||+.||+|||+ .||+||||+|+|
T Consensus 85 ~~~~--------------~~~v~e~~~-~~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~n 145 (296)
T cd06618 85 TDSD--------------VFICMELMS-TCLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSN 145 (296)
T ss_pred cCCe--------------EEEEeeccC-cCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHH
Confidence 6553 499999996 5888887652 2468999999999999999999997 599999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
|+++.+ +.+||+|||++..+..... .....++..|+|||++.+......++.++||||||++
T Consensus 146 ill~~~-------~~~kL~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~i 207 (296)
T cd06618 146 ILLDAS-------GNVKLCDFGISGRLVDSKA-----------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGIS 207 (296)
T ss_pred EEEcCC-------CCEEECccccchhccCCCc-----------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHH
Confidence 999866 4699999999876533211 1122478899999998753222457889999999999
Q ss_pred HHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 738 LLELLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~-~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
+|+|++|+.||..... .+....+.....+.++. ....+..+.+|+.+||..||.
T Consensus 208 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~p~ 262 (296)
T cd06618 208 LVELATGQFPYKNCKTEFEVLTKILQEEPPSLPP-------------------------NEGFSPDFCSFVDLCLTKDHR 262 (296)
T ss_pred HHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCC-------------------------CCCCCHHHHHHHHHHccCChh
Confidence 9999999999976432 33333333332221110 001345789999999999999
Q ss_pred CCCCHHHHHHHHH
Q 003185 817 ERPTAGDLYEMFV 829 (840)
Q Consensus 817 eRPSa~ELLehLe 829 (840)
+||++.+++.|..
T Consensus 263 ~Rp~~~~il~~~~ 275 (296)
T cd06618 263 KRPKYRELLQHPF 275 (296)
T ss_pred hCCCHHHHhcChh
Confidence 9999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=306.78 Aligned_cols=284 Identities=20% Similarity=0.231 Sum_probs=207.2
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|++.+.||.|+||.||+|.. .+..+++|...... ...... +.+.+|+.+++.++||||+++++++......
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLIDA----KRILREIKLLRHLRHENIIGLLDILRPPSPE 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc--ccchhh----hhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence 589999999999999999997 46788888764321 111222 3448999999999999999999988755311
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.....|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||.|||++.+
T Consensus 75 ---------~~~~~~lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~ 139 (330)
T cd07834 75 ---------DFNDVYIVTELME-TDLHKVIKS-----PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN 139 (330)
T ss_pred ---------cccceEEEecchh-hhHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 2234699999997 589888865 3478999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.++|+|||++......... ........++..|+|||++.+ ...++.++||||||+++|+|++
T Consensus 140 -------~~~~L~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~sDi~slG~il~~l~~ 202 (330)
T cd07834 140 -------CDLKICDFGLARGVDPDEDE-------KGFLTEYVVTRWYRAPELLLS---SSRYTKAIDIWSVGCIFAELLT 202 (330)
T ss_pred -------CCEEEcccCceEeecccccc-------cccccccccccCcCCceeeec---ccCCCcchhHHHHHHHHHHHHc
Confidence 46999999999876443210 001123457899999999976 1267899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcccccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|..||.+.+..+....+........++.+..........+... .............+..+.+||.+||+.+|.+||+
T Consensus 203 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 282 (330)
T cd07834 203 RKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT 282 (330)
T ss_pred CCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC
Confidence 9999998887777666655432222222211100000000000 0000011112234678999999999999999999
Q ss_pred HHHHHHH
Q 003185 821 AGDLYEM 827 (840)
Q Consensus 821 a~ELLeh 827 (840)
+.+++.|
T Consensus 283 ~~~ll~~ 289 (330)
T cd07834 283 ADEALAH 289 (330)
T ss_pred HHHHHhC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=302.39 Aligned_cols=251 Identities=27% Similarity=0.399 Sum_probs=195.7
Q ss_pred ceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 584 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p 584 (840)
|...+.||+|+||.||+|+. .+..+++|+...... ....... .+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 95 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQ----DIIKEVKFLQQLKHPNTIEYKGCYLKEHT-- 95 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc-CchHHHH----HHHHHHHHHHhCCCCCCccEEEEEEeCCE--
Confidence 66778899999999999986 567888888653321 1222222 34889999999999999999999886653
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEeccc
Q 003185 585 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 664 (840)
Q Consensus 585 ~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~ 664 (840)
.|+||||+. ++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+||+++.+
T Consensus 96 ------------~~lv~e~~~-~~l~~~l~~----~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~- 157 (313)
T cd06633 96 ------------AWLVMEYCL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP- 157 (313)
T ss_pred ------------EEEEEecCC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC-
Confidence 499999996 588888764 23468999999999999999999999999999999999999876
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 003185 665 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 744 (840)
Q Consensus 665 ~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG 744 (840)
+.+||+|||++..... .....|+..|+|||++.... ...++.++|||||||++|+|++|
T Consensus 158 ------~~~kL~dfg~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~-~~~~~~~sDv~slGvil~el~~g 216 (313)
T cd06633 158 ------GQVKLADFGSASKSSP--------------ANSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAER 216 (313)
T ss_pred ------CCEEEeecCCCcccCC--------------CCCccccccccChhhccccC-CCCCCchhhHHHHHHHHHHHHhC
Confidence 4599999998854221 12346889999999985321 24578899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 003185 745 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 824 (840)
Q Consensus 745 ~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~EL 824 (840)
..||...+.......+.....+.... ...+..+.+|+.+||+.+|.+||++.++
T Consensus 217 ~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~~P~~Rp~~~~~ 270 (313)
T cd06633 217 KPPLFNMNAMSALYHIAQNDSPTLQS--------------------------NEWTDSFRGFVDYCLQKIPQERPASAEL 270 (313)
T ss_pred CCCCCCCChHHHHHHHHhcCCCCCCc--------------------------cccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 99998877665555554432222110 1123468999999999999999999999
Q ss_pred HHHHH
Q 003185 825 YEMFV 829 (840)
Q Consensus 825 LehLe 829 (840)
+.|..
T Consensus 271 l~~~~ 275 (313)
T cd06633 271 LRHDF 275 (313)
T ss_pred hcCcc
Confidence 98844
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=298.54 Aligned_cols=247 Identities=21% Similarity=0.257 Sum_probs=184.6
Q ss_pred eecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCCC
Q 003185 512 EAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 589 (840)
Q Consensus 512 ~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g~ 589 (840)
.||+|+||.||+|.. .+..+|+|+...+........ ..+ ......+.++....||||+.+++++.....
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~------- 71 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE-TLA-LNERIMLSLVSTGDCPFIVCMSYAFHTPDK------- 71 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhH-HHH-HHHHHHHHHHHhCCCCcEeeeeeeeecCCE-------
Confidence 489999999999986 567899998754332211111 111 011223344555679999999999886553
Q ss_pred CccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCC
Q 003185 590 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 669 (840)
Q Consensus 590 ~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~ 669 (840)
.++||||+.|++|..++.. ...+++..++.++.|++.||.|||+++|+||||||+|||++.+
T Consensus 72 -------~~~v~e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~------ 133 (278)
T cd05606 72 -------LSFILDLMNGGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH------ 133 (278)
T ss_pred -------EEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCC------
Confidence 4999999999999998865 3568999999999999999999999999999999999999876
Q ss_pred CCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003185 670 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 749 (840)
Q Consensus 670 ~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~ 749 (840)
+.++|+|||++....... .....|+..|+|||++.+ ...++.++|||||||++|+|++|..||.
T Consensus 134 -~~~kl~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~s~G~~l~~l~~g~~p~~ 197 (278)
T cd05606 134 -GHVRISDLGLACDFSKKK------------PHASVGTHGYMAPEVLQK---GVAYDSSADWFSLGCMLFKLLRGHSPFR 197 (278)
T ss_pred -CCEEEccCcCccccCccC------------CcCcCCCcCCcCcHHhcC---CCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 469999999987543211 122368999999999874 2357889999999999999999999997
Q ss_pred CCCH---HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CH
Q 003185 750 GLSE---LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TA 821 (840)
Q Consensus 750 ~~~~---~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP-----Sa 821 (840)
.... ......+ ....+.++ ...+..+.+++.+||..+|.+|| ++
T Consensus 198 ~~~~~~~~~~~~~~-~~~~~~~~---------------------------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~ 249 (278)
T cd05606 198 QHKTKDKHEIDRMT-LTMAVELP---------------------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGA 249 (278)
T ss_pred CCCccchHHHHHHh-hccCCCCC---------------------------CcCCHHHHHHHHHHhhcCHHhccCCCCCCH
Confidence 6532 2222111 11111111 11245799999999999999999 99
Q ss_pred HHHHHHHH
Q 003185 822 GDLYEMFV 829 (840)
Q Consensus 822 ~ELLehLe 829 (840)
.++++|.+
T Consensus 250 ~~ll~~~~ 257 (278)
T cd05606 250 QEVKEHPF 257 (278)
T ss_pred HHHHhCcc
Confidence 99998854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=298.63 Aligned_cols=244 Identities=20% Similarity=0.265 Sum_probs=184.3
Q ss_pred CCCceeeeee--cccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEe
Q 003185 504 FPSLSSCDEA--GKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 578 (840)
Q Consensus 504 ~~~y~i~~~L--G~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~ 578 (840)
.++|.+.+.+ |+|+||.||++.. .+..+++|+...+... ..|+.....+ +||||+++++.+.
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-------------~~e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-------------AIEPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-------------hhhHHHHHHhhcCCCEEEEEEEEe
Confidence 3466666666 9999999999986 5678888886533211 0122222222 6999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
..+. .++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||
T Consensus 80 ~~~~--------------~~iv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ni 140 (267)
T PHA03390 80 TLKG--------------HVLIMDYIKDGDLFDLLKK-----EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENV 140 (267)
T ss_pred cCCe--------------eEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence 6553 4999999999999999976 23789999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
+++.++ ..++|+|||++...... ....|+..|+|||++.+ ..++.++|||||||++
T Consensus 141 l~~~~~------~~~~l~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il 196 (267)
T PHA03390 141 LYDRAK------DRIYLCDYGLCKIIGTP--------------SCYDGTLDYFSPEKIKG----HNYDVSFDWWAVGVLT 196 (267)
T ss_pred EEeCCC------CeEEEecCccceecCCC--------------ccCCCCCcccChhhhcC----CCCCchhhHHHHHHHH
Confidence 998773 26999999998755321 12358899999999975 5678899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHH-HHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 739 LELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~el~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
|+|++|..||.......+. ..+........+ .....+..+.+||.+||+.+|.+
T Consensus 197 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~ 251 (267)
T PHA03390 197 YELLTGKHPFKEDEDEELDLESLLKRQQKKLP-------------------------FIKNVSKNANDFVQSMLKYNINY 251 (267)
T ss_pred HHHHHCCCCCCCCCcchhhHHHHHHhhcccCC-------------------------cccccCHHHHHHHHHHhccChhh
Confidence 9999999999755433211 111111100000 00123567999999999999999
Q ss_pred CCC-HHHHHHHH
Q 003185 818 RPT-AGDLYEMF 828 (840)
Q Consensus 818 RPS-a~ELLehL 828 (840)
||+ ++++++|-
T Consensus 252 R~~~~~~~l~h~ 263 (267)
T PHA03390 252 RLTNYNEIIKHP 263 (267)
T ss_pred CCchHHHHhcCC
Confidence 996 69999874
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=295.80 Aligned_cols=276 Identities=24% Similarity=0.262 Sum_probs=198.4
Q ss_pred ceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEecCCCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWL 583 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~~~~~ 583 (840)
|++.+.||+|+||.||+|.. .+..+++|....... .... . ...+|+..+++++ ||||+++++++....
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~~~~-~----~~~~e~~~l~~~~~h~~i~~~~~~~~~~~-- 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--SWEE-C----MNLREVKSLRKLNEHPNIVKLKEVFREND-- 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--chhH-H----HHHHHHHHHHhccCCCCchhHHHHhhcCC--
Confidence 67889999999999999998 456788887543321 1111 1 1257999999999 999999999987644
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
..++||||+ +++|.+++... ....+++..+..++.||+.||.|||++||+|+||+|+||+++.+
T Consensus 72 ------------~~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~ 135 (283)
T cd07830 72 ------------ELYFVFEYM-EGNLYQLMKDR---KGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP 135 (283)
T ss_pred ------------cEEEEEecC-CCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC
Confidence 359999999 68999998761 12468999999999999999999999999999999999999976
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.++|+|||++........ .....++..|+|||++.. ...++.++||||||+++|+|++
T Consensus 136 -------~~~~l~d~~~~~~~~~~~~-----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~s~G~~l~el~~ 194 (283)
T cd07830 136 -------EVVKIADFGLAREIRSRPP-----------YTDYVSTRWYRAPEILLR---STSYSSPVDIWALGCIMAELYT 194 (283)
T ss_pred -------CCEEEeecccceeccCCCC-----------cCCCCCcccccCceeeec---CcCcCCccchhhHHHHHHHHHh
Confidence 4599999999976543211 122458899999998864 2457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccc-c-ccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH-E-VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~-~-~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
|+.||......+....+.....+.....+......... . .................+..+.+||.+||..+|.+|||+
T Consensus 195 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~ 274 (283)
T cd07830 195 LRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTA 274 (283)
T ss_pred CCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCH
Confidence 99999887766555544433222112111110000000 0 000000000011111224679999999999999999999
Q ss_pred HHHHHHH
Q 003185 822 GDLYEMF 828 (840)
Q Consensus 822 ~ELLehL 828 (840)
.|++.|.
T Consensus 275 ~ei~~~~ 281 (283)
T cd07830 275 SQALQHP 281 (283)
T ss_pred HHHhhCC
Confidence 9999873
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=338.47 Aligned_cols=278 Identities=25% Similarity=0.331 Sum_probs=197.7
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
-+.+|+..+.||+||||.||+++. .+..||||.+.++. .... ...+.+|+..|++|+|||||++|..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~----~skI~rEVk~LArLnHpNVVRYysAWVEs 549 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKL----YSKILREVKLLARLNHPNVVRYYSAWVES 549 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHH----HHHHHHHHHHHhhcCCcceeeeehhhhcc
Confidence 356788999999999999999985 79999999876653 2222 23458999999999999999999766543
Q ss_pred CCCC--------------------------------------------------C--------------------CCC--
Q 003185 581 KWLP--------------------------------------------------S--------------------ADG-- 588 (840)
Q Consensus 581 ~~~p--------------------------------------------------~--------------------~~g-- 588 (840)
..-. + .++
T Consensus 550 ~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~ 629 (1351)
T KOG1035|consen 550 TAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRN 629 (1351)
T ss_pred CCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccc
Confidence 2100 0 000
Q ss_pred --------------------------CCc-------cccceEEEEEeccCCCCHHHHHHHHhccCCCCC-CHHHHHHHHH
Q 003185 589 --------------------------NPE-------HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHV-SVKLALFIAQ 634 (840)
Q Consensus 589 --------------------------~~~-------~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~l-s~~~~~~Ia~ 634 (840)
... .....+||-||||+..+|..++.. +... ....+|++++
T Consensus 630 ~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~-----N~~~~~~d~~wrLFr 704 (1351)
T KOG1035|consen 630 LSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR-----NHFNSQRDEAWRLFR 704 (1351)
T ss_pred cccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh-----cccchhhHHHHHHHH
Confidence 000 011468999999998777777765 2222 4778999999
Q ss_pred HHHHHHHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccc------ccc--ccccccCCCCCCCcccC
Q 003185 635 DVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS------FLH--TCCIAHRGIPAPDVCVG 706 (840)
Q Consensus 635 QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~------~~~--~~~~~~~~~~~~~~~vG 706 (840)
+|+.||.|+|++|||||||||.||+++.++ .|||+|||+|..... ... ............+..+|
T Consensus 705 eIlEGLaYIH~~giIHRDLKP~NIFLd~~~-------~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VG 777 (1351)
T KOG1035|consen 705 EILEGLAYIHDQGIIHRDLKPRNIFLDSRN-------SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVG 777 (1351)
T ss_pred HHHHHHHHHHhCceeeccCCcceeEEcCCC-------CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccc
Confidence 999999999999999999999999999774 599999999987321 000 01111112223456789
Q ss_pred CCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCcchHHhhhccCccccccc
Q 003185 707 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG-LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 785 (840)
Q Consensus 707 T~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~-~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~ 785 (840)
|..|+|||++.+... ..|+.|+||||||+||+||+. ||.. +....++..+..+..|... .+
T Consensus 778 TalYvAPEll~~~~~-~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~----~f---------- 839 (1351)
T KOG1035|consen 778 TALYVAPELLSDTSS-NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPA----DF---------- 839 (1351)
T ss_pred eeeeecHHHhccccc-ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCc----cc----------
Confidence 999999999987432 479999999999999999984 5643 2334444444443332211 00
Q ss_pred cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003185 786 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 827 (840)
Q Consensus 786 ~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLeh 827 (840)
..+..+.-..+|..||+.||.+||||.|+|++
T Consensus 840 ----------~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 840 ----------FDPEHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred ----------ccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 11112345789999999999999999999975
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=300.53 Aligned_cols=266 Identities=24% Similarity=0.331 Sum_probs=209.7
Q ss_pred cee-eeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEecCCC
Q 003185 507 LSS-CDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 582 (840)
Q Consensus 507 y~i-~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~~~~ 582 (840)
|.+ .+.||+|+|+.|--+.. ++..+||||+. ++.. . .+.++.+|++++...+ |+||++++++|+++..
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiid--Kq~g--H----sR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIID--KQPG--H----SRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhh--cCCc--h----HHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 444 46789999999999874 88999999954 3311 1 2335589999999997 9999999999998876
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
+ |||||-+.||+|...|.+ ...|++.++.++.++|+.||.|||.+||.||||||+|||-..
T Consensus 151 F--------------YLVfEKm~GGplLshI~~-----~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~ 211 (463)
T KOG0607|consen 151 F--------------YLVFEKMRGGPLLSHIQK-----RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCES 211 (463)
T ss_pred E--------------EEEEecccCchHHHHHHH-----hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecC
Confidence 5 999999999999999987 467999999999999999999999999999999999999976
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~kSDVWSLGvIL~EL 741 (840)
.. ...-||||||.++.-+....... ....+.-.+.+|+..|||||+..-.. ....|..+.|.||||||||-|
T Consensus 212 pn----~vsPvKiCDfDLgSg~k~~~~~s---pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYIm 284 (463)
T KOG0607|consen 212 PN----KVSPVKICDFDLGSGIKLNNDCS---PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIM 284 (463)
T ss_pred CC----CcCceeeeccccccccccCCCCC---CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHH
Confidence 53 23459999999886544322211 11222234457999999999975322 235689999999999999999
Q ss_pred HhCCCCCCCCC---------------HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHH
Q 003185 742 LTLQVPYMGLS---------------ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 806 (840)
Q Consensus 742 LTG~~PF~~~~---------------~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dL 806 (840)
|+|.+||.+.- ...++..|+.+........ +..++.+.++|
T Consensus 285 LsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkd------------------------WahIS~eakdl 340 (463)
T KOG0607|consen 285 LSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKD------------------------WAHISSEAKDL 340 (463)
T ss_pred HhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhh------------------------hHHhhHHHHHH
Confidence 99999997642 2346777777755332222 34567789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHh
Q 003185 807 FRRCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 807 I~rCL~~DP~eRPSa~ELLehLe~ 830 (840)
+..+|..|+..|.++.++++|.+.
T Consensus 341 isnLlvrda~~rlsa~~vlnhPw~ 364 (463)
T KOG0607|consen 341 ISNLLVRDAKQRLSAAQVLNHPWV 364 (463)
T ss_pred HHHHHhccHHhhhhhhhccCCccc
Confidence 999999999999999999997553
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=303.62 Aligned_cols=276 Identities=19% Similarity=0.239 Sum_probs=198.2
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
-++|++.+.||.|+||.||+|.. .+..+|+|....... .....+ .+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~ 82 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS--TPVLAK----RTYRELKLLKHLRHENIISLSDIFISPL 82 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc--ccchhH----HHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence 46799999999999999999986 567788887643221 111222 3378999999999999999999886432
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. ..++||||+. ++|..++.. ..+++..+..++.||+.||.|||++||+||||||.|||++
T Consensus 83 ~-------------~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~ 142 (328)
T cd07856 83 E-------------DIYFVTELLG-TDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN 142 (328)
T ss_pred C-------------cEEEEeehhc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC
Confidence 1 3589999994 699988864 4578888999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.++|+|||++....... ....++..|+|||.+.+ ...++.++|||||||++|+|
T Consensus 143 ~~-------~~~~l~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~el 199 (328)
T cd07856 143 EN-------CDLKICDFGLARIQDPQM-------------TGYVSTRYYRAPEIMLT---WQKYDVEVDIWSAGCIFAEM 199 (328)
T ss_pred CC-------CCEEeCccccccccCCCc-------------CCCcccccccCceeeec---cCCcCcHHHHHHHHHHHHHH
Confidence 76 469999999987542211 12357889999998754 24578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccc-cccC--CCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV-AQSG--SGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~-~~~~--~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
++|+.||...........+.........+............+ .... ............+..+.++|.+||+.+|.+|
T Consensus 200 ~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 279 (328)
T cd07856 200 LEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKR 279 (328)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhC
Confidence 999999988776554444333211111111111000000000 0000 0000111112345789999999999999999
Q ss_pred CCHHHHHHHH
Q 003185 819 PTAGDLYEMF 828 (840)
Q Consensus 819 PSa~ELLehL 828 (840)
|++++++.|-
T Consensus 280 ~t~~ell~~~ 289 (328)
T cd07856 280 ISAAEALAHP 289 (328)
T ss_pred CCHHHHhcCC
Confidence 9999999983
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=296.93 Aligned_cols=254 Identities=25% Similarity=0.265 Sum_probs=189.7
Q ss_pred CceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEec
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 579 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~ 579 (840)
+|++.+.||+|+||.||++.. .+..+|+|+....... ........+.+|+.++.+++ ||||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~----~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV----QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH----hhhhHHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence 488999999999999999875 4567999986532111 11112234588999999995 9999999998875
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+.|++||||||.||+
T Consensus 77 ~~~--------------~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil 137 (288)
T cd05583 77 DTK--------------LHLILDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENIL 137 (288)
T ss_pred CCE--------------EEEEEecCCCCcHHHHHhh-----cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE
Confidence 543 4999999999999999875 246889999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.++|+|||+++........ ......|+..|+|||.+.+.. ...+.++||||||+++|
T Consensus 138 ~~~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~--~~~~~~~Dv~slG~il~ 199 (288)
T cd05583 138 LDSE-------GHVVLTDFGLSKEFLAEEEE---------RAYSFCGTIEYMAPEVIRGGS--GGHDKAVDWWSLGVLTF 199 (288)
T ss_pred ECCC-------CCEEEEECcccccccccccc---------ccccccCCccccCHHHhcCCC--CCCcchhhhHHHHHHHH
Confidence 9876 45999999998765332111 112245889999999987521 23678999999999999
Q ss_pred HHHhCCCCCCCCCH----HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 740 ELLTLQVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 740 ELLTG~~PF~~~~~----~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
+|++|..||..... .++...+.... +..+ ...+..+.++|.+||+.||
T Consensus 200 el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~l~~li~~~l~~~p 251 (288)
T cd05583 200 ELLTGASPFTVDGEQNSQSEISRRILKSK-PPFP---------------------------KTMSAEARDFIQKLLEKDP 251 (288)
T ss_pred HHHhCCCCcccCcccchHHHHHHHHHccC-CCCC---------------------------cccCHHHHHHHHHHhcCCH
Confidence 99999999964322 22222221111 1111 1124578999999999999
Q ss_pred CCCCCHHH---HHHHH
Q 003185 816 TERPTAGD---LYEMF 828 (840)
Q Consensus 816 ~eRPSa~E---LLehL 828 (840)
++|||+.+ +++|.
T Consensus 252 ~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 252 KKRLGANGADEIKNHP 267 (288)
T ss_pred hhccCcchHHHHhcCc
Confidence 99999654 45554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=329.70 Aligned_cols=150 Identities=26% Similarity=0.282 Sum_probs=127.3
Q ss_pred CCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.+++|.+.++||.|+||.||+|.+. +..||+|++...... .. .+...+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~-~~----~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 76 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI-NK----NMVHQVQAERDALALSKSPFIVHLYYSLQSA 76 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc-CH----HHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC
Confidence 3689999999999999999999985 789999997543211 11 2223458899999999999999999988765
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
. ..||||||+.|++|.+++.. ...+++..++.|+.||+.||.|||.+|||||||||+||||
T Consensus 77 ~--------------~~~lVmEy~~g~~L~~li~~-----~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl 137 (669)
T cd05610 77 N--------------NVYLVMEYLIGGDVKSLLHI-----YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI 137 (669)
T ss_pred C--------------EEEEEEeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE
Confidence 4 35999999999999999975 2468899999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCccc
Q 003185 661 DLERKKADGKPVVKLCDFDRAVP 683 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~ 683 (840)
+.+ +.+||+|||+++.
T Consensus 138 ~~~-------g~vkL~DFGls~~ 153 (669)
T cd05610 138 SNE-------GHIKLTDFGLSKV 153 (669)
T ss_pred cCC-------CCEEEEeCCCCcc
Confidence 876 4699999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=286.82 Aligned_cols=243 Identities=30% Similarity=0.368 Sum_probs=193.3
Q ss_pred ecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCCCC
Q 003185 513 AGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 590 (840)
Q Consensus 513 LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g~~ 590 (840)
||.|+||.||++.. .+..+++|+...... ....... .+..|+.++++++||||+++++.+.....
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-------- 67 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-IKRKEVE----HTLTERNILSRINHPFIVKLHYAFQTEEK-------- 67 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh-cchHHHH----HHHHHHHHHHHcCCCcHHHHHHHeecCCe--------
Confidence 69999999999997 467889998654322 1112223 34889999999999999999998876553
Q ss_pred ccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCCC
Q 003185 591 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 670 (840)
Q Consensus 591 ~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~ 670 (840)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+++|+||||+||+++.+
T Consensus 68 ------~~~v~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~------- 129 (250)
T cd05123 68 ------LYLVLEYAPGGELFSHLSK-----EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD------- 129 (250)
T ss_pred ------eEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC-------
Confidence 4999999999999999976 2468999999999999999999999999999999999999877
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003185 671 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 750 (840)
Q Consensus 671 ~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~ 750 (840)
+.++|+|||++........ ......++..|+|||.+.+ ...+.++|+||||+++|+|++|..||..
T Consensus 130 ~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~~~~Pe~~~~----~~~~~~~D~~slG~~~~~l~~g~~p~~~ 195 (250)
T cd05123 130 GHIKLTDFGLAKELSSEGS----------RTNTFCGTPEYLAPEVLLG----KGYGKAVDWWSLGVLLYEMLTGKPPFYA 195 (250)
T ss_pred CcEEEeecCcceecccCCC----------cccCCcCCccccChHHhCC----CCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 4599999999876543211 1123458899999999875 4578899999999999999999999987
Q ss_pred CCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 003185 751 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA---GDLYEM 827 (840)
Q Consensus 751 ~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa---~ELLeh 827 (840)
.+..+....+.... ..++. ..+..+.++|.+||..||.+||++ .++++|
T Consensus 196 ~~~~~~~~~~~~~~-~~~~~---------------------------~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 196 EDRKEIYEKILKDP-LRFPE---------------------------FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred CCHHHHHHHHhcCC-CCCCC---------------------------CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 77666555554421 11221 114578999999999999999999 787776
Q ss_pred H
Q 003185 828 F 828 (840)
Q Consensus 828 L 828 (840)
.
T Consensus 248 ~ 248 (250)
T cd05123 248 P 248 (250)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=324.61 Aligned_cols=291 Identities=22% Similarity=0.252 Sum_probs=206.9
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.-..|...+.||+||||.||+++. .|..+|||.++.... ....+ +..+|+++|++|+|||||+++++-.+.
T Consensus 11 ~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~---~r~~e----~~~~EieilkKLnh~NIVk~f~iee~~ 83 (732)
T KOG4250|consen 11 ENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS---LRPRE----RWCREIEILKKLNHPNIVKLFDIEETK 83 (732)
T ss_pred CCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcc---cchHH----HHHHHHHHHHHcCchhhhhhcccCCcc
Confidence 345678889999999999999995 788999998754321 11222 338999999999999999999876544
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
... . ......+|||||.||||..++.+ +.+...+++.+.+.++.+++.||.|||.+|||||||||.||++
T Consensus 84 ~~~--~------~~~~~vlvmEyC~gGsL~~~L~~--PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl 153 (732)
T KOG4250|consen 84 FLG--L------VTRLPVLVMEYCSGGSLRKVLNS--PENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVL 153 (732)
T ss_pred ccC--c------ccccceEEEeecCCCcHHHHhcC--cccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE
Confidence 311 0 12245899999999999999986 3444679999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
....+ +....||+|||.|+.+.+... ...++||+.|.+||++.. ...|+..+|.|||||++|+
T Consensus 154 ~~Ged---gq~IyKLtDfG~Arel~d~s~-----------~~S~vGT~~YLhPel~E~---q~~y~~tVDLWS~GvtlY~ 216 (732)
T KOG4250|consen 154 QIGED---GQSIYKLTDFGAARELDDNSL-----------FTSLVGTEEYLHPELYER---QKKYTATVDLWSFGVTLYE 216 (732)
T ss_pred eecCC---CceEEeeecccccccCCCCCe-----------eeeecCchhhcChHHHhh---ccCcCceeehhhhhhHHHH
Confidence 76532 557899999999998876542 255789999999999974 3678999999999999999
Q ss_pred HHhCCCCCCCCC-H---HHHHHHHHcCCCCCcchHHhhhccCccc-cccc-cCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003185 741 LLTLQVPYMGLS-E---LEIHDLIQMGKRPRLTDELEALGSCHEH-EVAQ-SGSGFEKPEAELETLSFLVDVFRRCTEEN 814 (840)
Q Consensus 741 LLTG~~PF~~~~-~---~el~~~I~~~~~p~l~~~l~~~~~~~~~-~~~~-~~~~~~~~~~~~~~s~~L~dLI~rCL~~D 814 (840)
++||..||.... + .++...+........--... ..+. .+.. ..... ...........+-..+..+|..+
T Consensus 217 caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~----~~eNgpv~~s~~lP~-p~~Ls~~l~~~~~kwLa~~L~~~ 291 (732)
T KOG4250|consen 217 CATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQ----EEENGPVEWSSTLPQ-PNHLSRGLATRLTKWLASMLEWN 291 (732)
T ss_pred HhccCCCCCcCCCccccchhhhhhhccCCCceeEeee----cccCCceeeeccCCC-cccccHHHHhhhhHHHHHHHhhh
Confidence 999999994332 2 23443333322111110000 0000 0000 00000 11112233445677888999999
Q ss_pred CCCCC--CHHHHHHHHHhhc
Q 003185 815 PTERP--TAGDLYEMFVART 832 (840)
Q Consensus 815 P~eRP--Sa~ELLehLe~l~ 832 (840)
|.+|. .+.+....+..+.
T Consensus 292 ~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 292 PRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred HHHhCCCCcchHHHHHHHHH
Confidence 99998 6666665554443
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=299.98 Aligned_cols=302 Identities=17% Similarity=0.232 Sum_probs=222.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
...+.|+...+||+|.||.||+|+. .++.||+|++.+.. +.+.|-...++|+.+|..|+|+|++.++..|..
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen------eKeGfpitalreikiL~~lkHenv~nliEic~t 87 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN------EKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc------cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhh
Confidence 4567889999999999999999986 55677887654422 223344445899999999999999999998876
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.... .......+|+||.+|+. +|..++.+ ...+++..++.+++.+++.||.|+|+..|+|||+||+|+|
T Consensus 88 k~Tp------~~r~r~t~ylVf~~ceh-DLaGlLsn----~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvL 156 (376)
T KOG0669|consen 88 KATP------TNRDRATFYLVFDFCEH-DLAGLLSN----RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVL 156 (376)
T ss_pred ccCC------cccccceeeeeHHHhhh-hHHHHhcC----ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEE
Confidence 5421 11134468999999986 99999875 3468999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
|+.+ +++||+|||+++.+...... ..+..+..+-|..|.+||.+.+ ...|+++.|||..|||+.
T Consensus 157 It~d-------gilklADFGlar~fs~~~n~------~kprytnrvvTLwYrppEllLG---~r~yg~~iDiWgAgCima 220 (376)
T KOG0669|consen 157 ITKD-------GILKLADFGLARAFSTSKNV------VKPRYTNRVVTLWYRPPELLLG---DREYGPPIDIWGAGCIMA 220 (376)
T ss_pred EcCC-------ceEEeeccccccceeccccc------CCCCcccceeeeecCCHHHhhc---ccccCCcchhHhHHHHHH
Confidence 9988 67999999999876543221 1111334466999999999998 467899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcc------ccccc-cCCCCCCchhhhhhHHHHHHHHHHhcc
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE------HEVAQ-SGSGFEKPEAELETLSFLVDVFRRCTE 812 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~------~~~~~-~~~~~~~~~~~~~~s~~L~dLI~rCL~ 812 (840)
||+|+.+.+++.+..+.+..|..-.....++.|+.....+. +...+ .....+..-......+...+|+.++|.
T Consensus 221 eMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~ 300 (376)
T KOG0669|consen 221 EMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLK 300 (376)
T ss_pred HHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhc
Confidence 99999999999988887777765322222222222211111 10000 000000000011123478899999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcCCCC
Q 003185 813 ENPTERPTAGDLYEMFVARTSSSI 836 (840)
Q Consensus 813 ~DP~eRPSa~ELLehLe~l~~~~~ 836 (840)
+||.+|++++++++|-.....+.+
T Consensus 301 ~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 301 LDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cCcccCcchHhhhchhhhhcCCcc
Confidence 999999999999999877665554
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=302.98 Aligned_cols=271 Identities=22% Similarity=0.325 Sum_probs=209.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHh--CCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGA--LRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~--L~HpNIV~l~g~~~~ 579 (840)
..+...++.+.||+|.||.||+|...++.||||++.. .+.+.| ..|-+|... ++|+||++|+++-..
T Consensus 207 ~~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~-------~~kqs~----~~Ek~Iy~lp~m~h~nIl~Fi~~ekr 275 (534)
T KOG3653|consen 207 LELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE-------QEKQSF----QNEKNIYSLPGMKHENILQFIGAEKR 275 (534)
T ss_pred ccCCchhhHHHhhcCccceeehhhccCceeEEEecCH-------HHHHHH----HhHHHHHhccCccchhHHHhhchhcc
Confidence 3466788899999999999999999999999999753 333444 666666554 579999999987543
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---------Ceec
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---------HIMH 650 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~---------gIVH 650 (840)
... .....+||++|.+.|+|.+||+. ..++|....+|+..+++||+|||.. .|+|
T Consensus 276 ~t~----------~~~eywLVt~fh~kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaH 339 (534)
T KOG3653|consen 276 GTA----------DRMEYWLVTEFHPKGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAH 339 (534)
T ss_pred CCc----------cccceeEEeeeccCCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcccc
Confidence 221 13356999999999999999986 6799999999999999999999973 6999
Q ss_pred ccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCC--CCCch
Q 003185 651 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN--LYGLE 728 (840)
Q Consensus 651 RDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~--~~s~k 728 (840)
||||..||||..+ .+..|+|||+|..+....... .....+||.+|||||++.+-..-. ..-.+
T Consensus 340 RDlkSkNVLvK~D-------lTccIaDFGLAl~~~p~~~~~--------d~~~qVGT~RYMAPEvLEgainl~d~~Afkr 404 (534)
T KOG3653|consen 340 RDLKSKNVLVKND-------LTCCIADFGLALRLEPGKPQG--------DTHGQVGTRRYMAPEVLEGAINLQDRDAFKR 404 (534)
T ss_pred ccccccceEEccC-------CcEEeeccceeEEecCCCCCc--------chhhhhhhhhhcCHHHHhhhcccccHHHHHH
Confidence 9999999999988 679999999999886433221 112358999999999998632111 12257
Q ss_pred hhHHHHHHHHHHHHhCC------------CCCC-----CCCHHHHHHHHH-cCCCCCcchHHhhhccCccccccccCCCC
Q 003185 729 VDIWSYGCLLLELLTLQ------------VPYM-----GLSELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGF 790 (840)
Q Consensus 729 SDVWSLGvIL~ELLTG~------------~PF~-----~~~~~el~~~I~-~~~~p~l~~~l~~~~~~~~~~~~~~~~~~ 790 (840)
.||||+|.+||||+++. .||. ..+..++...+. +..+|.+++.|...
T Consensus 405 ~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h--------------- 469 (534)
T KOG3653|consen 405 IDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH--------------- 469 (534)
T ss_pred HHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC---------------
Confidence 99999999999999853 3332 123344554444 44788888765432
Q ss_pred CCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 003185 791 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSI 836 (840)
Q Consensus 791 ~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~~~~ 836 (840)
.....+.+.++.||..||+.|.||.=+.+++..+.....
T Consensus 470 -------~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 470 -------AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred -------ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 125578999999999999999999999999888876654
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=315.17 Aligned_cols=251 Identities=25% Similarity=0.317 Sum_probs=204.9
Q ss_pred eeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCC
Q 003185 510 CDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 587 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~ 587 (840)
.+.||+|.||+||-|++ +++.||||++... ......... +..|++||+.+.||.||.+.-.|++.+.+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKl--rFp~kqesq----lR~EVaILq~l~HPGiV~le~M~ET~erv---- 638 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKL--RFPTKQESQ----LRNEVAILQNLHHPGIVNLECMFETPERV---- 638 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecc--cCCCchHHH----HHHHHHHHHhcCCCCeeEEEEeecCCceE----
Confidence 47899999999999986 7899999996433 333333333 48999999999999999999999987754
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccC
Q 003185 588 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667 (840)
Q Consensus 588 g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~ 667 (840)
++|||-+.| +..++|-. ....++++...+.++.||+.||.|||-++|+|+||||+|||+...
T Consensus 639 ----------FVVMEKl~G-DMLEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~---- 700 (888)
T KOG4236|consen 639 ----------FVVMEKLHG-DMLEMILS---SEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASA---- 700 (888)
T ss_pred ----------EEEehhhcc-hHHHHHHH---hhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccC----
Confidence 999999975 66666643 234689999999999999999999999999999999999999866
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003185 668 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 747 (840)
Q Consensus 668 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~P 747 (840)
.+-+++||||||+|+.+.+... ...++|||.|+|||+++. ..|+..-|+||.|||+|--++|..|
T Consensus 701 ~~FPQvKlCDFGfARiIgEksF-----------RrsVVGTPAYLaPEVLrn----kGyNrSLDMWSVGVIiYVsLSGTFP 765 (888)
T KOG4236|consen 701 SPFPQVKLCDFGFARIIGEKSF-----------RRSVVGTPAYLAPEVLRN----KGYNRSLDMWSVGVIIYVSLSGTFP 765 (888)
T ss_pred CCCCceeeccccceeecchhhh-----------hhhhcCCccccCHHHHhh----ccccccccceeeeEEEEEEeccccc
Confidence 3567899999999999876432 356789999999999997 7899999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003185 748 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 827 (840)
Q Consensus 748 F~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLeh 827 (840)
|... +++.++|++.....- +..+.+++...++||..+|+..-.+|.|.+..+.|
T Consensus 766 FNEd--EdIndQIQNAaFMyP------------------------p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 766 FNED--EDINDQIQNAAFMYP------------------------PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred CCCc--cchhHHhhccccccC------------------------CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 9644 445566665422111 11234456789999999999999999999998887
Q ss_pred HH
Q 003185 828 FV 829 (840)
Q Consensus 828 Le 829 (840)
.+
T Consensus 820 ~W 821 (888)
T KOG4236|consen 820 PW 821 (888)
T ss_pred hh
Confidence 54
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=292.79 Aligned_cols=258 Identities=23% Similarity=0.361 Sum_probs=207.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC--eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~ 578 (840)
.++++++++..||.|+.|+|+++++.. .-.|||.. ... ...++.+. +++.+.++..-. +|+||+.+|+|.
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M--~rt-~Nkee~kR----ILmDldvv~~s~dcpyIV~c~GyFi 161 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQM--RRT-GNKEENKR----ILMDLDVVLKSHDCPYIVQCFGYFI 161 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEee--ccc-CCHHHHHH----HHHhhhHHhhccCCCeeeeeeeEEe
Confidence 577888999999999999999999865 55666654 332 23344444 488888877665 899999999999
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCCCc
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSEN 657 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~-gIVHRDLKPeN 657 (840)
.+..+ +|.||.|. .-++.+++. -.+++++..+-++...++.||.||-.+ ||||||+||+|
T Consensus 162 ~n~dV--------------~IcMelMs-~C~ekLlkr----ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSN 222 (391)
T KOG0983|consen 162 TNTDV--------------FICMELMS-TCAEKLLKR----IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSN 222 (391)
T ss_pred eCchH--------------HHHHHHHH-HHHHHHHHH----hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccc
Confidence 77655 89999995 356666654 245699999999999999999999865 89999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
||+|..| .+||||||++-.+.+.... ....|-+.|||||.+... ....|..++||||||++
T Consensus 223 ILlDe~G-------niKlCDFGIsGrlvdSkAh-----------trsAGC~~YMaPERidp~-~~~kYDiRaDVWSlGIT 283 (391)
T KOG0983|consen 223 ILLDERG-------NIKLCDFGISGRLVDSKAH-----------TRSAGCAAYMAPERIDPP-DKPKYDIRADVWSLGIT 283 (391)
T ss_pred eEEccCC-------CEEeecccccceeeccccc-----------ccccCCccccCccccCCC-CCCccchhhhhhhhccc
Confidence 9999884 5999999999776553322 223689999999999753 24678999999999999
Q ss_pred HHHHHhCCCCCCCC-CHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 738 LLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 738 L~ELLTG~~PF~~~-~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
|+||.||+.||.+. ...+++..|.+...|.++... ..++.+.+|+..||..|+.
T Consensus 284 lveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~-------------------------gFSp~F~~fv~~CL~kd~r 338 (391)
T KOG0983|consen 284 LVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHM-------------------------GFSPDFQSFVKDCLTKDHR 338 (391)
T ss_pred hhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCccc-------------------------CcCHHHHHHHHHHhhcCcc
Confidence 99999999999874 577888888887666555321 1366899999999999999
Q ss_pred CCCCHHHHHHHHH
Q 003185 817 ERPTAGDLYEMFV 829 (840)
Q Consensus 817 eRPSa~ELLehLe 829 (840)
+||...++|+|-.
T Consensus 339 ~RP~Y~~Ll~h~F 351 (391)
T KOG0983|consen 339 KRPKYNKLLEHPF 351 (391)
T ss_pred cCcchHHHhcCcc
Confidence 9999999999854
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=294.41 Aligned_cols=261 Identities=24% Similarity=0.258 Sum_probs=206.5
Q ss_pred CCCceee-eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEec
Q 003185 504 FPSLSSC-DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 579 (840)
Q Consensus 504 ~~~y~i~-~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~~ 579 (840)
.++|.+. ++||-|-.|.|-.+.. .+..+|+|+.. + . .. ..+|+++--.. .|||||.++++|..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-D----s----~K----ARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-D----S----PK----ARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-c----C----HH----HHhHhhhhhhhcCCCceEEeehhhhh
Confidence 4566654 6789999999999986 67789999842 1 1 11 17888875555 49999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.-. ...-+.||||.++||.|...|.. .+...|++.++..|++||..|+.|||+.+|.||||||+|+|
T Consensus 127 s~~----------~rkcLLiVmE~meGGeLfsriq~---~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLL 193 (400)
T KOG0604|consen 127 SYQ----------GRKCLLIVMECMEGGELFSRIQD---RGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLL 193 (400)
T ss_pred hcc----------CceeeEeeeecccchHHHHHHHH---cccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhhee
Confidence 432 23346899999999999999987 45577999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
..... .+..+||+|||+|+....... -.+.+-||.|.|||++.. ..|....|+||+||++|
T Consensus 194 yt~t~----~na~lKLtDfGFAK~t~~~~~-----------L~TPc~TPyYvaPevlg~----eKydkscdmwSlgVimY 254 (400)
T KOG0604|consen 194 YTTTS----PNAPLKLTDFGFAKETQEPGD-----------LMTPCFTPYYVAPEVLGP----EKYDKSCDMWSLGVIMY 254 (400)
T ss_pred eecCC----CCcceEecccccccccCCCcc-----------ccCCcccccccCHHHhCc----hhcCCCCCccchhHHHH
Confidence 98764 457899999999987653211 122357999999999975 66899999999999999
Q ss_pred HHHhCCCCCCCCC----HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 740 ELLTLQVPYMGLS----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 740 ELLTG~~PF~~~~----~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
-|++|.+||.... ...+...|..+....-.. .+..+++..+++|..+|..+|
T Consensus 255 IlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p------------------------EWs~VSe~aKdlIR~LLkt~P 310 (400)
T KOG0604|consen 255 ILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP------------------------EWSCVSEAAKDLIRKLLKTEP 310 (400)
T ss_pred HhhcCCCcccccCCccCChhHHhHhhccCccCCCh------------------------hHhHHHHHHHHHHHHHhcCCc
Confidence 9999999996543 234556666664432222 234568899999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 003185 816 TERPTAGDLYEMFVARTS 833 (840)
Q Consensus 816 ~eRPSa~ELLehLe~l~~ 833 (840)
.+|.|+.++++|.+-...
T Consensus 311 teRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 311 TERLTIEEVMDHPWINQY 328 (400)
T ss_pred hhheeHHHhhcCchhccc
Confidence 999999999999765543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=318.61 Aligned_cols=265 Identities=23% Similarity=0.367 Sum_probs=219.1
Q ss_pred CCCCCceeeeeecccCceEEEEEE--ECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCK--FGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~--~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~ 578 (840)
.+-+.|++.+.||.|.+|.||+++ .+++.+|+||..... .. .+++ .-|.+||+.+. |||++.+||+|.
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--d~---deEi----E~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--DE---EEEI----ELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--cc---cHHH----HHHHHHHHhccCCCCcceEEEEEE
Confidence 345678999999999999999987 488999999965442 11 1222 56888888886 999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
..... ...++|||||||.|||..++++... ..++.+..+..|++.++.||.|||++.++|||||-.||
T Consensus 87 k~~~~---------~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~Ni 154 (953)
T KOG0587|consen 87 KKDPG---------NGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNV 154 (953)
T ss_pred EecCC---------CCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceE
Confidence 66542 3447899999999999999999854 57899999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC-CCCCchhhHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLEVDIWSYGCL 737 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~-~~~s~kSDVWSLGvI 737 (840)
|++.++ .|||+|||.+..+..... ..++++|||.|||||++...... ..|+.++|+||||++
T Consensus 155 LLT~e~-------~VKLvDFGvSaQldsT~g----------rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGIT 217 (953)
T KOG0587|consen 155 LLTENA-------EVKLVDFGVSAQLDSTVG----------RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGIT 217 (953)
T ss_pred EEeccC-------cEEEeeeeeeeeeecccc----------cccCcCCCcccccceeeecccCCCCCcccccchhhccce
Confidence 999885 499999999987765432 24667899999999999865432 457889999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
..||.-|.+|+..+.+...+..|-...+|.+.. ...-++.+.++|..||..|-.+
T Consensus 218 aIEladG~PPl~DmHPmraLF~IpRNPPPkLkr-------------------------p~kWs~~FndFIs~cL~Kd~e~ 272 (953)
T KOG0587|consen 218 AIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKR-------------------------PKKWSKKFNDFISTCLVKDYEQ 272 (953)
T ss_pred eehhcCCCCCccCcchhhhhccCCCCCCccccc-------------------------hhhHHHHHHHHHHHHHhhcccc
Confidence 999999999999998888777776665554442 1122668999999999999999
Q ss_pred CCCHHHHHHHHH
Q 003185 818 RPTAGDLYEMFV 829 (840)
Q Consensus 818 RPSa~ELLehLe 829 (840)
||+..++++|..
T Consensus 273 RP~~~~ll~hpF 284 (953)
T KOG0587|consen 273 RPSTEELLKHPF 284 (953)
T ss_pred CcchhhhccCCc
Confidence 999999998853
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=299.02 Aligned_cols=267 Identities=25% Similarity=0.380 Sum_probs=206.6
Q ss_pred CCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHh--CCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGA--LRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~--L~HpNIV~l~g~~~~~~~ 582 (840)
....+.+.||+|.||.||+|.|.|..||||||.-. +.+.+ .+|.+|.+. |+|+||+.|++.-..+.
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr-------dE~SW----frEtEIYqTvmLRHENILgFIaaD~~~~- 278 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR-------DERSW----FRETEIYQTVMLRHENILGFIAADNKDN- 278 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEeccc-------chhhh----hhHHHHHHHHHhccchhhhhhhccccCC-
Confidence 45689999999999999999999999999998532 12233 667776554 68999999998754332
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeecccCC
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--------HIMHRDIK 654 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~--------gIVHRDLK 654 (840)
....++|||++|-+.|||++||.. ..++....++++..+|.||+|||.. .|.|||||
T Consensus 279 ---------gs~TQLwLvTdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlK 343 (513)
T KOG2052|consen 279 ---------GSWTQLWLVTDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLK 343 (513)
T ss_pred ---------CceEEEEEeeecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccc
Confidence 245689999999999999999986 6799999999999999999999974 49999999
Q ss_pred CCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCC--CCchhhHH
Q 003185 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL--YGLEVDIW 732 (840)
Q Consensus 655 PeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~--~s~kSDVW 732 (840)
+.||||..+ ++..|+|+|+|.........- ...++..+||.+|||||++........ .-..+|||
T Consensus 344 SKNILVKkn-------~~C~IADLGLAv~h~~~t~~i------di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIY 410 (513)
T KOG2052|consen 344 SKNILVKKN-------GTCCIADLGLAVRHDSDTDTI------DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIY 410 (513)
T ss_pred cccEEEccC-------CcEEEeeceeeEEecccCCcc------cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHH
Confidence 999999987 679999999998776543221 122455689999999999975322222 23589999
Q ss_pred HHHHHHHHHHhC----------CCCCCCC-----CHHHHHHHHH-cCCCCCcchHHhhhccCccccccccCCCCCCchhh
Q 003185 733 SYGCLLLELLTL----------QVPYMGL-----SELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 796 (840)
Q Consensus 733 SLGvIL~ELLTG----------~~PF~~~-----~~~el~~~I~-~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 796 (840)
|||.++||++-+ ++||.+. +.+++.+.+. +..+|.++..|. .
T Consensus 411 afgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~----------------------s 468 (513)
T KOG2052|consen 411 AFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWK----------------------S 468 (513)
T ss_pred HHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccc----------------------c
Confidence 999999999863 5788543 2334444332 235555554332 2
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003185 797 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 833 (840)
Q Consensus 797 ~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~ 833 (840)
.+....+..||+.||..||..|.||--|.+.|.++.+
T Consensus 469 ~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 469 DPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 2345678899999999999999999999999998875
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=333.18 Aligned_cols=265 Identities=22% Similarity=0.274 Sum_probs=217.4
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|.+++.||+|+||.|.+++. .+..||+|+...-..... .+- .-|..|-.+|..-..+-||+++-+|.++.+
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr-~~t----A~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKR-AET----ACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhc-hhH----HHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 5799999999999999999997 567788888542111111 111 234778889999899999999999998876
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
+ |+||||++||+|..++.++ .++++..++.++..|+.||.-||+.|+|||||||+||||+.
T Consensus 150 L--------------YlVMdY~pGGDlltLlSk~-----~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~ 210 (1317)
T KOG0612|consen 150 L--------------YLVMDYMPGGDLLTLLSKF-----DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDK 210 (1317)
T ss_pred e--------------EEEEecccCchHHHHHhhc-----CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecc
Confidence 5 9999999999999999872 36999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC-CCCCchhhHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~-~~~s~kSDVWSLGvIL~EL 741 (840)
. |++||+|||.+-.+..... ......+|||.|.+||++..+..+ +.|++.+|.||+||++|||
T Consensus 211 ~-------GHikLADFGsClkm~~dG~---------V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEM 274 (1317)
T KOG0612|consen 211 S-------GHIKLADFGSCLKMDADGT---------VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEM 274 (1317)
T ss_pred c-------CcEeeccchhHHhcCCCCc---------EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHH
Confidence 8 5699999999987764332 224567899999999999987766 7899999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCC-CCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
+.|..||...+..+.+..|.+-. ...+| ....+++.+++||.+.+. +|..|..
T Consensus 275 lyG~TPFYadslveTY~KIm~hk~~l~FP-------------------------~~~~VSeeakdLI~~ll~-~~e~RLg 328 (1317)
T KOG0612|consen 275 LYGETPFYADSLVETYGKIMNHKESLSFP-------------------------DETDVSEEAKDLIEALLC-DREVRLG 328 (1317)
T ss_pred HcCCCcchHHHHHHHHHHHhchhhhcCCC-------------------------cccccCHHHHHHHHHHhc-Chhhhcc
Confidence 99999999998888888887652 11112 123357789999999887 8899988
Q ss_pred ---HHHHHHHHHhhcCCC
Q 003185 821 ---AGDLYEMFVARTSSS 835 (840)
Q Consensus 821 ---a~ELLehLe~l~~~~ 835 (840)
++++..|.+...-+|
T Consensus 329 rngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 329 RNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred cccHHHHHhCccccCCCh
Confidence 999999976554433
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=337.48 Aligned_cols=262 Identities=22% Similarity=0.240 Sum_probs=189.6
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
..|...+.||+|+||.||+|.+ .+..||+|... .... .. ..|++++++++|||||+++|++.....
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~------~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN--DVNS------IP----SSEIADMGKLQHPNIVKLIGLCRSEKG 757 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEcc--CCcc------cc----HHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence 3456678899999999999996 56788888753 1111 01 346888999999999999999986654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCCCcEE
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH---SKHIMHRDIKSENIL 659 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLH---s~gIVHRDLKPeNIL 659 (840)
. |+||||+++|+|.++++. +++..+..|+.||+.||+||| ..+|+||||||+||+
T Consensus 758 ~--------------~lv~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil 815 (968)
T PLN00113 758 A--------------YLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKII 815 (968)
T ss_pred C--------------EEEEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEE
Confidence 3 999999999999999963 788999999999999999999 669999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.++ .+++. ||.+..... .....||+.|||||++.+ ..++.++|||||||++|
T Consensus 816 ~~~~~-------~~~~~-~~~~~~~~~--------------~~~~~~t~~y~aPE~~~~----~~~~~~sDv~S~Gvvl~ 869 (968)
T PLN00113 816 IDGKD-------EPHLR-LSLPGLLCT--------------DTKCFISSAYVAPETRET----KDITEKSDIYGFGLILI 869 (968)
T ss_pred ECCCC-------ceEEE-ecccccccc--------------CCCccccccccCcccccC----CCCCcccchhhHHHHHH
Confidence 98763 35554 555432211 112358899999999875 66899999999999999
Q ss_pred HHHhCCCCCCCCCH--HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 740 ELLTLQVPYMGLSE--LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 740 ELLTG~~PF~~~~~--~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
||+||+.||..... ..+............. ..+.+..... ...........+.+++.+||+.||.+
T Consensus 870 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~-~~~~~~~~~~~~~~l~~~Cl~~~P~~ 937 (968)
T PLN00113 870 ELLTGKSPADAEFGVHGSIVEWARYCYSDCHL-----------DMWIDPSIRG-DVSVNQNEIVEVMNLALHCTATDPTA 937 (968)
T ss_pred HHHhCCCCCCcccCCCCcHHHHHHHhcCccch-----------hheeCccccC-CCCccHHHHHHHHHHHHhhCcCCchh
Confidence 99999999853211 1111111111000000 0000000000 01112334567889999999999999
Q ss_pred CCCHHHHHHHHHhhcCCCCCC
Q 003185 818 RPTAGDLYEMFVARTSSSISS 838 (840)
Q Consensus 818 RPSa~ELLehLe~l~~~~~s~ 838 (840)
|||+.||++.|+.+...++++
T Consensus 938 RPt~~evl~~L~~~~~~~~~~ 958 (968)
T PLN00113 938 RPCANDVLKTLESASRSSSSC 958 (968)
T ss_pred CcCHHHHHHHHHHhhcccccc
Confidence 999999999999998766554
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=271.62 Aligned_cols=280 Identities=20% Similarity=0.245 Sum_probs=211.6
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
.+|...++||+|.||+||+|+. ..+-||+|.++++....+-. ...++|+-+|+.|+|.|||+++++...+..
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvp------ssalreicllkelkhknivrl~dvlhsdkk 75 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVP------SSALREICLLKELKHKNIVRLHDVLHSDKK 75 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCc------HHHHHHHHHHHHhhhcceeehhhhhccCce
Confidence 4677889999999999999986 55678888887765433322 223899999999999999999999877664
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
+ -+|+|||. .+|..|... -++.++.+.++.++.|+++||.|+|++++.||||||+|+||+.
T Consensus 76 l--------------tlvfe~cd-qdlkkyfds----lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ 136 (292)
T KOG0662|consen 76 L--------------TLVFEFCD-QDLKKYFDS----LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINR 136 (292)
T ss_pred e--------------EEeHHHhh-HHHHHHHHh----cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEecc
Confidence 4 89999997 589888876 3567999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||+++.+.-.... . ..-+-|..|.+|.++.+ ..-|+...|+||.|||+.|+.
T Consensus 137 n-------gelkladfglarafgipvrc--y--------saevvtlwyrppdvlfg---akly~tsidmwsagcifaela 196 (292)
T KOG0662|consen 137 N-------GELKLADFGLARAFGIPVRC--Y--------SAEVVTLWYRPPDVLFG---AKLYSTSIDMWSAGCIFAELA 196 (292)
T ss_pred C-------CcEEecccchhhhcCCceEe--e--------eceeeeeeccCcceeee---eehhccchHhhhcchHHHHHh
Confidence 8 45999999999977653321 1 12256899999999987 567899999999999999998
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcccc-ccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 743 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE-VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 743 T-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
. |++.|++.+..+....|.......-.+.|+.+...++.. ++-...........+.....-.+|++++|.-+|.+|++
T Consensus 197 nagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qris 276 (292)
T KOG0662|consen 197 NAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRIS 276 (292)
T ss_pred hcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccC
Confidence 6 788899988887777776543333333443332222110 00000000011111222334578999999999999999
Q ss_pred HHHHHHHHH
Q 003185 821 AGDLYEMFV 829 (840)
Q Consensus 821 a~ELLehLe 829 (840)
+++.++|.-
T Consensus 277 aeaalqhpy 285 (292)
T KOG0662|consen 277 AEAALQHPY 285 (292)
T ss_pred HHHHhcCcc
Confidence 999998853
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=293.88 Aligned_cols=257 Identities=24% Similarity=0.366 Sum_probs=212.3
Q ss_pred CCCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEE
Q 003185 500 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 577 (840)
Q Consensus 500 ~p~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~ 577 (840)
.-..+++|..++.||+|.||.|.+++- .++.+|+||.+...... .+++..- +.|-++|+..+||.+..+--.|
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviia-kdEVAHT----lTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIA-KDEVAHT----LTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheee-hHHhhhh----hhHHHHHHhccCcHHHHhhhhh
Confidence 335789999999999999999999985 67899999976444332 3333333 7899999999999999988777
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
...+. +|+||||+.||.|.-.|.+ ...+++..++.+...|+.||.|||+++||.||||.+|
T Consensus 238 Qt~dr--------------lCFVMeyanGGeLf~HLsr-----er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLEN 298 (516)
T KOG0690|consen 238 QTQDR--------------LCFVMEYANGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLEN 298 (516)
T ss_pred ccCce--------------EEEEEEEccCceEeeehhh-----hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhh
Confidence 76554 5999999999999988876 4679999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
+|++.+ +.+||+|||+++.-.....+ ..+++|||.|+|||++.. ..|+.++|.|.+||+
T Consensus 299 LlLDkD-------GHIKitDFGLCKE~I~~g~t----------~kTFCGTPEYLAPEVleD----nDYgraVDWWG~GVV 357 (516)
T KOG0690|consen 299 LLLDKD-------GHIKITDFGLCKEEIKYGDT----------TKTFCGTPEYLAPEVLED----NDYGRAVDWWGVGVV 357 (516)
T ss_pred heeccC-------CceEeeecccchhcccccce----------eccccCChhhcCchhhcc----ccccceeehhhhhHH
Confidence 999998 56999999999854332211 356789999999999987 789999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
+|||++|+.||.+.+...++..|..... .+|. ..+++.+.|+..+|..||.+
T Consensus 358 MYEMmCGRLPFyn~dh~kLFeLIl~ed~-kFPr---------------------------~ls~eAktLLsGLL~kdP~k 409 (516)
T KOG0690|consen 358 MYEMMCGRLPFYNKDHEKLFELILMEDL-KFPR---------------------------TLSPEAKTLLSGLLKKDPKK 409 (516)
T ss_pred HHHHHhccCcccccchhHHHHHHHhhhc-cCCc---------------------------cCCHHHHHHHHHHhhcChHh
Confidence 9999999999999988888888866521 1121 12457899999999999999
Q ss_pred CC-----CHHHHHHHHH
Q 003185 818 RP-----TAGDLYEMFV 829 (840)
Q Consensus 818 RP-----Sa~ELLehLe 829 (840)
|. .+.||.+|-.
T Consensus 410 RLGgGpdDakEi~~h~F 426 (516)
T KOG0690|consen 410 RLGGGPDDAKEIMRHRF 426 (516)
T ss_pred hcCCCchhHHHHHhhhh
Confidence 94 5778887743
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=316.01 Aligned_cols=262 Identities=25% Similarity=0.396 Sum_probs=208.7
Q ss_pred CCCCceeeeeecccCceEEEEEEEC---------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcce
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVE 572 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~---------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~ 572 (840)
+-+++.+.+.||+|.||.|++|... ...||||. ++..... .+.+.+ ..|+.+|+.+. ||||+.
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~--~k~~~~~-~~~~~~----~~El~~m~~~g~H~niv~ 366 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKM--LKENASS-SEKKDL----MSELNVLKELGKHPNIVN 366 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEe--cccccCc-HHHHHH----HHHHHHHHHhcCCcchhh
Confidence 3455677789999999999999741 34667776 4433333 444444 99999999996 999999
Q ss_pred eeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHh---------ccCC--CCCCHHHHHHHHHHHHHHHH
Q 003185 573 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS---------ETGE--KHVSVKLALFIAQDVAAALV 641 (840)
Q Consensus 573 l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~---------~~~~--~~ls~~~~~~Ia~QIa~AL~ 641 (840)
++|++..... .++|+||+..|+|..|++... .... ..++....+.++.||+.|++
T Consensus 367 llG~~t~~~~--------------~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe 432 (609)
T KOG0200|consen 367 LLGACTQDGP--------------LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGME 432 (609)
T ss_pred heeeeccCCc--------------eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHH
Confidence 9999987554 399999999999999998743 0111 13889999999999999999
Q ss_pred HHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccC--CCcccchhhhhcc
Q 003185 642 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG--TPRWMAPEVLRAM 719 (840)
Q Consensus 642 yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vG--T~~YmAPEvL~~~ 719 (840)
||++.++|||||-..|||+..+ .++||+|||+|+.......... ....| ...|||||.+..
T Consensus 433 ~L~~~~~vHRDLAaRNVLi~~~-------~~~kIaDFGlar~~~~~~~y~~---------~~~~~~LP~kWmApEsl~~- 495 (609)
T KOG0200|consen 433 YLASVPCVHRDLAARNVLITKN-------KVIKIADFGLARDHYNKDYYRT---------KSSAGTLPVKWMAPESLFD- 495 (609)
T ss_pred HHhhCCccchhhhhhhEEecCC-------CEEEEccccceeccCCCCceEe---------cCCCCccceeecCHHHhcc-
Confidence 9999999999999999999977 5799999999986544322210 11112 235999999986
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC-HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhh
Q 003185 720 HKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 797 (840)
Q Consensus 720 ~~~~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 797 (840)
..|+.++|||||||+||||+| |..||.+.. ..++...+..+.+...|..
T Consensus 496 ---~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~-------------------------- 546 (609)
T KOG0200|consen 496 ---RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEH-------------------------- 546 (609)
T ss_pred ---CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCC--------------------------
Confidence 789999999999999999999 889999865 6777778888877655532
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 003185 798 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 832 (840)
Q Consensus 798 ~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~ 832 (840)
+..++.+++..||+.+|.+||++.++.+.|..+.
T Consensus 547 -c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 547 -CSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred -CCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 3557899999999999999999999999998854
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-33 Score=288.60 Aligned_cols=261 Identities=24% Similarity=0.305 Sum_probs=201.4
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHH-HHhCCCCCcceeeeEEecC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM-LGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~i-L~~L~HpNIV~l~g~~~~~ 580 (840)
-++++-+..||.|+||+|++-.++ +...|||.++.. .. ..+. ++++.|... ++.-+.||||++||+...+
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~--n~-~keq----~rll~e~d~~mks~~cp~IVkfyGa~F~E 135 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSN--NI-EKEQ----KRLLMEHDTVMKSSNCPNIVKFYGALFSE 135 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeec--cc-hHHH----HHHHHHHHHHHhhcCCcHHHHHhhhhhcC
Confidence 345667788999999999999885 455666654433 22 2222 345888876 4445699999999998866
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCCCcEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENIL 659 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~-gIVHRDLKPeNIL 659 (840)
+. +||.||+|. .||+.+.+..+.-....+++..+-.|....+.||.||-.. .||||||||+|||
T Consensus 136 Gd--------------cWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNIL 200 (361)
T KOG1006|consen 136 GD--------------CWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNIL 200 (361)
T ss_pred Cc--------------eeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheE
Confidence 54 599999997 5888776654444557799999999999999999999875 8999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++..|+ +||||||++-.+..... .+.-+|-..|||||.+.... ..|..+|||||||++||
T Consensus 201 ldr~G~-------vKLCDFGIcGqLv~SiA-----------kT~daGCrpYmAPERi~p~~--~gyDiRSDvWSLGITL~ 260 (361)
T KOG1006|consen 201 LDRHGD-------VKLCDFGICGQLVDSIA-----------KTVDAGCRPYMAPERIDPSD--KGYDIRSDVWSLGITLY 260 (361)
T ss_pred EecCCC-------EeeecccchHhHHHHHH-----------hhhccCCccccChhccCCcc--CCcchhhhhhhhcceEe
Confidence 998854 99999999876654321 23346899999999998632 35889999999999999
Q ss_pred HHHhCCCCCCCCC-HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 740 ELLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 740 ELLTG~~PF~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
|+.||..||.+.+ ..+.+..+..+..|.+... ....+.+..+..+|..||.+|-..|
T Consensus 261 EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~----------------------~~~~~~s~~~~~fintCl~Kd~~~R 318 (361)
T KOG1006|consen 261 EVATGNFPYRKWDSVFEQLCQVVIGDPPILLFD----------------------KECVHYSFSMVRFINTCLIKDRSDR 318 (361)
T ss_pred eeecCCCCcchHHHHHHHHHHHHcCCCCeecCc----------------------ccccccCHHHHHHHHHHhhcccccC
Confidence 9999999998774 4455556666665544421 1223446689999999999999999
Q ss_pred CCHHHHHHHH
Q 003185 819 PTAGDLYEMF 828 (840)
Q Consensus 819 PSa~ELLehL 828 (840)
|...+++++-
T Consensus 319 pky~~Lk~~~ 328 (361)
T KOG1006|consen 319 PKYDDLKKFP 328 (361)
T ss_pred cchhhhhcCc
Confidence 9999998763
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=294.81 Aligned_cols=282 Identities=19% Similarity=0.225 Sum_probs=208.8
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC--CCC----cceee
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSC----IVEMY 574 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~--HpN----IV~l~ 574 (840)
.-++|.+...+|+|.||.|-.+.+ .+..+|+||++ .+..+++..+-|+.+|++|. -|+ +|++.
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik---------~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK---------NVDKYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHH---------HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 357899999999999999999987 45688888853 23344445577999999995 233 68888
Q ss_pred eEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCC
Q 003185 575 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654 (840)
Q Consensus 575 g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLK 654 (840)
++|...+. .|||+|.+ |-|+.++|.. ++..+++...++.|++||+.+++|||+.+++|-|||
T Consensus 158 ~wFdyrgh--------------iCivfell-G~S~~dFlk~---N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLK 219 (415)
T KOG0671|consen 158 DWFDYRGH--------------ICIVFELL-GLSTFDFLKE---NNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLK 219 (415)
T ss_pred hhhhccCc--------------eEEEEecc-ChhHHHHhcc---CCccccchHHHHHHHHHHHHHHHHHHhcceeecCCC
Confidence 88876554 59999999 4699999975 556779999999999999999999999999999999
Q ss_pred CCcEEEecccc-------------cCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC
Q 003185 655 SENILIDLERK-------------KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 721 (840)
Q Consensus 655 PeNILLd~~~~-------------~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~ 721 (840)
|+|||+..... .......++|+|||.|+...... ..++.|..|.|||++.+
T Consensus 220 PENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-------------s~iVsTRHYRAPEViLg--- 283 (415)
T KOG0671|consen 220 PENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-------------STIVSTRHYRAPEVILG--- 283 (415)
T ss_pred hheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-------------ceeeeccccCCchheec---
Confidence 99999965421 11234669999999998654422 34578999999999998
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCC-----------
Q 003185 722 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF----------- 790 (840)
Q Consensus 722 ~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~----------- 790 (840)
-.++.++||||+||||+||.||...|++.+..+.+..+..... ++|..+..-.. ....+.+..+.+
T Consensus 284 -LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlG-p~P~~mi~r~~-~~Kyf~~~rldw~e~~~~~~~k~ 360 (415)
T KOG0671|consen 284 -LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILG-PIPSRMIKKTR-KEKYFRRGRLDWPEVSSKGKSKY 360 (415)
T ss_pred -cCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhC-CCcHHHhhhhh-hHhhhhcccccCccccccccchh
Confidence 6789999999999999999999999998876665544444333 23332221110 000010000000
Q ss_pred ----CC-----chhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003185 791 ----EK-----PEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 791 ----~~-----~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~ 830 (840)
.. -.........|.+||++||.+||.+|+|+.|++.|...
T Consensus 361 v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF 409 (415)
T KOG0671|consen 361 VFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFF 409 (415)
T ss_pred hhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHh
Confidence 00 01112334579999999999999999999999999654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-32 Score=309.15 Aligned_cols=257 Identities=23% Similarity=0.322 Sum_probs=211.5
Q ss_pred ceeeeeecccCceEEEEEEE--C----CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 507 LSSCDEAGKSVSSSLFRCKF--G----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~--~----~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
....++||+|+||+||+|.| + +.+||+|++.-.. ......++ +.|+.+|.+|+|||+++++|++...
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t---~~~~s~e~----LdeAl~masldHpnl~RLLgvc~~s 770 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT---SPKASIEL----LDEALRMASLDHPNLLRLLGVCMLS 770 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC---CchhhHHH----HHHHHHHhcCCCchHHHHhhhcccc
Confidence 45678999999999999998 2 3578888864222 22223333 8999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
. +.||++|+++|+|.+|++. .+..+..+..+.|..||++||.|||.+++|||||-..||||
T Consensus 771 ~---------------~qlvtq~mP~G~LlDyvr~----hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV 831 (1177)
T KOG1025|consen 771 T---------------LQLVTQLMPLGCLLDYVRE----HRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV 831 (1177)
T ss_pred h---------------HHHHHHhcccchHHHHHHH----hhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee
Confidence 4 3799999999999999986 34678889999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
... ..+||.|||+|+.+........ .....-.+.|||-|.+.. ..|+.++|||||||++||
T Consensus 832 ksP-------~hvkitdfgla~ll~~d~~ey~--------~~~gK~pikwmale~i~~----~~~thqSDVWsfGVtiWE 892 (1177)
T KOG1025|consen 832 KSP-------NHVKITDFGLAKLLAPDEKEYS--------APGGKVPIKWMALESIRI----RKYTHQSDVWSFGVTIWE 892 (1177)
T ss_pred cCC-------CeEEEEecchhhccCccccccc--------ccccccCcHHHHHHHhhc----cCCCchhhhhhhhhhHHH
Confidence 877 4699999999998766443311 111123467999999886 789999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|+| |..||.+....++...+..+.+..-|. .++.+++-++.+||..|+..||
T Consensus 893 lmTFGa~Py~gi~~~eI~dlle~geRLsqPp---------------------------iCtiDVy~~mvkCwmid~~~rp 945 (1177)
T KOG1025|consen 893 LMTFGAKPYDGIPAEEIPDLLEKGERLSQPP---------------------------ICTIDVYMVMVKCWMIDADSRP 945 (1177)
T ss_pred HHhcCCCccCCCCHHHhhHHHhccccCCCCC---------------------------CccHHHHHHHHHHhccCcccCc
Confidence 998 999999999999999988886633332 2355789999999999999999
Q ss_pred CHHHHHHHHHhhcCCC
Q 003185 820 TAGDLYEMFVARTSSS 835 (840)
Q Consensus 820 Sa~ELLehLe~l~~~~ 835 (840)
+|+++.+.+..+..+.
T Consensus 946 ~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 946 TFKELAEEFSRMARDP 961 (1177)
T ss_pred cHHHHHHHHHHHhcCc
Confidence 9999999998876553
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-33 Score=304.00 Aligned_cols=260 Identities=26% Similarity=0.314 Sum_probs=219.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCee--EEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+.+++++..||-||||.|-++..+... +|+|+.+.+..... ...+. +..|-.||..++.|.||++|-.|.+
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdt-kQqeH----v~sEr~Im~~~~s~fIvrLYrTfrd 491 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDT-KQQEH----VFSERNIMMECRSDFIVRLYRTFRD 491 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccch-hHHHH----HHhHHHHHHhcCchHHHHHHHHhcc
Confidence 56778889999999999999999987666 78888654433222 22333 3789999999999999999999998
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
+.++ |++||-|-||.|...+++ ++.|...++..++..++.|++|||++|||+|||||+|.|
T Consensus 492 ~kyv--------------YmLmEaClGGElWTiLrd-----Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENll 552 (732)
T KOG0614|consen 492 SKYV--------------YMLMEACLGGELWTILRD-----RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLL 552 (732)
T ss_pred chhh--------------hhhHHhhcCchhhhhhhh-----cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhhee
Confidence 8866 999999999999999987 578999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||.|||+|+.+.....+ -+++|||.|.|||++.. .....++|.||||+++|
T Consensus 553 Ld~~-------Gy~KLVDFGFAKki~~g~KT-----------wTFcGTpEYVAPEIILn----KGHD~avDyWaLGIli~ 610 (732)
T KOG0614|consen 553 LDNR-------GYLKLVDFGFAKKIGSGRKT-----------WTFCGTPEYVAPEIILN----KGHDRAVDYWALGILIY 610 (732)
T ss_pred eccC-------CceEEeehhhHHHhccCCce-----------eeecCCcccccchhhhc----cCcchhhHHHHHHHHHH
Confidence 9987 67999999999988764432 45789999999999986 66789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCC-CCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
||++|.+||.+.+++..+..|.++.. -.+|. .+.....+||.++...+|.+|
T Consensus 611 ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr---------------------------~I~k~a~~Lik~LCr~~P~ER 663 (732)
T KOG0614|consen 611 ELLTGSPPFSGVDPMKTYNLILKGIDKIEFPR---------------------------RITKTATDLIKKLCRDNPTER 663 (732)
T ss_pred HHHcCCCCCCCCchHHHHHHHHhhhhhhhccc---------------------------ccchhHHHHHHHHHhcCcHhh
Confidence 99999999999999999999988731 12221 124467899999999999999
Q ss_pred CC-----HHHHHHHHHhhcCC
Q 003185 819 PT-----AGDLYEMFVARTSS 834 (840)
Q Consensus 819 PS-----a~ELLehLe~l~~~ 834 (840)
.. +.+|-+|-+...-+
T Consensus 664 LG~~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 664 LGYQKGGINDIKKHRWFEGFD 684 (732)
T ss_pred hccccCChHHHHhhhhhhcCC
Confidence 75 88899986655433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=303.85 Aligned_cols=246 Identities=25% Similarity=0.243 Sum_probs=196.3
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEec
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 579 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~~ 579 (840)
..+.|.+...+|.|+|+.|-.+.. .+...++|++...... ..+|+.++... +||||+++.+.+..
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------------~~~e~~~~~~~~~h~niv~~~~v~~~ 387 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------------NQDEIPISLLVRDHPNIVKSHDVYED 387 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc------------cccccchhhhhcCCCcceeecceecC
Confidence 467899999999999999999986 6778899996533110 14577666665 49999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .|+|||++.|+-|.+.+.. .+.....+..|+.+|+.|+.|||.+|||||||||+|||
T Consensus 388 ~~~--------------~~~v~e~l~g~ell~ri~~------~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL 447 (612)
T KOG0603|consen 388 GKE--------------IYLVMELLDGGELLRRIRS------KPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNIL 447 (612)
T ss_pred Cce--------------eeeeehhccccHHHHHHHh------cchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhhee
Confidence 654 4999999999888777765 22333788889999999999999999999999999999
Q ss_pred Ee-cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 660 ID-LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 660 Ld-~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
++ .. ++++|+|||.++....... .-.-|..|.|||++.. ..|++++||||||++|
T Consensus 448 ~~~~~-------g~lrltyFG~a~~~~~~~~-------------tp~~t~~y~APEvl~~----~~yt~acD~WSLGvlL 503 (612)
T KOG0603|consen 448 LDGSA-------GHLRLTYFGFWSELERSCD-------------TPALTLQYVAPEVLAI----QEYTEACDWWSLGVLL 503 (612)
T ss_pred ecCCC-------CcEEEEEechhhhCchhhc-------------ccchhhcccChhhhcc----CCCCcchhhHHHHHHH
Confidence 95 44 5799999999987765411 1135789999999985 7899999999999999
Q ss_pred HHHHhCCCCCCCCCHH-HHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 739 LELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
|+||+|+.||...... ++...|..+.. . ..+++.+++||..||+.||.+
T Consensus 504 y~ML~G~tp~~~~P~~~ei~~~i~~~~~---s---------------------------~~vS~~AKdLl~~LL~~dP~~ 553 (612)
T KOG0603|consen 504 YEMLTGRTLFAAHPAGIEIHTRIQMPKF---S---------------------------ECVSDEAKDLLQQLLQVDPAL 553 (612)
T ss_pred HHHHhCCCccccCCchHHHHHhhcCCcc---c---------------------------cccCHHHHHHHHHhccCChhh
Confidence 9999999999765433 55555544322 1 224668999999999999999
Q ss_pred CCCHHHHHHHHHhhcCC
Q 003185 818 RPTAGDLYEMFVARTSS 834 (840)
Q Consensus 818 RPSa~ELLehLe~l~~~ 834 (840)
||++.++..|-+....+
T Consensus 554 Rl~~~~i~~h~w~~~~~ 570 (612)
T KOG0603|consen 554 RLGADEIGAHPWFLSHP 570 (612)
T ss_pred CcChhhhccCcchhcCC
Confidence 99999999997774433
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=275.96 Aligned_cols=224 Identities=21% Similarity=0.148 Sum_probs=171.6
Q ss_pred cCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCCCCccc
Q 003185 516 SVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 593 (840)
Q Consensus 516 G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g~~~~~ 593 (840)
|.||.||++.+ ++..+|+|...... .+ .+|...+....||||+++++++.....
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~----~~~~~~~~~~~~~~i~~~~~~~~~~~~----------- 59 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EY----SRERLTIIPHCVPNMVCLHKYIVSEDS----------- 59 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---------hh----hhHHHHHHhcCCCceeehhhheecCCe-----------
Confidence 89999999997 66789999864321 11 345555566679999999999876543
Q ss_pred cceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCCCCeE
Q 003185 594 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 673 (840)
Q Consensus 594 ~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~v 673 (840)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+
T Consensus 60 ---~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~-------~~~ 124 (237)
T cd05576 60 ---VFLVLQHAEGGKLWSHISK-----FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR-------GHI 124 (237)
T ss_pred ---EEEEEecCCCCCHHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-------CCE
Confidence 4999999999999999876 2358999999999999999999999999999999999999877 459
Q ss_pred EEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 003185 674 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE 753 (840)
Q Consensus 674 KL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~ 753 (840)
+|+|||.+....... ....++..|+|||++.. ..++.++||||+||++|||++|..|+.....
T Consensus 125 ~l~df~~~~~~~~~~-------------~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~g~~~~~~~~~ 187 (237)
T cd05576 125 QLTYFSRWSEVEDSC-------------DGEAVENMYCAPEVGGI----SEETEACDWWSLGAILFELLTGKTLVECHPS 187 (237)
T ss_pred EEecccchhcccccc-------------ccCCcCccccCCcccCC----CCCCchhhHHHHHHHHHHHHHCcchhhcCch
Confidence 999999876543321 11235678999999865 5578899999999999999999988743211
Q ss_pred HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 003185 754 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA-----GDLYEM 827 (840)
Q Consensus 754 ~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa-----~ELLeh 827 (840)
. +.......++ ...+..+.+||.+||+.||.+||++ +++++|
T Consensus 188 ~-----~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 234 (237)
T cd05576 188 G-----INTHTTLNIP---------------------------EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH 234 (237)
T ss_pred h-----cccccccCCc---------------------------ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcC
Confidence 0 0000000000 1134578999999999999999996 777766
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=287.16 Aligned_cols=248 Identities=25% Similarity=0.324 Sum_probs=202.1
Q ss_pred CCCCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeE
Q 003185 500 DPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGH 576 (840)
Q Consensus 500 ~p~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~ 576 (840)
+-+...+|.++..||+|+||.|.+|..+ ...+||||.+.+..... ++.+-- +.|-++|.... -|.+++++.+
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd-DDvect----m~EKrvLAL~~kppFL~qlHSc 418 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD-DDVECT----MVEKRVLALPGKPPFLVQLHSC 418 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeec-Ccccce----ehhhhheecCCCCchHHHHHHH
Confidence 4466788999999999999999999874 45789998765443222 222222 55777777664 7889999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
|.+-+.+ |+||||+.||+|.-.|++ -.++.+..+..++..|+-||-|||++|||.||||.+
T Consensus 419 FQTmDRL--------------yFVMEyvnGGDLMyhiQQ-----~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLD 479 (683)
T KOG0696|consen 419 FQTMDRL--------------YFVMEYVNGGDLMYHIQQ-----VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLD 479 (683)
T ss_pred hhhhhhe--------------eeEEEEecCchhhhHHHH-----hcccCCchhhhhhHHHHHHhhhhhcCCeeeeecccc
Confidence 9877654 999999999999999987 367888999999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
|||++.+ +.+||+|||+++.-.-... ...++.|||.|+|||++.. .+|+..+|.|||||
T Consensus 480 NvmLd~e-------GHiKi~DFGmcKEni~~~~----------TTkTFCGTPdYiAPEIi~Y----qPYgksvDWWa~GV 538 (683)
T KOG0696|consen 480 NVMLDSE-------GHIKIADFGMCKENIFDGV----------TTKTFCGTPDYIAPEIIAY----QPYGKSVDWWAFGV 538 (683)
T ss_pred ceEeccC-------CceEeeecccccccccCCc----------ceeeecCCCcccccceEEe----cccccchhHHHHHH
Confidence 9999988 5699999999975322211 2356789999999999987 78999999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 737 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 737 IL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
+||||+.|++||.+.+..+++..|....- ..+. ..+.+..++....|...|.
T Consensus 539 LLyEmlaGQpPFdGeDE~elF~aI~ehnv-syPK---------------------------slSkEAv~ickg~ltK~P~ 590 (683)
T KOG0696|consen 539 LLYEMLAGQPPFDGEDEDELFQAIMEHNV-SYPK---------------------------SLSKEAVAICKGLLTKHPG 590 (683)
T ss_pred HHHHHHcCCCCCCCCCHHHHHHHHHHccC-cCcc---------------------------cccHHHHHHHHHHhhcCCc
Confidence 99999999999999999999999876422 1121 1245788899999999999
Q ss_pred CCCC
Q 003185 817 ERPT 820 (840)
Q Consensus 817 eRPS 820 (840)
+|..
T Consensus 591 kRLG 594 (683)
T KOG0696|consen 591 KRLG 594 (683)
T ss_pred cccC
Confidence 9953
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=292.33 Aligned_cols=273 Identities=21% Similarity=0.227 Sum_probs=214.2
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
-++|-++..||+|||+.||+|.+ ..+.|||||..+..... .+..+++-+-..+|..|-+.|.||-||++|++|..+.
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~Wr-dEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWR-DEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchh-hHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 46799999999999999999986 78899999987765432 3344555566689999999999999999999998554
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeecccCCCCcEE
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--HIMHRDIKSENIL 659 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~--gIVHRDLKPeNIL 659 (840)
. .+|-|+|||+|.+|+-||+. ...+++.+++.|+.||+.||.||... .|||-||||.|||
T Consensus 541 d-------------sFCTVLEYceGNDLDFYLKQ-----hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNIL 602 (775)
T KOG1151|consen 541 D-------------SFCTVLEYCEGNDLDFYLKQ-----HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNIL 602 (775)
T ss_pred c-------------cceeeeeecCCCchhHHHHh-----hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEE
Confidence 3 35999999999999999987 46799999999999999999999986 6999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
+-... ..+.+||+|||+++.+...... ...+.....-..||..|++||.+.-.......+.|+||||+|||+|
T Consensus 603 Lv~Gt----acGeIKITDFGLSKIMdddSy~---~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFy 675 (775)
T KOG1151|consen 603 LVNGT----ACGEIKITDFGLSKIMDDDSYN---SVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFY 675 (775)
T ss_pred EecCc----ccceeEeeecchhhhccCCccC---cccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhh
Confidence 96542 3577999999999988765432 1223333445679999999999876544567899999999999999
Q ss_pred HHHhCCCCCCCCCHH-HHHH--HHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 740 ELLTLQVPYMGLSEL-EIHD--LIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 740 ELLTG~~PF~~~~~~-el~~--~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
..+.|+.||...... +++. .|.+...-.+| ..+.++.+.+++|.+||++.-+
T Consensus 676 QClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP-------------------------~KPvVsseAkaFIRRCLaYRKe 730 (775)
T KOG1151|consen 676 QCLYGRKPFGHNQSQQDILQENTILKATEVQFP-------------------------PKPVVSSEAKAFIRRCLAYRKE 730 (775)
T ss_pred hhhccCCCCCCchhHHHHHhhhchhcceeccCC-------------------------CCCccCHHHHHHHHHHHHhhhh
Confidence 999999999655332 2221 11111110111 0122355789999999999999
Q ss_pred CCCCHHHHHHH
Q 003185 817 ERPTAGDLYEM 827 (840)
Q Consensus 817 eRPSa~ELLeh 827 (840)
+|....++..+
T Consensus 731 DR~DV~qLA~d 741 (775)
T KOG1151|consen 731 DRIDVQQLACD 741 (775)
T ss_pred hhhhHHHHccC
Confidence 99999998876
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=293.52 Aligned_cols=257 Identities=25% Similarity=0.297 Sum_probs=203.4
Q ss_pred CCCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEE
Q 003185 500 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 577 (840)
Q Consensus 500 ~p~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~ 577 (840)
.|...+.|..-+.||+||||.||-+.. .+.-+|.|....+.. ..+.-....+.|-.||.++..+.||.+-.+|
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRi-----Kkr~ge~maLnEk~iL~kV~s~FiVslaYAf 254 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRI-----KKRKGETMALNEKQILEKVSSPFIVSLAYAF 254 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHH-----HHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence 456788899999999999999998874 677777776433221 1112223448899999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
.+.+.+ ++||..|.||+|.-.|.+ .+...|++..++.++.+|+.||++||+++||+|||||+|
T Consensus 255 eTkd~L--------------ClVLtlMNGGDLkfHiyn---~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeN 317 (591)
T KOG0986|consen 255 ETKDAL--------------CLVLTLMNGGDLKFHIYN---HGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPEN 317 (591)
T ss_pred cCCCce--------------EEEEEeecCCceeEEeec---cCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhh
Confidence 887755 999999999999999876 344679999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
||+|.. +.+.|+|+|+|..+...... ...+||.+|||||++.. ..|+...|.|||||+
T Consensus 318 ILLDd~-------GhvRISDLGLAvei~~g~~~-----------~~rvGT~GYMAPEvl~n----e~Y~~s~Dwf~lGCl 375 (591)
T KOG0986|consen 318 ILLDDH-------GHVRISDLGLAVEIPEGKPI-----------RGRVGTVGYMAPEVLQN----EVYDFSPDWFSLGCL 375 (591)
T ss_pred eeeccC-------CCeEeeccceEEecCCCCcc-----------ccccCcccccCHHHHcC----CcccCCccHHHHHhH
Confidence 999988 55999999999987653322 23479999999999986 669999999999999
Q ss_pred HHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 003185 738 LLELLTLQVPYMGLSEL----EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 813 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~----el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~ 813 (840)
||||+.|+.||...... ++-..+... ...++ ...++++++|.+.+|..
T Consensus 376 lYemi~G~sPFr~~KeKvk~eEvdrr~~~~-~~ey~---------------------------~kFS~eakslc~~LL~K 427 (591)
T KOG0986|consen 376 LYEMIAGHSPFRQRKEKVKREEVDRRTLED-PEEYS---------------------------DKFSEEAKSLCEGLLTK 427 (591)
T ss_pred HHHHHcccCchhhhhhhhhHHHHHHHHhcc-hhhcc---------------------------cccCHHHHHHHHHHHcc
Confidence 99999999999654222 222222221 11111 22366899999999999
Q ss_pred CCCCCC-----CHHHHHHHH
Q 003185 814 NPTERP-----TAGDLYEMF 828 (840)
Q Consensus 814 DP~eRP-----Sa~ELLehL 828 (840)
||.+|. .++++.+|.
T Consensus 428 dp~~RLGcrg~ga~evk~Hp 447 (591)
T KOG0986|consen 428 DPEKRLGCRGEGAQEVKEHP 447 (591)
T ss_pred CHHHhccCCCcCcchhhhCc
Confidence 999996 466777774
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=262.02 Aligned_cols=238 Identities=33% Similarity=0.435 Sum_probs=188.0
Q ss_pred CceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCCCCcccc
Q 003185 517 VSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594 (840)
Q Consensus 517 ~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g~~~~~~ 594 (840)
+||.||+|.+. +..+++|+......... .+ .+.+|+..+++++|+||+++++++....
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~---~~----~~~~e~~~~~~l~~~~i~~~~~~~~~~~------------- 60 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK---RE----RILREISILKKLKHPNIVRLYDVFEDED------------- 60 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH---HH----HHHHHHHHHHhCCCCcHHHHHhheeeCC-------------
Confidence 68999999984 58899998754322110 23 3489999999999999999999987554
Q ss_pred ceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCCCCeEE
Q 003185 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 674 (840)
Q Consensus 595 ~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vK 674 (840)
..+++|||+.+++|.+++.. ...++...++.++.+++.+|.|||+.+|+|+||+|.||+++.+ +.++
T Consensus 61 -~~~l~~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~-------~~~~ 127 (244)
T smart00220 61 -KLYLVMEYCDGGDLFDLLKK-----RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED-------GHVK 127 (244)
T ss_pred -EEEEEEeCCCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC-------CcEE
Confidence 35999999999999999976 2238899999999999999999999999999999999999876 4699
Q ss_pred EeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCH
Q 003185 675 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG-LSE 753 (840)
Q Consensus 675 L~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~-~~~ 753 (840)
|+|||.+........ .....++..|++||.+.. ..++.++||||||+++|+|++|..||.. ...
T Consensus 128 l~d~~~~~~~~~~~~-----------~~~~~~~~~~~~pE~~~~----~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~ 192 (244)
T smart00220 128 LADFGLARQLDPGGL-----------LTTFVGTPEYMAPEVLLG----KGYGKAVDVWSLGVILYELLTGKPPFPGDDQL 192 (244)
T ss_pred Eccccceeeeccccc-----------cccccCCcCCCCHHHHcc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 999999987654321 123458889999999875 5678899999999999999999999977 445
Q ss_pred HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003185 754 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 827 (840)
Q Consensus 754 ~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLeh 827 (840)
..+...+.......... ....+..+.+++.+||..+|.+||++.++++|
T Consensus 193 ~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 193 LELFKKIGKPKPPFPPP-------------------------EWKISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHHHHHhccCCCCccc-------------------------cccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 55555444332221110 00024578999999999999999999999985
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=304.02 Aligned_cols=288 Identities=15% Similarity=0.113 Sum_probs=175.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 575 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g 575 (840)
...++|++.+.||+|+||.||+|.+. +..+|+|... .. .. .+.+ ..| .+....+.+++.++.
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~--~~--~~--~e~~----~~e--~l~~~~~~~~~~~~~ 196 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKAT--EY--GA--VEIW----MNE--RVRRACPNSCADFVY 196 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEec--cc--ch--hHHH----HHH--HHHhhchhhHHHHHH
Confidence 46789999999999999999999973 5688888743 11 11 1111 111 122223344444333
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc---------------CCCCCCHHHHHHHHHHHHHHH
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---------------GEKHVSVKLALFIAQDVAAAL 640 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~---------------~~~~ls~~~~~~Ia~QIa~AL 640 (840)
.+..... .......+|||||+.+++|.+++...... .........+..++.||+.||
T Consensus 197 ~~~~~~~--------~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL 268 (566)
T PLN03225 197 GFLEPVS--------SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFAL 268 (566)
T ss_pred hhhcccc--------cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHH
Confidence 3221110 01223569999999999999998741100 001112345678999999999
Q ss_pred HHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003185 641 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720 (840)
Q Consensus 641 ~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~ 720 (840)
.|||++||+||||||+|||++.+. +.+||+|||+|+.+..... .......+|+.|||||.+....
T Consensus 269 ~yLH~~gIiHRDLKP~NILl~~~~------~~~KL~DFGlA~~l~~~~~---------~~~~~~~~t~~Y~APE~~~~~~ 333 (566)
T PLN03225 269 DGLHSTGIVHRDVKPQNIIFSEGS------GSFKIIDLGAAADLRVGIN---------YIPKEFLLDPRYAAPEQYIMST 333 (566)
T ss_pred HHHHHCCEEeCcCCHHHEEEeCCC------CcEEEEeCCCccccccccc---------cCCcccccCCCccChHHhhccC
Confidence 999999999999999999998542 4699999999976533211 1123457899999999764321
Q ss_pred CC------------------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcccc
Q 003185 721 KP------------------NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE 782 (840)
Q Consensus 721 ~~------------------~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~ 782 (840)
.. ..++.++|||||||+||||+++..|+... .......+..... .+......... ..
T Consensus 334 ~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~-~~~~~~~~~~~---~~ 408 (566)
T PLN03225 334 QTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDY-DLVAWRKLVEP---RA 408 (566)
T ss_pred CCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCC-cHHHHHHhhcc---cc
Confidence 11 12345679999999999999977664321 2222222222211 11111000000 00
Q ss_pred ccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 003185 783 VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 832 (840)
Q Consensus 783 ~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~ 832 (840)
..+....+ ..........++||.+||++||.+|||+.++++|..-..
T Consensus 409 ~~~~~~~~---~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~ 455 (566)
T PLN03225 409 SPDLRRGF---EVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDR 455 (566)
T ss_pred chhhhhhh---hhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCC
Confidence 00000000 000111235679999999999999999999999966543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=266.84 Aligned_cols=276 Identities=20% Similarity=0.266 Sum_probs=204.7
Q ss_pred CCCCCceeeeeecccCceEEEEEE--ECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCK--FGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~--~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~ 578 (840)
...++|++.+++|+|-|+.||.|. .++.++++|+.+ . -..+. +.+|+.||..|. ||||++++++..
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK--P-----VkkkK----IkREikIL~nL~gg~NIi~L~DiV~ 103 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK--P-----VKKKK----IKREIKILQNLRGGPNIIKLLDIVK 103 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeec--h-----HHHHH----HHHHHHHHHhccCCCCeeehhhhhc
Confidence 456799999999999999999998 478889999853 2 22233 489999999998 999999999887
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
+...- .+.||+||+.+.++..+.. .++...+..++.+++.||.|+|++||+|||+||+|+
T Consensus 104 Dp~Sk------------tpaLiFE~v~n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNv 163 (338)
T KOG0668|consen 104 DPESK------------TPSLIFEYVNNTDFKQLYP--------TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNV 163 (338)
T ss_pred Ccccc------------CchhHhhhhccccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhcCcccccCCccee
Confidence 54422 3589999999988877754 377888999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
+|+... -.++|+|+|+|.++...... +..+.+..|-.||.+.. -..|...-|+|||||+|
T Consensus 164 mIdh~~------rkLrlIDWGLAEFYHp~~eY-----------nVRVASRyfKGPELLVd---y~~YDYSLD~WS~Gcml 223 (338)
T KOG0668|consen 164 MIDHEL------RKLRLIDWGLAEFYHPGKEY-----------NVRVASRYFKGPELLVD---YQMYDYSLDMWSLGCML 223 (338)
T ss_pred eechhh------ceeeeeecchHhhcCCCcee-----------eeeeehhhcCCchheee---chhccccHHHHHHHHHH
Confidence 999774 36999999999887654332 34567888999999976 35678899999999999
Q ss_pred HHHHhCCCCCC-CCCHHHHHHHHHcC-CCCCcchHHhhhccCcccccc--------ccCCCCCCchhhhhhHHHHHHHHH
Q 003185 739 LELLTLQVPYM-GLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVA--------QSGSGFEKPEAELETLSFLVDVFR 808 (840)
Q Consensus 739 ~ELLTG~~PF~-~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~--------~~~~~~~~~~~~~~~s~~L~dLI~ 808 (840)
..|+..+.||. |.+..+.+-.|.+. ....+...+.+....-.+.+. .....+..++...-.++++.+|+.
T Consensus 224 A~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlld 303 (338)
T KOG0668|consen 224 ASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLD 303 (338)
T ss_pred HHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHH
Confidence 99999999984 44444433333332 111112211111111111111 111122223333334578899999
Q ss_pred HhcccCCCCCCCHHHHHHHH
Q 003185 809 RCTEENPTERPTAGDLYEMF 828 (840)
Q Consensus 809 rCL~~DP~eRPSa~ELLehL 828 (840)
++|.+|..+|+||.|.+.|.
T Consensus 304 klLrYDHqeRlTakEam~Hp 323 (338)
T KOG0668|consen 304 KLLRYDHQERLTAKEAMAHP 323 (338)
T ss_pred HHHhhccccccchHHHhcCc
Confidence 99999999999999999984
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=275.60 Aligned_cols=286 Identities=22% Similarity=0.266 Sum_probs=204.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-----C---CCcceee
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-----H---SCIVEMY 574 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-----H---pNIV~l~ 574 (840)
++|.+.++||-|.|++||+|.+ ..+.||+||.+- .+.|.+..+.||++|++++ | .+||+++
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS---------AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS---------AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh---------hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 6899999999999999999997 678999999752 2345555689999999985 2 4699999
Q ss_pred eEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccC
Q 003185 575 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDI 653 (840)
Q Consensus 575 g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~-gIVHRDL 653 (840)
+.|..... ...+.|+|+|++ |-+|..+|... .-+.++...++.|++||+.||.|||.. ||||-||
T Consensus 149 D~FkhsGp----------NG~HVCMVfEvL-GdnLLklI~~s---~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDl 214 (590)
T KOG1290|consen 149 DHFKHSGP----------NGQHVCMVFEVL-GDNLLKLIKYS---NYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDL 214 (590)
T ss_pred ccceecCC----------CCcEEEEEehhh-hhHHHHHHHHh---CCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCC
Confidence 99987653 345789999999 56999999873 345699999999999999999999987 9999999
Q ss_pred CCCcEEEecccc--------------------------------------------------------------------
Q 003185 654 KSENILIDLERK-------------------------------------------------------------------- 665 (840)
Q Consensus 654 KPeNILLd~~~~-------------------------------------------------------------------- 665 (840)
||+|||+.....
T Consensus 215 KPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~ 294 (590)
T KOG1290|consen 215 KPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGI 294 (590)
T ss_pred CcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccc
Confidence 999999954310
Q ss_pred ------------------------------------------c-------------------------------------
Q 003185 666 ------------------------------------------K------------------------------------- 666 (840)
Q Consensus 666 ------------------------------------------~------------------------------------- 666 (840)
.
T Consensus 295 ~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~ 374 (590)
T KOG1290|consen 295 EEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTI 374 (590)
T ss_pred cccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccc
Confidence 0
Q ss_pred ------------CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHH
Q 003185 667 ------------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 734 (840)
Q Consensus 667 ------------~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSL 734 (840)
......+||+|||.|..+.... +.-+.|..|+|||++.+ ..|++.+||||+
T Consensus 375 ~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khF-------------T~DIQTRQYRapEVllG----sgY~~~ADiWS~ 437 (590)
T KOG1290|consen 375 ASNPLVNPDIPLPECDIRVKIADLGNACWVHKHF-------------TEDIQTRQYRAPEVLLG----SGYSTSADIWST 437 (590)
T ss_pred ccccccCCCCCCCccceeEEEeeccchhhhhhhh-------------chhhhhhhccCcceeec----CCCCCchhHHHH
Confidence 0001235666666665433211 12257899999999998 789999999999
Q ss_pred HHHHHHHHhCCCCCCCC------CHHHHHHHHHcCCCCCcchHHhhhccCccccccccCC--------CC-------CCc
Q 003185 735 GCLLLELLTLQVPYMGL------SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS--------GF-------EKP 793 (840)
Q Consensus 735 GvIL~ELLTG~~PF~~~------~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~--------~~-------~~~ 793 (840)
+|++|||+||...|... .+.+.+..|.... -.+|..+..-.......|.+.+. .+ ++.
T Consensus 438 AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELL-G~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY 516 (590)
T KOG1290|consen 438 ACMAFELATGDYLFEPHSGENYSRDEDHIALIMELL-GKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKY 516 (590)
T ss_pred HHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHH-hhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHh
Confidence 99999999999998421 2233333333211 11222222111111111111110 00 112
Q ss_pred hhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 003185 794 EAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 831 (840)
Q Consensus 794 ~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l 831 (840)
....+...++.+||.-||+.+|.+||||.++++|.+-.
T Consensus 517 ~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn 554 (590)
T KOG1290|consen 517 EWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLN 554 (590)
T ss_pred CCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCcccc
Confidence 23445677899999999999999999999999997654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=254.71 Aligned_cols=227 Identities=25% Similarity=0.366 Sum_probs=183.3
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEec
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 579 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~~ 579 (840)
+-+.+..+..||+|+||.|-+.++ ++.-.|+|-++... . ..+. +++++|+.+..+. .+|.+|.+||.+..
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n-~q~q----~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--N-SQEQ----KRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--C-hHHH----HHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 345566788999999999877775 67777777755433 2 2222 3448899886555 59999999998876
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCCCcE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENI 658 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~-gIVHRDLKPeNI 658 (840)
+..+ +|.||.+. .||..+-++..+.+ ..+++..+-+|+..|+.||.|||++ .|||||+||+||
T Consensus 117 egdv--------------wIcME~M~-tSldkfy~~v~~~g-~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNi 180 (282)
T KOG0984|consen 117 EGDV--------------WICMELMD-TSLDKFYRKVLKKG-GTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNI 180 (282)
T ss_pred cccE--------------EEeHHHhh-hhHHHHHHHHHhcC-CcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceE
Confidence 6544 99999997 59998887655554 6799999999999999999999998 899999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
||+.+ ++||+||||++-.+.+.... +...|...|||||.+........|+.++||||||+++
T Consensus 181 LIn~~-------GqVKiCDFGIsG~L~dSiAk-----------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItm 242 (282)
T KOG0984|consen 181 LINYD-------GQVKICDFGISGYLVDSIAK-----------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITM 242 (282)
T ss_pred EEccC-------CcEEEcccccceeehhhhHH-----------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhh
Confidence 99988 45999999999776543221 2245889999999998766666899999999999999
Q ss_pred HHHHhCCCCCCCC-CHHHHHHHHHcCCCCCcch
Q 003185 739 LELLTLQVPYMGL-SELEIHDLIQMGKRPRLTD 770 (840)
Q Consensus 739 ~ELLTG~~PF~~~-~~~el~~~I~~~~~p~l~~ 770 (840)
+||.+++.||... ++.+.+.++.....|.++.
T Consensus 243 iElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp~ 275 (282)
T KOG0984|consen 243 IEMAILRFPYESWGTPFQQLKQVVEEPSPQLPA 275 (282)
T ss_pred hhhhhccccccccCCHHHHHHHHhcCCCCCCcc
Confidence 9999999999764 7888888888887777663
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=298.25 Aligned_cols=256 Identities=26% Similarity=0.337 Sum_probs=189.1
Q ss_pred ceeeeeecccCce-EEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEecCCCCC
Q 003185 507 LSSCDEAGKSVSS-SLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLP 584 (840)
Q Consensus 507 y~i~~~LG~G~fG-~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~~~~~p 584 (840)
|.-.+.+|.|+.| .||+|.+.++.||||-+.. ++.....+||..|+.-+ |||||++|+.-.+...
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~-----------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF-- 577 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLE-----------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQF-- 577 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhh-----------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCce--
Confidence 3456778999987 5899999999999997531 22223489999999886 9999999987655543
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEeccc
Q 003185 585 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 664 (840)
Q Consensus 585 ~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~ 664 (840)
.||..|.|. .+|.+++... ............+.++.|++.||+|||+.+||||||||+||||+...
T Consensus 578 ------------~YIalELC~-~sL~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~ 643 (903)
T KOG1027|consen 578 ------------LYIALELCA-CSLQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPS 643 (903)
T ss_pred ------------EEEEehHhh-hhHHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccC
Confidence 599999997 5999999862 01111111145678899999999999999999999999999998742
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 003185 665 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 744 (840)
Q Consensus 665 ~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG 744 (840)
......++|+|||+++.+........ ......||-+|+|||++.. ..-+.++|||||||++|..++|
T Consensus 644 --~~~~~ra~iSDfglsKkl~~~~sS~~-------r~s~~sGt~GW~APE~L~~----~~~~~avDiFslGCvfyYvltg 710 (903)
T KOG1027|consen 644 --ADGTLRAKISDFGLSKKLAGGKSSFS-------RLSGGSGTSGWQAPEQLRE----DRKTQAVDIFSLGCVFYYVLTG 710 (903)
T ss_pred --CCcceeEEecccccccccCCCcchhh-------cccCCCCcccccCHHHHhc----cccCcccchhhcCceEEEEecC
Confidence 23457899999999998866443211 1234579999999999987 3446699999999999999996
Q ss_pred -CCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003185 745 -QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823 (840)
Q Consensus 745 -~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~E 823 (840)
..||...-. ....|.++...-.. + ....++ ...+||.+|++++|..||+|.+
T Consensus 711 G~HpFGd~~~--R~~NIl~~~~~L~~-----L------------------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~ 763 (903)
T KOG1027|consen 711 GSHPFGDSLE--RQANILTGNYTLVH-----L------------------EPLPDC--EAKDLISRMLNPDPQLRPSATD 763 (903)
T ss_pred CccCCCchHH--hhhhhhcCccceee-----e------------------ccCchH--HHHHHHHHhcCCCcccCCCHHH
Confidence 899964422 22334333211000 0 000011 6899999999999999999999
Q ss_pred HHHHHH
Q 003185 824 LYEMFV 829 (840)
Q Consensus 824 LLehLe 829 (840)
||.|..
T Consensus 764 VL~HPl 769 (903)
T KOG1027|consen 764 VLNHPL 769 (903)
T ss_pred HhCCCc
Confidence 999853
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=284.69 Aligned_cols=276 Identities=21% Similarity=0.271 Sum_probs=210.9
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC------CCCcceeeeE
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR------HSCIVEMYGH 576 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~------HpNIV~l~g~ 576 (840)
.+|.+....|+|-|++|.+|.+ .+..|||||+.-.. ...+.- ++|+.||++|+ --|+++++-.
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-----~M~KtG----l~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-----VMHKTG----LKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-----HHhhhh----hHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 5788999999999999999997 56799999975331 122222 78999999996 3578999988
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
|...+ ++|||+|.+. .+|.++|+++.. +..|....+..++.|+..||.+|-..||+|.||||+
T Consensus 503 F~hkn--------------HLClVFE~Ls-lNLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPD 565 (752)
T KOG0670|consen 503 FKHKN--------------HLCLVFEPLS-LNLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPD 565 (752)
T ss_pred hhhcc--------------eeEEEehhhh-chHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHHhcCeeecccCcc
Confidence 87555 5699999996 699999998533 245788899999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
||||+... .++||||||.|........+. +.-+..|.|||++.| .+|....|+||.||
T Consensus 566 NiLVNE~k------~iLKLCDfGSA~~~~eneitP------------YLVSRFYRaPEIiLG----~~yd~~iD~WSvgc 623 (752)
T KOG0670|consen 566 NILVNESK------NILKLCDFGSASFASENEITP------------YLVSRFYRAPEIILG----LPYDYPIDTWSVGC 623 (752)
T ss_pred ceEeccCc------ceeeeccCccccccccccccH------------HHHHHhccCcceeec----CcccCCccceeece
Confidence 99998763 589999999998776544332 234568999999998 78899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccc-------------------cccCC---------
Q 003185 737 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV-------------------AQSGS--------- 788 (840)
Q Consensus 737 IL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~-------------------~~~~~--------- 788 (840)
+||||.||+..|+|.+..+++........+ +|..+..-..+....| .....
T Consensus 624 tLYElYtGkIlFpG~TNN~MLrl~me~KGk-~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~ 702 (752)
T KOG0670|consen 624 TLYELYTGKILFPGRTNNQMLRLFMELKGK-FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLG 702 (752)
T ss_pred eeEEeeccceecCCCCcHHHHHHHHHhcCC-CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHH
Confidence 999999999999999888877766543322 2221111111100000 00000
Q ss_pred -----CCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003185 789 -----GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 789 -----~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe 829 (840)
....+........+|.+||.+||..||.+|.|..++|+|..
T Consensus 703 s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpF 748 (752)
T KOG0670|consen 703 SELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPF 748 (752)
T ss_pred HHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCc
Confidence 00123444566788999999999999999999999999965
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-31 Score=271.41 Aligned_cols=285 Identities=18% Similarity=0.239 Sum_probs=205.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
.+.+--+.||.|+||.||.+++ .++.+++|.+. ........ .+++.+|+++|..++|.|++..+++......
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~p--nvfq~L~s----~krvFre~kmLcfFkHdNVLSaLDILQPph~ 126 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMP--NVFQNLAS----CKRVFREIKMLSSFRHDNVLSLLDILQPANP 126 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcc--hHHHHHHH----HHHHHHHHHHHHhhccccHHHHHHhcCCCCc
Confidence 3456678999999999999987 56667776532 11111111 3456899999999999999999987653321
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.-...+|+|+|++. .+|...|-. ...++...++-+++||++||+|||+.+|.||||||.|+|++.
T Consensus 127 ---------dfFqEiYV~TELmQ-SDLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNS 191 (449)
T KOG0664|consen 127 ---------SFFQELYVLTELMQ-SDLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNS 191 (449)
T ss_pred ---------hHHHHHHHHHHHHH-hhhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEecc
Confidence 12335689999996 599988865 467899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ .++||||||+|+......... .+.-+-|..|.|||++++ ...|+.+.||||.|||+.||+
T Consensus 192 N-------CvLKICDFGLARvee~d~~~h---------MTqEVVTQYYRAPEiLMG---aRhYs~AvDiWSVGCIFaELL 252 (449)
T KOG0664|consen 192 N-------CILKICDFGLARTWDQRDRLN---------MTHEVVTQYYRAPELLMG---ARRYTGAVDIWSVGCIFAELL 252 (449)
T ss_pred C-------ceEEecccccccccchhhhhh---------hHHHHHHHHhccHHHhhc---chhhcCccceehhhHHHHHHH
Confidence 7 789999999998664432110 111246789999999997 578999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCc------hhhhhhHHHHHHHHHHhcccCCC
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP------EAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~------~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
-.+..|+..++.+.++.|..-...+-.+.+..........+.+........ ........+..+++..+|.+||.
T Consensus 253 gRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~d 332 (449)
T KOG0664|consen 253 QRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPD 332 (449)
T ss_pred hhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCc
Confidence 999999999888888777665222222222221111111122211111000 00112233567889999999999
Q ss_pred CCCCHHHHHHHHH
Q 003185 817 ERPTAGDLYEMFV 829 (840)
Q Consensus 817 eRPSa~ELLehLe 829 (840)
+|.+.++.+.|+.
T Consensus 333 kris~~~A~~~~~ 345 (449)
T KOG0664|consen 333 KRISVEEALQHRY 345 (449)
T ss_pred ccccHhhhccccc
Confidence 9999999988753
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=283.63 Aligned_cols=292 Identities=17% Similarity=0.165 Sum_probs=185.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE------------------CCeeEEEEEEecccCCCChHHH------HHhHHhHHH
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF------------------GSADAAAKVRTLKVCGSSADEI------RNFEYSCLG 557 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~------------------~~~~vAVKI~~lk~~~~~~~~~------~~f~~~~~r 557 (840)
...++|.+.++||+|+||+||+|.+ .+..||||...........+.. ....+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 4577999999999999999999964 2356888886543221110000 001122356
Q ss_pred HHHHHHhCCCCCc-----ceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc--------------
Q 003185 558 EVRMLGALRHSCI-----VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------- 618 (840)
Q Consensus 558 Ei~iL~~L~HpNI-----V~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-------------- 618 (840)
|+.++.+++|.++ ++++++|..... ++ .......+|||||+++++|.+++.....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~----~g--~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~ 295 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTA----DG--AFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGK 295 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccc----cc--cccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCC
Confidence 7888888876654 677777754211 01 0112346999999999999999874210
Q ss_pred -----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCccccccccccccc
Q 003185 619 -----TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 693 (840)
Q Consensus 619 -----~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~ 693 (840)
.....+++..++.++.||+.||.|||+++|+||||||+|||++.+ ..+||+|||++.........
T Consensus 296 ~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~-------~~~kL~DFGla~~~~~~~~~--- 365 (507)
T PLN03224 296 KIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD-------GQVKIIDFGAAVDMCTGINF--- 365 (507)
T ss_pred chhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCC-------CcEEEEeCcCccccccCCcc---
Confidence 011234677889999999999999999999999999999999876 45999999999654321110
Q ss_pred ccCCCCCCCcccCCCcccchhhhhcccCCC------------------CCCchhhHHHHHHHHHHHHhCCC-CCCCCCHH
Q 003185 694 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPN------------------LYGLEVDIWSYGCLLLELLTLQV-PYMGLSEL 754 (840)
Q Consensus 694 ~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~------------------~~s~kSDVWSLGvIL~ELLTG~~-PF~~~~~~ 754 (840)
......+|+.|+|||.+....... ....+.||||+||+|++|+++.. ||.+....
T Consensus 366 ------~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f 439 (507)
T PLN03224 366 ------NPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLF 439 (507)
T ss_pred ------CccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhh
Confidence 011223588999999986421100 11235799999999999999885 66543211
Q ss_pred HHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC---CCCCCHHHHHHHHHh
Q 003185 755 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP---TERPTAGDLYEMFVA 830 (840)
Q Consensus 755 el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP---~eRPSa~ELLehLe~ 830 (840)
... +... ...+ ..+... ......+ ......++..++|+.+||..+| .+|+|++|+|+|.+-
T Consensus 440 ~~~--~~~~-~~~~-~~~r~~--------~~~~~~~---~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f 503 (507)
T PLN03224 440 NTE--LRQY-DNDL-NRWRMY--------KGQKYDF---SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF 503 (507)
T ss_pred hhH--Hhhc-cchH-HHHHhh--------cccCCCc---ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence 110 0000 0000 000000 0000000 0112235689999999999876 689999999999654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=276.95 Aligned_cols=263 Identities=22% Similarity=0.247 Sum_probs=193.1
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
-|..++.||-|+||.|.++.. ....+|.|..+.+.. ..++-..-+..|-.||.....+-||++|-.|.+.+.+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDV-----l~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADV-----LMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHH-----HhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 378899999999999999974 555677776432211 1111122347788999999999999999999988765
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
|+||+|++||++..+|-+ ...|.+..++.++..+..|+++.|+.|+|||||||+|||||.+
T Consensus 705 --------------YFVMdYIPGGDmMSLLIr-----mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrd 765 (1034)
T KOG0608|consen 705 --------------YFVMDYIPGGDMMSLLIR-----MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD 765 (1034)
T ss_pred --------------EEEEeccCCccHHHHHHH-----hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccC
Confidence 999999999999999976 4678999999999999999999999999999999999999998
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccC--------------------------------CCCCCCcccCCCccc
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR--------------------------------GIPAPDVCVGTPRWM 711 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~--------------------------------~~~~~~~~vGT~~Ym 711 (840)
+.+||+|||++.-+.-......+... ........+||+.|+
T Consensus 766 -------GHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyi 838 (1034)
T KOG0608|consen 766 -------GHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYI 838 (1034)
T ss_pred -------CceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCccc
Confidence 56999999998643211111111000 000112458999999
Q ss_pred chhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCcchHHhhhccCccccccccCCCC
Q 003185 712 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGF 790 (840)
Q Consensus 712 APEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~ 790 (840)
|||++.. ..++.-+|.||.|||||||+.|++||...++.+....|.+. ....++
T Consensus 839 apevl~r----~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~--------------------- 893 (1034)
T KOG0608|consen 839 APEVLAR----TGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIP--------------------- 893 (1034)
T ss_pred ChHHhcc----cCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccc---------------------
Confidence 9999986 67899999999999999999999999877665544444332 111111
Q ss_pred CCchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHHHHHHH
Q 003185 791 EKPEAELETLSFLVDVFRRCTEENPTERP---TAGDLYEMFV 829 (840)
Q Consensus 791 ~~~~~~~~~s~~L~dLI~rCL~~DP~eRP---Sa~ELLehLe 829 (840)
...+.+.++.+||.++.. +++.|. -+++|..|.+
T Consensus 894 ----~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpf 930 (1034)
T KOG0608|consen 894 ----YQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPF 930 (1034)
T ss_pred ----cccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCcc
Confidence 112335567778777544 677775 3556766643
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=264.23 Aligned_cols=279 Identities=19% Similarity=0.201 Sum_probs=205.0
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
-.+|.-...+|.|.- .|-.|.+ .+..||+|........ .... ++..+|..++..+.|+||++++.+|....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n--~~~a----kra~rel~l~~~v~~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN--QTHA----KRAYRELKLMKCVNHKNIISLLNVFTPQK 88 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc--Cccc----hhhhhhhhhhhhhcccceeeeeeccCccc
Confidence 357788888999988 6666665 6677777765433222 2222 23389999999999999999999987554
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
.+ ......|+||||+. .+|.+.+.. .++-+++..|+.|++.|++|||+.||+||||||+||++.
T Consensus 89 ~l--------~~~~e~y~v~e~m~-~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~ 152 (369)
T KOG0665|consen 89 TL--------EEFQEVYLVMELMD-ANLCQVILM-------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN 152 (369)
T ss_pred cH--------HHHHhHHHHHHhhh-hHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec
Confidence 32 23446799999997 599999873 477789999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +++||.|||+|+...... ..+.++.|..|.|||++.+ ..+.+.+||||+||++.||
T Consensus 153 ~~-------~~lKi~dfg~ar~e~~~~-----------~mtpyVvtRyyrapevil~----~~~ke~vdiwSvGci~gEl 210 (369)
T KOG0665|consen 153 SD-------CTLKILDFGLARTEDTDF-----------MMTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGEL 210 (369)
T ss_pred ch-------hheeeccchhhcccCccc-----------ccCchhheeeccCchheec----cCCcccchhhhhhhHHHHH
Confidence 87 679999999998654321 1234578999999999997 4488999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcc------c---------cccccCCCCCCchhhhhhHHHHHHH
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE------H---------EVAQSGSGFEKPEAELETLSFLVDV 806 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~------~---------~~~~~~~~~~~~~~~~~~s~~L~dL 806 (840)
++|...|.+.+..+.+.++.......-+..+.++..... + .+++..... ..+........+.+|
T Consensus 211 i~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~-~~e~~~~~~~~ardl 289 (369)
T KOG0665|consen 211 ILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPV-VLEGSKLDCSLARDL 289 (369)
T ss_pred hhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccc-cccCCccchHHHHHH
Confidence 999999999887776666654422222222222211000 0 011110000 011112345678999
Q ss_pred HHHhcccCCCCCCCHHHHHHHH
Q 003185 807 FRRCTEENPTERPTAGDLYEMF 828 (840)
Q Consensus 807 I~rCL~~DP~eRPSa~ELLehL 828 (840)
+.+||..||++|.+++++|.|.
T Consensus 290 l~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 290 LSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HHHhhccChhhcccHHHHhcCC
Confidence 9999999999999999999984
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=261.66 Aligned_cols=261 Identities=22% Similarity=0.316 Sum_probs=209.6
Q ss_pred CCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEE
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 577 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~ 577 (840)
.++++...+-+|.||.||+|.|.. +.+.+|.+ +. ..+.-... .++.|.-++..+.|||+.++.+++
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTv--k~-~AS~iQv~----~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTV--KQ-HASQIQVN----LLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHH--Hh-cccHHHHH----HHHHHHHHHhcCcCCCccceeEEE
Confidence 457788889999999999997732 23444432 21 12222333 448999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHh---ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCC
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS---ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~---~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLK 654 (840)
.++... +++++.+..-|+|..|+.... ....+.++..+...++.|++.|++|||++||||.||-
T Consensus 357 ie~~~~-------------P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiA 423 (563)
T KOG1024|consen 357 IEDYAT-------------PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIA 423 (563)
T ss_pred eeccCc-------------ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhh
Confidence 876543 489999999999999998422 2234567778889999999999999999999999999
Q ss_pred CCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHH
Q 003185 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 734 (840)
Q Consensus 655 PeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSL 734 (840)
..|.+|+.. .+|||+|=.+++.+-.....+ ..+.. .....||+||.+.. ..|+.++|||||
T Consensus 424 aRNCvIdd~-------LqVkltDsaLSRDLFP~DYhc-LGDnE-------nRPvkWMslEal~n----~~yssasDvWsf 484 (563)
T KOG1024|consen 424 ARNCVIDDQ-------LQVKLTDSALSRDLFPGDYHC-LGDNE-------NRPVKWMSLEALQN----SHYSSASDVWSF 484 (563)
T ss_pred hhcceehhh-------eeEEeccchhccccCcccccc-cCCCC-------CCcccccCHHHHhh----hhhcchhhhHHH
Confidence 999999876 679999999998776544332 22211 24578999999986 789999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 003185 735 GCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 813 (840)
Q Consensus 735 GvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~ 813 (840)
||+||||+| |+.||...++.++...+..+.+..-| .++++++..++.-||..
T Consensus 485 GVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP---------------------------~NCPDeLf~vMacCWal 537 (563)
T KOG1024|consen 485 GVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQP---------------------------FNCPDELFTVMACCWAL 537 (563)
T ss_pred HHHHHHHHhcCCCCccccCHHHHHHHHhccceecCC---------------------------CCCcHHHHHHHHHHHhc
Confidence 999999999 99999999999999999998764333 34578999999999999
Q ss_pred CCCCCCCHHHHHHHHHhh
Q 003185 814 NPTERPTAGDLYEMFVAR 831 (840)
Q Consensus 814 DP~eRPSa~ELLehLe~l 831 (840)
.|++||+++|+...|...
T Consensus 538 lpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 538 LPEERPSFSQLVICLSEF 555 (563)
T ss_pred CcccCCCHHHHHHHHHHH
Confidence 999999999999988764
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=260.70 Aligned_cols=253 Identities=22% Similarity=0.357 Sum_probs=195.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~ 578 (840)
..+++|.++..||+|+|+.|.+++. ..+-+|+|+++....+. .+++ ..+..|-.++.+. +||.+|-++.+|.
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nd-dedi----dwvqtek~vfe~asn~pflvglhscfq 321 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVND-DEDI----DWVQTEKHVFEQASNNPFLVGLHSCFQ 321 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCC-cccc----hhHHhhHHHHHhccCCCeEEehhhhhc
Confidence 5678999999999999999999987 56788999865443222 2222 2346677777776 4999999999999
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
++..+ ++|.||++||+|.-.+.+ ..+++++.++.+...|..||.|||++|||.||||.+|+
T Consensus 322 tesrl--------------ffvieyv~ggdlmfhmqr-----qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnv 382 (593)
T KOG0695|consen 322 TESRL--------------FFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNV 382 (593)
T ss_pred ccceE--------------EEEEEEecCcceeeehhh-----hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccce
Confidence 87754 999999999999877765 36799999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.. +.+||+|+|+++.--....+ ..+++|||.|.|||++++ ..|++.+|.|+|||++
T Consensus 383 lldae-------ghikltdygmcke~l~~gd~----------tstfcgtpnyiapeilrg----eeygfsvdwwalgvlm 441 (593)
T KOG0695|consen 383 LLDAE-------GHIKLTDYGMCKEGLGPGDT----------TSTFCGTPNYIAPEILRG----EEYGFSVDWWALGVLM 441 (593)
T ss_pred EEccC-------CceeecccchhhcCCCCCcc----------cccccCCCcccchhhhcc----cccCceehHHHHHHHH
Confidence 99988 56999999999764332221 345789999999999997 7899999999999999
Q ss_pred HHHHhCCCCCCC-------CCHHH-HHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 003185 739 LELLTLQVPYMG-------LSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 810 (840)
Q Consensus 739 ~ELLTG~~PF~~-------~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rC 810 (840)
+||+.|+.||.- .+..+ +++.|... .-.+|..+ +-....+++..
T Consensus 442 femmagrspfdivgm~n~d~ntedylfqvilek-qiriprsl---------------------------svkas~vlkgf 493 (593)
T KOG0695|consen 442 FEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK-QIRIPRSL---------------------------SVKASHVLKGF 493 (593)
T ss_pred HHHHcCCCCcceecCCCcccchhHHHHHHHhhh-ccccccee---------------------------ehhhHHHHHHh
Confidence 999999999942 12222 22333222 11222211 22456788999
Q ss_pred cccCCCCCC------CHHHHHHH
Q 003185 811 TEENPTERP------TAGDLYEM 827 (840)
Q Consensus 811 L~~DP~eRP------Sa~ELLeh 827 (840)
|++||.+|. .+.++..|
T Consensus 494 lnkdp~erlgc~~~~g~~dik~h 516 (593)
T KOG0695|consen 494 LNKDPKERLGCRPQTGFSDIKSH 516 (593)
T ss_pred hcCCcHHhcCCCcccchhhhhcc
Confidence 999999995 35555555
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-29 Score=286.68 Aligned_cols=256 Identities=29% Similarity=0.437 Sum_probs=212.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
.+-++|++.+.+|.|+||.||+|++ .+..+|+|++++... +.+..+ .+|+-+++..+|||||.++|.|..
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~----dd~~~i----qqei~~~~dc~h~nivay~gsylr 83 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG----DDFSGI----QQEIGMLRDCRHPNIVAYFGSYLR 83 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCC----cccccc----ccceeeeecCCCcChHHHHhhhhh
Confidence 3456899999999999999999997 678999999887653 233333 789999999999999999999887
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
...+ ||+||||.||+|.+.-+- ...+++.++..+.+..++||+|||+.|-+|||||-.|||
T Consensus 84 ~dkl--------------wicMEycgggslQdiy~~-----TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanil 144 (829)
T KOG0576|consen 84 RDKL--------------WICMEYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANIL 144 (829)
T ss_pred hcCc--------------EEEEEecCCCcccceeee-----cccchhHHHHHHHhhhhccchhhhcCCccccccccccee
Confidence 6654 999999999999987653 467999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++..++ +||.|||.+-.+..... ....+.||+.|||||+..- ...+.|+..+|||++|+...
T Consensus 145 ltd~gD-------vklaDfgvsaqitati~----------KrksfiGtpywmapEvaav-erkggynqlcdiwa~gitAi 206 (829)
T KOG0576|consen 145 LTDEGD-------VKLADFGVSAQITATIA----------KRKSFIGTPYWMAPEVAAV-ERKGGYNQLCDIWALGITAI 206 (829)
T ss_pred ecccCc-------eeecccCchhhhhhhhh----------hhhcccCCccccchhHHHH-Hhcccccccccccccccchh
Confidence 998854 99999999876654322 2456789999999999753 23467899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCC--CCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKR--PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~--p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
||-..++|.....+++....+.+... |.+.+. ....+.+.+|++.+|..+|++
T Consensus 207 el~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk-------------------------~kws~~fh~fvK~altknpKk 261 (829)
T KOG0576|consen 207 ELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDK-------------------------TKWSEFFHNFVKGALTKNPKK 261 (829)
T ss_pred hhhhcCCcccccchHHHHHHhhccCCCCCcccCC-------------------------ccchHHHHHHHHHHhcCCCcc
Confidence 99999999888888888777766522 222211 112567899999999999999
Q ss_pred CCCHHHHHHH
Q 003185 818 RPTAGDLYEM 827 (840)
Q Consensus 818 RPSa~ELLeh 827 (840)
||+++.+|.|
T Consensus 262 RptaeklL~h 271 (829)
T KOG0576|consen 262 RPTAEKLLQH 271 (829)
T ss_pred CCChhhheec
Confidence 9999998876
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=232.48 Aligned_cols=212 Identities=34% Similarity=0.498 Sum_probs=175.5
Q ss_pred ecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCCCC
Q 003185 513 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 590 (840)
Q Consensus 513 LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g~~ 590 (840)
||+|++|.||++... +..+++|++....... ....+.+|+.+++.++|++|+++++++....
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--------- 64 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-------LLEELLREIEILKKLNHPNIVKLYGVFEDEN--------- 64 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCC---------
Confidence 689999999999986 8899999976442211 1234489999999999999999999987653
Q ss_pred ccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec-ccccCCC
Q 003185 591 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL-ERKKADG 669 (840)
Q Consensus 591 ~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~-~~~~~~~ 669 (840)
..+++|||+.+++|.+++... ...++...++.++.+++.+|.+||+.|++|+||+|.||+++. +
T Consensus 65 -----~~~~~~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~------ 129 (215)
T cd00180 65 -----HLYLVMEYCEGGSLKDLLKEN----EGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDN------ 129 (215)
T ss_pred -----eEEEEEecCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCC------
Confidence 359999999999999999761 136889999999999999999999999999999999999997 4
Q ss_pred CCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003185 670 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 749 (840)
Q Consensus 670 ~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~ 749 (840)
..++|+|||.+........ ......+...|++||.+... ..++.+.|+|++|+++++|
T Consensus 130 -~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~~~~pe~~~~~---~~~~~~~D~~~lg~~~~~l-------- 187 (215)
T cd00180 130 -GKVKLADFGLSKLLTSDKS----------LLKTIVGTPAYMAPEVLLGK---GYYSEKSDIWSLGVILYEL-------- 187 (215)
T ss_pred -CcEEEecCCceEEccCCcc----------hhhcccCCCCccChhHhccc---CCCCchhhhHHHHHHHHHH--------
Confidence 4699999999976644221 01223578899999998751 2678899999999999999
Q ss_pred CCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003185 750 GLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828 (840)
Q Consensus 750 ~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehL 828 (840)
..+.+++.+|+..+|.+||++.+++++|
T Consensus 188 ---------------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---------------------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---------------------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 0478899999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=272.40 Aligned_cols=210 Identities=26% Similarity=0.347 Sum_probs=169.4
Q ss_pred CCCCCCCCceeeeeecccCceEEEEEEECC--eeEEEEEEecccCCCChHHHH-HhHHhHHHHHHHHHhCC---CCCcce
Q 003185 499 LDPGSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIR-NFEYSCLGEVRMLGALR---HSCIVE 572 (840)
Q Consensus 499 ~~p~~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKI~~lk~~~~~~~~~~-~f~~~~~rEi~iL~~L~---HpNIV~ 572 (840)
..+.-+.+|...+.||.|+||.|++|.++. ..|++|.+........ ..++ .-.-.+-.||.||..|+ |+||++
T Consensus 555 ~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~D-tWvrDrkLGtVp~EIqIla~l~~~sH~NIlK 633 (772)
T KOG1152|consen 555 KEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVD-TWVRDRKLGTVPSEIQILATLNKHSHENILK 633 (772)
T ss_pred eeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhh-hhhcccccCccchhHHHHHHhhhcCccchhh
Confidence 345677889999999999999999999844 4566665432221110 0000 00013367999999998 999999
Q ss_pred eeeEEecCCCCCCCCCCCccccceEEEEEecc-CCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Q 003185 573 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYV-KGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 651 (840)
Q Consensus 573 l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~-~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHR 651 (840)
++++|++++++ ||+||-- +|.+|.++|.. ...+++.++..|++||+.|+++||++|||||
T Consensus 634 lLdfFEddd~y--------------yl~te~hg~gIDLFd~IE~-----kp~m~E~eAk~IFkQV~agi~hlh~~~ivhr 694 (772)
T KOG1152|consen 634 LLDFFEDDDYY--------------YLETEVHGEGIDLFDFIEF-----KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHR 694 (772)
T ss_pred hhheeecCCee--------------EEEecCCCCCcchhhhhhc-----cCccchHHHHHHHHHHHhccccccccCceec
Confidence 99999988866 9999975 46699999986 4679999999999999999999999999999
Q ss_pred cCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhH
Q 003185 652 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 731 (840)
Q Consensus 652 DLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDV 731 (840)
|||-+|+.++.+ +.+||+|||.|...... +...++||..|.|||++.+ ....+..-||
T Consensus 695 dikdenvivd~~-------g~~klidfgsaa~~ksg------------pfd~f~gtv~~aapevl~g---~~y~gk~qdi 752 (772)
T KOG1152|consen 695 DIKDENVIVDSN-------GFVKLIDFGSAAYTKSG------------PFDVFVGTVDYAAPEVLGG---EKYLGKPQDI 752 (772)
T ss_pred ccccccEEEecC-------CeEEEeeccchhhhcCC------------CcceeeeeccccchhhhCC---CccCCCcchh
Confidence 999999999987 56999999998765432 2356789999999999987 3456889999
Q ss_pred HHHHHHHHHHHhCCCCCCC
Q 003185 732 WSYGCLLLELLTLQVPYMG 750 (840)
Q Consensus 732 WSLGvIL~ELLTG~~PF~~ 750 (840)
|++|++||.++....||.+
T Consensus 753 walgillytivykenpyyn 771 (772)
T KOG1152|consen 753 WALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhheeeEEEeccCCCcC
Confidence 9999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-26 Score=231.45 Aligned_cols=214 Identities=32% Similarity=0.447 Sum_probs=172.4
Q ss_pred ceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 584 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p 584 (840)
|.+.+.||.|++|.||++... +..+++|+....... .. ...+.+|+..+++++|+||+++++++.....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~----~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~-- 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQ----REEFLREIRILKKLKHPNIVKLYGVFEDPEP-- 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HH----HHHHHHHHHHHHhCCCCChhhheeeeecCCc--
Confidence 567899999999999999984 588999987543221 12 2345889999999999999999999876543
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCC-CCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 585 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 585 ~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~-ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.+++|||+++++|.+++.. ... +++..+..++.+++.+|.+||+++++|+||+|.||+++.+
T Consensus 72 ------------~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~ 134 (225)
T smart00221 72 ------------LYLVMEYCEGGDLFDYLRK-----KGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD 134 (225)
T ss_pred ------------eEEEEeccCCCCHHHHHHh-----cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 4999999999999999986 123 7899999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
..++|+|||.+......... ......++..|++||.+. ....++.++|||+||+++++|++
T Consensus 135 -------~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~~~~pe~~~---~~~~~~~~~Dv~~lG~~~~~l~~ 195 (225)
T smart00221 135 -------GLVKLADFGLARFIHRDLAA---------LLKTVKGTPFYLAPEVLL---GGKGYGEAVDIWSLGVILYELLW 195 (225)
T ss_pred -------CCEEEeeCceeeEecCcccc---------cccceeccCCcCCHhHhc---CCCCCCchhhHHHHHHHHHHHHH
Confidence 45999999998876442200 112345788999999984 23567779999999999999999
Q ss_pred CCCCCCC-C-CHHHHHHHHHcCCC
Q 003185 744 LQVPYMG-L-SELEIHDLIQMGKR 765 (840)
Q Consensus 744 G~~PF~~-~-~~~el~~~I~~~~~ 765 (840)
|+.||.. . +...+...+.++..
T Consensus 196 g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 196 GPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred CCCCccccchhHHHHHHHHhcCCc
Confidence 9999977 3 44467777776643
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-27 Score=254.48 Aligned_cols=287 Identities=24% Similarity=0.300 Sum_probs=196.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYG 575 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g 575 (840)
...+.|.++++||.|.|++||++.+ ....||+|-+.... . ..++..|+++|..+. +.||+.+.+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~--------p~ri~~El~~L~~~gG~~ni~~~~~ 102 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--S--------PSRILNELEMLYRLGGSDNIIKLNG 102 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--C--------chHHHHHHHHHHHhccchhhhcchh
Confidence 3456789999999999999999975 45688888754332 1 123488999999997 999999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCC
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 655 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKP 655 (840)
++...+. ..+||||++.....++... ++...+..+++.++.||.++|.+|||||||||
T Consensus 103 ~~rnnd~--------------v~ivlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKp 160 (418)
T KOG1167|consen 103 CFRNNDQ--------------VAIVLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKP 160 (418)
T ss_pred hhccCCe--------------eEEEecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccCccccCCCc
Confidence 9886664 4999999999999999875 77899999999999999999999999999999
Q ss_pred CcEEEecccccCCCCCeEEEeecCCcccccccccc-cccc---------------------------------cCCCCCC
Q 003185 656 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT-CCIA---------------------------------HRGIPAP 701 (840)
Q Consensus 656 eNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~-~~~~---------------------------------~~~~~~~ 701 (840)
.|+|.+... ..-.|+|||+|......... .... .......
T Consensus 161 sNFL~n~~t------~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~ 234 (418)
T KOG1167|consen 161 SNFLYNRRT------QRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSER 234 (418)
T ss_pred ccccccccc------CCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCcccee
Confidence 999998764 45789999999732211100 0000 0000011
Q ss_pred CcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHc--------------CC--
Q 003185 702 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL-SELEIHDLIQM--------------GK-- 764 (840)
Q Consensus 702 ~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~-~~~el~~~I~~--------------~~-- 764 (840)
-...||++|.|||++... ...++++||||.|||+.-+++++.||... ++...+..|.. +.
T Consensus 235 anrAGT~GfRaPEvL~k~---~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~ 311 (418)
T KOG1167|consen 235 ANRAGTPGFRAPEVLFRC---PRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRIL 311 (418)
T ss_pred cccCCCCCCCchHHHhhc---cCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCcee
Confidence 134799999999999863 44588999999999999999999999432 22111111110 01
Q ss_pred ------CCCcchHHhhhccCccccccccCC-CCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003185 765 ------RPRLTDELEALGSCHEHEVAQSGS-GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 765 ------~p~l~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe 829 (840)
.+.+++..-.+.......+....- ...........+..+.+|+.+||..||.+|.||++.|+|..
T Consensus 312 l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpF 383 (418)
T KOG1167|consen 312 LWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPF 383 (418)
T ss_pred eeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcC
Confidence 011111111111110000000000 00011111223447899999999999999999999999853
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.6e-26 Score=276.28 Aligned_cols=223 Identities=13% Similarity=0.148 Sum_probs=148.7
Q ss_pred HHhCCC-CCcceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHH
Q 003185 562 LGALRH-SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAAL 640 (840)
Q Consensus 562 L~~L~H-pNIV~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL 640 (840)
.+.+.| +||+.++++|..... ++ .....++++|||+. ++|.++|.. ....+++..++.+++||+.||
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~----~~---~~~~~~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al 93 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNL----DG---LDDDSIVRALECED-VSLRQWLDN----PDRSVDAFECFHVFRQIVEIV 93 (793)
T ss_pred cchhhHHHHHHHhhcccCCccc----cc---cccchhhhhhccCC-ccHHHHHhc----ccccccHHHHHHHHHHHHHHH
Confidence 445566 688888888743221 00 01123578889885 699999974 235699999999999999999
Q ss_pred HHHHhCCeecccCCCCcEEEeccccc------------CCCCCeEEEeecCCcccccccccc---cccccCC---CCCCC
Q 003185 641 VELHSKHIMHRDIKSENILIDLERKK------------ADGKPVVKLCDFDRAVPLRSFLHT---CCIAHRG---IPAPD 702 (840)
Q Consensus 641 ~yLHs~gIVHRDLKPeNILLd~~~~~------------~~~~~~vKL~DFGlA~~~~~~~~~---~~~~~~~---~~~~~ 702 (840)
.|||++|||||||||+||||+..+.. ......+||+|||+++........ ....... .....
T Consensus 94 ~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (793)
T PLN00181 94 NAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQI 173 (793)
T ss_pred HHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccccc
Confidence 99999999999999999999653210 012345788888887653211000 0000000 00112
Q ss_pred cccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcccc
Q 003185 703 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE 782 (840)
Q Consensus 703 ~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~ 782 (840)
..+||+.|||||++.+ ..++.++|||||||+||||++|..|+.... .....+.....+. ..
T Consensus 174 ~~~gt~~Y~APE~~~~----~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~---~~---------- 234 (793)
T PLN00181 174 LAMEMSWYTSPEEDNG----SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPP---QI---------- 234 (793)
T ss_pred ccCCCcceEChhhhcc----CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcCh---hh----------
Confidence 2468999999999886 568999999999999999999988875321 1222221111110 00
Q ss_pred ccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003185 783 VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 783 ~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe 829 (840)
........+++.+||.++|.+||++.||++|..
T Consensus 235 --------------~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~ 267 (793)
T PLN00181 235 --------------LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEF 267 (793)
T ss_pred --------------hhcCHHHHHHHHHhCCCChhhCcChHHHhhchh
Confidence 001224568889999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-25 Score=216.96 Aligned_cols=169 Identities=24% Similarity=0.286 Sum_probs=127.7
Q ss_pred CCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccc
Q 003185 607 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 686 (840)
Q Consensus 607 GSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~ 686 (840)
|+|.+++.. ....+++..++.|+.||+.||.|||+++ ||+|||++.+ +.+|+ ||++.....
T Consensus 1 GsL~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~-------~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEV----RGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWD-------GLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCc-------cceee--ccceEeecc
Confidence 689999975 2346999999999999999999999999 9999999877 45888 999876533
Q ss_pred cccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCC
Q 003185 687 FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE-LEIHDLIQMGKR 765 (840)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~-~el~~~I~~~~~ 765 (840)
. ...||+.|||||++.+ ..++.++|||||||++|||+||+.||..... ......+.....
T Consensus 62 ~---------------~~~g~~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 122 (176)
T smart00750 62 E---------------QSRVDPYFMAPEVIQG----QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP 122 (176)
T ss_pred c---------------cCCCcccccChHHhcC----CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc
Confidence 1 1148999999999986 6688999999999999999999999965533 223333332221
Q ss_pred CCcchHHhhhccCccccccccCCCCCCchhhhhhH--HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 003185 766 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL--SFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 766 p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~~ 834 (840)
+..+.. ........ ..+.++|.+||..+|.+||++.++++|+..+...
T Consensus 123 ~~~~~~---------------------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 123 ADDPRD---------------------RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred cCCccc---------------------cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 111100 00011122 2689999999999999999999999999877543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=231.90 Aligned_cols=248 Identities=19% Similarity=0.226 Sum_probs=182.7
Q ss_pred CCCceeeeeecccCceEEEEEEECC--eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEe-c
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI-S 579 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~-~ 579 (840)
.+.|.+.+.||+|.||.+-+|.+++ +.+++|.+.. .....++| .+|...--.|. |.||+..|++-. +
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-----p~tt~~dF----~rEfhY~~~Ls~H~hIi~tY~vaFqt 93 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-----PQTTQADF----VREFHYSFFLSPHQHIIDTYEVAFQT 93 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-----chhhHHHH----HHHhccceeeccchhhhHHHHHHhhc
Confidence 3578999999999999999999854 5666666432 22334455 88887655665 999999887543 3
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.+. .+++|||++.|+|.+-+.. ..+.+....+++.|+++||.|+|++++||||||.+|||
T Consensus 94 ~d~--------------YvF~qE~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiL 153 (378)
T KOG1345|consen 94 SDA--------------YVFVQEFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENIL 153 (378)
T ss_pred Cce--------------EEEeeccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEE
Confidence 332 4899999999999988764 45888899999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC-CCCCCchhhHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~-~~~~s~kSDVWSLGvIL 738 (840)
|...+ ...|||||||+.+..+..... .--+..|.+||....... .....+.+|||.||+++
T Consensus 154 if~~d-----f~rvKlcDFG~t~k~g~tV~~-------------~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~ 215 (378)
T KOG1345|consen 154 IFDAD-----FYRVKLCDFGLTRKVGTTVKY-------------LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIF 215 (378)
T ss_pred EecCC-----ccEEEeeecccccccCceehh-------------hhhhcccCCcHHHhhccccceEecccccchheeeee
Confidence 97663 357999999999876543221 124567999998764322 12357889999999999
Q ss_pred HHHHhCCCCCCCCCH----HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003185 739 LELLTLQVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 814 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~----~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~D 814 (840)
|.++||.+||+.... .--+.+..+...+.+|+. ....++.+..++++-|..+
T Consensus 216 f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~------------------------F~~fs~~a~r~Fkk~lt~~ 271 (378)
T KOG1345|consen 216 FYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKK------------------------FNPFSEKALRLFKKSLTPR 271 (378)
T ss_pred eeeecCCCcchhhhccCchHHHHHHHhcccCccCchh------------------------hcccCHHHHHHHHHhcCCc
Confidence 999999999974321 112233333444444432 2233567888999999999
Q ss_pred CCCCCCHH
Q 003185 815 PTERPTAG 822 (840)
Q Consensus 815 P~eRPSa~ 822 (840)
|++|-..-
T Consensus 272 ~~drcki~ 279 (378)
T KOG1345|consen 272 FKDRCKIW 279 (378)
T ss_pred ccccchhH
Confidence 99993333
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-22 Score=223.43 Aligned_cols=272 Identities=21% Similarity=0.214 Sum_probs=196.0
Q ss_pred CceeeeeecccCceEEEEEEECC---eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC----CCcceeeeEEe
Q 003185 506 SLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH----SCIVEMYGHKI 578 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~---~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~H----pNIV~l~g~~~ 578 (840)
+|.+.++||+|+||.||.+.... ..+|+|+.......... .+..|+.++..+.. +++..+++.+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--------~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--------VLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--------cchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 89999999999999999999744 36888887643222111 12668888888873 68899988874
Q ss_pred -cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 579 -SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 579 -~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
...+ .||||+.+ |.+|.++.... +...++..++..|+.|++.+|.+||+.|++||||||+|
T Consensus 91 ~~~~~--------------~~iVM~l~-G~sL~dl~~~~---~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N 152 (322)
T KOG1164|consen 91 STEDF--------------NFIVMSLL-GPSLEDLRKRN---PPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPEN 152 (322)
T ss_pred CCCce--------------eEEEEecc-CccHHHHHHhC---CCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHH
Confidence 3332 49999999 68999988652 24789999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcc--cccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAV--PLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~--~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLG 735 (840)
+++..... .....+.|.|||+++ .+....... ..........+.||..|+++.+..+ ...+.+.|+||++
T Consensus 153 ~~~g~~~~--~~~~~~~llDfGlar~~~~~~~~~~~--~~~~r~~~~~~rGT~ry~S~~~H~~----~e~~r~DDles~~ 224 (322)
T KOG1164|consen 153 FVVGQSSR--SEVRTLYLLDFGLARRFKYVGDSGGN--LRPPRPQKGLFRGTLRYASINVHLG----IEQGRRDDLESLF 224 (322)
T ss_pred eeecCCCC--cccceEEEEecCCCccccccCCCCcc--cccCCCCccCCCCccccccHHHhCC----CccCCchhhhhHH
Confidence 99986631 112469999999998 332222110 0001111234569999999999887 6678999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 736 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 736 vIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
.++.+|+.|..||.+.........+........... .....+..+..++..+-..+.
T Consensus 225 Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~ 281 (322)
T KOG1164|consen 225 YMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDR-----------------------FGDLKPEEFAKILEYIDSLDY 281 (322)
T ss_pred HHHHHHhcCCCCCccccccchHHHHHHHhhhhcccc-----------------------ccCCChHHHHHHHHHhhccCC
Confidence 999999999999977654332333222211100000 001123466777777777999
Q ss_pred CCCCCHHHHHHHHHhhcCC
Q 003185 816 TERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 816 ~eRPSa~ELLehLe~l~~~ 834 (840)
..+|....+...|+.....
T Consensus 282 ~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 282 EDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred cCCCCHHHHHHHHHHHHHh
Confidence 9999999999998766544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.9e-22 Score=204.44 Aligned_cols=269 Identities=32% Similarity=0.410 Sum_probs=197.5
Q ss_pred ceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCC-CcceeeeEEecCCCCCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKWLPS 585 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~Hp-NIV~l~g~~~~~~~~p~ 585 (840)
|.+.+.||.|+||.||++.+. ..+++|+......... .....+.+|+.++..+.|+ +|+++++.+....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~---- 71 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS-----KEVERFLREIQILASLNHPPNIVKLYDFFQDEG---- 71 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch-----hHHHHHHHHHHHHHHccCCcceeeEEEEEecCC----
Confidence 788999999999999999988 7788888654432221 1233458999999999988 7999999985433
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccc
Q 003185 586 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 665 (840)
Q Consensus 586 ~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~ 665 (840)
..+++++|+.+++|.+++...... ..+.......++.|++.++.|+|..+++||||||+||+++..+
T Consensus 72 ----------~~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~- 138 (384)
T COG0515 72 ----------SLYLVMEYVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDG- 138 (384)
T ss_pred ----------EEEEEEecCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCC-
Confidence 259999999999999777651100 2688999999999999999999999999999999999999773
Q ss_pred cCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCC
Q 003185 666 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 745 (840)
Q Consensus 666 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~ 745 (840)
..++++|||.+............ ........||..|+|||.+.+.. ...+....|+||+|++++++++|.
T Consensus 139 -----~~~~l~dfg~~~~~~~~~~~~~~----~~~~~~~~~t~~~~~pe~~~~~~-~~~~~~~~D~~s~g~~~~~~~~~~ 208 (384)
T COG0515 139 -----RVVKLIDFGLAKLLPDPGSTSSI----PALPSTSVGTPGYMAPEVLLGLS-LAYASSSSDIWSLGITLYELLTGL 208 (384)
T ss_pred -----CeEEEeccCcceecCCCCccccc----cccccccccccccCCHHHhcCCC-CCCCCchHhHHHHHHHHHHHHhCC
Confidence 15999999999855432211000 01134567999999999997511 135788999999999999999999
Q ss_pred CCCCCCCH----HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 746 VPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 746 ~PF~~~~~----~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
.||..... ......+.....+....... ..........+.+++.+|+..+|..|.+.
T Consensus 209 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~~~r~~~ 269 (384)
T COG0515 209 PPFEGEKNSSATSQTLKIILELPTPSLASPLS-------------------PSNPELISKAASDLLKKLLAKDPKNRLSS 269 (384)
T ss_pred CCCCCCCccccHHHHHHHHHhcCCcccccccC-------------------ccccchhhHHHHHHHHHHHhcCchhcCCH
Confidence 99876653 44444444443220000000 00001223578899999999999999999
Q ss_pred HHHHHH
Q 003185 822 GDLYEM 827 (840)
Q Consensus 822 ~ELLeh 827 (840)
.+...+
T Consensus 270 ~~~~~~ 275 (384)
T COG0515 270 SSDLSH 275 (384)
T ss_pred HHHhhc
Confidence 887775
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.2e-22 Score=209.76 Aligned_cols=224 Identities=23% Similarity=0.286 Sum_probs=179.7
Q ss_pred CCceeeeeecccCceEEEEEE--ECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEecCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCK--FGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 581 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~--~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~~~ 581 (840)
..|.++++||+|+||.++.|+ +++..||+|....+.. .. ++..|.+..+.|. .++|..+|-+..+..
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~---AP-------QLrdEYr~YKlL~g~~GIP~vYYFGqeG~ 97 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE---AP-------QLRDEYRTYKLLGGTEGIPQVYYFGQEGK 97 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC---cc-------hHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence 579999999999999999998 4999999998655431 22 2266888888886 799999987766544
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
+- .||||++ |.||.+++.- .+..|+.+++..++.|++.-++|+|.+.+|.|||||+|+||.
T Consensus 98 ~N--------------iLVidLL-GPSLEDLFD~----CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIG 158 (449)
T KOG1165|consen 98 YN--------------ILVIDLL-GPSLEDLFDL----CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIG 158 (449)
T ss_pred hh--------------hhhhhhh-CcCHHHHHHH----hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeec
Confidence 32 8999999 6899999874 567899999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
..+. .....+.|+|||+|+.+.+..... +..........||..||+--...+ ..-+.+-|+-|||-++...
T Consensus 159 rp~~--k~~n~IhiiDFGmAK~YrDp~Tkq---HIPYrE~KSLsGTARYMSINTHlG----rEQSRRDDLEaLGHvFmYF 229 (449)
T KOG1165|consen 159 RPGT--KDANVIHIIDFGMAKEYRDPKTKQ---HIPYREHKSLSGTARYMSINTHLG----REQSRRDDLEALGHVFMYF 229 (449)
T ss_pred CCCC--CCCceEEEEeccchhhhcCccccc---cCccccccccccceeeeEeecccc----chhhhhhhHHHhhhhhhhh
Confidence 7643 233569999999999887655432 222333456779999999888776 5568899999999999999
Q ss_pred HhCCCCCCCCC---HHHHHHHHHcCCCC
Q 003185 742 LTLQVPYMGLS---ELEIHDLIQMGKRP 766 (840)
Q Consensus 742 LTG~~PF~~~~---~~el~~~I~~~~~p 766 (840)
|-|.+||++.. ..+-++.|...++.
T Consensus 230 LRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 230 LRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred ccCCCccccccCcchHHHHHHhcccccc
Confidence 99999999864 44556667665443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.7e-22 Score=201.65 Aligned_cols=222 Identities=18% Similarity=0.205 Sum_probs=173.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC-CCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~H-pNIV~l~g~~~ 578 (840)
+..++|.++++||.|+||.+|+|.. .+..||+|+...+... + ++..|..+...|++ ..|..+..++.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h---p-------qL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH---P-------QLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC---c-------chhHHHHHHHHhccCCCCchhhhhcc
Confidence 5678999999999999999999985 8899999986543221 1 22678999999984 66666666665
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
+...- .+||+++ |.||.+++.- ....++..+++.++-|++.-++|+|.+++|||||||+|+
T Consensus 82 e~~yn--------------vlVMdLL-GPsLEdLfnf----C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNF 142 (341)
T KOG1163|consen 82 EKDYN--------------VLVMDLL-GPSLEDLFNF----CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNF 142 (341)
T ss_pred ccccc--------------eeeeecc-CccHHHHHHH----HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccce
Confidence 54432 8999999 6899999874 346799999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|..-+. ....+.|+|||+|+.+.+..... +.+........||..|.+--...+ ...+.+.|+-|+|.+|
T Consensus 143 LMGlgr----h~~kl~LIDFGLaKky~d~~t~~---HIpyre~r~ltGTaRYASinAh~g----~eqSRRDDmeSvgYvL 211 (341)
T KOG1163|consen 143 LMGLGR----HCNKLYLIDFGLAKKYRDIRTRQ---HIPYREDRNLTGTARYASINAHLG----IEQSRRDDMESVGYVL 211 (341)
T ss_pred eecccc----ccceEEEEeccchhhhccccccc---cCccccCCccceeeeehhhhhhhh----hhhhhhhhhhhhccee
Confidence 997653 23469999999999886543322 222233455679999999887765 3447899999999999
Q ss_pred HHHHhCCCCCCCCCHHH---HHHHHHcC
Q 003185 739 LELLTLQVPYMGLSELE---IHDLIQMG 763 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~e---l~~~I~~~ 763 (840)
..+.-|..||++..... -.+.|...
T Consensus 212 mYfnrG~LPWQglka~tk~QKyEkI~Ek 239 (341)
T KOG1163|consen 212 MYFNRGSLPWQGLKAATKKQKYEKISEK 239 (341)
T ss_pred eeeecCCCcccccchhhHHHHHHHHHHh
Confidence 99999999999986543 44455443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=217.07 Aligned_cols=175 Identities=19% Similarity=0.158 Sum_probs=125.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE---CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcce-eeeEE
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF---GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVE-MYGHK 577 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~---~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~-l~g~~ 577 (840)
...++|.+.+.||+|+||+||+|.+ .+..+|+|+........... .....+.+|+.+|++|+|+||+. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~---~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKP---LARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccH---HHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 4567899999999999999999986 45667888753221100111 12234599999999999999985 4432
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccC-CCC
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI-KSE 656 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDL-KPe 656 (840)
. ..||||||++|++|.. +.. .. ...++.|++.||.|||++||+|||| ||+
T Consensus 91 ---~--------------~~~LVmE~~~G~~L~~-~~~--------~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~ 141 (365)
T PRK09188 91 ---G--------------KDGLVRGWTEGVPLHL-ARP--------HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQ 141 (365)
T ss_pred ---C--------------CcEEEEEccCCCCHHH-hCc--------cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcc
Confidence 1 1399999999999962 211 11 1467899999999999999999999 999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhc
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~ 718 (840)
|||++.+ +.+||+|||+|+.+.......... ....-....+++.|+|||++..
T Consensus 142 NILv~~~-------~~ikLiDFGlA~~~~~~~~~~~~~--~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 142 NWLMGPD-------GEAAVIDFQLASVFRRRGALYRIA--AYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred eEEEcCC-------CCEEEEECccceecccCcchhhhh--hhhhhhhhhccCccCCcccCCh
Confidence 9999765 459999999999775432111100 0011134578899999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-22 Score=238.34 Aligned_cols=268 Identities=18% Similarity=0.178 Sum_probs=190.7
Q ss_pred CCCc-eeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 504 FPSL-SSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 504 ~~~y-~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
+..| .....+|.|++|.|+.+.. .....+.|.+..+ .. ..+....+...+..|+-+-..|.||||+..+..+...
T Consensus 316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~-~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~ 393 (601)
T KOG0590|consen 316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK-PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI 393 (601)
T ss_pred ccccCCccceeeecccCceEEEEecCCCccchhhhhhcc-cC-CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc
Confidence 3445 4577899999998877764 3333444444322 11 2233334444468899999999999998887766644
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
... .-+||||++ +|..++.. ...+....+-.++.|++.|++|||..||.||||||+|+++
T Consensus 394 ~~~--------------~~~mE~~~~-Dlf~~~~~-----~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~ 453 (601)
T KOG0590|consen 394 DGI--------------LQSMEYCPY-DLFSLVMS-----NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV 453 (601)
T ss_pred ccc--------------hhhhhcccH-HHHHHHhc-----ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE
Confidence 322 334999998 99999986 3478999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
... +++||+|||.+....-.... .......++|+..|+|||.+.+ ...-....||||.|+++..
T Consensus 454 ~~~-------g~lki~Dfg~~~vf~~~~e~------~~~~~~g~~gS~pY~apE~~~~---~~ydpr~vDiwS~~ii~~~ 517 (601)
T KOG0590|consen 454 TEN-------GILKIIDFGAASVFRYPWEK------NIHESSGIVGSDPYLAPEVLTG---KEYDPRAVDVWSCGIIYIC 517 (601)
T ss_pred ecC-------CceEEeecCcceeeccCcch------hhhhhcCcccCCcCcCcccccc---cccCcchhhhhhccceEEE
Confidence 988 57999999998765433221 1122345679999999999986 2334578999999999999
Q ss_pred HHhCCCCCCCCCHHHHH-HHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|++|+.||......+.. ........-. ............+...+.+|.+||++||.+|.
T Consensus 518 m~~~~~~Wk~a~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ 577 (601)
T KOG0590|consen 518 MILGRFPWKVAKKSDNSFKTNNYSDQRN--------------------IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRI 577 (601)
T ss_pred EecCCCccccccccccchhhhccccccc--------------------cccChHHHHHhchhhHHHHHHHHccCChhhee
Confidence 99999999654332211 1111100000 00111222344567889999999999999999
Q ss_pred CHHHHHHHHH
Q 003185 820 TAGDLYEMFV 829 (840)
Q Consensus 820 Sa~ELLehLe 829 (840)
|+++|++.-+
T Consensus 578 ti~~i~~d~W 587 (601)
T KOG0590|consen 578 TIEQILNDEW 587 (601)
T ss_pred cHHHHhhChH
Confidence 9999998643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-21 Score=231.36 Aligned_cols=264 Identities=20% Similarity=0.204 Sum_probs=187.8
Q ss_pred CceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 585 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~ 585 (840)
+|...+.||.+.|=.|.+|++....++|||+..+....+.....+ + +.|++ ...++|||.+.+.-+......
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~q---r-L~~ik-~~l~~~pn~lPfqk~~~t~kA--- 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQ---R-LEEIK-FALMKAPNCLPFQKVLVTDKA--- 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHH---H-HHHHH-HHhhcCCcccchHHHHHhhHH---
Confidence 788999999999999999999777799999966554444443333 2 55666 777789999999887665553
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccc
Q 003185 586 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 665 (840)
Q Consensus 586 ~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~ 665 (840)
.|||-+|+.+ +|++.|.. +.-+..-+.+.|+.||+.||.-+|..||+|||||.+||||+.-
T Consensus 96 -----------AylvRqyvkh-nLyDRlST-----RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSW-- 156 (1431)
T KOG1240|consen 96 -----------AYLVRQYVKH-NLYDRLST-----RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSW-- 156 (1431)
T ss_pred -----------HHHHHHHHhh-hhhhhhcc-----chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeee--
Confidence 3899999986 99999975 3557788899999999999999999999999999999999977
Q ss_pred cCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-------CCCCCCchhhHHHHHHHH
Q 003185 666 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-------KPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 666 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-------~~~~~s~kSDVWSLGvIL 738 (840)
.-+.|+||..-+..--+.. ...+-.... ++...-..|.|||.+.... .....+++.||||+||++
T Consensus 157 -----NW~~LtDFAsFKPtYLPeD--NPadf~fFF-DTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCVi 228 (1431)
T KOG1240|consen 157 -----NWLYLTDFASFKPTYLPED--NPADFTFFF-DTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVI 228 (1431)
T ss_pred -----chhhhhcccccCCccCCCC--CcccceEEE-ecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHH
Confidence 3589999987654321111 011111111 1112335799999986411 112267899999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 739 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 739 ~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
+||++ |++||. -.+++.. ..+..-.....+.++ ....+++||..|++.||.+
T Consensus 229 aELf~Eg~PlF~---LSQL~aY-r~~~~~~~e~~Le~I-----------------------ed~~~Rnlil~Mi~rdPs~ 281 (1431)
T KOG1240|consen 229 AELFLEGRPLFT---LSQLLAY-RSGNADDPEQLLEKI-----------------------EDVSLRNLILSMIQRDPSK 281 (1431)
T ss_pred HHHHhcCCCccc---HHHHHhH-hccCccCHHHHHHhC-----------------------cCccHHHHHHHHHccCchh
Confidence 99988 688873 2233222 222111111122111 1225889999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 003185 818 RPTAGDLYEMFVAR 831 (840)
Q Consensus 818 RPSa~ELLehLe~l 831 (840)
|.+|++.|+.-..+
T Consensus 282 RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 282 RLSAEDYLQKYRGL 295 (1431)
T ss_pred ccCHHHHHHhhhcc
Confidence 99999999875443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-21 Score=202.07 Aligned_cols=256 Identities=24% Similarity=0.332 Sum_probs=198.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+++..+.+.-+|.+...|..|+|+|.+.++++|+..... ......+. |..|.-.|+-+.||||+.++|.|...
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~--~t~risrd----fneefp~lrifshpnilpvlgacnsp- 259 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVRE--VTARISRD----FNEEFPALRIFSHPNILPVLGACNSP- 259 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhh--cchhhcch----hhhhCcceeeecCCchhhhhhhccCC-
Confidence 678888899999999999999999999999999965443 33333333 48888889889999999999998744
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-Cee-cccCCCCcEE
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIM-HRDIKSENIL 659 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~-gIV-HRDLKPeNIL 659 (840)
+++.++..|++.|+|+.+++. .....++..++.+++.+|++|++|||+. .++ ---|....++
T Consensus 260 -------------pnlv~isq~mp~gslynvlhe---~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvm 323 (448)
T KOG0195|consen 260 -------------PNLVIISQYMPFGSLYNVLHE---QTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVM 323 (448)
T ss_pred -------------CCceEeeeeccchHHHHHHhc---CccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEE
Confidence 356999999999999999986 3334567889999999999999999997 344 3458888999
Q ss_pred EecccccCCCCCeEEEe--ecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLC--DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~--DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
|+.+ .+++|. |--++.. .....-.|.||+||.++..+. ...-.++|+|||.++
T Consensus 324 ided-------ltarismad~kfsfq-----------------e~gr~y~pawmspealqrkpe-d~n~raadmwsfail 378 (448)
T KOG0195|consen 324 IDED-------LTARISMADTKFSFQ-----------------EVGRAYSPAWMSPEALQRKPE-DLNIRAADMWSFAIL 378 (448)
T ss_pred ecch-------hhhheecccceeeee-----------------ccccccCcccCCHHHHhcCch-hcchhhhhHHHHHHH
Confidence 9987 344443 3222211 011234689999999986322 233568999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~-~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
||||.|...||...++.+.-.+|. .+.++.++. ..+..+..|+.-|+..||.
T Consensus 379 lwel~trevpfadlspmecgmkialeglrv~ipp---------------------------gis~hm~klm~icmnedpg 431 (448)
T KOG0195|consen 379 LWELNTREVPFADLSPMECGMKIALEGLRVHIPP---------------------------GISRHMNKLMNICMNEDPG 431 (448)
T ss_pred HHHhhccccccccCCchhhhhhhhhccccccCCC---------------------------CccHHHHHHHHHHhcCCCC
Confidence 999999999999999988765554 445555552 2255788999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 003185 817 ERPTAGDLYEMFVART 832 (840)
Q Consensus 817 eRPSa~ELLehLe~l~ 832 (840)
+||.++.|+-.|+++.
T Consensus 432 krpkfdmivpilekm~ 447 (448)
T KOG0195|consen 432 KRPKFDMIVPILEKMI 447 (448)
T ss_pred cCCCcceehhhHHHhc
Confidence 9999999999998874
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-20 Score=202.08 Aligned_cols=219 Identities=21% Similarity=0.300 Sum_probs=152.5
Q ss_pred CCCCcceeeeEEecCCCCCCCCCC--------------CccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHH
Q 003185 566 RHSCIVEMYGHKISSKWLPSADGN--------------PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALF 631 (840)
Q Consensus 566 ~HpNIV~l~g~~~~~~~~p~~~g~--------------~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~ 631 (840)
+|||||+++++|.++-.+ -.++. ..-+.-.+|+||.-++. +|.+|+-. ...+.....-
T Consensus 274 ~HPNIvri~~aF~dsv~~-lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~------~~~s~r~~~~ 345 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKV-LPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT------RHRSYRTGRV 345 (598)
T ss_pred CCCCEEeehhhhhhhhcc-CCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc------CCCchHHHHH
Confidence 599999999988765321 00110 00123468999999974 99999975 4577888999
Q ss_pred HHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCccc
Q 003185 632 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 711 (840)
Q Consensus 632 Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~Ym 711 (840)
|+.|+++|+.|||++||.|||||.+||||..+. +.-+.++|+|||++---......-..... .-..-|.-.-|
T Consensus 346 ~laQlLEav~hL~~hgvAhRDlKSDNiL~Eldd---D~~P~LVvaDFGCcLAd~~hGlqlpy~S~----~Vd~GGNa~lm 418 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHKHGVAHRDLKSDNILLELDD---DEIPQLVVADFGCCLADDNHGLQLPYESD----EVDLGGNAKLM 418 (598)
T ss_pred HHHHHHHHHHHHHHccchhhcccccceEEEecC---CCCcEEEEcccceeeeccccccccccccc----cccCCCcceec
Confidence 999999999999999999999999999998763 35678999999988533221110000000 11234788899
Q ss_pred chhhhhcccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHcCCCCCcchHHhhhccCccccccccCC
Q 003185 712 APEVLRAMHKPN--LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGS 788 (840)
Q Consensus 712 APEvL~~~~~~~--~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~ 788 (840)
|||+.....+.. ....|+|.|+.|.+.||+++...||.+.....+- ...+....|.+++
T Consensus 419 APEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~------------------ 480 (598)
T KOG4158|consen 419 APEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPS------------------ 480 (598)
T ss_pred chhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcc------------------
Confidence 999997654322 1246999999999999999999999763322211 1122223333332
Q ss_pred CCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003185 789 GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826 (840)
Q Consensus 789 ~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLe 826 (840)
.+++.+.+|+..+|+.||++|++..=..+
T Consensus 481 ---------~vpp~~rqlV~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 481 ---------RVPPVARQLVFDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred ---------cCChHHHHHHHHHhcCCccccCCccHHHh
Confidence 23567899999999999999998654433
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.6e-20 Score=198.19 Aligned_cols=255 Identities=20% Similarity=0.216 Sum_probs=157.7
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC----------CCccee
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH----------SCIVEM 573 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~H----------pNIV~l 573 (840)
.+...+.||.|+++.||.+++ +++.+|+|++.... .......+.+ .+|.-....+.+ -.++-.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~----~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQL----KEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHH----HHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHH----HHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 457889999999999999998 56999999998766 3333344444 555544444322 223333
Q ss_pred eeEEecCCCCCCCCCCC---ccccceEEEEEeccCCCCHHHHHHHHhccCCC--CCCHHHHHHHHHHHHHHHHHHHhCCe
Q 003185 574 YGHKISSKWLPSADGNP---EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEK--HVSVKLALFIAQDVAAALVELHSKHI 648 (840)
Q Consensus 574 ~g~~~~~~~~p~~~g~~---~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~--~ls~~~~~~Ia~QIa~AL~yLHs~gI 648 (840)
++.....+.-+-..... .+-....+++|+-+. ++|..++.-....... .+.......+..|+++.+++||..||
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl 166 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL 166 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce
Confidence 33333221110001111 111235688999996 6999987654333322 23344556777999999999999999
Q ss_pred ecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc----CCCC
Q 003185 649 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH----KPNL 724 (840)
Q Consensus 649 VHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~----~~~~ 724 (840)
||+||||+|+|++.+ +.++|+||+.....+..... ...+..|.+||...... ....
T Consensus 167 VHgdi~~~nfll~~~-------G~v~Lg~F~~~~r~g~~~~~-------------~~~~~~~~PPe~~~~~~~~~~~~~~ 226 (288)
T PF14531_consen 167 VHGDIKPENFLLDQD-------GGVFLGDFSSLVRAGTRYRC-------------SEFPVAFTPPELESCAGQFGQNNAP 226 (288)
T ss_dssp EEST-SGGGEEE-TT-------S-EEE--GGGEEETTEEEEG-------------GGS-TTTS-HHHHHHHTSCHHSEEE
T ss_pred EecccceeeEEEcCC-------CCEEEcChHHHeecCceeec-------------cCCCcccCChhhhhhhcccCcccce
Confidence 999999999999988 56999999987765542221 12457899999875421 1235
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHH
Q 003185 725 YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 804 (840)
Q Consensus 725 ~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~ 804 (840)
++.+.|.|+||++||.|+++..||....+...... ....+. +.++.++
T Consensus 227 ~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-------------------------------~f~~C~-~~Pe~v~ 274 (288)
T PF14531_consen 227 YTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-------------------------------DFSRCR-DMPEPVQ 274 (288)
T ss_dssp E-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-------------------------------GGTTSS----HHHH
T ss_pred eeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-------------------------------cchhcC-CcCHHHH
Confidence 78999999999999999999999975532211000 011222 4577899
Q ss_pred HHHHHhcccCCCCC
Q 003185 805 DVFRRCTEENPTER 818 (840)
Q Consensus 805 dLI~rCL~~DP~eR 818 (840)
.||..+|+.||.+|
T Consensus 275 ~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 275 FLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHT-SSGGGS
T ss_pred HHHHHHccCCcccC
Confidence 99999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=185.00 Aligned_cols=146 Identities=14% Similarity=0.076 Sum_probs=108.4
Q ss_pred eeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChH-H----HHH-------------hHHhHHHHHHHHHhCCCCCc
Q 003185 510 CDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSAD-E----IRN-------------FEYSCLGEVRMLGALRHSCI 570 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~-~----~~~-------------f~~~~~rEi~iL~~L~HpNI 570 (840)
...||+|+||.||+|.. .+..||+|+.+......... . ... ......+|+.+|.++.+++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46899999999999987 57899999986543211110 0 001 11233569999999988877
Q ss_pred ceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH-HhCCee
Q 003185 571 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVEL-HSKHIM 649 (840)
Q Consensus 571 V~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yL-Hs~gIV 649 (840)
.....+... ..+|||||++|++|...+.. ...++...+..++.||+.+|.|| |+.||+
T Consensus 82 ~~p~~~~~~----------------~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~~gii 140 (190)
T cd05147 82 PCPEPILLK----------------SHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQDCRLV 140 (190)
T ss_pred CCCcEEEec----------------CCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 544333211 12899999998877655432 24688999999999999999999 799999
Q ss_pred cccCCCCcEEEecccccCCCCCeEEEeecCCcccc
Q 003185 650 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 684 (840)
Q Consensus 650 HRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~ 684 (840)
||||||+|||++. ..++|+|||+|...
T Consensus 141 HrDlkP~NIli~~--------~~v~LiDFG~a~~~ 167 (190)
T cd05147 141 HADLSEYNLLYHD--------GKLYIIDVSQSVEH 167 (190)
T ss_pred cCCCCHHHEEEEC--------CcEEEEEccccccC
Confidence 9999999999983 24999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.3e-19 Score=187.08 Aligned_cols=184 Identities=13% Similarity=0.127 Sum_probs=132.9
Q ss_pred CCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHh--HHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNF--EYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f--~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|.+.+.||.|+||.||++...+..+|+|++.-+.... ......| -..+.+|+..+.+|.||+|..+.+++.....
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~-~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRT-ERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred CceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCch-HHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 689999999999999999988888899999975433211 1111111 0124789999999999999999988764321
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
. .-......+|||||++|.+|.++.. ++. ....+|+.+|..||..|++||||||.||+++.
T Consensus 110 ~------~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 110 K------TLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSK 170 (232)
T ss_pred c------cccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeC
Confidence 1 0001124599999999999988732 222 24669999999999999999999999999986
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ + ++|+|||........... ..++.. ..+..++|||+||+++..+.
T Consensus 171 ~-------g-i~liDfg~~~~~~e~~a~----------------------d~~vle----r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 N-------G-LRIIDLSGKRCTAQRKAK----------------------DRIDLE----RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-------C-EEEEECCCcccccchhhH----------------------HHHHHH----hHhcccccccceeEeehHHH
Confidence 5 4 999999988654321100 112222 34567999999999987664
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.8e-19 Score=178.97 Aligned_cols=146 Identities=14% Similarity=0.118 Sum_probs=110.1
Q ss_pred eeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChH------------------HHHHhHHhHHHHHHHHHhCCCCCc
Q 003185 510 CDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSAD------------------EIRNFEYSCLGEVRMLGALRHSCI 570 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~------------------~~~~f~~~~~rEi~iL~~L~HpNI 570 (840)
...||+|+||.||+|.. ++..||+|+........... ........+.+|+..+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 56899999999999987 48999999987553211100 001112234689999999999988
Q ss_pred ceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHH-HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCe
Q 003185 571 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY-IEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHI 648 (840)
Q Consensus 571 V~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~-L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs-~gI 648 (840)
.....+.... .+|||||++|+++... +.. ..++...+..++.|++.+|.+||. +||
T Consensus 82 ~~p~~~~~~~----------------~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~gi 139 (190)
T cd05145 82 PVPEPILLKK----------------NVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAGL 139 (190)
T ss_pred CCceEEEecC----------------CEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCCE
Confidence 5544443221 2899999998755443 332 457888999999999999999999 999
Q ss_pred ecccCCCCcEEEecccccCCCCCeEEEeecCCccccc
Q 003185 649 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 685 (840)
Q Consensus 649 VHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~ 685 (840)
+||||||+|||++ + +.++|+|||++....
T Consensus 140 vHrDlkP~NIll~-~-------~~~~liDFG~a~~~~ 168 (190)
T cd05145 140 VHGDLSEYNILYH-D-------GKPYIIDVSQAVELD 168 (190)
T ss_pred ecCCCChhhEEEE-C-------CCEEEEEcccceecC
Confidence 9999999999998 4 359999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.8e-18 Score=176.25 Aligned_cols=201 Identities=12% Similarity=0.028 Sum_probs=140.0
Q ss_pred eeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEecCCCCCCC
Q 003185 508 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSA 586 (840)
Q Consensus 508 ~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~~~~~p~~ 586 (840)
.+...|++|+||+||++...+.+++.+-+...... ...-+...+.+|+++|++|. |++|++++++.
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~----~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~--------- 71 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWW----LRGVAWWLARREALALRQLDGLPRTPRLLHWD--------- 71 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhh----hhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------
Confidence 45678999999999998888887776654332211 01111224689999999996 58899998862
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccC-CCCcEEEecccc
Q 003185 587 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI-KSENILIDLERK 665 (840)
Q Consensus 587 ~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDL-KPeNILLd~~~~ 665 (840)
..+++|||+.|.+|.+.+.. ....++.|++.+|.++|++||+|||| ||+|||++.+
T Consensus 72 ---------~~~lvmeyI~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~-- 128 (218)
T PRK12274 72 ---------GRHLDRSYLAGAAMYQRPPR------------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQED-- 128 (218)
T ss_pred ---------CEEEEEeeecCccHHhhhhh------------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCC--
Confidence 13999999999998754321 11347889999999999999999999 7999999866
Q ss_pred cCCCCCeEEEeecCCccccccccccccccc-C--CCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 666 KADGKPVVKLCDFDRAVPLRSFLHTCCIAH-R--GIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 666 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~-~--~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+.++|+|||+|.............. + ..........++.|+.|+...-.. ..--...+.++.|+-+|.++
T Consensus 129 -----g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~--~~~~~~~~w~~~g~~~~~~~ 201 (218)
T PRK12274 129 -----GSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLK--RTSWIRELWFATGKPVYRFV 201 (218)
T ss_pred -----CCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhc--cchhHHHHHHHhcchHHHHH
Confidence 3599999999985543221000000 0 000000113678899998765421 22236788899999999999
Q ss_pred hCCCCCCCC
Q 003185 743 TLQVPYMGL 751 (840)
Q Consensus 743 TG~~PF~~~ 751 (840)
|+..|+.+.
T Consensus 202 ~~~~~~~~~ 210 (218)
T PRK12274 202 TRRVLHWED 210 (218)
T ss_pred hccCCcccc
Confidence 999987544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-19 Score=206.25 Aligned_cols=226 Identities=25% Similarity=0.290 Sum_probs=178.0
Q ss_pred eecccCceEEEEEE-----ECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEecCCCCCC
Q 003185 512 EAGKSVSSSLFRCK-----FGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPS 585 (840)
Q Consensus 512 ~LG~G~fG~Vy~a~-----~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~~~~~p~ 585 (840)
.+|+|+||.|++++ +.+.-+|+|+.+.......... . ...|-.++...+ ||.+|++...+..+..+
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~----t~~er~il~~~~~~~f~v~lhyafqt~~kl-- 72 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--H----TKQERIILAFVHNTPFLVKLHYAFQTDGKL-- 72 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc--c----cccHHHHHhhccCCCceeeeeeeeccccch--
Confidence 37999999999865 4566778887543332222211 1 256778888887 99999999999877654
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccc
Q 003185 586 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 665 (840)
Q Consensus 586 ~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~ 665 (840)
+++++|..||.|...+.+ ...+.+.....+...++-|++++|+.+|+|||+|++||+++.+
T Consensus 73 ------------~l~ld~~rgg~lft~l~~-----~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~-- 133 (612)
T KOG0603|consen 73 ------------YLILDFLRGGDLFTRLSK-----EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLE-- 133 (612)
T ss_pred ------------hHhhhhcccchhhhcccc-----CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeeccc--
Confidence 999999999999888765 4567788888899999999999999999999999999999988
Q ss_pred cCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCC
Q 003185 666 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 745 (840)
Q Consensus 666 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~ 745 (840)
+.+++.|||+++....... .+||..|||||++.+ ....+|.||||++++||+||.
T Consensus 134 -----Ghi~~tdfglske~v~~~~--------------~cgt~eymApEI~~g------h~~a~D~ws~gvl~felltg~ 188 (612)
T KOG0603|consen 134 -----GHIKLTDFGLSKEAVKEKI--------------ACGTYEYRAPEIING------HLSAADWWSFGVLAFELLTGT 188 (612)
T ss_pred -----CccccCCchhhhHhHhhhh--------------cccchhhhhhHhhhc------cCCcccchhhhhhHHHHhhCC
Confidence 5699999999987654221 168999999999984 367899999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 746 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 746 ~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
.||.+ ++...|.+... ..+.. ....+.+++..++..+|..|.-.
T Consensus 189 ~pf~~----~~~~~Il~~~~-~~p~~---------------------------l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 189 LPFGG----DTMKRILKAEL-EMPRE---------------------------LSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CCCch----HHHHHHhhhcc-CCchh---------------------------hhHHHHHHHHHHHhhCHHHHhcc
Confidence 99987 55555554322 22222 24468899999999999999644
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-17 Score=170.79 Aligned_cols=143 Identities=20% Similarity=0.228 Sum_probs=112.9
Q ss_pred eeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 590 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g~~ 590 (840)
+.||+|++|.||+|.+.+..+++|+...+..............++.+|+.++..+.|++|+....++.....
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-------- 73 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN-------- 73 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC--------
Confidence 579999999999999999999999865332222111222222456899999999999998877766654432
Q ss_pred ccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCCC
Q 003185 591 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 670 (840)
Q Consensus 591 ~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~ 670 (840)
.++||||++|++|.+++.. ... .+..++.+|+.+|.+||+.|++|+|++|.|||++ +
T Consensus 74 ------~~lv~e~~~G~~L~~~~~~--------~~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~------- 130 (211)
T PRK14879 74 ------FIIVMEYIEGEPLKDLINS--------NGM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G------- 130 (211)
T ss_pred ------CEEEEEEeCCcCHHHHHHh--------ccH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C-------
Confidence 3899999999999999865 112 8889999999999999999999999999999998 3
Q ss_pred CeEEEeecCCcccc
Q 003185 671 PVVKLCDFDRAVPL 684 (840)
Q Consensus 671 ~~vKL~DFGlA~~~ 684 (840)
..++|+|||++...
T Consensus 131 ~~~~liDf~~a~~~ 144 (211)
T PRK14879 131 GKIYLIDFGLAEFS 144 (211)
T ss_pred CCEEEEECCcccCC
Confidence 35999999998753
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-17 Score=173.43 Aligned_cols=143 Identities=14% Similarity=0.119 Sum_probs=104.1
Q ss_pred eeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-----CCCCcceeeeEEecCCC
Q 003185 508 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-----RHSCIVEMYGHKISSKW 582 (840)
Q Consensus 508 ~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-----~HpNIV~l~g~~~~~~~ 582 (840)
.-.+.||+|+||.||.-... ...++|+...... ...+ .+.+|+.+++.| .||||++++|++.++..
T Consensus 5 ~~~~~LG~G~~~~Vy~hp~~-~~k~IKv~~~~~~----~~~~----~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g 75 (210)
T PRK10345 5 SEQSPLGTGRHRKCYAHPED-AQRCIKIVYHRGD----GGDK----EIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG 75 (210)
T ss_pred CCcceecCCCceEEEECCCC-cCeEEEEEecccc----chHH----HHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence 34578999999999962223 3346777654321 1122 349999999999 57999999999987641
Q ss_pred CCCCCCCCccccce-EEEEEec--cCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHH-HHHHhCCeecccCCCCcE
Q 003185 583 LPSADGNPEHHLLQ-SAIFMEY--VKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAAL-VELHSKHIMHRDIKSENI 658 (840)
Q Consensus 583 ~p~~~g~~~~~~~~-~~LVmEy--~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL-~yLHs~gIVHRDLKPeNI 658 (840)
... ..+|||| +.+++|.+++.+ ..+++. ..++.|++.++ +|||+++||||||||+||
T Consensus 76 -----------~g~v~~~I~e~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NI 136 (210)
T PRK10345 76 -----------TGYVYDVIADFDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNI 136 (210)
T ss_pred -----------CeEEEEEEecCCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHE
Confidence 112 3478999 557999999975 235555 35678888887 999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCc
Q 003185 659 LIDLERKKADGKPVVKLCDFDRA 681 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA 681 (840)
|++..+. +...++|+||+.+
T Consensus 137 Ll~~~~~---~~~~~~LiDg~G~ 156 (210)
T PRK10345 137 LCQRISE---SEVIPVVCDNIGE 156 (210)
T ss_pred EEeccCC---CCCcEEEEECCCC
Confidence 9986431 2357999995443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.2e-18 Score=192.99 Aligned_cols=220 Identities=25% Similarity=0.344 Sum_probs=166.8
Q ss_pred HHhCCCCCcceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHH
Q 003185 562 LGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALV 641 (840)
Q Consensus 562 L~~L~HpNIV~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~ 641 (840)
|+.+.|.|+.+++|.+.... ..++|.+||..|+|.+.+.. ....+++.....++++|+.||+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~--------------~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ 62 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGP--------------EMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLA 62 (484)
T ss_pred CcccchhhhhhheeeEecCC--------------ceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHH
Confidence 45788999999999998654 45999999999999999986 3467888999999999999999
Q ss_pred HHHhCCe-ecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003185 642 ELHSKHI-MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720 (840)
Q Consensus 642 yLHs~gI-VHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~ 720 (840)
|||...| .|+.+++.|.+++.. +.+||+|||+.......... . ......-..-|.|||.+....
T Consensus 63 ylh~s~i~~hg~l~s~nClvd~~-------w~lklt~~Gl~~~~~~~~~~---~-----~~~~~~~~~lw~aPellr~~~ 127 (484)
T KOG1023|consen 63 YLHNSPIGYHGALKSSNCLVDSR-------WVLKLTDFGLNSLLEETAEP---E-----AHHPIRKALLWTAPELLRGAL 127 (484)
T ss_pred HHhcCcceeeeeeccccceeeee-------EEEEechhhhcccccccccc---c-----ccchhHHHHhccCHHHhcccc
Confidence 9999866 999999999999977 88999999998766431000 0 001112346799999998743
Q ss_pred CCCC---CCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCc
Q 003185 721 KPNL---YGLEVDIWSYGCLLLELLTLQVPYMGL----SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP 793 (840)
Q Consensus 721 ~~~~---~s~kSDVWSLGvIL~ELLTG~~PF~~~----~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~ 793 (840)
.... .+.+.||||||++++|+++.+.||... .+.++...+.++..+.+...+..
T Consensus 128 ~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~------------------- 188 (484)
T KOG1023|consen 128 SQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIEL------------------- 188 (484)
T ss_pred cccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhh-------------------
Confidence 2222 578899999999999999999999652 34456666666322222211110
Q ss_pred hhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 003185 794 EAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 835 (840)
Q Consensus 794 ~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~~~ 835 (840)
..+..+.+..++.+||..+|.+||++++|-..++.+....
T Consensus 189 --~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 189 --LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred --hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 0023447899999999999999999999999988877643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=201.15 Aligned_cols=202 Identities=17% Similarity=0.212 Sum_probs=155.0
Q ss_pred CCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC---CCCcceeeeEEe
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKI 578 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~---HpNIV~l~g~~~ 578 (840)
.-..|.|.+.||+|+||.||+|.. ++..+|+|+-+..... . -.+ -.+++.+|+ -+.|+.++.++.
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--E---fYI------~~q~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--E---FYI------CLQVMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--e---eee------hHHHHHhhchhhhcchHHHHHHHc
Confidence 346789999999999999999986 6788999986432211 0 011 122344444 355666666555
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
..+. .+||+||.+.|+|.+++.. .+.+++..+..+..|++.-+++||..+|||+||||+|+
T Consensus 765 ~~~~--------------S~lv~ey~~~Gtlld~~N~-----~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNf 825 (974)
T KOG1166|consen 765 FQNA--------------SVLVSEYSPYGTLLDLINT-----NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNF 825 (974)
T ss_pred cCCc--------------ceeeeeccccccHHHhhcc-----CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCccee
Confidence 4332 3899999999999999973 57799999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
||...-....+...++|+|||.+.-+.-.... ..-....+|-.+-.+|+..| ..++..+|.|.|..++
T Consensus 826 ll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~--------~~F~~~~~td~f~C~EM~~g----rpWtYq~DyfGlAa~~ 893 (974)
T KOG1166|consen 826 LLRREICADSDSKGLYLIDFGRSIDMKLFPDG--------TKFKAVWHTDLFDCIEMREG----RPWTYQIDYFGLAATV 893 (974)
T ss_pred EeecccCCCCcccceEEEecccceeeeEcCCC--------cEEeeeeccccchhHHHhcC----CCCchhhhhHHHHHHH
Confidence 99876544445677999999998654332111 11234568889999999987 8899999999999999
Q ss_pred HHHHhCCC
Q 003185 739 LELLTLQV 746 (840)
Q Consensus 739 ~ELLTG~~ 746 (840)
+-||.|+.
T Consensus 894 h~mLFG~y 901 (974)
T KOG1166|consen 894 HVMLFGKY 901 (974)
T ss_pred HHHHHHHH
Confidence 99999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.3e-17 Score=164.68 Aligned_cols=139 Identities=22% Similarity=0.278 Sum_probs=106.1
Q ss_pred eecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCCCCc
Q 003185 512 EAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 591 (840)
Q Consensus 512 ~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g~~~ 591 (840)
.||+|+||.||+|.+.+..+++|++..+...........-..++.+|+.++..++|++|.....++.....
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~--------- 71 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN--------- 71 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC---------
Confidence 48999999999999999999999865432222211111122456899999999998876554444443332
Q ss_pred cccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCCCC
Q 003185 592 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 671 (840)
Q Consensus 592 ~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~ 671 (840)
.++||||++|++|.+++.. . . . .++.+++.+|.+||+.|++|+|++|.|||++ + .
T Consensus 72 -----~~lv~e~~~g~~l~~~~~~----~-~-~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~-------~ 126 (199)
T TIGR03724 72 -----KTIVMEYIEGKPLKDVIEE----G-N-D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D-------D 126 (199)
T ss_pred -----CEEEEEEECCccHHHHHhh----c-H-H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C-------C
Confidence 3899999999999998764 1 1 1 7899999999999999999999999999998 4 3
Q ss_pred eEEEeecCCcccc
Q 003185 672 VVKLCDFDRAVPL 684 (840)
Q Consensus 672 ~vKL~DFGlA~~~ 684 (840)
.++|+|||++...
T Consensus 127 ~~~liDfg~a~~~ 139 (199)
T TIGR03724 127 KLYLIDFGLGKYS 139 (199)
T ss_pred cEEEEECCCCcCC
Confidence 5999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1e-17 Score=199.31 Aligned_cols=224 Identities=22% Similarity=0.298 Sum_probs=156.4
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
-.+|..++.|..|+||.||.++++ .+.+|+|+-+-+ .|++ ||..+-+.
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~--------------------lilR-----nilt~a~n----- 131 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN--------------------LILR-----NILTFAGN----- 131 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc--------------------hhhh-----ccccccCC-----
Confidence 357899999999999999999875 677777652110 0111 23333221
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
.+.| |+-...++. -+.++... +.+++|||+.||+|||+||+|.||+
T Consensus 132 ---------------pfvv------gDc~tllk~-----~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT 177 (1205)
T KOG0606|consen 132 ---------------PFVV------GDCATLLKN-----IGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLIT 177 (1205)
T ss_pred ---------------ccee------chhhhhccc-----CCCCcchh--------hHHhHhhccCCeecCCCCCCcceee
Confidence 1344 344444443 12333322 8899999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccc-----cCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-----HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~-----~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
.- +.+|++|||+++.......++... .......+-++||+.|.|||++.. ..|++.+|.|++|+
T Consensus 178 ~m-------GhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr----qgygkpvdwwamGi 246 (1205)
T KOG0606|consen 178 SM-------GHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR----QGYGKPVDWWAMGI 246 (1205)
T ss_pred ec-------ccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh----hccCCCccHHHHHH
Confidence 87 569999999987654332221110 011122344579999999999986 77999999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 737 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 737 IL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
|+||.+.|..||.+.++++++..+...... +++ .....+.+++++|.++|+.+|.
T Consensus 247 IlyeFLVgcvpffGdtpeelfg~visd~i~-wpE------------------------~dea~p~Ea~dli~~LL~qnp~ 301 (1205)
T KOG0606|consen 247 ILYEFLVGCVPFFGDTPEELFGQVISDDIE-WPE------------------------EDEALPPEAQDLIEQLLRQNPL 301 (1205)
T ss_pred HHHHHheeeeeccCCCHHHHHhhhhhhhcc-ccc------------------------cCcCCCHHHHHHHHHHHHhChH
Confidence 999999999999999999998887654221 111 1122356789999999999999
Q ss_pred CCC---CHHHHHHH
Q 003185 817 ERP---TAGDLYEM 827 (840)
Q Consensus 817 eRP---Sa~ELLeh 827 (840)
.|. .+-+|.+|
T Consensus 302 ~Rlgt~ga~evk~h 315 (1205)
T KOG0606|consen 302 CRLGTGGALEVKQH 315 (1205)
T ss_pred hhcccchhhhhhhc
Confidence 994 34444444
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=1e-16 Score=188.31 Aligned_cols=146 Identities=20% Similarity=0.218 Sum_probs=113.8
Q ss_pred CCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
...|...+.||+|+||.||++.+.+..+++|++..+..............++.+|+.++..++|++|+..+.++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~- 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE- 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC-
Confidence 4455778999999999999999987777777654332221111111223456899999999999999887766654332
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.++||||++|++|.+++. ....++.||+.+|.|||+.||+||||||+|||++ +
T Consensus 411 -------------~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~ 463 (535)
T PRK09605 411 -------------KTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-D 463 (535)
T ss_pred -------------CEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-C
Confidence 389999999999999875 2467899999999999999999999999999994 3
Q ss_pred cccCCCCCeEEEeecCCcccc
Q 003185 664 RKKADGKPVVKLCDFDRAVPL 684 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~ 684 (840)
..++|+|||+++..
T Consensus 464 -------~~~~liDFGla~~~ 477 (535)
T PRK09605 464 -------DRLYLIDFGLGKYS 477 (535)
T ss_pred -------CcEEEEeCcccccC
Confidence 35999999998653
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=168.95 Aligned_cols=148 Identities=14% Similarity=0.163 Sum_probs=109.5
Q ss_pred CceeeeeecccCceEEEEEE---ECCeeEEEEEEecccCCCCh----------------HHHHHhHHhHHHHHHHHHhCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCK---FGSADAAAKVRTLKVCGSSA----------------DEIRNFEYSCLGEVRMLGALR 566 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~---~~~~~vAVKI~~lk~~~~~~----------------~~~~~f~~~~~rEi~iL~~L~ 566 (840)
-|.+.+.||+|+||.||+|. .++..||+|+.......... ...+.....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 36788999999999999998 37889999998754321100 001112234578999999997
Q ss_pred CCC--cceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH
Q 003185 567 HSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH 644 (840)
Q Consensus 567 HpN--IV~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLH 644 (840)
+.+ +.+++++ . ..+|||||++|.+|..++.. ...+....+..++.||+.+|.+||
T Consensus 109 ~~~i~~p~~~~~---~---------------~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH 165 (237)
T smart00090 109 EAGVPVPKPIAW---R---------------RNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLY 165 (237)
T ss_pred hcCCCCCeeeEe---c---------------CceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHH
Confidence 533 3444432 1 12899999999888765422 234566677899999999999999
Q ss_pred hCC-eecccCCCCcEEEecccccCCCCCeEEEeecCCcccc
Q 003185 645 SKH-IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 684 (840)
Q Consensus 645 s~g-IVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~ 684 (840)
.+| |+||||||+|||++ + ..++|+|||.+...
T Consensus 166 ~~g~iiH~Dikp~NIli~-~-------~~i~LiDFg~a~~~ 198 (237)
T smart00090 166 KEGELVHGDLSEYNILVH-D-------GKVVIIDVSQSVEL 198 (237)
T ss_pred hcCCEEeCCCChhhEEEE-C-------CCEEEEEChhhhcc
Confidence 999 99999999999998 4 35999999998654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2e-16 Score=178.21 Aligned_cols=182 Identities=24% Similarity=0.336 Sum_probs=132.4
Q ss_pred eEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCCCCeEEE
Q 003185 596 QSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675 (840)
Q Consensus 596 ~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL 675 (840)
.+||.|++|.-.+|.++|.. .......++...+.++.|++.|+.| ++.+|+|+||.||++..+ .++||
T Consensus 330 ~lyI~Mn~c~~~tledWl~r--r~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d-------~q~kI 397 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRR--RRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDD-------DQLKI 397 (516)
T ss_pred chhhhhhhhhhhhHHHHhhC--CCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccc-------hhhhh
Confidence 57999999999999999974 2233456788899999999999999 999999999999999877 35999
Q ss_pred eecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 003185 676 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSEL 754 (840)
Q Consensus 676 ~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~ 754 (840)
.|||+...........+ ........+||..||+||.+.+ ..|+.++||||||+||+||++ -..+|. ..
T Consensus 398 gDFgl~ts~~~~~~~~~----~~a~~t~~~gt~~YmsPEQi~g----~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~ 466 (516)
T KOG1033|consen 398 GDFGLVTSQDKDETVAP----AAASHTQQVGTLLYMSPEQIRG----QQYSEKVDIYALGLILAELLIQFSTQFE---RI 466 (516)
T ss_pred hhhhheeecccCCcccc----hhhhhhhcccccccCCHHHHhh----hhhhhhcchhhHHHHHHHHHHHhccHHH---HH
Confidence 99999876654331110 0111234579999999999997 789999999999999999997 222221 12
Q ss_pred HHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003185 755 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 827 (840)
Q Consensus 755 el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLeh 827 (840)
.....+..+..|+ ..+ .+ .+.-..|+..||...|.+||++.+..-|
T Consensus 467 ~t~~d~r~g~ip~--~~~------------------------~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~ 512 (516)
T KOG1033|consen 467 ATLTDIRDGIIPP--EFL------------------------QD-YPEEYTLLQQLLSPSPEERPSAIEVALH 512 (516)
T ss_pred HhhhhhhcCCCCh--HHh------------------------hc-CcHHHHHHHHhcCCCcccCchHHHHhhh
Confidence 2233333343221 111 11 1234689999999999999966665544
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.5e-15 Score=155.30 Aligned_cols=143 Identities=17% Similarity=0.163 Sum_probs=106.1
Q ss_pred ceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChH--------------HHHHhHHhHHHHHHHHHhCCCCC--
Q 003185 507 LSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSAD--------------EIRNFEYSCLGEVRMLGALRHSC-- 569 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~--------------~~~~f~~~~~rEi~iL~~L~HpN-- 569 (840)
|.+.+.||+|+||.||++.. .+..+|||++.......... ........+.+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 67789999999999999987 68899999976543111000 00011123578999999998874
Q ss_pred cceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Q 003185 570 IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 649 (840)
Q Consensus 570 IV~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIV 649 (840)
++..++. . ..++||||++|++|..+... .....++.+|+.++.++|..||+
T Consensus 97 v~~~~~~----~--------------~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~gi~ 147 (198)
T cd05144 97 VPKPIDW----N--------------RHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHGII 147 (198)
T ss_pred CCceeec----C--------------CceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCCCC
Confidence 4444432 1 13899999999998765321 24567889999999999999999
Q ss_pred cccCCCCcEEEecccccCCCCCeEEEeecCCccccc
Q 003185 650 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 685 (840)
Q Consensus 650 HRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~ 685 (840)
||||||.||+++.+ +.++|+|||++....
T Consensus 148 H~Dl~p~Nill~~~-------~~~~liDfg~~~~~~ 176 (198)
T cd05144 148 HGDLSEFNILVDDD-------EKIYIIDWPQMVSTD 176 (198)
T ss_pred cCCCCcccEEEcCC-------CcEEEEECCccccCC
Confidence 99999999999876 469999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.5e-14 Score=153.36 Aligned_cols=147 Identities=16% Similarity=0.221 Sum_probs=106.1
Q ss_pred eeeec-ccCceEEEEEEECCeeEEEEEEecccCCCC--hHH--H-HHhHHhHHHHHHHHHhCCCCCc--ceeeeEEecCC
Q 003185 510 CDEAG-KSVSSSLFRCKFGSADAAAKVRTLKVCGSS--ADE--I-RNFEYSCLGEVRMLGALRHSCI--VEMYGHKISSK 581 (840)
Q Consensus 510 ~~~LG-~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~--~~~--~-~~f~~~~~rEi~iL~~L~HpNI--V~l~g~~~~~~ 581 (840)
...|| .||.|+||.+...+..+++|.+........ ... . .....++.+|+.++.+|.|++| +..+++.....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 35677 889999999998889999998753211000 000 0 0112355899999999998885 67777654332
Q ss_pred CCCCCCCCCccccceEEEEEeccCC-CCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~g-GSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. ....+|||||++| .+|.+++.. ..++.. .+.+|+.+|.+||++||+||||||.|||+
T Consensus 116 ~~----------~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv 175 (239)
T PRK01723 116 GL----------FYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILL 175 (239)
T ss_pred Cc----------ceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEE
Confidence 11 1234699999997 699998864 234543 36789999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCccc
Q 003185 661 DLERKKADGKPVVKLCDFDRAVP 683 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~ 683 (840)
+.+ ..++|+|||.+..
T Consensus 176 ~~~-------~~v~LIDfg~~~~ 191 (239)
T PRK01723 176 DPD-------GKFWLIDFDRGEL 191 (239)
T ss_pred cCC-------CCEEEEECCCccc
Confidence 876 3599999998753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.4e-14 Score=142.19 Aligned_cols=143 Identities=15% Similarity=0.198 Sum_probs=96.1
Q ss_pred eeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHH----------------HhHHhHHHHHHHHHhCCCCC--c
Q 003185 510 CDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIR----------------NFEYSCLGEVRMLGALRHSC--I 570 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~----------------~f~~~~~rEi~iL~~L~HpN--I 570 (840)
.+.||+|+||+||+|... +..||+|+.............. ........|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 568999999999999975 8899999976432211110000 00001135666666665432 3
Q ss_pred ceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHH-HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCe
Q 003185 571 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN-YIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHI 648 (840)
Q Consensus 571 V~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~-~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs-~gI 648 (840)
.++++.. ..++||||++++++.. .+... .. ...+..++.+++.++.++|. .||
T Consensus 82 ~~~~~~~------------------~~~lv~e~~~g~~~~~~~l~~~------~~-~~~~~~~~~~~~~~l~~lh~~~~i 136 (187)
T cd05119 82 PKPIDLN------------------RHVLVMEFIGGDGIPAPRLKDV------RL-LEDPEELYDQILELMRKLYREAGL 136 (187)
T ss_pred CceEecC------------------CCEEEEEEeCCCCccChhhhhh------hh-cccHHHHHHHHHHHHHHHhhccCc
Confidence 4444321 1389999999854321 12210 01 16678999999999999999 999
Q ss_pred ecccCCCCcEEEecccccCCCCCeEEEeecCCccccc
Q 003185 649 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 685 (840)
Q Consensus 649 VHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~ 685 (840)
+|+||||+||+++ + ..++|+|||.+....
T Consensus 137 vH~Dl~p~Nili~-~-------~~~~liDfg~a~~~~ 165 (187)
T cd05119 137 VHGDLSEYNILVD-D-------GKVYIIDVPQAVEID 165 (187)
T ss_pred CcCCCChhhEEEE-C-------CcEEEEECccccccc
Confidence 9999999999998 4 459999999996553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=9.9e-14 Score=131.56 Aligned_cols=132 Identities=20% Similarity=0.219 Sum_probs=105.2
Q ss_pred eeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC--CCcceeeeEEecCCCCCCC
Q 003185 509 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SCIVEMYGHKISSKWLPSA 586 (840)
Q Consensus 509 i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~H--pNIV~l~g~~~~~~~~p~~ 586 (840)
+.+.||.|.++.||++...+..+++|+...... .. .+.+|+.++..++| .+++++++++...+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~------~~----~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~----- 66 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK------GA----DREREVAILQLLARKGLPVPKVLASGESDG----- 66 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc------hh----HHHHHHHHHHHHHHcCCCCCeEEEEcCCCC-----
Confidence 457899999999999999888899998643211 12 33889999999986 58899888765432
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCCCcEEEecc
Q 003185 587 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHRDIKSENILIDLE 663 (840)
Q Consensus 587 ~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~---gIVHRDLKPeNILLd~~ 663 (840)
..+++|||++++.+..+ +......++.+++.+|++||.. +++|+||+|.|||++..
T Consensus 67 ---------~~~~v~e~~~g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~ 125 (155)
T cd05120 67 ---------WSYLLMEWIEGETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG 125 (155)
T ss_pred ---------ccEEEEEecCCeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC
Confidence 24999999998766543 4456677899999999999985 79999999999999874
Q ss_pred cccCCCCCeEEEeecCCccc
Q 003185 664 RKKADGKPVVKLCDFDRAVP 683 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~ 683 (840)
..++++|||.+..
T Consensus 126 -------~~~~l~Df~~~~~ 138 (155)
T cd05120 126 -------KILGIIDWEYAGY 138 (155)
T ss_pred -------cEEEEEecccccC
Confidence 4699999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.3e-15 Score=180.59 Aligned_cols=267 Identities=22% Similarity=0.223 Sum_probs=189.8
Q ss_pred CCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~~ 580 (840)
+...|.+.+.||+|+|+.|-.+.. +....+++...+.......... ..+..|..+-+.+. |+|++.+++.....
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~----~~i~~e~~~~~~~s~h~n~~~~~~~~~~~ 93 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSS----EHIDTETDIQKKLSKHSNTVHMIEPSSSP 93 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchh----hhcCccccccccccccccccccCCccCCC
Confidence 466788999999999999988875 3333444443343332222222 23366888888887 99999999987765
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeecccCCCCcEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH-SKHIMHRDIKSENIL 659 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLH-s~gIVHRDLKPeNIL 659 (840)
... +++++|..|+++...+.. ......+...+..++.|+..++.|+| ..++.|+||||+|.+
T Consensus 94 ~~~--------------~~~~~~s~g~~~f~~i~~---~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~ 156 (601)
T KOG0590|consen 94 RSY--------------LLSLSYSDGGSLFSKISH---PDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSL 156 (601)
T ss_pred ccc--------------ccccCccccccccccccc---CCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccch
Confidence 543 999999999999988831 12225677888999999999999999 999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccC-CCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG-TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vG-T~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
++..+. .+++.|||+|..+....... .......| ++.|+|||.+.+ .....+..|+||.|+++
T Consensus 157 l~~s~~------~l~~~df~~At~~~~~~g~~-------~~~~~~~g~s~~y~a~E~~~~---~~~~~~~~d~~S~g~~l 220 (601)
T KOG0590|consen 157 LDESGS------ALKIADFGLATAYRNKNGAE-------RSLKDRCGSSPPYGAPEHLSG---KAYRGPSVDVWSLGIVL 220 (601)
T ss_pred hccCCC------cccCCCchhhccccccCCcc-------eeeecccCCCCCCCCcccccc---hhhcCCCcccccccccc
Confidence 998741 59999999998765521111 11123357 999999999876 23557899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHH--HHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 739 LELLTLQVPYMGLSELEIH--DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~el~--~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
.-+++|..||......... ..+..... ..............+++.+++..+|.
T Consensus 221 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~l~k~l~~~~~ 275 (601)
T KOG0590|consen 221 SAMLTGELPWDFPSRKDGRYSSWKSNKGR-------------------------FTQLPWNSISDQAHDLLHKILKENPS 275 (601)
T ss_pred cccccCCCCccccccccccceeecccccc-------------------------cccCccccCChhhhhcccccccCCch
Confidence 9999999999655433211 00000000 00111122345678899999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 003185 817 ERPTAGDLYEMFVAR 831 (840)
Q Consensus 817 eRPSa~ELLehLe~l 831 (840)
.|.+.+++-.+-...
T Consensus 276 ~r~s~~~~~~d~~~~ 290 (601)
T KOG0590|consen 276 NRLSIEELKLDNWLS 290 (601)
T ss_pred hcccccccccccccc
Confidence 999999887654433
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.7e-11 Score=141.02 Aligned_cols=150 Identities=15% Similarity=0.149 Sum_probs=98.2
Q ss_pred eeeecccCceEEEEEEE-CCeeEEEEEEecccCCCC--------------------------hHHHHHhHH------hHH
Q 003185 510 CDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSS--------------------------ADEIRNFEY------SCL 556 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~--------------------------~~~~~~f~~------~~~ 556 (840)
.+.||.|++|.||+|+. +++.||||+.+......- ....++|.. .+.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999997 688999999753321000 011122222 245
Q ss_pred HHHHHHHhCC----CCCcceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHH
Q 003185 557 GEVRMLGALR----HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFI 632 (840)
Q Consensus 557 rEi~iL~~L~----HpNIV~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~I 632 (840)
+|+..+.+++ |.+-+.+-.++..-. ...+|||||++|++|.++.... . ... ....+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~-------------~~~vLvmE~i~G~~L~~~~~~~-~---~~~---~~~~i 261 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRT-------------SERVLTMEWIDGIPLSDIAALD-E---AGL---DRKAL 261 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhc-------------CCceEEEEeECCcccccHHHHH-h---cCC---CHHHH
Confidence 5666666653 322233222322110 1238999999999999887531 1 112 23456
Q ss_pred HHHHHH-HHHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccc
Q 003185 633 AQDVAA-ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 686 (840)
Q Consensus 633 a~QIa~-AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~ 686 (840)
+.+++. .+..+|..|++|+|+||.||+++.+ +.++|+|||++..+..
T Consensus 262 a~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~-------g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 262 AENLARSFLNQVLRDGFFHADLHPGNIFVLKD-------GKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHHHHHHHhCCceeCCCCcccEEECCC-------CcEEEEeCCCeeECCH
Confidence 666666 4788999999999999999999876 4599999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.2e-11 Score=144.75 Aligned_cols=168 Identities=14% Similarity=0.164 Sum_probs=99.5
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCC--------------------------CChHHHHHhHHhH
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCG--------------------------SSADEIRNFEYSC 555 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~--------------------------~~~~~~~~f~~~~ 555 (840)
|..|.. +.||+|++|+||+|+.. ++.||||+.+..... ......++|.+.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 556666 79999999999999973 789999997633210 0112233455555
Q ss_pred HHHHHHHHhCCCCCcceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccC--CCCCCHHHHHHHH
Q 003185 556 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--EKHVSVKLALFIA 633 (840)
Q Consensus 556 ~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~--~~~ls~~~~~~Ia 633 (840)
.+|+.++... .|+.++...|.....+.-..--++ .....+|||||+.|+.|.++..- ...+ ...+....+..++
T Consensus 198 ~~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d-~st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~ 273 (537)
T PRK04750 198 HDELDLMREA--ANASQLRRNFEDSDMLYVPEVYWD-YCSETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFF 273 (537)
T ss_pred HHhhCHHHHH--HHHHHHHHHccCCCCeecceeecc-cCCCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHH
Confidence 5555554444 244444333322211100000000 01124799999999999875321 1111 1123333444444
Q ss_pred HHHHHHHHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccc
Q 003185 634 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 686 (840)
Q Consensus 634 ~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~ 686 (840)
.|| +..|++|+|+||.||+++.++. ..+.++++|||++..+..
T Consensus 274 ~Qi-------f~~GffHaDpHPGNIlv~~~g~---~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQV-------FRDGFFHADMHPGNIFVSYDPP---ENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHH-------HhCCeeeCCCChHHeEEecCCC---CCCeEEEEecceEEECCH
Confidence 554 4589999999999999987742 234799999999987754
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.2e-10 Score=117.56 Aligned_cols=137 Identities=20% Similarity=0.262 Sum_probs=104.1
Q ss_pred eeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCc--ceeeeEEecCCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI--VEMYGHKISSKWLPSADG 588 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNI--V~l~g~~~~~~~~p~~~g 588 (840)
..+++|+-+.||.+.+-+.++++|....|.-..+.-+.+--..+..+|++++.+++--.| ..++++ +..
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D~~------- 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--DPD------- 72 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--cCC-------
Confidence 357899999999999988889999875554333333333334677899999999974444 444443 222
Q ss_pred CCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCC
Q 003185 589 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 668 (840)
Q Consensus 589 ~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~ 668 (840)
...|+|||++|..|.+++.. . ...++..|-.-+.-||..||||+||.++||++..+
T Consensus 73 -------~~~I~me~I~G~~lkd~l~~------~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~----- 128 (204)
T COG3642 73 -------NGLIVMEYIEGELLKDALEE------A------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG----- 128 (204)
T ss_pred -------CCEEEEEEeCChhHHHHHHh------c------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-----
Confidence 23899999999888888875 1 25567777888889999999999999999999866
Q ss_pred CCCeEEEeecCCccc
Q 003185 669 GKPVVKLCDFDRAVP 683 (840)
Q Consensus 669 ~~~~vKL~DFGlA~~ 683 (840)
.+.++|||++..
T Consensus 129 ---~i~~IDfGLg~~ 140 (204)
T COG3642 129 ---RIYFIDFGLGEF 140 (204)
T ss_pred ---cEEEEECCcccc
Confidence 399999999864
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.23 E-value=1e-10 Score=120.52 Aligned_cols=144 Identities=14% Similarity=0.105 Sum_probs=102.7
Q ss_pred eeeecccCceEEEEEEEC--------CeeEEEEEEecccCCCChH------------------HHHHhHHhHHHHHHHHH
Q 003185 510 CDEAGKSVSSSLFRCKFG--------SADAAAKVRTLKVCGSSAD------------------EIRNFEYSCLGEVRMLG 563 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~--------~~~vAVKI~~lk~~~~~~~------------------~~~~f~~~~~rEi~iL~ 563 (840)
...||.|--+.||.|... +..+|+|+++......... ..+.+.....+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 357899999999999753 3799999988644322111 01122223348999999
Q ss_pred hCC--CCCcceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHH-HHHHHhccCCCCCCHHHHHHHHHHHHHHH
Q 003185 564 ALR--HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN-YIEKLSETGEKHVSVKLALFIAQDVAAAL 640 (840)
Q Consensus 564 ~L~--HpNIV~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~-~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL 640 (840)
+|. .-++.+++++. . -+|||||+.+..+.. .++. ..++......+..+++.+|
T Consensus 82 rl~~~Gv~vP~pi~~~--~----------------~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l 137 (197)
T cd05146 82 RMQKAGIPCPEVVVLK--K----------------HVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMM 137 (197)
T ss_pred HHHHcCCCCCeEEEec--C----------------CEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHH
Confidence 996 35666777641 1 289999997654422 2322 2355566778899999999
Q ss_pred HHH-HhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCccccc
Q 003185 641 VEL-HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 685 (840)
Q Consensus 641 ~yL-Hs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~ 685 (840)
..| |..||||+||++.|||+..+ .++|+|||.+....
T Consensus 138 ~~l~H~~glVHGDLs~~NIL~~~~--------~v~iIDF~qav~~~ 175 (197)
T cd05146 138 KQLYKECNLVHADLSEYNMLWHDG--------KVWFIDVSQSVEPT 175 (197)
T ss_pred HHHHHhCCeecCCCCHHHEEEECC--------cEEEEECCCceeCC
Confidence 999 89999999999999999743 49999999887553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.6e-10 Score=116.29 Aligned_cols=154 Identities=22% Similarity=0.231 Sum_probs=115.2
Q ss_pred eeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCC
Q 003185 509 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 588 (840)
Q Consensus 509 i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g 588 (840)
....|-+|+-+.|+++.+.++.+++|....+.-.-+.-+.+--..+..+|+++|.++.--.|.-..=++.+...
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~------ 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG------ 84 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC------
Confidence 46778899999999999999999999876665444444444455788999999999974444333333332221
Q ss_pred CCccccceEEEEEeccCC-CCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccC
Q 003185 589 NPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667 (840)
Q Consensus 589 ~~~~~~~~~~LVmEy~~g-GSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~ 667 (840)
-.|+|||++| .++.+++..... ..........++.+|-..+.-||.++|||+||..+||++..+++
T Consensus 85 --------~~i~ME~~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~-- 151 (229)
T KOG3087|consen 85 --------GQIYMEFIDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGN-- 151 (229)
T ss_pred --------CeEEEEeccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCC--
Confidence 2899999986 488899876322 22333344788999999999999999999999999999988753
Q ss_pred CCCCeEEEeecCCccc
Q 003185 668 DGKPVVKLCDFDRAVP 683 (840)
Q Consensus 668 ~~~~~vKL~DFGlA~~ 683 (840)
...+.|+|||++..
T Consensus 152 --~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 152 --QITPILIDFGLSSV 165 (229)
T ss_pred --cCceEEEeecchhc
Confidence 45679999999853
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.22 E-value=5.9e-11 Score=117.12 Aligned_cols=127 Identities=15% Similarity=0.172 Sum_probs=92.8
Q ss_pred eeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcc-eeeeEEecCCCCCCCCC
Q 003185 510 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV-EMYGHKISSKWLPSADG 588 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV-~l~g~~~~~~~~p~~~g 588 (840)
.+.|+.|.++.||++...+..+++|+...... ... .+.+|+.+++.+.+.+++ +++.+...
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-----~~~----~~~~E~~~l~~l~~~~~~P~~~~~~~~--------- 64 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-----LLI----NRENEAENSKLAAEAGIGPKLYYFDPE--------- 64 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc-----ccc----CHHHHHHHHHHHHHhCCCCceEEEeCC---------
Confidence 46789999999999999999999998542211 011 226789999988755544 45544321
Q ss_pred CCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCe-----ecccCCCCcEEEecc
Q 003185 589 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHI-----MHRDIKSENILIDLE 663 (840)
Q Consensus 589 ~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gI-----VHRDLKPeNILLd~~ 663 (840)
..++||||++|.++... . .....++.+++.+|+.||..++ +|+|++|.||+++ +
T Consensus 65 -------~~~lv~e~i~G~~l~~~--~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~ 123 (170)
T cd05151 65 -------TGVLITEFIEGSELLTE--D-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D 123 (170)
T ss_pred -------CCeEEEEecCCCccccc--c-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C
Confidence 12899999999877542 0 0113456899999999999985 9999999999998 3
Q ss_pred cccCCCCCeEEEeecCCcc
Q 003185 664 RKKADGKPVVKLCDFDRAV 682 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~ 682 (840)
..++|+|||.+.
T Consensus 124 -------~~~~liDf~~a~ 135 (170)
T cd05151 124 -------GRLWLIDWEYAG 135 (170)
T ss_pred -------CeEEEEeccccc
Confidence 248999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.8e-11 Score=140.67 Aligned_cols=254 Identities=22% Similarity=0.196 Sum_probs=177.4
Q ss_pred Cceeeeeecc--cCceEEEEEEE----CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEe
Q 003185 506 SLSSCDEAGK--SVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 578 (840)
Q Consensus 506 ~y~i~~~LG~--G~fG~Vy~a~~----~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~ 578 (840)
.+.+.+.+|. |.+|.||.+.. ....+|+|.-.+.... ....... .+|+...+.++ |+|.++.+..+.
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~-p~~~~~k-----~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSP-PLDSKRK-----LREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCC-ccccccc-----cchhhcccccCccccccccCcccc
Confidence 4567888999 99999999875 4566777763322211 1111111 56777777776 999999888877
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHH----HHHHHHhCCeecccCC
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAA----ALVELHSKHIMHRDIK 654 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~----AL~yLHs~gIVHRDLK 654 (840)
..+.. |+-+|++. .+|..+... ....++...++..+.+... ||.++|..+|+|-|+|
T Consensus 189 ~~~~l--------------fiqtE~~~-~sl~~~~~~----~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~k 249 (524)
T KOG0601|consen 189 GSGIL--------------FIQTELCG-ESLQSYCHT----PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLK 249 (524)
T ss_pred cCCcc--------------eeeecccc-chhHHhhhc----ccccCCchhhhhHHhhhhhcccccccccCCCcccccccc
Confidence 66543 99999996 688888775 2344788889999999999 9999999999999999
Q ss_pred CCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHH
Q 003185 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 734 (840)
Q Consensus 655 PeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSL 734 (840)
|.||++..+. ...+++|||+...+.......... ......|...|++||.+.+ .++...|||++
T Consensus 250 p~~i~~~~~~------~s~~~~df~~v~~i~~~~~~~~~~-----~~~r~~~~~~Y~~ke~~~~-----l~~~~~di~sl 313 (524)
T KOG0601|consen 250 PANIFTTSDW------TSCKLTDFGLVSKISDGNFSSVFK-----VSKRPEGDCIYAAKELLNG-----LATFASDIFSL 313 (524)
T ss_pred hhheeccccc------ceeecCCcceeEEccCCcccccee-----eeecCCCCceEeChhhhcc-----ccchHhhhcch
Confidence 9999998772 458999999998876543221110 0111247788999999874 67899999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003185 735 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 814 (840)
Q Consensus 735 GvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~D 814 (840)
|.++.+..++..++...-. .....+.+.. ++..+ ...-...+...+..|+..+
T Consensus 314 ~ev~l~~~l~~~~~~~g~~-~~W~~~r~~~---ip~e~-----------------------~~~~s~~l~~~~~~~~d~~ 366 (524)
T KOG0601|consen 314 GEVILEAILGSHLPSVGKN-SSWSQLRQGY---IPLEF-----------------------CEGGSSSLRSVTSQMLDED 366 (524)
T ss_pred hhhhHhhHhhcccccCCCC-CCcccccccc---Cchhh-----------------------hcCcchhhhhHHHHhcCcc
Confidence 9999999998776633200 0000011110 11111 1111234555899999999
Q ss_pred CCCCCCHHHHHHH
Q 003185 815 PTERPTAGDLYEM 827 (840)
Q Consensus 815 P~eRPSa~ELLeh 827 (840)
|..|++++.+.++
T Consensus 367 ~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 367 PRLRLTAQILTAL 379 (524)
T ss_pred hhhhhHHHHHhcc
Confidence 9999999988775
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.9e-11 Score=128.15 Aligned_cols=211 Identities=22% Similarity=0.261 Sum_probs=142.2
Q ss_pred HHhCCCCCcceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHH
Q 003185 562 LGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALV 641 (840)
Q Consensus 562 L~~L~HpNIV~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~ 641 (840)
|-++-|.|||+++.++.+...- ..+...+++||+..|+|.++|++..+. ...+......+|+.||+.||.
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~---------e~~rviFiteymssgs~~~fLkrt~~~-~~a~~~~~wkkw~tqIlsal~ 190 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYE---------EKPRVIFITEYMSSGSLKQFLKRTKKN-QKALFQKAWKKWCTQILSALS 190 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccc---------cccceEEEEecccchhHHHHHHHHHHh-hhhhhHHHHHHHHHHHHhhhh
Confidence 5556699999999998765532 456779999999999999999975444 367888899999999999999
Q ss_pred HHHhC--CeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcc
Q 003185 642 ELHSK--HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 719 (840)
Q Consensus 642 yLHs~--gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~ 719 (840)
|||+. .|+|+++..+-|++..+ +-+|+. -+.-.......... .. .......+-++|.+||.=..
T Consensus 191 yLhs~~PpiihgnlTc~tifiq~n-------gLIkig-~~ap~s~h~s~~~~----~~-~Ek~~~~~~~g~~a~~sg~~- 256 (458)
T KOG1266|consen 191 YLHSCDPPIIHGNLTCDTIFIQHN-------GLIKIG-SVAPDSTHPSVNST----RE-AEKSVNTSLPGFSAPESGTT- 256 (458)
T ss_pred hhhccCCccccCCcchhheeecCC-------ceEEec-ccCccccchhhhhh----hH-hhhhccccCCccccCCcCcc-
Confidence 99987 69999999999999866 335543 22111111000000 00 00111236688999997443
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhh
Q 003185 720 HKPNLYGLEVDIWSYGCLLLELLTLQVP-YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 798 (840)
Q Consensus 720 ~~~~~~s~kSDVWSLGvIL~ELLTG~~P-F~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 798 (840)
...+.++|||+||....+|..+..- -.+.+.......+.+... .+.
T Consensus 257 ---tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~-~le----------------------------- 303 (458)
T KOG1266|consen 257 ---TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVII-GLE----------------------------- 303 (458)
T ss_pred ---cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhee-ecc-----------------------------
Confidence 3456799999999999999887643 222222222222222110 000
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003185 799 TLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 799 ~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~ 830 (840)
...-.+++.+|++..|..||+|.+++-|.-.
T Consensus 304 -n~lqr~~i~kcl~~eP~~rp~ar~llfHpll 334 (458)
T KOG1266|consen 304 -NGLQRGSITKCLEGEPNGRPDARLLLFHPLL 334 (458)
T ss_pred -CccccCcCcccccCCCCCCcchhhhhcCcee
Confidence 0112467899999999999999999987543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.2e-11 Score=148.36 Aligned_cols=261 Identities=22% Similarity=0.253 Sum_probs=176.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..++.+.+.+.+-+|+++.++.+.-. +...+.|+..+...... ...+.. .++-.++-..++|-+++..--+..
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~-~~~~s~----r~~s~~~i~p~~P~v~~~~~s~~~ 875 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT-NDYESI----RSKSNILITPRSPAVVRSFPSFPC 875 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhcc-cccccc----CCccCccccCCCCceecccCCCCC
Confidence 47888999999999999999988742 22233333221111000 011111 223233322334545443322111
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
. ...+|||+|+.+++|...++. ....+.+.+...+..+..+++|||...++|+|++|.|+|
T Consensus 876 r--------------sP~~L~~~~~~~~~~~Skl~~-----~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l 936 (1205)
T KOG0606|consen 876 R--------------SPLPLVGHYLNGGDLPSKLHN-----SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLL 936 (1205)
T ss_pred C--------------CCcchhhHHhccCCchhhhhc-----CCCcccccccchhHHHHhhhhccccchhhcccccccchh
Confidence 1 235999999999999999986 234666777788888999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccc---------------------cccCCCCCCCcccCCCcccchhhhhc
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCC---------------------IAHRGIPAPDVCVGTPRWMAPEVLRA 718 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~---------------------~~~~~~~~~~~~vGT~~YmAPEvL~~ 718 (840)
+..+ +..++.|||............. .............||+.|.+||.+.+
T Consensus 937 ~~~~-------gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg 1009 (1205)
T KOG0606|consen 937 IAYD-------GHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG 1009 (1205)
T ss_pred hccc-------CCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc
Confidence 9888 4589999984433221110000 00001112345679999999999987
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhh
Q 003185 719 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 798 (840)
Q Consensus 719 ~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 798 (840)
......+|.|++|++++|.++|.+||....+.+++..|.+...+... ....
T Consensus 1010 ----~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~-------------------------g~~~ 1060 (1205)
T KOG0606|consen 1010 ----RRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPE-------------------------GPEE 1060 (1205)
T ss_pred ----ccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCC-------------------------Cccc
Confidence 55678999999999999999999999999999998887766432111 1112
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHH
Q 003185 799 TLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 799 ~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
.+...++++.+.+..+|.+|..+.
T Consensus 1061 ~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1061 GSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cChhhhhhhhhhhccCchhccCcc
Confidence 245688999999999999998766
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.3e-11 Score=137.57 Aligned_cols=252 Identities=23% Similarity=0.165 Sum_probs=177.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE---CCeeEEEEEEecccCCCC-hHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeE
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF---GSADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGH 576 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~---~~~~vAVKI~~lk~~~~~-~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~ 576 (840)
....+|..+..||.|.|+.|+.... ++..+++|-. ...... ..++.. +.|+.+...+. |.+++.++..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~--~~~l~~~~~di~s-----l~ev~l~~~l~~~~~~~g~~~~ 334 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL--LNGLATFASDIFS-----LGEVILEAILGSHLPSVGKNSS 334 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhh--hccccchHhhhcc-----hhhhhHhhHhhcccccCCCCCC
Confidence 3467788999999999999999875 3455666653 322222 222222 67888877776 9999987766
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
+.... +.||-.|||+++++...+.- ...+.+...+++..|++.++.++|+..++|+|+||+
T Consensus 335 W~~~r--------------~~~ip~e~~~~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~ps 395 (524)
T KOG0601|consen 335 WSQLR--------------QGYIPLEFCEGGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPS 395 (524)
T ss_pred ccccc--------------cccCchhhhcCcchhhhhHH-----HHhcCcchhhhhHHHHHhccccccchhhhccccccc
Confidence 55433 23788999999888776633 245788899999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCccc-chhhhhcccCCCCCCchhhHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYG 735 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~Ym-APEvL~~~~~~~~~s~kSDVWSLG 735 (840)
||++..++ +.-++.|||++..+.-.. ....+.-.++ .+|.+.. ...+..+.|+||||
T Consensus 396 ni~i~~~~------~~~~~~~~~~~t~~~~~~-------------~~~~~~~r~~p~~~~~~e---~~~~~~~~~~~sl~ 453 (524)
T KOG0601|consen 396 NILISNDG------FFSKLGDFGCWTRLAFSS-------------GVFHHIDRLYPIAEILLE---DYPHLSKADIFSLG 453 (524)
T ss_pred ceeeccch------hhhhccccccccccceec-------------ccccccccccccchhhcc---cccccccccccccc
Confidence 99998763 458999999986532211 1122333444 2555543 35678899999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 736 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 736 vIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
..+.+.+++...-.... ....|..+..+..+. ...++..+.+.++..++
T Consensus 454 ~~~~e~~~~~~ls~~~~---~~~~i~~~~~p~~~~----------------------------~~~~~q~~~kv~~~~~~ 502 (524)
T KOG0601|consen 454 LSVDEAITGSPLSESGV---QSLTIRSGDTPNLPG----------------------------LKLQLQVLLKVMINPDR 502 (524)
T ss_pred ccccccccCcccCcccc---cceeeecccccCCCc----------------------------hHHhhhhhhhhhcCCcc
Confidence 99999999875432221 112233333333221 12467889999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 003185 816 TERPTAGDLYEMFVART 832 (840)
Q Consensus 816 ~eRPSa~ELLehLe~l~ 832 (840)
..||.+.++..|.....
T Consensus 503 ~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 503 KRRPSAVELSLHSEFYR 519 (524)
T ss_pred ccchhhhhhcccchhhh
Confidence 99999999888766544
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=7.4e-09 Score=120.62 Aligned_cols=163 Identities=16% Similarity=0.203 Sum_probs=119.2
Q ss_pred CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCCCCccccceEEEEEeccCC
Q 003185 527 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG 606 (840)
Q Consensus 527 ~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~g 606 (840)
.+.++.|.+...... ... ....+-+..|+.|+||||++++..+..+.. .|||+|-+.
T Consensus 36 ~~~~vsVF~~~~~~~----~~~----~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~--------------~ylvTErV~- 92 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG----EVT----ELAKRAVKRLKTLRHPNILSYLDTTEEEGT--------------LYLVTERVR- 92 (690)
T ss_pred cCCceEEEEEeCCCc----hhh----HHHHHHHHHhhhccCchhhhhhhhhcccCc--------------eEEEeeccc-
Confidence 455666666544322 111 223677888999999999999999887664 499999995
Q ss_pred CCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCCCcEEEecccccCCCCCeEEEeecCCccccc
Q 003185 607 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 685 (840)
Q Consensus 607 GSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs-~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~ 685 (840)
.|..++++ +....+..-+.||+.||.|||+ .+++|++|.-+-|+|+..| ..||++|-++....
T Consensus 93 -Pl~~~lk~--------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-------eWkLggle~v~~~~ 156 (690)
T KOG1243|consen 93 -PLETVLKE--------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-------EWKLGGLELVSKAS 156 (690)
T ss_pred -cHHHHHHH--------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-------cEEEeeeEEEeccc
Confidence 89999886 3466778889999999999985 5899999999999999985 49999998876443
Q ss_pred ccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 003185 686 SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 744 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG 744 (840)
.... ......--..|..|+.+.. -....|.|-|||++||++.|
T Consensus 157 ~~~~----------~~~~~~~~~s~~~P~~~~~------s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 157 GFNA----------PAKSLYLIESFDDPEEIDP------SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCCc----------ccccchhhhcccChhhcCc------cccchhhhhHHHHHHHHhCc
Confidence 2211 0011112234666766532 12467999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.89 E-value=1e-08 Score=105.06 Aligned_cols=143 Identities=19% Similarity=0.177 Sum_probs=95.8
Q ss_pred eeecccCceEEEEEEECC-eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC--CCcceeeeEEecCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SCIVEMYGHKISSKWLPSAD 587 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~-~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~H--pNIV~l~g~~~~~~~~p~~~ 587 (840)
+.|+.|.++.||++...+ ..+++|+....... . ....+.+|+.+++.+.+ .++.+++.+.....
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~---~----~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~------ 70 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL---P----SAHDVAREYRVLRALAGTGVPVPKVLALCEDPS------ 70 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC---c----ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC------
Confidence 578999999999998865 78999985432211 0 11234889999999975 44566776654321
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------
Q 003185 588 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS---------------------- 645 (840)
Q Consensus 588 g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs---------------------- 645 (840)
.....++||||++|.+|...+.. ..++......++.+++.+|.+||+
T Consensus 71 -----~~~~~~~v~e~i~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~ 139 (223)
T cd05154 71 -----VLGTPFYVMERVDGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQV 139 (223)
T ss_pred -----ccCCceEEEEEeCCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHH
Confidence 01124899999999877664421 124445555555555555555552
Q ss_pred ----------------------------------CCeecccCCCCcEEEecccccCCCCCeEEEeecCCcc
Q 003185 646 ----------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 682 (840)
Q Consensus 646 ----------------------------------~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~ 682 (840)
..++|+|++|.|||++.+. ...+.|+||+.+.
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~-----~~~~~iID~e~~~ 205 (223)
T cd05154 140 ARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDE-----PRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCC-----CcEEEEEeccccc
Confidence 3579999999999998731 1458999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=5.5e-08 Score=105.09 Aligned_cols=151 Identities=16% Similarity=0.134 Sum_probs=99.5
Q ss_pred CceEEEEEEECCeeEEEEEEecccCCCChHHHHHhH------HhHHHHHHHHHhCCCCCc--ceeeeEEecCCCCCCCCC
Q 003185 517 VSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFE------YSCLGEVRMLGALRHSCI--VEMYGHKISSKWLPSADG 588 (840)
Q Consensus 517 ~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~------~~~~rEi~iL~~L~HpNI--V~l~g~~~~~~~~p~~~g 588 (840)
....|++..+++..+.||...... .....+.+. ..+.+|...+.+|..-+| +++++++......
T Consensus 34 ~~rrvvr~~~~g~~~~vKr~~~~~---~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~----- 105 (268)
T PRK15123 34 EGRRTLRFELAGKSYFLKWHRGTG---WGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP----- 105 (268)
T ss_pred CCceEEEEEECCEEEEEEEecCCc---HHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC-----
Confidence 334477888888899999653211 001111100 024789998888854343 3444454322110
Q ss_pred CCccccceEEEEEeccCCC-CHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccC
Q 003185 589 NPEHHLLQSAIFMEYVKGG-SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667 (840)
Q Consensus 589 ~~~~~~~~~~LVmEy~~gG-SL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~ 667 (840)
.....+||||++++. +|.+++.... ....+......++.+|+..+.-||..||+|+|+++.|||++.+....
T Consensus 106 ----~~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~ 178 (268)
T PRK15123 106 ----ATRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGR 178 (268)
T ss_pred ----ccceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCC
Confidence 122459999999975 8999986421 23456677889999999999999999999999999999998520001
Q ss_pred CCCCeEEEeecCCcc
Q 003185 668 DGKPVVKLCDFDRAV 682 (840)
Q Consensus 668 ~~~~~vKL~DFGlA~ 682 (840)
.+...+.|+||+.+.
T Consensus 179 ~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 179 EEDLKLSVIDLHRAQ 193 (268)
T ss_pred CCCceEEEEECCccc
Confidence 123679999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.7e-08 Score=103.57 Aligned_cols=132 Identities=20% Similarity=0.236 Sum_probs=84.8
Q ss_pred EEEEEEE-CCeeEEEEEEecccCCCCh------------------HHHHHhHHhHHHHHHHHHhCCCC--CcceeeeEEe
Q 003185 520 SLFRCKF-GSADAAAKVRTLKVCGSSA------------------DEIRNFEYSCLGEVRMLGALRHS--CIVEMYGHKI 578 (840)
Q Consensus 520 ~Vy~a~~-~~~~vAVKI~~lk~~~~~~------------------~~~~~f~~~~~rEi~iL~~L~Hp--NIV~l~g~~~ 578 (840)
.||.|.. .+..+|+|+.+........ ........+..+|++.|.++..- ++.+++++..
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~ 80 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR 80 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence 3899987 6789999999865433221 11112234668999999999855 5677775531
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccC--CCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHH-HHhCCeecccCCC
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVK--GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVE-LHSKHIMHRDIKS 655 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~--gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~y-LHs~gIVHRDLKP 655 (840)
+ +|||||++ |..+..+... .++......++.+++..+.. +|..||||+||.+
T Consensus 81 --~----------------~ivME~I~~~G~~~~~l~~~-------~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~ 135 (188)
T PF01163_consen 81 --N----------------VIVMEYIGEDGVPLPRLKDV-------DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSE 135 (188)
T ss_dssp --T----------------EEEEE--EETTEEGGCHHHC-------GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-ST
T ss_pred --C----------------EEEEEecCCCccchhhHHhc-------cccchhHHHHHHHHHHHHHHHHHhcCceecCCCh
Confidence 1 89999998 6555443321 22244567788888886665 5799999999999
Q ss_pred CcEEEecccccCCCCCeEEEeecCCcccc
Q 003185 656 ENILIDLERKKADGKPVVKLCDFDRAVPL 684 (840)
Q Consensus 656 eNILLd~~~~~~~~~~~vKL~DFGlA~~~ 684 (840)
.|||++.+ .+.|+|||.+...
T Consensus 136 ~NIlv~~~--------~~~iIDf~qav~~ 156 (188)
T PF01163_consen 136 YNILVDDG--------KVYIIDFGQAVDS 156 (188)
T ss_dssp TSEEEETT--------CEEE--GTTEEET
T ss_pred hhEEeecc--------eEEEEecCcceec
Confidence 99999866 3999999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=5.6e-07 Score=100.20 Aligned_cols=274 Identities=17% Similarity=0.134 Sum_probs=160.2
Q ss_pred eeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEecCCCCCCCC
Q 003185 509 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 587 (840)
Q Consensus 509 i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~~~~~~p~~~ 587 (840)
....||+|+-+.+|-.---+ +.+.||+..... ... .+-++.|... .||-+-.-+.|-...-+
T Consensus 15 ~gr~LgqGgea~ly~l~e~~-d~VAKIYh~Ppp---a~~--------aqk~a~la~~p~~p~~~~rvaWPqa~L~----- 77 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR-DQVAKIYHAPPP---AAQ--------AQKVAELAATPDAPLLNYRVAWPQATLH----- 77 (637)
T ss_pred CCccccCCccceeeecchhh-chhheeecCCCc---hHH--------HHHHHHhccCCCCcchhhhhcccHHHhh-----
Confidence 45789999999999754322 345566542221 111 1123334444 36654331221111000
Q ss_pred CCCccccceEEEEEeccCCCC-HHHHHHH-HhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccc
Q 003185 588 GNPEHHLLQSAIFMEYVKGGS-VKNYIEK-LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 665 (840)
Q Consensus 588 g~~~~~~~~~~LVmEy~~gGS-L~~~L~~-~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~ 665 (840)
.........++|+.+.|.- ...+... .....-..+.|..+++.++.|+.+.+.||..|.+-+|+.++|||+..++
T Consensus 78 --G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~- 154 (637)
T COG4248 78 --GGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS- 154 (637)
T ss_pred --CCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc-
Confidence 0011123689999988742 2222211 1122234577899999999999999999999999999999999999884
Q ss_pred cCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhh-cccCCCCCCchhhHHHHHHHHHHHHhC
Q 003185 666 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR-AMHKPNLYGLEVDIWSYGCLLLELLTL 744 (840)
Q Consensus 666 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~-~~~~~~~~s~kSDVWSLGvIL~ELLTG 744 (840)
.|.|.|=..-......... .--+|...|.+||.-. +...+..-+...|.|.||+++++|+.|
T Consensus 155 ------~V~LVdsDsfqi~~ng~~~-----------~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~g 217 (637)
T COG4248 155 ------KVVLVDSDSFQINANGTLH-----------LCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFG 217 (637)
T ss_pred ------eEEEEcccceeeccCCceE-----------ecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhc
Confidence 4788764322211111111 1136899999999865 222223456789999999999999997
Q ss_pred -CCCCCCCCH-----HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCC---chhhhhhHHHHHHHHHHhccc--
Q 003185 745 -QVPYMGLSE-----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK---PEAELETLSFLVDVFRRCTEE-- 813 (840)
Q Consensus 745 -~~PF~~~~~-----~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~s~~L~dLI~rCL~~-- 813 (840)
+.||.+... ......|..+....-+ +...+... .....-.++.+..|+.+|+..
T Consensus 218 grHPysGI~~~~~ap~p~E~~Ia~g~f~ya~---------------~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~ 282 (637)
T COG4248 218 GRHPYSGIPLISDAPNPLETDIAHGRFAYAS---------------DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESG 282 (637)
T ss_pred CCCCCCcccccCCCCCcchhhhhcceeeech---------------hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccC
Confidence 999976421 1111122222111000 00111100 011122356788899999875
Q ss_pred CCCCCCCHHHHHHHHHhhcCC
Q 003185 814 NPTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 814 DP~eRPSa~ELLehLe~l~~~ 834 (840)
++.-|||++..+..|.++.+.
T Consensus 283 ~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 283 VATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred CCCCCCCHHHHHHHHHHHHHh
Confidence 366899999998888776544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.7e-07 Score=95.69 Aligned_cols=111 Identities=23% Similarity=0.237 Sum_probs=85.6
Q ss_pred hHHHHHHHHHhCCC--CCcceeeeEEecCCCCCCCCCCCccccceEEEEEeccCC-CCHHHHHHHHhccCCCCCCHHHHH
Q 003185 554 SCLGEVRMLGALRH--SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLAL 630 (840)
Q Consensus 554 ~~~rEi~iL~~L~H--pNIV~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~g-GSL~~~L~~~~~~~~~~ls~~~~~ 630 (840)
+..+|...+.+|.. -.+++.+++....... ....+||||++++ .+|.+++... ..++.....
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~----------~~~s~lite~l~~~~~L~~~~~~~-----~~~~~~~~~ 121 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGG----------GYRSYLITEALPGAQDLRDLLQQW-----EQLDPSQRR 121 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCC----------ceeEEEEEEeCCCcccHHHHHHhh-----cccchhhHH
Confidence 44788888888863 3345666666543321 1356999999987 4899998752 226677888
Q ss_pred HHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCccc
Q 003185 631 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 683 (840)
Q Consensus 631 ~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~ 683 (840)
.++.+++..+.-||.+||+|+|+++.|||++.++ +...+.|+||+.++.
T Consensus 122 ~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~----~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 122 ELLRALARLIAKLHDAGIYHGDLNPSNILVDPDD----GQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCC----CceeEEEEcchhcee
Confidence 9999999999999999999999999999999874 345799999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.7e-06 Score=98.60 Aligned_cols=220 Identities=16% Similarity=0.084 Sum_probs=144.7
Q ss_pred CceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCCCCcccc
Q 003185 517 VSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594 (840)
Q Consensus 517 ~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g~~~~~~ 594 (840)
-..+.|++.. .|..|++|............ ...=+++++++.|+|||++.++|.+... +-
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk--------~t~lve~wkkl~h~NvV~frevf~t~tF----------~D 349 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNK--------DTSLVEAWKKLCHTNVVPFREVFLTYTF----------GD 349 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCccc--------chHHHHHHHHhccCceeehhhhhhhhcc----------Cc
Confidence 3467888875 55566666542221111111 1345678999999999999999985443 23
Q ss_pred ceEEEEEeccCC-CCHHHHHHHH----------hccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 595 LQSAIFMEYVKG-GSVKNYIEKL----------SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 595 ~~~~LVmEy~~g-GSL~~~L~~~----------~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
..+++|++|+++ ++|.++--.- ....+...++..+|.++.||..||.++|+.|+.-+-|.|.+||++.+
T Consensus 350 ~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~ 429 (655)
T KOG3741|consen 350 LSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGK 429 (655)
T ss_pred ceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCc
Confidence 357999999986 5777764221 11223567889999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
..++|+.-|+...+.... + |.+.+ -.+-|.=.||.+++.|.|
T Consensus 430 -------~RIriS~C~i~Dvl~~d~-----------------~-------~~le~-------~Qq~D~~~lG~ll~aLAt 471 (655)
T KOG3741|consen 430 -------MRIRISGCGIMDVLQEDP-----------------T-------EPLES-------QQQNDLRDLGLLLLALAT 471 (655)
T ss_pred -------ceEEEecccceeeecCCC-----------------C-------cchhH-------HhhhhHHHHHHHHHHHhh
Confidence 457887777654433211 0 12222 236799999999999999
Q ss_pred CCCC-CCCCCHHHH-HHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 744 LQVP-YMGLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 744 G~~P-F~~~~~~el-~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
|..- +......+. ...|.. ..+.++.++|.-....++.+ -++
T Consensus 472 ~~~ns~~~d~~~~s~~~~I~~-----------------------------------~yS~D~rn~v~yl~s~~~~~-ksI 515 (655)
T KOG3741|consen 472 GTENSNRTDSTQSSHLTRITT-----------------------------------TYSTDLRNVVEYLESLNFRE-KSI 515 (655)
T ss_pred cccccccccchHHHHHHHhhh-----------------------------------hhhHHHHHHHHHHHhcCccc-ccH
Confidence 9643 222222222 222221 12446677777777777776 666
Q ss_pred HHHHHHH
Q 003185 822 GDLYEMF 828 (840)
Q Consensus 822 ~ELLehL 828 (840)
.+++.++
T Consensus 516 ~~llp~~ 522 (655)
T KOG3741|consen 516 QDLLPMI 522 (655)
T ss_pred HHHHHHH
Confidence 6766654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.1e-06 Score=91.52 Aligned_cols=148 Identities=14% Similarity=0.108 Sum_probs=101.6
Q ss_pred cccCceEEEEEEECCeeEEEEEEecccCC--CChHHHHHhHHhHHHHHHHHHhCCCCC--cceeeeEEecCCCCCCCCCC
Q 003185 514 GKSVSSSLFRCKFGSADAAAKVRTLKVCG--SSADEIRNFEYSCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADGN 589 (840)
Q Consensus 514 G~G~fG~Vy~a~~~~~~vAVKI~~lk~~~--~~~~~~~~f~~~~~rEi~iL~~L~HpN--IV~l~g~~~~~~~~p~~~g~ 589 (840)
|+||.+.|++....+..+-+|--.-.... ..... ...|.+|+..|.+|..-+ +.++. ++.....
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g----~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~------- 94 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFG----RPTIVREVAVIKELERAGVIVPKIV-FGEAVKI------- 94 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCC----chHHHHHHHHHHHHHHcCCCCCccc-eeeeecc-------
Confidence 56899999999887776666643211000 00111 234589999999986322 44444 2221111
Q ss_pred CccccceEEEEEeccCC-CCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCC
Q 003185 590 PEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 668 (840)
Q Consensus 590 ~~~~~~~~~LVmEy~~g-GSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~ 668 (840)
....+.+||+|-+.| .+|.+++.+ ....+.+......++.+|+..+.-||+.|+.|+|+.+.|||++.++
T Consensus 95 --~~~~rA~LVTe~L~g~~~L~~~l~~---~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g---- 165 (216)
T PRK09902 95 --EGEWRALLVTEDMAGFISIADWYAQ---HAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG---- 165 (216)
T ss_pred --CCceEEEEEEEeCCCCccHHHHHhc---CCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC----
Confidence 123467999998864 589998864 2223567788889999999999999999999999999999998653
Q ss_pred CCCeEEEeecCCccc
Q 003185 669 GKPVVKLCDFDRAVP 683 (840)
Q Consensus 669 ~~~~vKL~DFGlA~~ 683 (840)
...++++||--++.
T Consensus 166 -~~~v~lIDlEk~r~ 179 (216)
T PRK09902 166 -KAEAGFLDLEKSRR 179 (216)
T ss_pred -CeeEEEEEhhccch
Confidence 25699999987653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.1e-07 Score=111.38 Aligned_cols=155 Identities=19% Similarity=0.163 Sum_probs=103.3
Q ss_pred HHHHHHHHHhC-CeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchh
Q 003185 636 VAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714 (840)
Q Consensus 636 Ia~AL~yLHs~-gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPE 714 (840)
++.||.|+|+. ++||+.|.|++|.++.. +.+||+.|+.+..........+.. -....+-.......|.|||
T Consensus 108 v~dgl~flh~sAk~VH~ni~p~~i~~na~-------~~wkl~Gf~f~v~~~~~~~~p~~~-yd~~lp~~~~~~~~f~apE 179 (700)
T KOG2137|consen 108 VADGLAFLHRSAKVVHGNIQPEAIVVNAN-------GDWKLAGFSFCVNANGPTEYPFSE-YDPPLPLLLQPHLNFLAPE 179 (700)
T ss_pred ccchhhhhccCcceeecccchhheeeccC-------cceeeccchhhhccCCCCcccccc-CCCCCChhhccCcccccch
Confidence 34999999987 89999999999999988 459999999887655432221111 1111223344667899999
Q ss_pred hhhcccCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCc
Q 003185 715 VLRAMHKPNLYGLEVDIWSYGCLLLELL-TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP 793 (840)
Q Consensus 715 vL~~~~~~~~~s~kSDVWSLGvIL~ELL-TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~ 793 (840)
++.+ ...+.++|+||+||++|.+. .|+..+......... ....... ... ..
T Consensus 180 ~~~~----~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~~-~~~----------------------~~ 231 (700)
T KOG2137|consen 180 YLLG----TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNLL-NAG----------------------AF 231 (700)
T ss_pred hhcc----ccccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhccc-ccc----------------------cc
Confidence 9986 56689999999999999998 455555433221111 1111100 000 00
Q ss_pred hhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003185 794 EAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826 (840)
Q Consensus 794 ~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLe 826 (840)
......+.++.+=|.++|..++..||++.+++.
T Consensus 232 ~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 232 GYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred cccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 111344668899999999999999997776654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.8e-06 Score=92.36 Aligned_cols=141 Identities=18% Similarity=0.202 Sum_probs=100.6
Q ss_pred eeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHH--------------HHHhHHhHHHHHHHHHhCCCC--Cc
Q 003185 508 SSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADE--------------IRNFEYSCLGEVRMLGALRHS--CI 570 (840)
Q Consensus 508 ~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~--------------~~~f~~~~~rEi~iL~~L~Hp--NI 570 (840)
.++.+||-|--+.||.|.. .+.++|+|+-+.-........ +..-+....+|..+|.+|.-. .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4678999999999999998 589999998775432221100 000112347899999999643 56
Q ss_pred ceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Q 003185 571 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 650 (840)
Q Consensus 571 V~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVH 650 (840)
.+.+++- ...+||||++|--|... ++..+..-.++..|+.-+..+-..||||
T Consensus 174 P~P~~~n------------------RHaVvMe~ieG~eL~~~----------r~~~en~~~il~~il~~~~~~~~~GiVH 225 (304)
T COG0478 174 PKPIAWN------------------RHAVVMEYIEGVELYRL----------RLDVENPDEILDKILEEVRKAYRRGIVH 225 (304)
T ss_pred CCccccc------------------cceeeeehcccceeecc----------cCcccCHHHHHHHHHHHHHHHHHcCccc
Confidence 6666542 23899999998554332 2234556667777777777777899999
Q ss_pred ccCCCCcEEEecccccCCCCCeEEEeecCCccc
Q 003185 651 RDIKSENILIDLERKKADGKPVVKLCDFDRAVP 683 (840)
Q Consensus 651 RDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~ 683 (840)
+|+.+-|||++.++ .++++||--+..
T Consensus 226 GDlSefNIlV~~dg-------~~~vIDwPQ~v~ 251 (304)
T COG0478 226 GDLSEFNILVTEDG-------DIVVIDWPQAVP 251 (304)
T ss_pred cCCchheEEEecCC-------CEEEEeCccccc
Confidence 99999999999984 499999976543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.33 E-value=9.1e-06 Score=85.17 Aligned_cols=148 Identities=11% Similarity=0.115 Sum_probs=95.3
Q ss_pred CCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhH--HhHHHHHHHHHhCC---CCCcceeeeEEec
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFE--YSCLGEVRMLGALR---HSCIVEMYGHKIS 579 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~--~~~~rEi~iL~~L~---HpNIV~l~g~~~~ 579 (840)
++|.+.+.+-......|.+....+..+++|..+-+... .......|. ....+++..+.+++ --.++.++-+...
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred CCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 57888899988888999999999999999986543211 111111110 01133444444443 3333443333332
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.... -....+|||||++|..|.++.. +++ .+...|+.++.-||..|++|+|..|.|++
T Consensus 110 k~~~---------~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFl 167 (229)
T PF06176_consen 110 KIFR---------YTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFL 167 (229)
T ss_pred eecc---------ceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEE
Confidence 2210 1223468999999987766532 222 24566788899999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCccc
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVP 683 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~ 683 (840)
++.+ .++++||+..+.
T Consensus 168 v~~~--------~i~iID~~~k~~ 183 (229)
T PF06176_consen 168 VSNN--------GIRIIDTQGKRM 183 (229)
T ss_pred EECC--------cEEEEECccccc
Confidence 9865 399999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.29 E-value=9.2e-06 Score=84.14 Aligned_cols=147 Identities=18% Similarity=0.217 Sum_probs=101.5
Q ss_pred CCceeeeeecccCc-eEEEEEEECCeeEEEEEEec---ccCCCChHH----------HHHhHHhHHHHHHHHHhCC---C
Q 003185 505 PSLSSCDEAGKSVS-SSLFRCKFGSADAAAKVRTL---KVCGSSADE----------IRNFEYSCLGEVRMLGALR---H 567 (840)
Q Consensus 505 ~~y~i~~~LG~G~f-G~Vy~a~~~~~~vAVKI~~l---k~~~~~~~~----------~~~f~~~~~rEi~iL~~L~---H 567 (840)
.+++.++.||.|.- |.||++..++..+|+|++.. .......+. ...+...|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 67899999999999 99999999999999999332 111111000 1133446788999888876 5
Q ss_pred CCc--ceeeeEEecCC--CCCC--CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHH
Q 003185 568 SCI--VEMYGHKISSK--WLPS--ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALV 641 (840)
Q Consensus 568 pNI--V~l~g~~~~~~--~~p~--~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~ 641 (840)
.++ |+.+||..-.. .... .++......+...||.||++... .+.. .-+.+|.+-|.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~~----~~~~~~~~dl~ 178 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQI----RDIPQMLRDLK 178 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccch----hHHHHHHHHHH
Confidence 566 99999986441 0000 01223334556789999987532 1222 23466777788
Q ss_pred HHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCc
Q 003185 642 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA 681 (840)
Q Consensus 642 yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA 681 (840)
.+|..||+-+|+|+.|..= -||+|||.+
T Consensus 179 ~~~k~gI~~~Dv~~~ny~~------------G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKLGIVPRDVKPRNYRG------------GKLVDFSSS 206 (207)
T ss_pred HHHHCCeeeccCccccccC------------CEEEecccC
Confidence 9999999999999999872 489999965
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.4e-05 Score=83.11 Aligned_cols=144 Identities=14% Similarity=0.123 Sum_probs=100.5
Q ss_pred eeeecccCceEEEEEEE-CCeeEEEEEEecccCCCCh----------------HHHHHhHHhHHHHHHHHHhCC--CCCc
Q 003185 510 CDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSA----------------DEIRNFEYSCLGEVRMLGALR--HSCI 570 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~----------------~~~~~f~~~~~rEi~iL~~L~--HpNI 570 (840)
...|..|--+.||+|.. .+..+|+|+++........ ...+.......+|+..|+++. +-.+
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 44778888899999985 6889999999865433221 011112234577888888885 4555
Q ss_pred ceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCC-HHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCe
Q 003185 571 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS-VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHI 648 (840)
Q Consensus 571 V~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGS-L~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs-~gI 648 (840)
.+.+++.. -.|||||+.... -.-.|+ ...+...++..+..++++.+.-|-. .++
T Consensus 133 P~Pi~~~~------------------nVLvMEfIg~~g~pAP~Lk------Dv~~e~~e~~~~~~~~v~~~~~l~~~a~L 188 (268)
T COG1718 133 PEPIAFRN------------------NVLVMEFIGDDGLPAPRLK------DVPLELEEAEGLYEDVVEYMRRLYKEAGL 188 (268)
T ss_pred CCceeecC------------------CeEEEEeccCCCCCCCCcc------cCCcCchhHHHHHHHHHHHHHHHHHhcCc
Confidence 66666543 279999996421 111111 1233444788899999999999988 899
Q ss_pred ecccCCCCcEEEecccccCCCCCeEEEeecCCccccc
Q 003185 649 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 685 (840)
Q Consensus 649 VHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~ 685 (840)
||+||..=|||+..+ .+.|+|||-|....
T Consensus 189 VHgDLSEyNiL~~~~--------~p~iID~~QaV~~~ 217 (268)
T COG1718 189 VHGDLSEYNILVHDG--------EPYIIDVSQAVTID 217 (268)
T ss_pred ccccchhhheEEECC--------eEEEEECccccccC
Confidence 999999999999833 59999999887554
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.97 E-value=2.9e-05 Score=91.08 Aligned_cols=146 Identities=17% Similarity=0.219 Sum_probs=92.3
Q ss_pred eeecccCceEEEEEEEC-CeeEEEEEEecccCC--------------------------CChHHHHHhHHh------HHH
Q 003185 511 DEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCG--------------------------SSADEIRNFEYS------CLG 557 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~--------------------------~~~~~~~~f~~~------~~r 557 (840)
+.|+.++-|+||+|++. |+.|||||.+..... ......++|.+. +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67899999999999985 899999996632211 111223333333 355
Q ss_pred HHHHHHhCC-----CCCc--ceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHH
Q 003185 558 EVRMLGALR-----HSCI--VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLAL 630 (840)
Q Consensus 558 Ei~iL~~L~-----HpNI--V~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~ 630 (840)
|+..+.+++ .|+| .++|--+.. ...|+|||++|-.+.+..... ...++. .
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~----------------~~VLtmE~i~Gi~i~d~~~l~----~~g~d~---k 267 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTT----------------RRVLTMEWIDGIKISDIAALK----SAGIDR---K 267 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccC----------------CcEEEEEeeCCEecccHHHHH----hcCCCH---H
Confidence 565565553 2332 222211111 238999999998888885431 123442 2
Q ss_pred HHHHHHHHH-HHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccc
Q 003185 631 FIAQDVAAA-LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 686 (840)
Q Consensus 631 ~Ia~QIa~A-L~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~ 686 (840)
.++..++++ +..+-..|++|.|.+|.||+++.+ +.+.+.|||+...+..
T Consensus 268 ~ia~~~~~~f~~q~~~dgffHaDpHpGNi~v~~~-------g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 268 ELAELLVRAFLRQLLRDGFFHADPHPGNILVRSD-------GRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHHHHHHHHhcCccccCCCccceEEecC-------CcEEEEcCcceecCCH
Confidence 333333333 344445899999999999999988 4599999999877654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00013 Score=74.92 Aligned_cols=81 Identities=15% Similarity=0.175 Sum_probs=55.6
Q ss_pred eeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCC--CcceeeeEEecCCCCCCCC
Q 003185 510 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS--CIVEMYGHKISSKWLPSAD 587 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~Hp--NIV~l~g~~~~~~~~p~~~ 587 (840)
++.|+.|..+.||+....+..+++|+.... ... ..+.+|+.++..|... .+.+++........
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~------~~~----~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~----- 66 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP------DAA----ERLRREAAVLRQLAEHGIPVPRVLAFDTSDEF----- 66 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH------HHH----HHHHHHHHHHHHHHHTTSBS--EEEEEEETEE-----
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC------CCH----HHHHHHHHHHHHHHhcCCCCceEEeecccccc-----
Confidence 468999999999999998889999985321 122 2347888888888633 35667764433221
Q ss_pred CCCccccceEEEEEeccCCCCHHH
Q 003185 588 GNPEHHLLQSAIFMEYVKGGSVKN 611 (840)
Q Consensus 588 g~~~~~~~~~~LVmEy~~gGSL~~ 611 (840)
....+++|++++|..+..
T Consensus 67 ------~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 67 ------NGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp ------TSEEEEEEEEESSEEHHH
T ss_pred ------cccceEEEEEeccccccc
Confidence 123699999999987777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00012 Score=77.40 Aligned_cols=72 Identities=8% Similarity=0.022 Sum_probs=48.2
Q ss_pred eeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCC--cceeeeEEecCCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADG 588 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpN--IV~l~g~~~~~~~~p~~~g 588 (840)
..||+|..+.||+.. +..+++|+.... ... . .+.+|.+++..+..-. +.+++++....+.
T Consensus 7 ~~i~~G~t~~~y~~~--~~~~VlR~~~~~---~~~---~----~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~------ 68 (226)
T TIGR02172 7 TQTGEGGNGESYTHK--TGKWMLKLYNPG---FDK---E----TIKREFDASRKVFSLGIPTPHPFDLVEDGGR------ 68 (226)
T ss_pred eeecCCCCcceeEec--CCCEEEEeCCCC---CCH---H----HHHHHHHHHHHHHHcCCCCCceEEEEecCCe------
Confidence 578999999999843 456778875421 111 1 2378999998886433 4666766654432
Q ss_pred CCccccceEEEEEeccCCCC
Q 003185 589 NPEHHLLQSAIFMEYVKGGS 608 (840)
Q Consensus 589 ~~~~~~~~~~LVmEy~~gGS 608 (840)
.++|||+++|.+
T Consensus 69 --------~glv~e~i~G~~ 80 (226)
T TIGR02172 69 --------LGLIYELIVGKR 80 (226)
T ss_pred --------eeeeeeecCCcc
Confidence 378999999863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.85 E-value=7.2e-05 Score=75.80 Aligned_cols=129 Identities=23% Similarity=0.225 Sum_probs=90.5
Q ss_pred ceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcc-eeeeEEecCCCCCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV-EMYGHKISSKWLPS 585 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV-~l~g~~~~~~~~p~ 585 (840)
....+.||+|.+|.||++.|.+..+|+|+.+-+. ... .+..|+++|..+.-.++. ++|.+..
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds------~r~----~l~kEakiLeil~g~~~~p~vy~yg~------- 86 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS------PRR----NLEKEAKILEILAGEGVTPEVYFYGE------- 86 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecCCc------chh----hHHHHHHHHHHhhhcCCCceEEEech-------
Confidence 3567899999999999999999999999865331 222 338899999999866663 4554432
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCC-CC-cEEEecc
Q 003185 586 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK-SE-NILIDLE 663 (840)
Q Consensus 586 ~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLK-Pe-NILLd~~ 663 (840)
-++.|||+.|-.|...-.. ... +-+..++.+---|-..||-|+.|. |. ||++...
T Consensus 87 -----------~~i~me~i~G~~L~~~~~~--------~~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~ 143 (201)
T COG2112 87 -----------DFIRMEYIDGRPLGKLEIG--------GDR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR 143 (201)
T ss_pred -----------hhhhhhhhcCcchhhhhhc--------ccH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCC
Confidence 1677999998888776542 122 223445555445666799999997 44 5555432
Q ss_pred cccCCCCCeEEEeecCCccc
Q 003185 664 RKKADGKPVVKLCDFDRAVP 683 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~ 683 (840)
.+.|+||..|+.
T Consensus 144 --------~~~iIDFd~At~ 155 (201)
T COG2112 144 --------DVYIIDFDSATF 155 (201)
T ss_pred --------cEEEEEccchhh
Confidence 399999998863
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00022 Score=75.22 Aligned_cols=75 Identities=12% Similarity=0.032 Sum_probs=49.3
Q ss_pred ecccCc-eEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEecCCCCCCCCCCC
Q 003185 513 AGKSVS-SSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSADGNP 590 (840)
Q Consensus 513 LG~G~f-G~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~~~~~p~~~g~~ 590 (840)
|-.|.+ ..||+....+..+.+|+..... .. .+.+|+.+++.+. +--+.+++++.....
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-------~~----~~~~E~~~l~~l~~~~~vP~v~~~~~~~~--------- 65 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP-------TY----ELEREAERLRWLAGKLPVPEVIDYGSDDG--------- 65 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc-------cc----chHHHHHHHHHHHhcCCCCeEEEEEecCC---------
Confidence 444555 7899998776788888753211 11 2367888888885 444567777655332
Q ss_pred ccccceEEEEEeccCCCCHHHH
Q 003185 591 EHHLLQSAIFMEYVKGGSVKNY 612 (840)
Q Consensus 591 ~~~~~~~~LVmEy~~gGSL~~~ 612 (840)
..++|||+++|.+|...
T Consensus 66 -----~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 66 -----RAWLLTSAVPGVPAAAL 82 (244)
T ss_pred -----ccEEEEEeeCCccHhHh
Confidence 23899999998777643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00023 Score=88.57 Aligned_cols=81 Identities=19% Similarity=0.199 Sum_probs=53.0
Q ss_pred eeeecccCceEEEEEEECC----eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCc--ceeeeEEecCCC
Q 003185 510 CDEAGKSVSSSLFRCKFGS----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCI--VEMYGHKISSKW 582 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~----~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNI--V~l~g~~~~~~~ 582 (840)
...|+.|.+..+|+..+.+ ..+++|.......... . ..+.+|+.+|+.|. |++| .+++.++.+...
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~---~----~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS---A----HAVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc---H----HHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 6778999999999988744 3566665322111111 1 13478999999996 6665 777777654321
Q ss_pred CCCCCCCCccccceEEEEEeccCCCC
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGS 608 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGS 608 (840)
. ...|+||||++|..
T Consensus 116 ~-----------G~~flVME~v~G~~ 130 (822)
T PLN02876 116 I-----------GTAFYIMEYLEGRI 130 (822)
T ss_pred C-----------CCceEEEEecCCcc
Confidence 1 23489999999754
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00017 Score=84.65 Aligned_cols=151 Identities=16% Similarity=0.202 Sum_probs=90.9
Q ss_pred eeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChH-----------------------HHHHhHHh------HHHHH
Q 003185 510 CDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSAD-----------------------EIRNFEYS------CLGEV 559 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~-----------------------~~~~f~~~------~~rEi 559 (840)
.+.||.-+.|.||+|+. ++..|||||-+......-.. -.+++.+. |.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 46789999999999997 67889999855322111100 11222222 34444
Q ss_pred HHHHhC----CCCC------cceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHH
Q 003185 560 RMLGAL----RHSC------IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA 629 (840)
Q Consensus 560 ~iL~~L----~HpN------IV~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~ 629 (840)
+...++ .|-+ |.++|-.+.. ...|+|||++|..+.+.-.- . ...++...+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----------------~RVLtME~~~G~~i~Dl~~i-~---~~gi~~~~i 305 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLST----------------KRVLTMEYVDGIKINDLDAI-D---KRGISPHDI 305 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCc----------------ceEEEEEecCCccCCCHHHH-H---HcCCCHHHH
Confidence 443333 3444 4444432221 34899999999766554321 1 134555533
Q ss_pred HHHHHHHHHH-HHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccc
Q 003185 630 LFIAQDVAAA-LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 686 (840)
Q Consensus 630 ~~Ia~QIa~A-L~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~ 686 (840)
+..+.++ +.-|-..|++|+|=+|.||++..+. .+...+.+-|||+...+..
T Consensus 306 ---~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~---~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 306 ---LNKLVEAYLEQIFKTGFFHADPHPGNILVRPNP---EGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ---HHHHHHHHHHHHHhcCCccCCCCCCcEEEecCC---CCCccEEEEcccccccccH
Confidence 3333333 2223456899999999999999653 2447799999999876654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.60 E-value=6.9e-06 Score=95.76 Aligned_cols=186 Identities=20% Similarity=0.143 Sum_probs=130.0
Q ss_pred ceeeeeecccCceEEEEEEECCeeEE-EEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCC-cceeeeEEecCCCCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKFGSADAA-AKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC-IVEMYGHKISSKWLP 584 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~~~vA-VKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpN-IV~l~g~~~~~~~~p 584 (840)
+...+.+++|+++.+++.+...+... .+++... . . ..-++++|.+++||| .+..++-+..+.
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l--~----~rl~~eLLdK~n~P~~~v~~~~d~~~E~--- 307 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------L--S----RRLAIELLDKVNNPNPVVRYLEDYDGED--- 307 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-------h--h----hHHHHHHHHHccCCCCcccccccCCccc---
Confidence 56788899999999999986444333 3332211 1 1 155888999999999 555555444333
Q ss_pred CCCCCCccccceEEEEEeccCCC-CHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 585 SADGNPEHHLLQSAIFMEYVKGG-SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 585 ~~~g~~~~~~~~~~LVmEy~~gG-SL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
..+|+|+++.++ +-...+.. ....+.......+.+.-+++|++||+.--+|+| ||+....
T Consensus 308 -----------~~~i~~~i~s~~rs~~~~~~~----se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~ 368 (829)
T KOG0576|consen 308 -----------YLWIPMRICSTGRSSALEMTV----SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE 368 (829)
T ss_pred -----------ccchhhhhhcCCccccccCCh----hhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc
Confidence 459999999876 22111110 012233344556677778899999998779999 8888764
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
..++.||+....+.... .++...+|+.|+|||+... ..+....|+|++|+-..+|.-
T Consensus 369 --------~~~~~~~~v~~~L~~~~-----------~~~t~~~~~~~~~pev~~~----~~~~~~p~~~~~~~~~~~~ap 425 (829)
T KOG0576|consen 369 --------EVKLLDFAVPPQLTRTM-----------KPRTAIGTPEPLAPEVIQE----NTIDGCPDSGSLAVSAIQMAP 425 (829)
T ss_pred --------ccccccccCCcccCccc-----------ccccCCCCCCCCCchhhcc----cccccCCCccCCCcchhhcCC
Confidence 48999999987665532 2355679999999998876 677889999999998888877
Q ss_pred CCCCCCC
Q 003185 744 LQVPYMG 750 (840)
Q Consensus 744 G~~PF~~ 750 (840)
|-+|-..
T Consensus 426 ~~pPr~~ 432 (829)
T KOG0576|consen 426 GLPPRSS 432 (829)
T ss_pred CCCCCCC
Confidence 7777543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00088 Score=69.58 Aligned_cols=140 Identities=17% Similarity=0.228 Sum_probs=93.0
Q ss_pred eeeecccCceEEEEEEECCeeEEEEEEecccCCC------------ChHHHHHhHHhHHHHHHHHHhCC------CCCcc
Q 003185 510 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGS------------SADEIRNFEYSCLGEVRMLGALR------HSCIV 571 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~------------~~~~~~~f~~~~~rEi~iL~~L~------HpNIV 571 (840)
...||+|+.-.||.--. +....|||........ ..... .+..+|+.....+. +.+|.
T Consensus 6 ~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~----~~~~~E~~~y~~l~~~~~~~~~~i~ 80 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRY----RQNRRELRYYKQLSLRRGVDWSHIP 80 (199)
T ss_pred CcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchh----HHHHHHHHHHHHHhhccCCcccccc
Confidence 45789999999987543 3446777765443000 00111 22366666665555 88999
Q ss_pred eeeeEEecCCCCCCCCCCCccccceEEEEEeccCC------CCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 003185 572 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG------GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS 645 (840)
Q Consensus 572 ~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~g------GSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs 645 (840)
+++|+..++... .+|+|.+.. .+|.+++.. ..++. . +...+-.-..||-.
T Consensus 81 r~~G~veT~~G~--------------Glv~e~I~d~dG~~s~TL~~~l~~------~~~~~-~---~~~~L~~f~~~l~~ 136 (199)
T PF10707_consen 81 RFYGFVETNLGL--------------GLVVELIRDADGNISPTLEDYLKE------GGLTE-E---LRQALDEFKRYLLD 136 (199)
T ss_pred cEeEEEecCCce--------------EEEEEEEECCCCCcCccHHHHHHc------CCccH-H---HHHHHHHHHHHHHH
Confidence 999999877643 889987643 378888864 34555 3 33444455678889
Q ss_pred CCeecccCCCCcEEEecccccCCCCCeEEEee-cCCc
Q 003185 646 KHIMHRDIKSENILIDLERKKADGKPVVKLCD-FDRA 681 (840)
Q Consensus 646 ~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~D-FGlA 681 (840)
.+|+.+||+|.||++....+ +...+.|+| ||..
T Consensus 137 ~~Iv~~dl~~~NIv~~~~~~---~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 137 HHIVIRDLNPHNIVVQRRDS---GEFRLVLIDGLGEK 170 (199)
T ss_pred cCCeecCCCcccEEEEecCC---CceEEEEEeCCCCc
Confidence 99999999999999987743 334678887 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00065 Score=84.38 Aligned_cols=250 Identities=17% Similarity=0.161 Sum_probs=153.7
Q ss_pred eeeeecccCceEEEEEEECC------eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 509 SCDEAGKSVSSSLFRCKFGS------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 509 i~~~LG~G~fG~Vy~a~~~~------~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
+...|..-.+|+++...|.- .++-++-..... .....++ +...-|+..+.++.|+|++.++.|......
T Consensus 182 vy~~ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~-~~~k~~i----~~~E~e~~~l~k~~~~n~~~~~~~~le~~~ 256 (1351)
T KOG1035|consen 182 VYPILSHLTQGTLLLVKWVEQAQSLSEPIEISHDYEST-PCGKKEI----QTTEIELESLSKIAHDNLGGYFVYGLERLF 256 (1351)
T ss_pred eeeeeccccCceEEEEehhhhHHhhcCcccccCcccCc-cchHHHH----HHHHHHHHHHHhhccccccceeEEeehhhc
Confidence 33347777888898888622 122222111111 0111111 122557777888999999999998876543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
. .....+..+++..-++...+.. -..++..+.+.+..++..||.|+|+....|.-|-.+-..
T Consensus 257 ~----------g~~~~v~~~~~s~~~~~~~~q~-----v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~--- 318 (1351)
T KOG1035|consen 257 R----------GIVLDVLQEICSKVELRSLLQS-----VGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSK--- 318 (1351)
T ss_pred c----------hHHHHHHHhhcCccchHHHHhh-----ccccCHHHHHHHHHHHhhhHHHHHHhccceeEEeccccc---
Confidence 2 0123456688888899888876 467889999999999999999999995444433333111
Q ss_pred ccccCCCCCeEEEe--ecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLC--DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 663 ~~~~~~~~~~vKL~--DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+...++.+++.++ ||+....+...... ....-+..|.+||.... .........|+|.+|..+..
T Consensus 319 -~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-----------~~~~~~~~~~~~e~~~~--~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 319 -ESTVDGEGVVAISLSDFDSSKPLPDNEKS-----------FSDLLAEIRNADEDLKE--NTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred -ccccCccceeecchhhhcccccCCCcccc-----------hhhcCcccccccccccc--ccchhhhhhHHHHHHHHHhh
Confidence 1111223456666 88888766543221 11234556778887764 11233445799999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
+..|..+-.... +...+... .......+++.+|+.-++++|++
T Consensus 385 ~~~~~~i~~~~~---~~~~~l~~----------------------------------~~~~~~~d~~~~~~~~~~~~Rl~ 427 (1351)
T KOG1035|consen 385 LSQGEDISEKSA---VPVSLLDV----------------------------------LSTSELLDALPKCLDEDSEERLS 427 (1351)
T ss_pred hhhcCccccccc---chhhhhcc----------------------------------ccchhhhhhhhhhcchhhhhccc
Confidence 998776532110 00000000 00114677889999999999999
Q ss_pred HHHHHHHHHhhc
Q 003185 821 AGDLYEMFVART 832 (840)
Q Consensus 821 a~ELLehLe~l~ 832 (840)
+.+++.|.....
T Consensus 428 ~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 428 ALELLTHPFLRF 439 (1351)
T ss_pred hhhhhhchhccc
Confidence 999999966543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0017 Score=68.44 Aligned_cols=29 Identities=21% Similarity=0.284 Sum_probs=24.1
Q ss_pred CeecccCCCCcEEEecccccCCCCCeEEEeecCCcc
Q 003185 647 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 682 (840)
Q Consensus 647 gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~ 682 (840)
+++|+|+.|.|||++.+ ...-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~-------~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDG-------RLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECC-------CEEEEEeCcccC
Confidence 59999999999999754 346799999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0007 Score=69.62 Aligned_cols=100 Identities=20% Similarity=0.181 Sum_probs=79.9
Q ss_pred HHHHHHHHhCCC-CCcceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHH---HHHHhccCCCCCCHHHHHH
Q 003185 556 LGEVRMLGALRH-SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY---IEKLSETGEKHVSVKLALF 631 (840)
Q Consensus 556 ~rEi~iL~~L~H-pNIV~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~---L~~~~~~~~~~ls~~~~~~ 631 (840)
..|..+|+.+++ +++++++|+|- .++|+||...+++... +.. -...+|..+.+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG------------------~~~v~E~~~~~~~~~~~~~l~~-----~~~~~w~~R~~ 63 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG------------------RFYVVEYVGAGSLYGIYRPLSQ-----FLQSPWEQRAK 63 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC------------------CEEEEEeecCcccccccccccc-----ccccCHHHHHH
Confidence 458889999986 79999999984 1789999987666421 111 12368999999
Q ss_pred HHHHHHHHHHHHHh---CCeecccCCCCcEEEecccccCCCCCeEEEeecCCccccc
Q 003185 632 IAQDVAAALVELHS---KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 685 (840)
Q Consensus 632 Ia~QIa~AL~yLHs---~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~ 685 (840)
|+.++++.+.+|+. ..+.-.|++|+|+-++.+ +.+|++|...+....
T Consensus 64 iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~-------~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 64 IALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDD-------GRLKLIDLDDVFVED 113 (188)
T ss_pred HHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCC-------CcEEEEechhcchhH
Confidence 99999999999998 358889999999999977 459999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0049 Score=64.54 Aligned_cols=73 Identities=14% Similarity=0.161 Sum_probs=46.5
Q ss_pred eeeecccCceEEEEEEEC---CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCC-cceeeeEEecCCCCCC
Q 003185 510 CDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC-IVEMYGHKISSKWLPS 585 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~---~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpN-IV~l~g~~~~~~~~p~ 585 (840)
.+.|..|-...+|++... +..+++|+...... ... ...+|+.+++.+...+ .+++++.+. .
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~-----d~~~E~~~~~~l~~~gl~P~v~~~~~--~---- 67 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LII-----DRERELRIHKLLSKHGLAPKLYATFQ--N---- 67 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----cee-----cHHHHHHHHHHHHhCCCCCeEEEEeC--C----
Confidence 467788888999999875 46788887542211 001 1156888888885333 344444321 1
Q ss_pred CCCCCccccceEEEEEeccCCCCH
Q 003185 586 ADGNPEHHLLQSAIFMEYVKGGSV 609 (840)
Q Consensus 586 ~~g~~~~~~~~~~LVmEy~~gGSL 609 (840)
.+||||++|.++
T Consensus 68 ------------~~l~e~i~G~~l 79 (235)
T cd05157 68 ------------GLIYEFIPGRTL 79 (235)
T ss_pred ------------cEEEEeeCCCcC
Confidence 589999998665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0068 Score=66.67 Aligned_cols=81 Identities=15% Similarity=0.121 Sum_probs=55.9
Q ss_pred eeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC---CCcceeeeEEecCCCCC
Q 003185 508 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH---SCIVEMYGHKISSKWLP 584 (840)
Q Consensus 508 ~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~H---pNIV~l~g~~~~~~~~p 584 (840)
.-.+.||.|..+.||+....+..+.+|+.+.. ... . .+..|+..|+.|.- -.+.++++++.....
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~---~~~---~----~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~-- 84 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGNPMPLMARSF---STP---G----VAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS-- 84 (297)
T ss_pred heeeecCCccceeEEEEEcCCCCEEEEEeccc---ccc---h----HHHHHHHHHHHHccCCCCCcCcEEEEeccCCc--
Confidence 44678999999999999876667788874310 011 1 23789999988853 467888887754321
Q ss_pred CCCCCCccccceEEEEEeccCCCCH
Q 003185 585 SADGNPEHHLLQSAIFMEYVKGGSV 609 (840)
Q Consensus 585 ~~~g~~~~~~~~~~LVmEy~~gGSL 609 (840)
....+||||+++|.++
T Consensus 85 ---------~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 85 ---------PGPDVLLLERLRGVSV 100 (297)
T ss_pred ---------CCCeEEEEeccCCEec
Confidence 1124999999998765
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.00019 Score=90.44 Aligned_cols=163 Identities=14% Similarity=-0.040 Sum_probs=116.3
Q ss_pred HhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHH
Q 003185 553 YSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFI 632 (840)
Q Consensus 553 ~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~I 632 (840)
+....|...++.+.|+++...+.-..... ....+++|+|+.+|.+...|.+-.+. ...+....+...
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~------------s~ee~~r~~~~~~g~~f~iIikg~ee-~~~ld~~~v~~~ 1340 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSE------------STEEYIRSLYVEFGKLFSIIIKGLEE-SPDLDRSPVHLR 1340 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCC------------ChHHHHHHHHHHHhHHHHHHHhcccc-CCcchhchHHHH
Confidence 34466666677788999887665433222 22348999999999999999762221 123444444445
Q ss_pred HHHHHHHHHHHHhC-----CeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCC
Q 003185 633 AQDVAAALVELHSK-----HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 707 (840)
Q Consensus 633 a~QIa~AL~yLHs~-----gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT 707 (840)
..+.+.+..-+|.. -.+|++||+-|.+|..+ ..+|++++|+.+....... ..+..+++
T Consensus 1341 ~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtn-------y~v~~gk~gLdKIknp~~s----------f~Gl~l~s 1403 (2724)
T KOG1826|consen 1341 HKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTN-------YNVKLGKGGLDKIKNPVLS----------FFGLELCS 1403 (2724)
T ss_pred HHHHHhccchhhhcccCCccchhhhhhhhccceecC-------CcccccccccccccCchHh----------hhhhhhCC
Confidence 55557788887865 27899999999999877 4599999999983222111 12455788
Q ss_pred CcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003185 708 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 749 (840)
Q Consensus 708 ~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~ 749 (840)
+.|+.|++... -.++.++|+|..|+.+|++--|..+|.
T Consensus 1404 p~~v~qli~N~----ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1404 PIYVLQLIKNE----IKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHHHHHHHH----HhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 89999999876 456778999999999999988887763
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.012 Score=62.87 Aligned_cols=137 Identities=13% Similarity=0.136 Sum_probs=75.8
Q ss_pred eecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCc-ceeeeEEecCCCCCCCCCCC
Q 003185 512 EAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI-VEMYGHKISSKWLPSADGNP 590 (840)
Q Consensus 512 ~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNI-V~l~g~~~~~~~~p~~~g~~ 590 (840)
.+..|-.+.+|+....+..+++|+........ .. ...+|..+++.+....+ .+++....
T Consensus 3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~---~~-----~r~~E~~~l~~l~~~g~~P~~i~~~~------------ 62 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKAL---GV-----DRQREYQILQALSALGLAPKPILVNE------------ 62 (256)
T ss_pred cCCCcCcCCeEEEEeCCccEEEeeCCcccccc---cC-----cHHHHHHHHHHHHhcCCCCceEEEeC------------
Confidence 35668888999998888888888743211100 00 11678888888864333 33443321
Q ss_pred ccccceEEEEEeccCCCCHHH--------------HHHHHhcc--CCCCCCHH-HHHHHHHHH---------HHHHHHHH
Q 003185 591 EHHLLQSAIFMEYVKGGSVKN--------------YIEKLSET--GEKHVSVK-LALFIAQDV---------AAALVELH 644 (840)
Q Consensus 591 ~~~~~~~~LVmEy~~gGSL~~--------------~L~~~~~~--~~~~ls~~-~~~~Ia~QI---------a~AL~yLH 644 (840)
-++||||++|..+.. .+.+.-.. ....++.. .+..+..++ ...+..+-
T Consensus 63 ------~~~v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 136 (256)
T TIGR02721 63 ------HWLLVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFR 136 (256)
T ss_pred ------CEEEEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHH
Confidence 178999999865431 12211111 11222221 111221111 11122221
Q ss_pred h--------CCeecccCCCCcEEEecccccCCCCCeEEEeecCCcc
Q 003185 645 S--------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 682 (840)
Q Consensus 645 s--------~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~ 682 (840)
. ..++|+|+.|.|||++.+ . +.|+||..|.
T Consensus 137 ~~~~~~~~~~~l~H~Dl~~~Nil~~~~-------~-~~lIDwE~a~ 174 (256)
T TIGR02721 137 SAPEPAPLPLAPLHMDVHAYNLVVTPQ-------G-LKLIDWEYAS 174 (256)
T ss_pred hccCCCCCCCeeecCCCCcCcEEEeCC-------C-CEEEeccccC
Confidence 1 258999999999999865 2 6899999774
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.014 Score=67.00 Aligned_cols=78 Identities=14% Similarity=0.044 Sum_probs=49.9
Q ss_pred eeeecccCceEEEEEEECC--eeEEEEEEecccCCCCh---HHHHHhHHhHHHHHHHHHhCC---CCCcceeeeEEecCC
Q 003185 510 CDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSA---DEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKISSK 581 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~--~~vAVKI~~lk~~~~~~---~~~~~f~~~~~rEi~iL~~L~---HpNIV~l~g~~~~~~ 581 (840)
.+.||.|.+..||++...+ +.++||.-......... ...+ +...|.+.|..+. ..++++++.+...
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~e----R~~~Eae~L~~l~~~~p~~VPkV~~~D~~-- 104 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLD----RARIEAEALKIQAKYVPDLVPKVYHYDEE-- 104 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHH----HHHHHHHHHHHHHhhCCCCCCeEEEECCC--
Confidence 4689999999999999855 37899974311110000 1112 2366888877763 3567778876331
Q ss_pred CCCCCCCCCccccceEEEEEeccCCC
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGG 607 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gG 607 (840)
..++||||+++.
T Consensus 105 --------------~~~lVME~L~~~ 116 (401)
T PRK09550 105 --------------LAVTVMEDLSDH 116 (401)
T ss_pred --------------CCEEEEecCCCc
Confidence 138999999864
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.00058 Score=75.00 Aligned_cols=141 Identities=16% Similarity=0.221 Sum_probs=95.6
Q ss_pred ceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHH-h-------------HHhHHHHHHHHHhCC-C-CC
Q 003185 507 LSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRN-F-------------EYSCLGEVRMLGALR-H-SC 569 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~-f-------------~~~~~rEi~iL~~L~-H-pN 569 (840)
+.++++||-|--+.||.+.+ .+.+.++|+.++-......-.... + +-...+|++.|+.|. | =-
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 36788999999999999987 488999998766443322111000 0 012367888898885 2 22
Q ss_pred cceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Q 003185 570 IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 649 (840)
Q Consensus 570 IV~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIV 649 (840)
+.+.+++. ..++|||++.|..|.+.-+- .+ +-.+...+..-+--|..+|+|
T Consensus 174 VPkpiD~~------------------RH~Vvmelv~g~Pl~~v~~v--------~d---~~~ly~~lm~~Iv~la~~GlI 224 (465)
T KOG2268|consen 174 VPKPIDHN------------------RHCVVMELVDGYPLRQVRHV--------ED---PPTLYDDLMGLIVRLANHGLI 224 (465)
T ss_pred CCCccccc------------------ceeeHHHhhcccceeeeeec--------CC---hHHHHHHHHHHHHHHHHcCce
Confidence 34444432 34899999998877665321 12 233445555566778899999
Q ss_pred cccCCCCcEEEecccccCCCCCeEEEeecCCccc
Q 003185 650 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 683 (840)
Q Consensus 650 HRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~ 683 (840)
|+|..-=||+|..+ ..++++||--...
T Consensus 225 HgDFNEFNimv~dd-------~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 225 HGDFNEFNIMVKDD-------DKIVVIDFPQMVS 251 (465)
T ss_pred ecccchheeEEecC-------CCEEEeechHhhc
Confidence 99999999999976 4599999975543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.014 Score=64.17 Aligned_cols=152 Identities=16% Similarity=0.174 Sum_probs=81.5
Q ss_pred CceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCC--cceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC--IVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpN--IV~l~g~~~~~~~~ 583 (840)
.....+.++.|....+|+....+..+++|+.... ..... +..|++++..|.... +.+++.... ...+
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~---~~~~~-------i~~e~~~l~~L~~~g~pvp~~i~t~~-g~~~ 91 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTTDVGRYILTLYEKR---VKAEE-------LPFFLALTTHLAARGLPVPKPVKSRD-GRQL 91 (307)
T ss_pred CceeccccCCccccceEEEEeCCCcEEEEEecCC---CCHHH-------HHHHHHHHHHHHHCCCCCCccccCCC-CCee
Confidence 3445677788888899998876667888875321 11111 145667777774222 344443211 0000
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHH-----------HHHHHH---hc---cCCC---CCC-HHHHH------------
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVK-----------NYIEKL---SE---TGEK---HVS-VKLAL------------ 630 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~-----------~~L~~~---~~---~~~~---~ls-~~~~~------------ 630 (840)
.......++||+|++|..+. ..+.+. .. .... .++ +....
T Consensus 92 -------~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~ 164 (307)
T TIGR00938 92 -------STLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA 164 (307)
T ss_pred -------hhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence 00112458999999885421 111111 00 0000 011 10000
Q ss_pred HHHHHHHHHHHHHHh-------CCeecccCCCCcEEEecccccCCCCCeEEEeecCCcc
Q 003185 631 FIAQDVAAALVELHS-------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 682 (840)
Q Consensus 631 ~Ia~QIa~AL~yLHs-------~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~ 682 (840)
.....+...++++.. .+++|+|+.+.||+++.+ ..+.|+||+.+.
T Consensus 165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~-------~~~~vIDfd~~~ 216 (307)
T TIGR00938 165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGD-------SVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECC-------ceEEEeeccccc
Confidence 011223345555542 589999999999999876 346899999773
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.016 Score=65.08 Aligned_cols=149 Identities=13% Similarity=0.117 Sum_probs=100.8
Q ss_pred eeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCCh------------------HHHHHhHHhHHHHHHHHHhCCCC
Q 003185 508 SSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSA------------------DEIRNFEYSCLGEVRMLGALRHS 568 (840)
Q Consensus 508 ~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~------------------~~~~~f~~~~~rEi~iL~~L~Hp 568 (840)
.+...|..|--+.||.|.- .|..+|+||++-....... ...+...-+...|++-|++|...
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3456788899999999985 6777999998744322211 11222333456788888888755
Q ss_pred CcceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCH-HHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-
Q 003185 569 CIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSV-KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK- 646 (840)
Q Consensus 569 NIV~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL-~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~- 646 (840)
.|.-.--+... ...|||+|+..... .-.|+ ...++...+..+-.|++.-|.-|.+.
T Consensus 227 GIP~PePIlLk----------------~hVLVM~FlGrdgw~aPkLK------d~~ls~~ka~~~Y~~~v~~MR~lY~~c 284 (520)
T KOG2270|consen 227 GIPCPEPILLK----------------NHVLVMEFLGRDGWAAPKLK------DASLSTSKARELYQQCVRIMRRLYQKC 284 (520)
T ss_pred CCCCCCceeee----------------cceEeeeeccCCCCcCcccc------cccCChHHHHHHHHHHHHHHHHHHHHh
Confidence 54322222221 12799999953221 12222 24577778889999999999888665
Q ss_pred CeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccc
Q 003185 647 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 686 (840)
Q Consensus 647 gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~ 686 (840)
++||.||.-=|+|+... .+.|+|.+-+.....
T Consensus 285 ~LVHADLSEfN~LyhdG--------~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 285 RLVHADLSEFNLLYHDG--------KLYIIDVSQSVEHDH 316 (520)
T ss_pred ceeccchhhhhheEECC--------EEEEEEccccccCCC
Confidence 89999999999999754 699999998876544
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.072 Score=58.61 Aligned_cols=30 Identities=23% Similarity=0.442 Sum_probs=24.9
Q ss_pred CCeecccCCCCcEEEecccccCCCCCeEEEeecCCcc
Q 003185 646 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 682 (840)
Q Consensus 646 ~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~ 682 (840)
.++||+|+.|.|||++.+ ...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~-------~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGD-------RLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECC-------ceEEEEeccccc
Confidence 389999999999999854 345799999774
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.015 Score=67.54 Aligned_cols=85 Identities=20% Similarity=0.205 Sum_probs=57.8
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHH
Q 003185 727 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 806 (840)
Q Consensus 727 ~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dL 806 (840)
+|+|||++|.++.++.-|...|......+....+.+-...........+ ........+..+.++
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~----------------e~~~~~~~d~~~~~~ 173 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAM----------------EHLIQLLADKKRLPL 173 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHH----------------HHHHHHhhhHhHHHH
Confidence 4899999999999999999888777666666555554322211111000 002223456678899
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 003185 807 FRRCTEENPTERPTAGDLYEM 827 (840)
Q Consensus 807 I~rCL~~DP~eRPSa~ELLeh 827 (840)
..+|+-..|..||...++.++
T Consensus 174 ~~~c~~~~~~ir~l~~~~~k~ 194 (725)
T KOG1093|consen 174 LKKCLWLEPIIRPLPMELSKR 194 (725)
T ss_pred hccCCccccccccchhHHhcC
Confidence 999999999999987776553
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.073 Score=57.76 Aligned_cols=148 Identities=14% Similarity=0.162 Sum_probs=81.5
Q ss_pred eeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCC--cceeeeEEecCCCCCCC
Q 003185 509 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSA 586 (840)
Q Consensus 509 i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpN--IV~l~g~~~~~~~~p~~ 586 (840)
-.+.|..|....+|+....+..+++|+... ... .. +..|+.++..|.+.+ +.+++.... ...+
T Consensus 18 ~i~~i~~G~~n~~y~v~~~~~~~vLr~~~~----~~~---~~----~~~e~~~l~~L~~~g~~vp~~i~~~~-g~~~--- 82 (296)
T cd05153 18 SFEGISAGIENTNYFVTTDSGRYVLTLFEK----VSA---EE----LPFFLALLDHLAERGLPVPRPIADRD-GEYL--- 82 (296)
T ss_pred heecccCccccceEEEEeCCCcEEEEEcCC----CCh---Hh----ccHHHHHHHHHHHCCCCCCccccCCC-CcEe---
Confidence 366788888899999987777889998542 111 11 266888888875332 444443211 0000
Q ss_pred CCCCccccceEEEEEeccCCCCHHH-----------HHHHH---hcc-CC-----CCCCHHHH----------HHHHHHH
Q 003185 587 DGNPEHHLLQSAIFMEYVKGGSVKN-----------YIEKL---SET-GE-----KHVSVKLA----------LFIAQDV 636 (840)
Q Consensus 587 ~g~~~~~~~~~~LVmEy~~gGSL~~-----------~L~~~---~~~-~~-----~~ls~~~~----------~~Ia~QI 636 (840)
.......++||+|++|..+.. .+.+. ... .. ....+... ......+
T Consensus 83 ----~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 158 (296)
T cd05153 83 ----SELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALL 158 (296)
T ss_pred ----eeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHH
Confidence 001123589999999865421 11111 000 00 00011100 0111223
Q ss_pred HHHHHHHHh-------CCeecccCCCCcEEEecccccCCCCCeEEEeecCCcc
Q 003185 637 AAALVELHS-------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 682 (840)
Q Consensus 637 a~AL~yLHs-------~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~ 682 (840)
..++.++.. .+++|+|+.|.|||++.+ ..+.|+||+.+.
T Consensus 159 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~-------~~~~iIDfe~a~ 204 (296)
T cd05153 159 ADELARQDAFDPSDLPRGVIHADLFRDNVLFDGD-------ELSGVIDFYFAC 204 (296)
T ss_pred HHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCC-------ceEEEeehhhhc
Confidence 334455443 379999999999999875 346899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.072 Score=61.23 Aligned_cols=78 Identities=14% Similarity=0.051 Sum_probs=51.5
Q ss_pred eeeeecccCceEEEEEEECCeeEEEEEEecccCCCCh---HHHHHhHHhHHHHHHHHHhCC---CCCcceeeeEEecCCC
Q 003185 509 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSA---DEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKISSKW 582 (840)
Q Consensus 509 i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~---~~~~~f~~~~~rEi~iL~~L~---HpNIV~l~g~~~~~~~ 582 (840)
..+.||.|....||+....+..++||.-.......+. .... +-..|+..|+.+. ..++.++|.++.+..
T Consensus 36 ~~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~----R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~- 110 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKE----RAYFEATALREHGRLCPDHVPEVYHFDRTMA- 110 (418)
T ss_pred eEEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCcc----HHHHHHHHHHHhhhcCCCCCCeEEEECCCCC-
Confidence 4778999999999999887777888875422221111 0111 1144666666654 357888888876332
Q ss_pred CCCCCCCCccccceEEEEEeccCC
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKG 606 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~g 606 (840)
+++|||+++
T Consensus 111 ---------------vlvME~L~~ 119 (418)
T PLN02756 111 ---------------LIGMRYLEP 119 (418)
T ss_pred ---------------EEEEeecCC
Confidence 889999976
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.086 Score=57.51 Aligned_cols=33 Identities=27% Similarity=0.347 Sum_probs=25.0
Q ss_pred CeecccCCCCcEEEecccccCCCCCeEEEeecCCcc
Q 003185 647 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 682 (840)
Q Consensus 647 gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~ 682 (840)
.++|+|+.|.|||++.+. .....+.|+||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~---~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPS---SETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCC---CCCCcEEEEeeCCCC
Confidence 689999999999998630 001248999998773
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.067 Score=60.50 Aligned_cols=75 Identities=13% Similarity=-0.001 Sum_probs=44.8
Q ss_pred eecccCceEEEEEEECC--eeEEEEEEecccCCCC---hHHHHHhHHhHHHHHHHHHhCC--CC-CcceeeeEEecCCCC
Q 003185 512 EAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSS---ADEIRNFEYSCLGEVRMLGALR--HS-CIVEMYGHKISSKWL 583 (840)
Q Consensus 512 ~LG~G~fG~Vy~a~~~~--~~vAVKI~~lk~~~~~---~~~~~~f~~~~~rEi~iL~~L~--Hp-NIV~l~g~~~~~~~~ 583 (840)
.||.|....||++...+ ..++||.-.......+ .-.. .+..-|...|+... -| .+.++|.+-..
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~----~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e---- 73 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTL----DRARIESSALIRQGEHVPHLVPRIFHFDTE---- 73 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCc----cHHHHHHHHHHHhhccCccccCeEEEEccc----
Confidence 58999999999998754 4788886432211111 1111 12256777777664 34 45566654221
Q ss_pred CCCCCCCccccceEEEEEeccCC
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKG 606 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~g 606 (840)
...+|||+++.
T Consensus 74 ------------~~~~vMEdL~~ 84 (370)
T TIGR01767 74 ------------MAVTVMEDLSH 84 (370)
T ss_pred ------------cceehHhhCcc
Confidence 23699999954
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.14 Score=55.89 Aligned_cols=30 Identities=33% Similarity=0.512 Sum_probs=24.4
Q ss_pred CeecccCCCCcEEEecccccCCCCCeEEEeecCCcc
Q 003185 647 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 682 (840)
Q Consensus 647 gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~ 682 (840)
.++|+|++|.|||++.++ ...-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~------~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDA------RVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCC------CEEEEECcHhcc
Confidence 589999999999998632 246799999874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.18 Score=56.24 Aligned_cols=32 Identities=25% Similarity=0.366 Sum_probs=26.8
Q ss_pred CeecccCCCCcEEEecccccCCCCCeEEEeecCCccccc
Q 003185 647 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 685 (840)
Q Consensus 647 gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~ 685 (840)
.++|+|+.+.||+|+..+ -+=|.||+++..-+
T Consensus 199 ~lvHGD~~~gNlii~~~~-------~~gVlDwe~~~lGD 230 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGR-------PTGVLDWELATLGD 230 (321)
T ss_pred eeeeCCcccCCEEEeCCC-------eeEEEeccccccCC
Confidence 599999999999999873 28899999986543
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.83 E-value=0.14 Score=58.65 Aligned_cols=79 Identities=16% Similarity=0.090 Sum_probs=47.5
Q ss_pred eeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC--CC-CcceeeeEEecCCCCC
Q 003185 510 CDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HS-CIVEMYGHKISSKWLP 584 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~--Hp-NIV~l~g~~~~~~~~p 584 (840)
.+.||.|.-..||++... +..++||.-..... ... ...--..+..-|..+|+.+. -| +++++|.+-.+
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vR-v~~-swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e----- 106 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTAR-ISD-EFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSV----- 106 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhc-cCC-CCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcH-----
Confidence 678899999999999974 56788886432211 110 00000123356777777764 34 45666654222
Q ss_pred CCCCCCccccceEEEEEeccCC
Q 003185 585 SADGNPEHHLLQSAIFMEYVKG 606 (840)
Q Consensus 585 ~~~g~~~~~~~~~~LVmEy~~g 606 (840)
...+|||+++.
T Consensus 107 -----------~~~~vMEdL~~ 117 (409)
T PRK12396 107 -----------MNCCVMEDLSD 117 (409)
T ss_pred -----------HhhHHHHhCcc
Confidence 23789999854
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.79 E-value=0.37 Score=52.52 Aligned_cols=29 Identities=31% Similarity=0.440 Sum_probs=24.2
Q ss_pred CCeecccCCCCcEEEecccccCCCCCeEEEeecCCcc
Q 003185 646 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 682 (840)
Q Consensus 646 ~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~ 682 (840)
.+++|+|+.+.|||++.+ .+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~--------~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKDN--------EVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeCC--------cEEEEECcccc
Confidence 479999999999999863 27899998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=93.96 E-value=0.59 Score=52.59 Aligned_cols=31 Identities=29% Similarity=0.477 Sum_probs=25.6
Q ss_pred CeecccCCCCcEEEecccccCCCCCeEEEeecCCccc
Q 003185 647 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 683 (840)
Q Consensus 647 gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~ 683 (840)
.++|+|+++.|||++.+. ..+.|+||..|..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~------~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEET------RAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCC------CcEEEEeehhccc
Confidence 689999999999998541 3599999988753
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.96 E-value=0.36 Score=55.29 Aligned_cols=29 Identities=31% Similarity=0.200 Sum_probs=23.9
Q ss_pred CCeecccCCCCcEEEecccccCCCCCeEEEeecCCcc
Q 003185 646 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 682 (840)
Q Consensus 646 ~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~ 682 (840)
...+|.|+-+.|||.+.+ .+.++||-.|.
T Consensus 227 ~VfCHNDL~~gNIL~~~~--------~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ--------GIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecCC--------CEEEEEecccc
Confidence 368999999999998644 39999998774
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=93.95 E-value=0.41 Score=53.48 Aligned_cols=30 Identities=20% Similarity=0.383 Sum_probs=24.7
Q ss_pred eecccCCCCcEEEecccccCCCCCeEEEeecCCccc
Q 003185 648 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 683 (840)
Q Consensus 648 IVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~ 683 (840)
++|.|+.+.|||++.++ ..++|+||..|-.
T Consensus 184 ~CHnDl~~~NiL~~~~~------~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDE------GKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCC------CcEEEEcccccCC
Confidence 79999999999997542 3599999998753
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=92.31 E-value=1.2 Score=48.91 Aligned_cols=29 Identities=21% Similarity=0.336 Sum_probs=24.9
Q ss_pred CeecccCCCCcEEEecccccCCCCCeEEEeecCCcc
Q 003185 647 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 682 (840)
Q Consensus 647 gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~ 682 (840)
+++|+|+.++|||++.++ .+.|+||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~-------~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETR-------GGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCC-------CEEEEEhhhcc
Confidence 799999999999998763 48899998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >smart00460 TGc Transglutaminase/protease-like homologues | Back alignment and domain information |
|---|
Probab=90.85 E-value=0.041 Score=46.23 Aligned_cols=43 Identities=30% Similarity=0.759 Sum_probs=35.0
Q ss_pred eeeccccceeeeeeeccccCCCccccccccccc-----------cCCCCcceeEEe
Q 003185 403 QFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLD-----------FQPHAWNTILVK 447 (840)
Q Consensus 403 ~~g~~~~rallfk~l~d~~~~~lpcrlvrG~~~-----------~~~~a~~s~lvr 447 (840)
..|.|.+.|.||..++-.++ ||||++.|+.- ...|+|.++.+.
T Consensus 5 ~~G~C~~~a~l~~~llr~~G--Ipar~v~g~~~~~~~~~~~~~~~~~H~W~ev~~~ 58 (68)
T smart00460 5 KYGTCGEFAALFVALLRSLG--IPARVVSGYLKAPDTIGGLRSIWEAHAWAEVYLE 58 (68)
T ss_pred cceeeHHHHHHHHHHHHHCC--CCeEEEeeeecCCCCCcccccCCCcEEEEEEEEC
Confidence 46999999999999999999 99999999643 246677665554
|
Transglutaminases are enzymes that establish covalent links between proteins. A subset of transglutaminase homologues appear to catalyse the reverse reaction, the hydrolysis of peptide bonds. Proteins with this domain are both extracellular and intracellular, and it is likely that the eukaryotic intracellular proteins are involved in signalling events. |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.77 E-value=0.33 Score=54.08 Aligned_cols=84 Identities=24% Similarity=0.277 Sum_probs=49.2
Q ss_pred EEEEeccCCCCHHHHHHH-HhccCCCCCCHHHHHHHHHHHHHHHHHHHh----CCeecccCCCCcEEEeccccc------
Q 003185 598 AIFMEYVKGGSVKNYIEK-LSETGEKHVSVKLALFIAQDVAAALVELHS----KHIMHRDIKSENILIDLERKK------ 666 (840)
Q Consensus 598 ~LVmEy~~gGSL~~~L~~-~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs----~gIVHRDLKPeNILLd~~~~~------ 666 (840)
.||++++.. +-..+-.. ..+.+ -.-..+-++.++.||+.-.-.+.. .+.+|-||||+||||-...+.
T Consensus 251 IIIfPLArc-Sadkv~~~~~~e~G-F~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~ 328 (444)
T PHA03111 251 IIIFPLARC-SADKVTEENAAELG-FKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLK 328 (444)
T ss_pred EEEEehhhc-ccccCCHHHHHHcC-CccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEEC
Confidence 788887753 22222111 01112 222345677888898866545543 369999999999999766320
Q ss_pred -----CCCCCeEEEeecCCccc
Q 003185 667 -----ADGKPVVKLCDFDRAVP 683 (840)
Q Consensus 667 -----~~~~~~vKL~DFGlA~~ 683 (840)
......++|.||.+++.
T Consensus 329 ~~~~vF~Epi~~~LnDFDfSqv 350 (444)
T PHA03111 329 DATYVFNEPIKACLNDFDFSQV 350 (444)
T ss_pred CeEEEeccchhhhhcccCHHHH
Confidence 11234466777777654
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=90.36 E-value=1.4 Score=48.47 Aligned_cols=75 Identities=15% Similarity=0.106 Sum_probs=45.9
Q ss_pred eeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC---CCCcceeeeEEecCCCCC
Q 003185 508 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKISSKWLP 584 (840)
Q Consensus 508 ~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~---HpNIV~l~g~~~~~~~~p 584 (840)
+-.+.++.|....+|+....+..+.||+..-. .. ..|..|++-|+.|. --.+.+++++....+.
T Consensus 20 ~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~-------~~----~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~-- 86 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLDTDGGSYFVKVNSES-------GR----DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD-- 86 (288)
T ss_dssp -EEEEE--SSSSEEEEEETTS-EEEEEEEEGG-------GC----CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC--
T ss_pred eeeEecCCCChhheEEEECCCccEEEEecChh-------hH----HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC--
Confidence 45678888999999999988889999986511 11 12377888888884 4457788888765442
Q ss_pred CCCCCCccccceEEEEEeccCCC
Q 003185 585 SADGNPEHHLLQSAIFMEYVKGG 607 (840)
Q Consensus 585 ~~~g~~~~~~~~~~LVmEy~~gG 607 (840)
.+|||||++.+
T Consensus 87 ------------~fLlle~l~~~ 97 (288)
T PF03881_consen 87 ------------AFLLLEFLEMG 97 (288)
T ss_dssp ------------CEEEEE-----
T ss_pred ------------ceEEEEeecCC
Confidence 29999999865
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=90.02 E-value=0.39 Score=53.78 Aligned_cols=86 Identities=21% Similarity=0.217 Sum_probs=49.4
Q ss_pred EEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh----CCeecccCCCCcEEEeccccc-------
Q 003185 598 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS----KHIMHRDIKSENILIDLERKK------- 666 (840)
Q Consensus 598 ~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs----~gIVHRDLKPeNILLd~~~~~------- 666 (840)
.||++++.. +-...-......-+-..-.+-++.++.|||.-.--+.. .+.+|-||||+||||-...+.
T Consensus 247 IIIfPLA~~-Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~ 325 (434)
T PF05445_consen 247 IIIFPLARC-SADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGN 325 (434)
T ss_pred EEEEehhhc-chhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECC
Confidence 688888753 33322211111111222345667778888644322323 369999999999999766321
Q ss_pred ----CCCCCeEEEeecCCcccc
Q 003185 667 ----ADGKPVVKLCDFDRAVPL 684 (840)
Q Consensus 667 ----~~~~~~vKL~DFGlA~~~ 684 (840)
......++|.||.+++..
T Consensus 326 ~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 326 RNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred eEEEecccceeeecccCHHHhc
Confidence 112345788888887643
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=88.90 E-value=1.3 Score=50.80 Aligned_cols=61 Identities=23% Similarity=0.335 Sum_probs=45.6
Q ss_pred EEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH-HhCCeecccCCCCcEEEecc
Q 003185 597 SAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVEL-HSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 597 ~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yL-Hs~gIVHRDLKPeNILLd~~ 663 (840)
..||-+|..|-++..++.. ...+++...+++.-.++||.-+ --.+++|.|+.|.||++-..
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~------~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW------KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhc------ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 4666778889999999975 3345566677777667775544 34689999999999999654
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=88.52 E-value=1 Score=50.99 Aligned_cols=70 Identities=26% Similarity=0.231 Sum_probs=54.5
Q ss_pred eEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCCCcEEEecccccCCCCCeEE
Q 003185 596 QSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPVVK 674 (840)
Q Consensus 596 ~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~-gIVHRDLKPeNILLd~~~~~~~~~~~vK 674 (840)
..|++|++- |++|... ..-.++++..++++.+.-+.-+..+ ..-|||+.-.||||+ + +.|.
T Consensus 300 y~yl~~kdh-gt~is~i---------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~-------Gnvt 361 (488)
T COG5072 300 YLYLHFKDH-GTPISII---------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E-------GNVT 361 (488)
T ss_pred EEEEEEecC-Cceeeee---------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c-------CceE
Confidence 468888886 4455332 2245788899999988888777765 789999999999999 5 3499
Q ss_pred EeecCCccc
Q 003185 675 LCDFDRAVP 683 (840)
Q Consensus 675 L~DFGlA~~ 683 (840)
|+||-+++.
T Consensus 362 LIDfklsRl 370 (488)
T COG5072 362 LIDFKLSRL 370 (488)
T ss_pred EEEeeeeec
Confidence 999999984
|
|
| >PF01841 Transglut_core: Transglutaminase-like superfamily; InterPro: IPR002931 This domain is found in many proteins known to have transglutaminase activity, i | Back alignment and domain information |
|---|
Probab=85.88 E-value=0.1 Score=48.06 Aligned_cols=46 Identities=30% Similarity=0.676 Sum_probs=35.2
Q ss_pred eeccccceeeeeeeccccCCCccccccccccc------------cCCCCcceeEEeeCCce
Q 003185 404 FGVCRHRAVLLKYLCDRVEPPVPCELVRGYLD------------FQPHAWNTILVKKGDSW 452 (840)
Q Consensus 404 ~g~~~~rallfk~l~d~~~~~lpcrlvrG~~~------------~~~~a~~s~lvr~G~~~ 452 (840)
.|.|.+-|.||..|+-.++ ||||+|.|... ...|+|+++.+ .+..|
T Consensus 51 ~G~C~~~a~l~~allr~~G--ipar~v~g~~~~~~~~~~~~~~~~~~H~w~ev~~-~~~~W 108 (113)
T PF01841_consen 51 RGDCEDYASLFVALLRALG--IPARVVSGYVKGPDPDGDYSVDGNDNHAWVEVYL-PGGGW 108 (113)
T ss_dssp EESHHHHHHHHHHHHHHHT----EEEEEEEEEECSSTTCTSTSSEEEEEEEEEEE-TTTEE
T ss_pred CCccHHHHHHHHHHHhhCC--CceEEEEEEcCCccccccccCCCCCCEEEEEEEE-cCCcE
Confidence 4999999999999999999 99999999664 22477877776 34445
|
e. which cross-link proteins through an acyl-transfer reaction between the gamma-carboxamide group of peptide-bound glutamine and the epsilon-amino group of peptide-bound lysine, resulting in a epsilon-(gamma-glutamyl)lysine isopeptide bond. Tranglutaminases have been found in a diverse range of species, from bacteria through to mammals. The enzymes require calcium binding and their activity leads to post-translational modification of proteins through acyl-transfer reactions, involving peptidyl glutamine residues as acyl donors and a variety of primary amines as acyl acceptors, with the generation of proteinase resistant isopeptide bonds []. Sequence conservation in this superfamily primarily involves three motifs that centre around conserved cysteine, histidine, and aspartate residues that form the catalytic triad in the structurally characterised transglutaminase, the human blood clotting factor XIIIa' []. On the basis of the experimentally demonstrated activity of the Methanobacterium phage psiM2 pseudomurein endoisopeptidase [], it is proposed that many, if not all, microbial homologs of the transglutaminases are proteases and that the eukaryotic transglutaminases have evolved from an ancestral protease []. A subunit of plasma Factor XIII revealed that each Factor XIIIA subunit is composed of four domains (termed N-terminal beta-sandwich, core domain (containing the catalytic and the regulatory sites), and C-terminal beta-barrels 1 and 2) and that two monomers assemble into the native dimer through the surfaces in domains 1 and 2, in opposite orientation. This organisation in four domains is highly conserved during evolution among transglutaminase isoforms [].; PDB: 2F4M_A 2F4O_A 1GGY_B 1FIE_B 1GGU_B 1GGT_B 1F13_A 1QRK_B 1EVU_A 1EX0_B .... |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=85.32 E-value=8.4 Score=45.06 Aligned_cols=28 Identities=25% Similarity=0.457 Sum_probs=23.4
Q ss_pred CeecccCCCCcEEEecccccCCCCCeEEEeecCCcc
Q 003185 647 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 682 (840)
Q Consensus 647 gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~ 682 (840)
.++|.|+-+.|||.+.+ .++|+||-.|.
T Consensus 285 VfCHNDl~~~NiL~~~~--------~l~LIDfEYAg 312 (442)
T PTZ00296 285 VFCHNDLQENNIINTNK--------CLRLIDFEYSG 312 (442)
T ss_pred eEEeCCCCccceeecCC--------CEEEEeecccc
Confidence 58999999999997643 39999998774
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 840 | ||||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-16 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-15 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-15 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-14 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-14 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-13 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-12 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-10 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-08 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-08 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-08 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-08 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-08 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-08 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-08 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-08 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-08 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-07 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-07 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-07 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 6e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-06 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 6e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 7e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 7e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 7e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 7e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 7e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 7e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 7e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 7e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 8e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 8e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-05 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-05 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-05 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-05 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 9e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-04 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 3e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 3e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-04 |
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 840 | |||
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-43 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 4e-41 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 5e-41 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-40 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 3e-40 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 5e-40 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-39 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 6e-39 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-37 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-37 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 5e-37 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 6e-37 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 9e-37 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-36 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 1e-36 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-36 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 1e-36 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 3e-36 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-35 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 6e-35 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-34 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 3e-34 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-34 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-34 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 3e-34 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 6e-34 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 7e-34 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-33 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-33 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 4e-33 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 6e-33 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 4e-32 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 9e-32 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-30 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-30 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 4e-30 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 5e-30 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 5e-30 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-29 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-29 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 3e-29 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 6e-29 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-28 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 3e-28 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 4e-28 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 4e-28 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 5e-28 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 9e-28 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 1e-27 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-27 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-27 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 3e-27 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-26 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-26 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-26 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-26 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 4e-26 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 8e-26 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 8e-26 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 9e-26 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-25 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-25 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-25 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-25 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-25 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 7e-25 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 7e-25 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 9e-25 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-24 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-24 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 1e-24 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-24 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-24 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 3e-24 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 6e-24 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 6e-24 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 8e-24 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 8e-24 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-23 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-23 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-23 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-23 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-23 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-23 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-23 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-23 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 3e-23 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 3e-23 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 3e-23 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-23 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 5e-23 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 6e-23 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 6e-23 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 6e-23 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 9e-23 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 9e-23 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 9e-23 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-22 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-22 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-22 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-22 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-22 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-22 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-22 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-22 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-22 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-22 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 3e-22 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-22 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 3e-22 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 3e-22 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 4e-22 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 4e-22 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 5e-22 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 5e-22 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 6e-22 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 6e-22 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 8e-22 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 9e-22 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-21 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-21 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-21 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-21 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-21 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-21 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-21 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-21 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-21 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-21 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-21 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 3e-21 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 3e-21 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 3e-21 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-21 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 4e-21 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 4e-21 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 5e-21 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 5e-21 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 5e-21 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 6e-21 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 6e-21 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 9e-21 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 9e-21 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-20 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-20 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-20 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-20 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-20 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-20 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-20 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 3e-20 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 3e-20 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 3e-20 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 3e-20 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 4e-20 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 5e-20 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 5e-20 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 6e-20 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 6e-20 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 9e-20 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-19 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-19 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-19 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-19 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-19 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-19 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-19 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 3e-19 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 4e-19 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 5e-19 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 5e-19 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 7e-19 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-18 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-18 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-18 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 4e-18 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 5e-18 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 6e-18 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 6e-18 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 7e-18 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 8e-18 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 1e-17 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-17 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 4e-17 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 6e-17 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 7e-17 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 8e-17 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-16 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-16 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 3e-16 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 5e-16 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-15 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-15 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 4e-15 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 5e-15 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 6e-15 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-14 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 2e-14 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 3e-14 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 3e-14 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 3e-14 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 4e-14 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 5e-14 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 5e-14 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 8e-14 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-13 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-13 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 4e-13 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 4e-13 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 5e-13 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 5e-13 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 9e-13 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 2e-12 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 2e-12 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 4e-12 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 5e-12 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 5e-12 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 6e-12 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 1e-11 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-11 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-11 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-11 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-11 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 3e-11 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 4e-11 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-10 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-09 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 4e-09 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 4e-09 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 5e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-05 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-04 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 4e-08 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 9e-08 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 3e-07 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 4e-07 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 5e-06 |
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-43
Identities = 67/311 (21%), Positives = 111/311 (35%), Gaps = 76/311 (24%)
Query: 514 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 573
++ S L++ ++ D KV LKV S + R+F E L H ++ +
Sbjct: 19 NENHSGELWKGRWQGNDIVVKV--LKVRDWSTRKSRDF----NEECPRLRIFSHPNVLPV 72
Query: 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 633
G + P H + ++ GS+ N L E V A+ A
Sbjct: 73 LG---------ACQSPPAPHP---TLITHWMPYGSLYNV---LHEGTNFVVDQSQAVKFA 117
Query: 634 QDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 691
D+A + LH+ I + S +++ID + ++ D SF
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-------TARISMADVK---FSFQSP- 166
Query: 692 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLEVDIWSYGCLLLELLTLQVPYMG 750
+ P W+APE L+ KP + D+WS+ LL EL+T +VP+
Sbjct: 167 -----------GRMYAPAWVAPEALQ--KKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
Query: 751 LSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 809
LS +EI + G RP + H + + +
Sbjct: 214 LSNMEIGMKVALEGLRPTIPP------GISPH---------------------VSKLMKI 246
Query: 810 CTEENPTERPT 820
C E+P +RP
Sbjct: 247 CMNEDPAKRPK 257
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-41
Identities = 53/268 (19%), Positives = 103/268 (38%), Gaps = 69/268 (25%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
EV ++ L H IV++YG + + ME+V G + + + +
Sbjct: 73 EVFIMSNLNHPNIVKLYG--LMHNPP--------------RMVMEFVPCGDLYHRLLDKA 116
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKL 675
+ + L + D+A + + +++ I+HRD++S NI + + A K+
Sbjct: 117 ----HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAP--VCAKV 170
Query: 676 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735
DF + + +H+ +G +WMAPE + A + Y + D +S+
Sbjct: 171 ADFGLS---QQSVHSV----------SGLLGNFQWMAPETIGAEEES--YTEKADTYSFA 215
Query: 736 CLLLELLTLQVPYMGLSELEI---HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 792
+L +LT + P+ S +I + + + G RP + + C
Sbjct: 216 MILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE------DCPPR----------- 258
Query: 793 PEAELETLSFLVDVFRRCTEENPTERPT 820
L +V C +P +RP
Sbjct: 259 ----------LRNVIELCWSGDPKKRPH 276
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-41
Identities = 55/291 (18%), Positives = 98/291 (33%), Gaps = 66/291 (22%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
+R + + + D+++ F EV RH +V G A +P H
Sbjct: 60 IRLIDIERDNEDQLKAF----KREVMAYRQTRHENVVLFMG----------ACMSPPHL- 104
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
AI KG ++ + + + + V IAQ++ + LH+K I+H+D+K
Sbjct: 105 ---AIITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLK 157
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714
S+N+ D V + DF L S R G +APE
Sbjct: 158 SKNVFYD--------NGKVVITDFG----LFSISGVLQAGRREDKLRIQN-GWLCHLAPE 204
Query: 715 VLRAMHKPNL-----YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT 769
++R + + D+++ G + EL + P+ I + G +P
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP--- 261
Query: 770 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820
+++ + D+ C ERPT
Sbjct: 262 -----------------------NLSQIGMGKEISDILLFCWAFEQEERPT 289
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 65/312 (20%), Positives = 108/312 (34%), Gaps = 72/312 (23%)
Query: 514 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 573
G ++R + + A K + I N E ++ L+H I+ +
Sbjct: 16 GIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENV----RQEAKLFAMLKHPNIIAL 71
Query: 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 633
G + + ME+ +GG + + K + + + A
Sbjct: 72 RG----------VCLKEPNL----CLVMEFARGGPLNRVLSG------KRIPPDILVNWA 111
Query: 634 QDVAAALVELHSKH---IMHRDIKSENILIDLERKKAD-GKPVVKLCDFDRAVPLRSFLH 689
+A + LH + I+HRD+KS NILI + + D ++K+ DF
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG---------- 161
Query: 690 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 749
HR G WMAPEV+R + D+WSYG LL ELLT +VP+
Sbjct: 162 LAREWHRT--TKMSAAGAYAWMAPEVIR--ASM--FSKGSDVWSYGVLLWELLTGEVPFR 215
Query: 750 GLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 808
G+ L + + + + +C E +
Sbjct: 216 GIDGLAVAYGVAMNKLALPIPS------TCPEP---------------------FAKLME 248
Query: 809 RCTEENPTERPT 820
C +P RP+
Sbjct: 249 DCWNPDPHSRPS 260
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 75/310 (24%), Positives = 125/310 (40%), Gaps = 73/310 (23%)
Query: 514 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 573
G ++ R ++ +D A K+ L A+ + F L EV ++ LRH IV
Sbjct: 46 GAGSFGTVHRAEWHGSDVAVKI--LMEQDFHAERVNEF----LREVAIMKRLRHPNIVLF 99
Query: 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 633
G A P + +I EY+ GS+ + K + + + L +A
Sbjct: 100 MG----------AVTQPPNL----SIVTEYLSRGSLYRLLHK--SGAREQLDERRRLSMA 143
Query: 634 QDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 691
DVA + LH+++ I+HR++KS N+L+D K VK+CDF +
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-------KKYTVKVCDFGLS---------- 186
Query: 692 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL 751
+ + GTP WMAPEVLR +P + D++S+G +L EL TLQ P+ L
Sbjct: 187 RLKASTFLSSKSAAGTPEWMAPEVLR--DEP--SNEKSDVYSFGVILWELATLQQPWGNL 242
Query: 752 SELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 810
+ ++ + KR + + + + + C
Sbjct: 243 NPAQVVAAVGFKCKRLEIPR------NLNPQ---------------------VAAIIEGC 275
Query: 811 TEENPTERPT 820
P +RP+
Sbjct: 276 WTNEPWKRPS 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-40
Identities = 66/288 (22%), Positives = 114/288 (39%), Gaps = 65/288 (22%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+ L V + +++ F EV +L RH I+ G S+ L
Sbjct: 51 VKMLNVTAPTPQQLQAF----KNEVGVLRKTRHVNILLFMG--YSTA----------PQL 94
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
AI ++ +G S+ +++ E +K + IA+ A + LH+K I+HRD+K
Sbjct: 95 ---AIVTQWCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714
S NI + VK+ DF A + G+ WMAPE
Sbjct: 148 SNNIFL-------HEDNTVKIGDFGLA---TEKSRWSGSHQFEQLS-----GSILWMAPE 192
Query: 715 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE--IHDLIQMGKRPRLTDEL 772
V+R M N Y + D++++G +L EL+T Q+PY ++ + I + + P L
Sbjct: 193 VIR-MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL---S 248
Query: 773 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820
+ +C + + + C ++ ERP+
Sbjct: 249 KVRSNCPKR---------------------MKRLMAECLKKKRDERPS 275
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 66/312 (21%), Positives = 120/312 (38%), Gaps = 83/312 (26%)
Query: 514 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 573
G+ + + K+ + D A K ++ S E + F E+R L + H IV++
Sbjct: 17 GRGAFGVVCKAKWRAKDVAIKQ--IE----SESERKAFI----VELRQLSRVNHPNIVKL 66
Query: 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 633
YG + + MEY +GGS+ N + + + A+
Sbjct: 67 YG--ACLNPV--------------CLVMEYAEGGSLYNVLHGAEPL--PYYTAAHAMSWC 108
Query: 634 QDVAAALVELHS---KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 690
+ + LHS K ++HRD+K N+L+ G V+K+CDF A +++ +
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLV------AGGTVLKICDFGTACDIQTHMTN 162
Query: 691 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 750
G+ WMAPEV Y + D++S+G +L E++T + P+
Sbjct: 163 NK-------------GSAAWMAPEVFE--GSN--YSEKCDVFSWGIILWEVITRRKPFDE 205
Query: 751 LS--ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 808
+ I + G RP L + + + +
Sbjct: 206 IGGPAFRIMWAVHNGTRPPLIK------NLPKP---------------------IESLMT 238
Query: 809 RCTEENPTERPT 820
RC ++P++RP+
Sbjct: 239 RCWSKDPSQRPS 250
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 66/276 (23%), Positives = 104/276 (37%), Gaps = 64/276 (23%)
Query: 554 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 613
C+ E+ +L L H +++ Y I ++ L I +E G + I
Sbjct: 78 DCIKEIDLLKQLNHPNVIKYYASFIE-----------DNELN---IVLELADAGDLSRMI 123
Query: 614 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 673
+ + + + + + +AL +HS+ +MHRDIK N+ I A G VV
Sbjct: 124 KHFKKQK-RLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT-----ATG--VV 175
Query: 674 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 733
KL D R F AH VGTP +M+PE + Y + DIWS
Sbjct: 176 KLGDLGLG---RFFSSKTTAAH-------SLVGTPYYMSPERIH--ENG--YNFKSDIWS 221
Query: 734 YGCLLLELLTLQVPYMG--LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 791
GCLL E+ LQ P+ G ++ + I+ P L + S
Sbjct: 222 LGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD------------HYS----- 264
Query: 792 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 827
L + C +P +RP +Y++
Sbjct: 265 ---------EELRQLVNMCINPDPEKRPDVTYVYDV 291
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 56/296 (18%), Positives = 101/296 (34%), Gaps = 60/296 (20%)
Query: 547 EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA--IFMEYV 604
++ EV+ L L H IV G + P I ME+
Sbjct: 43 RVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFC 102
Query: 605 KGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 664
G+++ +IEK + + LAL + + + + +HSK +++RD+K NI +
Sbjct: 103 DKGTLEQWIEK---RRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV--- 156
Query: 665 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 724
VK+ DF L++ GT R+M+PE + +
Sbjct: 157 --DTK--QVKIGDFGLVTSLKNDGKRTRS-----------KGTLRYMSPEQIS--SQD-- 197
Query: 725 YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVA 784
YG EVD+++ G +L ELL + E + ++D
Sbjct: 198 YGKEVDLYALGLILAELLHVCDTAF-----ETSKFFTDLRDGIISDIF------------ 240
Query: 785 QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSSSISSR 839
+ ++ + P +RP ++ V + S + R
Sbjct: 241 -DKK--------------EKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 61/290 (21%), Positives = 107/290 (36%), Gaps = 71/290 (24%)
Query: 538 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 597
L+ + E + F+ E ML L+H IV Y W + G + ++
Sbjct: 59 LQDRKLTKSERQRFK----EEAEMLKGLQHPNIVRFYDS-----WESTVKG--KKCIV-- 105
Query: 598 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKS 655
+ E + G++K Y+++ K + + + L LH++ I+HRD+K
Sbjct: 106 -LVTELMTSGTLKTYLKRFKVMKIKVLRS-----WCRQILKGLQFLHTRTPPIIHRDLKC 159
Query: 656 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 715
+NI I G VK+ D + +GTP +MAPE+
Sbjct: 160 DNIFIT----GPTG--SVKIGDL------------GLATLKRASFAKAVIGTPEFMAPEM 201
Query: 716 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEA 774
Y VD++++G +LE+ T + PY +I+ + G +P D++
Sbjct: 202 YE-----EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256
Query: 775 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 824
PE + + C +N ER + DL
Sbjct: 257 ------------------PEVK----EII----EGCIRQNKDERYSIKDL 280
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-37
Identities = 56/286 (19%), Positives = 93/286 (32%), Gaps = 75/286 (26%)
Query: 552 EYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVK 610
E + L EV L +HS +V + W + H+L I EY GGS+
Sbjct: 54 EQNALREVYAHAVLGQHSHVVRYFSA-----WAE------DDHML---IQNEYCNGGSLA 99
Query: 611 NYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID--------- 661
+ I + + + V L +HS ++H DIK NI I
Sbjct: 100 DAISENYRIM-SYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAAS 158
Query: 662 ---LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718
E A K + K+ D + S P V G R++A EVL+
Sbjct: 159 EEGDEDDWASNKVMFKIGDLGHVTRISS--------------PQVEEGDSRFLANEVLQ- 203
Query: 719 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 778
+ + + DI++ ++ + + I+ G+ PR+ L
Sbjct: 204 ENYT--HLPKADIFALALTVVCAAGAEPLPRNGDQWHE---IRQGRLPRIPQVL------ 252
Query: 779 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 824
S ++ + +P RP+A L
Sbjct: 253 -------SQE--------------FTELLKVMIHPDPERRPSAMAL 277
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-37
Identities = 56/276 (20%), Positives = 99/276 (35%), Gaps = 55/276 (19%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA----IFMEYVKGGSVKNYI 613
EV +L +L H +V Y WL + ++ I MEY + G++ + I
Sbjct: 52 EVMLLASLNHQYVVRYYAA-----WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI 106
Query: 614 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 673
+ + + + AL +HS+ I+HRD+K NI ID V
Sbjct: 107 HS----ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID-----ESRN--V 155
Query: 674 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWMAPEVLRAMHKPNLYGLEV 729
K+ DF A + L + + +P +GT ++A EVL + Y ++
Sbjct: 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG--TGH-YNEKI 212
Query: 730 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG 789
D++S G + E++ G+ + I ++
Sbjct: 213 DMYSLGIIFFEMIYP--FSTGMERVNILKKLRSVS------------------------- 245
Query: 790 FEKPEAELETLS-FLVDVFRRCTEENPTERPTAGDL 824
E P + + R + +P +RP A L
Sbjct: 246 IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 56/314 (17%), Positives = 108/314 (34%), Gaps = 68/314 (21%)
Query: 521 LFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580
+ ++ L + R F L EV+++ L H +++ G +
Sbjct: 26 AIKVTHRETGEVMVMKELI--RFDEETQRTF----LKEVKVMRCLEHPNVLKFIG--VLY 77
Query: 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAAL 640
K + L EY+KGG+++ I+ + + A+D+A+ +
Sbjct: 78 K---------DKRL---NFITEYIKGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGM 121
Query: 641 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGI 698
LHS +I+HRD+ S N L+ + V + DF R + + +
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENK-------NVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 699 PAPDV--CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY--MGLSEL 754
VG P WMAPE++ + Y +VD++S+G +L E++ +
Sbjct: 175 DRKKRYTVVGNPYWMAPEMIN--GRS--YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM 230
Query: 755 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 814
+ ++ +C + RC + +
Sbjct: 231 DFGLNVRGFLDR------YCPPNCPPS---------------------FFPITVRCCDLD 263
Query: 815 PTERPTAGDLYEMF 828
P +RP+ L
Sbjct: 264 PEKRPSFVKLEHWL 277
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 72/279 (25%), Positives = 106/279 (37%), Gaps = 66/279 (23%)
Query: 554 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 613
+ EV +L L+H IV Y I L I MEY +GG + + I
Sbjct: 51 MLVSEVNLLRELKHPNIVRYYDRIIDRT---------NTTLY---IVMEYCEGGDLASVI 98
Query: 614 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-----IMHRDIKSENILIDLERKKAD 668
K ++ +++ + L + + AL E H + ++HRD+K N+ +D
Sbjct: 99 TKGTKER-QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD------- 150
Query: 669 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 728
GK VKL DF A R H A VGTP +M+PE + Y +
Sbjct: 151 GKQNVKLGDFGLA---RILNHDTSFAK-------TFVGTPYYMSPEQMN--RMS--YNEK 196
Query: 729 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 788
DIWS GCLL EL L P+ S+ E+ I+ GK R+ S
Sbjct: 197 SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY----S----------- 241
Query: 789 GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 827
L ++ R RP+ ++ E
Sbjct: 242 ------------DELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-36
Identities = 69/288 (23%), Positives = 107/288 (37%), Gaps = 66/288 (22%)
Query: 554 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 613
EV +L ++H IV+ + L I M+Y +GG + I
Sbjct: 69 ESRREVAVLANMKHPNIVQYRESFEENGSL--------------YIVMDYCEGGDLFKRI 114
Query: 614 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 673
L + AL +H + I+HRDIKS+NI + DG V
Sbjct: 115 NA---QKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT-----KDG--TV 164
Query: 674 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 733
+L DF A R T +A C+GTP +++PE+ +KP Y + DIW+
Sbjct: 165 QLGDFGIA---RVLNSTVELAR-------ACIGTPYYLSPEICE--NKP--YNNKSDIWA 210
Query: 734 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP 793
GC+L EL TL+ + S + I G P ++ S
Sbjct: 211 LGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHY----S---------------- 250
Query: 794 EAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSSSISSRS 840
L + + + NP +RP+ + E F+A+ S
Sbjct: 251 -------YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQ 291
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 58/268 (21%), Positives = 92/268 (34%), Gaps = 61/268 (22%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+ L IV +YG W+ IFME ++GGS+ I+++
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWV--------------NIFMELLEGGSLGQLIKQMG 145
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
E L LH++ I+H D+K++N+L+ +DG LCD
Sbjct: 146 CLPEDRALY-----YLGQALEGLEYLHTRRILHGDVKADNVLLS-----SDGS-RAALCD 194
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F A+ L+ + D GT MAPEV+ +VDIWS C+
Sbjct: 195 FGHALCLQPDGLGKSLLTG-----DYIPGTETHMAPEVVMG----KPCDAKVDIWSSCCM 245
Query: 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 797
+L +L P+ + I P E P
Sbjct: 246 MLHMLNGCHPWTQYFRGPLCLKIASEPPPIR----------------------EIP---- 279
Query: 798 ETLS-FLVDVFRRCTEENPTERPTAGDL 824
+ + + + P R +A +L
Sbjct: 280 PSCAPLTAQAIQEGLRKEPVHRASAMEL 307
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 61/274 (22%), Positives = 96/274 (35%), Gaps = 48/274 (17%)
Query: 554 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 613
+ EV+ L L H IV + + + L I M+ + ++K+++
Sbjct: 49 KVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYL--YIQMQLCRKENLKDWM 106
Query: 614 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 673
+ + L I +A A+ LHSK +MHRD+K NI D VV
Sbjct: 107 NG--RCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT-----MDD--VV 157
Query: 674 KLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 731
K+ DF A+ T VGT +M+PE + Y +VDI
Sbjct: 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS----YSHKVDI 213
Query: 732 WSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 790
+S G +L ELL P+ E ++ K P L
Sbjct: 214 FSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPL---------------------- 248
Query: 791 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 824
+ +V + +P ERP A ++
Sbjct: 249 --FTQKYPCEYVMV---QDMLSPSPMERPEAINI 277
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 61/285 (21%), Positives = 101/285 (35%), Gaps = 53/285 (18%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+ LRH I+ +D H Q + Y + GS+ +Y++
Sbjct: 52 ELYNTVMLRHENILGFIA----------SDMTSRHSSTQLWLITHYHEMGSLYDYLQL-- 99
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKH--------IMHRDIKSENILIDLERKKADG 669
+ L I +A+ L LH + I HRD+KS+NIL+ +G
Sbjct: 100 ----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK-----KNG 150
Query: 670 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE- 728
+ D AV + + + VGT R+MAPEVL + +
Sbjct: 151 --QCCIADLGLAVMHSQSTNQLDVGNNPR------VGTKRYMAPEVLD--ETIQVDCFDS 200
Query: 729 ---VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 785
VDIW++G +L E+ V + + + + P D + V
Sbjct: 201 YKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV--------VCV 252
Query: 786 SGS--GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
TL+ L + + C +NP+ R TA + +
Sbjct: 253 DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 68/286 (23%), Positives = 110/286 (38%), Gaps = 64/286 (22%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+ + L+H IV+ G + IFME V GGS+ +
Sbjct: 69 EIALHKHLKHKNIVQYLGSFSE-----------NGFIK---IFMEQVPGGSLSALLRSKW 114
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
+ + + + Q + L LH I+HRDIK +N+LI+ G V+K+ D
Sbjct: 115 GPLKDNEQT-IGFYTKQ-ILEGLKYLHDNQIVHRDIKGDNVLINTY----SG--VLKISD 166
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F + L P + GT ++MAPE++ P YG DIWS GC
Sbjct: 167 FGTSKRLAGI----------NPCTETFTGTLQYMAPEIID--KGPRGYGKAADIWSLGCT 214
Query: 738 LLELLTLQVPYMGLSE-LEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEA 795
++E+ T + P+ L E + M K P + + + A
Sbjct: 215 IIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA------------------- 255
Query: 796 ELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSSISSRS 840
+F+ +C E +P +R A DL F+ +S ++
Sbjct: 256 ----KAFI----LKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQP 293
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 64/281 (22%), Positives = 96/281 (34%), Gaps = 75/281 (26%)
Query: 554 SCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 612
L EV + +H C V + W +G L + E G S++ +
Sbjct: 102 RKLAEVGSHEKVGQHPCCVRLEQA-----W---EEGG---ILY---LQTELC-GPSLQQH 146
Query: 613 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 672
E + +D AL LHS+ ++H D+K NI + G
Sbjct: 147 CEAWG----ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG-----PRG--R 195
Query: 673 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 732
KL DF V L + +V G PR+MAPE+L+ YG D++
Sbjct: 196 CKLGDFGLLVELGTAGAG-----------EVQEGDPRYMAPELLQ-----GSYGTAADVF 239
Query: 733 SYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 791
S G +LE+ +++P+ G L Q P T L S
Sbjct: 240 SLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGL----S-------------- 278
Query: 792 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVAR 831
E L V E +P R TA L + + +
Sbjct: 279 -SE--------LRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 49/288 (17%), Positives = 100/288 (34%), Gaps = 82/288 (28%)
Query: 554 SCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 611
S E+ L L+ I+ +Y ++I+ +++ + ME + +
Sbjct: 72 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI--------------YMVMECG-NIDLNS 116
Query: 612 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 671
+++K +K + +++ A+ +H I+H D+K N LI
Sbjct: 117 WLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--------DG 163
Query: 672 VVKLCDFDRAVPLRS-----FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL-- 724
++KL DF A ++ + GT +M PE ++ M
Sbjct: 164 MLKLIDFGIANQMQPDTTSVVKDSQV-------------GTVNYMPPEAIKDMSSSRENG 210
Query: 725 -----YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 779
+ D+WS GC+L + + P+ + +++ L
Sbjct: 211 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-----------------IINQISKL---- 249
Query: 780 EHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDLYE 826
H + E P + L DV + C + +P +R + +L
Sbjct: 250 -HAIIDPNHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 60/299 (20%), Positives = 106/299 (35%), Gaps = 81/299 (27%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
EV L ++H I++ G A+ + + + + GS+ ++++
Sbjct: 68 EVYSLPGMKHENILQFIG----------AEKRGTSVDVDLWLITAFHEKGSLSDFLKA-- 115
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSK----------HIMHRDIKSENILIDLERKKA 667
VS IA+ +A L LH I HRDIKS+N+L+
Sbjct: 116 ----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK-----N 166
Query: 668 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR-AMHKPNLYG 726
+ + DF A+ + + VGT R+MAPEVL A++
Sbjct: 167 NL--TACIADFGLALKFEAGKSAGDTHGQ--------VGTRRYMAPEVLEGAINFQRDAF 216
Query: 727 LEVDIWSYGCLLLELLTLQVPYMGL----------------SELEIHDLI-QMGKRPRLT 769
L +D+++ G +L EL + G S ++ +++ KRP L
Sbjct: 217 LRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLR 276
Query: 770 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
D +H ++ L + C + + R +AG + E
Sbjct: 277 D------YWQKHAG----------------MAMLCETIEECWDHDAEARLSAGCVGERI 313
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 49/288 (17%), Positives = 101/288 (35%), Gaps = 82/288 (28%)
Query: 554 SCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 611
S E+ L L+ I+ +Y ++I+ +++ + ME + +
Sbjct: 53 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI--------------YMVMECG-NIDLNS 97
Query: 612 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 671
+++K +K + +++ A+ +H I+H D+K N LI
Sbjct: 98 WLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--------DG 144
Query: 672 VVKLCDFDRAVPLRS-----FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM------- 719
++KL DF A ++ + GT +M PE ++ M
Sbjct: 145 MLKLIDFGIANQMQPDTTSVVKDSQV-------------GTVNYMPPEAIKDMSSSRENG 191
Query: 720 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 779
+ + D+WS GC+L + + P+ + +++ L
Sbjct: 192 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-----------------IINQISKL---- 230
Query: 780 EHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDLYE 826
H + E P + L DV + C + +P +R + +L
Sbjct: 231 -HAIIDPNHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 44/228 (19%), Positives = 82/228 (35%), Gaps = 28/228 (12%)
Query: 555 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 614
E M H I+ + + + + +H + + + K G++ N IE
Sbjct: 73 AQREADMHRLFNHPNILRLVAYCLRER-------GAKHEAW---LLLPFFKRGTLWNEIE 122
Query: 615 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 674
+L + G ++ L++ + L +H+K HRD+K NIL+ +G
Sbjct: 123 RLKDKGN-FLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG-----DEG--QPV 174
Query: 675 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL-YGLEVDIWS 733
L D + A T + APE+ + + D+WS
Sbjct: 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQR-CTISYRAPELFSV--QSHCVIDERTDVWS 231
Query: 734 YGCLLLELLTLQVPYMGLSE-LEIHDLIQMGKR-----PRLTDELEAL 775
GC+L ++ + PY + + + L + PR + L L
Sbjct: 232 LGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQL 279
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 50/277 (18%), Positives = 90/277 (32%), Gaps = 37/277 (13%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E +L L H IV+++ + + H +L ME+ GS+ +E+ S
Sbjct: 57 EFEVLKKLNHKNIVKLFAIE--------EETTTRHKVL----IMEFCPCGSLYTVLEEPS 104
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
+ L + +DV + L I+HR+IK NI+ DG+ V KL D
Sbjct: 105 NAYG--LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRV---IGEDGQSVYKLTD 159
Query: 678 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL----YGLEVDI 731
F R + + GT ++ P++ YG VD+
Sbjct: 160 FGAARELEDDEQFVSLY-------------GTEEYLHPDMYERAVLRKDHQKKYGATVDL 206
Query: 732 WSYGCLLLELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 790
WS G T +P+ + +++ + + + + + SG
Sbjct: 207 WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMP 266
Query: 791 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 827
L V E + + +
Sbjct: 267 VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 78/316 (24%), Positives = 115/316 (36%), Gaps = 79/316 (25%)
Query: 523 RCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISS 580
C A K L+ C +S DE+ E++ + H IV Y
Sbjct: 35 YCAPKKEKVAIKRINLEKCQTSMDELLK-------EIQAMSQCHHPNIVSYYTSFVVKDE 87
Query: 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--------EKHVSVKLALFI 632
W + M+ + GGSV + I+ + G E ++ I
Sbjct: 88 LW----------------LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT-----I 126
Query: 633 AQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCC 692
++V L LH +HRD+K+ NIL+ DG V++ DF + L +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLG-----EDGS--VQIADFGVSAFLATGGDITR 179
Query: 693 IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS 752
R VGTP WMAPEV M + Y + DIWS+G +EL T PY
Sbjct: 180 NKVR-----KTFVGTPCWMAPEV---MEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231
Query: 753 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR---- 808
+++ L P L E + E L FR
Sbjct: 232 PMKVLMLTLQNDPPSL----------------------ETGVQDKEMLKKYGKSFRKMIS 269
Query: 809 RCTEENPTERPTAGDL 824
C +++P +RPTA +L
Sbjct: 270 LCLQKDPEKRPTAAEL 285
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 48/288 (16%), Positives = 100/288 (34%), Gaps = 82/288 (28%)
Query: 554 SCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 611
S E+ L L+ I+ +Y ++I+ +++ + ME + +
Sbjct: 100 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI--------------YMVMECG-NIDLNS 144
Query: 612 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 671
+++K +K + +++ A+ +H I+H D+K N LI
Sbjct: 145 WLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--------DG 191
Query: 672 VVKLCDFDRAVPLRS-----FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM------- 719
++KL DF A ++ + G +M PE ++ M
Sbjct: 192 MLKLIDFGIANQMQPDTTSVVKDSQV-------------GAVNYMPPEAIKDMSSSRENG 238
Query: 720 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 779
+ + D+WS GC+L + + P+ + +++ L
Sbjct: 239 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-----------------IINQISKL---- 277
Query: 780 EHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDLYE 826
H + E P + L DV + C + +P +R + +L
Sbjct: 278 -HAIIDPNHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLA 320
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 61/283 (21%), Positives = 97/283 (34%), Gaps = 49/283 (17%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+ +RH I+ AD Q + +Y + GS+ +Y++
Sbjct: 81 EIYQTVLMRHENILGFIA----------ADIKGTGSWTQLYLITDYHENGSLYDYLKS-- 128
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSK--------HIMHRDIKSENILIDLERKKADG 669
+ K L +A + L LH++ I HRD+KS+NIL+
Sbjct: 129 ----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-------K 177
Query: 670 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL--YGL 727
+ D AV S + I VGT R+M PEVL N +
Sbjct: 178 NGTCCIADLGLAVKFISDTNEVDIPPNTR------VGTKRYMPPEVLDESLNRNHFQSYI 231
Query: 728 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG 787
D++S+G +L E+ V + E ++ + P D E V
Sbjct: 232 MADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREI--------VCIKK 283
Query: 788 S--GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
F + E L + + C NP R TA + +
Sbjct: 284 LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-33
Identities = 50/277 (18%), Positives = 90/277 (32%), Gaps = 37/277 (13%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E +L L H IV+++ + + H +L ME+ GS+ +E+ S
Sbjct: 57 EFEVLKKLNHKNIVKLFAIE--------EETTTRHKVL----IMEFCPCGSLYTVLEEPS 104
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
+ L + +DV + L I+HR+IK NI+ DG+ V KL D
Sbjct: 105 NAYG--LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRV---IGEDGQSVYKLTD 159
Query: 678 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL----YGLEVDI 731
F R + + GT ++ P++ YG VD+
Sbjct: 160 FGAARELEDDEQFVSLY-------------GTEEYLHPDMYERAVLRKDHQKKYGATVDL 206
Query: 732 WSYGCLLLELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 790
WS G T +P+ + +++ + + + + + SG
Sbjct: 207 WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMP 266
Query: 791 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 827
L V E + + +
Sbjct: 267 VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 4e-32
Identities = 63/323 (19%), Positives = 102/323 (31%), Gaps = 59/323 (18%)
Query: 523 RCKFGSADAAAKVRTLKVC-GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581
R K + L+ C ++ E+ + H IV I+
Sbjct: 47 RYKPTGEYVTVRRINLEACSNEMVTFLQG-------ELHVSKLFNHPNIVPYRATFIADN 99
Query: 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--EKHVSVKLALFIAQDVAAA 639
L + ++ GS K+ I G E ++ +I Q V A
Sbjct: 100 EL--------------WVVTSFMAYGSAKDLICTHFMDGMNELAIA-----YILQGVLKA 140
Query: 640 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP 699
L +H +HR +K+ +ILI DGK V L S +
Sbjct: 141 LDYIHHMGYVHRSVKASHILIS-----VDGK--VYLSGLRSN---LSMISHGQRQRVVHD 190
Query: 700 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 759
P V W++PEVL+ + Y + DI+S G EL VP+ + ++
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQG--YDAKSDIYSVGITACELANGHVPFKDMPATQMLLE 248
Query: 760 IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV--------------D 805
G P L D ++S + ++ +
Sbjct: 249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSP 308
Query: 806 VFR----RCTEENPTERPTAGDL 824
F +C + NP RP+A L
Sbjct: 309 HFHHFVEQCLQRNPDARPSASTL 331
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 9e-32
Identities = 66/299 (22%), Positives = 103/299 (34%), Gaps = 81/299 (27%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+ LRH I+ AD Q + +Y + GS+ +Y+ + +
Sbjct: 86 EIYQTVMLRHENILGFIA----------ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT 135
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKH--------IMHRDIKSENILIDLERKKADG 669
V+V+ + +A A+ L LH + I HRD+KS+NIL+
Sbjct: 136 ------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-------K 182
Query: 670 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR----AMHKPNLY 725
+ D AV S T IA VGT R+MAPEVL H
Sbjct: 183 NGTCCIADLGLAVRHDSATDTIDIAPNHR------VGTKRYMAPEVLDDSINMKHFE--S 234
Query: 726 GLEVDIWSYGCLLLELLTL----------QVPYMGL-----SELEIHDLI-QMGKRPRLT 769
DI++ G + E+ Q+PY L S E+ ++ + RP +
Sbjct: 235 FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP 294
Query: 770 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
+ + E L + + R C N R TA + +
Sbjct: 295 NRWQ----------------------SCEALRVMAKIMRECWYANGAARLTALRIKKTL 331
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 70/270 (25%), Positives = 107/270 (39%), Gaps = 72/270 (26%)
Query: 558 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 615
E+ ++ ++ IV W + MEY+ GGS+ + + +
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELW----------------VVMEYLAGGSLTDVVTE 110
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
+ E ++ + ++ AL LHS ++HRDIKS+NIL+ DG VKL
Sbjct: 111 -TCMDEGQIAA-----VCRECLQALEFLHSNQVIHRDIKSDNILLG-----MDGS--VKL 157
Query: 676 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735
DF + T + R VGTP WMAPEV+ YG +VDIWS G
Sbjct: 158 TDFGFCAQI-----TPEQSKR-----STMVGTPYWMAPEVV----TRKAYGPKVDIWSLG 203
Query: 736 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 795
+ +E++ + PY+ + L LI P L +
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP------------------------ 239
Query: 796 ELETLS-FLVDVFRRCTEENPTERPTAGDL 824
E LS D RC E + +R +A +L
Sbjct: 240 --EKLSAIFRDFLNRCLEMDVEKRGSAKEL 267
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 69/270 (25%), Positives = 115/270 (42%), Gaps = 72/270 (26%)
Query: 558 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 615
EV ++ +H +VEMY W + ME+++GG++ + + +
Sbjct: 92 EVVIMRDYQHFNVVEMYKSYLVGEELW----------------VLMEFLQGGALTDIVSQ 135
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
+ E+ ++ + + V AL LH++ ++HRDIKS++IL+ L DG+ VKL
Sbjct: 136 VRLN-EEQIAT-----VCEAVLQALAYLHAQGVIHRDIKSDSILLTL-----DGR--VKL 182
Query: 676 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735
DF + + + R VGTP WMAPEV+ Y EVDIWS G
Sbjct: 183 SDFGFCAQI-----SKDVPKR-----KSLVGTPYWMAPEVISRSL----YATEVDIWSLG 228
Query: 736 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 795
+++E++ + PY S ++ ++ P+L +
Sbjct: 229 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS------------------------ 264
Query: 796 ELETLS-FLVDVFRRCTEENPTERPTAGDL 824
+S L D R +P ER TA +L
Sbjct: 265 --HKVSPVLRDFLERMLVRDPQERATAQEL 292
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 78/311 (25%), Positives = 121/311 (38%), Gaps = 80/311 (25%)
Query: 531 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISSKWLPSADG 588
A K+ L+ ++I+ E+ +L + + YG K + W
Sbjct: 50 VAIKIIDLEEAEDEIEDIQQ-------EITVLSQCDSPYVTKYYGSYLKDTKLW------ 96
Query: 589 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHI 648
I MEY+ GGS + + + E ++ I +++ L LHS+
Sbjct: 97 ----------IIMEYLGGGSALD-LLEPGPLDETQIAT-----ILREILKGLDYLHSEKK 140
Query: 649 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 708
+HRDIK+ N+L+ G+ VKL DF A L T R + VGTP
Sbjct: 141 IHRDIKAANVLLS-----EHGE--VKLADFGVAGQL-----TDTQIKR-----NTFVGTP 183
Query: 709 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 768
WMAPEV+ K + Y + DIWS G +EL + P+ L +++ LI P L
Sbjct: 184 FWMAPEVI----KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL 239
Query: 769 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM- 827
+ KP L + C + P+ RPTA +L +
Sbjct: 240 EGN------------------YSKP---------LKEFVEACLNKEPSFRPTAKELLKHK 272
Query: 828 FVARTSSSISS 838
F+ R + S
Sbjct: 273 FILRNAKKTSY 283
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 51/301 (16%), Positives = 97/301 (32%), Gaps = 76/301 (25%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
+ + + H I + ++ + MEY GS+ Y+
Sbjct: 57 NIYRVPLMEHDNIARFIV---------GDERVTADGRMEYLLVMEYYPNGSLXKYLSL-- 105
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKH---------IMHRDIKSENILIDLERKKAD 668
+ +A V L LH++ I HRD+ S N+L+ D
Sbjct: 106 ----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK-----ND 156
Query: 669 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR---AMHKPNLY 725
G + DF ++ L +V GT R+MAPEVL +
Sbjct: 157 G--TCVISDFGLSMRLTGNRLVRPGEEDNAAISEV--GTIRYMAPEVLEGAVNLRDXESA 212
Query: 726 GLEVDIWSYGCLLLELLT-------------LQVPYMGL-----SELEIHDLI-QMGKRP 766
+VD+++ G + E+ Q+ + + ++ L+ + +RP
Sbjct: 213 LKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRP 272
Query: 767 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
+ + + E+ +A + L + C +++ R TA E
Sbjct: 273 KFPE------AWKENSLA---------------VRSLKETIEDCWDQDAEARLTAQXAEE 311
Query: 827 M 827
Sbjct: 312 R 312
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 65/291 (22%), Positives = 106/291 (36%), Gaps = 64/291 (21%)
Query: 538 LKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQ 596
+KV + DE + E+ ML H I YG ++ + L
Sbjct: 54 IKVMDVTGDEEEEIKQ----EINMLKKYSHHRNIATYYGA-----FIKKNPPGMDDQLW- 103
Query: 597 SAIFMEYVKGGSVKNYIEKLSETG--EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
+ ME+ GSV + I+ E+ ++ +I +++ L LH ++HRDIK
Sbjct: 104 --LVMEFCGAGSVTDLIKNTKGNTLKEEWIA-----YICREILRGLSHLHQHKVIHRDIK 156
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714
+N+L+ + + VKL DF + L + R + +GTP WMAPE
Sbjct: 157 GQNVLLT-----ENAE--VKLVDFGVSAQL-----DRTVGRR-----NTFIGTPYWMAPE 199
Query: 715 VLRAMHKPNL-YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 773
V+ P+ Y + D+WS G +E+ P + + LI PRL
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL----- 254
Query: 774 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 824
+ K C +N ++RP L
Sbjct: 255 ------------KSKKWSKK---------FQSFIESCLVKNHSQRPATEQL 284
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 73/298 (24%), Positives = 117/298 (39%), Gaps = 75/298 (25%)
Query: 531 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISSKWLPSADG 588
AAAKV K S +E+ ++ E+ +L H IV++ G + W
Sbjct: 47 AAAKVIETK----SEEELEDYI----VEIEILATCDHPYIVKLLGAYYHDGKLW------ 92
Query: 589 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-GEKHVSVKLALFIAQDVAAALVELHSKH 647
I +E+ GG+V + +L E + + + + AL LHSK
Sbjct: 93 ----------IMIEFCPGGAVDAIMLELDRGLTEPQIQ-----VVCRQMLEALNFLHSKR 137
Query: 648 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 707
I+HRD+K+ N+L+ +G ++L DF + L R D +GT
Sbjct: 138 IIHRDLKAGNVLMT-----LEGD--IRLADFGVSAKNLKTL-----QKR-----DSFIGT 180
Query: 708 PRWMAPEV-LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 766
P WMAPEV + K Y + DIWS G L+E+ ++ P+ L+ + + I P
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP 240
Query: 767 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 824
L + S + D + ++NP RP+A L
Sbjct: 241 TL----------------LTPSKWSVE---------FRDFLKIALDKNPETRPSAAQL 273
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 54/274 (19%), Positives = 107/274 (39%), Gaps = 55/274 (20%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 615
E++++ +++ + G I++ ++ EY++ S+ + E
Sbjct: 93 ELQIITDIKNEYCLTCEGI-ITNY---------------DEVYIIYEYMENDSILKFDEY 136
Query: 616 ---LSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLERKKADGKP 671
L + + +++ I + V + +H+ K+I HRD+K NIL+D +G+
Sbjct: 137 FFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD-----KNGR- 190
Query: 672 VVKLCDFDRAVPLR-SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 730
VKL DF + + + GT +M PE ++ + G +VD
Sbjct: 191 -VKLSDFGESEYMVDKKIKGSR-------------GTYEFMPPEFF--SNESSYNGAKVD 234
Query: 731 IWSYGCLLLELLTLQVPYMG-LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG 789
IWS G L + VP+ +S +E+ + I+ + ++ + +
Sbjct: 235 IWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKN-IEYPLDRNHFLYPLTNKKSTCSNN 293
Query: 790 FEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823
F E D + +NP ER T+ D
Sbjct: 294 FLSNEDI--------DFLKLFLRKNPAERITSED 319
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 48/210 (22%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 615
EV + LRH I+ +YG+ + ++ +EY G+V ++K
Sbjct: 59 EVEIQSHLRHPNILRLYGYFHDAT----------------RVYLILEYAPLGTVYRELQK 102
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
+ ++A AL HSK ++HRDIK EN+L+ + G+ +K+
Sbjct: 103 -----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-----SAGE--LKI 150
Query: 676 CDFDRAVPLRS-FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 734
DF +V S C GT ++ PE++ ++ +VD+WS
Sbjct: 151 ADFGWSVHAPSSRRTDLC-------------GTLDYLPPEMIEG----RMHDEKVDLWSL 193
Query: 735 GCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
G L E L + P+ + E + I +
Sbjct: 194 GVLCYEFLVGKPPFEANTYQETYKRISRVE 223
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 68/271 (25%), Positives = 100/271 (36%), Gaps = 72/271 (26%)
Query: 558 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 615
E+ ++ +V+ YG K + W I MEY GSV + I
Sbjct: 74 EISIMQQCDSPHVVKYYGSYFKNTDLW----------------IVMEYCGAGSVSDIIRL 117
Query: 616 LSET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 674
++T E ++ I Q L LH +HRDIK+ NIL++ +G K
Sbjct: 118 RNKTLTEDEIAT-----ILQSTLKGLEYLHFMRKIHRDIKAGNILLN-----TEGH--AK 165
Query: 675 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 734
L DF A L T +A R + +GTP WMAPEV+ + Y DIWS
Sbjct: 166 LADFGVAGQL-----TDTMAKR-----NTVIGTPFWMAPEVI----QEIGYNCVADIWSL 211
Query: 735 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 794
G +E+ + PY + + +I P
Sbjct: 212 GITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKP----------------------- 248
Query: 795 AELETLS-FLVDVFRRCTEENPTERPTAGDL 824
E S D ++C ++P +R TA L
Sbjct: 249 ---ELWSDNFTDFVKQCLVKSPEQRATATQL 276
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 34/202 (16%), Positives = 67/202 (33%), Gaps = 44/202 (21%)
Query: 553 YSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVK 610
Y + L ++ Y HL Q+ E G++
Sbjct: 112 YIGTQLMERLKPSMQHMFMKFY----------------SAHLFQNGSVLVGELYSYGTLL 155
Query: 611 NYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI----DLERKK 666
N I T EK + L + A + + ++H I+H DIK +N ++ + +
Sbjct: 156 NAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215
Query: 667 ADGKPVVKLCDFDRAVPLRSF-----LHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 721
D + L D +++ ++ F C T + E+L +K
Sbjct: 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKC-------------ETSGFQCVEMLS--NK 260
Query: 722 PNLYGLEVDIWSYGCLLLELLT 743
P + ++D + + +L
Sbjct: 261 P--WNYQIDYFGVAATVYCMLF 280
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-28
Identities = 59/276 (21%), Positives = 96/276 (34%), Gaps = 56/276 (20%)
Query: 558 EVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 616
EV + L H IV+ K + L + E KG V +++K+
Sbjct: 75 EVCFMKKLSGHPNIVQFCSAASIGK---EESDTGQAEFL---LLTELCKGQLV-EFLKKM 127
Query: 617 SETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVK 674
G +S L I A+ +H + I+HRD+K EN+L+ G +K
Sbjct: 128 ESRG--PLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-----NQG--TIK 178
Query: 675 LCDFDRAVPLRSFLHTCCIAHRGIPAPDV--CVGTPRWMAPEVLRAM-HKPNLYGLEVDI 731
LCDF A + + A R + TP + PE++ + P G + DI
Sbjct: 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFP--IGEKQDI 236
Query: 732 WSYGCLLLELLTLQVPYMGLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 790
W+ GC+L L Q P+ ++L I + + +L
Sbjct: 237 WALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDTQYTVFHSL--------------- 281
Query: 791 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
R + NP ER + ++
Sbjct: 282 ----------------IRAMLQVNPEERLSIAEVVH 301
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 47/210 (22%), Positives = 79/210 (37%), Gaps = 48/210 (22%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 615
E+ + LRH I+ MY + + I+ +E+ G + ++K
Sbjct: 64 EIEIQSHLRHPNILRMYNY-FHDR---------------KRIYLMLEFAPRGELYKELQK 107
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
+ + +++A AL H + ++HRDIK EN+L+ G +K+
Sbjct: 108 -----HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG-----YKG--ELKI 155
Query: 676 CDFDRAV-PLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 734
DF +V T C GT ++ PE++ K + +VD+W
Sbjct: 156 ADFGWSVHAPSLRRRTMC-------------GTLDYLPPEMIE--GKT--HDEKVDLWCA 198
Query: 735 GCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
G L E L P+ S E H I
Sbjct: 199 GVLCYEFLVGMPPFDSPSHTETHRRIVNVD 228
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 33/303 (10%), Positives = 69/303 (22%), Gaps = 56/303 (18%)
Query: 538 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH----------KISSKWLPSAD 587
LKV A+ R+ L E + S+ +
Sbjct: 92 LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151
Query: 588 GNPEHHLLQSAIF--MEYVKGGSVKNYIEKLSETGEKH--VSVKLALFIAQDVAAALVEL 643
+ + M ++ L + + + L
Sbjct: 152 SPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL 210
Query: 644 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 703
SK ++H +N+ I DG+ + L D + +
Sbjct: 211 QSKGLVHGHFTPDNLFIM-----PDGR--LMLGDVSALWKVGTRGPASS----------- 252
Query: 704 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG 763
+ E L + ++ W G + + L +P+ ++ +
Sbjct: 253 --VPVTYAPREFLN--ASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPS 308
Query: 764 KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823
R TD L + + + R + R +
Sbjct: 309 LRVPGTDSLAFGSCTPLPDFVK-------------------TLIGRFLNFDRRRRLLPLE 349
Query: 824 LYE 826
E
Sbjct: 350 AME 352
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 69/303 (22%), Positives = 111/303 (36%), Gaps = 74/303 (24%)
Query: 558 EVRMLGALRHSCIVEMYG-----HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 612
E+++L IV YG +IS I ME++ GGS+
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGEIS-------------------ICMEHMDGGSLDQV 121
Query: 613 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENILIDLERKKADGKP 671
++K E+ + ++ V L L KH IMHRD+K NIL++ +
Sbjct: 122 LKKAGRIPEQILGK-----VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE------ 170
Query: 672 VVKLCDFDRAVPL-RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 730
+KLCDF + L S ++ VGT +M+PE L + Y ++ D
Sbjct: 171 -IKLCDFGVSGQLIDSMANS-------------FVGTRSYMSPERL----QGTHYSVQSD 212
Query: 731 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 790
IWS G L+E+ + P E+ + + + + + G
Sbjct: 213 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT-PGRPLNKFGMDS 271
Query: 791 EKPEAELETLSFLV-----------------DVFRRCTEENPTERPTAGDLYEM-FVART 832
P A E L ++V D +C +NP ER L F+ R+
Sbjct: 272 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331
Query: 833 SSS 835
+
Sbjct: 332 DAE 334
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 9e-28
Identities = 59/261 (22%), Positives = 93/261 (35%), Gaps = 44/261 (16%)
Query: 566 RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVS 625
+ V++ S P + I M+ + ++K+++ + +
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR--RCSLEDRE 162
Query: 626 VKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVP 683
+ L I +A A+ LHSK +MHRD+K NI D VVK+ DF A+
Sbjct: 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT-----MDD--VVKVGDFGLVTAMD 215
Query: 684 LRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743
T VGT +M+PE + + Y +VDI+S G +L ELL
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN----YSHKVDIFSLGLILFELLY 271
Query: 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 803
M + I D+ K P L + +
Sbjct: 272 SFSTQMERVRI-ITDVRN-LKFPLL------------------------FTQKYPQEHMM 305
Query: 804 VDVFRRCTEENPTERPTAGDL 824
V + +PTERP A D+
Sbjct: 306 V---QDMLSPSPTERPEATDI 323
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 1e-27
Identities = 49/233 (21%), Positives = 82/233 (35%), Gaps = 53/233 (22%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
I +E +++ Y+E+ + + + Q + L LHS +I+HRD+K NI
Sbjct: 95 IAIELC-AATLQEYVEQ----KDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNI 149
Query: 659 LIDLERKKADGKPVVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 712
LI A GK + DF S GT W+A
Sbjct: 150 LIS--MPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-------------GTEGWIA 194
Query: 713 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 771
PE+L K N VDI+S GC+ +++ P+ + + + L+ L E
Sbjct: 195 PEMLSEDCKEN-PTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE 253
Query: 772 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 824
E A ++ + +P +RP+A +
Sbjct: 254 KH-----------------EDVIAR--------ELIEKMIAMDPQKRPSAKHV 281
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 66/295 (22%), Positives = 108/295 (36%), Gaps = 70/295 (23%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V++ + D F L E R+L H IV + G + ++ P +
Sbjct: 144 VKSCR-ETLPPDLKAKF----LQEARILKQYSHPNIVRLIG--VCTQKQP---------I 187
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
I ME V+GG ++ + VK L + D AA + L SK +HRD+
Sbjct: 188 Y---IVMELVQGGDFLTFLRT----EGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLA 240
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714
+ N L+ + V+K+ DF + ++ R +P +W APE
Sbjct: 241 ARNCLVTEKN-------VLKISDFGMSREEADGVYAASGGLRQVPV--------KWTAPE 285
Query: 715 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 773
L Y E D+WS+G LL E +L PY LS + + ++ G R L
Sbjct: 286 ALNY----GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR------LP 335
Query: 774 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
C + + + +C P +RP+ +Y+
Sbjct: 336 CPELCPDA---------------------VFRLMEQCWAYEPGQRPSFSTIYQEL 369
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 66/273 (24%), Positives = 100/273 (36%), Gaps = 79/273 (28%)
Query: 558 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 615
EVR L LRH ++ G + + W + MEY GS + +E
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAW----------------LVMEYC-LGSASDLLEV 146
Query: 616 LSET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 674
+ E ++ + L LHS +++HRD+K+ NIL+ G VK
Sbjct: 147 HKKPLQEVEIAA-----VTHGALQGLAYLHSHNMIHRDVKAGNILLS-----EPGL--VK 194
Query: 675 LCDFDRAVPL---RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 731
L DF A + SF VGTP WMAPEV+ AM Y +VD+
Sbjct: 195 LGDFGSASIMAPANSF-----------------VGTPYWMAPEVILAM-DEGQYDGKVDV 236
Query: 732 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 791
WS G +EL + P ++ + I + P L +
Sbjct: 237 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS-----------------GHWS 279
Query: 792 KPEAELETLSFLVDVFRRCTEENPTERPTAGDL 824
+ + C ++ P +RPT+ L
Sbjct: 280 EY---------FRNFVDSCLQKIPQDRPTSEVL 303
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 3e-27
Identities = 45/212 (21%), Positives = 81/212 (38%), Gaps = 33/212 (15%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E++++ L H +V + L D + MEY +GG ++ Y+ +
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPND--------LPLLAMEYCEGGDLRKYLNQFE 113
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
+ + D+++AL LH I+HRD+K ENI++ + + K+ D
Sbjct: 114 NCCG--LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPG----PQRLIHKIID 167
Query: 678 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735
+ + GT +++APE+L K Y + VD WS+G
Sbjct: 168 LGYAKELDQGELCTEFV-------------GTLQYLAPELLE--QKK--YTVTVDYWSFG 210
Query: 736 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPR 767
L E +T P++ + K
Sbjct: 211 TLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 58/234 (24%), Positives = 83/234 (35%), Gaps = 52/234 (22%)
Query: 599 IFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAALVELHSKH-IMHRDI 653
I ME + K Y S E+ + I AL L I+HRDI
Sbjct: 98 ICMELMSTSFDKFYKYVYSVLDDVIPEEILGK-----ITLATVKALNHLKENLKIIHRDI 152
Query: 654 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 713
K NIL+D G +KLCDF + L IA G +MAP
Sbjct: 153 KPSNILLD-----RSGN--IKLCDFGISGQL-----VDSIAKT------RDAGCRPYMAP 194
Query: 714 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDEL 772
E + Y + D+WS G L EL T + PY S + + G P+L++
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE 254
Query: 773 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
E S P +F+ C ++ ++RP +L +
Sbjct: 255 EREFS---------------PSFI----NFV----NLCLTKDESKRPKYKELLK 285
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 51/236 (21%), Positives = 98/236 (41%), Gaps = 41/236 (17%)
Query: 532 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 591
A ++ + + + + + E+ +L L H CI+++ + +
Sbjct: 164 AIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA----------ED 213
Query: 592 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 651
++++ +E ++GG + + + G K + + A+ LH I+HR
Sbjct: 214 YYIV-----LELMEGGELFDKV-----VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHR 263
Query: 652 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPR 709
D+K EN+L+ + + +K+ DF + L S + T C GTP
Sbjct: 264 DLKPENVLLSSQEEDCL----IKITDFGHSKILGETSLMRTLC-------------GTPT 306
Query: 710 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP-YMGLSELEIHDLIQMGK 764
++APEVL ++ Y VD WS G +L L+ P +++ + D I GK
Sbjct: 307 YLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 361
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 44/191 (23%), Positives = 76/191 (39%), Gaps = 49/191 (25%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 615
EV++ L+H I+E+Y + + ++ +E G + Y++
Sbjct: 61 EVKIHCQLKHPSILELYNY-FEDS---------------NYVYLVLEMCHNGEMNRYLKN 104
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
K S A + ++ LHS I+HRD+ N+L+ +K+
Sbjct: 105 RV----KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN-------IKI 153
Query: 676 CDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 732
DF A L+ +T C GTP +++PE+ + +GLE D+W
Sbjct: 154 ADFGLATQLKMPHEKHYTLC-------------GTPNYISPEIATR----SAHGLESDVW 196
Query: 733 SYGCLLLELLT 743
S GC+ LL
Sbjct: 197 SLGCMFYTLLI 207
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 57/302 (18%), Positives = 113/302 (37%), Gaps = 72/302 (23%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+ LK ++ +I F L E + H + ++ G +S + L
Sbjct: 56 VKMLKADIIASSDIEEF----LREAACMKEFDHPHVAKLVG--VSL------RSRAKGRL 103
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMHRDI 653
+ + ++K G + ++ + ++ + D+A + L S++ +HRD+
Sbjct: 104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDL 163
Query: 654 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-CVGT----P 708
+ N ++ + V + DF + R I + D G P
Sbjct: 164 AARNCMLAEDM-------TVCVADFGLS--------------RKIYSGDYYRQGCASKLP 202
Query: 709 -RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 766
+W+A E L NLY + D+W++G + E++T Q PY G+ EI++ + G R
Sbjct: 203 VKWLALESLAD----NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR- 257
Query: 767 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
++P E + + D+ +C +P +RP+ L
Sbjct: 258 -----------------------LKQPP---ECMEEVYDLMYQCWSADPKQRPSFTCLRM 291
Query: 827 MF 828
Sbjct: 292 EL 293
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 62/302 (20%), Positives = 115/302 (38%), Gaps = 73/302 (24%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+T+K+ SS EI F L E + H ++ + G + + P
Sbjct: 67 VKTMKLDNSSQREIEEF----LSEAACMKDFSHPNVIRLLG--VCIEMSSQGIPKP---- 116
Query: 595 LQSAIFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 653
+ + ++K G + Y+ ETG KH+ ++ L D+A + L +++ +HRD+
Sbjct: 117 ---MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDL 173
Query: 654 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-CVGTP---- 708
+ N ++ + V + DF + + I + D G
Sbjct: 174 AARNCMLRDDM-------TVCVADFGLS--------------KKIYSGDYYRQGRIAKMP 212
Query: 709 -RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 766
+W+A E L +Y + D+W++G + E+ T PY G+ E++D + G R
Sbjct: 213 VKWIAIESLAD----RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR- 267
Query: 767 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
++PE + L L ++ C +P +RPT L
Sbjct: 268 -----------------------LKQPE---DCLDELYEIMYSCWRTDPLDRPTFSVLRL 301
Query: 827 MF 828
Sbjct: 302 QL 303
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-26
Identities = 52/283 (18%), Positives = 102/283 (36%), Gaps = 69/283 (24%)
Query: 558 EVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK- 615
E+++L H ++ Y + + ++L I +E ++++ +E
Sbjct: 58 EIKLLTESDDHPNVIRYYCSETTDRFL--------------YIALELC-NLNLQDLVESK 102
Query: 616 -LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV-- 672
+S+ K + + + +A+ + LHS I+HRD+K +NIL+ + +
Sbjct: 103 NVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA 162
Query: 673 ----VKLCDF-------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 721
+ + DF R+ L+ GT W APE+L +
Sbjct: 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPS-------------GTSGWRAPELLEESNN 209
Query: 722 PNL---YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 778
+DI+S GC+ +L+ G + I G L+ +
Sbjct: 210 LQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG-DKYSRESNIIRGIF-----SLDEMKCL 263
Query: 779 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821
H+ + EA D+ + + +P +RPTA
Sbjct: 264 HDRSLI--------AEAT--------DLISQMIDHDPLKRPTA 290
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 40/191 (20%), Positives = 71/191 (37%), Gaps = 50/191 (26%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 615
E+ + +L H +V +G +F +E + S+ ++
Sbjct: 65 EISIHRSLAHQHVVGFHGF-FEDN---------------DFVFVVLELCRRRSLLELHKR 108
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
K ++ A + + + LH ++HRD+K N+ ++ D + VK+
Sbjct: 109 -----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-----EDLE--VKI 156
Query: 676 CDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 732
DF + C GTP ++APEVL + EVD+W
Sbjct: 157 GDFGLATKVEYDGERKKVLC-------------GTPNYIAPEVLSK----KGHSFEVDVW 199
Query: 733 SYGCLLLELLT 743
S GC++ LL
Sbjct: 200 SIGCIMYTLLV 210
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-26
Identities = 38/256 (14%), Positives = 78/256 (30%), Gaps = 31/256 (12%)
Query: 532 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP- 590
V ++ I+ + + +R+L +++ +++ I L
Sbjct: 107 EVHVPY-FTERPPSNAIKQMK-EEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 164
Query: 591 --------EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH--VSVKLALFIAQDVAAAL 640
+ S F+ +++ + E L H + L + V L
Sbjct: 165 MIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLL 224
Query: 641 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA 700
LH ++H ++ +I++D G V L F+ V + +
Sbjct: 225 ASLHHYGLVHTYLRPVDIVLD-----QRGG--VFLTGFEHLVRDGASAVSPI-------- 269
Query: 701 PDVCVGTPRWMAPEVLRAM-HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 759
P A +L H P L D W+ G + + +P + L +
Sbjct: 270 -GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEW 328
Query: 760 IQMGKRPRLTDELEAL 775
I + + AL
Sbjct: 329 I-FRSCKNIPQPVRAL 343
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 59/233 (25%), Positives = 93/233 (39%), Gaps = 54/233 (23%)
Query: 599 IFMEYVKGGSVKNYIEKLSETG---EKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIK 654
I ME + K Y + + + E + IA + AL LHSK ++HRD+K
Sbjct: 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGK-----IAVSIVKALEHLHSKLSVIHRDVK 137
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714
N+LI+ A G+ VK+CDF + L + A D+ G +MAPE
Sbjct: 138 PSNVLIN-----ALGQ--VKMCDFGISGYLVDDV-----------AKDIDAGCKPYMAPE 179
Query: 715 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELE 773
+ Y ++ DIWS G ++EL L+ PY + + + P+L +
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD-- 237
Query: 774 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
F E + F +C ++N ERPT +L +
Sbjct: 238 ---------------KFSA-----EFVDFT----SQCLKKNSKERPTYPELMQ 266
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 40/191 (20%), Positives = 71/191 (37%), Gaps = 50/191 (26%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 615
E+ + +L H +V +G +F +E + S+ ++
Sbjct: 91 EISIHRSLAHQHVVGFHGF-FEDN---------------DFVFVVLELCRRRSLLELHKR 134
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
K ++ A + + + LH ++HRD+K N+ ++ D + VK+
Sbjct: 135 -----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-----EDLE--VKI 182
Query: 676 CDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 732
DF + C GTP ++APEVL + EVD+W
Sbjct: 183 GDFGLATKVEYDGERKKVLC-------------GTPNYIAPEVLSK----KGHSFEVDVW 225
Query: 733 SYGCLLLELLT 743
S GC++ LL
Sbjct: 226 SIGCIMYTLLV 236
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 33/236 (13%), Positives = 73/236 (30%), Gaps = 40/236 (16%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNP---------EHHLLQSAIFMEYVKGGS 608
+R+L +++ +++ I L + S F+ +
Sbjct: 126 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 185
Query: 609 VKNYIEKLSETGEKH--VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 666
++ + E L H + L + V L LH ++H ++ +I++D
Sbjct: 186 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD----- 240
Query: 667 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL-------RAM 719
G V L F+ V + + + + + PE+
Sbjct: 241 QRGG--VFLTGFEHLVRDGARVVSS--------------VSRGFEPPELEARRATISYHR 284
Query: 720 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL 775
+ L D W+ G ++ + +P + L + I + + AL
Sbjct: 285 DRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI-FRSCKNIPQPVRAL 339
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 54/231 (23%), Positives = 81/231 (35%), Gaps = 51/231 (22%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSEN 657
I ME + + K E+ + + + AL L KH ++HRD+K N
Sbjct: 101 IAMELMGTCAEKLKKRMQGPIPERILGK-----MTVAIVKALYYLKEKHGVIHRDVKPSN 155
Query: 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717
IL+D G+ +KLCDF + L A D G +MAPE +
Sbjct: 156 ILLD-----ERGQ--IKLCDFGISGRLVDDK-----------AKDRSAGCAAYMAPERID 197
Query: 718 AMHKPNL-YGLEVDIWSYGCLLLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEAL 775
Y + D+WS G L+EL T Q PY ++ E+ + + P L
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH---- 253
Query: 776 GSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
GF + C ++ +RP L E
Sbjct: 254 ------------MGFSGD---------FQSFVKDCLTKDHRKRPKYNKLLE 283
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 52/236 (22%), Positives = 98/236 (41%), Gaps = 41/236 (17%)
Query: 532 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 591
A K+ + + + + + E+ +L L H CI+++ + +
Sbjct: 39 AIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA----------ED 88
Query: 592 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 651
++++ +E ++GG + + + G K + + A+ LH I+HR
Sbjct: 89 YYIV-----LELMEGGELFDKV-----VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHR 138
Query: 652 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPR 709
D+K EN+L+ + + +K+ DF + L S + T C GTP
Sbjct: 139 DLKPENVLLSSQEEDCL----IKITDFGHSKILGETSLMRTLC-------------GTPT 181
Query: 710 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP-YMGLSELEIHDLIQMGK 764
++APEVL ++ Y VD WS G +L L+ P +++ + D I GK
Sbjct: 182 YLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-25
Identities = 47/169 (27%), Positives = 74/169 (43%), Gaps = 23/169 (13%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
MEY GG + + K + + ++A F ++ A+ +H +HRDIK +NIL+
Sbjct: 140 MEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL 195
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM- 719
D G ++L DF + LR+ V VGTP +++PE+L+A+
Sbjct: 196 D-----RCGH--IRLADFGSCLKLRADGTVRS---------LVAVGTPDYLSPEILQAVG 239
Query: 720 --HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 766
YG E D W+ G E+ Q P+ S E + I K
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-25
Identities = 53/215 (24%), Positives = 83/215 (38%), Gaps = 44/215 (20%)
Query: 556 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF----MEYVKGGSVKN 611
E ++ +V++ + Q + MEY+ GG
Sbjct: 117 WEERDIMAFANSPWVVQL------------------FYAFQDDRYLYMVMEYMPGG---- 154
Query: 612 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 671
+ ++ V K A F +V AL +HS +HRD+K +N+L+D G
Sbjct: 155 --DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-----KSGH- 206
Query: 672 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 731
+KL DF + + C D VGTP +++PEVL++ YG E D
Sbjct: 207 -LKLADFGTCMKMNKEGMVRC---------DTAVGTPDYISPEVLKSQGGDGYYGRECDW 256
Query: 732 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 766
WS G L E+L P+ S + + I K
Sbjct: 257 WSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 291
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 51/296 (17%), Positives = 97/296 (32%), Gaps = 72/296 (24%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
++ L + +F M+ L H +V YG + +
Sbjct: 45 LKVLDKA--HRNYSESF----FEAASMMSKLSHKHLVLNYG--VCVCGDENI-------- 88
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
+ E+VK GS+ Y++K + +++ L +A+ +AAA+ L ++H ++
Sbjct: 89 ----LVQEFVKFGSLDTYLKK----NKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVC 140
Query: 655 SENILIDLERKKADGKP-VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 713
++NIL+ E + G P +KL D + + D+ W+ P
Sbjct: 141 AKNILLIREEDRKTGNPPFIKLSDPGIS--------------ITVLPKDILQERIPWVPP 186
Query: 714 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDEL 772
E + P L D WS+G L E+ + P L + + L
Sbjct: 187 E---CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ------L 237
Query: 773 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
A + ++ C + P RP+ +
Sbjct: 238 PAPKAAELA-----------------------NLINNCMDYEPDHRPSFRAIIRDL 270
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 56/255 (21%), Positives = 92/255 (36%), Gaps = 39/255 (15%)
Query: 532 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--------------- 575
A K+ K+ + ++ + EVR++ L H I +Y
Sbjct: 55 AIKIMNKNKIRQINPKDVERIK----TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELC 110
Query: 576 ------HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA 629
K++ S + ++ I E+ + KL
Sbjct: 111 HGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLI 170
Query: 630 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 689
I + + +AL LH++ I HRDIK EN L + +KL DF + +
Sbjct: 171 SNIMRQIFSALHYLHNQGICHRDIKPENFLFS-----TNKSFEIKLVDFGLSKEFYKLNN 225
Query: 690 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 749
GTP ++APEVL ++ YG + D WS G LL LL VP+
Sbjct: 226 GEYYGMTTK------AGTPYFVAPEVLNTTNES--YGPKCDAWSAGVLLHLLLMGAVPFP 277
Query: 750 GLSELEIHDLIQMGK 764
G+++ + + K
Sbjct: 278 GVNDADTISQVLNKK 292
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 49/188 (26%), Positives = 75/188 (39%), Gaps = 41/188 (21%)
Query: 599 IFMEYVKGGSVKNYIEK--LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656
+ E V G V LSE A F QD+ + LH + I+HRDIK
Sbjct: 115 MVFELVNQGPVMEVPTLKPLSE--------DQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166
Query: 657 NILIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 713
N+L+ DG +K+ DF + + L GTP +MAP
Sbjct: 167 NLLVG-----EDG--HIKIADFGVSNEFKGSDALLSNTV-------------GTPAFMAP 206
Query: 714 EVLRAMHKPNLY-GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-----RPR 767
E L K + G +D+W+ G L + Q P+M + +H I+ +P
Sbjct: 207 ESLSETRKI--FSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPD 264
Query: 768 LTDELEAL 775
+ ++L+ L
Sbjct: 265 IAEDLKDL 272
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 52/235 (22%), Positives = 97/235 (41%), Gaps = 61/235 (25%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+ MEY++G ++ YIE +SV A+ + + H I+HRDIK +NI
Sbjct: 88 LVMEYIEGPTLSEYIES-----HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNI 142
Query: 659 LIDLERKKADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 716
LID ++ +K+ DF +A+ + + + +GT ++ +PE
Sbjct: 143 LID-----SNKT--LKIFDFGIAKAL-----------SETSLTQTNHVLGTVQYFSPEQA 184
Query: 717 RAMHKPNLYGLEV----DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL 772
+ G DI+S G +L E+L + P+ G + + I I+ + D +
Sbjct: 185 K--------GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIK-----HIQDSV 229
Query: 773 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-TAGDLYE 826
+ + ++ QS L +V R TE++ R T ++ +
Sbjct: 230 PNVTTDVRKDIPQS----------------LSNVILRATEKDKANRYKTIQEMKD 268
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 66/297 (22%), Positives = 105/297 (35%), Gaps = 77/297 (25%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+ +K S DE F E + + L H +V+ YG + SK P +
Sbjct: 37 VKMIKEGSMSEDE---F----FQEAQTMMKLSHPKLVKFYG--VCSK------EYPIY-- 79
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
I EY+ G + NY+ K + L + DV + L S +HRD+
Sbjct: 80 ----IVTEYISNGCLLNYLRS----HGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLA 131
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 712
+ N L+D + VK+ DF R L ++ G P +W A
Sbjct: 132 ARNCLVDRDL-------CVKVSDFGMT---RYVLDDQYVSSVGTKFPV--------KWSA 173
Query: 713 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 771
PEV Y + D+W++G L+ E+ +L ++PY + E+ + G R
Sbjct: 174 PEVFHY----FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR------ 223
Query: 772 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
L + + + C E P +RPT L
Sbjct: 224 LYRPHLA--------------SDT-------IYQIMYSCWHELPEKRPTFQQLLSSI 259
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 59/297 (19%), Positives = 106/297 (35%), Gaps = 76/297 (25%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
++T K +S F L E + H IV++ G + ++ NP
Sbjct: 48 IKTCKN-CTSDSVREKF----LQEALTMRQFDHPHIVKLIG--VITE-------NP---- 89
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
I ME G ++++++ + + + + A ++ AL L SK +HRDI
Sbjct: 90 --VWIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIA 143
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 712
+ N+L+ VKL DF + R + +P +WMA
Sbjct: 144 ARNVLVSSND-------CVKLGDFGLS---RYMEDSTYYKASKGKLPI--------KWMA 185
Query: 713 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 771
PE + + D+W +G + E+L P+ G+ ++ I+ G+R
Sbjct: 186 PESINF----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------ 235
Query: 772 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
L +C P L + +C +P+ RP +L
Sbjct: 236 LPMPPNC--------------PPT-------LYSLMTKCWAYDPSRRPRFTELKAQL 271
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 61/239 (25%), Positives = 95/239 (39%), Gaps = 56/239 (23%)
Query: 532 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 590
AAK+ T K+ ++ E R+ L+H IV ++ S
Sbjct: 35 AAKIINTKKLSARDFQKLER-------EARICRKLQHPNIVRLHD---------SIQEES 78
Query: 591 EHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 647
H+L+ + V GG + I E SE A Q + ++ HS
Sbjct: 79 FHYLV-----FDLVTGGELFEDIVAREFYSE--------ADASHCIQQILESIAYCHSNG 125
Query: 648 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCV 705
I+HR++K EN+L+ KA G VKL DF A+ + H
Sbjct: 126 IVHRNLKPENLLLA---SKAKGAA-VKLADFGLAIEVNDSEAWHGFA------------- 168
Query: 706 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
GTP +++PEVL+ + Y VDIW+ G +L LL P+ + ++ I+ G
Sbjct: 169 GTPGYLSPEVLKK----DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 223
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 66/270 (24%), Positives = 113/270 (41%), Gaps = 39/270 (14%)
Query: 558 EVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 616
EV ML + H ++E+ + +L+ E ++GGS+ ++I K
Sbjct: 60 EVEMLYQCQGHRNVLELIE---------FFEEEDRFYLV-----FEKMRGGSILSHIHK- 104
Query: 617 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 676
+H + A + QDVA+AL LH+K I HRD+K ENIL E VK+C
Sbjct: 105 ----RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENIL--CEHPNQVSP--VKIC 156
Query: 677 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM-HKPNLYGLEVDIWSYG 735
DFD ++ I+ + P G+ +MAPEV+ A + ++Y D+WS G
Sbjct: 157 DFDLGSGIKLNGDCSPISTPELLTP---CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG 213
Query: 736 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 795
+L LL+ P++G + E++ +E P+
Sbjct: 214 VILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK----------YEFPDK 263
Query: 796 ELETLSFLV-DVFRRCTEENPTERPTAGDL 824
+ +S D+ + + +R +A +
Sbjct: 264 DWAHISCAAKDLISKLLVRDAKQRLSAAQV 293
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 60/242 (24%), Positives = 99/242 (40%), Gaps = 51/242 (21%)
Query: 532 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGN 589
A K+ SA+E++ + L EV +L + H I+++ + + N
Sbjct: 46 AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD---------TYETN 96
Query: 590 PEHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSK 646
L+ + +K G + +Y+ LSE K I + + + LH
Sbjct: 97 TFFFLV-----FDLMKKGELFDYLTEKVTLSE--------KETRKIMRALLEVICALHKL 143
Query: 647 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVC 704
+I+HRD+K ENIL+ D +KL DF + L L C
Sbjct: 144 NIVHRDLKPENILL-------DDDMNIKLTDFGFSCQLDPGEKLREVC------------ 184
Query: 705 VGTPRWMAPEVLRAMHKPNL--YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 762
GTP ++APE++ N YG EVD+WS G ++ LL P+ ++ + +I
Sbjct: 185 -GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243
Query: 763 GK 764
G
Sbjct: 244 GN 245
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 51/301 (16%), Positives = 107/301 (35%), Gaps = 83/301 (27%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
++ L+ +S + L E ++ ++ + + + G I +
Sbjct: 49 IKELRE-ATSPKANKEI----LDEAYVMASVDNPHVCRLLG--ICLT-------ST---- 90
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
+Q + + + G + +Y+ + + ++ + L +A + L + ++HRD+
Sbjct: 91 VQ--LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 144
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 708
+ N+L+ + VK+ DF A + + A +
Sbjct: 145 ARNVLVKTPQ-------HVKITDFGLA--------------KLLGAEEKEYHAEGGKVPI 183
Query: 709 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPR 767
+WMA E + +Y + D+WSYG + EL+T PY G+ EI +++ G+R
Sbjct: 184 KWMALESILH----RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-- 237
Query: 768 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 827
L C + + R+C + RP +L
Sbjct: 238 ----LPQPPIC--------------TID-------VYMIMRKCWMIDADSRPKFRELIIE 272
Query: 828 F 828
F
Sbjct: 273 F 273
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 55/297 (18%), Positives = 105/297 (35%), Gaps = 77/297 (25%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
++T++ S ++ F + E ++ L H +V++YG + + P
Sbjct: 37 IKTIREGAMSEED---F----IEEAEVMMKLSHPKLVQLYG--VCLEQAPIC-------- 79
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
+ E+++ G + +Y+ + + L + DV + L ++HRD+
Sbjct: 80 ----LVTEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 131
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 712
+ N L+ + V+K+ DF R L + G P +W +
Sbjct: 132 ARNCLVGENQ-------VIKVSDFGMT---RFVLDDQYTSSTGTKFPV--------KWAS 173
Query: 713 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 771
PEV + Y + D+WS+G L+ E+ + ++PY S E+ + I G R
Sbjct: 174 PEVFSF----SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------ 223
Query: 772 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
L + + C E P +RP L
Sbjct: 224 LYKPRLA--------------STH-------VYQIMNHCWRERPEDRPAFSRLLRQL 259
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 66/297 (22%), Positives = 119/297 (40%), Gaps = 77/297 (25%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V++LK S D F L E ++ L+H +V +Y + ++ P +
Sbjct: 42 VKSLKQGSMSPDA---F----LAEANLMKQLQHQRLVRLYA--VVTQ-------EPIY-- 83
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
I EY++ GS+ ++ L +++ L +A +A + + ++ +HRD++
Sbjct: 84 ----IITEYMENGSLVDF---LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 712
+ NIL+ K+ DF A R A G P +W A
Sbjct: 137 AANILVSDTL-------SCKIADFGLA---RLIEDNEYTAREGAKFPI--------KWTA 178
Query: 713 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 771
PE + + ++ D+WS+G LL E++T ++PY G++ E+ ++ G R
Sbjct: 179 PEAINY----GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR------ 228
Query: 772 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
+ +C PE L + R C +E P +RPT L +
Sbjct: 229 MVRPDNC--------------PEE-------LYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 68/299 (22%), Positives = 113/299 (37%), Gaps = 77/299 (25%)
Query: 532 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 590
A K+ R V SS ++ EV +L L H I+++Y +
Sbjct: 66 AIKIIRKTSVSTSSNSKLLE-------EVAVLKLLDHPNIMKLYDFFEDKR--------- 109
Query: 591 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 650
++L+ ME KGG + + I + A I + V + + LH +I+H
Sbjct: 110 NYYLV-----MECYKGGELFDEIIH-----RMKFNEVDAAVIIKQVLSGVTYLHKHNIVH 159
Query: 651 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTP 708
RD+K EN+L LE K+ D +K+ DF + + GT
Sbjct: 160 RDLKPENLL--LESKEKDAL--IKIVDFGLSAVFENQKKMKERL-------------GTA 202
Query: 709 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 768
++APEVLR Y + D+WS G +L LL P+ G ++ EI ++ GK
Sbjct: 203 YYIAPEVLRKK-----YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK---- 253
Query: 769 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV-DVFRRCTEENPTERPTAGDLYE 826
+ E + +S D+ ++ + + R +A E
Sbjct: 254 ---------------------YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 59/300 (19%), Positives = 105/300 (35%), Gaps = 82/300 (27%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+T K + D F + E ++ L H IV++ G I + P
Sbjct: 45 VKTCKK-DCTLDNKEKF----MSEAVIMKNLDHPHIVKLIG--IIEE-------EP---- 86
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
+ I ME G + +Y+E+ + + V + + + A+ L S + +HRDI
Sbjct: 87 --TWIIMELYPYGELGHYLER----NKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIA 140
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 712
NIL+ VKL DF + R +P +WM+
Sbjct: 141 VRNILVASPE-------CVKLGDFGLS---RYIEDEDYYKASVTRLPI--------KWMS 182
Query: 713 PEVLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRL 768
PE + + D+W + + E+L+ + P+ L ++ +++ G R
Sbjct: 183 PESI-------NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR--- 232
Query: 769 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
L C P L + RC + +P++RP +L
Sbjct: 233 ---LPKPDLC--------------PPV-------LYTLMTRCWDYDPSDRPRFTELVCSL 268
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 21/167 (12%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
M+Y GG + + K E + ++A F ++ A+ +H H +HRDIK +NIL+
Sbjct: 153 MDYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 208
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720
D +G ++L DF + L G V VGTP +++PE+L+AM
Sbjct: 209 D-----MNGH--IRLADFGSCLKLME---------DGTVQSSVAVGTPDYISPEILQAME 252
Query: 721 KPNL-YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 766
YG E D WS G + E+L + P+ S +E + I K
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 299
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 43/209 (20%)
Query: 556 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 615
L E R+L A+ +V++ + L +++ MEYV GG + +++ +
Sbjct: 89 LNEKRILQAVNFPFLVKLEFSFKDNSNL---------YMV-----MEYVAGGEMFSHLRR 134
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
S A F A + LHS +++RD+K EN+LID G +++
Sbjct: 135 -----IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-----QQGY--IQV 182
Query: 676 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735
DF A ++ T C GTP +APE++ + K Y VD W+ G
Sbjct: 183 TDFGFAKRVKGRTWTLC-------------GTPEALAPEII--LSKG--YNKAVDWWALG 225
Query: 736 CLLLELLTLQVPYMGLSELEIHDLIQMGK 764
L+ E+ P+ ++I++ I GK
Sbjct: 226 VLIYEMAAGYPPFFADQPIQIYEKIVSGK 254
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 57/236 (24%), Positives = 96/236 (40%), Gaps = 51/236 (21%)
Query: 532 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 590
A KV I EV +L L H I++++ + +
Sbjct: 51 AVKVINKASAKNKDTSTILR-------EVELLKKLDHPNIMKLFE---------ILEDSS 94
Query: 591 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 650
+++ E GG + + I K K S A I + V + + +H +I+H
Sbjct: 95 SFYIV-----GELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 651 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTP 708
RD+K ENIL++ + K D +K+ DF + + + + GT
Sbjct: 145 RDLKPENILLESKEKDCD----IKIIDFGLSTCFQQNTKMKDRI-------------GTA 187
Query: 709 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
++APEVLR Y + D+WS G +L LL+ P+ G +E +I ++ GK
Sbjct: 188 YYIAPEVLR---GT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK 238
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 66/303 (21%), Positives = 110/303 (36%), Gaps = 77/303 (25%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+TL S + +F L E ++ H IV G +S + LP
Sbjct: 65 VKTLPE-VCSEQDELDF----LMEALIISKFNHQNIVRCIG--VSLQSLP---------R 108
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA--LFIAQDVAAALVELHSKHIMHRD 652
I ME + GG +K+++ + + S+ + L +A+D+A L H +HRD
Sbjct: 109 F---ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRD 165
Query: 653 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP---- 708
I + N L+ G+ V K+ DF A R I
Sbjct: 166 IAARNCLLT---CPGPGR-VAKIGDFGMA--------------RDIYRASYYRKGGCAML 207
Query: 709 --RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 765
+WM PE ++ + D WS+G LL E+ +L +PY S E+ + + G R
Sbjct: 208 PVKWMPPEAF----MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263
Query: 766 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 825
++ +C P + + +C + P +RP +
Sbjct: 264 ------MDPPKNC--------------PGP-------VYRIMTQCWQHQPEDRPNFAIIL 296
Query: 826 EMF 828
E
Sbjct: 297 ERI 299
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 68/297 (22%), Positives = 111/297 (37%), Gaps = 77/297 (25%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
++ +K S DE F + E +++ L H +V++YG + +K P
Sbjct: 53 IKMIKEGSMSEDE---F----IEEAKVMMNLSHEKLVQLYG--VCTK------QRPIF-- 95
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
I EY+ G + NY+ + + L + +DV A+ L SK +HRD+
Sbjct: 96 ----IITEYMANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 147
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 712
+ N L++ + VVK+ DF + R L + G P RW
Sbjct: 148 ARNCLVNDQG-------VVKVSDFGLS---RYVLDDEYTSSVGSKFPV--------RWSP 189
Query: 713 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 771
PEVL + + + DIW++G L+ E+ +L ++PY + E + I G R
Sbjct: 190 PEVLMY----SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR------ 239
Query: 772 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
L E + + C E ERPT L
Sbjct: 240 LYRPHLA--------------SEK-------VYTIMYSCWHEKADERPTFKILLSNI 275
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 46/218 (21%), Positives = 80/218 (36%), Gaps = 56/218 (25%)
Query: 556 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF----MEYVKGGSVKN 611
E ++ L H V++Y Q + Y K G +
Sbjct: 78 TRERDVMSRLDHPFFVKLYFT------------------FQDDEKLYFGLSYAKNGELLK 119
Query: 612 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 671
YI K F ++ +AL LH K I+HRD+K ENIL++ D
Sbjct: 120 YIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-----EDMH- 168
Query: 672 VVKLCDFDRA-----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 726
+++ DF A ++ ++ GT ++++PE+L K
Sbjct: 169 -IQITDFGTAKVLSPESKQARANSFV-------------GTAQYVSPELLT--EKS--AC 210
Query: 727 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
D+W+ GC++ +L+ P+ +E I I +
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 248
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-23
Identities = 47/220 (21%), Positives = 77/220 (35%), Gaps = 50/220 (22%)
Query: 558 EVRMLGALRHSCIVEMY--GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 615
E + L + H IV+++ G+P + I MEYV G S+K +
Sbjct: 129 ERQFLAEVVHPSIVQIFNFVEH------TDRHGDPVGY-----IVMEYVGGQSLKRSKGQ 177
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
+ V A+ ++ AL LHS +++ D+K ENI++ E+ +KL
Sbjct: 178 -------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ--------LKL 222
Query: 676 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735
D I + GTP + APE++R DI++ G
Sbjct: 223 IDLG-------------AV-SRINSFGYLYGTPGFQAPEIVRTGPTV-----ATDIYTVG 263
Query: 736 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL 775
L L G + + + D L
Sbjct: 264 RTLAALTLDLPTRNGRYVDGLPEDDP---VLKTYDSYGRL 300
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-23
Identities = 60/236 (25%), Positives = 95/236 (40%), Gaps = 51/236 (21%)
Query: 532 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 590
A KV I EV +L L H I++++ S
Sbjct: 51 AVKVINKASAKNKDTSTILR-------EVELLKKLDHPNIMKLFEILEDSS--------- 94
Query: 591 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 650
+++ E GG + + I K K S A I + V + + +H +I+H
Sbjct: 95 SFYIV-----GELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 651 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTP 708
RD+K ENIL LE K+ D +K+ DF + + + + GT
Sbjct: 145 RDLKPENIL--LESKEKDCD--IKIIDFGLSTCFQQNTKMKDRI-------------GTA 187
Query: 709 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
++APEVLR Y + D+WS G +L LL+ P+ G +E +I ++ GK
Sbjct: 188 YYIAPEVLR---GT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK 238
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 66/299 (22%), Positives = 115/299 (38%), Gaps = 77/299 (25%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
++TLK G + + +F LGE ++G H I+ + G + SK+ P
Sbjct: 78 IKTLKA-GYTEKQRVDF----LGEAGIMGQFSHHNIIRLEG--VISKYKPMM-------- 122
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
I EY++ G++ ++ + + SV + + + +AA + L + + +HRD+
Sbjct: 123 ----IITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA 174
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAP 713
+ NIL++ V K+ DF + L G IP RW AP
Sbjct: 175 ARNILVNSNL-------VCKVSDFGLSRVLEDDPEATYTTSGGKIPI--------RWTAP 219
Query: 714 EVLRAMHKPNLYGL---EVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 769
E + Y D+WS+G ++ E++T + PY LS E+ I G R
Sbjct: 220 EAI-------SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR---- 268
Query: 770 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
L C P A + + +C ++ RP D+ +
Sbjct: 269 --LPTPMDC--------------PSA-------IYQLMMQCWQQERARRPKFADIVSIL 304
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 6e-23
Identities = 58/267 (21%), Positives = 101/267 (37%), Gaps = 69/267 (25%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+ ++ +L H I+ +Y + + +L+ ME GG + +
Sbjct: 56 EIEIMKSLDHPNIIRLYETFEDNT---------DIYLV-----MELCTGGELFERVVH-- 99
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
++ A I +DV +A+ H ++ HRD+K EN L + + +KL D
Sbjct: 100 ---KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSP----LKLID 152
Query: 678 FDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735
F A + + T GTP +++P+VL LYG E D WS G
Sbjct: 153 FGLAARFKPGKMMRTKV-------------GTPYYVSPQVLE-----GLYGPECDEWSAG 194
Query: 736 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 795
++ LL P+ ++ E+ I+ G F PE
Sbjct: 195 VMMYVLLCGYPPFSAPTDSEVMLKIREGT-------------------------FTFPEK 229
Query: 796 ELETLSFLV-DVFRRCTEENPTERPTA 821
+ +S + RR ++P +R T+
Sbjct: 230 DWLNVSPQAESLIRRLLTKSPKQRITS 256
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-23
Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 73/295 (24%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
++TLK S + L E +++ LRH +V++Y
Sbjct: 213 IKTLKPGTMSPEAF-------LQEAQVMKKLRHEKLVQLYAVVSEEPIY----------- 254
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
I EY+ GS+ ++ L K++ + + +A +A+ + + + +HRD++
Sbjct: 255 ----IVTEYMSKGSLLDF---LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 307
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714
+ NIL+ V K+ DF A R A +G P +W APE
Sbjct: 308 AANILVGENL-------VCKVADFGLA---RLIEDNEYTARQGAKFP------IKWTAPE 351
Query: 715 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 773
+ ++ D+WS+G LL EL T +VPY G+ E+ D ++ G R +
Sbjct: 352 AALY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------MP 401
Query: 774 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
C PE+ L D+ +C + P ERPT L
Sbjct: 402 CPPEC--------------PES-------LHDLMCQCWRKEPEERPTFEYLQAFL 435
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-23
Identities = 68/297 (22%), Positives = 129/297 (43%), Gaps = 76/297 (25%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+TLK +E F L E ++ ++H +V++ G + ++ P +
Sbjct: 43 VKTLKEDTMEVEE---F----LKEAAVMKEIKHPNLVQLLG--VCTR------EPPFY-- 85
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
I E++ G++ +Y L E + VS + L++A +++A+ L K+ +HRD+
Sbjct: 86 ----IITEFMTYGNLLDY---LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 138
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 712
+ N L+ +VK+ DF + R AH G P +W A
Sbjct: 139 ARNCLVGENH-------LVKVADFGLS---RLMTGDTYTAHAGAKFPI--------KWTA 180
Query: 713 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 771
PE L N + ++ D+W++G LL E+ T PY G+ ++++L++ R
Sbjct: 181 PESLAY----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------ 230
Query: 772 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
+E C PE + ++ R C + NP++RP+ ++++ F
Sbjct: 231 MERPEGC--------------PEK-------VYELMRACWQWNPSDRPSFAEIHQAF 266
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 9e-23
Identities = 48/170 (28%), Positives = 73/170 (42%), Gaps = 31/170 (18%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
E +KGG + + I + +K S + A + + + LH++ ++HRD+K NIL
Sbjct: 95 TELMKGGELLDKILR-----QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILY 149
Query: 661 DLERKKADGKPVVKLCDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717
++ +++CDF A LR L T C T ++APEVL
Sbjct: 150 ---VDESGNPESIRICDFGFAKQLRAENGLLMTPC-------------YTANFVAPEVL- 192
Query: 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGK 764
+ Y DIWS G LL +LT P+ + EI I GK
Sbjct: 193 ---ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK 239
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-23
Identities = 68/313 (21%), Positives = 121/313 (38%), Gaps = 89/313 (28%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V++LK S + I + E+ +L L H IV+ G I ++ GN
Sbjct: 55 VKSLKP-ESGGNHIADL----KKEIEILRNLYHENIVKYKG--ICTE----DGGNG---- 99
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
++ + ME++ GS+K Y+ K + +++K L A + + L S+ +HRD+
Sbjct: 100 IK--LIMEFLPSGSLKEYLPK----NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLA 153
Query: 655 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 710
+ N+L++ E VK+ DF +A+ +T P W
Sbjct: 154 ARNVLVESEH-------QVKIGDFGLTKAIETDKEYYT---VKDDRDSPV--------FW 195
Query: 711 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL---------------QVPYMGLSELE 755
APE L + + + D+WS+G L ELLT + ++
Sbjct: 196 YAPECLMQ----SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251
Query: 756 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815
+ + ++ GKR L +C P+ + + R+C E P
Sbjct: 252 LVNTLKEGKR------LPCPPNC--------------PDE-------VYQLMRKCWEFQP 284
Query: 816 TERPTAGDLYEMF 828
+ R + +L E F
Sbjct: 285 SNRTSFQNLIEGF 297
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 56/233 (24%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
I MEYV G ++++ + E ++ K A+ + D AL H I+HRD+K NI
Sbjct: 93 IVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANI 147
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718
+I A VK+ DF A + ++ + +GT ++++PE R
Sbjct: 148 MIS-----ATNA--VKVMDFGIARAIADSGNS-------VTQTAAVIGTAQYLSPEQAR- 192
Query: 719 MHKPNLYGLEV----DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEA 774
G V D++S GC+L E+LT + P+ G S + + Q + ++
Sbjct: 193 -------GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQ-----HVREDPIP 238
Query: 775 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-TAGDLYE 826
S ++ L V + +NP R TA ++
Sbjct: 239 P-SARHEGLSAD----------------LDAVVLKALAKNPENRYQTAAEMRA 274
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 50/213 (23%)
Query: 556 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA----IFMEYVKGGSVKN 611
E++++ L H +V ++ Q + ++ + GG ++
Sbjct: 63 FKELQIMQGLEHPFLVNLWYS------------------FQDEEDMFMVVDLLLGGDLRY 104
Query: 612 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 671
++++ E+ V LFI + + AL L ++ I+HRD+K +NIL+D G
Sbjct: 105 HLQQNVHFKEETV----KLFICE-LVMALDYLQNQRIIHRDMKPDNILLD-----EHGH- 153
Query: 672 VVKLCDFDRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 729
V + DF+ A +P + + T GT +MAPE+ K Y V
Sbjct: 154 -VHITDFNIAAMLPRETQITTMA-------------GTKPYMAPEMFS-SRKGAGYSFAV 198
Query: 730 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 762
D WS G ELL + PY S +++
Sbjct: 199 DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT 231
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 43/209 (20%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
EV++L L H I+++Y + +L+ E GG + + I
Sbjct: 76 EVQLLKQLDHPNIMKLYE---------FFEDKGYFYLV-----GEVYTGGELFDEIIS-- 119
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
K S A I + V + + +H I+HRD+K EN+L++ + K A+ +++ D
Sbjct: 120 ---RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDAN----IRIID 172
Query: 678 FDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735
F + + + GT ++APEVL Y + D+WS G
Sbjct: 173 FGLSTHFEASKKMKDKI-------------GTAYYIAPEVLH-----GTYDEKCDVWSTG 214
Query: 736 CLLLELLTLQVPYMGLSELEIHDLIQMGK 764
+L LL+ P+ G +E +I ++ GK
Sbjct: 215 VILYILLSGCPPFNGANEYDILKKVEKGK 243
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 49/209 (23%), Positives = 83/209 (39%), Gaps = 39/209 (18%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+ +L +L H I++++ +++ ME +GG + I
Sbjct: 70 EIEVLKSLDHPNIIKIFEVFEDYH---------NMYIV-----METCEGGELLERIVSAQ 115
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
G K +S + + + AL HS+H++H+D+K ENIL + +K+ D
Sbjct: 116 ARG-KALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENIL--FQDTSPHSP--IKIID 170
Query: 678 FDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735
F A +S GT +MAPEV + + DIWS G
Sbjct: 171 FGLAELFKSDEHSTNAA-------------GTALYMAPEVFK-----RDVTFKCDIWSAG 212
Query: 736 CLLLELLTLQVPYMGLSELEIHDLIQMGK 764
++ LLT +P+ G S E+ +
Sbjct: 213 VVMYFLLTGCLPFTGTSLEEVQQKATYKE 241
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-22
Identities = 66/295 (22%), Positives = 127/295 (43%), Gaps = 72/295 (24%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+TLK +E L E ++ ++H +V++ G + ++ E
Sbjct: 250 VKTLKEDTMEVEEF-------LKEAAVMKEIKHPNLVQLLG--VCTR---------EPPF 291
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
I E++ G++ +Y L E + VS + L++A +++A+ L K+ +HR++
Sbjct: 292 Y---IITEFMTYGNLLDY---LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLA 345
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714
+ N L+ +VK+ DF + R AH G P +W APE
Sbjct: 346 ARNCLVGENH-------LVKVADFGLS---RLMTGDTYTAHAGAKFP------IKWTAPE 389
Query: 715 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 773
L N + ++ D+W++G LL E+ T PY G+ ++++L++ R +E
Sbjct: 390 SLAY----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------ME 439
Query: 774 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
C PE + ++ R C + NP++RP+ ++++ F
Sbjct: 440 RPEGC--------------PEK-------VYELMRACWQWNPSDRPSFAEIHQAF 473
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 60/239 (25%), Positives = 95/239 (39%), Gaps = 56/239 (23%)
Query: 532 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 590
AAK+ T K+ ++ E R+ L+H IV ++ S
Sbjct: 58 AAKIINTKKLSARDFQKLER-------EARICRKLQHPNIVRLHD---------SIQEES 101
Query: 591 EHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 647
H+L+ + V GG + I E SE A Q + ++ HS
Sbjct: 102 FHYLV-----FDLVTGGELFEDIVAREFYSE--------ADASHCIQQILESIAYCHSNG 148
Query: 648 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCV 705
I+HR++K EN+L+ + K A VKL DF A+ + H
Sbjct: 149 IVHRNLKPENLLLASKAKGAA----VKLADFGLAIEVNDSEAWHGFA------------- 191
Query: 706 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
GTP +++PEVL+ + Y VDIW+ G +L LL P+ + ++ I+ G
Sbjct: 192 GTPGYLSPEVLKK----DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 246
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 59/297 (19%), Positives = 107/297 (36%), Gaps = 71/297 (23%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
+++L + ++ F L E ++ L H ++ + G I
Sbjct: 54 IKSLSR-ITEMQQVEAF----LREGLLMRGLNHPNVLALIG--IMLPPEGLP-------- 98
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
+ + Y+ G + +I +++ +VK + VA + L + +HRD+
Sbjct: 99 ---HVLLPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLA 151
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 712
+ N ++D VK+ DF A + + HR +P +W A
Sbjct: 152 ARNCMLDESF-------TVKVADFGLARDILDREYYSVQQHRHARLPV--------KWTA 196
Query: 713 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 771
E L + + + D+WS+G LL ELLT PY + ++ + G+R
Sbjct: 197 LESL----QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR------ 246
Query: 772 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
L C P++ L V ++C E +P RPT L
Sbjct: 247 LPQPEYC--------------PDS-------LYQVMQQCWEADPAVRPTFRVLVGEV 282
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-22
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 43/209 (20%)
Query: 556 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 615
E ML + H I+ M+G ++ + ++ M+Y++GG + + + K
Sbjct: 54 NDERLMLSIVTHPFIIRMWGTFQDAQQI---------FMI-----MDYIEGGELFSLLRK 99
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
+ +A F A +V AL LHSK I++RD+K ENIL+D +G +K+
Sbjct: 100 -----SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD-----KNGH--IKI 147
Query: 676 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735
DF A + +T C GTP ++APEV+ KP Y +D WS+G
Sbjct: 148 TDFGFAKYVPDVTYTLC-------------GTPDYIAPEVVS--TKP--YNKSIDWWSFG 190
Query: 736 CLLLELLTLQVPYMGLSELEIHDLIQMGK 764
L+ E+L P+ + ++ ++ I +
Sbjct: 191 ILIYEMLAGYTPFYDSNTMKTYEKILNAE 219
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 56/215 (26%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 613
EVR++ L H IV+++ I ++ ++ MEY GG V +Y+
Sbjct: 64 EVRIMKILNHPNIVKLF-EVIETE---------------KTLYLIMEYASGGEVFDYLVA 107
Query: 614 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 672
++ E K A + + +A+ H K I+HRD+K+EN+L+D +
Sbjct: 108 HGRMKE--------KEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN------- 152
Query: 673 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 729
+K+ DF + L C G P + APE+ + Y G EV
Sbjct: 153 IKIADFGFSNEFTVGGKLDAFC-------------GAPPYAAPELFQG----KKYDGPEV 195
Query: 730 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
D+WS G +L L++ +P+ G + E+ + + GK
Sbjct: 196 DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 61/314 (19%), Positives = 111/314 (35%), Gaps = 91/314 (28%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+ L+ S+ + +R+F E+ +L +L+H IV+ G S+
Sbjct: 44 VKKLQH--STEEHLRDF----EREIEILKSLQHDNIVKYKGVCYSAGRRN---------- 87
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
L+ + MEY+ GS+++Y++K ++ + L + + L +K +HRD+
Sbjct: 88 LK--LIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 141
Query: 655 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 710
+ NIL++ E VK+ DF + +P P W
Sbjct: 142 TRNILVENEN-------RVKIGDFGLTKVLPQDKEFFK---VKEPGESPI--------FW 183
Query: 711 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL----------------QVPYMGLSEL 754
APE L + + + D+WS+G +L EL T +
Sbjct: 184 YAPESLTE----SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 755 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 814
+ +L++ R L C P+ + + C N
Sbjct: 240 HLIELLKNNGR------LPRPDGC--------------PDE-------IYMIMTECWNNN 272
Query: 815 PTERPTAGDLYEMF 828
+RP+ DL
Sbjct: 273 VNQRPSFRDLALRV 286
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 59/296 (19%), Positives = 110/296 (37%), Gaps = 71/296 (23%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
++ LK G + + R+F L E ++G H I+ + G + ++ G
Sbjct: 82 IKALKA-GYTERQRRDF----LSEASIMGQFDHPNIIRLEG--VVTR------GRLAM-- 126
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
I EY++ GS+ ++ + ++ + + + V A + L +HRD+
Sbjct: 127 ----IVTEYMENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLA 178
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAP 713
+ N+L+D V K+ DF + L G IP RW AP
Sbjct: 179 ARNVLVDSNL-------VCKVSDFGLSRVLEDDPDAAYTTTGGKIPI--------RWTAP 223
Query: 714 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDEL 772
E + A + D+WS+G ++ E+L + PY ++ ++ ++ G R L
Sbjct: 224 EAI-AFRT---FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR------L 273
Query: 773 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
A C P A L + C ++ +RP + +
Sbjct: 274 PAPMGC--------------PHA-------LHQLMLDCWHKDRAQRPRFSQIVSVL 308
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 52/237 (21%), Positives = 80/237 (33%), Gaps = 71/237 (29%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+ M + G + + + + ++ A+ I + + +AL H+ HRD+K ENI
Sbjct: 111 VDMRLINGVDLAAMLRR-----QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENI 165
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR----GIPAPDVCVGTPRWMAPE 714
L+ AD L DF IA + VGT +MAPE
Sbjct: 166 LVS-----ADDF--AYLVDFG-------------IASATTDEKLTQLGNTVGTLYYMAPE 205
Query: 715 VLRAMHKPNLYGLEV----DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 770
DI++ C+L E LT PY G D + +
Sbjct: 206 RFS--------ESHATYRADIYALTCVLYECLTGSPPYQG-------DQLSV-------- 242
Query: 771 ELEALGSCHEHEVAQSGSGFEKPE--AELETLSFLVDVFRRCTEENPTER-PTAGDL 824
H ++ S +P + V R +NP +R T GDL
Sbjct: 243 ---MGA--HINQAIPRPSTV-RPGIPVAFD------AVIARGMAKNPEDRYVTCGDL 287
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 47/211 (22%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---E 614
E+ +L ++H IV + S+ ++L M+ V GG + + I
Sbjct: 56 EIAVLKKIKHENIVTLEDIYESTT---------HYYL-----VMQLVSGGELFDRILERG 101
Query: 615 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 674
+E K A + Q V +A+ LH I+HRD+K EN+L + + K +
Sbjct: 102 VYTE--------KDASLVIQQVLSAVKYLHENGIVHRDLKPENLL--YLTPEENSK--IM 149
Query: 675 LCDFDRAVPLR-SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 733
+ DF + + + T C GTP ++APEVL KP Y VD WS
Sbjct: 150 ITDFGLSKMEQNGIMSTAC-------------GTPGYVAPEVLA--QKP--YSKAVDCWS 192
Query: 734 YGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
G + LL P+ +E ++ + I+ G
Sbjct: 193 IGVITYILLCGYPPFYEETESKLFEKIKEGY 223
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 64/303 (21%), Positives = 108/303 (35%), Gaps = 77/303 (25%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+TL S + +F L E ++ H IV G +S + LP
Sbjct: 106 VKTLPE-VCSEQDELDF----LMEALIISKFNHQNIVRCIG--VSLQSLP---------R 149
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA--LFIAQDVAAALVELHSKHIMHRD 652
I +E + GG +K+++ + + S+ + L +A+D+A L H +HRD
Sbjct: 150 F---ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRD 206
Query: 653 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP---- 708
I + N L+ G+ V K+ DF A R I
Sbjct: 207 IAARNCLLT---CPGPGR-VAKIGDFGMA--------------RDIYRAGYYRKGGCAML 248
Query: 709 --RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 765
+WM PE ++ + D WS+G LL E+ +L +PY S E+ + + G R
Sbjct: 249 PVKWMPPEAF----MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304
Query: 766 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 825
+ P+ + + +C + P +RP +
Sbjct: 305 ------------------------MDPPK---NCPGPVYRIMTQCWQHQPEDRPNFAIIL 337
Query: 826 EMF 828
E
Sbjct: 338 ERI 340
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 62/297 (20%), Positives = 113/297 (38%), Gaps = 71/297 (23%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V++L + E+ F L E ++ H ++ + G I + ++G+P
Sbjct: 58 VKSLNR-ITDIGEVSQF----LTEGIIMKDFSHPNVLSLLG--ICLR----SEGSP---- 102
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
+ + Y+K G ++N+I + +VK + VA + L SK +HRD+
Sbjct: 103 ---LVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLA 155
Query: 655 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 712
+ N ++D + VK+ DF R + + + +P +WMA
Sbjct: 156 ARNCMLDEKF-------TVKVADFGLARDMYDKEYYSVHNKTGAKLPV--------KWMA 200
Query: 713 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 771
E L+ + + D+WS+G LL EL+T PY ++ +I + G+R
Sbjct: 201 LESLQT----QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR------ 250
Query: 772 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
L C P+ L +V +C RP+ +L
Sbjct: 251 LLQPEYC--------------PDP-------LYEVMLKCWHPKAEMRPSFSELVSRI 286
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-22
Identities = 55/241 (22%), Positives = 98/241 (40%), Gaps = 50/241 (20%)
Query: 532 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSADGNP 590
A K+ + S +++ + E +L + H I+ + S + +
Sbjct: 123 AVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID---------SYESSS 173
Query: 591 EHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 647
L+ + ++ G + +Y+ LSE K I + + A+ LH+ +
Sbjct: 174 FMFLV-----FDLMRKGELFDYLTEKVALSE--------KETRSIMRSLLEAVSFLHANN 220
Query: 648 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCV 705
I+HRD+K ENIL+ D ++L DF + L L C
Sbjct: 221 IVHRDLKPENILL-------DDNMQIRLSDFGFSCHLEPGEKLRELC------------- 260
Query: 706 GTPRWMAPEVLRAMHKPNL--YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG 763
GTP ++APE+L+ YG EVD+W+ G +L LL P+ ++ + +I G
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG 320
Query: 764 K 764
+
Sbjct: 321 Q 321
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 4e-22
Identities = 57/297 (19%), Positives = 102/297 (34%), Gaps = 76/297 (25%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
++T K +S F L E + H IV++ G +
Sbjct: 423 IKTCKN-CTSDSVREKF----LQEALTMRQFDHPHIVKLIGVITENPVW----------- 466
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
I ME G ++++++ + + + + A ++ AL L SK +HRDI
Sbjct: 467 ----IIMELCTLGELRSFLQV----RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIA 518
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 712
+ N+L+ VKL DF + R + +P +WMA
Sbjct: 519 ARNVLVSSND-------CVKLGDFGLS---RYMEDSTYYKASKGKLPI--------KWMA 560
Query: 713 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 771
PE + + D+W +G + E+L P+ G+ ++ I+ G+R
Sbjct: 561 PESINF----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------ 610
Query: 772 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
L +C P L + +C +P+ RP +L
Sbjct: 611 LPMPPNC--------------PPT-------LYSLMTKCWAYDPSRRPRFTELKAQL 646
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-22
Identities = 64/296 (21%), Positives = 113/296 (38%), Gaps = 71/296 (23%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
++TLKV G + + R+F LGE ++G H I+ + G + +K P
Sbjct: 78 IKTLKV-GYTEKQRRDF----LGEASIMGQFDHPNIIRLEG--VVTKSKPVM-------- 122
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
I EY++ GS+ +++ K + +V + + + +A+ + L +HRD+
Sbjct: 123 ----IVTEYMENGSLDSFLRK----HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLA 174
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAP 713
+ NILI+ V K+ DF L G IP RW +P
Sbjct: 175 ARNILINSNL-------VCKVSDFGLGRVLEDDPEAAYTTRGGKIPI--------RWTSP 219
Query: 714 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDEL 772
E + + D+WSYG +L E+++ + PY +S ++ + G R L
Sbjct: 220 EAI----AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR------L 269
Query: 773 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
C P A L + C +++ RP + +
Sbjct: 270 PPPMDC--------------PAA-------LYQLMLDCWQKDRNNRPKFEQIVSIL 304
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 5e-22
Identities = 61/314 (19%), Positives = 112/314 (35%), Gaps = 91/314 (28%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+ L+ S+ + +R+F E+ +L +L+H IV+ G S+
Sbjct: 75 VKKLQH--STEEHLRDF----EREIEILKSLQHDNIVKYKGVCYSAGRRN---------- 118
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
L+ + MEY+ GS+++Y++K ++ + L + + L +K +HRD+
Sbjct: 119 LK--LIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 172
Query: 655 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 710
+ NIL++ E VK+ DF + +P + P W
Sbjct: 173 TRNILVENEN-------RVKIGDFGLTKVLPQDKEYYK---VKEPGESPI--------FW 214
Query: 711 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL----------------QVPYMGLSEL 754
APE L + + + D+WS+G +L EL T +
Sbjct: 215 YAPESLTE----SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270
Query: 755 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 814
+ +L++ R L C P+ + + C N
Sbjct: 271 HLIELLKNNGR------LPRPDGC--------------PDE-------IYMIMTECWNNN 303
Query: 815 PTERPTAGDLYEMF 828
+RP+ DL
Sbjct: 304 VNQRPSFRDLALRV 317
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 6e-22
Identities = 49/195 (25%), Positives = 75/195 (38%), Gaps = 55/195 (28%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE--- 614
E+ + L H +V+ YGH + +F+EY GG + + IE
Sbjct: 55 EICINKMLNHENVVKFYGH-RREG----------NIQ---YLFLEYCSGGELFDRIEPDI 100
Query: 615 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 674
+ E A + A +V LH I HRDIK EN+L+ D + +K
Sbjct: 101 GMPE--------PDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL-------DERDNLK 145
Query: 675 LCDF-----DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLE 728
+ DF R L+ C GT ++APE+L+ +
Sbjct: 146 ISDFGLATVFRYNNRERLLNKMC-------------GTLPYVAPELLKR----REFHAEP 188
Query: 729 VDIWSYGCLLLELLT 743
VD+WS G +L +L
Sbjct: 189 VDVWSCGIVLTAMLA 203
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 54/240 (22%), Positives = 95/240 (39%), Gaps = 53/240 (22%)
Query: 532 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 586
AAK R + EI EV +L + H ++ ++
Sbjct: 41 AAKFIKKRQSRASRRGVSREEIER-------EVSILRQVLHHNVITLHD---------VY 84
Query: 587 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 646
+ + L+ +E V GG + +++ ++ +S + A + + + LH+K
Sbjct: 85 ENRTDVVLI-----LELVSGGELFDFL-----AQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 647 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL--RSFLHTCCIAHRGIPAPDVC 704
I H D+K ENI++ K P +KL DF A +
Sbjct: 135 KIAHFDLKPENIML---LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF------------ 179
Query: 705 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
GTP ++APE++ ++P GLE D+WS G + LL+ P++G ++ E I
Sbjct: 180 -GTPEFVAPEIVN--YEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS 234
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-22
Identities = 63/318 (19%), Positives = 113/318 (35%), Gaps = 83/318 (26%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
++T+ +S E F L E ++ +V + G + S+ P
Sbjct: 60 IKTVNE-AASMRERIEF----LNEASVMKEFNCHHVVRLLG--VVSQGQP---------T 103
Query: 595 LQSAIFMEYVKGGSVKNYI-----EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 649
L + ME + G +K+Y+ + S+ + +A ++A + L++ +
Sbjct: 104 L---VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 160
Query: 650 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT-- 707
HRD+ + N ++ + VK+ DF R I D
Sbjct: 161 HRDLAARNCMVAEDF-------TVKIGDFGMT--------------RDIYETDYYRKGGK 199
Query: 708 ---P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQM 762
P RWM+PE L K ++ D+WS+G +L E+ TL + PY GLS ++ +
Sbjct: 200 GLLPVRWMSPESL----KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
Query: 763 GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822
G +KP+ L ++ R C + NP RP+
Sbjct: 256 GGL------------------------LDKPD---NCPDMLFELMRMCWQYNPKMRPSFL 288
Query: 823 DLYEMFVARTSSSISSRS 840
++ S
Sbjct: 289 EIISSIKEEMEPGFREVS 306
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 9e-22
Identities = 53/167 (31%), Positives = 78/167 (46%), Gaps = 32/167 (19%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
MEY+ GG + +I+ + A F A ++ L LHSK I++RD+K +NIL+
Sbjct: 97 MEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 151
Query: 661 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717
D DG +K+ DF + + +T C GTP ++APE+L
Sbjct: 152 D-----KDGH--IKIADFGMCKENMLGDAKTNTFC-------------GTPDYIAPEILL 191
Query: 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
Y VD WS+G LL E+L Q P+ G E E+ I+M
Sbjct: 192 GQK----YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN 234
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 1e-21
Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 73/295 (24%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
++TLK S + L E +++ LRH +V++Y
Sbjct: 296 IKTLKPGTMSPEAF-------LQEAQVMKKLRHEKLVQLYAVVSEEPIY----------- 337
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
I EY+ GS+ ++ L K++ + + +A +A+ + + + +HRD++
Sbjct: 338 ----IVTEYMSKGSLLDF---LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 390
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714
+ NIL+ V K+ DF A R A +G P +W APE
Sbjct: 391 AANILVGENL-------VCKVADFGLA---RLIEDNEYTARQGAKFP------IKWTAPE 434
Query: 715 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 773
+ ++ D+WS+G LL EL T +VPY G+ E+ D ++ G R +
Sbjct: 435 AALY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------MP 484
Query: 774 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
C PE+ L D+ +C + P ERPT L
Sbjct: 485 CPPEC--------------PES-------LHDLMCQCWRKEPEERPTFEYLQAFL 518
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 46/174 (26%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
+++++GG + + K E + + F ++A AL LHS I++RD+K ENIL+
Sbjct: 105 LDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 159
Query: 661 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 710
D +G +KL DF +A ++ C GT +
Sbjct: 160 D-----EEGH--IKLTDFGLSKESIDHEKKA-------YSFC-------------GTVEY 192
Query: 711 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
MAPEV+ + D WS+G L+ E+LT +P+ G E +I K
Sbjct: 193 MAPEVVNRRG----HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 242
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 61/243 (25%), Positives = 96/243 (39%), Gaps = 59/243 (24%)
Query: 532 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 586
AAK R L EI EV +L +RH I+ ++
Sbjct: 34 AAKFIKKRRLSSSRRGVSREEIER-------EVNILREIRHPNIITLHD---------IF 77
Query: 587 DGNPEHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVEL 643
+ + L+ +E V GG + +++ E L+E A + + + L
Sbjct: 78 ENKTDVVLI-----LELVSGGELFDFLAEKESLTE--------DEATQFLKQILDGVHYL 124
Query: 644 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAP 701
HSK I H D+K ENI+ L K P +KL DF A + +
Sbjct: 125 HSKRIAHFDLKPENIM--LLDKNVPN-PRIKLIDFGIAHKIEAGNEFKNIF--------- 172
Query: 702 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 761
GTP ++APE++ ++P GLE D+WS G + LL+ P++G ++ E I
Sbjct: 173 ----GTPEFVAPEIVN--YEP--LGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS 224
Query: 762 MGK 764
Sbjct: 225 AVN 227
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-21
Identities = 55/272 (20%), Positives = 100/272 (36%), Gaps = 69/272 (25%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+ +L +L H I++++ K +L+ E+ +GG + I
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKK---------YFYLV-----TEFYEGGELFEQIIN-- 139
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
A I + + + + LH +I+HRDIK ENIL LE K + +K+ D
Sbjct: 140 ---RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENIL--LENKNSLLN--IKIVD 192
Query: 678 FDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735
F + L GT ++APEVL+ Y + D+WS G
Sbjct: 193 FGLSSFFSKDYKLRDRL-------------GTAYYIAPEVLK-----KKYNEKCDVWSCG 234
Query: 736 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 795
++ LL P+ G ++ +I ++ GK +
Sbjct: 235 VIMYILLCGYPPFGGQNDQDIIKKVEKGK-------------------------YYFDFN 269
Query: 796 ELETLSFLV-DVFRRCTEENPTERPTAGDLYE 826
+ + +S ++ + + +R TA +
Sbjct: 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 55/299 (18%), Positives = 102/299 (34%), Gaps = 78/299 (26%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+ LK + L E ++ L + IV M G I E +
Sbjct: 49 VKILKNEANDPALKDEL----LAEANVMQQLDNPYIVRMIG--ICEA---------ESWM 93
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
+ ME + G + Y+++ +HV K + + V+ + L + +HRD+
Sbjct: 94 ----LVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA 144
Query: 655 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 710
+ N+L+ + K+ DF +A+ + A P +W
Sbjct: 145 ARNVLLVTQH-------YAKISDFGLSKALRADENYYK---AQTHGKWPV--------KW 186
Query: 711 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 769
APE + + + D+WS+G L+ E + Q PY G+ E+ +++ G+R
Sbjct: 187 YAPECINY----YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---- 238
Query: 770 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
+ C P + D+ C + RP +
Sbjct: 239 --MGCPAGC--------------PRE-------MYDLMNLCWTYDVENRPGFAAVELRL 274
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 68/315 (21%), Positives = 118/315 (37%), Gaps = 96/315 (30%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+ LK + ++F E +L L+H IV+ YG + P L
Sbjct: 50 VKALK--DPTLAARKDF----QREAELLTNLQHEHIVKFYG--VCGDGDP---------L 92
Query: 595 LQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVEL 643
+ + EY+K G + + ++ + + + L IA +A+ +V L
Sbjct: 93 I---MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL 149
Query: 644 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 703
S+H +HRD+ + N L+ +VK+ DF + R + + D
Sbjct: 150 ASQHFVHRDLATRNCLVGANL-------LVKIGDFGMS--------------RDVYSTDY 188
Query: 704 CVGT-----P-RWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSE 753
P RWM PE + +Y E D+WS+G +L E+ T + P+ LS
Sbjct: 189 YRVGGHTMLPIRWMPPESI-------MYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 241
Query: 754 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 813
E+ + I G+ LE C P+ + DV C +
Sbjct: 242 TEVIECITQGRV------LERPRVC--------------PKE-------VYDVMLGCWQR 274
Query: 814 NPTERPTAGDLYEMF 828
P +R ++Y++
Sbjct: 275 EPQQRLNIKEIYKIL 289
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 2e-21
Identities = 49/174 (28%), Positives = 73/174 (41%), Gaps = 46/174 (26%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
+EY+ GG + +E+ E A F +++ AL LH K I++RD+K ENI++
Sbjct: 100 LEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML 154
Query: 661 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 710
+ G VKL DF HT C GT +
Sbjct: 155 N-----HQGH--VKLTDFGLCKESIHDGTVT-------HTFC-------------GTIEY 187
Query: 711 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
MAPE+L + + VD WS G L+ ++LT P+ G + + D I K
Sbjct: 188 MAPEILMR----SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK 237
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 46/174 (26%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
MEY GG + ++ + E+ + + A F ++ +AL LHS+ +++RDIK EN+++
Sbjct: 84 MEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 138
Query: 661 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 710
D DG +K+ DF T C GTP +
Sbjct: 139 D-----KDGH--IKITDFGLCKEGISDGATM-------KTFC-------------GTPEY 171
Query: 711 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
+APEVL N YG VD W G ++ E++ ++P+ + +LI M +
Sbjct: 172 LAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 49/301 (16%), Positives = 105/301 (34%), Gaps = 83/301 (27%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
++ L+ +S + L E ++ ++ + + + G ++S
Sbjct: 49 IKELRE-ATSPKANKEI----LDEAYVMASVDNPHVCRLLGICLTSTVQ----------- 92
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
+ + + G + +Y+ + + ++ + L +A + L + ++HRD+
Sbjct: 93 ----LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 144
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 708
+ N+L+ + VK+ DF A + + A +
Sbjct: 145 ARNVLVKTPQ-------HVKITDFGLA--------------KLLGAEEKEYHAEGGKVPI 183
Query: 709 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPR 767
+WMA E + +Y + D+WSYG + EL+T PY G+ EI +++ G+R
Sbjct: 184 KWMALESILH----RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-- 237
Query: 768 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 827
L C + + +C + RP +L
Sbjct: 238 ----LPQPPIC--------------TID-------VYMIMVKCWMIDADSRPKFRELIIE 272
Query: 828 F 828
F
Sbjct: 273 F 273
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 49/195 (25%), Positives = 75/195 (38%), Gaps = 55/195 (28%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE--- 614
E+ + L H +V+ YGH + +F+EY GG + + IE
Sbjct: 55 EICINKMLNHENVVKFYGH-RREG----------NIQ---YLFLEYCSGGELFDRIEPDI 100
Query: 615 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 674
+ E A + A +V LH I HRDIK EN+L+ D + +K
Sbjct: 101 GMPE--------PDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL-------DERDNLK 145
Query: 675 LCDF-----DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLE 728
+ DF R L+ C GT ++APE+L+ +
Sbjct: 146 ISDFGLATVFRYNNRERLLNKMC-------------GTLPYVAPELLKR----REFHAEP 188
Query: 729 VDIWSYGCLLLELLT 743
VD+WS G +L +L
Sbjct: 189 VDVWSCGIVLTAMLA 203
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 62/313 (19%), Positives = 114/313 (36%), Gaps = 90/313 (28%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+ L+ G D+ R+F E+++L AL IV+ G
Sbjct: 57 VKQLQHSGP--DQQRDF----QREIQILKALHSDFIVKYRGVSYGPGRQS---------- 100
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
L+ + MEY+ G +++++++ + L + + + L S+ +HRD+
Sbjct: 101 LR--LVMEYLPSGCLRDFLQR----HRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLA 154
Query: 655 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 710
+ NIL++ E VK+ DF + +PL + P W
Sbjct: 155 ARNILVESEA-------HVKIADFGLAKLLPLDKDYYV---VREPGQSPI--------FW 196
Query: 711 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSEL--------------E 755
APE L N++ + D+WS+G +L EL T +E
Sbjct: 197 YAPESLSD----NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 756 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815
+ +L++ G+R L A +C P + ++ + C +P
Sbjct: 253 LLELLEEGQR------LPAPPAC--------------PAE-------VHELMKLCWAPSP 285
Query: 816 TERPTAGDLYEMF 828
+RP+ L
Sbjct: 286 QDRPSFSALGPQL 298
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 3e-21
Identities = 62/297 (20%), Positives = 117/297 (39%), Gaps = 77/297 (25%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+T+K S + L E ++ L+H +V+++ + +K P +
Sbjct: 217 VKTMKPGSMSVEAF-------LAEANVMKTLQHDKLVKLHA--VVTK-------EPIY-- 258
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
I E++ GS+ ++ L + + + +A + + ++ +HRD++
Sbjct: 259 ----IITEFMAKGSLLDF---LKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR 311
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 712
+ NIL+ V K+ DF A R A G P +W A
Sbjct: 312 AANILVSASL-------VCKIADFGLA---RVIEDNEYTAREGAKFPI--------KWTA 353
Query: 713 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 771
PE + + ++ D+WS+G LL+E++T ++PY G+S E+ ++ G R
Sbjct: 354 PEAINF----GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR------ 403
Query: 772 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
+ +C PE L ++ RC + P ERPT + +
Sbjct: 404 MPRPENC--------------PEE-------LYNIMMRCWKNRPEERPTFEYIQSVL 439
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 51/240 (21%), Positives = 97/240 (40%), Gaps = 53/240 (22%)
Query: 532 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 586
AAK R K +I EV +L ++H ++ ++
Sbjct: 40 AAKFIKKRRTKSSRRGVSREDIER-------EVSILKEIQHPNVITLHE---------VY 83
Query: 587 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 646
+ + L+ +E V GG + +++ + ++ ++ + A + + + LHS
Sbjct: 84 ENKTDVILI-----LELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSL 133
Query: 647 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVC 704
I H D+K ENI+ L + P +K+ DF A + +
Sbjct: 134 QIAHFDLKPENIM--LLDRNVPK-PRIKIIDFGLAHKIDFGNEFKNIF------------ 178
Query: 705 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
GTP ++APE++ ++P GLE D+WS G + LL+ P++G ++ E +
Sbjct: 179 -GTPEFVAPEIVN--YEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 233
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 55/299 (18%), Positives = 100/299 (33%), Gaps = 78/299 (26%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
++ LK G+ + + E +++ L + IV + G + +
Sbjct: 42 IKVLKQ-GTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAEALM----------- 85
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
+ ME GG + ++ + + V + V+ + L K+ +HRD+
Sbjct: 86 ----LVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLA 137
Query: 655 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 710
+ N+L+ K+ DF +A+ +T A P +W
Sbjct: 138 ARNVLLVNRH-------YAKISDFGLSKALGADDSYYT---ARSAGKWPL--------KW 179
Query: 711 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 769
APE + K + D+WSYG + E L+ Q PY + E+ I+ GKR
Sbjct: 180 YAPECI-NFRK---FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---- 231
Query: 770 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
+E C P L + C +RP + +
Sbjct: 232 --MECPPEC--------------PPE-------LYALMSDCWIYKWEDRPDFLTVEQRM 267
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 46/179 (25%), Positives = 72/179 (40%), Gaps = 49/179 (27%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
++Y+ GG + ++ + + + ++ AL LH I++RDIK ENIL+
Sbjct: 138 LDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL 192
Query: 661 DLERKKADGKPVVKLCDF-----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 709
D ++G V L DF +RA + C GT
Sbjct: 193 D-----SNGH--VVLTDFGLSKEFVADETERA-------YDFC-------------GTIE 225
Query: 710 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE----LEIHDLIQMGK 764
+MAP+++R + VD WS G L+ ELLT P+ E EI I +
Sbjct: 226 YMAPDIVRGGDSG--HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 66/313 (21%), Positives = 118/313 (37%), Gaps = 90/313 (28%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 593
V+ LK ++ ++ + + E+ M+ + +H I+ + G P +
Sbjct: 72 VKMLK-DDATEKDLSDL----VSEMEMMKMIGKHKNIINLLGA--------CTQDGPLY- 117
Query: 594 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 642
+ +EY G+++ Y ++ E+ ++ K + +A +
Sbjct: 118 -----VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 702
L S+ +HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 173 LASQKCIHRDLAARNVLV------TENN-VMKIADFGLA--------------RDINNID 211
Query: 703 VCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELE 755
T P +WMAPE L +Y + D+WS+G L+ E+ TL PY G+ E
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFD----RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 756 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815
+ L++ G R +KP + L + R C P
Sbjct: 268 LFKLLKEGHR------------------------MDKPA---NCTNELYMMMRDCWHAVP 300
Query: 816 TERPTAGDLYEMF 828
++RPT L E
Sbjct: 301 SQRPTFKQLVEDL 313
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 4e-21
Identities = 61/297 (20%), Positives = 110/297 (37%), Gaps = 80/297 (26%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+ +K ++A L E ++ LRHS +V++ G + +
Sbjct: 49 VKCIK-NDATAQAF-------LAEASVMTQLRHSNLVQLLG--VIVEEKGGL-------- 90
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
I EY+ GS+ +Y L G + L + DV A+ L + +HRD+
Sbjct: 91 ---YIVTEYMAKGSLVDY---LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 144
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 712
+ N+L+ + V K+ DF + + +P +W A
Sbjct: 145 ARNVLVSEDN-------VAKVSDFGLT---KE-ASS---TQDTGKLPV--------KWTA 182
Query: 713 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 771
PE LR + + D+WS+G LL E+ + +VPY + ++ ++ G +
Sbjct: 183 PEALRE----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------ 232
Query: 772 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
++A C P A + +V + C + RP+ L E
Sbjct: 233 MDAPDGC--------------PPA-------VYEVMKNCWHLDAAMRPSFLQLREQL 268
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 5e-21
Identities = 67/320 (20%), Positives = 125/320 (39%), Gaps = 97/320 (30%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+ LK +S E+R+ L E +L + H ++++YG + P L
Sbjct: 58 VKMLKE-NASPSELRDL----LSEFNVLKQVNHPHVIKLYGA--------CSQDGP---L 101
Query: 595 LQSAIFMEYVKGGSVKNY-------------------IEKLSETGEKHVSVKLALFIAQD 635
L + +EY K GS++ + L E+ +++ + A
Sbjct: 102 L---LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQ 158
Query: 636 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 695
++ + L ++HRD+ + NIL+ A+G+ +K+ DF +
Sbjct: 159 ISQGMQYLAEMKLVHRDLAARNILV------AEGR-KMKISDFGLS-------------- 197
Query: 696 RGIPAPDVCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPY 748
R + D V P +WMA E L ++Y + D+WS+G LL E++TL PY
Sbjct: 198 RDVYEEDSYVKRSQGRIPVKWMAIESLFD----HIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 749 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 808
G+ + +L++ G R E+P+ + +
Sbjct: 254 PGIPPERLFNLLKTGHR------------------------MERPD---NCSEEMYRLML 286
Query: 809 RCTEENPTERPTAGDLYEMF 828
+C ++ P +RP D+ +
Sbjct: 287 QCWKQEPDKRPVFADISKDL 306
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 71/311 (22%), Positives = 115/311 (36%), Gaps = 89/311 (28%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+ LK S ++F E +L L+H IV +G + ++ P L
Sbjct: 76 VKALKEA--SESARQDF----QREAELLTMLQHQHIVRFFG--VCTEGRP---------L 118
Query: 595 LQSAIFMEYVKGGSVKNY----------IEKLSETGEKHVSVKLALFIAQDVAAALVELH 644
L + EY++ G + + + + + + L +A VAA +V L
Sbjct: 119 L---MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA 175
Query: 645 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC 704
H +HRD+ + N L+ VVK+ DF + R I + D
Sbjct: 176 GLHFVHRDLATRNCLVGQGL-------VVKIGDFGMS--------------RDIYSTDYY 214
Query: 705 -VGT----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIH 757
VG P RWM PE + + E D+WS+G +L E+ T + P+ LS E
Sbjct: 215 RVGGRTMLPIRWMPPESI----LYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270
Query: 758 DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817
D I G+ LE +C P + + R C + P +
Sbjct: 271 DCITQGRE------LERPRAC--------------PPE-------VYAIMRGCWQREPQQ 303
Query: 818 RPTAGDLYEMF 828
R + D++
Sbjct: 304 RHSIKDVHARL 314
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 48/174 (27%), Positives = 73/174 (41%), Gaps = 36/174 (20%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
ME + GG + I+K +KH S A +I + + +A+ +H ++HRD+K EN+L
Sbjct: 85 MELLNGGELFERIKK-----KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLF 139
Query: 661 DLERKKADGKPVVKLCDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717
+ +K+ DF A L T C T + APE+L
Sbjct: 140 ----TDENDNLEIKIIDFGFARLKPPDNQPLKTPC-------------FTLHYAAPELLN 182
Query: 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQVP-------YMGLSELEIHDLIQMGK 764
N Y D+WS G +L +L+ QVP S +EI I+ G
Sbjct: 183 Q----NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 6e-21
Identities = 64/297 (21%), Positives = 109/297 (36%), Gaps = 80/297 (26%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+ +K ++A L E ++ LRHS +V++ G + +
Sbjct: 221 VKCIK-NDATAQAF-------LAEASVMTQLRHSNLVQLLG--VIVEEKGGL-------- 262
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
I EY+ GS+ +Y L G + L + DV A+ L + +HRD+
Sbjct: 263 ---YIVTEYMAKGSLVDY---LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 316
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 712
+ N+L+ + V K+ DF S +P +W A
Sbjct: 317 ARNVLVSEDN-------VAKVSDFGLTKEASS-------TQDTGKLPV--------KWTA 354
Query: 713 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 771
PE LR + + D+WS+G LL E+ + +VPY + ++ ++ G +
Sbjct: 355 PEALRE----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------ 404
Query: 772 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
++A C P A + DV + C + RPT L E
Sbjct: 405 MDAPDGC--------------PPA-------VYDVMKNCWHLDAATRPTFLQLREQL 440
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-21
Identities = 57/223 (25%), Positives = 88/223 (39%), Gaps = 47/223 (21%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
ME ++GG + ++ E G++ + + A I +D+ A+ LHS +I HRD+K EN+L
Sbjct: 105 MECMEGGEL---FSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL- 160
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRS-FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 719
K+ D V+KL DF A L T C TP ++APEVL
Sbjct: 161 -YTSKEKD--AVLKLTDFGFAKETTQNALQTPC-------------YTPYYVAPEVLGPE 204
Query: 720 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 779
Y D+WS G ++ LL P+ + I + +
Sbjct: 205 K----YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM-----------KRRIRLGQ 249
Query: 780 EHEVAQSGSGFEKPEAELETLSFLV-DVFRRCTEENPTERPTA 821
+ P E +S + R + +PTER T
Sbjct: 250 ----------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTI 282
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 9e-21
Identities = 58/243 (23%), Positives = 95/243 (39%), Gaps = 59/243 (24%)
Query: 532 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 586
AAK R + EI EV +L + H I+ ++
Sbjct: 41 AAKFIKKRQSRASRRGVCREEIER-------EVSILRQVLHPNIITLHD---------VY 84
Query: 587 DGNPEHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVEL 643
+ + L+ +E V GG + +++ E LSE + A + + + L
Sbjct: 85 ENRTDVVLI-----LELVSGGELFDFLAQKESLSE--------EEATSFIKQILDGVNYL 131
Query: 644 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL--RSFLHTCCIAHRGIPAP 701
H+K I H D+K ENI++ K P +KL DF A +
Sbjct: 132 HTKKIAHFDLKPENIML---LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--------- 179
Query: 702 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 761
GTP ++APE++ ++P GLE D+WS G + LL+ P++G ++ E I
Sbjct: 180 ----GTPEFVAPEIVN--YEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231
Query: 762 MGK 764
Sbjct: 232 AVS 234
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 9e-21
Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 46/174 (26%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
MEYV GG + +I+++ E H A+F A ++A L L SK I++RD+K +N+++
Sbjct: 100 MEYVNGGDLMYHIQQVGRFKEPH-----AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 154
Query: 661 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 710
D ++G +K+ DF T C GTP +
Sbjct: 155 D-----SEGH--IKIADFGMCKENIWDGVTT-------KTFC-------------GTPDY 187
Query: 711 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
+APE++ YG VD W++G LL E+L Q P+ G E E+ I
Sbjct: 188 IAPEIIAYQP----YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 237
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 1e-20
Identities = 63/297 (21%), Positives = 112/297 (37%), Gaps = 71/297 (23%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V++L + E+ F L E ++ H ++ + G I + ++G+P
Sbjct: 122 VKSLNR-ITDIGEVSQF----LTEGIIMKDFSHPNVLSLLG--ICLR----SEGSP---- 166
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
+ + Y+K G ++N+I + +VK + VA + L SK +HRD+
Sbjct: 167 ---LVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLA 219
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 712
+ N ++D + VK+ DF A + G +P +WMA
Sbjct: 220 ARNCMLDEKF-------TVKVADFGLARDMYDKEFDSVHNKTGAKLPV--------KWMA 264
Query: 713 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 771
E L+ + + D+WS+G LL EL+T PY ++ +I + G+R
Sbjct: 265 LESLQT----QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR------ 314
Query: 772 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
L C P+ L +V +C RP+ +L
Sbjct: 315 LLQPEYC--------------PDP-------LYEVMLKCWHPKAEMRPSFSELVSRI 350
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 72/313 (23%), Positives = 120/313 (38%), Gaps = 90/313 (28%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 593
V+ LK ++ ++ + + E+ M+ + +H I+ + G ++ +
Sbjct: 106 VKMLK-SDATEKDLSDL----ISEMEMMKMIGKHKNIINLLG--ACTQ---------DGP 149
Query: 594 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 642
L + +EY G+++ Y S E+ +S K + A VA +
Sbjct: 150 LY---VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 702
L SK +HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 207 LASKKCIHRDLAARNVLVTEDN-------VMKIADFGLA--------------RDIHHID 245
Query: 703 VCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELE 755
T P +WMAPE L +Y + D+WS+G LL E+ TL PY G+ E
Sbjct: 246 YYKKTTNGRLPVKWMAPEAL----FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301
Query: 756 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815
+ L++ G R +KP + L + R C P
Sbjct: 302 LFKLLKEGHR------------------------MDKPS---NCTNELYMMMRDCWHAVP 334
Query: 816 TERPTAGDLYEMF 828
++RPT L E
Sbjct: 335 SQRPTFKQLVEDL 347
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 50/174 (28%), Positives = 78/174 (44%), Gaps = 46/174 (26%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
ME+V GG + +I+K + A F A ++ +AL+ LH K I++RD+K +N+L+
Sbjct: 103 MEFVNGGDLMFHIQK-----SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL 157
Query: 661 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 710
D +G KL DF T C GTP +
Sbjct: 158 D-----HEGH--CKLADFGMCKEGICNGVTT-------ATFC-------------GTPDY 190
Query: 711 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
+APE+L+ M YG VD W+ G LL E+L P+ +E ++ + I +
Sbjct: 191 IAPEILQEML----YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE 240
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 45/198 (22%), Positives = 74/198 (37%), Gaps = 53/198 (26%)
Query: 558 EVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIE 614
EV +L + ++ + W D + + +E + + ++I
Sbjct: 96 EVVLLKKVSSGFSGVIRLLD------WFERPD-----SFV---LILERPEPVQDLFDFIT 141
Query: 615 ---KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 671
L E +LA V A+ H+ ++HRDIK ENILIDL R +
Sbjct: 142 ERGALQE--------ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE----- 188
Query: 672 VVKLCDFD-RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 729
+KL DF A+ + GT + PE +R + Y G
Sbjct: 189 -LKLIDFGSGALLKDTVYTDFD-------------GTRVYSPPEWIRY----HRYHGRSA 230
Query: 730 DIWSYGCLLLELLTLQVP 747
+WS G LL +++ +P
Sbjct: 231 AVWSLGILLYDMVCGDIP 248
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 66/313 (21%), Positives = 118/313 (37%), Gaps = 90/313 (28%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 593
V+ LK ++ ++ + + E+ M+ + +H I+ + G P +
Sbjct: 118 VKMLKD-DATEKDLSDL----VSEMEMMKMIGKHKNIINLLGA--------CTQDGPLY- 163
Query: 594 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 642
+ +EY G+++ Y ++ E+ ++ K + +A +
Sbjct: 164 -----VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 218
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 702
L S+ +HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 219 LASQKCIHRDLAARNVLV------TENN-VMKIADFGLA--------------RDINNID 257
Query: 703 VCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELE 755
T P +WMAPE L +Y + D+WS+G L+ E+ TL PY G+ E
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFD----RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313
Query: 756 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815
+ L++ G R +KP + L + R C P
Sbjct: 314 LFKLLKEGHR------------------------MDKPA---NCTNELYMMMRDCWHAVP 346
Query: 816 TERPTAGDLYEMF 828
++RPT L E
Sbjct: 347 SQRPTFKQLVEDL 359
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 67/313 (21%), Positives = 114/313 (36%), Gaps = 91/313 (29%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+ LK + + E+ +L L H I++ G A
Sbjct: 65 VKALKA-DAGPQHRSGW----KQEIDILRTLYHEHIIKYKG--CCED----AGAAS---- 109
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
LQ + MEYV GS+++Y+ + + + L AQ + + LH++H +HRD+
Sbjct: 110 LQ--LVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLA 161
Query: 655 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 710
+ N+L+D +R +VK+ DF +AVP + P W
Sbjct: 162 ARNVLLDNDR-------LVKIGDFGLAKAVPEGHEYYR---VREDGDSPV--------FW 203
Query: 711 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL---------------QVPYMGLSELE 755
APE L+ + D+WS+G L ELLT + ++ L
Sbjct: 204 YAPECLKE----YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259
Query: 756 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815
+ +L++ G+R L C P + + + C E
Sbjct: 260 LTELLERGER------LPRPDKC--------------PAE-------VYHLMKNCWETEA 292
Query: 816 TERPTAGDLYEMF 828
+ RPT +L +
Sbjct: 293 SFRPTFENLIPIL 305
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 53/205 (25%), Positives = 83/205 (40%), Gaps = 57/205 (27%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--ME-YVKGGSVKNYIE 614
E+ +L + H+ I+++ ++ ME + G + +I+
Sbjct: 79 EIAILSRVEHANIIKVL-DIFENQ---------------GFFQLVMEKHGSGLDLFAFID 122
Query: 615 ---KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 671
+L E LA +I + + +A+ L K I+HRDIK ENI+I
Sbjct: 123 RHPRLDE--------PLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI-------AEDF 167
Query: 672 VVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLE 728
+KL DF A L +T C GT + APEVL N Y G E
Sbjct: 168 TIKLIDFGSAAYLERGKLFYTFC-------------GTIEYCAPEVLMG----NPYRGPE 210
Query: 729 VDIWSYGCLLLELLTLQVPYMGLSE 753
+++WS G L L+ + P+ L E
Sbjct: 211 LEMWSLGVTLYTLVFEENPFCELEE 235
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 56/301 (18%), Positives = 103/301 (34%), Gaps = 83/301 (27%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
++ ++ S + + +G+L H+ IV + G S
Sbjct: 47 IKVIED-KSGRQSFQAV----TDHMLAIGSLDHAHIVRLLGLCPGSSLQ----------- 90
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
+ +Y+ GS+ +++ + + +L L +A + L ++HR++
Sbjct: 91 ----LVTQYLPLGSLLDHVRQ----HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLA 142
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 708
+ N+L+ V++ DF A +P D +
Sbjct: 143 ARNVLLKSPS-------QVQVADFGVA--------------DLLPPDDKQLLYSEAKTPI 181
Query: 709 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPR 767
+WMA E + Y + D+WSYG + EL+T PY GL E+ DL++ G+R
Sbjct: 182 KWMALESIHF----GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER-- 235
Query: 768 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 827
L C + V +C + RPT +L
Sbjct: 236 ----LAQPQIC--------------TID-------VYMVMVKCWMIDENIRPTFKELANE 270
Query: 828 F 828
F
Sbjct: 271 F 271
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-20
Identities = 48/174 (27%), Positives = 75/174 (43%), Gaps = 46/174 (26%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
++Y+ GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 118 LDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL 172
Query: 661 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 710
D + G + L DF T C GTP +
Sbjct: 173 D-----SQGH--IVLTDFGLCKENIEHNSTT-------STFC-------------GTPEY 205
Query: 711 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
+APEVL Y VD W G +L E+L P+ + E++D I
Sbjct: 206 LAPEVLHKQP----YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP 255
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-20
Identities = 55/237 (23%), Positives = 93/237 (39%), Gaps = 51/237 (21%)
Query: 532 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 590
AA + T K+ ++ E R+ L+H IV ++
Sbjct: 40 AAMIINTKKLSARDHQKLER-------EARICRLLKHPNIVRLHDSISEEG--------- 83
Query: 591 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 650
H+L+ + V GG + I ++ S A Q + A++ H ++H
Sbjct: 84 HHYLI-----FDLVTGGELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQMGVVH 133
Query: 651 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS---FLHTCCIAHRGIPAPDVCVGT 707
R++K EN+L+ + K A VKL DF A+ + GT
Sbjct: 134 RNLKPENLLLASKLKGAA----VKLADFGLAIEVEGEQQAWFGFA-------------GT 176
Query: 708 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
P +++PEVLR + YG VD+W+ G +L LL P+ + ++ I+ G
Sbjct: 177 PGYLSPEVLRK----DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA 229
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 52/210 (24%), Positives = 83/210 (39%), Gaps = 40/210 (19%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E + L+H IVE+ S +++ E++ G + I K
Sbjct: 76 EASICHMLKHPHIVELLETYSSDG---------MLYMV-----FEFMDGADLCFEIVK-R 120
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
S +A + + AL H +I+HRD+K +L+ K + P VKL
Sbjct: 121 ADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLA---SKENSAP-VKLGG 176
Query: 678 FDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 734
F A+ L GTP +MAPEV++ YG VD+W
Sbjct: 177 FGVAIQLGESGLVAGGRV-------------GTPHFMAPEVVKR----EPYGKPVDVWGC 219
Query: 735 GCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
G +L LL+ +P+ G ++ + + I GK
Sbjct: 220 GVILFILLSGCLPFYG-TKERLFEGIIKGK 248
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-20
Identities = 49/242 (20%), Positives = 87/242 (35%), Gaps = 59/242 (24%)
Query: 532 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKWLPSADGN 589
AAK + + EI + E+ +L + ++ ++ +
Sbjct: 58 AAKFLKKRRRGQDCRAEILH-------EIAVLELAKSCPRVINLHE---------VYENT 101
Query: 590 PEHHLLQSAIFMEYVKGGS-----VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH 644
E L+ +EY GG + E +SE + + + + + LH
Sbjct: 102 SEIILI-----LEYAAGGEIFSLCLPELAEMVSE--------NDVIRLIKQILEGVYYLH 148
Query: 645 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPD 702
+I+H D+K +NIL L G +K+ DF + + L
Sbjct: 149 QNNIVHLDLKPQNIL--LSSIYPLGD--IKIVDFGMSRKIGHACELREIM---------- 194
Query: 703 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 762
GTP ++APE+L + P D+W+ G + LLT P++G E + I
Sbjct: 195 ---GTPEYLAPEILN--YDP--ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ 247
Query: 763 GK 764
Sbjct: 248 VN 249
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 56/194 (28%), Positives = 83/194 (42%), Gaps = 56/194 (28%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 613
E++ L RH I+++Y IS+ + F MEYV GG + +YI
Sbjct: 61 EIQNLKLFRHPHIIKLY-QVISTP---------------TDFFMVMEYVSGGELFDYICK 104
Query: 614 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 672
++ E A + Q + +A+ H ++HRD+K EN+L+D
Sbjct: 105 HGRVEE--------MEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN------- 149
Query: 673 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 729
K+ DF + + FL T C G+P + APEV+ LY G EV
Sbjct: 150 AKIADFGLSNMMSDGEFLRTSC-------------GSPNYAAPEVISG----RLYAGPEV 192
Query: 730 DIWSYGCLLLELLT 743
DIWS G +L LL
Sbjct: 193 DIWSCGVILYALLC 206
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 68/314 (21%), Positives = 119/314 (37%), Gaps = 90/314 (28%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 593
V+ LK G++ E R + E+++L + H +V + G +K P
Sbjct: 62 VKMLKE-GATHSEHRAL----MSELKILIHIGHHLNVVNLLG--ACTK--------PGGP 106
Query: 594 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 642
L+ + +E+ K G++ Y + + ++++ + + VA +
Sbjct: 107 LM---VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 163
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 702
L S+ +HRD+ + NIL+ ++ VVK+CDF A R I
Sbjct: 164 LASRKCIHRDLAARNILL------SEKN-VVKICDFGLA--------------RDIYKDP 202
Query: 703 VCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSE-L 754
V P +WMAPE + +Y ++ D+WS+G LL E+ +L PY G+
Sbjct: 203 DYVRKGDARLPLKWMAPETIFD----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258
Query: 755 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 814
E ++ G R P+ T + C
Sbjct: 259 EFCRRLKEGTR------------------------MRAPD---YTTPEMYQTMLDCWHGE 291
Query: 815 PTERPTAGDLYEMF 828
P++RPT +L E
Sbjct: 292 PSQRPTFSELVEHL 305
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 6e-20
Identities = 50/190 (26%), Positives = 76/190 (40%), Gaps = 48/190 (25%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---E 614
E+ +L L H I+++ + E L+ +E V GG + + I
Sbjct: 98 EIGVLLRLSHPNIIKLKE------IFETPT---EISLV-----LELVTGGELFDRIVEKG 143
Query: 615 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 674
SE + A + + A+ LH I+HRD+K EN+L D +K
Sbjct: 144 YYSE--------RDAADAVKQILEAVAYLHENGIVHRDLKPENLL--YATPAPDAP--LK 191
Query: 675 LCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 732
+ DF + + + T C GTP + APE+LR YG EVD+W
Sbjct: 192 IADFGLSKIVEHQVLMKTVC-------------GTPGYCAPEILRGCA----YGPEVDMW 234
Query: 733 SYGCLLLELL 742
S G + LL
Sbjct: 235 SVGIITYILL 244
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 6e-20
Identities = 56/192 (29%), Positives = 75/192 (39%), Gaps = 50/192 (26%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---E 614
E+ +LRH IV I + HL AI MEY GG + I
Sbjct: 66 EIINHRSLRHPNIVRFK-EVILTP----------THL---AIIMEYASGGELYERICNAG 111
Query: 615 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 674
+ SE A F Q + + + HS I HRD+K EN L+D P +K
Sbjct: 112 RFSE--------DEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLD-----GSPAPRLK 158
Query: 675 LCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEVDI 731
+CDF ++ L S + GTP ++APEVL Y G D+
Sbjct: 159 ICDFGYSKSSVLHSQPKSTV-------------GTPAYIAPEVLLR----QEYDGKIADV 201
Query: 732 WSYGCLLLELLT 743
WS G L +L
Sbjct: 202 WSCGVTLYVMLV 213
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 9e-20
Identities = 65/310 (20%), Positives = 115/310 (37%), Gaps = 75/310 (24%)
Query: 535 VRTLKV-CGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 593
V+ LK S + + +F + EV + +L H ++ +YG + P
Sbjct: 51 VKCLKPDVLSQPEAMDDF----IREVNAMHSLDHRNLIRLYG--VVL-------TPP--- 94
Query: 594 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 653
++ + E GS+ + + K + H + A VA + L SK +HRD+
Sbjct: 95 -MK--MVTELAPLGSLLDRLRK----HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDL 147
Query: 654 KSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 711
+ N+L+ + +VK+ DF RA+P + P W
Sbjct: 148 AARNLLL-------ATRDLVKIGDFGLMRALPQND---DHYVMQEHRKVP------FAWC 191
Query: 712 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLI-QMGKRPRLT 769
APE L+ + D W +G L E+ T Q P++GL+ +I I + G+R
Sbjct: 192 APESLKT----RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER---- 243
Query: 770 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 829
L C P+ + +V +C P +RPT L + +
Sbjct: 244 --LPRPEDC--------------PQD-------IYNVMVQCWAHKPEDRPTFVALRDFLL 280
Query: 830 ARTSSSISSR 839
+ + +
Sbjct: 281 EAQPTDMRAE 290
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 49/170 (28%), Positives = 75/170 (44%), Gaps = 30/170 (17%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
ME + GG + ++ + G++ + + A I + + A+ LHS +I HRD+K EN+L
Sbjct: 138 MECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 194
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718
+R A +KL DF A S L T C TP ++APEVL
Sbjct: 195 TSKRPNAI----LKLTDFGFAKETTSHNSLTTPC-------------YTPYYVAPEVL-- 235
Query: 719 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG----LSELEIHDLIQMGK 764
P Y D+WS G ++ LL P+ + I+MG+
Sbjct: 236 --GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 40/155 (25%), Positives = 59/155 (38%), Gaps = 37/155 (23%)
Query: 599 IFMEY-VKGGSVKNYIE---KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
+ +E + + +YI L E + V AA+ HS+ ++HRDIK
Sbjct: 115 LVLERPLPAQDLFDYITEKGPLGE--------GPSRCFFGQVVAAIQHCHSRGVVHRDIK 166
Query: 655 SENILIDLERKKADGKPVVKLCDFD-RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 713
ENILIDL R KL DF A+ GT + P
Sbjct: 167 DENILIDLRRGC------AKLIDFGSGALLHDEPYTDFD-------------GTRVYSPP 207
Query: 714 EVLRAMHKPNLY-GLEVDIWSYGCLLLELLTLQVP 747
E + + Y L +WS G LL +++ +P
Sbjct: 208 EWISR----HQYHALPATVWSLGILLYDMVCGDIP 238
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-19
Identities = 52/227 (22%), Positives = 88/227 (38%), Gaps = 46/227 (20%)
Query: 549 RNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS 608
R E L E ++L + +V + A + L + + GG
Sbjct: 225 RKGEAMALNEKQILEKVNSRFVVSLA----------YAYETKDALCL----VLTLMNGGD 270
Query: 609 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 668
+K +I + G+ A+F A ++ L +LH + I++RD+K ENIL+D
Sbjct: 271 LKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD-----DH 322
Query: 669 GKPVVKLCDFDRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 726
G +++ D A VP + GT +MAPEV++ Y
Sbjct: 323 GH--IRISDLGLAVHVPEGQTIKGRV-------------GTVGYMAPEVVKNER----YT 363
Query: 727 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 773
D W+ GCLL E++ Q P+ + + + +R E
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKEVPEE 407
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 68/320 (21%), Positives = 113/320 (35%), Gaps = 97/320 (30%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+ LK +SAD +F E ++ + IV++ G A G P +
Sbjct: 82 VKMLKE-EASADMQADF----QREAALMAEFDNPNIVKLLG--------VCAVGKP---M 125
Query: 595 LQSAIFMEYVKGGSVKNY-------------------IEKLSETGEKHVSVKLALFIAQD 635
+ EY+ G + + ++S G +S L IA+
Sbjct: 126 C---LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 182
Query: 636 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 695
VAA + L + +HRD+ + N L+ VVK+ DF +
Sbjct: 183 VAAGMAYLSERKFVHRDLATRNCLVGENM-------VVKIADFGLS-------------- 221
Query: 696 RGIPAPDVCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPY 748
R I + D P RWM PE + N Y E D+W+YG +L E+ + PY
Sbjct: 222 RNIYSADYYKADGNDAIPIRWMPPESI----FYNRYTTESDVWAYGVVLWEIFSYGLQPY 277
Query: 749 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 808
G++ E+ ++ G PE L ++ R
Sbjct: 278 YGMAHEEVIYYVRDGNI------------------------LACPE---NCPLELYNLMR 310
Query: 809 RCTEENPTERPTAGDLYEMF 828
C + P +RP+ ++ +
Sbjct: 311 LCWSKLPADRPSFCSIHRIL 330
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 33/168 (19%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENIL 659
MEY GG + ++ + E+ S A F ++ +AL LHS+ +++RD+K EN++
Sbjct: 227 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 281
Query: 660 IDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 716
+D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 282 LD-----KDGH--IKITDFGLCKEGIKDGATMKTFC-------------GTPEYLAPEVL 321
Query: 717 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
N YG VD W G ++ E++ ++P+ ++ +LI M +
Sbjct: 322 ED----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 365
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 60/314 (19%), Positives = 107/314 (34%), Gaps = 95/314 (30%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
++TLK + F E + L+H +V + G + +K P
Sbjct: 44 IKTLKD-KAEGPLREEF----RHEAMLRARLQHPNVVCLLG--VVTK------DQP---- 86
Query: 595 LQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVEL 643
++ Y G + + T + + + + +AA + L
Sbjct: 87 --LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL 144
Query: 644 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 703
S H++H+D+ + N+L+ + VK+ D R + A D
Sbjct: 145 SSHHVVHKDLATRNVLVYDKL-------NVKISDLGLF--------------REVYAADY 183
Query: 704 CVGT-----P-RWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSE 753
P RWMAPE + +YG ++ DIWSYG +L E+ + PY G S
Sbjct: 184 YKLLGNSLLPIRWMAPEAI-------MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 236
Query: 754 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 813
++ ++I+ + L C P + + C E
Sbjct: 237 QDVVEMIRNRQV------LPCPDDC--------------PAW-------VYALMIECWNE 269
Query: 814 NPTERPTAGDLYEM 827
P+ RP D++
Sbjct: 270 FPSRRPRFKDIHSR 283
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 2e-19
Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 46/174 (26%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
MEYV GG + +I+++ E H A+F A ++A L L SK I++RD+K +N+++
Sbjct: 421 MEYVNGGDLMYHIQQVGRFKEPH-----AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 475
Query: 661 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 710
D ++G +K+ DF T C GTP +
Sbjct: 476 D-----SEGH--IKIADFGMCKENIWDGVTT-------KTFC-------------GTPDY 508
Query: 711 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
+APE++ YG VD W++G LL E+L Q P+ G E E+ I
Sbjct: 509 IAPEIIAYQP----YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 558
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 50/233 (21%), Positives = 98/233 (42%), Gaps = 47/233 (20%)
Query: 532 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 591
AK +KV G+ ++ E+ +L RH I+ ++ S + E
Sbjct: 34 MAKF--VKVKGTDQVLVKK-------EISILNIARHRNILHLHE---------SFESMEE 75
Query: 592 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 651
++ E++ G + E+++ + + ++ ++ Q V AL LHS +I H
Sbjct: 76 LVMI-----FEFISGLDI---FERINTSAFELNEREIVSYVHQ-VCEALQFLHSHNIGHF 126
Query: 652 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 711
DI+ ENI+ + +++ +K+ +F +A L+ G + P +
Sbjct: 127 DIRPENII--YQTRRSS---TIKIIEFGQARQLKP----------GDNFRLLF-TAPEYY 170
Query: 712 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
APEV + H D+WS G L+ LL+ P++ + +I + I +
Sbjct: 171 APEVHQ--HDV--VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE 219
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 4e-19
Identities = 38/163 (23%), Positives = 67/163 (41%), Gaps = 29/163 (17%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
++ + GG + ++ + S F A ++ L +H++ +++RD+K NIL+
Sbjct: 271 LDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 325
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFL-HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 719
D G V++ D A H GT +MAPEVL+
Sbjct: 326 D-----EHGH--VRISDLGLACDFSKKKPHASV-------------GTHGYMAPEVLQKG 365
Query: 720 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 762
Y D +S GC+L +LL P+ + H++ +M
Sbjct: 366 VA---YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 405
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 72/316 (22%), Positives = 115/316 (36%), Gaps = 93/316 (29%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 593
V+ LK + E + E+++L L H IV + G G P
Sbjct: 58 VKMLKP-SAHLTEREAL----MSELKVLSYLGNHMNIVNLLGA--------CTIGGP--- 101
Query: 594 LLQSAIFMEYVKGGSVKNY-------------IEKLSETGEKHVSVKLALFIAQDVAAAL 640
L + EY G + N+ + E E + ++ L + VA +
Sbjct: 102 TL---VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158
Query: 641 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA 700
L SK+ +HRD+ + NIL+ R + K+CDF A R I
Sbjct: 159 AFLASKNCIHRDLAARNILLTHGR-------ITKICDFGLA--------------RDIKN 197
Query: 701 PDVCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSE 753
V P +WMAPE + +Y E D+WSYG L EL +L PY G+
Sbjct: 198 DSNYVVKGNARLPVKWMAPESI----FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 754 -LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 812
+ + +I+ G R PE + + D+ + C +
Sbjct: 254 DSKFYKMIKEGFR------------------------MLSPE---HAPAEMYDIMKTCWD 286
Query: 813 ENPTERPTAGDLYEMF 828
+P +RPT + ++
Sbjct: 287 ADPLKRPTFKQIVQLI 302
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 5e-19
Identities = 45/162 (27%), Positives = 81/162 (50%), Gaps = 34/162 (20%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
+EYV GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 89 IEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNYLHERGIIYRDLKLDNVLL 143
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWMAPEVL 716
D ++G +KL D+ + G+ D C GTP ++APE+L
Sbjct: 144 D-----SEGH--IKLTDY-------------GMCKEGLRPGDTTSTFC-GTPNYIAPEIL 182
Query: 717 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 758
R YG VD W+ G L+ E++ + P+ + + D
Sbjct: 183 RG----EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 68/312 (21%), Positives = 112/312 (35%), Gaps = 89/312 (28%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 593
V+ LK + ADE + E++++ L +H IV + G G P
Sbjct: 81 VKMLKS-TAHADEKEAL----MSELKIMSHLGQHENIVNLLGA--------CTHGGP--- 124
Query: 594 LLQSAIFMEYVKGGSVKNY---------IEKLSETGEKHVSVKLALFIAQDVAAALVELH 644
+L + EY G + N+ + S + L + VA + L
Sbjct: 125 VL---VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA 181
Query: 645 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC 704
SK+ +HRD+ + N+L+ +G V K+ DF A R I
Sbjct: 182 SKNCIHRDVAARNVLL------TNGH-VAKIGDFGLA--------------RDIMNDSNY 220
Query: 705 VGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMG-LSELEI 756
+ P +WMAPE + +Y ++ D+WSYG LL E+ +L PY G L +
Sbjct: 221 IVKGNARLPVKWMAPESI----FDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276
Query: 757 HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816
+ L++ G + +P + + + C PT
Sbjct: 277 YKLVKDGYQ------------------------MAQPA---FAPKNIYSIMQACWALEPT 309
Query: 817 ERPTAGDLYEMF 828
RPT +
Sbjct: 310 HRPTFQQICSFL 321
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 1e-18
Identities = 53/299 (17%), Positives = 99/299 (33%), Gaps = 78/299 (26%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
++ LK G+ + + E +++ L + IV + G + +
Sbjct: 368 IKVLKQ-GTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAEALM----------- 411
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
+ ME GG + ++ + + V + V+ + L K+ +HR++
Sbjct: 412 ----LVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLA 463
Query: 655 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 710
+ N+L+ K+ DF +A+ +T A P +W
Sbjct: 464 ARNVLLVNRH-------YAKISDFGLSKALGADDSYYT---ARSAGKWPL--------KW 505
Query: 711 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 769
APE + + D+WSYG + E L+ Q PY + E+ I+ GKR
Sbjct: 506 YAPECINF----RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---- 557
Query: 770 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
+E C P L + C +RP + +
Sbjct: 558 --MECPPEC--------------PPE-------LYALMSDCWIYKWEDRPDFLTVEQRM 593
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 1e-18
Identities = 42/171 (24%), Positives = 71/171 (41%), Gaps = 32/171 (18%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
M + GG ++ +I + E A+F + + L LH ++I++RD+K EN+L+
Sbjct: 264 MTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL 322
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSF---LHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717
D DG V++ D AV L++ GTP +MAPE+L
Sbjct: 323 D-----DDGN--VRISDLGLAVELKAGQTKTKGYA-------------GTPGFMAPELLL 362
Query: 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL----EIHDLIQMGK 764
Y VD ++ G L E++ + P+ E E+ +
Sbjct: 363 GEE----YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA 409
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 68/307 (22%), Positives = 117/307 (38%), Gaps = 81/307 (26%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 593
++ +K +S D+ R+F GE+ +L L H I+ + G +
Sbjct: 57 IKRMKE-YASKDDHRDF----AGELEVLCKLGHHPNIINLLGA--------CEHRGYLY- 102
Query: 594 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 642
+ +EY G++ ++ ++ + +S + L A DVA +
Sbjct: 103 -----LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 157
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 702
L K +HRD+ + NIL+ V K+ DF + R +P
Sbjct: 158 LSQKQFIHRDLAARNILVGENY-------VAKIADFGLS---RGQEVYVKKTMGRLPV-- 205
Query: 703 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQ 761
RWMA E L ++Y D+WSYG LL E+++L PY G++ E+++ +
Sbjct: 206 ------RWMAIESLNY----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255
Query: 762 MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821
G R LE +C + + D+ R+C E P ERP+
Sbjct: 256 QGYR------LEKPLNC--------------DDE-------VYDLMRQCWREKPYERPSF 288
Query: 822 GDLYEMF 828
+
Sbjct: 289 AQILVSL 295
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-18
Identities = 45/168 (26%), Positives = 79/168 (47%), Gaps = 46/168 (27%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
+EYV GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 132 IEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNYLHERGIIYRDLKLDNVLL 186
Query: 661 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 710
D ++G +KL D+ D T C GTP +
Sbjct: 187 D-----SEGH--IKLTDYGMCKEGLRPGDTT-------STFC-------------GTPNY 219
Query: 711 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 758
+APE+LR YG VD W+ G L+ E++ + P+ + + D
Sbjct: 220 IAPEILRGED----YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 5e-18
Identities = 54/242 (22%), Positives = 86/242 (35%), Gaps = 58/242 (23%)
Query: 547 EIRNFEYSCLGEVRMLGALRHSCIVEMY----GHKISSKWLPSADGNPEHHLLQSAIFME 602
E S E+ +L L+H ++ + H WL +
Sbjct: 57 EGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL----------------LFD 100
Query: 603 YVKGGSVKNYIEKLSETGEKHVSVKLAL-----FIAQDVAAALVELHSKHIMHRDIKSEN 657
Y + + + I+ + V+L + Q + + LH+ ++HRD+K N
Sbjct: 101 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ-ILDGIHYLHANWVLHRDLKPAN 158
Query: 658 ILIDLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-A 712
IL+ E + VK+ D A PL+ D V T W A
Sbjct: 159 ILVMGE---GPERGRVKIADMGFARLFNSPLKPLAD-----------LDPVVVT-FWYRA 203
Query: 713 PEVL-RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE 771
PE+L A H Y +DIW+ GC+ ELLT + + E P D+
Sbjct: 204 PELLLGARH----YTKAIDIWAIGCIFAELLTSEPIFHCRQE------DIKTSNPYHHDQ 253
Query: 772 LE 773
L+
Sbjct: 254 LD 255
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 6e-18
Identities = 46/207 (22%), Positives = 82/207 (39%), Gaps = 38/207 (18%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+ ++ L H ++ ++ + + E L +E++ GG + ++++
Sbjct: 98 EISIMNQLHHPKLINLHD---------AFEDKYEMVL-----ILEFLSGGEL---FDRIA 140
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
K ++ ++ Q L +H I+H DIK ENI+ E KKA VK+ D
Sbjct: 141 AEDYKMSEAEVINYMRQ-ACEGLKHMHEHSIVHLDIKPENIM--CETKKAS---SVKIID 194
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F A L T + APE++ +P G D+W+ G L
Sbjct: 195 FGLATKLNP----------DEIVKVTT-ATAEFAAPEIVD--REP--VGFYTDMWAIGVL 239
Query: 738 LLELLTLQVPYMGLSELEIHDLIQMGK 764
LL+ P+ G +LE ++
Sbjct: 240 GYVLLSGLSPFAGEDDLETLQNVKRCD 266
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 7e-18
Identities = 58/194 (29%), Positives = 84/194 (43%), Gaps = 56/194 (28%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 613
E++ L RH I+++Y IS+ S IF MEYV GG + +YI
Sbjct: 66 EIQNLKLFRHPHIIKLY-QVISTP---------------SDIFMVMEYVSGGELFDYICK 109
Query: 614 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 672
+L E K + + Q + + + H ++HRD+K EN+L+D
Sbjct: 110 NGRLDE--------KESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN------- 154
Query: 673 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 729
K+ DF + + FL T C G+P + APEV+ LY G EV
Sbjct: 155 AKIADFGLSNMMSDGEFLRTSC-------------GSPNYAAPEVISG----RLYAGPEV 197
Query: 730 DIWSYGCLLLELLT 743
DIWS G +L LL
Sbjct: 198 DIWSSGVILYALLC 211
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 8e-18
Identities = 46/207 (22%), Positives = 79/207 (38%), Gaps = 38/207 (18%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E++ + LRH +V ++ + + + E ++ E++ GG + +
Sbjct: 204 EIQTMSVLRHPTLVNLHD---------AFEDDNEMVMI-----YEFMSGGELFEKV--AD 247
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
E +S A+ + V L +H + +H D+K ENI+ +R +KL D
Sbjct: 248 EHN--KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE-----LKLID 300
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F L GT + APEV KP G D+WS G L
Sbjct: 301 FGLTAHLDP----------KQSVKVTT-GTAEFAAPEVAE--GKP--VGYYTDMWSVGVL 345
Query: 738 LLELLTLQVPYMGLSELEIHDLIQMGK 764
LL+ P+ G ++ E ++
Sbjct: 346 SYILLSGLSPFGGENDDETLRNVKSCD 372
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 57/194 (29%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 613
E+ L LRH I+++Y I++ + I +EY GG + +YI
Sbjct: 59 EISYLKLLRHPHIIKLY-DVITTP---------------TDIVMVIEYA-GGELFDYIVE 101
Query: 614 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 672
++++E Q + A+ H I+HRD+K EN+L+D
Sbjct: 102 KKRMTE--------DEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN------- 146
Query: 673 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 729
VK+ DF + + +FL T C G+P + APEV+ LY G EV
Sbjct: 147 VKIADFGLSNIMTDGNFLKTSC-------------GSPNYAAPEVING----KLYAGPEV 189
Query: 730 DIWSYGCLLLELLT 743
D+WS G +L +L
Sbjct: 190 DVWSCGIVLYVMLV 203
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 39/199 (19%), Positives = 69/199 (34%), Gaps = 59/199 (29%)
Query: 558 EVRMLGALRHSCIVEMY---GHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVK-- 610
E+++L LRH ++++ ++ K ++ MEY G +
Sbjct: 56 EIQLLRRLRHKNVIQLVDVLYNEEKQK-----------------MYMVMEYCVCGMQEML 98
Query: 611 NYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 670
+ + + K V A + L LHS+ I+H+DIK N+L+
Sbjct: 99 DSVPE------KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT----- 147
Query: 671 PVVKLCDF-----DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 725
+K+ T G+P + PE+ + +
Sbjct: 148 --LKISALGVAEALHPFAADDTCRTSQ-------------GSPAFQPPEIANGLD---TF 189
Query: 726 -GLEVDIWSYGCLLLELLT 743
G +VDIWS G L + T
Sbjct: 190 SGFKVDIWSAGVTLYNITT 208
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 47/213 (22%), Positives = 85/213 (39%), Gaps = 50/213 (23%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---- 613
E+ ++ L H+ ++++Y + + + L MEYV GG + + I
Sbjct: 136 EISVMNQLDHANLIQLYD---------AFESKNDIVL-----VMEYVDGGELFDRIIDES 181
Query: 614 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 673
L+E + + + + +H +I+H D+K ENIL + A +
Sbjct: 182 YNLTE--------LDTILFMKQICEGIRHMHQMYILHLDLKPENIL--CVNRDAK---QI 228
Query: 674 KLCDFDRAVPL--RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 731
K+ DF A R L GTP ++APEV+ + D+
Sbjct: 229 KIIDFGLARRYKPREKLKVNF-------------GTPEFLAPEVVN--YDF--VSFPTDM 271
Query: 732 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 764
WS G + LL+ P++G ++ E + I +
Sbjct: 272 WSVGVIAYMLLSGLSPFLGDNDAETLNNILACR 304
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 6e-17
Identities = 53/207 (25%), Positives = 82/207 (39%), Gaps = 57/207 (27%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYIEK 615
E+RML L+H +V + + + + EY +V + +++
Sbjct: 52 EIRMLKQLKHPNLVNLL--------------EVFRR--KRRLHLVFEYCDH-TVLHELDR 94
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
+H+ VK Q A+ H + +HRD+K ENILI V+KL
Sbjct: 95 YQRGVPEHL-VKS--ITWQ-TLQAVNFCHKHNCIHRDVKPENILIT-----KHS--VIKL 143
Query: 676 CDFD--RA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL-RAMHKPNLYGLEV 729
CDF R P + V T RW +PE+L YG V
Sbjct: 144 CDFGFARLLTGPSDYYDDE--------------VAT-RWYRSPELLVGDTQ----YGPPV 184
Query: 730 DIWSYGCLLLELLTLQVPYM-GLSELE 755
D+W+ GC+ ELL+ P G S+++
Sbjct: 185 DVWAIGCVFAELLSGV-PLWPGKSDVD 210
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-17
Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 45/203 (22%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
EV +L L+H I+E+ + HH + + EY + +K Y++K
Sbjct: 83 EVSLLKELQHRNIIEL--KSV------------IHHNHRLHLIFEYAEN-DLKKYMDKNP 127
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
+ + + F+ Q + + HS+ +HRD+K +N+L+ + V+K+ D
Sbjct: 128 DVSMRVI----KSFLYQ-LINGVNFCHSRRCLHRDLKPQNLLLSVSDASETP--VLKIGD 180
Query: 678 F--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIW 732
F RA +P+R F H + T W PE+L Y VDIW
Sbjct: 181 FGLARAFGIPIRQFTHE--------------IIT-LWYRPPEILLGSRH---YSTSVDIW 222
Query: 733 SYGCLLLELLTLQVPYMGLSELE 755
S C+ E+L + G SE++
Sbjct: 223 SIACIWAEMLMKTPLFPGDSEID 245
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 8e-17
Identities = 69/324 (21%), Positives = 112/324 (34%), Gaps = 104/324 (32%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 593
V+ LK + + E + E++M+ L H IV + G P
Sbjct: 80 VKMLKE-KADSSEREAL----MSELKMMTQLGSHENIVNLLGA--------CTLSGP--- 123
Query: 594 LLQSAIFMEYVKGGSVKNY------------------IEKLSETGEKHVSVKLALFIAQD 635
+ + EY G + NY E ++ + L A
Sbjct: 124 IY---LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 180
Query: 636 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 695
VA + L K +HRD+ + N+L+ + VVK+CDF A
Sbjct: 181 VAKGMEFLEFKSCVHRDLAARNVLVTHGK-------VVKICDFGLA-------------- 219
Query: 696 RGIPAPDVCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPY 748
R I + V P +WMAPE L +Y ++ D+WSYG LL E+ +L PY
Sbjct: 220 RDIMSDSNYVVRGNARLPVKWMAPESLFE----GIYTIKSDVWSYGILLWEIFSLGVNPY 275
Query: 749 MGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE---AELETLSFLV 804
G+ + + LIQ G + ++P E+
Sbjct: 276 PGIPVDANFYKLIQNGFK------------------------MDQPFYATEEIY------ 305
Query: 805 DVFRRCTEENPTERPTAGDLYEMF 828
+ + C + +RP+ +L
Sbjct: 306 IIMQSCWAFDSRKRPSFPNLTSFL 329
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 57/207 (27%)
Query: 558 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 615
E+++L LRH +V + K +L +F E+V ++ + +E
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYL---------------VF-EFVDH-TILDDLEL 116
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
+ V V+ ++ Q + + HS +I+HRDIK ENIL+ G VVKL
Sbjct: 117 FPNGLDYQV-VQK--YLFQ-IINGIGFCHSHNIIHRDIKPENILVS-----QSG--VVKL 165
Query: 676 CDF--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL-RAMHKPNLYGLEV 729
CDF R P + V T RW APE+L + YG V
Sbjct: 166 CDFGFARTLAAPGEVYDD--------------EVAT-RWYRAPELLVGDVK----YGKAV 206
Query: 730 DIWSYGCLLLELLTLQVPYM-GLSELE 755
D+W+ GCL+ E+ + P G S+++
Sbjct: 207 DVWAIGCLVTEMFMGE-PLFPGDSDID 232
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 48/206 (23%), Positives = 82/206 (39%), Gaps = 54/206 (26%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 615
E+ +L L+H IV ++ + H + E+ +K Y +
Sbjct: 51 EICLLKELKHKNIVRLH--------------DVLHS--DKKLTLVFEFCDQ-DLKKYFDS 93
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
+ + + VK F+ Q + L HS++++HRD+K +N+LI+ +G +KL
Sbjct: 94 CNGDLDPEI-VKS--FLFQ-LLKGLGFCHSRNVLHRDLKPQNLLIN-----RNG--ELKL 142
Query: 676 CDF--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVD 730
+F RA +P+R + V T W P+VL Y +D
Sbjct: 143 ANFGLARAFGIPVRCYSA--------------EVVT-LWYRPPDVLFGAKL---YSTSID 184
Query: 731 IWSYGCLLLELLTLQVPYM-GLSELE 755
+WS GC+ EL P G +
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 46/193 (23%), Positives = 84/193 (43%), Gaps = 40/193 (20%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E++++ ++H +V++ + + D E L + +EYV +V +
Sbjct: 82 ELQIMRIVKHPNVVDLKAF-----FYSNGDKKDEVFLN---LVLEYV-PETVYRASRHYA 132
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
+ + + + L++ Q + +L +HS I HRDIK +N+L+D V+KL D
Sbjct: 133 KLKQTMPMLLIKLYMYQ-LLRSLAYIHSIGICHRDIKPQNLLLDPP------SGVLKLID 185
Query: 678 FDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEV-LRAMHKPNLYGLEVDIW 732
F A + + +C R+ APE+ A + Y +DIW
Sbjct: 186 FGSAKILIAGEPNVS------------YICS---RYYRAPELIFGATN----YTTNIDIW 226
Query: 733 SYGCLLLELLTLQ 745
S GC++ EL+ Q
Sbjct: 227 STGCVMAELMQGQ 239
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 67/286 (23%), Positives = 111/286 (38%), Gaps = 67/286 (23%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E++++ +H +VE+ G S+DG+ L ++ Y+ GS+ + +
Sbjct: 80 EIKVMAKCQHENLVELLGF--------SSDGD--DLCL---VY-VYMPNGSLLDRL--SC 123
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
G +S + IAQ A + LH H +HRDIKS NIL+D K+ D
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD-----EAFTA--KISD 176
Query: 678 FD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735
F RA + + R + VGT +MAPE LR + + DI+S+G
Sbjct: 177 FGLARASEKFAQTV---MTSR------I-VGTTAYMAPEALRG----EIT-PKSDIYSFG 221
Query: 736 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE--LEA-----LGSCHEHEVAQSGS 788
+LLE++T E L+ + K +E +E + V
Sbjct: 222 VVLLEIITGLPAVD--EHREPQLLLDI-KEEIEDEEKTIEDYIDKKMNDADSTSVEA--- 275
Query: 789 GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 834
+ V +C E +RP + ++ T+S
Sbjct: 276 --------------MYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 37/151 (24%), Positives = 64/151 (42%), Gaps = 30/151 (19%)
Query: 598 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657
A+ E+V K + L++ + ++ + + AL HS IMHRD+K N
Sbjct: 109 ALVFEHVNNTDFKQLYQTLTD---YDI----RFYMYE-ILKALDYCHSMGIMHRDVKPHN 160
Query: 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL 716
++ID E +K ++L D+ A + R V + R+ PE+L
Sbjct: 161 VMIDHEHRK------LRLIDWGLA---EFYHPGQEYNVR--------VAS-RYFKGPELL 202
Query: 717 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 747
Y +D+WS GC+L ++ + P
Sbjct: 203 VDYQM---YDYSLDMWSLGCMLASMIFRKEP 230
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-15
Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 46/206 (22%)
Query: 548 IRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG 607
+ + E++++ L H IV + + S + E +L + ++YV
Sbjct: 87 VLQDKRFKNRELQIMRKLDHCNIVRLRYF-----FYSSGEKKDEVYL---NLVLDYV-PE 137
Query: 608 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667
+V S + + + L++ Q + +L +HS I HRDIK +N+L+D +
Sbjct: 138 TVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSLAYIHSFGICHRDIKPQNLLLDPD---- 192
Query: 668 DGKPVVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEV-LRAM 719
V+KLCDF R P S+ +C R+ APE+ A
Sbjct: 193 --TAVLKLCDFGSAKQLVRGEPNVSY---------------ICS---RYYRAPELIFGAT 232
Query: 720 HKPNLYGLEVDIWSYGCLLLELLTLQ 745
Y +D+WS GC+L ELL Q
Sbjct: 233 D----YTSSIDVWSAGCVLAELLLGQ 254
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 5e-15
Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 49/203 (24%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+ +L L+HS IV++Y + H + + E++ +K ++
Sbjct: 50 EISILKELKHSNIVKLY--------------DVIHTKKRLVLVFEHLDQ-DLKKLLDVCE 94
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
E K F+ Q + + H + ++HRD+K +N+LI+ +G +K+ D
Sbjct: 95 GGLESVT-AKS--FLLQ-LLNGIAYCHDRRVLHRDLKPQNLLIN-----REG--ELKIAD 143
Query: 678 F--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIW 732
F RA +P+R + H + T W AP+VL K Y +DIW
Sbjct: 144 FGLARAFGIPVRKYTH--------------EIVT-LWYRAPDVLMGSKK---YSTTIDIW 185
Query: 733 SYGCLLLELLTLQVPYMGLSELE 755
S GC+ E++ + G+SE +
Sbjct: 186 SVGCIFAEMVNGTPLFPGVSEAD 208
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 53/205 (25%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 615
E+ +L L H IV + + H + + E+++ +K +++
Sbjct: 69 EISLLKELHHPNIVSLI--------------DVIHS--ERCLTLVFEFMEK-DLKKVLDE 111
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
+ +K+ ++ Q + + H I+HRD+K +N+LI+ +DG +KL
Sbjct: 112 NKTGLQDSQ-IKI--YLYQ-LLRGVAHCHQHRILHRDLKPQNLLIN-----SDG--ALKL 160
Query: 676 CDF--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVD 730
DF RA +P+RS+ H V T W AP+VL K Y VD
Sbjct: 161 ADFGLARAFGIPVRSYTH--------------EVVT-LWYRAPDVLMGSKK---YSTSVD 202
Query: 731 IWSYGCLLLELLTLQVPYMGLSELE 755
IWS GC+ E++T + + G+++ +
Sbjct: 203 IWSIGCIFAEMITGKPLFPGVTDDD 227
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 45/126 (35%), Positives = 65/126 (51%), Gaps = 38/126 (30%)
Query: 639 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFD--RA--VPLRSFLHTCCIA 694
L LH I+HRD+K N+L+D +G V+KL DF ++ P R++ H
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLD-----ENG--VLKLADFGLAKSFGSPNRAYTH----- 171
Query: 695 HRGIPAPDVCVGTPRWM-APEVL---RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM- 749
V T RW APE+L R YG+ VD+W+ GC+L ELL +VP++
Sbjct: 172 ---------QVVT-RWYRAPELLFGARM------YGVGVDMWAVGCILAELLL-RVPFLP 214
Query: 750 GLSELE 755
G S+L+
Sbjct: 215 GDSDLD 220
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 48/164 (29%), Positives = 67/164 (40%), Gaps = 44/164 (26%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
E+V ++ Y++K G ++K + Q L LH+ I+HRD+K ENIL+
Sbjct: 98 FEHVDQ-DLRTYLDKAPPPGLPAETIKD--LMRQ-FLRGLDFLHANCIVHRDLKPENILV 153
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP----RWM-APEV 715
+ G VKL DF A R + TP W APEV
Sbjct: 154 T-----SGG--TVKLADFGLA---RIY---------SYQMA----LTPVVVTLWYRAPEV 190
Query: 716 LRAMHKPNL---YGLEVDIWSYGCLLLELLTLQVPYM-GLSELE 755
L L Y VD+WS GC+ E+ + P G SE +
Sbjct: 191 L-------LQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEAD 226
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 51/203 (25%), Positives = 85/203 (41%), Gaps = 49/203 (24%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
EV +L L+H+ IV + H I H + EY+ +K Y++
Sbjct: 50 EVSLLKDLKHANIVTL--HDI------------IHTEKSLTLVFEYLDK-DLKQYLDDCG 94
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
H VKL F+ Q + L H + ++HRD+K +N+LI+ G +KL D
Sbjct: 95 NIINMHN-VKL--FLFQ-LLRGLAYCHRQKVLHRDLKPQNLLIN-----ERG--ELKLAD 143
Query: 678 F--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIW 732
F RA +P +++ + V T W P++L Y ++D+W
Sbjct: 144 FGLARAKSIPTKTYDN--------------EVVT-LWYRPPDILLGSTD---YSTQIDMW 185
Query: 733 SYGCLLLELLTLQVPYMGLSELE 755
GC+ E+ T + + G + E
Sbjct: 186 GVGCIFYEMATGRPLFPGSTVEE 208
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 54/216 (25%), Positives = 86/216 (39%), Gaps = 56/216 (25%)
Query: 548 IRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG 607
IR E + L R L H +V + + + + E L + E+V
Sbjct: 59 IR--EVAVL---RHLETFEHPNVVRL--FDV----CTVSRTDRETKLT---LVFEHVDQ- 103
Query: 608 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667
+ Y++K+ E G ++K + Q + L LHS ++HRD+K +NIL+ +
Sbjct: 104 DLTTYLDKVPEPGVPTETIKD--MMFQ-LLRGLDFLHSHRVVHRDLKPQNILVT-----S 155
Query: 668 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP----RWM-APEVLRAMHKP 722
G +KL DF A R + T W APEVL
Sbjct: 156 SG--QIKLADFGLA---RIY---------SFQMA----LTSVVVTLWYRAPEVL------ 191
Query: 723 NL---YGLEVDIWSYGCLLLELLTLQVPYMGLSELE 755
L Y VD+WS GC+ E+ + + G S+++
Sbjct: 192 -LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 226
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 52/207 (25%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+ ++ L+H IV + + + H + + E++ +K Y++ +
Sbjct: 53 EISLMKELKHENIVRL--YDV------------IHTENKLTLVFEFMDN-DLKKYMDSRT 97
Query: 618 ETGEKH----VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 673
VK F Q + L H I+HRD+K +N+LI+ G +
Sbjct: 98 VGNTPRGLELNLVKY--FQWQ-LLQGLAFCHENKILHRDLKPQNLLIN-----KRG--QL 147
Query: 674 KLCDF--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLE 728
KL DF RA +P+ +F V T W AP+VL Y
Sbjct: 148 KLGDFGLARAFGIPVNTFSS--------------EVVT-LWYRAPDVLMGSRT---YSTS 189
Query: 729 VDIWSYGCLLLELLTLQVPYMGLSELE 755
+DIWS GC+L E++T + + G ++ E
Sbjct: 190 IDIWSCGCILAEMITGKPLFPGTNDEE 216
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-14
Identities = 51/212 (24%), Positives = 84/212 (39%), Gaps = 55/212 (25%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK---GGSVKNYIE 614
E+++L L+H +V + +K P +L+ ++ + G + N +
Sbjct: 66 EIKILQLLKHENVVNLIE-ICRTKASPYNRCKGSIYLV-----FDFCEHDLAGLLSNVLV 119
Query: 615 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 674
K + + K + + L +H I+HRD+K+ N+LI DG V+K
Sbjct: 120 KFTLSEIKR-------VMQM-LLNGLYYIHRNKILHRDMKAANVLIT-----RDG--VLK 164
Query: 675 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG-TPR----WM-APEVLRAMHKPNL---- 724
L DF A R+F + T R W PE+L L
Sbjct: 165 LADFGLA---RAF---------SLAKNSQPNRYTNRVVTLWYRPPELL-------LGERD 205
Query: 725 YGLEVDIWSYGCLLLELLTLQVPYM-GLSELE 755
YG +D+W GC++ E+ T P M G +E
Sbjct: 206 YGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQH 236
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 5e-14
Identities = 51/229 (22%), Positives = 85/229 (37%), Gaps = 60/229 (26%)
Query: 608 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667
S E + + ++++ + + VA + L S+ +HRD+ + NIL+ +
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN--- 230
Query: 668 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT-----P-RWMAPEVLRAMHK 721
VVK+CDF A R I V P +WMAPE +
Sbjct: 231 ----VVKICDFGLA--------------RDIYKDPDYVRKGDARLPLKWMAPETIFD--- 269
Query: 722 PNLYGLEVDIWSYGCLLLELLTL-QVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCH 779
+Y ++ D+WS+G LL E+ +L PY G+ + E ++ G R + A
Sbjct: 270 -RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR------MRAPDYTT 322
Query: 780 EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
+ C P++RPT +L E
Sbjct: 323 PE---------------------MYQTMLDCWHGEPSQRPTFSELVEHL 350
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 53/241 (21%), Positives = 82/241 (34%), Gaps = 53/241 (21%)
Query: 614 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 673
E + + + S+ L A + L LH I+H D+K ENIL+ K G+ +
Sbjct: 187 ELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL-----KQQGRSGI 241
Query: 674 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 733
K+ DF + ++T I R AP+V +G YG+ +D+WS
Sbjct: 242 KVIDFGSSCYEHQRVYT-YIQSRFYRAPEVILGAR----------------YGMPIDMWS 284
Query: 734 YGCLLLELLTLQVPYMGLSELEI------------HDLIQMGKRPRLTDELEALGSCHEH 781
GC+L ELLT G E + L+ KR + +
Sbjct: 285 LGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTV 344
Query: 782 EVAQSGSGFEKP-------------------EAELETLSFLVDVFRRCTEENPTERPTAG 822
GS + +D ++C E +P R T G
Sbjct: 345 TTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404
Query: 823 D 823
Sbjct: 405 Q 405
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 8e-14
Identities = 47/251 (18%), Positives = 84/251 (33%), Gaps = 66/251 (26%)
Query: 614 EKLSETGEKHVSVKLALFIAQDVAAALVELHSK--HIMHRDIKSENILIDLERKKADGKP 671
+ L T + VS+ L AQ + AL+ L + I+H D+K ENIL+ +
Sbjct: 144 DLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL-----CNPKRS 198
Query: 672 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 731
+K+ DF + L ++ I R +P+V +G P Y L +D+
Sbjct: 199 AIKIVDFGSSCQLGQRIYQY-IQSRFYRSPEVLLGMP----------------YDLAIDM 241
Query: 732 WSYGCLLLELLTLQVPYMGLSELEI------------HDLIQMGKR-------------- 765
WS GC+L+E+ T + + G +E++ ++ +
Sbjct: 242 WSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWN 301
Query: 766 -------------PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 812
P LG + + + D+ R +
Sbjct: 302 LKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAG---ESGHTVADYLKFKDLILRMLD 358
Query: 813 ENPTERPTAGD 823
+P R
Sbjct: 359 YDPKTRIQPYY 369
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 57/288 (19%), Positives = 99/288 (34%), Gaps = 67/288 (23%)
Query: 556 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 615
L ++ L L H IV++ + + +L + MEYV ++
Sbjct: 67 LQIMQDLAVLHHPNIVQLQ-SYFYT---LGERDRRDIYL---NVVMEYV-PDTLHRCCRN 118
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELH--SKHIMHRDIKSENILIDLERKKADGKPVV 673
+ + +F+ Q + ++ LH S ++ HRDIK N+L++ +ADG +
Sbjct: 119 YYRRQVAPPPILIKVFLFQ-LIRSIGCLHLPSVNVCHRDIKPHNVLVN----EADG--TL 171
Query: 674 KLCDFDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEV-LRAMHKPNLYGLE 728
KLCDF A P + C + R+ APE+ H Y
Sbjct: 172 KLCDFGSAKKLSPSEPNVAYIC--------------S-RYYRAPELIFGNQH----YTTA 212
Query: 729 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 788
VDIWS GC+ E++ + + G + I + LG + +
Sbjct: 213 VDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI-----------VRVLGCPSREVLRKLNP 261
Query: 789 G-------------FEK--PEAELETLSFLVDVFRRCTEENPTERPTA 821
+ + L+ D+ + P ER
Sbjct: 262 SHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP 309
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 27/195 (13%), Positives = 43/195 (22%), Gaps = 73/195 (37%)
Query: 558 EVRMLGALRHSCIVEMY--GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 615
L + + + H + E+++GGS
Sbjct: 81 RTLRLSRIDKPGVARVLDVVH---------TRAGG-------LVVAEWIRGGS------- 117
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
L E + S A+ Q +AAA H + + + DG V
Sbjct: 118 LQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS-----IDGDVV--- 169
Query: 676 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735
+ P M + DI G
Sbjct: 170 -----------------------------LAYPATMPDANPQD-----------DIRGIG 189
Query: 736 CLLLELLTLQVPYMG 750
L LL + P
Sbjct: 190 ASLYALLVNRWPLPE 204
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 53/318 (16%), Positives = 110/318 (34%), Gaps = 85/318 (26%)
Query: 548 IRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA--------- 598
+ E+ ++ L H I+++ + ++ P +
Sbjct: 40 VLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNH 99
Query: 599 ---------------IFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAA 639
+ MEYV ++ ++ +G +S ++I Q + A
Sbjct: 100 HKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLIS----IYIYQ-LFRA 153
Query: 640 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA---VPLRSFLHTCCIAHR 696
+ +HS I HRDIK +N+L++ + D +KLCDF A +P + C
Sbjct: 154 VGFIHSLGICHRDIKPQNLLVNSK----DN--TLKLCDFGSAKKLIPSEPSVAYIC---- 203
Query: 697 GIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 755
+ R+ APE+ M Y +D+WS GC+ EL+ + + G + ++
Sbjct: 204 ----------S-RFYRAPEL---MLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSID 249
Query: 756 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF------EKPEAELETL------SFL 803
I ++ +G+ + ++ + + + + S
Sbjct: 250 QLVRI-----------IQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298
Query: 804 VDVFRRCTEENPTERPTA 821
+D+ + P R
Sbjct: 299 IDLLEQILRYEPDLRINP 316
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 49/192 (25%), Positives = 77/192 (40%), Gaps = 32/192 (16%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 702
LH +++HRD+K N+LI+ ++ +K+CDF A R +
Sbjct: 128 LHGSNVIHRDLKPSNLLIN-----SNCD--LKVCDFGLA---RIIDESAADNSEPTGQQS 177
Query: 703 VC---VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 758
V T RW APEV+ K Y +D+WS GC+L EL + + G
Sbjct: 178 GMVEFVAT-RWYRAPEVMLTSAK---YSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233
Query: 759 LI--QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-------PEAELETLSFLVDVFRR 809
LI +G P ++L + S E +S + P + + L +R
Sbjct: 234 LIFGIIGT-PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLL----QR 288
Query: 810 CTEENPTERPTA 821
+P +R TA
Sbjct: 289 MLVFDPAKRITA 300
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 38/168 (22%), Positives = 63/168 (37%), Gaps = 47/168 (27%)
Query: 601 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660
ME + GG + ++ + G++ + + A I + + A+ LHS +I HRD+K EN+L
Sbjct: 94 MECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL- 149
Query: 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720
K+ + +KL DF G A E
Sbjct: 150 -YTSKRPNAI--LKLTDF------------------GF-------------AKETTG--- 172
Query: 721 KPNLYGLEVDIWSYGCLLLELLTLQVPYMG----LSELEIHDLIQMGK 764
Y D+WS G ++ LL P+ + I+MG+
Sbjct: 173 --EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 218
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 41/209 (19%), Positives = 71/209 (33%), Gaps = 64/209 (30%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 702
LHS I+HRD+K NI++ +D +K+ DF A R
Sbjct: 143 LHSAGIIHRDLKPSNIVVK-----SDCT--LKILDFGLA--------------RTAGTSF 181
Query: 703 VC---VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 758
+ V T R+ APEV+ M Y VDIWS GC++ E++ V + G ++ +
Sbjct: 182 MMTPYVVT-RYYRAPEVILGMG----YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 236
Query: 759 LI------------------------QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 794
+ K + E L + + +
Sbjct: 237 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYS--FEKLFPDVLFPADSEHNKLKASQ 294
Query: 795 AELETLSFLVDVFRRCTEENPTERPTAGD 823
A D+ + + ++R + +
Sbjct: 295 A--------RDLLSKMLVIDASKRISVDE 315
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 36/237 (15%), Positives = 66/237 (27%), Gaps = 71/237 (29%)
Query: 632 IAQDVAAALVELHSKHIMHRDIKSENILI------------------DLERKKADGKPVV 673
++ AL L + H D+K ENIL+ + +
Sbjct: 142 YCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 674 KLCDFDRAVPLRSFLHTCCIAHRGIP---------APDVCVGTPRWMAPEVLRAMHKPNL 724
KL DF A AP+V +
Sbjct: 202 KLIDFGCA----------TFKSDYHGSIINTRQYRAPEVILNLG---------------- 235
Query: 725 YGLEVDIWSYGCLLLELLTLQVPYMGLSELEI------------HDLIQMGKRPR----L 768
+ + D+WS+GC+L EL T + + +E +++ + +
Sbjct: 236 WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYV 295
Query: 769 TDELEALGSCHEHEVAQSGSGFE--KPEAELETLSFLVDVFRRCTEENPTERPTAGD 823
+ L S + P ++ D + +PT RP+ +
Sbjct: 296 NKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAE 352
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 58/278 (20%), Positives = 101/278 (36%), Gaps = 69/278 (24%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+ L RH +V + G + N +L I+ +Y++ G++K ++ S
Sbjct: 85 EIETLSFCRHPHLVSLIGF--------CDERN--EMIL---IY-KYMENGNLKRHLYG-S 129
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
+ +S + L I A L LH++ I+HRD+KS NIL+ D V K+ D
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL-------DENFVPKITD 182
Query: 678 FD--RAVPLRSFLH--TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV--DI 731
F + H T V GT ++ PE L D+
Sbjct: 183 FGISKKGTELDQTHLST------------VVKGTLGYIDPEYFIKGR------LTEKSDV 224
Query: 732 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL------GSCHEHEVAQ 785
+S+G +L E+L + + E+ +L + +LE + + +
Sbjct: 225 YSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRK 284
Query: 786 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823
D +C + +RP+ GD
Sbjct: 285 -----------------FGDTAVKCLALSSEDRPSMGD 305
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 33/112 (29%), Positives = 48/112 (42%), Gaps = 21/112 (18%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPA 700
LHS ++HRD+K NIL++ A+ VK+ DF R+ +
Sbjct: 125 LHSGGLLHRDMKPSNILLN-----AECH--VKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 701 PDVCVGTP--------RWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743
+ P RW APE+L K Y +D+WS GC+L E+L
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTK---YTKGIDMWSLGCILGEILC 226
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 46/200 (23%), Positives = 77/200 (38%), Gaps = 56/200 (28%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 702
+HS +++HRD+K N+ I+ E +K+ DF A R +
Sbjct: 136 IHSANVLHRDLKPANLFINTEDLV------LKIGDFGLA--------------RIMDPHY 175
Query: 703 VC-------VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 754
+ T +W +P +L + + Y +D+W+ GC+ E+LT + + G EL
Sbjct: 176 SHKGHLSEGLVT-KWYRSPRLLLSPNN---YTKAIDMWAAGCIFAEMLTGKTLFAGAHEL 231
Query: 755 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF--------EKPEAELETL-----S 801
E LI LE++ HE + + S +P L L
Sbjct: 232 EQMQLI-----------LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISR 280
Query: 802 FLVDVFRRCTEENPTERPTA 821
VD + +P +R TA
Sbjct: 281 EAVDFLEQILTFSPMDRLTA 300
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 43/224 (19%), Positives = 73/224 (32%), Gaps = 53/224 (23%)
Query: 632 IAQDVAAALVELHSKHIMHRDIKSENILI------------DLERKKADGKPVVKLCDFD 679
+A + AL LH + H D+K ENIL +K+ +++ DF
Sbjct: 128 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 680 RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739
A HT +A R P+V + + D+WS GC+L
Sbjct: 188 SATFDHEH-HTTIVATRHYRPPEVILELG----------------WAQPCDVWSIGCILF 230
Query: 740 ELLTLQVPYMGLSELEI------------HDLIQMGKRPRLTDELEALGSCHEHEVAQSG 787
E + E +I ++ + + G E + G
Sbjct: 231 EYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYK----GGLVWDENSSDG 286
Query: 788 SGFEKPEAELETL--------SFLVDVFRRCTEENPTERPTAGD 823
++ L++ L D+ RR E +P +R T +
Sbjct: 287 RYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 40/224 (17%), Positives = 73/224 (32%), Gaps = 53/224 (23%)
Query: 632 IAQDVAAALVELHSKHIMHRDIKSENILI------------DLERKKADGKPVVKLCDFD 679
+A + ++ LHS + H D+K ENIL ++ P +K+ DF
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 680 RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739
A T ++ R AP+V + + D+WS GC+L+
Sbjct: 183 SATYDDEHHST-LVSTRHYRAPEVILALG----------------WSQPCDVWSIGCILI 225
Query: 740 ELLTLQVPYMGLSELEI------------HDLIQMGKRPRLTDELEALGSCHEHEVAQSG 787
E + E +IQ ++ + E + +G
Sbjct: 226 EYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHH----DRLDWDEHSSAG 281
Query: 788 SGFEKPEAELETL--------SFLVDVFRRCTEENPTERPTAGD 823
+ L+ L D+ ++ E +P +R T +
Sbjct: 282 RYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 46/197 (23%), Positives = 75/197 (38%), Gaps = 52/197 (26%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 702
+HS ++HRD+K N+ ++ D + +K+ DF A R +
Sbjct: 142 IHSAGVVHRDLKPGNLAVN-----EDCE--LKILDFGLA--------------RHA-DAE 179
Query: 703 VC--VGTPRW-MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 759
+ V T RW APEV+ + Y VDIWS GC++ E+LT + + G L+
Sbjct: 180 MTGYVVT-RWYRAPEVILSWMH---YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ 235
Query: 760 I--QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-----------PEAELETLSFLVDV 806
I G + ++ L QS + P+A D+
Sbjct: 236 ILKVTGVPGT--EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQA--------ADL 285
Query: 807 FRRCTEENPTERPTAGD 823
+ E + +R TA
Sbjct: 286 LEKMLELDVDKRLTAAQ 302
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 43/209 (20%), Positives = 72/209 (34%), Gaps = 64/209 (30%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 702
LHS I+HRD+K NI++ +D +K+ DF A R
Sbjct: 180 LHSAGIIHRDLKPSNIVVK-----SDCT--LKILDFGLA--------------RTAGTSF 218
Query: 703 VC---VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 758
+ V T R+ APEV+ M Y VDIWS GC++ E++ ++ + G ++ +
Sbjct: 219 MMTPYVVT-RYYRAPEVILGMG----YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 273
Query: 759 LI------------------------QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 794
+ K LT L + + +
Sbjct: 274 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLT--FPKLFPDSLFPADSEHNKLKASQ 331
Query: 795 AELETLSFLVDVFRRCTEENPTERPTAGD 823
A D+ + +P +R + D
Sbjct: 332 A--------RDLLSKMLVIDPAKRISVDD 352
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 48/195 (24%), Positives = 75/195 (38%), Gaps = 48/195 (24%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 702
+HS I+HRD+K N+ ++ D + +K+ DF A +
Sbjct: 148 IHSADIIHRDLKPSNLAVN-----EDCE--LKILDFGLARHTADEM-------------T 187
Query: 703 VCVGTPRW-MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI- 760
V T RW APE++ Y VDIWS GC++ ELLT + + G ++ LI
Sbjct: 188 GYVAT-RWYRAPEIMLNWMH---YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 243
Query: 761 -QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-----------PEAELETLSFLVDVFR 808
+G + L+ + S QS + K P A VD+
Sbjct: 244 RLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLA--------VDLLE 293
Query: 809 RCTEENPTERPTAGD 823
+ + +R TA
Sbjct: 294 KMLVLDSDKRITAAQ 308
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 47/195 (24%), Positives = 77/195 (39%), Gaps = 48/195 (24%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 702
+H+ I+HRD+K N+ ++ D + +K+ DF A S +
Sbjct: 144 IHAAGIIHRDLKPGNLAVN-----EDCE--LKILDFGLARQADSEMTG------------ 184
Query: 703 VCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI- 760
V T RW APEV+ + Y VDIWS GC++ E++T + + G L+ I
Sbjct: 185 -YVVT-RWYRAPEVILNWMR---YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 239
Query: 761 -QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-----------PEAELETLSFLVDVFR 808
G P + ++ L S + EK P A V++
Sbjct: 240 KVTGTPPA--EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLA--------VNLLE 289
Query: 809 RCTEENPTERPTAGD 823
+ + +R TAG+
Sbjct: 290 KMLVLDAEQRVTAGE 304
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 28/117 (23%), Positives = 43/117 (36%), Gaps = 22/117 (18%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPA 700
+H I+HRD+K N L++ D VK+CDF R + +
Sbjct: 145 IHESGIIHRDLKPANCLLN-----QDCS--VKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 701 PDVCVGTPRWM----------APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 747
+ + APE++ Y +DIWS GC+ ELL +
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQEN---YTKSIDIWSTGCIFAELLNMLQS 251
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 45/232 (19%), Positives = 72/232 (31%), Gaps = 65/232 (28%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPA 700
+HS I+HRD+K N L++ D VK+CDF R V ++
Sbjct: 172 VHSAGILHRDLKPANCLVN-----QDCS--VKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 701 PDVCVGTP--------------RWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 745
++ RW APE++ Y +D+WS GC+ ELL +
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN---YTEAIDVWSIGCIFAELLNMI 281
Query: 746 VP----------------YMGLSELEIHDLIQMGKRPRLTDEL----EALGSCHEHEVAQ 785
LS + D+L LG+ E ++
Sbjct: 282 KENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEA 341
Query: 786 SGSGFEKPEAELETLSF-----LVDVFRRCTEE-----------NPTERPTA 821
E + + L + F + + NP +R T
Sbjct: 342 LEK--EDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITI 391
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 27/105 (25%), Positives = 42/105 (40%), Gaps = 29/105 (27%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 702
LH ++HRD+ NIL+ + + +CDF+ A R A
Sbjct: 150 LHEAGVVHRDLHPGNILLA-----DNND--ITICDFNLA--------------REDTADA 188
Query: 703 VC---VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743
V RW APE++ + VD+WS GC++ E+
Sbjct: 189 NKTHYVTH-RWYRAPELVMQFKG---FTKLVDMWSAGCVMAEMFN 229
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 45/226 (19%), Positives = 74/226 (32%), Gaps = 49/226 (21%)
Query: 625 SVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 683
+ I++ + L +H + I+H DIK EN+L+++ + +K+ D A
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV-DSPENLIQIKIADLGNA-- 185
Query: 684 LRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743
C + T + +PEVL +G DIWS CL+ EL+T
Sbjct: 186 --------CWYDEHYTNS---IQTREYRSPEVLLGAP----WGCGADIWSTACLIFELIT 230
Query: 744 LQVPYMGLSELEI------------------HDLIQMGKRPRL--TDELEALGSCHE--- 780
+ L++ GK R
Sbjct: 231 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 290
Query: 781 --HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 824
+V F K EA+ + D + +P +R AG L
Sbjct: 291 PLEDVLTEKYKFSKDEAKE-----ISDFLSPMLQLDPRKRADAGGL 331
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 45/196 (22%), Positives = 75/196 (38%), Gaps = 48/196 (24%)
Query: 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 702
+HS +++HRD+K N+L++ +K+CDF A R
Sbjct: 144 IHSANVLHRDLKPSNLLLN-----TTCD--LKICDFGLA--------------RVADPDH 182
Query: 703 VC-------VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 754
V T RW APE++ Y +DIWS GC+L E+L+ + + G L
Sbjct: 183 DHTGFLTEYVAT-RWYRAPEIMLNSKG---YTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238
Query: 755 EIHDLI--QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-------PEAELETLSFLVD 805
+ + I +G + ++L + + S K P A+ + L L
Sbjct: 239 DQLNHILGILGSPSQ--EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLL-- 294
Query: 806 VFRRCTEENPTERPTA 821
+ NP +R
Sbjct: 295 --DKMLTFNPHKRIEV 308
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 50/254 (19%), Positives = 72/254 (28%), Gaps = 64/254 (25%)
Query: 628 LALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLE-----------------RKKADG 669
I Q V L LH+K I+H DIK ENIL+ +
Sbjct: 147 CVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 670 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV------------CVGTPRWMAPEVLR 717
V L + L + D+ + T ++ + EVL
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLI 266
Query: 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD----LIQM----GKRP--- 766
Y DIWS C+ EL T + S E + + GK P
Sbjct: 267 GSG----YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322
Query: 767 ----RLTDE----------LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 812
+ + E + L EV + + EA D E
Sbjct: 323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG-----FTDFLLPMLE 377
Query: 813 ENPTERPTAGDLYE 826
P +R TA +
Sbjct: 378 LIPEKRATAAECLR 391
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 39/168 (23%), Positives = 67/168 (39%), Gaps = 24/168 (14%)
Query: 614 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 673
E L + + SVK A+ + A + +H K +++RDIK +N LI K +
Sbjct: 93 EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANM--I 150
Query: 674 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC--VGTPRWMAPEVLRAMHKPNLYGLEV-- 729
+ DF + + H IP + GT R+M+ H G E
Sbjct: 151 YVVDFGMV---KFYRDPVTKQH--IPYREKKNLSGTARYMS----INTHL----GREQSR 197
Query: 730 --DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 772
D+ + G + + L +P+ GL + + ++ I K+ EL
Sbjct: 198 RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 245
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 39/169 (23%), Positives = 72/169 (42%), Gaps = 28/169 (16%)
Query: 614 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 673
E L + S+K L +A + + + +HSK+ +HRD+K +N L+ L +K +V
Sbjct: 92 EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKK----GNLV 147
Query: 674 KLCDFDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV- 729
+ DF A R+ H ++ + GT R+ + H G+E
Sbjct: 148 YIIDFGLAKKYRDARTHQHIPYRENKNL------TGTARYAS----INTHL----GIEQS 193
Query: 730 ---DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 772
D+ S G +L+ +P+ GL ++ + ++ I K + L
Sbjct: 194 RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 5e-09
Identities = 74/314 (23%), Positives = 113/314 (35%), Gaps = 88/314 (28%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+ LK + E F EV M+ H ++ + G L
Sbjct: 59 VKRLKEERTQGGE-LQF----QTEVEMISMAVHRNLLRLRGF--------CMTPT--ERL 103
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHR 651
L ++ Y+ GSV + + + E + + IA A L LH I+HR
Sbjct: 104 L---VY-PYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHR 158
Query: 652 DIKSENILID--LERKKAD-GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 708
D+K+ NIL+D E D G + KL D+ + + T V GT
Sbjct: 159 DVKAANILLDEEFEAVVGDFG--LAKLMDYK-----DTHVTT-----------AV-RGTI 199
Query: 709 RWMAPEVLRAMH-----KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD----- 758
+APE K D++ YG +LLEL+T Q + D
Sbjct: 200 GHIAPEY--LSTGKSSEK-------TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 759 ----LIQMGKRPRLTD-ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 813
L++ K L D +L+ G+ + EV Q L+ V CT+
Sbjct: 251 WVKGLLKEKKLEALVDVDLQ--GNYKDEEVEQ-----------------LIQVALLCTQS 291
Query: 814 NPTERPTAGDLYEM 827
+P ERP ++ M
Sbjct: 292 SPMERPKMSEVVRM 305
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 3e-08
Identities = 92/647 (14%), Positives = 172/647 (26%), Gaps = 209/647 (32%)
Query: 92 LDALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAG 151
D S EE II D L LF
Sbjct: 39 QDMPKSILSKEEIDHIIMSKDAVSGTL--------RLFWT-------------------- 70
Query: 152 LESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKS 211
L S +E + + K + + +
Sbjct: 71 LLSKQEEMVQK----------FVEEVLRINYKFLMSPIKTEQR-----QPSMMTRMYIEQ 115
Query: 212 RKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTG--YEQTPHLDSREVIL 269
R + N +Q ++ Y+ R +P+++L E P + +L
Sbjct: 116 RDRL---YNDNQVFAK--------------YNVSRLQPYLKLRQALLELRPA----KNVL 154
Query: 270 VDR-----KSDEELDAIALSAQALV---------LHLKQLNGLTKDGVIEPVDNLQIALL 315
+D K+ + + + L+LK N + + V+E + L
Sbjct: 155 IDGVLGSGKT--WVALDVCLSYKVQCKMDFKIFWLNLKNCN--SPETVLEMLQKL----- 205
Query: 316 LALFVSDHFGGSDRSG--------IVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQ 367
L + SD S I R+ + Y +
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL----------------- 248
Query: 368 ILDAVEDI-VLS--DL-C-------EKSLRSIKSKRNSVVVPIGSVQFGVCRH--RAVLL 414
+L V++ + +L C K + S + + + + +++LL
Sbjct: 249 VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL 308
Query: 415 KYLCDRVE--PPVPC-----------ELVRGYLD-FQPHAWNTILVKKGDSWIRMIVDAC 460
KYL R + P E +R L + W + K + I ++
Sbjct: 309 KYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDN--WKHVNCDKLTTIIESSLNVL 366
Query: 461 RPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDE--AGKSVS 518
P + R+ ++ ++ F S H P L F + S K
Sbjct: 367 EPAEYRK------------MFDRLSVFP-PSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413
Query: 519 SSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 578
SL + K T+ + + E + H IV+ Y I
Sbjct: 414 YSL-------VEKQPKESTISI----PSIYLELKVKLENEYAL-----HRSIVDHY--NI 455
Query: 579 SSKWLPSADGNPE----------HHLLQ----------SAIFMEYVKGGSVKNYIE-KLS 617
+ P HHL +F+++ ++E K+
Sbjct: 456 PKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDF-------RFLEQKIR 508
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 664
+ L Q ++ + +I D K E ++ +
Sbjct: 509 HDSTAWNASGSILNTLQQ-----LKFYKPYICDNDPKYERLVNAILD 550
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 2e-05
Identities = 69/519 (13%), Positives = 139/519 (26%), Gaps = 179/519 (34%)
Query: 275 DEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVE 334
D E + ++ + + + V ++ ++L + D V
Sbjct: 8 DFETGEHQYQYKDILSVFED--AFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDA---VS 62
Query: 335 RTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSD---LCEKSLRSIKSK 391
T + F S + VE+++ + L IK++
Sbjct: 63 GTLRL---------FWTLLSKQEE--------MVQKFVEEVLRINYKFLMSP----IKTE 101
Query: 392 RNSVVVPIGSVQFGVCRHRA-----VLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILV 446
+ + + + R R V KY R++P + +L + L+ +P +L+
Sbjct: 102 QRQPSMM--TRMYIEQRDRLYNDNQVFAKYNVSRLQPYL--KLRQALLELRPAKN--VLI 155
Query: 447 K----KGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAP---------FSTESDH 493
G +W + +D C + ++ + D + F ++ L +P + D
Sbjct: 156 DGVLGSGKTW--VALDVCLSYKVQCKMDFKIF--WLNLKNCNSPETVLEMLQKLLYQIDP 211
Query: 494 SPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTL----KVCGSSADEIR 549
+ S D S L + ++ L + K L V +A
Sbjct: 212 NWTSRSDHSSNIKLRI--HSIQAELRRLLKSK-------PYENCLLVLLNVQ--NAKAWN 260
Query: 550 NFEYSCLGEVRML--------------GALRHSCIVEM-------YGHKISSKW------ 582
F SC ++L H + + K+
Sbjct: 261 AFNLSC----KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQ 316
Query: 583 -LPS--ADGNPEHHLLQSAIFMEYVKGG-----------------SVKNYIEKLSETGEK 622
LP NP + +I E ++ G +++ + L +
Sbjct: 317 DLPREVLTTNP----RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR 372
Query: 623 HVSVKLALF-----I----------------AQDVAAALV-------------------- 641
+ +L++F I V L
Sbjct: 373 KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY 432
Query: 642 -----------ELHSKHIMHRDIKSENILIDLERKKADG 669
LH + H +I DL D
Sbjct: 433 LELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQ 471
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 2e-04
Identities = 79/483 (16%), Positives = 142/483 (29%), Gaps = 145/483 (30%)
Query: 26 HTSSSISTVSSSNSRSLTARKSS-KQWKRHHLQQRARQERL------NNSRKWRG-EGHA 77
+ T S +S ++ R S + R L+ + + L N++ W
Sbjct: 207 YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC 266
Query: 78 Q---TSMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDD 134
+ T+ R+K D L++ T + I LD L E ++LL D
Sbjct: 267 KILLTT-----RFKQ-VTDFLSAATTTH-----ISLDHHSMTLT--PDEVKSLLLKYLDC 313
Query: 135 KIRSGTGLHVENCSCAGLESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAV-C 193
+ + L E + LS + +D ++ +N K V C
Sbjct: 314 RPQD---LPREVLTTNPR-----------------RLSII-AESIRDGLATWDNWKHVNC 352
Query: 194 KTKRHS-DRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQ 252
+ L+ +P + R + + S+ P A P +
Sbjct: 353 DKLTTIIESSLNVLEPAEYR----------KMFDR---LSV---FPP---SA--HIPTIL 391
Query: 253 LTGY-EQTPHLDSREVI-------LVDRKSDEE--------LDAIALSAQALVLH---LK 293
L+ D V+ LV+++ E L+ LH +
Sbjct: 392 LSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVD 451
Query: 294 QLNGLTK----DGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPF 349
N D + +D + H + + R ++R F
Sbjct: 452 HYNIPKTFDSDDLIPPYLDQY-----FYSHIGHHLKNIEHPERMTLFRMVFL--DFR--F 502
Query: 350 VCT--CSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVC 407
+ + +A+ S IL+ ++ L+ K
Sbjct: 503 LEQKIRHDSTAWNASGS---ILNTLQQ----------LKFYK------------------ 531
Query: 408 RHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHD-IR 466
Y+CD P LV LDF P ++ K +R+ + A + I
Sbjct: 532 -------PYICD--NDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMA--EDEAIF 580
Query: 467 EEA 469
EEA
Sbjct: 581 EEA 583
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 42/168 (25%), Positives = 72/168 (42%), Gaps = 24/168 (14%)
Query: 614 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 673
E L + ++ S+K L IA + + + +HSK++++RD+K EN LI K +
Sbjct: 92 EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQV--I 149
Query: 674 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC--VGTPRWMAPEVLRAMHKPNLYGLEV-- 729
+ DF A + ++ H IP + GT R+M+ H G E
Sbjct: 150 HIIDFALA---KEYIDPETKKH--IPYREHKSLTGTARYMS----INTHL----GKEQSR 196
Query: 730 --DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 772
D+ + G + + L +P+ GL + E + I KR + L
Sbjct: 197 RDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVL 244
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 41/169 (24%), Positives = 71/169 (42%), Gaps = 28/169 (16%)
Query: 614 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 673
E L + +S+K L +A + + +HSK +HRDIK +N L+ L R+ V
Sbjct: 90 EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR----ANQV 145
Query: 674 KLCDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV- 729
+ DF A R + H ++ + GT R+ + H G+E
Sbjct: 146 YIIDFGLAKKYRDTSTHQHIPYRENKNL------TGTARYAS----VNTHL----GIEQS 191
Query: 730 ---DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 772
D+ S G +L+ L +P+ GL ++ + ++ I K + L
Sbjct: 192 RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 31/169 (18%), Positives = 60/169 (35%), Gaps = 27/169 (15%)
Query: 613 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 672
++K+ E K S K L ++ + L +H +H DIK+ N+L++ +
Sbjct: 138 LQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD-----Q 192
Query: 673 VKLCDFDRAVPLRSFLHTCCIAHRGIP-APDVC-VGTPRWMAPEVLRAMHKPNLYGLEV- 729
V L D+ A + H+ P C GT + + H G+
Sbjct: 193 VYLVDYGLA---YRYCPEGV--HKAYAADPKRCHDGTIEFTS----IDAHN----GVAPS 239
Query: 730 ---DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 772
D+ G +++ LT +P+ + I+ + +
Sbjct: 240 RRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDK 288
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 30/168 (17%), Positives = 61/168 (36%), Gaps = 31/168 (18%)
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 675
L + + +S + L +A + AL LH +H ++ +ENI +D E + V L
Sbjct: 148 LDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQS-----QVTL 202
Query: 676 CDFDRAVPLRSFLHTCCIAHRGIPAPDVC----VGTPRWMAPEVLRAMHKPNLYGLEV-- 729
+ A + C + + + + G +++ +HK G
Sbjct: 203 AGYGFA---FRY----CPSGKHVAYVEGSRSPHEGDLEFIS----MDLHK----GCGPSR 247
Query: 730 --DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 772
D+ S G +L+ L +P+ +E + + +P
Sbjct: 248 RSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGP 295
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 25/134 (18%), Positives = 45/134 (33%), Gaps = 26/134 (19%)
Query: 625 SVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF---DRA 681
L + + L +H +H DIK+ N+L+ + V L D+ R
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-----QVYLADYGLSYRY 203
Query: 682 VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV----DIWSYGCL 737
P + +G GT + + HK G+ + D+ G
Sbjct: 204 CPNGNHKQYQENPRKGH------NGTIEFTS----LDAHK----GVALSRRSDVEILGYC 249
Query: 738 LLELLTLQVPYMGL 751
+L L ++P+
Sbjct: 250 MLRWLCGKLPWEQN 263
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 840 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.97 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.95 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.84 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.48 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.23 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.1 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.02 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.83 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.79 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.67 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.64 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.26 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.22 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.9 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.89 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.68 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.63 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.25 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.1 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.05 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.86 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.51 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.44 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.47 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.22 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.12 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.47 | |
| 2f4m_A | 295 | Peptide N-glycanase; glycoproteins, ubiquitin-depe | 80.07 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-53 Score=467.01 Aligned_cols=257 Identities=25% Similarity=0.343 Sum_probs=213.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++++.||+|+||.||+|++ .++.||+|++.... ......+ .+.+|+.+|++|+|||||++++++.+
T Consensus 21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~----~~~~E~~il~~l~HpnIV~~~~~~~~ 94 (350)
T 4b9d_A 21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR--MSSKERE----ESRREVAVLANMKHPNIVQYRESFEE 94 (350)
T ss_dssp SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTT--SCHHHHH----HHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHH--CCHHHHH----HHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence 5688999999999999999999997 57899999975442 2333333 45999999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... +|||||||+||+|.++|.. .....+++..++.|+.||+.||+|||++|||||||||+|||
T Consensus 95 ~~~--------------~yiVmEy~~gg~L~~~i~~---~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL 157 (350)
T 4b9d_A 95 NGS--------------LYIVMDYCEGGDLFKRINA---QKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIF 157 (350)
T ss_dssp TTE--------------EEEEEECCTTCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEE
T ss_pred CCE--------------EEEEEeCCCCCcHHHHHHH---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEE
Confidence 654 5999999999999999975 23356799999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
|+.+ +.+||+|||+|+.+...... ....+||+.|||||++.+ ..|+.++|||||||+||
T Consensus 158 l~~~-------g~vKl~DFGla~~~~~~~~~----------~~~~~GT~~YmAPE~l~~----~~y~~~~DiwSlGvily 216 (350)
T 4b9d_A 158 LTKD-------GTVQLGDFGIARVLNSTVEL----------ARACIGTPYYLSPEICEN----KPYNNKSDIWALGCVLY 216 (350)
T ss_dssp ECTT-------CCEEECSTTEESCCCHHHHH----------HHHHHSCCTTCCHHHHTT----CCCCHHHHHHHHHHHHH
T ss_pred ECCC-------CCEEEcccccceeecCCccc----------ccccCCCccccCHHHHCC----CCCCcHHHHHHHHHHHH
Confidence 9877 46999999999876543211 123579999999999986 67899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
||+||+.||.+.+..+++..|..+..+.++. ..++++.+||.+||+.||.+||
T Consensus 217 emltG~~PF~~~~~~~~~~~i~~~~~~~~~~---------------------------~~s~~~~~li~~~L~~dP~~R~ 269 (350)
T 4b9d_A 217 ELCTLKHAFEAGSMKNLVLKIISGSFPPVSL---------------------------HYSYDLRSLVSQLFKRNPRDRP 269 (350)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHCCCCCCCcCHHHHHHHHHcCCCCCCCc---------------------------cCCHHHHHHHHHHccCChhHCc
Confidence 9999999999999999999888876554432 1245799999999999999999
Q ss_pred CHHHHHHHHH
Q 003185 820 TAGDLYEMFV 829 (840)
Q Consensus 820 Sa~ELLehLe 829 (840)
|++|+++|.+
T Consensus 270 s~~e~l~hp~ 279 (350)
T 4b9d_A 270 SVNSILEKGF 279 (350)
T ss_dssp CHHHHHTSHH
T ss_pred CHHHHhcCHH
Confidence 9999999843
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=452.98 Aligned_cols=269 Identities=25% Similarity=0.369 Sum_probs=212.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
++.++|++.++||+|+||+||+|++.+ .||||+++ .........+.| .+|+.+|++|+|||||+++|++...
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~--~~~~~~~~~~~f----~~E~~il~~l~HpNIV~l~g~~~~~- 104 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILK--VVDPTPEQFQAF----RNEVAVLRKTRHVNILLFMGYMTKD- 104 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECC--CSSCCHHHHHHH----HHHHHHHTTCCCTTBCCEEEEECSS-
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEE--ecCCCHHHHHHH----HHHHHHHHhCCCCCEeeEEEEEECC-
Confidence 567889999999999999999999865 58999854 333444444444 9999999999999999999987532
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. +|||||||+||+|.++|.. ....+++..++.|+.||+.||+|||+++||||||||+||||+
T Consensus 105 ~--------------~~iVmEy~~gGsL~~~l~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~ 166 (307)
T 3omv_A 105 N--------------LAIVTQWCEGSSLYKHLHV----QETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH 166 (307)
T ss_dssp S--------------CEEEEECCSSCBHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE
T ss_pred e--------------EEEEEEcCCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC
Confidence 2 4999999999999999975 235699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||+|+........ ......+||+.|||||++.+.. ...|+.++|||||||+||||
T Consensus 167 ~~-------~~~Ki~DFGla~~~~~~~~~--------~~~~~~~GT~~ymAPE~l~~~~-~~~y~~ksDVwS~Gvvl~El 230 (307)
T 3omv_A 167 EG-------LTVKIGDFGLATVKSRWSGS--------QQVEQPTGSVLWMAPEVIRMQD-NNPFSFQSDVYSYGIVLYEL 230 (307)
T ss_dssp TT-------EEEEECCCSSCBC--------------------CCCCTTSCCHHHHHCCS-SCCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEEeeccCceecccCCcc--------eeecccccCCCccCHHHhhccC-CCCCCcHHHhHhHHHHHHHH
Confidence 77 56999999999866432211 1123457999999999997522 24689999999999999999
Q ss_pred HhCCCCCCCCCHHH-HHHHHHcCCC-CCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 742 LTLQVPYMGLSELE-IHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 742 LTG~~PF~~~~~~e-l~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+||+.||.+.+... +...+..+.. |.++. ....+++.+.+||.+||+.||.+||
T Consensus 231 ltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~------------------------~~~~~~~~l~~li~~cl~~dP~~RP 286 (307)
T 3omv_A 231 MTGELPYSHINNRDQIIFMVGRGYASPDLSK------------------------LYKNCPKAMKRLVADCVKKVKEERP 286 (307)
T ss_dssp HHSSCTTTTCCCHHHHHHHHHTTCCCCCSTT------------------------SCTTSCHHHHHHHHHHTCSSSTTSC
T ss_pred HHCCCCCCCCChHHHHHHHHhcCCCCCCccc------------------------ccccchHHHHHHHHHHcCCCHhHCc
Confidence 99999998876544 4444544432 22221 1123456899999999999999999
Q ss_pred CHHHHHHHHHhhcCCCC
Q 003185 820 TAGDLYEMFVARTSSSI 836 (840)
Q Consensus 820 Sa~ELLehLe~l~~~~~ 836 (840)
|+.||+++|+.+..+-+
T Consensus 287 s~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 287 LFPQILSSIELLQHSLP 303 (307)
T ss_dssp CHHHHHHHHHHHHTTCC
T ss_pred CHHHHHHHHHHHhccCC
Confidence 99999999999876644
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=453.55 Aligned_cols=267 Identities=23% Similarity=0.322 Sum_probs=221.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 574 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~ 574 (840)
+.-++|.+.++||+|+||.||+|++. +..||||+... ......+ .|.+|+.+|++|+|||||+++
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~----~~~~~~~----~f~~E~~il~~l~HpnIV~l~ 81 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD----ASDNARK----DFHREAELLTNLQHEHIVKFY 81 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS----CCHHHHH----HHHHHHHHHTTCCCTTBCCEE
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC----CChHHHH----HHHHHHHHHHhCCCCCCccEE
Confidence 45578999999999999999999863 56789998542 1233333 459999999999999999999
Q ss_pred eEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHh--------ccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 003185 575 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS--------ETGEKHVSVKLALFIAQDVAAALVELHSK 646 (840)
Q Consensus 575 g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~--------~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~ 646 (840)
|++.+.+. .|||||||++|+|.++|.... ......+++..++.|+.||+.||+|||++
T Consensus 82 g~~~~~~~--------------~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~ 147 (299)
T 4asz_A 82 GVCVEGDP--------------LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ 147 (299)
T ss_dssp EEECSSSS--------------EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEeeCCE--------------EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99986654 499999999999999998631 12235799999999999999999999999
Q ss_pred CeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCC
Q 003185 647 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 726 (840)
Q Consensus 647 gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s 726 (840)
+||||||||+||||+.+ +++||+|||+|+.......... .....||+.|||||++.+ ..|+
T Consensus 148 ~iiHRDlKp~NILl~~~-------~~~Ki~DFGla~~~~~~~~~~~--------~~~~~gt~~ymAPE~~~~----~~~~ 208 (299)
T 4asz_A 148 HFVHRDLATRNCLVGEN-------LLVKIGDFGMSRDVYSTDYYRV--------GGHTMLPIRWMPPESIMY----RKFT 208 (299)
T ss_dssp TCCCSCCSGGGEEECGG-------GCEEECCCSCHHHHTGGGCEEE--------TTTEEECGGGCCHHHHHH----CCCC
T ss_pred CcccCccCHhhEEECCC-------CcEEECCcccceecCCCCceee--------cCceecChhhcCHHHHcC----CCCC
Confidence 99999999999999987 5699999999987644322110 123468999999999987 6799
Q ss_pred chhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHH
Q 003185 727 LEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 805 (840)
Q Consensus 727 ~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~d 805 (840)
.++|||||||+||||+| |+.||.+.+..++...+..+.++..+.. +++.+.+
T Consensus 209 ~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~---------------------------~~~~~~~ 261 (299)
T 4asz_A 209 TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRT---------------------------CPQEVYE 261 (299)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCCCCTT---------------------------CCHHHHH
T ss_pred chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCcc---------------------------chHHHHH
Confidence 99999999999999999 8999999999999999988876554432 2457999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 003185 806 VFRRCTEENPTERPTAGDLYEMFVARTSSSI 836 (840)
Q Consensus 806 LI~rCL~~DP~eRPSa~ELLehLe~l~~~~~ 836 (840)
||.+||+.||.+|||+.+|++.|+.+.+.++
T Consensus 262 li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 262 LMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 9999999999999999999999999876554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-52 Score=455.78 Aligned_cols=267 Identities=23% Similarity=0.321 Sum_probs=215.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 574 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~ 574 (840)
+...+|.+.++||+|+||.||+|++. +..||||+... ......+ .|.+|+.+|++|+|||||+++
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~----~~~~~~~----~f~~E~~il~~l~HpnIV~l~ 109 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE----ASESARQ----DFQREAELLTMLQHQHIVRFF 109 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC----CSHHHHH----HHHHHHHHHTTCCCTTBCCEE
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc----CCHHHHH----HHHHHHHHHHhCCCCCCCcEE
Confidence 44567899999999999999999873 56799998642 2233333 459999999999999999999
Q ss_pred eEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc----------cCCCCCCHHHHHHHHHHHHHHHHHHH
Q 003185 575 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE----------TGEKHVSVKLALFIAQDVAAALVELH 644 (840)
Q Consensus 575 g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~----------~~~~~ls~~~~~~Ia~QIa~AL~yLH 644 (840)
|++.+... +|||||||++|+|.++|+.... .....+++..++.|+.||+.||+|||
T Consensus 110 g~~~~~~~--------------~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH 175 (329)
T 4aoj_A 110 GVCTEGRP--------------LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA 175 (329)
T ss_dssp EEECSSSS--------------EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEECCE--------------EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 99986654 4999999999999999975221 11246999999999999999999999
Q ss_pred hCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCC
Q 003185 645 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 724 (840)
Q Consensus 645 s~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~ 724 (840)
+++||||||||+||||+.+ +.+||+|||+|+.+...... .......||+.|||||++.+ ..
T Consensus 176 ~~~iiHRDLKp~NILl~~~-------~~~Ki~DFGla~~~~~~~~~--------~~~~~~~gt~~ymAPE~~~~----~~ 236 (329)
T 4aoj_A 176 GLHFVHRDLATRNCLVGQG-------LVVKIGDFGMSRDIYSTDYY--------RVGGRTMLPIRWMPPESILY----RK 236 (329)
T ss_dssp HTTCCCSCCCGGGEEEETT-------TEEEECCCC------------------------CCCCGGGCCHHHHTT----CC
T ss_pred cCCeecccccHhhEEECCC-------CcEEEcccccceeccCCCcc--------eecCcccccccccChhhhcC----CC
Confidence 9999999999999999977 57999999999876432211 11233569999999999986 77
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHH
Q 003185 725 YGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 803 (840)
Q Consensus 725 ~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L 803 (840)
++.++|||||||+||||+| |+.||.+.+..++...+..+.++..+.. +++.+
T Consensus 237 ~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~~---------------------------~~~~~ 289 (329)
T 4aoj_A 237 FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRA---------------------------CPPEV 289 (329)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCCCCTT---------------------------CCHHH
T ss_pred CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCccc---------------------------ccHHH
Confidence 8999999999999999999 8999999999999999888766555432 24579
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 003185 804 VDVFRRCTEENPTERPTAGDLYEMFVARTSSSI 836 (840)
Q Consensus 804 ~dLI~rCL~~DP~eRPSa~ELLehLe~l~~~~~ 836 (840)
.+||.+||+.||.+|||+.||+++|+.+.+..+
T Consensus 290 ~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp 322 (329)
T 4aoj_A 290 YAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 322 (329)
T ss_dssp HHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred HHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence 999999999999999999999999999987654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=450.00 Aligned_cols=264 Identities=20% Similarity=0.317 Sum_probs=218.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 574 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~ 574 (840)
+++.++++.++||+|+||.||+|.+ .+..||||+.... . ..... +.|.+|+.+|++|+|||||+++
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~--~-~~~~~----~~f~~E~~il~~l~HpNIV~l~ 95 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK--A-EGPLR----EEFRHEAMLRARLQHPNVVCLL 95 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC---C-CC-CH----HHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcc--c-ChHHH----HHHHHHHHHHHhCCCCCCCCcc
Confidence 6678899999999999999999987 3467899985322 1 11222 3459999999999999999999
Q ss_pred eEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHHH
Q 003185 575 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVEL 643 (840)
Q Consensus 575 g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-----------~~~~ls~~~~~~Ia~QIa~AL~yL 643 (840)
|++.....+ +||||||++|+|.++|...... ....+++..++.|+.||+.||+||
T Consensus 96 g~~~~~~~~--------------~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL 161 (308)
T 4gt4_A 96 GVVTKDQPL--------------SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL 161 (308)
T ss_dssp EEECSSSSC--------------EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHH
T ss_pred eEEEECCEE--------------EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence 999876644 9999999999999999752111 124689999999999999999999
Q ss_pred HhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCC
Q 003185 644 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 723 (840)
Q Consensus 644 Hs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~ 723 (840)
|+++||||||||+||||+.+ +++||+|||+|+.+...... .......||+.|||||++.+ .
T Consensus 162 H~~~iiHRDLK~~NILl~~~-------~~~Ki~DFGlar~~~~~~~~--------~~~~~~~gt~~ymAPE~l~~----~ 222 (308)
T 4gt4_A 162 SSHHVVHKDLATRNVLVYDK-------LNVKISDLGLFREVYAADYY--------KLLGNSLLPIRWMAPEAIMY----G 222 (308)
T ss_dssp HHTTCCCSCCSGGGEEECGG-------GCEEECCSCCBCGGGGGGCB--------CSSSSSCBCGGGCCHHHHHH----C
T ss_pred HhCCCCCCCccccceEECCC-------CCEEECCcccceeccCCCce--------eEecccccCCcccCHHHHhC----C
Confidence 99999999999999999987 56999999999876543211 11234579999999999987 6
Q ss_pred CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHH
Q 003185 724 LYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 802 (840)
Q Consensus 724 ~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 802 (840)
.++.++|||||||+||||+| |..||.+.+..++...+..+.+++.++. ++..
T Consensus 223 ~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~---------------------------~~~~ 275 (308)
T 4gt4_A 223 KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDD---------------------------CPAW 275 (308)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCCCTT---------------------------CCHH
T ss_pred CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCccc---------------------------chHH
Confidence 79999999999999999999 8999999999999999988766554422 3557
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 003185 803 LVDVFRRCTEENPTERPTAGDLYEMFVART 832 (840)
Q Consensus 803 L~dLI~rCL~~DP~eRPSa~ELLehLe~l~ 832 (840)
+.+|+.+||+.||.+|||+.||+++|++..
T Consensus 276 ~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 276 VYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 899999999999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=456.01 Aligned_cols=256 Identities=26% Similarity=0.406 Sum_probs=216.9
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
-..|++.++||+|+||.||+|++ ++..||+|++...... ..+ .+.+|+.+|++|+|||||+++++|.+.+
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~----~~~----~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 144 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ----RRE----LLFNEVVIMRDYQHENVVEMYNSYLVGD 144 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS----SGG----GGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh----HHH----HHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 45799999999999999999998 5789999997654321 122 3489999999999999999999999766
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. +|||||||+||+|.+++.+ ..+++..++.|+.||+.||+|||++|||||||||+||||+
T Consensus 145 ~--------------~~ivmEy~~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 204 (346)
T 4fih_A 145 E--------------LWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT 204 (346)
T ss_dssp E--------------EEEEECCCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred E--------------EEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEC
Confidence 4 5999999999999999976 4699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||+|+.+..... .....+||+.|||||++.+ ..|+.++|||||||+||||
T Consensus 205 ~~-------g~vKl~DFGla~~~~~~~~----------~~~~~~GTp~YmAPEvl~~----~~y~~~~DiWSlGvilyem 263 (346)
T 4fih_A 205 HD-------GRVKLSDFGFCAQVSKEVP----------RRKSLVGTPYWMAPELISR----LPYGPEVDIWSLGIMVIEM 263 (346)
T ss_dssp TT-------CCEEECCCTTCEECCSSSC----------CBCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEecCcCceecCCCCC----------cccccccCcCcCCHHHHCC----CCCCcHHHHHHHHHHHHHH
Confidence 77 4699999999987654221 1234679999999999976 6789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
++|++||.+.+..+++..|.....+.++. ....++.+.+||.+||..||.+|||+
T Consensus 264 l~G~~PF~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~s~~~~dli~~~L~~dP~~R~ta 318 (346)
T 4fih_A 264 VDGEPPYFNEPPLKAMKMIRDNLPPRLKN-------------------------LHKVSPSLKGFLDRLLVRDPAQRATA 318 (346)
T ss_dssp HHSSCTTTTSCHHHHHHHHHHSSCCCCSC-------------------------GGGSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHCCCCCCCcCHHHHHHHHHcCCCCCCCc-------------------------cccCCHHHHHHHHHHcCCChhHCcCH
Confidence 99999999999999888887764433321 12235689999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 003185 822 GDLYEMFVARTS 833 (840)
Q Consensus 822 ~ELLehLe~l~~ 833 (840)
+|+++|.+-...
T Consensus 319 ~e~l~Hp~~~~~ 330 (346)
T 4fih_A 319 AELLKHPFLAKA 330 (346)
T ss_dssp HHHTTCGGGGGC
T ss_pred HHHhcCHhhcCC
Confidence 999999665443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=451.58 Aligned_cols=258 Identities=24% Similarity=0.339 Sum_probs=210.4
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.++.|++.++||+|+||.||+|++ .+..||+|++..+.. . .+|+.+|++|+|||||++++++.+.
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~----~~E~~il~~l~HpnIV~l~~~~~~~ 122 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------R----VEELVACAGLSSPRIVPLYGAVREG 122 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------C----THHHHTTTTCCCTTBCCEEEEEEET
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------H----HHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 456799999999999999999998 478999999764321 1 5799999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. +|||||||+||+|.++|.+ ...+++..++.|+.||+.||+|||++|||||||||+||||
T Consensus 123 ~~--------------~~ivmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 183 (336)
T 4g3f_A 123 PW--------------VNIFMELLEGGSLGQLIKQ-----MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL 183 (336)
T ss_dssp TE--------------EEEEECCCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE
T ss_pred CE--------------EEEEEeccCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE
Confidence 54 5999999999999999986 2569999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.++ ..+||+|||+|+.+....... .......++||+.|||||++.+ ..|+.++|||||||+|||
T Consensus 184 ~~~g------~~vKl~DFGla~~~~~~~~~~-----~~~~~~~~~GT~~YmAPE~~~~----~~y~~~~DiwSlGvilye 248 (336)
T 4g3f_A 184 SSDG------SRAALCDFGHALCLQPDGLGK-----SLLTGDYIPGTETHMAPEVVMG----KPCDAKVDIWSSCCMMLH 248 (336)
T ss_dssp CTTS------CCEEECCCTTCEEC-----------------CCCCCCGGGCCHHHHTT----CCCCTHHHHHHHHHHHHH
T ss_pred eCCC------CEEEEeeCCCCeEccCCCccc-----ceecCCccccCccccCHHHHCC----CCCCcHHHHHHHHHHHHH
Confidence 8773 259999999998765432111 1111234579999999999986 678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|+||++||.+.+..++...|.....+. .+ ....+++.+.+||.+||+.||.+|||
T Consensus 249 mltG~~Pf~~~~~~~~~~~i~~~~~~~-~~------------------------~~~~~s~~~~~li~~~L~~dP~~R~s 303 (336)
T 4g3f_A 249 MLNGCHPWTQYFRGPLCLKIASEPPPI-RE------------------------IPPSCAPLTAQAIQEGLRKEPVHRAS 303 (336)
T ss_dssp HHHSSCSSTTTCCSCCHHHHHHSCCGG-GG------------------------SCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHCcCCCCCCCHHHHHHHHHcCCCCc-hh------------------------cCccCCHHHHHHHHHHccCCHhHCcC
Confidence 999999998887777777776653211 10 01123568999999999999999999
Q ss_pred HHHHHHHHHhhc
Q 003185 821 AGDLYEMFVART 832 (840)
Q Consensus 821 a~ELLehLe~l~ 832 (840)
+.||+++|....
T Consensus 304 a~el~~~l~~~l 315 (336)
T 4g3f_A 304 AMELRRKVGKAL 315 (336)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 999999987654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=445.21 Aligned_cols=253 Identities=21% Similarity=0.271 Sum_probs=212.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
...++|++++.||+|+||+||+|++ .++.||+|++..... ......+.+.+|+.+|++|+|||||+++++|.+
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 103 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-----IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 103 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC-----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 3456899999999999999999997 578999999754321 111223456999999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.+. +|||||||+||+|.++|.+ ...+++..++.++.||+.||+|||++|||||||||+|||
T Consensus 104 ~~~--------------~yivmEy~~gG~L~~~i~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNIL 164 (311)
T 4aw0_A 104 DEK--------------LYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENIL 164 (311)
T ss_dssp SSE--------------EEEEECCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CCE--------------EEEEEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeE
Confidence 664 4999999999999999986 357999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
|+.+ +.+||+|||+|+.+...... ......+||+.|||||++.+ ..|+.++|||||||+||
T Consensus 165 l~~~-------g~vKl~DFGla~~~~~~~~~--------~~~~~~~GTp~YmAPEvl~~----~~y~~~~DiWSlGvily 225 (311)
T 4aw0_A 165 LNED-------MHIQITDFGTAKVLSPESKQ--------ARANSFVGTAQYVSPELLTE----KSACKSSDLWALGCIIY 225 (311)
T ss_dssp ECTT-------SCEEECCCTTCEECCTTTTC--------CCBCCCCSCGGGCCHHHHHH----SCBCHHHHHHHHHHHHH
T ss_pred EcCC-------CCEEEEEcCCceecCCCCCc--------ccccCcccCcccCCHHHHcC----CCCCcHHHHHHHHHHHH
Confidence 9877 46999999999876432211 11245689999999999987 67899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
||+||+.||.+.+..+++..|.+... .+++ ..++++++||.+||..||.+||
T Consensus 226 eml~G~~PF~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~dli~~lL~~dp~~R~ 277 (311)
T 4aw0_A 226 QLVAGLPPFRAGNEGLIFAKIIKLEY-DFPE---------------------------KFFPKARDLVEKLLVLDATKRL 277 (311)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHTCC-CCCT---------------------------TCCHHHHHHHHHHSCSSGGGST
T ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCC-CCCc---------------------------ccCHHHHHHHHHHccCCHhHCc
Confidence 99999999999999999988877642 2221 1245789999999999999999
Q ss_pred CHHHHH
Q 003185 820 TAGDLY 825 (840)
Q Consensus 820 Sa~ELL 825 (840)
|++|++
T Consensus 278 t~~e~~ 283 (311)
T 4aw0_A 278 GCEEME 283 (311)
T ss_dssp TSGGGT
T ss_pred ChHHHc
Confidence 999853
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=435.27 Aligned_cols=255 Identities=24% Similarity=0.298 Sum_probs=198.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++.+.||+|+||+||+|.+ .++.||+|++....... .....++.+|+.+|++|+|||||++++++.+
T Consensus 10 ~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~ 84 (275)
T 3hyh_A 10 AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK-----SDMQGRIEREISYLRLLRHPHIIKLYDVIKS 84 (275)
T ss_dssp ----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC-----HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 4578999999999999999999997 57899999975432211 1223345999999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.+. .||||||+ +|+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 85 ~~~--------------~~ivmEy~-~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NIL 144 (275)
T 3hyh_A 85 KDE--------------IIMVIEYA-GNELFDYIVQ-----RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLL 144 (275)
T ss_dssp SSE--------------EEEEEECC-CEEHHHHHHH-----SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEE
T ss_pred CCE--------------EEEEEeCC-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeE
Confidence 654 59999999 5799999986 357999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
|+.+ +.+||+|||+|+....... ....+||+.|||||++.+ ...++.++|||||||+||
T Consensus 145 l~~~-------~~vkl~DFGla~~~~~~~~-----------~~~~~GT~~Y~APE~~~~---~~y~~~~~DiwSlGvily 203 (275)
T 3hyh_A 145 LDEH-------LNVKIADFGLSNIMTDGNF-----------LKTSCGSPNYAAPEVISG---KLYAGPEVDVWSCGVILY 203 (275)
T ss_dssp ECTT-------CCEEECCSSCC--------------------------CTTSCHHHHSS---SSCCCTHHHHHHHHHHHH
T ss_pred ECCC-------CCEEEeecCCCeecCCCCc-----------cCCeeECcccCChhhhcC---CCCCCChhhhHHHHHHHH
Confidence 9877 4599999999986543221 234579999999999986 233468999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
||+||+.||.+.+..++...+.++.. .++. ..++.+.+||.+||+.||.+||
T Consensus 204 ~lltg~~PF~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~~li~~~L~~dP~~R~ 255 (275)
T 3hyh_A 204 VMLCRRLPFDDESIPVLFKNISNGVY-TLPK---------------------------FLSPGAAGLIKRMLIVNPLNRI 255 (275)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHTCC-CCCT---------------------------TSCHHHHHHHHHHSCSSGGGSC
T ss_pred HHHHCCCCCCCCCHHHHHHHHHcCCC-CCCC---------------------------CCCHHHHHHHHHHccCChhHCc
Confidence 99999999999988888888876643 1221 1245789999999999999999
Q ss_pred CHHHHHHHHHh
Q 003185 820 TAGDLYEMFVA 830 (840)
Q Consensus 820 Sa~ELLehLe~ 830 (840)
|++|+++|.+-
T Consensus 256 s~~eil~hpw~ 266 (275)
T 3hyh_A 256 SIHEIMQDDWF 266 (275)
T ss_dssp CHHHHHHCHHH
T ss_pred CHHHHHcCccc
Confidence 99999999654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=458.07 Aligned_cols=255 Identities=26% Similarity=0.403 Sum_probs=216.5
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
-..|++.++||+|+||.||+|++ .+..||+|++.+.... .. +.+.+|+.+|+.|+|||||+++++|...+
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~----~~----~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 221 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ----RR----ELLFNEVVIMRDYQHENVVEMYNSYLVGD 221 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS----SG----GGHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh----HH----HHHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence 45799999999999999999998 5789999997654321 12 23589999999999999999999999766
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. +|||||||+||+|.+++.. ..+++..+..|+.||+.||+|||++|||||||||+||||+
T Consensus 222 ~--------------~~iVmEy~~gG~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~ 281 (423)
T 4fie_A 222 E--------------LWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT 281 (423)
T ss_dssp E--------------EEEEEECCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC
T ss_pred E--------------EEEEEeCCCCCcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc
Confidence 4 5999999999999999976 4699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||+|+.+..... .....+||+.|||||++.+ ..|+.++|||||||+||||
T Consensus 282 ~~-------g~vKl~DFGla~~~~~~~~----------~~~~~~GTp~YmAPEvl~~----~~y~~~~DiWSlGvilyem 340 (423)
T 4fie_A 282 HD-------GRVKLSDFGFCAQVSKEVP----------RRKSLVGTPYWMAPELISR----LPYGPEVDIWSLGIMVIEM 340 (423)
T ss_dssp TT-------CCEEECCCTTCEECCSSCC----------CBCCCEECTTTCCHHHHTT----CCBCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEecCccceECCCCCc----------cccccccCcCcCCHHHHCC----CCCCcHHHHHHHHHHHHHH
Confidence 77 4599999999987644221 1244689999999999986 6789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
++|++||.+.+..+++..|.....+.+.. ....++.+.+||.+||..||.+|||+
T Consensus 341 l~G~~PF~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~s~~~~dli~~~L~~dP~~R~ta 395 (423)
T 4fie_A 341 VDGEPPYFNEPPLKAMKMIRDNLPPRLKN-------------------------LHKVSPSLKGFLDRLLVRDPAQRATA 395 (423)
T ss_dssp HHSSCTTTTSCHHHHHHHHHHSCCCCCSC-------------------------TTSSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHCCCCCCCcCHHHHHHHHHcCCCCCCcc-------------------------cccCCHHHHHHHHHHcCCChhHCcCH
Confidence 99999999999999988887765433321 01235689999999999999999999
Q ss_pred HHHHHHHHhhc
Q 003185 822 GDLYEMFVART 832 (840)
Q Consensus 822 ~ELLehLe~l~ 832 (840)
+||++|-+-..
T Consensus 396 ~ell~Hp~~~~ 406 (423)
T 4fie_A 396 AELLKHPFLAK 406 (423)
T ss_dssp HHHTTCGGGGG
T ss_pred HHHhcCHHhcC
Confidence 99999966543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-50 Score=431.34 Aligned_cols=256 Identities=23% Similarity=0.339 Sum_probs=203.0
Q ss_pred CCc-eeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 505 PSL-SSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 505 ~~y-~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
++| ++.++||+|+||+||+|.+. +..||+|++... .......+ +|.+|+.+|++|+|||||+++++|....
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--~~~~~~~~----~~~~E~~il~~l~HpnIV~~~~~~~~~~ 98 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR--KLTKSERQ----RFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGG--GSCHHHHH----HHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchh--hCCHHHHH----HHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence 344 78889999999999999984 667888876433 22333333 4599999999999999999999987532
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCCCcEE
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENIL 659 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~g--IVHRDLKPeNIL 659 (840)
. ....+|||||||+||+|.++|.+ ...+++..++.|+.||+.||+|||++| ||||||||+|||
T Consensus 99 ~----------~~~~~~lvmEy~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NIL 163 (290)
T 3fpq_A 99 K----------GKKCIVLVTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF 163 (290)
T ss_dssp T----------TEEEEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEE
T ss_pred C----------CCcEEEEEEeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhhee
Confidence 1 12346999999999999999986 357999999999999999999999998 999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
|+.. .+.+||+|||+|+...... ....+||+.|||||++.+ .|+.++|||||||+||
T Consensus 164 l~~~------~g~vKl~DFGla~~~~~~~------------~~~~~GTp~YmAPE~~~~-----~y~~~~DiwSlGvily 220 (290)
T 3fpq_A 164 ITGP------TGSVKIGDLGLATLKRASF------------AKAVIGTPEFMAPEMYEE-----KYDESVDVYAFGMCML 220 (290)
T ss_dssp ESST------TSCEEECCTTGGGGCCTTS------------BEESCSSCCCCCGGGGGT-----CCCTHHHHHHHHHHHH
T ss_pred EECC------CCCEEEEeCcCCEeCCCCc------------cCCcccCccccCHHHcCC-----CCCcHHHHHHHHHHHH
Confidence 9742 1469999999997543211 134579999999999863 5899999999999999
Q ss_pred HHHhCCCCCCCCC-HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 740 ELLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 740 ELLTG~~PF~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
||+||+.||.+.. ...+...+..+..|... ....++++.+||.+||..||.+|
T Consensus 221 elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~~~~~li~~~L~~dP~~R 274 (290)
T 3fpq_A 221 EMATSEYPYSECQNAAQIYRRVTSGVKPASF--------------------------DKVAIPEVKEIIEGCIRQNKDER 274 (290)
T ss_dssp HHHHSSCTTTTCSSHHHHHHHHTTTCCCGGG--------------------------GGCCCHHHHHHHHHHSCSSGGGS
T ss_pred HHHHCCCCCCCCCcHHHHHHHHHcCCCCCCC--------------------------CccCCHHHHHHHHHHccCChhHC
Confidence 9999999997654 45556666554332111 01124578999999999999999
Q ss_pred CCHHHHHHHHHh
Q 003185 819 PTAGDLYEMFVA 830 (840)
Q Consensus 819 PSa~ELLehLe~ 830 (840)
||++|+++|.+-
T Consensus 275 ~s~~e~l~Hp~~ 286 (290)
T 3fpq_A 275 YSIKDLLNHAFF 286 (290)
T ss_dssp CCHHHHHTSGGG
T ss_pred cCHHHHhcCccc
Confidence 999999998653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=442.74 Aligned_cols=268 Identities=23% Similarity=0.357 Sum_probs=216.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC-CCccee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEM 573 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~H-pNIV~l 573 (840)
++.++|++.+.||+|+||.||+|.+.+ +.||||+.... ......+. +.+|+.+|.++.| ||||++
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~---~~~~~~~~----~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRA----LMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT---CCHHHHHH----HHHHHHHHHHHCCCTTBCCE
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc---cChHHHHH----HHHHHHHHHHcCCCCcEEEE
Confidence 456789999999999999999999743 46888875322 22333333 4999999999975 999999
Q ss_pred eeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHH
Q 003185 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 642 (840)
Q Consensus 574 ~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-----------~~~~ls~~~~~~Ia~QIa~AL~y 642 (840)
+|+|..... .+|||||||++|+|.++|+..... ....+++..++.|+.||+.||+|
T Consensus 134 ~g~~~~~~~-------------~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~y 200 (353)
T 4ase_A 134 LGACTKPGG-------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 200 (353)
T ss_dssp EEEECCTTS-------------CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEecCC-------------EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHh
Confidence 999875432 249999999999999999863221 13458999999999999999999
Q ss_pred HHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC
Q 003185 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 722 (840)
Q Consensus 643 LHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~ 722 (840)
||+++||||||||+||||+.+ +++||+|||+|+.+....... ......||+.|||||++.+
T Consensus 201 LH~~~iiHRDLK~~NILl~~~-------~~vKi~DFGlar~~~~~~~~~--------~~~~~~gt~~ymAPE~l~~---- 261 (353)
T 4ase_A 201 LASRKCIHRDLAARNILLSEK-------NVVKICDFGLARDIYKDPDYV--------RKGDARLPLKWMAPETIFD---- 261 (353)
T ss_dssp HHHTTCCCSCCSGGGEEECGG-------GCEEECCCGGGSCTTTCTTSE--------EETTEEECGGGCCHHHHHH----
T ss_pred HhhCCeecCccCccceeeCCC-------CCEEECcchhhhhcccCCCce--------eeccccccccccCHHHHhc----
Confidence 999999999999999999987 569999999998764432110 1234568999999999987
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCC-HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhH
Q 003185 723 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 800 (840)
Q Consensus 723 ~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s 800 (840)
..|+.++|||||||+||||+| |+.||.+.+ ...+...+..+.++..++. ++
T Consensus 262 ~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~---------------------------~~ 314 (353)
T 4ase_A 262 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY---------------------------TT 314 (353)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTT---------------------------CC
T ss_pred CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCcc---------------------------CC
Confidence 779999999999999999998 899998875 4456666777766555432 24
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 003185 801 SFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 835 (840)
Q Consensus 801 ~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~~~ 835 (840)
+.+.+||.+||+.||.+|||+.+|++||+.+.+..
T Consensus 315 ~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 315 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 57899999999999999999999999999887543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=440.81 Aligned_cols=251 Identities=24% Similarity=0.277 Sum_probs=204.3
Q ss_pred CCceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
++|++++.||+|+||+||+|+. .+..||+|++...... .... .++.+|+.+|++|+|||||++++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~--~~~~----~~~~~E~~il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK--VRDR----VRTKMERDILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEE--EEEC----C------CCCCCCCCTTEECEEEEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcC--hHHH----HHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 6799999999999999999986 3568999997543211 1111 134889999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.+. +|||||||+||+|.++|.+ ...+++..++.++.||+.||+|||++|||||||||+|||
T Consensus 98 ~~~--------------~~ivmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL 158 (304)
T 3ubd_A 98 EGK--------------LYLILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENIL 158 (304)
T ss_dssp TTE--------------EEEEECCCTTCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEE
T ss_pred CCE--------------EEEEEEcCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeE
Confidence 664 5999999999999999986 356999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||+|+....... .....+||+.|||||++.+ ..|+.++|||||||+||
T Consensus 159 l~~~-------g~vKl~DFGla~~~~~~~~----------~~~~~~GT~~YmAPE~~~~----~~y~~~~DiwSlGvily 217 (304)
T 3ubd_A 159 LDEE-------GHIKLTDFGLSKESIDHEK----------KAYSFCGTVEYMAPEVVNR----RGHTQSADWWSFGVLMF 217 (304)
T ss_dssp ECTT-------SCEEEESSEEEEC-----C----------CCCSCCCCGGGCCHHHHHT----SCCCTHHHHHHHHHHHH
T ss_pred EcCC-------CCEEecccccceeccCCCc----------cccccccCcccCCHHHhcc----CCCCCCCcccchHHHHH
Confidence 9887 4599999999986543211 1234679999999999986 67899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
||+||+.||.+.+..++...|.+...+ ++. ..++++.+||.+||+.||.+||
T Consensus 218 emltG~~PF~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~~li~~~L~~dP~~R~ 269 (304)
T 3ubd_A 218 EMLTGTLPFQGKDRKETMTMILKAKLG-MPQ---------------------------FLSPEAQSLLRMLFKRNPANRL 269 (304)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCC-CCT---------------------------TSCHHHHHHHHHHTCSSGGGST
T ss_pred HHHhCCCCCCCcCHHHHHHHHHcCCCC-CCC---------------------------cCCHHHHHHHHHHcccCHHHCC
Confidence 999999999999999998888776432 221 1245789999999999999999
Q ss_pred C-----HHHHHHHHH
Q 003185 820 T-----AGDLYEMFV 829 (840)
Q Consensus 820 S-----a~ELLehLe 829 (840)
| ++|+++|.+
T Consensus 270 ta~~~~~~eil~Hp~ 284 (304)
T 3ubd_A 270 GAGPDGVEEIKRHSF 284 (304)
T ss_dssp TCSTTTHHHHHTSGG
T ss_pred CCCcCCHHHHHcCcc
Confidence 8 589998854
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-49 Score=425.19 Aligned_cols=269 Identities=25% Similarity=0.290 Sum_probs=203.9
Q ss_pred CceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 585 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~ 585 (840)
+|.+.++||+|+||.||+|+++++.||||++... ..+.+ ....|+..+.+|+|||||+++|++.....
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~-------~~~~~--~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~--- 71 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-------EERSW--FREAEIYQTVMLRHENILGFIAADNKDNG--- 71 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGG-------GHHHH--HHHHHHHTSTTCCCTTBCCEEEEEEEECS---
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc-------chhhH--HHHHHHHHHhcCCCCCCCcEEEEEEecCC---
Confidence 5889999999999999999999999999986432 11222 12457777788999999999999986542
Q ss_pred CCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeecccCCCCc
Q 003185 586 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--------HIMHRDIKSEN 657 (840)
Q Consensus 586 ~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~--------gIVHRDLKPeN 657 (840)
....+|||||||++|+|.++|+. ..+++..+.+++.|++.||+|||++ +||||||||+|
T Consensus 72 -------~~~~~~lV~Ey~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~N 138 (303)
T 3hmm_A 72 -------TWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 138 (303)
T ss_dssp -------SSEEEEEEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGG
T ss_pred -------CceEEEEEecCCCCCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCccc
Confidence 12357999999999999999986 4689999999999999999999987 99999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC--CCCCCchhhHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK--PNLYGLEVDIWSYG 735 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~--~~~~s~kSDVWSLG 735 (840)
|||+.+ +++||+|||+|+.......... ......+||+.|||||++.+... ...++.++||||||
T Consensus 139 ILl~~~-------~~~Ki~DFGla~~~~~~~~~~~------~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~G 205 (303)
T 3hmm_A 139 ILVKKN-------GTCCIADLGLAVRHDSATDTID------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 205 (303)
T ss_dssp EEECTT-------SCEEECCCTTCEEEETTTTEES------CC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHH
T ss_pred EEECCC-------CCEEEEeCCCCccccCCCCcee------eecccccccccccCHHHhcccccccCCccChhHhhhhHH
Confidence 999877 5699999999987654332211 11234579999999999975211 12367899999999
Q ss_pred HHHHHHHhCCCCCCCC---------------CHHHHHHHHHc-CCCCCcchHHhhhccCccccccccCCCCCCchhhhhh
Q 003185 736 CLLLELLTLQVPYMGL---------------SELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 799 (840)
Q Consensus 736 vIL~ELLTG~~PF~~~---------------~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 799 (840)
|+||||+||.+||... ...++...+.. ..+|.++..+ ...+.
T Consensus 206 vvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~----------------------~~~~~ 263 (303)
T 3hmm_A 206 LVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW----------------------QSCEA 263 (303)
T ss_dssp HHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG----------------------GSSHH
T ss_pred HHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccc----------------------cchHH
Confidence 9999999997765322 11223333322 2334443221 11234
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 003185 800 LSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 800 s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~~ 834 (840)
+..+.+|+.+||+.||.+||||.||+++|+.+.+.
T Consensus 264 ~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 264 LRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 66889999999999999999999999999988754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=433.77 Aligned_cols=290 Identities=17% Similarity=0.192 Sum_probs=214.5
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++++.||+|+||+||+|++ .+..||||++... ....... +++.+|+.+|+.|+|||||++++++.....
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~--~~~~~~~----~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 127 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNA--FDVVTNA----KRTLRELKILKHFKHDNIIAIKDILRPTVP 127 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTT--TSSHHHH----HHHHHHHHHHHHCCCTTBCCEEEECCCSSC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcc--ccchHHH----HHHHHHHHHHHhcCCCCcceEeeeeecccc
Confidence 4799999999999999999998 5789999996432 2223333 345899999999999999999999875432
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
+ .....+|||||||+ |+|.++|.+ ...+++..++.|++||+.||.|||++|||||||||+|||++.
T Consensus 128 ~--------~~~~~~~ivmE~~~-g~L~~~i~~-----~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~ 193 (398)
T 4b99_A 128 Y--------GEFKSVYVVLDLME-SDLHQIIHS-----SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNE 193 (398)
T ss_dssp T--------TTCCCEEEEEECCS-EEHHHHHTS-----SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT
T ss_pred c--------ccCCEEEEEEeCCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCC
Confidence 2 01235799999996 689999864 467999999999999999999999999999999999999997
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||+|+.+...... ........+||+.|||||++.+ ...++.++||||+|||||||+
T Consensus 194 ~-------~~~Ki~DFGla~~~~~~~~~------~~~~~~~~~GT~~Y~APEv~~~---~~~~~~~~DiWSlG~il~ell 257 (398)
T 4b99_A 194 N-------CELKIGDFGMARGLCTSPAE------HQYFMTEYVATRWYRAPELMLS---LHEYTQAIDLWSVGCIFGEML 257 (398)
T ss_dssp T-------CCEEECCCTTCBCC-------------CCCCCSSCCCCTTCCHHHHTT---CSCCCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEeecceeeecccCccc------cccccccceeChHhcCHHHhcC---CCCCCChhheehhHHHHHHHH
Confidence 7 46999999999876432211 1112345689999999999876 245799999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCC---CCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF---EKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|++||.+.+..+.+..|...........+.................. .........++++++||.+||.+||.+||
T Consensus 258 ~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ 337 (398)
T 4b99_A 258 ARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARI 337 (398)
T ss_dssp HTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSC
T ss_pred HCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCc
Confidence 999999999998888888665222212111111000000000000000 00111223467899999999999999999
Q ss_pred CHHHHHHHHHh
Q 003185 820 TAGDLYEMFVA 830 (840)
Q Consensus 820 Sa~ELLehLe~ 830 (840)
|++|+|+|.+-
T Consensus 338 ta~e~L~Hp~f 348 (398)
T 4b99_A 338 SAAAALRHPFL 348 (398)
T ss_dssp CHHHHTTSGGG
T ss_pred CHHHHhcCHhh
Confidence 99999999654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=418.74 Aligned_cols=274 Identities=23% Similarity=0.287 Sum_probs=191.0
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+++|++.+.||+|+||.||+|++ .+..||+|++.... .... .+.+.+|+.+|++|+|||||++++++...+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~----~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 76 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELA----REKVMREVKALAKLEHPGIVRYFNAWLEKN 76 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHH----HHHHHHHHHHHTTCCCTTBCCEEEEEEEEC
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHH----HHHHHHHHHHHHhCCCCCCCeEEEEEEecC
Confidence 35699999999999999999997 47899999875432 2222 234599999999999999999999998654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
.... -........+|||||||+||+|.+++... .......+..++.|+.||+.||+|||++|||||||||+||||+
T Consensus 77 ~~~~--~~~~~~~~~l~ivmE~~~gg~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~ 152 (299)
T 4g31_A 77 TTEK--LQPSSPKVYLYIQMQLCRKENLKDWMNGR--CTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT 152 (299)
T ss_dssp ------------CEEEEEEEECCCSCCHHHHHHTC--CSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred cccc--ccccCCCcEEEEEEecCCCCcHHHHHHhc--CCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEEC
Confidence 2100 00011233579999999999999999751 1112345677899999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccc--cCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA--HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~--~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
.+ +.+||+|||+|+.+.......... ..........+||+.|||||++.+ ..|+.++|||||||+||
T Consensus 153 ~~-------~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~----~~y~~~~DiwSlGvily 221 (299)
T 4g31_A 153 MD-------DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG----NSYSHKVDIFSLGLILF 221 (299)
T ss_dssp TT-------CCEEECCCCCC--------------------------CCCTTSCHHHHTT----CCCCTHHHHHHHHHHHH
T ss_pred CC-------CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC----CCCCCHHHHHHHHHHHH
Confidence 77 469999999998775432211100 001111234579999999999986 67899999999999999
Q ss_pred HHHhCCCCCCCCC-HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 740 ELLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 740 ELLTG~~PF~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
||++ ||.+.. .......+.....|. .....++.+.+||.+||+.||.+|
T Consensus 222 ell~---Pf~~~~~~~~~~~~~~~~~~p~---------------------------~~~~~~~~~~~li~~~L~~dP~~R 271 (299)
T 4g31_A 222 ELLY---PFSTQMERVRTLTDVRNLKFPP---------------------------LFTQKYPCEYVMVQDMLSPSPMER 271 (299)
T ss_dssp HHHS---CCSSHHHHHHHHHHHHTTCCCH---------------------------HHHHHCHHHHHHHHHHTCSSGGGS
T ss_pred HHcc---CCCCccHHHHHHHHHhcCCCCC---------------------------CCcccCHHHHHHHHHHcCCChhHC
Confidence 9996 775432 222333333333221 112224467889999999999999
Q ss_pred CCHHHHHHHHH
Q 003185 819 PTAGDLYEMFV 829 (840)
Q Consensus 819 PSa~ELLehLe 829 (840)
||+.||++|..
T Consensus 272 ps~~eil~h~~ 282 (299)
T 4g31_A 272 PEAINIIENAV 282 (299)
T ss_dssp CCHHHHHTSGG
T ss_pred cCHHHHhcCHh
Confidence 99999999844
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=435.46 Aligned_cols=259 Identities=22% Similarity=0.253 Sum_probs=216.1
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.+++|++.+.||+|+||.||+|.+ .+..||+|++... ..... +.+.+|+.+|+.|+|||||+++++|...
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~----~~~~~----~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 226 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDK----ETVRKEIQTMSVLRHPTLVNLHDAFEDD 226 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHH----HHHHHHHHHHHHTCCTTBCCEEEEEECS
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc----chhhH----HHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 468999999999999999999997 5788999987533 12222 3458999999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. +|||||||+||+|.++|.. ....+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 227 ~~--------------~~iv~E~~~gg~L~~~i~~----~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill 288 (573)
T 3uto_A 227 NE--------------MVMIYEFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF 288 (573)
T ss_dssp SE--------------EEEEEECCCCCBHHHHHTC----TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CE--------------EEEEEeecCCCcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccc
Confidence 54 5999999999999999863 23579999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+. .+.+||+|||+|+.+...... ...+||+.|||||++.+ ..|+.++|||||||+|||
T Consensus 289 ~~~~-----~~~vKl~DFG~a~~~~~~~~~-----------~~~~GT~~y~APEv~~~----~~y~~~~DiWSlGvilye 348 (573)
T 3uto_A 289 TTKR-----SNELKLIDFGLTAHLDPKQSV-----------KVTTGTAEFAAPEVAEG----KPVGYYTDMWSVGVLSYI 348 (573)
T ss_dssp SSSS-----CCCEEECCCSSCEECCTTSEE-----------EEECSSGGGCCHHHHTT----CCBCHHHHHHHHHHHHHH
T ss_pred cCCC-----CCCEEEeeccceeEccCCCce-----------eeeEECccccCHHHhCC----CCCCcHHHHHHHHHHHHH
Confidence 8652 257999999999877543221 23579999999999986 678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|++|..||.+.+..+++..|.......... .....++.+++||.+||..||.+|||
T Consensus 349 ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~dli~~~L~~dp~~R~t 404 (573)
T 3uto_A 349 LLSGLSPFGGENDDETLRNVKSCDWNMDDS------------------------AFSGISEDGKDFIRKLLLADPNTRMT 404 (573)
T ss_dssp HHHSCCSSCCSSHHHHHHHHHTTCCCCCSG------------------------GGTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred HHHCCCCCCCcCHHHHHHHHHhCCCCCCcc------------------------cccCCCHHHHHHHHHHccCChhHCcC
Confidence 999999999999999988887764321111 11223567899999999999999999
Q ss_pred HHHHHHHHHhh
Q 003185 821 AGDLYEMFVAR 831 (840)
Q Consensus 821 a~ELLehLe~l 831 (840)
+.|+++|.+-.
T Consensus 405 ~~e~l~Hpw~~ 415 (573)
T 3uto_A 405 IHQALEHPWLT 415 (573)
T ss_dssp HHHHHHSTTTS
T ss_pred HHHHhcCcCcC
Confidence 99999996543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=412.12 Aligned_cols=285 Identities=20% Similarity=0.171 Sum_probs=199.7
Q ss_pred CCceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEe
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 578 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~ 578 (840)
++|++.++||+|+||+||+|++ .+..||+|++.... . ..++.+|+.+|+.+ .|||||+++++|.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~------~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS------H----PIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS------C----HHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc------C----HHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 5799999999999999999986 25678998753221 1 12348899999999 5999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
..+. .||||||++||+|.+++. .+++..++.++.||+.||+|||++|||||||||+||
T Consensus 91 ~~~~--------------~~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNi 148 (361)
T 4f9c_A 91 KNDH--------------VVIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNF 148 (361)
T ss_dssp ETTE--------------EEEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred ECCE--------------EEEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHe
Confidence 7654 599999999999999984 389999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCccccccccccccc------------------ccCCCCCCCcccCCCcccchhhhhccc
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI------------------AHRGIPAPDVCVGTPRWMAPEVLRAMH 720 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~------------------~~~~~~~~~~~vGT~~YmAPEvL~~~~ 720 (840)
||+.+. +.+||+|||+|+........... ...........+||+.|||||++.+
T Consensus 149 Ll~~~~------~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-- 220 (361)
T 4f9c_A 149 LYNRRL------KKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK-- 220 (361)
T ss_dssp EEETTT------TEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT--
T ss_pred EEeCCC------CeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC--
Confidence 998652 46999999999865432211000 0000111234579999999999976
Q ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCC-----------------------CcchHHhhhc
Q 003185 721 KPNLYGLEVDIWSYGCLLLELLTLQVPYMG-LSELEIHDLIQMGKRP-----------------------RLTDELEALG 776 (840)
Q Consensus 721 ~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~-~~~~el~~~I~~~~~p-----------------------~l~~~l~~~~ 776 (840)
...++.++||||+||+||||+||+.||.. .+..+.+..|...... ..........
T Consensus 221 -~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 299 (361)
T 4f9c_A 221 -CPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLR 299 (361)
T ss_dssp -CSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC
T ss_pred -CCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhc
Confidence 24589999999999999999999999954 4555555554331100 0000000000
Q ss_pred cCcc--ccc-cccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003185 777 SCHE--HEV-AQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 777 ~~~~--~~~-~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~ 830 (840)
.... +.. ................++++++||.+||.+||.+|||++|+++|.+-
T Consensus 300 ~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f 356 (361)
T 4f9c_A 300 GMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFF 356 (361)
T ss_dssp ----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred cccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence 0000 000 00000000111223456789999999999999999999999999653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=434.57 Aligned_cols=257 Identities=21% Similarity=0.251 Sum_probs=205.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++++.||+|+||.||+|+. .+..||+|++......... ..........++.+++.++|||||+++++|.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~--~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhh--hHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 6789999999999999999999997 6789999997543211100 01111112445677788899999999999997
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... +|||||||+||+|..+|.+ ...+++..++.++.||+.||.|||++|||||||||+|||
T Consensus 264 ~~~--------------lylVmEy~~GGdL~~~l~~-----~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNIL 324 (689)
T 3v5w_A 264 PDK--------------LSFILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL 324 (689)
T ss_dssp SSE--------------EEEEECCCCSCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEE
T ss_pred CCE--------------EEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeE
Confidence 764 5999999999999999986 356999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
|+.+ +.+||+|||+|+.+.... ....+||+.|||||++.. +..|+.++|||||||+||
T Consensus 325 ld~~-------G~vKL~DFGlA~~~~~~~------------~~t~~GTp~YmAPEvl~~---~~~y~~~vDiWSLGvilY 382 (689)
T 3v5w_A 325 LDEH-------GHVRISDLGLACDFSKKK------------PHASVGTHGYMAPEVLQK---GVAYDSSADWFSLGCMLF 382 (689)
T ss_dssp ECTT-------SCEEECCCTTCEECSSCC------------CCSCCSCGGGCCHHHHST---TCCCCTHHHHHHHHHHHH
T ss_pred EeCC-------CCEEecccceeeecCCCC------------CCCccCCcCccCHHHHhC---CCCCCcHHHHHHHHHHHH
Confidence 9987 569999999998764321 234579999999999964 256899999999999999
Q ss_pred HHHhCCCCCCCC---CHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 740 ELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 740 ELLTG~~PF~~~---~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
||++|.+||.+. +..++...+..... .++. ..++++.+||.+||..||.
T Consensus 383 EmLtG~~PF~~~~~~~~~~i~~~i~~~~~-~~p~---------------------------~~S~~a~dLI~~lL~~dP~ 434 (689)
T 3v5w_A 383 KLLRGHSPFRQHKTKDKHEIDRMTLTMAV-ELPD---------------------------SFSPELRSLLEGLLQRDVN 434 (689)
T ss_dssp HHHHSSCTTCGGGCCCHHHHHHHHHHCCC-CCCT---------------------------TSCHHHHHHHHHHTCSCGG
T ss_pred HHHhCCCCCCCCChHHHHHHHHhhcCCCC-CCCc---------------------------cCCHHHHHHHHHHccCCHh
Confidence 999999999754 33344444443321 1221 1255789999999999999
Q ss_pred CCCC-----HHHHHHHHH
Q 003185 817 ERPT-----AGDLYEMFV 829 (840)
Q Consensus 817 eRPS-----a~ELLehLe 829 (840)
+|++ ++||++|.+
T Consensus 435 ~Rl~~~~~ga~ei~~Hpf 452 (689)
T 3v5w_A 435 RRLGCLGRGAQEVKESPF 452 (689)
T ss_dssp GCTTCSSSTHHHHTTSGG
T ss_pred HCCCCCCCCHHHHhcCcc
Confidence 9998 799999854
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=382.47 Aligned_cols=266 Identities=27% Similarity=0.452 Sum_probs=209.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+.+.+|++.+.||+|+||.||+|.+.+..+|+|++... .......+. +.+|+.+|++++||||+++++++....
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~~----~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQ--DFHAERVNE----FLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCC--CCSHHHHHH----HHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred CChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCC--CCCHHHHHH----HHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 56789999999999999999999999999999996533 233333344 489999999999999999999998665
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCCCcEE
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENIL 659 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~g--IVHRDLKPeNIL 659 (840)
.. ++||||+++|+|.+++... .....+++..++.++.||+.||+|||++| |+||||||+|||
T Consensus 108 ~~--------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIl 171 (309)
T 3p86_A 108 NL--------------SIVTEYLSRGSLYRLLHKS--GAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLL 171 (309)
T ss_dssp CC--------------EEEEECCTTCBHHHHHHST--THHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEE
T ss_pred ce--------------EEEEecCCCCcHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEE
Confidence 43 9999999999999999751 11123899999999999999999999999 999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 172 l~~~-------~~~kL~Dfg~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ 230 (309)
T 3p86_A 172 VDKK-------YTVKVCDFGLSRLKASTFL----------SSKSAAGTPEWMAPEVLRD----EPSNEKSDVYSFGVILW 230 (309)
T ss_dssp ECTT-------CCEEECCCC---------------------------CCTTSCHHHHTT----CCCCTTHHHHHHHHHHH
T ss_pred EeCC-------CcEEECCCCCCcccccccc----------ccccCCCCccccChhhhcC----CCCCchhhHHHHHHHHH
Confidence 9877 4699999999975433211 1233469999999999986 56789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcC-CCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
+|++|+.||.+.+..+....+... ....++. ..+..+.+||.+||..||.+|
T Consensus 231 elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dP~~R 283 (309)
T 3p86_A 231 ELATLQQPWGNLNPAQVVAAVGFKCKRLEIPR---------------------------NLNPQVAAIIEGCWTNEPWKR 283 (309)
T ss_dssp HHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCc---------------------------cCCHHHHHHHHHHccCChhhC
Confidence 999999999998888877766533 2222221 124578999999999999999
Q ss_pred CCHHHHHHHHHhhcCCCCC
Q 003185 819 PTAGDLYEMFVARTSSSIS 837 (840)
Q Consensus 819 PSa~ELLehLe~l~~~~~s 837 (840)
||+.+|++.|+.+......
T Consensus 284 ps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 284 PSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp CCHHHHHHHHHHHHC----
T ss_pred cCHHHHHHHHHHHHHhCCC
Confidence 9999999999999876443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=382.91 Aligned_cols=255 Identities=24% Similarity=0.344 Sum_probs=212.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++.+.||+|+||.||+|.+ .+..||+|++.... ......+ .+.+|+.+|+.++||||+++++++..
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~----~~~~E~~~l~~l~hpnIv~l~~~~~~ 85 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ--LNPTSLQ----KLFREVRIMKILNHPNIVKLFEVIET 85 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHH----HHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhc--CCHHHHH----HHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 4678999999999999999999997 67899999975432 2233333 34899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .|+||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 86 ~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIl 146 (328)
T 3fe3_A 86 EKT--------------LYLIMEYASGGEVFDYLVA-----HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLL 146 (328)
T ss_dssp SSE--------------EEEEECCCTTCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CCE--------------EEEEEECCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEE
Confidence 553 5999999999999999976 256999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++........ .....||+.|+|||++.+ ....+.++|||||||+||
T Consensus 147 l~~~-------~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 205 (328)
T 3fe3_A 147 LDAD-------MNIKIADFGFSNEFTVGGK-----------LDAFCGAPPYAAPELFQG---KKYDGPEVDVWSLGVILY 205 (328)
T ss_dssp ECTT-------SCEEECSTTCCGGGSSSCG-----------GGTTSSSGGGCCHHHHHT---CCCCSHHHHHHHHHHHHH
T ss_pred EcCC-------CCEEEeeccCceecCCCCc-----------cccccCCcceeCcccccC---CCcCCchhhhhhhHHHHH
Confidence 9877 4599999999976543221 123469999999999986 233458999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|++|+.||.+.+..++...+..+... ++. ..+..+.+||.+||..||.+||
T Consensus 206 ell~g~~pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~~li~~~L~~dP~~R~ 257 (328)
T 3fe3_A 206 TLVSGSLPFDGQNLKELRERVLRGKYR-IPF---------------------------YMSTDCENLLKRFLVLNPIKRG 257 (328)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCC-CCT---------------------------TSCHHHHHHHHHHCCSSTTTSC
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCC-CCC---------------------------CCCHHHHHHHHHHCCCChhHCc
Confidence 999999999999988888887765321 111 1245789999999999999999
Q ss_pred CHHHHHHHHHh
Q 003185 820 TAGDLYEMFVA 830 (840)
Q Consensus 820 Sa~ELLehLe~ 830 (840)
|++|+++|.+-
T Consensus 258 t~~eil~h~~~ 268 (328)
T 3fe3_A 258 TLEQIMKDRWI 268 (328)
T ss_dssp CHHHHTTCTTT
T ss_pred CHHHHhcCHhh
Confidence 99999998553
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=374.90 Aligned_cols=256 Identities=25% Similarity=0.418 Sum_probs=211.5
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
..++|++.+.||+|+||.||+|.+ .+..||+|++....... . +.+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~----~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK----K----ELIINEILVMRENKNPNIVNYLDSYLVG 89 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC----H----HHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH----H----HHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence 457899999999999999999986 67889999976543211 1 2348899999999999999999999866
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .++||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 90 ~~--------------~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~ 149 (297)
T 3fxz_A 90 DE--------------LWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149 (297)
T ss_dssp TE--------------EEEEEECCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CE--------------EEEEEECCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE
Confidence 53 5999999999999999986 468999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||++......... .....||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 150 ~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~e 208 (297)
T 3fxz_A 150 GMD-------GSVKLTDFGFCAQITPEQSK----------RSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIE 208 (297)
T ss_dssp CTT-------CCEEECCCTTCEECCSTTCC----------BCCCCSCGGGCCHHHHHC----SCBCTHHHHHHHHHHHHH
T ss_pred CCC-------CCEEEeeCCCceecCCcccc----------cCCccCCcCccChhhhcC----CCCCcHHHHHHHHHHHHH
Confidence 877 45999999999766432211 233569999999999986 678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|++|..||.+.+.......+.....+.+.. ....+..+.+||.+||+.||.+|||
T Consensus 209 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~dp~~Rps 263 (297)
T 3fxz_A 209 MIEGEPPYLNENPLRALYLIATNGTPELQN-------------------------PEKLSAIFRDFLNRCLEMDVEKRGS 263 (297)
T ss_dssp HHHSSCTTTTSCHHHHHHHHHHHCSCCCSC-------------------------GGGSCHHHHHHHHHHSCSSTTTSCC
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCCCC-------------------------ccccCHHHHHHHHHHccCChhHCcC
Confidence 999999999888777666655443322210 1123567899999999999999999
Q ss_pred HHHHHHHHHhhc
Q 003185 821 AGDLYEMFVART 832 (840)
Q Consensus 821 a~ELLehLe~l~ 832 (840)
+.|+++|..-..
T Consensus 264 ~~ell~h~~~~~ 275 (297)
T 3fxz_A 264 AKELLQHQFLKI 275 (297)
T ss_dssp HHHHTTCGGGGG
T ss_pred HHHHhhChhhcc
Confidence 999999865543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=364.65 Aligned_cols=263 Identities=24% Similarity=0.399 Sum_probs=204.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
..+++|++.+.||+|+||.||+|.+.+..+|+|+......... ....+.+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDI----SQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP 79 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC--------------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-
T ss_pred cchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccH----HHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 5678999999999999999999999999999999654322211 122234589999999999999999999998665
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCCCcE
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH---IMHRDIKSENI 658 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~g---IVHRDLKPeNI 658 (840)
. .++||||+++++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+||
T Consensus 80 ~--------------~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Ni 139 (271)
T 3dtc_A 80 N--------------LCLVMEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNI 139 (271)
T ss_dssp ---------------CEEEEECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGE
T ss_pred c--------------eEEEEEcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHE
Confidence 4 3999999999999999853 57999999999999999999999999 99999999999
Q ss_pred EEecccccC-CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 659 LIDLERKKA-DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 659 LLd~~~~~~-~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
|++...+.. ...+.+||+|||++........ ....||+.|+|||++.+ ..++.++||||||++
T Consensus 140 l~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~ 203 (271)
T 3dtc_A 140 LILQKVENGDLSNKILKITDFGLAREWHRTTK------------MSAAGAYAWMAPEVIRA----SMFSKGSDVWSYGVL 203 (271)
T ss_dssp EESSCCSSSCCSSCCEEECCCCC-------------------------CCGGGSCHHHHHH----CCCSHHHHHHHHHHH
T ss_pred EEecccccccccCcceEEccCCcccccccccc------------cCCCCccceeCHHHhcc----CCCCchhhHHHHHHH
Confidence 998642211 1236799999999976543211 12368999999999987 668999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
+|+|++|+.||.+.+.......+..... ..++ ...++.+.+||.+||..||.
T Consensus 204 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~ 256 (271)
T 3dtc_A 204 LWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP---------------------------STCPEPFAKLMEDCWNPDPH 256 (271)
T ss_dssp HHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC---------------------------TTCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC---------------------------cccCHHHHHHHHHHhcCCcc
Confidence 9999999999998887776666554422 1111 12245799999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 003185 817 ERPTAGDLYEMFVAR 831 (840)
Q Consensus 817 eRPSa~ELLehLe~l 831 (840)
+|||+.+++++|+.+
T Consensus 257 ~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 257 SRPSFTNILDQLTTI 271 (271)
T ss_dssp GSCCHHHHHHHHHC-
T ss_pred cCcCHHHHHHHHhcC
Confidence 999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=376.14 Aligned_cols=268 Identities=20% Similarity=0.314 Sum_probs=216.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeE
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 576 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~ 576 (840)
...++|.+.+.||+|+||.||+|.+. +..||+|+.... ......+ .+.+|+.+|++++||||++++++
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~ 118 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG---YTERQRR----DFLSEASIMGQFDHPNIIRLEGV 118 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT---CCHHHHH----HHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC---CCHHHHH----HHHHHHHHHHhCCCCCCCcEEEE
Confidence 45678999999999999999999972 345899986432 1233333 44899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
+..... .||||||+++++|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+
T Consensus 119 ~~~~~~--------------~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~ 180 (325)
T 3kul_A 119 VTRGRL--------------AMIVTEYMENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAAR 180 (325)
T ss_dssp ECGGGC--------------CEEEEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEeCCc--------------cEEEeeCCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcc
Confidence 976554 3999999999999999964 2356999999999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
||||+.+ +.+||+|||+++.......... ......+|+.|+|||++.+ ..++.++|||||||
T Consensus 181 NIll~~~-------~~~kl~Dfg~a~~~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~ 242 (325)
T 3kul_A 181 NVLVDSN-------LVCKVSDFGLSRVLEDDPDAAY-------TTTGGKIPIRWTAPEAIAF----RTFSSASDVWSFGV 242 (325)
T ss_dssp GEEECTT-------CCEEECCCSSCEECC----CCE-------ECC---CCGGGSCHHHHHH----CEECHHHHHHHHHH
T ss_pred eEEECCC-------CCEEECCCCcccccccCcccee-------eccCCCCcccccCHhHhcC----CCCCcHHHHHHHHH
Confidence 9999876 5699999999987654321110 0122346789999999986 56899999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 737 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 737 IL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
+||||++ |..||.+....++...+..+..+..+. .++..+.+||.+||..||
T Consensus 243 il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dp 295 (325)
T 3kul_A 243 VMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPM---------------------------GCPHALHQLMLDCWHKDR 295 (325)
T ss_dssp HHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSG
T ss_pred HHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCC---------------------------CcCHHHHHHHHHHccCCh
Confidence 9999999 999999999888888887764433331 234579999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCCCCCC
Q 003185 816 TERPTAGDLYEMFVARTSSSISSR 839 (840)
Q Consensus 816 ~eRPSa~ELLehLe~l~~~~~s~~ 839 (840)
.+|||+.+|++.|+.+.....+.+
T Consensus 296 ~~Rps~~eil~~L~~l~~~~~~~~ 319 (325)
T 3kul_A 296 AQRPRFSQIVSVLDALIRSPESLR 319 (325)
T ss_dssp GGSCCHHHHHHHHHHHHHSCC---
T ss_pred hhCcCHHHHHHHHHHHHhCccccc
Confidence 999999999999999987665543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=382.39 Aligned_cols=265 Identities=22% Similarity=0.358 Sum_probs=215.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC---------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcc
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIV 571 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~---------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV 571 (840)
...++|++.+.||+|+||.||+|.+. +..||+|+.... ......+ .+.+|+.+|+++ +||||+
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~E~~~l~~l~~hpnIv 150 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLS----DLVSEMEMMKMIGKHKNII 150 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT---CBHHHHH----HHHHHHHHHHHSCCCTTBC
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC---cCHHHHH----HHHHHHHHHHHhcCCCCEe
Confidence 34578999999999999999999862 245888885322 2223333 449999999999 899999
Q ss_pred eeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----------cCCCCCCHHHHHHHHHHHHHHH
Q 003185 572 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAAL 640 (840)
Q Consensus 572 ~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----------~~~~~ls~~~~~~Ia~QIa~AL 640 (840)
++++++.....+ ||||||+++|+|.+++..... .....+++..++.++.||+.||
T Consensus 151 ~~~~~~~~~~~~--------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL 216 (370)
T 2psq_A 151 NLLGACTQDGPL--------------YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 216 (370)
T ss_dssp CEEEEECSSSSC--------------EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHH
T ss_pred eEEEEEccCCCE--------------EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHH
Confidence 999999866544 999999999999999986321 1124588999999999999999
Q ss_pred HHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003185 641 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720 (840)
Q Consensus 641 ~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~ 720 (840)
.|||++||+||||||+||||+.+ +.+||+|||+++.+...... .......+|+.|+|||++.+
T Consensus 217 ~~LH~~~ivHrDlkp~NIll~~~-------~~~kl~DFG~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~-- 279 (370)
T 2psq_A 217 EYLASQKCIHRDLAARNVLVTEN-------NVMKIADFGLARDINNIDYY--------KKTTNGRLPVKWMAPEALFD-- 279 (370)
T ss_dssp HHHHHTTEECSCCCGGGEEECTT-------CCEEECCCSSCEETTCCCTT--------CTTTTTTSCGGGCCHHHHHT--
T ss_pred HHHHhCCeeccccchhhEEECCC-------CCEEEccccCCcccCcccce--------ecccCCCcccceECHhHhcC--
Confidence 99999999999999999999877 46999999999866432211 01122357889999999986
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhh
Q 003185 721 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 799 (840)
Q Consensus 721 ~~~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 799 (840)
..++.++|||||||+||||++ |..||.+....++...+..+.++..+. .+
T Consensus 280 --~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~ 330 (370)
T 2psq_A 280 --RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPA---------------------------NC 330 (370)
T ss_dssp --CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT---------------------------TS
T ss_pred --CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCC---------------------------CC
Confidence 678999999999999999999 999999988888887777765544332 12
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003185 800 LSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 833 (840)
Q Consensus 800 s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~ 833 (840)
+..+.+||.+||..||.+|||+.+|+++|+.+..
T Consensus 331 ~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 331 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 4579999999999999999999999999998764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=376.50 Aligned_cols=258 Identities=21% Similarity=0.265 Sum_probs=213.5
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
-.++|++.+.||+|+||.||+|.+ .+..+|+|++... ..... .+.+|+.+|+.++||||+++++++...
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~----~~~~E~~~l~~l~hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQV----LVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHH----HHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHH----HHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence 357899999999999999999998 4678999986532 12222 348999999999999999999999866
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .++||||++|++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 74 ~~--------------~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~ 135 (321)
T 1tki_A 74 EE--------------LVMIFEFISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIY 135 (321)
T ss_dssp TE--------------EEEEECCCCCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CE--------------EEEEEEeCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE
Confidence 53 5999999999999999864 23468999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+. .+.+||+|||++..+...... ....||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 136 ~~~~-----~~~~kl~Dfg~a~~~~~~~~~-----------~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~ 195 (321)
T 1tki_A 136 QTRR-----SSTIKIIEFGQARQLKPGDNF-----------RLLFTAPEYYAPEVHQH----DVVSTATDMWSLGTLVYV 195 (321)
T ss_dssp SSSS-----CCCEEECCCTTCEECCTTCEE-----------EEEESCGGGSCHHHHTT----CEECHHHHHHHHHHHHHH
T ss_pred ccCC-----CCCEEEEECCCCeECCCCCcc-----------ccccCChhhcCcHHhcC----CCCCchhhHHHHHHHHHH
Confidence 8642 257999999999876432211 23468999999999986 567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|++|..||.+.+..++...+........... ....+..+.+||.+||..||.+|||
T Consensus 196 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~~dp~~Rpt 251 (321)
T 1tki_A 196 LLSGINPFLAETNQQIIENIMNAEYTFDEEA------------------------FKEISIEAMDFVDRLLVKERKSRMT 251 (321)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH------------------------HTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred HHhCCCCCcCCCHHHHHHHHHcCCCCCChhh------------------------hccCCHHHHHHHHHHcCCChhHCcC
Confidence 9999999999988888888877644322211 1223567999999999999999999
Q ss_pred HHHHHHHHHhh
Q 003185 821 AGDLYEMFVAR 831 (840)
Q Consensus 821 a~ELLehLe~l 831 (840)
+.|+++|.+-.
T Consensus 252 ~~e~l~hp~~~ 262 (321)
T 1tki_A 252 ASEALQHPWLK 262 (321)
T ss_dssp HHHHHHSHHHH
T ss_pred HHHHhcChhhc
Confidence 99999997644
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=362.42 Aligned_cols=259 Identities=21% Similarity=0.332 Sum_probs=215.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
+..++|++.+.||+|+||.||+|.+ .+..+|+|++.... .. .+ .+.+|+.++++++||||+++++++...
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~---~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~ 77 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MS---EE----DFIEEAEVMMKLSHPKLVQLYGVCLEQ 77 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS--BC---HH----HHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred eChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc--cC---HH----HHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4457899999999999999999998 67789999875332 11 12 348999999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 78 ~~--------------~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~ 139 (269)
T 4hcu_A 78 AP--------------ICLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 139 (269)
T ss_dssp SS--------------EEEEEECCTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred Cc--------------eEEEEEeCCCCcHHHHHHh----cCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE
Confidence 53 4999999999999999975 23568999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||++.......... .....+|+.|+|||++.+ ..++.++||||||+++|+
T Consensus 140 ~~~-------~~~kl~Dfg~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~ 199 (269)
T 4hcu_A 140 GEN-------QVIKVSDFGMTRFVLDDQYTS---------STGTKFPVKWASPEVFSF----SRYSSKSDVWSFGVLMWE 199 (269)
T ss_dssp CGG-------GCEEECCTTGGGGBCCHHHHS---------TTSTTCCGGGCCHHHHHH----CCCCHHHHHHHHHHHHHH
T ss_pred cCC-------CCEEecccccccccccccccc---------ccCcccccccCCHHHhcC----CCCCchhhhHHHHHHHHH
Confidence 877 459999999998664432111 122357889999999986 668999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|++ |..||.+....++...+.....+..+. ..+..+.+|+.+||+.||.+||
T Consensus 200 ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp 252 (269)
T 4hcu_A 200 VFSEGKIPYENRSNSEVVEDISTGFRLYKPR---------------------------LASTHVYQIMNHCWRERPEDRP 252 (269)
T ss_dssp HHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSC
T ss_pred HhcCCCCCCCCCCHHHHHHHHhcCccCCCCC---------------------------cCCHHHHHHHHHHccCCcccCc
Confidence 999 999999998888888877664433321 1245789999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 003185 820 TAGDLYEMFVARTSS 834 (840)
Q Consensus 820 Sa~ELLehLe~l~~~ 834 (840)
|+.+++++|+.+...
T Consensus 253 s~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 253 AFSRLLRQLAEIAES 267 (269)
T ss_dssp CHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHHHHc
Confidence 999999999998754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=384.09 Aligned_cols=264 Identities=22% Similarity=0.266 Sum_probs=214.3
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
-+.|++.+.||+|+||.||+|.+ .+..+|+|++.......... ....+.+.+|+.+|++++||||+++++++....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR--GVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccc--hhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 45799999999999999999998 47889999976543322110 011234589999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
..||||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 89 --------------~~~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~ 149 (361)
T 2yab_A 89 --------------DVVLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149 (361)
T ss_dssp --------------EEEEEEECCCSCBHHHHHTT-----CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES
T ss_pred --------------EEEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe
Confidence 35999999999999999964 35799999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.++. ....+||+|||++..+..... .....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 150 ~~~~---~~~~vkl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~~l 211 (361)
T 2yab_A 150 DKNI---PIPHIKLIDFGLAHEIEDGVE-----------FKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYIL 211 (361)
T ss_dssp CTTS---SSCCEEECCCSSCEECCTTCC-----------CCCCCSCGGGCCHHHHTT----CCCCTHHHHHHHHHHHHHH
T ss_pred CCCC---CccCEEEEecCCceEcCCCCc-----------cccCCCCccEECchHHcC----CCCCccccHHHHHHHHHHH
Confidence 6631 123699999999987643211 133469999999999976 6789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
++|..||.+.+..+....+........+.. ....+..+.+||.+||..||.+|||+
T Consensus 212 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~~dP~~R~t~ 267 (361)
T 2yab_A 212 LSGASPFLGDTKQETLANITAVSYDFDEEF------------------------FSQTSELAKDFIRKLLVKETRKRLTI 267 (361)
T ss_dssp HHSCCSSCCSSHHHHHHHHHTTCCCCCHHH------------------------HTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HhCCCCCCCCCHHHHHHHHHhcCCCCCchh------------------------ccCCCHHHHHHHHHHCCCChhHCcCH
Confidence 999999999998888888877643222211 12235679999999999999999999
Q ss_pred HHHHHHHHh
Q 003185 822 GDLYEMFVA 830 (840)
Q Consensus 822 ~ELLehLe~ 830 (840)
.|+++|.+-
T Consensus 268 ~e~l~hp~~ 276 (361)
T 2yab_A 268 QEALRHPWI 276 (361)
T ss_dssp HHHHTSTTT
T ss_pred HHHhcCcCc
Confidence 999998553
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=367.11 Aligned_cols=267 Identities=24% Similarity=0.305 Sum_probs=212.5
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.-++|++.+.||+|+||.||+|.+ .+..+|+|++..... ...... +.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~----~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 83 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETL----KRFEREVHNSSQLSHQNIVSMIDVDEED 83 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-CCHHHH----HHHHHHHHHHTTCCBTTBCCEEEEEECS
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-ccHHHH----HHHHHHHHHHhcCCCCCCceEEEeeeeC
Confidence 346899999999999999999997 577899998754332 222333 3459999999999999999999998865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
. ..|+||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 84 ~--------------~~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~ 144 (294)
T 4eqm_A 84 D--------------CYYLVMEYIEGPTLSEYIES-----HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI 144 (294)
T ss_dssp S--------------EEEEEEECCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred C--------------eEEEEEeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 5 35999999999999999986 2468999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 145 ~~~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~~l~~ 204 (294)
T 4eqm_A 145 DSN-------KTLKIFDFGIAKALSETSLT---------QTNHVLGTVQYFSPEQAKG----EATDECTDIYSIGIVLYE 204 (294)
T ss_dssp CTT-------SCEEECCCSSSTTC----------------------CCSSCCHHHHHT----CCCCTTHHHHHHHHHHHH
T ss_pred CCC-------CCEEEEeCCCcccccccccc---------ccCccccCccccCHhHhcC----CCCCchHhHHHHHHHHHH
Confidence 877 45999999999866432211 1233469999999999986 667899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP- 819 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP- 819 (840)
|++|+.||.+.+.............+.....+ ....++.+.++|.+||..||.+||
T Consensus 205 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~l~~li~~~l~~dp~~R~~ 261 (294)
T 4eqm_A 205 MLVGEPPFNGETAVSIAIKHIQDSVPNVTTDV-----------------------RKDIPQSLSNVILRATEKDKANRYK 261 (294)
T ss_dssp HHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHS-----------------------CTTSCHHHHHHHHHHSCSSGGGSCS
T ss_pred HHhCCCCCCCCChHHHHHHHhhccCCCcchhc-----------------------ccCCCHHHHHHHHHHhcCCHhHccc
Confidence 99999999998877766555555443332211 112356799999999999999998
Q ss_pred CHHHHHHHHHhhcCCCC
Q 003185 820 TAGDLYEMFVARTSSSI 836 (840)
Q Consensus 820 Sa~ELLehLe~l~~~~~ 836 (840)
+++++.+.|+.+.....
T Consensus 262 ~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 262 TIQEMKDDLSSVLHENR 278 (294)
T ss_dssp SHHHHHHHHHTSSSSSS
T ss_pred cHHHHHHHHHHHHhhcc
Confidence 89999999998875543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=371.89 Aligned_cols=268 Identities=23% Similarity=0.357 Sum_probs=216.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 574 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~ 574 (840)
...++|++.+.||+|+||.||+|.+.+ ..||+|+.... ...... ..+.+|+.++++++||||++++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~----~~~~~E~~~l~~l~hp~iv~~~ 116 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQ----ADFQREAALMAEFDNPNIVKLL 116 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT---CCHHHH----HHHHHHHHHHHTCCCTTBCCEE
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc---cCHHHH----HHHHHHHHHHHhCCCCCEEEEE
Confidence 456789999999999999999999854 78999986422 122223 3459999999999999999999
Q ss_pred eEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-------------------CCCCCCHHHHHHHHHH
Q 003185 575 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-------------------GEKHVSVKLALFIAQD 635 (840)
Q Consensus 575 g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-------------------~~~~ls~~~~~~Ia~Q 635 (840)
+++...... +|||||+++++|.+++...... ....+++..++.++.|
T Consensus 117 ~~~~~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 182 (343)
T 1luf_A 117 GVCAVGKPM--------------CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 182 (343)
T ss_dssp EEECSSSSC--------------EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHH
T ss_pred EEEccCCce--------------EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHH
Confidence 999866543 9999999999999999863211 1256899999999999
Q ss_pred HHHHHHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhh
Q 003185 636 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 715 (840)
Q Consensus 636 Ia~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEv 715 (840)
|+.||.|||++||+||||||+|||++.+ +.+||+|||+++........ .......||+.|+|||+
T Consensus 183 i~~~l~~LH~~~ivH~Dlkp~NIl~~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~t~~y~aPE~ 247 (343)
T 1luf_A 183 VAAGMAYLSERKFVHRDLATRNCLVGEN-------MVVKIADFGLSRNIYSADYY--------KADGNDAIPIRWMPPES 247 (343)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGG-------GCEEECCCSCHHHHTGGGCB--------C----CCBCGGGCCHHH
T ss_pred HHHHHHHHHhCCeecCCCCcceEEECCC-------CeEEEeecCCCcccccCccc--------cccCCCcccceecChhh
Confidence 9999999999999999999999999877 46999999999866432211 01123457899999999
Q ss_pred hhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCch
Q 003185 716 LRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 794 (840)
Q Consensus 716 L~~~~~~~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~ 794 (840)
+.+ ..++.++|||||||++|||++ |..||.+....++...+..+..+.++.
T Consensus 248 ~~~----~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------------ 299 (343)
T 1luf_A 248 IFY----NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPE------------------------ 299 (343)
T ss_dssp HHH----CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT------------------------
T ss_pred hcc----CCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCC------------------------
Confidence 986 568999999999999999999 999999998888888887765443332
Q ss_pred hhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 003185 795 AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSI 836 (840)
Q Consensus 795 ~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~~~~ 836 (840)
..+..+.+||.+||..||.+|||+.+|+++|+.+.....
T Consensus 300 ---~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 300 ---NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred ---CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 124578999999999999999999999999999876544
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=379.52 Aligned_cols=258 Identities=25% Similarity=0.313 Sum_probs=212.8
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
.++|++.+.||+|+||.||+|.+ .+..+|+|++.... ......+. +.+|+.++++|+|||||++++++....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~----~~~E~~il~~l~hpnIv~~~~~~~~~~ 101 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK--LSARDFQK----LEREARICRKLQHPNIVRLHDSIQEES 101 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEccc--CCHHHHHH----HHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 35799999999999999999998 47789999976442 23333333 489999999999999999999998665
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .|+||||+.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 102 ~--------------~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~ 162 (362)
T 2bdw_A 102 F--------------HYLVFDLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA 162 (362)
T ss_dssp E--------------EEEEECCCCSCBHHHHHTT-----CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEES
T ss_pred E--------------EEEEEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEe
Confidence 3 4999999999999999864 35689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+++ ...+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 163 ~~~~----~~~~kl~DfG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~l 223 (362)
T 2bdw_A 163 SKAK----GAAVKLADFGLAIEVNDSEA-----------WHGFAGTPGYLSPEVLKK----DPYSKPVDIWACGVILYIL 223 (362)
T ss_dssp CSST----TCCEEECCCTTCBCCTTCCS-----------CCCSCSCTTTCCHHHHTT----CCCCTHHHHHHHHHHHHHH
T ss_pred cCCC----CCCEEEeecCcceEecCCcc-----------cccCCCCccccCHHHHcc----CCCCchhhHHHHHHHHHHH
Confidence 6531 25699999999976643211 123569999999999976 5789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
++|..||.+.+...+...+..+....... .....++.+.+||.+||..||.+|||+
T Consensus 224 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~li~~~L~~dP~~R~t~ 279 (362)
T 2bdw_A 224 LVGYPPFWDEDQHRLYAQIKAGAYDYPSP------------------------EWDTVTPEAKSLIDSMLTVNPKKRITA 279 (362)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHTCCCCCTT------------------------GGGGSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred HHCCCCCCCCCHHHHHHHHHhCCCCCCcc------------------------cccCCCHHHHHHHHHHcCCChhhCcCH
Confidence 99999999988888888887664321111 112235679999999999999999999
Q ss_pred HHHHHHHH
Q 003185 822 GDLYEMFV 829 (840)
Q Consensus 822 ~ELLehLe 829 (840)
.++++|.+
T Consensus 280 ~e~l~hp~ 287 (362)
T 2bdw_A 280 DQALKVPW 287 (362)
T ss_dssp HHHTTSHH
T ss_pred HHHhcCcc
Confidence 99999854
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=383.25 Aligned_cols=270 Identities=21% Similarity=0.326 Sum_probs=218.8
Q ss_pred CCCCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCccee
Q 003185 501 PGSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 573 (840)
Q Consensus 501 p~~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l 573 (840)
....++|++.+.||+|+||.||+|.+. +..||+|++. . ......... +.+|+.++++++|||||++
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~--~-~~~~~~~~~----~~~E~~~l~~l~hpnIv~~ 139 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP--E-VCSEQDELD----FLMEALIISKFNHQNIVRC 139 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECC--S-SCCHHHHHH----HHHHHHHHHHCCCTTBCCE
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecc--c-ccChhhHHH----HHHHHHHHHhCCCCCCCeE
Confidence 356789999999999999999999953 4578999853 2 122333333 4899999999999999999
Q ss_pred eeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Q 003185 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHIMHR 651 (840)
Q Consensus 574 ~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~--~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHR 651 (840)
++++...... +|||||+++|+|.+++...... ....+++..++.++.||+.||.|||++||+||
T Consensus 140 ~~~~~~~~~~--------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr 205 (367)
T 3l9p_A 140 IGVSLQSLPR--------------FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHR 205 (367)
T ss_dssp EEEECSSSSC--------------EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEEecCCCC--------------EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence 9999866543 9999999999999999874321 22458999999999999999999999999999
Q ss_pred cCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhH
Q 003185 652 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 731 (840)
Q Consensus 652 DLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDV 731 (840)
||||+||||+.++. ...+||+|||+++.+...... .......||+.|+|||++.+ ..++.++||
T Consensus 206 Dlkp~NIll~~~~~----~~~~kL~DFG~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~----~~~~~~~Dv 269 (367)
T 3l9p_A 206 DIAARNCLLTCPGP----GRVAKIGDFGMARDIYRAGYY--------RKGGCAMLPVKWMPPEAFME----GIFTSKTDT 269 (367)
T ss_dssp CCCGGGEEESCSST----TCCEEECCCHHHHHHHHHSSC--------TTCCGGGSCGGGCCHHHHHH----CCCCHHHHH
T ss_pred CCChhhEEEecCCC----CceEEECCCcccccccccccc--------ccCCCcCCcccEECHHHhcC----CCCCcHHHH
Confidence 99999999986532 256999999999865432211 11233468999999999987 678999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 003185 732 WSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 810 (840)
Q Consensus 732 WSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rC 810 (840)
|||||+||||++ |..||.+....++...+..+..+..+. ..+..+.+||.+|
T Consensus 270 wslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~ 322 (367)
T 3l9p_A 270 WSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK---------------------------NCPGPVYRIMTQC 322 (367)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cCCHHHHHHHHHH
Confidence 999999999998 999999999988888887765443332 1245789999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhcCC
Q 003185 811 TEENPTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 811 L~~DP~eRPSa~ELLehLe~l~~~ 834 (840)
|+.||.+|||+.+|+++|+.+...
T Consensus 323 l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 323 WQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCCCHhHCcCHHHHHHHHHHHhhC
Confidence 999999999999999999988653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=358.55 Aligned_cols=261 Identities=22% Similarity=0.348 Sum_probs=212.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+.+++|++.+.||+|+||.||+|.+.+..+|+|++... .......+. +.+|+.++++++||||+++++++....
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~--~~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVR--DWSTRKSRD----FNEECPRLRIFSHPNVLPVLGACQSPP 80 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCT--TCCHHHHHH----HHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEeccc--ccCHHHHHH----HHHHHHHHHhcCCCchhheEEEEccCC
Confidence 67889999999999999999999999999999997543 223333333 499999999999999999999987652
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCCCcEE
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENIL 659 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~g--IVHRDLKPeNIL 659 (840)
. ...++||||+++|+|.+++.. .....+++..++.++.||+.||.|||++| |+||||||+|||
T Consensus 81 ~------------~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil 145 (271)
T 3kmu_A 81 A------------PHPTLITHWMPYGSLYNVLHE---GTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVM 145 (271)
T ss_dssp S------------SSCEEEEECCTTCBHHHHHHS---CSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEE
T ss_pred C------------CCeEeeecccCCCcHHHHHhh---cccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEE
Confidence 1 135999999999999999975 22235899999999999999999999999 999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.++|+|||++..... ....||+.|+|||++.+.. ...++.++|||||||++|
T Consensus 146 ~~~~-------~~~~l~~~~~~~~~~~---------------~~~~~t~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~ 202 (271)
T 3kmu_A 146 IDED-------MTARISMADVKFSFQS---------------PGRMYAPAWVAPEALQKKP-EDTNRRSADMWSFAVLLW 202 (271)
T ss_dssp ECTT-------SCEEEEGGGSCCTTSC---------------TTCBSCGGGSCHHHHHSCG-GGSCHHHHHHHHHHHHHH
T ss_pred EcCC-------cceeEEeccceeeecc---------------cCccCCccccChhhhccCC-CCCCCchhhHHHHHHHHH
Confidence 9877 4589988887654221 2236899999999998621 123445899999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcC-CCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
||++|+.||.+.+..+....+... ..+.++. ..+..+.+||.+||+.||.+|
T Consensus 203 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~R 255 (271)
T 3kmu_A 203 ELVTREVPFADLSNMEIGMKVALEGLRPTIPP---------------------------GISPHVSKLMKICMNEDPAKR 255 (271)
T ss_dssp HHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhCCCCccccChHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCChhhC
Confidence 999999999988877776555443 3333321 124579999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 003185 819 PTAGDLYEMFVARTS 833 (840)
Q Consensus 819 PSa~ELLehLe~l~~ 833 (840)
||+.++++.|+.+..
T Consensus 256 ps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 256 PKFDMIVPILEKMQD 270 (271)
T ss_dssp CCHHHHHHHHHHHCC
T ss_pred cCHHHHHHHHHHhhc
Confidence 999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=371.47 Aligned_cols=270 Identities=22% Similarity=0.284 Sum_probs=208.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
...++|++.+.||+|+||.||+|++.+..||+|++.... .... ...+|+.+|++++|||||++++++....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD-----KQSW----QNEYEVYSLPGMKHENILQFIGAEKRGT 91 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG-----HHHH----HHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc-----hHHH----HHHHHHHHHhcCCCCCchhhcceeccCC
Confidence 456789999999999999999999999999999975331 1222 2367999999999999999999998654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC----------Ceecc
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK----------HIMHR 651 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~----------gIVHR 651 (840)
.. ....++||||+++|+|.+++.. ..+++..++.++.||+.||.|||+. ||+||
T Consensus 92 ~~----------~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~ 155 (322)
T 3soc_A 92 SV----------DVDLWLITAFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHR 155 (322)
T ss_dssp SS----------SEEEEEEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECS
T ss_pred CC----------CceEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeC
Confidence 21 2357999999999999999976 4599999999999999999999999 99999
Q ss_pred cCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC-CCCCCchhh
Q 003185 652 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVD 730 (840)
Q Consensus 652 DLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~-~~~~s~kSD 730 (840)
||||+|||++.+ +.+||+|||+++.+...... .......||+.|+|||++.+... ...++.++|
T Consensus 156 Dlkp~Nill~~~-------~~~kL~DFg~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~D 220 (322)
T 3soc_A 156 DIKSKNVLLKNN-------LTACIADFGLALKFEAGKSA--------GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRID 220 (322)
T ss_dssp CCSGGGEEECTT-------CCEEECCCTTCEEECTTSCC--------CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHH
T ss_pred CCChHhEEECCC-------CeEEEccCCcccccccccCc--------cccccCccCccccCHhhcccccccCcCCCccch
Confidence 999999999877 56999999999876543211 11233569999999999975211 124567899
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHcC-CCCCcchHHhhhccCccccccccCCCCCCc
Q 003185 731 IWSYGCLLLELLTLQVPYMGLSEL----------------EIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKP 793 (840)
Q Consensus 731 VWSLGvIL~ELLTG~~PF~~~~~~----------------el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~ 793 (840)
||||||++|||+||+.||.+.... .+...+... ..+.++. .
T Consensus 221 iwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~ 278 (322)
T 3soc_A 221 MYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRD----------------------Y 278 (322)
T ss_dssp HHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCG----------------------G
T ss_pred hHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccc----------------------c
Confidence 999999999999999999764221 111111111 1111111 1
Q ss_pred hhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003185 794 EAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 833 (840)
Q Consensus 794 ~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~ 833 (840)
......+..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus 279 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 279 WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1122345679999999999999999999999999998864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=363.05 Aligned_cols=282 Identities=20% Similarity=0.237 Sum_probs=208.7
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+++|++.+.||+|+||+||+|.+ .+..+|+|++..... ...... .+.+|+.++++++||||+++++++....
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 74 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPS----SALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHH----HHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC--cCCcch----HHHHHHHHHhcCCCCCEeeEEeEEEeCC
Confidence 47899999999999999999998 567899999765432 222222 3489999999999999999999998665
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .+|||||+.+ +|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 75 ~--------------~~lv~e~~~~-~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~ 135 (292)
T 3o0g_A 75 K--------------LTLVFEFCDQ-DLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 135 (292)
T ss_dssp E--------------EEEEEECCSE-EHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred E--------------EEEEEecCCC-CHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence 3 5999999985 77777654 235799999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||+++........ .....||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 136 ~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l 195 (292)
T 3o0g_A 136 RN-------GELKLANFGLARAFGIPVRC----------YSAEVVTLWYRPPDVLFG---AKLYSTSIDMWSAGCIFAEL 195 (292)
T ss_dssp TT-------SCEEECCCTTCEECCSCCSC----------CCSCCSCGGGCCHHHHTT---CSCCCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeecccceecCCcccc----------ccCCccccCCcChHHHcC---CCCcCchHHHHHHHHHHHHH
Confidence 77 45999999999866432111 233468999999999975 23479999999999999999
Q ss_pred HhCCCC-CCCCCHHHHHHHHHcCCCCCcchHHhhhccCccc-cccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 742 LTLQVP-YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH-EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 742 LTG~~P-F~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
++|..| |.+.+..+....+...........+......... ..................+..+.+||.+||+.||.+||
T Consensus 196 ~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 275 (292)
T 3o0g_A 196 ANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275 (292)
T ss_dssp TTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred HHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCC
Confidence 988877 5666666666665543211111111111100000 00000011111122234567899999999999999999
Q ss_pred CHHHHHHHHHh
Q 003185 820 TAGDLYEMFVA 830 (840)
Q Consensus 820 Sa~ELLehLe~ 830 (840)
|++|+++|.+-
T Consensus 276 t~~e~l~hp~f 286 (292)
T 3o0g_A 276 SAEEALQHPYF 286 (292)
T ss_dssp CHHHHHTSGGG
T ss_pred CHHHHhcCccc
Confidence 99999998654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=357.86 Aligned_cols=258 Identities=22% Similarity=0.291 Sum_probs=212.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
...++|++.+.||+|+||.||+|.+. +..+|+|++.... .. .+. +.+|+.++++++||||+++++++...
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~---~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MS---EDE----FFQEAQTMMKLSHPKLVKFYGVCSKE 75 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT--BC---HHH----HHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC--Cc---HHH----HHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34578999999999999999999985 4579999875332 11 122 48999999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 76 ~~--------------~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~ 137 (268)
T 3sxs_A 76 YP--------------IYIVTEYISNGCLLNYLRSH----GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV 137 (268)
T ss_dssp SS--------------EEEEEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE
T ss_pred Cc--------------eEEEEEccCCCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE
Confidence 43 49999999999999999762 2458999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||++.......... .....+|+.|+|||++.+ ..++.++||||||+++|+
T Consensus 138 ~~~-------~~~~l~Dfg~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 197 (268)
T 3sxs_A 138 DRD-------LCVKVSDFGMTRYVLDDQYVS---------SVGTKFPVKWSAPEVFHY----FKYSSKSDVWAFGILMWE 197 (268)
T ss_dssp CTT-------CCEEECCTTCEEECCTTCEEE---------CCSCCCCGGGCCHHHHHH----SEEETTHHHHHHHHHHHH
T ss_pred CCC-------CCEEEccCccceecchhhhhc---------ccCCCcCcccCCHHHHhc----cCCchhhhhHHHHHHHHH
Confidence 877 469999999998664432211 122346788999999986 567899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|++ |..||......+....+.....+..+.. .++.+.+||.+||+.||.+||
T Consensus 198 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~l~~li~~~l~~~p~~Rp 250 (268)
T 3sxs_A 198 VFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHL---------------------------ASDTIYQIMYSCWHELPEKRP 250 (268)
T ss_dssp HHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTT---------------------------SCHHHHHHHHHTTCSSGGGSC
T ss_pred HHcCCCCCccccChHHHHHHHHcCCCCCCCCc---------------------------ChHHHHHHHHHHcCCChhhCc
Confidence 999 9999999888888777776644332211 244789999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 003185 820 TAGDLYEMFVARTS 833 (840)
Q Consensus 820 Sa~ELLehLe~l~~ 833 (840)
|+.+++++|+.+..
T Consensus 251 s~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 251 TFQQLLSSIEPLRE 264 (268)
T ss_dssp CHHHHHHHHGGGCC
T ss_pred CHHHHHHHHHHhhh
Confidence 99999999999865
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=388.62 Aligned_cols=259 Identities=25% Similarity=0.302 Sum_probs=211.6
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
.++|++.+.||+|+||.||+|.+ .+..+|+|++..+. ...... +.+.+|+.+|+.|+|||||++++++....
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~--~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 83 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK--LSARDH----QKLEREARICRLLKHPNIVRLHDSISEEG 83 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCS--CHHHHH----HHHHHHHHHHHHCCBTTBCCEEEEEECSS
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEccc--CCHHHH----HHHHHHHHHHHhCCCcCCCeEEEEEEECC
Confidence 36799999999999999999987 67889999876442 222222 34589999999999999999999998665
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .||||||+.||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 84 ~--------------~~lv~E~~~gg~L~~~i~~-----~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~ 144 (444)
T 3soa_A 84 H--------------HYLIFDLVTGGELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLA 144 (444)
T ss_dssp E--------------EEEEECCCBCCBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEES
T ss_pred E--------------EEEEEEeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEe
Confidence 3 5999999999999999986 35699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+. ..+.+||+|||++......... .....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 145 ~~~----~~~~vkL~DFG~a~~~~~~~~~----------~~~~~gt~~Y~APE~l~~----~~~~~~~DIwSlGvilyel 206 (444)
T 3soa_A 145 SKL----KGAAVKLADFGLAIEVEGEQQA----------WFGFAGTPGYLSPEVLRK----DPYGKPVDLWACGVILYIL 206 (444)
T ss_dssp BSS----TTCCEEECCCSSCBCCCTTCCB----------CCCSCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHH
T ss_pred ccC----CCCcEEEccCceeEEecCCCce----------eecccCCcccCCHHHhcC----CCCCCccccHHHHHHHHHH
Confidence 542 1257999999999766432211 123569999999999976 5789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
++|..||.+.+..++...+..+........ ....++.+.+||.+||..||.+|||+
T Consensus 207 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~~dP~~Rpta 262 (444)
T 3soa_A 207 LVGYPPFWDEDQHRLYQQIKAGAYDFPSPE------------------------WDTVTPEAKDLINKMLTINPSKRITA 262 (444)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHTCCCCCTTT------------------------TTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HhCCCCCCCccHHHHHHHHHhCCCCCCccc------------------------cccCCHHHHHHHHHHcCCChhHCCCH
Confidence 999999999998888888877643221111 11235679999999999999999999
Q ss_pred HHHHHHHH
Q 003185 822 GDLYEMFV 829 (840)
Q Consensus 822 ~ELLehLe 829 (840)
.|+++|.+
T Consensus 263 ~e~L~hp~ 270 (444)
T 3soa_A 263 AEALKHPW 270 (444)
T ss_dssp HHHHHSCT
T ss_pred HHHhcCcc
Confidence 99999854
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=369.86 Aligned_cols=263 Identities=22% Similarity=0.283 Sum_probs=212.0
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
+.|.+.+.||+|+||.||+|.+ .+..+|+|++.......... ....+.+.+|+.+|++++||||+++++++....
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 87 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR--GVSREDIEREVSILKEIQHPNVITLHEVYENKT- 87 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-
Confidence 5699999999999999999998 47889999976543322111 001223489999999999999999999998654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 88 -------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~ 149 (326)
T 2y0a_A 88 -------------DVILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149 (326)
T ss_dssp -------------EEEEEEECCCSCBHHHHHTT-----SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESC
T ss_pred -------------EEEEEEEcCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEec
Confidence 35999999999999999864 356999999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
++. ....+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 150 ~~~---~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~ll 211 (326)
T 2y0a_A 150 RNV---PKPRIKIIDFGLAHKIDFGNE-----------FKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYILL 211 (326)
T ss_dssp SSS---SSCCEEECCCTTCEECCTTSC-----------CCCCCSCTTTCCHHHHTT----CCCCTHHHHHHHHHHHHHHH
T ss_pred CCC---CCCCEEEEECCCCeECCCCCc-----------cccccCCcCcCCceeecC----CCCCcHHHHHHHHHHHHHHH
Confidence 631 223699999999987643211 123469999999999975 67899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
+|..||.+....+....+........... ....+..+.+||.+||..||.+|||+.
T Consensus 212 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~li~~~L~~dP~~Rpt~~ 267 (326)
T 2y0a_A 212 SGASPFLGDTKQETLANVSAVNYEFEDEY------------------------FSNTSALAKDFIRRLLVKDPKKRMTIQ 267 (326)
T ss_dssp HSCCSSCCSSHHHHHHHHHHTCCCCCHHH------------------------HTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred HCcCCCCCCCHHHHHHHHHhcCCCcCccc------------------------cccCCHHHHHHHHHHccCChhhCCCHH
Confidence 99999999888887777766533221111 122356789999999999999999999
Q ss_pred HHHHHHHh
Q 003185 823 DLYEMFVA 830 (840)
Q Consensus 823 ELLehLe~ 830 (840)
++++|..-
T Consensus 268 e~l~hp~~ 275 (326)
T 2y0a_A 268 DSLQHPWI 275 (326)
T ss_dssp HHHHSTTT
T ss_pred HHhcCCCc
Confidence 99998543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=373.86 Aligned_cols=263 Identities=26% Similarity=0.308 Sum_probs=208.7
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCC-hHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~-~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+.|++.+.||+|+||.||+|.+ .+..||+|++........ ... .+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 99 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLS----TEDLKREASICHMLKHPHIVELLETYSSDG 99 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCC----HHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccch----HHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 5799999999999999999997 578999999764321110 001 233489999999999999999999998665
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .||||||++|++|.+++..... ....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 100 ~--------------~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~ 164 (351)
T 3c0i_A 100 M--------------LYMVFEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLA 164 (351)
T ss_dssp E--------------EEEEEECCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred E--------------EEEEEeCCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEe
Confidence 3 5999999999999998875322 234689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.++ ....+||+|||++......... .....||+.|+|||++.+ ..++.++|||||||+||+|
T Consensus 165 ~~~----~~~~vkl~Dfg~a~~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~l 226 (351)
T 3c0i_A 165 SKE----NSAPVKLGGFGVAIQLGESGLV----------AGGRVGTPHFMAPEVVKR----EPYGKPVDVWGCGVILFIL 226 (351)
T ss_dssp SSS----TTCCEEECCCTTCEECCTTSCB----------CCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHH
T ss_pred cCC----CCCcEEEecCcceeEecCCCee----------ecCCcCCcCccCHHHHcC----CCCCchHhhHHHHHHHHHH
Confidence 653 2356999999999876542211 123469999999999986 5689999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
++|..||.+. ..++...+..+.....+.. ....+..+.+||.+||..||.+|||+
T Consensus 227 l~g~~pf~~~-~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~~dP~~R~s~ 281 (351)
T 3c0i_A 227 LSGCLPFYGT-KERLFEGIIKGKYKMNPRQ------------------------WSHISESAKDLVRRMLMLDPAERITV 281 (351)
T ss_dssp HHSSCSSCSS-HHHHHHHHHHTCCCCCHHH------------------------HTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHCCCCCCCc-HHHHHHHHHcCCCCCCccc------------------------cccCCHHHHHHHHHHCCCChhHCcCH
Confidence 9999999875 4455555555433222211 12235679999999999999999999
Q ss_pred HHHHHHHH
Q 003185 822 GDLYEMFV 829 (840)
Q Consensus 822 ~ELLehLe 829 (840)
.++++|.+
T Consensus 282 ~e~l~hp~ 289 (351)
T 3c0i_A 282 YEALNHPW 289 (351)
T ss_dssp HHHHTSHH
T ss_pred HHHhcChh
Confidence 99999854
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=370.17 Aligned_cols=284 Identities=19% Similarity=0.229 Sum_probs=208.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
..+++|++.+.||+|+||+||+|.+ .+..+|+|++..... . ......+.+|+.++++++||||+++++++...
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 91 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE--D----EGIPSTAIREISLLKELHHPNIVSLIDVIHSE 91 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc--c----chhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence 5678999999999999999999998 678899998754321 1 11223458999999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .+|||||++ ++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 92 ~~--------------~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~ 152 (311)
T 3niz_A 92 RC--------------LTLVFEFME-KDLKKVLDE----NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI 152 (311)
T ss_dssp SC--------------EEEEEECCS-EEHHHHHHT----CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CE--------------EEEEEcCCC-CCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE
Confidence 53 499999998 489888864 23568999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||+++........ .....||+.|+|||++.+ ...++.++|||||||++|+
T Consensus 153 ~~~-------~~~kl~Dfg~a~~~~~~~~~----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ 212 (311)
T 3niz_A 153 NSD-------GALKLADFGLARAFGIPVRS----------YTHEVVTLWYRAPDVLMG---SKKYSTSVDIWSIGCIFAE 212 (311)
T ss_dssp CTT-------CCEEECCCTTCEETTSCCC-------------CCCCCCTTCCHHHHTT---CCSCCTHHHHHHHHHHHHH
T ss_pred CCC-------CCEEEccCcCceecCCCccc----------ccCCcccCCcCCHHHhcC---CCCCCchHHhHHHHHHHHH
Confidence 877 45999999999866432111 123468999999999875 2467899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccc--cccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH--EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
|++|+.||.+....+....+........+..+......... ..................++++.+||.+||+.||.+|
T Consensus 213 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 292 (311)
T 3niz_A 213 MITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKR 292 (311)
T ss_dssp HHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTS
T ss_pred HHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHC
Confidence 99999999887666555555432111111111111000000 0000000000111122345688999999999999999
Q ss_pred CCHHHHHHHHHh
Q 003185 819 PTAGDLYEMFVA 830 (840)
Q Consensus 819 PSa~ELLehLe~ 830 (840)
||++|+++|.+-
T Consensus 293 pt~~ell~hp~f 304 (311)
T 3niz_A 293 ISARDAMNHPYF 304 (311)
T ss_dssp CCHHHHHTSGGG
T ss_pred CCHHHHhcCccc
Confidence 999999998554
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=363.83 Aligned_cols=265 Identities=22% Similarity=0.365 Sum_probs=214.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 574 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~ 574 (840)
....+|.+.+.||+|+||.||+|.+ .+..+|+|+.... ......+. +.+|+.++++++||||++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~hp~iv~~~ 92 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN---ASPSELRD----LLSEFNVLKQVNHPHVIKLY 92 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT---CCHHHHHH----HHHHHHHHTTCCCTTBCCEE
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC---CCHHHHHH----HHHHHHHHhhCCCCceeeEE
Confidence 3457899999999999999999986 2367889885422 22333333 48999999999999999999
Q ss_pred eEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-------------------CCCCCCHHHHHHHHHH
Q 003185 575 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-------------------GEKHVSVKLALFIAQD 635 (840)
Q Consensus 575 g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-------------------~~~~ls~~~~~~Ia~Q 635 (840)
+++...... ++||||+++++|.+++...... ....+++..++.++.|
T Consensus 93 ~~~~~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q 158 (314)
T 2ivs_A 93 GACSQDGPL--------------LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQ 158 (314)
T ss_dssp EEECSSSSC--------------EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHH
T ss_pred EEEecCCce--------------EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHH
Confidence 998766543 9999999999999999863211 1234899999999999
Q ss_pred HHHHHHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhh
Q 003185 636 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 715 (840)
Q Consensus 636 Ia~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEv 715 (840)
|+.||.|||++||+||||||+|||++.+ +.+||+|||++.......... ......+|+.|+|||+
T Consensus 159 i~~~l~~lH~~~ivH~dikp~NIli~~~-------~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~ 223 (314)
T 2ivs_A 159 ISQGMQYLAEMKLVHRDLAARNILVAEG-------RKMKISDFGLSRDVYEEDSYV--------KRSQGRIPVKWMAIES 223 (314)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEETT-------TEEEECCCTTCEECTTTSCEE--------CSSCCCSCGGGCCHHH
T ss_pred HHHHHHHHHHCCCcccccchheEEEcCC-------CCEEEccccccccccccccce--------eccCCCCcccccChhh
Confidence 9999999999999999999999999977 469999999998664422110 1122357889999999
Q ss_pred hhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCch
Q 003185 716 LRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 794 (840)
Q Consensus 716 L~~~~~~~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~ 794 (840)
+.+ ..++.++|||||||++|||++ |..||.+.....+...+.....+..+.
T Consensus 224 ~~~----~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------------ 275 (314)
T 2ivs_A 224 LFD----HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPD------------------------ 275 (314)
T ss_dssp HHH----CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT------------------------
T ss_pred hcC----CCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCc------------------------
Confidence 986 568999999999999999999 999999888888777776664433321
Q ss_pred hhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003185 795 AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 833 (840)
Q Consensus 795 ~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~ 833 (840)
..++.+.+||.+||..||.+|||+.+|+++|+.+..
T Consensus 276 ---~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 276 ---NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 124579999999999999999999999999998764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=378.72 Aligned_cols=256 Identities=24% Similarity=0.306 Sum_probs=206.4
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEE
Q 003185 501 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 577 (840)
Q Consensus 501 p~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~ 577 (840)
...+++|++.+.||+|+||.||+|++ .+..+|+|++..... ........+.+|+.+|..+ +||||+++++++
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~-----~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 93 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI-----LQDDDVECTMTEKRILSLARNHPFLTQLFCCF 93 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHh-----cchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence 36789999999999999999999997 467899999753211 1111223458899999998 699999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
..... .||||||++||+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 94 ~~~~~--------------~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 154 (353)
T 3txo_A 94 QTPDR--------------LFFVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDN 154 (353)
T ss_dssp ECSSE--------------EEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred EeCCE--------------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHH
Confidence 86653 5999999999999999986 2569999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
|||+.+ +.+||+|||+++....... .....+||+.|+|||++.+ ..++.++|||||||+
T Consensus 155 ILl~~~-------g~ikL~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~i 213 (353)
T 3txo_A 155 VLLDHE-------GHCKLADFGMCKEGICNGV----------TTATFCGTPDYIAPEILQE----MLYGPAVDWWAMGVL 213 (353)
T ss_dssp EEECTT-------SCEEECCCTTCBCSCC-------------------CCGGGCCHHHHHH----HHCTTHHHHHHHHHH
T ss_pred EEECCC-------CCEEEccccceeecccCCc----------cccccCCCcCeEChhhcCC----CCcCCccCCCcchHH
Confidence 999877 4699999999975332111 1234579999999999987 567899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
+|||++|..||.+.+..++...|...... ++. ..+..+.+||.+||..||.+
T Consensus 214 l~ell~G~~Pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~~~~~~~li~~lL~~dP~~ 265 (353)
T 3txo_A 214 LYEMLCGHAPFEAENEDDLFEAILNDEVV-YPT---------------------------WLHEDATGILKSFMTKNPTM 265 (353)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCC-CCT---------------------------TSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCC---------------------------CCCHHHHHHHHHHhhhCHHH
Confidence 99999999999999999888888765321 111 12457899999999999999
Q ss_pred CCCH------HHHHHHHH
Q 003185 818 RPTA------GDLYEMFV 829 (840)
Q Consensus 818 RPSa------~ELLehLe 829 (840)
||++ ++|++|..
T Consensus 266 R~~~~~~~~~~~il~hp~ 283 (353)
T 3txo_A 266 RLGSLTQGGEHAILRHPF 283 (353)
T ss_dssp STTSGGGTCTHHHHTSGG
T ss_pred ccCCcccCCHHHHhhCCc
Confidence 9998 89998854
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=370.56 Aligned_cols=258 Identities=24% Similarity=0.274 Sum_probs=203.3
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 003185 501 PGSFPSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 575 (840)
Q Consensus 501 p~~~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g 575 (840)
....++|++.+.||+|+||.||+|+. .+..+|+|++............. .+.+|+.+|+.++||||+++++
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~----~~~~E~~~l~~l~hp~iv~~~~ 88 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTA----HTKAERNILEEVKHPFIVDLIY 88 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC------------------HHHHHHHCCCTTBCCEEE
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHH----HHHHHHHHHHhCCCCCccceeE
Confidence 35678999999999999999999987 57889999975432211112222 3488999999999999999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCC
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 655 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKP 655 (840)
++..... .||||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||
T Consensus 89 ~~~~~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp 149 (327)
T 3a62_A 89 AFQTGGK--------------LYLILEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKP 149 (327)
T ss_dssp EEECSSC--------------EEEEEECCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCT
T ss_pred EEEcCCE--------------EEEEEeCCCCCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCH
Confidence 9986654 4999999999999999976 24689999999999999999999999999999999
Q ss_pred CcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003185 656 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735 (840)
Q Consensus 656 eNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLG 735 (840)
+|||++.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++||||||
T Consensus 150 ~Nill~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG 208 (327)
T 3a62_A 150 ENIMLNHQ-------GHVKLTDFGLCKESIHDGT----------VTHTFCGTIEYMAPEILMR----SGHNRAVDWWSLG 208 (327)
T ss_dssp TTEEECTT-------SCEEECCCSCC--------------------CTTSSCCTTSCHHHHTT----SCCCTHHHHHHHH
T ss_pred HHeEECCC-------CcEEEEeCCcccccccCCc----------cccccCCCcCccCHhhCcC----CCCCCcccchhHH
Confidence 99999877 4699999999975432211 1133469999999999976 5679999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 736 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 736 vIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
|++|+|++|..||.+.+..+....+..... .++. ..+..+.+||.+||..||
T Consensus 209 ~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~~~~~~~li~~~L~~dp 260 (327)
T 3a62_A 209 ALMYDMLTGAPPFTGENRKKTIDKILKCKL-NLPP---------------------------YLTQEARDLLKKLLKRNA 260 (327)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCT---------------------------TSCHHHHHHHHHHSCSCG
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-CCCC---------------------------CCCHHHHHHHHHHHhcCH
Confidence 999999999999999888887777766532 1111 124578999999999999
Q ss_pred CCCC-----CHHHHHHHHHh
Q 003185 816 TERP-----TAGDLYEMFVA 830 (840)
Q Consensus 816 ~eRP-----Sa~ELLehLe~ 830 (840)
.+|| ++.++++|..-
T Consensus 261 ~~R~~~~~~~~~e~l~hp~f 280 (327)
T 3a62_A 261 ASRLGAGPGDAGEVQAHPFF 280 (327)
T ss_dssp GGSTTSSTTTHHHHHHSGGG
T ss_pred hhccCCCCCCHHHHHcCCcc
Confidence 9999 89999998553
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=373.87 Aligned_cols=255 Identities=23% Similarity=0.323 Sum_probs=210.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++.+.||+|+||.||+|+. .+..+|+|+...... ........+.+|+.+|+.++||||+++++++..
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 76 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-----IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh-----hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence 3567999999999999999999997 578899999753211 011112345899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .||||||++||+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 77 ~~~--------------~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl 137 (337)
T 1o6l_A 77 HDR--------------LCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137 (337)
T ss_dssp SSE--------------EEEEEECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred CCE--------------EEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEE
Confidence 653 5999999999999999976 256899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 138 l~~~-------g~vkL~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ 196 (337)
T 1o6l_A 138 LDKD-------GHIKITDFGLCKEGISDGA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMY 196 (337)
T ss_dssp ECTT-------SCEEECCCTTCBCSCCTTC----------CBCCCEECGGGCCGGGGSS----SCBCTTHHHHHHHHHHH
T ss_pred ECCC-------CCEEEeeccchhhcccCCC----------cccccccChhhCChhhhcC----CCCCchhhcccchhHHH
Confidence 9877 4699999999975432111 1234579999999999976 66899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
||++|..||.+.+...+...+..... .++. ..+..+.+||.+||..||.+||
T Consensus 197 ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~~li~~lL~~dP~~R~ 248 (337)
T 1o6l_A 197 EMMCGRLPFYNQDHERLFELILMEEI-RFPR---------------------------TLSPEAKSLLAGLLKKDPKQRL 248 (337)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCC-CCCT---------------------------TSCHHHHHHHHHHTCSSTTTST
T ss_pred HHhcCCCCCCCCCHHHHHHHHHcCCC-CCCC---------------------------CCCHHHHHHHHHHhhcCHHHhc
Confidence 99999999999888888877765422 1121 1245789999999999999999
Q ss_pred -----CHHHHHHHHH
Q 003185 820 -----TAGDLYEMFV 829 (840)
Q Consensus 820 -----Sa~ELLehLe 829 (840)
++++|++|..
T Consensus 249 g~~~~~~~ei~~h~~ 263 (337)
T 1o6l_A 249 GGGPSDAKEVMEHRF 263 (337)
T ss_dssp TCSTTTHHHHHTSGG
T ss_pred CCCCCCHHHHHcCCC
Confidence 9999999854
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=380.95 Aligned_cols=261 Identities=24% Similarity=0.367 Sum_probs=213.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
+..++|.+.+.||+|+||.||+|.+ .+..||+|+.... ......+. +.+|+.+|++++|||||++++++..
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~hpniv~~~~~~~~ 183 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET---LPPDLKAK----FLQEARILKQYSHPNIVRLIGVCTQ 183 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT---SCHHHHTT----TTHHHHHHTTCCCTTBCCEEEEECS
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc---CCHHHHHH----HHHHHHHHHhCCCCCEEEEEEEEec
Confidence 4457899999999999999999998 4788999985422 22233333 4899999999999999999999976
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.... ||||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 184 ~~~~--------------~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil 245 (377)
T 3cbl_A 184 KQPI--------------YIVMELVQGGDFLTFLRTE----GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCL 245 (377)
T ss_dssp SSSC--------------EEEEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CCCc--------------EEEEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEE
Confidence 6543 9999999999999999762 245899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||+++......... ......+++.|+|||++.+ ..++.++|||||||+||
T Consensus 246 ~~~~-------~~~kl~DfG~s~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~ 306 (377)
T 3cbl_A 246 VTEK-------NVLKISDFGMSREEADGVYAA--------SGGLRQVPVKWTAPEALNY----GRYSSESDVWSFGILLW 306 (377)
T ss_dssp ECTT-------CCEEECCGGGCEECTTSEEEC--------CSSCCEEEGGGSCHHHHHH----CEEEHHHHHHHHHHHHH
T ss_pred EcCC-------CcEEECcCCCceecCCCceee--------cCCCCCCCcCcCCHhHhcc----CCCCchhhHHHHHHHHH
Confidence 9877 469999999998654321110 0111235678999999986 56899999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 740 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 740 ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
||++ |..||.+....++...+..+.+...+. .+++.+.+||.+||+.||.+|
T Consensus 307 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~R 359 (377)
T 3cbl_A 307 ETFSLGASPYPNLSNQQTREFVEKGGRLPCPE---------------------------LCPDAVFRLMEQCWAYEPGQR 359 (377)
T ss_dssp HHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCchhC
Confidence 9998 999999998888888877765543332 124578999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 003185 819 PTAGDLYEMFVARTS 833 (840)
Q Consensus 819 PSa~ELLehLe~l~~ 833 (840)
||+.+|++.|+.+..
T Consensus 360 ps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 360 PSFSTIYQELQSIRK 374 (377)
T ss_dssp CCHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHh
Confidence 999999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=356.70 Aligned_cols=262 Identities=25% Similarity=0.307 Sum_probs=214.1
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
..++|++.+.||+|+||.||+|.+ .+..+|+|++..... .....+. +.+|+.++++++||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQK----LEREARICRKLQHPNIVRLHDSIQEE 77 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC--CHHHHHH----HHHHHHHHHHcCCCCcCeEEEEEEcC
Confidence 457899999999999999999997 477899999764432 3333333 48999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 78 ~~--------------~~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~ 138 (284)
T 3kk8_A 78 SF--------------HYLVFDLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLL 138 (284)
T ss_dssp SE--------------EEEEECCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred CE--------------EEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEE
Confidence 53 4999999999999999876 2568999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.++. ...+||+|||++........ .....||+.|+|||++.+ ..++.++||||||+++|+
T Consensus 139 ~~~~~----~~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~ 199 (284)
T 3kk8_A 139 ASKAK----GAAVKLADFGLAIEVNDSEA-----------WHGFAGTPGYLSPEVLKK----DPYSKPVDIWACGVILYI 199 (284)
T ss_dssp SSSST----TCCEEECCCTTCEECCSSCB-----------CCCSCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHH
T ss_pred ecCCC----CCcEEEeeceeeEEcccCcc-----------ccCCCCCcCCcCchhhcC----CCCCcccchHHHHHHHHH
Confidence 86632 35699999999976543221 123469999999999986 668999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|++|..||.+.........+........... ....++.+.+||.+||+.||.+|||
T Consensus 200 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~li~~~l~~dp~~Rps 255 (284)
T 3kk8_A 200 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE------------------------WDTVTPEAKSLIDSMLTVNPKKRIT 255 (284)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT------------------------TTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred HHHCCCCCCCCchhHHHHHHHhccccCCchh------------------------hcccCHHHHHHHHHHcccChhhCCC
Confidence 9999999999888888877766533211110 1123557899999999999999999
Q ss_pred HHHHHHHHHhhc
Q 003185 821 AGDLYEMFVART 832 (840)
Q Consensus 821 a~ELLehLe~l~ 832 (840)
+.++++|..-..
T Consensus 256 ~~~~l~h~~~~~ 267 (284)
T 3kk8_A 256 ADQALKVPWICN 267 (284)
T ss_dssp HHHHTTSHHHHS
T ss_pred HHHHhcCccccC
Confidence 999999866443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=359.23 Aligned_cols=258 Identities=24% Similarity=0.329 Sum_probs=210.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
+..++|++.+.||+|+||.||+|.+. +..+|+|++.... .. .+ .+.+|+.++++++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~---~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MS---ED----EFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS--BC---HH----HHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC--CC---HH----HHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 55679999999999999999999984 4579999875332 11 12 348999999999999999999999765
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 92 ~~--------------~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili 153 (283)
T 3gen_A 92 RP--------------IFIITEYMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV 153 (283)
T ss_dssp SS--------------EEEEECCCTTCBHHHHHHCG----GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE
T ss_pred CC--------------eEEEEeccCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE
Confidence 53 49999999999999999741 2468999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||++.......... .....+|+.|+|||++.+ ..++.++||||||+++|+
T Consensus 154 ~~~-------~~~kl~Dfg~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~~l~~ 213 (283)
T 3gen_A 154 NDQ-------GVVKVSDFGLSRYVLDDEYTS---------SVGSKFPVRWSPPEVLMY----SKFSSKSDIWAFGVLMWE 213 (283)
T ss_dssp CTT-------SCEEECSTTGGGGBCCHHHHS---------TTSTTSCGGGCCHHHHHH----CCCSHHHHHHHHHHHHHH
T ss_pred cCC-------CCEEEcccccccccccccccc---------ccCCccCcccCCHHHhcc----CCCCchhhHHHHHHHHHH
Confidence 877 469999999998664432111 122347889999999986 568999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|++ |+.||......+....+........+.. .++.+.+||.+||+.||.+||
T Consensus 214 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~l~~li~~~l~~~p~~Rp 266 (283)
T 3gen_A 214 IYSLGKMPYERFTNSETAEHIAQGLRLYRPHL---------------------------ASEKVYTIMYSCWHEKADERP 266 (283)
T ss_dssp HHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTT---------------------------CCHHHHHHHHHTTCSSGGGSC
T ss_pred HHhCCCCCccccChhHHHHHHhcccCCCCCCc---------------------------CCHHHHHHHHHHccCChhHCc
Confidence 998 9999999988888888877644333211 135789999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 003185 820 TAGDLYEMFVARTS 833 (840)
Q Consensus 820 Sa~ELLehLe~l~~ 833 (840)
|+.+++++|+.+..
T Consensus 267 s~~~ll~~L~~~~~ 280 (283)
T 3gen_A 267 TFKILLSNILDVMD 280 (283)
T ss_dssp CHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhh
Confidence 99999999998764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=363.29 Aligned_cols=280 Identities=19% Similarity=0.244 Sum_probs=205.8
Q ss_pred CCCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
+++|++.+.||+|+||.||+|.+. +..+|+|++...... ......+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED------EGIPSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG------GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred CccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc------cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence 468999999999999999999984 778999987543211 1112344899999999999999999999986553
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.++||||+++ +|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 75 --------------~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 135 (288)
T 1ob3_A 75 --------------LVLVFEHLDQ-DLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR 135 (288)
T ss_dssp --------------EEEEEECCSE-EHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred --------------EEEEEEecCC-CHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 4999999985 99999874 2356899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||++......... .....||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 136 ~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~ 195 (288)
T 1ob3_A 136 E-------GELKIADFGLARAFGIPVRK----------YTHEIVTLWYRAPDVLMG---SKKYSTTIDIWSVGCIFAEMV 195 (288)
T ss_dssp T-------SCEEECCTTHHHHHCC-------------------CCCTTCCHHHHTT---CCSCCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEeECccccccCccccc----------cccccccccccCchheeC---CCCCCcHHHHHHHHHHHHHHH
Confidence 7 45999999999765432111 123468999999999975 245789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCc--cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH--EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
+|..||.+.+..+....+...........+....... ...+. ..............++.+.+||.+||+.||.+|||
T Consensus 196 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 274 (288)
T 1ob3_A 196 NGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT-VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT 274 (288)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC-CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC
T ss_pred hCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccc-cccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCC
Confidence 9999999888777666554421111111111000000 00000 00000001111234678899999999999999999
Q ss_pred HHHHHHHHH
Q 003185 821 AGDLYEMFV 829 (840)
Q Consensus 821 a~ELLehLe 829 (840)
++|+++|..
T Consensus 275 ~~e~l~hp~ 283 (288)
T 1ob3_A 275 AKQALEHAY 283 (288)
T ss_dssp HHHHHTSGG
T ss_pred HHHHhcCcc
Confidence 999999865
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=372.53 Aligned_cols=266 Identities=23% Similarity=0.356 Sum_probs=209.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCccee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 573 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l 573 (840)
...++|++.+.||+|+||.||+|.+ .+..||+|+.... ......+ .+.+|+.++.++ +|||||++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHR----ALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHH----HHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc---CCHHHHH----HHHHHHHHHHhhcCCcceeee
Confidence 4567899999999999999999985 2368999986422 2223333 349999999999 69999999
Q ss_pred eeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc----------------------------------
Q 003185 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---------------------------------- 619 (840)
Q Consensus 574 ~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~---------------------------------- 619 (840)
++++..... ..++||||+++|+|.+++......
T Consensus 92 ~~~~~~~~~-------------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (359)
T 3vhe_A 92 LGACTKPGG-------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITS 158 (359)
T ss_dssp EEEECSTTS-------------CCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------
T ss_pred eeeeecCCC-------------ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCc
Confidence 999876442 249999999999999999752110
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCCCCe
Q 003185 620 ---------------------------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 672 (840)
Q Consensus 620 ---------------------------~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~ 672 (840)
....+++..++.++.||+.||.|||++||+||||||+||||+.+ +.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~-------~~ 231 (359)
T 3vhe_A 159 SQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-------NV 231 (359)
T ss_dssp -------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-------GC
T ss_pred cccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-------Cc
Confidence 01228999999999999999999999999999999999999877 45
Q ss_pred EEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003185 673 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGL 751 (840)
Q Consensus 673 vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~ 751 (840)
+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||+| |..||.+.
T Consensus 232 ~kl~Dfg~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~il~ellt~g~~p~~~~ 299 (359)
T 3vhe_A 232 VKICDFGLARDIYKDPDY--------VRKGDARLPLKWMAPETIFD----RVYTIQSDVWSFGVLLWEIFSLGASPYPGV 299 (359)
T ss_dssp EEECCCGGGSCTTSCTTC--------EEC--CEECGGGCCHHHHHH----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred EEEEeccceeeecccccc--------hhccccCCCceeEChhhhcC----CCCCchhhhhhHHHHHHHHHhcCCCCCCcc
Confidence 999999999865432211 01233468899999999986 678999999999999999998 99999877
Q ss_pred CH-HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003185 752 SE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 752 ~~-~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~ 830 (840)
.. ..+...+.....+..+. ..++.+.+||.+||+.||.+|||+.+|++||+.
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 300 KIDEEFCRRLKEGTRMRAPD---------------------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp CCSHHHHHHHHHTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred chhHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 54 33444444443333321 124578999999999999999999999999998
Q ss_pred hcC
Q 003185 831 RTS 833 (840)
Q Consensus 831 l~~ 833 (840)
+.+
T Consensus 353 ~~~ 355 (359)
T 3vhe_A 353 LLQ 355 (359)
T ss_dssp HHH
T ss_pred HHH
Confidence 864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=364.38 Aligned_cols=290 Identities=21% Similarity=0.212 Sum_probs=210.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC---CCCcceeeeE
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEMYGH 576 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~---HpNIV~l~g~ 576 (840)
...++|++.+.||+|+||+||+|.+ .+..||+|++.......... .....+.+|+.++++++ ||||++++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGG---GLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSS---CCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccccccc---ccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 3457999999999999999999995 67889999976543221111 11122367777776664 9999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
+...... .....++||||+. ++|.+++.. .....+++..++.++.||+.||+|||++||+||||||+
T Consensus 83 ~~~~~~~---------~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~ 149 (308)
T 3g33_A 83 CATSRTD---------REIKVTLVFEHVD-QDLRTYLDK---APPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE 149 (308)
T ss_dssp EEECCSS---------SEEEEEEEEECCC-CBHHHHHHT---CCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTT
T ss_pred eeccCCC---------CceeEEEEehhhh-cCHHHHHhh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 9865421 2335799999997 599999975 22344999999999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
|||++.+ +.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||
T Consensus 150 Nil~~~~-------~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~ 207 (308)
T 3g33_A 150 NILVTSG-------GTVKLADFGLARIYSYQMA-----------LTPVVVTLWYRAPEVLLQ----STYATPVDMWSVGC 207 (308)
T ss_dssp TEEECTT-------SCEEECSCSCTTTSTTCCC-----------SGGGGCCCSSCCHHHHHT----SCCCSTHHHHHHHH
T ss_pred HEEEcCC-------CCEEEeeCccccccCCCcc-----------cCCccccccccCchHHcC----CCCCchHHHHHHHH
Confidence 9999877 4699999999976543211 133569999999999986 66899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 737 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 737 IL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
++|+|++|+.||.+.+..+....+...........+..........+.. .............++.+.+||.+||+.||.
T Consensus 208 il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 286 (308)
T 3g33_A 208 IFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPP-RGPRPVQSVVPEMEESGAQLLLEMLTFNPH 286 (308)
T ss_dssp HHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCC-CCCCCHHHHSCSCCHHHHHHHHHHTCSSTT
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCC-CCCCcHHHhCccccHHHHHHHHHHhcCCCc
Confidence 9999999999999988887776665432111111111110000000000 000011112234567899999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 003185 817 ERPTAGDLYEMFVA 830 (840)
Q Consensus 817 eRPSa~ELLehLe~ 830 (840)
+|||+.|+++|.+-
T Consensus 287 ~R~t~~e~l~h~~~ 300 (308)
T 3g33_A 287 KRISAFRALQHSYL 300 (308)
T ss_dssp TSCCHHHHHTSTTC
T ss_pred cCCCHHHHhcCccc
Confidence 99999999998543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=375.25 Aligned_cols=266 Identities=24% Similarity=0.366 Sum_probs=217.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC---------eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcc
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIV 571 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV 571 (840)
...++|.+.+.||+|+||.||+|.+.+ ..+|+|+.... ......+ .+.+|+.+++++ +|||||
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~E~~~l~~l~~hpnIv 138 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLS----DLISEMEMMKMIGKHKNII 138 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT---CCHHHHH----HHHHHHHHHHHHCCCTTBC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc---cCHHHHH----HHHHHHHHHHHhcCCchhh
Confidence 456789999999999999999999632 46899986432 2233333 348999999999 899999
Q ss_pred eeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHH
Q 003185 572 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAAL 640 (840)
Q Consensus 572 ~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-----------~~~~ls~~~~~~Ia~QIa~AL 640 (840)
++++++...... +|||||+++|+|.+++...... ....+++..++.|+.||+.||
T Consensus 139 ~~~~~~~~~~~~--------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL 204 (382)
T 3tt0_A 139 NLLGACTQDGPL--------------YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 204 (382)
T ss_dssp CEEEEECSSSSC--------------EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHH
T ss_pred hheeeeccCCce--------------EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHH
Confidence 999999876544 9999999999999999873211 124589999999999999999
Q ss_pred HHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003185 641 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720 (840)
Q Consensus 641 ~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~ 720 (840)
.|||++||+||||||+||||+.+ +.+||+|||+++........ .......+|+.|+|||++.+
T Consensus 205 ~~LH~~~ivH~Dlkp~NIll~~~-------~~~kL~DFG~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~-- 267 (382)
T 3tt0_A 205 EYLASKKCIHRDLAARNVLVTED-------NVMKIADFGLARDIHHIDYY--------KKTTNGRLPVKWMAPEALFD-- 267 (382)
T ss_dssp HHHHHTTCCCSCCCGGGEEECTT-------CCEEECSCSCCCCSSCCCTT--------CCCTTCCCGGGGSCHHHHHS--
T ss_pred HHHHhCCEecCCCCcceEEEcCC-------CcEEEcccCccccccccccc--------ccccCCCCCcceeCHHHhcC--
Confidence 99999999999999999999877 46999999999866432211 11223357889999999986
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhh
Q 003185 721 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 799 (840)
Q Consensus 721 ~~~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 799 (840)
..++.++|||||||++|+|++ |..||.+....++...+..+..+..+. ..
T Consensus 268 --~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~ 318 (382)
T 3tt0_A 268 --RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS---------------------------NC 318 (382)
T ss_dssp --CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCS---------------------------SC
T ss_pred --CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cC
Confidence 678999999999999999999 999999999888888887765443331 12
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 003185 800 LSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 800 s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~~ 834 (840)
+..+.+||.+||+.||.+|||+.+|+++|+.+...
T Consensus 319 ~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 319 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 45799999999999999999999999999988643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=365.55 Aligned_cols=266 Identities=24% Similarity=0.268 Sum_probs=204.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChH------------------HHHHhHHhHHHHHHH
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSAD------------------EIRNFEYSCLGEVRM 561 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~------------------~~~~f~~~~~rEi~i 561 (840)
..+++|++.+.||+|+||.||+|.+ .+..||+|+........... ......+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 5678999999999999999999987 57889999976443211100 001112345899999
Q ss_pred HHhCCCCCcceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHH
Q 003185 562 LGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALV 641 (840)
Q Consensus 562 L~~L~HpNIV~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~ 641 (840)
|++++||||+++++++.... ....||||||+++++|.+++. ...+++..++.++.||+.||.
T Consensus 90 l~~l~h~~iv~~~~~~~~~~------------~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~ 151 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPN------------EDHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIKGIE 151 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSS------------SSEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCeEEEEEEcCC------------CCEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHH
Confidence 99999999999999987532 124699999999999987643 357999999999999999999
Q ss_pred HHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC
Q 003185 642 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 721 (840)
Q Consensus 642 yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~ 721 (840)
|||++||+||||||+|||++.+ +.+||+|||+++........ .....||+.|+|||++.+..
T Consensus 152 ~lH~~~ivH~Dlkp~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~- 213 (298)
T 2zv2_A 152 YLHYQKIIHRDIKPSNLLVGED-------GHIKIADFGVSNEFKGSDAL----------LSNTVGTPAFMAPESLSETR- 213 (298)
T ss_dssp HHHHTTEECCCCCGGGEEECTT-------SCEEECCCTTCEECSSSSCE----------ECCCCSCGGGCCGGGCCTTC-
T ss_pred HHHHCCeeccCCCHHHEEECCC-------CCEEEecCCCcccccccccc----------ccCCcCCccccChhhhccCC-
Confidence 9999999999999999999877 45999999999876432211 12246999999999987511
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHH
Q 003185 722 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 801 (840)
Q Consensus 722 ~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 801 (840)
...++.++|||||||++|+|++|+.||.......+...+...... ++. ....++
T Consensus 214 ~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~-------------------------~~~~~~ 267 (298)
T 2zv2_A 214 KIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALE-FPD-------------------------QPDIAE 267 (298)
T ss_dssp CCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-CCS-------------------------SSCCCH
T ss_pred CCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCC-CCC-------------------------ccccCH
Confidence 012478999999999999999999999988777776666554221 110 012345
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003185 802 FLVDVFRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 802 ~L~dLI~rCL~~DP~eRPSa~ELLehLe 829 (840)
.+.+||.+||+.||.+|||+.||++|.+
T Consensus 268 ~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 268 DLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred HHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 7999999999999999999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=351.91 Aligned_cols=259 Identities=21% Similarity=0.330 Sum_probs=214.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
+..++|++.+.||+|+||.||+|.+ ++..+|+|++..... . .+ .+.+|+.++++++||||+++++++...
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~---~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~ 75 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--S---EE----DFIEEAEVMMKLSHPKLVQLYGVCLEQ 75 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB--C---HH----HHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC--C---HH----HHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 3457899999999999999999998 667899999753321 1 12 348999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 76 ~~--------------~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili 137 (267)
T 3t9t_A 76 AP--------------ICLVTEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 137 (267)
T ss_dssp SS--------------CEEEECCCTTCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE
T ss_pred CC--------------eEEEEeCCCCCcHHHHHhh----CcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE
Confidence 54 3999999999999999976 23468999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||++.......... .....+|+.|+|||++.+ ..++.++||||||+++|+
T Consensus 138 ~~~-------~~~kl~dfg~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 197 (267)
T 3t9t_A 138 GEN-------QVIKVSDFGMTRFVLDDQYTS---------STGTKFPVKWASPEVFSF----SRYSSKSDVWSFGVLMWE 197 (267)
T ss_dssp CGG-------GCEEECCTTGGGGBCCHHHHS---------TTSTTCCGGGCCHHHHHH----CCCCHHHHHHHHHHHHHH
T ss_pred CCC-------CCEEEcccccccccccccccc---------cccccccccccChhhhcC----CCccchhchhhhHHHHHH
Confidence 877 459999999998664321110 122357889999999986 568999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|++ |..||......+....+..+..+..+. ..+..+.+|+.+||..||.+||
T Consensus 198 l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rp 250 (267)
T 3t9t_A 198 VFSEGKIPYENRSNSEVVEDISTGFRLYKPR---------------------------LASTHVYQIMNHCWRERPEDRP 250 (267)
T ss_dssp HHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSC
T ss_pred HhccCCCCCCCCCHHHHHHHHhcCCcCCCCc---------------------------cCcHHHHHHHHHHccCChhhCc
Confidence 999 899999988888887777664433221 1245789999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 003185 820 TAGDLYEMFVARTSS 834 (840)
Q Consensus 820 Sa~ELLehLe~l~~~ 834 (840)
|+.+++++|+.+...
T Consensus 251 s~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 251 AFSRLLRQLAEIAES 265 (267)
T ss_dssp CHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHHHhc
Confidence 999999999988654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=385.27 Aligned_cols=256 Identities=25% Similarity=0.378 Sum_probs=214.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+..++|++.+.||+|+||.||+|.+.+..||||+..... ..+ .+.+|+.+|++++|||||++++++....
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~------~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~ 259 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA------TAQ----AFLAEASVMTQLRHSNLVQLLGVIVEEK 259 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT------TSH----HHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred cChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch------HHH----HHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence 567889999999999999999999999999999965321 122 3489999999999999999999987543
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. ..||||||+++|+|.+++... +...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 260 ~-------------~~~iv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~ 323 (450)
T 1k9a_A 260 G-------------GLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS 323 (450)
T ss_dssp S-------------CEEEEEECCTTCBHHHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred C-------------ceEEEEEecCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEC
Confidence 1 259999999999999999862 334579999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||+++...... ....+++.|+|||++.+ ..++.++|||||||+||||
T Consensus 324 ~~-------~~~kl~DfG~a~~~~~~~-------------~~~~~~~~y~aPE~~~~----~~~~~~sDvwslG~~l~el 379 (450)
T 1k9a_A 324 ED-------NVAKVSDFGLTKEASSTQ-------------DTGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEI 379 (450)
T ss_dssp TT-------SCEEECCCTTCEECC-------------------CCCTTTSCHHHHHS----SCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeeCCCcccccccc-------------cCCCCCcceeCHHHhcC----CCCCcHHHHHHHHHHHHHH
Confidence 77 469999999997543211 11247889999999986 6789999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 742 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 742 LT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
+| |..||.+.+..++...+..+.++..+. .+++.+.+||.+||..||.+|||
T Consensus 380 ~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~dp~~Rpt 432 (450)
T 1k9a_A 380 YSFGRVPYPRIPLKDVVPRVEKGYKMDAPD---------------------------GCPPAVYDVMKNCWHLDAATRPT 432 (450)
T ss_dssp HTTTCCSSTTSCTTTHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------cCCHHHHHHHHHHcCCChhHCcC
Confidence 98 999999888878877777765543332 13557999999999999999999
Q ss_pred HHHHHHHHHhhcCC
Q 003185 821 AGDLYEMFVARTSS 834 (840)
Q Consensus 821 a~ELLehLe~l~~~ 834 (840)
+.+|++.|+.+...
T Consensus 433 ~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 433 FLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHh
Confidence 99999999988754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=361.42 Aligned_cols=279 Identities=22% Similarity=0.301 Sum_probs=203.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 575 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g 575 (840)
..-++|++.+.||+|+||.||+|++ .+..||+|++... .....+ .+.+|+.++++++||||+++++
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~----~~~~E~~~l~~l~h~~iv~~~~ 78 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLR----DFEREIEILKSLQHDNIVKYKG 78 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC----CHHHHH----HHHHHHHHHHTCCCTTBCCEEE
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC----CHHHHH----HHHHHHHHHHhCCCCCEeeEEE
Confidence 4457899999999999999999985 5778999986422 233333 3489999999999999999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCC
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 655 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKP 655 (840)
++..... ...++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||
T Consensus 79 ~~~~~~~------------~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp 142 (295)
T 3ugc_A 79 VCYSAGR------------RNLKLIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLAT 142 (295)
T ss_dssp EECHHHH------------TSCEEEEECCTTCBHHHHHHH----CGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEecCCC------------CceEEEEEeCCCCCHHHHHHh----cccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCH
Confidence 9864321 135999999999999999986 224589999999999999999999999999999999
Q ss_pred CcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003185 656 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735 (840)
Q Consensus 656 eNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLG 735 (840)
+|||++.+ +.+||+|||++.......... .......+|..|+|||++.+ ..++.++||||||
T Consensus 143 ~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG 204 (295)
T 3ugc_A 143 RNILVENE-------NRVKIGDFGLTKVLPQDKEFF-------KVKEPGESPIFWYAPESLTE----SKFSVASDVWSFG 204 (295)
T ss_dssp GGEEEEET-------TEEEECCCCSCC--------------------CTTCGGGGCCHHHHHH----CCCCHHHHHHHHH
T ss_pred hhEEEcCC-------CeEEEccCcccccccCCccee-------eeccCCCCccceeCcHHhcC----CCCChHHHHHHHH
Confidence 99999977 469999999998764432110 01122347788999999987 6789999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcch-HHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003185 736 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD-ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 814 (840)
Q Consensus 736 vIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~D 814 (840)
|++|||+||..||.... ......+.......... .+... ..... .......+++.+.+||.+||+.|
T Consensus 205 ~~l~~l~~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~---~~~~~~~~~~~l~~li~~~l~~d 272 (295)
T 3ugc_A 205 VVLYELFTYIEKSKSPP-AEFMRMIGNDKQGQMIVFHLIEL--------LKNNG---RLPRPDGCPDEIYMIMTECWNNN 272 (295)
T ss_dssp HHHHHHHHTTCTTCSHH-HHHHHHHCTTCCTHHHHHHHHHH--------HHTTC---CCCCCTTCCHHHHHHHHHHSCSS
T ss_pred HHHHHHHhcccccCCCh-HHHHhhhcCccccchhHHHHHHH--------HhccC---cCCCCcCcCHHHHHHHHHHcCCC
Confidence 99999999999986432 22222211111100000 00000 00000 00111234568999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCC
Q 003185 815 PTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 815 P~eRPSa~ELLehLe~l~~~ 834 (840)
|.+|||+.+|++.|+.+...
T Consensus 273 p~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 273 VNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp GGGSCCHHHHHHHHHHHHHC
T ss_pred hhhCCCHHHHHHHHHHHHHh
Confidence 99999999999999988654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=366.30 Aligned_cols=291 Identities=20% Similarity=0.238 Sum_probs=211.1
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
-++|++.+.||+|+||.||+|.+. +..||+|++....... .. ..+.+|+.+|++++||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR---PV----DVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS---CH----HHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc---hH----HHHHHHHHHHHhcCCCCcceEEEEeecCC
Confidence 467999999999999999999984 7889999975332111 12 23479999999999999999999987544
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. ...+|||||+++++|.+++... .....+++..++.++.||+.||.|||++||+||||||+|||+.
T Consensus 81 ~------------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~ 146 (319)
T 4euu_A 81 T------------RHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRV 146 (319)
T ss_dssp T------------CCEEEEEECCTTCBHHHHHHSG--GGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred C------------ceEEEEEeCCCCCCHHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEe
Confidence 2 1459999999999999999852 1223489999999999999999999999999999999999983
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc----CCCCCCchhhHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH----KPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~----~~~~~s~kSDVWSLGvI 737 (840)
... +..+.+||+|||+++....... .....||+.|+|||++.... ....++.++|||||||+
T Consensus 147 ~~~---~~~~~~kL~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~i 212 (319)
T 4euu_A 147 IGE---DGQSVYKLTDFGAARELEDDEQ-----------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212 (319)
T ss_dssp ECT---TSCEEEEECCCTTCEECCTTCC-----------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHH
T ss_pred ccC---CCCceEEEccCCCceecCCCCc-----------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHH
Confidence 221 1236799999999987644221 12346999999999986311 12567899999999999
Q ss_pred HHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 003185 738 LLELLTLQVPYMGLS----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 813 (840)
Q Consensus 738 L~ELLTG~~PF~~~~----~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~ 813 (840)
+|||++|+.||.... ..++...+..+..+.....+.... ...+................+..+.+||.+||+.
T Consensus 213 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 289 (319)
T 4euu_A 213 FYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAE---NGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289 (319)
T ss_dssp HHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECST---TCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCC
T ss_pred HHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhccc---CCccccCccCCcccccchhHHHHhHHHHHHhccC
Confidence 999999999996432 234444444433222211111100 0000000000011123355678899999999999
Q ss_pred CCCCCCCHHHHHHHHHhhc
Q 003185 814 NPTERPTAGDLYEMFVART 832 (840)
Q Consensus 814 DP~eRPSa~ELLehLe~l~ 832 (840)
||.+|||++|+++|+....
T Consensus 290 dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 290 DQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CTTTSCCHHHHHHHHHHHT
T ss_pred ChhhhccHHHhhhccHHHh
Confidence 9999999999999987643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=358.33 Aligned_cols=268 Identities=24% Similarity=0.361 Sum_probs=203.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHh--CCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGA--LRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~--L~HpNIV~l~g~~~~ 579 (840)
...++|++.+.||+|+||.||+|.+.+..||+|++... ....+ .+|.+++.. ++||||+++++++..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-------~~~~~----~~e~~~~~~~~l~h~niv~~~~~~~~ 73 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR-------DEKSW----FRETELYNTVMLRHENILGFIASDMT 73 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG-------GHHHH----HHHHHHHHHTCCCCTTBCCEEEEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc-------cchhh----HHHHHHHHHhhccCcCeeeEEEeecc
Confidence 44578999999999999999999999999999997432 12222 556666666 789999999998765
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCeecc
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH--------SKHIMHR 651 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLH--------s~gIVHR 651 (840)
... .....++||||+++|+|.++++. ..+++..++.++.||+.||+||| ++||+||
T Consensus 74 ~~~----------~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~ 137 (301)
T 3q4u_A 74 SRH----------SSTQLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHR 137 (301)
T ss_dssp EET----------TEEEEEEEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECS
T ss_pred ccC----------CCceeEEehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecC
Confidence 321 12357999999999999999953 56999999999999999999999 9999999
Q ss_pred cCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCC--CCCchh
Q 003185 652 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN--LYGLEV 729 (840)
Q Consensus 652 DLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~--~~s~kS 729 (840)
||||+|||++.+ +.+||+|||+++.......... .......||+.|+|||++.+..... .++.++
T Consensus 138 Dlkp~Nill~~~-------~~~kl~Dfg~a~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 204 (301)
T 3q4u_A 138 DLKSKNILVKKN-------GQCCIADLGLAVMHSQSTNQLD------VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRV 204 (301)
T ss_dssp CCCGGGEEECTT-------SCEEECCCTTCEEEETTTTEEE------CCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHH
T ss_pred CCChHhEEEcCC-------CCEEEeeCCCeeeccccccccc------ccccccccccceeChhhhcCcCCCCcccCCchh
Confidence 999999999877 4699999999986654322111 0112346999999999998621111 345799
Q ss_pred hHHHHHHHHHHHHhC----------CCCCCCCC-----HHHHHHHHHcC-CCCCcchHHhhhccCccccccccCCCCCCc
Q 003185 730 DIWSYGCLLLELLTL----------QVPYMGLS-----ELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKP 793 (840)
Q Consensus 730 DVWSLGvIL~ELLTG----------~~PF~~~~-----~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~ 793 (840)
|||||||++|||+|| ..||.... ...+...+... ..+.++..
T Consensus 205 DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------- 262 (301)
T 3q4u_A 205 DIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNR---------------------- 262 (301)
T ss_dssp HHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG----------------------
T ss_pred hHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChh----------------------
Confidence 999999999999999 88885432 12222222211 22222211
Q ss_pred hhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 003185 794 EAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 831 (840)
Q Consensus 794 ~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l 831 (840)
......+..+.+||.+||+.||.+|||+.+|++.|+.+
T Consensus 263 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 263 WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 11234567899999999999999999999999999876
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=364.06 Aligned_cols=273 Identities=19% Similarity=0.310 Sum_probs=202.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCe-----eEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeE
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGSA-----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 576 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~ 576 (840)
+..++|++.+.||+|+||.||+|.+... .+|+|+..... ......+ .+.+|+.++++++||||++++++
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADI--IASSDIE----EFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHH----HHHHHHHHHTTCCCTTBCCCCEE
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccc--cCHHHHH----HHHHHHHHHHHCCCCceehhhce
Confidence 4567899999999999999999986332 68999864322 1223333 34899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 655 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKP 655 (840)
+...... ......++||||+.+|+|.+++..... .....+++..++.++.||+.||.|||++||+||||||
T Consensus 94 ~~~~~~~--------~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp 165 (323)
T 3qup_A 94 SLRSRAK--------GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAA 165 (323)
T ss_dssp EECC---------------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred eeccccc--------cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCc
Confidence 9865422 112235999999999999999976322 1223589999999999999999999999999999999
Q ss_pred CcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003185 656 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735 (840)
Q Consensus 656 eNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLG 735 (840)
+|||++.+ +.+||+|||+++......... ......+|+.|+|||++.+ ..++.++||||||
T Consensus 166 ~NIli~~~-------~~~kl~Dfg~a~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG 226 (323)
T 3qup_A 166 RNCMLAED-------MTVCVADFGLSRKIYSGDYYR--------QGCASKLPVKWLALESLAD----NLYTVHSDVWAFG 226 (323)
T ss_dssp GGEEECTT-------SCEEECCCCC-------------------------CCGGGCCHHHHHH----CCCCHHHHHHHHH
T ss_pred ceEEEcCC-------CCEEEeecccccccccccccc--------ccccccCcccccCchhhcC----CCCCCccchhhHH
Confidence 99999877 469999999998664422110 1122347889999999987 6789999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003185 736 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 814 (840)
Q Consensus 736 vIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~D 814 (840)
|++|+|++ |..||.+....++...+.....+..+. ..+..+.+||.+||..|
T Consensus 227 ~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~d 279 (323)
T 3qup_A 227 VTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPP---------------------------ECMEEVYDLMYQCWSAD 279 (323)
T ss_dssp HHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHTTCSS
T ss_pred HHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCCC---------------------------ccCHHHHHHHHHHccCC
Confidence 99999999 999999988888777776654433221 12457999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCC
Q 003185 815 PTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 815 P~eRPSa~ELLehLe~l~~~ 834 (840)
|.+|||+.++++.|+.+...
T Consensus 280 p~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 280 PKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp GGGSCCHHHHHHHHHHHHHC
T ss_pred hhhCcCHHHHHHHHHHHHHH
Confidence 99999999999999987644
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=359.55 Aligned_cols=265 Identities=21% Similarity=0.346 Sum_probs=203.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC---------eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcce
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVE 572 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~ 572 (840)
+..++|.+.+.||+|+||.||+|.+.. ..+|+|+..... ....+.+.+|+.++++++||||++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~ 76 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--------RNYSESFFEAASMMSKLSHKHLVL 76 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--------GGGHHHHHHHHHHHHTSCCTTBCC
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--------HHHHHHHHHHHHHHHhCCCCCEeE
Confidence 456789999999999999999998633 468999864221 122334589999999999999999
Q ss_pred eeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Q 003185 573 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRD 652 (840)
Q Consensus 573 l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRD 652 (840)
+++++...... ++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+|||
T Consensus 77 ~~~~~~~~~~~--------------~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~D 138 (289)
T 4fvq_A 77 NYGVCVCGDEN--------------ILVQEFVKFGSLDTYLKK----NKNCINILWKLEVAKQLAAAMHFLEENTLIHGN 138 (289)
T ss_dssp EEEEECCTTCC--------------EEEEECCTTCBHHHHHHH----TGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred EEEEEEeCCCC--------------EEEEECCCCCCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCC
Confidence 99999866543 999999999999999986 223489999999999999999999999999999
Q ss_pred CCCCcEEEeccccc-CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhH
Q 003185 653 IKSENILIDLERKK-ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 731 (840)
Q Consensus 653 LKPeNILLd~~~~~-~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDV 731 (840)
|||+|||++.++.. ......+||+|||++...... ....||+.|+|||++.+ ...++.++||
T Consensus 139 lkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~---~~~~~~~~Di 201 (289)
T 4fvq_A 139 VCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK--------------DILQERIPWVPPECIEN---PKNLNLATDK 201 (289)
T ss_dssp CCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH--------------HHHHHTTTTSCHHHHHC---GGGCCHHHHH
T ss_pred cCcceEEEecCCcccccccceeeeccCcccccccCc--------------cccCCcCcccCHHHhCC---CCCCCchhHH
Confidence 99999999877421 112234999999998755332 12347899999999975 2457899999
Q ss_pred HHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 003185 732 WSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 810 (840)
Q Consensus 732 WSLGvIL~ELLTG-~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rC 810 (840)
|||||++|||++| .+||................. ++. ..+..+.+||.+|
T Consensus 202 wslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~--~~~---------------------------~~~~~l~~li~~~ 252 (289)
T 4fvq_A 202 WSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ--LPA---------------------------PKAAELANLINNC 252 (289)
T ss_dssp HHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--CCC---------------------------CSSCTTHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCccccchHHHHHHhhccCC--CCC---------------------------CCCHHHHHHHHHH
Confidence 9999999999995 555655555554444332211 110 0123578999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhcCCCCCC
Q 003185 811 TEENPTERPTAGDLYEMFVARTSSSISS 838 (840)
Q Consensus 811 L~~DP~eRPSa~ELLehLe~l~~~~~s~ 838 (840)
|+.||.+|||+.+++++|+.+..+..+.
T Consensus 253 l~~dp~~Rps~~~ll~~l~~l~~p~~~~ 280 (289)
T 4fvq_A 253 MDYEPDHRPSFRAIIRDLNSLFTPDLVP 280 (289)
T ss_dssp SCSSGGGSCCHHHHHHHHHTCC------
T ss_pred cCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999999998876544
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=362.57 Aligned_cols=281 Identities=23% Similarity=0.287 Sum_probs=206.6
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+++|++.+.||+|+||.||+|.+. +..+|+|++... ...... .+.+.+|+.++++++||||+++++++....
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 75 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLES--EDDPVI----KKIALREIRMLKQLKHPNLVNLLEVFRRKR 75 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCC--CC-HHH----HHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecc--ccchHH----HHHHHHHHHHHHhCCCCCccchhheeecCC
Confidence 578999999999999999999984 778999986432 222222 234489999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .++||||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 76 ~--------------~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~ 136 (311)
T 4agu_A 76 R--------------LHLVFEYCDHTVLHELDRY-----QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT 136 (311)
T ss_dssp E--------------EEEEEECCSEEHHHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred e--------------EEEEEEeCCCchHHHHHhh-----hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc
Confidence 3 5999999999999988764 35689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||++......... .....||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 137 ~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~~l 196 (311)
T 4agu_A 137 KH-------SVIKLCDFGFARLLTGPSDY----------YDDEVATRWYRSPELLVG---DTQYGPPVDVWAIGCVFAEL 196 (311)
T ss_dssp TT-------SCEEECCCTTCEECC----------------------GGGCCHHHHHT---CSCCCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeeCCCchhccCcccc----------cCCCcCCccccChHHHhc---CCCCCcchhhHHHHHHHHHH
Confidence 77 46999999999876432211 123468999999999975 35678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCc---cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH---EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~---~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
++|..||.+....+....+........+.......... ....................+..+.+||.+||..||.+|
T Consensus 197 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 276 (311)
T 4agu_A 197 LSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTER 276 (311)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTS
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhc
Confidence 99999999988877766665542222222111110000 000000000000011123456789999999999999999
Q ss_pred CCHHHHHHHHH
Q 003185 819 PTAGDLYEMFV 829 (840)
Q Consensus 819 PSa~ELLehLe 829 (840)
||++++++|.+
T Consensus 277 pt~~ell~hp~ 287 (311)
T 4agu_A 277 LTCEQLLHHPY 287 (311)
T ss_dssp CCHHHHHTSGG
T ss_pred CCHHHHhcChH
Confidence 99999999854
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=366.54 Aligned_cols=252 Identities=25% Similarity=0.331 Sum_probs=210.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++.+.||+|+||.||+|+. .+..+|+|+...... ......+.+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 77 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-----VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD 77 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe
Confidence 4578999999999999999999997 578899999753211 011112345889999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .|+||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 78 ~~~--------------~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl 138 (318)
T 1fot_A 78 AQQ--------------IFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL 138 (318)
T ss_dssp SSE--------------EEEEECCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEE
T ss_pred CCE--------------EEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEE
Confidence 553 5999999999999999986 356999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||+++...... ....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 139 l~~~-------g~~kL~Dfg~a~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ 194 (318)
T 1fot_A 139 LDKN-------GHIKITDFGFAKYVPDVT-------------YTLCGTPDYIAPEVVST----KPYNKSIDWWSFGILIY 194 (318)
T ss_dssp ECTT-------SCEEECCCSSCEECSSCB-------------CCCCSCTTTCCHHHHTT----CCBCTTHHHHHHHHHHH
T ss_pred EcCC-------CCEEEeecCcceecCCcc-------------ccccCCccccCHhHhcC----CCCCcccchhhhHHHHH
Confidence 9877 469999999998654311 23469999999999976 66899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
||++|..||.+.+.......+..... .++. ..+..+.+||.+||..||.+||
T Consensus 195 ell~g~~pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~~~~~~~li~~lL~~dp~~R~ 246 (318)
T 1fot_A 195 EMLAGYTPFYDSNTMKTYEKILNAEL-RFPP---------------------------FFNEDVKDLLSRLITRDLSQRL 246 (318)
T ss_dssp HHHHSSCTTCCSSHHHHHHHHHHCCC-CCCT---------------------------TSCHHHHHHHHHHTCSCTTTCT
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCC-CCCC---------------------------CCCHHHHHHHHHHhccCHHHcC
Confidence 99999999999888888877766532 1111 1245789999999999999999
Q ss_pred -----CHHHHHHHHH
Q 003185 820 -----TAGDLYEMFV 829 (840)
Q Consensus 820 -----Sa~ELLehLe 829 (840)
++++|++|..
T Consensus 247 ~~~~~~~~~i~~hp~ 261 (318)
T 1fot_A 247 GNLQNGTEDVKNHPW 261 (318)
T ss_dssp TSSTTTTHHHHTSGG
T ss_pred CCcCCCHHHHhcCcc
Confidence 9999999854
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=356.42 Aligned_cols=259 Identities=20% Similarity=0.306 Sum_probs=200.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeE
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 576 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~ 576 (840)
+..++|++.+.||+|+||.||+|.+. +..+|+|+.. .. ...... +.+.+|+.++++++||||++++++
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~--~~-~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~ 84 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK--NC-TSDSVR----EKFLQEALTMRQFDHPHIVKLIGV 84 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECT--TT-TSHHHH----HHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecc--cc-CCHHHH----HHHHHHHHHHHhCCCCccceEEEE
Confidence 45678999999999999999999873 2347777643 21 122222 345899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
+... . .++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+
T Consensus 85 ~~~~-~--------------~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 145 (281)
T 1mp8_A 85 ITEN-P--------------VWIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAAR 145 (281)
T ss_dssp ECSS-S--------------CEEEEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EccC-c--------------cEEEEecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHH
Confidence 7432 2 3999999999999999976 2346899999999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
|||++.+ +.+||+|||+++........ ......+|+.|+|||++.+ ..++.++|||||||
T Consensus 146 Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~ 205 (281)
T 1mp8_A 146 NVLVSSN-------DCVKLGDFGLSRYMEDSTYY---------KASKGKLPIKWMAPESINF----RRFTSASDVWMFGV 205 (281)
T ss_dssp GEEEEET-------TEEEECC----------------------------CCGGGCCHHHHHH----CCCSHHHHHHHHHH
T ss_pred HEEECCC-------CCEEECccccccccCccccc---------ccccCCCcccccChhhccc----CCCCCccCchHHHH
Confidence 9999977 46999999999876442211 1122357889999999986 67899999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 737 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 737 IL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
++|||++ |..||.+....++...+.....+.++. ..+..+.+||.+||..||
T Consensus 206 ~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p 258 (281)
T 1mp8_A 206 CMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------------------NCPPTLYSLMTKCWAYDP 258 (281)
T ss_dssp HHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSG
T ss_pred HHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHccCCh
Confidence 9999997 999999888877777777664433321 124578999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 003185 816 TERPTAGDLYEMFVARTS 833 (840)
Q Consensus 816 ~eRPSa~ELLehLe~l~~ 833 (840)
.+|||+.+|+++|+.+..
T Consensus 259 ~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 259 SRRPRFTELKAQLSTILE 276 (281)
T ss_dssp GGSCCHHHHHHHHHHHHH
T ss_pred hhCcCHHHHHHHHHHHHH
Confidence 999999999999998753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=366.07 Aligned_cols=255 Identities=27% Similarity=0.451 Sum_probs=210.8
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
.|...+.||+|+||.||+|.. .+..||||+...... ...+ .+.+|+.++++++||||+++++++.....
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~----~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~- 116 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ----QRRE----LLFNEVVIMRDYQHFNVVEMYKSYLVGEE- 116 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CSHH----HHHHHHHHHTTCCCTTBCCEEEEEEETTE-
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch----hHHH----HHHHHHHHHHhCCCCCcceEEEEEEECCE-
Confidence 478888999999999999997 578999999764321 1122 34899999999999999999999986553
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.++||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 117 -------------~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 117 -------------LWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp -------------EEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred -------------EEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC
Confidence 5999999999999999864 469999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.+||+|||++......... .....||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 178 -------~~~kl~Dfg~~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~il~el~~ 236 (321)
T 2c30_A 178 -------GRVKLSDFGFCAQISKDVPK----------RKSLVGTPYWMAPEVISR----SLYATEVDIWSLGIMVIEMVD 236 (321)
T ss_dssp -------CCEEECCCTTCEECCSSSCC----------BCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHHHH
T ss_pred -------CcEEEeeeeeeeecccCccc----------cccccCCccccCHhhhcC----CCCCchhhHHHHHHHHHHHHh
Confidence 45999999999766432111 133469999999999976 668899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~E 823 (840)
|+.||.+....+....+.....+.+.. ....+..+.+||.+||..||.+|||+.+
T Consensus 237 g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~e 291 (321)
T 2c30_A 237 GEPPYFSDSPVQAMKRLRDSPPPKLKN-------------------------SHKVSPVLRDFLERMLVRDPQERATAQE 291 (321)
T ss_dssp SSCTTTTSCHHHHHHHHHHSSCCCCTT-------------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCCCCCHHHHHHHHhcCCCCCcCc-------------------------cccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 999999888888777776654433221 1123557899999999999999999999
Q ss_pred HHHHHHhhcCC
Q 003185 824 LYEMFVARTSS 834 (840)
Q Consensus 824 LLehLe~l~~~ 834 (840)
+++|..-....
T Consensus 292 ll~hp~~~~~~ 302 (321)
T 2c30_A 292 LLDHPFLLQTG 302 (321)
T ss_dssp HHTSGGGGGCC
T ss_pred HhcChhhccCC
Confidence 99997765543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=367.57 Aligned_cols=260 Identities=19% Similarity=0.306 Sum_probs=205.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCee----EEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSAD----AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 575 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~----vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g 575 (840)
...++|++.+.||+|+||.||+|.+ .+.. +|+|..... ... .....+.+|+.++++++||||+++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~ 84 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSP----KANKEILDEAYVMASVDNPHVCRLLG 84 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------------CHHHHHHHHHHHHHCCBTTBCCEEE
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc---cCH----HHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 4457899999999999999999997 3333 455553211 111 12234589999999999999999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCC
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 655 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKP 655 (840)
++.... .++||||+.+|+|.+++.. ....+++..++.|+.||+.||.|||++||+||||||
T Consensus 85 ~~~~~~---------------~~~v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp 145 (327)
T 3poz_A 85 ICLTST---------------VQLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAA 145 (327)
T ss_dssp EEESSS---------------EEEEEECCTTCBHHHHHHH----STTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred EEecCC---------------eEEEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCh
Confidence 998543 4899999999999999976 235689999999999999999999999999999999
Q ss_pred CcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003185 656 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735 (840)
Q Consensus 656 eNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLG 735 (840)
+|||++.+ +.+||+|||+++......... ......||+.|+|||++.+ ..++.++||||||
T Consensus 146 ~NIll~~~-------~~~kl~Dfg~a~~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG 206 (327)
T 3poz_A 146 RNVLVKTP-------QHVKITDFGLAKLLGAEEKEY--------HAEGGKVPIKWMALESILH----RIYTHQSDVWSYG 206 (327)
T ss_dssp GGEEEEET-------TEEEECCTTHHHHHTTTCC---------------CCCGGGSCHHHHHH----CCCCHHHHHHHHH
T ss_pred heEEECCC-------CCEEEccCcceeEccCCcccc--------cccCCCccccccChHHhcc----CCCCchhhhhhhH
Confidence 99999877 469999999998764432211 1122357889999999987 6789999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003185 736 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 814 (840)
Q Consensus 736 vIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~D 814 (840)
|++|||+| |..||.+....++...+........+. ..+..+.+|+.+||+.|
T Consensus 207 ~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~ 259 (327)
T 3poz_A 207 VTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP---------------------------ICTIDVYMIMVKCWMID 259 (327)
T ss_dssp HHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT---------------------------TBCHHHHHHHHHHTCSC
T ss_pred HHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCc---------------------------cCCHHHHHHHHHHcCCC
Confidence 99999999 999999888877777776664433221 12457899999999999
Q ss_pred CCCCCCHHHHHHHHHhhcC
Q 003185 815 PTERPTAGDLYEMFVARTS 833 (840)
Q Consensus 815 P~eRPSa~ELLehLe~l~~ 833 (840)
|.+||++.+|+++|+.+..
T Consensus 260 p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 260 ADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp GGGSCCHHHHHHHHHHHHT
T ss_pred hhhCCCHHHHHHHHHHHHh
Confidence 9999999999999988754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=358.13 Aligned_cols=267 Identities=24% Similarity=0.396 Sum_probs=199.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+.-++|++.+.||+|+||.||+|.+.+ .+|+|++... .......+.+ .+|+.++++++||||++++++....
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~--~~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~- 92 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVT--APTPQQLQAF----KNEVGVLRKTRHVNILLFMGYSTAP- 92 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCS--SCCHHHHHHH----HHHHHHHTTCCCTTBCCEEEEECSS-
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEecc--CCCHHHHHHH----HHHHHHHHhCCCCcEEEEEeeccCC-
Confidence 556789999999999999999999766 4899986543 2333344444 8999999999999999999975432
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
..++||||+.+++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 93 --------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~ 154 (289)
T 3og7_A 93 --------------QLAIVTQWCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH 154 (289)
T ss_dssp --------------SCEEEEECCCEEEHHHHHTT----C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred --------------ccEEEEEecCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence 24999999999999999864 235689999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||++......... .......||+.|+|||++... ....++.++|||||||++|+|
T Consensus 155 ~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~Di~slG~il~el 218 (289)
T 3og7_A 155 ED-------NTVKIGDFGLATEKSRWSGS--------HQFEQLSGSILWMAPEVIRMQ-DSNPYSFQSDVYAFGIVLYEL 218 (289)
T ss_dssp TT-------TEEEECCCC--------------------------CCCTTCCHHHHC-----CCSCHHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEccceecccccccccc--------ccccccCCCccccCchhhccc-CCCCCCcccchHHHHHHHHHH
Confidence 77 46999999999765432111 112234699999999998632 125678999999999999999
Q ss_pred HhCCCCCCCCCH-HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 742 LTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 742 LTG~~PF~~~~~-~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
++|+.||.+... ..+...+.....+.... .....+++.+.+||.+||..||.+|||
T Consensus 219 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps 275 (289)
T 3og7_A 219 MTGQLPYSNINNRDQIIEMVGRGSLSPDLS-----------------------KVRSNCPKRMKRLMAECLKKKRDERPS 275 (289)
T ss_dssp HHSSCTTSSCCCHHHHHHHHHHTSCCCCTT-----------------------SSCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHCCCCccccchHHHHHHHhcccccCcchh-----------------------hccccCCHHHHHHHHHHccCChhhCCC
Confidence 999999987644 44445554443211110 011223568999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 003185 821 AGDLYEMFVARTS 833 (840)
Q Consensus 821 a~ELLehLe~l~~ 833 (840)
+.+|++.|+.+..
T Consensus 276 ~~ell~~L~~l~~ 288 (289)
T 3og7_A 276 FPRILAEIEELAR 288 (289)
T ss_dssp HHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhh
Confidence 9999999998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=362.80 Aligned_cols=285 Identities=21% Similarity=0.306 Sum_probs=196.0
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
..++|++.+.||+|+||.||+|.+ .+..||+|++....... .. ..+.+|+.+|++++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~----~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 75 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG---TP----STAIREISLMKELKHENIVRLYDVIHTE 75 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTC---SC----HHHHHHHHHHTTCCBTTBCCEEEEECCT
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc---cH----HHHHHHHHHHHhcCCCCcceEEEEEEEC
Confidence 356899999999999999999987 47889999976543211 11 2348899999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
. ..+|||||++ ++|.+++..... .....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 76 ~--------------~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl 140 (317)
T 2pmi_A 76 N--------------KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLL 140 (317)
T ss_dssp T--------------EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred C--------------eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeE
Confidence 4 3599999998 599999976322 12245899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||+++........ .....||+.|+|||++.+ ...++.++|||||||++|
T Consensus 141 ~~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 200 (317)
T 2pmi_A 141 INKR-------GQLKLGDFGLARAFGIPVNT----------FSSEVVTLWYRAPDVLMG---SRTYSTSIDIWSCGCILA 200 (317)
T ss_dssp ECTT-------CCEEECCCSSCEETTSCCCC----------CCCCCSCCTTCCHHHHTT---CCCCCTHHHHHHHHHHHH
T ss_pred EcCC-------CCEEECcCccceecCCCccc----------CCCCcccccccCchHhhC---CCCCCcHHHHHHHHHHHH
Confidence 9877 45999999999866432111 123468999999999975 245789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCC---CcchHHhhhccCccccccccCC-CC---CCchhhhhhHHHHHHHHHHhcc
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRP---RLTDELEALGSCHEHEVAQSGS-GF---EKPEAELETLSFLVDVFRRCTE 812 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p---~l~~~l~~~~~~~~~~~~~~~~-~~---~~~~~~~~~s~~L~dLI~rCL~ 812 (840)
||++|+.||.+.+..+....+...... .....+......... +..... .. ..+......+..+.+||.+||+
T Consensus 201 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 279 (317)
T 2pmi_A 201 EMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPN-IQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQ 279 (317)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTT-CCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSC
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccc-cccccchhHHHhhcccccccCCHHHHHHHHHHCC
Confidence 999999999998887777666543111 111111110000000 000000 00 0000111345689999999999
Q ss_pred cCCCCCCCHHHHHHHHHh
Q 003185 813 ENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 813 ~DP~eRPSa~ELLehLe~ 830 (840)
.||.+|||+.|+++|.+-
T Consensus 280 ~dP~~Rpt~~e~l~hp~f 297 (317)
T 2pmi_A 280 LNPDMRLSAKQALHHPWF 297 (317)
T ss_dssp SSGGGSCCHHHHTTSGGG
T ss_pred CCcccCCCHHHHhCChhh
Confidence 999999999999998543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=354.38 Aligned_cols=256 Identities=24% Similarity=0.291 Sum_probs=209.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++.+.||+|+||.||+|.+ .+..+|+|++.... .........+.+|+.++++++||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-----LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD 80 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccc-----cchhhHHHHHHHHHHHHHcCCCCCCcchhheEec
Confidence 4678999999999999999999998 45579999875321 1122234456899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.. ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 81 ~~--------------~~~lv~e~~~~~~l~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nil 141 (279)
T 3fdn_A 81 AT--------------RVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL 141 (279)
T ss_dssp SS--------------EEEEEECCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEE
T ss_pred CC--------------EEEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEE
Confidence 55 35999999999999999986 246899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++....... .....||+.|+|||++.+ ..++.++||||||+++|
T Consensus 142 i~~~-------~~~~l~Dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 198 (279)
T 3fdn_A 142 LGSA-------GELKIADFGWSVHAPSSR------------RTDLCGTLDYLPPEMIEG----RMHDEKVDLWSLGVLCY 198 (279)
T ss_dssp ECTT-------SCEEECSCCEESCC--------------------CCCCTTCCHHHHTT----CCCCTTHHHHHHHHHHH
T ss_pred EcCC-------CCEEEEeccccccCCccc------------ccccCCCCCccCHhHhcc----CCCCccchhHhHHHHHH
Confidence 9877 459999999986543321 123468999999999976 66789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|++|..||...+..+....+...... ++. ..+..+.+||.+||..||.+||
T Consensus 199 ~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp 250 (279)
T 3fdn_A 199 EFLVGKPPFEANTYQETYKRISRVEFT-FPD---------------------------FVTEGARDLISRLLKHNPSQRP 250 (279)
T ss_dssp HHHHSSCTTCCSSHHHHHHHHHHTCCC-CCT---------------------------TSCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHCCCCCCCCcHHHHHHHHHhCCCC-CCC---------------------------cCCHHHHHHHHHHhccChhhCC
Confidence 999999999988888877777654321 111 1245789999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 003185 820 TAGDLYEMFVART 832 (840)
Q Consensus 820 Sa~ELLehLe~l~ 832 (840)
|+.+|++|.+-..
T Consensus 251 s~~e~l~h~~~~~ 263 (279)
T 3fdn_A 251 MLREVLEHPWITA 263 (279)
T ss_dssp CHHHHHHCHHHHH
T ss_pred CHHHHhhCccccC
Confidence 9999999976444
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=354.29 Aligned_cols=265 Identities=21% Similarity=0.314 Sum_probs=207.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
...++|++.+.||+|+||.||+|.+ .+..+|+|++............ ...+.+.+|+.++++++||||+++++++..
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI-EKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHH-CCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHH-HHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 5568999999999999999999998 6788999987554333222221 112455899999999999999999999864
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCCCc
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSEN 657 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~g--IVHRDLKPeN 657 (840)
.. ++||||+++++|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|
T Consensus 95 ~~----------------~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~N 154 (287)
T 4f0f_A 95 PP----------------RMVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPN 154 (287)
T ss_dssp TT----------------EEEEECCTTCBHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGG
T ss_pred CC----------------eEEEEecCCCCHHHHHhc----ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcce
Confidence 32 799999999999998864 3357999999999999999999999999 9999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
||++.++. .....+||+|||+++...... ....||+.|+|||++.. ....++.++|||||||+
T Consensus 155 il~~~~~~--~~~~~~kl~Dfg~~~~~~~~~-------------~~~~g~~~y~aPE~~~~--~~~~~~~~~Di~slG~~ 217 (287)
T 4f0f_A 155 IFLQSLDE--NAPVCAKVADFGLSQQSVHSV-------------SGLLGNFQWMAPETIGA--EEESYTEKADTYSFAMI 217 (287)
T ss_dssp EEESCCCT--TCSCCEEECCCTTCBCCSSCE-------------ECCCCCCTTSCGGGSSC--SSCEECHHHHHHHHHHH
T ss_pred EEEeccCC--CCceeEEeCCCCccccccccc-------------cccCCCccccCchhhcc--CCCCcCchhhHHHHHHH
Confidence 99987632 233459999999997543311 22468999999999853 12457899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHH--HHHHHcC-CCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003185 738 LLELLTLQVPYMGLSELEI--HDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 814 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el--~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~D 814 (840)
+|+|++|+.||........ ...+... ..+.++. ..++.+.+||.+||+.|
T Consensus 218 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~d 270 (287)
T 4f0f_A 218 LYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE---------------------------DCPPRLRNVIELCWSGD 270 (287)
T ss_dssp HHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCT---------------------------TSCHHHHHHHHHHTCSS
T ss_pred HHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCc---------------------------ccCHHHHHHHHHHhcCC
Confidence 9999999999976643332 3333332 2222221 23557999999999999
Q ss_pred CCCCCCHHHHHHHHHhh
Q 003185 815 PTERPTAGDLYEMFVAR 831 (840)
Q Consensus 815 P~eRPSa~ELLehLe~l 831 (840)
|.+|||+.+|++.|+.+
T Consensus 271 p~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 271 PKKRPHFSYIVKELSEL 287 (287)
T ss_dssp GGGSCCHHHHHHHHHTC
T ss_pred hhhCcCHHHHHHHHHhC
Confidence 99999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=369.10 Aligned_cols=258 Identities=22% Similarity=0.357 Sum_probs=205.8
Q ss_pred CCCCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeee
Q 003185 499 LDPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 575 (840)
Q Consensus 499 ~~p~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g 575 (840)
+++..+++|++.+.||+|+||.||+|++ .+..+|+|++..... ......+ .+.+|+.++.++ +||||+++++
T Consensus 3 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~----~~~~E~~~l~~~~~hp~iv~l~~ 77 (345)
T 3a8x_A 3 MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV-NDDEDID----WVQTEKHVFEQASNHPFLVGLHS 77 (345)
T ss_dssp CCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS-CSHHHHH----HHHHHHHHHHHTTTCTTBCCEEE
T ss_pred CCCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh-cchHHHH----HHHHHHHHHHhcCCCCccCeEEE
Confidence 3456788999999999999999999998 478899999764432 2222333 348899999988 7999999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCC
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 655 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKP 655 (840)
++..... .||||||++||+|..++.. ...+++..++.++.||+.||.|||++||+||||||
T Consensus 78 ~~~~~~~--------------~~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp 138 (345)
T 3a8x_A 78 CFQTESR--------------LFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKL 138 (345)
T ss_dssp EEECSSE--------------EEEEECCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred EEEeCCE--------------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCH
Confidence 9986553 5999999999999999976 24699999999999999999999999999999999
Q ss_pred CcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003185 656 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735 (840)
Q Consensus 656 eNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLG 735 (840)
+|||++.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++||||||
T Consensus 139 ~NIll~~~-------g~~kL~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG 197 (345)
T 3a8x_A 139 DNVLLDSE-------GHIKLTDYGMCKEGLRPGD----------TTSTFCGTPNYIAPEILRG----EDYGFSVDWWALG 197 (345)
T ss_dssp GGEEECTT-------SCEEECCGGGCBCSCCTTC----------CBCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHH
T ss_pred HHEEECCC-------CCEEEEeccccccccCCCC----------cccccCCCccccCccccCC----CCCChHHhHHHHH
Confidence 99999877 4699999999975432111 1233579999999999986 6689999999999
Q ss_pred HHHHHHHhCCCCCCCC---------CHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHH
Q 003185 736 CLLLELLTLQVPYMGL---------SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 806 (840)
Q Consensus 736 vIL~ELLTG~~PF~~~---------~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dL 806 (840)
|+||||++|+.||... ....+...+..... .++. ..+..+.+|
T Consensus 198 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~~l 249 (345)
T 3a8x_A 198 VLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPR---------------------------SLSVKAASV 249 (345)
T ss_dssp HHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-CCCT---------------------------TSCHHHHHH
T ss_pred HHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-CCCC---------------------------CCCHHHHHH
Confidence 9999999999999652 22233334433211 1111 124578999
Q ss_pred HHHhcccCCCCCCCH------HHHHHHHH
Q 003185 807 FRRCTEENPTERPTA------GDLYEMFV 829 (840)
Q Consensus 807 I~rCL~~DP~eRPSa------~ELLehLe 829 (840)
|.+||..||.+||++ ++|++|..
T Consensus 250 i~~lL~~dP~~R~~~~~~~~~~~i~~hp~ 278 (345)
T 3a8x_A 250 LKSFLNKDPKERLGCHPQTGFADIQGHPF 278 (345)
T ss_dssp HHHHTCSSTTTSTTCCTTTHHHHHHTSGG
T ss_pred HHHHhcCCHhHCCCCCCcCCHHHHhcCCc
Confidence 999999999999995 89998854
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=361.01 Aligned_cols=270 Identities=24% Similarity=0.343 Sum_probs=207.4
Q ss_pred ceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 586 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~ 586 (840)
|...+.||+|+||.||+|.+++..+|+|++............ +.+.+|+.++++++||||+++++++......
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~--- 105 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK----QQFDQEIKVMAKCQHENLVELLGFSSDGDDL--- 105 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSC---
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHH----HHHHHHHHHHHhcCCCCeEEEEEEEecCCce---
Confidence 556799999999999999999999999997543322222222 3458999999999999999999999866543
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEeccccc
Q 003185 587 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 666 (840)
Q Consensus 587 ~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~ 666 (840)
++||||+++++|.+++... .....+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 106 -----------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~--- 169 (307)
T 2nru_A 106 -----------CLVYVYMPNGSLLDRLSCL--DGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEA--- 169 (307)
T ss_dssp -----------EEEEECCTTCBHHHHHHTG--GGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---
T ss_pred -----------EEEEEecCCCcHHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCC---
Confidence 9999999999999999752 223568999999999999999999999999999999999999876
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 003185 667 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 746 (840)
Q Consensus 667 ~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~ 746 (840)
+.+||+|||++.......... ......||+.|+|||++.+ .++.++|||||||++|+|++|..
T Consensus 170 ----~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~-----~~~~~~Dv~slG~il~~l~~g~~ 232 (307)
T 2nru_A 170 ----FTAKISDFGLARASEKFAQTV--------MTSRIVGTTAYMAPEALRG-----EITPKSDIYSFGVVLLEIITGLP 232 (307)
T ss_dssp ----CCEEECCCTTCEECCSCSSCE--------ECSSCCSCGGGCCHHHHTT-----EECTHHHHHHHHHHHHHHHHCCC
T ss_pred ----CcEEEeecccccccccccccc--------cccccCCCcCcCChHHhcC-----CCCccchhHHHHHHHHHHHHCCC
Confidence 469999999998654322110 1123469999999999874 46889999999999999999999
Q ss_pred CCCCCCHHHH----HHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 747 PYMGLSELEI----HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 747 PF~~~~~~el----~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
||......+. ...+... ...+...+. . .........+..+.+|+.+||..||.+|||+.
T Consensus 233 p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~------------~----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 295 (307)
T 2nru_A 233 AVDEHREPQLLLDIKEEIEDE-EKTIEDYID------------K----KMNDADSTSVEAMYSVASQCLHEKKNKRPDIK 295 (307)
T ss_dssp SBCTTBSSSBTTHHHHHHHTT-SCCHHHHSC------------S----SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CcccCcchHHHHHHHHHhhhh-hhhhhhhcc------------c----cccccchHHHHHHHHHHHHHcCCCcccCcCHH
Confidence 9976543322 2222211 111111110 0 01122344577899999999999999999999
Q ss_pred HHHHHHHhhcC
Q 003185 823 DLYEMFVARTS 833 (840)
Q Consensus 823 ELLehLe~l~~ 833 (840)
+|+++|+.+..
T Consensus 296 ~l~~~L~~l~~ 306 (307)
T 2nru_A 296 KVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHHHC-
T ss_pred HHHHHHHHHhc
Confidence 99999999865
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=370.80 Aligned_cols=253 Identities=24% Similarity=0.297 Sum_probs=212.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++.+.||+|+||.||+|++ .+..+|+|+...... ........+.+|+.+|+.++||||+++++++..
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 112 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-----VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHh-----ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 5688999999999999999999998 578899999753211 111122345899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.. ..||||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~--------------~~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl 173 (350)
T 1rdq_E 113 NS--------------NLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173 (350)
T ss_dssp SS--------------EEEEEEECCTTCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CC--------------EEEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEE
Confidence 55 35999999999999999986 246899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||+++...... ....||+.|+|||++.+ ..++.++|||||||+||
T Consensus 174 l~~~-------g~~kL~DFg~a~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ 229 (350)
T 1rdq_E 174 IDQQ-------GYIQVTDFGFAKRVKGRT-------------WTLCGTPEALAPEIILS----KGYNKAVDWWALGVLIY 229 (350)
T ss_dssp ECTT-------SCEEECCCTTCEECSSCB-------------CCCEECGGGCCHHHHTT----CCBCTHHHHHHHHHHHH
T ss_pred ECCC-------CCEEEcccccceeccCCc-------------ccccCCccccCHHHhcC----CCCCCcCCEecccHhHh
Confidence 9877 469999999998654321 23469999999999986 56899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
||++|..||.+.+..++...+..+.. .++. ..+..+.+||.+||+.||.+||
T Consensus 230 ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~~~~~~~li~~lL~~dp~~R~ 281 (350)
T 1rdq_E 230 EMAAGYPPFFADQPIQIYEKIVSGKV-RFPS---------------------------HFSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCC-CCCT---------------------------TCCHHHHHHHHHHSCSCTTTCT
T ss_pred HHhhCCCCCCCCCHHHHHHHHHcCCC-CCCC---------------------------CCCHHHHHHHHHHhhcCHHhcc
Confidence 99999999999988888888876632 1221 1245789999999999999999
Q ss_pred C-----HHHHHHHHHh
Q 003185 820 T-----AGDLYEMFVA 830 (840)
Q Consensus 820 S-----a~ELLehLe~ 830 (840)
+ +++|++|..-
T Consensus 282 ~~~~~~~~ei~~h~~f 297 (350)
T 1rdq_E 282 GNLKNGVNDIKNHKWF 297 (350)
T ss_dssp TSSTTTTHHHHTSGGG
T ss_pred CCccCCHHHHHhCcCc
Confidence 8 9999998653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=367.50 Aligned_cols=289 Identities=21% Similarity=0.247 Sum_probs=206.4
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEe
Q 003185 501 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 578 (840)
Q Consensus 501 p~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~ 578 (840)
...+++|++.+.||+|+||.||+|.+ .+..||+|++.... ......+ .+.+|+.++++++||||+++++++.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH--EEEGVPG----TAIREVSLLKELQHRNIIELKSVIH 103 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc--cccccch----hHHHHHHHHHHcCCCCcceEEEEEe
Confidence 36788999999999999999999987 67889999864332 2222222 3389999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
.... .+|||||++ |+|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+||
T Consensus 104 ~~~~--------------~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NI 163 (329)
T 3gbz_A 104 HNHR--------------LHLIFEYAE-NDLKKYMDK-----NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNL 163 (329)
T ss_dssp ETTE--------------EEEEEECCS-EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred cCCE--------------EEEEEecCC-CCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHE
Confidence 6653 599999998 599999986 35699999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.++. ...+.+||+|||+++........ .....||+.|+|||++.+ ...++.++|||||||++
T Consensus 164 ll~~~~~--~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il 228 (329)
T 3gbz_A 164 LLSVSDA--SETPVLKIGDFGLARAFGIPIRQ----------FTHEIITLWYRPPEILLG---SRHYSTSVDIWSIACIW 228 (329)
T ss_dssp EEEC-------CCEEEECCTTHHHHHC---------------------CCTTCCHHHHTT---CCCCCTHHHHHHHHHHH
T ss_pred EEecCCC--CccceEEECcCCCccccCCcccc----------cCCCcCCccccCHHHhcC---CCCCCcHHHHHHHHHHH
Confidence 9975531 23467999999999866432111 123468999999999975 24579999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCC----CchhhhhhHHHHHHHHHHhcccC
Q 003185 739 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE----KPEAELETLSFLVDVFRRCTEEN 814 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~----~~~~~~~~s~~L~dLI~rCL~~D 814 (840)
|||++|..||.+....+....+...........+....... .+........ ........++.+.+||.+||+.|
T Consensus 229 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 306 (329)
T 3gbz_A 229 AEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP--DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMD 306 (329)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST--TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSS
T ss_pred HHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh--hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCC
Confidence 99999999999988777666665431111111111110000 0000000000 01111224578999999999999
Q ss_pred CCCCCCHHHHHHHHHhhc
Q 003185 815 PTERPTAGDLYEMFVART 832 (840)
Q Consensus 815 P~eRPSa~ELLehLe~l~ 832 (840)
|.+|||+.|+++|.+-..
T Consensus 307 P~~R~t~~e~l~hp~f~~ 324 (329)
T 3gbz_A 307 PVKRISAKNALEHPYFSH 324 (329)
T ss_dssp GGGSCCHHHHHTSGGGSS
T ss_pred hhhCCCHHHHhCCcccCC
Confidence 999999999999866443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=357.12 Aligned_cols=265 Identities=26% Similarity=0.357 Sum_probs=213.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++.+.||+|+||.||+|.+ .+..+|+|++.... ......+ .+.+|+.++++++||||+++++++..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS--MTEAEKQ----MLVSEVNLLRELKHPNIVRYYDRIID 76 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTT--CCHHHHH----HHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEccc--CCHHHHH----HHHHHHHHHHhcCCCCCCeEEEEEec
Confidence 4567999999999999999999998 57789999875432 2333333 44899999999999999999998864
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecccCC
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-----IMHRDIK 654 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~g-----IVHRDLK 654 (840)
.. ....++||||+++++|.+++..... ....+++..++.++.||+.||.|||++| |+|||||
T Consensus 77 ~~------------~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~ 143 (279)
T 2w5a_A 77 RT------------NTTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143 (279)
T ss_dssp GG------------GTEEEEEEECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCS
T ss_pred CC------------CceEEEEEeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccc
Confidence 32 1246999999999999999986322 2345899999999999999999999999 9999999
Q ss_pred CCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHH
Q 003185 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 734 (840)
Q Consensus 655 PeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSL 734 (840)
|+|||++.+ +.+||+|||++......... .....||+.|+|||++.+ ..++.++|||||
T Consensus 144 p~NIl~~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~sl 202 (279)
T 2w5a_A 144 PANVFLDGK-------QNVKLGDFGLARILNHDTSF----------AKTFVGTPYYMSPEQMNR----MSYNEKSDIWSL 202 (279)
T ss_dssp GGGEEECSS-------SCEEECCCCHHHHC---CHH----------HHHHHSCCTTCCHHHHHC----C-CCHHHHHHHH
T ss_pred hhhEEEcCC-------CCEEEecCchheeecccccc----------ccccCCCccccChHHhcc----CCCCchhhHHHH
Confidence 999999877 46999999999765432211 012358999999999986 568899999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003185 735 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 814 (840)
Q Consensus 735 GvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~D 814 (840)
|+++|+|++|..||...+..++...+..+..+.++. ..+..+.+||.+||..|
T Consensus 203 G~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~ 255 (279)
T 2w5a_A 203 GCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY---------------------------RYSDELNEIITRMLNLK 255 (279)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCT---------------------------TSCHHHHHHHHHHTCSS
T ss_pred HHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCc---------------------------ccCHHHHHHHHHHcCCC
Confidence 999999999999999988888888887765544332 12457899999999999
Q ss_pred CCCCCCHHHHHHHHHhhcC
Q 003185 815 PTERPTAGDLYEMFVARTS 833 (840)
Q Consensus 815 P~eRPSa~ELLehLe~l~~ 833 (840)
|.+|||+.+|+++++....
T Consensus 256 p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 256 DYHRPSVEEILENPLILEH 274 (279)
T ss_dssp GGGSCCHHHHHTSTTCCGG
T ss_pred cccCCCHHHHHhChhhhhh
Confidence 9999999999999876543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=362.51 Aligned_cols=268 Identities=23% Similarity=0.277 Sum_probs=203.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
...++|++.+.||+|+||.||+|.+ .+..||+|++..... .... ....+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 83 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-RDPS----FYLRFRREAQNAAALNHPAIVAVYDTGEA 83 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT-TSHH----HHHHHHHHHTTCCCCCCTTBCCEEEEEEE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc-CCHH----HHHHHHHHHHHHHcCCCCCcceEEEeeec
Confidence 3457899999999999999999996 678999999754322 1222 23345899999999999999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.... ....||||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 84 ~~~~----------~~~~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil 148 (311)
T 3ork_A 84 ETPA----------GPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIM 148 (311)
T ss_dssp EETT----------EEEEEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred cCCC----------CcccEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEE
Confidence 5421 2245999999999999999976 246899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++..+...... ........||+.|+|||++.+ ..++.++|||||||++|
T Consensus 149 ~~~~-------~~~kl~Dfg~a~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~~l~ 210 (311)
T 3ork_A 149 ISAT-------NAVKVMDFGIARAIADSGNS-------VTQTAAVIGTAQYLSPEQARG----DSVDARSDVYSLGCVLY 210 (311)
T ss_dssp EETT-------SCEEECCCSCC-------------------------CCTTCCHHHHHT----CCCCHHHHHHHHHHHHH
T ss_pred EcCC-------CCEEEeeccCcccccccccc-------cccccccCcCcccCCHHHhcC----CCCCchHhHHHHHHHHH
Confidence 9877 45999999999866442211 011233569999999999986 67899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|++|+.||.+....+....+.......... .....+..+.+||.+||+.||.+||
T Consensus 211 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~l~~li~~~l~~dP~~R~ 266 (311)
T 3ork_A 211 EVLTGEPPFTGDSPVSVAYQHVREDPIPPSA------------------------RHEGLSADLDAVVLKALAKNPENRY 266 (311)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHCCCCCHHH------------------------HSTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHhCCCCCCCCChHHHHHHHhcCCCCCccc------------------------ccCCCCHHHHHHHHHHHhcCHhhCh
Confidence 9999999999988877766655543221111 0112356799999999999999999
Q ss_pred CHHHHHHH-HHhh
Q 003185 820 TAGDLYEM-FVAR 831 (840)
Q Consensus 820 Sa~ELLeh-Le~l 831 (840)
++.+++.+ |...
T Consensus 267 ~~~~~l~~~l~~~ 279 (311)
T 3ork_A 267 QTAAEMRADLVRV 279 (311)
T ss_dssp SSHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHH
Confidence 77666655 4444
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=383.10 Aligned_cols=261 Identities=21% Similarity=0.347 Sum_probs=215.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
+..++|.+.+.||+|+||.||+|.+. +..||||+..... ...+ .+.+|+.+|++|+|||||++++++..
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-----~~~~----~~~~E~~~l~~l~h~~iv~l~~~~~~- 254 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVE----AFLAEANVMKTLQHDKLVKLHAVVTK- 254 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-----BCHH----HHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-----ccHH----HHHHHHHHHhhCCCCCEeeEEEEEeC-
Confidence 45578999999999999999999984 6789999865321 1123 34899999999999999999999862
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .+|||||+.+|+|.+++... ....+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 255 ~~--------------~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill 317 (454)
T 1qcf_A 255 EP--------------IYIITEFMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV 317 (454)
T ss_dssp SS--------------CEEEECCCTTCBHHHHHHSH---HHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE
T ss_pred Cc--------------cEEEEeecCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 22 39999999999999999742 12357899999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||+++......... .....+|+.|+|||++.. ..++.++|||||||+|||
T Consensus 318 ~~~-------~~~kl~DFG~a~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~~l~e 377 (454)
T 1qcf_A 318 SAS-------LVCKIADFGLARVIEDNEYTA---------REGAKFPIKWTAPEAINF----GSFTIKSDVWSFGILLME 377 (454)
T ss_dssp CTT-------CCEEECSTTGGGGBCCHHHHT---------TCSSSSCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHH
T ss_pred CCC-------CcEEEeeCCCceEcCCCceec---------cCCCcccccccCHHHhcc----CCCCcHHHHHhHHHHHHH
Confidence 877 569999999998764322110 122346889999999986 678999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|+| |+.||.+.+..++...+..+.+...+. .+++.+.+||.+||..||.+||
T Consensus 378 l~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dp~~RP 430 (454)
T 1qcf_A 378 IVTYGRIPYPGMSNPEVIRALERGYRMPRPE---------------------------NCPEELYNIMMRCWKNRPEERP 430 (454)
T ss_dssp HHTTSCCSSTTCCHHHHHHHHHHTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHccCChhHCc
Confidence 999 999999999888888887765433321 1345799999999999999999
Q ss_pred CHHHHHHHHHhhcCCCC
Q 003185 820 TAGDLYEMFVARTSSSI 836 (840)
Q Consensus 820 Sa~ELLehLe~l~~~~~ 836 (840)
|+.+|++.|+.+.....
T Consensus 431 t~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 431 TFEYIQSVLDDFYTATE 447 (454)
T ss_dssp CHHHHHHHHHTSSSSSC
T ss_pred CHHHHHHHHHHHHhccc
Confidence 99999999999876543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=354.90 Aligned_cols=259 Identities=20% Similarity=0.319 Sum_probs=207.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-----eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeE
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 576 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~ 576 (840)
...++|.+.+.||+|+||.||+|.+.. ..+|+|+.... ......+ .+.+|+.++++++||||++++++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~E~~~l~~l~h~~i~~~~~~ 81 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD---CTLDNKE----KFMSEAVIMKNLDHPHIVKLIGI 81 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT---SCHHHHH----HHHHHHHHHHHHCCTTBCCEEEE
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc---cCchHHH----HHHHHHHHHHhCCCCCcceEEEE
Confidence 566899999999999999999998632 24788875422 1222333 44899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
+.... .++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 82 ~~~~~---------------~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ 142 (281)
T 3cc6_A 82 IEEEP---------------TWIIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVR 142 (281)
T ss_dssp ECSSS---------------CEEEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred EcCCC---------------CEEEEecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccc
Confidence 76432 38999999999999999762 345899999999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
|||++.+ +.+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||||
T Consensus 143 Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~ 202 (281)
T 3cc6_A 143 NILVASP-------ECVKLGDFGLSRYIEDEDYY---------KASVTRLPIKWMSPESINF----RRFTTASDVWMFAV 202 (281)
T ss_dssp GEEEEET-------TEEEECCCCGGGCC------------------CCCCCGGGCCHHHHHH----CCCCHHHHHHHHHH
T ss_pred eEEECCC-------CcEEeCccCCCccccccccc---------ccccCCCCcceeCchhhcc----CCCCchhccHHHHH
Confidence 9999877 46999999999866442211 1122357889999999986 67899999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 737 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 737 IL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
++|+|++ |+.||......+....+.....+..+. ..++.+.+||.+||..||
T Consensus 203 il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p 255 (281)
T 3cc6_A 203 CMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPD---------------------------LCPPVLYTLMTRCWDYDP 255 (281)
T ss_dssp HHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSG
T ss_pred HHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHccCCc
Confidence 9999998 999998877777776666654333221 124578999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 003185 816 TERPTAGDLYEMFVARTS 833 (840)
Q Consensus 816 ~eRPSa~ELLehLe~l~~ 833 (840)
.+|||+.+++++|+.+.+
T Consensus 256 ~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 256 SDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp GGSCCHHHHHHHHHHHHH
T ss_pred hhCcCHHHHHHHHHHHHH
Confidence 999999999999998753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=357.38 Aligned_cols=269 Identities=21% Similarity=0.290 Sum_probs=202.7
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
..++|.+.+.||+|+||.||+|.+ .+..+|+|+... ......+. +.+|+.++++++||||+++++++...
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~----~~~~~~~~----~~~E~~~l~~l~hp~iv~~~~~~~~~ 79 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR----FDEETQRT----FLKEVKVMRCLEHPNVLKFIGVLYKD 79 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC----CCHHHHHH----HHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc----CCHHHHHH----HHHHHHHHHhCCCcCcccEEEEEecC
Confidence 457899999999999999999998 477889887532 22333333 48999999999999999999999866
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 80 ~~--------------~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~ 141 (310)
T 3s95_A 80 KR--------------LNFITEYIKGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV 141 (310)
T ss_dssp TE--------------EEEEEECCTTCBHHHHHHH----CCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred Ce--------------eEEEEEecCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE
Confidence 53 5999999999999999986 24569999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCccccccccccccc----ccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI----AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~----~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
+.+ +.+||+|||+++........... ............||+.|+|||++.+ ..++.++|||||||
T Consensus 142 ~~~-------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~ 210 (310)
T 3s95_A 142 REN-------KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING----RSYDEKVDVFSFGI 210 (310)
T ss_dssp CTT-------SCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTT----CCCCTHHHHHHHHH
T ss_pred CCC-------CCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcC----CCCCcHHHHHHHHH
Confidence 877 45999999999876543221100 0000011124579999999999986 67899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 737 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 737 IL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
++|||++|..||......... ............ ....+++.+.+||.+||+.||.
T Consensus 211 ~l~el~~g~~~~~~~~~~~~~------~~~~~~~~~~~~-------------------~~~~~~~~l~~li~~~l~~dP~ 265 (310)
T 3s95_A 211 VLCEIIGRVNADPDYLPRTMD------FGLNVRGFLDRY-------------------CPPNCPPSFFPITVRCCDLDPE 265 (310)
T ss_dssp HHHHHHHTCCSSTTTSCBCTT------SSBCHHHHHHHT-------------------CCTTCCTTHHHHHHHHTCSSGG
T ss_pred HHHHHhcCCCCCcchhhhHHH------Hhhhhhcccccc-------------------CCCCCCHHHHHHHHHHccCChh
Confidence 999999999998654221100 000000000000 0011234689999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 003185 817 ERPTAGDLYEMFVARTS 833 (840)
Q Consensus 817 eRPSa~ELLehLe~l~~ 833 (840)
+|||+.+|++.|+.+..
T Consensus 266 ~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 266 KRPSFVKLEHWLETLRM 282 (310)
T ss_dssp GSCCHHHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHHHH
Confidence 99999999999988753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=368.53 Aligned_cols=260 Identities=24% Similarity=0.286 Sum_probs=203.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++.+.||+|+||.||+|.+ .+..||+|++..+... .. .+.+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~----~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 76 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DC----PENIKKEICINKMLNHENVVKFYGHRRE 76 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc---ch----HHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 4578999999999999999999987 5788999997644321 11 1234899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .||||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 77 ~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIl 137 (323)
T 3tki_A 77 GNI--------------QYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL 137 (323)
T ss_dssp SSE--------------EEEEEECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CCe--------------EEEEEEcCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEE
Confidence 553 4999999999999998864 356999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++..+....... ......||+.|+|||++.+ ...++.++|||||||+||
T Consensus 138 l~~~-------~~~kl~Dfg~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 199 (323)
T 3tki_A 138 LDER-------DNLKISDFGLATVFRYNNRER--------LLNKMCGTLPYVAPELLKR---REFHAEPVDVWSCGIVLT 199 (323)
T ss_dssp ECTT-------CCEEECCCTTCEECEETTEEC--------CBCSCCSCGGGSCHHHHHC---SSBCHHHHHHHHHHHHHH
T ss_pred EeCC-------CCEEEEEeeccceeccCCccc--------ccCCCccCcCccCcHHhcc---CCCCCCcccHHHHHHHHH
Confidence 9877 459999999998664322110 1123569999999999976 233478999999999999
Q ss_pred HHHhCCCCCCCCCHH-HHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 740 ELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 740 ELLTG~~PF~~~~~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
+|++|+.||...... .....+..... ... .....+..+.+||.+||..||.+|
T Consensus 200 ~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~-------------------------~~~~~~~~~~~li~~~L~~dP~~R 253 (323)
T 3tki_A 200 AMLAGELPWDQPSDSCQEYSDWKEKKT-YLN-------------------------PWKKIDSAPLALLHKILVENPSAR 253 (323)
T ss_dssp HHHHSSCSCSSSCTTSHHHHHHHTTCT-TST-------------------------TGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred HHHhCCCCCCCCchHHHHHHHHhcccc-cCC-------------------------ccccCCHHHHHHHHHHccCChhhC
Confidence 999999999766543 22222222211 000 112235678999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 003185 819 PTAGDLYEMFVAR 831 (840)
Q Consensus 819 PSa~ELLehLe~l 831 (840)
||+.|+++|.+-.
T Consensus 254 ~t~~eil~h~~~~ 266 (323)
T 3tki_A 254 ITIPDIKKDRWYN 266 (323)
T ss_dssp CCHHHHTTCTTTT
T ss_pred cCHHHHhhChhhc
Confidence 9999999996543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=383.62 Aligned_cols=282 Identities=17% Similarity=0.217 Sum_probs=208.6
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
..++|++.+.||+|+||.||+|.+ .+..||+|++... ....... +++.+|+.+|+.++|||||++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~----~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 133 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--FQNQTHA----KRAYRELVLMKCVNHKNIISLLNVFTPQ 133 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG--GGSHHHH----HHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc--ccChHHH----HHHHHHHHHHHhCCCCCCCcEEEEEccC
Confidence 357899999999999999999987 5788999987532 1122222 3458999999999999999999999765
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
... ......||||||+++ +|.+.+. ..+++..++.++.||+.||+|||++||+||||||+||||
T Consensus 134 ~~~--------~~~~~~~lv~E~~~~-~l~~~~~-------~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll 197 (464)
T 3ttj_A 134 KTL--------EEFQDVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197 (464)
T ss_dssp CST--------TTCCEEEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred Ccc--------ccCCeEEEEEeCCCC-CHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE
Confidence 422 122457999999985 6777764 348999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||+|+....... ....+||+.|+|||++.+ ..++.++|||||||+|||
T Consensus 198 ~~~-------~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~e 255 (464)
T 3ttj_A 198 KSD-------CTLKILDFGLARTAGTSFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGE 255 (464)
T ss_dssp CTT-------SCEEECCCCCC-----CCC-----------C----CCCTTCCHHHHTT----CCCCTTHHHHHHHHHHHH
T ss_pred eCC-------CCEEEEEEEeeeecCCCcc-----------cCCCcccccccCHHHHcC----CCCCHHHHHHHHHHHHHH
Confidence 977 4699999999986543211 233579999999999986 578999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCC---------------CCCchhhhhhHHHHHH
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG---------------FEKPEAELETLSFLVD 805 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~s~~L~d 805 (840)
|++|+.||.+.+..+.+..|........++.+....... ..+...... ..........+..+.+
T Consensus 256 ll~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 334 (464)
T 3ttj_A 256 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV-RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 334 (464)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH-HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh-hhHhhcccccCCCChHHhCcccccccccccccccCHHHHH
Confidence 999999999998888777776643333333322211000 000000000 0011122233678999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHH
Q 003185 806 VFRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 806 LI~rCL~~DP~eRPSa~ELLehLe 829 (840)
||.+||.+||.+|||++|+++|..
T Consensus 335 Ll~~mL~~dP~~R~ta~e~L~Hp~ 358 (464)
T 3ttj_A 335 LLSKMLVIDPAKRISVDDALQHPY 358 (464)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred HHHHHcCCChhhCCCHHHHhcChh
Confidence 999999999999999999999954
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=356.58 Aligned_cols=261 Identities=22% Similarity=0.289 Sum_probs=205.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
...++|.+.+.||+|+||.||+|.. .+..+|+|+......... .+ .+.+|+.+|++++||||+++++++..
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~----~~~~E~~~l~~l~hp~iv~~~~~~~~ 91 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP---ME----QIEAEIEVLKSLDHPNIIKIFEVFED 91 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC---HH----HHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh---HH----HHHHHHHHHHhCCCchHHhHHHheec
Confidence 3447899999999999999999997 567899998765432211 22 34899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.. ..++||||+++++|.+++...... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 92 ~~--------------~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl 156 (285)
T 3is5_A 92 YH--------------NMYIVMETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENIL 156 (285)
T ss_dssp SS--------------EEEEEECCCSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEE
T ss_pred CC--------------eEEEEEEeCCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEE
Confidence 54 359999999999999999753322 356999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++... ..+.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|
T Consensus 157 ~~~~~----~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~~t~~y~aPE~~~-----~~~~~~~Di~slG~il~ 216 (285)
T 3is5_A 157 FQDTS----PHSPIKIIDFGLAELFKSDEH-----------STNAAGTALYMAPEVFK-----RDVTFKCDIWSAGVVMY 216 (285)
T ss_dssp ESSSS----TTCCEEECCCCCCCC---------------------CTTGGGCCHHHHT-----TCCCHHHHHHHHHHHHH
T ss_pred EecCC----CCCCEEEEeeecceecCCccc-----------CcCcccccCcCChHHhc-----cCCCcccCeehHHHHHH
Confidence 96532 235799999999976543211 12346899999999986 35789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|++|+.||.+....++...+.......... ....++.+.+||.+||+.||.+||
T Consensus 217 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rp 271 (285)
T 3is5_A 217 FLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-------------------------CRPLTPQAVDLLKQMLTKDPERRP 271 (285)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---------------------------CCCCHHHHHHHHHHTCSCTTTSC
T ss_pred HHHhCCCCCCCCCHHHHHhhhccCCcccccc-------------------------cCcCCHHHHHHHHHHccCChhhCc
Confidence 9999999999988877766665442211110 011245789999999999999999
Q ss_pred CHHHHHHHHH
Q 003185 820 TAGDLYEMFV 829 (840)
Q Consensus 820 Sa~ELLehLe 829 (840)
|+.||++|..
T Consensus 272 s~~e~l~hp~ 281 (285)
T 3is5_A 272 SAAQVLHHEW 281 (285)
T ss_dssp CHHHHHTSGG
T ss_pred CHHHHhcCHH
Confidence 9999999854
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=360.02 Aligned_cols=263 Identities=22% Similarity=0.261 Sum_probs=212.2
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
.++|++.+.||+|+||.||+|.+ .+..+|+|++.......... ....+.+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR--GVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEeccccccccc--chhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 45799999999999999999998 47789999976543322111 011233489999999999999999999998654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 89 --------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~ 149 (321)
T 2a2a_A 89 --------------DVVLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149 (321)
T ss_dssp --------------EEEEEECCCCSCBHHHHHHT-----CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES
T ss_pred --------------EEEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEe
Confidence 35999999999999999975 35689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.++. ....+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 150 ~~~~---~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 211 (321)
T 2a2a_A 150 DKNI---PIPHIKLIDFGLAHEIEDGVE-----------FKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYIL 211 (321)
T ss_dssp CTTS---SSCCEEECCCTTCEECCTTCC-----------CCCCCSCGGGCCHHHHTT----CCCCTHHHHHHHHHHHHHH
T ss_pred cCCC---CcCCEEEccCccceecCcccc-----------ccccCCCCCccCcccccC----CCCCCccccHHHHHHHHHH
Confidence 7631 123699999999986643211 123469999999999976 6689999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
++|..||.+....+....+........+.. ....+..+.+||.+||..||.+|||+
T Consensus 212 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~~~~~~~li~~~l~~dp~~Rps~ 267 (321)
T 2a2a_A 212 LSGASPFLGDTKQETLANITSVSYDFDEEF------------------------FSHTSELAKDFIRKLLVKETRKRLTI 267 (321)
T ss_dssp HHSCCSSCCSSHHHHHHHHHTTCCCCCHHH------------------------HTTCCHHHHHHHHTTSCSSTTTSCCH
T ss_pred HHCCCCCCCCCHHHHHHHHHhcccccChhh------------------------hcccCHHHHHHHHHHcCCChhhCcCH
Confidence 999999999888888777766533211111 12235578999999999999999999
Q ss_pred HHHHHHHH
Q 003185 822 GDLYEMFV 829 (840)
Q Consensus 822 ~ELLehLe 829 (840)
.++++|..
T Consensus 268 ~e~l~hp~ 275 (321)
T 2a2a_A 268 QEALRHPW 275 (321)
T ss_dssp HHHHHSTT
T ss_pred HHHhcCcc
Confidence 99999854
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=365.27 Aligned_cols=267 Identities=25% Similarity=0.335 Sum_probs=206.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCccee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 573 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l 573 (840)
.+.++|.+.+.||+|+||.||+|.+ .+..||+|+..... .... ...+.+|+.+|+++ +||||+++
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~----~~~~~~E~~~l~~l~~hp~iv~~ 114 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSE----REALMSELKMMTQLGSHENIVNL 114 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHH----HHHHHHHHHHHHhhcCCCCeeeE
Confidence 4567899999999999999999996 34579999875321 1112 23458999999999 89999999
Q ss_pred eeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc------------------CCCCCCHHHHHHHHHH
Q 003185 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------------------GEKHVSVKLALFIAQD 635 (840)
Q Consensus 574 ~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~------------------~~~~ls~~~~~~Ia~Q 635 (840)
++++...... +|||||+++|+|.+++...... ....+++..++.++.|
T Consensus 115 ~~~~~~~~~~--------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 180 (344)
T 1rjb_A 115 LGACTLSGPI--------------YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 180 (344)
T ss_dssp EEEECSSSSC--------------EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHH
T ss_pred EEEEeeCCcc--------------EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHH
Confidence 9999866543 9999999999999999752110 0134789999999999
Q ss_pred HHHHHHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhh
Q 003185 636 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 715 (840)
Q Consensus 636 Ia~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEv 715 (840)
|+.||.|||++||+||||||+||||+.+ +.+||+|||++.......... ......||+.|+|||+
T Consensus 181 i~~aL~~LH~~~ivH~Dikp~NIll~~~-------~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~~t~~y~aPE~ 245 (344)
T 1rjb_A 181 VAKGMEFLEFKSCVHRDLAARNVLVTHG-------KVVKICDFGLARDIMSDSNYV--------VRGNARLPVKWMAPES 245 (344)
T ss_dssp HHHHHHHHHHTTEEETTCSGGGEEEETT-------TEEEECCCGGGSCGGGCTTSE--------EETTEEECGGGCCHHH
T ss_pred HHHHHHHHHhCCcccCCCChhhEEEcCC-------CcEEeCCCccCcccccCccce--------eccCccCccCccCHHH
Confidence 9999999999999999999999999877 569999999998664432110 1123457889999999
Q ss_pred hhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCc
Q 003185 716 LRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP 793 (840)
Q Consensus 716 L~~~~~~~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~ 793 (840)
+.+ ..++.++|||||||+||+|+| |..||.+..... +...+.....+..+.
T Consensus 246 ~~~----~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----------------------- 298 (344)
T 1rjb_A 246 LFE----GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPF----------------------- 298 (344)
T ss_dssp HHH----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCT-----------------------
T ss_pred hcc----CCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCC-----------------------
Confidence 986 678999999999999999998 999998776443 333444333322221
Q ss_pred hhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 003185 794 EAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 835 (840)
Q Consensus 794 ~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~~~ 835 (840)
..++.+.+||.+||..||.+|||+.+|+++|+.+....
T Consensus 299 ----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 299 ----YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp ----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred ----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 12457999999999999999999999999999987653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=365.65 Aligned_cols=260 Identities=22% Similarity=0.298 Sum_probs=207.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--Cee----EEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG--SAD----AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 575 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~----vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g 575 (840)
...++|++.+.||+|+||.||+|.+. +.. +++|+..... ....... +.+|+.++++++||||+++++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~---~~~~~~~----~~~e~~~l~~l~h~~iv~~~~ 82 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS---GRQSFQA----VTDHMLAIGSLDHAHIVRLLG 82 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT---SCSCBCS----CCHHHHHHHTCCCTTBCCEEE
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc---cHHHHHH----HHHHHHHHhcCCCCCcCeEEE
Confidence 45678999999999999999999973 333 6666643221 1111223 378999999999999999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCC
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 655 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKP 655 (840)
++... ..++||||+.+|+|.+++.. ....+++..++.|+.||+.||.|||++||+||||||
T Consensus 83 ~~~~~---------------~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp 143 (325)
T 3kex_A 83 LCPGS---------------SLQLVTQYLPLGSLLDHVRQ----HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAA 143 (325)
T ss_dssp EECBS---------------SEEEEEECCTTCBSHHHHHS----SGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSS
T ss_pred EEcCC---------------ccEEEEEeCCCCCHHHHHHH----ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccch
Confidence 88532 24899999999999999974 234688999999999999999999999999999999
Q ss_pred CcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003185 656 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735 (840)
Q Consensus 656 eNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLG 735 (840)
+|||++.+ +.+||+|||+++.+...... .......||+.|+|||++.+ ..++.++||||||
T Consensus 144 ~Nil~~~~-------~~~kl~Dfg~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG 204 (325)
T 3kex_A 144 RNVLLKSP-------SQVQVADFGVADLLPPDDKQ--------LLYSEAKTPIKWMALESIHF----GKYTHQSDVWSYG 204 (325)
T ss_dssp TTEEESSS-------SCEEECSCSGGGGSCCCTTC--------CC-----CCTTTSCHHHHHH----CCCCHHHHHHHHH
T ss_pred heEEECCC-------CeEEECCCCcccccCccccc--------ccccCCCCcccccChHHhcc----CCCChhhHhHHhH
Confidence 99999877 45999999999876443211 11233468889999999987 6689999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003185 736 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 814 (840)
Q Consensus 736 vIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~D 814 (840)
|++|+|+| |..||.+....++...+.....+..+.. .+..+.+||.+||..|
T Consensus 205 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~li~~~l~~d 257 (325)
T 3kex_A 205 VTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQI---------------------------CTIDVYMVMVKCWMID 257 (325)
T ss_dssp HHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTT---------------------------BCTTTTHHHHHHTCSC
T ss_pred HHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCc---------------------------CcHHHHHHHHHHcCCC
Confidence 99999999 9999998888888777776654433321 1235788999999999
Q ss_pred CCCCCCHHHHHHHHHhhcC
Q 003185 815 PTERPTAGDLYEMFVARTS 833 (840)
Q Consensus 815 P~eRPSa~ELLehLe~l~~ 833 (840)
|.+|||+.+|+++|+.+..
T Consensus 258 p~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 258 ENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp TTTSCCHHHHHHHHHHHTT
T ss_pred hhhCcCHHHHHHHHHHHHh
Confidence 9999999999999998864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=369.37 Aligned_cols=290 Identities=22% Similarity=0.232 Sum_probs=207.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
...++|++.+.||+|+||.||+|.+ .+..||+|++....... ....+...+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE---AKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcch---hhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence 3467899999999999999999997 47789999865432211 111222345899999999999999999999976
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.... ++||||+++ +|..++.. ....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 84 ~~~~--------------~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 144 (346)
T 1ua2_A 84 KSNI--------------SLVFDFMET-DLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLL 144 (346)
T ss_dssp TTCC--------------EEEEECCSE-EHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred CCce--------------EEEEEcCCC-CHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEE
Confidence 5543 999999985 89888864 3356889999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||+++.+..... ......||+.|+|||++.+ ...++.++|||||||++|
T Consensus 145 ~~~~-------~~~kl~Dfg~a~~~~~~~~----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 204 (346)
T 1ua2_A 145 LDEN-------GVLKLADFGLAKSFGSPNR----------AYTHQVVTRWYRAPELLFG---ARMYGVGVDMWAVGCILA 204 (346)
T ss_dssp ECTT-------CCEEECCCGGGSTTTSCCC----------CCCCSCCCCTTCCHHHHTT---CSCCCHHHHHHHHHHHHH
T ss_pred EcCC-------CCEEEEecccceeccCCcc----------cCCcccccccccCchHhhC---CCCCCchhhhHhHHHHHH
Confidence 9877 4699999999986643211 1233468999999999975 245789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|++|.+||.+.+..+....+...........+...........................+..+.+||.+||..||.+||
T Consensus 205 ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 284 (346)
T 1ua2_A 205 ELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 284 (346)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCC
Confidence 99999999999888777766654321111111111111000000000001111111234467899999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 003185 820 TAGDLYEMFVARTS 833 (840)
Q Consensus 820 Sa~ELLehLe~l~~ 833 (840)
|+.|+++|..-...
T Consensus 285 t~~ell~h~~f~~~ 298 (346)
T 1ua2_A 285 TATQALKMKYFSNR 298 (346)
T ss_dssp CHHHHHTSGGGTSS
T ss_pred CHHHHhcChhhhcC
Confidence 99999999765443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=376.29 Aligned_cols=258 Identities=21% Similarity=0.278 Sum_probs=210.8
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
..+.|++.+.||+|+||.||+|.+ .+..+|+|+..... ..... .+.+|+.+|+.|+||||+++++++...
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~----~~~~E~~il~~l~hpnIv~~~~~~~~~ 120 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKY----TVKNEISIMNQLHHPKLINLHDAFEDK 120 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHH----HHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc----hhhHH----HHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence 457899999999999999999998 56789999875321 22222 348999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
. ..+|||||+.+|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 121 ~--------------~~~lv~E~~~gg~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll 182 (387)
T 1kob_A 121 Y--------------EMVLILEFLSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMC 182 (387)
T ss_dssp S--------------EEEEEEECCCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred C--------------EEEEEEEcCCCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEE
Confidence 5 35999999999999998864 23469999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.++ .+.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++||
T Consensus 183 ~~~~-----~~~vkL~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~e 242 (387)
T 1kob_A 183 ETKK-----ASSVKIIDFGLATKLNPDEI-----------VKVTTATAEFAAPEIVDR----EPVGFYTDMWAIGVLGYV 242 (387)
T ss_dssp SSTT-----CCCEEECCCTTCEECCTTSC-----------EEEECSSGGGCCHHHHTT----CCBCHHHHHHHHHHHHHH
T ss_pred ecCC-----CCceEEEecccceecCCCcc-----------eeeeccCCCccCchhccC----CCCCCcccEeeHhHHHHH
Confidence 7542 25699999999987643221 122369999999999986 668999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|++|..||.+.+..+....+.......... .....+..+.+||.+||..||.+|||
T Consensus 243 lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt 298 (387)
T 1kob_A 243 LLSGLSPFAGEDDLETLQNVKRCDWEFDED------------------------AFSSVSPEAKDFIKNLLQKEPRKRLT 298 (387)
T ss_dssp HHHSCCSSCCSSHHHHHHHHHHCCCCCCSS------------------------TTTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCCcc------------------------ccccCCHHHHHHHHHHcCCChhHCcC
Confidence 999999999988888777776653221110 11123567999999999999999999
Q ss_pred HHHHHHHHHh
Q 003185 821 AGDLYEMFVA 830 (840)
Q Consensus 821 a~ELLehLe~ 830 (840)
+.++++|..-
T Consensus 299 ~~ell~hp~~ 308 (387)
T 1kob_A 299 VHDALEHPWL 308 (387)
T ss_dssp HHHHHTSTTT
T ss_pred HHHHhhCccc
Confidence 9999998654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=372.08 Aligned_cols=293 Identities=19% Similarity=0.241 Sum_probs=203.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~ 578 (840)
..+++|++.+.||+|+||.||+|.+ .+..||+|++.. ......... ++.+|+.+|+.+. ||||+++++++.
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~--~~~~~~~~~----~~~~E~~~l~~l~~h~niv~l~~~~~ 79 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD--AFQNSTDAQ----RTFREIMILTELSGHENIVNLLNVLR 79 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC----CCHHHHH----HHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecc--cccChHHHH----HHHHHHHHHHhccCCCCCCeeeeEEe
Confidence 3467899999999999999999987 577899998632 222333333 3489999999998 999999999997
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
..+. ...||||||++ ++|..++.. ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus 80 ~~~~------------~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 140 (388)
T 3oz6_A 80 ADND------------RDVYLVFDYME-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNI 140 (388)
T ss_dssp CTTS------------SCEEEEEECCS-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred cCCC------------CEEEEEecccC-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHe
Confidence 5432 24699999998 599999976 4689999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCccccccccccccc-----------ccCCCCCCCcccCCCcccchhhhhcccCCCCCCc
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI-----------AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 727 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~-----------~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~ 727 (840)
||+.+ +.+||+|||+|+.+......... ...........+||+.|+|||++.+ ...++.
T Consensus 141 ll~~~-------~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~ 210 (388)
T 3oz6_A 141 LLNAE-------CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG---STKYTK 210 (388)
T ss_dssp EECTT-------CCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT---CCCCCT
T ss_pred EEcCC-------CCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC---CCCCCC
Confidence 99877 46999999999876432111000 0001112234579999999999975 356899
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccc----cc----cCCCCCC--c----
Q 003185 728 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV----AQ----SGSGFEK--P---- 793 (840)
Q Consensus 728 kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~----~~----~~~~~~~--~---- 793 (840)
++|||||||+||||++|++||.+.+..+.+..+......+..+.+..........+ .. ....... +
T Consensus 211 ~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (388)
T 3oz6_A 211 GIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKN 290 (388)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhh
Confidence 99999999999999999999999988887777654322222222211100000000 00 0000000 0
Q ss_pred -----hhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003185 794 -----EAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 794 -----~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe 829 (840)
......++.+.+||.+||..||.+|||++|+++|..
T Consensus 291 ~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~ 331 (388)
T 3oz6_A 291 LLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPF 331 (388)
T ss_dssp HHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTT
T ss_pred hcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHH
Confidence 000134568999999999999999999999999954
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=353.68 Aligned_cols=261 Identities=22% Similarity=0.300 Sum_probs=212.6
Q ss_pred CCCCceeee-eecccCceEEEEEEE----CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEE
Q 003185 503 SFPSLSSCD-EAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 577 (840)
Q Consensus 503 ~~~~y~i~~-~LG~G~fG~Vy~a~~----~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~ 577 (840)
..++|.+.+ .||+|+||.||+|.+ .+..+|+|+.... ......+ .+.+|+.++++++||||+++++++
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~E~~~l~~l~h~~i~~~~~~~ 79 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTE----EMMREAQIMHQLDNPYIVRLIGVC 79 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHH----HHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc---cchhHHH----HHHHHHHHHHhCCCCCEeEEEEEe
Confidence 346777877 999999999999986 4667999986532 1223333 348999999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
... ..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 80 ~~~---------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 140 (287)
T 1u59_A 80 QAE---------------ALMLVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARN 140 (287)
T ss_dssp ESS---------------SEEEEEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred cCC---------------CcEEEEEeCCCCCHHHHHHh----CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchhe
Confidence 432 24999999999999999864 23569999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
||++.+ +.+||+|||++.......... .......||+.|+|||++.+ ..++.++|||||||+
T Consensus 141 ili~~~-------~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~i 202 (287)
T 1u59_A 141 VLLVNR-------HYAKISDFGLSKALGADDSYY-------TARSAGKWPLKWYAPECINF----RKFSSRSDVWSYGVT 202 (287)
T ss_dssp EEEEET-------TEEEECCCTTCEECTTCSCEE-------CCCCSSCCCGGGCCHHHHHH----CEECHHHHHHHHHHH
T ss_pred EEEcCC-------CCEEECcccceeeeccCccee-------eccccccccccccCHHHhcc----CCCCchhhHHHHHHH
Confidence 999877 569999999998764332111 01122357899999999986 567899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 738 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 738 L~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
+|+|++ |+.||......++...+..+..+.++. ..++.+.+||.+||..||.
T Consensus 203 l~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~ 255 (287)
T 1u59_A 203 MWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP---------------------------ECPPELYALMSDCWIYKWE 255 (287)
T ss_dssp HHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHTTCSSGG
T ss_pred HHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCC---------------------------CcCHHHHHHHHHHcCCChh
Confidence 999998 999999888888887777765443332 1245799999999999999
Q ss_pred CCCCHHHHHHHHHhhcCC
Q 003185 817 ERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 817 eRPSa~ELLehLe~l~~~ 834 (840)
+||++.+|+++|+.+..+
T Consensus 256 ~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 256 DRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp GSCCHHHHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHHHHh
Confidence 999999999999988643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=362.56 Aligned_cols=268 Identities=24% Similarity=0.371 Sum_probs=211.3
Q ss_pred CCCCCCCCCceeeeeecccCceEEEEEEE--CCeeE--EEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcce
Q 003185 498 GLDPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADA--AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVE 572 (840)
Q Consensus 498 ~~~p~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~v--AVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~ 572 (840)
.++...+++|++.+.||+|+||.||+|.+ .+..+ ++|+.... ...... +.+.+|+.+++++ +||||++
T Consensus 18 ~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~---~~~~~~----~~~~~E~~~l~~l~~hp~iv~ 90 (327)
T 1fvr_A 18 IYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDH----RDFAGELEVLCKLGHHPNIIN 90 (327)
T ss_dssp CSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCC
T ss_pred ccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc---cchHHH----HHHHHHHHHHHhccCCCchhh
Confidence 34557789999999999999999999986 45544 66665321 112222 2348999999999 8999999
Q ss_pred eeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHh-----------ccCCCCCCHHHHHHHHHHHHHHHH
Q 003185 573 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS-----------ETGEKHVSVKLALFIAQDVAAALV 641 (840)
Q Consensus 573 l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~-----------~~~~~~ls~~~~~~Ia~QIa~AL~ 641 (840)
+++++..... .||||||+++++|.+++.... ......+++..++.++.||+.||.
T Consensus 91 ~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~ 156 (327)
T 1fvr_A 91 LLGACEHRGY--------------LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD 156 (327)
T ss_dssp EEEEEEETTE--------------EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHH
T ss_pred hceeeeeCCc--------------eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHH
Confidence 9999986653 599999999999999997521 011246899999999999999999
Q ss_pred HHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC
Q 003185 642 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 721 (840)
Q Consensus 642 yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~ 721 (840)
|||++||+||||||+|||++.+ +.+||+|||+++....... .....+|+.|+|||++.+
T Consensus 157 ~LH~~~ivH~dlkp~NIl~~~~-------~~~kL~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~--- 215 (327)
T 1fvr_A 157 YLSQKQFIHRDLAARNILVGEN-------YVAKIADFGLSRGQEVYVK-----------KTMGRLPVRWMAIESLNY--- 215 (327)
T ss_dssp HHHHTTEECSCCSGGGEEECGG-------GCEEECCTTCEESSCEECC-----------C----CCTTTCCHHHHHH---
T ss_pred HHHhCCccCCCCccceEEEcCC-------CeEEEcccCcCcccccccc-----------ccCCCCCccccChhhhcc---
Confidence 9999999999999999999877 4699999999874332111 122357889999999986
Q ss_pred CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhH
Q 003185 722 PNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 800 (840)
Q Consensus 722 ~~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s 800 (840)
..++.++|||||||++|+|++ |..||.+.+..++...+..+..+..+. ..+
T Consensus 216 -~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~ 267 (327)
T 1fvr_A 216 -SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL---------------------------NCD 267 (327)
T ss_dssp -CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCT---------------------------TBC
T ss_pred -ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCCCCC---------------------------CCC
Confidence 567899999999999999998 999999988888777766553332221 224
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 003185 801 SFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 835 (840)
Q Consensus 801 ~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~~~ 835 (840)
..+.+||.+||..||.+|||+.+++++|..+....
T Consensus 268 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 268 DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 57999999999999999999999999999887543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=350.31 Aligned_cols=256 Identities=23% Similarity=0.279 Sum_probs=207.7
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
.++|++.+.||+|+||.||+|.+. +..+|+|+....... ..+ .+.+|+.++++++||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~----~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE----DVD----RFKQEIEIMKSLDHPNIIRLYETFEDNT 79 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS----CHH----HHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc----hHH----HHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 357999999999999999999984 457888876533211 122 3489999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+.
T Consensus 80 --------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~ 140 (277)
T 3f3z_A 80 --------------DIYLVMELCTGGELFERVVH-----KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFL 140 (277)
T ss_dssp --------------EEEEEEECCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES
T ss_pred --------------eEEEEEeccCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEe
Confidence 35999999999999999876 25689999999999999999999999999999999999994
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+. ..+.+||+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|
T Consensus 141 ~~~----~~~~~~l~Dfg~~~~~~~~~~-----------~~~~~~t~~y~aPE~~~~-----~~~~~~Di~slG~~l~~l 200 (277)
T 3f3z_A 141 TDS----PDSPLKLIDFGLAARFKPGKM-----------MRTKVGTPYYVSPQVLEG-----LYGPECDEWSAGVMMYVL 200 (277)
T ss_dssp SSS----TTCCEEECCCTTCEECCTTSC-----------BCCCCSCTTTCCHHHHTT-----CBCTTHHHHHHHHHHHHH
T ss_pred cCC----CCCcEEEEecccceeccCccc-----------hhccCCCCCccChHHhcc-----cCCchhhehhHHHHHHHH
Confidence 321 225699999999976543221 123469999999999874 478999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
++|..||......+....+..+........+ ...++.+.+||.+||+.||.+|||+
T Consensus 201 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~li~~~l~~dp~~R~s~ 256 (277)
T 3f3z_A 201 LCGYPPFSAPTDSEVMLKIREGTFTFPEKDW------------------------LNVSPQAESLIRRLLTKSPKQRITS 256 (277)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH------------------------TTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHCCCCCCCCCHHHHHHHHHhCCCCCCchhh------------------------hcCCHHHHHHHHHHccCChhhCcCH
Confidence 9999999998888888887776443222111 1235679999999999999999999
Q ss_pred HHHHHHHHh
Q 003185 822 GDLYEMFVA 830 (840)
Q Consensus 822 ~ELLehLe~ 830 (840)
.++++|..-
T Consensus 257 ~~~l~h~~~ 265 (277)
T 3f3z_A 257 LQALEHEWF 265 (277)
T ss_dssp HHHTTSHHH
T ss_pred HHHhcCHHH
Confidence 999998553
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=359.79 Aligned_cols=255 Identities=25% Similarity=0.463 Sum_probs=201.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+..++|++.+.||+|+||.||+|.+.+..+|+|+... ....+ .+.+|+.+|++++||||+++++++...
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~------~~~~~----~~~~E~~~l~~l~hp~iv~~~~~~~~~- 73 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIES------ESERK----AFIVELRQLSRVNHPNIVKLYGACLNP- 73 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSS------TTHHH----HHHHHHHHHHHCCCTTBCCEEEBCTTT-
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecC------hhHHH----HHHHHHHHHhcCCCCCcCeEEEEEcCC-
Confidence 5678999999999999999999999999999998531 12223 348999999999999999999987522
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCCCcE
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS---KHIMHRDIKSENI 658 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs---~gIVHRDLKPeNI 658 (840)
.++||||+++++|.+++... .....++...++.++.||+.||.|||+ +||+||||||+||
T Consensus 74 ---------------~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NI 136 (307)
T 2eva_A 74 ---------------VCLVMEYAEGGSLYNVLHGA--EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNL 136 (307)
T ss_dssp ---------------TEEEEECCTTCBHHHHHHCS--SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGE
T ss_pred ---------------cEEEEEcCCCCCHHHHHhcc--CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHE
Confidence 39999999999999999751 111247889999999999999999999 8999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.++ ..+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||++
T Consensus 137 ll~~~~------~~~kl~Dfg~~~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il 193 (307)
T 2eva_A 137 LLVAGG------TVLKICDFGTACDIQTHM-------------TNNKGSAAWMAPEVFEG----SNYSEKCDVFSWGIIL 193 (307)
T ss_dssp EEETTT------TEEEECCCCC-------------------------CCTTSSCHHHHTC----CCCCTHHHHHHHHHHH
T ss_pred EEeCCC------CEEEEccccccccccccc-------------ccCCCCCceEChhhhCC----CCCCcHHHHHHHHHHH
Confidence 998763 358999999997553321 12358999999999976 6789999999999999
Q ss_pred HHHHhCCCCCCCCC--HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 739 LELLTLQVPYMGLS--ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 739 ~ELLTG~~PF~~~~--~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
|||++|+.||.... ...+...+.....+.+.. ..+..+.+||.+||..||.
T Consensus 194 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dp~ 246 (307)
T 2eva_A 194 WEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIK---------------------------NLPKPIESLMTRCWSKDPS 246 (307)
T ss_dssp HHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBT---------------------------TCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHCCCCchhhCccHHHHHHHHhcCCCCCccc---------------------------ccCHHHHHHHHHHhcCChh
Confidence 99999999997543 333444444443333221 1245789999999999999
Q ss_pred CCCCHHHHHHHHHhhcCC
Q 003185 817 ERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 817 eRPSa~ELLehLe~l~~~ 834 (840)
+|||+.+|+++|+.+...
T Consensus 247 ~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 247 QRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp GSCCHHHHHHHHHHHGGG
T ss_pred hCcCHHHHHHHHHHHHHh
Confidence 999999999999988643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=358.60 Aligned_cols=266 Identities=21% Similarity=0.321 Sum_probs=214.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 574 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~ 574 (840)
...++|++.+.||+|+||.||+|.+. +..+|+|++... ....... .+.+|+.+++.++||||++++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~----~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA---ASMRERI----EFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT---SCHHHHH----HHHHHHHHGGGCCCTTBCCEE
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc---cCHHHHH----HHHHHHHHHHhcCCCCEeeeE
Confidence 34578999999999999999999864 467888885421 1222222 348999999999999999999
Q ss_pred eEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Q 003185 575 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----TGEKHVSVKLALFIAQDVAAALVELHSKHIM 649 (840)
Q Consensus 575 g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIV 649 (840)
+++...... ++||||+++|+|.+++..... .....+++..++.++.||+.||.|||++||+
T Consensus 95 ~~~~~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~ 160 (322)
T 1p4o_A 95 GVVSQGQPT--------------LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 160 (322)
T ss_dssp EEECSSSSC--------------EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred EEEccCCcc--------------EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 999765543 999999999999999986321 1124578999999999999999999999999
Q ss_pred cccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchh
Q 003185 650 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 729 (840)
Q Consensus 650 HRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kS 729 (840)
||||||+|||++.+ +.+||+|||+++.......... .....||+.|+|||++.+ ..++.++
T Consensus 161 H~dikp~NIli~~~-------~~~kl~Dfg~~~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~----~~~~~~~ 221 (322)
T 1p4o_A 161 HRDLAARNCMVAED-------FTVKIGDFGMTRDIYETDYYRK--------GGKGLLPVRWMSPESLKD----GVFTTYS 221 (322)
T ss_dssp CSCCSGGGEEECTT-------CCEEECCTTCCCGGGGGGCEEG--------GGSSEECGGGCCHHHHHH----CCCCHHH
T ss_pred cCCCccceEEEcCC-------CeEEECcCcccccccccccccc--------ccCCCCCCCccChhhhcc----CCCCchh
Confidence 99999999999877 4699999999986644321110 122357889999999986 6689999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHH
Q 003185 730 DIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 808 (840)
Q Consensus 730 DVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~ 808 (840)
|||||||++|+|++ |..||.+.+..++...+.....+..+. ..+..+.+||.
T Consensus 222 Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~ 274 (322)
T 1p4o_A 222 DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD---------------------------NCPDMLFELMR 274 (322)
T ss_dssp HHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHHHHHHH
Confidence 99999999999999 899999988888887777654433221 12457899999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhcCC
Q 003185 809 RCTEENPTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 809 rCL~~DP~eRPSa~ELLehLe~l~~~ 834 (840)
+||..||.+|||+.+++++|+.+...
T Consensus 275 ~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 275 MCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp HHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 99999999999999999999987553
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=364.68 Aligned_cols=283 Identities=19% Similarity=0.247 Sum_probs=211.2
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-----CCCcceeee
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-----HSCIVEMYG 575 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-----HpNIV~l~g 575 (840)
.-++|.+.+.||+|+||.||+|.+ .+..||+|++.. ..... ..+..|+.+++.++ ||||+++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~----~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYT----RSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CHHHH----HHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-----chhhh----hhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 347899999999999999999998 677899998642 12222 23478999999997 999999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCC
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 655 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKP 655 (840)
++.... ..+|||||+ +++|.+++.. .....+++..++.++.||+.||+|||++||+||||||
T Consensus 104 ~~~~~~--------------~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp 165 (360)
T 3llt_A 104 KFMYYD--------------HMCLIFEPL-GPSLYEIITR---NNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKP 165 (360)
T ss_dssp EEEETT--------------EEEEEECCC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred eeeECC--------------eeEEEEcCC-CCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCc
Confidence 998655 359999999 8899999986 2234589999999999999999999999999999999
Q ss_pred CcEEEeccccc------------------CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhh
Q 003185 656 ENILIDLERKK------------------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717 (840)
Q Consensus 656 eNILLd~~~~~------------------~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~ 717 (840)
+||||+..... ....+.+||+|||++...... .....||+.|+|||++.
T Consensus 166 ~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-------------~~~~~gt~~y~aPE~~~ 232 (360)
T 3llt_A 166 ENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-------------HGSIINTRQYRAPEVIL 232 (360)
T ss_dssp GGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-------------CCSCCSCGGGCCHHHHT
T ss_pred ccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-------------CcCccCcccccCcHHHc
Confidence 99999752100 001367999999999764331 12346899999999998
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcccccccc-C-----CCC-
Q 003185 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS-G-----SGF- 790 (840)
Q Consensus 718 ~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~-~-----~~~- 790 (840)
+ ..++.++|||||||+||+|++|+.||.+.+..+....+.....+.....+.............. . ...
T Consensus 233 ~----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 308 (360)
T 3llt_A 233 N----LGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENA 308 (360)
T ss_dssp T----CCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTC
T ss_pred C----CCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccc
Confidence 6 6789999999999999999999999999888887777766544333322222111110000000 0 000
Q ss_pred -----------CCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003185 791 -----------EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 791 -----------~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe 829 (840)
..+.......+.+.+||.+||+.||.+|||+.|+++|.+
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~ 358 (360)
T 3llt_A 309 SSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKF 358 (360)
T ss_dssp SCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred cchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcc
Confidence 001111222367889999999999999999999998853
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=366.99 Aligned_cols=265 Identities=25% Similarity=0.369 Sum_probs=218.5
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEecC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISS 580 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~~~ 580 (840)
.++|.+.+.||+|+||.||+|.+ .+..||||+...............+.+.+.+|+.+++++ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 35799999999999999999998 478999999876655455556666667789999999999 799999999998865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
. ..|+||||++|++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+
T Consensus 173 ~--------------~~~lv~e~~~g~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~ 233 (365)
T 2y7j_A 173 S--------------FMFLVFDLMRKGELFDYLTE-----KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL 233 (365)
T ss_dssp S--------------EEEEEECCCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred C--------------EEEEEEEeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 4 35999999999999999976 2568999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC--CCCCCchhhHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK--PNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~--~~~~s~kSDVWSLGvIL 738 (840)
+.+ +.+||+|||++..+..... .....||+.|+|||++.+... ...++.++|||||||++
T Consensus 234 ~~~-------~~ikl~DfG~~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il 295 (365)
T 2y7j_A 234 DDN-------MQIRLSDFGFSCHLEPGEK-----------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295 (365)
T ss_dssp CTT-------CCEEECCCTTCEECCTTCC-----------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHH
T ss_pred CCC-------CCEEEEecCcccccCCCcc-----------cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHH
Confidence 877 4699999999987643221 123469999999999975321 23578899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 739 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
|+|++|..||.+.........+..+........+ ...+..+.+||.+||..||.+|
T Consensus 296 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~~~~~~~li~~~L~~dP~~R 351 (365)
T 2y7j_A 296 FTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW------------------------DDRSSTVKDLISRLLQVDPEAR 351 (365)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH------------------------SSSCHHHHHHHHHHSCSSTTTS
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc------------------------ccCCHHHHHHHHHHcCCChhHC
Confidence 9999999999988888777777665432221111 1234578999999999999999
Q ss_pred CCHHHHHHHHH
Q 003185 819 PTAGDLYEMFV 829 (840)
Q Consensus 819 PSa~ELLehLe 829 (840)
||+.++++|.+
T Consensus 352 ps~~ell~hp~ 362 (365)
T 2y7j_A 352 LTAEQALQHPF 362 (365)
T ss_dssp CCHHHHHHSGG
T ss_pred cCHHHHhcCcc
Confidence 99999999854
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=365.02 Aligned_cols=271 Identities=23% Similarity=0.241 Sum_probs=207.2
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCC-CChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCG-SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~-~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
++|++.+.||+|+||.||+|.+ .+..+|+|++...... ...... +.+.+|+.++++++||||+++++++....
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDV----ERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHH----HHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHH----HHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 5799999999999999999997 5668899987543211 111222 34589999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----------------------------------cCCCCCCH
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------------------------------TGEKHVSV 626 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----------------------------------~~~~~ls~ 626 (840)
..+|||||+++|+|.+++..... .....+++
T Consensus 102 --------------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (345)
T 3hko_A 102 --------------YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQRE 167 (345)
T ss_dssp --------------EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHH
T ss_pred --------------eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccH
Confidence 35999999999999999842110 01223467
Q ss_pred HHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccC
Q 003185 627 KLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 706 (840)
Q Consensus 627 ~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vG 706 (840)
..++.|+.||+.||+|||++||+||||||+|||++.++ ...+||+|||++..+...... .........|
T Consensus 168 ~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~-----~~~~kl~Dfg~a~~~~~~~~~------~~~~~~~~~g 236 (345)
T 3hko_A 168 KLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK-----SFEIKLVDFGLSKEFYKLNNG------EYYGMTTKAG 236 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSS-----SCCEEECCCTTCEEGGGTTCC--------------CC
T ss_pred HHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCC-----CceEEEeeccccccccccCcc------ccccccccCC
Confidence 88899999999999999999999999999999998663 247999999999866432211 0111233469
Q ss_pred CCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcccccccc
Q 003185 707 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS 786 (840)
Q Consensus 707 T~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~ 786 (840)
|+.|+|||++.+. ...++.++|||||||+||||++|+.||.+....+....+..........
T Consensus 237 t~~y~aPE~~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------- 298 (345)
T 3hko_A 237 TPYFVAPEVLNTT--NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP---------------- 298 (345)
T ss_dssp CGGGCCHHHHTCS--SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG----------------
T ss_pred CccccCchhhccC--CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc----------------
Confidence 9999999999742 2567899999999999999999999999988888777776653321111
Q ss_pred CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003185 787 GSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 787 ~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~ 830 (840)
.....++.+.+||.+||..||.+|||+.++++|.+-
T Consensus 299 --------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~ 334 (345)
T 3hko_A 299 --------NYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWI 334 (345)
T ss_dssp --------GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHH
T ss_pred --------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhh
Confidence 112235679999999999999999999999998653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=358.57 Aligned_cols=272 Identities=22% Similarity=0.337 Sum_probs=207.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeE
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 576 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~ 576 (840)
...++|.+.+.||+|+||.||+|.+. +..+|+|++... .......+. +.+|+.++++++||||++++++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLD--NSSQREIEE----FLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC-----CCCHHHHHH----HHHHHHHHHTCCCTTBCCCCEE
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecc--ccchhHHHH----HHHHHHHHhcCCCCCeeeeeEE
Confidence 34578999999999999999999863 337888885433 233333344 4899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 655 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKP 655 (840)
+...... .....++||||+++++|.+++..... .....+++..++.++.||+.||.|||++||+||||||
T Consensus 105 ~~~~~~~---------~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp 175 (313)
T 3brb_A 105 CIEMSSQ---------GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAA 175 (313)
T ss_dssp EEC----------------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSG
T ss_pred Eeecccc---------CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCc
Confidence 9865421 22346999999999999999965221 2345699999999999999999999999999999999
Q ss_pred CcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003185 656 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735 (840)
Q Consensus 656 eNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLG 735 (840)
+|||++.+ +.+||+|||++......... .......+++.|+|||++.+ ..++.++||||||
T Consensus 176 ~NIli~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG 236 (313)
T 3brb_A 176 RNCMLRDD-------MTVCVADFGLSKKIYSGDYY--------RQGRIAKMPVKWIAIESLAD----RVYTSKSDVWAFG 236 (313)
T ss_dssp GGEEECTT-------SCEEECSCSCC------------------------CCGGGSCHHHHHS----SCCCHHHHHHHHH
T ss_pred ceEEEcCC-------CcEEEeecCcceeccccccc--------CcccccCCCccccCchhhcC----CCccchhhhHHHH
Confidence 99999877 46999999999866432211 01123457889999999986 6789999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003185 736 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 814 (840)
Q Consensus 736 vIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~D 814 (840)
|++|+|++ |..||.+....++...+..+..+..+. ..+..+.+||.+||..|
T Consensus 237 ~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~d 289 (313)
T 3brb_A 237 VTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPE---------------------------DCLDELYEIMYSCWRTD 289 (313)
T ss_dssp HHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBT---------------------------TCCHHHHHHHHHTTCSS
T ss_pred HHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCc---------------------------cccHHHHHHHHHHcCCC
Confidence 99999999 999999888887777777665443332 12457999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCC
Q 003185 815 PTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 815 P~eRPSa~ELLehLe~l~~~ 834 (840)
|.+|||+.+|+++|+.+...
T Consensus 290 p~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 290 PLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp GGGSCCHHHHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHHHHh
Confidence 99999999999999998654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=356.49 Aligned_cols=268 Identities=24% Similarity=0.365 Sum_probs=210.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCccee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 573 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l 573 (840)
...++|++.+.||+|+||.||+|.+ .+..+|+|+.... ......+ .+.+|+.+++++ +||||+++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~E~~~l~~l~~h~~i~~~ 92 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS---AHLTERE----ALMSELKVLSYLGNHMNIVNL 92 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHH----HHHHHHHHHHHHCCCTTBCCE
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc---hhHHHHH----HHHHHHHHHhhcccCCCeeeE
Confidence 4557899999999999999999985 3468999986532 1222333 448999999999 89999999
Q ss_pred eeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-------------cCCCCCCHHHHHHHHHHHHHHH
Q 003185 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------TGEKHVSVKLALFIAQDVAAAL 640 (840)
Q Consensus 574 ~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-------------~~~~~ls~~~~~~Ia~QIa~AL 640 (840)
++++...... ++||||+++|+|.+++..... .....+++..++.++.||+.||
T Consensus 93 ~~~~~~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l 158 (313)
T 1t46_A 93 LGACTIGGPT--------------LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158 (313)
T ss_dssp EEEECSSSSC--------------EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHH
T ss_pred EEEEecCCCc--------------EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHH
Confidence 9999866543 999999999999999986321 1123589999999999999999
Q ss_pred HHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003185 641 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720 (840)
Q Consensus 641 ~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~ 720 (840)
.|||++||+||||||+|||++.+ +.+||+|||++.......... ......||+.|+|||++.+
T Consensus 159 ~~lH~~~i~H~dlkp~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-- 221 (313)
T 1t46_A 159 AFLASKNCIHRDLAARNILLTHG-------RITKICDFGLARDIKNDSNYV--------VKGNARLPVKWMAPESIFN-- 221 (313)
T ss_dssp HHHHHTTCCCSCCSGGGEEEETT-------TEEEECCCGGGSCTTSCTTSE--------ECSSSEECGGGCCHHHHHH--
T ss_pred HHHHHCCeecCCCccceEEEcCC-------CCEEEccccccccccccccce--------eccCCCCcceeeChHHhcC--
Confidence 99999999999999999999877 569999999998765432110 1123457889999999986
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhh
Q 003185 721 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 798 (840)
Q Consensus 721 ~~~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 798 (840)
..++.++|||||||++|+|+| |..||.+..... ....+.....+..+ ..
T Consensus 222 --~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~ 272 (313)
T 1t46_A 222 --CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP---------------------------EH 272 (313)
T ss_dssp --CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCC---------------------------TT
T ss_pred --CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCc---------------------------cc
Confidence 678999999999999999999 999998765443 33333333222111 11
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 003185 799 TLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSI 836 (840)
Q Consensus 799 ~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~~~~ 836 (840)
.+..+.+||.+||..||.+|||+.+|+++|+.+.....
T Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 273 APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 24578999999999999999999999999998876543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=353.41 Aligned_cols=259 Identities=22% Similarity=0.375 Sum_probs=214.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
...++|++.+.||+|+||.||+|.+. +..+|+|++... ....+. +.+|+.++++++||||+++++++..
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~----~~~E~~~l~~l~h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEE----FLKEAAVMKEIKHPNLVQLLGVCTR 80 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-----STHHHH----HHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-----HHHHHH----HHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 45678999999999999999999985 678899986432 122333 4899999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .++||||+++++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 81 ~~~--------------~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil 143 (288)
T 3kfa_A 81 EPP--------------FYIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143 (288)
T ss_dssp SSS--------------EEEEEECCTTEEHHHHHHH---CCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEE
T ss_pred CCC--------------EEEEEEcCCCCcHHHHHHh---cccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEE
Confidence 553 4999999999999999976 33456899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++.......... .....+|+.|+|||++.+ ..++.++||||||+++|
T Consensus 144 ~~~~-------~~~~l~Dfg~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 203 (288)
T 3kfa_A 144 VGEN-------HLVKVADFGLSRLMTGDTYTA---------HAGAKFPIKWTAPESLAY----NKFSIKSDVWAFGVLLW 203 (288)
T ss_dssp ECGG-------GCEEECCCCGGGTSCSSSSEE---------ETTEEECGGGCCHHHHHH----CCCCHHHHHHHHHHHHH
T ss_pred EcCC-------CCEEEccCccceeccCCcccc---------ccCCccccCcCChhhhcc----CCCCchhhHHHHHHHHH
Confidence 9877 459999999998665332111 122357889999999987 56899999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 740 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 740 ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
+|++ |..||.+.+..++...+.....+..+. ..++.+.+||.+||..||.+|
T Consensus 204 ~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dp~~R 256 (288)
T 3kfa_A 204 EIATYGMSPYPGIDLSQVYELLEKDYRMERPE---------------------------GCPEKVYELMRACWQWNPSDR 256 (288)
T ss_dssp HHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhCCCCCCCCCCHHHHHHHHhccCCCCCCC---------------------------CCCHHHHHHHHHHhCCChhhC
Confidence 9999 999999888877777776654433221 124579999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 003185 819 PTAGDLYEMFVARTS 833 (840)
Q Consensus 819 PSa~ELLehLe~l~~ 833 (840)
||+.++++.|+.+..
T Consensus 257 ps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 257 PSFAEIHQAFETMFQ 271 (288)
T ss_dssp CCHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHH
Confidence 999999999988754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=370.03 Aligned_cols=257 Identities=24% Similarity=0.253 Sum_probs=206.4
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEec
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 579 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~~ 579 (840)
..++|++.+.||+|+||.||+|.+ .+..+|+|++..... .. .+|+.++.++ +||||+++++++..
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~----~~E~~~l~~~~~hp~iv~~~~~~~~ 87 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DP----TEEIEILLRYGQHPNIITLKDVYDD 87 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CC----HHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------Ch----HHHHHHHHHhcCCCCcCeEEEEEEc
Confidence 356799999999999999999998 478899999753321 12 5688888888 69999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.. ..||||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 88 ~~--------------~~~lv~E~~~gg~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl 148 (342)
T 2qr7_A 88 GK--------------YVYVVTELMKGGELLDKILR-----QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNIL 148 (342)
T ss_dssp SS--------------EEEEEECCCCSCBHHHHHHT-----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred CC--------------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEE
Confidence 55 35999999999999999975 356999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
+..... ....+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 149 ~~~~~~---~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ 211 (342)
T 2qr7_A 149 YVDESG---NPESIRICDFGFAKQLRAENGL----------LMTPCYTANFVAPEVLER----QGYDAACDIWSLGVLLY 211 (342)
T ss_dssp ESSSSC---SGGGEEECCCTTCEECBCTTCC----------BCCSSCCSSCCCHHHHHH----HHHHHHHHHHHHHHHHH
T ss_pred EecCCC---CcCeEEEEECCCcccCcCCCCc----------eeccCCCccccCHHHhcC----CCCCCccCeeeHhHHHH
Confidence 965421 2246999999999866432211 123468999999999986 45788999999999999
Q ss_pred HHHhCCCCCCC---CCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 740 ELLTLQVPYMG---LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 740 ELLTG~~PF~~---~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
+|++|..||.+ ....++...+..+....... .....++.+.+||.+||..||.
T Consensus 212 ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~ 267 (342)
T 2qr7_A 212 TMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG------------------------YWNSVSDTAKDLVSKMLHVDPH 267 (342)
T ss_dssp HHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCST------------------------TTTTSCHHHHHHHHHHTCSSTT
T ss_pred HHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcc------------------------ccccCCHHHHHHHHHHCCCChh
Confidence 99999999975 35666777776654321111 1112356799999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 003185 817 ERPTAGDLYEMFVAR 831 (840)
Q Consensus 817 eRPSa~ELLehLe~l 831 (840)
+|||+.++++|.+-.
T Consensus 268 ~R~t~~~il~hp~~~ 282 (342)
T 2qr7_A 268 QRLTAALVLRHPWIV 282 (342)
T ss_dssp TSCCHHHHTTSHHHH
T ss_pred HCcCHHHHhcCCeec
Confidence 999999999997653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=374.17 Aligned_cols=263 Identities=21% Similarity=0.343 Sum_probs=202.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeE
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 576 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~ 576 (840)
....+|.+.+.||+|+||.||+|++. +..||+|+.... ......+ .+.+|+.+|++++||||++++++
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~ 114 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG---YTEKQRR----DFLGEASIMGQFDHPNIIRLEGV 114 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT---CCHHHHH----HHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc---cCHHHHH----HHHHHHHHHHhCCCCCCCeEEEE
Confidence 45568999999999999999999863 567999985432 1223333 44999999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
+...... +|||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+
T Consensus 115 ~~~~~~~--------------~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 176 (373)
T 2qol_A 115 VTKSKPV--------------MIVTEYMENGSLDSFLRK----HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAAR 176 (373)
T ss_dssp ECSSSSC--------------EEEEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred EeeCCce--------------EEEEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcc
Confidence 9866543 999999999999999975 2346899999999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
|||++.+ +.+||+|||+++.......... ......+|+.|+|||++.+ ..++.++|||||||
T Consensus 177 NIll~~~-------~~~kl~Dfg~a~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~SlG~ 238 (373)
T 2qol_A 177 NILINSN-------LVCKVSDFGLGRVLEDDPEAAY-------TTRGGKIPIRWTSPEAIAY----RKFTSASDVWSYGI 238 (373)
T ss_dssp GEEECTT-------CCEEECCC-----------------------------CTTSCHHHHHH----CCCCHHHHHHHHHH
T ss_pred eEEEcCC-------CCEEECcCccccccccCCccce-------eccCCCcCCCccChhhhcc----CCcCchhcHHHHHH
Confidence 9999877 5699999999987654221100 0112235788999999987 67899999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 737 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 737 IL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
+||||++ |..||...+..++...+..+.....+ ...+..+.+||.+||+.||
T Consensus 239 il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dp 291 (373)
T 2qol_A 239 VLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPP---------------------------MDCPAALYQLMLDCWQKDR 291 (373)
T ss_dssp HHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCC---------------------------TTCBHHHHHHHHHHTCSSG
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------ccccHHHHHHHHHHhCcCh
Confidence 9999998 99999998888888777665332221 1234578999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCC
Q 003185 816 TERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 816 ~eRPSa~ELLehLe~l~~~ 834 (840)
.+||++.+|++.|+.+...
T Consensus 292 ~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 292 NNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp GGSCCHHHHHHHHHHHHHC
T ss_pred hhCcCHHHHHHHHHHHHhC
Confidence 9999999999999987543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=350.87 Aligned_cols=261 Identities=24% Similarity=0.309 Sum_probs=208.5
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||.||+|.+ .+..+|+|++.......... ....+.+.+|+.++++++||||+++++++....
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 81 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRR--GVSREEIEREVNILREIRHPNIITLHDIFENKT- 81 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhcccccccc--chHHHHHHHHHHHHHhCCCCCeeehhheecCCC-
Confidence 4699999999999999999998 47899999976543322111 011234489999999999999999999998654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 82 -------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~ 143 (283)
T 3bhy_A 82 -------------DVVLILELVSGGELFDFLAE-----KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLD 143 (283)
T ss_dssp -------------EEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred -------------eEEEEEeecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEec
Confidence 35999999999999999976 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
++. ....+||+|||++........ .....||+.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 144 ~~~---~~~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~ 205 (283)
T 3bhy_A 144 KNV---PNPRIKLIDFGIAHKIEAGNE-----------FKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYILL 205 (283)
T ss_dssp SSS---SSCCEEECCCTTCEECC-------------------CCCGGGCCHHHHTT----CCCCTHHHHHHHHHHHHHHH
T ss_pred CCC---CCCceEEEecccceeccCCCc-----------ccccCCCcCccCcceecC----CCCCcchhhhhHHHHHHHHH
Confidence 632 224699999999986543211 123468999999999976 66889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
+|..||.+....+....+........... ....+..+.+||.+||..||.+|||+.
T Consensus 206 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~ 261 (283)
T 3bhy_A 206 SGASPFLGETKQETLTNISAVNYDFDEEY------------------------FSNTSELAKDFIRRLLVKDPKRRMTIA 261 (283)
T ss_dssp HSSCTTCCSSHHHHHHHHHTTCCCCCHHH------------------------HTTCCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred HCCCCCCCcchHHHHHHhHhcccCCcchh------------------------cccCCHHHHHHHHHHccCCHhHCcCHH
Confidence 99999999888877777765533221111 122355789999999999999999999
Q ss_pred HHHHHH
Q 003185 823 DLYEMF 828 (840)
Q Consensus 823 ELLehL 828 (840)
++++|.
T Consensus 262 ~~l~h~ 267 (283)
T 3bhy_A 262 QSLEHS 267 (283)
T ss_dssp HHHHCH
T ss_pred HHHhCH
Confidence 999974
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=371.04 Aligned_cols=253 Identities=20% Similarity=0.305 Sum_probs=201.2
Q ss_pred ceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 584 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p 584 (840)
|...+.||+|+||.||+|.+ .+..||+|++.... ....+ .+.+|+.+|++|+||||+++++++....
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~----~~~~~----~~~~E~~~l~~l~hpnIv~~~~~~~~~~--- 159 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG----MKDKE----EVKNEISVMNQLDHANLIQLYDAFESKN--- 159 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCS----HHHHH----HHHHHHHHHTTCCCTTBCCEEEEEECSS---
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc----cccHH----HHHHHHHHHHhCCCCCCCeEEEEEEECC---
Confidence 34477899999999999997 57889999975431 22233 3489999999999999999999998655
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEeccc
Q 003185 585 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 664 (840)
Q Consensus 585 ~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~ 664 (840)
..+|||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+..+.
T Consensus 160 -----------~~~lv~E~~~~~~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 224 (373)
T 2x4f_A 160 -----------DIVLVMEYVDGGELFDRIID----ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRD 224 (373)
T ss_dssp -----------EEEEEEECCTTCEEHHHHHH----TGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETT
T ss_pred -----------EEEEEEeCCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCC
Confidence 35999999999999999875 234689999999999999999999999999999999999996442
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 003185 665 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 744 (840)
Q Consensus 665 ~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG 744 (840)
.+.+||+|||+++.+..... .....||+.|+|||++.+ ..++.++|||||||+||||++|
T Consensus 225 -----~~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~elltg 284 (373)
T 2x4f_A 225 -----AKQIKIIDFGLARRYKPREK-----------LKVNFGTPEFLAPEVVNY----DFVSFPTDMWSVGVIAYMLLSG 284 (373)
T ss_dssp -----TTEEEECCCSSCEECCTTCB-----------CCCCCSSCTTCCHHHHTT----CBCCHHHHHHHHHHHHHHHHHS
T ss_pred -----CCcEEEEeCCCceecCCccc-----------cccccCCCcEeChhhccC----CCCCcHHhHHHHHHHHHHHHhC
Confidence 26799999999987643221 123469999999999975 6789999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 003185 745 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 824 (840)
Q Consensus 745 ~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~EL 824 (840)
..||.+.+..+....+.......... .....++.+.+||.+||..||.+|||+.++
T Consensus 285 ~~pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~ 340 (373)
T 2x4f_A 285 LSPFLGDNDAETLNNILACRWDLEDE------------------------EFQDISEEAKEFISKLLIKEKSWRISASEA 340 (373)
T ss_dssp SCTTCCSSHHHHHHHHHHTCCCSCSG------------------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred CCCCCCCCHHHHHHHHHhccCCCChh------------------------hhccCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 99999998888877776653321111 112235689999999999999999999999
Q ss_pred HHHHH
Q 003185 825 YEMFV 829 (840)
Q Consensus 825 LehLe 829 (840)
++|..
T Consensus 341 l~hp~ 345 (373)
T 2x4f_A 341 LKHPW 345 (373)
T ss_dssp HHSHH
T ss_pred hcCcC
Confidence 99854
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=370.84 Aligned_cols=255 Identities=25% Similarity=0.322 Sum_probs=208.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~ 578 (840)
..+++|.+.+.||+|+||.||+|++ .+..||+|+...... ........+..|..++..+ +||||+++++++.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~ 88 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-----LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ 88 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHh-----hhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE
Confidence 5688999999999999999999998 478899999754311 0111123347899999877 8999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
.... .||||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 89 ~~~~--------------~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI 149 (345)
T 1xjd_A 89 TKEN--------------LFFVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNI 149 (345)
T ss_dssp CSSE--------------EEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred eCCE--------------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhE
Confidence 6653 5999999999999999986 25689999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 150 ll~~~-------g~vkL~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il 208 (345)
T 1xjd_A 150 LLDKD-------GHIKIADFGMCKENMLGDA----------KTNTFCGTPDYIAPEILLG----QKYNHSVDWWSFGVLL 208 (345)
T ss_dssp EECTT-------SCEEECCCTTCBCCCCTTC----------CBCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHH
T ss_pred EECCC-------CCEEEeEChhhhhcccCCC----------cccCCCCCcccCChhhhcC----CCCCChhhhHHHHHHH
Confidence 99877 4699999999975432111 1234579999999999986 5689999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 739 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
|||++|..||.+.+..++...+..... .++. ..+..+.+||.+||..||.+|
T Consensus 209 ~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~~li~~lL~~dp~~R 260 (345)
T 1xjd_A 209 YEMLIGQSPFHGQDEEELFHSIRMDNP-FYPR---------------------------WLEKEAKDLLVKLFVREPEKR 260 (345)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCT---------------------------TSCHHHHHHHHHHSCSSGGGS
T ss_pred HHHhcCCCCCCCCCHHHHHHHHHhCCC-CCCc---------------------------ccCHHHHHHHHHHhcCCHhHc
Confidence 999999999999988888888766532 2221 124578999999999999999
Q ss_pred CCHH-HHHHHHH
Q 003185 819 PTAG-DLYEMFV 829 (840)
Q Consensus 819 PSa~-ELLehLe 829 (840)
|++. +|++|..
T Consensus 261 ~~~~~~i~~hp~ 272 (345)
T 1xjd_A 261 LGVRGDIRQHPL 272 (345)
T ss_dssp BTTBSCGGGSGG
T ss_pred CCChHHHHcCcc
Confidence 9998 8887744
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=353.57 Aligned_cols=261 Identities=21% Similarity=0.306 Sum_probs=210.2
Q ss_pred CCCCCceeee-eecccCceEEEEEEE----CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeE
Q 003185 502 GSFPSLSSCD-EAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 576 (840)
Q Consensus 502 ~~~~~y~i~~-~LG~G~fG~Vy~a~~----~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~ 576 (840)
....+|.+.+ .||+|+||.||+|.+ .+..+|+|+..... .... ..+.+.+|+.+++.++||||++++++
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~ 86 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPA----LKDELLAEANVMQQLDNPYIVRMIGI 86 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CH----HHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc--cCHH----HHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3456899998 999999999999965 35679999865331 1112 22345899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
+... ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 87 ~~~~---------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~ 146 (291)
T 1xbb_A 87 CEAE---------------SWMLVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAAR 146 (291)
T ss_dssp EESS---------------SEEEEEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred ECCC---------------CcEEEEEeCCCCCHHHHHHh-----CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcc
Confidence 8432 24999999999999999986 356899999999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
|||++.+ +.+||+|||++........... ......+|+.|+|||++.+ ..++.++||||||+
T Consensus 147 Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~ 208 (291)
T 1xbb_A 147 NVLLVTQ-------HYAKISDFGLSKALRADENYYK-------AQTHGKWPVKWYAPECINY----YKFSSKSDVWSFGV 208 (291)
T ss_dssp GEEEEET-------TEEEECCCTTCEECCTTCSEEE-------C----CCCGGGCCHHHHHH----CEEEHHHHHHHHHH
T ss_pred eEEEeCC-------CcEEEccCCcceeeccCCCccc-------ccccCCCCceeeChHHhcc----CCCChhhhHHHHHH
Confidence 9999977 4699999999987644322110 0122346789999999986 56789999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 737 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 737 IL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
++|+|++ |..||.+....++...+..+..+.++. ..+..+.+||.+||..||
T Consensus 209 il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dp 261 (291)
T 1xbb_A 209 LMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA---------------------------GCPREMYDLMNLCWTYDV 261 (291)
T ss_dssp HHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSST
T ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCh
Confidence 9999999 999999998888888877765443331 124579999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 003185 816 TERPTAGDLYEMFVARTS 833 (840)
Q Consensus 816 ~eRPSa~ELLehLe~l~~ 833 (840)
.+||++.+|++.|+.+..
T Consensus 262 ~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 262 ENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp TTSCCHHHHHHHHHHHHH
T ss_pred hhCcCHHHHHHHHHHHHH
Confidence 999999999999988753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=385.25 Aligned_cols=261 Identities=22% Similarity=0.381 Sum_probs=215.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
+...+|++.+.||+|+||.||+|.+. +..||+|++... .. ..+. +.+|+.+|++++|||||++++++..
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~---~~~~----~~~E~~~l~~l~hpniv~l~~~~~~ 287 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TM---EVEE----FLKEAAVMKEIKHPNLVQLLGVCTR 287 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS--SS---CHHH----HHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc--cc---chHH----HHHHHHHHHhcCCCCEeeEEEEEec
Confidence 34567999999999999999999985 678899985422 11 1233 4899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
...+ ||||||+++|+|.+++.. .....+++..++.|+.||+.||.|||++||+||||||+|||
T Consensus 288 ~~~~--------------~lv~E~~~~g~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIl 350 (495)
T 1opk_A 288 EPPF--------------YIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCL 350 (495)
T ss_dssp SSSC--------------EEEEECCTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CCcE--------------EEEEEccCCCCHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEE
Confidence 6544 999999999999999986 23356899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
|+.+ +.+||+|||+++........ ......+|+.|+|||++.. ..++.++|||||||+||
T Consensus 351 l~~~-------~~~kl~DFG~a~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~sDvwSlG~~l~ 410 (495)
T 1opk_A 351 VGEN-------HLVKVADFGLSRLMTGDTYT---------AHAGAKFPIKWTAPESLAY----NKFSIKSDVWAFGVLLW 410 (495)
T ss_dssp ECGG-------GCEEECCTTCEECCTTCCEE---------CCTTCCCCGGGCCHHHHHH----CEECHHHHHHHHHHHHH
T ss_pred ECCC-------CcEEEeecccceeccCCcee---------ecCCCcCCcceeCHhHHhc----CCCCcHHhHHhHHHHHH
Confidence 9877 46999999999876432211 0122346789999999986 56899999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 740 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 740 ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
||+| |..||.+.+..++...+....+...+. .+++.+.+||.+||+.||.+|
T Consensus 411 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~R 463 (495)
T 1opk_A 411 EIATYGMSPYPGIDLSQVYELLEKDYRMERPE---------------------------GCPEKVYELMRACWQWNPSDR 463 (495)
T ss_dssp HHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCcChhHC
Confidence 9999 999999988888877777665433331 124578999999999999999
Q ss_pred CCHHHHHHHHHhhcCCC
Q 003185 819 PTAGDLYEMFVARTSSS 835 (840)
Q Consensus 819 PSa~ELLehLe~l~~~~ 835 (840)
||+.+|++.|+.+....
T Consensus 464 Ps~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 464 PSFAEIHQAFETMFQES 480 (495)
T ss_dssp CCHHHHHHHHHTSCSSS
T ss_pred cCHHHHHHHHHHHHhcc
Confidence 99999999999886543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=352.70 Aligned_cols=275 Identities=23% Similarity=0.309 Sum_probs=201.3
Q ss_pred CCCceeeeeecccCceEEEEEEE------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEE
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 577 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~ 577 (840)
...|++.+.||+|+||.||+|.+ .+..||+|++..... .... ..+.+|+.++++++||||+++++++
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG---GNHI----ADLKKEIEILRNLYHENIVKYKGIC 92 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCH----HHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc---chhH----HHHHHHHHHHHhCCCCCeeeeeeEE
Confidence 34599999999999999999985 678999999754321 1112 3348999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
..... ...++||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 93 ~~~~~------------~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~N 156 (302)
T 4e5w_A 93 TEDGG------------NGIKLIMEFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARN 156 (302)
T ss_dssp EC---------------CCEEEEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred ecCCC------------ceEEEEEEeCCCCcHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchhe
Confidence 86531 1359999999999999999652 3568999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
||++.+ +.+||+|||++........... ......||..|+|||++.+ ..++.++|||||||+
T Consensus 157 il~~~~-------~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~i 218 (302)
T 4e5w_A 157 VLVESE-------HQVKIGDFGLTKAIETDKEYYT-------VKDDRDSPVFWYAPECLMQ----SKFYIASDVWSFGVT 218 (302)
T ss_dssp EEEEET-------TEEEECCCTTCEECCTTCCEEE-------CCCCTTCCGGGCCHHHHHH----CEEEHHHHHHHHHHH
T ss_pred EEEcCC-------CCEEECcccccccccCCCccee-------ccCCCCCCccccCCeeecC----CCCCcchhHHHHHHH
Confidence 999877 4699999999987654322100 1123458889999999987 567899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcc-hHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLT-DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
+|+|++|..|+... ................ ..+... . .... ........++.+.+||.+||..||.
T Consensus 219 l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~-------~-~~~~---~~~~~~~~~~~l~~li~~~l~~dp~ 285 (302)
T 4e5w_A 219 LHELLTYCDSDSSP--MALFLKMIGPTHGQMTVTRLVNT-------L-KEGK---RLPCPPNCPDEVYQLMRKCWEFQPS 285 (302)
T ss_dssp HHHHHTTTCGGGSH--HHHHHHHHCSCCGGGHHHHHHHH-------H-HTTC---CCCCCTTCCHHHHHHHHHTTCSSGG
T ss_pred HHHHHHccCCCcch--hhHHhhccCCcccccCHHHHHHH-------H-hccC---CCCCCCCCCHHHHHHHHHHcCCCCC
Confidence 99999999986422 1111111111000000 000000 0 0000 0001123456899999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 003185 817 ERPTAGDLYEMFVART 832 (840)
Q Consensus 817 eRPSa~ELLehLe~l~ 832 (840)
+|||+.++++.|+.+.
T Consensus 286 ~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 286 NRTSFQNLIEGFEALL 301 (302)
T ss_dssp GSCCHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHh
Confidence 9999999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=359.08 Aligned_cols=267 Identities=21% Similarity=0.211 Sum_probs=207.4
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEecC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISS 580 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~~~ 580 (840)
-++|++.+.||+|+||.||+|.+ .+..||+|+...... .+ .+.+|+.++++| +||||+++++++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~----~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 77 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR------AP----QLHLEYRFYKQLGSGDGIPQVYYFGPCG 77 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS------SC----CHHHHHHHHHHHCSCTTSCCEEEEEEET
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc------hH----HHHHHHHHHHHhhCCCCCCEEEEEEecC
Confidence 36899999999999999999996 688999999754321 11 248899999999 899999999998865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .+|||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 78 ~~--------------~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill 138 (330)
T 2izr_A 78 KY--------------NAMVLELL-GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI 138 (330)
T ss_dssp TE--------------EEEEEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred Cc--------------cEEEEEeC-CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee
Confidence 53 59999999 89999999862 3579999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.++. .....+||+|||+++.+........ ..........||+.|+|||++.+ ..++.++|||||||+|||
T Consensus 139 ~~~~~--~~~~~~kl~DFg~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~e 209 (330)
T 2izr_A 139 GRPGN--KTQQVIHIIDFALAKEYIDPETKKH---IPYREHKSLTGTARYMSINTHLG----KEQSRRDDLEALGHMFMY 209 (330)
T ss_dssp CCGGG--TCTTSEEECCCTTCEESBCTTTCCB---CCCCCCCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHHHHH
T ss_pred ccCCC--CCCceEEEEEcccceeeecCCCCcc---ccccccCCcCCCccccChHHHcC----CCCCchhHHHHHHHHHHH
Confidence 87742 1223499999999987644322110 01111244679999999999986 668999999999999999
Q ss_pred HHhCCCCCCCCC---HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 741 LLTLQVPYMGLS---ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 741 LLTG~~PF~~~~---~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
|++|..||.+.. ..+.+..+.....+.....+ ....+ .+.+||..||..||.+
T Consensus 210 ll~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~-----------------------~~~~p-~~~~li~~~l~~~p~~ 265 (330)
T 2izr_A 210 FLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVL-----------------------CENFP-EMATYLRYVRRLDFFE 265 (330)
T ss_dssp HHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHH-----------------------TTTCH-HHHHHHHHHHHCCTTC
T ss_pred HhcCCCCccccccccHHHHHHHHHhhhccCCHHHH-----------------------hccCh-HHHHHHHHHHhCCCCC
Confidence 999999998753 33344444332111111100 01124 7999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 003185 818 RPTAGDLYEMFVART 832 (840)
Q Consensus 818 RPSa~ELLehLe~l~ 832 (840)
||++++|++.|+.+.
T Consensus 266 RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 266 KPDYDYLRKLFTDLF 280 (330)
T ss_dssp CCCHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHH
Confidence 999999999998765
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=371.37 Aligned_cols=293 Identities=20% Similarity=0.224 Sum_probs=208.3
Q ss_pred CCCCCceeeeeeccc--CceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEE
Q 003185 502 GSFPSLSSCDEAGKS--VSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 577 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G--~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~ 577 (840)
...++|++.+.||+| +||.||+|++ .+..||+|++..... ..... ..+.+|+.+++.++|||||++++++
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~ 95 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC--SNEMV----TFLQGELHVSKLFNHPNIVPYRATF 95 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS--CHHHH----HHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc--ChHHH----HHHHHHHHHHHhCCCCCCCcEeEEE
Confidence 456789999999999 9999999998 478899999765432 22333 3448999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
..... .||||||+++|+|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 96 ~~~~~--------------~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N 158 (389)
T 3gni_B 96 IADNE--------------LWVVTSFMAYGSAKDLICT---HFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASH 158 (389)
T ss_dssp EETTE--------------EEEEEECCTTCBHHHHHHH---TCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred EECCE--------------EEEEEEccCCCCHHHHHhh---hcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 86653 5999999999999999986 223568999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
|||+.+ +.+||+|||.+............ .........||+.|+|||++.+. ...++.++|||||||+
T Consensus 159 Ill~~~-------~~~kl~dfg~~~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DiwslG~i 226 (389)
T 3gni_B 159 ILISVD-------GKVYLSGLRSNLSMISHGQRQRV---VHDFPKYSVKVLPWLSPEVLQQN--LQGYDAKSDIYSVGIT 226 (389)
T ss_dssp EEECTT-------CCEEECCGGGCEECEETTEECSC---BCCCCTTCTTTGGGSCHHHHSTT--SSCBCTHHHHHHHHHH
T ss_pred EEEcCC-------CCEEEcccccceeeccccccccc---cccccccccccccccCHHHHhcc--CCCCCcHhHHHHHHHH
Confidence 999877 46999999998765432211110 11122344799999999999751 1467899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhh----ccCccc-----cc--------cc-cCCCCCCchhhhhh
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL----GSCHEH-----EV--------AQ-SGSGFEKPEAELET 799 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~----~~~~~~-----~~--------~~-~~~~~~~~~~~~~~ 799 (840)
+|||++|+.||.+.+..+....+..+..+.+.+..... ...... .. .. ..............
T Consensus 227 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (389)
T 3gni_B 227 ACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTF 306 (389)
T ss_dssp HHHHHHSSCTTTTCCSTTHHHHC--------------------------------------------------------C
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCcccccc
Confidence 99999999999887655554443333222111100000 000000 00 00 00000011122345
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003185 800 LSFLVDVFRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 800 s~~L~dLI~rCL~~DP~eRPSa~ELLehLe 829 (840)
++.+.+||.+||+.||.+|||+.|+++|..
T Consensus 307 s~~~~~li~~~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 307 SPHFHHFVEQCLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence 678999999999999999999999999843
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=374.17 Aligned_cols=256 Identities=21% Similarity=0.268 Sum_probs=202.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|.+.+.||+|+||.||+|.+ .+..||+|++.... .........+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 80 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQL-----LKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT 80 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHH-----ccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 5688999999999999999999998 67899999975321 1111223356899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .++||||+ +|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 81 ~~~--------------~~lv~E~~-~g~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIl 140 (336)
T 3h4j_B 81 PTD--------------IVMVIEYA-GGELFDYIVE-----KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLL 140 (336)
T ss_dssp SSE--------------EEEEECCC-CEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEE
T ss_pred CCE--------------EEEEEECC-CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEE
Confidence 653 59999999 6799999876 256999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++........ .....||+.|+|||++.+ ....+.++|||||||++|
T Consensus 141 l~~~-------~~~kl~DFG~s~~~~~~~~-----------~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 199 (336)
T 3h4j_B 141 LDDN-------LNVKIADFGLSNIMTDGNF-----------LKTSCGSPNYAAPEVING---KLYAGPEVDVWSCGIVLY 199 (336)
T ss_dssp ECTT-------CCEEECCSSCTBTTTTSBT-----------TCCCTTSTTTSCGGGSCC---SGGGCHHHHHHHHHHHHH
T ss_pred EcCC-------CCEEEEEeccceeccCCcc-----------cccccCCcCcCCHHHHcC---CCCCCCccchhHHHHHHH
Confidence 9877 4599999999976543211 123469999999999975 122378999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|++|..||.+.....+...+..... ......++.+.+||.+||..||.+||
T Consensus 200 ~ll~g~~Pf~~~~~~~~~~~i~~~~~----------------------------~~p~~~s~~~~~li~~~L~~dP~~Rp 251 (336)
T 3h4j_B 200 VMLVGRLPFDDEFIPNLFKKVNSCVY----------------------------VMPDFLSPGAQSLIRRMIVADPMQRI 251 (336)
T ss_dssp HHHHSSCSSBCSSSTTCBCCCCSSCC----------------------------CCCTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred HHHhCCCCCCCccHHHHHHHHHcCCC----------------------------CCcccCCHHHHHHHHHHcCCChhHCc
Confidence 99999999976533222111111100 00112356789999999999999999
Q ss_pred CHHHHHHHHHhh
Q 003185 820 TAGDLYEMFVAR 831 (840)
Q Consensus 820 Sa~ELLehLe~l 831 (840)
|++||++|.+-.
T Consensus 252 t~~eil~hp~~~ 263 (336)
T 3h4j_B 252 TIQEIRRDPWFN 263 (336)
T ss_dssp CHHHHTTCHHHH
T ss_pred CHHHHHhChhhc
Confidence 999999997643
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=354.72 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=205.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
..+++|++.+.||+|+||.||+|.+.+..+|+|+..... ..+ .+.+|+.++++++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA------TAQ----AFLAEASVMTQLRHSNLVQLLGVIVEEK 87 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--------H----HHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred CChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh------HHH----HHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 567899999999999999999999999999999864221 222 3489999999999999999999876433
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. ..++||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 88 ~-------------~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~ 151 (278)
T 1byg_A 88 G-------------GLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS 151 (278)
T ss_dssp --------------CCEEEECCCTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred C-------------ceEEEEecCCCCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEe
Confidence 1 2499999999999999997621 12378999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||++....... ....+++.|+|||++.+ ..++.++||||||+++|+|
T Consensus 152 ~~-------~~~~l~Dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 207 (278)
T 1byg_A 152 ED-------NVAKVSDFGLTKEASSTQ-------------DTGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEI 207 (278)
T ss_dssp TT-------SCEEECCCCC-------------------------CCTTTSCHHHHHH----CCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEEeeccccccccccc-------------cCCCccccccCHHHhCC----CCCCchhcHHHHHHHHHHH
Confidence 76 469999999987554321 12247889999999986 6789999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 742 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 742 LT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
++ |..||......++...+..+..+..+. ..++.+.+||.+||..||.+|||
T Consensus 208 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rps 260 (278)
T 1byg_A 208 YSFGRVPYPRIPLKDVVPRVEKGYKMDAPD---------------------------GCPPAVYEVMKNCWHLDAAMRPS 260 (278)
T ss_dssp HTTSCCSCTTSCGGGHHHHHTTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhCCCCCCCCCCHHHHHHHHhcCCCCCCcc---------------------------cCCHHHHHHHHHHhcCChhhCCC
Confidence 98 999998887777776665554332221 23457999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 003185 821 AGDLYEMFVARTS 833 (840)
Q Consensus 821 a~ELLehLe~l~~ 833 (840)
+.++++.|+.+..
T Consensus 261 ~~~l~~~L~~i~~ 273 (278)
T 1byg_A 261 FLQLREQLEHIKT 273 (278)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHh
Confidence 9999999998864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=376.67 Aligned_cols=255 Identities=21% Similarity=0.339 Sum_probs=202.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~ 578 (840)
..+++|++.+.||+|+||.||+|++ .+..+|+|++...... .....+ .+.+|..+|.++ +|||||++++++.
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~-~~~~~~----~~~~E~~il~~~~~hp~Iv~l~~~~~ 123 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN-DDEDID----WVQTEKHVFEQASNHPFLVGLHSCFQ 123 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----CC----HHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHH----HHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence 5678999999999999999999997 4678999997644322 112222 348899999887 7999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
.... .||||||++||+|..++.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 124 ~~~~--------------~~lV~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NI 184 (396)
T 4dc2_A 124 TESR--------------LFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 184 (396)
T ss_dssp CSSE--------------EEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred ECCE--------------EEEEEEcCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHE
Confidence 6653 5999999999999999986 25699999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
||+.+ +.+||+|||+++....... .....+||+.|+|||++.+ ..++.++|||||||+|
T Consensus 185 Ll~~~-------g~ikL~DFGla~~~~~~~~----------~~~~~~gt~~Y~aPE~l~~----~~~~~~~DiwslGvll 243 (396)
T 4dc2_A 185 LLDSE-------GHIKLTDYGMCKEGLRPGD----------TTSTFCGTPNYIAPEILRG----EDYGFSVDWWALGVLM 243 (396)
T ss_dssp EECTT-------SCEEECCCTTCBCCCCTTC----------CBCCCCBCGGGCCHHHHTT----CCBCTHHHHHHHHHHH
T ss_pred EECCC-------CCEEEeecceeeecccCCC----------ccccccCCcccCCchhhcC----CCCChHHHHHHHHHHH
Confidence 99877 4699999999975322111 1234579999999999986 6789999999999999
Q ss_pred HHHHhCCCCCCCCC---------HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHH
Q 003185 739 LELLTLQVPYMGLS---------ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 809 (840)
Q Consensus 739 ~ELLTG~~PF~~~~---------~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~r 809 (840)
|||++|+.||.... ...+...+.... ..++. ..+..+.+||.+
T Consensus 244 yell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-~~~p~---------------------------~~s~~~~~li~~ 295 (396)
T 4dc2_A 244 FEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-IRIPR---------------------------SLSVKAASVLKS 295 (396)
T ss_dssp HHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-CCCCT---------------------------TSCHHHHHHHHH
T ss_pred HHHHhCCCCCcccccccccchhhHHHHHHHHhccc-cCCCC---------------------------cCCHHHHHHHHH
Confidence 99999999996431 222333443332 11221 124578999999
Q ss_pred hcccCCCCCCCH------HHHHHHHH
Q 003185 810 CTEENPTERPTA------GDLYEMFV 829 (840)
Q Consensus 810 CL~~DP~eRPSa------~ELLehLe 829 (840)
||+.||.+||++ ++|++|..
T Consensus 296 lL~~dP~~R~~~~~~~~~~ei~~Hpf 321 (396)
T 4dc2_A 296 FLNKDPKERLGCHPQTGFADIQGHPF 321 (396)
T ss_dssp HTCSCTTTSTTCSTTTHHHHHHHSTT
T ss_pred HhcCCHhHcCCCCCCCCHHHHhcCcc
Confidence 999999999985 79998854
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=368.57 Aligned_cols=282 Identities=19% Similarity=0.225 Sum_probs=206.3
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
-++|++.+.||+|+||.||+|.+ .+..||+|+... ...... ..+++.+|+.+|+.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~--~~~~~~----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--PFQSEL----FAKRAYRELRLLKHMRHENVIGLLDVFTPDE 97 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSS--TTSSHH----HHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCc--cccCHH----HHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence 46899999999999999999997 577899998532 222222 2344589999999999999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
.. ......|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 98 ~~--------~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~ 162 (367)
T 1cm8_A 98 TL--------DDFTDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN 162 (367)
T ss_dssp ST--------TTCCCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred cc--------ccCceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEc
Confidence 22 1123469999999 7899999976 4689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||+++..... ....+||+.|+|||++.+ ...++.++|||||||++|||
T Consensus 163 ~~-------~~~kl~Dfg~a~~~~~~-------------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el 219 (367)
T 1cm8_A 163 ED-------CELKILDFGLARQADSE-------------MTGYVVTRWYRAPEVILN---WMRYTQTVDIWSVGCIMAEM 219 (367)
T ss_dssp TT-------CCEEECCCTTCEECCSS-------------CCSSCSCGGGCCTHHHHT---TTCCCTTHHHHHHHHHHHHH
T ss_pred CC-------CCEEEEeeecccccccc-------------cCcCcCCCCcCCHHHHhC---CCCCChhhhHHHHHHHHHHH
Confidence 77 46999999999865431 123468999999999875 24689999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccC---CCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG---SGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
++|+.||.+.+..+.+..+.........+.+..+.......+.... ............++.+.+||.+||..||.+|
T Consensus 220 l~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R 299 (367)
T 1cm8_A 220 ITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR 299 (367)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTS
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHC
Confidence 9999999998887777776554222222222111100000000000 0001111223346789999999999999999
Q ss_pred CCHHHHHHHHH
Q 003185 819 PTAGDLYEMFV 829 (840)
Q Consensus 819 PSa~ELLehLe 829 (840)
||+.++++|..
T Consensus 300 ~t~~e~l~hp~ 310 (367)
T 1cm8_A 300 VTAGEALAHPY 310 (367)
T ss_dssp CCHHHHHHSGG
T ss_pred CCHHHHhcChH
Confidence 99999999854
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=360.25 Aligned_cols=263 Identities=21% Similarity=0.320 Sum_probs=207.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC------eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGS------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 575 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g 575 (840)
+.-.+|.+.+.||+|+||.||+|.+.. ..||+|+.... ....... .+.+|+.++++++||||+++++
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~ 113 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRV----DFLGEAGIMGQFSHHNIIRLEG 113 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT---CCHHHHH----HHHHHHHHHHTCCCTTBCCEEE
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC---CCHHHHH----HHHHHHHHHHhCCCCCCCcEEE
Confidence 456789999999999999999998632 34888886432 1222223 3489999999999999999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCC
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 655 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKP 655 (840)
++..... .+|||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||
T Consensus 114 ~~~~~~~--------------~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 175 (333)
T 1mqb_A 114 VISKYKP--------------MMIITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAA 175 (333)
T ss_dssp EECSSSS--------------EEEEEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred EEecCCC--------------cEEEEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence 9876543 4999999999999999976 235689999999999999999999999999999999
Q ss_pred CcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003185 656 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735 (840)
Q Consensus 656 eNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLG 735 (840)
+|||++.+ +.+||+|||+++......... .......+|+.|+|||++.+ ..++.++||||||
T Consensus 176 ~NIl~~~~-------~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG 237 (333)
T 1mqb_A 176 RNILVNSN-------LVCKVSDFGLSRVLEDDPEAT-------YTTSGGKIPIRWTAPEAISY----RKFTSASDVWSFG 237 (333)
T ss_dssp GGEEECTT-------CCEEECCCCC------------------------CCCGGGSCHHHHHS----CCCCHHHHHHHHH
T ss_pred heEEECCC-------CcEEECCCCcchhhccccccc-------cccCCCCccccccCchhccc----CCCCchhhhHHHH
Confidence 99999876 469999999998765422110 01122346889999999986 6789999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003185 736 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 814 (840)
Q Consensus 736 vIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~D 814 (840)
|++|||++ |..||.+....++...+..+.++..+. ..+..+.+||.+||..|
T Consensus 238 ~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~ 290 (333)
T 1mqb_A 238 IVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM---------------------------DCPSAIYQLMMQCWQQE 290 (333)
T ss_dssp HHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TCBHHHHHHHHHHTCSS
T ss_pred HHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcc---------------------------cCCHHHHHHHHHHcCCC
Confidence 99999999 999999988888888777664433221 12457899999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCC
Q 003185 815 PTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 815 P~eRPSa~ELLehLe~l~~~ 834 (840)
|.+||++.+|+++|+.+...
T Consensus 291 p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 291 RARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp TTTSCCHHHHHHHHHHHHHS
T ss_pred hhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999987644
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=382.04 Aligned_cols=266 Identities=22% Similarity=0.298 Sum_probs=212.0
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCC-----hHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSS-----ADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 575 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~-----~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g 575 (840)
..++|.+.+.||+|+||.||+|.+ .+..+|+|++........ ....+.+.+.+.+|+.+|++|+|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 457899999999999999999997 567899999764432111 1111233456699999999999999999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCC
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 655 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKP 655 (840)
++.... ..||||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||
T Consensus 114 ~~~~~~--------------~~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp 174 (504)
T 3q5i_A 114 VFEDKK--------------YFYLVTEFYEGGELFEQIIN-----RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKP 174 (504)
T ss_dssp EEECSS--------------EEEEEEECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEcCC--------------EEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcH
Confidence 998655 35999999999999999976 25699999999999999999999999999999999
Q ss_pred CcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003185 656 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735 (840)
Q Consensus 656 eNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLG 735 (840)
+|||++.++ ....+||+|||++........ .....||+.|+|||++.+ .++.++||||||
T Consensus 175 ~Nil~~~~~----~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG 234 (504)
T 3q5i_A 175 ENILLENKN----SLLNIKIVDFGLSSFFSKDYK-----------LRDRLGTAYYIAPEVLKK-----KYNEKCDVWSCG 234 (504)
T ss_dssp GGEEESSTT----CCSSEEECCCTTCEECCTTSC-----------BCCCCSCTTTCCHHHHTT-----CBCTHHHHHHHH
T ss_pred HHEEEecCC----CCccEEEEECCCCEEcCCCCc-----------cccccCCcCCCCHHHhcc-----CCCchHHHHHHH
Confidence 999998763 124699999999986643211 123469999999999863 578999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 736 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 736 vIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
|++|+|++|..||.+.+..++...+..+........+ ...++.+.+||.+||..||
T Consensus 235 ~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dp 290 (504)
T 3q5i_A 235 VIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW------------------------KNISDEAKELIKLMLTYDY 290 (504)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH------------------------TTSCHHHHHHHHHHTCSST
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccc------------------------CCCCHHHHHHHHHHcCCCh
Confidence 9999999999999999999988888876433222111 2235679999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 003185 816 TERPTAGDLYEMFVAR 831 (840)
Q Consensus 816 ~eRPSa~ELLehLe~l 831 (840)
.+|||+.|+++|.+-.
T Consensus 291 ~~R~t~~e~l~h~~~~ 306 (504)
T 3q5i_A 291 NKRCTAEEALNSRWIK 306 (504)
T ss_dssp TTSCCHHHHHTSHHHH
T ss_pred hHCCCHHHHhcCHhhh
Confidence 9999999999996543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=382.56 Aligned_cols=256 Identities=24% Similarity=0.333 Sum_probs=206.5
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||+||+|.+ .+..+|+|++....... ... ..+.+|+.+|+.++|||||++++++....
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~- 109 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST--SSN----SKLLEEVAVLKLLDHPNIMKLYDFFEDKR- 109 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTT----HHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc--hHH----HHHHHHHHHHHhCCCCCCCeEEEEEEeCC-
Confidence 4699999999999999999998 56789999976432211 112 23489999999999999999999998655
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
..||||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 110 -------------~~~lv~e~~~~g~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~ 171 (494)
T 3lij_A 110 -------------NYYLVMECYKGGELFDEIIH-----RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLES 171 (494)
T ss_dssp -------------EEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred -------------EEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeC
Confidence 35999999999999999876 256899999999999999999999999999999999999976
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
.+ ....+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|+
T Consensus 172 ~~----~~~~~kl~DfG~a~~~~~~~~-----------~~~~~gt~~y~aPE~l~~-----~~~~~~DiwslG~il~~ll 231 (494)
T 3lij_A 172 KE----KDALIKIVDFGLSAVFENQKK-----------MKERLGTAYYIAPEVLRK-----KYDEKCDVWSIGVILFILL 231 (494)
T ss_dssp SS----TTCCEEECCCTTCEECBTTBC-----------BCCCCSCTTTCCHHHHTT-----CBCTHHHHHHHHHHHHHHH
T ss_pred CC----CCCcEEEEECCCCeECCCCcc-----------ccccCCCcCeeCHHHHcc-----cCCCchhHHHHHHHHHHHH
Confidence 53 235699999999987643221 123469999999999863 5789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
+|..||.+.+..++...+..+........ ....++.+.+||.+||+.||.+|||+.
T Consensus 232 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~ 287 (494)
T 3lij_A 232 AGYPPFGGQTDQEILRKVEKGKYTFDSPE------------------------WKNVSEGAKDLIKQMLQFDSQRRISAQ 287 (494)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCCCSGG------------------------GTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCchh------------------------cccCCHHHHHHHHHHCCCChhhCccHH
Confidence 99999999999988888877644322211 112356799999999999999999999
Q ss_pred HHHHHHH
Q 003185 823 DLYEMFV 829 (840)
Q Consensus 823 ELLehLe 829 (840)
++++|.+
T Consensus 288 e~l~hp~ 294 (494)
T 3lij_A 288 QALEHPW 294 (494)
T ss_dssp HHHTCHH
T ss_pred HHhcCcc
Confidence 9999844
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=368.39 Aligned_cols=255 Identities=24% Similarity=0.289 Sum_probs=208.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~ 578 (840)
..+++|++.+.||+|+||.||+|++. +..||+|+...... ........+.+|..+|..+ +||||+++++++.
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~-----~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~ 91 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV-----IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 91 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE
Confidence 57889999999999999999999985 46799998754311 0111123448899999988 7999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
.... .||||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 92 ~~~~--------------~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 152 (353)
T 2i0e_A 92 TMDR--------------LYFVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNV 152 (353)
T ss_dssp CSSE--------------EEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred cCCE--------------EEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHE
Confidence 6553 5999999999999999986 24699999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 153 ll~~~-------g~vkL~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il 211 (353)
T 2i0e_A 153 MLDSE-------GHIKIADFGMCKENIWDGV----------TTKTFCGTPDYIAPEIIAY----QPYGKSVDWWAFGVLL 211 (353)
T ss_dssp EECTT-------SCEEECCCTTCBCCCCTTC----------CBCCCCSCGGGCCHHHHTT----CCBSTHHHHHHHHHHH
T ss_pred EEcCC-------CcEEEEeCCcccccccCCc----------ccccccCCccccChhhhcC----CCcCCcccccchHHHH
Confidence 99877 4699999999975432111 1234579999999999976 6689999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 739 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
|||++|+.||.+.+..++...+..... .++. ..+..+.+||.+||..||.+|
T Consensus 212 ~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~~li~~lL~~dP~~R 263 (353)
T 2i0e_A 212 YEMLAGQAPFEGEDEDELFQSIMEHNV-AYPK---------------------------SMSKEAVAICKGLMTKHPGKR 263 (353)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCT---------------------------TSCHHHHHHHHHHTCSCTTSC
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHhCCC-CCCC---------------------------CCCHHHHHHHHHHhhcCHHHc
Confidence 999999999999988888888876532 1221 124578999999999999999
Q ss_pred C-----CHHHHHHHHH
Q 003185 819 P-----TAGDLYEMFV 829 (840)
Q Consensus 819 P-----Sa~ELLehLe 829 (840)
| ++++|++|..
T Consensus 264 ~~~~~~~~~~i~~h~~ 279 (353)
T 2i0e_A 264 LGCGPEGERDIKEHAF 279 (353)
T ss_dssp TTCSTTHHHHHHTSGG
T ss_pred CCCCCCCHHHHhcCcc
Confidence 9 4699998854
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=366.23 Aligned_cols=282 Identities=20% Similarity=0.222 Sum_probs=205.6
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+++|.+.+.||+|+||.||+|.+ .+..||+|++..... .... ..+.+|+.+|++++||||+++++++....
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAP----CTAIREVSLLKDLKHANIVTLHDIIHTEK 73 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------C----CCCCCCHHHHSCCCCTTBCCEEEEEECSS
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc---cccc----hhHHHHHHHHHhcCCCCCCeeeeEEeeCC
Confidence 57899999999999999999998 577899998754321 1111 12267999999999999999999998665
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .+|||||+. |+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 74 ~--------------~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~ 134 (324)
T 3mtl_A 74 S--------------LTLVFEYLD-KDLKQYLDD----CGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN 134 (324)
T ss_dssp C--------------EEEEEECCS-EEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEEC
T ss_pred E--------------EEEEecccc-cCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEEC
Confidence 4 499999998 599999876 235689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||+++........ .....||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 135 ~~-------~~~kl~Dfg~a~~~~~~~~~----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l 194 (324)
T 3mtl_A 135 ER-------GELKLADFGLARAKSIPTKT----------YDNEVVTLWYRPPDILLG---STDYSTQIDMWGVGCIFYEM 194 (324)
T ss_dssp TT-------CCEEECSSSEEECC----------------------CGGGCCHHHHTT---CCCCCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEccCcccccccCCccc----------cccccCcccccChhhhcC---CCCCCcHHHHHHHHHHHHHH
Confidence 77 45999999999765432111 123468999999999875 34678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccC--CCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG--SGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
++|+.||.+.+..+....+...........+............... ............+..+.+||.+||+.||.+||
T Consensus 195 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 274 (324)
T 3mtl_A 195 ATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI 274 (324)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCC
Confidence 9999999999888777776554222222211111100000000000 00001112233467889999999999999999
Q ss_pred CHHHHHHHHHhh
Q 003185 820 TAGDLYEMFVAR 831 (840)
Q Consensus 820 Sa~ELLehLe~l 831 (840)
|++|+++|.+-.
T Consensus 275 t~~e~l~hp~f~ 286 (324)
T 3mtl_A 275 SAEDAMKHPFFL 286 (324)
T ss_dssp CHHHHTTSGGGG
T ss_pred CHHHHhcChhhh
Confidence 999999986543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=362.74 Aligned_cols=260 Identities=19% Similarity=0.310 Sum_probs=204.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeE----EEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADA----AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 575 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~v----AVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g 575 (840)
...++|++.+.||+|+||.||+|.+ .+..+ ++|...... ..... ..+.+|+.++++++||||+++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~---~~~~~----~~~~~E~~~l~~l~hp~iv~~~~ 84 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKAN----KEILDEAYVMASVDNPHVCRLLG 84 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS---SCCCH----HHHHHHHHHHTTCCBTTBCCCCE
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc---CHHHH----HHHHHHHHHHHhCCCCCeeEEEE
Confidence 4567899999999999999999997 34444 555432111 11122 23489999999999999999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCC
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 655 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKP 655 (840)
++.... .++||||+.+|+|.+++.. ....+++..++.|+.||+.||.|||++||+||||||
T Consensus 85 ~~~~~~---------------~~~v~~~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 145 (327)
T 3lzb_A 85 ICLTST---------------VQLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAA 145 (327)
T ss_dssp EEESSS---------------EEEEECCCSSCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred EEecCC---------------ceEEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCH
Confidence 998543 4899999999999999986 235689999999999999999999999999999999
Q ss_pred CcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003185 656 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735 (840)
Q Consensus 656 eNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLG 735 (840)
+|||++.+ +.+||+|||+++......... ......+|+.|+|||++.+ ..++.++||||||
T Consensus 146 ~NIl~~~~-------~~~kL~DfG~a~~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG 206 (327)
T 3lzb_A 146 RNVLVKTP-------QHVKITDFGLAKLLGAEEKEY--------HAEGGKVPIKWMALESILH----RIYTHQSDVWSYG 206 (327)
T ss_dssp GGEEEEET-------TEEEECCTTC------------------------CCCGGGSCHHHHHH----CCCCHHHHHHHHH
T ss_pred HHEEEcCC-------CCEEEccCcceeEccCccccc--------cccCCCccccccCHHHHcC----CCCChHHHHHHHH
Confidence 99999877 469999999998764432211 1122357889999999987 6789999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003185 736 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 814 (840)
Q Consensus 736 vIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~D 814 (840)
|++|||++ |..||.+....++...+........+. ..+..+.+||.+||..|
T Consensus 207 ~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~d 259 (327)
T 3lzb_A 207 VTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP---------------------------ICTIDVYMIMRKCWMID 259 (327)
T ss_dssp HHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT---------------------------TBCHHHHHHHHHHTCSS
T ss_pred HHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cCCHHHHHHHHHHcCCC
Confidence 99999999 999999988888777777664433321 12457899999999999
Q ss_pred CCCCCCHHHHHHHHHhhcC
Q 003185 815 PTERPTAGDLYEMFVARTS 833 (840)
Q Consensus 815 P~eRPSa~ELLehLe~l~~ 833 (840)
|.+|||+.+|++.|+.+..
T Consensus 260 p~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 260 ADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp GGGSCCHHHHHHHHHHHHT
T ss_pred hhHCcCHHHHHHHHHHHHh
Confidence 9999999999999998864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=360.65 Aligned_cols=265 Identities=22% Similarity=0.355 Sum_probs=213.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC---------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcc
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIV 571 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~---------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV 571 (840)
...++|++.+.||+|+||.||+|.+. +..||+|+.... ......+ .+.+|+.+++++ +||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~E~~~l~~l~~hp~iv 104 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLS----DLVSEMEMMKMIGKHKNII 104 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT---CCHHHHH----HHHHHHHHHHHHCCCTTBC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC---CcHHHHH----HHHHHHHHHHHhhcCCCEe
Confidence 45578999999999999999999863 457899985422 2223333 348999999999 899999
Q ss_pred eeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHH
Q 003185 572 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAAL 640 (840)
Q Consensus 572 ~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-----------~~~~ls~~~~~~Ia~QIa~AL 640 (840)
++++++...... ++||||+++|+|.+++...... ....+++..++.++.||+.||
T Consensus 105 ~~~~~~~~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL 170 (334)
T 2pvf_A 105 NLLGACTQDGPL--------------YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170 (334)
T ss_dssp CEEEEECSSSCC--------------EEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHH
T ss_pred eEEEEEccCCce--------------EEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHH
Confidence 999999766543 9999999999999999852110 123489999999999999999
Q ss_pred HHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003185 641 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720 (840)
Q Consensus 641 ~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~ 720 (840)
.|||++||+||||||+|||++.+ +.+||+|||+++......... ......+|+.|+|||++.+
T Consensus 171 ~~LH~~~ivH~Dlkp~NIll~~~-------~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-- 233 (334)
T 2pvf_A 171 EYLASQKCIHRDLAARNVLVTEN-------NVMKIADFGLARDINNIDYYK--------KTTNGRLPVKWMAPEALFD-- 233 (334)
T ss_dssp HHHHHTTEECSCCSGGGEEECTT-------CCEEECCCTTCEECTTTSSEE--------CCSCCCCCGGGCCHHHHHH--
T ss_pred HHHHhCCeeCCCCccceEEEcCC-------CCEEEcccccccccccccccc--------ccCCCCcccceeChHHhcC--
Confidence 99999999999999999999877 469999999998665422110 0122357889999999986
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhh
Q 003185 721 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 799 (840)
Q Consensus 721 ~~~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 799 (840)
..++.++|||||||++|+|++ |..||.+....++...+..+..+..+. ..
T Consensus 234 --~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~ 284 (334)
T 2pvf_A 234 --RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPA---------------------------NC 284 (334)
T ss_dssp --CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCT---------------------------TC
T ss_pred --CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCCCCc---------------------------cC
Confidence 568899999999999999999 999999998888887777665433321 12
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003185 800 LSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 833 (840)
Q Consensus 800 s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~ 833 (840)
+..+.+||.+||..||.+|||+.+|+++|+.+..
T Consensus 285 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 285 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 4578999999999999999999999999998864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=359.88 Aligned_cols=276 Identities=24% Similarity=0.278 Sum_probs=198.7
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+++|++.+.||+|+||.||+|++ .+..||+|++.... ..... +.+.+|+.+|++|+|||||++++++....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 77 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAR----EKVMREVKALAKLEHPGIVRYFNAWLETP 77 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHH----HHHHHHHHHHTSCCCTTBCCEEEEEEECC
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHH----HHHHHHHHHHHhCCCCCEeeEEEEEEEec
Confidence 56799999999999999999998 57889999976432 11222 34489999999999999999999987543
Q ss_pred CCC-------------------------------------------CCCCCCccccceEEEEEeccCCCCHHHHHHHHhc
Q 003185 582 WLP-------------------------------------------SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE 618 (840)
Q Consensus 582 ~~p-------------------------------------------~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~ 618 (840)
... .............++||||+++++|.+++...
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-- 155 (332)
T 3qd2_B 78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR-- 155 (332)
T ss_dssp SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC--
T ss_pred cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc--
Confidence 200 00000011223479999999999999999852
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccc--cC
Q 003185 619 TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA--HR 696 (840)
Q Consensus 619 ~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~--~~ 696 (840)
......++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||+++............ ..
T Consensus 156 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-------~~~kL~DfG~a~~~~~~~~~~~~~~~~~ 228 (332)
T 3qd2_B 156 CSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-------DVVKVGDFGLVTAMDQDEEEQTVLTPMP 228 (332)
T ss_dssp CSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-------CCEEECCCTTCEECSCC-----------
T ss_pred cCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCC-------CCEEEeecCcccccccchhhcccccccc
Confidence 222345677899999999999999999999999999999999877 469999999998765432111000 00
Q ss_pred CCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhc
Q 003185 697 GIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG 776 (840)
Q Consensus 697 ~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~ 776 (840)
.........||+.|+|||++.+ ..++.++|||||||++|||++|..|+. ........+.....+
T Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~el~~~~~~~~--~~~~~~~~~~~~~~~---------- 292 (332)
T 3qd2_B 229 AYATHTGQVGTKLYMSPEQIHG----NNYSHKVDIFSLGLILFELLYSFSTQM--ERVRIITDVRNLKFP---------- 292 (332)
T ss_dssp ---CCCSCC-CGGGSCHHHHHC----CCCCTHHHHHHHHHHHHHHHSCCCCHH--HHHHHHHHHHTTCCC----------
T ss_pred ccccccccCCCcCccChHHhcC----CCCcchhhHHHHHHHHHHHHHcCCChh--HHHHHHHHhhccCCC----------
Confidence 0111234579999999999986 678999999999999999999877652 122223333332221
Q ss_pred cCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003185 777 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828 (840)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehL 828 (840)
......++.+.+||.+||+.||.+|||+.++++|.
T Consensus 293 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 327 (332)
T 3qd2_B 293 -----------------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENA 327 (332)
T ss_dssp -----------------HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHST
T ss_pred -----------------cccccCChhHHHHHHHHccCCCCcCCCHHHHhhch
Confidence 11222345679999999999999999999999984
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=348.70 Aligned_cols=271 Identities=16% Similarity=0.166 Sum_probs=210.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~ 578 (840)
..-++|++.+.||+|+||.||+|.+ .+..||+|+...... .+ .+.+|+.+++.+ +|+||+++++++.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~----~~~~e~~~~~~l~~~~~i~~~~~~~~ 76 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------AP----QLRDEYRTYKLLAGCTGIPNVYYFGQ 76 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SC----CHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc------cH----HHHHHHHHHHHHhcCCCCCeEEeecC
Confidence 3456799999999999999999995 788999998653221 11 238899999999 6999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
... ..++||||+ +++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 77 ~~~--------------~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NI 137 (298)
T 1csn_A 77 EGL--------------HNVLVIDLL-GPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 137 (298)
T ss_dssp ETT--------------EEEEEEECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred CCc--------------eeEEEEEec-CCCHHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence 655 359999999 8999999986 234699999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.++. .....+||+|||+++.......... ..........||+.|+|||++.+ ..++.++|||||||++
T Consensus 138 l~~~~~~--~~~~~~kl~Dfg~~~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il 208 (298)
T 1csn_A 138 LIGRPNS--KNANMIYVVDFGMVKFYRDPVTKQH---IPYREKKNLSGTARYMSINTHLG----REQSRRDDLEALGHVF 208 (298)
T ss_dssp EECCSSS--TTTTCEEECCCTTCEESBCTTTCCB---CCCCCCCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHHH
T ss_pred EeccCCC--CCCCeEEEEECcccccccccccccc---ccccCccCCCCCcccCCchhhcC----CCCChHHHHHHHHHHH
Confidence 9987632 2335699999999987654322110 01112344579999999999976 6689999999999999
Q ss_pred HHHHhCCCCCCCC---CHHHHHHHHHcCCC-CCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003185 739 LELLTLQVPYMGL---SELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 814 (840)
Q Consensus 739 ~ELLTG~~PF~~~---~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~D 814 (840)
|||++|+.||.+. ...+....+..... +..+. .....++.+.+||.+||..|
T Consensus 209 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~l~~li~~~l~~d 264 (298)
T 1csn_A 209 MYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE------------------------LCAGFPEEFYKYMHYARNLA 264 (298)
T ss_dssp HHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH------------------------HTTTSCHHHHHHHHHHHHCC
T ss_pred HHHHcCCCCcchhhccccHHHHHHHHhhccCccHHH------------------------HHhhCcHHHHHHHHHHhcCC
Confidence 9999999999874 33444444433211 11111 11123568999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCC
Q 003185 815 PTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 815 P~eRPSa~ELLehLe~l~~~ 834 (840)
|.+||++++|++.|+.+...
T Consensus 265 p~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 265 FDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp TTCCCCHHHHHHHHHHHHHH
T ss_pred cccCCCHHHHHHHHHHHHHh
Confidence 99999999999999987643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=367.25 Aligned_cols=255 Identities=25% Similarity=0.282 Sum_probs=193.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
...++|++.+.||+|+||.||+|+. .+..||+|++..... . . ..+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~---~----~~~~~E~~~l~~l~hpniv~~~~~~~~ 87 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--I---D----ENVQREIINHRSLRHPNIVRFKEVILT 87 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--S---C----HHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--c---c----HHHHHHHHHHHhCCCCCCCcEEEEEee
Confidence 4568999999999999999999998 577899998753221 1 1 234899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .+|||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 88 ~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nil 148 (361)
T 3uc3_A 88 PTH--------------LAIIMEYASGGELYERICN-----AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTL 148 (361)
T ss_dssp SSE--------------EEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEE
T ss_pred CCE--------------EEEEEEeCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 553 5999999999999999976 246999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCC-CchhhHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEVDIWSYGCLL 738 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~-s~kSDVWSLGvIL 738 (840)
++.++. ..+||+|||+++....... .....||+.|+|||++.+ ..+ +.++|||||||++
T Consensus 149 l~~~~~-----~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il 208 (361)
T 3uc3_A 149 LDGSPA-----PRLKICDFGYSKSSVLHSQ-----------PKSTVGTPAYIAPEVLLR----QEYDGKIADVWSCGVTL 208 (361)
T ss_dssp ECSSSS-----CCEEECCCCCC--------------------------CTTSCHHHHHC----SSCCHHHHHHHHHHHHH
T ss_pred EcCCCC-----ceEEEeecCccccccccCC-----------CCCCcCCCCcCChhhhcC----CCCCCCeeeeehhHHHH
Confidence 986632 5699999999974322111 133469999999999986 344 4459999999999
Q ss_pred HHHHhCCCCCCCCCH----HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003185 739 LELLTLQVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 814 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~----~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~D 814 (840)
|+|++|+.||.+... ......+..... .++. ....++.+.+||.+||..|
T Consensus 209 ~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~-------------------------~~~~s~~~~~li~~~L~~d 262 (361)
T 3uc3_A 209 YVMLVGAYPFEDPEEPRDYRKTIQRILSVKY-SIPD-------------------------DIRISPECCHLISRIFVAD 262 (361)
T ss_dssp HHHHHSSCSCC----CCCHHHHHHHHHTTCC-CCCT-------------------------TSCCCHHHHHHHHHHSCSC
T ss_pred HHHHhCCCCCCCCccHHHHHHHHHHHhcCCC-CCCC-------------------------cCCCCHHHHHHHHHHccCC
Confidence 999999999976543 233333332211 1110 0113457899999999999
Q ss_pred CCCCCCHHHHHHHHHh
Q 003185 815 PTERPTAGDLYEMFVA 830 (840)
Q Consensus 815 P~eRPSa~ELLehLe~ 830 (840)
|.+|||+.||++|.+-
T Consensus 263 P~~Rps~~ell~hp~f 278 (361)
T 3uc3_A 263 PATRISIPEIKTHSWF 278 (361)
T ss_dssp TTTSCCHHHHHTSHHH
T ss_pred hhHCcCHHHHHhCcch
Confidence 9999999999999664
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=377.27 Aligned_cols=296 Identities=18% Similarity=0.174 Sum_probs=194.3
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
-++|++.+.||+|+||.||+|.+ .+..||+|++.. ........+ ++.+|+.+|+.|+|||||++++++....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~--~~~~~~~~~----~~~~E~~~l~~l~h~niv~l~~~~~~~~ 125 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR--VFEDLIDCK----RILREIAILNRLNHDHVVKVLDIVIPKD 125 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECS--TTSSHHHHH----HHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEech--hhcCHHHHH----HHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence 47899999999999999999987 577899998632 222333333 4489999999999999999999986543
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
.. .....||||||+. ++|.+++.. ...+++..++.++.||+.||.|||++|||||||||+||||+
T Consensus 126 ~~---------~~~~~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~ 190 (458)
T 3rp9_A 126 VE---------KFDELYVVLEIAD-SDFKKLFRT-----PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN 190 (458)
T ss_dssp TT---------TCCCEEEEECCCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred cc---------cCceEEEEEeccc-cchhhhccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEEC
Confidence 11 2235799999985 699999874 35699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCccccccccccccc-----------------ccCCCCCCCcccCCCcccchhhhhcccCCCC
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCI-----------------AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 724 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~-----------------~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~ 724 (840)
.+ +.+||+|||+|+........... ...........+||+.|+|||++.. ...
T Consensus 191 ~~-------~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~ 260 (458)
T 3rp9_A 191 QD-------CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL---QEN 260 (458)
T ss_dssp TT-------CCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTT---CCC
T ss_pred CC-------CCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhC---CCC
Confidence 77 46999999999876532211000 0000011234578999999998753 256
Q ss_pred CCchhhHHHHHHHHHHHHh-----------CCCCCCCCCH--------------------HHHHHHHHcCCCCCcchHHh
Q 003185 725 YGLEVDIWSYGCLLLELLT-----------LQVPYMGLSE--------------------LEIHDLIQMGKRPRLTDELE 773 (840)
Q Consensus 725 ~s~kSDVWSLGvIL~ELLT-----------G~~PF~~~~~--------------------~el~~~I~~~~~p~l~~~l~ 773 (840)
++.++||||||||||||++ |+++|.+.+. .+.+..|.........+.+.
T Consensus 261 ~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~ 340 (458)
T 3rp9_A 261 YTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIE 340 (458)
T ss_dssp CCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHH
T ss_pred CCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHh
Confidence 8999999999999999999 7777766542 12222222211111111111
Q ss_pred hhccCcccccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003185 774 ALGSCHEHEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 774 ~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~ 830 (840)
.........+... .............+..+.+||.+||..||.+|||++|+++|..-
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f 400 (458)
T 3rp9_A 341 ALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF 400 (458)
T ss_dssp TSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred hcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhh
Confidence 1100000000000 00111122233446789999999999999999999999999553
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=354.81 Aligned_cols=271 Identities=25% Similarity=0.410 Sum_probs=203.7
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEe
Q 003185 501 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 578 (840)
Q Consensus 501 p~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~ 578 (840)
...+++|++.+.||+|+||.||+|.. .+..+|+|++..... ....... .+.+|+.++++++||||+++++++.
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~----~~~~E~~~l~~l~h~~i~~~~~~~~ 102 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL-MDAKARA----DCIKEIDLLKQLNHPNVIKYYASFI 102 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS-CCHHHHH----HHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc-cCHHHHH----HHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 35678999999999999999999997 678899998754322 2223333 4489999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
.... .++||||+++++|.+++..... ....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 103 ~~~~--------------~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NI 167 (310)
T 2wqm_A 103 EDNE--------------LNIVLELADAGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANV 167 (310)
T ss_dssp ETTE--------------EEEEEECCCSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred cCCc--------------EEEEEecCCCCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHE
Confidence 6553 5999999999999999976433 235689999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.+ +.+||+|||++......... .....||+.|+|||++.+ ..++.++||||||+++
T Consensus 168 l~~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il 226 (310)
T 2wqm_A 168 FITAT-------GVVKLGDLGLGRFFSSKTTA----------AHSLVGTPYYMSPERIHE----NGYNFKSDIWSLGCLL 226 (310)
T ss_dssp EECTT-------SCEEECCC----------------------------CCSSCCHHHHTT----CCCCHHHHHHHHHHHH
T ss_pred EEcCC-------CCEEEEeccceeeecCCCcc----------ccccCCCeeEeChHHhCC----CCCCchhhHHHHHHHH
Confidence 99876 46999999999765432111 123468999999999976 6789999999999999
Q ss_pred HHHHhCCCCCCCC--CHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 739 LELLTLQVPYMGL--SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 739 ~ELLTG~~PF~~~--~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
|+|++|..||.+. ....+...+.....+.+.. ...+..+.+||.+||..||.
T Consensus 227 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~dp~ 280 (310)
T 2wqm_A 227 YEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPS--------------------------DHYSEELRQLVNMCINPDPE 280 (310)
T ss_dssp HHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCT--------------------------TTSCHHHHHHHHHHTCSSGG
T ss_pred HHHHhCCCCCcccchhHHHHHHHhhcccCCCCcc--------------------------cccCHHHHHHHHHHcCCChh
Confidence 9999999999654 3344555555443322210 12345799999999999999
Q ss_pred CCCCHHHHHHHHHhhcCCCCCC
Q 003185 817 ERPTAGDLYEMFVARTSSSISS 838 (840)
Q Consensus 817 eRPSa~ELLehLe~l~~~~~s~ 838 (840)
+|||+.+|+++|+.+......+
T Consensus 281 ~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 281 KRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp GSCCHHHHHHHHHHHHHHHC--
T ss_pred hCCCHHHHHHHHHHHHHhhhhh
Confidence 9999999999999987654443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=381.10 Aligned_cols=255 Identities=24% Similarity=0.328 Sum_probs=203.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++.+.||+|+||.||+|.. .+..||+|++...... ..... ..+.+|+.+|+.++||||+++++++..
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~----~~~~~e~~~l~~l~h~~iv~l~~~~~~ 219 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEV----AHTLTENRVLQNSRHPFLTALKYSFQT 219 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC------------------CCCCCSCTTSCCEEEEEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh-hhHHH----HHHHHHHHHHHhCCCCeEeeEEEEEee
Confidence 4678899999999999999999997 5778999997643211 11122 234889999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCCCcE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENI 658 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs-~gIVHRDLKPeNI 658 (840)
... .||||||+++|+|..++.. ...+++..++.++.||+.||+|||+ +||+||||||+||
T Consensus 220 ~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NI 280 (446)
T 4ejn_A 220 HDR--------------LCFVMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENL 280 (446)
T ss_dssp TTE--------------EEEEECCCSSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGE
T ss_pred CCE--------------EEEEEeeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHE
Confidence 653 5999999999999999976 2568999999999999999999998 9999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
||+.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||+|
T Consensus 281 ll~~~-------~~~kl~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il 339 (446)
T 4ejn_A 281 MLDKD-------GHIKITDFGLCKEGIKDGA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVM 339 (446)
T ss_dssp EECSS-------SCEEECCCCCCCTTCC---------------CCSSSCGGGCCHHHHHT----SCCCTHHHHHHHHHHH
T ss_pred EECCC-------CCEEEccCCCceeccCCCc----------ccccccCCccccCHhhcCC----CCCCCccchhhhHHHH
Confidence 99877 4699999999975432211 1234579999999999986 6789999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 739 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
|||++|+.||.+.+..++...+...... ++. ..++.+.+||.+||..||.+|
T Consensus 340 ~ell~g~~Pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~~~~~~~li~~~L~~dP~~R 391 (446)
T 4ejn_A 340 YEMMCGRLPFYNQDHEKLFELILMEEIR-FPR---------------------------TLGPEAKSLLSGLLKKDPKQR 391 (446)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHCCCC-CCT---------------------------TSCHHHHHHHHHHTCSSTTTS
T ss_pred HHHhhCCCCCCCCCHHHHHHHHHhCCCC-CCc---------------------------cCCHHHHHHHHHHcccCHHHh
Confidence 9999999999999888888777655321 111 124578999999999999999
Q ss_pred C-----CHHHHHHHHH
Q 003185 819 P-----TAGDLYEMFV 829 (840)
Q Consensus 819 P-----Sa~ELLehLe 829 (840)
| +++++++|..
T Consensus 392 ~~~~~~t~~ell~hp~ 407 (446)
T 4ejn_A 392 LGGGSEDAKEIMQHRF 407 (446)
T ss_dssp TTCSTTTHHHHHTSGG
T ss_pred CCCCCCCHHHHHhCcc
Confidence 9 9999999854
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=381.48 Aligned_cols=261 Identities=26% Similarity=0.315 Sum_probs=212.5
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
..++|++.+.||+|+||+||+|.+ .+..||+|++........ . ...+.+|+.+|++++|||||++++++...
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 93 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK--D----TSTILREVELLKKLDHPNIMKLFEILEDS 93 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS--C----HHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch--H----HHHHHHHHHHHHhCCCCCcCeEEEEEEcC
Confidence 346899999999999999999998 578899999754321111 1 23448999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
. ..|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 94 ~--------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~ 154 (486)
T 3mwu_A 94 S--------------SFYIVGELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILL 154 (486)
T ss_dssp S--------------EEEEEECCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred C--------------EEEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEE
Confidence 5 35999999999999999876 2569999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+..+ ..+.+||+|||+++....... ....+||+.|+|||++.+ .++.++|||||||++|+
T Consensus 155 ~~~~----~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ 214 (486)
T 3mwu_A 155 ESKE----KDCDIKIIDFGLSTCFQQNTK-----------MKDRIGTAYYIAPEVLRG-----TYDEKCDVWSAGVILYI 214 (486)
T ss_dssp SSSS----TTCCEEECSCSCTTTBCCC---------------CCTTGGGGCCGGGGGS-----CCCHHHHHHHHHHHHHH
T ss_pred ecCC----CCCCEEEEECCcCeECCCCCc-----------cCCCcCCCCCCCHHHhCC-----CCCchhhHHHHHHHHHH
Confidence 7542 235799999999976543211 123469999999999874 48999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|++|..||.+.+..++...+..+..+.... .....++.+.+||.+||..||.+|||
T Consensus 215 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dp~~R~t 270 (486)
T 3mwu_A 215 LLSGTPPFYGKNEYDILKRVETGKYAFDLP------------------------QWRTISDDAKDLIRKMLTFHPSLRIT 270 (486)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCCSCSG------------------------GGGGSCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCCCc------------------------ccCCCCHHHHHHHHHHcCCChhhCcC
Confidence 999999999999988888887764322111 11233567999999999999999999
Q ss_pred HHHHHHHHHhhc
Q 003185 821 AGDLYEMFVART 832 (840)
Q Consensus 821 a~ELLehLe~l~ 832 (840)
+.++++|.+-..
T Consensus 271 ~~~~l~hp~~~~ 282 (486)
T 3mwu_A 271 ATQCLEHPWIQK 282 (486)
T ss_dssp HHHHHHCHHHHH
T ss_pred HHHHhcCHhhcc
Confidence 999999965443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=352.53 Aligned_cols=265 Identities=22% Similarity=0.318 Sum_probs=207.0
Q ss_pred CCCCceeeeeecccCceEEEEEEEC---Ce--eEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEE
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFG---SA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 577 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~---~~--~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~ 577 (840)
...+|++.+.||+|+||.||+|.+. +. .+|+|+. .. .......+. +.+|+.++++++||||+++++++
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~--~~-~~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~ 95 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NR-ITDIGEVSQ----FLTEGIIMKDFSHPNVLSLLGIC 95 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEE--TT-CCSHHHHHH----HHHHHHHHHTCCCTTBCCCCEEE
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEec--cc-CCCHHHHHH----HHHHHHHHHhCCCCCEeeeeeEE
Confidence 4457999999999999999999863 22 3566654 32 122333333 48999999999999999999987
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
..... ..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 96 ~~~~~-------------~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~N 158 (298)
T 3f66_A 96 LRSEG-------------SPLVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARN 158 (298)
T ss_dssp CCSSS-------------CCEEEEECCTTCBHHHHHHC----TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EcCCC-------------ceEEEEeCCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchhe
Confidence 64332 24999999999999999964 23568999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
||++.+ +.+||+|||+++......... ........||+.|+|||.+.+ ..++.++|||||||+
T Consensus 159 il~~~~-------~~~kl~Dfg~a~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~i 221 (298)
T 3f66_A 159 CMLDEK-------FTVKVADFGLARDMYDKEYYS------VHNKTGAKLPVKWMALESLQT----QKFTTKSDVWSFGVL 221 (298)
T ss_dssp EEECTT-------CCEEECSCGGGCCCSCGGGCB------C-----CCBCGGGSCHHHHHH----CCCCHHHHHHHHHHH
T ss_pred EEECCC-------CCEEECcccccccccccchhc------cccccCCCCCccccChHHhcC----CCCChHHHHHHHHHH
Confidence 999876 469999999998765432211 111233457889999999987 678999999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 738 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 738 L~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
+|+|++ |.+||...+..+....+..+..+..+. ..+..+.+||.+||..||.
T Consensus 222 l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~ 274 (298)
T 3f66_A 222 LWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE---------------------------YCPDPLYEVMLKCWHPKAE 274 (298)
T ss_dssp HHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCc---------------------------cCCHHHHHHHHHHcCCChh
Confidence 999999 677787777766666666654433221 1245789999999999999
Q ss_pred CCCCHHHHHHHHHhhcCCC
Q 003185 817 ERPTAGDLYEMFVARTSSS 835 (840)
Q Consensus 817 eRPSa~ELLehLe~l~~~~ 835 (840)
+|||+.++++.|+.+....
T Consensus 275 ~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 275 MRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp GSCCHHHHHHHHHHHHHTS
T ss_pred hCcCHHHHHHHHHHHHHhh
Confidence 9999999999999987643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=378.05 Aligned_cols=260 Identities=25% Similarity=0.344 Sum_probs=209.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
+..++|++.+.||+|+||.||+|.+.+ ..||+|+.... ... .+. +.+|+.+|++|+||||+++++++..
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~---~~~----~~~E~~~l~~l~hp~iv~~~~~~~~- 250 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMS---PEA----FLQEAQVMKKLRHEKLVQLYAVVSE- 250 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT--SSC---HHH----HHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccC--CCC---HHH----HHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence 455789999999999999999999854 67999985432 111 223 4899999999999999999999864
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .+|||||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 251 ~~--------------~~iv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill 313 (452)
T 1fmk_A 251 EP--------------IYIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 313 (452)
T ss_dssp SS--------------CEEEECCCTTCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred Cc--------------eEEEehhhcCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE
Confidence 22 39999999999999999752 12458999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||+++........ ......+|+.|+|||++.. ..++.++|||||||+|||
T Consensus 314 ~~~-------~~~kl~DfG~a~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~sDvwslG~~l~e 373 (452)
T 1fmk_A 314 GEN-------LVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTE 373 (452)
T ss_dssp CGG-------GCEEECCCCTTC-----------------------CCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHH
T ss_pred CCC-------CCEEECCCccceecCCCcee---------cccCCcccccccCHhHHhc----CCCCccccHHhHHHHHHH
Confidence 877 46999999999876432211 1122347889999999986 678999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|++ |..||.+....++...+..+.++..+. .+++.+.+||.+||..||.+||
T Consensus 374 l~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~Rp 426 (452)
T 1fmk_A 374 LTTKGRVPYPGMVNREVLDQVERGYRMPCPP---------------------------ECPESLHDLMCQCWRKEPEERP 426 (452)
T ss_dssp HHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHccCChhhCc
Confidence 999 999999999888888887765543331 2345789999999999999999
Q ss_pred CHHHHHHHHHhhcCCC
Q 003185 820 TAGDLYEMFVARTSSS 835 (840)
Q Consensus 820 Sa~ELLehLe~l~~~~ 835 (840)
|+++|++.|+.+....
T Consensus 427 t~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 427 TFEYLQAFLEDYFTST 442 (452)
T ss_dssp CHHHHHHHHHTTTSCS
T ss_pred CHHHHHHHHHHHhccC
Confidence 9999999999987543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=364.11 Aligned_cols=287 Identities=22% Similarity=0.267 Sum_probs=211.2
Q ss_pred CCCCCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeE
Q 003185 499 LDPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 576 (840)
Q Consensus 499 ~~p~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~ 576 (840)
+....+++|++.+.||+|+||.||+|.+. +..||+|++... ....... +.+.+|+.++++++||||++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~ 92 (331)
T 4aaa_A 19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES--DDDKMVK----KIAMREIKLLKQLRHENLVNLLEV 92 (331)
T ss_dssp CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESC--SSCHHHH----HHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecC--CCchHHH----HHHHHHHHHHhhCCCCCEeeEEEE
Confidence 44567899999999999999999999984 778999987433 2222222 334899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
+..... .++||||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 93 ~~~~~~--------------~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~ 153 (331)
T 4aaa_A 93 CKKKKR--------------WYLVFEFVDHTILDDLELF-----PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPE 153 (331)
T ss_dssp EEETTE--------------EEEEEECCSEEHHHHHHHS-----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred eecCCE--------------EEEEEecCCcchHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChh
Confidence 986553 5999999999888887653 356999999999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
|||++.+ +.+||+|||++......... .....||+.|+|||++.+ ...++.++|||||||
T Consensus 154 Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~t~~y~aPE~~~~---~~~~~~~~Di~slG~ 213 (331)
T 4aaa_A 154 NILVSQS-------GVVKLCDFGFARTLAAPGEV----------YDDEVATRWYRAPELLVG---DVKYGKAVDVWAIGC 213 (331)
T ss_dssp GEEECTT-------SCEEECCCTTC----------------------CCCCCTTCCHHHHTT---CTTCCTHHHHHHHHH
T ss_pred eEEEcCC-------CcEEEEeCCCceeecCCccc----------cCCCcCCccccCcccccC---CCCcchHHHHHHHHH
Confidence 9999877 46999999999765432211 123468999999999975 236789999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccC---ccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 003185 737 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC---HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 813 (840)
Q Consensus 737 IL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~---~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~ 813 (840)
++|+|++|+.||.+....+....+........+.....+... .....................++.+.+||.+||+.
T Consensus 214 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 293 (331)
T 4aaa_A 214 LVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHI 293 (331)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCS
T ss_pred HHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhcc
Confidence 999999999999998877766665543222222211111000 00000000001111112234567899999999999
Q ss_pred CCCCCCCHHHHHHHHHh
Q 003185 814 NPTERPTAGDLYEMFVA 830 (840)
Q Consensus 814 DP~eRPSa~ELLehLe~ 830 (840)
||.+|||+.||++|..-
T Consensus 294 dP~~Rpt~~ell~hp~f 310 (331)
T 4aaa_A 294 DPDKRPFCAELLHHDFF 310 (331)
T ss_dssp SGGGSCCGGGGGGSHHH
T ss_pred CcccCCCHHHHhcCchh
Confidence 99999999999998543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=379.02 Aligned_cols=265 Identities=22% Similarity=0.292 Sum_probs=212.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
...++|++.+.||+|+||.||+|++ .+..+|+|+...... ........+.+|+.+++.++|||||++++++.+
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~-----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-----IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhh-----hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3567899999999999999999998 467899999753210 011111235889999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .||||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 141 ~~~--------------~~lV~E~~~gg~L~~~l~~------~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NIL 200 (410)
T 3v8s_A 141 DRY--------------LYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 200 (410)
T ss_dssp SSE--------------EEEEECCCTTEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CCE--------------EEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHee
Confidence 653 5999999999999999976 45899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
|+.+ +.+||+|||+++........ .....+||+.|+|||++.+......++.++|||||||+||
T Consensus 201 l~~~-------g~ikL~DFG~a~~~~~~~~~---------~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvily 264 (410)
T 3v8s_A 201 LDKS-------GHLKLADFGTCMKMNKEGMV---------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 264 (410)
T ss_dssp ECTT-------SCEEECCCTTCEECCTTSEE---------ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHH
T ss_pred ECCC-------CCEEEeccceeEeeccCCcc---------cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHH
Confidence 9877 46999999999876442211 1234579999999999986322223789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCC-CCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC-
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE- 817 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e- 817 (840)
||++|+.||.+.+..+....|.... ...++. ....+..+.+||.+||..+|.+
T Consensus 265 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------------------~~~~s~~~~~li~~lL~~~~~rl 319 (410)
T 3v8s_A 265 EMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD-------------------------DNDISKEAKNLICAFLTDREVRL 319 (410)
T ss_dssp HHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT-------------------------TCCCCHHHHHHHHHHSSCGGGCT
T ss_pred HHHhCCCCCCCCChhhHHHHHHhccccccCCC-------------------------cccccHHHHHHHHHHccChhhhC
Confidence 9999999999999888888776531 111110 0123567999999999999988
Q ss_pred -CCCHHHHHHHHHhhc
Q 003185 818 -RPTAGDLYEMFVART 832 (840)
Q Consensus 818 -RPSa~ELLehLe~l~ 832 (840)
||+++||++|.+-..
T Consensus 320 gR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 320 GRNGVEEIKRHLFFKN 335 (410)
T ss_dssp TSSCHHHHHTSGGGCC
T ss_pred CCCCHHHHhcCccccC
Confidence 999999999966543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=365.78 Aligned_cols=285 Identities=14% Similarity=0.129 Sum_probs=207.4
Q ss_pred CCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHHh----HHhHHHHHHHHHhCCCCCcc
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNF----EYSCLGEVRMLGALRHSCIV 571 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~f----~~~~~rEi~iL~~L~HpNIV 571 (840)
.-++|++.+.||+|+||.||+|.+. +..||+|+....... ...+.+.+ ...+.+|+..+..++||||+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP-LFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHH-HHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchh-HHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 4458999999999999999999873 368999997543210 00111111 12345677788899999999
Q ss_pred eeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Q 003185 572 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 651 (840)
Q Consensus 572 ~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHR 651 (840)
++++++..... .....||||||+ |++|.+++.. ....+++..++.|+.||+.||.|||++||+||
T Consensus 112 ~~~~~~~~~~~----------~~~~~~lv~e~~-g~~L~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHr 176 (364)
T 3op5_A 112 KYWGSGLHDKN----------GKSYRFMIMDRF-GSDLQKIYEA----NAKRFSRKTVLQLSLRILDILEYIHEHEYVHG 176 (364)
T ss_dssp CEEEEEEEEET----------TEEEEEEEEECE-EEEHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred eEEeeeeeccC----------CcceEEEEEeCC-CCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEe
Confidence 99999875421 123569999999 8999999986 23579999999999999999999999999999
Q ss_pred cCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhH
Q 003185 652 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 731 (840)
Q Consensus 652 DLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDV 731 (840)
||||+||||+.+. .+.+||+|||+++.+........ ..........||+.|+|||++.+ ..++.++||
T Consensus 177 Dlkp~Nill~~~~-----~~~~kl~DFG~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di 244 (364)
T 3op5_A 177 DIKASNLLLNYKN-----PDQVYLVDYGLAYRYCPEGVHKA---YAADPKRCHDGTIEFTSIDAHNG----VAPSRRGDL 244 (364)
T ss_dssp CCCGGGEEEESSC-----TTCEEECCCTTCEESSGGGCCCC---SSCCSSCCCCCCTTTCCHHHHTT----CCCCHHHHH
T ss_pred cCCHHHEEEecCC-----CCeEEEEECCcceecccCCcccc---cccCcccccCCCCCccCHHHhCC----CCCCchhhH
Confidence 9999999998431 25799999999987654322111 01111234569999999999986 568999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 003185 732 WSYGCLLLELLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 810 (840)
Q Consensus 732 WSLGvIL~ELLTG~~PF~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rC 810 (840)
|||||+||||+||+.||.+.. .............+.+...+...+. ....+..+.+||..|
T Consensus 245 ~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~li~~c 306 (364)
T 3op5_A 245 EILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFP------------------AANAPGEIAKYMETV 306 (364)
T ss_dssp HHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSC------------------TTCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcc------------------cccCHHHHHHHHHHH
Confidence 999999999999999998542 2222222222222222222211110 012356899999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhcC
Q 003185 811 TEENPTERPTAGDLYEMFVARTS 833 (840)
Q Consensus 811 L~~DP~eRPSa~ELLehLe~l~~ 833 (840)
|..||.+||++.+|++.|+.+..
T Consensus 307 l~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 307 KLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp HTCCTTCCCCHHHHHHHHHHHHH
T ss_pred hcCCCCCCCCHHHHHHHHHHHHH
Confidence 99999999999999999988764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=358.78 Aligned_cols=269 Identities=21% Similarity=0.330 Sum_probs=213.0
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCccee
Q 003185 501 PGSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 573 (840)
Q Consensus 501 p~~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l 573 (840)
....++|++.+.||+|+||.||+|.+ .+..||+|++... ....... .+.+|+.++++++||||+++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~E~~~l~~l~h~~iv~~ 98 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV---CSEQDEL----DFLMEALIISKFNHQNIVRC 98 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS---CCHHHHH----HHHHHHHHHHHCCCTTBCCE
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc---cchhhHH----HHHHHHHHHhhCCCCCCCeE
Confidence 35678999999999999999999984 3457999985321 2233333 34899999999999999999
Q ss_pred eeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Q 003185 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHIMHR 651 (840)
Q Consensus 574 ~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~--~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHR 651 (840)
++++...... ||||||+++++|.+++...... ....+++..++.++.||+.||.|||++||+||
T Consensus 99 ~~~~~~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~ 164 (327)
T 2yfx_A 99 IGVSLQSLPR--------------FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHR 164 (327)
T ss_dssp EEEECSSSSC--------------EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEEcCCCCc--------------EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecC
Confidence 9999866543 9999999999999999873211 11458899999999999999999999999999
Q ss_pred cCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhH
Q 003185 652 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 731 (840)
Q Consensus 652 DLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDV 731 (840)
||||+|||++.++. ...+||+|||++......... .......||+.|+|||++.+ ..++.++||
T Consensus 165 dlkp~NIli~~~~~----~~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di 228 (327)
T 2yfx_A 165 DIAARNCLLTCPGP----GRVAKIGDFGMARDIYRASYY--------RKGGCAMLPVKWMPPEAFME----GIFTSKTDT 228 (327)
T ss_dssp CCCGGGEEESCSST----TCCEEECCCHHHHHHHC--------------CCGGGSCGGGCCHHHHHH----CCCCHHHHH
T ss_pred cCCHhHEEEecCCC----cceEEECcccccccccccccc--------ccCCCcCCCcceeCHhHhcC----CCCCchhhH
Confidence 99999999986531 256999999999765432211 01223468999999999986 668999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 003185 732 WSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 810 (840)
Q Consensus 732 WSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rC 810 (840)
|||||++|+|+| |..||......++...+..+..+..+. ..+..+.+||.+|
T Consensus 229 ~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~ 281 (327)
T 2yfx_A 229 WSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK---------------------------NCPGPVYRIMTQC 281 (327)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHH
Confidence 999999999998 999999888888887777665433321 1245789999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhcC
Q 003185 811 TEENPTERPTAGDLYEMFVARTS 833 (840)
Q Consensus 811 L~~DP~eRPSa~ELLehLe~l~~ 833 (840)
|..||.+||++.+|+++|+.+..
T Consensus 282 l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 282 WQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCChhhCcCHHHHHHHHHHHhc
Confidence 99999999999999999998764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=366.93 Aligned_cols=256 Identities=24% Similarity=0.280 Sum_probs=193.1
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
-++|++.+.||+|+||.||+|.+. +..||+|++.... ..+ .+.+|+.+|++++||||+++++++....
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~ 121 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKK----IVRTEIGVLLRLSHPNIIKLKEIFETPT 121 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------------CHHHHHCCCTTBCCEEEEEECSS
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHH----HHHHHHHHHHhCCCCCCcceeeeEecCC
Confidence 357999999999999999999984 5679999875321 122 3378999999999999999999998654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
..+|||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 122 --------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~ 182 (349)
T 2w4o_A 122 --------------EISLVLELVTGGELFDRIVE-----KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYA 182 (349)
T ss_dssp --------------EEEEEECCCCSCBHHHHHTT-----CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEES
T ss_pred --------------eEEEEEEeCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEe
Confidence 35999999999999999864 35689999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
... ..+.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||+||||
T Consensus 183 ~~~----~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el 243 (349)
T 2w4o_A 183 TPA----PDAPLKIADFGLSKIVEHQVL-----------MKTVCGTPGYCAPEILRG----CAYGPEVDMWSVGIITYIL 243 (349)
T ss_dssp SSS----TTCCEEECCCC---------------------------CGGGSCHHHHTT----CCCCTHHHHHHHHHHHHHH
T ss_pred cCC----CCCCEEEccCccccccCcccc-----------cccccCCCCccCHHHhcC----CCCCcccchHHHHHHHHHH
Confidence 521 136799999999986543211 123469999999999986 5689999999999999999
Q ss_pred HhCCCCCCCCCHHH-HHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 742 LTLQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 742 LTG~~PF~~~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
++|..||......+ +...+.......... .....+..+.+||.+||..||.+|||
T Consensus 244 l~g~~pf~~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt 299 (349)
T 2w4o_A 244 LCGFEPFYDERGDQFMFRRILNCEYYFISP------------------------WWDEVSLNAKDLVRKLIVLDPKKRLT 299 (349)
T ss_dssp HHSSCTTCCTTCHHHHHHHHHTTCCCCCTT------------------------TTTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred HhCCCCCCCCcccHHHHHHHHhCCCccCCc------------------------hhhhCCHHHHHHHHHHccCChhhCcC
Confidence 99999997765443 555555543221111 01123567999999999999999999
Q ss_pred HHHHHHHHHhh
Q 003185 821 AGDLYEMFVAR 831 (840)
Q Consensus 821 a~ELLehLe~l 831 (840)
+.++++|.+-.
T Consensus 300 ~~e~l~hp~~~ 310 (349)
T 2w4o_A 300 TFQALQHPWVT 310 (349)
T ss_dssp HHHHHHSTTTT
T ss_pred HHHHhcCcccC
Confidence 99999986543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=348.54 Aligned_cols=268 Identities=25% Similarity=0.357 Sum_probs=216.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCC-CChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEE
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCG-SSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHK 577 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~-~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~ 577 (840)
..+++|++.+.||+|+||.||+|.+ .+..||+|++...... ......+...+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 4678999999999999999999998 5688999997654322 223344455567799999999996 99999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
.... ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 94 ~~~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~N 154 (298)
T 1phk_A 94 ETNT--------------FFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPEN 154 (298)
T ss_dssp ECSS--------------EEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred ccCC--------------eEEEEEeccCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcce
Confidence 7654 35999999999999999986 2568999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc--CCCCCCchhhHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYG 735 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~--~~~~~s~kSDVWSLG 735 (840)
||++.+ +.+||+|||++........ .....||+.|+|||++.+.. ....++.++||||||
T Consensus 155 il~~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG 216 (298)
T 1phk_A 155 ILLDDD-------MNIKLTDFGFSCQLDPGEK-----------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 216 (298)
T ss_dssp EEECTT-------CCEEECCCTTCEECCTTCC-----------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHH
T ss_pred EEEcCC-------CcEEEecccchhhcCCCcc-----------cccccCCccccCHHHhccccccccccCCcccccHhHH
Confidence 999877 4599999999976543211 12346899999999986321 124578899999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 736 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 736 vIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
+++|+|++|..||...+.......+.......... .....+..+.+||.+||..||
T Consensus 217 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~l~~li~~~l~~dp 272 (298)
T 1phk_A 217 VIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP------------------------EWDDYSDTVKDLVSRFLVVQP 272 (298)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT------------------------TGGGSCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc------------------------cccccCHHHHHHHHHHccCCc
Confidence 99999999999999888877777776653221110 112335679999999999999
Q ss_pred CCCCCHHHHHHHHHh
Q 003185 816 TERPTAGDLYEMFVA 830 (840)
Q Consensus 816 ~eRPSa~ELLehLe~ 830 (840)
.+|||+.++++|..-
T Consensus 273 ~~Rps~~~ll~h~~~ 287 (298)
T 1phk_A 273 QKRYTAEEALAHPFF 287 (298)
T ss_dssp GGSCCHHHHTTSGGG
T ss_pred ccCCCHHHHHhChHh
Confidence 999999999998543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=363.52 Aligned_cols=258 Identities=27% Similarity=0.395 Sum_probs=208.9
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
..|.+.+.||+|+||.||+|.+ .+..||+|++..... ...... +.+.+|+.+|++++||||+++++++....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~- 127 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKW----QDIIKEVRFLQKLRHPNTIQYRGCYLREH- 127 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-CHHHHH----HHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-cchHHH----HHHHHHHHHHHhCCCCCEeeEEEEEEECC-
Confidence 4589999999999999999996 678899998754321 112222 34589999999999999999999998655
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
..+|||||+. |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 128 -------------~~~lv~e~~~-g~l~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 189 (348)
T 1u5q_A 128 -------------TAWLVMEYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE 189 (348)
T ss_dssp -------------EEEEEEECCS-EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET
T ss_pred -------------eEEEEEecCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC
Confidence 3599999997 6898888641 356899999999999999999999999999999999999997
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||++...... ....||+.|+|||++.+.. ...++.++|||||||+||||+
T Consensus 190 ~-------~~~kL~DfG~a~~~~~~--------------~~~~gt~~y~aPE~~~~~~-~~~~~~~~DiwslG~il~ell 247 (348)
T 1u5q_A 190 P-------GLVKLGDFGSASIMAPA--------------NSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELA 247 (348)
T ss_dssp T-------TEEEECCCTTCBSSSSB--------------CCCCSCGGGCCHHHHHTTS-SCCBCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEeeccCceecCCC--------------CcccCCcceeCHhhhcccc-CCCCCcHHHHHHHHHHHHHHH
Confidence 7 56999999999765321 2246999999999996422 256789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
+|..||.+.+.......+.....+.+.. ...++.+.+||.+||+.||.+|||++
T Consensus 248 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~dP~~Rps~~ 301 (348)
T 1u5q_A 248 ERKPPLFNMNAMSALYHIAQNESPALQS--------------------------GHWSEYFRNFVDSCLQKIPQDRPTSE 301 (348)
T ss_dssp HSSCTTTTSCHHHHHHHHHHSCCCCCCC--------------------------TTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hCCCCCCCCChHHHHHHHHhcCCCCCCC--------------------------CCCCHHHHHHHHHHcccChhhCcCHH
Confidence 9999999888777666666554332211 11245789999999999999999999
Q ss_pred HHHHHHHhhcCC
Q 003185 823 DLYEMFVARTSS 834 (840)
Q Consensus 823 ELLehLe~l~~~ 834 (840)
+|++|.+-....
T Consensus 302 ~ll~h~~~~~~~ 313 (348)
T 1u5q_A 302 VLLKHRFVLRER 313 (348)
T ss_dssp HHTTCHHHHSCC
T ss_pred HHhhChhhhccC
Confidence 999998765543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=361.41 Aligned_cols=301 Identities=17% Similarity=0.216 Sum_probs=214.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++.+.||+|+||.||+|.+ .+..||+|++...... .. ....+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 87 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EG----FPITALREIKILQLLKHENVVNLIEICRT 87 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS--SS----SCHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc--cc----chHHHHHHHHHHHhccCCCcccHhheeec
Confidence 4678999999999999999999998 5778999986443221 11 12234889999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.... ........+|||||+.+ +|...+.. ....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 88 ~~~~------~~~~~~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl 156 (351)
T 3mi9_A 88 KASP------YNRCKGSIYLVFDFCEH-DLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVL 156 (351)
T ss_dssp C--------------CEEEEEEECCSE-EHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred cccc------cccCCceEEEEEeccCC-CHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEE
Confidence 5321 00112357999999985 88888764 2356999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||+++.+...... .........||+.|+|||++.+ ...++.++|||||||++|
T Consensus 157 ~~~~-------~~~kl~Dfg~a~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 220 (351)
T 3mi9_A 157 ITRD-------GVLKLADFGLARAFSLAKNS------QPNRYTNRVVTLWYRPPELLLG---ERDYGPPIDLWGAGCIMA 220 (351)
T ss_dssp ECTT-------SCEEECCCTTCEECCCCSSS------SCCCCCSSCSCGGGCCHHHHTT---CCSCCTHHHHHHHHHHHH
T ss_pred EcCC-------CCEEEccchhcccccccccc------cccccCCcccccCccCchhhcC---CCCCCcHhHHHHHHHHHH
Confidence 9877 46999999999876532211 1111234568999999999975 245789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchh-----hhhhHHHHHHHHHHhcccC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA-----ELETLSFLVDVFRRCTEEN 814 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~s~~L~dLI~rCL~~D 814 (840)
+|++|..||.+.+.......+........+..+................. ..... ....++.+.+||.+||+.|
T Consensus 221 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~d 299 (351)
T 3mi9_A 221 EMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKG-QKRKVKDRLKAYVRDPYALDLIDKLLVLD 299 (351)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSS-CCCCHHHHHHHHHCCHHHHHHHHHHSCSS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccc-cccCHHHHhhhccCChHHHHHHHHHhcCC
Confidence 99999999999888777766655322111111111100000000000000 00000 0112456899999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCCCC
Q 003185 815 PTERPTAGDLYEMFVARTSSSI 836 (840)
Q Consensus 815 P~eRPSa~ELLehLe~l~~~~~ 836 (840)
|.+|||++|+++|.+-.....+
T Consensus 300 P~~R~t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 300 PAQRIDSDDALNHDFFWSDPMP 321 (351)
T ss_dssp GGGSCCHHHHHTSGGGGSSSCC
T ss_pred hhhCCCHHHHhCCCCcCCCCCc
Confidence 9999999999999776544433
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=350.39 Aligned_cols=261 Identities=21% Similarity=0.287 Sum_probs=212.4
Q ss_pred CCCCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEE
Q 003185 500 DPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 577 (840)
Q Consensus 500 ~p~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~ 577 (840)
++...++|.+.+.||+|+||.||+|.+. +..+|+|++..... ......+ .+.+|+.+++.++||||+++++++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~ 84 (294)
T 2rku_A 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQRE----KMSMEISIHRSLAHQHVVGFHGFF 84 (294)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHH----HHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc-cCHHHHH----HHHHHHHHHHhCCCCCEeeeeeee
Confidence 3456788999999999999999999984 67899998754432 2222333 448999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
.... ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 85 ~~~~--------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~N 145 (294)
T 2rku_A 85 EDND--------------FVFVVLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGN 145 (294)
T ss_dssp ECSS--------------EEEEEEECCTTCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred ccCC--------------EEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHh
Confidence 8655 35999999999999999876 2468999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
||++.+ +.+||+|||++......... .....||+.|+|||++.+ ..++.++||||||++
T Consensus 146 il~~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~ 204 (294)
T 2rku_A 146 LFLNED-------LEVKIGDFGLATKVEYDGER----------KKVLCGTPNYIAPEVLSK----KGHSFEVDVWSIGCI 204 (294)
T ss_dssp EEECTT-------CCEEECCCTTCEECCSTTCC----------BCCCCSCCSSCCHHHHTT----SCBCTHHHHHHHHHH
T ss_pred EEEcCC-------CCEEEEeccCceecccCccc----------cccccCCCCcCCcchhcc----CCCCchhhHHHHHHH
Confidence 999877 45999999999865432111 123468999999999976 567899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
+|+|++|+.||......+....+..... .++. ..+..+.+||.+||+.||.+
T Consensus 205 l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~li~~~l~~~p~~ 256 (294)
T 2rku_A 205 MYTLLVGKPPFETSCLKETYLRIKKNEY-SIPK---------------------------HINPVAASLIQKMLQTDPTA 256 (294)
T ss_dssp HHHHHHSSCTTCCSSHHHHHHHHHTTCC-CCCT---------------------------TSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHhhccC-CCcc---------------------------ccCHHHHHHHHHHcccChhh
Confidence 9999999999998887776666654422 1111 12457899999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 003185 818 RPTAGDLYEMFVARTS 833 (840)
Q Consensus 818 RPSa~ELLehLe~l~~ 833 (840)
|||+.++++|..-...
T Consensus 257 Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 257 RPTINELLNDEFFTSG 272 (294)
T ss_dssp SCCGGGGGGSHHHHTS
T ss_pred CcCHHHHhhChheecC
Confidence 9999999998665443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=370.74 Aligned_cols=257 Identities=23% Similarity=0.301 Sum_probs=205.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++.+.||+|+||.||+|.+ .+..+|+|++..... ........+.+|+.+|+.++|||||++++++..
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~-----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 86 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC-----VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD 86 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhc-----ccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 6788999999999999999999997 467799998753321 111122345899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .|+||||+.||+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 87 ~~~--------------~~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIl 147 (384)
T 4fr4_A 87 EED--------------MFMVVDLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNIL 147 (384)
T ss_dssp SSE--------------EEEEECCCTTEEHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CCE--------------EEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeE
Confidence 653 5999999999999999975 356999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
|+.+ +.+||+|||+++.+..... .....||+.|+|||++.... ...++.++|||||||+||
T Consensus 148 l~~~-------g~vkL~DFG~a~~~~~~~~-----------~~~~~gt~~Y~aPE~~~~~~-~~~~~~~~DiwSlG~il~ 208 (384)
T 4fr4_A 148 LDEH-------GHVHITDFNIAAMLPRETQ-----------ITTMAGTKPYMAPEMFSSRK-GAGYSFAVDWWSLGVTAY 208 (384)
T ss_dssp ECTT-------SCEEECCCTTCEECCTTCC-----------BCCCCSCGGGCCGGGTCCCS-SCCBCTTHHHHHHHHHHH
T ss_pred ECCC-------CCEEEeccceeeeccCCCc-----------eeccCCCccccCCeeeccCC-CCCCCccceeechHHHHH
Confidence 9877 4699999999986543211 13457999999999997421 245789999999999999
Q ss_pred HHHhCCCCCCCC---CHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 740 ELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 740 ELLTG~~PF~~~---~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
||++|+.||... ....+...+..... .++. ..+..+.+||.+||..||.
T Consensus 209 elltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~p~---------------------------~~s~~~~~li~~lL~~dP~ 260 (384)
T 4fr4_A 209 ELLRGRRPYHIRSSTSSKEIVHTFETTVV-TYPS---------------------------AWSQEMVSLLKKLLEPNPD 260 (384)
T ss_dssp HHHHSSCSSCCCTTSCHHHHHHHHHHCCC-CCCT---------------------------TSCHHHHHHHHHHSCSSGG
T ss_pred HHHhCCCCCCCCCCccHHHHHHHHhhccc-CCCC---------------------------cCCHHHHHHHHHHhcCCHh
Confidence 999999999754 33344444433321 1111 1245789999999999999
Q ss_pred CCCC-HHHHHHHHH
Q 003185 817 ERPT-AGDLYEMFV 829 (840)
Q Consensus 817 eRPS-a~ELLehLe 829 (840)
+||+ +++|++|..
T Consensus 261 ~R~s~~~~l~~hp~ 274 (384)
T 4fr4_A 261 QRFSQLSDVQNFPY 274 (384)
T ss_dssp GSCCSHHHHHTSGG
T ss_pred HhcccHHHHHcChh
Confidence 9998 888888643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=357.14 Aligned_cols=296 Identities=20% Similarity=0.216 Sum_probs=201.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
..+++|++.+.||+|+||.||+|++.+..||+|++.... ...+ ....|+..+..++||||+++++.+....
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-------~~~~--~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-------RQNF--INEKNIYRVPLMEHDNIARFIVGDERVT 80 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-------HHHH--HHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-------hhhH--HHHHHHHHHHhccCcchhhheecccccc
Confidence 678999999999999999999999999999999975331 1122 1123444455689999999998765432
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---------Ceeccc
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---------HIMHRD 652 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~---------gIVHRD 652 (840)
.. .....+|||||+++|+|.+++.. ...++..++.++.||+.||.|||++ ||+|||
T Consensus 81 ~~---------~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~D 145 (336)
T 3g2f_A 81 AD---------GRMEYLLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRD 145 (336)
T ss_dssp TT---------SCEEEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSS
T ss_pred cC---------CCceEEEEEecCCCCcHHHHHhh------cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecc
Confidence 11 22356899999999999999976 3468999999999999999999999 999999
Q ss_pred CCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC---CCCCchh
Q 003185 653 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP---NLYGLEV 729 (840)
Q Consensus 653 LKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~---~~~s~kS 729 (840)
|||+||||+.+ +.+||+|||+++.+........ ...........||+.|+|||++.+.... ..++.++
T Consensus 146 ikp~Nill~~~-------~~~kL~DFG~a~~~~~~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~ 216 (336)
T 3g2f_A 146 LNSRNVLVKND-------GTCVISDFGLSMRLTGNRLVRP--GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQV 216 (336)
T ss_dssp CSGGGEEECTT-------SCEEECCCTTCEECSSSSCC-----------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHH
T ss_pred cccceEEEcCC-------CcEEEeeccceeecccccccCc--cccccccccCCCccceeCchhhcCCccccccccccccc
Confidence 99999999876 4699999999987654321110 0011112334699999999999752110 2356789
Q ss_pred hHHHHHHHHHHHHhCCCCCCCC-CHHH--HHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHH
Q 003185 730 DIWSYGCLLLELLTLQVPYMGL-SELE--IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 806 (840)
Q Consensus 730 DVWSLGvIL~ELLTG~~PF~~~-~~~e--l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dL 806 (840)
|||||||+||||++|..||... .... ..........+.... +...... ......... ........++.+.+|
T Consensus 217 DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~---~~~~~~~~~~~l~~l 291 (336)
T 3g2f_A 217 DMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFED-MQVLVSR-EKQRPKFPE---AWKENSLAVRSLKET 291 (336)
T ss_dssp HHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHH-HHHHHTT-SCCCCCCCT---TCCCCSHHHHHHHHH
T ss_pred chHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHH-HHhhhcc-cccCCCCCc---ccccccchHHHHHHH
Confidence 9999999999999997776332 1110 000000011111110 0000000 000000000 001122356789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 003185 807 FRRCTEENPTERPTAGDLYEMFVARTSSS 835 (840)
Q Consensus 807 I~rCL~~DP~eRPSa~ELLehLe~l~~~~ 835 (840)
|.+||..||.+|||+.||++.|+.+....
T Consensus 292 i~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 292 IEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp HHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred HHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 99999999999999999999999987654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=347.20 Aligned_cols=262 Identities=21% Similarity=0.231 Sum_probs=202.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~ 578 (840)
...++|++.+.||+|+||.||+|.+ .+..+|+|+..... ....... .+.+|+.++..+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~----~~~~e~~~~~~l~~h~~iv~~~~~~~ 81 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPL--AGSVDEQ----NALREVYAHAVLGQHSHVVRYFSAWA 81 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCC--TTSHHHH----HHHHHHHHHHHSCSCTTBCCEEEEEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccc--cccHHHH----HHHHHHHHHHHhCCCCCeeeeeeeee
Confidence 3446899999999999999999998 58899999875432 2222223 348999999999 8999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
... ..+|||||+++++|.+++...... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 82 ~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NI 146 (289)
T 1x8b_A 82 EDD--------------HMLIQNEYCNGGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNI 146 (289)
T ss_dssp ETT--------------EEEEEEECCTTCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred cCC--------------eEEEEEEecCCCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHE
Confidence 655 359999999999999999863322 25689999999999999999999999999999999999
Q ss_pred EEeccccc------------CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCC
Q 003185 659 LIDLERKK------------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 726 (840)
Q Consensus 659 LLd~~~~~------------~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s 726 (840)
|++.++.. ......+||+|||++...... ....||+.|+|||++.+ ...++
T Consensus 147 l~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------------~~~~gt~~y~aPE~~~~---~~~~~ 209 (289)
T 1x8b_A 147 FISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP--------------QVEEGDSRFLANEVLQE---NYTHL 209 (289)
T ss_dssp EEC--------------------CCCEEECCCTTCEETTCS--------------CCCCCCGGGCCHHHHTT---CCTTH
T ss_pred EEcCCCCCcccccccccccccCCceEEEEcccccccccCCc--------------cccCCCccccChhHhcC---CCCCC
Confidence 99865310 012357999999999765432 12358999999999975 23567
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHH
Q 003185 727 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 806 (840)
Q Consensus 727 ~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dL 806 (840)
.++|||||||++|+|++|.+|+.... ....+..+..+.++. ..+..+.+|
T Consensus 210 ~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~---------------------------~~~~~~~~l 259 (289)
T 1x8b_A 210 PKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQGRLPRIPQ---------------------------VLSQEFTEL 259 (289)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHTTCCCCCSS---------------------------CCCHHHHHH
T ss_pred chhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHcCCCCCCCc---------------------------ccCHHHHHH
Confidence 89999999999999999998775442 233444444333331 124578999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhh
Q 003185 807 FRRCTEENPTERPTAGDLYEMFVAR 831 (840)
Q Consensus 807 I~rCL~~DP~eRPSa~ELLehLe~l 831 (840)
|.+||..||.+|||+.++++|..-.
T Consensus 260 i~~~l~~dp~~Rps~~~ll~h~~~~ 284 (289)
T 1x8b_A 260 LKVMIHPDPERRPSAMALVKHSVLL 284 (289)
T ss_dssp HHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred HHHHhCCCcccCCCHHHHhhChHhh
Confidence 9999999999999999999986543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=348.02 Aligned_cols=256 Identities=21% Similarity=0.268 Sum_probs=209.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++.+.||+|+||.||+|.+ .+..+|+|+..... .........+.+|+.++++++||||+++++++..
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 85 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQ-----LEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD 85 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccc-----cchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence 5678999999999999999999998 46779999875321 1111223456899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.. ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 86 ~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil 146 (284)
T 2vgo_A 86 RK--------------RIYLMLEFAPRGELYKELQK-----HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLL 146 (284)
T ss_dssp SS--------------EEEEEECCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEE
T ss_pred CC--------------EEEEEEEeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEE
Confidence 54 35999999999999999986 246899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++....... .....||+.|+|||++.+ ..++.++||||||+++|
T Consensus 147 ~~~~-------~~~kl~Dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 203 (284)
T 2vgo_A 147 MGYK-------GELKIADFGWSVHAPSLR------------RRTMCGTLDYLPPEMIEG----KTHDEKVDLWCAGVLCY 203 (284)
T ss_dssp ECTT-------CCEEECCCTTCEECSSSC------------BCCCCSCGGGCCHHHHTT----CCBCTTHHHHHHHHHHH
T ss_pred EcCC-------CCEEEecccccccCcccc------------cccccCCCCcCCHHHhcc----CCCCcccchhhHHHHHH
Confidence 9877 459999999986543311 123468999999999986 56789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|++|..||......+....+..... .++ ...+..+.+||.+||..||.+||
T Consensus 204 ~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 255 (284)
T 2vgo_A 204 EFLVGMPPFDSPSHTETHRRIVNVDL-KFP---------------------------PFLSDGSKDLISKLLRYHPPQRL 255 (284)
T ss_dssp HHHHSSCTTCCSSHHHHHHHHHTTCC-CCC---------------------------TTSCHHHHHHHHHHSCSSGGGSC
T ss_pred HHHHCCCCCCCCCHhHHHHHHhcccc-CCC---------------------------CcCCHHHHHHHHHHhhcCHhhCC
Confidence 99999999998887777666655422 111 11245789999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 003185 820 TAGDLYEMFVART 832 (840)
Q Consensus 820 Sa~ELLehLe~l~ 832 (840)
|+.++++|..-..
T Consensus 256 s~~~ll~h~~~~~ 268 (284)
T 2vgo_A 256 PLKGVMEHPWVKA 268 (284)
T ss_dssp CHHHHHTCHHHHH
T ss_pred CHHHHhhCHHHHh
Confidence 9999999865443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=377.72 Aligned_cols=266 Identities=20% Similarity=0.282 Sum_probs=200.9
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
.++|.+.+.||+|+||.||+|.+ .+..||+|++..+...............+.+|+.+|++++|||||++++++...
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~- 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 47899999999999999999997 567999999875543322222122223458999999999999999999997533
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
..||||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 213 --------------~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~ 273 (419)
T 3i6u_A 213 --------------DYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS 273 (419)
T ss_dssp --------------EEEEEEECCTTCBGGGGTSS-----SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred --------------ceEEEEEcCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEe
Confidence 24999999999999988754 45799999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.++ ....+||+|||+++....... .....||+.|+|||++.+.. ...++.++|||||||+||+|
T Consensus 274 ~~~----~~~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~-~~~~~~~~DiwslG~il~~l 337 (419)
T 3i6u_A 274 SQE----EDCLIKITDFGHSKILGETSL-----------MRTLCGTPTYLAPEVLVSVG-TAGYNRAVDCWSLGVILFIC 337 (419)
T ss_dssp SSS----SSCCEEECCSSTTTSCC----------------------CTTCCTTTTC-----CTTHHHHHHHHHHHHHHHH
T ss_pred cCC----CcceEEEeecccceecCCCcc-----------ccccCCCCCccCceeeecCC-CCCCCchhhhHhHHHHHHHH
Confidence 653 135699999999987643221 13356999999999986321 25678999999999999999
Q ss_pred HhCCCCCCCCCH-HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 742 LTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 742 LTG~~PF~~~~~-~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
++|..||..... ..+...+..+.....+..+ ...++.+.+||.+||+.||.+|||
T Consensus 338 ltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~~~~~~~li~~~L~~dP~~Rps 393 (419)
T 3i6u_A 338 LSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW------------------------AEVSEKALDLVKKLLVVDPKARFT 393 (419)
T ss_dssp HHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH------------------------TTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred HHCCCCCCCCcchHHHHHHHhcCCCCCCchhh------------------------cccCHHHHHHHHHHccCChhHCcC
Confidence 999999976533 3344555554433333221 223568999999999999999999
Q ss_pred HHHHHHHHH
Q 003185 821 AGDLYEMFV 829 (840)
Q Consensus 821 a~ELLehLe 829 (840)
++++++|.+
T Consensus 394 ~~e~l~hp~ 402 (419)
T 3i6u_A 394 TEEALRHPW 402 (419)
T ss_dssp HHHHHHSGG
T ss_pred HHHHhCCcc
Confidence 999999854
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=364.22 Aligned_cols=276 Identities=22% Similarity=0.278 Sum_probs=208.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
...++|++.+.||+|+||.||+|.+ .+..||+|+.... .....+. +.+|+.+++.++||||+++++++...
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE----SSQGIEE----FETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC----CSSHHHH----HHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc----ChHHHHH----HHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 3567899999999999999999997 4778999975432 1122333 48999999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .++||||+++|+|.+++... ......+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 108 ~~--------------~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~ 172 (321)
T 2qkw_B 108 NE--------------MILIYKYMENGNLKRHLYGS-DLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL 172 (321)
T ss_dssp TC--------------CEEEEECCTTCBTGGGSSSS-CCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE
T ss_pred Ce--------------EEEEEEcCCCCcHHHHHhcc-CCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE
Confidence 54 39999999999999998641 1122458999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++||
T Consensus 173 ~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~e 233 (321)
T 2qkw_B 173 DEN-------FVPKITDFGISKKGTELDQT--------HLSTVVKGTLGYIDPEYFIK----GRLTEKSDVYSFGVVLFE 233 (321)
T ss_dssp CTT-------CCEEECCCTTCEECSSSSCC--------CCBCCCEEETTTCCHHHHHH----CBCCTHHHHHHHHHHHHH
T ss_pred CCC-------CCEEEeeccccccccccccc--------ccccccCCCccccCHHHhcC----CCCCcccchHhHHHHHHH
Confidence 876 56999999999765432111 11123458999999999986 568999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHH----cCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQ----MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~----~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
|++|+.||.+..+.+....+. ......+.. .... ..........+..+.+|+.+||+.||.
T Consensus 234 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~ 298 (321)
T 2qkw_B 234 VLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ------------IVDP---NLADKIRPESLRKFGDTAVKCLALSSE 298 (321)
T ss_dssp HHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS------------SSSS---SCTTCSCHHHHHHHHHHHHHHTCSSGG
T ss_pred HHhCCCcccccCcHHHHHHHHHhhhccccccHHH------------hcCh---hhccccCHHHHHHHHHHHHHHcCCCcc
Confidence 999999997654322111110 000000000 0000 001122345678899999999999999
Q ss_pred CCCCHHHHHHHHHhhcCC
Q 003185 817 ERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 817 eRPSa~ELLehLe~l~~~ 834 (840)
+|||+.+|+++|+.+...
T Consensus 299 ~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 299 DRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp GSCCHHHHHHHHHHHHHS
T ss_pred cCcCHHHHHHHHHHHhhc
Confidence 999999999999987643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=361.35 Aligned_cols=257 Identities=24% Similarity=0.278 Sum_probs=187.2
Q ss_pred CCCceee---eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEE
Q 003185 504 FPSLSSC---DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHK 577 (840)
Q Consensus 504 ~~~y~i~---~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~ 577 (840)
+.+|++. +.||+|+||.||+|.+ .+..+|+|++... .. ..+.+|+.+++.+. ||||+++++++
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~----~~~~~e~~~l~~l~~h~niv~~~~~~ 75 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------ME----ANTQKEITALKLCEGHPNIVKLHEVF 75 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-------GH----HHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-------hh----hhHHHHHHHHHHhcCCCCeeEEEEEE
Confidence 3456664 7899999999999998 4778999997422 11 23378999999997 99999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
.... ..||||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 76 ~~~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N 136 (325)
T 3kn6_A 76 HDQL--------------HTFLVMELLNGGELFERIKK-----KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPEN 136 (325)
T ss_dssp ECSS--------------EEEEEECCCCSCBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred EcCC--------------EEEEEEEccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHH
Confidence 8655 35999999999999999986 3579999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
||++.++ ....+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||+
T Consensus 137 Ill~~~~----~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~t~~y~aPE~~~~----~~~~~~~DiwslG~i 198 (325)
T 3kn6_A 137 LLFTDEN----DNLEIKIIDFGFARLKPPDNQP----------LKTPCFTLHYAAPELLNQ----NGYDESCDLWSLGVI 198 (325)
T ss_dssp EEEEC--------CEEEECCCTTCEECCC------------------------------------CCCCHHHHHHHHHHH
T ss_pred EEEecCC----CcccEEEeccccceecCCCCCc----------ccccCCCcCccCHHHhcC----CCCCCccchHHHHHH
Confidence 9998653 2247999999999765432111 123468999999999976 678999999999999
Q ss_pred HHHHHhCCCCCCCCCH-------HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 003185 738 LLELLTLQVPYMGLSE-------LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 810 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~-------~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rC 810 (840)
+|+|++|..||.+... .++...+..+..+... ......++.+.+||.+|
T Consensus 199 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~------------------------~~~~~~s~~~~~li~~~ 254 (325)
T 3kn6_A 199 LYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG------------------------EAWKNVSQEAKDLIQGL 254 (325)
T ss_dssp HHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS------------------------HHHHTSCHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc------------------------ccccCCCHHHHHHHHHH
Confidence 9999999999976432 3455555444322111 11233466899999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhc
Q 003185 811 TEENPTERPTAGDLYEMFVART 832 (840)
Q Consensus 811 L~~DP~eRPSa~ELLehLe~l~ 832 (840)
|..||.+|||+.++++|.+-..
T Consensus 255 L~~dP~~Rpt~~ell~h~w~~~ 276 (325)
T 3kn6_A 255 LTVDPNKRLKMSGLRYNEWLQD 276 (325)
T ss_dssp HCCCTTTCCCTTTSTTCGGGCT
T ss_pred CCCChhHCCCHHHHhcChhhcc
Confidence 9999999999999999966544
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=348.41 Aligned_cols=259 Identities=22% Similarity=0.374 Sum_probs=210.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
...++|++.+.||+|+||.||+|.+. +..+|+|+..... .. .+ .+.+|+.++++++||||+++++++...
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~---~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~ 80 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MS---PD----AFLAEANLMKQLQHQRLVRLYAVVTQE 80 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SC---HH----HHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--cc---HH----HHHHHHHHHHhCCCcCcceEEEEEcCC
Confidence 44578999999999999999999985 4589999864322 11 22 348999999999999999999987633
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
. .++||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 81 ~---------------~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~ 142 (279)
T 1qpc_A 81 P---------------IYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV 142 (279)
T ss_dssp S---------------CEEEEECCTTCBHHHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred C---------------cEEEEecCCCCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE
Confidence 2 39999999999999998641 11258999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||++.......... .....+|+.|+|||++.+ ..++.++||||||+++||
T Consensus 143 ~~~-------~~~kl~Dfg~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~e 202 (279)
T 1qpc_A 143 SDT-------LSCKIADFGLARLIEDNEYTA---------REGAKFPIKWTAPEAINY----GTFTIKSDVWSFGILLTE 202 (279)
T ss_dssp CTT-------SCEEECCCTTCEECSSSCEEC---------CTTCCCCTTTSCHHHHHH----CEECHHHHHHHHHHHHHH
T ss_pred cCC-------CCEEECCCcccccccCccccc---------ccCCCCccCccChhhhcc----CCCCchhhhHHHHHHHHH
Confidence 876 469999999998765422110 122357889999999986 567899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|++ |..||.+....++...+..+..+..+. ..+..+.+||.+||..||.+||
T Consensus 203 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rp 255 (279)
T 1qpc_A 203 IVTHGRIPYPGMTNPEVIQNLERGYRMVRPD---------------------------NCPEELYQLMRLCWKERPEDRP 255 (279)
T ss_dssp HHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhCCCCCCcccCHHHHHHHHhcccCCCCcc---------------------------cccHHHHHHHHHHhccChhhCC
Confidence 999 999999988888877776654332221 1245799999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 003185 820 TAGDLYEMFVARTSS 834 (840)
Q Consensus 820 Sa~ELLehLe~l~~~ 834 (840)
|+.+|++.|+.+...
T Consensus 256 s~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 256 TFDYLRSVLEDFFTA 270 (279)
T ss_dssp CHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHh
Confidence 999999999887643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=362.01 Aligned_cols=283 Identities=17% Similarity=0.216 Sum_probs=206.8
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.+++|++.+.||+|+||.||+|.+ .+..||+|++.... ......+ .+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~ 96 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAK----RAYRELVLMKCVNHKNIIGLLNVFTPQ 96 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT--SSHHHHH----HHHHHHHHHHHCCCTTBCCEEEEECSC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc--CChHHHH----HHHHHHHHHHhcCCCCccceEEeeccc
Confidence 457899999999999999999987 57889999875332 2223333 348999999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
... ......||||||++ ++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 97 ~~~--------~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~ 160 (371)
T 2xrw_A 97 KSL--------EEFQDVYIVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 160 (371)
T ss_dssp CST--------TTCCEEEEEEECCS-EEHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred ccc--------ccccceEEEEEcCC-CCHHHHHh-------hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE
Confidence 422 12235799999997 48988885 248999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 161 ~~~-------~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~e 218 (371)
T 2xrw_A 161 KSD-------CTLKILDFGLARTAGTSFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGE 218 (371)
T ss_dssp CTT-------SCEEECCCCC---------------------------CTTCCHHHHTT----CCCCTTHHHHHHHHHHHH
T ss_pred cCC-------CCEEEEEeecccccccccc-----------cCCceecCCccCHHHhcC----CCCCchHhHHHHHHHHHH
Confidence 877 4699999999976543211 123468999999999986 568899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCC---------------CCCchhhhhhHHHHHH
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG---------------FEKPEAELETLSFLVD 805 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~s~~L~d 805 (840)
|++|..||.+.+..+....+........++.+..+...... +...... ..........+..+.+
T Consensus 219 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (371)
T 2xrw_A 219 MIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT-YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 297 (371)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH-HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH-HHhhCccccccchhhhcccccCcccccccccccHHHHH
Confidence 99999999999888888777766444434333221100000 0000000 0011122334678999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHh
Q 003185 806 VFRRCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 806 LI~rCL~~DP~eRPSa~ELLehLe~ 830 (840)
||.+||..||.+|||++|+++|..-
T Consensus 298 li~~mL~~dP~~R~t~~e~l~hp~~ 322 (371)
T 2xrw_A 298 LLSKMLVIDASKRISVDEALQHPYI 322 (371)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred HHHHHCcCChhhCCCHHHHhCCcch
Confidence 9999999999999999999999653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=357.02 Aligned_cols=265 Identities=23% Similarity=0.335 Sum_probs=207.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCccee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 573 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l 573 (840)
...++|.+.+.||+|+||.||+|.+.+ ..+|+|+.... ......+ .+.+|+.+++++ +||||+++
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~E~~~l~~l~~h~~iv~~ 115 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST---AHADEKE----ALMSELKIMSHLGQHENIVNL 115 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT---CCHHHHH----HHHHHHHHHHHHCCCTTBCCE
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc---cChHHHH----HHHHHHHHHHhhcCCCCeeeE
Confidence 456789999999999999999999732 36889886432 1223333 348999999999 89999999
Q ss_pred eeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc---------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 003185 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---------GEKHVSVKLALFIAQDVAAALVELH 644 (840)
Q Consensus 574 ~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~---------~~~~ls~~~~~~Ia~QIa~AL~yLH 644 (840)
++++...... ++||||+++|+|.+++...... ....+++..++.++.||+.||.|||
T Consensus 116 ~~~~~~~~~~--------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH 181 (333)
T 2i1m_A 116 LGACTHGGPV--------------LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA 181 (333)
T ss_dssp EEEECSSSSC--------------EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEecCCce--------------EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh
Confidence 9999866543 9999999999999999863211 1245899999999999999999999
Q ss_pred hCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCC
Q 003185 645 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 724 (840)
Q Consensus 645 s~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~ 724 (840)
++||+||||||+|||++.+ +.+||+|||++.......... ......||+.|+|||++.+ ..
T Consensus 182 ~~~ivH~Dlkp~NIl~~~~-------~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~ 242 (333)
T 2i1m_A 182 SKNCIHRDVAARNVLLTNG-------HVAKIGDFGLARDIMNDSNYI--------VKGNARLPVKWMAPESIFD----CV 242 (333)
T ss_dssp HTTEECSCCSGGGCEEEGG-------GEEEBCCCGGGCCGGGCTTSE--------ECSSCEECGGGSCHHHHHH----CC
T ss_pred cCCcccCCcccceEEECCC-------CeEEECcccccccccccccee--------ecCCCCCCccccCHHHhcc----CC
Confidence 9999999999999999877 469999999998664322110 1123457889999999986 66
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHH
Q 003185 725 YGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 802 (840)
Q Consensus 725 ~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 802 (840)
++.++|||||||++|+|+| |..||.+....... ..+.....+..+. ..+..
T Consensus 243 ~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 295 (333)
T 2i1m_A 243 YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPA---------------------------FAPKN 295 (333)
T ss_dssp CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCT---------------------------TCCHH
T ss_pred CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCC---------------------------CCCHH
Confidence 8999999999999999999 99999876544433 3333332222111 12457
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003185 803 LVDVFRRCTEENPTERPTAGDLYEMFVARTS 833 (840)
Q Consensus 803 L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~ 833 (840)
+.+||.+||+.||.+|||+.+|+++|+.+..
T Consensus 296 l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 296 IYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 8999999999999999999999999988753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=354.50 Aligned_cols=267 Identities=23% Similarity=0.358 Sum_probs=209.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCccee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 573 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l 573 (840)
...++|++.+.||+|+||.||+|.+ .+..||+|+.... ......+ .+.+|+.++.++ +||||+++
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHR----ALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHH----HHHHHHHHHHHHCCCTTBCCE
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC---CCcHHHH----HHHHHHHHHHhcccCCCeeeE
Confidence 3457899999999999999999985 3478999986432 2223333 348999999999 69999999
Q ss_pred eeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHH
Q 003185 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 642 (840)
Q Consensus 574 ~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-----------~~~~ls~~~~~~Ia~QIa~AL~y 642 (840)
++++..... ..++||||+++++|.+++...... ....+++..++.++.||+.||.|
T Consensus 97 ~~~~~~~~~-------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~ 163 (316)
T 2xir_A 97 LGACTKPGG-------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 163 (316)
T ss_dssp EEEECCTTS-------------CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHH
T ss_pred EEEEecCCC-------------ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHH
Confidence 999875432 249999999999999999752110 01238899999999999999999
Q ss_pred HHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC
Q 003185 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 722 (840)
Q Consensus 643 LHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~ 722 (840)
||++||+||||||+|||++.+ +.+||+|||+++......... ......||+.|+|||++.+
T Consensus 164 lH~~~i~H~dikp~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~---- 224 (316)
T 2xir_A 164 LASRKCIHRDLAARNILLSEK-------NVVKICDFGLARDIYKDPDYV--------RKGDARLPLKWMAPETIFD---- 224 (316)
T ss_dssp HHHTTCCCSCCSGGGEEECGG-------GCEEECCCGGGSCTTTCTTSE--------EETTEEECGGGCCHHHHHH----
T ss_pred HHhCCcccccCccceEEECCC-------CCEEECCCccccccccCccce--------eccCCCcceeecCchhhcc----
Confidence 999999999999999999877 459999999998654322110 0123457899999999986
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH-HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhH
Q 003185 723 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 800 (840)
Q Consensus 723 ~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~-~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s 800 (840)
..++.++|||||||++|+|+| |..||.+... ..+...+..+..+..+. ..+
T Consensus 225 ~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~ 277 (316)
T 2xir_A 225 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD---------------------------YTT 277 (316)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT---------------------------TCC
T ss_pred ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCC---------------------------CCC
Confidence 678999999999999999998 9999987653 34444454443332221 124
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 003185 801 SFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 801 ~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~~ 834 (840)
+.+.+||.+||+.||.+|||+.+|+++|+.+.+.
T Consensus 278 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 278 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 5789999999999999999999999999988754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=353.05 Aligned_cols=256 Identities=28% Similarity=0.401 Sum_probs=211.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..-+.|++.+.||+|+||.||+|.+ .+..+|+|++...... ...+ .+.+|+.+++.++||||+++++++..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~ 91 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE---DEIE----DIQQEITVLSQCDSPYVTKYYGSYLK 91 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS---TTHH----HHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH---HHHH----HHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 3446799999999999999999987 5778999997654321 1223 34899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .++||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 92 ~~~--------------~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil 151 (303)
T 3a7i_A 92 DTK--------------LWIIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVL 151 (303)
T ss_dssp TTE--------------EEEEEECCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CCe--------------EEEEEEeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEE
Confidence 553 5999999999999999863 56899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++......... .....||+.|+|||++.+ ..++.++||||||+++|
T Consensus 152 ~~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 210 (303)
T 3a7i_A 152 LSEH-------GEVKLADFGVAGQLTDTQIK----------RNTFVGTPFWMAPEVIKQ----SAYDSKADIWSLGITAI 210 (303)
T ss_dssp ECTT-------SCEEECCCTTCEECBTTBCC----------BCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHH
T ss_pred ECCC-------CCEEEeecccceecCccccc----------cCccCCCcCccCHHHHhc----CCCCchhhhHHHHHHHH
Confidence 9877 45999999999776432211 123468999999999976 56789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|++|..||...........+.....+.++. ..+..+.+||.+||..||.+||
T Consensus 211 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dp~~Rp 263 (303)
T 3a7i_A 211 ELARGEPPHSELHPMKVLFLIPKNNPPTLEG---------------------------NYSKPLKEFVEACLNKEPSFRP 263 (303)
T ss_dssp HHHHSSCTTTTSCHHHHHHHHHHSCCCCCCS---------------------------SCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHccCCCCCCCcCHHHHHHHhhcCCCCCCcc---------------------------ccCHHHHHHHHHHcCCChhhCc
Confidence 9999999999888887777766554433321 1245789999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 003185 820 TAGDLYEMFVART 832 (840)
Q Consensus 820 Sa~ELLehLe~l~ 832 (840)
|+.+|++|..-..
T Consensus 264 s~~~ll~~~~~~~ 276 (303)
T 3a7i_A 264 TAKELLKHKFILR 276 (303)
T ss_dssp CHHHHTTCHHHHH
T ss_pred CHHHHhhChhhhc
Confidence 9999999876544
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=353.13 Aligned_cols=271 Identities=25% Similarity=0.362 Sum_probs=200.5
Q ss_pred CCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC--CCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL--RHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L--~HpNIV~l~g~~~~~ 580 (840)
..++|++.+.||+|+||.||+|++.+..||+|++... ....+ .+|.+++..+ +||||+++++++...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-------~~~~~----~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT-------EEASW----FRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG-------GHHHH----HHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred cccceEEEeEeecCCCeEEEEEEECCceEEEEEEecc-------ccchh----hhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 3468999999999999999999999999999997432 11122 4555555554 899999999998865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--------Ceeccc
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--------HIMHRD 652 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~--------gIVHRD 652 (840)
.. .....++||||+++|+|.+++.. ..+++..++.++.||+.||.|||++ ||+|||
T Consensus 104 ~~----------~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~D 167 (337)
T 3mdy_A 104 TG----------SWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRD 167 (337)
T ss_dssp CG----------GGCEEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSC
T ss_pred CC----------CCCceEEEEeccCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecc
Confidence 31 12356999999999999999976 4699999999999999999999999 999999
Q ss_pred CCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCC--CCchhh
Q 003185 653 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL--YGLEVD 730 (840)
Q Consensus 653 LKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~--~s~kSD 730 (840)
|||+|||++.+ +.+||+|||+++.+....... ........||+.|+|||++.+...... ++.++|
T Consensus 168 ikp~Nill~~~-------~~~kl~Dfg~a~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~D 234 (337)
T 3mdy_A 168 LKSKNILVKKN-------GTCCIADLGLAVKFISDTNEV------DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMAD 234 (337)
T ss_dssp CCGGGEEECTT-------SCEEECCCTTCEECC---------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHH
T ss_pred cchHHEEECCC-------CCEEEEeCCCceeeccccccc------cCCCCCCccCcceeChhhcccccCCccccCccccc
Confidence 99999999877 469999999997664432211 011234579999999999976221110 112599
Q ss_pred HHHHHHHHHHHHhC----------CCCCCCCC-----HHHHHHHHHcC-CCCCcchHHhhhccCccccccccCCCCCCch
Q 003185 731 IWSYGCLLLELLTL----------QVPYMGLS-----ELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPE 794 (840)
Q Consensus 731 VWSLGvIL~ELLTG----------~~PF~~~~-----~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~ 794 (840)
||||||++|||+|| +.||.... .......+... ..+.++.. .
T Consensus 235 iwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~ 292 (337)
T 3mdy_A 235 MYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNR----------------------W 292 (337)
T ss_dssp HHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG----------------------G
T ss_pred hHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCcccccc----------------------c
Confidence 99999999999999 67775431 12222222111 22222211 1
Q ss_pred hhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 003185 795 AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 835 (840)
Q Consensus 795 ~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~~~ 835 (840)
....+++.+.+||.+||+.||.+|||+.+|+++|+.+..+.
T Consensus 293 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 293 SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 12345778999999999999999999999999999987654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=366.47 Aligned_cols=293 Identities=18% Similarity=0.183 Sum_probs=208.5
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
..++|++.+.||+|+||.||+|.+ .+..||+|++..... .. .+|+.+|+.++|||||++++++...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--------~~----~~E~~il~~l~hpnIv~l~~~~~~~ 72 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR--------YK----NRELDIMKVLDHVNIIKLVDYFYTT 72 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT--------SC----CHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc--------hH----HHHHHHHHHcCCCCccchhheeeec
Confidence 457899999999999999999987 678999998753311 11 5799999999999999999998754
Q ss_pred CCCCCCC-----------C-------------CCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHH
Q 003185 581 KWLPSAD-----------G-------------NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDV 636 (840)
Q Consensus 581 ~~~p~~~-----------g-------------~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QI 636 (840)
....... + .........+|||||++ ++|.+++...... ...+++..++.++.||
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi 150 (383)
T 3eb0_A 73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQL 150 (383)
T ss_dssp -------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHH
T ss_pred CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHHH
Confidence 3100000 0 00012335799999998 5999888764333 3679999999999999
Q ss_pred HHHHHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhh
Q 003185 637 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 716 (840)
Q Consensus 637 a~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL 716 (840)
+.||.|||++||+||||||+|||++... +.+||+|||+++....... .....||+.|+|||++
T Consensus 151 ~~aL~~LH~~gi~H~Dikp~Nil~~~~~------~~~kl~Dfg~a~~~~~~~~-----------~~~~~~t~~y~aPE~~ 213 (383)
T 3eb0_A 151 FRAVGFIHSLGICHRDIKPQNLLVNSKD------NTLKLCDFGSAKKLIPSEP-----------SVAYICSRFYRAPELM 213 (383)
T ss_dssp HHHHHHHHTTTEECSCCCGGGEEEETTT------TEEEECCCTTCEECCTTSC-----------CCCCCCCSSCCCHHHH
T ss_pred HHHHHHHHHCcCccCccCHHHEEEcCCC------CcEEEEECCCCcccCCCCC-----------CcCcccCCCccCHHHh
Confidence 9999999999999999999999998431 5799999999986543221 1234689999999998
Q ss_pred hcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccC-ccccccccCCCCCCchh
Q 003185 717 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC-HEHEVAQSGSGFEKPEA 795 (840)
Q Consensus 717 ~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~-~~~~~~~~~~~~~~~~~ 795 (840)
.+ ...++.++|||||||++|||++|+.||.+.+..+....+.........+.+...... ....+.......-....
T Consensus 214 ~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (383)
T 3eb0_A 214 LG---ATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKIL 290 (383)
T ss_dssp TT---CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHS
T ss_pred cC---CCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhC
Confidence 75 245899999999999999999999999998887777666554222222222221100 00000000000000001
Q ss_pred hhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003185 796 ELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 796 ~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe 829 (840)
....+..+.+||.+||..||.+|||+.|+++|..
T Consensus 291 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 324 (383)
T 3eb0_A 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF 324 (383)
T ss_dssp CTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHH
Confidence 1224667999999999999999999999998843
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=380.56 Aligned_cols=261 Identities=24% Similarity=0.306 Sum_probs=213.3
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.-++|++.+.||+|+||.||+|.+ .+..+|+|++....... ....+ .+.+|+.+|++++|||||++++++...
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~ 98 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-KTDKE----SLLREVQLLKQLDHPNIMKLYEFFEDK 98 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB-SSCHH----HHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc-chHHH----HHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 346799999999999999999998 57899999975443221 11222 348999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
. ..|+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 99 ~--------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 159 (484)
T 3nyv_A 99 G--------------YFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 159 (484)
T ss_dssp S--------------EEEEEECCCCSCBHHHHHHT-----CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred C--------------EEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE
Confidence 5 35999999999999999875 4579999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+... ..+.+||+|||++..+..... .....||+.|+|||++.+ .++.++|||||||++|+
T Consensus 160 ~~~~----~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ 219 (484)
T 3nyv_A 160 ESKS----KDANIRIIDFGLSTHFEASKK-----------MKDKIGTAYYIAPEVLHG-----TYDEKCDVWSTGVILYI 219 (484)
T ss_dssp SSSS----TTCCEEECCTTHHHHBCCCCS-----------HHHHTTGGGTCCHHHHHT-----CCCTHHHHHHHHHHHHH
T ss_pred ecCC----CCCcEEEEeeeeeEEcccccc-----------cccCCCCccccCceeecC-----CCCCcceeHHHHHHHHH
Confidence 6432 235799999999986643221 122469999999999974 57899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|++|.+||.+.+..++...+..+....... .....++.+.+||.+||..||.+|||
T Consensus 220 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dp~~R~s 275 (484)
T 3nyv_A 220 LLSGCPPFNGANEYDILKKVEKGKYTFELP------------------------QWKKVSESAKDLIRKMLTYVPSMRIS 275 (484)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHCCCCCCSG------------------------GGGGSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHCCCCCCCCCHHHHHHHHHcCCCCCCCc------------------------ccccCCHHHHHHHHHHCCCChhHCcC
Confidence 999999999999998888887764321111 11233568999999999999999999
Q ss_pred HHHHHHHHHhh
Q 003185 821 AGDLYEMFVAR 831 (840)
Q Consensus 821 a~ELLehLe~l 831 (840)
+.++++|.+-.
T Consensus 276 ~~e~l~h~~~~ 286 (484)
T 3nyv_A 276 ARDALDHEWIQ 286 (484)
T ss_dssp HHHHHTSHHHH
T ss_pred HHHHhhChhhc
Confidence 99999986543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=356.77 Aligned_cols=280 Identities=24% Similarity=0.321 Sum_probs=205.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 575 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g 575 (840)
..-++|++.+.||+|+||.||+|.+ .+..||+|++... .....+ .+.+|+.++++++||||+++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~----~~~~E~~~l~~l~h~~i~~~~~ 91 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQR----DFQREIQILKALHSDFIVKYRG 91 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHH----HHHHHHHHHHTCCCTTBCCEEE
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHH----HHHHHHHHHHhcCCCceeEEEE
Confidence 4457899999999999999999985 5678999986432 223333 3489999999999999999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCC
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 655 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKP 655 (840)
++..... ...+|||||+++++|.+++... ...+++..++.|+.||+.||.|||++||+||||||
T Consensus 92 ~~~~~~~------------~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp 155 (327)
T 3lxl_A 92 VSYGPGR------------QSLRLVMEYLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAA 155 (327)
T ss_dssp EEECSSS------------CEEEEEEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEecCCC------------ceEEEEEeecCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCh
Confidence 9874332 2469999999999999999762 23589999999999999999999999999999999
Q ss_pred CcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003185 656 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735 (840)
Q Consensus 656 eNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLG 735 (840)
+|||++.+ +.+||+|||++........... ......||+.|+|||++.+ ..++.++||||||
T Consensus 156 ~NIl~~~~-------~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG 217 (327)
T 3lxl_A 156 RNILVESE-------AHVKIADFGLAKLLPLDKDYYV-------VREPGQSPIFWYAPESLSD----NIFSRQSDVWSFG 217 (327)
T ss_dssp GGEEEEET-------TEEEECCGGGCEECCTTCSEEE-------CSSCCCSCGGGSCHHHHHH----CEEEHHHHHHHHH
T ss_pred hhEEECCC-------CCEEEcccccceecccCCccce-------eeccCCccccccCHHHhcc----CCCChHHhHHHHH
Confidence 99999877 4699999999987643322110 1123458889999999987 5678999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 736 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 736 vIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
|++|+|++|..||.................+........... .. ........++.+.+||.+||..||
T Consensus 218 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~---~~~~~~~~~~~l~~li~~~l~~dP 285 (327)
T 3lxl_A 218 VVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE---------GQ---RLPAPPACPAEVHELMKLCWAPSP 285 (327)
T ss_dssp HHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT---------TC---CCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc---------cc---CCCCCCcccHHHHHHHHHHcCCCh
Confidence 999999999999865432211110000011111110000000 00 001112346689999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCC
Q 003185 816 TERPTAGDLYEMFVARTSSS 835 (840)
Q Consensus 816 ~eRPSa~ELLehLe~l~~~~ 835 (840)
.+|||+.+|+++|+.+....
T Consensus 286 ~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 286 QDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp GGSCCHHHHHHHHHHC----
T ss_pred hhCcCHHHHHHHHHHHHhhh
Confidence 99999999999999886543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=358.17 Aligned_cols=275 Identities=21% Similarity=0.257 Sum_probs=205.9
Q ss_pred CCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
..++|++.+.||+|+||.||+|.+ ++..||+|++...... .. ...+.+|+.+++.++||||+++++++....
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ---GG----ELQFQTEVEMISMAVHRNLLRLRGFCMTPT 100 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC--------C----CCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred HhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc---hH----HHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence 457899999999999999999986 5788999986433211 11 123489999999999999999999998665
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCCCcE
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHRDIKSENI 658 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~---gIVHRDLKPeNI 658 (840)
.. ++||||+.+|+|.+++.... .....+++..++.|+.||+.||.|||++ ||+||||||+||
T Consensus 101 ~~--------------~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Ni 165 (326)
T 3uim_A 101 ER--------------LLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI 165 (326)
T ss_dssp CC--------------EEEEECCTTCBHHHHHHCCS-TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGE
T ss_pred ce--------------EEEEEeccCCCHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhE
Confidence 43 99999999999999997521 1234589999999999999999999999 999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.+ +.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 166 l~~~~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il 225 (326)
T 3uim_A 166 LLDEE-------FEAVVGDFGLAKLMDYKDTH---------VTTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGVML 225 (326)
T ss_dssp EECTT-------CCEEECCCSSCEECCSSSSC---------EECCCCSCGGGCCHHHHHH----SEECHHHHHHHHHHHH
T ss_pred EECCC-------CCEEeccCccccccCccccc---------ccccccCCcCccCHHHhcc----CCCCccccchhHHHHH
Confidence 99877 46999999999876432211 1123459999999999986 5679999999999999
Q ss_pred HHHHhCCCCCCCC-----CHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 003185 739 LELLTLQVPYMGL-----SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 813 (840)
Q Consensus 739 ~ELLTG~~PF~~~-----~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~ 813 (840)
|+|++|..||... ........+........ .................+..+.+|+.+||+.
T Consensus 226 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 291 (326)
T 3uim_A 226 LELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK--------------LEALVDVDLQGNYKDEEVEQLIQVALLCTQS 291 (326)
T ss_dssp HHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC--------------STTSSCTTCTTSCCHHHHHHHHHHHHHHTCS
T ss_pred HHHHhCCCcccccccccccchhHHHHHHHHhhchh--------------hhhhcChhhccccCHHHHHHHHHHHHHHhCc
Confidence 9999999999521 11111111111110000 0000000011122345678899999999999
Q ss_pred CCCCCCCHHHHHHHHHhhcC
Q 003185 814 NPTERPTAGDLYEMFVARTS 833 (840)
Q Consensus 814 DP~eRPSa~ELLehLe~l~~ 833 (840)
||.+|||+.+|+++|+....
T Consensus 292 dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 292 SPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp CGGGSCCHHHHHHHHHTSSC
T ss_pred CCccCCCHHHHHHHhcCcch
Confidence 99999999999999987543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=348.77 Aligned_cols=263 Identities=24% Similarity=0.331 Sum_probs=193.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
...++|++.+.||+|+||.||+|.+ .+..+|+|++.... . ..... ..+..+...++.++||||+++++++..
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~-~~~~~---~~~~~~~~~~~~~~h~~iv~~~~~~~~ 77 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV--N-SQEQK---RLLMDLDISMRTVDCPFTVTFYGALFR 77 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC-----C-HHHHH---HHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc--C-cHHHH---HHHHHHHHHHHhCCCCeEEEEeeeeec
Confidence 4567899999999999999999998 78899999865321 1 11111 222455556888899999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCCCcE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENI 658 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~-gIVHRDLKPeNI 658 (840)
... .++||||++ |+|.+++...... ...+++..++.++.||+.||.|||++ ||+||||||+||
T Consensus 78 ~~~--------------~~lv~e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Ni 141 (290)
T 3fme_A 78 EGD--------------VWICMELMD-TSLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNV 141 (290)
T ss_dssp SSS--------------EEEEEECCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGC
T ss_pred cCC--------------EEEEEehhc-cchHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHE
Confidence 553 499999998 5999888754333 36799999999999999999999998 999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.+ +.+||+|||++........ .....||+.|+|||++........++.++|||||||++
T Consensus 142 l~~~~-------~~~kl~Dfg~~~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il 203 (290)
T 3fme_A 142 LINAL-------GQVKMCDFGISGYLVDDVA-----------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITM 203 (290)
T ss_dssp EECTT-------CCEEBCCC--------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHH
T ss_pred EECCC-------CCEEEeecCCccccccccc-----------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHH
Confidence 99876 4699999999976644221 12236899999999985322346789999999999999
Q ss_pred HHHHhCCCCCCCC-CHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 739 LELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 739 ~ELLTG~~PF~~~-~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
|+|++|..||... ........+.....+..+. ...+..+.+||.+||+.||.+
T Consensus 204 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~li~~~l~~~p~~ 257 (290)
T 3fme_A 204 IELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA--------------------------DKFSAEFVDFTSQCLKKNSKE 257 (290)
T ss_dssp HHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCT--------------------------TTSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHCCCCccccCchHHHHHHHhccCCCCccc--------------------------ccCCHHHHHHHHHHhhcChhh
Confidence 9999999999763 3444444443332222211 112457899999999999999
Q ss_pred CCCHHHHHHHHHh
Q 003185 818 RPTAGDLYEMFVA 830 (840)
Q Consensus 818 RPSa~ELLehLe~ 830 (840)
|||+.++++|..-
T Consensus 258 Rpt~~e~l~hp~f 270 (290)
T 3fme_A 258 RPTYPELMQHPFF 270 (290)
T ss_dssp SCCHHHHTTSHHH
T ss_pred CcCHHHHHhCccc
Confidence 9999999998654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=379.12 Aligned_cols=267 Identities=23% Similarity=0.268 Sum_probs=211.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
...++|++.+.||+|+||.||+|++ .+..+|+|++..... ........+.+|+.++..++||||+++++++..
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~-----~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-----LKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH-----HHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHh-----hhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3457899999999999999999998 467899998753210 111111235889999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .||||||++||+|.+++.. ....+++..++.++.||+.||.|||++|||||||||+|||
T Consensus 146 ~~~--------------~~lV~Ey~~gg~L~~~l~~----~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NIL 207 (437)
T 4aw2_A 146 DNN--------------LYLVMDYYVGGDLLTLLSK----FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 207 (437)
T ss_dssp SSE--------------EEEEECCCTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CCE--------------EEEEEecCCCCcHHHHHHH----ccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHee
Confidence 653 5999999999999999975 2356999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~kSDVWSLGvIL 738 (840)
|+.+ +.+||+|||+|+........ .....+||+.|||||++.... ....++.++|||||||+|
T Consensus 208 l~~~-------g~vkL~DFGla~~~~~~~~~---------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil 271 (437)
T 4aw2_A 208 MDMN-------GHIRLADFGSCLKLMEDGTV---------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCM 271 (437)
T ss_dssp ECTT-------SCEEECCCTTCEECCTTSCE---------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHH
T ss_pred EcCC-------CCEEEcchhhhhhcccCCCc---------ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHH
Confidence 9877 46999999999765432211 123357999999999997321 124678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCC-CCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 739 LELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
|||++|+.||.+.+..+....|.... ...++. .....++.+.+||.+||..+|.+
T Consensus 272 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~------------------------~~~~~s~~~~dLi~~lL~~~~~r 327 (437)
T 4aw2_A 272 YEMLYGETPFYAESLVETYGKIMNHKERFQFPT------------------------QVTDVSENAKDLIRRLICSREHR 327 (437)
T ss_dssp HHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS------------------------SCCCSCHHHHHHHHTTSSCGGGC
T ss_pred HHHHhCCCCCCCCChhHHHHhhhhccccccCCc------------------------ccccCCHHHHHHHHHHhcccccc
Confidence 99999999999998888887775431 111111 00123567999999999998888
Q ss_pred --CCCHHHHHHHHHhh
Q 003185 818 --RPTAGDLYEMFVAR 831 (840)
Q Consensus 818 --RPSa~ELLehLe~l 831 (840)
||+++||++|.+-.
T Consensus 328 ~~r~~~~eil~Hpff~ 343 (437)
T 4aw2_A 328 LGQNGIEDFKKHPFFS 343 (437)
T ss_dssp TTTTTTHHHHTSGGGT
T ss_pred cCCCCHHHHhCCCccC
Confidence 99999999996543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=357.13 Aligned_cols=260 Identities=22% Similarity=0.286 Sum_probs=212.0
Q ss_pred CCCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEE
Q 003185 500 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 577 (840)
Q Consensus 500 ~p~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~ 577 (840)
++....+|.+.+.||+|+||.||+|.+ .+..+|+|++..... ......+ .+.+|+.+++.++||||+++++++
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~ 110 (335)
T 2owb_A 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQRE----KMSMEISIHRSLAHQHVVGFHGFF 110 (335)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHH----HHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh-cCHHHHH----HHHHHHHHHHhCCCCCCCeEEEEE
Confidence 345677899999999999999999998 467899998764432 2222333 348999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
.... ..|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 111 ~~~~--------------~~~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N 171 (335)
T 2owb_A 111 EDND--------------FVFVVLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGN 171 (335)
T ss_dssp ECSS--------------EEEEEECCCTTCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred ecCC--------------eEEEEEecCCCCCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchh
Confidence 8655 35999999999999999876 2568999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
||++.+ +.+||+|||++......... .....||+.|+|||++.+ ..++.++|||||||+
T Consensus 172 Il~~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~i 230 (335)
T 2owb_A 172 LFLNED-------LEVKIGDFGLATKVEYDGER----------KKVLCGTPNYIAPEVLSK----KGHSFEVDVWSIGCI 230 (335)
T ss_dssp EEECTT-------CCEEECCCTTCEECCSTTCC----------BCCCCSCCSSCCHHHHHT----SCBCTHHHHHHHHHH
T ss_pred EEEcCC-------CCEEEeeccCceecccCccc----------ccccCCCccccCHHHhcc----CCCCchhhHHHHHHH
Confidence 999877 45999999999865432111 123469999999999986 567899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
+|+|++|+.||......+....+..... .++. ..+..+.+||.+||+.||.+
T Consensus 231 l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~li~~~l~~dp~~ 282 (335)
T 2owb_A 231 MYTLLVGKPPFETSCLKETYLRIKKNEY-SIPK---------------------------HINPVAASLIQKMLQTDPTA 282 (335)
T ss_dssp HHHHHHSSCTTCCSSHHHHHHHHHHTCC-CCCT---------------------------TSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHCcCCCCCCCHHHHHHHHhcCCC-CCCc---------------------------cCCHHHHHHHHHHccCChhH
Confidence 9999999999998877776666655422 1111 12457899999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 003185 818 RPTAGDLYEMFVART 832 (840)
Q Consensus 818 RPSa~ELLehLe~l~ 832 (840)
|||+.++++|..-..
T Consensus 283 Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 283 RPTINELLNDEFFTS 297 (335)
T ss_dssp SCCGGGGGGSHHHHT
T ss_pred CcCHHHHhcCccccC
Confidence 999999999866443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=379.12 Aligned_cols=256 Identities=23% Similarity=0.284 Sum_probs=211.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|.+.+.||+|+||.||+|.+ .+..||+|++..... ........+.+|+.+|+.++||||+++++++..
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~-----~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 87 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI-----RSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST 87 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHH-----HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc-----cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 5678999999999999999999997 578999999753211 111223456899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.. ..||||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 88 ~~--------------~~~lv~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIl 148 (476)
T 2y94_A 88 PS--------------DIFMVMEYVSGGELFDYICK-----NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVL 148 (476)
T ss_dssp SS--------------EEEEEEECCSSEEHHHHTTS-----SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEE
T ss_pred CC--------------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEE
Confidence 55 35999999999999999864 357999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++........ .....||+.|+|||++.+ ....+.++|||||||++|
T Consensus 149 l~~~-------~~vkL~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlGvil~ 207 (476)
T 2y94_A 149 LDAH-------MNAKIADFGLSNMMSDGEF-----------LRTSCGSPNYAAPEVISG---RLYAGPEVDIWSSGVILY 207 (476)
T ss_dssp ECTT-------CCEEECCCSSCEECCTTCC-----------BCCCCSCSTTCCHHHHTT---CCBCSHHHHHHHHHHHHH
T ss_pred EecC-------CCeEEEeccchhhcccccc-----------ccccCCCcCeEChhhccC---CCCCCCcceehhhHHHHH
Confidence 9877 4599999999986543211 123469999999999986 223478999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|++|..||.+.+...+...+..+... .+. ..++.+.+||.+||..||.+||
T Consensus 208 elltG~~Pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~~Li~~~L~~dP~~Rp 259 (476)
T 2y94_A 208 ALLCGTLPFDDDHVPTLFKKICDGIFY-TPQ---------------------------YLNPSVISLLKHMLQVDPMKRA 259 (476)
T ss_dssp HHHHSSCSSCCSSSHHHHHHHHTTCCC-CCT---------------------------TCCHHHHHHHHHHTCSSTTTSC
T ss_pred HHhhCCCCCCCCCHHHHHHHHhcCCcC-CCc---------------------------cCCHHHHHHHHHHcCCCchhCc
Confidence 999999999988877777777665321 111 1245789999999999999999
Q ss_pred CHHHHHHHHHh
Q 003185 820 TAGDLYEMFVA 830 (840)
Q Consensus 820 Sa~ELLehLe~ 830 (840)
|+.+|++|..-
T Consensus 260 t~~eil~hp~~ 270 (476)
T 2y94_A 260 TIKDIREHEWF 270 (476)
T ss_dssp CHHHHHTCHHH
T ss_pred CHHHHHhCHHh
Confidence 99999998654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=359.65 Aligned_cols=286 Identities=18% Similarity=0.212 Sum_probs=212.0
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||.||+|.+ ++..||+|++... ..... ...+.+|+.+|++++||||+++++++.....
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF---EHQTY----CQRTLREIKILLRFRHENIIGINDIIRAPTI 99 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT---TCHHH----HHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc---cCcHH----HHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence 5899999999999999999987 5778999986421 12222 2345899999999999999999999875432
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
. .....|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 100 ~---------~~~~~~iv~e~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~ 163 (364)
T 3qyz_A 100 E---------QMKDVYIVQDLME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 163 (364)
T ss_dssp T---------TCCCEEEEEECCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred c---------ccceEEEEEcccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECC
Confidence 1 2234699999997 599999976 46999999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||++.......... .......||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 164 ~-------~~~kl~Dfg~a~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell 226 (364)
T 3qyz_A 164 T-------CDLKICDFGLARVADPDHDHT-------GFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEML 226 (364)
T ss_dssp T-------CCEEECCCTTCEECCGGGCBC-------CTTCCCCSCGGGCCHHHHHT---BCSCSTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEEeCcceEecCCCCCcc-------ccccccccccCCCCCHHhcC---CCCCCcchhHHHHHHHHHHHH
Confidence 7 459999999998765432211 11233579999999999764 245789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcccccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|+.||.+.+..+....+.........+.+..........+... .............+..+.+||.+||..||.+||
T Consensus 227 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 306 (364)
T 3qyz_A 227 SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 306 (364)
T ss_dssp HSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred HCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCC
Confidence 99999998887777766654322222222211100000000000 000001111233467899999999999999999
Q ss_pred CHHHHHHHHHh
Q 003185 820 TAGDLYEMFVA 830 (840)
Q Consensus 820 Sa~ELLehLe~ 830 (840)
|+.|+++|..-
T Consensus 307 t~~e~l~hp~~ 317 (364)
T 3qyz_A 307 EVEQALAHPYL 317 (364)
T ss_dssp CHHHHHTSGGG
T ss_pred CHHHHhcCcch
Confidence 99999998654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=358.40 Aligned_cols=264 Identities=21% Similarity=0.291 Sum_probs=201.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|.+.+.||+|+||.||+|.+ .+..||+|++..................+.+|+.+|++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5799999999999999999998 5678999997543221111111111234589999999999999999999986432
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 89 --------------~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~ 149 (322)
T 2ycf_A 89 --------------YYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSS 149 (322)
T ss_dssp --------------EEEEEECCTTEETHHHHST-----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESS
T ss_pred --------------eEEEEecCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEec
Confidence 4999999999999998864 357999999999999999999999999999999999999986
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
++. ...+||+|||++......... ....||+.|+|||++.... ...++.++|||||||++|+|+
T Consensus 150 ~~~----~~~~kl~Dfg~~~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~~l~ 213 (322)
T 2ycf_A 150 QEE----DCLIKITDFGHSKILGETSLM-----------RTLCGTPTYLAPEVLVSVG-TAGYNRAVDCWSLGVILFICL 213 (322)
T ss_dssp SSS----SCCEEECCCTTCEECCCCHHH-----------HHHHSCCTTCCHHHHHHTT-TTTCTTHHHHHHHHHHHHHHH
T ss_pred CCC----CCeEEEccCccceeccccccc-----------ccccCCcCccCchhhccCC-CCCCCchhhHHHHHHHHHHHH
Confidence 631 356999999999876432211 1235899999999985321 256789999999999999999
Q ss_pred hCCCCCCCCCH-HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 743 TLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 743 TG~~PF~~~~~-~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
+|..||..... ..+...+..+.....+.. ....+..+.+||.+||..||.+|||+
T Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~li~~~l~~dP~~Rps~ 269 (322)
T 2ycf_A 214 SGYPPFSEHRTQVSLKDQITSGKYNFIPEV------------------------WAEVSEKALDLVKKLLVVDPKARFTT 269 (322)
T ss_dssp HSSCSSCSTTCSSCHHHHHHHTCCCCCHHH------------------------HTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred hCCCCCcccchHHHHHHHHHhCccccCchh------------------------hhhcCHHHHHHHHHHcccCHhhCCCH
Confidence 99999976543 234444444433322221 12235679999999999999999999
Q ss_pred HHHHHHH
Q 003185 822 GDLYEMF 828 (840)
Q Consensus 822 ~ELLehL 828 (840)
.++++|.
T Consensus 270 ~~~l~h~ 276 (322)
T 2ycf_A 270 EEALRHP 276 (322)
T ss_dssp HHHHTSG
T ss_pred HHHhhCc
Confidence 9999873
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=367.78 Aligned_cols=254 Identities=24% Similarity=0.292 Sum_probs=201.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHH-HHhCCCCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM-LGALRHSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~i-L~~L~HpNIV~l~g~~~ 578 (840)
...++|++.+.||+|+||.||+|++ .+..+|+|+......... .... .+.+|..+ ++.++|||||++++++.
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~-~~~~----~~~~e~~~ll~~~~hp~Iv~l~~~~~ 109 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK-KEEK----HIMSERNVLLKNVKHPFLVGLHFSFQ 109 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC------------------CCBCCCCCTTBCCEEEEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhh-HHHH----HHHHHHHHHHHhCCCCCCCCEEEEEE
Confidence 5678999999999999999999998 467899999765432221 1222 23667776 57789999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
.... .||||||++||+|..++.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 110 ~~~~--------------~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 170 (373)
T 2r5t_A 110 TADK--------------LYFVLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENI 170 (373)
T ss_dssp CSSE--------------EEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred eCCE--------------EEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHE
Confidence 6653 5999999999999999986 25689999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
||+.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 171 ll~~~-------g~ikL~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il 229 (373)
T 2r5t_A 171 LLDSQ-------GHIVLTDFGLCKENIEHNS----------TTSTFCGTPEYLAPEVLHK----QPYDRTVDWWCLGAVL 229 (373)
T ss_dssp EECTT-------SCEEECCCCBCGGGBCCCC----------CCCSBSCCCCCCCHHHHTT----CCCCTHHHHHHHHHHH
T ss_pred EECCC-------CCEEEeeCccccccccCCC----------ccccccCCccccCHHHhCC----CCCCchhhhHHHHHHH
Confidence 99877 4699999999975432111 1234579999999999986 6789999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 739 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
|||++|..||.+.+..++...+...... ++. ..+..+.+||.+||+.||.+|
T Consensus 230 ~ell~G~~Pf~~~~~~~~~~~i~~~~~~-~~~---------------------------~~~~~~~~li~~lL~~dp~~R 281 (373)
T 2r5t_A 230 YEMLYGLPPFYSRNTAEMYDNILNKPLQ-LKP---------------------------NITNSARHLLEGLLQKDRTKR 281 (373)
T ss_dssp HHHHHSSCTTCCSBHHHHHHHHHHSCCC-CCS---------------------------SSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHhcccC-CCC---------------------------CCCHHHHHHHHHHcccCHHhC
Confidence 9999999999999888888887765321 111 124578999999999999999
Q ss_pred CCH----HHHHHHH
Q 003185 819 PTA----GDLYEMF 828 (840)
Q Consensus 819 PSa----~ELLehL 828 (840)
|++ .+|++|.
T Consensus 282 ~~~~~~~~~i~~h~ 295 (373)
T 2r5t_A 282 LGAKDDFMEIKSHV 295 (373)
T ss_dssp TTTTTTHHHHHTSG
T ss_pred CCCCCCHHHHhCCc
Confidence 987 5777764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=349.20 Aligned_cols=265 Identities=22% Similarity=0.269 Sum_probs=206.9
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
-+++|.+.+.||+|+||.||+|.+ .+..+|+|++........ ......+.+|+.++++++||||+++++++...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRI----PNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE 78 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHS----TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccccc----chhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 357899999999999999999997 567899999754321111 11223458999999999999999999998643
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. ...+|||||+.++ |.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 79 ~~------------~~~~lv~e~~~~~-l~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~ 142 (305)
T 2wtk_C 79 EK------------QKMYMVMEYCVCG-MQEMLDS---VPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL 142 (305)
T ss_dssp ---------------CEEEEEECCSEE-HHHHHHH---STTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CC------------CeEEEEehhccCC-HHHHHHh---CcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE
Confidence 21 2469999999865 8888775 234579999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||++.......... ......||+.|+|||++.+. ...++.++|||||||++|+
T Consensus 143 ~~~-------~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Di~slG~il~~ 205 (305)
T 2wtk_C 143 TTG-------GTLKISALGVAEALHPFAADD--------TCRTSQGSPAFQPPEIANGL--DTFSGFKVDIWSAGVTLYN 205 (305)
T ss_dssp CTT-------CCEEECCCTTCEECCTTCSSC--------EECCCCSCGGGCCHHHHTCC--SCEESHHHHHHHHHHHHHH
T ss_pred cCC-------CcEEeeccccccccCcccccc--------ccccCCCCCCCcChhhccCc--ccCCcchhhHHHHHHHHHH
Confidence 877 459999999998664321110 01234589999999999751 1234789999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|++|..||.+.+..+....+.....+ ++ ...+..+.+||.+||..||.+|||
T Consensus 206 l~~g~~p~~~~~~~~~~~~i~~~~~~-~~---------------------------~~~~~~l~~li~~~l~~dp~~Rps 257 (305)
T 2wtk_C 206 ITTGLYPFEGDNIYKLFENIGKGSYA-IP---------------------------GDCGPPLSDLLKGMLEYEPAKRFS 257 (305)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHCCCC-CC---------------------------SSSCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhCCCCCCCchHHHHHHHHhcCCCC-CC---------------------------CccCHHHHHHHHHHccCChhhCCC
Confidence 99999999998888877777665321 11 012457899999999999999999
Q ss_pred HHHHHHHHHhhc
Q 003185 821 AGDLYEMFVART 832 (840)
Q Consensus 821 a~ELLehLe~l~ 832 (840)
+.++++|..-..
T Consensus 258 ~~~ll~~~~~~~ 269 (305)
T 2wtk_C 258 IRQIRQHSWFRK 269 (305)
T ss_dssp HHHHHHSHHHHS
T ss_pred HHHHhcCccccc
Confidence 999999966543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=367.00 Aligned_cols=264 Identities=23% Similarity=0.346 Sum_probs=198.4
Q ss_pred CCceeeeeecccCceEEEEEEE---CCe--eEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF---GSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~---~~~--~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..|.+.+.||+|+||.||+|.+ ++. .+|+|+ ++.. ......+. +.+|+.+|++++||||+++++++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~--~~~~-~~~~~~~~----~~~E~~il~~l~hpnIv~~~~~~~~ 161 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS--LNRI-TDIGEVSQ----FLTEGIIMKDFSHPNVLSLLGICLR 161 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEE--CCSC-SCSHHHHH----HHHHHTTSTTCCCTTBCCCCEEECC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEE--cCCC-CCHHHHHH----HHHHHHHHHhCCCCCcceEEEEEEc
Confidence 4588999999999999999986 223 456665 3322 22233334 4899999999999999999998764
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... ..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 162 ~~~-------------~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 224 (373)
T 3c1x_A 162 SEG-------------SPLVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCM 224 (373)
T ss_dssp CSS-------------CCEEEEECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CCC-------------CeEEEEECCCCCCHHHHHhh----cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEE
Confidence 331 24999999999999999974 2356889999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||+++.+....... ........+|+.|+|||++.+ ..++.++|||||||+||
T Consensus 225 l~~~-------~~~kL~DFG~a~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwSlG~il~ 287 (373)
T 3c1x_A 225 LDEK-------FTVKVADFGLARDMYDKEFDS------VHNKTGAKLPVKWMALESLQT----QKFTTKSDVWSFGVLLW 287 (373)
T ss_dssp ECTT-------CCEEECCC---------------------------CCGGGSCHHHHHH----CCCCHHHHHHHHHHHHH
T ss_pred ECCC-------CCEEEeecccccccccccccc------ccccCCCCCcccccChHHhcC----CCCCcHHHHHHHHHHHH
Confidence 9876 469999999998664322110 011123457889999999987 67899999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 740 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 740 ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
||+| |.+||...+..++...+..+.++..+. .++..+.+||.+||..||.+|
T Consensus 288 ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~dp~~R 340 (373)
T 3c1x_A 288 ELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE---------------------------YCPDPLYEVMLKCWHPKAEMR 340 (373)
T ss_dssp HHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCChhhC
Confidence 9999 788888777666666666654433221 124578999999999999999
Q ss_pred CCHHHHHHHHHhhcCCCC
Q 003185 819 PTAGDLYEMFVARTSSSI 836 (840)
Q Consensus 819 PSa~ELLehLe~l~~~~~ 836 (840)
||+.+|+++|+.+.....
T Consensus 341 Ps~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 341 PSFSELVSRISAIFSTFI 358 (373)
T ss_dssp CCHHHHHHHHHHHHHTCC
T ss_pred cCHHHHHHHHHHHHHhcc
Confidence 999999999999876543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.11 Aligned_cols=301 Identities=21% Similarity=0.232 Sum_probs=209.1
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
-++|++.+.||+|+||.||+|.+. +..||+|++... .....+ .+.+|+.++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVK----HALREIKIIRRLDHDNIVKVFEILGPSG 81 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHH----HHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHH----HHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence 468999999999999999999984 788999987533 223333 3489999999999999999999986443
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
................++||||+. |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN 154 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE
T ss_pred cccccccccccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc
Confidence 110000011122346799999998 599999863 5689999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.++ +.+||+|||+++........ ........+|+.|+|||++.+ ...++.++|||||||++|||
T Consensus 155 ~~~------~~~kl~Dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~el 218 (320)
T 2i6l_A 155 TED------LVLKIGDFGLARIMDPHYSH-------KGHLSEGLVTKWYRSPRLLLS---PNNYTKAIDMWAAGCIFAEM 218 (320)
T ss_dssp TTT------TEEEECCCTTCBCC---------------CCCGGGSCCTTCCHHHHHC---TTCCCHHHHHHHHHHHHHHH
T ss_pred CCC------CeEEEccCccccccCCCccc-------ccccccccccccccCcHHhcC---cccCCchhhhHhHHHHHHHH
Confidence 542 57999999999876432111 011223457999999999874 25689999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccC--CCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG--SGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
++|+.||.+.+..+....+........................... ............+..+.+||.+||+.||.+||
T Consensus 219 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 298 (320)
T 2i6l_A 219 LTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL 298 (320)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSC
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccC
Confidence 9999999998887777666654332222222111110000000000 00000111223567899999999999999999
Q ss_pred CHHHHHHHHHhhcCCC
Q 003185 820 TAGDLYEMFVARTSSS 835 (840)
Q Consensus 820 Sa~ELLehLe~l~~~~ 835 (840)
|+.++++|..-..-+.
T Consensus 299 t~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 299 TAEEALSHPYMSIYSF 314 (320)
T ss_dssp CHHHHHTSHHHHTTCC
T ss_pred CHHHHhCCcccccccC
Confidence 9999999966544333
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=344.86 Aligned_cols=261 Identities=22% Similarity=0.337 Sum_probs=206.9
Q ss_pred CceeeeeecccCceEEEEEEE--CC---eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~---~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.|.+.+.||+|+||.||+|.+ .+ ..+|+|+... .......+. +.+|+.++++++||||+++++++...
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~---~~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR---ITEMQQVEA----FLREGLLMRGLNHPNVLALIGIMLPP 94 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT---CCSHHHHHH----HHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc---cccHHHHHH----HHHHHHHHHhCCCCCeeeEEEEEecC
Confidence 466789999999999999986 22 2578887532 222333334 48999999999999999999998755
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
... .++||||+.+++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 95 ~~~-------------~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili 157 (298)
T 3pls_A 95 EGL-------------PHVLLPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML 157 (298)
T ss_dssp SSC-------------CEEEECCCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCC-------------cEEEEecccCCCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE
Confidence 432 3899999999999999974 34568999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||+++......... ........+|+.|+|||.+.+ ..++.++|||||||++|+
T Consensus 158 ~~~-------~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 220 (298)
T 3pls_A 158 DES-------FTVKVADFGLARDILDREYYS------VQQHRHARLPVKWTALESLQT----YRFTTKSDVWSFGVLLWE 220 (298)
T ss_dssp CTT-------CCEEECCTTSSCTTTTGGGGC------SCCSSCTTCGGGGSCHHHHTT----CCCCHHHHHHHHHHHHHH
T ss_pred cCC-------CcEEeCcCCCcccccCCcccc------cccCcCCCCCccccChhhhcc----CCCChhhchhhHHHHHHH
Confidence 876 469999999998664432111 111233468899999999976 678999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|++ +.+||...+..++...+.....+..+. ..++.+.+||.+||..||.+||
T Consensus 221 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rp 273 (298)
T 3pls_A 221 LLTRGAPPYRHIDPFDLTHFLAQGRRLPQPE---------------------------YCPDSLYQVMQQCWEADPAVRP 273 (298)
T ss_dssp HHHTSCCTTTTSCGGGHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred HhhCCCCCCccCCHHHHHHHhhcCCCCCCCc---------------------------cchHHHHHHHHHHccCChhhCc
Confidence 999 556666677777777776654433221 1245789999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 003185 820 TAGDLYEMFVARTSS 834 (840)
Q Consensus 820 Sa~ELLehLe~l~~~ 834 (840)
|+.++++.|+.+...
T Consensus 274 s~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 274 TFRVLVGEVEQIVSA 288 (298)
T ss_dssp CHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHH
Confidence 999999999988654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=370.38 Aligned_cols=285 Identities=22% Similarity=0.225 Sum_probs=208.1
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
..+|++.+.||+|+||.||+|.+ .+..||+|++.... ..+ .+|+.+|+.|+|||||++++++....
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--------~~~----~~E~~il~~l~hpniv~l~~~~~~~~ 120 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--------RFK----NRELQIMRKLDHCNIVRLRYFFYSSG 120 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT--------TSC----CHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc--------hhH----HHHHHHHHHcCCCCccceeeEEeccC
Confidence 34799999999999999999998 57889999864321 111 57999999999999999999986432
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
.. .....+++||||+++ +|.+++..... ....+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus 121 ~~--------~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~ 190 (420)
T 1j1b_A 121 EK--------KDEVYLNLVLDYVPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD 190 (420)
T ss_dssp TT--------TTEEEEEEEEECCCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEE
T ss_pred CC--------CcceeEEeehhcccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe
Confidence 10 122346899999985 88887765333 346799999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.++ ..+||+|||+++.+..... ....+||+.|+|||++.+ ...++.++|||||||+||||
T Consensus 191 ~~~------~~~kl~DFG~a~~~~~~~~-----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlG~il~el 250 (420)
T 1j1b_A 191 PDT------AVLKLCDFGSAKQLVRGEP-----------NVSYICSRYYRAPELIFG---ATDYTSSIDVWSAGCVLAEL 250 (420)
T ss_dssp TTT------TEEEECCCTTCEECCTTCC-----------CCSCCSCTTSCCHHHHTT---CSSCCTHHHHHHHHHHHHHH
T ss_pred CCC------CeEEeccchhhhhcccCCC-----------ceeeeeCCCcCCHHHHcC---CCCCCchhhhHHHHHHHHHH
Confidence 652 4689999999986543211 123468999999999975 24689999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccC-ccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC-HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
++|+.||.+.+..+.+..+.+.......+.+...... ....+.......-........+..+.+||.+||.+||.+|||
T Consensus 251 l~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t 330 (420)
T 1j1b_A 251 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 330 (420)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCC
Confidence 9999999998877666665543222222222221100 000000000000000001234578999999999999999999
Q ss_pred HHHHHHHHHh
Q 003185 821 AGDLYEMFVA 830 (840)
Q Consensus 821 a~ELLehLe~ 830 (840)
+.|+++|..-
T Consensus 331 ~~e~l~hp~f 340 (420)
T 1j1b_A 331 PLEACAHSFF 340 (420)
T ss_dssp HHHHHTSGGG
T ss_pred HHHHhCCHhh
Confidence 9999998543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=358.35 Aligned_cols=260 Identities=22% Similarity=0.308 Sum_probs=197.4
Q ss_pred CCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC--CCcceeeeEEecC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SCIVEMYGHKISS 580 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~H--pNIV~l~g~~~~~ 580 (840)
-.+|++.+.||+|+||.||+|.+ .+..||+|++.... ......+. +.+|+.+|.+++| |||+++++++...
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~----~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE--ADNQTLDS----YRNEIAYLNKLQQHSDKIIRLYDYEITD 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT--CCHHHHHH----HHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc--cchHHHHH----HHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence 35699999999999999999987 56779999976442 23333334 4899999999986 9999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .+||||+ .+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 82 ~~--------------~~lv~e~-~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll 141 (343)
T 3dbq_A 82 QY--------------IYMVMEC-GNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI 141 (343)
T ss_dssp SE--------------EEEEECC-CSEEHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred CE--------------EEEEEeC-CCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE
Confidence 53 5999995 56899999986 3578999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-------CCCCCCchhhHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-------KPNLYGLEVDIWS 733 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-------~~~~~s~kSDVWS 733 (840)
+. +.+||+|||+++........ .......||+.|+|||++.+.. ....++.++||||
T Consensus 142 ~~--------~~~kl~DFG~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Diws 205 (343)
T 3dbq_A 142 VD--------GMLKLIDFGIANQMQPDTTS--------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 205 (343)
T ss_dssp ET--------TEEEECCCSSSCCC--------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHH
T ss_pred EC--------CcEEEeecccccccCccccc--------ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHH
Confidence 63 36999999999876432211 0123356999999999997421 1246789999999
Q ss_pred HHHHHHHHHhCCCCCCCCC-HHHHHHHHHcC-CCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 003185 734 YGCLLLELLTLQVPYMGLS-ELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 811 (840)
Q Consensus 734 LGvIL~ELLTG~~PF~~~~-~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL 811 (840)
|||+||||++|+.||.... .......+... ....++. ..+..+.+||.+||
T Consensus 206 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~L 258 (343)
T 3dbq_A 206 LGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD---------------------------IPEKDLQDVLKCCL 258 (343)
T ss_dssp HHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCC---------------------------CSCHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcc---------------------------cCCHHHHHHHHHHc
Confidence 9999999999999997643 22333333222 1111111 11347899999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhc
Q 003185 812 EENPTERPTAGDLYEMFVART 832 (840)
Q Consensus 812 ~~DP~eRPSa~ELLehLe~l~ 832 (840)
..||.+|||+.++++|.+-..
T Consensus 259 ~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 259 KRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp CSSTTTSCCHHHHHTSHHHHS
T ss_pred CCChhHCCCHHHHHhCccccc
Confidence 999999999999999976544
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=344.14 Aligned_cols=256 Identities=23% Similarity=0.281 Sum_probs=202.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|.+.+.||+|+||.||+|.+ .+..+|+|++.... .........+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQK-----IRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST 82 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccc-----ccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 5678999999999999999999998 47899999975321 1111223456899999999999999999999886
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.. ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+|||
T Consensus 83 ~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil 143 (276)
T 2h6d_A 83 PT--------------DFFMVMEYVSGGELFDYICK-----HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVL 143 (276)
T ss_dssp SS--------------EEEEEEECCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEE
T ss_pred CC--------------eEEEEEeccCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEE
Confidence 54 35999999999999999976 246899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++........ .....||+.|+|||++.+ ....+.++||||||+++|
T Consensus 144 ~~~~-------~~~~l~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~~l~ 202 (276)
T 2h6d_A 144 LDAH-------MNAKIADFGLSNMMSDGEF-----------LRTSCGSPNYAAPEVISG---RLYAGPEVDIWSCGVILY 202 (276)
T ss_dssp ECTT-------SCEEECCCCGGGCCCC------------------------CCTGGGTT---SCCCHHHHHHHHHHHHHH
T ss_pred ECCC-------CCEEEeecccccccCCCcc-----------eecccCCccccCHHHHcC---CCCCCccchHHHHHHHHH
Confidence 9877 4599999999976543211 123468999999999875 123468999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|++|..||.......+...+...... ++. ..+..+.+||.+||+.||.+||
T Consensus 203 ~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~l~~li~~~l~~~p~~Rp 254 (276)
T 2h6d_A 203 ALLCGTLPFDDEHVPTLFKKIRGGVFY-IPE---------------------------YLNRSVATLLMHMLQVDPLKRA 254 (276)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCC-CCT---------------------------TSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHhCCCCCCCCcHHHHHHHhhcCccc-Cch---------------------------hcCHHHHHHHHHHccCChhhCC
Confidence 999999999988877777776654321 111 1245789999999999999999
Q ss_pred CHHHHHHHHHh
Q 003185 820 TAGDLYEMFVA 830 (840)
Q Consensus 820 Sa~ELLehLe~ 830 (840)
|+.+|++|..-
T Consensus 255 s~~~~l~h~~~ 265 (276)
T 2h6d_A 255 TIKDIREHEWF 265 (276)
T ss_dssp CHHHHHHSHHH
T ss_pred CHHHHHhChhh
Confidence 99999998553
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=349.95 Aligned_cols=258 Identities=21% Similarity=0.324 Sum_probs=185.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++.+.||+|+||.||+|.+ .+..+|+|++.... .......+.+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA-----MYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED 82 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC
T ss_pred cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhh-----hhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc
Confidence 4567899999999999999999997 67889999975321 1111223456899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.. ..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 83 ~~--------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil 144 (278)
T 3cok_A 83 SN--------------YVYLVLEMCHNGEMNRYLKN----RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLL 144 (278)
T ss_dssp SS--------------EEEEEEECCTTEEHHHHHHT----CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEE
T ss_pred CC--------------eEEEEEecCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 54 35999999999999999975 2356899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++......... .....||+.|+|||++.+ ..++.++||||||+++|
T Consensus 145 i~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 203 (278)
T 3cok_A 145 LTRN-------MNIKIADFGLATQLKMPHEK----------HYTLCGTPNYISPEIATR----SAHGLESDVWSLGCMFY 203 (278)
T ss_dssp ECTT-------CCEEECCCTTCEECC------------------------------------------CTHHHHHHHHHH
T ss_pred EcCC-------CCEEEEeecceeeccCCCCc----------ceeccCCCCcCCcchhcC----CCCCchhhHHHHHHHHH
Confidence 9877 45999999999865432111 123468999999999876 56788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|++|+.||......+....+..... .+ ....+..+.+||.+||..||.+||
T Consensus 204 ~l~~g~~p~~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~li~~~l~~dp~~Rp 255 (278)
T 3cok_A 204 TLLIGRPPFDTDTVKNTLNKVVLADY-EM---------------------------PSFLSIEAKDLIHQLLRRNPADRL 255 (278)
T ss_dssp HHHHSSCSSCCCSCC-----CCSSCC-CC---------------------------CTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred HHHhCCCCCCChhHHHHHHHHhhccc-CC---------------------------ccccCHHHHHHHHHHcccCHhhCC
Confidence 99999999976654333222211100 00 011345789999999999999999
Q ss_pred CHHHHHHHHHhh
Q 003185 820 TAGDLYEMFVAR 831 (840)
Q Consensus 820 Sa~ELLehLe~l 831 (840)
|+.++++|..-.
T Consensus 256 s~~~~l~h~~~~ 267 (278)
T 3cok_A 256 SLSSVLDHPFMS 267 (278)
T ss_dssp CHHHHTTSTTTC
T ss_pred CHHHHhcCcccc
Confidence 999999986543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=368.91 Aligned_cols=297 Identities=19% Similarity=0.204 Sum_probs=201.9
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.-++|++.+.||+|+||.||+|.+ .+..||+|++.. ........+ ++.+|+.+|++++||||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~--~~~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~ 97 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR--MFEDLIDCK----RILREITILNRLKSDYIIRLYDLIIPD 97 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS--TTTSHHHHH----HHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCc--hhcChHHHH----HHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 347899999999999999999997 567899998642 222333333 449999999999999999999998755
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
... .....||||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 98 ~~~---------~~~~~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl 162 (432)
T 3n9x_A 98 DLL---------KFDELYIVLEIAD-SDLKKLFKT-----PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL 162 (432)
T ss_dssp CTT---------TCCCEEEEEECCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CCC---------cCCeEEEEEecCC-cCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE
Confidence 321 2235799999997 599999975 3569999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccc------------cCCCCCCCcccCCCcccchhhhhcccCCCCCCch
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA------------HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 728 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~------------~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~k 728 (840)
+.+ +.+||+|||+|+............ ..........+||+.|+|||++.. ...++.+
T Consensus 163 ~~~-------~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~~~~~ 232 (432)
T 3n9x_A 163 NQD-------CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL---QENYTKS 232 (432)
T ss_dssp CTT-------CCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTT---CSCCCTH
T ss_pred CCC-------CCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc---CCCCCcc
Confidence 877 469999999998765432110000 000011244679999999999754 2568999
Q ss_pred hhHHHHHHHHHHHHhC-----------CCCCCCCC-----------------HHHHHHHHHcCCCCCcchHHhhhccCcc
Q 003185 729 VDIWSYGCLLLELLTL-----------QVPYMGLS-----------------ELEIHDLIQMGKRPRLTDELEALGSCHE 780 (840)
Q Consensus 729 SDVWSLGvIL~ELLTG-----------~~PF~~~~-----------------~~el~~~I~~~~~p~l~~~l~~~~~~~~ 780 (840)
+|||||||+||||++| .++|.+.+ ..+.+..|.........+.+........
T Consensus 233 ~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~ 312 (432)
T 3n9x_A 233 IDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEV 312 (432)
T ss_dssp HHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred cccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHH
Confidence 9999999999999984 44444432 1222222222111111111111100000
Q ss_pred cccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003185 781 HEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 781 ~~~~~~---~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~ 830 (840)
...... .............++.+.+||.+||..||.+|||++|+++|..-
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 365 (432)
T 3n9x_A 313 IKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365 (432)
T ss_dssp HHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGG
T ss_pred HHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhh
Confidence 000000 00011111223456789999999999999999999999999553
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=353.28 Aligned_cols=259 Identities=22% Similarity=0.326 Sum_probs=202.4
Q ss_pred CCc-eeeeeecccCceEEEEEEE------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEE
Q 003185 505 PSL-SSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 577 (840)
Q Consensus 505 ~~y-~i~~~LG~G~fG~Vy~a~~------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~ 577 (840)
++| ++.+.||+|+||.||++.+ .+..||+|++... ......+ .+.+|+.+|++++||||+++++++
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~ 102 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD---AGPQHRS----GWKQEIDILRTLYHEHIIKYKGCC 102 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT---CCHHHHH----HHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc---cChHHHH----HHHHHHHHHHhCCCcchhhEEEEE
Confidence 445 9999999999999999875 5778999997533 2223333 348999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
..... ...++||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 103 ~~~~~------------~~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~N 164 (318)
T 3lxp_A 103 EDAGA------------ASLQLVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARN 164 (318)
T ss_dssp EETTT------------TEEEEEECCCTTCBHHHHGGG------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred ecCCC------------ceEEEEEecccCCcHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchhe
Confidence 86431 246999999999999999865 358999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
||++.+ +.+||+|||++........... ......||+.|+|||++.+ ..++.++|||||||+
T Consensus 165 il~~~~-------~~~kl~Dfg~a~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~i 226 (318)
T 3lxp_A 165 VLLDND-------RLVKIGDFGLAKAVPEGHEYYR-------VREDGDSPVFWYAPECLKE----YKFYYASDVWSFGVT 226 (318)
T ss_dssp EEECTT-------CCEEECCGGGCEECCTTCSEEE-------C---CCCCGGGCCHHHHHH----CEEEHHHHHHHHHHH
T ss_pred EEEcCC-------CCEEECCccccccccccccccc-------cccCCCCCceeeChHHhcC----CCCCcHHHHHHHHHH
Confidence 999877 4699999999987654321110 1123358889999999987 567899999999999
Q ss_pred HHHHHhCCCCCCCCCHHH---------------HHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHH
Q 003185 738 LLELLTLQVPYMGLSELE---------------IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 802 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~e---------------l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 802 (840)
+|+|++|..||....... +...+.....+. .....+..
T Consensus 227 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~ 279 (318)
T 3lxp_A 227 LYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLP---------------------------RPDKCPAE 279 (318)
T ss_dssp HHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCC---------------------------CCTTCCHH
T ss_pred HHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCC---------------------------CCccccHH
Confidence 999999999996532211 111111111111 11234568
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003185 803 LVDVFRRCTEENPTERPTAGDLYEMFVARTS 833 (840)
Q Consensus 803 L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~ 833 (840)
+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus 280 l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 280 VYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999998764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=349.69 Aligned_cols=272 Identities=26% Similarity=0.324 Sum_probs=199.9
Q ss_pred CCCCCceee-eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEE
Q 003185 502 GSFPSLSSC-DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 577 (840)
Q Consensus 502 ~~~~~y~i~-~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~ 577 (840)
..-+.|++. +.||+|+||.||+|.+ .+..||+|++..... ... ..+.+|+.++.++ +||||+++++++
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~----~~~~~E~~~l~~~~~h~~i~~~~~~~ 80 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG----HIR----SRVFREVEMLYQCQGHRNVLELIEFF 80 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS----CCH----HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc----hhH----HHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345678885 7899999999999986 678999999754321 112 2348999999995 699999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
..... .||||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 81 ~~~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 141 (316)
T 2ac3_A 81 EEEDR--------------FYLVFEKMRGGSILSHIHK-----RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPEN 141 (316)
T ss_dssp EETTE--------------EEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred eeCCE--------------EEEEEEcCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHH
Confidence 86553 5999999999999999986 2468999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC-CCCCCchhhHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVDIWSYGC 736 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~-~~~~s~kSDVWSLGv 736 (840)
||++.++. ...+||+|||++........... ..........||+.|+|||++.+... ...++.++|||||||
T Consensus 142 il~~~~~~----~~~~kl~Dfg~~~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~ 214 (316)
T 2ac3_A 142 ILCEHPNQ----VSPVKICDFDLGSGIKLNGDCSP---ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGV 214 (316)
T ss_dssp EEESCSSS----SCSEEECCTTCCC----------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHH
T ss_pred EEEccCCC----cCceEEEEccCccccccCCcccc---ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHH
Confidence 99987632 24599999999976543211100 00011123469999999999874110 023678999999999
Q ss_pred HHHHHHhCCCCCCCCCH---------------HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHH
Q 003185 737 LLLELLTLQVPYMGLSE---------------LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 801 (840)
Q Consensus 737 IL~ELLTG~~PF~~~~~---------------~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 801 (840)
++|+|++|+.||.+... ..+...+...... ++. ......+.
T Consensus 215 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-~~~-----------------------~~~~~~~~ 270 (316)
T 2ac3_A 215 ILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYE-FPD-----------------------KDWAHISC 270 (316)
T ss_dssp HHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCC-CCH-----------------------HHHTTSCH
T ss_pred HHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcc-cCc-----------------------hhcccCCH
Confidence 99999999999976532 2334444443221 111 01122356
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 003185 802 FLVDVFRRCTEENPTERPTAGDLYEMFVAR 831 (840)
Q Consensus 802 ~L~dLI~rCL~~DP~eRPSa~ELLehLe~l 831 (840)
.+.+||.+||..||.+|||+.|+++|..-.
T Consensus 271 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 300 (316)
T 2ac3_A 271 AAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300 (316)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred HHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence 799999999999999999999999986543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=345.07 Aligned_cols=255 Identities=24% Similarity=0.339 Sum_probs=200.8
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
-..|.+.+.||+|+||.||+|.+ .+..+|+|++.... ......+ .+.+|+.++++++||||+++++++....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~--~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSERQ----RFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHH----HHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchh--hCHHHHH----HHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence 34589999999999999999998 45667777765332 2333333 3489999999999999999999987532
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCCCcEE
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENIL 659 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~g--IVHRDLKPeNIL 659 (840)
. .....++||||+++++|.+++.. ...+++..++.|+.||+.||.|||++| |+||||||+|||
T Consensus 99 ~----------~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil 163 (290)
T 1t4h_A 99 K----------GKKCIVLVTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF 163 (290)
T ss_dssp S----------SCEEEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEE
T ss_pred C----------CCceEEEEEEecCCCCHHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEE
Confidence 1 12357999999999999999986 256899999999999999999999999 999999999999
Q ss_pred Ee-cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 660 ID-LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 660 Ld-~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
++ .+ +.+||+|||++....... .....||+.|+|||++.+ .++.++|||||||++
T Consensus 164 ~~~~~-------~~~kl~Dfg~~~~~~~~~------------~~~~~~t~~y~aPE~~~~-----~~~~~~Di~slG~~l 219 (290)
T 1t4h_A 164 ITGPT-------GSVKIGDLGLATLKRASF------------AKAVIGTPEFMAPEMYEE-----KYDESVDVYAFGMCM 219 (290)
T ss_dssp ESSTT-------SCEEECCTTGGGGCCTTS------------BEESCSSCCCCCGGGGGT-----CCCTHHHHHHHHHHH
T ss_pred EECCC-------CCEEEeeCCCcccccccc------------cccccCCcCcCCHHHHhc-----cCCCcchHHHHHHHH
Confidence 97 34 469999999996543321 123468999999999863 478999999999999
Q ss_pred HHHHhCCCCCCCCC-HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 739 LELLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 739 ~ELLTG~~PF~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
|+|++|..||.... .......+..+..+... ....++.+.+||.+||..||.+
T Consensus 220 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~l~~li~~~l~~dp~~ 273 (290)
T 1t4h_A 220 LEMATSEYPYSECQNAAQIYRRVTSGVKPASF--------------------------DKVAIPEVKEIIEGCIRQNKDE 273 (290)
T ss_dssp HHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGG--------------------------GGCCCHHHHHHHHHHSCSSGGG
T ss_pred HHHHhCCCCCCCcCcHHHHHHHHhccCCcccc--------------------------CCCCCHHHHHHHHHHccCChhh
Confidence 99999999998754 44444444443222110 1112357899999999999999
Q ss_pred CCCHHHHHHHHH
Q 003185 818 RPTAGDLYEMFV 829 (840)
Q Consensus 818 RPSa~ELLehLe 829 (840)
|||+.+|++|.+
T Consensus 274 Rps~~ell~h~~ 285 (290)
T 1t4h_A 274 RYSIKDLLNHAF 285 (290)
T ss_dssp SCCHHHHHTSGG
T ss_pred CCCHHHHhhCcc
Confidence 999999999854
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=350.03 Aligned_cols=257 Identities=24% Similarity=0.240 Sum_probs=207.4
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
.++|.+.+.||+|+||.||+|.+ .+..+|+|++..... ...+ .+.+|+.++++++||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA----FRDS----SLENEIAVLKKIKHENIVTLEDIYESTT 79 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------------HHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc----cchH----HHHHHHHHHHhCCCCCeeehhhhcccCC
Confidence 35799999999999999999997 578899999764321 1112 3489999999999999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+.
T Consensus 80 --------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~ 140 (304)
T 2jam_A 80 --------------HYYLVMQLVSGGELFDRILE-----RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYL 140 (304)
T ss_dssp --------------EEEEEECCCCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEES
T ss_pred --------------EEEEEEEcCCCccHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEe
Confidence 35999999999999999876 24689999999999999999999999999999999999994
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
..+ ..+.+||+|||++....... .....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 141 ~~~----~~~~~kl~Dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 200 (304)
T 2jam_A 141 TPE----ENSKIMITDFGLSKMEQNGI------------MSTACGTPGYVAPEVLAQ----KPYSKAVDCWSIGVITYIL 200 (304)
T ss_dssp SSS----TTCCEEBCSCSTTCCCCCBT------------THHHHSCCCBCCTTTBSS----CSCCHHHHHHHHHHHHHHH
T ss_pred cCC----CCCCEEEccCCcceecCCCc------------cccccCCCCccChHHhcc----CCCCchhhHHHHHHHHHHH
Confidence 321 22569999999987543211 122358999999999875 6789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
++|..||.......+...+..+....... .....+..+.+||.+||..||.+|||+
T Consensus 201 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~ 256 (304)
T 2jam_A 201 LCGYPPFYEETESKLFEKIKEGYYEFESP------------------------FWDDISESAKDFICHLLEKDPNERYTC 256 (304)
T ss_dssp HHSSCTTTTSCHHHHHHHHHHCCCCCCTT------------------------TTTTSCHHHHHHHHHHHCSSTTTSCCH
T ss_pred HHCCCCCCCCCHHHHHHHHHcCCCCCCcc------------------------ccccCCHHHHHHHHHHcCCChhHCcCH
Confidence 99999999988888887777654321110 011235679999999999999999999
Q ss_pred HHHHHHHHhh
Q 003185 822 GDLYEMFVAR 831 (840)
Q Consensus 822 ~ELLehLe~l 831 (840)
.++++|..-.
T Consensus 257 ~~~l~h~~~~ 266 (304)
T 2jam_A 257 EKALSHPWID 266 (304)
T ss_dssp HHHHTSHHHH
T ss_pred HHHhcCcccc
Confidence 9999986543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=353.14 Aligned_cols=266 Identities=23% Similarity=0.248 Sum_probs=200.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++.+.||+|+||.||+|.+ .+..||+|++..... .. ..+...+.+|+.++++++||||+++++++..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-SD----PVFRTRMQREARTAGRLQEPHVVPIHDFGEI 105 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG-GS----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc-cC----HHHHHHHHHHHHHHhhcCCCCeeEEEEEEee
Confidence 5789999999999999999999997 577899998643321 11 2233455899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 106 ~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl 166 (309)
T 2h34_A 106 DGQ--------------LYVDMRLINGVDLAAMLRR-----QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENIL 166 (309)
T ss_dssp TTE--------------EEEEEECCCCEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CCe--------------EEEEEEecCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEE
Confidence 553 5999999999999999986 246899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++......... ......||+.|+|||++.+ ..++.++||||||+++|
T Consensus 167 ~~~~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 226 (309)
T 2h34_A 167 VSAD-------DFAYLVDFGIASATTDEKLT---------QLGNTVGTLYYMAPERFSE----SHATYRADIYALTCVLY 226 (309)
T ss_dssp ECTT-------SCEEECSCCC-------------------------CCGGGCCGGGTCC--------CCCHHHHHHHHHH
T ss_pred EcCC-------CCEEEecCccCccccccccc---------cccccCCCcCccCHHHHcC----CCCCchHhHHHHHHHHH
Confidence 9877 45999999999765432211 1123468999999999875 56788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|++|+.||.+.....+...+..... .... .....+..+.+||.+||..||.+||
T Consensus 227 ~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~------------------------~~~~~~~~l~~li~~~l~~dP~~Rp 281 (309)
T 2h34_A 227 ECLTGSPPYQGDQLSVMGAHINQAIP-RPST------------------------VRPGIPVAFDAVIARGMAKNPEDRY 281 (309)
T ss_dssp HHHHSSCSSCSCHHHHHHHHHHSCCC-CGGG------------------------TSTTCCTHHHHHHHHHTCSSGGGSC
T ss_pred HHHHCCCCCCCchHHHHHHHhccCCC-Cccc------------------------cCCCCCHHHHHHHHHhccCCHHHHH
Confidence 99999999988766554444443321 1110 0112345789999999999999999
Q ss_pred -CHHHHHHHHHhhcCCCC
Q 003185 820 -TAGDLYEMFVARTSSSI 836 (840)
Q Consensus 820 -Sa~ELLehLe~l~~~~~ 836 (840)
+++++++.|+.......
T Consensus 282 ~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 282 VTCGDLSAAAHAALATAD 299 (309)
T ss_dssp SSHHHHHHHHHHTCC---
T ss_pred HhHHHHHHHHHHHHHhhc
Confidence 99999999998876543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=347.40 Aligned_cols=265 Identities=22% Similarity=0.315 Sum_probs=201.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC---Ce--eEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeE
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG---SA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 576 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~---~~--~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~ 576 (840)
...++|++.+.||+|+||.||+|.+. +. .+|+|+....... ..... +.+.+|+.++++++||||++++++
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~ 89 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAM----DDFIREVNAMHSLDHRNLIRLYGV 89 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHH----HHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC-CHHHH----HHHHHHHHHHHhCCCCCcccEEEE
Confidence 34568999999999999999999862 22 4788875432211 11222 345899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
+.... .++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 90 ~~~~~---------------~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~ 150 (291)
T 1u46_A 90 VLTPP---------------MKMVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAAR 150 (291)
T ss_dssp ECSSS---------------CEEEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EccCC---------------ceeeEecccCCCHHHHHHhc----cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchh
Confidence 87543 38999999999999999862 245899999999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
|||++.+ +.+||+|||++........... ......+|+.|+|||++.+ ..++.++||||||+
T Consensus 151 Nili~~~-------~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~ 212 (291)
T 1u46_A 151 NLLLATR-------DLVKIGDFGLMRALPQNDDHYV-------MQEHRKVPFAWCAPESLKT----RTFSHASDTWMFGV 212 (291)
T ss_dssp GEEEEET-------TEEEECCCTTCEECCC-CCEEE-------C-----CCGGGCCHHHHHH----CEEEHHHHHHHHHH
T ss_pred eEEEcCC-------CCEEEccccccccccccccchh-------hhccCCCCceeeCchhhcC----CCCCchhhHHHHHH
Confidence 9999877 4699999999987644321100 1123357889999999986 56789999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003185 737 LLLELLT-LQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 814 (840)
Q Consensus 737 IL~ELLT-G~~PF~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~D 814 (840)
++|+|++ |+.||.+.+..++...+..... +..+ ...+..+.+||.+||..|
T Consensus 213 il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~~ 265 (291)
T 1u46_A 213 TLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP---------------------------EDCPQDIYNVMVQCWAHK 265 (291)
T ss_dssp HHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC---------------------------TTCCHHHHHHHHHHTCSS
T ss_pred HHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCC---------------------------cCcCHHHHHHHHHHccCC
Confidence 9999999 9999999888887777765422 1111 123567999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCCC
Q 003185 815 PTERPTAGDLYEMFVARTSSS 835 (840)
Q Consensus 815 P~eRPSa~ELLehLe~l~~~~ 835 (840)
|.+|||+.+|+++|+.+....
T Consensus 266 p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 266 PEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp GGGSCCHHHHHHHHHHHC---
T ss_pred cccCcCHHHHHHHHHHhCccc
Confidence 999999999999999887644
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=351.52 Aligned_cols=297 Identities=19% Similarity=0.210 Sum_probs=209.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
...++|++.+.||+|+||.||+|.+. +..||+|++... ...... ..+.+|+.++++++||||+++++++..
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~ 80 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFA----LRTLREIKILKHFKHENIITIFNIQRP 80 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---SSHHHH----HHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc---ccchHH----HHHHHHHHHHHhCcCCCcCCeeeeecc
Confidence 34578999999999999999999984 788999986421 122222 344899999999999999999998765
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.... .....++||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 81 ~~~~---------~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil 144 (353)
T 2b9h_A 81 DSFE---------NFNEVYIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLL 144 (353)
T ss_dssp SCST---------TCCCEEEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred cccC---------ccceEEEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence 4311 2235799999997 599999976 46899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++........................||+.|+|||++.. ...++.++|||||||++|
T Consensus 145 ~~~~-------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~Di~slG~il~ 214 (353)
T 2b9h_A 145 INSN-------CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT---SAKYSRAMDVWSCGCILA 214 (353)
T ss_dssp ECTT-------CCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHS---CCCCCHHHHHHHHHHHHH
T ss_pred EcCC-------CcEEEEecccccccccccccccCccccccchhhccccccccCCeeecc---CCCccchhhHHHHHHHHH
Confidence 9877 459999999998765432211100000111223578999999999864 356899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcC-CCCCcchHHhhhccCccccccccCCC---CCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSG---FEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~---~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
+|++|..||.+.+..+....+... ..+.....+................. ..........+..+.+||.+||..||
T Consensus 215 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 294 (353)
T 2b9h_A 215 ELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP 294 (353)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSG
T ss_pred HHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCc
Confidence 999999999988876655554432 11111110000000000000000000 00011123456789999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 003185 816 TERPTAGDLYEMFVAR 831 (840)
Q Consensus 816 ~eRPSa~ELLehLe~l 831 (840)
.+|||+.++++|..-.
T Consensus 295 ~~Rpt~~ell~hp~~~ 310 (353)
T 2b9h_A 295 AKRITAKEALEHPYLQ 310 (353)
T ss_dssp GGSCCHHHHHTSGGGT
T ss_pred ccCCCHHHHhcCcccc
Confidence 9999999999986543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=381.77 Aligned_cols=260 Identities=25% Similarity=0.343 Sum_probs=214.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
+..++|++.+.||+|+||.||+|.+.+ ..||||++.... .. .+. +.+|+.+|++|+|||||++++++..
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~---~~~----~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MS---PEA----FLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SC---HHH----HHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CC---HHH----HHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 455789999999999999999999854 679999865322 11 223 4899999999999999999999864
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .||||||+.+|+|.+++... ....+++..++.|+.||+.||.|||++|||||||||+||||
T Consensus 334 ~~--------------~~lv~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll 396 (535)
T 2h8h_A 334 EP--------------IYIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 396 (535)
T ss_dssp SS--------------CEEEECCCTTEEHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cc--------------ceEeeehhcCCcHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE
Confidence 22 39999999999999999752 12458999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||+++.+....... .....++..|+|||++.. ..++.++|||||||+|||
T Consensus 397 ~~~-------~~~kl~DFG~a~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~----~~~~~~sDvwSlGv~l~e 456 (535)
T 2h8h_A 397 GEN-------LVCKVADFGLARLIEDNEYTA---------RQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTE 456 (535)
T ss_dssp CGG-------GCEEECCTTSTTTCCCHHHHT---------TCSTTSCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHH
T ss_pred cCC-------CcEEEcccccceecCCCceec---------ccCCcCcccccCHHHhcc----CCCCchhhHHHHHHHHHH
Confidence 877 469999999998764322110 122347889999999986 678999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|++ |+.||.+....++...+..+.+...+. .++..+.+||.+||..||.+||
T Consensus 457 l~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~RP 509 (535)
T 2h8h_A 457 LTTKGRVPYPGMVNREVLDQVERGYRMPCPP---------------------------ECPESLHDLMCQCWRKEPEERP 509 (535)
T ss_dssp HTTTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCChhHCc
Confidence 999 999999999888888887765433331 1345789999999999999999
Q ss_pred CHHHHHHHHHhhcCCC
Q 003185 820 TAGDLYEMFVARTSSS 835 (840)
Q Consensus 820 Sa~ELLehLe~l~~~~ 835 (840)
|+.+|++.|+.+....
T Consensus 510 t~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 510 TFEYLQAFLEDYFTST 525 (535)
T ss_dssp CHHHHHHHHHTSSCCC
T ss_pred CHHHHHHHHHHHhhcc
Confidence 9999999999987543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=365.34 Aligned_cols=282 Identities=20% Similarity=0.234 Sum_probs=195.0
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||.||+|.+ .+..||+|++.. ........+ ++.+|+.+|+.++||||+++++++.....
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~--~~~~~~~~~----~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--PFQSIIHAK----RTYRELRLLKHMKHENVIGLLDVFTPARS 102 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSS--TTSSHHHHH----HHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCc--cccCHHHHH----HHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence 6899999999999999999987 577899998532 222223333 44899999999999999999999875422
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
. ......|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 103 ~--------~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~ 167 (367)
T 2fst_X 103 L--------EEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 167 (367)
T ss_dssp G--------GGCCCCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred c--------ccCCeEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECC
Confidence 1 1123469999999 5799999864 46999999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||+++..... ....+||+.|+|||++.+ ...++.++|||||||++|||+
T Consensus 168 ~-------~~~kL~DFG~a~~~~~~-------------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell 224 (367)
T 2fst_X 168 D-------CELKILDFGLARHTADE-------------MTGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAELL 224 (367)
T ss_dssp T-------CCEEECC----------------------------CCCTTCCHHHHTT---CCSCCTTHHHHHHHHHHHHHH
T ss_pred C-------CCEEEeecccccccccc-------------CCCcCcCcCccChHHHcC---CcCCCchhhHHHHHHHHHHHH
Confidence 7 46999999999765431 123469999999999875 346789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCC---CCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS---GFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|+.||.+.+..+....+.........+.+..........+.+... ...........++.+.+||.+||..||.+||
T Consensus 225 ~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~ 304 (367)
T 2fst_X 225 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 304 (367)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCc
Confidence 9999999998877777766542222222222111000000000000 1111122233467899999999999999999
Q ss_pred CHHHHHHHHHh
Q 003185 820 TAGDLYEMFVA 830 (840)
Q Consensus 820 Sa~ELLehLe~ 830 (840)
|+.++++|..-
T Consensus 305 t~~e~L~hp~~ 315 (367)
T 2fst_X 305 TAAQALAHAYF 315 (367)
T ss_dssp CHHHHHTSGGG
T ss_pred CHHHHhcChhh
Confidence 99999998543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=343.01 Aligned_cols=264 Identities=22% Similarity=0.277 Sum_probs=203.1
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
..+|++.+.||+|+||.||+|.+. +..+|+|+..... +.+ .+|+.++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~ 77 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKA----EREVKALAKLDHVNIVHYNGCWDGFD 77 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGG----HHHHHHHHHCCCTTBCCEEEEEEEEE
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHH----HHHHHHHHhCCCCCEEEEeeeEeccc
Confidence 367999999999999999999984 7899999875431 123 78999999999999999999886422
Q ss_pred CCCCCC--CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 582 WLPSAD--GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 582 ~~p~~~--g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
..+... ..........++||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil 154 (284)
T 2a19_B 78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR---RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIF 154 (284)
T ss_dssp EC---------CCEEEEEEEEECCCCSCBHHHHHHHG---GGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred cCcccccccccccCcceEEEEEeccCCCCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEE
Confidence 110000 00001233579999999999999999862 2246899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 155 ~~~~-------~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 212 (284)
T 2a19_B 155 LVDT-------KQVKIGDFGLVTSLKNDGK-----------RTRSKGTLRYMSPEQISS----QDYGKEVDLYALGLILA 212 (284)
T ss_dssp EEET-------TEEEECCCTTCEESSCCSC-----------CCCCCSCCTTSCHHHHHC----SCCCTHHHHHHHHHHHH
T ss_pred EcCC-------CCEEECcchhheecccccc-----------ccccCCcccccChhhhcc----CCCcchhhhHHHHHHHH
Confidence 9877 4699999999986643211 123468999999999986 56789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|++|..||... ......+.....+ ...+..+.+||.+||..||.+||
T Consensus 213 ~l~~~~~~~~~~--~~~~~~~~~~~~~------------------------------~~~~~~~~~li~~~l~~dp~~Rp 260 (284)
T 2a19_B 213 ELLHVCDTAFET--SKFFTDLRDGIIS------------------------------DIFDKKEKTLLQKLLSKKPEDRP 260 (284)
T ss_dssp HHHSCCSSHHHH--HHHHHHHHTTCCC------------------------------TTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHhcCCcchhH--HHHHHHhhccccc------------------------------ccCCHHHHHHHHHHccCChhhCc
Confidence 999999887421 2222223222111 01244689999999999999999
Q ss_pred CHHHHHHHHHhhcCCCC
Q 003185 820 TAGDLYEMFVARTSSSI 836 (840)
Q Consensus 820 Sa~ELLehLe~l~~~~~ 836 (840)
|+.+++++|+.+.....
T Consensus 261 s~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 261 NTSEILRTLTVWKKSPE 277 (284)
T ss_dssp CHHHHHHHHHHHTC---
T ss_pred CHHHHHHHHHHHhhCCC
Confidence 99999999999876543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=370.07 Aligned_cols=266 Identities=24% Similarity=0.261 Sum_probs=210.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
...++|++.+.||+|+||.||+|+. .+..||+|+..... .........+.+|..++..++||||+++++++.+
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~-----~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD-----MLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-----HHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH-----hhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3467899999999999999999998 57899999975321 1111122345899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... +||||||++||+|.+++.+. ...+++..++.++.||+.||.|||++|||||||||+|||
T Consensus 133 ~~~--------------~~lVmE~~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NIL 194 (412)
T 2vd5_A 133 ENY--------------LYLVMEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNIL 194 (412)
T ss_dssp SSE--------------EEEEECCCCSCBHHHHHHHH----SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CCE--------------EEEEEcCCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHee
Confidence 653 59999999999999999862 246999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc---CCCCCCchhhHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH---KPNLYGLEVDIWSYGC 736 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~---~~~~~s~kSDVWSLGv 736 (840)
|+.+ +.+||+|||+++........ .....+||+.|+|||++.... ....++.++|||||||
T Consensus 195 ld~~-------g~vkL~DFGla~~~~~~~~~---------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGv 258 (412)
T 2vd5_A 195 LDRC-------GHIRLADFGSCLKLRADGTV---------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGV 258 (412)
T ss_dssp ECTT-------SCEEECCCTTCEECCTTSCE---------ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHH
T ss_pred ecCC-------CCEEEeechhheeccCCCcc---------ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhH
Confidence 9877 46999999999876432211 112357999999999997321 1245789999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 737 LLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 737 IL~ELLTG~~PF~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
++|||++|+.||.+.+..++...|.... ...++. .....+..+.+||.+||. +|
T Consensus 259 ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~------------------------~~~~~s~~~~dli~~lL~-~p 313 (412)
T 2vd5_A 259 FAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL------------------------VDEGVPEEARDFIQRLLC-PP 313 (412)
T ss_dssp HHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----------------------------CCCHHHHHHHHTTSS-CG
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc------------------------cccCCCHHHHHHHHHHcC-Ch
Confidence 9999999999999998888877776421 111110 011235689999999999 99
Q ss_pred CCC---CCHHHHHHHHHhh
Q 003185 816 TER---PTAGDLYEMFVAR 831 (840)
Q Consensus 816 ~eR---PSa~ELLehLe~l 831 (840)
.+| |++++|++|..-.
T Consensus 314 ~~Rlgr~~~~ei~~Hpff~ 332 (412)
T 2vd5_A 314 ETRLGRGGAGDFRTHPFFF 332 (412)
T ss_dssp GGCTTTTTHHHHHTSGGGT
T ss_pred hhcCCCCCHHHHhcCCCcC
Confidence 998 5999999996543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=363.45 Aligned_cols=261 Identities=22% Similarity=0.270 Sum_probs=202.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 575 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g 575 (840)
..+++|++.+.||+|+||.||+|+. .+..||+|++............+. +.+|+.+|+.+ +||||+++++
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~----~~~E~~~l~~l~~h~~iv~~~~ 126 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH----TRTERQVLEHIRQSPFLVTLHY 126 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGG----CCCHHHHHHHHHTCTTBCCEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHH----HHHHHHHHHHccCCCceeEEEE
Confidence 5678999999999999999999997 678999999753321111111222 37899999999 6999999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCC
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 655 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKP 655 (840)
++..... .+|||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||
T Consensus 127 ~~~~~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp 187 (355)
T 1vzo_A 127 AFQTETK--------------LHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKL 187 (355)
T ss_dssp EEEETTE--------------EEEEECCCCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred EEeeCce--------------EEEEeecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 9986553 5999999999999999986 24689999999999999999999999999999999
Q ss_pred CcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003185 656 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735 (840)
Q Consensus 656 eNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLG 735 (840)
+||||+.+ +.+||+|||+++.+....... .....||+.|+|||++.+. ...++.++||||||
T Consensus 188 ~NIll~~~-------~~~kl~DfG~a~~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~--~~~~~~~~DvwslG 249 (355)
T 1vzo_A 188 ENILLDSN-------GHVVLTDFGLSKEFVADETER---------AYDFCGTIEYMAPDIVRGG--DSGHDKAVDWWSLG 249 (355)
T ss_dssp GGEEECTT-------SCEEESCSSEEEECCGGGGGG---------GCGGGSCCTTCCHHHHTTC--C---CTHHHHHHHH
T ss_pred HHEEECCC-------CcEEEeeCCCCeecccCCCCc---------ccCcccCcCccChhhhcCC--CCCCCchhhHHHHH
Confidence 99999877 469999999998654322111 1234699999999999751 23578899999999
Q ss_pred HHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 003185 736 CLLLELLTLQVPYMGLS----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 811 (840)
Q Consensus 736 vIL~ELLTG~~PF~~~~----~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL 811 (840)
|+||||++|+.||.... ...+...+.... +.++ ...+..+.+||.+||
T Consensus 250 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~~li~~~L 301 (355)
T 1vzo_A 250 VLMYELLTGASPFTVDGEKNSQAEISRRILKSE-PPYP---------------------------QEMSALAKDLIQRLL 301 (355)
T ss_dssp HHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC-CCCC---------------------------TTSCHHHHHHHHHHT
T ss_pred HHHHHHHHCCCCCccCCccchHHHHHHHHhccC-CCCC---------------------------cccCHHHHHHHHHHh
Confidence 99999999999996432 333333333221 1111 112457899999999
Q ss_pred ccCCCCCC-----CHHHHHHHHHhh
Q 003185 812 EENPTERP-----TAGDLYEMFVAR 831 (840)
Q Consensus 812 ~~DP~eRP-----Sa~ELLehLe~l 831 (840)
..||.+|| +++++++|+.-.
T Consensus 302 ~~dP~~R~~~~~~s~~ell~h~~f~ 326 (355)
T 1vzo_A 302 MKDPKKRLGCGPRDADEIKEHLFFQ 326 (355)
T ss_dssp CSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred hhCHHHhcCCCCCCHHHHHcCcchh
Confidence 99999999 999999987543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=357.19 Aligned_cols=270 Identities=21% Similarity=0.303 Sum_probs=209.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+.+++|++.+.||+|+||.||+|.+.+ .+|+|++..... .....+.+ .+|+.++++++||||+++++++....
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~--~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERD--NEDQLKAF----KREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSC--CCCCCCCC----CTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCC--CHHHHHHH----HHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 678999999999999999999999876 588988654322 22222333 78999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 103 ~--------------~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~ 164 (319)
T 2y4i_B 103 H--------------LAIITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD 164 (319)
T ss_dssp C--------------EEEECBCCCSEEHHHHTTS----SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC
T ss_pred c--------------eEEEeecccCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe
Confidence 3 4999999999999999864 234689999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-----CCCCCCchhhHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-----KPNLYGLEVDIWSYGC 736 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-----~~~~~s~kSDVWSLGv 736 (840)
+ +.+||+|||++......... ..........||+.|+|||++.+.. ....++.++|||||||
T Consensus 165 -~-------~~~~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~ 231 (319)
T 2y4i_B 165 -N-------GKVVITDFGLFSISGVLQAG-----RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231 (319)
T ss_dssp ----------CCEECCCSCCC---------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHH
T ss_pred -C-------CCEEEeecCCcccccccccc-----ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHH
Confidence 3 35999999998765322111 0111123345899999999997532 1245789999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 737 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 737 IL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
++|||++|..||.......+...+..+..+.+.. ...+..+.+||.+||..||.
T Consensus 232 il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~~p~ 285 (319)
T 2y4i_B 232 IWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQ--------------------------IGMGKEISDILLFCWAFEQE 285 (319)
T ss_dssp HHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCC--------------------------SSCCTTHHHHHHHHHCSSTT
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCc--------------------------CCCCHHHHHHHHHHhcCChh
Confidence 9999999999999988888887777665443321 01233689999999999999
Q ss_pred CCCCHHHHHHHHHhhcCCC
Q 003185 817 ERPTAGDLYEMFVARTSSS 835 (840)
Q Consensus 817 eRPSa~ELLehLe~l~~~~ 835 (840)
+|||+.+|++.|+.+....
T Consensus 286 ~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 286 ERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp TSCCHHHHHHHHTTC----
T ss_pred hCcCHHHHHHHHHHHHHhh
Confidence 9999999999999987653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=351.07 Aligned_cols=269 Identities=27% Similarity=0.366 Sum_probs=208.1
Q ss_pred CCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHh--CCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGA--LRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~--L~HpNIV~l~g~~~~~~~ 582 (840)
++|.+.+.||+|+||.||+|.+.+..||+|++... ... .+.+|+.++.. ++||||+++++++.....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-------~~~----~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-------EER----SWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-------GHH----HHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-------hHH----HHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 68999999999999999999999999999997422 122 23788888887 789999999999886541
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCeecccCC
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH--------SKHIMHRDIK 654 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLH--------s~gIVHRDLK 654 (840)
.....++||||+++|+|.+++.. ..+++..++.++.||+.||.||| ++||+|||||
T Consensus 111 ----------~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlk 174 (342)
T 1b6c_B 111 ----------TWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174 (342)
T ss_dssp ----------SCCCEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCS
T ss_pred ----------ccceeEEEEeecCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCC
Confidence 11246999999999999999976 46899999999999999999999 8999999999
Q ss_pred CCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCC--CCCchhhHH
Q 003185 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN--LYGLEVDIW 732 (840)
Q Consensus 655 PeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~--~~s~kSDVW 732 (840)
|+||||+.+ +.+||+|||++............ ......||+.|+|||++.+..... .++.++|||
T Consensus 175 p~NIll~~~-------~~~kL~Dfg~~~~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~ 241 (342)
T 1b6c_B 175 SKNILVKKN-------GTCCIADLGLAVRHDSATDTIDI------APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY 241 (342)
T ss_dssp GGGEEECTT-------SCEEECCCTTCEEEETTTTEEEE------CCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHH
T ss_pred HHHEEECCC-------CCEEEEECCCceecccccccccc------ccccCCcCcccCCHhhhcccccccccccCCcccHH
Confidence 999999877 46999999999876543221100 123346999999999997621111 233789999
Q ss_pred HHHHHHHHHHhC----------CCCCCCCC-----HHHHHHHHHcC-CCCCcchHHhhhccCccccccccCCCCCCchhh
Q 003185 733 SYGCLLLELLTL----------QVPYMGLS-----ELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 796 (840)
Q Consensus 733 SLGvIL~ELLTG----------~~PF~~~~-----~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 796 (840)
||||+||||+|| ..||.... ...+...+... .++.++..+ ..
T Consensus 242 slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~ 299 (342)
T 1b6c_B 242 AMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW----------------------QS 299 (342)
T ss_dssp HHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG----------------------GT
T ss_pred HHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccc----------------------cc
Confidence 999999999999 78886542 23333333322 333333211 11
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 003185 797 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 835 (840)
Q Consensus 797 ~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~~~ 835 (840)
...+..+.+||.+||+.||.+|||+.+|+++|+.+....
T Consensus 300 ~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 300 CEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp SHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 245678999999999999999999999999999987653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=359.84 Aligned_cols=285 Identities=13% Similarity=0.085 Sum_probs=203.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHHh----HHhHHHHHHHHHhCCCCCcce
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNF----EYSCLGEVRMLGALRHSCIVE 572 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~f----~~~~~rEi~iL~~L~HpNIV~ 572 (840)
..-++|.+.+.||+|+||.||+|.+ .+..+|+|+....... ...+.+.+ ...+.+|+.+++.++||||++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP-LFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CH-HHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcc-hHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 3446899999999999999999998 4578999987543210 01111111 124578999999999999999
Q ss_pred eeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Q 003185 573 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRD 652 (840)
Q Consensus 573 l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRD 652 (840)
+++++..... .....||||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+|||
T Consensus 113 ~~~~~~~~~~----------~~~~~~lv~e~~-~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~D 176 (345)
T 2v62_A 113 FYGSGLTEFK----------GRSYRFMVMERL-GIDLQKISGQ-----NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGD 176 (345)
T ss_dssp EEEEEEEESS----------SCEEEEEEEECE-EEEHHHHCBG-----GGBCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred eecccccccC----------CCcEEEEEEecc-CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence 9999886321 123569999999 8999999865 23799999999999999999999999999999
Q ss_pred CCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHH
Q 003185 653 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 732 (840)
Q Consensus 653 LKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVW 732 (840)
|||+|||++.++. ..+||+|||+++.+........ ..........||+.|+|||++.+ ..++.++|||
T Consensus 177 lkp~NIll~~~~~-----~~~kL~Dfg~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~ 244 (345)
T 2v62_A 177 IKAANLLLGYKNP-----DQVYLADYGLSYRYCPNGNHKQ---YQENPRKGHNGTIEFTSLDAHKG----VALSRRSDVE 244 (345)
T ss_dssp CSGGGEEEESSST-----TSEEECCCTTCEESSGGGCCCC---CCCCGGGCSCSCTTTCCHHHHHT----CCCCHHHHHH
T ss_pred cCHHHEEEccCCC-----CcEEEEeCCCceeccccccccc---chhccccccCCCccccCHHHhcC----CCCCchhhHH
Confidence 9999999987732 3799999999987654321100 00111134579999999999986 5789999999
Q ss_pred HHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 003185 733 SYGCLLLELLTLQVPYMGL--SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 810 (840)
Q Consensus 733 SLGvIL~ELLTG~~PF~~~--~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rC 810 (840)
||||+||||++|+.||.+. ...... .......+.++..+..... ....+..+.+||.+|
T Consensus 245 slG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~------------------~~~~~~~l~~li~~~ 305 (345)
T 2v62_A 245 ILGYCMLRWLCGKLPWEQNLKDPVAVQ-TAKTNLLDELPQSVLKWAP------------------SGSSCCEIAQFLVCA 305 (345)
T ss_dssp HHHHHHHHHHHSSCTTGGGTTCHHHHH-HHHHHHHHTTTHHHHHHSC------------------TTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCccccccccHHHH-HHHHhhcccccHHHHhhcc------------------ccccHHHHHHHHHHH
Confidence 9999999999999999652 222222 2222211222222211100 012356899999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhcCC
Q 003185 811 TEENPTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 811 L~~DP~eRPSa~ELLehLe~l~~~ 834 (840)
|..||.+|||+.+|++.|+.+...
T Consensus 306 l~~dp~~Rps~~~l~~~L~~~~~~ 329 (345)
T 2v62_A 306 HSLAYDEKPNYQALKKILNPHGIP 329 (345)
T ss_dssp HTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred hhcCcccCCCHHHHHHHHhccCCc
Confidence 999999999999999999987643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=357.32 Aligned_cols=277 Identities=23% Similarity=0.295 Sum_probs=206.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
...++|++.+.||+|+||.||+|.+. +..+|+|+..... ..... ..+.+|+.++++++||||+++++++..
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIR----NQIIRELQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC---CHHHH----HHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc---CHHHH----HHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence 45678999999999999999999984 7889999976432 22222 345899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCCCcE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENI 658 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~-gIVHRDLKPeNI 658 (840)
... .+|||||+++++|.+++.. ...+++..+..++.||+.||.|||++ ||+||||||+||
T Consensus 103 ~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Ni 163 (360)
T 3eqc_A 103 DGE--------------ISICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 163 (360)
T ss_dssp TTE--------------EEEEECCCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGE
T ss_pred CCE--------------EEEEEECCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHE
Confidence 553 5999999999999999986 24689999999999999999999996 999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.+ +.+||+|||++....... .....||+.|+|||++.+ ..++.++|||||||++
T Consensus 164 l~~~~-------~~~kl~Dfg~~~~~~~~~------------~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il 220 (360)
T 3eqc_A 164 LVNSR-------GEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYSVQSDIWSMGLSL 220 (360)
T ss_dssp EECTT-------CCEEECCCCCCHHHHHHC----------------CCCCTTCCHHHHTT----CCCSHHHHHHHHHHHH
T ss_pred EECCC-------CCEEEEECCCCccccccc------------ccCCCCCCCeECHHHHcC----CCCCchhhHHHHHHHH
Confidence 99877 459999999997654321 123469999999999986 6789999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcc-------------------ccccccCCCCCCchhhhhh
Q 003185 739 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE-------------------HEVAQSGSGFEKPEAELET 799 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~ 799 (840)
|+|++|+.||...+..++...+.................... ........ ........
T Consensus 221 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 297 (360)
T 3eqc_A 221 VEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP---PKLPSGVF 297 (360)
T ss_dssp HHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCC---CCCCTTTS
T ss_pred HHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCC---CCCCcccc
Confidence 999999999988876665443321110000000000000000 00000000 00011224
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003185 800 LSFLVDVFRRCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 800 s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~ 830 (840)
+..+.+||.+||..||.+|||+.++++|.+-
T Consensus 298 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 328 (360)
T 3eqc_A 298 SLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328 (360)
T ss_dssp CHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred cHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 5689999999999999999999999998653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=345.72 Aligned_cols=270 Identities=17% Similarity=0.157 Sum_probs=200.9
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.-++|++.+.||+|+||.||+|.+ .+..||+|+....... . .+.+|+.+++.++|++++..++.+...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~----~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------P----QLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C------C----CHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc------h----HHHHHHHHHHHhcCCCCCCeeeeecCC
Confidence 346899999999999999999996 6789999986543211 1 238899999999999888888776543
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. ..++||||+ +++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 77 ~~-------------~~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~ 138 (296)
T 4hgt_A 77 GD-------------YNVMVMELL-GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLM 138 (296)
T ss_dssp TT-------------EEEEEEECC-CCBHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CC-------------ceEEEEEcc-CCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeee
Confidence 32 459999999 8899999975 23569999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+. ..+.+||+|||+++.......... ..........||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 139 ~~~~----~~~~~kL~Dfg~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 207 (296)
T 4hgt_A 139 GLGK----KGNLVYIIDFGLAKKYRDARTHQH---IPYRENKNLTGTARYASINTHLG----IEQSRRDDLESLGYVLMY 207 (296)
T ss_dssp CCGG----GTTCEEECCCTTCEECBCTTTCCB---CCCCCSCCCCSCGGGCCHHHHTT----CCCCHHHHHHHHHHHHHH
T ss_pred eccC----CCCeEEEecCccceeccCcccCcc---CCCCcccccCCCccccchHHhcC----CCCCchhHHHHHHHHHHH
Confidence 4221 125699999999987654322110 01112234579999999999986 668999999999999999
Q ss_pred HHhCCCCCCCCCHH---HHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 741 LLTLQVPYMGLSEL---EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 741 LLTG~~PF~~~~~~---el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
|++|+.||.+.... +....+.....+... .......++.+.+||.+||+.||.+
T Consensus 208 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~~l~~~p~~ 264 (296)
T 4hgt_A 208 FNLGSLPWQGLKAATKRQKYERISEKKMSTPI-----------------------EVLCKGYPSEFATYLNFCRSLRFDD 264 (296)
T ss_dssp HHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-----------------------HHHTTTSCHHHHHHHHHHHTSCTTC
T ss_pred HhcCCCCCcccchhhhhhhhhhhhcccccchh-----------------------hhhhccCCHHHHHHHHHHHhcCCCC
Confidence 99999999765322 222222111000000 0011123568999999999999999
Q ss_pred CCCHHHHHHHHHhhcCC
Q 003185 818 RPTAGDLYEMFVARTSS 834 (840)
Q Consensus 818 RPSa~ELLehLe~l~~~ 834 (840)
|||+.+|++.|+.+...
T Consensus 265 Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 265 KPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp CCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHH
Confidence 99999999999987653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=349.15 Aligned_cols=260 Identities=28% Similarity=0.430 Sum_probs=205.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
...++|++.+.||+|+||.||+|.+. +..+|+|++.... ....+ .+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~ 87 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELE----DYIVEIEILATCDHPYIVKLLGAYYH 87 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHH----HHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC----HHHHH----HHHHHHHHHhcCCCCCEeeeeeeeee
Confidence 45578999999999999999999984 7789999865331 11222 34899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 88 ~~~--------------~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil 149 (302)
T 2j7t_A 88 DGK--------------LWIMIEFCPGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVL 149 (302)
T ss_dssp C-C--------------EEEEEECCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEE
T ss_pred CCe--------------EEEEEEeCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEE
Confidence 553 49999999999999998752 356899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~kSDVWSLGvIL 738 (840)
++.+ +.+||+|||++......... .....||+.|+|||++.... ....++.++|||||||++
T Consensus 150 ~~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il 212 (302)
T 2j7t_A 150 MTLE-------GDIRLADFGVSAKNLKTLQK----------RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 212 (302)
T ss_dssp ECTT-------SCEEECCCHHHHHHHHHHHC---------------CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHH
T ss_pred ECCC-------CCEEEEECCCCccccccccc----------cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHH
Confidence 9877 45999999988644321111 12346899999999985211 125678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 739 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
|+|++|..||...+.......+.....+.+.. ....+..+.+||.+||..||.+|
T Consensus 213 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~dp~~R 267 (302)
T 2j7t_A 213 IEMAQIEPPHHELNPMRVLLKIAKSDPPTLLT-------------------------PSKWSVEFRDFLKIALDKNPETR 267 (302)
T ss_dssp HHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSS-------------------------GGGSCHHHHHHHHHHSCSCTTTS
T ss_pred HHHhcCCCCCccCCHHHHHHHHhccCCcccCC-------------------------ccccCHHHHHHHHHHcccChhhC
Confidence 99999999999888877776666554332210 11234578999999999999999
Q ss_pred CCHHHHHHHHH
Q 003185 819 PTAGDLYEMFV 829 (840)
Q Consensus 819 PSa~ELLehLe 829 (840)
||+.+|++|..
T Consensus 268 ps~~~ll~h~~ 278 (302)
T 2j7t_A 268 PSAAQLLEHPF 278 (302)
T ss_dssp CCHHHHTTSTT
T ss_pred CCHHHHhcChH
Confidence 99999999854
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=353.81 Aligned_cols=290 Identities=19% Similarity=0.183 Sum_probs=201.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++.+.||+|+||.||+|.+ .+..||+|++....... ....+|+..+..++||||+++++++..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~~l~~l~h~niv~~~~~~~~ 90 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---------NRELQIMQDLAVLHHPNIVQLQSYFYT 90 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---------CHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---------HHHHHHHHHHHhcCCCCcccHHHhhhc
Confidence 4678999999999999999999998 47789999874332111 122678888899999999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecccCCCCc
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH--SKHIMHRDIKSEN 657 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLH--s~gIVHRDLKPeN 657 (840)
.... .......++||||+.+ +|...+..... ....+++..++.++.||+.||.||| ++||+||||||+|
T Consensus 91 ~~~~-------~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~N 161 (360)
T 3e3p_A 91 LGER-------DRRDIYLNVVMEYVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHN 161 (360)
T ss_dssp ECSS-------CTTCEEEEEEEECCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGG
T ss_pred cccc-------cccceeEEEEeecccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHH
Confidence 4321 1122346899999985 77766654332 2457899999999999999999999 9999999999999
Q ss_pred EEEec-ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 658 ILIDL-ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 658 ILLd~-~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
|||+. + +.+||+|||+++....... .....||+.|+|||++.+ ...++.++|||||||
T Consensus 162 Ill~~~~-------~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~---~~~~~~~~Di~slG~ 220 (360)
T 3e3p_A 162 VLVNEAD-------GTLKLCDFGSAKKLSPSEP-----------NVAYICSRYYRAPELIFG---NQHYTTAVDIWSVGC 220 (360)
T ss_dssp EEEETTT-------TEEEECCCTTCBCCCTTSC-----------CCSTTSCGGGCCHHHHTT---CSSCCTHHHHHHHHH
T ss_pred EEEeCCC-------CcEEEeeCCCceecCCCCC-----------cccccCCcceeCHHHHcC---CCCCCcHHHHHHHHH
Confidence 99986 4 5799999999986643221 123468999999999865 245799999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCC----CchhhhhhHHHHHHHHHHhcc
Q 003185 737 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE----KPEAELETLSFLVDVFRRCTE 812 (840)
Q Consensus 737 IL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~----~~~~~~~~s~~L~dLI~rCL~ 812 (840)
++|+|++|+.||.+.+.......+.........+.+................... ........+..+.+||.+||+
T Consensus 221 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 300 (360)
T 3e3p_A 221 IFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQ 300 (360)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTC
T ss_pred HHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhc
Confidence 9999999999999988887777766542222222222211100000000000000 011112246789999999999
Q ss_pred cCCCCCCCHHHHHHHHHh
Q 003185 813 ENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 813 ~DP~eRPSa~ELLehLe~ 830 (840)
.||.+|||+.|+++|.+-
T Consensus 301 ~dP~~Rpt~~e~l~hp~f 318 (360)
T 3e3p_A 301 YLPEERMKPYEALCHPYF 318 (360)
T ss_dssp SSGGGSCCHHHHTTSGGG
T ss_pred cCccccCCHHHHhcCccc
Confidence 999999999999999544
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=349.68 Aligned_cols=248 Identities=25% Similarity=0.256 Sum_probs=192.1
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEecCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 581 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~~~~ 581 (840)
++|++.++||+|+||+||+|.+ .+..||||+.... ......... ...|+..+.++ +||||+++++++....
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~----~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP--FRGPKDRAR----KLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSS--CCSHHHHHH----HHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccc--ccChHHHHH----HHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 6799999999999999999998 4788999985432 222222222 25666666555 8999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .+|||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 131 ~--------------~~lv~e~~-~~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~ 191 (311)
T 3p1a_A 131 I--------------LYLQTELC-GPSLQQHCEAW----GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG 191 (311)
T ss_dssp E--------------EEEEEECC-CCBHHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred E--------------EEEEEecc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC
Confidence 3 59999999 57999998762 35699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|||
T Consensus 192 ~~-------~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~el 248 (311)
T 3p1a_A 192 PR-------GRCKLGDFGLLVELGTAGA-----------GEVQEGDPRYMAPELLQG-----SYGTAADVFSLGLTILEV 248 (311)
T ss_dssp GG-------GCEEECCCTTCEECC-----------------CCCCCGGGCCGGGGGT-----CCSTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEccceeeeecccCCC-----------CcccCCCccccCHhHhcC-----CCCchhhHHHHHHHHHHH
Confidence 77 4599999999876543221 123469999999999874 578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
++|..||.+... ...+..... +. ......++.+.+||.+||+.||.+|||+
T Consensus 249 ~~g~~~~~~~~~---~~~~~~~~~---~~-----------------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 299 (311)
T 3p1a_A 249 ACNMELPHGGEG---WQQLRQGYL---PP-----------------------EFTAGLSSELRSVLVMMLEPDPKLRATA 299 (311)
T ss_dssp HHTCCCCSSHHH---HHHHTTTCC---CH-----------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HhCCCCCCCccH---HHHHhccCC---Cc-----------------------ccccCCCHHHHHHHHHHcCCChhhCcCH
Confidence 999777654322 223322211 11 1112235689999999999999999999
Q ss_pred HHHHHHHH
Q 003185 822 GDLYEMFV 829 (840)
Q Consensus 822 ~ELLehLe 829 (840)
.++++|.+
T Consensus 300 ~ell~hp~ 307 (311)
T 3p1a_A 300 EALLALPV 307 (311)
T ss_dssp HHHHTSGG
T ss_pred HHHHhCcc
Confidence 99999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=347.84 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=203.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
...++|++.+.||+|+||.||+|.+. +..||+|++.... ..+ .+.+|+.++++++||||+++++++..
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQ----EIIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS------CCH----HHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH------HHH----HHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 45678999999999999999999984 7889999875431 112 34889999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.. ..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+|||
T Consensus 96 ~~--------------~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil 157 (314)
T 3com_A 96 NT--------------DLWIVMEYCGAGSVSDIIRL----RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNIL 157 (314)
T ss_dssp TT--------------EEEEEEECCTTEEHHHHHHH----HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CC--------------EEEEEeecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEE
Confidence 55 35999999999999999974 1356899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++......... .....||+.|+|||++.+ ..++.++||||||+++|
T Consensus 158 ~~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 216 (314)
T 3com_A 158 LNTE-------GHAKLADFGVAGQLTDTMAK----------RNTVIGTPFWMAPEVIQE----IGYNCVADIWSLGITAI 216 (314)
T ss_dssp ECTT-------CCEEECCCTTCEECBTTBSC----------BCCCCSCGGGCCHHHHSS----SCBCTTHHHHHHHHHHH
T ss_pred ECCC-------CCEEEeecccchhhhhhccc----------cCccCCCCCccChhhcCC----CCCCccccHHHHHHHHH
Confidence 9877 45999999999766432211 123468999999999976 56889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|++|..||...........+.....+.+.. ....+..+.+||.+||..||.+||
T Consensus 217 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~dp~~Rp 271 (314)
T 3com_A 217 EMAEGKPPYADIHPMRAIFMIPTNPPPTFRK-------------------------PELWSDNFTDFVKQCLVKSPEQRA 271 (314)
T ss_dssp HHHHSSCTTTTSCHHHHHHHHHHSCCCCCSS-------------------------GGGSCHHHHHHHHHHTCSCTTTSC
T ss_pred HHHhCCCCCCCCChHHHHHHHhcCCCcccCC-------------------------cccCCHHHHHHHHHHccCChhhCc
Confidence 9999999998887776665555443322210 112345799999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 003185 820 TAGDLYEMFVART 832 (840)
Q Consensus 820 Sa~ELLehLe~l~ 832 (840)
|+.++++|..-..
T Consensus 272 t~~~ll~~~~~~~ 284 (314)
T 3com_A 272 TATQLLQHPFVRS 284 (314)
T ss_dssp CHHHHTTSHHHHT
T ss_pred CHHHHHhCHHHhc
Confidence 9999999865443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=364.11 Aligned_cols=283 Identities=22% Similarity=0.241 Sum_probs=205.1
Q ss_pred CCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
..+|.+.+.||+|+||.||+|++ ....+|+|.+..... .. .+|+.+|+.++||||+++++++.....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~--------~~----~~E~~il~~l~h~niv~l~~~~~~~~~ 106 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR--------FK----NRELQIMRIVKHPNVVDLKAFFYSNGD 106 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT--------SC----CHHHHHHHTCCCTTBCCEEEEEEEESS
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc--------hH----HHHHHHHHhCCCCCcceEEEEEEecCC
Confidence 45799999999999999999998 445577776542211 11 479999999999999999999975432
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe-
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID- 661 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd- 661 (840)
. ......++||||+++ +|...+..... ....+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus 107 ~--------~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~ 176 (394)
T 4e7w_A 107 K--------KDEVFLNLVLEYVPE-TVYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP 176 (394)
T ss_dssp S--------SSCEEEEEEEECCSE-EHHHHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET
T ss_pred C--------CCceEEEEEeeccCc-cHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcC
Confidence 1 122346899999986 66555543222 235799999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||+++....... .....||+.|+|||++.+ ...++.++|||||||+||||
T Consensus 177 ~~-------~~~kL~DFG~a~~~~~~~~-----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlG~il~el 235 (394)
T 4e7w_A 177 PS-------GVLKLIDFGSAKILIAGEP-----------NVSYICSRYYRAPELIFG---ATNYTTNIDIWSTGCVMAEL 235 (394)
T ss_dssp TT-------TEEEECCCTTCEECCTTCC-----------CCSSCSCGGGCCHHHHTT---CSSCCTHHHHHHHHHHHHHH
T ss_pred CC-------CcEEEeeCCCcccccCCCC-----------CcccccCcCccCHHHHcC---CCCCCcHHHHHHHHHHHHHH
Confidence 44 5799999999987643211 123468999999999975 24589999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhcc-CccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS-CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
++|+.||.+.+..+....+.+.......+.+..... .....+................++.+.+||.+||.+||.+|||
T Consensus 236 l~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 315 (394)
T 4e7w_A 236 MQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT 315 (394)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCC
Confidence 999999999887777666655422222222222110 0000000000000000011224678999999999999999999
Q ss_pred HHHHHHHHH
Q 003185 821 AGDLYEMFV 829 (840)
Q Consensus 821 a~ELLehLe 829 (840)
+.|+++|..
T Consensus 316 ~~e~l~hp~ 324 (394)
T 4e7w_A 316 AIEALCHPF 324 (394)
T ss_dssp HHHHHTSGG
T ss_pred HHHHhcChh
Confidence 999999944
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=362.43 Aligned_cols=259 Identities=21% Similarity=0.312 Sum_probs=197.8
Q ss_pred CCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC--CCCcceeeeEEecCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISSK 581 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~--HpNIV~l~g~~~~~~ 581 (840)
..|++.+.||+|+||.||+|.+ .+..||+|++.... ......+. +.+|+.+|++|+ |||||++++++....
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~--~~~~~~~~----~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE--ADNQTLDS----YRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTT--CCHHHHHH----HHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccc--ccHHHHHH----HHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 4599999999999999999987 46789999976543 23333333 499999999997 599999999988655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .||||| +.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus 130 ~--------------~~lv~E-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~ 189 (390)
T 2zmd_A 130 Y--------------IYMVME-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV 189 (390)
T ss_dssp E--------------EEEEEE-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES
T ss_pred E--------------EEEEEe-cCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE
Confidence 3 599999 457899999986 35789999999999999999999999999999999999995
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC-------CCCCCchhhHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-------PNLYGLEVDIWSY 734 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~-------~~~~s~kSDVWSL 734 (840)
. +.+||+|||+++.+...... ......+||+.|+|||++.+... ...++.++|||||
T Consensus 190 ~--------~~~kl~DFG~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSl 253 (390)
T 2zmd_A 190 D--------GMLKLIDFGIANQMQPDTTS--------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253 (390)
T ss_dssp S--------SCEEECCCSSSCCC-----------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHH
T ss_pred C--------CeEEEEecCccccccCCCcc--------ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHH
Confidence 3 35999999999876432211 01233569999999999975211 1368999999999
Q ss_pred HHHHHHHHhCCCCCCCCC-HHHHHHHHHcC-CCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 003185 735 GCLLLELLTLQVPYMGLS-ELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 812 (840)
Q Consensus 735 GvIL~ELLTG~~PF~~~~-~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~ 812 (840)
||+||||++|+.||.... .......+... ....++. ..+..+.+||.+||.
T Consensus 254 Gvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~L~ 306 (390)
T 2zmd_A 254 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD---------------------------IPEKDLQDVLKCCLK 306 (390)
T ss_dssp HHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC---------------------------CSCHHHHHHHHHHTC
T ss_pred HHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc---------------------------cchHHHHHHHHHHcc
Confidence 999999999999997653 33334343332 1111110 013478999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhc
Q 003185 813 ENPTERPTAGDLYEMFVART 832 (840)
Q Consensus 813 ~DP~eRPSa~ELLehLe~l~ 832 (840)
.||.+|||+.+|++|.+-..
T Consensus 307 ~dP~~Rps~~ell~hp~~~~ 326 (390)
T 2zmd_A 307 RDPKQRISIPELLAHPYVQI 326 (390)
T ss_dssp SSTTTSCCHHHHHTSHHHHS
T ss_pred cChhhCCCHHHHhhCcCccc
Confidence 99999999999999976543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=367.63 Aligned_cols=263 Identities=24% Similarity=0.256 Sum_probs=196.0
Q ss_pred CCCCCceee-eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHH-hCCCCCcceeeeEE
Q 003185 502 GSFPSLSSC-DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLG-ALRHSCIVEMYGHK 577 (840)
Q Consensus 502 ~~~~~y~i~-~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~-~L~HpNIV~l~g~~ 577 (840)
..+++|.+. +.||+|+||.||+|.+ .+..||+|++... .. +.+|+.++. .++||||+++++++
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~----~~~E~~~~~~~~~hp~iv~l~~~~ 124 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PK----ARREVELHWRASQCPHIVRIVDVY 124 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HH----HHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------hh----HHHHHHHHHHhcCCCCcceEeEEE
Confidence 346778887 7899999999999998 4778999986411 12 277888874 45799999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
..... .....||||||++||+|.+++.. .....+++..++.|+.||+.||.|||++||+||||||+|
T Consensus 125 ~~~~~----------~~~~~~lv~E~~~gg~L~~~l~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 191 (400)
T 1nxk_A 125 ENLYA----------GRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 191 (400)
T ss_dssp EEEET----------TEEEEEEEEECCCSEEHHHHHHC---C---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred eeccc----------CCcEEEEEEEeCCCCcHHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcce
Confidence 64210 12246999999999999999975 223469999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
||++..+ ..+.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||+
T Consensus 192 ill~~~~----~~~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~i 252 (400)
T 1nxk_A 192 LLYTSKR----PNAILKLTDFGFAKETTSHNS-----------LTTPCYTPYYVAPEVLGP----EKYDKSCDMWSLGVI 252 (400)
T ss_dssp EEESSSS----TTCCEEECCCTTCEECC----------------------CTTCCGGGSCC----CCSSSHHHHHHHHHH
T ss_pred EEEecCC----CCccEEEEecccccccCCCCc-----------cccCCCCCCccCHhhcCC----CCCCCcccHHHHHHH
Confidence 9998742 136799999999986543211 123468999999999875 678999999999999
Q ss_pred HHHHHhCCCCCCCCCHHH----HHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 003185 738 LLELLTLQVPYMGLSELE----IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 813 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~e----l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~ 813 (840)
||||++|..||.+..... +...+..+... ++ .......+..+.+||.+||..
T Consensus 253 l~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~-~~-----------------------~~~~~~~s~~~~~li~~~L~~ 308 (400)
T 1nxk_A 253 MYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE-FP-----------------------NPEWSEVSEEVKMLIRNLLKT 308 (400)
T ss_dssp HHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC-CC-----------------------TTTTTTSCHHHHHHHHTTSCS
T ss_pred HHHHHhCCCCCCCCccccccHHHHHHHHcCccc-CC-----------------------CcccccCCHHHHHHHHHHCCC
Confidence 999999999997654321 23333333211 00 001122356799999999999
Q ss_pred CCCCCCCHHHHHHHHHhhcC
Q 003185 814 NPTERPTAGDLYEMFVARTS 833 (840)
Q Consensus 814 DP~eRPSa~ELLehLe~l~~ 833 (840)
||.+|||+.+|++|.+-...
T Consensus 309 dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 309 EPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp SGGGSCCHHHHHHSHHHHTT
T ss_pred ChhHCcCHHHHhcCccccCC
Confidence 99999999999999776543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=355.26 Aligned_cols=291 Identities=16% Similarity=0.164 Sum_probs=206.8
Q ss_pred CCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCCh---HHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEe
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSA---DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 578 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~---~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~ 578 (840)
..++|++.+.||+|+||.||+|.+ .+..||+|++......... .....+.+.+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 346899999999999999999986 5778999987543322111 111222345699999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
..... .....|+||||+. |+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 100 ~~~~~---------~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NI 165 (362)
T 3pg1_A 100 HFEEP---------AMHKLYLVTELMR-TDLAQVIHD----QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNI 165 (362)
T ss_dssp ECCTT---------TCCEEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred eccCC---------CcceEEEEEccCC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHE
Confidence 54321 2335799999998 699988874 335699999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.+ +.+||+|||++........ .....||+.|+|||++.+ ...++.++|||||||++
T Consensus 166 l~~~~-------~~~kl~Dfg~~~~~~~~~~-----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il 224 (362)
T 3pg1_A 166 LLADN-------NDITICDFNLAREDTADAN-----------KTHYVTHRWYRAPELVMQ---FKGFTKLVDMWSAGCVM 224 (362)
T ss_dssp EECTT-------CCEEECCTTC--------------------------CGGGCCHHHHTT---CTTCCTHHHHHHHHHHH
T ss_pred EEcCC-------CCEEEEecCcccccccccc-----------cceecccceecCcHHhcC---CCCCCcHhHHHhHHHHH
Confidence 99877 4599999999975433211 123468999999999875 24578999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcC-CCCCcchHHhhhccCcccccc-c---cCCCCCCchhhhhhHHHHHHHHHHhccc
Q 003185 739 LELLTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVA-Q---SGSGFEKPEAELETLSFLVDVFRRCTEE 813 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~-~---~~~~~~~~~~~~~~s~~L~dLI~rCL~~ 813 (840)
|+|++|+.||.+.+..+....+... ..+...... ........... . ..............++.+.+||.+||+.
T Consensus 225 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 303 (362)
T 3pg1_A 225 AEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVV-MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEF 303 (362)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHH-HTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCS
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhh-hccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcC
Confidence 9999999999998877777666543 333222111 10000000000 0 0000011122233467799999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 003185 814 NPTERPTAGDLYEMFV 829 (840)
Q Consensus 814 DP~eRPSa~ELLehLe 829 (840)
||.+|||+.++++|..
T Consensus 304 dP~~Rpt~~ell~hp~ 319 (362)
T 3pg1_A 304 NPQRRISTEQALRHPY 319 (362)
T ss_dssp SGGGSCCHHHHHTSGG
T ss_pred ChhhCCCHHHHHcCch
Confidence 9999999999999854
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=350.25 Aligned_cols=274 Identities=24% Similarity=0.345 Sum_probs=194.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
+..++|++.+.||+|+||.||+|.+ .+..||+|++..... .... ..+.+|+.++++++||||+++++++..
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~ 84 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC---QTSM----DELLKEIQAMSQCHHPNIVSYYTSFVV 84 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------------CCCCCCCTTBCCEEEEEES
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc---chhH----HHHHHHHHHHhhcCCCCEeeEEEEEee
Confidence 5678999999999999999999986 677899998643321 1112 234899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~---~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
... .++||||+++++|.+++...... ....+++..++.++.||+.||.|||++||+||||||+
T Consensus 85 ~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ 150 (303)
T 2vwi_A 85 KDE--------------LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAG 150 (303)
T ss_dssp SSC--------------EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred cCC--------------cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChh
Confidence 653 49999999999999999754322 2356899999999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
|||++.+ +.+||+|||++.......... .........||+.|+|||++.+. ..++.++|||||||
T Consensus 151 Nil~~~~-------~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG~ 215 (303)
T 2vwi_A 151 NILLGED-------GSVQIADFGVSAFLATGGDIT-----RNKVRKTFVGTPCWMAPEVMEQV---RGYDFKADIWSFGI 215 (303)
T ss_dssp GEEECTT-------CCEEECCCHHHHHCC--------------------CCCTTCCHHHHHHH---HCCCTHHHHHHHHH
T ss_pred hEEEcCC-------CCEEEEeccchheeccCCCcc-----chhhhcccCCCccccCHHHhccc---cCCCchhhHHHHHH
Confidence 9999877 459999999987654321110 00112334699999999998741 34688999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 737 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 737 IL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
++|+|++|..||.................+.+...... .......+..+.+||.+||..||.
T Consensus 216 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~li~~~l~~dp~ 277 (303)
T 2vwi_A 216 TAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQD------------------KEMLKKYGKSFRKMISLCLQKDPE 277 (303)
T ss_dssp HHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----------------------CCCCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHhCCCCCccCchhhHHHHHhccCCCcccccccc------------------chhhhhhhHHHHHHHHHHccCChh
Confidence 99999999999988776665555544433322211100 001112356789999999999999
Q ss_pred CCCCHHHHHHHHH
Q 003185 817 ERPTAGDLYEMFV 829 (840)
Q Consensus 817 eRPSa~ELLehLe 829 (840)
+|||+.++++|..
T Consensus 278 ~Rps~~~ll~h~~ 290 (303)
T 2vwi_A 278 KRPTAAELLRHKF 290 (303)
T ss_dssp GSCCHHHHHTSTT
T ss_pred hCcCHHHHhhChh
Confidence 9999999999854
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=340.73 Aligned_cols=270 Identities=17% Similarity=0.160 Sum_probs=205.0
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.-++|++.+.||+|+||.||+|.+ .+..||+|+....... . .+.+|+.+++.++|++++..+.++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~----~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------P----QLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC------C----HHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch------h----HHHHHHHHHHHhhcCCCCCccccccCC
Confidence 457899999999999999999996 6889999987543211 1 238899999999999888777766543
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. ..++||||+ +++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 77 ~~-------------~~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~ 138 (296)
T 3uzp_A 77 GD-------------YNVMVMELL-GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLM 138 (296)
T ss_dssp TT-------------EEEEEEECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred CC-------------ceEEEEEec-CCCHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEE
Confidence 32 459999999 8899999975 23569999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+. ..+.+||+|||++........... ..........||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 139 ~~~~----~~~~~kl~Dfg~~~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 207 (296)
T 3uzp_A 139 GLGK----KGNLVYIIDFGLAKKYRDARTHQH---IPYRENKNLTGTARYASINTHLG----IEQSRRDDLESLGYVLMY 207 (296)
T ss_dssp CCGG----GTTCEEECCCTTCEECBCTTTCCB---CCCCCSCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHHHHH
T ss_pred ecCC----CCCeEEEeeCCCcccccccccccc---cccccccccccccccCChhhhcC----CCCCcchhhHHHHHHHHH
Confidence 5221 125699999999987654322110 01112244579999999999986 668999999999999999
Q ss_pred HHhCCCCCCCCCH---HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 741 LLTLQVPYMGLSE---LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 741 LLTG~~PF~~~~~---~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
|++|+.||.+... .+....+.......... ......++.+.+||.+||+.||.+
T Consensus 208 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~dp~~ 264 (296)
T 3uzp_A 208 FNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-----------------------VLCKGYPSEFATYLNFCRSLRFDD 264 (296)
T ss_dssp HHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-----------------------HHTTTSCHHHHHHHHHHHTSCTTC
T ss_pred HHhCCCCCCCcCchhhhhhhhhhcccccCCchH-----------------------HHHhhCCHHHHHHHHHHHhcCcCc
Confidence 9999999976432 22222222211000000 011223567999999999999999
Q ss_pred CCCHHHHHHHHHhhcCC
Q 003185 818 RPTAGDLYEMFVARTSS 834 (840)
Q Consensus 818 RPSa~ELLehLe~l~~~ 834 (840)
|||+.+|++.|+.+...
T Consensus 265 Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 265 KPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp CCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHh
Confidence 99999999999987644
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=348.94 Aligned_cols=285 Identities=22% Similarity=0.243 Sum_probs=207.9
Q ss_pred CCCCceeeeeecccCceEEEEEEE---CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC---CCCCcceeeeE
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF---GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGH 576 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~---~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L---~HpNIV~l~g~ 576 (840)
.-++|++.+.||+|+||.||+|.+ ++..||+|++........ .. ..+.+|+.+++.+ +||||++++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~--~~----~~~~~e~~~l~~l~~~~h~~i~~~~~~ 82 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MP----LSTIREVAVLRHLETFEHPNVVRLFDV 82 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS--CB----CTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc--CC----chhhHHHHHHHhhhccCCCCeEeeeee
Confidence 347899999999999999999997 467899999765432211 11 1236777777666 89999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
+...... .....++||||+. |+|.+++.. .....+++..++.++.||+.||.|||++||+||||||+
T Consensus 83 ~~~~~~~---------~~~~~~lv~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~ 149 (326)
T 1blx_A 83 CTVSRTD---------RETKLTLVFEHVD-QDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQ 149 (326)
T ss_dssp EEEEECS---------SEEEEEEEEECCS-CBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred eeecccC---------CCceEEEEEecCC-CCHHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHH
Confidence 8732110 1235799999998 599999986 22345899999999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
|||++.+ +.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||
T Consensus 150 Nili~~~-------~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~ 207 (326)
T 1blx_A 150 NILVTSS-------GQIKLADFGLARIYSFQMA-----------LTSVVVTLWYRAPEVLLQ----SSYATPVDLWSVGC 207 (326)
T ss_dssp GEEECTT-------CCEEECSCCSCCCCCGGGG-----------GCCCCCCCTTCCHHHHTT----CCCCTHHHHHHHHH
T ss_pred HeEEcCC-------CCEEEecCcccccccCCCC-----------ccccccccceeCHHHHhc----CCCCcchhHHHHHH
Confidence 9999877 4699999999986543221 123468999999999976 56899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 737 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 737 IL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
++|+|++|+.||.+....+....+...........+..........+. ..............+..+.+||.+||..||.
T Consensus 208 il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 286 (326)
T 1blx_A 208 IFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH-SKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 286 (326)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSC-CCCCCCGGGTCCSCCHHHHHHHHHHSCSSTT
T ss_pred HHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhc-ccCcchhhhccccCCHHHHHHHHHHcCCCcc
Confidence 999999999999998877776666543111111111110000000000 0000001112234567899999999999999
Q ss_pred CCCCHHHHHHHHH
Q 003185 817 ERPTAGDLYEMFV 829 (840)
Q Consensus 817 eRPSa~ELLehLe 829 (840)
+|||+.++++|..
T Consensus 287 ~Rpt~~e~l~hp~ 299 (326)
T 1blx_A 287 KRISAYSALSHPY 299 (326)
T ss_dssp TSCCHHHHHTSGG
T ss_pred cCCCHHHHhcCcc
Confidence 9999999998843
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=349.11 Aligned_cols=267 Identities=24% Similarity=0.366 Sum_probs=204.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~ 578 (840)
...++|++.+.||+|+||.||+|.+ .+..||+|++..... ..+ .+.+|+.+++++ +||||+++++++.
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~----~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-----EEE----EIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----TTH----HHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-----cHH----HHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 3567899999999999999999998 678999999754321 112 348899999999 7999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
..... ......+|||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 92 ~~~~~--------~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NI 160 (326)
T 2x7f_A 92 KKNPP--------GMDDQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNV 160 (326)
T ss_dssp ECC----------CCCCEEEEEEECCTTEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGE
T ss_pred eccCc--------cccceEEEEEEcCCCCcHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHE
Confidence 64311 0123579999999999999999862 224689999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~kSDVWSLGvI 737 (840)
|++.+ +.+||+|||++......... .....||+.|+|||++.... ....++.++|||||||+
T Consensus 161 l~~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~i 223 (326)
T 2x7f_A 161 LLTEN-------AEVKLVDFGVSAQLDRTVGR----------RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT 223 (326)
T ss_dssp EECTT-------CCEEECCCTTTC-----------------------CCGGGCCHHHHC--------CCTTHHHHHHHHH
T ss_pred EEcCC-------CCEEEeeCcCceecCcCccc----------cccccCCccccChhhhccccccCcCCCccchHHHHHHH
Confidence 99876 45999999999765432111 12346899999999996321 12567899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
+|+|++|..||...........+.....+.+.. ...+..+.+||.+||..||.+
T Consensus 224 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~dp~~ 277 (326)
T 2x7f_A 224 AIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS--------------------------KKWSKKFQSFIESCLVKNHSQ 277 (326)
T ss_dssp HHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC--------------------------SCSCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHhCCCCCCCCcHHHHHHHhhcCccccCCc--------------------------cccCHHHHHHHHHHhccChhh
Confidence 999999999998888777666665543322110 112457899999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 003185 818 RPTAGDLYEMFVAR 831 (840)
Q Consensus 818 RPSa~ELLehLe~l 831 (840)
||++.++++|..-.
T Consensus 278 Rps~~~ll~hp~~~ 291 (326)
T 2x7f_A 278 RPATEQLMKHPFIR 291 (326)
T ss_dssp SCCHHHHHTSHHHH
T ss_pred CCCHHHHhhChHHh
Confidence 99999999986543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=356.43 Aligned_cols=260 Identities=20% Similarity=0.250 Sum_probs=204.8
Q ss_pred CCceee-eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEecC
Q 003185 505 PSLSSC-DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 580 (840)
Q Consensus 505 ~~y~i~-~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~~ 580 (840)
+.|.+. +.||+|+||.||+|.+ .+..||+|++...... .... ..+.+|+.++..+. ||||+++++++...
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~----~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG--QDCR----AEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT--EECH----HHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc--hHHH----HHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 346776 8999999999999998 4789999997644321 1112 23489999999996 69999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
. ..++||||+.+|+|.+++.. .....+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 102 ~--------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~ 164 (327)
T 3lm5_A 102 S--------------EIILILEYAAGGEIFSLCLP---ELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILL 164 (327)
T ss_dssp S--------------EEEEEEECCTTEEGGGGGSS---CC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred C--------------eEEEEEEecCCCcHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEE
Confidence 5 35999999999999998753 223568999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+... ..+.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 165 ~~~~----~~~~~kL~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~ 225 (327)
T 3lm5_A 165 SSIY----PLGDIKIVDFGMSRKIGHACE-----------LREIMGTPEYLAPEILNY----DPITTATDMWNIGIIAYM 225 (327)
T ss_dssp SCBT----TBCCEEECCGGGCEEC--------------------CCCGGGCCHHHHTT----CCCCTHHHHHHHHHHHHH
T ss_pred ecCC----CCCcEEEeeCccccccCCccc-----------cccccCCcCccCCeeecC----CCCCchhhHHHHHHHHHH
Confidence 8731 125699999999987643221 123469999999999976 678899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|++|..||.+.+..+....+.......... .....+..+.+||.+||..||.+|||
T Consensus 226 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt 281 (327)
T 3lm5_A 226 LLTHTSPFVGEDNQETYLNISQVNVDYSEE------------------------TFSSVSQLATDFIQSLLVKNPEKRPT 281 (327)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCCCCTT------------------------TTTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred HHhCCCCCCCCCchHHHHHHHhcccccCch------------------------hhcccCHHHHHHHHHHcCCChhhCcC
Confidence 999999999988888777766553221111 11223567899999999999999999
Q ss_pred HHHHHHHHHh
Q 003185 821 AGDLYEMFVA 830 (840)
Q Consensus 821 a~ELLehLe~ 830 (840)
++++++|.+-
T Consensus 282 ~~~ll~h~~~ 291 (327)
T 3lm5_A 282 AEICLSHSWL 291 (327)
T ss_dssp HHHHTTCGGG
T ss_pred HHHHhCCHhh
Confidence 9999998553
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=344.41 Aligned_cols=258 Identities=26% Similarity=0.322 Sum_probs=209.5
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
.++|++.+.||+|+||.||+|.+ .+..+|+|++....... ...+ .+.+|+.++++++||||+++++++....
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~--~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTS----TILREVELLKKLDHPNIMKLFEILEDSS 94 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS--SCHH----HHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch--HHHH----HHHHHHHHHHhccCCCccEEEEEEeCCC
Confidence 46899999999999999999998 57889999976443221 1222 3489999999999999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 95 --------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~ 155 (287)
T 2wei_A 95 --------------SFYIVGELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE 155 (287)
T ss_dssp --------------EEEEEECCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred --------------eEEEEEEccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEe
Confidence 35999999999999999876 24689999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.++ ....+||+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|
T Consensus 156 ~~~----~~~~~kL~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~-----~~~~~~Di~slG~~l~~l 215 (287)
T 2wei_A 156 SKE----KDCDIKIIDFGLSTCFQQNTK-----------MKDRIGTAYYIAPEVLRG-----TYDEKCDVWSAGVILYIL 215 (287)
T ss_dssp CSS----TTCCEEECSTTGGGTBCCCSS-----------CSCHHHHHTTCCHHHHTT-----CCCTHHHHHHHHHHHHHH
T ss_pred cCC----CcccEEEeccCcceeecCCCc-----------cccccCcccccChHHhcC-----CCCCchhhHhHHHHHHHH
Confidence 653 235799999999976543211 122358899999999874 478999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
++|..||.+.+..++...+..+..+.... .....+..+.+||.+||..||.+|||+
T Consensus 216 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~ 271 (287)
T 2wei_A 216 LSGTPPFYGKNEYDILKRVETGKYAFDLP------------------------QWRTISDDAKDLIRKMLTFHPSLRITA 271 (287)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHCCCCCCSG------------------------GGTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCCch------------------------hhhhcCHHHHHHHHHHcccChhhCcCH
Confidence 99999999988888877777654321110 011235679999999999999999999
Q ss_pred HHHHHHHHh
Q 003185 822 GDLYEMFVA 830 (840)
Q Consensus 822 ~ELLehLe~ 830 (840)
.++++|..-
T Consensus 272 ~ell~hp~~ 280 (287)
T 2wei_A 272 TQCLEHPWI 280 (287)
T ss_dssp HHHHHSHHH
T ss_pred HHHhcCHHH
Confidence 999998543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=382.75 Aligned_cols=257 Identities=22% Similarity=0.303 Sum_probs=205.3
Q ss_pred CCceeee-eecccCceEEEEEEE----CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 505 PSLSSCD-EAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 505 ~~y~i~~-~LG~G~fG~Vy~a~~----~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
+++.+.+ .||+|+||.||+|.+ .+..||||+.... . .....+. +.+|+.+|++++|||||++++++..
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~--~-~~~~~~~----~~~E~~il~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--T-EKADTEE----MMREAQIMHQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC--C-SSTTHHH----HHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC--C-ChHHHHH----HHHHHHHHHhCCCCCEeeEEEEecc
Confidence 4556666 899999999999987 3456888885432 1 1122233 4899999999999999999999874
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.. .+|||||+.+|+|.+++.. ....+++..++.|+.||+.||+|||++|||||||||+|||
T Consensus 408 ~~---------------~~lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIL 468 (613)
T 2ozo_A 408 EA---------------LMLVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVL 468 (613)
T ss_dssp SS---------------EEEEEECCTTCBHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred CC---------------eEEEEEeCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEE
Confidence 32 4999999999999999864 2356999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
|+.+ +.+||+|||+++.+....... .......+|+.|+|||++.+ ..++.++|||||||+||
T Consensus 469 l~~~-------~~vkL~DFGla~~~~~~~~~~-------~~~~~~~~~~~y~APE~~~~----~~~~~~sDvwSlGv~l~ 530 (613)
T 2ozo_A 469 LVNR-------HYAKISDFGLSKALGADDSYY-------TARSAGKWPLKWYAPECINF----RKFSSRSDVWSYGVTMW 530 (613)
T ss_dssp EEET-------TEEEECCCSTTTTCC---------------------CCTTSCHHHHHH----CCCCHHHHHHHHHHHHH
T ss_pred EcCC-------CcEEEeeccCcccccCCCcee-------eeccCCCCccceeCHhhhcC----CCCCcHHHHHHHHHHHH
Confidence 9977 569999999998764322110 00112246789999999986 67899999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 740 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 740 ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
||++ |+.||.+.+..++...+..+.++..+. .++..+.+||.+||..||.+|
T Consensus 531 ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~dP~~R 583 (613)
T 2ozo_A 531 EALSYGQKPYKKMKGPEVMAFIEQGKRMECPP---------------------------ECPPELYALMSDCWIYKWEDR 583 (613)
T ss_dssp HHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHTTCSSTTTS
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------cCCHHHHHHHHHHcCCChhHC
Confidence 9998 999999998888888888776544432 134579999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 003185 819 PTAGDLYEMFVART 832 (840)
Q Consensus 819 PSa~ELLehLe~l~ 832 (840)
|++.+|++.|+.+.
T Consensus 584 Ps~~~l~~~L~~~~ 597 (613)
T 2ozo_A 584 PDFLTVEQRMRACY 597 (613)
T ss_dssp CCHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHH
Confidence 99999999988764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=347.00 Aligned_cols=275 Identities=20% Similarity=0.248 Sum_probs=202.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~ 578 (840)
...++|++.+.||+|+||.||+|.+ .+..||+|++... ..+ .+.+|+.++++++ ||||+++++++.
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~----~~~~E~~~l~~l~~~~~i~~~~~~~~ 101 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKK----KIKREIKILENLRGGPNIITLADIVK 101 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-------CHH----HHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-------chH----HHHHHHHHHHHcCCCCCEEEeeeeec
Confidence 3457899999999999999999987 6789999986421 112 3489999999998 999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
.... ...++||||+.+++|.+++. .+++..++.++.||+.||.|||++||+||||||+||
T Consensus 102 ~~~~------------~~~~lv~e~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Ni 161 (330)
T 3nsz_A 102 DPVS------------RTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNV 161 (330)
T ss_dssp CTTT------------CCEEEEEECCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred cCCC------------CceEEEEeccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence 6321 24699999999999999874 388999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.++ ..+||+|||+++....... .....||+.|+|||++.+ ...++.++|||||||+|
T Consensus 162 l~~~~~------~~~kl~Dfg~a~~~~~~~~-----------~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il 221 (330)
T 3nsz_A 162 MIDHEH------RKLRLIDWGLAEFYHPGQE-----------YNVRVASRYFKGPELLVD---YQMYDYSLDMWSLGCML 221 (330)
T ss_dssp EEETTT------TEEEECCCTTCEECCTTCC-----------CCSCCSCGGGCCHHHHTT---CCCCCTHHHHHHHHHHH
T ss_pred EEcCCC------CEEEEEeCCCceEcCCCCc-----------cccccccccccChhhhcC---CCcCCchhhHHHHHHHH
Confidence 998663 3699999999986543221 123468999999999875 35688999999999999
Q ss_pred HHHHhCCCCCCCC-CHHHHHHHHHcC-CCC-----------CcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHH
Q 003185 739 LELLTLQVPYMGL-SELEIHDLIQMG-KRP-----------RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 805 (840)
Q Consensus 739 ~ELLTG~~PF~~~-~~~el~~~I~~~-~~p-----------~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~d 805 (840)
|+|++|..||... ...+....+... ..+ .+...+......... ...............+..+.+
T Consensus 222 ~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 298 (330)
T 3nsz_A 222 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSR---KRWERFVHSENQHLVSPEALD 298 (330)
T ss_dssp HHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCC---CCGGGGCCTTTGGGCCHHHHH
T ss_pred HHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccc---cchhhhccccccccCCHHHHH
Confidence 9999999999443 333333322221 110 111111110000000 000000111222335678999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHh
Q 003185 806 VFRRCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 806 LI~rCL~~DP~eRPSa~ELLehLe~ 830 (840)
||.+||+.||.+|||++|+++|.+-
T Consensus 299 li~~~L~~dP~~Rpta~e~l~hp~f 323 (330)
T 3nsz_A 299 FLDKLLRYDHQSRLTAREAMEHPYF 323 (330)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHhcCCcccCCCHHHHhcCccH
Confidence 9999999999999999999998543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=362.31 Aligned_cols=293 Identities=20% Similarity=0.226 Sum_probs=212.5
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
-++|.+.+.||+|+||.||+|.+. +..||+|++....... . ...+.+|+.+|++++||||+++++++....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 80 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR---P----VDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS---C----HHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc---h----HHHHHHHHHHHHhcCCCCCCeEEEeeccCC
Confidence 457999999999999999999984 7899999975322111 1 223478999999999999999999987543
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. ...+|||||+++|+|.+++... .....+++..++.++.||+.||.|||++||+||||||+|||+.
T Consensus 81 ~------------~~~~lv~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 146 (396)
T 4eut_A 81 T------------RHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRV 146 (396)
T ss_dssp T------------CCEEEEECCCTTEEHHHHTTSG--GGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEE
T ss_pred C------------CeeEEEEecCCCCCHHHHHHhh--hcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEe
Confidence 2 1459999999999999999752 1223489999999999999999999999999999999999983
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC----CCCCchhhHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP----NLYGLEVDIWSYGCL 737 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~----~~~s~kSDVWSLGvI 737 (840)
... +....+||+|||+++....... .....||+.|+|||++.+.... ..++.++|||||||+
T Consensus 147 ~~~---~~~~~~kL~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~i 212 (396)
T 4eut_A 147 IGE---DGQSVYKLTDFGAARELEDDEQ-----------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212 (396)
T ss_dssp ECT---TSCEEEEECCGGGCEECCCGGG-----------SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHH
T ss_pred ecC---CCceeEEEecCCCceEccCCCc-----------cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHH
Confidence 221 1236799999999987644321 1234699999999998642100 246789999999999
Q ss_pred HHHHHhCCCCCCCC----CHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 003185 738 LLELLTLQVPYMGL----SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 813 (840)
Q Consensus 738 L~ELLTG~~PF~~~----~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~ 813 (840)
+|||++|+.||... ...++...+..+..+.....+.... ...+................+..+.+||.+||..
T Consensus 213 l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~ 289 (396)
T 4eut_A 213 FYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAE---NGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289 (396)
T ss_dssp HHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECST---TCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCC
T ss_pred HHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheecc---CCCcccCccCCcccccchHHHhhchHHHHHhhcc
Confidence 99999999999642 3344555555543332221111000 0000000000001122355678899999999999
Q ss_pred CCCCCCCHHHHHHHHHhhcCC
Q 003185 814 NPTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 814 DP~eRPSa~ELLehLe~l~~~ 834 (840)
||.+||++.++++++..+...
T Consensus 290 dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 290 DQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CTTTSCCHHHHHHHHHHHHTC
T ss_pred ChhhhccHHHHHHHHHHHhhc
Confidence 999999999999999887653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=384.22 Aligned_cols=252 Identities=21% Similarity=0.327 Sum_probs=204.5
Q ss_pred eeecccCceEEEEEEE----CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 586 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~----~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~ 586 (840)
+.||+|+||.||+|.+ .+..||||+..... .... ..+.+.+|+.+|++|+|||||++++++....
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 443 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPA----LKDELLAEANVMQQLDNPYIVRMIGICEAES----- 443 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG--GCGG----GHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-----
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc--CCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----
Confidence 4899999999999976 34679999865332 1112 2234599999999999999999999986432
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEeccccc
Q 003185 587 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 666 (840)
Q Consensus 587 ~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~ 666 (840)
.+|||||+++|+|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+||||+.+
T Consensus 444 ----------~~lv~E~~~~g~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~--- 505 (635)
T 4fl3_A 444 ----------WMLVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ--- 505 (635)
T ss_dssp ----------EEEEEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET---
T ss_pred ----------EEEEEEccCCCCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCC---
Confidence 4899999999999999976 3568999999999999999999999999999999999999977
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CC
Q 003185 667 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQ 745 (840)
Q Consensus 667 ~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT-G~ 745 (840)
+.+||+|||+++.+....... .......+|+.|+|||++.+ ..++.++|||||||+||||++ |+
T Consensus 506 ----~~~kL~DFGla~~~~~~~~~~-------~~~~~~~~t~~y~APE~~~~----~~~~~~sDvwSlGv~l~ellt~G~ 570 (635)
T 4fl3_A 506 ----HYAKISDFGLSKALRADENYY-------KAQTHGKWPVKWYAPECINY----YKFSSKSDVWSFGVLMWEAFSYGQ 570 (635)
T ss_dssp ----TEEEECCTTHHHHTTC--------------------CGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred ----CCEEEEEcCCccccccCcccc-------ccccCCCCceeeeChhhhcC----CCCCcHHHHHHHHHHHHHHHhCCC
Confidence 569999999998764432110 01122347889999999986 678999999999999999998 99
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 003185 746 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 825 (840)
Q Consensus 746 ~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELL 825 (840)
.||.+.+..++...+..+.++..+. .++..+.+||.+||..||.+||++.+|+
T Consensus 571 ~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~dP~~RPs~~~l~ 623 (635)
T 4fl3_A 571 KPYRGMKGSEVTAMLEKGERMGCPA---------------------------GCPREMYDLMNLCWTYDVENRPGFAAVE 623 (635)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 9999999999888888876554442 1245799999999999999999999999
Q ss_pred HHHHhhcC
Q 003185 826 EMFVARTS 833 (840)
Q Consensus 826 ehLe~l~~ 833 (840)
+.|+.+..
T Consensus 624 ~~L~~~~~ 631 (635)
T 4fl3_A 624 LRLRNYYY 631 (635)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99987643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=343.56 Aligned_cols=257 Identities=25% Similarity=0.292 Sum_probs=202.1
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+++|++.+.||+|+||.||+|.+ .+..+|+|+....... ... ..+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCP----ENIKKEICINKMLNHENVVKFYGHRREGN 78 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT---THH----HHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch---hhh----HHHHHHHHHHHhcCCCCceeeeeEEEcCC
Confidence 46899999999999999999998 4788999997654321 122 34489999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 79 ~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~ 139 (276)
T 2yex_A 79 I--------------QYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 139 (276)
T ss_dssp E--------------EEEEEECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred E--------------EEEEEEecCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEc
Confidence 3 4999999999999998853 35689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||++.......... ......||+.|+|||++.+ ...++.++||||||+++|+|
T Consensus 140 ~~-------~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~~l 201 (276)
T 2yex_A 140 ER-------DNLKISDFGLATVFRYNNRER--------LLNKMCGTLPYVAPELLKR---REFHAEPVDVWSCGIVLTAM 201 (276)
T ss_dssp TT-------CCEEECCCTTCEECEETTEEC--------CBCCCCSCGGGCCGGGGTC---SSBCHHHHHHHHHHHHHHHH
T ss_pred cC-------CCEEEeeCCCccccCCCcchh--------cccCCccccCccChHHHhc---CCCCCCcchHHHHHHHHHHH
Confidence 76 459999999998664322110 1123468999999999975 22347899999999999999
Q ss_pred HhCCCCCCCCCHH-HHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 742 LTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 742 LTG~~PF~~~~~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
++|..||...... .....+..... ... .....+..+.+||.+||..||.+|||
T Consensus 202 ~~g~~p~~~~~~~~~~~~~~~~~~~-~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~Rps 255 (276)
T 2yex_A 202 LAGELPWDQPSDSCQEYSDWKEKKT-YLN-------------------------PWKKIDSAPLALLHKILVENPSARIT 255 (276)
T ss_dssp HHSSCCCSCSCTTSHHHHHHHTTCT-TST-------------------------TGGGSCHHHHHHHHHHSCSSTTTSCC
T ss_pred HhCCCCCCCCchHHHHHHHhhhccc-ccC-------------------------chhhcCHHHHHHHHHHCCCCchhCCC
Confidence 9999999775432 22222222211 000 01223567899999999999999999
Q ss_pred HHHHHHHHHh
Q 003185 821 AGDLYEMFVA 830 (840)
Q Consensus 821 a~ELLehLe~ 830 (840)
+.+|++|..-
T Consensus 256 ~~~il~~~~~ 265 (276)
T 2yex_A 256 IPDIKKDRWY 265 (276)
T ss_dssp HHHHTTCTTT
T ss_pred HHHHhcCccc
Confidence 9999998553
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=344.54 Aligned_cols=282 Identities=20% Similarity=0.210 Sum_probs=207.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE---CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCC------Ccce
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF---GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS------CIVE 572 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~---~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~Hp------NIV~ 572 (840)
..-++|++.+.||+|+||.||+|.+ .+..||+|+.... ... ...+.+|+.+++.++|+ +|++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~----~~~~~~e~~~l~~l~~~~~~~~~~i~~ 81 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-----DRY----CEAARSEIQVLEHLNTTDPNSTFRCVQ 81 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-----HHH----HHHHHHHHHHHHHHHHHCTTCTTCBCC
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-----Cch----hHHHHHHHHHHHHhhhcCCCCceeeEe
Confidence 3457899999999999999999987 5788999996421 222 23448899999988765 4999
Q ss_pred eeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Q 003185 573 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRD 652 (840)
Q Consensus 573 l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRD 652 (840)
+++++.... ..+|||||+ +++|.+++.. .....+++..++.++.||+.||+|||++||+|||
T Consensus 82 ~~~~~~~~~--------------~~~lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~D 143 (339)
T 1z57_A 82 MLEWFEHHG--------------HICIVFELL-GLSTYDFIKE---NGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTD 143 (339)
T ss_dssp EEEEEEETT--------------EEEEEEECC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred eecccccCC--------------cEEEEEcCC-CCCHHHHHHh---cCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCC
Confidence 999998655 359999999 7899999976 2334689999999999999999999999999999
Q ss_pred CCCCcEEEeccccc------------CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003185 653 IKSENILIDLERKK------------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720 (840)
Q Consensus 653 LKPeNILLd~~~~~------------~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~ 720 (840)
|||+|||++..+.. ....+.+||+|||++...... .....||+.|+|||++.+
T Consensus 144 lkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------------~~~~~gt~~y~aPE~~~~-- 208 (339)
T 1z57_A 144 LKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-------------HSTLVSTRHYRAPEVILA-- 208 (339)
T ss_dssp CCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-------------CCSSCSCGGGCCHHHHTT--
T ss_pred CCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-------------cccccCCccccChHHhhC--
Confidence 99999999864210 000356999999999764321 123468999999999986
Q ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCC---------
Q 003185 721 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE--------- 791 (840)
Q Consensus 721 ~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~--------- 791 (840)
..++.++|||||||++|||++|..||...+..+....+.....+.....+.... .. ..+......+.
T Consensus 209 --~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~ 284 (339)
T 1z57_A 209 --LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTR-KR-KYFHHDRLDWDEHSSAGRYV 284 (339)
T ss_dssp --SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCS-CG-GGEETTEECCCTTSHHHHHH
T ss_pred --CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcc-ch-hHHhhccccccccccccchh
Confidence 568999999999999999999999999888777666554432221111111110 00 00000000000
Q ss_pred ---------CchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003185 792 ---------KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 792 ---------~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe 829 (840)
........++.+.+||.+||..||.+|||+.|+++|..
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 331 (339)
T 1z57_A 285 SRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPF 331 (339)
T ss_dssp HHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGG
T ss_pred hhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHH
Confidence 00111234678999999999999999999999999843
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=359.31 Aligned_cols=252 Identities=22% Similarity=0.235 Sum_probs=197.8
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
.++|++.+.||+|+||.||+|.+ .+..||+|++..................+.+|+.+|++++||||+++++++....
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 46799999999999999999986 6788999997654322210000001123378999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCC-CHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGG-SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gG-SL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
. .++||||+.+| +|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+
T Consensus 103 ~--------------~~lv~e~~~~g~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll 163 (335)
T 3dls_A 103 F--------------FQLVMEKHGSGLDLFAFIDR-----HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI 163 (335)
T ss_dssp E--------------EEEEEECCTTSCBHHHHHHT-----CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred E--------------EEEEEEeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE
Confidence 3 49999999766 99999975 3569999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||++........ .....||+.|+|||++.+ ...++.++|||||||++|+
T Consensus 164 ~~~-------~~~kL~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~e 222 (335)
T 3dls_A 164 AED-------FTIKLIDFGSAAYLERGKL-----------FYTFCGTIEYCAPEVLMG---NPYRGPELEMWSLGVTLYT 222 (335)
T ss_dssp CTT-------SCEEECCCTTCEECCTTCC-----------BCEECSCGGGCCHHHHTT---CCBCSHHHHHHHHHHHHHH
T ss_pred cCC-------CcEEEeecccceECCCCCc-----------eeccCCCccccChhhhcC---CCCCCCcccchhHHHHHHH
Confidence 877 4699999999986643221 123469999999999986 2234889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|++|..||...... +.... .. ....+..+.+||.+||..||.+|||
T Consensus 223 l~~g~~pf~~~~~~-----~~~~~--~~---------------------------~~~~~~~l~~li~~~L~~dP~~Rps 268 (335)
T 3dls_A 223 LVFEENPFCELEET-----VEAAI--HP---------------------------PYLVSKELMSLVSGLLQPVPERRTT 268 (335)
T ss_dssp HHHSSCSCSSGGGG-----TTTCC--CC---------------------------SSCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHhCCCchhhHHHH-----Hhhcc--CC---------------------------CcccCHHHHHHHHHHccCChhhCcC
Confidence 99999999653110 00000 00 0113557999999999999999999
Q ss_pred HHHHHHHHH
Q 003185 821 AGDLYEMFV 829 (840)
Q Consensus 821 a~ELLehLe 829 (840)
+.+|++|.+
T Consensus 269 ~~ell~hp~ 277 (335)
T 3dls_A 269 LEKLVTDPW 277 (335)
T ss_dssp HHHHHHCTT
T ss_pred HHHHhcCcc
Confidence 999999965
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=385.30 Aligned_cols=255 Identities=24% Similarity=0.294 Sum_probs=209.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~ 578 (840)
..+++|++.+.||+|+||.||+|.+ .+..||+|++..... ......+.+..|..+|..+ +||||+++++++.
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~-----~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~ 412 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV-----IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 412 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHH-----HHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccc-----ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE
Confidence 5688999999999999999999998 456799999753211 0111123448899999988 5999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
... .+||||||++||+|..++.. ...+++..++.++.||+.||+|||++|||||||||+||
T Consensus 413 ~~~--------------~~~lV~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NI 473 (674)
T 3pfq_A 413 TMD--------------RLYFVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNV 473 (674)
T ss_dssp CSS--------------EEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTE
T ss_pred eCC--------------EEEEEEeCcCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhE
Confidence 655 35999999999999999986 25699999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
||+.+ +.+||+|||+|+....... ......||+.|||||++.+ ..++.++|||||||+|
T Consensus 474 Ll~~~-------g~ikL~DFGla~~~~~~~~----------~~~~~~GT~~Y~APE~l~~----~~~~~~~DvwSlGvil 532 (674)
T 3pfq_A 474 MLDSE-------GHIKIADFGMCKENIWDGV----------TTKTFCGTPDYIAPEIIAY----QPYGKSVDWWAFGVLL 532 (674)
T ss_dssp EECSS-------SCEEECCCTTCEECCCTTC----------CBCCCCSCSSSCCHHHHTC----CCBSTHHHHHHHHHHH
T ss_pred EEcCC-------CcEEEeecceeeccccCCc----------ccccccCCCcccCHhhhcC----CCCCccceEechHHHH
Confidence 99877 4699999999985432111 1234579999999999976 6789999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 739 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
|||++|+.||.+.+..+++..|..... .++. ..+..+.+||.+||..||.+|
T Consensus 533 yelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~~li~~lL~~dP~~R 584 (674)
T 3pfq_A 533 YEMLAGQAPFEGEDEDELFQSIMEHNV-AYPK---------------------------SMSKEAVAICKGLMTKHPGKR 584 (674)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHSSCC-CCCT---------------------------TSCHHHHHHHHHHSCSSSTTC
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHhCCC-CCCc---------------------------cCCHHHHHHHHHHccCCHHHC
Confidence 999999999999999999888876532 1221 124579999999999999999
Q ss_pred CCH-----HHHHHHHH
Q 003185 819 PTA-----GDLYEMFV 829 (840)
Q Consensus 819 PSa-----~ELLehLe 829 (840)
|++ ++|++|..
T Consensus 585 ~~~~~~~~~ei~~h~f 600 (674)
T 3pfq_A 585 LGCGPEGERDIKEHAF 600 (674)
T ss_dssp TTCSTTHHHHHHSSGG
T ss_pred CCCCCCcHHHHhcCcc
Confidence 997 89998743
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=364.30 Aligned_cols=280 Identities=21% Similarity=0.225 Sum_probs=207.2
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC------CCCCcceee
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL------RHSCIVEMY 574 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L------~HpNIV~l~ 574 (840)
...+|++.+.||+|+||.||+|.+ .+..||+|++... ... ...+.+|+.+++.+ .|+||++++
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-----~~~----~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-----KRF----HRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-----HHH----HHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-----cch----HHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 346799999999999999999987 4688999986422 122 23347788888877 577999999
Q ss_pred eEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCC
Q 003185 575 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654 (840)
Q Consensus 575 g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLK 654 (840)
+++.... ..+|||||+. ++|.+++.. .....+++..++.|+.||+.||.|||++||||||||
T Consensus 166 ~~~~~~~--------------~~~lv~e~~~-~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlK 227 (429)
T 3kvw_A 166 ENFTFRN--------------HICMTFELLS-MNLYELIKK---NKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLK 227 (429)
T ss_dssp EEEEETT--------------EEEEEECCCC-CBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCS
T ss_pred eecccCC--------------eEEEEEeccC-CCHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 9998665 3599999996 699999986 223458999999999999999999999999999999
Q ss_pred CCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHH
Q 003185 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 734 (840)
Q Consensus 655 PeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSL 734 (840)
|+||||+.++. ..+||+|||++...... .....||+.|+|||++.+ ..++.++|||||
T Consensus 228 p~NILl~~~~~-----~~vkL~DFG~a~~~~~~-------------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSl 285 (429)
T 3kvw_A 228 PENILLKQQGR-----SGIKVIDFGSSCYEHQR-------------VYTYIQSRFYRAPEVILG----ARYGMPIDMWSL 285 (429)
T ss_dssp GGGEEESSTTS-----CCEEECCCTTCEETTCC-------------CCSSCSCGGGCCHHHHHT----BCCCTHHHHHHH
T ss_pred HHHeEEccCCC-----cceEEeecccceecCCc-------------ccccCCCCCccChHHHhC----CCCCchHHHHhH
Confidence 99999987732 34999999999754321 123469999999999986 568999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccC----cccccccc-------------------CC---
Q 003185 735 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC----HEHEVAQS-------------------GS--- 788 (840)
Q Consensus 735 GvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~----~~~~~~~~-------------------~~--- 788 (840)
||+||||++|.+||.+.+..+.+..+...........+...... ........ ..
T Consensus 286 G~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (429)
T 3kvw_A 286 GCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLR 365 (429)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEE
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhcc
Confidence 99999999999999999888777666554222222221110000 00000000 00
Q ss_pred -CCCCc----hhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 003185 789 -GFEKP----EAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 831 (840)
Q Consensus 789 -~~~~~----~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l 831 (840)
..... ......++.+.+||.+||++||.+|||++|+++|.+-.
T Consensus 366 ~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~ 413 (429)
T 3kvw_A 366 GPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413 (429)
T ss_dssp CSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC
T ss_pred CCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhc
Confidence 00000 00011256789999999999999999999999996544
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=347.40 Aligned_cols=282 Identities=17% Similarity=0.163 Sum_probs=206.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
+.-++|++.+.||+|+||.||+|.. .+..||+|++... .....+ .+.+|+.+++.++||||+++++++..
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDRE----EAQREADMHRLFNHPNILRLVAYCLR 97 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHH----HHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHH----HHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence 3456899999999999999999996 6788999987532 223333 34899999999999999999999874
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .....++||||+.+++|.+++..... ....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 98 ~~~----------~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl 166 (317)
T 2buj_A 98 ERG----------AKHEAWLLLPFFKRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNIL 166 (317)
T ss_dssp EET----------TEEEEEEEEECCTTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred ccC----------CCceeEEEEEeCCCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence 321 12356999999999999999986433 2367999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||++.............. .........||+.|+|||++.+.. ...++.++|||||||++|
T Consensus 167 ~~~~-------~~~kl~dfg~~~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~ 237 (317)
T 2buj_A 167 LGDE-------GQPVLMDLGSMNQACIHVEGSRQAL-TLQDWAAQRCTISYRAPELFSVQS-HCVIDERTDVWSLGCVLY 237 (317)
T ss_dssp ECTT-------SCEEECCCSSCEESCEEEESHHHHH-HHHHHHHHHSCGGGCCGGGSSCCS-EEEECTHHHHHHHHHHHH
T ss_pred EcCC-------CCEEEEecCcchhcccccccccccc-cccccccccCCcccCCHhHhccCC-CcCCCchhhHHHHHHHHH
Confidence 9877 4599999999876532111000000 000001235799999999987411 123688999999999999
Q ss_pred HHHhCCCCCCCCCH--HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 740 ELLTLQVPYMGLSE--LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 740 ELLTG~~PF~~~~~--~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
+|++|+.||..... ..+...+........ ....+..+.+||.+||..||.+
T Consensus 238 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~l~~li~~~l~~dp~~ 290 (317)
T 2buj_A 238 AMMFGEGPYDMVFQKGDSVALAVQNQLSIPQ---------------------------SPRHSSALWQLLNSMMTVDPHQ 290 (317)
T ss_dssp HHHHSSCTTHHHHHTTSCHHHHHHCC--CCC---------------------------CTTSCHHHHHHHHHHTCSSGGG
T ss_pred HHHhCCCChhhhhcccchhhHHhhccCCCCc---------------------------cccCCHHHHHHHHHHhhcChhh
Confidence 99999999953110 111112221111000 0123557999999999999999
Q ss_pred CCCHHHHHHHHHhhcCCCCCC
Q 003185 818 RPTAGDLYEMFVARTSSSISS 838 (840)
Q Consensus 818 RPSa~ELLehLe~l~~~~~s~ 838 (840)
|||+.+|+++|+.+..+.+..
T Consensus 291 Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 291 RPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp SCCHHHHHHHHHHTCCCCCC-
T ss_pred CCCHHHHHHHhhhcCCCCCCC
Confidence 999999999999998776643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=354.71 Aligned_cols=281 Identities=19% Similarity=0.195 Sum_probs=206.6
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|.+.+.||+|+||.||+|.+ .+..||+|++... ...... ...+.+|+.+++.++||||+++++++.....
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP--FQSEIF----AKRAYRELLLLKHMQHENVIGLLDVFTPASS 115 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECST--TSSHHH----HHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccc--ccchhH----HHHHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence 6899999999999999999987 5789999986432 222222 3345899999999999999999999986543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
. ......|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 116 ~--------~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~ 179 (371)
T 4exu_A 116 L--------RNFYDFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE 179 (371)
T ss_dssp S--------TTCCCCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred c--------ccceeEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECC
Confidence 2 12224599999998 58888763 35999999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||+++...... ....||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 180 ~-------~~~kL~Dfg~a~~~~~~~-------------~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~ 236 (371)
T 4exu_A 180 D-------CELKILDFGLARHADAEM-------------TGYVVTRWYRAPEVILS---WMHYNQTVDIWSVGCIMAEML 236 (371)
T ss_dssp T-------CCEEECSTTCC---------------------CTTCCCTTSCHHHHSC---CSCCCTTHHHHHHHHHHHHHH
T ss_pred C-------CCEEEEecCcccccccCc-------------CCcccCccccCHHHhcC---CCCCCcHHhHHHHHHHHHHHH
Confidence 7 459999999997654321 23468999999999875 246789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcccccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|+.||.+.+..+....+.........+.+..........+... .............++.+.+||.+||+.||.+||
T Consensus 237 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 316 (371)
T 4exu_A 237 TGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL 316 (371)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSC
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcC
Confidence 99999999888777766655322222221111100000000000 000001112233467899999999999999999
Q ss_pred CHHHHHHHHHh
Q 003185 820 TAGDLYEMFVA 830 (840)
Q Consensus 820 Sa~ELLehLe~ 830 (840)
|+.|+++|..-
T Consensus 317 t~~ell~hp~f 327 (371)
T 4exu_A 317 TAAQALTHPFF 327 (371)
T ss_dssp CHHHHHTSGGG
T ss_pred CHHHHhcCccc
Confidence 99999999553
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=346.73 Aligned_cols=275 Identities=20% Similarity=0.281 Sum_probs=186.7
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEecCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 581 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~~~ 581 (840)
.+|++.+.||+|+||.||+|.+ .+..||+|++... .....+ .+.+|+.+++++. ||||+++++++....
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~----~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNR----AIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHH----HHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHH----HHHHHHHHHHHhccCCChhhccccccccc
Confidence 4799999999999999999998 6789999986432 222333 3489999999996 999999999986433
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCCCcEE
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENIL 659 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~g--IVHRDLKPeNIL 659 (840)
.. ........++||||+. |+|.+++..... ...+++..++.++.||+.||.|||++| |+||||||+|||
T Consensus 100 ~~------~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl 170 (337)
T 3ll6_A 100 EE------SDTGQAEFLLLTELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLL 170 (337)
T ss_dssp TT------STTSSEEEEEEEECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCE
T ss_pred cc------cccCCceEEEEEEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEE
Confidence 21 0112345799999997 699999976322 346999999999999999999999999 999999999999
Q ss_pred EecccccCCCCCeEEEeecCCccccccccccccccc--CCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~--~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
|+.+ +.+||+|||+++............. ..........||+.|+|||++... ....++.++|||||||+
T Consensus 171 ~~~~-------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~~~Dv~slG~i 242 (337)
T 3ll6_A 171 LSNQ-------GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY-SNFPIGEKQDIWALGCI 242 (337)
T ss_dssp ECTT-------SCEEBCCCTTCBCCSSCC-------------------------------CC-TTSCSSHHHHHHHHHHH
T ss_pred ECCC-------CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhcc-ccCCCChHHhHHHHHHH
Confidence 9877 4699999999987654322110000 000111234689999999998421 12567899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
+|+|++|+.||.......+.... ...... ...+..+.+||.+||+.||.+
T Consensus 243 l~el~~g~~p~~~~~~~~~~~~~---~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~ 292 (337)
T 3ll6_A 243 LYLLCFRQHPFEDGAKLRIVNGK---YSIPPH---------------------------DTQYTVFHSLIRAMLQVNPEE 292 (337)
T ss_dssp HHHHHHSSCCC---------------CCCCTT---------------------------CCSSGGGHHHHHHHSCSSGGG
T ss_pred HHHHHhCCCCCcchhHHHhhcCc---ccCCcc---------------------------cccchHHHHHHHHHccCChhh
Confidence 99999999999765433222111 000000 011235789999999999999
Q ss_pred CCCHHHHHHHHHhhcCC
Q 003185 818 RPTAGDLYEMFVARTSS 834 (840)
Q Consensus 818 RPSa~ELLehLe~l~~~ 834 (840)
|||+.+++++|+.+...
T Consensus 293 Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 293 RLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp SCCHHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHhc
Confidence 99999999999988754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=352.83 Aligned_cols=268 Identities=14% Similarity=0.101 Sum_probs=202.9
Q ss_pred CCCceeeeeecccCceEEEEEEEC----------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcce-
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFG----------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVE- 572 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~----------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~- 572 (840)
-++|++.+.||+|+||.||+|.+. +..+|+|+.... + .+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~----~~~~E~~~l~~l~h~niv~~ 107 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------G----RLFNEQNFFQRAAKPLQVNK 107 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------S----THHHHHHHHHHHCCHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------c----hHHHHHHHHHHhcccchhhh
Confidence 478999999999999999999974 678999997532 1 2388999999999999998
Q ss_pred --------------eeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHH
Q 003185 573 --------------MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAA 638 (840)
Q Consensus 573 --------------l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~ 638 (840)
+++++.... ...||||||+ +++|.+++... ....+++..++.++.||+.
T Consensus 108 ~~~~~~~~~~~i~~~~~~~~~~~-------------~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~ 170 (352)
T 2jii_A 108 WKKLYSTPLLAIPTCMGFGVHQD-------------KYRFLVLPSL-GRSLQSALDVS---PKHVLSERSVLQVACRLLD 170 (352)
T ss_dssp HHHHTTCTTCSCCCCCEEEEETT-------------TEEEEEEECC-CEEHHHHHHHS---GGGCCCHHHHHHHHHHHHH
T ss_pred hhhhccCCccCccchhhccccCC-------------cEEEEEecCC-CcCHHHHHHhC---CcCCCCHHHHHHHHHHHHH
Confidence 445544321 2469999999 89999999862 1256999999999999999
Q ss_pred HHHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhc
Q 003185 639 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718 (840)
Q Consensus 639 AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~ 718 (840)
||.|||++||+||||||+|||++.++. ..+||+|||+++.+........ ..........||+.|+|||++.+
T Consensus 171 ~L~~LH~~~ivH~Dikp~NIl~~~~~~-----~~~kl~Dfg~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~ 242 (352)
T 2jii_A 171 ALEFLHENEYVHGNVTAENIFVDPEDQ-----SQVTLAGYGFAFRYCPSGKHVA---YVEGSRSPHEGDLEFISMDLHKG 242 (352)
T ss_dssp HHHHHHHTTCBCSCCCGGGEEEETTEE-----EEEEECCGGGCBCSSGGGCCCC---CCTTSSCTTCSCTTTCCHHHHTT
T ss_pred HHHHHHhCCccCCCCCHHHEEEcCCCC-----ceEEEecCcceeeccCCCcccc---ccccccccccCCccccCHHHHcc
Confidence 999999999999999999999997731 3699999999987654322110 01111233479999999999986
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcC--CCCCcchHHhhhccCccccccccCCCCCCch
Q 003185 719 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS--ELEIHDLIQMG--KRPRLTDELEALGSCHEHEVAQSGSGFEKPE 794 (840)
Q Consensus 719 ~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~--~~el~~~I~~~--~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~ 794 (840)
..++.++|||||||+||||++|+.||.... ...+....... ..+.+.... .
T Consensus 243 ----~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~ 297 (352)
T 2jii_A 243 ----CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPC---------------------G 297 (352)
T ss_dssp ----CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTT---------------------S
T ss_pred ----CCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhc---------------------c
Confidence 578999999999999999999999997653 33333332211 111111000 0
Q ss_pred hhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 003185 795 AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 795 ~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~~ 834 (840)
.....+..+.+||.+||..||.+|||+++|++.|+.+...
T Consensus 298 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 298 HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 0112356899999999999999999999999999988754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=366.05 Aligned_cols=268 Identities=13% Similarity=0.121 Sum_probs=189.3
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHH---HHHHhCCCCCcceee---
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEV---RMLGALRHSCIVEMY--- 574 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi---~iL~~L~HpNIV~l~--- 574 (840)
..++|++.+.||+|+||.||+|.+ .+..||+|++....... ....+. +.+|+ .+|++++|||||+++
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~----~~~E~~~l~~l~~l~hpniv~~~~~~ 145 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP-SNAIKQ----MKEEVLRLRLLRGIKNQKQAKVHLRF 145 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CC-TTHHHH----HHHHHHGGGGSTTCCSHHHHHHHHCB
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccc-hHHHHH----HHHHHHHHHhccccCCHHHHHHHhhh
Confidence 346899999999999999999996 57899999976432222 222333 48999 455556799999998
Q ss_pred ----eEEecCCCCC---CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHh
Q 003185 575 ----GHKISSKWLP---SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--EKHVSVKLALFIAQDVAAALVELHS 645 (840)
Q Consensus 575 ----g~~~~~~~~p---~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~--~~~ls~~~~~~Ia~QIa~AL~yLHs 645 (840)
+++...+... .............||||||+ +|+|.+++....... ...+++..++.|+.||+.||+|||+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 224 (377)
T 3byv_A 146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 224 (377)
T ss_dssp CCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 5554332100 00000111112469999999 579999998632211 1234458888999999999999999
Q ss_pred CCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-----
Q 003185 646 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH----- 720 (840)
Q Consensus 646 ~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~----- 720 (840)
+||+||||||+||||+.+ +.+||+|||+++...... ....| +.|+|||++.+..
T Consensus 225 ~~ivHrDikp~NIll~~~-------~~~kL~DFG~a~~~~~~~-------------~~~~g-~~y~aPE~~~~~~~~~~~ 283 (377)
T 3byv_A 225 YGLVHTYLRPVDIVLDQR-------GGVFLTGFEHLVRDGARV-------------VSSVS-RGFEPPELEARRATISYH 283 (377)
T ss_dssp TTEECSCCCGGGEEECTT-------CCEEECCGGGCEETTCEE-------------ECCCC-TTCCCHHHHHHHTSTHHH
T ss_pred CCeecCCCCHHHEEEcCC-------CCEEEEechhheecCCcc-------------cCCCC-cCccChhhhccccccccc
Confidence 999999999999999977 469999999998643311 22357 9999999998720
Q ss_pred --CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhh
Q 003185 721 --KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 798 (840)
Q Consensus 721 --~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 798 (840)
....++.++|||||||+||||++|+.||.+.........+... ...
T Consensus 284 ~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--------------------------------~~~ 331 (377)
T 3byv_A 284 RDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS--------------------------------CKN 331 (377)
T ss_dssp HCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGSS--------------------------------CCC
T ss_pred ccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhhh--------------------------------ccC
Confidence 0016899999999999999999999999755432211111100 012
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003185 799 TLSFLVDVFRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 799 ~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe 829 (840)
.++.+.+||.+||..||.+|||+.++++|..
T Consensus 332 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 362 (377)
T 3byv_A 332 IPQPVRALLEGFLRYPKEDRLLPLQAMETPE 362 (377)
T ss_dssp CCHHHHHHHHHHTCSSGGGCCCHHHHHTSHH
T ss_pred CCHHHHHHHHHHcCCCchhCCCHHHHhhChH
Confidence 2457999999999999999999999998743
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=352.59 Aligned_cols=286 Identities=23% Similarity=0.230 Sum_probs=202.9
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC--------CCCcce
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--------HSCIVE 572 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~--------HpNIV~ 572 (840)
..++|++.+.||+|+||.||+|.+ .+..||+|++... ... ...+.+|+.+|+.++ ||||++
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-----EHY----TETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHH----HHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-----Ccc----hHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 347899999999999999999987 5788999996421 222 234489999999996 788999
Q ss_pred eeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-Ceecc
Q 003185 573 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHR 651 (840)
Q Consensus 573 l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~-gIVHR 651 (840)
+++++..... .....+|||||+ +++|.+++.. .....+++..++.|+.||+.||.|||++ ||+||
T Consensus 106 ~~~~~~~~~~----------~~~~~~lv~e~~-~~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHr 171 (397)
T 1wak_A 106 LLDDFKISGV----------NGTHICMVFEVL-GHHLLKWIIK---SNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHT 171 (397)
T ss_dssp EEEEEEEEET----------TEEEEEEEECCC-CCBHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECC
T ss_pred eecceeecCC----------CCceEEEEEecc-CccHHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 9999874321 123569999999 5677777765 2235699999999999999999999999 99999
Q ss_pred cCCCCcEEEecccc------------------------------------------cCCCCCeEEEeecCCccccccccc
Q 003185 652 DIKSENILIDLERK------------------------------------------KADGKPVVKLCDFDRAVPLRSFLH 689 (840)
Q Consensus 652 DLKPeNILLd~~~~------------------------------------------~~~~~~~vKL~DFGlA~~~~~~~~ 689 (840)
||||+||||+.++. .......+||+|||++.......
T Consensus 172 Dikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~- 250 (397)
T 1wak_A 172 DIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF- 250 (397)
T ss_dssp CCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-
T ss_pred CCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-
Confidence 99999999986630 00011369999999998654321
Q ss_pred ccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHcC
Q 003185 690 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS------ELEIHDLIQMG 763 (840)
Q Consensus 690 ~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~------~~el~~~I~~~ 763 (840)
....||+.|+|||++.+ ..++.++|||||||+||||++|+.||...+ .......+...
T Consensus 251 ------------~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 314 (397)
T 1wak_A 251 ------------TEDIQTRQYRSLEVLIG----SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIEL 314 (397)
T ss_dssp ------------CSCCSCGGGCCHHHHHT----SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHH
T ss_pred ------------ccCCCCCcccCChhhcC----CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHh
Confidence 22468999999999986 568999999999999999999999997654 22233333221
Q ss_pred CCCCcchHHhhhccCcccccccc-----CCCCC----------CchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003185 764 KRPRLTDELEALGSCHEHEVAQS-----GSGFE----------KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828 (840)
Q Consensus 764 ~~p~l~~~l~~~~~~~~~~~~~~-----~~~~~----------~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehL 828 (840)
... .+..+..........+... ..... ........+..+.+||.+||+.||.+|||+.||++|.
T Consensus 315 ~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 393 (397)
T 1wak_A 315 LGK-VPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHP 393 (397)
T ss_dssp HCS-CCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSG
T ss_pred cCC-CChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCc
Confidence 111 1111110000000000000 00000 0011245577899999999999999999999999985
Q ss_pred H
Q 003185 829 V 829 (840)
Q Consensus 829 e 829 (840)
+
T Consensus 394 ~ 394 (397)
T 1wak_A 394 W 394 (397)
T ss_dssp G
T ss_pred c
Confidence 4
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=345.83 Aligned_cols=278 Identities=22% Similarity=0.293 Sum_probs=203.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 575 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g 575 (840)
....+|++.+.||+|+||.||+|.+ .+..||+|++... .....+ .+.+|+.++++++||||+++++
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~----~~~~E~~~l~~l~h~~iv~~~~ 109 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLR----DFEREIEILKSLQHDNIVKYKG 109 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC----CSHHHH----HHHHHHHHHHTCCCTTBCCEEE
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC----CHHHHH----HHHHHHHHHHhCCCCCeeeEEE
Confidence 3456799999999999999999985 5778999986432 222333 3489999999999999999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCC
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 655 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKP 655 (840)
++..... ...++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||
T Consensus 110 ~~~~~~~------------~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp 173 (326)
T 2w1i_A 110 VCYSAGR------------RNLKLIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLAT 173 (326)
T ss_dssp EECC----------------CCEEEECCCTTCBHHHHHHH----STTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred EEEecCC------------CceEEEEECCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCc
Confidence 9875431 135999999999999999986 234689999999999999999999999999999999
Q ss_pred CcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003185 656 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735 (840)
Q Consensus 656 eNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLG 735 (840)
+|||++.+ +.+||+|||++........... ......+|..|+|||++.+ ..++.++||||||
T Consensus 174 ~NIli~~~-------~~~kL~Dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG 235 (326)
T 2w1i_A 174 RNILVENE-------NRVKIGDFGLTKVLPQDKEYYK-------VKEPGESPIFWYAPESLTE----SKFSVASDVWSFG 235 (326)
T ss_dssp GGEEEEET-------TEEEECCCTTCEECCSSCSEEE-------CSSCCSCCGGGCCHHHHHH----CEEEHHHHHHHHH
T ss_pred ceEEEcCC-------CcEEEecCcchhhccccccccc-------cccCCCCceeEECchhhcC----CCCCchhhHHHHH
Confidence 99999877 4699999999987654321100 0122357888999999986 5678999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcc-hHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003185 736 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT-DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 814 (840)
Q Consensus 736 vIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~D 814 (840)
|++|+|+||..||.... ......+......... ..+... ...... .......+..+.+||.+||..|
T Consensus 236 ~il~el~tg~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~---~~~~~~~~~~l~~li~~cl~~d 303 (326)
T 2w1i_A 236 VVLYELFTYIEKSKSPP-AEFMRMIGNDKQGQMIVFHLIEL--------LKNNGR---LPRPDGCPDEIYMIMTECWNNN 303 (326)
T ss_dssp HHHHHHHHTTCGGGSHH-HHHHHHHCTTCCTHHHHHHHHHH--------HHTTCC---CCCCTTCCHHHHHHHHHHSCSS
T ss_pred HHHHHHHhcCCCCCCCH-HHHHHhhccccchhhhHHHHHHH--------hhcCCC---CCCCCcccHHHHHHHHHHcCCC
Confidence 99999999999985431 1111111111100000 000000 000000 0011234568999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcC
Q 003185 815 PTERPTAGDLYEMFVARTS 833 (840)
Q Consensus 815 P~eRPSa~ELLehLe~l~~ 833 (840)
|.+|||+.+|++.|+.+..
T Consensus 304 P~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 304 VNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp GGGSCCHHHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHHHH
Confidence 9999999999999998753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=338.68 Aligned_cols=260 Identities=25% Similarity=0.353 Sum_probs=198.3
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.+++|.....||+|+||.||+|.+ ++..||+|+..... .... +.+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 91 (295)
T 2clq_A 20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD----SRYS----QPLHEEIALHKHLKHKNIVQYLGSFSEN 91 (295)
T ss_dssp CBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC----C-------HHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred cccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc----hHHH----HHHHHHHHHHHhCCCCCEeeEeeEEEeC
Confidence 455666677999999999999998 56788999865331 1122 2348999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
. ..++||||+++++|.+++... .....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 92 ~--------------~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~ 155 (295)
T 2clq_A 92 G--------------FIKIFMEQVPGGSLSALLRSK--WGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLI 155 (295)
T ss_dssp T--------------EEEEEEECCSEEEHHHHHHHT--TCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred C--------------cEEEEEEeCCCCCHHHHHHhh--ccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEE
Confidence 5 359999999999999999862 223456789999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+... +.+||+|||++......... .....||+.|+|||++.+.. ..++.++||||||+++|+
T Consensus 156 ~~~~------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~--~~~~~~~Di~slG~il~~ 217 (295)
T 2clq_A 156 NTYS------GVLKISDFGTSKRLAGINPC----------TETFTGTLQYMAPEIIDKGP--RGYGKAADIWSLGCTIIE 217 (295)
T ss_dssp ETTT------CCEEECCTTTCEESCC---------------CCCCCCGGGCCHHHHHHGG--GGCSHHHHHHHHHHHHHH
T ss_pred ECCC------CCEEEeecccccccCCCCCc----------ccccCCCccccChhhhcCCC--CCCCcHHHHHHHHHHHHH
Confidence 8621 46999999999865432111 12346899999999997521 237899999999999999
Q ss_pred HHhCCCCCCCCCHHH--HHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 741 LLTLQVPYMGLSELE--IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 741 LLTG~~PF~~~~~~e--l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
|++|+.||....... ..........+.++ ...+..+.+||.+||..||.+|
T Consensus 218 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~dp~~R 270 (295)
T 2clq_A 218 MATGKPPFYELGEPQAAMFKVGMFKVHPEIP---------------------------ESMSAEAKAFILKCFEPDPDKR 270 (295)
T ss_dssp HHHTSCTTGGGSSHHHHHHHHHHHCCCCCCC---------------------------TTSCHHHHHHHHHTTCSSTTTS
T ss_pred HHHCCCCccCCCchhHHHHhhcccccccccc---------------------------ccCCHHHHHHHHHHccCChhhC
Confidence 999999997543222 11111122222222 1234578999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 003185 819 PTAGDLYEMFVAR 831 (840)
Q Consensus 819 PSa~ELLehLe~l 831 (840)
||+.++++|..-.
T Consensus 271 ps~~~ll~~~~~~ 283 (295)
T 2clq_A 271 ACANDLLVDEFLK 283 (295)
T ss_dssp CCHHHHHTSGGGC
T ss_pred CCHHHHhcChhhh
Confidence 9999999985543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=376.56 Aligned_cols=257 Identities=23% Similarity=0.307 Sum_probs=206.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
...++|++.+.||+|+||.||+|.+ .+..||+|++..... ........+.+|+.+|+.++|||||++++++..
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~-----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-----KKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhh-----hhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee
Confidence 5667899999999999999999998 578999999754321 111112345899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .||||||++||+|..++.. .+...+++..++.++.||+.||.|||++|||||||||+|||
T Consensus 256 ~~~--------------l~lVmEy~~gg~L~~~l~~---~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNIL 318 (576)
T 2acx_A 256 KDA--------------LCLVLTLMNGGDLKFHIYH---MGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENIL 318 (576)
T ss_dssp SSE--------------EEEEECCCCSCBHHHHHHS---SSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CCE--------------EEEEEEcCCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEE
Confidence 553 5999999999999999875 22345999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
|+.+ +.+||+|||+++....... ....+||+.|+|||++.+ ..++.++|||||||+||
T Consensus 319 ld~~-------g~vKL~DFGla~~~~~~~~-----------~~~~~GT~~Y~APEvl~~----~~~~~~~DiwSLGvily 376 (576)
T 2acx_A 319 LDDH-------GHIRISDLGLAVHVPEGQT-----------IKGRVGTVGYMAPEVVKN----ERYTFSPDWWALGCLLY 376 (576)
T ss_dssp ECTT-------SCEEECCCTTCEECCTTCC-----------EECCCSCGGGCCHHHHTT----CEESSHHHHHHHHHHHH
T ss_pred EeCC-------CCeEEEecccceecccCcc-----------ccccCCCccccCHHHHcC----CCCCccchHHHHHHHHH
Confidence 9877 4699999999987643221 122469999999999986 56899999999999999
Q ss_pred HHHhCCCCCCCCC----HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 740 ELLTLQVPYMGLS----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 740 ELLTG~~PF~~~~----~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
||++|..||.+.. ...+...+..... .++ ...+..+.+||.+||..||
T Consensus 377 eLltG~~PF~~~~~~~~~~~i~~~i~~~~~-~~p---------------------------~~~s~~~~dLI~~lL~~dP 428 (576)
T 2acx_A 377 EMIAGQSPFQQRKKKIKREEVERLVKEVPE-EYS---------------------------ERFSPQARSLCSQLLCKDP 428 (576)
T ss_dssp HHHHSSCSSSCSSSCCCHHHHHHHHHHCCC-CCC---------------------------TTSCHHHHHHHHHHTCSSG
T ss_pred HHHhCCCCCcccccchhHHHHHHHhhcccc-cCC---------------------------ccCCHHHHHHHHHhccCCH
Confidence 9999999997653 3444444443311 111 1124579999999999999
Q ss_pred CCCC-----CHHHHHHHHHh
Q 003185 816 TERP-----TAGDLYEMFVA 830 (840)
Q Consensus 816 ~eRP-----Sa~ELLehLe~ 830 (840)
.+|| +++||++|..-
T Consensus 429 ~~R~g~~~~sa~eil~HpfF 448 (576)
T 2acx_A 429 AERLGCRGGSAREVKEHPLF 448 (576)
T ss_dssp GGSTTCSSSHHHHHHTSGGG
T ss_pred HHcCCCCCCCHHHHHhChhh
Confidence 9999 89999998543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=358.52 Aligned_cols=292 Identities=20% Similarity=0.247 Sum_probs=188.6
Q ss_pred Ccee-eeeecccCceEEEEEEEC----CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 506 SLSS-CDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 506 ~y~i-~~~LG~G~fG~Vy~a~~~----~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.|.+ +++||+|+||.||+|++. +..||+|++... ... ..+.+|+.+|++|+|||||++++++...
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~--------~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GIS--------MSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCC--------HHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCC--------HHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 3555 568999999999999964 678999985322 111 1338899999999999999999999653
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~----~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
.. ...||||||+. ++|.+++...... ....+++..++.|+.||+.||.|||++||+||||||+
T Consensus 91 ~~------------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~ 157 (405)
T 3rgf_A 91 AD------------RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPA 157 (405)
T ss_dssp TT------------TEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred CC------------CeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHH
Confidence 21 24699999997 5899888643221 1235899999999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
||||...+. ..+.+||+|||+++.+...... ........||+.|+|||++.+ ...++.++|||||||
T Consensus 158 NIll~~~~~---~~~~~kl~Dfg~a~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~ 224 (405)
T 3rgf_A 158 NILVMGEGP---ERGRVKIADMGFARLFNSPLKP-------LADLDPVVVTFWYRAPELLLG---ARHYTKAIDIWAIGC 224 (405)
T ss_dssp GEEECCSST---TTTCEEECCTTCCC-----------------------CCCTTCCHHHHTT---CCSCCHHHHHHHHHH
T ss_pred HeEEecCCC---CCCcEEEEECCCceecCCCCcc-------cccCCCceecCcccCchhhcC---CCcccchhhhHHHHH
Confidence 999954311 2367999999999876532111 011233579999999999975 245899999999999
Q ss_pred HHHHHHhCCCCCCCCCHH---------HHHHHHHcC-CCCCcchHHhhhccCccc-----cccccC-CCCCCc----hhh
Q 003185 737 LLLELLTLQVPYMGLSEL---------EIHDLIQMG-KRPRLTDELEALGSCHEH-----EVAQSG-SGFEKP----EAE 796 (840)
Q Consensus 737 IL~ELLTG~~PF~~~~~~---------el~~~I~~~-~~p~l~~~l~~~~~~~~~-----~~~~~~-~~~~~~----~~~ 796 (840)
+||||++|..||.+.... +.+..+... ..+. ...+......... .+.... ...... ...
T Consensus 225 il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (405)
T 3rgf_A 225 IFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPA-DKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHK 303 (405)
T ss_dssp HHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCC-TTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTT
T ss_pred HHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCC-hhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcC
Confidence 999999999999765431 333333222 1111 1111111000000 000000 000000 000
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 003185 797 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 797 ~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~~ 834 (840)
...+..+.+||.+||..||.+|||++|+++|.+-....
T Consensus 304 ~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 304 VKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDP 341 (405)
T ss_dssp CCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSS
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCC
Confidence 01145789999999999999999999999998765544
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=372.27 Aligned_cols=259 Identities=20% Similarity=0.268 Sum_probs=206.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
...++|.+.+.||+|+||.||+|++ .+..||+|+...... ........+.+|+.+|++++||||+++++++..
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~-----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 256 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL-----KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET 256 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHh-----hhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee
Confidence 5678999999999999999999998 578999999753321 111112345899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... +||||||++||+|..++.... .....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 257 ~~~--------------l~lVmE~~~gg~L~~~l~~~~-~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NIL 321 (543)
T 3c4z_A 257 KTD--------------LCLVMTIMNGGDIRYHIYNVD-EDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVL 321 (543)
T ss_dssp SSE--------------EEEEECCCTTCBHHHHHHTSS-TTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CCE--------------EEEEEEeccCCCHHHHHHHhh-cccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEE
Confidence 553 599999999999999987521 11346999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
|+.+ +.+||+|||+++.+...... .....||+.|+|||++.+ ..++.++|||||||+||
T Consensus 322 l~~~-------g~vkL~DFGla~~~~~~~~~----------~~~~~GT~~Y~APE~l~~----~~~~~~~DiwSlGvily 380 (543)
T 3c4z_A 322 LDDD-------GNVRISDLGLAVELKAGQTK----------TKGYAGTPGFMAPELLLG----EEYDFSVDYFALGVTLY 380 (543)
T ss_dssp ECTT-------SCEEECCCTTCEECCTTCCC----------BCCCCSCTTTSCHHHHTT----CCBCTHHHHHHHHHHHH
T ss_pred EeCC-------CCEEEeecceeeeccCCCcc----------cccccCCccccChhhhcC----CCCChHHhcCcchHHHH
Confidence 9877 46999999999876432111 123479999999999986 67899999999999999
Q ss_pred HHHhCCCCCCCC----CHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003185 740 ELLTLQVPYMGL----SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 740 ELLTG~~PF~~~----~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP 815 (840)
||++|+.||.+. ...++...+..... .++ ...+..+.+||.+||..||
T Consensus 381 elltG~~PF~~~~~~~~~~~~~~~i~~~~~-~~p---------------------------~~~s~~~~~li~~lL~~dP 432 (543)
T 3c4z_A 381 EMIAARGPFRARGEKVENKELKQRVLEQAV-TYP---------------------------DKFSPASKDFCEALLQKDP 432 (543)
T ss_dssp HHHHSSCSSCCTTCCCCHHHHHHHHHHCCC-CCC---------------------------TTSCHHHHHHHHHHSCSSG
T ss_pred HHHhCCCCCCCCccchhHHHHHHHHhhccc-CCC---------------------------cccCHHHHHHHHHhccCCH
Confidence 999999999765 33455555544321 111 1124578999999999999
Q ss_pred CCCCC-----HHHHHHHHH
Q 003185 816 TERPT-----AGDLYEMFV 829 (840)
Q Consensus 816 ~eRPS-----a~ELLehLe 829 (840)
.+||+ +++|++|..
T Consensus 433 ~~R~~~~~~~a~ei~~Hpf 451 (543)
T 3c4z_A 433 EKRLGFRDGSCDGLRTHPL 451 (543)
T ss_dssp GGSCCCBTTBSHHHHTSGG
T ss_pred hHCCCCcccCHHHHHcCcc
Confidence 99996 588998743
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=334.31 Aligned_cols=274 Identities=20% Similarity=0.287 Sum_probs=195.5
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||.||+|.+ .+..+|+|++... .... ..+.+|+.++++++||||+++++++.....
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 76 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKL----STILSEVMLLASLNHQYVVRYYAAWLERRN 76 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-----HHHH----HHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-----HHHH----HHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence 4799999999999999999997 5788999987432 2223 344899999999999999999999876532
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
+.. ...........|+||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 77 ~~~-~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~ 151 (303)
T 1zy4_A 77 FVK-PMTAVKKKSTLFIQMEYCENGTLYDLIHS----ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE 151 (303)
T ss_dssp CCC-------CEEEEEEEEECCCSCBHHHHHHH----SCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred hhh-hhcccccCCceEEEEecCCCCCHHHhhhc----cccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcC
Confidence 200 00111123467999999999999999986 2356788999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccc----cCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA----HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~----~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
+ +.+||+|||++............. ...........||+.|+|||++.+ ...++.++|||||||++
T Consensus 152 ~-------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il 221 (303)
T 1zy4_A 152 S-------RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG---TGHYNEKIDMYSLGIIF 221 (303)
T ss_dssp T-------SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTS---CSCCCTHHHHHHHHHHH
T ss_pred C-------CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC---CCCCcchhhHHHHHHHH
Confidence 7 459999999998664321100000 000111234568999999999975 24678999999999999
Q ss_pred HHHHhCCCCCCCC-CHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 739 LELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 739 ~ELLTG~~PF~~~-~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
|+|++ ||... ...+....+..... .++.. .....+..+.+||.+||..||.+
T Consensus 222 ~~l~~---p~~~~~~~~~~~~~~~~~~~-~~~~~-----------------------~~~~~~~~~~~li~~~l~~dp~~ 274 (303)
T 1zy4_A 222 FEMIY---PFSTGMERVNILKKLRSVSI-EFPPD-----------------------FDDNKMKVEKKIIRLLIDHDPNK 274 (303)
T ss_dssp HHHHS---CCSSHHHHHHHHHHHHSTTC-CCCTT-----------------------CCTTTSHHHHHHHHHHTCSSGGG
T ss_pred HHHHh---ccCCchhHHHHHHhcccccc-ccCcc-----------------------ccccchHHHHHHHHHHHhcCccc
Confidence 99998 55432 33344444433211 11110 11223457899999999999999
Q ss_pred CCCHHHHHHHHH
Q 003185 818 RPTAGDLYEMFV 829 (840)
Q Consensus 818 RPSa~ELLehLe 829 (840)
|||+.++++|.+
T Consensus 275 Rps~~~ll~h~~ 286 (303)
T 1zy4_A 275 RPGARTLLNSGW 286 (303)
T ss_dssp SCCHHHHHHSSC
T ss_pred CcCHHHHhCCCC
Confidence 999999999854
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=341.17 Aligned_cols=281 Identities=18% Similarity=0.190 Sum_probs=204.3
Q ss_pred CCCCceeeeeecccCceEEEEEEEC---CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCC------ccee
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC------IVEM 573 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~---~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpN------IV~l 573 (840)
.-++|++.+.||+|+||.||+|.+. +..||+|++.. ..... ..+.+|+.+++.++|++ |+.+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~----~~~~~E~~~l~~l~~~~~~~~~~~~~~ 87 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-----VGKYR----EAARLEINVLKKIKEKDKENKFLCVLM 87 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----CHHHH----HHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-----cccch----hHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence 3578999999999999999999973 36899999642 12222 34488999999997665 8999
Q ss_pred eeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccC
Q 003185 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 653 (840)
Q Consensus 574 ~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDL 653 (840)
++++.... ..+|||||+ +++|.+++.. .....+++..++.++.||+.||.|||++||+||||
T Consensus 88 ~~~~~~~~--------------~~~lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dl 149 (355)
T 2eu9_A 88 SDWFNFHG--------------HMCIAFELL-GKNTFEFLKE---NNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDL 149 (355)
T ss_dssp EEEEEETT--------------EEEEEEECC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCC
T ss_pred eeeeeeCC--------------eEEEEEecc-CCChHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 99887655 359999999 5688888765 22346899999999999999999999999999999
Q ss_pred CCCcEEEecccc------------cCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC
Q 003185 654 KSENILIDLERK------------KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 721 (840)
Q Consensus 654 KPeNILLd~~~~------------~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~ 721 (840)
||+||||+..+. .....+.+||+|||+++..... .....||+.|+|||++.+
T Consensus 150 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------------~~~~~gt~~y~aPE~~~~--- 213 (355)
T 2eu9_A 150 KPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-------------HTTIVATRHYRPPEVILE--- 213 (355)
T ss_dssp CGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-------------CCSSCSCGGGCCHHHHTT---
T ss_pred CHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc-------------ccCCcCCCcccCCeeeec---
Confidence 999999953210 0012367999999999764321 123469999999999986
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCC----------
Q 003185 722 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE---------- 791 (840)
Q Consensus 722 ~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~---------- 791 (840)
..++.++|||||||+||||++|..||.+....+....+.....+ ++..+....... ..+......+.
T Consensus 214 -~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 290 (355)
T 2eu9_A 214 -LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGP-IPSHMIHRTRKQ-KYFYKGGLVWDENSSDGRYVK 290 (355)
T ss_dssp -CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCHHHHHHCSCG-GGEETTEECCCTTSHHHHHHH
T ss_pred -CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC-CcHHHhhhccch-hhhcccccccccccchhcccc
Confidence 66899999999999999999999999988877766555443222 222211110000 00000000000
Q ss_pred --------CchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003185 792 --------KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 792 --------~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe 829 (840)
........+..+.+||.+||..||.+|||+.++++|..
T Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~ 336 (355)
T 2eu9_A 291 ENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPF 336 (355)
T ss_dssp HHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGG
T ss_pred ccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 00011233568999999999999999999999999854
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=353.67 Aligned_cols=262 Identities=14% Similarity=0.136 Sum_probs=199.2
Q ss_pred CCCCceeeeeecccCceEEEEEE-------ECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC---CCCcce
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCK-------FGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVE 572 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~-------~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~---HpNIV~ 572 (840)
.-++|.+.+.||+|+||.||+|. ..+..||+|+.... . ... +.+|+.++..++ |+||++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~---~~~----~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----N---PWE----FYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----C---HHH----HHHHHHHHHHSCGGGGGGBCC
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----C---hhH----HHHHHHHHHHhhhhhhhhhhh
Confidence 34679999999999999999993 36789999996422 1 122 377888888887 999999
Q ss_pred eeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Q 003185 573 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRD 652 (840)
Q Consensus 573 l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRD 652 (840)
+++++...+. .||||||+++|+|.+++..........+++..++.|+.||+.||+|||++||||||
T Consensus 132 ~~~~~~~~~~--------------~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrD 197 (365)
T 3e7e_A 132 FYSAHLFQNG--------------SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGD 197 (365)
T ss_dssp EEEEEECSSC--------------EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCC
T ss_pred hheeeecCCC--------------cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCC
Confidence 9999987654 49999999999999999875444456799999999999999999999999999999
Q ss_pred CCCCcEEEecccc----cCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCch
Q 003185 653 IKSENILIDLERK----KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 728 (840)
Q Consensus 653 LKPeNILLd~~~~----~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~k 728 (840)
|||+||||+.... .....+.+||+|||+|+.+....... .....+||+.|||||++.+ ..++.+
T Consensus 198 iKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~----~~~~~~ 265 (365)
T 3e7e_A 198 IKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT--------IFTAKCETSGFQCVEMLSN----KPWNYQ 265 (365)
T ss_dssp CSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTE--------EECCSSCTTSCCCHHHHTT----CCBSTH
T ss_pred CCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCc--------eeeeecCCCCCCChHHhcC----CCCCcc
Confidence 9999999987100 01123679999999997654221110 1133469999999999986 568999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHH
Q 003185 729 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 808 (840)
Q Consensus 729 SDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~ 808 (840)
+|||||||+||||+||+.||....... .. +. .... .....+.+.+++.
T Consensus 266 ~DiwslG~il~elltg~~pf~~~~~~~------~~----~~---------------~~~~-------~~~~~~~~~~~~~ 313 (365)
T 3e7e_A 266 IDYFGVAATVYCMLFGTYMKVKNEGGE------CK----PE---------------GLFR-------RLPHLDMWNEFFH 313 (365)
T ss_dssp HHHHHHHHHHHHHHHSSCCCEEEETTE------EE----EC---------------SCCT-------TCSSHHHHHHHHH
T ss_pred ccHHHHHHHHHHHHhCCCccccCCCCc------ee----ec---------------hhcc-------ccCcHHHHHHHHH
Confidence 999999999999999999995432100 00 00 0000 0012557889999
Q ss_pred HhcccCCCCC-CCHHHHHHHHHhhcC
Q 003185 809 RCTEENPTER-PTAGDLYEMFVARTS 833 (840)
Q Consensus 809 rCL~~DP~eR-PSa~ELLehLe~l~~ 833 (840)
.||+.+|.+| |++.++.+.|+.+..
T Consensus 314 ~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 314 VMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp HHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 9999999999 678888887777654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=348.72 Aligned_cols=281 Identities=19% Similarity=0.186 Sum_probs=205.2
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|.+.+.||+|+||.||+|.+ .+..||+|++... ...... ...+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 97 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP--FQSEIF----AKRAYRELLLLKHMQHENVIGLLDVFTPASS 97 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESST--TSSHHH----HHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccc--ccchHH----HHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence 6899999999999999999997 5788999986432 222222 3345899999999999999999999876542
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
. ......|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 98 ~--------~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~ 161 (353)
T 3coi_A 98 L--------RNFYDFYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE 161 (353)
T ss_dssp G--------GGCCCCEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECT
T ss_pred c--------ccceeEEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECC
Confidence 1 11224599999997 58887763 35899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||++...... .....||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 162 ~-------~~~kl~Dfg~~~~~~~~-------------~~~~~~t~~y~aPE~~~~---~~~~~~~~Di~slG~il~el~ 218 (353)
T 3coi_A 162 D-------CELKILDFGLARHADAE-------------MTGYVVTRWYRAPEVILS---WMHYNQTVDIWSVGCIMAEML 218 (353)
T ss_dssp T-------CCEEECSTTCTTC---------------------CCSBCCSCHHHHSC---CSCCCTTHHHHHHHHHHHHHH
T ss_pred C-------CcEEEeecccccCCCCC-------------ccccccCcCcCCHHHHhC---cCCCCchhhHHHHHHHHHHHH
Confidence 7 46999999999765332 122468999999999875 246789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccc---cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ---SGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|..||.+.+..+....+.........+.+..........+.. ..............+..+.+||.+||..||.+||
T Consensus 219 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp 298 (353)
T 3coi_A 219 TGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL 298 (353)
T ss_dssp HSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSC
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCC
Confidence 9999999988777666665432111111111100000000000 0000001112234567899999999999999999
Q ss_pred CHHHHHHHHHh
Q 003185 820 TAGDLYEMFVA 830 (840)
Q Consensus 820 Sa~ELLehLe~ 830 (840)
|+.++++|..-
T Consensus 299 t~~e~l~hp~f 309 (353)
T 3coi_A 299 TAAQALTHPFF 309 (353)
T ss_dssp CHHHHHTSGGG
T ss_pred CHHHHhcCcch
Confidence 99999998553
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=351.62 Aligned_cols=280 Identities=19% Similarity=0.229 Sum_probs=210.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHH---------HHHhHHhHHHHHHHHHhCCCCCcce
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADE---------IRNFEYSCLGEVRMLGALRHSCIVE 572 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~---------~~~f~~~~~rEi~iL~~L~HpNIV~ 572 (840)
..+++|++.+.||+|+||.||+|.+.+..||+|++........... .......+.+|+.++++++||||++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 4578999999999999999999999999999999864432211000 0000134589999999999999999
Q ss_pred eeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHH------HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-
Q 003185 573 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY------IEKLSETGEKHVSVKLALFIAQDVAAALVELHS- 645 (840)
Q Consensus 573 l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~------L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs- 645 (840)
+++++.... ..++||||+++++|.++ +.. .....+++..++.++.||+.||.|||+
T Consensus 108 ~~~~~~~~~--------------~~~lv~e~~~~~~L~~~~~~~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 170 (348)
T 2pml_X 108 CEGIITNYD--------------EVYIIYEYMENDSILKFDEYFFVLDK---NYTCFIPIQVIKCIIKSVLNSFSYIHNE 170 (348)
T ss_dssp CSEEEESSS--------------EEEEEEECCTTCBSSEESSSEESSCS---SSCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEEeeCC--------------eEEEEEeccCCCcHHHHHHHhhhhhh---ccccCCCHHHHHHHHHHHHHHHHHHhcc
Confidence 999998654 35999999999999998 432 224679999999999999999999999
Q ss_pred CCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCC
Q 003185 646 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 725 (840)
Q Consensus 646 ~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~ 725 (840)
+||+||||||+|||++.+ +.+||+|||++....... .....||+.|+|||++.+ ...+
T Consensus 171 ~~i~H~dl~p~Nil~~~~-------~~~kl~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~---~~~~ 228 (348)
T 2pml_X 171 KNICHRDVKPSNILMDKN-------GRVKLSDFGESEYMVDKK------------IKGSRGTYEFMPPEFFSN---ESSY 228 (348)
T ss_dssp SCEECCCCCGGGEEECTT-------SCEEECCCTTCEECBTTE------------ECSSCSCGGGCCGGGGSS---CCCE
T ss_pred CCEeecCCChHhEEEcCC-------CcEEEecccccccccccc------------ccCCCCCcCccCchhhcC---CCCC
Confidence 999999999999999877 469999999998754321 123468999999999976 1245
Q ss_pred Cc-hhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHH
Q 003185 726 GL-EVDIWSYGCLLLELLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 803 (840)
Q Consensus 726 s~-kSDVWSLGvIL~ELLTG~~PF~~~~~-~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L 803 (840)
+. ++|||||||++|+|++|..||..... .++...+..... .++.... .+................+..+
T Consensus 229 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~-~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~l 299 (348)
T 2pml_X 229 NGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNI-EYPLDRN--------HFLYPLTNKKSTCSNNFLSNED 299 (348)
T ss_dssp EHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCC-CCCCSSS--------SSTTTTCC--------CCCHHH
T ss_pred CcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCc-CCccchh--------hhhccccccccccchhhcCHHH
Confidence 55 99999999999999999999988766 666666655432 1221000 0000000000111123346789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHH
Q 003185 804 VDVFRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 804 ~dLI~rCL~~DP~eRPSa~ELLehLe 829 (840)
.+||.+||..||.+|||+.++++|..
T Consensus 300 ~~li~~~L~~dP~~Rps~~e~l~hp~ 325 (348)
T 2pml_X 300 IDFLKLFLRKNPAERITSEDALKHEW 325 (348)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHHccCChhhCCCHHHHhcCcc
Confidence 99999999999999999999999854
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=347.73 Aligned_cols=280 Identities=21% Similarity=0.247 Sum_probs=206.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CC-----Cccee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HS-----CIVEM 573 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-Hp-----NIV~l 573 (840)
...++|++.+.||+|+||.||+|.+ .+..||+|++... .. +...+.+|+.+++.++ |+ +|+++
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~----~~~~~~~e~~~l~~l~~~~~~~~~~iv~~ 121 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-----KA----FLNQAQIEVRLLELMNKHDTEMKYYIVHL 121 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-----HH----HHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-----HH----HHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence 4568999999999999999999997 4778999986422 12 2233478899988886 55 49999
Q ss_pred eeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecc
Q 003185 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH--SKHIMHR 651 (840)
Q Consensus 574 ~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLH--s~gIVHR 651 (840)
++++.... ..+|||||+. ++|.+++.. .....+++..++.++.||+.||.||| +.|||||
T Consensus 122 ~~~~~~~~--------------~~~lv~e~~~-~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHr 183 (382)
T 2vx3_A 122 KRHFMFRN--------------HLCLVFEMLS-YNLYDLLRN---TNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHC 183 (382)
T ss_dssp EEEEEETT--------------EEEEEEECCC-CBHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECC
T ss_pred eeeeccCC--------------ceEEEEecCC-CCHHHHHhh---cCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcC
Confidence 99988655 3599999997 599999986 22245899999999999999999999 4699999
Q ss_pred cCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhH
Q 003185 652 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 731 (840)
Q Consensus 652 DLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDV 731 (840)
||||+||||+.+. .+.+||+|||+++..... .....||+.|+|||++.+ ..++.++||
T Consensus 184 Dlkp~NIll~~~~-----~~~~kL~DFG~a~~~~~~-------------~~~~~~t~~y~aPE~~~~----~~~~~~~Di 241 (382)
T 2vx3_A 184 DLKPENILLCNPK-----RSAIKIVDFGSSCQLGQR-------------IYQYIQSRFYRSPEVLLG----MPYDLAIDM 241 (382)
T ss_dssp CCSGGGEEESSTT-----SCCEEECCCTTCEETTCC-------------CCSSCSCGGGCCHHHHTT----CCCCTHHHH
T ss_pred CCCcccEEEecCC-----CCcEEEEeccCceecccc-------------cccccCCccccChHHHcC----CCCCcHHHH
Confidence 9999999996542 267999999999866432 123468999999999986 568999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhc-------cCcccccc-----ccCCCCC--------
Q 003185 732 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG-------SCHEHEVA-----QSGSGFE-------- 791 (840)
Q Consensus 732 WSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~-------~~~~~~~~-----~~~~~~~-------- 791 (840)
|||||+||||++|+.||.+.+..+....+...........+.... ......+. .......
T Consensus 242 wSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 321 (382)
T 2vx3_A 242 WSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLH 321 (382)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHH
Confidence 999999999999999999988888777766542222111111100 00000000 0000000
Q ss_pred ----------------CchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003185 792 ----------------KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 792 ----------------~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~ 830 (840)
.........+.+.+||.+||+.||.+|||++|+++|.+-
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f 376 (382)
T 2vx3_A 322 NILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFF 376 (382)
T ss_dssp HHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred HHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCccc
Confidence 000112234579999999999999999999999998653
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=373.57 Aligned_cols=257 Identities=21% Similarity=0.317 Sum_probs=207.0
Q ss_pred CCCCceeeeeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEE
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 577 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~ 577 (840)
..++|++.+.||+|+||.||+|.+. +..+|+|+. +.. ...... +.+.+|+.+|++++||||+++++++
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~--~~~-~~~~~~----~~~~~E~~~l~~l~HpnIv~l~~~~ 460 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNC-TSDSVR----EKFLQEALTMRQFDHPHIVKLIGVI 460 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEEC--SST-TCHHHH----HHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEe--ccc-CCHHHH----HHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3467999999999999999999973 234666663 321 122222 3458999999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
... . .||||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 461 ~~~-~--------------~~lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~N 521 (656)
T 2j0j_A 461 TEN-P--------------VWIIMELCTLGELRSFLQV----RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 521 (656)
T ss_dssp CSS-S--------------CEEEEECCTTCBHHHHHHH----TTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ecC-c--------------eEEEEEcCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHh
Confidence 432 2 3999999999999999975 23468999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
||++.+ +.+||+|||+++........ ......+|+.|+|||++.+ ..++.++|||||||+
T Consensus 522 ILl~~~-------~~vkL~DFG~a~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~----~~~~~~~DiwSlG~i 581 (656)
T 2j0j_A 522 VLVSSN-------DCVKLGDFGLSRYMEDSTYY---------KASKGKLPIKWMAPESINF----RRFTSASDVWMFGVC 581 (656)
T ss_dssp EEEEET-------TEEEECCCCCCCSCCC-------------------CCGGGCCHHHHHH----CCCCHHHHHHHHHHH
T ss_pred EEEeCC-------CCEEEEecCCCeecCCCcce---------eccCCCCCcceeCHHHhcC----CCCCchhhHHHHHHH
Confidence 999977 46999999999876432211 1122357889999999986 678999999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 738 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 738 L~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
+|||++ |..||.+....++...+..+.++.++. ..+..+.+||.+||..||.
T Consensus 582 l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dP~ 634 (656)
T 2j0j_A 582 MWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------------------NCPPTLYSLMTKCWAYDPS 634 (656)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cccHHHHHHHHHHcCCChh
Confidence 999997 999999998888888887765544332 1245789999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 003185 817 ERPTAGDLYEMFVART 832 (840)
Q Consensus 817 eRPSa~ELLehLe~l~ 832 (840)
+|||+.+|++.|+.+.
T Consensus 635 ~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 635 RRPRFTELKAQLSTIL 650 (656)
T ss_dssp GSCCHHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHHH
Confidence 9999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=345.09 Aligned_cols=266 Identities=23% Similarity=0.331 Sum_probs=182.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHH-HHHhCCCCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~-iL~~L~HpNIV~l~g~~~ 578 (840)
...++|.+.+.||+|+||.||+|.+. +..||+|++.... ....... +.+|+. +++.++||||+++++++.
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~----~~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQ----LLMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC---CHHHHHH----HHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc---CchHHHH----HHHHHHHHHHcCCCCcEeeeeeEEE
Confidence 45689999999999999999999984 8899999875331 2222222 256665 677789999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCCCc
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSEN 657 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~-gIVHRDLKPeN 657 (840)
... ..+|||||+.+ +|.+++..........+++..++.++.||+.||.|||++ ||+||||||+|
T Consensus 92 ~~~--------------~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~N 156 (327)
T 3aln_A 92 REG--------------DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSN 156 (327)
T ss_dssp CSS--------------EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGG
T ss_pred eCC--------------ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHH
Confidence 654 35999999985 999988754444456799999999999999999999999 99999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
||++.+ +.+||+|||+++....... .....||+.|+|||++........++.++|||||||+
T Consensus 157 Ill~~~-------~~~kl~Dfg~~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~i 218 (327)
T 3aln_A 157 ILLDRS-------GNIKLCDFGISGQLVDSIA-----------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGIT 218 (327)
T ss_dssp EEEETT-------TEEEECCCSSSCC-----------------------------------------CCSHHHHHHHHHH
T ss_pred EEEcCC-------CCEEEccCCCceecccccc-----------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHH
Confidence 999877 5699999999976643211 1223689999999998532223568899999999999
Q ss_pred HHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 738 LLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
+|+|++|+.||...... +....+..+..+.++. ......+..+.+||.+||..||.
T Consensus 219 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~dp~ 275 (327)
T 3aln_A 219 LYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSN-----------------------SEEREFSPSFINFVNLCLTKDES 275 (327)
T ss_dssp HHHHHHSCCCSSCC-------CCCCCSCCCCCCC-----------------------CSSCCCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCC-----------------------cccccCCHHHHHHHHHHhhCChh
Confidence 99999999999765321 1111111111111110 00112356899999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 003185 817 ERPTAGDLYEMFVA 830 (840)
Q Consensus 817 eRPSa~ELLehLe~ 830 (840)
+|||+.+|++|..-
T Consensus 276 ~Rps~~ell~hp~~ 289 (327)
T 3aln_A 276 KRPKYKELLKHPFI 289 (327)
T ss_dssp GSCCHHHHTTSHHH
T ss_pred hCcCHHHHHhChHH
Confidence 99999999987543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=337.34 Aligned_cols=263 Identities=21% Similarity=0.305 Sum_probs=196.9
Q ss_pred CCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC--CCCcceeeeEEecC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISS 580 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~--HpNIV~l~g~~~~~ 580 (840)
-.+|++.+.||+|+||.||+|.+ .+..+|+|++.... ......+. +.+|+.++.+++ ||||+++++++...
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~----~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE--ADNQTLDS----YRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSS--CCHHHHHH----HHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccc--ccccchHH----HHHHHHHHHhccccCCceEEEEEEeecC
Confidence 45699999999999999999987 46789999976543 23333333 489999999997 59999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .++|||+ .+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 101 ~~--------------~~lv~e~-~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~ 160 (313)
T 3cek_A 101 QY--------------IYMVMEC-GNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI 160 (313)
T ss_dssp SE--------------EEEEECC-CSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred CE--------------EEEEEec-CCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE
Confidence 53 5999995 56899999986 3578999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC-------CCCCCchhhHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-------PNLYGLEVDIWS 733 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~-------~~~~s~kSDVWS 733 (840)
+. +.+||+|||++......... .......||+.|+|||++.+... ...++.++||||
T Consensus 161 ~~--------~~~kL~Dfg~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~s 224 (313)
T 3cek_A 161 VD--------GMLKLIDFGIANQMQPDTTS--------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 224 (313)
T ss_dssp ET--------TEEEECCCSSSCC----------------------CCGGGCCHHHHTTCC----------CCCHHHHHHH
T ss_pred EC--------CeEEEeeccccccccCcccc--------ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHH
Confidence 63 36999999999876432211 01123468999999999975211 136789999999
Q ss_pred HHHHHHHHHhCCCCCCCCC-HHHHHHHHHcC-CCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 003185 734 YGCLLLELLTLQVPYMGLS-ELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 811 (840)
Q Consensus 734 LGvIL~ELLTG~~PF~~~~-~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL 811 (840)
|||++|+|++|..||.... .......+... ....++. ..+..+.+||.+||
T Consensus 225 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l 277 (313)
T 3cek_A 225 LGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD---------------------------IPEKDLQDVLKCCL 277 (313)
T ss_dssp HHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCC---------------------------CSCHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcc---------------------------cchHHHHHHHHHHc
Confidence 9999999999999997653 22333333222 1111110 11357899999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhcCCC
Q 003185 812 EENPTERPTAGDLYEMFVARTSSS 835 (840)
Q Consensus 812 ~~DP~eRPSa~ELLehLe~l~~~~ 835 (840)
..||.+||++.++++|.+-.....
T Consensus 278 ~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 278 KRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp CSSTTTSCCHHHHHTSHHHHCC--
T ss_pred cCCcccCcCHHHHhcCccccCCCC
Confidence 999999999999999977655443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=337.44 Aligned_cols=260 Identities=23% Similarity=0.346 Sum_probs=186.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++.+.||+|+||.||+|.+ .+..||+|++.... ...... +.+..+..+++.++||||+++++++..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~---~~~~~~~~~~~~~~h~~i~~~~~~~~~ 95 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG---NKEENK---RILMDLDVVLKSHDCPYIVQCFGTFIT 95 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS---CHHHHH---HHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc---cchHHH---HHHHHHHHHHHhcCCCceeeEEEEEec
Confidence 4678999999999999999999998 57899999975432 112211 222455567888899999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCCCcE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENI 658 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~-gIVHRDLKPeNI 658 (840)
.. ..+|||||+ ++.+..++.. ....+++..++.++.||+.||.|||++ ||+||||||+||
T Consensus 96 ~~--------------~~~lv~e~~-~~~~~~l~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Ni 156 (318)
T 2dyl_A 96 NT--------------DVFIAMELM-GTCAEKLKKR----MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 156 (318)
T ss_dssp SS--------------EEEEEECCC-SEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGE
T ss_pred CC--------------cEEEEEecc-CCcHHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHE
Confidence 54 359999999 5566666553 135689999999999999999999995 999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~kSDVWSLGvI 737 (840)
|++.+ +.+||+|||++........ .....||+.|+|||++.... ....++.++|||||||+
T Consensus 157 l~~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~i 218 (318)
T 2dyl_A 157 LLDER-------GQIKLCDFGISGRLVDDKA-----------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGIS 218 (318)
T ss_dssp EECTT-------SCEEECCCTTC-------------------------CCTTCCHHHHC--------CCTHHHHHHHHHH
T ss_pred EECCC-------CCEEEEECCCchhccCCcc-----------ccccCCCccccChhhcccccccccCCccccchhhHHHH
Confidence 99877 4699999999976543211 12246899999999995321 12467899999999999
Q ss_pred HHHHHhCCCCCCCC-CHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 738 LLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 738 L~ELLTG~~PF~~~-~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
+|+|++|+.||... ...+....+.....+.++.. ...+..+.+||.+||..||.
T Consensus 219 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~l~~li~~~l~~dp~ 273 (318)
T 2dyl_A 219 LVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH-------------------------MGFSGDFQSFVKDCLTKDHR 273 (318)
T ss_dssp HHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSS-------------------------SCCCHHHHHHHHHHTCSCTT
T ss_pred HHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCcc-------------------------CCCCHHHHHHHHHHccCChh
Confidence 99999999999763 45566666655544333210 11245789999999999999
Q ss_pred CCCCHHHHHHHHH
Q 003185 817 ERPTAGDLYEMFV 829 (840)
Q Consensus 817 eRPSa~ELLehLe 829 (840)
+||++.+|++|..
T Consensus 274 ~Rps~~~ll~h~~ 286 (318)
T 2dyl_A 274 KRPKYNKLLEHSF 286 (318)
T ss_dssp TSCCHHHHTTSHH
T ss_pred HCcCHHHHhhCHH
Confidence 9999999999744
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=360.77 Aligned_cols=269 Identities=19% Similarity=0.215 Sum_probs=203.2
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcc-eeeeEE
Q 003185 501 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV-EMYGHK 577 (840)
Q Consensus 501 p~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV-~l~g~~ 577 (840)
+...++|++.+.||+|+||.||+|.+ .+..||||+....... . .+.+|+.+++.|+|++++ .+..++
T Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~----~~~~E~~il~~L~~~~~i~~i~~~~ 72 (483)
T 3sv0_A 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------P----QLLYESKIYRILQGGTGIPNVRWFG 72 (483)
T ss_dssp CEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS------C----CHHHHHHHHHHTTTSTTCCCEEEEE
T ss_pred CCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc------H----HHHHHHHHHHHhcCCCCCCeEEEEE
Confidence 45567899999999999999999997 4789999987644321 1 238899999999975544 444444
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
.... ..+|||||+ +++|.+++.. ....+++..++.|+.||+.||.|||++|||||||||+|
T Consensus 73 ~~~~--------------~~~lvme~~-g~sL~~ll~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~N 133 (483)
T 3sv0_A 73 VEGD--------------YNVLVMDLL-GPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 133 (483)
T ss_dssp EETT--------------EEEEEEECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred eeCC--------------EEEEEEECC-CCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcce
Confidence 4333 359999999 8899999975 23569999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
|||+.+. ..+.+||+|||+++.+........ ..........||+.|+|||++.+ ..++.++|||||||+
T Consensus 134 ILl~~~~----~~~~vkL~DFGla~~~~~~~~~~~---~~~~~~~~~~gt~~Y~aPE~~~~----~~~s~~sDvwSlGvi 202 (483)
T 3sv0_A 134 FLMGLGR----RANQVYIIDFGLAKKYRDTSTHQH---IPYRENKNLTGTARYASVNTHLG----IEQSRRDDLESLGYV 202 (483)
T ss_dssp EEECCGG----GTTCEEECCCTTCEECBCTTTCCB---CCCCCCCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHH
T ss_pred EEEecCC----CCCeEEEEeCCcceeccCCccccc---cccccccccCCCccccCHHHhcC----CCCChHHHHHHHHHH
Confidence 9995221 125799999999987654322110 11112235679999999999986 678999999999999
Q ss_pred HHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003185 738 LLELLTLQVPYMGLSE---LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 814 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~---~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~D 814 (840)
||||++|+.||.+... .+.+..+........... .....+..+.+||.+||..|
T Consensus 203 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~-----------------------l~~~~p~~l~~li~~cl~~d 259 (483)
T 3sv0_A 203 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA-----------------------LCRGYPTEFASYFHYCRSLR 259 (483)
T ss_dssp HHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH-----------------------HHTTSCHHHHHHHHHHHTCC
T ss_pred HHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH-----------------------HhcCCcHHHHHHHHHHhcCC
Confidence 9999999999987543 333333322211111110 11223568999999999999
Q ss_pred CCCCCCHHHHHHHHHhhc
Q 003185 815 PTERPTAGDLYEMFVART 832 (840)
Q Consensus 815 P~eRPSa~ELLehLe~l~ 832 (840)
|.+||++.+|++.|+.+.
T Consensus 260 P~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 260 FDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp TTCCCCHHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHHH
Confidence 999999999999998874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=352.19 Aligned_cols=275 Identities=14% Similarity=0.084 Sum_probs=181.2
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC--CCCCcceee-----
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL--RHSCIVEMY----- 574 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L--~HpNIV~l~----- 574 (840)
...|.+.+.||+|+||.||+|.+ .+..||+|++...... ..... ..+.+|+.+++.| +||||++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~----~~~~~E~~~~~~l~~~hp~iv~~~~~~~~ 135 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN-SRSEL----ERLHEATFAAARLLGESPEEARDRRRLLL 135 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT-HHHHH----HHHHHHHHHHHHHHC----------CBCC
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc-cccHH----HHHHHHHHHHHHhcccChhhhhhceeEEe
Confidence 34599999999999999999997 5788999997654211 12222 2347785554444 699988855
Q ss_pred --eEEecCCCCC---CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHH------HHHHHHHHHHHHHH
Q 003185 575 --GHKISSKWLP---SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA------LFIAQDVAAALVEL 643 (840)
Q Consensus 575 --g~~~~~~~~p---~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~------~~Ia~QIa~AL~yL 643 (840)
+++....... ..+..........||||||++ |+|.+++.... ..+....+ +.++.||+.||+||
T Consensus 136 p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~L 210 (371)
T 3q60_A 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANL 210 (371)
T ss_dssp CCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence 4443322100 000000111245799999998 79999998631 22344444 67789999999999
Q ss_pred HhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCC
Q 003185 644 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 723 (840)
Q Consensus 644 Hs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~ 723 (840)
|++||+||||||+||||+.+ +.+||+|||+++....... ...+|+.|+|||++.+ ...
T Consensus 211 H~~~ivHrDikp~NIll~~~-------~~~kL~DFG~a~~~~~~~~-------------~~~~t~~y~aPE~~~~--~~~ 268 (371)
T 3q60_A 211 QSKGLVHGHFTPDNLFIMPD-------GRLMLGDVSALWKVGTRGP-------------ASSVPVTYAPREFLNA--STA 268 (371)
T ss_dssp HHTTEEETTCSGGGEEECTT-------SCEEECCGGGEEETTCEEE-------------GGGSCGGGCCHHHHTC--SEE
T ss_pred HHCCCccCcCCHHHEEECCC-------CCEEEEecceeeecCCCcc-------------CccCCcCCcChhhccC--CCC
Confidence 99999999999999999877 4599999999986643211 2357799999999964 114
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHH
Q 003185 724 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 803 (840)
Q Consensus 724 ~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L 803 (840)
.++.++|||||||+||||++|+.||.+..+.... ........ ....... ........++.+
T Consensus 269 ~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~----~~~~~~~~--------------~~~~~~~-~~~~~~~~~~~~ 329 (371)
T 3q60_A 269 TFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG----SWKRPSLR--------------VPGTDSL-AFGSCTPLPDFV 329 (371)
T ss_dssp ECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTT----CCCBCCTT--------------SCCCCSC-CCTTSSCCCHHH
T ss_pred CcCccccHHHHHHHHHHHHhCCCCCCCcCccccc----chhhhhhh--------------hcccccc-chhhccCCCHHH
Confidence 5799999999999999999999999766432100 00000000 0000000 001112346789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHH
Q 003185 804 VDVFRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 804 ~dLI~rCL~~DP~eRPSa~ELLehLe 829 (840)
.+||.+||+.||.+|||+.++++|.+
T Consensus 330 ~~li~~~L~~dP~~Rpt~~e~l~hp~ 355 (371)
T 3q60_A 330 KTLIGRFLNFDRRRRLLPLEAMETPE 355 (371)
T ss_dssp HHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCHH
Confidence 99999999999999999999998754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=343.88 Aligned_cols=288 Identities=19% Similarity=0.225 Sum_probs=204.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-----------CC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-----------HS 568 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-----------Hp 568 (840)
...++|++.+.||+|+||.||+|.+ .+..||+|++... .... ..+.+|+.+++++. ||
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~ 86 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYT----EAAEDEIKLLQRVNDADNTKEDSMGAN 86 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHH----HHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-----ccch----hhhhHHHHHHHHhhcccccchhccccc
Confidence 4567899999999999999999997 6789999997421 2222 23488999998886 89
Q ss_pred CcceeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-C
Q 003185 569 CIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-H 647 (840)
Q Consensus 569 NIV~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~-g 647 (840)
||+++++++..... .....++||||+ +++|.+++... ....+++..++.++.||+.||.|||++ |
T Consensus 87 ~i~~~~~~~~~~~~----------~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ 152 (373)
T 1q8y_A 87 HILKLLDHFNHKGP----------NGVHVVMVFEVL-GENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHRRCG 152 (373)
T ss_dssp TBCCCCEEEEEEET----------TEEEEEEEECCC-CEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred hHHHHHHHhhccCC----------CCceEEEEEecC-CCCHHHHHHHh---hccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 99999999875431 123579999999 78999999862 234589999999999999999999998 9
Q ss_pred eecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCc
Q 003185 648 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 727 (840)
Q Consensus 648 IVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~ 727 (840)
|+||||||+||||+.++. ....+.+||+|||++....... ....||+.|+|||++.+ ..++.
T Consensus 153 ivH~Dikp~NIll~~~~~-~~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~t~~y~aPE~~~~----~~~~~ 214 (373)
T 1q8y_A 153 IIHTDIKPENVLMEIVDS-PENLIQIKIADLGNACWYDEHY-------------TNSIQTREYRSPEVLLG----APWGC 214 (373)
T ss_dssp EECSCCSGGGEEEEEEET-TTTEEEEEECCCTTCEETTBCC-------------CSCCSCGGGCCHHHHHT----CCCCT
T ss_pred EEecCCChHHeEEeccCC-CcCcceEEEcccccccccCCCC-------------CCCCCCccccCcHHHhC----CCCCc
Confidence 999999999999975431 1123579999999997664321 22368999999999986 56899
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHcCCCCCcchHHhhhccCccc-----cccccCCCCC-----
Q 003185 728 EVDIWSYGCLLLELLTLQVPYMGLS------ELEIHDLIQMGKRPRLTDELEALGSCHEH-----EVAQSGSGFE----- 791 (840)
Q Consensus 728 kSDVWSLGvIL~ELLTG~~PF~~~~------~~el~~~I~~~~~p~l~~~l~~~~~~~~~-----~~~~~~~~~~----- 791 (840)
++|||||||+||||++|..||.+.. .......+..... .++..+......... ..........
T Consensus 215 ~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (373)
T 1q8y_A 215 GADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG-ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLE 293 (373)
T ss_dssp HHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHC-SCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHH
T ss_pred hHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcC-CCCHHHHhccchhhhhcCCcchhcccccccccchh
Confidence 9999999999999999999997654 2222222222111 112111110000000 0000000000
Q ss_pred -----CchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 003185 792 -----KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 831 (840)
Q Consensus 792 -----~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l 831 (840)
........+..+.+||.+||+.||.+|||+.||++|..-.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 338 (373)
T 1q8y_A 294 DVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 338 (373)
T ss_dssp HHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGT
T ss_pred hhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhh
Confidence 0011235678899999999999999999999999986544
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=345.77 Aligned_cols=265 Identities=24% Similarity=0.261 Sum_probs=177.5
Q ss_pred CCCCCceeee-eecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHH-HHHHhCCCCCcceeeeEE
Q 003185 502 GSFPSLSSCD-EAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEV-RMLGALRHSCIVEMYGHK 577 (840)
Q Consensus 502 ~~~~~y~i~~-~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi-~iL~~L~HpNIV~l~g~~ 577 (840)
...++|.+.+ .||+|+||.||+|.+. +..||+|++... ... .+|+ ..++.++||||+++++++
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~--------~~e~~~~~~~~~h~~i~~~~~~~ 91 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKA--------RQEVDHHWQASGGPHIVCILDVY 91 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHH--------HHHHHHHHHHTTSTTBCCEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHH--------HHHHHHHHHhcCCCChHHHHHHH
Confidence 3457899965 6999999999999984 789999997421 111 2233 346677899999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
..... .....+|||||+++|+|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 92 ~~~~~----------~~~~~~lv~e~~~gg~L~~~l~~---~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~N 158 (336)
T 3fhr_A 92 ENMHH----------GKRCLLIIMECMEGGELFSRIQE---RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPEN 158 (336)
T ss_dssp EEEET----------TEEEEEEEEECCTTEEHHHHHHT---C-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred hhccC----------CCceEEEEEeccCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 75321 12346999999999999999975 223469999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
||++.++ ..+.+||+|||++....... .....||+.|+|||++.+ ..++.++|||||||+
T Consensus 159 Ill~~~~----~~~~~kl~Dfg~~~~~~~~~------------~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~i 218 (336)
T 3fhr_A 159 LLYTSKE----KDAVLKLTDFGFAKETTQNA------------LQTPCYTPYYVAPEVLGP----EKYDKSCDMWSLGVI 218 (336)
T ss_dssp EEESCSS----TTCCEEECCCTTCEEC--------------------------------------CHHHHHHHHHHHHHH
T ss_pred EEEEecC----CCceEEEeccccceeccccc------------cccCCCCcCccChhhhCC----CCCCchhhHHHHHHH
Confidence 9998653 23569999999997654321 123468999999999865 567899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
+|+|++|..||...........+......... .. ........+..+.+||.+||..||.+
T Consensus 219 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------~~-~~~~~~~~~~~~~~li~~~L~~dP~~ 278 (336)
T 3fhr_A 219 MYILLCGFPPFYSNTGQAISPGMKRRIRLGQY-------------------GF-PNPEWSEVSEDAKQLIRLLLKTDPTE 278 (336)
T ss_dssp HHHHHHSSCCC----------------------------------------CC-CTTTSTTCCHHHHHHHHHHSCSSGGG
T ss_pred HHHHHHCCCCCCCccchhhhhhHHHhhhcccc-------------------cc-CchhhccCCHHHHHHHHHHCCCChhH
Confidence 99999999999766544332211111000000 00 00111234568999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 003185 818 RPTAGDLYEMFVART 832 (840)
Q Consensus 818 RPSa~ELLehLe~l~ 832 (840)
|||+.++++|.+-..
T Consensus 279 Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 279 RLTITQFMNHPWINQ 293 (336)
T ss_dssp SCCHHHHHHSHHHHT
T ss_pred CcCHHHHhcCccccc
Confidence 999999999876543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=333.47 Aligned_cols=252 Identities=21% Similarity=0.258 Sum_probs=189.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC----CCCCcceeee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL----RHSCIVEMYG 575 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L----~HpNIV~l~g 575 (840)
...++|++.+.||+|+||.||+|.+ .+..||+|++.......... ......+.+|+.++.++ +||||+++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSP--LSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC----------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEeccccccccc--chhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3456899999999999999999987 67789999865432211100 01112337899999999 8999999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEec-cCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCC
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEY-VKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy-~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLK 654 (840)
++...... ++|||| +.+++|.+++.. ...+++..++.++.||+.||.|||++||+|||||
T Consensus 106 ~~~~~~~~--------------~~v~e~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 166 (312)
T 2iwi_A 106 WFETQEGF--------------MLVLERPLPAQDLFDYITE-----KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIK 166 (312)
T ss_dssp EC-----C--------------EEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCS
T ss_pred EEecCCeE--------------EEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence 98766543 999999 788999999986 2468999999999999999999999999999999
Q ss_pred CCcEEEe-cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHH
Q 003185 655 SENILID-LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 733 (840)
Q Consensus 655 PeNILLd-~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWS 733 (840)
|+|||++ .+ +.+||+|||++....... .....||+.|+|||++.+ ....+.++||||
T Consensus 167 p~Nil~~~~~-------~~~kl~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~s 224 (312)
T 2iwi_A 167 DENILIDLRR-------GCAKLIDFGSGALLHDEP------------YTDFDGTRVYSPPEWISR---HQYHALPATVWS 224 (312)
T ss_dssp GGGEEEETTT-------TEEEECCCSSCEECCSSC------------BCCCCSCTTTSCHHHHHH---SCBCHHHHHHHH
T ss_pred hhhEEEeCCC-------CeEEEEEcchhhhcccCc------------ccccCCcccccCceeeec---CCCCCccchHHH
Confidence 9999998 44 569999999998764321 122458999999999976 123356999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 003185 734 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 813 (840)
Q Consensus 734 LGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~ 813 (840)
|||++|+|++|+.||.... . +.... ..++ ...+..+.+||.+||..
T Consensus 225 lG~il~~l~~g~~pf~~~~--~----~~~~~-~~~~---------------------------~~~~~~~~~li~~~l~~ 270 (312)
T 2iwi_A 225 LGILLYDMVCGDIPFERDQ--E----ILEAE-LHFP---------------------------AHVSPDCCALIRRCLAP 270 (312)
T ss_dssp HHHHHHHHHHSSCSCCSHH--H----HHHTC-CCCC---------------------------TTSCHHHHHHHHHHTCS
T ss_pred HHHHHHHHHHCCCCCCChH--H----Hhhhc-cCCc---------------------------ccCCHHHHHHHHHHccC
Confidence 9999999999999996431 1 11111 0111 11245789999999999
Q ss_pred CCCCCCCHHHHHHHHHh
Q 003185 814 NPTERPTAGDLYEMFVA 830 (840)
Q Consensus 814 DP~eRPSa~ELLehLe~ 830 (840)
||.+|||+.++++|..-
T Consensus 271 ~p~~Rps~~e~l~~~~~ 287 (312)
T 2iwi_A 271 KPSSRPSLEEILLDPWM 287 (312)
T ss_dssp STTTSCCHHHHHHSTTT
T ss_pred ChhhCcCHHHHhcChhh
Confidence 99999999999998553
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=335.52 Aligned_cols=252 Identities=22% Similarity=0.244 Sum_probs=197.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC--CCCcceeeeEE
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHK 577 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~--HpNIV~l~g~~ 577 (840)
...++|++.+.||+|+||.||+|.+ .+..||+|++.......... . .....+.+|+.++++++ ||||+++++++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-~-~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-L-PNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEE-C-TTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhh-h-hhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 3467899999999999999999987 67889999976543221100 0 00123378999999996 59999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCC-CCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~g-GSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
..... .++||||+.+ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 118 ~~~~~--------------~~lv~e~~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~ 178 (320)
T 3a99_A 118 ERPDS--------------FVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDE 178 (320)
T ss_dssp ECSSE--------------EEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred ecCCc--------------EEEEEEcCCCCccHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHH
Confidence 86553 5999999976 899999986 256899999999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
|||++.+. +.+||+|||++....... .....||+.|+|||++.+ ...++.++|||||||
T Consensus 179 NIll~~~~------~~~kL~Dfg~~~~~~~~~------------~~~~~gt~~y~aPE~~~~---~~~~~~~~Di~slG~ 237 (320)
T 3a99_A 179 NILIDLNR------GELKLIDFGSGALLKDTV------------YTDFDGTRVYSPPEWIRY---HRYHGRSAAVWSLGI 237 (320)
T ss_dssp GEEEETTT------TEEEECCCTTCEECCSSC------------BCCCCSCGGGSCHHHHHH---SCBCHHHHHHHHHHH
T ss_pred HEEEeCCC------CCEEEeeCcccccccccc------------ccCCCCCccCCChHHhcc---CCCCCccchHHhHHH
Confidence 99998331 469999999998764321 122468999999999976 233478999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 737 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 737 IL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
++|||++|+.||..... +..... .++ ...+..+.+||.+||..||.
T Consensus 238 il~el~~g~~pf~~~~~------~~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~dp~ 283 (320)
T 3a99_A 238 LLYDMVCGDIPFEHDEE------IIRGQV-FFR---------------------------QRVSSECQHLIRWCLALRPS 283 (320)
T ss_dssp HHHHHHHSSCSCCSHHH------HHHCCC-CCS---------------------------SCCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHCCCCCCChhh------hhcccc-ccc---------------------------ccCCHHHHHHHHHHccCChh
Confidence 99999999999965321 111111 000 11245789999999999999
Q ss_pred CCCCHHHHHHHHH
Q 003185 817 ERPTAGDLYEMFV 829 (840)
Q Consensus 817 eRPSa~ELLehLe 829 (840)
+|||+++|++|..
T Consensus 284 ~Rps~~~ll~hp~ 296 (320)
T 3a99_A 284 DRPTFEEIQNHPW 296 (320)
T ss_dssp GSCCHHHHHTSGG
T ss_pred hCcCHHHHhcCHh
Confidence 9999999999854
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=351.09 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=189.1
Q ss_pred CceeeeeecccCceE-EEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSS-LFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~-Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~~~~~~ 583 (840)
+|.+.+.||+|+||+ ||++...+..||||++.... ...+ .+|+.+|+.+ +|||||++++++.....
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~-------~~~~----~~E~~~l~~l~~HpnIv~l~~~~~~~~~- 92 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC-------FSFA----DREVQLLRESDEHPNVIRYFCTEKDRQF- 92 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT-------EEEC----HHHHHHHHHSCCCTTBCCEEEEEEETTE-
T ss_pred EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH-------HHHH----HHHHHHHHhccCCCCcCeEEEEEecCCE-
Confidence 589999999999998 55566788999999864221 1122 7899999999 79999999999886553
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.||||||+. |+|.+++.. ....+....++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 93 -------------~~lv~E~~~-g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~ 154 (432)
T 3p23_A 93 -------------QYIAIELCA-ATLQEYVEQ----KDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMP 154 (432)
T ss_dssp -------------EEEEEECCS-EEHHHHHHS----SSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCC
T ss_pred -------------EEEEEECCC-CCHHHHHHh----cCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecC
Confidence 499999997 599999975 22334555678999999999999999999999999999999654
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+. .+...+||+|||+++......... .......||+.|+|||++.+.. ...++.++|||||||++|||++
T Consensus 155 ~~--~~~~~~kL~DFG~a~~~~~~~~~~-------~~~~~~~gt~~y~APE~l~~~~-~~~~t~~~DiwSlG~il~ellt 224 (432)
T 3p23_A 155 NA--HGKIKAMISDFGLCKKLAVGRHSF-------SRRSGVPGTEGWIAPEMLSEDC-KENPTYTVDIFSAGCVFYYVIS 224 (432)
T ss_dssp BT--TTBCCEEECCTTEEECC-------------------CCSCTTSCCGGGTSCC----CCCTHHHHHHHHHHHHHHHT
T ss_pred CC--CCceeEEEecccceeeccCCCcce-------eeccccCCCcCccChhhhhccc-ccCCCcHHHHHHHHHHHHHHHc
Confidence 21 233569999999998765322110 1123356999999999997421 2456789999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 744 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 744 -G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
|..||...........+.......+. .....+..+.+||.+||+.||.+|||+.
T Consensus 225 ~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ 279 (432)
T 3p23_A 225 EGSHPFGKSLQRQANILLGACSLDCLH-------------------------PEKHEDVIARELIEKMIAMDPQKRPSAK 279 (432)
T ss_dssp TSCBTTBSTTTHHHHHHTTCCCCTTSC-------------------------TTCHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCcchhhHHHHHHHhccCCccccC-------------------------ccccccHHHHHHHHHHHhCCHhhCCCHH
Confidence 99999665444333222211111100 0112355688999999999999999999
Q ss_pred HHHHHH
Q 003185 823 DLYEMF 828 (840)
Q Consensus 823 ELLehL 828 (840)
+|++|.
T Consensus 280 evl~hp 285 (432)
T 3p23_A 280 HVLKHP 285 (432)
T ss_dssp HHHTST
T ss_pred HHHhCc
Confidence 999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=343.64 Aligned_cols=272 Identities=21% Similarity=0.289 Sum_probs=188.6
Q ss_pred CCCC-ceeeeeecccCceEEEEE-EECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEec
Q 003185 503 SFPS-LSSCDEAGKSVSSSLFRC-KFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 579 (840)
Q Consensus 503 ~~~~-y~i~~~LG~G~fG~Vy~a-~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~~ 579 (840)
.+.+ |.+.+.||+|+||+||.+ ...+..||||+..... . ..+.+|+.+|+++ +|||||++++++..
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-------~----~~~~~E~~~l~~l~~HpnIv~~~~~~~~ 80 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-------C----DIALMEIKLLTESDDHPNVIRYYCSETT 80 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-------H----HHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred hhhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-------H----HHHHHHHHHHHhccCCCCcCeEEEEEec
Confidence 3444 456788999999999754 4578999999875321 1 2337899999886 79999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE--KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~--~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
.. ..||||||+. |+|.+++........ ....+..++.++.||+.||+|||++||+||||||+|
T Consensus 81 ~~--------------~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~N 145 (434)
T 2rio_A 81 DR--------------FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQN 145 (434)
T ss_dssp SS--------------EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CC--------------eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHh
Confidence 55 3599999996 699999975211100 011233467899999999999999999999999999
Q ss_pred EEEecccc------cCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc---CCCCCCch
Q 003185 658 ILIDLERK------KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH---KPNLYGLE 728 (840)
Q Consensus 658 ILLd~~~~------~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~---~~~~~s~k 728 (840)
|||+.++. .......+||+|||+++.......... .......||+.|+|||++.+.. ....++.+
T Consensus 146 ILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 219 (434)
T 2rio_A 146 ILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR------TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS 219 (434)
T ss_dssp EEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------------CCTTSCHHHHSCCCTTSCCCCCCTH
T ss_pred EEEecCcccccccccCCCceEEEEcccccceecCCCCccce------eeecCCCCCCCccCHHHhccccccccccCcchh
Confidence 99986531 112346799999999987654321100 0112346999999999997521 12568999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHH
Q 003185 729 VDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVF 807 (840)
Q Consensus 729 SDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI 807 (840)
+|||||||++|||+| |..||....... ..+...... ++.. ........+..+.+||
T Consensus 220 ~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~-~~~~--------------------~~~~~~~~~~~~~~li 276 (434)
T 2rio_A 220 IDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFS-LDEM--------------------KCLHDRSLIAEATDLI 276 (434)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCC-CCCC--------------------TTCCCHHHHHHHHHHH
T ss_pred hhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCC-cccc--------------------cccccccchHHHHHHH
Confidence 999999999999999 999997654333 122222110 0000 0001123467899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHH
Q 003185 808 RRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 808 ~rCL~~DP~eRPSa~ELLehLe 829 (840)
.+||+.||.+|||+.+|++|..
T Consensus 277 ~~~L~~dP~~Rps~~eil~hp~ 298 (434)
T 2rio_A 277 SQMIDHDPLKRPTAMKVLRHPL 298 (434)
T ss_dssp HHHTCSSGGGSCCHHHHHTSGG
T ss_pred HHHhhCChhhCCCHHHHHhCCc
Confidence 9999999999999999998754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=319.75 Aligned_cols=245 Identities=21% Similarity=0.203 Sum_probs=182.4
Q ss_pred CCCCCceee-eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHH-HhCCCCCcceeeeEE
Q 003185 502 GSFPSLSSC-DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRML-GALRHSCIVEMYGHK 577 (840)
Q Consensus 502 ~~~~~y~i~-~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL-~~L~HpNIV~l~g~~ 577 (840)
..+++|.+. +.||+|+||.||+|.+ .+..||+|++... .. +.+|+.++ +.++||||+++++++
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~----~~~e~~~~~~~~~h~~i~~~~~~~ 80 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PK----ARREVELHWRASQCPHIVRIVDVY 80 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HH----HHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HH----HHHHHHHHHHhccCCCchhHHhhh
Confidence 456889888 7899999999999998 5778999986421 12 27788887 556899999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
..... .....+|||||+++++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 81 ~~~~~----------~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~N 147 (299)
T 3m2w_A 81 ENLYA----------GRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 147 (299)
T ss_dssp EEEET----------TEEEEEEEECCCCSCBHHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred hhhcC----------CCceEEEEEeecCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 75110 12246999999999999999986 233469999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
||++..+ ..+.+||+|||++..... ..++.++|||||||+
T Consensus 148 il~~~~~----~~~~~kl~Dfg~a~~~~~------------------------------------~~~~~~~DiwslG~i 187 (299)
T 3m2w_A 148 LLYTSKR----PNAILKLTDFGFAKETTG------------------------------------EKYDKSCDMWSLGVI 187 (299)
T ss_dssp EEESSSS----TTCCEEECCCTTCEECTT------------------------------------CGGGGHHHHHHHHHH
T ss_pred EEEecCC----CCCcEEEecccccccccc------------------------------------ccCCchhhHHHHHHH
Confidence 9998742 125799999999854311 234679999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
+|||++|..||.+.........+....... ............+..+.+||.+||..||.+
T Consensus 188 l~el~tg~~pf~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 247 (299)
T 3m2w_A 188 MYILLCGYPPFYSNHGLAISPGMKTRIRMG--------------------QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 247 (299)
T ss_dssp HHHHHHSSCSCCC-------CCSCCSSCTT--------------------CCSSCHHHHTTSCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHCCCCCCCCcchhhhHHHHHHHhhc--------------------cccCCchhcccCCHHHHHHHHHHcccChhh
Confidence 999999999997665433221111110000 000011112335678999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 003185 818 RPTAGDLYEMFVART 832 (840)
Q Consensus 818 RPSa~ELLehLe~l~ 832 (840)
|||+.++++|..-..
T Consensus 248 Rps~~e~l~hp~~~~ 262 (299)
T 3m2w_A 248 RMTITEFMNHPWIMQ 262 (299)
T ss_dssp SCCHHHHHTSHHHHT
T ss_pred CCCHHHHhcChhhcc
Confidence 999999999976543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=337.92 Aligned_cols=274 Identities=16% Similarity=0.099 Sum_probs=189.5
Q ss_pred CCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC---------CCCccee
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---------HSCIVEM 573 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~---------HpNIV~l 573 (840)
..++|++.+.||+|+||.||+|++++..||+|++................+.+.+|+.+|+.|+ |||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 3578999999999999999999999999999998765322100000111123488888888885 7777777
Q ss_pred eeEEecCCCC----------------CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHH
Q 003185 574 YGHKISSKWL----------------PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVA 637 (840)
Q Consensus 574 ~g~~~~~~~~----------------p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa 637 (840)
++++...... ...+...-......||||||+++|+|.+.+.+ ..+++..++.|+.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHH
Confidence 6664321100 00000000013357999999999976666532 4689999999999999
Q ss_pred HHHHHHH-hCCeecccCCCCcEEEeccccc-------------CCCCCeEEEeecCCcccccccccccccccCCCCCCCc
Q 003185 638 AALVELH-SKHIMHRDIKSENILIDLERKK-------------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 703 (840)
Q Consensus 638 ~AL~yLH-s~gIVHRDLKPeNILLd~~~~~-------------~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~ 703 (840)
.||.||| ++||+||||||+||||+.++.. ......+||+|||+|+..... .
T Consensus 172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---------------~ 236 (336)
T 2vuw_A 172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---------------I 236 (336)
T ss_dssp HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---------------E
T ss_pred HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---------------c
Confidence 9999999 9999999999999999977310 001137999999999876431 2
Q ss_pred ccCCCcccchhhhhcccCCCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHcC-CCCCcchHHhhhccCcc
Q 003185 704 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL-LLELLTLQVPYMGLSE-LEIHDLIQMG-KRPRLTDELEALGSCHE 780 (840)
Q Consensus 704 ~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI-L~ELLTG~~PF~~~~~-~el~~~I~~~-~~p~l~~~l~~~~~~~~ 780 (840)
.+||+.|||||++.+ .. +.++||||||++ .+++++|..||.+... ..+...+... .....
T Consensus 237 ~~gt~~y~aPE~~~g----~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------ 299 (336)
T 2vuw_A 237 VVFCDVSMDEDLFTG----DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTK------------ 299 (336)
T ss_dssp EECCCCTTCSGGGCC----CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSC------------
T ss_pred EEEeecccChhhhcC----CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcc------------
Confidence 369999999999985 23 889999998777 7888899999843211 1122222211 11000
Q ss_pred ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH-HHHH
Q 003185 781 HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY-EMFV 829 (840)
Q Consensus 781 ~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELL-ehLe 829 (840)
.........++.+.+||.+||+.| |++|++ +|..
T Consensus 300 ----------~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~ 334 (336)
T 2vuw_A 300 ----------CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334 (336)
T ss_dssp ----------CCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGG
T ss_pred ----------cchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCC
Confidence 012233456789999999999977 999999 8743
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=321.09 Aligned_cols=235 Identities=14% Similarity=0.078 Sum_probs=179.3
Q ss_pred CCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||.||+|.+. +..||+|++..... ......+ .+.+|+.++.+++||||+++++++...+.
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~----~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 105 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGV-LPDDVLQ----ETLSRTLRLSRIDKPGVARVLDVVHTRAG 105 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCC-SCHHHHH----HHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccc-cCHHHHH----HHHHHHHHHhcCCCCCcceeeEEEEECCc
Confidence 77999999999999999999984 78999998643321 1222233 44899999999999999999999986653
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.||||||++|++|.+++.. ......+..|+.||+.||.|||++||+||||||+||||+.
T Consensus 106 --------------~~lv~e~~~g~~L~~~l~~-------~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~ 164 (286)
T 3uqc_A 106 --------------GLVVAEWIRGGSLQEVADT-------SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSI 164 (286)
T ss_dssp --------------EEEEEECCCEEEHHHHHTT-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEET
T ss_pred --------------EEEEEEecCCCCHHHHHhc-------CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcC
Confidence 5999999999999999853 2456678999999999999999999999999999999997
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+++| |++| ++.++|||||||+||||+
T Consensus 165 ~-------g~~kl~~~~------------------------------~~~~-----------~~~~~Di~slG~il~ell 196 (286)
T 3uqc_A 165 D-------GDVVLAYPA------------------------------TMPD-----------ANPQDDIRGIGASLYALL 196 (286)
T ss_dssp T-------SCEEECSCC------------------------------CCTT-----------CCHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEEecc------------------------------ccCC-----------CCchhHHHHHHHHHHHHH
Confidence 7 458887443 2222 478999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
||+.||.+.+..+............... ........++.+.+||.+||+.||.+| |+.
T Consensus 197 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~ 254 (286)
T 3uqc_A 197 VNRWPLPEAGVRSGLAPAERDTAGQPIE---------------------PADIDRDIPFQISAVAARSVQGDGGIR-SAS 254 (286)
T ss_dssp HSEECSCCCSBCCCSEECCBCTTSCBCC---------------------HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHH
T ss_pred HCCCCCCcCCcchhhHHHHHHhccCCCC---------------------hhhcccCCCHHHHHHHHHHcccCCccC-CHH
Confidence 9999998764322110000000000000 001112346689999999999999999 999
Q ss_pred HHHHHHHhhcCCC
Q 003185 823 DLYEMFVARTSSS 835 (840)
Q Consensus 823 ELLehLe~l~~~~ 835 (840)
++++.|+.+....
T Consensus 255 el~~~L~~~~~~~ 267 (286)
T 3uqc_A 255 TLLNLMQQATAVA 267 (286)
T ss_dssp HHHHHHHHHHC--
T ss_pred HHHHHHHHHhccC
Confidence 9999999877543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=356.90 Aligned_cols=285 Identities=19% Similarity=0.191 Sum_probs=195.9
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEe
Q 003185 501 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 578 (840)
Q Consensus 501 p~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~ 578 (840)
...+++|++.+.||+|+||.||+|.+ .+..||+|++... ......+ .+.+|+.++++++||||+++++++.
T Consensus 10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~---~~~~~~~----~~~~Ei~iL~~L~HpnIV~l~~v~~ 82 (676)
T 3qa8_A 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE---LSPKNRE----RWCLEIQIMKKLNHPNVVSAREVPD 82 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC---CCHHHHH----HHHHHHHHHHHCCBTTBCCEEECCT
T ss_pred CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc---CCHHHHH----HHHHHHHHHHhCCCCCCCceeeeec
Confidence 35678999999999999999999987 5788999985422 2233333 3489999999999999999999876
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
..... ......+|||||++||+|.+++... .....+++..++.|+.||+.||.|||++||+||||||+||
T Consensus 83 ~~~~~--------~~~~~~~LVmEy~~ggsL~~~L~~~--~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NI 152 (676)
T 3qa8_A 83 GLQKL--------APNDLPLLAMEYCEGGDLRKYLNQF--ENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENI 152 (676)
T ss_dssp TTCCC--------CTTSSCCCEEECCSSCBHHHHHHSS--SCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTE
T ss_pred ccccc--------cCCCeEEEEEEeCCCCCHHHHHHhc--ccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHe
Confidence 42211 0122459999999999999999752 2223588999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.++. ...+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++
T Consensus 153 Ll~~~g~----~~~vKL~DFG~a~~~~~~~~-----------~~~~~gt~~Y~APE~l~~----~~~s~ksDIwSLGviL 213 (676)
T 3qa8_A 153 VLQPGPQ----RLIHKIIDLGYAKELDQGEL-----------CTEFVGTLQYLAPELLEQ----KKYTVTVDYWSFGTLA 213 (676)
T ss_dssp EEECCSS----SCEEEECSCCCCCBTTSCCC-----------CCCCCSCCTTCSSCSSCC----SCCSTTHHHHHHHHHH
T ss_pred EeecCCC----ceeEEEcccccccccccccc-----------cccccCCcccCChHHhcc----CCCCchhHHHHHHHHH
Confidence 9987632 35699999999986643221 123469999999999875 6789999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcc-ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 739 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE-HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 739 ~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
|+|++|..||.+......... .................. ..+... ...........++.+.+||.+||..||.+
T Consensus 214 yeLltG~~Pf~~~~~~~~~~~---~i~~~~~~~~~~~~~l~g~~~~~~~--lp~p~~l~~~ls~~L~dLI~~mL~~DP~k 288 (676)
T 3qa8_A 214 FECITGFRPFLPNWQPVQWHG---KVREKSNEHIVVYDDLTGAVKFSSV--LPTPNHLSGILAGKLERWLQCMLMWHQRQ 288 (676)
T ss_dssp HHHHSSCSSCCSSCHHHHSST---TCC------CCSCCCCSSSCCCCSS--SCCSCCCCGGGHHHHHHHHHHHSCSSCC-
T ss_pred HHHHHCCCCCCcccchhhhhh---hhhcccchhhhhhhhhccccccccc--cCCchhhchhhhHHHHHHHHHHccCCHhh
Confidence 999999999976543221100 000000000000000000 000000 00011223446789999999999999999
Q ss_pred CCCHHHHHH
Q 003185 818 RPTAGDLYE 826 (840)
Q Consensus 818 RPSa~ELLe 826 (840)
|||+.++++
T Consensus 289 RPTa~elL~ 297 (676)
T 3qa8_A 289 RGTDPQNPN 297 (676)
T ss_dssp --CCTTCCC
T ss_pred CcCHHHHhc
Confidence 999988543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=350.44 Aligned_cols=244 Identities=23% Similarity=0.249 Sum_probs=188.5
Q ss_pred CCCceeeeeecccCceEEEEEEE---CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF---GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~---~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.++|++.+.||+|+||.||+|.+ ++..||+|++... ...... ..+.+|+.+|++++|||||++++++...
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~---~~~~~~----~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS---GDAEAQ----AMAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS---CCHHHH----HHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc---CCHHHH----HHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 47899999999999999999997 4688999975321 122222 3448999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
... ..+..||||||++|++|.+++. ..+++..++.|+.||+.||.|||++|||||||||+||||
T Consensus 152 ~~~---------~~~~~~lv~E~~~g~~L~~~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll 215 (681)
T 2pzi_A 152 DRH---------GDPVGYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIML 215 (681)
T ss_dssp CTT---------SCEEEEEEEECCCCEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CCC---------CCceeEEEEEeCCCCcHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEE
Confidence 431 2233699999999999988764 268999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ .+||+|||+++..... ....||+.|+|||++.+ .++.++|||||||+||+
T Consensus 216 ~~~--------~~kl~DFG~a~~~~~~--------------~~~~gt~~y~aPE~~~~-----~~~~~sDi~slG~~l~~ 268 (681)
T 2pzi_A 216 TEE--------QLKLIDLGAVSRINSF--------------GYLYGTPGFQAPEIVRT-----GPTVATDIYTVGRTLAA 268 (681)
T ss_dssp CSS--------CEEECCCTTCEETTCC--------------SCCCCCTTTSCTTHHHH-----CSCHHHHHHHHHHHHHH
T ss_pred eCC--------cEEEEecccchhcccC--------------CccCCCccccCHHHHcC-----CCCCceehhhhHHHHHH
Confidence 764 4999999999765432 23469999999999976 23889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|++|..||.+.... .++. .......++.+.+||.+||..||.+||+
T Consensus 269 l~~g~~~~~~~~~~------------~~~~----------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~ 314 (681)
T 2pzi_A 269 LTLDLPTRNGRYVD------------GLPE----------------------DDPVLKTYDSYGRLLRRAIDPDPRQRFT 314 (681)
T ss_dssp HHSCCCEETTEECS------------SCCT----------------------TCHHHHHCHHHHHHHHHHTCSSGGGSCS
T ss_pred HHhCCCCCcccccc------------cccc----------------------cccccccCHHHHHHHhhhccCChhhCCC
Confidence 99999988642100 0000 0011123457899999999999999995
Q ss_pred -HHHHHHHHHhh
Q 003185 821 -AGDLYEMFVAR 831 (840)
Q Consensus 821 -a~ELLehLe~l 831 (840)
++++.+.|..+
T Consensus 315 ~~~~l~~~l~~~ 326 (681)
T 2pzi_A 315 TAEEMSAQLTGV 326 (681)
T ss_dssp SHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 55555555543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=334.33 Aligned_cols=266 Identities=14% Similarity=0.127 Sum_probs=184.8
Q ss_pred CCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC-CCccee------
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEM------ 573 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~H-pNIV~l------ 573 (840)
....|.+.+.||+|+||.||+|.+. +..||||+...... ...... +.+.+|+.+++.++| +|+..+
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~-~~~~~~----~~~~~E~~~~~~l~~~~~~~~~~~~~~~ 150 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAI----KQMKEEVLRLRLLRGIKNQKQAKVHLRF 150 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CC----HHHHHHHHGGGGSTTCCSHHHHHHHTCB
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC-ccHHHH----HHHHHHHHHHHhhccCCCHHHHHHhccc
Confidence 3456889999999999999999984 88999998753321 111222 334899999999987 332211
Q ss_pred ---eeEEecCCCCC---CCCCCCccccceEEEEEeccCCCCHHHHHHHHh--ccCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 003185 574 ---YGHKISSKWLP---SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS--ETGEKHVSVKLALFIAQDVAAALVELHS 645 (840)
Q Consensus 574 ---~g~~~~~~~~p---~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~--~~~~~~ls~~~~~~Ia~QIa~AL~yLHs 645 (840)
+.......... .............+++|+++. ++|.+++.... ......+++..++.|+.||+.||+|||+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 229 (413)
T 3dzo_A 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 229 (413)
T ss_dssp CCCCEEEECCC---------------CCSEEEEEECCS-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccchhhcccCCCCccccccCCCccccccceEEEeehhc-CCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 11111111000 000000111334688888875 79999996432 1223457888999999999999999999
Q ss_pred CCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-----
Q 003185 646 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH----- 720 (840)
Q Consensus 646 ~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~----- 720 (840)
+|||||||||+||||+.+ +.+||+|||+++...... ....| +.|+|||++.+..
T Consensus 230 ~~iiHrDiKp~NILl~~~-------~~~kL~DFG~a~~~~~~~-------------~~~~g-~~y~aPE~~~~~~~~~~~ 288 (413)
T 3dzo_A 230 YGLVHTYLRPVDIVLDQR-------GGVFLTGFEHLVRDGASA-------------VSPIG-RGFAPPETTAERMLPFGQ 288 (413)
T ss_dssp TTEECSCCCGGGEEECTT-------CCEEECCGGGCEETTEEE-------------CCCCC-TTTCCHHHHHHHTSTTGG
T ss_pred CCcccCCcccceEEEecC-------CeEEEEeccceeecCCcc-------------ccCCC-CceeCchhhhcccccccc
Confidence 999999999999999987 459999999998654421 22357 9999999995321
Q ss_pred -CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhh
Q 003185 721 -KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 799 (840)
Q Consensus 721 -~~~~~s~kSDVWSLGvIL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 799 (840)
....++.++|||||||+||||++|+.||...+.......+... . ...
T Consensus 289 ~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~-----------------------~---------~~~ 336 (413)
T 3dzo_A 289 HHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRS-----------------------C---------KNI 336 (413)
T ss_dssp GCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGSS-----------------------C---------CCC
T ss_pred ccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHhh-----------------------c---------ccC
Confidence 2355788999999999999999999999766432211111100 0 012
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003185 800 LSFLVDVFRRCTEENPTERPTAGDLYEM 827 (840)
Q Consensus 800 s~~L~dLI~rCL~~DP~eRPSa~ELLeh 827 (840)
++.+.+||.+||..||.+||++.++++|
T Consensus 337 ~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 337 PQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 4579999999999999999998888765
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-29 Score=294.35 Aligned_cols=193 Identities=15% Similarity=0.113 Sum_probs=129.9
Q ss_pred eeeecccCceEEEEEE--ECCeeEEEEEEecccCC--CChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEEecCCCCC
Q 003185 510 CDEAGKSVSSSLFRCK--FGSADAAAKVRTLKVCG--SSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLP 584 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~--~~~~~vAVKI~~lk~~~--~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~~~~~~~p 584 (840)
...++.|++|.+..++ +-+..+++|++...... ......+.-.+.|.+|+.+|+++ .|+||+++++++.++..
T Consensus 239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~-- 316 (569)
T 4azs_A 239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS-- 316 (569)
T ss_dssp ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE--
T ss_pred hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE--
Confidence 3456677777776654 36788999998654322 22233333345679999999999 59999999999987764
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEeccc
Q 003185 585 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 664 (840)
Q Consensus 585 ~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~ 664 (840)
.||||||++|++|.++|.. ...++.. .|+.||+.||+|||++|||||||||+||||+.+
T Consensus 317 ------------~yLVMEyv~G~~L~d~i~~-----~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~d- 375 (569)
T 4azs_A 317 ------------GWLVMEKLPGRLLSDMLAA-----GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDAR- 375 (569)
T ss_dssp ------------EEEEEECCCSEEHHHHHHT-----TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTT-
T ss_pred ------------EEEEEecCCCCcHHHHHHh-----CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCC-
Confidence 5999999999999999975 3456654 588999999999999999999999999999877
Q ss_pred ccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 003185 665 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 744 (840)
Q Consensus 665 ~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG 744 (840)
+.+||+|||+|+....... .....+||+.|||||++.+ .+..++|+||+|+++++|.++
T Consensus 376 ------g~vKL~DFGlAr~~~~~~~----------~~~t~vGTp~YmAPE~l~g-----~~~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 376 ------QHARLIDFGSIVTTPQDCS----------WPTNLVQSFFVFVNELFAE-----NKSWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp ------SCEEECCCTTEESCC---C----------CSHHHHHHHHHHHHHHC----------------------CCCCTT
T ss_pred ------CCEEEeecccCeeCCCCCc----------cccCceechhhccHHHhCC-----CCCCcccccccccchhhhccc
Confidence 4599999999986644221 1244679999999999975 356789999999998887665
Q ss_pred CC
Q 003185 745 QV 746 (840)
Q Consensus 745 ~~ 746 (840)
..
T Consensus 435 ~~ 436 (569)
T 4azs_A 435 WS 436 (569)
T ss_dssp HH
T ss_pred cc
Confidence 43
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-26 Score=267.59 Aligned_cols=201 Identities=19% Similarity=0.176 Sum_probs=146.8
Q ss_pred eeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCCC
Q 003185 508 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 587 (840)
Q Consensus 508 ~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~~ 587 (840)
...+.||+|+||.||+|.+.+..+++|....+.............+++.+|+.+|++++||||+++..++......
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~---- 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNK---- 414 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTT----
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCcc----
Confidence 4467899999999999998999999998765433322222333345679999999999999999555544444332
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecccccC
Q 003185 588 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 667 (840)
Q Consensus 588 g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~~ 667 (840)
||||||++|++|.+++.. +..++.||+.||.|||++||+||||||+|||++.
T Consensus 415 ----------~lVmE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----- 466 (540)
T 3en9_A 415 ----------RIMMSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----- 466 (540)
T ss_dssp ----------EEEEECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-----
T ss_pred ----------EEEEECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-----
Confidence 999999999999999852 5689999999999999999999999999999985
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003185 668 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 747 (840)
Q Consensus 668 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~P 747 (840)
.+||+|||+++............ ........||+.|||||++.... ..|+..+|+|+..+-..+.+.++.+
T Consensus 467 ----~~kL~DFGla~~~~~~~~~~~~~---~~~~~~~~GT~~y~APEv~~~~~--~~Y~~~~d~ws~vl~~l~~v~~r~r 537 (540)
T 3en9_A 467 ----DLYIIDFGLGKISNLDEDKAVDL---IVFKKAVLSTHHEKFDEIWERFL--EGYKSVYDRWEIILELMKDVERRAR 537 (540)
T ss_dssp ----SEEECCCTTCEECCCHHHHHHHH---HHHHHHHHHHCGGGHHHHHHHHH--HHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred ----eEEEEECccCEECCCccccccch---hhhhhhhcCCCCcCCHHHHHHHH--HHHHHHHhHHHHHHHHHHHHHhccc
Confidence 39999999998775432110000 00012357999999999997522 2467788999999999998888877
Q ss_pred CC
Q 003185 748 YM 749 (840)
Q Consensus 748 F~ 749 (840)
|.
T Consensus 538 Y~ 539 (540)
T 3en9_A 538 YV 539 (540)
T ss_dssp CC
T ss_pred cC
Confidence 74
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=4.8e-21 Score=205.27 Aligned_cols=151 Identities=16% Similarity=0.140 Sum_probs=113.2
Q ss_pred ceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChH----------HHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 003185 507 LSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSAD----------EIRNFEYSCLGEVRMLGALRHSCIVEMYG 575 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~----------~~~~f~~~~~rEi~iL~~L~HpNIV~l~g 575 (840)
|.+.+.||+|+||.||+|.+ .+..+|+|+........... ........+.+|+.+|++++ | +++++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~ 168 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK 168 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence 56669999999999999998 57899999975432111100 00012234589999999998 5 66666
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCC
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 655 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKP 655 (840)
++... ..|+||||++|++|.+ +.. .....++.||+.||.|||++||+||||||
T Consensus 169 ~~~~~---------------~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~giiHrDlkp 221 (282)
T 1zar_A 169 VYAWE---------------GNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRGIVHGDLSQ 221 (282)
T ss_dssp EEEEE---------------TTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTTEECSCCST
T ss_pred EEecc---------------ceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCCCEeCCCCH
Confidence 55432 1399999999999987 421 23457999999999999999999999999
Q ss_pred CcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhc
Q 003185 656 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718 (840)
Q Consensus 656 eNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~ 718 (840)
+|||++ + +.+||+|||+|+. +..|+|||++..
T Consensus 222 ~NILl~-~-------~~vkl~DFG~a~~-----------------------~~~~~a~e~l~r 253 (282)
T 1zar_A 222 YNVLVS-E-------EGIWIIDFPQSVE-----------------------VGEEGWREILER 253 (282)
T ss_dssp TSEEEE-T-------TEEEECCCTTCEE-----------------------TTSTTHHHHHHH
T ss_pred HHEEEE-C-------CcEEEEECCCCeE-----------------------CCCCCHHHHHHH
Confidence 999999 6 4699999999852 346789999864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=5.9e-19 Score=186.15 Aligned_cols=143 Identities=15% Similarity=0.131 Sum_probs=105.2
Q ss_pred ceeeeeecccCceEEEEEEE--CCee--EEEEEEecccCCCChH----------------HHHHhHHhHHHHHHHHHhCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKF--GSAD--AAAKVRTLKVCGSSAD----------------EIRNFEYSCLGEVRMLGALR 566 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~--~~~~--vAVKI~~lk~~~~~~~----------------~~~~f~~~~~rEi~iL~~L~ 566 (840)
|.+.+.||+|+||.||+|.+ .+.. +|+|++.......... ........+.+|+.+|.+|.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67899999999999999998 7888 9999965432111100 00111235689999999999
Q ss_pred CCCc--ceeeeEEecCCCCCCCCCCCccccceEEEEEeccCC-C----CHHHHHHHHhccCCCCCCHHHHHHHHHHHHHH
Q 003185 567 HSCI--VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG-G----SVKNYIEKLSETGEKHVSVKLALFIAQDVAAA 639 (840)
Q Consensus 567 HpNI--V~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~g-G----SL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~A 639 (840)
|++| +.+++. . ..+|||||+.+ | +|.+++.. .++..+..++.||+.|
T Consensus 129 ~~~i~~p~~~~~--~----------------~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~ 182 (258)
T 1zth_A 129 EAGVSVPQPYTY--M----------------KNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVEN 182 (258)
T ss_dssp HTTCCCCCEEEE--E----------------TTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHH
T ss_pred hCCCCCCeEEEc--C----------------CCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHH
Confidence 8864 344432 1 12899999942 3 67765432 2345678999999999
Q ss_pred HHHHH-hCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccc
Q 003185 640 LVELH-SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 684 (840)
Q Consensus 640 L~yLH-s~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~ 684 (840)
|.||| +.||+||||||+|||++. .++|+|||+|...
T Consensus 183 l~~lH~~~givHrDlkp~NILl~~---------~~~liDFG~a~~~ 219 (258)
T 1zth_A 183 VKRLYQEAELVHADLSEYNIMYID---------KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHHHHTSCEECSSCSTTSEEESS---------SEEECCCTTCEET
T ss_pred HHHHHHHCCEEeCCCCHHHEEEcC---------cEEEEECcccccC
Confidence 99999 999999999999999975 3999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=4.1e-16 Score=174.43 Aligned_cols=149 Identities=17% Similarity=0.186 Sum_probs=102.0
Q ss_pred ceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCCh--------------HHHHHhHHhHHHHHHHHHhCCCCCcc
Q 003185 507 LSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSA--------------DEIRNFEYSCLGEVRMLGALRHSCIV 571 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~--------------~~~~~f~~~~~rEi~iL~~L~HpNIV 571 (840)
|++...||.|+||.||+|.. .+..+|||+.+........ ......+....+|...|.+|.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 89999999999999999986 6789999997653221110 00011111224566666666544332
Q ss_pred --eeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Q 003185 572 --EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 649 (840)
Q Consensus 572 --~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIV 649 (840)
..+++. ..+|||||++|++|.++.. ......++.||+.+|.|||++|||
T Consensus 177 vp~p~~~~------------------~~~LVME~i~G~~L~~l~~-----------~~~~~~l~~qll~~l~~lH~~gIV 227 (397)
T 4gyi_A 177 VPEPIAQS------------------RHTIVMSLVDALPMRQVSS-----------VPDPASLYADLIALILRLAKHGLI 227 (397)
T ss_dssp CCCEEEEE------------------TTEEEEECCSCEEGGGCCC-----------CSCHHHHHHHHHHHHHHHHHTTEE
T ss_pred CCeeeecc------------------CceEEEEecCCccHhhhcc-----------cHHHHHHHHHHHHHHHHHHHCCCc
Confidence 222211 1279999999988754321 123467889999999999999999
Q ss_pred cccCCCCcEEEecccccCCCCC---eEEEeecCCcccc
Q 003185 650 HRDIKSENILIDLERKKADGKP---VVKLCDFDRAVPL 684 (840)
Q Consensus 650 HRDLKPeNILLd~~~~~~~~~~---~vKL~DFGlA~~~ 684 (840)
||||||.||||+.+++..+... .+.|+||+-+...
T Consensus 228 HrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 228 HGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9999999999998864332222 4899999988654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=3.7e-11 Score=125.30 Aligned_cols=140 Identities=15% Similarity=0.130 Sum_probs=107.8
Q ss_pred CCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEecCCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 582 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~~~~ 582 (840)
++.|.+...++.|+++.||++...+..+++|+........ . ..+.+|+.+|+.|. +.++.++++++....
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~----~----~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~- 83 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT----T----YDVEREKDMMLWLEGKLPVPKVLHFERHDG- 83 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS----T----TCHHHHHHHHHHHTTTSCCCCEEEEEEETT-
T ss_pred hccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC----H----HHHHHHHHHHHHHhcCCCCCeEEEEEecCC-
Confidence 4678999999999999999999888899999865321111 1 12488999999995 677889998876543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS----------------- 645 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs----------------- 645 (840)
..|+||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 84 -------------~~~lv~e~i~G~~l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~ 140 (263)
T 3tm0_A 84 -------------WSNLLMSEADGVLCSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLA 140 (263)
T ss_dssp -------------EEEEEEECCSSEEHHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHH
T ss_pred -------------ceEEEEEecCCeehhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHH
Confidence 3599999999999876531 112234788999999999998
Q ss_pred ------------------------------------------CCeecccCCCCcEEEecccccCCCCCeEEEeecCCcc
Q 003185 646 ------------------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 682 (840)
Q Consensus 646 ------------------------------------------~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~ 682 (840)
..++|+|++|.|||++.+ ..+.|+||+.+.
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~-------~~~~lIDwe~a~ 212 (263)
T 3tm0_A 141 ELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-------KVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT-------EEEEECCCTTCE
T ss_pred HHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC-------cEEEEEEchhcc
Confidence 458999999999999754 346799999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.97 E-value=1.2e-09 Score=112.38 Aligned_cols=135 Identities=14% Similarity=0.111 Sum_probs=93.3
Q ss_pred CCCCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCC--cceeeeEEec
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC--IVEMYGHKIS 579 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpN--IV~l~g~~~~ 579 (840)
.+..|.+....+.|..+.||++... +..+++|+.... ... .+.+|+.+++.|.+.+ +.+++++...
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-------~~~----~~~~E~~~l~~l~~~~~~vP~~~~~~~~ 86 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-------ALN----ELQDEAARLSWLATTGVPCAAVLDVVTE 86 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-------TTS----CHHHHHHHHHHHHTTTCCBCCEEEEEEC
T ss_pred hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-------cch----hhhHHHHHHHHHHhCCCCCCeEEEeccC
Confidence 4556776655556777999999764 567999985421 111 2378999999986544 4568887664
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH------------ 647 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~g------------ 647 (840)
.+ ..++||||++|.+|. .. ... ...++.+++..|..||+..
T Consensus 87 ~~--------------~~~~v~e~i~G~~l~--~~--------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~ 139 (264)
T 1nd4_A 87 AG--------------RDWLLLGEVPGQDLL--SS--------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKH 139 (264)
T ss_dssp SS--------------CEEEEEECCSSEETT--TS--------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHH
T ss_pred CC--------------CCEEEEEecCCcccC--cC--------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHH
Confidence 33 249999999998874 11 011 1245666777777777643
Q ss_pred ----------------------------------------------eecccCCCCcEEEecccccCCCCCeEEEeecCCc
Q 003185 648 ----------------------------------------------IMHRDIKSENILIDLERKKADGKPVVKLCDFDRA 681 (840)
Q Consensus 648 ----------------------------------------------IVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA 681 (840)
++|+|++|.|||++.+ ..+.|+|||.+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~-------~~~~liD~~~a 212 (264)
T 1nd4_A 140 RIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENG-------RFSGFIDCGRL 212 (264)
T ss_dssp HHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT-------EEEEECCCTTC
T ss_pred HHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC-------cEEEEEcchhc
Confidence 9999999999999754 34679999987
Q ss_pred c
Q 003185 682 V 682 (840)
Q Consensus 682 ~ 682 (840)
.
T Consensus 213 ~ 213 (264)
T 1nd4_A 213 G 213 (264)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.95 E-value=1.5e-09 Score=118.90 Aligned_cols=147 Identities=15% Similarity=0.171 Sum_probs=106.1
Q ss_pred eeeeeecccCceEEEEEEECCeeEEEEEEe--cccCCCChHHHHHhHHhHHHHHHHHHhCC--CCCcceeeeEEecCCCC
Q 003185 508 SSCDEAGKSVSSSLFRCKFGSADAAAKVRT--LKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISSKWL 583 (840)
Q Consensus 508 ~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~--lk~~~~~~~~~~~f~~~~~rEi~iL~~L~--HpNIV~l~g~~~~~~~~ 583 (840)
...+.|+.|.++.||++...+..+++|+.. .... .... ..+.+|+.+++.|. +..+++++.++.....
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~---~~~~----~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~- 112 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL---LPSA----HAIEREYRVMDALAGTDVPVAKMYALCEDESV- 112 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSSCEEEEECCCC-----------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT-
T ss_pred ceEEEcCCcccceEEEEEECCceEEEEeCCCCCCCC---CCcH----HHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc-
Confidence 346789999999999999877888888743 1110 0111 23488999999997 4567888888765432
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh------------------
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS------------------ 645 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs------------------ 645 (840)
....|+||||++|..|.+.. ...++......++.+++.+|..||+
T Consensus 113 ----------~g~~~~vme~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3dxp_A 113 ----------IGRAFYIMEFVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYF 175 (359)
T ss_dssp ----------TSSCEEEEECCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHH
T ss_pred ----------cCCeEEEEEecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCch
Confidence 12349999999987764311 1346788888999999999999997
Q ss_pred ----------------------------------------CCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccc
Q 003185 646 ----------------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 684 (840)
Q Consensus 646 ----------------------------------------~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~ 684 (840)
..++|+|++|.|||++.++. ..+.|+||+.+..-
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~-----~v~~viDwe~a~~g 249 (359)
T 3dxp_A 176 QRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP-----RVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS-----CEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC-----cEEEEECccccccC
Confidence 36999999999999986631 35799999988643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.84 E-value=2.1e-09 Score=115.13 Aligned_cols=196 Identities=18% Similarity=0.210 Sum_probs=119.5
Q ss_pred eeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCC--cceeeeEEecCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSC--IVEMYGHKISSKWLPSAD 587 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpN--IV~l~g~~~~~~~~p~~~ 587 (840)
+.++.|.+..||++. ..+++|+... .... ..+.+|+.+|+.|. +.. +.+++.......
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~------~~~~----~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~------ 86 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKH------SRGS----TNLFNEVNILKRIHNKLPLPIPEVVFTGMPSE------ 86 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESS------HHHH----HHHHHHHHHHHHHTTSSSSCCCCEEEECCCCS------
T ss_pred EecCCCCcceEEEEC---CEEEEEecCC------cchH----HHHHHHHHHHHHHHhcCCCCCCceEeecCCCC------
Confidence 458999999999874 5688887431 1122 34489999998884 333 344444432221
Q ss_pred CCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------
Q 003185 588 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS---------------------- 645 (840)
Q Consensus 588 g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs---------------------- 645 (840)
.....|+||++++|.+|...... .++......++.+++..|..||+
T Consensus 87 -----~~~~~~~vm~~i~G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~ 154 (304)
T 3sg8_A 87 -----TYQMSFAGFTKIKGVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDN 154 (304)
T ss_dssp -----SCSCSCEEEECCCCEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHH
T ss_pred -----CCCcceEEEcccCCeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHH
Confidence 11234899999999888654322 36677777788888888888885
Q ss_pred ------------------------------------CCeecccCCCCcEEEecccccCCCCCeEEEeecCCccccccccc
Q 003185 646 ------------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 689 (840)
Q Consensus 646 ------------------------------------~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~ 689 (840)
..++|+|++|.|||++.+. ...+.|+||+.+..-.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~-----~~~~~~iD~~~~~~~~~~~D 229 (304)
T 3sg8_A 155 KKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEK-----NTICGIIDFGDAAISDPDND 229 (304)
T ss_dssp HHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTT-----TEEEEECCCTTCEEECTTHH
T ss_pred HHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCC-----CCEEEEEeCCCCccCChHHH
Confidence 1479999999999998741 14588999999865432111
Q ss_pred ccccccC-CCCCC---CcccCCCcccc-hhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003185 690 TCCIAHR-GIPAP---DVCVGTPRWMA-PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 748 (840)
Q Consensus 690 ~~~~~~~-~~~~~---~~~vGT~~YmA-PEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~PF 748 (840)
....... ..... ..+.....+.. |+.... .....+.|++|.++|.+.+|..+|
T Consensus 230 l~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r------~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 230 FISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEK------YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHH------HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHH------HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1000000 00000 00000001122 333322 123478999999999999998876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=1.2e-05 Score=86.48 Aligned_cols=139 Identities=16% Similarity=0.143 Sum_probs=86.8
Q ss_pred eeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCC---CcceeeeEEecCCCCCCC
Q 003185 510 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS---CIVEMYGHKISSKWLPSA 586 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~Hp---NIV~l~g~~~~~~~~p~~ 586 (840)
.+.++.|....||+. +..+++|+.. ..... ..+.+|+.+|..|.+. .|.+++.+.....
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~------~~~~~----~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~----- 85 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPK------SQQGA----DELNKEIQLLPLLVGCVKVNIPQYVYIGKRSD----- 85 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEES------SHHHH----HHHHHHHHHHHHHTTTCSSBCCCEEEEEECTT-----
T ss_pred eeecCCCcceeEEEE---CCEEEEEecC------CchHH----HHHHHHHHHHHHHHhcCCCCCCCeEeecccCC-----
Confidence 456788999999998 6778888742 11222 3448999999999742 2556666654211
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------
Q 003185 587 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS--------------------- 645 (840)
Q Consensus 587 ~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs--------------------- 645 (840)
...++||||++|.+|....- ..++......++.+++..|..||+
T Consensus 86 --------g~~~~v~e~i~G~~l~~~~~-------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~ 150 (306)
T 3tdw_A 86 --------GNPFVGYRKVQGQILGEDGM-------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKIL 150 (306)
T ss_dssp --------SCEEEEEECCCSEECHHHHH-------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHH
T ss_pred --------CceEEEEeccCCeECchhhh-------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHH
Confidence 12489999999987765321 112333333333333333333332
Q ss_pred ---------------------------------------CCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccc
Q 003185 646 ---------------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 684 (840)
Q Consensus 646 ---------------------------------------~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~ 684 (840)
..++|+|++|.|||++.+.. ....+.|+||+.+..-
T Consensus 151 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~---~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 151 LLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSR---QTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCS---SCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCC---CCceEEEEehhhcCCC
Confidence 24699999999999986210 1134689999987643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=3.5e-05 Score=80.12 Aligned_cols=136 Identities=15% Similarity=0.116 Sum_probs=88.4
Q ss_pred CCceeeeeecccCce-EEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEecC
Q 003185 505 PSLSSCDEAGKSVSS-SLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 580 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG-~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~~ 580 (840)
..|+.. .+..|..| .||+... .+..+++|+.... ... .+.+|+.+|+.|. +--+.++++++...
T Consensus 25 ~g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-------~~~----~~~~E~~~l~~l~~~vPVP~v~~~~~~~ 92 (272)
T 4gkh_A 25 YGYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-------VAN----DVTDEMVRLNWLTAFMPLPTIKHFIRTP 92 (272)
T ss_dssp TTCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETH-------HHH----HHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred cCCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCC-------CHh----HHHHHHHHHHHhccCCCcCeEEEEEEEC
Confidence 344433 34445555 6998775 4567899986421 122 3478999998885 33467788877654
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---------------
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS--------------- 645 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs--------------- 645 (840)
+ ..|+|||+++|.++.+..... ......+..+++..|..||.
T Consensus 93 ~--------------~~~lvme~l~G~~~~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~ 149 (272)
T 4gkh_A 93 D--------------DAWLLTTAIPGKTAFQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFR 149 (272)
T ss_dssp T--------------EEEEEEECCCSEEHHHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHH
T ss_pred C--------------eEEEEEEeeCCccccccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccc
Confidence 3 349999999998887765430 11223344455555555553
Q ss_pred ------------------------------------C-------CeecccCCCCcEEEecccccCCCCCeEEEeecCCcc
Q 003185 646 ------------------------------------K-------HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 682 (840)
Q Consensus 646 ------------------------------------~-------gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~ 682 (840)
. .++|+|+.|.|||++.+ ..+-|+||+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~-------~~~~viDwe~a~ 222 (272)
T 4gkh_A 150 LAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEG-------KLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETT-------EEEEECCCTTCE
T ss_pred hhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECC-------eEEEEEECcccc
Confidence 1 27999999999999865 356799999774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.83 E-value=3.5e-05 Score=83.74 Aligned_cols=84 Identities=12% Similarity=0.033 Sum_probs=53.8
Q ss_pred eeeeee-cccCceEEEEEEEC--------CeeEEEEEEecccC--CCChHHHHHhHHhHHHHHHHHHhCC-C--CCccee
Q 003185 508 SSCDEA-GKSVSSSLFRCKFG--------SADAAAKVRTLKVC--GSSADEIRNFEYSCLGEVRMLGALR-H--SCIVEM 573 (840)
Q Consensus 508 ~i~~~L-G~G~fG~Vy~a~~~--------~~~vAVKI~~lk~~--~~~~~~~~~f~~~~~rEi~iL~~L~-H--pNIV~l 573 (840)
...+.| +.|....+|+.... +..+++|+...... ... . ..+.+|+.+|+.|. + -.+.++
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~----~~~~~E~~~l~~L~~~~~vpvP~v 95 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---T----YRLDHQFEVIRLVGELTDVPVPRV 95 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---C----CCHHHHHHHHHHHHHHCCSCCCCE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---h----hHHHHHHHHHHHHhhcCCCCCCcE
Confidence 345778 88999999998764 66788887532210 000 0 12377888888885 3 356778
Q ss_pred eeEEecCCCCCCCCCCCccccceEEEEEeccCCCCH
Q 003185 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSV 609 (840)
Q Consensus 574 ~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL 609 (840)
+.+...... ....|+||||++|..|
T Consensus 96 ~~~~~~~~~-----------~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 96 RWIETTGDV-----------LGTPFFLMDYVEGVVP 120 (357)
T ss_dssp EEEECSSTT-----------TSSCEEEEECCCCBCC
T ss_pred EEEccCCCc-----------cCCceEEEEecCCCCh
Confidence 877654321 1234899999998654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00017 Score=79.77 Aligned_cols=82 Identities=11% Similarity=-0.029 Sum_probs=47.1
Q ss_pred eeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC--CC-cceeeeEEecCCCC
Q 003185 509 SCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SC-IVEMYGHKISSKWL 583 (840)
Q Consensus 509 i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~H--pN-IV~l~g~~~~~~~~ 583 (840)
..+.||.|.++.||++.. .+..+++|........... .......++..|+.+|+.+.. |. +.+++.+. ...
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~-~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~- 109 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGE-SWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEM- 109 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC--------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTT-
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCC-CCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCc-
Confidence 356899999999999954 5678999975422110000 000011234778888888742 33 34555432 221
Q ss_pred CCCCCCCccccceEEEEEeccCCC
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGG 607 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gG 607 (840)
.++||||+++.
T Consensus 110 -------------~~lvmE~l~g~ 120 (397)
T 2olc_A 110 -------------AVTVMEDLSHL 120 (397)
T ss_dssp -------------TEEEECCCTTS
T ss_pred -------------cEEEEEeCCCc
Confidence 28999999863
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00072 Score=72.14 Aligned_cols=30 Identities=20% Similarity=0.339 Sum_probs=25.6
Q ss_pred CCeecccCCCCcEEEecccccCCCCCeEEEeecCCcc
Q 003185 646 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 682 (840)
Q Consensus 646 ~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~ 682 (840)
..++|+|+++.|||++.+ ..+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~-------~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGEN-------EQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGG-------GCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCC-------CcEEEEehhhcc
Confidence 579999999999999765 349999999774
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0016 Score=69.15 Aligned_cols=71 Identities=13% Similarity=0.145 Sum_probs=43.6
Q ss_pred eeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCc-ceeeeEEecCCCCCCCCC
Q 003185 510 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI-VEMYGHKISSKWLPSADG 588 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNI-V~l~g~~~~~~~~p~~~g 588 (840)
.+.|+.|....+|++ ..+++|+..... ..... ..+|+.+++.+...++ .+++++....
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~-----~~~~~----r~~E~~~l~~l~~~g~~P~~~~~~~~~-------- 81 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGT-----EEYIN----RANEAVAAREAAKAGVSPEVLHVDPAT-------- 81 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC---------CCC----HHHHHHHHHHHHHTTSSCCEEEECTTT--------
T ss_pred eeEcCCcccccccee----eeEEEECCCCCc-----cceeC----HHHHHHHHHHHHHcCCCCceEEEECCC--------
Confidence 788999999999999 678888864321 11111 1567777777752222 4555543211
Q ss_pred CCccccceEEEEEecc-CCCCH
Q 003185 589 NPEHHLLQSAIFMEYV-KGGSV 609 (840)
Q Consensus 589 ~~~~~~~~~~LVmEy~-~gGSL 609 (840)
-++||||+ +|.+|
T Consensus 82 --------~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 82 --------GVMVTRYIAGAQTM 95 (301)
T ss_dssp --------CCEEEECCTTCEEC
T ss_pred --------CEEEEeecCCCccC
Confidence 17899999 66443
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0017 Score=72.50 Aligned_cols=81 Identities=9% Similarity=0.070 Sum_probs=48.4
Q ss_pred HhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccC--CCcccchhhhhcccC
Q 003185 644 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG--TPRWMAPEVLRAMHK 721 (840)
Q Consensus 644 Hs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vG--T~~YmAPEvL~~~~~ 721 (840)
+...++|+|++|.|||++.+ . ++|+||+.+..-....... .... ...|++|+......
T Consensus 230 ~~~~liHGDl~~~Nil~~~~-------~-~~lID~e~a~~G~p~~Dla-----------~~l~~~~~~~~~~~~~~~~~- 289 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQD-------S-TQVIDPEFSFYGPMGFDIG-----------AYLGNLILAFFAQDGHATQE- 289 (420)
T ss_dssp BCCEEECSCCSGGGEEECSS-------C-EEECCCTTCEEECHHHHHH-----------HHHHHHHHHHHHGGGGCCSS-
T ss_pred CCCeEEecCCCCCcEEEeCC-------C-CEEEeCcccccCchHHHHH-----------HHHHHHHHHHHhcccccccc-
Confidence 45689999999999999765 2 8999999886533211100 0000 12456665543100
Q ss_pred CCCCCchhhHHHHHHHHHHHHhC
Q 003185 722 PNLYGLEVDIWSYGCLLLELLTL 744 (840)
Q Consensus 722 ~~~~s~kSDVWSLGvIL~ELLTG 744 (840)
.........+..+...+|+.+++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~y~~ 312 (420)
T 2pyw_A 290 NDRKEYKQWILRTIEQTWNLFNK 312 (420)
T ss_dssp CCSHHHHHHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHHHHHHHHHH
Confidence 01112346667888888888764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0046 Score=66.42 Aligned_cols=36 Identities=33% Similarity=0.400 Sum_probs=27.1
Q ss_pred CCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccc
Q 003185 646 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 684 (840)
Q Consensus 646 ~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~ 684 (840)
..++|||+.+.|||++.+.. +...+.|+||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~---~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPERE---GLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSC---GGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcC---CCCCeEEEeCCCcCcC
Confidence 47999999999999976310 0135899999988643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0036 Score=67.72 Aligned_cols=76 Identities=12% Similarity=0.036 Sum_probs=56.6
Q ss_pred eeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC---CCCcceeeeEEecCCCCCC
Q 003185 509 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKISSKWLPS 585 (840)
Q Consensus 509 i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~---HpNIV~l~g~~~~~~~~p~ 585 (840)
-.+.|+.|.+..+|+....+..+++|+.... .. ..+.+|+..|+.|. ...+++++.+.....
T Consensus 40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-------~~----~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g---- 104 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDEVQTVFVKINERS-------YR----SMFRAEADQLALLAKTNSINVPLVYGIGNSQG---- 104 (312)
T ss_dssp EEEEECCSSSSEEEEEESSSCEEEEEEEEGG-------GH----HHHHHHHHHHHHHHHTTSSBCCCEEEEEECSS----
T ss_pred eeEEeCCccceeeeEEEECCCeEEEEeCCcc-------cH----HHHHHHHHHHHHHHhhCCCCcceEEEEeecCC----
Confidence 4677899999999999988888999986521 11 23478999888884 356788888765432
Q ss_pred CCCCCccccceEEEEEeccCCCCH
Q 003185 586 ADGNPEHHLLQSAIFMEYVKGGSV 609 (840)
Q Consensus 586 ~~g~~~~~~~~~~LVmEy~~gGSL 609 (840)
..++||||++|..+
T Consensus 105 ----------~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 105 ----------HSFLLLEALNKSKN 118 (312)
T ss_dssp ----------EEEEEEECCCCCCC
T ss_pred ----------ceEEEEEeccCCCC
Confidence 35999999998753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0077 Score=64.08 Aligned_cols=151 Identities=17% Similarity=0.139 Sum_probs=78.0
Q ss_pred ceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCC--cceeeeEEecCCCCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC--IVEMYGHKISSKWLP 584 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpN--IV~l~g~~~~~~~~p 584 (840)
..-.+.|+.|....+|+....+..+++|+..... ... .+..|+.++..|...+ +.+++... ....+
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~------~~~----~l~~e~~~l~~L~~~g~~vP~~~~~~-~g~~~- 91 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV------EKN----DLPFFLGLMQHLAAKGLSCPLPLPRK-DGELL- 91 (322)
T ss_dssp EEEEEEECC---EEEEEEEESSCCEEEEEECC---------CC----HHHHHHHHHHHHHHTTCCCCCBCCBT-TCCSC-
T ss_pred ceEeeccCCCcccceEEEEeCCccEEEEEeCCCC------CHH----HHHHHHHHHHHHHHCCCCCCcccCCC-CCCEE-
Confidence 3456778889999999998877788999865310 111 2256777777774222 23333210 00000
Q ss_pred CCCCCCccccceEEEEEeccCCCCHH-----------HHH---HHHhcc-CCC---CCC---HHHHHH------------
Q 003185 585 SADGNPEHHLLQSAIFMEYVKGGSVK-----------NYI---EKLSET-GEK---HVS---VKLALF------------ 631 (840)
Q Consensus 585 ~~~g~~~~~~~~~~LVmEy~~gGSL~-----------~~L---~~~~~~-~~~---~ls---~~~~~~------------ 631 (840)
.......++||+|++|..+. +.+ +..... ... ... +.....
T Consensus 92 ------~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 165 (322)
T 2ppq_A 92 ------GELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 165 (322)
T ss_dssp ------EEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred ------EEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhh
Confidence 00012358999999975421 111 111000 000 011 111000
Q ss_pred HHHHHHHHHHHHHh-------CCeecccCCCCcEEEecccccCCCCCeEEEeecCCcc
Q 003185 632 IAQDVAAALVELHS-------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 682 (840)
Q Consensus 632 Ia~QIa~AL~yLHs-------~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~ 682 (840)
+...+...+.+++. .+++|+|+.+.|||++.+ ..+.|+||+.+.
T Consensus 166 l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~-------~~~~lIDf~~a~ 216 (322)
T 2ppq_A 166 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGD-------ELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETT-------EEEEECCCTTCE
T ss_pred hHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCC-------ceEEEecchhcc
Confidence 00113444555552 369999999999999865 235799999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.023 Score=59.72 Aligned_cols=76 Identities=18% Similarity=0.147 Sum_probs=51.1
Q ss_pred ceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC---CCcceeeeEEecCCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH---SCIVEMYGHKISSKW 582 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~H---pNIV~l~g~~~~~~~ 582 (840)
..-.+.+|.|..+.||+... .++.+++|+..-... . . ...+.+|++.|+.|.- --+.+++++..
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~--~--~----~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~---- 84 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP--A--L----DGLFRAEALGLDWLGRSFGSPVPQVAGWDD---- 84 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC--C--C----TTHHHHHHHHHHHHTCSTTCCSCCEEEEET----
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc--c--h----hhHHHHHHHHHHHHHhhCCCCcceEEeccC----
Confidence 45578899999999999997 567899997432211 1 0 1124789999988852 23455555421
Q ss_pred CCCCCCCCccccceEEEEEeccCCCC
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGS 608 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGS 608 (840)
.++||||+.++.
T Consensus 85 --------------~~lv~e~l~~~~ 96 (288)
T 3f7w_A 85 --------------RTLAMEWVDERP 96 (288)
T ss_dssp --------------TEEEEECCCCCC
T ss_pred --------------ceEEEEeecccC
Confidence 189999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.25 E-value=0.0085 Score=65.43 Aligned_cols=72 Identities=10% Similarity=0.180 Sum_probs=42.6
Q ss_pred eeeecccCceEEEEEEECC----------eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCC-cceeeeEEe
Q 003185 510 CDEAGKSVSSSLFRCKFGS----------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC-IVEMYGHKI 578 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~----------~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpN-IV~l~g~~~ 578 (840)
.+.|+.|....+|++...+ ..+++|+.... ..... ....|..+++.|...+ +.++++..
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~-----~~~~~----~~~~E~~~l~~L~~~g~~P~~~~~~- 107 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH-----VDELY----NTISEFEVYKTMSKYKIAPQLLNTF- 107 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT-----GGGTS----CHHHHHHHHHHHHHTTSSCCEEEEE-
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC-----cccee----cHHHHHHHHHHHHhcCCCCceEEec-
Confidence 5678888889999998754 57888875321 11111 1256888888775333 44666543
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCC
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGS 608 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGS 608 (840)
.+ ++||||++|.+
T Consensus 108 -~~----------------~~v~e~i~G~~ 120 (369)
T 3c5i_A 108 -NG----------------GRIEEWLYGDP 120 (369)
T ss_dssp -TT----------------EEEEECCCSEE
T ss_pred -CC----------------cEEEEEecCCc
Confidence 11 78999998743
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.10 E-value=0.052 Score=55.96 Aligned_cols=101 Identities=15% Similarity=0.117 Sum_probs=63.9
Q ss_pred CHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccc
Q 003185 608 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 686 (840)
Q Consensus 608 SL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs-~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~ 686 (840)
||.+.|..+ +.+++++++|.++.|.+.+|.-+-. +.-..+=+-|..|+|..+|. |-+.+ +.+.
T Consensus 34 SL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~-------V~f~~-~~s~---- 97 (229)
T 2yle_A 34 SLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA-------VTLAP-AADD---- 97 (229)
T ss_dssp EHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC-------EEECC-C-------
T ss_pred cHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc-------eeccc-cccc----
Confidence 899999863 4689999999999999999887621 12122334468888888743 55442 1110
Q ss_pred cccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003185 687 FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 747 (840)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~P 747 (840)
.....+.|||.+. ...+.+.=|||||++||..+-=..|
T Consensus 98 ------------------~~~~~~~~pe~~~-----~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ------------------AGEPPPVAGKLGY-----SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ---------------------------CCSS-----SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ------------------ccccCCCChhhcc-----ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0223566888753 2457899999999999999864433
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.05 E-value=0.055 Score=61.58 Aligned_cols=72 Identities=17% Similarity=0.110 Sum_probs=46.9
Q ss_pred eeeecccCceEEEEEEECC--eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCc-ceeeeEEecCCCCCCC
Q 003185 510 CDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI-VEMYGHKISSKWLPSA 586 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~--~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNI-V~l~g~~~~~~~~p~~ 586 (840)
.+.|+.|-...+|++...+ ..+++|+...... ..+. . .+|+.++..|...+| .++++.+. +
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~----~~id-R----~~E~~vl~~L~~~gl~P~ll~~~~--~----- 176 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD----EIIN-R----EREKKISCILYNKNIAKKIYVFFT--N----- 176 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC----SCSC-H----HHHHHHHHHHTTSSSBCCEEEEET--T-----
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh----hhcC-H----HHHHHHHHHHHhcCCCCCEEEEeC--C-----
Confidence 5678889999999999876 7889998632110 0000 1 578899998875444 56776652 1
Q ss_pred CCCCccccceEEEEEeccCCCC
Q 003185 587 DGNPEHHLLQSAIFMEYVKGGS 608 (840)
Q Consensus 587 ~g~~~~~~~~~~LVmEy~~gGS 608 (840)
++||||++|.+
T Consensus 177 -----------G~v~e~I~G~~ 187 (458)
T 2qg7_A 177 -----------GRIEEFMDGYA 187 (458)
T ss_dssp -----------EEEEECCCSEE
T ss_pred -----------eEEEEeeCCcc
Confidence 56999998743
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.86 E-value=0.036 Score=62.37 Aligned_cols=71 Identities=15% Similarity=0.258 Sum_probs=46.8
Q ss_pred eeeeecccCceEEEEEEEC---------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCc-ceeeeEEe
Q 003185 509 SCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI-VEMYGHKI 578 (840)
Q Consensus 509 i~~~LG~G~fG~Vy~a~~~---------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNI-V~l~g~~~ 578 (840)
-.+.|+.|-...||++... +..+++|+.... .. ...+ .+|+.+++.|...+| .++++.+.
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~---~~~l----i~E~~~l~~L~~~g~~P~l~~~~~ 146 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ET---ESHL----VAESVIFTLLSERHLGPKLYGIFS 146 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CC---HHHH----HHHHHHHHHHHHTTSSSCEEEEET
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---Cc---HHHH----HHHHHHHHHHHhCCCCCcEEEEeC
Confidence 3567888999999999874 467888886311 11 0122 578888888863333 56666542
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCC
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGG 607 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gG 607 (840)
+ ++||||++|.
T Consensus 147 --~----------------g~v~e~l~G~ 157 (429)
T 1nw1_A 147 --G----------------GRLEEYIPSR 157 (429)
T ss_dssp --T----------------EEEECCCCEE
T ss_pred --C----------------CEEEEEeCCc
Confidence 1 5899999863
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.51 E-value=0.034 Score=61.76 Aligned_cols=144 Identities=19% Similarity=0.218 Sum_probs=78.3
Q ss_pred eeeecccCceEEEEEEEC---------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEec
Q 003185 510 CDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 579 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~---------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~ 579 (840)
.+.|..|-...+|++... +..+++++.. .... ... .+.+|..+++.|. +.-..++++.+.
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g--~~~~---~~~----~~~rE~~vl~~L~~~gv~P~ll~~~~- 124 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYG--AILQ---GVD----SLVLESVMFAILAERSLGPQLYGVFP- 124 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----C---CHH----HHHHHHHHHHHHHHTTSSCCEEEEET-
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECC--Cccc---hHH----HHHHHHHHHHHHHhcCCCCeEEEEcC-
Confidence 356777888899998863 3578888742 1111 111 2268999888885 322356666542
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHH--------------HHHHHHhcc---CCCCCC--HHHHHHHHHHHHH--
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVK--------------NYIEKLSET---GEKHVS--VKLALFIAQDVAA-- 638 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~--------------~~L~~~~~~---~~~~ls--~~~~~~Ia~QIa~-- 638 (840)
+ .+||||++|.+|. +.|.++-.. ...... +..+.+++.++..
T Consensus 125 -~----------------g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~ 187 (379)
T 3feg_A 125 -E----------------GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLP 187 (379)
T ss_dssp -T----------------EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCC
T ss_pred -C----------------ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhcc
Confidence 1 4899999875432 112211111 011122 3455555554422
Q ss_pred -----------------HHHHHH----h----CCeecccCCCCcEEEecccccCCCCCeEEEeecCCccc
Q 003185 639 -----------------ALVELH----S----KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 683 (840)
Q Consensus 639 -----------------AL~yLH----s----~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~ 683 (840)
.+..|. . ..++|+|+.+.|||++.+.. ....+.|+||..+..
T Consensus 188 ~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~---~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 188 PTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPE---NADSLMLVDFEYSSY 254 (379)
T ss_dssp CCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC------CCEEECCCTTCEE
T ss_pred CcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCC---ccCcEEEEecccCCc
Confidence 233332 2 25999999999999986511 123589999998863
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.44 E-value=0.067 Score=56.84 Aligned_cols=79 Identities=13% Similarity=0.016 Sum_probs=44.4
Q ss_pred eeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCC--CcceeeeEEecCCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS--CIVEMYGHKISSKWLPSAD 587 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~Hp--NIV~l~g~~~~~~~~p~~~ 587 (840)
..|+ |....||+.... +..+++|+..... ... . .+..|+.++..|... .+++++.. ....+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~--~~~---~----~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~---- 95 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER--WTA---D----QILEEHQFALQLVNDEVPVAAPVAF--NGQTL---- 95 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT--SCH---H----HHHHHHHHHHHHHHTTCSBCCCCCB--TTBSC----
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC--CCH---H----HHHHHHHHHHHHHHcCCeecceeec--CCcEE----
Confidence 4566 888899998764 4579999864221 111 1 225677777777522 24444443 11111
Q ss_pred CCCccccceEEEEEeccCCCC
Q 003185 588 GNPEHHLLQSAIFMEYVKGGS 608 (840)
Q Consensus 588 g~~~~~~~~~~LVmEy~~gGS 608 (840)
.......++||+|++|..
T Consensus 96 ---~~~~g~~~~l~~~i~G~~ 113 (328)
T 1zyl_A 96 ---LNHQGFYFAVFPSVGGRQ 113 (328)
T ss_dssp ---EEETTEEEEEEECCCCEE
T ss_pred ---EEECCEEEEEEEecCCCC
Confidence 001224588999998743
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.47 E-value=0.15 Score=55.18 Aligned_cols=32 Identities=25% Similarity=0.427 Sum_probs=26.5
Q ss_pred CCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccc
Q 003185 646 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 684 (840)
Q Consensus 646 ~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~ 684 (840)
..++|+|+.+.|||++.+ ..+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~-------~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNE-------ESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGG-------GCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCC-------CeEEEEECCCCeeC
Confidence 369999999999999865 34899999887644
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.12 E-value=0.66 Score=52.15 Aligned_cols=73 Identities=10% Similarity=0.114 Sum_probs=46.6
Q ss_pred eeeeecccCceEEEEEEEC---------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEe
Q 003185 509 SCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 578 (840)
Q Consensus 509 i~~~LG~G~fG~Vy~a~~~---------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~ 578 (840)
-.+.|..|-...+|+.... +..+++++..... ...-. ..+|..+++.|. +.-..++++.+.
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-----~~~id----R~~E~~~l~~L~~~gi~P~l~~~~~ 144 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-----GKFYD----SKVELDVFRYLSNINIAPNIIADFP 144 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC------CCCC----HHHHHHHHHHHHHTTSSCCEEEEET
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-----chhcC----HHHHHHHHHHHHhcCCCCCEEEEcC
Confidence 3567778889999999876 5778888753211 11101 157888888875 322455565331
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCC
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGS 608 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGS 608 (840)
+ ++||||++|.+
T Consensus 145 --~----------------~~I~efI~G~~ 156 (424)
T 3mes_A 145 --E----------------GRIEEFIDGEP 156 (424)
T ss_dssp --T----------------EEEEECCCSEE
T ss_pred --C----------------CEEEEEeCCcc
Confidence 1 78999999855
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.47 E-value=1.9 Score=47.62 Aligned_cols=35 Identities=29% Similarity=0.357 Sum_probs=25.9
Q ss_pred eecccCCCCcEEEecccccCCCCCeEEEeecCCccc
Q 003185 648 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 683 (840)
Q Consensus 648 IVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~ 683 (840)
++|+|+.+.|||+..+.. ......+.|+||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~-~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRE-NSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGG-GCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcc-cCcCCeEEEechHhccC
Confidence 679999999999965321 11235699999998864
|
| >2f4m_A Peptide N-glycanase; glycoproteins, ubiquitin-dependent protein degradation, NUCL excision repair, peptide:N-glycanase; 1.85A {Mus musculus} SCOP: d.3.1.4 PDB: 2f4o_A* | Back alignment and structure |
|---|
Probab=80.07 E-value=0.23 Score=53.12 Aligned_cols=51 Identities=24% Similarity=0.591 Sum_probs=42.9
Q ss_pred eeeccccceeeeeeeccccCCCccccccccccccCCCCcceeEEeeCCceEEEEeccc
Q 003185 403 QFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDAC 460 (840)
Q Consensus 403 ~~g~~~~rallfk~l~d~~~~~lpcrlvrG~~~~~~~a~~s~lvr~G~~~~~~lvd~~ 460 (840)
..|+|++-|.||-.||=.++ ||+|+|.|+ ..|+|.++-+.....|+ .+|.+
T Consensus 139 r~G~C~d~A~lf~al~Ra~G--IpAR~V~Gy---~~HaW~Evy~~g~~gWv--~~Dpt 189 (295)
T 2f4m_A 139 RCGRCGEWANCFTLCCRALG--FEARYVWDY---TDHVWTEVYSPSQQRWL--HCDAC 189 (295)
T ss_dssp CEESHHHHHHHHHHHHHHTT--CCEEEEEET---TTEEEEEEEETTTTEEE--EEETT
T ss_pred CCEeeHHHHHHHHHHHHHCC--CCEEEEcCC---CCEEEEEEEECCCCeEE--EEeCC
Confidence 57999999999999999999 999999998 56999888886435663 55655
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 840 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-38 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-37 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-37 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-36 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-36 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-36 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-36 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-35 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-35 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-34 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-34 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-34 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-34 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-33 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-33 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-33 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-33 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-33 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-32 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-32 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-32 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-32 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-31 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-31 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-31 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-30 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-30 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-30 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-30 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-29 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-29 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-29 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-28 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-28 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-28 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-28 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-28 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-28 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-27 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-27 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-26 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-26 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-25 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-25 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-25 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-24 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-23 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-21 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-21 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-10 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 5e-42
Identities = 65/315 (20%), Positives = 123/315 (39%), Gaps = 64/315 (20%)
Query: 514 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 573
G ++++ K+ D A K+ L V + +++ F EV +L RH I+
Sbjct: 17 GSGSFGTVYKGKWHG-DVAVKM--LNVTAPTPQQLQAF----KNEVGVLRKTRHVNILLF 69
Query: 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 633
G+ + + I ++ +G S+ +++ + E + + IA
Sbjct: 70 MGYSTAPQLA---------------IVTQWCEGSSLYHHLHII----ETKFEMIKLIDIA 110
Query: 634 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 693
+ A + LH+K I+HRD+KS NI + VK+ DF A + +
Sbjct: 111 RQTAQGMDYLHAKSIIHRDLKSNNIFL-------HEDLTVKIGDFGLATVKSRWSGSHQF 163
Query: 694 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE 753
G+ WMAPEV+R M N Y + D++++G +L EL+T Q+PY ++
Sbjct: 164 EQ--------LSGSILWMAPEVIR-MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214
Query: 754 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 813
+ + +G+ D + +C + + + C ++
Sbjct: 215 RDQIIFM-VGRGYLSPDLSKVRSNCPKA---------------------MKRLMAECLKK 252
Query: 814 NPTERPTAGDLYEMF 828
ERP +
Sbjct: 253 KRDERPLFPQILASI 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-38
Identities = 69/314 (21%), Positives = 118/314 (37%), Gaps = 67/314 (21%)
Query: 514 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 573
G +++ + A + + S +E+ ++ + E+ +L + H IV++
Sbjct: 21 GDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDY----MVEIDILASCDHPNIVKL 74
Query: 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 633
L I +E+ GG+V + +L E+ ++ +
Sbjct: 75 LDAFYYENNL--------------WILIEFCAGGAVDAVMLEL----ERPLTESQIQVVC 116
Query: 634 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 693
+ AL LH I+HRD+K+ NIL DG +KL DF +
Sbjct: 117 KQTLDALNYLHDNKIIHRDLKAGNILFT-----LDG--DIKLADFGVS----------AK 159
Query: 694 AHRGIPAPDVCVGTPRWMAPEVLRA-MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS 752
R I D +GTP WMAPEV+ K Y + D+WS G L+E+ ++ P+ L+
Sbjct: 160 NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 219
Query: 753 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 812
+ + I + P L +P S D ++C E
Sbjct: 220 PMRVLLKIAKSEPPTL----------------------AQPS---RWSSNFKDFLKKCLE 254
Query: 813 ENPTERPTAGDLYE 826
+N R T L +
Sbjct: 255 KNVDARWTTSQLLQ 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 6e-37
Identities = 68/311 (21%), Positives = 115/311 (36%), Gaps = 66/311 (21%)
Query: 531 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 590
A K+ L++ + ++I E+++L IV YG S +
Sbjct: 34 MARKLIHLEIKPAIRNQIIR-------ELQVLHECNSPYIVGFYGAFYSDGEI------- 79
Query: 591 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IM 649
+I ME++ GGS+ ++K + ++ ++ V L L KH IM
Sbjct: 80 -------SICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIM 127
Query: 650 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 709
HRD+K NIL++ + +KLCDF + L + VGT
Sbjct: 128 HRDVKPSNILVN-------SRGEIKLCDFGVSGQLIDSMAN------------SFVGTRS 168
Query: 710 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI--------- 760
+M+PE L+ H Y ++ DIWS G L+E+ + P E+ +
Sbjct: 169 YMSPERLQGTH----YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224
Query: 761 ------QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEE 813
+ RP + +++ E+ P+ S D +C +
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
Query: 814 NPTERPTAGDL 824
NP ER L
Sbjct: 285 NPAERADLKQL 295
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 9e-37
Identities = 74/318 (23%), Positives = 115/318 (36%), Gaps = 70/318 (22%)
Query: 514 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 573
G + + S + L + E + + EV +L L+H IV
Sbjct: 13 GTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQML----VSEVNLLRELKHPNIVRY 68
Query: 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 633
Y I L I MEY +GG + + I K ++ +++ + L +
Sbjct: 69 YDRIIDRT---------NTTLY---IVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVM 115
Query: 634 QDVAAALVELHSKH-----IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFL 688
+ AL E H + ++HRD+K N+ +D GK VKL DF A
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-------GKQNVKLGDFGLA------- 161
Query: 689 HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 748
I + VGTP +M+PE + M Y + DIWS GCLL EL L P+
Sbjct: 162 ---RILNHDTSFAKAFVGTPYYMSPEQMNRMS----YNEKSDIWSLGCLLYELCALMPPF 214
Query: 749 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 808
S+ E+ I+ GK R+ + L ++
Sbjct: 215 TAFSQKELAGKIREGKFRRIPYRY--------------------SDE-------LNEIIT 247
Query: 809 RCTEENPTERPTAGDLYE 826
R RP+ ++ E
Sbjct: 248 RMLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 67/317 (21%), Positives = 116/317 (36%), Gaps = 73/317 (23%)
Query: 514 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 573
G+ ++++ L+ + E + F E ML L+H IV
Sbjct: 18 GRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRF----KEEAEMLKGLQHPNIVRF 73
Query: 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 633
Y W + G L+ E + G++K Y+++ K + +K+
Sbjct: 74 YDS-----WESTVKGKKCIVLV-----TELMTSGTLKTYLKR-----FKVMKIKVLRSWC 118
Query: 634 QDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR-SFLHT 690
+ + L LH++ I+HRD+K +NI I VK+ D A R SF
Sbjct: 119 RQILKGLQFLHTRTPPIIHRDLKCDNIFIT------GPTGSVKIGDLGLATLKRASFAKA 172
Query: 691 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 750
GTP +MAPE+ Y VD++++G +LE+ T + PY
Sbjct: 173 VI-------------GTPEFMAPEMYE-----EKYDESVDVYAFGMCMLEMATSEYPYSE 214
Query: 751 L-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 809
+ +I+ + G +P D++ PE + ++
Sbjct: 215 CQNAAQIYRRVTSGVKPASFDKVAI------------------PEVK--------EIIEG 248
Query: 810 CTEENPTERPTAGDLYE 826
C +N ER + DL
Sbjct: 249 CIRQNKDERYSIKDLLN 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-36
Identities = 52/294 (17%), Positives = 99/294 (33%), Gaps = 70/294 (23%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V+ LK + L E ++ L + IV M G + W+
Sbjct: 39 VKILKNEANDPALKDEL----LAEANVMQQLDNPYIVRMIGICEAESWM----------- 83
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
+ ME + G + Y+++ +HV K + + V+ + L + +HRD+
Sbjct: 84 ----LVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA 134
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714
+ N+L+ + K+ DF + LR+ + +W APE
Sbjct: 135 ARNVLL-------VTQHYAKISDFGLSKALRADENYYKAQTH-------GKWPVKWYAPE 180
Query: 715 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 773
+ + + D+WS+G L+ E + Q PY G+ E+ +++ G+R
Sbjct: 181 CINYYK----FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC- 235
Query: 774 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 827
P + D+ C + RP +
Sbjct: 236 -------------------PRE-------MYDLMNLCWTYDVENRPGFAAVELR 263
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 2e-36
Identities = 59/272 (21%), Positives = 98/272 (36%), Gaps = 68/272 (25%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E ++ LRHS +V++ G + K L I EY+ GS+ +Y+
Sbjct: 50 EASVMTQLRHSNLVQLLGVIVEEK----------GGLY---IVTEYMAKGSLVDYLRS-- 94
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
G + L + DV A+ L + +HRD+ + N+L+ D V K+ D
Sbjct: 95 -RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-----EDN--VAKVSD 146
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F S T +W APE LR + + D+WS+G L
Sbjct: 147 FGLTKEASSTQDTGK-------------LPVKWTAPEALREKK----FSTKSDVWSFGIL 189
Query: 738 LLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 796
L E+ + +VPY + ++ ++ G + D P A
Sbjct: 190 LWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC--------------------PPA- 228
Query: 797 LETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
+ +V + C + RP+ L E
Sbjct: 229 ------VYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 135 bits (341), Expect = 4e-36
Identities = 60/299 (20%), Positives = 109/299 (36%), Gaps = 64/299 (21%)
Query: 531 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSADGN 589
A + SA+E++ + L EV +L + H I+++ ++ +
Sbjct: 32 AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF------ 85
Query: 590 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 649
+ + +K G + +Y+ + + +S K I + + + LH +I+
Sbjct: 86 --------FLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLNIV 132
Query: 650 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 709
HRD+K ENIL+ D +KL DF + L GTP
Sbjct: 133 HRDLKPENILL-------DDDMNIKLTDFGFSCQLDPGEKL-----------REVCGTPS 174
Query: 710 WMAPEVLRAMHKPNL--YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPR 767
++APE++ N YG EVD+WS G ++ LL P+ ++ + +I G
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234
Query: 768 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
+ E + + D+ R P +R TA +
Sbjct: 235 GSPEWDDYSDT------------------------VKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 6e-36
Identities = 64/298 (21%), Positives = 107/298 (35%), Gaps = 71/298 (23%)
Query: 538 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 597
LKV + E E+ EV + LRH I+ +YG+ + +
Sbjct: 36 LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY------------- 82
Query: 598 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657
+ +EY G+V ++K + ++A AL HSK ++HRDIK EN
Sbjct: 83 -LILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 136
Query: 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717
+L+ +K+ DF +V S T GT ++ PE++
Sbjct: 137 LLL-------GSAGELKIADFGWSVHAPSSRRTT------------LCGTLDYLPPEMIE 177
Query: 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 777
+ +VD+WS G L E L + P+ + E + I D +
Sbjct: 178 GRM----HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPDFV----- 227
Query: 778 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSS 834
E D+ R + NP++RP ++ E ++ SS
Sbjct: 228 ---------------TEG-------ARDLISRLLKHNPSQRPMLREVLEHPWITANSS 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (338), Expect = 2e-35
Identities = 66/289 (22%), Positives = 100/289 (34%), Gaps = 67/289 (23%)
Query: 538 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 597
+K S + + EVR L LRH ++ G + EH
Sbjct: 45 IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----------EHTAW-- 91
Query: 598 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657
+ MEY G + +K + + L LHS +++HRD+K+ N
Sbjct: 92 -LVMEYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGN 145
Query: 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717
IL+ +VKL DF A PA GTP WMAPEV+
Sbjct: 146 ILL-------SEPGLVKLGDF-------------GSASIMAPANSFV-GTPYWMAPEVIL 184
Query: 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 777
AM + Y +VD+WS G +EL + P ++ + I + P L
Sbjct: 185 AMDE-GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG------ 237
Query: 778 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
E + C ++ P +RPT+ L +
Sbjct: 238 -------------HWSEY-------FRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 9e-35
Identities = 63/295 (21%), Positives = 110/295 (37%), Gaps = 69/295 (23%)
Query: 532 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 591
A K+ +K + I+ E+ + L H +V+ YGH+
Sbjct: 34 AVKIVDMKRAVDCPENIKK-------EICINKMLNHENVVKFYGHRREGNIQ-------- 78
Query: 592 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 651
+F+EY GG + + IE + + A + A +V LH I HR
Sbjct: 79 ------YLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 127
Query: 652 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 711
DIK EN+L+ D + +K+ DF L T + + GT ++
Sbjct: 128 DIKPENLLL-------DERDNLKISDFG--------LATVFRYNNRERLLNKMCGTLPYV 172
Query: 712 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE 771
APE+L+ + + VD+WS G +L +L ++P+ S+ K+ L
Sbjct: 173 APELLK---RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--- 226
Query: 772 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
P +++ S + + + ENP+ R T D+ +
Sbjct: 227 --------------------NPWKKID--SAPLALLHKILVENPSARITIPDIKK 259
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 133 bits (335), Expect = 2e-34
Identities = 48/270 (17%), Positives = 83/270 (30%), Gaps = 64/270 (23%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E++ + LRH +V ++ + + E++ GG + +
Sbjct: 73 EIQTMSVLRHPTLVNLHDAFEDDNEM--------------VMIYEFMSGGELFEKVAD-- 116
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
+S A+ + V L +H + +H D+K ENI+ +KL D
Sbjct: 117 --EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT-----TKRSNELKLID 169
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F L GT + APEV G D+WS G L
Sbjct: 170 FGLTAHLDPKQSVKV-----------TTGTAEFAAPEVAEGKP----VGYYTDMWSVGVL 214
Query: 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 797
LL+ P+ G ++ E ++ + ++
Sbjct: 215 SYILLSGLSPFGGENDDETLRNVKSCD-------------------------WNMDDSAF 249
Query: 798 ETLSF-LVDVFRRCTEENPTERPTAGDLYE 826
+S D R+ +P R T E
Sbjct: 250 SGISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 4e-34
Identities = 66/268 (24%), Positives = 102/268 (38%), Gaps = 68/268 (25%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+ ++ ++ IV + L + MEY+ GGS+ + + +
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDEL--------------WVVMEYLAGGSLTDVVTE-- 110
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
+ + ++ AL LHS ++HRDIKS+NIL+ DG VKL D
Sbjct: 111 ----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG-----MDGS--VKLTD 159
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F + VGTP WMAPEV+ YG +VDIWS G +
Sbjct: 160 FGFCAQITPEQSKR----------STMVGTPYWMAPEVVTRKA----YGPKVDIWSLGIM 205
Query: 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 797
+E++ + PY+ + L LI P L +
Sbjct: 206 AIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-------------------------- 239
Query: 798 ETLS-FLVDVFRRCTEENPTERPTAGDL 824
E LS D RC + + +R +A +L
Sbjct: 240 EKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 7e-34
Identities = 49/287 (17%), Positives = 91/287 (31%), Gaps = 69/287 (24%)
Query: 542 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 601
G+ + + E +++ L + IV + G + + + M
Sbjct: 47 GTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAEALM---------------LVM 87
Query: 602 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661
E GG + ++ + + V + V+ + L K+ +HRD+ + N+L+
Sbjct: 88 EMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL- 142
Query: 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 721
+ K+ DF + L + G +W APE +
Sbjct: 143 ------VNRHYAKISDFGLSKALGADDSYYTARSAG-------KWPLKWYAPECINFRK- 188
Query: 722 PNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE 780
+ D+WSYG + E L+ Q PY + E+ I+ GKR E
Sbjct: 189 ---FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC-------- 237
Query: 781 HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 827
P L + C +RP + +
Sbjct: 238 ------------PPE-------LYALMSDCWIYKWEDRPDFLTVEQR 265
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 131 bits (330), Expect = 7e-34
Identities = 51/284 (17%), Positives = 96/284 (33%), Gaps = 65/284 (22%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+ ++ L H ++ ++ + + +E++ GG + + I
Sbjct: 76 EISIMNQLHHPKLINLHDAFEDKYEM--------------VLILEFLSGGELFDRIAA-- 119
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
+ +S + + L +H I+H DIK ENI+ + VK+ D
Sbjct: 120 --EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCE-----TKKASSVKIID 172
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F A L T + APE++ G D+W+ G L
Sbjct: 173 FGLATKLNPDEIVKV-----------TTATAEFAAPEIVDREP----VGFYTDMWAIGVL 217
Query: 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 797
LL+ P+ G +LE ++ +E E
Sbjct: 218 GYVLLSGLSPFAGEDDLETLQNVKRCD-------------------------WEFDEDAF 252
Query: 798 ETLSF-LVDVFRRCTEENPTERPTAGDLYEM-FVARTSSSISSR 839
++S D + ++ P +R T D E ++ S+++SR
Sbjct: 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (325), Expect = 1e-33
Identities = 55/315 (17%), Positives = 119/315 (37%), Gaps = 69/315 (21%)
Query: 527 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 586
G + ++TLK G + + R+F L E ++G H ++ + G S +
Sbjct: 51 GKREIFVAIKTLKS-GYTEKQRRDF----LSEASIMGQFDHPNVIHLEGVVTKSTPV--- 102
Query: 587 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 646
I E+++ GS+ +++ + + +V + + + +AA + L
Sbjct: 103 -----------MIITEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLADM 147
Query: 647 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 706
+ +HRD+ + NIL++ ++ V K+ DF + L
Sbjct: 148 NYVHRDLAARNILVN-----SNL--VCKVSDFGLSRFLEDDTSDPTYTSAL-----GGKI 195
Query: 707 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 765
RW APE ++ + D+WSYG ++ E+++ + PY ++ ++ + I+ R
Sbjct: 196 PIRWTAPEAIQYRK----FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR 251
Query: 766 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 825
++ S L + C +++ RP G +
Sbjct: 252 L---------------------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 826 EMF--VARTSSSISS 838
+ R +S+ +
Sbjct: 285 NTLDKMIRNPNSLKA 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-33
Identities = 60/295 (20%), Positives = 110/295 (37%), Gaps = 73/295 (24%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
V++LK S D E ++ L+H +V +Y
Sbjct: 42 VKSLKQGSMSPDAFLA-------EANLMKQLQHQRLVRLYAVVTQEPIY----------- 83
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
I EY++ GS+ ++++ +++ L +A +A + + ++ +HRD++
Sbjct: 84 ----IITEYMENGSLVDFLKT---PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714
+ NIL+ K+ DF A I A + +W APE
Sbjct: 137 AANILV-------SDTLSCKIADFGLA---------RLIEDNEYTAREGAKFPIKWTAPE 180
Query: 715 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 773
+ + ++ D+WS+G LL E++T ++PY G++ E+ ++ G R D
Sbjct: 181 AINYGT----FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC- 235
Query: 774 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
PE L + R C +E P +RPT L +
Sbjct: 236 -------------------PEE-------LYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 3e-33
Identities = 62/294 (21%), Positives = 106/294 (36%), Gaps = 73/294 (24%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
++ +K S DE E +++ L H +V++YG + +
Sbjct: 33 IKMIKEGSMSEDEFIE-------EAKVMMNLSHEKLVQLYGVCTKQRPIF---------- 75
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
I EY+ G + NY+ + + L + +DV A+ L SK +HRD+
Sbjct: 76 ----IITEYMANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 127
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714
+ N L+ + + VVK+ DF + + +T + RW PE
Sbjct: 128 ARNCLV-------NDQGVVKVSDFGLSRYVLDDEYTSSVG---------SKFPVRWSPPE 171
Query: 715 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 773
VL + + DIW++G L+ E+ +L ++PY + E + I G R
Sbjct: 172 VLMYSK----FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL------- 220
Query: 774 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 827
+P E + + C E ERPT L
Sbjct: 221 -----------------YRPHLASEK---VYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 8e-33
Identities = 58/286 (20%), Positives = 97/286 (33%), Gaps = 39/286 (13%)
Query: 542 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 601
G ++ + L E+++L L H I+ + + ++
Sbjct: 34 GHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI--------------SLVF 79
Query: 602 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661
++++ + H L LH I+HRD+K N+L+D
Sbjct: 80 DFMETDLEVIIKDNSLVLTPSH-----IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD 134
Query: 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 721
V+KL DF A S V T + APE+L
Sbjct: 135 -------ENGVLKLADFGLAKSFGSPNRAYTH----------QVVTRWYRAPELLFGARM 177
Query: 722 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH 781
YG+ VD+W+ GC+L ELL G S+L+ I ++ + S ++
Sbjct: 178 ---YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 782 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 827
+S G L+D+ + NP R TA +M
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 9e-33
Identities = 58/295 (19%), Positives = 98/295 (33%), Gaps = 37/295 (12%)
Query: 538 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 597
+K+ S + E E+ LRH I+ AD Q
Sbjct: 31 VKIFSSREERSWFRE----AEIYQTVMLRHENILGFIA----------ADNKDNGTWTQL 76
Query: 598 AIFMEYVKGGSVKNYIEK--LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 655
+ +Y + GS+ +Y+ + ++ G +++ A +A + I HRD+KS
Sbjct: 77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 136
Query: 656 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 715
+NIL+ + D AV S T IA VGT R+MAPEV
Sbjct: 137 KNILV-------KKNGTCCIADLGLAVRHDSATDTIDIAPNHR------VGTKRYMAPEV 183
Query: 716 LR--AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 773
L K DI++ G + E+ + ++ + P + + +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 774 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
+ E L + + R C N R TA + +
Sbjct: 244 VVCEQKLRP------NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 3e-32
Identities = 63/292 (21%), Positives = 109/292 (37%), Gaps = 70/292 (23%)
Query: 538 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 597
+K F L E +++ LRH +V++Y
Sbjct: 46 IKTLKPGTMSPEAF----LQEAQVMKKLRHEKLVQLYAVVSEEPIY-------------- 87
Query: 598 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657
I EY+ GS+ ++++ K++ + + +A +A+ + + + +HRD+++ N
Sbjct: 88 -IVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 143
Query: 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717
IL+ V K+ DF A + +T A +W APE
Sbjct: 144 ILV-------GENLVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAAL 187
Query: 718 AMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALG 776
+ ++ D+WS+G LL EL T +VPY G+ E+ D ++ G R E
Sbjct: 188 YGR----FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---- 239
Query: 777 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
PE+ L D+ +C + P ERPT L
Sbjct: 240 ----------------PES-------LHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 4e-32
Identities = 56/316 (17%), Positives = 99/316 (31%), Gaps = 64/316 (20%)
Query: 514 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 573
G + R ++ + +K + EV + +L H ++ +
Sbjct: 17 GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL 76
Query: 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 633
YG ++ + E GS+ + + K + H + A
Sbjct: 77 YGVVLTPPMK---------------MVTELAPLGSLLDRLRK----HQGHFLLGTLSRYA 117
Query: 634 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 693
VA + L SK +HRD+ + N+L+ +VK+ DF L +
Sbjct: 118 VQVAEGMGYLESKRFIHRDLAARNLLLATRD-------LVKIGDFGLMRALPQNDDHYVM 170
Query: 694 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLS 752
W APE L+ + D W +G L E+ T Q P++GL+
Sbjct: 171 QEH-------RKVPFAWCAPESLKTRT----FSHASDTWMFGVTLWEMFTYGQEPWIGLN 219
Query: 753 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 812
+I I +PE + + +V +C
Sbjct: 220 GSQILHKIDKEGER-----------------------LPRPEDCPQD---IYNVMVQCWA 253
Query: 813 ENPTERPTAGDLYEMF 828
P +RPT L +
Sbjct: 254 HKPEDRPTFVALRDFL 269
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 5e-32
Identities = 52/316 (16%), Positives = 105/316 (33%), Gaps = 74/316 (23%)
Query: 514 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 573
G + + + D A ++T++ S ++ E ++ L H +V++
Sbjct: 14 GSGQFGLVHLGYWLNKDKVA-IKTIREGAMSEEDFIE-------EAEVMMKLSHPKLVQL 65
Query: 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 633
YG + + + E+++ G + +Y+ + + L +
Sbjct: 66 YGVCLEQAPI--------------CLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMC 107
Query: 634 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 693
DV + L ++HRD+ + N L+ V+K+ DF + +T
Sbjct: 108 LDVCEGMAYLEEACVIHRDLAARNCLVG-------ENQVIKVSDFGMTRFVLDDQYTSST 160
Query: 694 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLS 752
+W +PEV Y + D+WS+G L+ E+ + ++PY S
Sbjct: 161 G---------TKFPVKWASPEVFSFSR----YSSKSDVWSFGVLMWEVFSEGKIPYENRS 207
Query: 753 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 812
E+ + I G R + + + C +
Sbjct: 208 NSEVVEDISTGFRLYKPRLAS---------------------------THVYQIMNHCWK 240
Query: 813 ENPTERPTAGDLYEMF 828
E P +RP L
Sbjct: 241 ERPEDRPAFSRLLRQL 256
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (312), Expect = 5e-32
Identities = 58/306 (18%), Positives = 106/306 (34%), Gaps = 84/306 (27%)
Query: 543 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 602
+SAD +F E ++ + IV++ G K + + E
Sbjct: 55 ASADMQADF----QREAALMAEFDNPNIVKLLGVCAVGKPM--------------CLLFE 96
Query: 603 YVKGGSVKNYIEKL-------------------SETGEKHVSVKLALFIAQDVAAALVEL 643
Y+ G + ++ + S G +S L IA+ VAA + L
Sbjct: 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 156
Query: 644 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 703
+ +HRD+ + N L+ VVK+ DF + + S + +
Sbjct: 157 SERKFVHRDLATRNCLV-------GENMVVKIADFGLSRNIYSADYYKADGN-------- 201
Query: 704 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQM 762
RWM PE + Y E D+W+YG +L E+ + + PY G++ E+ ++
Sbjct: 202 DAIPIRWMPPESIFYNR----YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD 257
Query: 763 GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822
G + P L ++ R C + P +RP+
Sbjct: 258 GNILACPENC--------------------PLE-------LYNLMRLCWSKLPADRPSFC 290
Query: 823 DLYEMF 828
++ +
Sbjct: 291 SIHRIL 296
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 123 bits (310), Expect = 7e-32
Identities = 59/292 (20%), Positives = 120/292 (41%), Gaps = 69/292 (23%)
Query: 538 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 597
+K E+ F L E ++ ++H +V++ G
Sbjct: 47 VKTLKEDTMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTREPPF-------------- 88
Query: 598 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657
I E++ G++ +Y L E + VS + L++A +++A+ L K+ +HRD+ + N
Sbjct: 89 YIITEFMTYGNLLDY---LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 145
Query: 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717
L+ + +VK+ DF + + +T +W APE L
Sbjct: 146 CLVG-----ENH--LVKVADFGLSRLMTGDTYTAHAG---------AKFPIKWTAPESLA 189
Query: 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALG 776
+ ++ D+W++G LL E+ T + PY G+ ++++L++ R
Sbjct: 190 YNK----FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---------- 235
Query: 777 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
E+PE E + ++ R C + NP++RP+ ++++ F
Sbjct: 236 --------------ERPEGCPEK---VYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 9e-32
Identities = 52/287 (18%), Positives = 95/287 (33%), Gaps = 66/287 (22%)
Query: 538 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 597
+K+ N E ++ L H V++Y + L
Sbjct: 38 IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL-------------- 83
Query: 598 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657
+ Y K G + YI K F ++ +AL LH K I+HRD+K EN
Sbjct: 84 YFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 138
Query: 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717
IL+ + +++ DF A + VGT ++++PE+L
Sbjct: 139 ILL-------NEDMHIQITDFGTA--------KVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 777
D+W+ GC++ +L+ P+ +E I I + ++
Sbjct: 184 EKS----ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFF---- 234
Query: 778 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 824
P+A D+ + + T+R ++
Sbjct: 235 ---------------PKA--------RDLVEKLLVLDATKRLGCEEM 258
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 5e-31
Identities = 59/265 (22%), Positives = 94/265 (35%), Gaps = 54/265 (20%)
Query: 561 MLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG 620
A + IV + + LL I ME + GG + + I+ G
Sbjct: 58 HWRASQCPHIVRIVDVYENL-------YAGRKCLL---IVMECLDGGELFSRIQD---RG 104
Query: 621 EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDR 680
++ + + A I + + A+ LHS +I HRD+K EN+L ++KL DF
Sbjct: 105 DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT----SKRPNAILKLTDFGF 160
Query: 681 AVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740
A S + TP ++APEVL Y D+WS G ++
Sbjct: 161 AKETTSHNSLTTPCY-----------TPYYVAPEVLGPEK----YDKSCDMWSLGVIMYI 205
Query: 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 800
LL P+ L I ++ R +E P E +
Sbjct: 206 LLCGYPPFYSNHGLAISPGMKTRIRM---------------------GQYEFPNPEWSEV 244
Query: 801 SF-LVDVFRRCTEENPTERPTAGDL 824
S + + R + PT+R T +
Sbjct: 245 SEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 6e-31
Identities = 56/314 (17%), Positives = 106/314 (33%), Gaps = 71/314 (22%)
Query: 514 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 573
G+ + RC S+ + +KV G+ ++ E+ +L RH I+ +
Sbjct: 14 GRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK-------EISILNIARHRNILHL 66
Query: 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 633
+ S + L + E++ G + I ++ + +
Sbjct: 67 HESFESMEEL--------------VMIFEFISGLDIFERINT----SAFELNEREIVSYV 108
Query: 634 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 693
V AL LHS +I H DI+ ENI+ +K+ +F +A L+ +
Sbjct: 109 HQVCEALQFLHSHNIGHFDIRPENIIYQ-----TRRSSTIKIIEFGQARQLKPGDNF--- 160
Query: 694 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE 753
+ P + APEV + D+WS G L+ LL+ P++ +
Sbjct: 161 --------RLLFTAPEYYAPEVHQHDV----VSTATDMWSLGTLVYVLLSGINPFLAETN 208
Query: 754 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTE 812
+I + I + + E + +S +D R
Sbjct: 209 QQIIENIMNAE-------------------------YTFDEEAFKEISIEAMDFVDRLLV 243
Query: 813 ENPTERPTAGDLYE 826
+ R TA + +
Sbjct: 244 KERKSRMTASEALQ 257
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 6e-31
Identities = 48/270 (17%), Positives = 96/270 (35%), Gaps = 36/270 (13%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+++L RH I+ + + P ++ + ++ G + ++
Sbjct: 56 EIKILLRFRHENIIGINDIIRA----------PTIEQMKDVYLVTHLMGADLYKLLKT-- 103
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
+H+S + + L +HS +++HRD+K N+L+ + +K+CD
Sbjct: 104 ----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL-------NTTCDLKICD 152
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F A V T + APE++ Y +DIWS GC+
Sbjct: 153 FGLARVADPDHDHTGFLTE-------YVATRWYRAPEIMLNSKG---YTKSIDIWSVGCI 202
Query: 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 797
L E+L+ + + G L+ + I ++L + + S K
Sbjct: 203 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 262
Query: 798 ETLSF---LVDVFRRCTEENPTERPTAGDL 824
+ +D+ + NP +R
Sbjct: 263 LFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 120 bits (302), Expect = 2e-30
Identities = 58/280 (20%), Positives = 96/280 (34%), Gaps = 64/280 (22%)
Query: 546 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 605
+ E S E+ +L ++H IV + S L + M+ V
Sbjct: 45 KALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL--------------YLIMQLVS 90
Query: 606 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 665
GG + + I + + + + A + V A+ LH I+HRD+K EN+L
Sbjct: 91 GGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL-- 143
Query: 666 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 725
D + + DF + G C GTP ++APEVL Y
Sbjct: 144 --DEDSKIMISDF----------GLSKMEDPGSVLSTAC-GTPGYVAPEVLAQKP----Y 186
Query: 726 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 785
VD WS G + LL P+ ++ ++ + I +
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE--------------------- 225
Query: 786 SGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDL 824
+E + +S D R E++P +R T
Sbjct: 226 ----YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-30
Identities = 71/348 (20%), Positives = 124/348 (35%), Gaps = 88/348 (25%)
Query: 501 PGSFPSLSSCD-----EAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEY 553
P +P L D G+ + + + A ++ +K +S D+ R+F
Sbjct: 1 PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDF-- 57
Query: 554 SCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 612
GE+ +L L H I+ + G +L + +EY G++ ++
Sbjct: 58 --AGELEVLCKLGHHPNIINLLGACEHRGYL--------------YLAIEYAPHGNLLDF 101
Query: 613 IEK-----------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661
+ K ++ + +S + L A DVA + L K +HRD+ + NIL+
Sbjct: 102 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 161
Query: 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 721
V K+ DF + ++ RWMA E L
Sbjct: 162 -------ENYVAKIADFGLSRGQEVYVKKTM-----------GRLPVRWMAIESLNYSV- 202
Query: 722 PNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE 780
Y D+WSYG LL E+++L PY G++ E+++ + G R +
Sbjct: 203 ---YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD------- 252
Query: 781 HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
+ D+ R+C E P ERP+ +
Sbjct: 253 --------------------DEVYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-30
Identities = 51/286 (17%), Positives = 101/286 (35%), Gaps = 31/286 (10%)
Query: 543 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 602
+E F + L E+++L L+H +V + + + + + +
Sbjct: 44 LMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY------LVFD 97
Query: 603 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662
+ + L ++ + Q + L +H I+HRD+K+ N+LI
Sbjct: 98 FCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT- 151
Query: 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 722
DG V+KL DF A ++ + V T + PE+L
Sbjct: 152 ----RDG--VLKLADFGLARAFSLAKNSQPNRYTNR------VVTLWYRPPELLLGERD- 198
Query: 723 NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE 782
YG +D+W GC++ E+ T G +E LI + + + +E
Sbjct: 199 --YGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYE 256
Query: 783 VAQSGSGFEKPEAELETLSFL----VDVFRRCTEENPTERPTAGDL 824
+ G ++ + +D+ + +P +R + D
Sbjct: 257 KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 3e-30
Identities = 56/299 (18%), Positives = 102/299 (34%), Gaps = 72/299 (24%)
Query: 531 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 590
A ++T K C +S F L E + H IV++ G I+ +
Sbjct: 36 LAVAIKTCKNC-TSDSVREKF----LQEALTMRQFDHPHIVKLIGV-ITENPVW------ 83
Query: 591 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 650
I ME G ++++++ + + + + A ++ AL L SK +H
Sbjct: 84 --------IIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKRFVH 131
Query: 651 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 710
RDI + N+L+ VKL DF + + + +W
Sbjct: 132 RDIAARNVLVS-------SNDCVKLGDFGLSRYMEDSTYYKA---------SKGKLPIKW 175
Query: 711 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 769
MAPE + + D+W +G + E+L P+ G+ ++ I+ G+R +
Sbjct: 176 MAPESINFRR----FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 231
Query: 770 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
P L + +C +P+ RP +L
Sbjct: 232 PNC--------------------PPT-------LYSLMTKCWAYDPSRRPRFTELKAQL 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 117 bits (294), Expect = 8e-30
Identities = 65/294 (22%), Positives = 104/294 (35%), Gaps = 60/294 (20%)
Query: 538 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 597
+KV + +F E + AL H IV +Y +
Sbjct: 37 VKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA----------ETPAGPLP 86
Query: 598 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657
I MEYV G ++++ + E ++ K A+ + D AL H I+HRD+K N
Sbjct: 87 YIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPAN 141
Query: 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717
I+I VK+ DF A + ++ +GT ++++PE R
Sbjct: 142 IMIS-------ATNAVKVMDFGIARAIADSGNSVTQTAA-------VIGTAQYLSPEQAR 187
Query: 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 777
D++S GC+L E+LT + P+ G S + +
Sbjct: 188 GDS----VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP---------- 233
Query: 778 CHEHEVAQSGSGFEKPEAELETLS-FLVDVFRRCTEENPTERP-TAGDLYEMFV 829
P A E LS L V + +NP R TA ++ V
Sbjct: 234 ---------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 1e-29
Identities = 61/298 (20%), Positives = 105/298 (35%), Gaps = 66/298 (22%)
Query: 543 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 602
+ E+ F L E ++ H ++ + G + E L + +
Sbjct: 67 TDIGEVSQF----LTEGIIMKDFSHPNVLSLLGICL----------RSEGSPL---VVLP 109
Query: 603 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662
Y+K G ++N+I + +VK + VA + L SK +HRD+ + N ++
Sbjct: 110 YMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML-- 163
Query: 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 722
D K VK+ DF A + G +WMA E L+
Sbjct: 164 -----DEKFTVKVADFGLARDMYDKEFDSVHNKTG------AKLPVKWMALESLQTQK-- 210
Query: 723 NLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH 781
+ + D+WS+G LL EL+T PY ++ +I + G+R +
Sbjct: 211 --FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC--------- 259
Query: 782 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSISSR 839
P+ L +V +C RP+ +L A S+ I
Sbjct: 260 -----------PDP-------LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 2e-29
Identities = 66/292 (22%), Positives = 105/292 (35%), Gaps = 76/292 (26%)
Query: 558 EVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE-- 614
E+ M+ + +H I+ + G L + +EY G+++ Y++
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPL--------------YVIVEYASKGNLREYLQAR 113
Query: 615 ---------KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 665
S E+ +S K + A VA + L SK +HRD+ + N+L+
Sbjct: 114 RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---- 169
Query: 666 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 725
V+K+ DF A + + + +WMAPE L Y
Sbjct: 170 ---EDNVMKIADFGLARDIHHIDYYKKTTN--------GRLPVKWMAPEALFDRI----Y 214
Query: 726 GLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVA 784
+ D+WS+G LL E+ TL PY G+ E+ L++ G R
Sbjct: 215 THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNC------------ 262
Query: 785 QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF---VARTS 833
L + R C P++RPT L E VA TS
Sbjct: 263 --------TNE-------LYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 4e-29
Identities = 54/295 (18%), Positives = 103/295 (34%), Gaps = 69/295 (23%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
++TLK + + LGE ++G H I+ + G K +
Sbjct: 41 IKTLKAGYTEKQRVD-----FLGEAGIMGQFSHHNIIRLEGVISKYKPMM---------- 85
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 654
I EY++ G++ ++ + + SV + + + +AA + L + + +HRD+
Sbjct: 86 ----IITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA 137
Query: 655 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 714
+ NIL+ + V K+ DF + L G RW APE
Sbjct: 138 ARNILV-------NSNLVCKVSDFGLSRVLEDDPEATYTTSGG-------KIPIRWTAPE 183
Query: 715 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM-GLSELEIHDLIQMGKRPRLTDELE 773
+ + D+WS+G ++ E++T LS E+ I G R
Sbjct: 184 AISYRKFTS----ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-------- 231
Query: 774 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
++ S + + +C ++ RP D+ +
Sbjct: 232 -------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 9e-29
Identities = 56/296 (18%), Positives = 108/296 (36%), Gaps = 65/296 (21%)
Query: 532 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 591
AAK +K + + EV +L ++H ++ ++ + +
Sbjct: 39 AAKF--IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV-------- 88
Query: 592 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 651
+ +E V GG + +++ + ++ ++ + A + + + LHS I H
Sbjct: 89 ------ILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQIAHF 137
Query: 652 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 711
D+K ENI++ + KP +K+ DF A + GTP ++
Sbjct: 138 DLKPENIMLL---DRNVPKPRIKIIDFGLAHKIDFGNEFKN-----------IFGTPEFV 183
Query: 712 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE 771
APE++ GLE D+WS G + LL+ P++G ++ E +
Sbjct: 184 APEIVNYEP----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN------- 232
Query: 772 LEALGSCHEHEVAQSGSGFEKPEAELETLS-FLVDVFRRCTEENPTERPTAGDLYE 826
+E + S D RR ++P +R T D +
Sbjct: 233 ------------------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (287), Expect = 1e-28
Identities = 40/271 (14%), Positives = 86/271 (31%), Gaps = 49/271 (18%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E ++ ++ + + ++++ + ME + +
Sbjct: 52 ESKIYKMMQGGVGIPTIRWCGA---------EGDYNV----MVMELLGPSLEDLFNFC-- 96
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
+ S+K L +A + + + +HSK+ +HRD+K +N L+ L +V + D
Sbjct: 97 ---SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG----KKGNLVYIID 149
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F A R I + GT R+ + + D+ S G +
Sbjct: 150 FGLAKKYRDARTHQHIPY---RENKNLTGTARYASINTHLGIE----QSRRDDLESLGYV 202
Query: 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 797
L+ +P+ GL + +++ +E L + E
Sbjct: 203 LMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSE--------------- 247
Query: 798 ETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
C ++P L ++F
Sbjct: 248 -----FATYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 2e-28
Identities = 47/288 (16%), Positives = 98/288 (34%), Gaps = 70/288 (24%)
Query: 542 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 601
+S + L E ++ ++ + + + G ++S +
Sbjct: 49 ATSPKANKEI----LDEAYVMASVDNPHVCRLLGICLTSTVQ---------------LIT 89
Query: 602 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661
+ + G + +Y+ + + ++ + L +A + L + ++HRD+ + N+L+
Sbjct: 90 QLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK 145
Query: 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 721
VK+ DF A L + + +WMA E +
Sbjct: 146 -------TPQHVKITDFGLAKLLGAEEKEYHA--------EGGKVPIKWMALESILHRI- 189
Query: 722 PNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE 780
Y + D+WSYG + EL+T PY G+ EI +++ G+R
Sbjct: 190 ---YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-------------- 232
Query: 781 HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
+P + + +C + RP +L F
Sbjct: 233 ----------PQPPICTIDV---YMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 2e-28
Identities = 61/291 (20%), Positives = 98/291 (33%), Gaps = 81/291 (27%)
Query: 558 EVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK- 615
E++M+ L H IV + G S + + EY G + NY+
Sbjct: 90 ELKMMTQLGSHENIVNLLGACTLSGPI--------------YLIFEYCCYGDLLNYLRSK 135
Query: 616 -----------------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
E ++ + L A VA + L K +HRD+ + N+
Sbjct: 136 REKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718
L+ VVK+CDF A + S + + +WMAPE L
Sbjct: 196 LV-------THGKVVKICDFGLARDIMSDSNYVVRGN--------ARLPVKWMAPESLFE 240
Query: 719 MHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELE-IHDLIQMGKRPRLTDELEALG 776
Y ++ D+WSYG LL E+ +L PY G+ + LIQ G +
Sbjct: 241 GI----YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYA---- 292
Query: 777 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 827
E + + + C + +RP+ +L
Sbjct: 293 ----------------TEE-------IYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 3e-28
Identities = 61/264 (23%), Positives = 92/264 (34%), Gaps = 68/264 (25%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
+ + A H + M+ + + L MEY+ GG + +I+
Sbjct: 53 KRVLSLAWEHPFLTHMFCTFQTKENL--------------FFVMEYLNGGDLMYHIQS-- 96
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
+ A F A ++ L LHSK I++RD+K +NIL+D +K+ D
Sbjct: 97 ---CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD-------KDGHIKIAD 146
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F GTP ++APE+L Y VD WS+G L
Sbjct: 147 FGMCKENMLGDAKTN----------TFCGTPDYIAPEILLGQK----YNHSVDWWSFGVL 192
Query: 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 797
L E+L Q P+ G E E+ I+M P LE EA
Sbjct: 193 LYEMLIGQSPFHGQDEEELFHSIRMD-NPFYPRWLE-------------------KEA-- 230
Query: 798 ETLSFLVDVFRRCTEENPTERPTA 821
D+ + P +R
Sbjct: 231 ------KDLLVKLFVREPEKRLGV 248
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 3e-28
Identities = 53/268 (19%), Positives = 96/268 (35%), Gaps = 38/268 (14%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
+R L H +V ++ S+ + + E+V L
Sbjct: 60 VLRHLETFEHPNVVRLFDVCTVSR---------TDRETKLTLVFEHVDQD----LTTYLD 106
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
+ E V + + + L LHS ++HRD+K +NIL+ + G+ +
Sbjct: 107 KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT-----SSGQIKLADFG 161
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
R + L + T + APEVL Y VD+WS GC+
Sbjct: 162 LARIYSFQMALTSVV-------------VTLWYRAPEVLLQSS----YATPVDLWSVGCI 204
Query: 738 LLELLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 796
E+ + + G S+++ I + P D + + ++S EK +
Sbjct: 205 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD 264
Query: 797 LETLSFLVDVFRRCTEENPTERPTAGDL 824
++ L D+ +C NP +R +A
Sbjct: 265 IDEL--GKDLLLKCLTFNPAKRISAYSA 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 112 bits (281), Expect = 6e-28
Identities = 38/230 (16%), Positives = 72/230 (31%), Gaps = 33/230 (14%)
Query: 599 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658
+ + + G S+++ ++ + SVK A+ + A + +H K +++RDIK +N
Sbjct: 77 VLVIDLLGPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 132
Query: 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 718
LI K + + DF R + I + GT R+M+
Sbjct: 133 LIGRPNSKNANM--IYVVDFGMVKFYRDPVTKQHIPY---REKKNLSGTARYMSINT--- 184
Query: 719 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 778
H D+ + G + + L +P+ GL + + + L L +
Sbjct: 185 -HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243
Query: 779 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
E P L +F
Sbjct: 244 FPEE--------------------FYKYMHYARNLAFDATPDYDYLQGLF 273
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 1e-27
Identities = 53/300 (17%), Positives = 103/300 (34%), Gaps = 71/300 (23%)
Query: 535 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 594
++T+ S + I L E ++ +V + G +
Sbjct: 55 IKTVNEAASMRERIE-----FLNEASVMKEFNCHHVVRLLGVVSQGQPTL---------- 99
Query: 595 LQSAIFMEYVKGGSVKNYIEKLSETGEKHV-----SVKLALFIAQDVAAALVELHSKHIM 649
+ ME + G +K+Y+ L + S+ + +A ++A + L++ +
Sbjct: 100 ----VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 155
Query: 650 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 709
HRD+ + N ++ VK+ DF + + R
Sbjct: 156 HRDLAARNCMVA-------EDFTVKIGDFG--------MTRDIYETDYYRKGGKGLLPVR 200
Query: 710 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRL 768
WM+PE L+ ++ D+WS+G +L E+ TL + PY GLS ++ + G
Sbjct: 201 WMSPESLK----DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 256
Query: 769 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
D + L ++ R C + NP RP+ ++
Sbjct: 257 PDNCPDM---------------------------LFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 109 bits (273), Expect = 5e-27
Identities = 52/277 (18%), Positives = 101/277 (36%), Gaps = 40/277 (14%)
Query: 549 RNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS 608
+ + E+ +L L+HS IV++Y + K L + E++
Sbjct: 41 EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLV--------------LVFEHLDQDL 86
Query: 609 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 668
K E + A + + H + ++HRD+K +N+LI+
Sbjct: 87 KKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN------- 134
Query: 669 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 728
+ +K+ DF A + + T + AP+VL K Y
Sbjct: 135 REGELKIADFGLARAFGIPVRKYT----------HEIVTLWYRAPDVLMGSKK---YSTT 181
Query: 729 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 788
+DIWS GC+ E++ + G+SE + I + + +++ +
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 789 GFEKPEAELETLS-FLVDVFRRCTEENPTERPTAGDL 824
E+ L+ L +D+ + + +P +R TA
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-26
Identities = 60/268 (22%), Positives = 97/268 (36%), Gaps = 31/268 (11%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E++++ L H IV + + S + E +L + ++YV +
Sbjct: 63 ELQIMRKLDHCNIVRLRYF-----FYSSGEKKDEVYL---NLVLDYVPETVYRVARHYSR 114
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
++ + V + +L +HS I HRDIK +N+L+D V+KLCD
Sbjct: 115 A--KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD------PDTAVLKLCD 166
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F A L RG P + A Y +D+WS GC+
Sbjct: 167 FGSAKQLV----------RGEPNVSYICSRYYRAPELIFGATD----YTSSIDVWSAGCV 212
Query: 738 LLELLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 796
L ELL Q + G S ++ I ++ P E + E + Q +
Sbjct: 213 LAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 272
Query: 797 LETLSFLVDVFRRCTEENPTERPTAGDL 824
T + + R E PT R T +
Sbjct: 273 PRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 2e-26
Identities = 57/287 (19%), Positives = 102/287 (35%), Gaps = 76/287 (26%)
Query: 558 EVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK- 615
E+++L L H IV + G + EY G + N++ +
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPT--------------LVITEYCCYGDLLNFLRRK 121
Query: 616 ------------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663
+ E E + ++ L + VA + L SK+ +HRD+ + NIL+
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-- 179
Query: 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 723
+ K+CDF A +++ + + +WMAPE +
Sbjct: 180 -----HGRITKICDFGLARDIKNDSNYVVKGN--------ARLPVKWMAPESIFNCV--- 223
Query: 724 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELE--IHDLIQMGKRPRLTDELEALGSCHEH 781
Y E D+WSYG L EL +L ++ + +I+ G R
Sbjct: 224 -YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM--------------- 267
Query: 782 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 828
PE + D+ + C + +P +RPT + ++
Sbjct: 268 ---------LSPEHAPAEM---YDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (266), Expect = 1e-25
Identities = 59/241 (24%), Positives = 101/241 (41%), Gaps = 46/241 (19%)
Query: 538 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 597
+KV E ML + H I+ M+G ++ +
Sbjct: 34 MKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI-------------- 79
Query: 598 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657
+ M+Y++GG + + + K A F A +V AL LHSK I++RD+K EN
Sbjct: 80 FMIMDYIEGGELFSLLRKSQRFPNPV-----AKFYAAEVCLALEYLHSKDIIYRDLKPEN 134
Query: 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717
IL+D +G +K+ DF A + +T C GTP ++APEV+
Sbjct: 135 ILLD-----KNGH--IKITDFGFAKYVPDVTYTLC-------------GTPDYIAPEVVS 174
Query: 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR---PRLTDELEA 774
Y +D WS+G L+ E+L P+ + ++ ++ I + P ++++
Sbjct: 175 TKP----YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD 230
Query: 775 L 775
L
Sbjct: 231 L 231
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 1e-25
Identities = 51/279 (18%), Positives = 99/279 (35%), Gaps = 39/279 (13%)
Query: 547 EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG 606
E + + E+ +L L H IV++ + L + E++
Sbjct: 40 ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY--------------LVFEFLH- 84
Query: 607 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 666
++ + + + + + L + L HS ++HRD+K +N+LI
Sbjct: 85 ---QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI------ 135
Query: 667 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 726
+ + +KL DF A + T V T + APE+L Y
Sbjct: 136 -NTEGAIKLADFGLARAFGVPVRTYT----------HEVVTLWYRAPEILLGCKY---YS 181
Query: 727 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS 786
VDIWS GC+ E++T + + G SE++ I + S +++ +
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 787 GSGFEKPEAELETLS-FLVDVFRRCTEENPTERPTAGDL 824
+ + L + + +P +R +A
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 105 bits (264), Expect = 3e-25
Identities = 46/265 (17%), Positives = 86/265 (32%), Gaps = 66/265 (24%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
+ ++ IV M + L + ++ + GG + ++ +
Sbjct: 57 MLSLVSTGDCPFIVCMSYAFHTPDKL--------------SFILDLMNGGDLHYHLSQHG 102
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
E F A ++ L +H++ +++RD+K NIL+ D V++ D
Sbjct: 103 VFSEAD-----MRFYAAEIILGLEHMHNRFVVYRDLKPANILL-------DEHGHVRISD 150
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
A + GT +MAPEVL+ Y D +S GC+
Sbjct: 151 LGLACDFSKKKPHASV------------GTHGYMAPEVLQKGVA---YDSSADWFSLGCM 195
Query: 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 797
L +LL P+ + H++ +M + E+ S S PE
Sbjct: 196 LFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-------------ELPDSFS----PELR- 237
Query: 798 ETLSFLVDVFRRCTEENPTERPTAG 822
+ + + R
Sbjct: 238 -------SLLEGLLQRDVNRRLGCL 255
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 4e-25
Identities = 50/270 (18%), Positives = 97/270 (35%), Gaps = 41/270 (15%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+R+L +RH ++ + + M ++ G + ++
Sbjct: 67 ELRLLKHMRHENVIGLLDVFT--------PDETLDDFTDFYLVMPFM-GTDLGKLMKH-- 115
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
+ + F+ + L +H+ I+HRD+K N+ + + +K+ D
Sbjct: 116 ----EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV-------NEDCELKILD 164
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F A S + T + APEV+ + Y VDIWS GC+
Sbjct: 165 FGLARQADSEMTGYV-------------VTRWYRAPEVILNWMR---YTQTVDIWSVGCI 208
Query: 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE- 796
+ E++T + + G L+ I + ++ L S + EK +
Sbjct: 209 MAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS 268
Query: 797 -LETLS-FLVDVFRRCTEENPTERPTAGDL 824
L S V++ + + +R TAG+
Sbjct: 269 ILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 5e-25
Identities = 52/272 (19%), Positives = 94/272 (34%), Gaps = 77/272 (28%)
Query: 558 EVRMLGALR--HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS-VKNYIE 614
EV +L + S ++ + + +E + + ++I
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSF--------------VLILERPEPVQDLFDFIT 102
Query: 615 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 674
+ + +LA V A+ H+ ++HRDIK ENILIDL R + +K
Sbjct: 103 E-----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE------LK 151
Query: 675 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 734
L DF L+ ++T GT + PE +R +G +WS
Sbjct: 152 LIDFGSGALLKDTVYTD------------FDGTRVYSPPEWIRYHRY---HGRSAAVWSL 196
Query: 735 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 794
G LL +++ +P+ E+ + R R++ E +
Sbjct: 197 GILLYDMVCGDIPFEHDEEIIRGQVFF---RQRVSSECQ--------------------- 232
Query: 795 AELETLSFLVDVFRRCTEENPTERPTAGDLYE 826
+ R C P++RPT ++
Sbjct: 233 ----------HLIRWCLALRPSDRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 5e-25
Identities = 59/285 (20%), Positives = 104/285 (36%), Gaps = 68/285 (23%)
Query: 538 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 597
+K+ ++ + E R+L RH + + + L
Sbjct: 35 MKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC------------- 81
Query: 598 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657
MEY GG + ++ + E+ + + A F ++ +AL LHS+ +++RDIK EN
Sbjct: 82 -FVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 135
Query: 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717
+++ D +K+ DF S T GTP ++APEVL
Sbjct: 136 LML-------DKDGHIKITDFGLCKEGISDGATMKT----------FCGTPEYLAPEVLE 178
Query: 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 777
YG VD W G ++ E++ ++P+ + +LI M + R L
Sbjct: 179 DND----YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLS---- 229
Query: 778 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822
PEA + +++P +R G
Sbjct: 230 ---------------PEA--------KSLLAGLLKKDPKQRLGGG 251
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 2e-24
Identities = 50/270 (18%), Positives = 97/270 (35%), Gaps = 41/270 (15%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+R+L ++H ++ + ++ L + ++ G + N ++
Sbjct: 67 ELRLLKHMKHENVIGLLDVFTPARSL---------EEFNDVYLVTHLMGADLNNIVKC-- 115
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
+ ++ F+ + L +HS I+HRD+K N+ ++ +K+ D
Sbjct: 116 ----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-------EDCELKILD 164
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F A + T + APE++ Y VDIWS GC+
Sbjct: 165 FGLARHTDDEMTGYVA-------------TRWYRAPEIMLNWMH---YNQTVDIWSVGCI 208
Query: 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 797
+ ELLT + + G ++ LI + L+ + S QS + K
Sbjct: 209 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN 268
Query: 798 ETLSF---LVDVFRRCTEENPTERPTAGDL 824
+ VD+ + + +R TA
Sbjct: 269 VFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-24
Identities = 50/313 (15%), Positives = 108/313 (34%), Gaps = 45/313 (14%)
Query: 514 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 573
G+ ++F+ K ++ +++ + L E+ +L L+H IV +
Sbjct: 11 GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA----LREICLLKELKHKNIVRL 66
Query: 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 633
+ S K L + E+ ++K ++ + ++
Sbjct: 67 HDVLHSDKKLT--------------LVFEFCD-----QDLKKYFDSCNGDLDPEIVKSFL 107
Query: 634 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 693
+ L HS++++HRD+K +N+LI + +KL +F
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLI-------NRNGELKLANFG----------LARA 150
Query: 694 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP-YMGLS 752
+ V T + P+VL Y +D+WS GC+ EL P + G
Sbjct: 151 FGIPVRCYSAEVVTLWYRPPDVLFGAKL---YSTSIDMWSAGCIFAELANAGRPLFPGND 207
Query: 753 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRRCT 811
+ I ++ ++ +++ + L+ D+ +
Sbjct: 208 VDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLL 267
Query: 812 EENPTERPTAGDL 824
+ NP +R +A +
Sbjct: 268 KCNPVQRISAEEA 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 101 bits (252), Expect = 6e-24
Identities = 51/278 (18%), Positives = 94/278 (33%), Gaps = 51/278 (18%)
Query: 558 EVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 616
E+++L LR I+ + +P A+ E+V K + L
Sbjct: 79 EIKILENLRGGPNIITLADIVK----------DPVSRTP--ALVFEHVNNTDFKQLYQTL 126
Query: 617 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 676
++ F ++ AL HS IMHRD+K N++ID E +K ++L
Sbjct: 127 TD--------YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK------LRLI 172
Query: 677 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736
D+ A V + + PE+ + +Y +D+WS GC
Sbjct: 173 DWGLAEFYHPGQEYNV-----------RVASRYFKGPEL---LVDYQMYDYSLDMWSLGC 218
Query: 737 LLLELLTLQVPYM-GLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 794
+L ++ + P+ G + I ++ L D ++ + +
Sbjct: 219 MLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKR 278
Query: 795 AELETLSF--------LVDVFRRCTEENPTERPTAGDL 824
E S +D + + R TA +
Sbjct: 279 WERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 7e-23
Identities = 58/292 (19%), Positives = 97/292 (33%), Gaps = 66/292 (22%)
Query: 532 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKWLPSADGNP 590
A KV A + E ++L +R S +V ++ + L
Sbjct: 56 AMKVLKKATIVQKAKTTEHT----RTERQVLEHIRQSPFLVTLHYAFQTETKLH------ 105
Query: 591 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 650
+ ++Y+ GG + ++ + E V + + ++ AL LH I++
Sbjct: 106 --------LILDYINGGELFTHLSQRERFTEHEVQIYVG-----EIVLALEHLHKLGIIY 152
Query: 651 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 710
RDIK ENIL+D V L DF + + G +
Sbjct: 153 RDIKLENILLD-------SNGHVVLTDFGLSKEFVADETERAYDFCGTI---------EY 196
Query: 711 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 770
MAP+++R + VD WS G L+ ELLT P+ E I
Sbjct: 197 MAPDIVRGGDSG--HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK---- 250
Query: 771 ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822
+P E + D+ +R ++P +R G
Sbjct: 251 --------------------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCG 282
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 7e-23
Identities = 61/283 (21%), Positives = 103/283 (36%), Gaps = 71/283 (25%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK-- 615
E+++L + H V L A P L+ + +E+ K G++ Y+
Sbjct: 66 ELKILIHIGHHLNV---------VNLLGACTKPGGPLM---VIVEFCKFGNLSTYLRSKR 113
Query: 616 ---------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 666
+ + ++++ + + VA + L S+ +HRD+ + NIL+
Sbjct: 114 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----- 168
Query: 667 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 726
K VVK+CDF A + +WMAPE + Y
Sbjct: 169 --EKNVVKICDFGLARDIYKDPDYVRKGD--------ARLPLKWMAPETIFDRV----YT 214
Query: 727 LEVDIWSYGCLLLELLTLQV-PYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVA 784
++ D+WS+G LL E+ +L PY G+ E ++ G R R D
Sbjct: 215 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT----------- 263
Query: 785 QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 827
PE + C P++RPT +L E
Sbjct: 264 --------PE--------MYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.4 bits (236), Expect = 1e-21
Identities = 47/281 (16%), Positives = 92/281 (32%), Gaps = 52/281 (18%)
Query: 558 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 617
E+ ++ + H I+ + K L + ME + + +L
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQ--------DVYLVMELMDANLCQVIQMELD 117
Query: 618 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 677
+ ++ + + LHS I+HRD+K NI++ +K+ D
Sbjct: 118 H--------ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV-------KSDCTLKILD 162
Query: 678 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737
F A + V T + APEV+ M Y VDIWS GC+
Sbjct: 163 FGLARTAGTSFMMTPY-----------VVTRYYRAPEVILGMG----YKENVDIWSVGCI 207
Query: 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 797
+ E++ ++ + G ++ + + + ++ L + V +L
Sbjct: 208 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267
Query: 798 ETLSF--------------LVDVFRRCTEENPTERPTAGDL 824
S D+ + +P +R + D
Sbjct: 268 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 93.7 bits (232), Expect = 4e-21
Identities = 47/229 (20%), Positives = 81/229 (35%), Gaps = 43/229 (18%)
Query: 538 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 597
+K+ L E R+L A+ +V++ + L + S
Sbjct: 71 MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 598 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657
+ S A F A + LHS +++RD+K EN
Sbjct: 131 HLRRI-------------------GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 717
+LI D + +++ DF A ++ T C GTP +APE++
Sbjct: 172 LLI-------DQQGYIQVTDFGFAKRVKGRTWTLC-------------GTPEALAPEIIL 211
Query: 718 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 766
+ Y VD W+ G L+ E+ P+ ++I++ I GK
Sbjct: 212 SKG----YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 82.0 bits (201), Expect = 3e-17
Identities = 48/290 (16%), Positives = 96/290 (33%), Gaps = 46/290 (15%)
Query: 558 EVRMLGALRHSCIVEMY--GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 615
E+++L + + + G K L +H + + + V +N +
Sbjct: 59 EIKLLQRVNDADNTKEDSMGANHILKLLDH-----FNHKGPNGVHVVMVFEVLGENLLAL 113
Query: 616 LSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENILIDLERKKADGKPVVK 674
+ + + + + I++ + L +H + I+H DIK EN+L+++ + +K
Sbjct: 114 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV-DSPENLIQIK 172
Query: 675 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 734
+ D A T + +PEVL +G DIWS
Sbjct: 173 IADLGNACWYDEHYTNSI-------------QTREYRSPEVLLGAP----WGCGADIWST 215
Query: 735 GCLLLELLTLQVPYMG-------------------LSELEIHDLIQMGKRPRLTDELEAL 775
CL+ EL+T + L EL + L + L
Sbjct: 216 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLL 275
Query: 776 GSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDL 824
+ + + + + + + D + +P +R AG L
Sbjct: 276 RNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 57.1 bits (137), Expect = 8e-10
Identities = 27/197 (13%), Positives = 59/197 (29%), Gaps = 65/197 (32%)
Query: 549 RNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS 608
S E R L L+ + ++Y + +A+ ME +
Sbjct: 55 VLAIRSARNEFRALQKLQGLAVPKVYAWE------------------GNAVLMELIDAKE 96
Query: 609 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 668
+ + + + + + + + + I+H D+ N+L+
Sbjct: 97 LYRVRVENPDE------------VLDMILEEVAKFYHRGIVHGDLSQYNVLVS------- 137
Query: 669 GKPVVKLCDFDRAVPL-----RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 723
+ + + DF ++V + R L DV ++ +
Sbjct: 138 -EEGIWIIDFPQSVEVGEEGWREIL-----------ERDVRN---------IITYFSRT- 175
Query: 724 LYGLEVDIWSYGCLLLE 740
Y E DI S +L+
Sbjct: 176 -YRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 840 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.17 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.33 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.3 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.65 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.47 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.81 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-51 Score=433.95 Aligned_cols=269 Identities=24% Similarity=0.373 Sum_probs=211.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
++.++|++.+.||+|+||+||+|++++ .||||++... .......+.| .+|+.+|++++|||||++++++...
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~--~~~~~~~~~~----~~E~~~l~~l~HpnIv~~~~~~~~~- 76 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVT--APTPQQLQAF----KNEVGVLRKTRHVNILLFMGYSTAP- 76 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCS--SCCTTHHHHH----HHHHHHHTTCCCTTBCCEEEEECSS-
T ss_pred cccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcc--cCCHHHHHHH----HHHHHHHHhCCCCCEeeeeEEEecc-
Confidence 456789999999999999999998765 5999986433 2333344444 8999999999999999999987532
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
..+|||||+++|+|.+++.. ....+++..+..|+.||+.||+|||++|||||||||+||||+
T Consensus 77 --------------~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~ 138 (276)
T d1uwha_ 77 --------------QLAIVTQWCEGSSLYHHLHI----IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH 138 (276)
T ss_dssp --------------SCEEEEECCCEEEHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred --------------EEEEEEecCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEc
Confidence 24999999999999999975 235699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||+|+........ .......||+.|||||++.+.. ...++.++|||||||+||||
T Consensus 139 ~~-------~~~Kl~DFGla~~~~~~~~~--------~~~~~~~gt~~y~APE~l~~~~-~~~~~~~sDiwS~Gv~l~el 202 (276)
T d1uwha_ 139 ED-------LTVKIGDFGLATVKSRWSGS--------HQFEQLSGSILWMAPEVIRMQD-KNPYSFQSDVYAFGIVLYEL 202 (276)
T ss_dssp TT-------SSEEECCCCCSCC--------------------CCCCGGGCCHHHHTTCS-SCCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEccccceeeccccCCc--------ccccccccCcccCCHHHHhccc-CCCCCchhhhhhhHHHHHHH
Confidence 77 56999999999876432211 1123457999999999997522 24689999999999999999
Q ss_pred HhCCCCCCCCCHH-HHHHHHHcCCCC-CcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 742 LTLQVPYMGLSEL-EIHDLIQMGKRP-RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 742 LTG~~PF~~~~~~-el~~~I~~~~~p-~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+||+.||.+.+.. .+...+.++..+ .+.. ....+++.+.+||.+||..||.+||
T Consensus 203 ~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~------------------------~~~~~~~~l~~li~~cl~~dp~~RP 258 (276)
T d1uwha_ 203 MTGQLPYSNINNRDQIIFMVGRGYLSPDLSK------------------------VRSNCPKAMKRLMAECLKKKRDERP 258 (276)
T ss_dssp HHSSCTTTTCCCHHHHHHHHHHTSCCCCGGG------------------------SCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHCCCCCCCCChHHHHHHHHhcCCCCCcchh------------------------ccccchHHHHHHHHHHcCCCHhHCc
Confidence 9999999887654 444555555332 2111 1122356899999999999999999
Q ss_pred CHHHHHHHHHhhcCCCC
Q 003185 820 TAGDLYEMFVARTSSSI 836 (840)
Q Consensus 820 Sa~ELLehLe~l~~~~~ 836 (840)
|+.+|+++|+.+..+-|
T Consensus 259 t~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 259 LFPQILASIELLARSLP 275 (276)
T ss_dssp CHHHHHHHHHHHHHTCC
T ss_pred CHHHHHHHHHHHHHcCC
Confidence 99999999999876543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-51 Score=431.51 Aligned_cols=258 Identities=27% Similarity=0.370 Sum_probs=205.1
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
.++|++.+.||+|+||.||+|++ ++..||+|++... .......+ .+.+|+.+|++++|||||++++++.+..
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~----~~~~E~~il~~l~HpnIv~~~~~~~~~~ 76 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYG--SMTEAEKQ----MLVSEVNLLRELKHPNIVRYYDRIIDRT 76 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCT--TSCHHHHH----HHHHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChh--hCCHHHHH----HHHHHHHHHHHCCCCCEeeEEEEEEeCC
Confidence 36799999999999999999997 4778999986543 22333333 3489999999999999999999987532
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecccCCCC
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-----IMHRDIKSE 656 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~g-----IVHRDLKPe 656 (840)
. ..+|||||||++|+|.+++.+.... ...+++..++.++.||+.||+|||++| ||||||||+
T Consensus 77 ~------------~~~~ivmEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~ 143 (269)
T d2java1 77 N------------TTLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 143 (269)
T ss_dssp --------------CEEEEEECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGG
T ss_pred C------------CEEEEEEecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchh
Confidence 1 1369999999999999999764333 357999999999999999999999976 999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
||||+.+ +.+||+|||+|+.+...... .....||+.|||||++.+ ..++.++|||||||
T Consensus 144 NIll~~~-------~~vkl~DFG~a~~~~~~~~~----------~~~~~gt~~Y~APE~l~~----~~~~~~~DIwSlGv 202 (269)
T d2java1 144 NVFLDGK-------QNVKLGDFGLARILNHDTSF----------AKAFVGTPYYMSPEQMNR----MSYNEKSDIWSLGC 202 (269)
T ss_dssp GEEECTT-------SCEEECCHHHHHHC---------------------CCCSCCCHHHHTT----CCCCHHHHHHHHHH
T ss_pred hcCcCCC-------CcEEEeeccceeecccCCCc----------cccCCCCcccCCHHHHcC----CCCChHHHHHhhCH
Confidence 9999877 45999999999876542211 234579999999999976 67899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 737 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 737 IL~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
+||||+||+.||.+.+..++...+..+..+.++.. .++.+.+||.+||+.||.
T Consensus 203 ilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~---------------------------~s~~l~~li~~~L~~dp~ 255 (269)
T d2java1 203 LLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR---------------------------YSDELNEIITRMLNLKDY 255 (269)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTT---------------------------SCHHHHHHHHHHTCSSGG
T ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc---------------------------cCHHHHHHHHHHcCCChh
Confidence 99999999999999999998888887765444321 245799999999999999
Q ss_pred CCCCHHHHHHHH
Q 003185 817 ERPTAGDLYEMF 828 (840)
Q Consensus 817 eRPSa~ELLehL 828 (840)
+|||++||++|.
T Consensus 256 ~Rps~~ell~hp 267 (269)
T d2java1 256 HRPSVEEILENP 267 (269)
T ss_dssp GSCCHHHHHTST
T ss_pred HCcCHHHHHhCC
Confidence 999999999884
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=427.79 Aligned_cols=254 Identities=24% Similarity=0.297 Sum_probs=213.7
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.+++|++.+.||+|+||+||+|++ ++..||+|++.... .........+.+|+.+|++++|||||++++++.+.
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 78 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-----LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA 78 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHH-----ccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC
Confidence 467899999999999999999998 46789999875321 11122334568999999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .|||||||++|+|.+++.. ...+++..++.++.||+.||+|||++|||||||||+||||
T Consensus 79 ~~--------------~~ivmEy~~~g~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill 139 (263)
T d2j4za1 79 TR--------------VYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 139 (263)
T ss_dssp SE--------------EEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred CE--------------EEEEEeecCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee
Confidence 53 5999999999999999986 3569999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||+|+...... .....||+.|||||++.+ ..++.++|||||||+|||
T Consensus 140 ~~~-------~~~kl~DFG~a~~~~~~~------------~~~~~Gt~~Y~APE~~~~----~~~~~~~DiwSlGvilye 196 (263)
T d2j4za1 140 GSA-------GELKIADFGWSVHAPSSR------------RTTLCGTLDYLPPEMIEG----RMHDEKVDLWSLGVLCYE 196 (263)
T ss_dssp CTT-------SCEEECCCCSCSCCCCCC------------CEETTEEGGGCCHHHHTT----CCCCTTHHHHHHHHHHHH
T ss_pred cCC-------CCEeecccceeeecCCCc------------ccccCCCCcccCHHHHcC----CCCCchhhhhhHhHHHHH
Confidence 877 459999999997654321 123469999999999986 668999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|++|+.||.+.+..++...+.+... .+++ ..++.+.+||.+||+.||.+|||
T Consensus 197 ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~~li~~~L~~dp~~R~t 248 (263)
T d2j4za1 197 FLVGKPPFEANTYQETYKRISRVEF-TFPD---------------------------FVTEGARDLISRLLKHNPSQRPM 248 (263)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHTTCC-CCCT---------------------------TSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCC-CCCc---------------------------cCCHHHHHHHHHHccCCHhHCcC
Confidence 9999999999998888888776532 1221 12457899999999999999999
Q ss_pred HHHHHHHHHhh
Q 003185 821 AGDLYEMFVAR 831 (840)
Q Consensus 821 a~ELLehLe~l 831 (840)
++||++|.+-.
T Consensus 249 ~~eil~hp~~~ 259 (263)
T d2j4za1 249 LREVLEHPWIT 259 (263)
T ss_dssp HHHHHTCHHHH
T ss_pred HHHHHcCcCcC
Confidence 99999986543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-50 Score=429.60 Aligned_cols=253 Identities=25% Similarity=0.420 Sum_probs=211.6
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
-.+|++.++||+|+||+||+|.+ .+..||+|++...... .. +.+.+|+.+|++++|||||++++++...+
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~----~~----~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 90 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KK----ELIINEILVMRENKNPNIVNYLDSYLVGD 90 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS----CH----HHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh----HH----HHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence 35799999999999999999996 5889999997654321 12 23489999999999999999999998766
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .|||||||+||+|.+++.+ ..+++..++.++.||+.||+|||++|||||||||+|||++
T Consensus 91 ~--------------~~ivmEy~~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~ 150 (293)
T d1yhwa1 91 E--------------LWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150 (293)
T ss_dssp E--------------EEEEEECCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred E--------------EEEEEEecCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEEC
Confidence 4 4999999999999998875 4699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||+|+.+...... ....+||+.|||||++.+ ..++.++|||||||+||+|
T Consensus 151 ~~-------~~vkl~DFG~a~~~~~~~~~----------~~~~~gt~~Y~aPE~~~~----~~~~~~~DiwSlGvilyem 209 (293)
T d1yhwa1 151 MD-------GSVKLTDFGFCAQITPEQSK----------RSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIEM 209 (293)
T ss_dssp TT-------CCEEECCCTTCEECCSTTCC----------BCCCCSCGGGCCHHHHSS----SCBCTHHHHHHHHHHHHHH
T ss_pred CC-------CcEeeccchhheeecccccc----------ccccccCCCccChhhhcC----CCCCchhceehHhHHHHHH
Confidence 77 45999999999876432211 233579999999999986 6789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
+||+.||.+.+..+....+.....+.+.. ....++.+.+||.+||+.||.+|||+
T Consensus 210 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dP~~R~s~ 264 (293)
T d1yhwa1 210 IEGEPPYLNENPLRALYLIATNGTPELQN-------------------------PEKLSAIFRDFLNRCLDMDVEKRGSA 264 (293)
T ss_dssp HHSSCTTTTSCHHHHHHHHHHHCSCCCSS-------------------------GGGSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred hhCCCCCCCCCHHHHHHHHHhCCCCCCCC-------------------------cccCCHHHHHHHHHHccCChhHCcCH
Confidence 99999999988877776665543332221 11235679999999999999999999
Q ss_pred HHHHHHHHh
Q 003185 822 GDLYEMFVA 830 (840)
Q Consensus 822 ~ELLehLe~ 830 (840)
+|+++|.+-
T Consensus 265 ~eil~Hp~~ 273 (293)
T d1yhwa1 265 KELLQHQFL 273 (293)
T ss_dssp HHHTTCGGG
T ss_pred HHHhcCHhh
Confidence 999998654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.8e-50 Score=429.74 Aligned_cols=270 Identities=19% Similarity=0.319 Sum_probs=207.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC---CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~---~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~ 578 (840)
+...+|++.+.||+|+||+||+|.+. +..++|+++.+... ......+. |.+|+.+|++|+|||||+++|++.
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~----~~~E~~~l~~l~HpnIv~l~g~~~ 97 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRD----FLSEASIMGQFDHPNVIHLEGVVT 97 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHH----HHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHH----HHHHHHHHHhCCCCCCccEEEEEe
Confidence 45678999999999999999999973 23334444334322 22333334 499999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
....+ +||||||++|+|.+++.. ....+++..++.|+.||+.||.|||++|||||||||+||
T Consensus 98 ~~~~~--------------~iv~Ey~~~g~L~~~~~~----~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NI 159 (299)
T d1jpaa_ 98 KSTPV--------------MIITEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNI 159 (299)
T ss_dssp SSSSC--------------EEEEECCTTEEHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eCCEE--------------EEEEEecCCCcceeeecc----ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceE
Confidence 66544 999999999999998875 235689999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
||+.+ +++||+|||+|+.+........ ........||+.|||||++.+ ..++.++|||||||+|
T Consensus 160 Ll~~~-------~~~Kl~DFGla~~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~----~~~~~~sDvwS~Gvvl 223 (299)
T d1jpaa_ 160 LVNSN-------LVCKVSDFGLSRFLEDDTSDPT-----YTSALGGKIPIRWTAPEAIQY----RKFTSASDVWSYGIVM 223 (299)
T ss_dssp EECTT-------CCEEECCC----------------------------CGGGSCHHHHHS----CCCCHHHHHHHHHHHH
T ss_pred EECCC-------CcEEECCcccceEccCCCCcce-----eeecccccCCccccCHHHHhc----CCCCcccccccchHHH
Confidence 99877 5699999999987654322110 011122358999999999986 6789999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 739 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 739 ~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
|||+| |+.||.+.+..++...+..+.++..+. .+++.+.+||.+||+.||.+
T Consensus 224 ~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~~P~~ 276 (299)
T d1jpaa_ 224 WEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM---------------------------DCPSALHQLMLDCWQKDRNH 276 (299)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cchHHHHHHHHHHcCCCHhH
Confidence 99998 899999999999988888776544332 13557999999999999999
Q ss_pred CCCHHHHHHHHHhhcCCCCC
Q 003185 818 RPTAGDLYEMFVARTSSSIS 837 (840)
Q Consensus 818 RPSa~ELLehLe~l~~~~~s 837 (840)
|||+.||+++|+.+.++..+
T Consensus 277 RPs~~ei~~~L~~~l~~p~s 296 (299)
T d1jpaa_ 277 RPKFGQIVNTLDKMIRNPNS 296 (299)
T ss_dssp SCCHHHHHHHHHHHHHSGGG
T ss_pred CcCHHHHHHHHHHHhcChhh
Confidence 99999999999998766544
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=419.43 Aligned_cols=255 Identities=21% Similarity=0.355 Sum_probs=204.9
Q ss_pred CCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
.+|++.+.||+|+||.||+|.+ ++..||||++. ..... .+. +.+|+.++++++|||||+++|++.....+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~--~~~~~---~~~----~~~E~~~l~~l~HpnIv~~~g~~~~~~~~ 75 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR--EGAMS---EED----FIEEAEVMMKLSHPKLVQLYGVCLEQAPI 75 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECC--SSSSC---HHH----HHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEEC--CCcCc---HHH----HHHHHHHHHhcCCCCcccccceeccCCce
Confidence 5799999999999999999998 46679999854 22222 223 48999999999999999999999876544
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
+|||||+++|+|.+++.. ....+++..++.|+.||+.||.|||+++|+||||||+||||+.+
T Consensus 76 --------------~lv~E~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~ 137 (263)
T d1sm2a_ 76 --------------CLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN 137 (263)
T ss_dssp --------------EEEEECCTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGG
T ss_pred --------------EEEEEecCCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCC
Confidence 999999999999999875 34568999999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.+||+|||+++........ ......||+.|||||++.+ ..++.++|||||||+||||+|
T Consensus 138 -------~~~Kl~DFGla~~~~~~~~~---------~~~~~~gt~~y~aPE~l~~----~~~~~k~DVwS~Gvil~el~t 197 (263)
T d1sm2a_ 138 -------QVIKVSDFGMTRFVLDDQYT---------SSTGTKFPVKWASPEVFSF----SRYSSKSDVWSFGVLMWEVFS 197 (263)
T ss_dssp -------GCEEECSCC---------------------------CTTSCCHHHHTT----CCCCHHHHHHHHHHHHHHHHT
T ss_pred -------CCeEecccchheeccCCCce---------eecceecCcccCChHHhcC----CCCCchhhhcchHHHHHHHHH
Confidence 46999999999876543221 1123468999999999986 678999999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 744 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 744 -G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
|.+||...+..++...+..+.++..+.. .++.+.+||.+||+.||.+|||++
T Consensus 198 ~~~~~~~~~~~~~~~~~i~~~~~~~~p~~---------------------------~~~~l~~li~~cl~~~p~~Rps~~ 250 (263)
T d1sm2a_ 198 EGKIPYENRSNSEVVEDISTGFRLYKPRL---------------------------ASTHVYQIMNHCWKERPEDRPAFS 250 (263)
T ss_dssp TSCCTTCSCCHHHHHHHHHHTCCCCCCTT---------------------------SCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCCCCCHHHHHHHHHhcCCCCCccc---------------------------cCHHHHHHHHHHccCCHhHCcCHH
Confidence 5777777888888888887765544421 245789999999999999999999
Q ss_pred HHHHHHHhhcC
Q 003185 823 DLYEMFVARTS 833 (840)
Q Consensus 823 ELLehLe~l~~ 833 (840)
+|+++|+.+.+
T Consensus 251 ~il~~L~~i~e 261 (263)
T d1sm2a_ 251 RLLRQLAEIAE 261 (263)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHh
Confidence 99999998864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-50 Score=428.08 Aligned_cols=257 Identities=28% Similarity=0.427 Sum_probs=213.1
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
+.|++.+.||+|+||.||+|++ ++..||+|++... .....+.+ .+|+.+|++|+|||||++++++...+.
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----~~~~~~~~----~~E~~il~~l~HpnIv~l~~~~~~~~~ 83 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK----SEEELEDY----MVEIDILASCDHPNIVKLLDAFYYENN 83 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----SSGGGGGT----HHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC----CHHHHHHH----HHHHHHHHhCCCCCCCeEEEEEeeCCe
Confidence 4689999999999999999998 5678999997543 12233444 899999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.|||||||++|+|.+++.+. ...+++..+..++.||+.||.|||++|||||||||+||||+.
T Consensus 84 --------------~~lvmEy~~~g~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~ 145 (288)
T d2jfla1 84 --------------LWILIEFCAGGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL 145 (288)
T ss_dssp --------------EEEEEECCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred --------------EEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECC
Confidence 49999999999999998752 356999999999999999999999999999999999999997
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~kSDVWSLGvIL~EL 741 (840)
+ +.+||+|||+|+........ .....||+.|||||++.... ....++.++|||||||+||||
T Consensus 146 ~-------~~~Kl~DFG~a~~~~~~~~~----------~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyem 208 (288)
T d2jfla1 146 D-------GDIKLADFGVSAKNTRTIQR----------RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 208 (288)
T ss_dssp T-------SCEEECCCTTCEECHHHHHH----------HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHH
T ss_pred C-------CCEEEEechhhhccCCCccc----------ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHH
Confidence 7 45999999999766442211 12346999999999996432 235689999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
+||+.||.+.+..++...+.+...+.+.. ....++.+.+||.+||+.||.+|||+
T Consensus 209 ltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dp~~R~t~ 263 (288)
T d2jfla1 209 AEIEPPHHELNPMRVLLKIAKSEPPTLAQ-------------------------PSRWSSNFKDFLKKCLEKNVDARWTT 263 (288)
T ss_dssp HHSSCTTTTSCGGGHHHHHHHSCCCCCSS-------------------------GGGSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred hhCCCCCCCCCHHHHHHHHHcCCCCCCCc-------------------------cccCCHHHHHHHHHHccCChhHCcCH
Confidence 99999999998888888887765443321 11235689999999999999999999
Q ss_pred HHHHHHHH
Q 003185 822 GDLYEMFV 829 (840)
Q Consensus 822 ~ELLehLe 829 (840)
+||++|.+
T Consensus 264 ~ell~hp~ 271 (288)
T d2jfla1 264 SQLLQHPF 271 (288)
T ss_dssp HHHTTSGG
T ss_pred HHHhcCcc
Confidence 99999854
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=427.31 Aligned_cols=257 Identities=25% Similarity=0.292 Sum_probs=203.6
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.+++|++.+.||+|+||+||+|++ ++..||+|++..+.. ... .+.+.+|+.+|++++|||||++++++.+.
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~----~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~ 75 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDC----PENIKKEICINKMLNHENVVKFYGHRREG 75 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chH----HHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence 367899999999999999999998 477999999764421 111 23458999999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
+. .|||||||+||+|.++|.. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 76 ~~--------------~~ivmEy~~gg~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl 136 (271)
T d1nvra_ 76 NI--------------QYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 136 (271)
T ss_dssp TE--------------EEEEEECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred ce--------------eEEEEeccCCCcHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE
Confidence 64 4999999999999999864 4579999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||+|+.+....... .....+||+.|||||++.+ ...++.++|||||||+|||
T Consensus 137 ~~~-------~~~KL~DFG~a~~~~~~~~~~--------~~~~~~GT~~Y~APE~~~~---~~~~~~~~DiwSlGvilye 198 (271)
T d1nvra_ 137 DER-------DNLKISDFGLATVFRYNNRER--------LLNKMCGTLPYVAPELLKR---REFHAEPVDVWSCGIVLTA 198 (271)
T ss_dssp CTT-------CCEEECCCTTCEECEETTEEC--------CBCCCCSCGGGSCTHHHHC---SSBCHHHHHHHHHHHHHHH
T ss_pred CCC-------CCEEEccchhheeeccCCccc--------cccceeeCcCccCHhHhcC---CCCCCCceeeeHhHHHHHH
Confidence 877 459999999998765432110 1234579999999999986 2234688999999999999
Q ss_pred HHhCCCCCCCCCHHH-HHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLTLQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLTG~~PF~~~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|+||+.||....... ....+..... ... .....++.+.+||.+||+.||.+||
T Consensus 199 ml~G~~pf~~~~~~~~~~~~~~~~~~-~~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~ 252 (271)
T d1nvra_ 199 MLAGELPWDQPSDSCQEYSDWKEKKT-YLN-------------------------PWKKIDSAPLALLHKILVENPSARI 252 (271)
T ss_dssp HHHSSCSCSSSSTTSHHHHHHHTTCT-TST-------------------------TGGGSCHHHHHHHHHHSCSSTTTSC
T ss_pred HHhCCCCCCCCChHHHHHHHHhcCCC-CCC-------------------------ccccCCHHHHHHHHHHcCCChhHCc
Confidence 999999997654332 2223322211 110 1122356789999999999999999
Q ss_pred CHHHHHHHHH
Q 003185 820 TAGDLYEMFV 829 (840)
Q Consensus 820 Sa~ELLehLe 829 (840)
|++|+++|.+
T Consensus 253 t~~eil~hpw 262 (271)
T d1nvra_ 253 TIPDIKKDRW 262 (271)
T ss_dssp CHHHHTTCTT
T ss_pred CHHHHhcCHh
Confidence 9999999854
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-49 Score=422.52 Aligned_cols=262 Identities=23% Similarity=0.278 Sum_probs=215.6
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++++.||+|+||+||+|++ ++..||+|++.......... ....+.+.+|+.+|++|+|||||++++++.+...
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR--GVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhh--hHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4699999999999999999998 47899999976543322111 1122345899999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.|||||||+||+|.++|.. ...+++..++.++.||+.||+|||++|||||||||+|||++.
T Consensus 88 --------------~~iv~E~~~gg~L~~~i~~-----~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~ 148 (293)
T d1jksa_ 88 --------------VILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 148 (293)
T ss_dssp --------------EEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC
T ss_pred --------------EEEEEEcCCCccccchhcc-----ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEec
Confidence 5999999999999999986 256999999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
++. ....+||+|||+|........ .....||+.|||||++.+ ..++.++|||||||+||||+
T Consensus 149 ~~~---~~~~vkl~DfG~a~~~~~~~~-----------~~~~~~t~~y~APE~~~~----~~~~~~~DiwSlGvilyell 210 (293)
T d1jksa_ 149 RNV---PKPRIKIIDFGLAHKIDFGNE-----------FKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYILL 210 (293)
T ss_dssp SSS---SSCCEEECCCTTCEECTTSCB-----------CSCCCCCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHHH
T ss_pred CCC---cccceEecchhhhhhcCCCcc-----------ccccCCCCcccCHHHHcC----CCCCCcccchhhhHHHHHHH
Confidence 642 234699999999987643221 133469999999999986 67899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
+|+.||.+.+..++...+.......... .....+..+.+||.+||+.||.+|||++
T Consensus 211 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~ 266 (293)
T d1jksa_ 211 SGASPFLGDTKQETLANVSAVNYEFEDE------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQ 266 (293)
T ss_dssp HSSCSSCCSSHHHHHHHHHTTCCCCCHH------------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred cCCCCCCCCCHHHHHHHHHhcCCCCCch------------------------hcCCCCHHHHHHHHHHccCChhHCcCHH
Confidence 9999999999998888887764322211 1122356789999999999999999999
Q ss_pred HHHHHHH
Q 003185 823 DLYEMFV 829 (840)
Q Consensus 823 ELLehLe 829 (840)
|+++|.+
T Consensus 267 eil~hp~ 273 (293)
T d1jksa_ 267 DSLQHPW 273 (293)
T ss_dssp HHHHSTT
T ss_pred HHhcCcc
Confidence 9999843
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-49 Score=422.34 Aligned_cols=261 Identities=21% Similarity=0.378 Sum_probs=215.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
++.++|++.+.||+|+||+||+|.+ .+..||||++... .. ..+. +.+|+.+|++|+|||||++++++..
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~--~~---~~~~----~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TM---EVEE----FLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT--CS---CHHH----HHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc--cc---hHHH----HHHHHHHHHhCCCCCEecCCccEee
Confidence 4556899999999999999999998 4778999985322 11 2233 4899999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
...+ +|||||+++|+|..++.. .....+++..++.|+.||+.||+|||++|||||||||+|||
T Consensus 85 ~~~~--------------~iv~E~~~~g~l~~~l~~---~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NIL 147 (287)
T d1opja_ 85 EPPF--------------YIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 147 (287)
T ss_dssp SSSC--------------EEEEECCTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred CCee--------------EEEeecccCcchHHHhhh---ccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEE
Confidence 6644 999999999999999976 33467899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
|+.+ +.+||+|||+|+......... .....||+.|||||++.+ ..++.++|||||||+||
T Consensus 148 l~~~-------~~~Kl~DFG~a~~~~~~~~~~---------~~~~~g~~~y~aPE~~~~----~~~~~k~DiwS~Gv~l~ 207 (287)
T d1opja_ 148 VGEN-------HLVKVADFGLSRLMTGDTYTA---------HAGAKFPIKWTAPESLAY----NKFSIKSDVWAFGVLLW 207 (287)
T ss_dssp ECGG-------GCEEECCCCCTTTCCSSSSEE---------ETTEEECGGGCCHHHHHH----CCCSHHHHHHHHHHHHH
T ss_pred ECCC-------CcEEEccccceeecCCCCcee---------eccccccccccChHHHcC----CCCCchhhhhhHHHHHH
Confidence 9987 469999999998765432211 122358999999999987 67899999999999999
Q ss_pred HHHhCCCC-CCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 740 ELLTLQVP-YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 740 ELLTG~~P-F~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
||++|..| |.+.+..++...+..+.++.++.. .++.+.+||.+||+.||.+|
T Consensus 208 ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~---------------------------~~~~l~~li~~cl~~dP~~R 260 (287)
T d1opja_ 208 EIATYGMSPYPGIDLSQVYELLEKDYRMERPEG---------------------------CPEKVYELMRACWQWNPSDR 260 (287)
T ss_dssp HHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTT---------------------------CCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhCCCCCCCcchHHHHHHHHhcCCCCCCCcc---------------------------chHHHHHHHHHHcCCCHhHC
Confidence 99996555 566677777777777655544421 24579999999999999999
Q ss_pred CCHHHHHHHHHhhcCCC
Q 003185 819 PTAGDLYEMFVARTSSS 835 (840)
Q Consensus 819 PSa~ELLehLe~l~~~~ 835 (840)
||+++|++.|+.+.+.+
T Consensus 261 ps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 261 PSFAEIHQAFETMFQES 277 (287)
T ss_dssp CCHHHHHHHHHHTTSSS
T ss_pred cCHHHHHHHHHHHHHhC
Confidence 99999999999886653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-49 Score=425.47 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=210.3
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
.|++.+.||+|+||+||+|++ ++..||||++..... ...... +.+.+|+.+|++|+|||||++++++.+...
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~----~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~- 89 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKW----QDIIKEVRFLQKLRHPNTIQYRGCYLREHT- 89 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-CHHHHH----HHHHHHHHHHTTCCCTTBCCEEEEEEETTE-
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc-cCHHHH----HHHHHHHHHHHHCCCCCEeeEEEEEEECCE-
Confidence 499999999999999999997 577899998654321 112222 345999999999999999999999987653
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.|||||||.+|+|..++.. ...+++..++.++.||+.||.|||++|||||||||+||||+.+
T Consensus 90 -------------~~iv~E~~~~g~l~~~~~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~ 151 (309)
T d1u5ra_ 90 -------------AWLVMEYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 151 (309)
T ss_dssp -------------EEEEEECCSEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT
T ss_pred -------------EEEEEEecCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCC
Confidence 5999999999999877665 3579999999999999999999999999999999999999977
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.+||+|||+|+..... ....||+.|||||++.+.. ...|+.++|||||||+||||++
T Consensus 152 -------~~~Kl~DFG~a~~~~~~--------------~~~~GT~~Y~APE~~~~~~-~~~y~~~~DiwSlGvilyel~~ 209 (309)
T d1u5ra_ 152 -------GLVKLGDFGSASIMAPA--------------NSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAE 209 (309)
T ss_dssp -------TEEEECCCTTCBSSSSB--------------CCCCSCGGGCCHHHHTTTT-SCCBCTHHHHHHHHHHHHHHHH
T ss_pred -------CCEEEeecccccccCCC--------------CccccCccccCHHHHhccC-CCCcCchhhhhhHHHHHHHHHH
Confidence 56999999999765331 2246999999999997522 2468899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 823 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~E 823 (840)
|..||.+.+..+....+.....+.+.. ...++.+.+||.+||+.||.+|||++|
T Consensus 210 g~~Pf~~~~~~~~~~~i~~~~~~~~~~--------------------------~~~s~~~~~li~~~L~~dP~~Rpt~~e 263 (309)
T d1u5ra_ 210 RKPPLFNMNAMSALYHIAQNESPALQS--------------------------GHWSEYFRNFVDSCLQKIPQDRPTSEV 263 (309)
T ss_dssp SSCTTTTSCHHHHHHHHHHSCCCCCSC--------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCCC--------------------------CCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 999999988888887777665443321 112457999999999999999999999
Q ss_pred HHHHHHhh
Q 003185 824 LYEMFVAR 831 (840)
Q Consensus 824 LLehLe~l 831 (840)
+++|.+-.
T Consensus 264 ll~Hp~~~ 271 (309)
T d1u5ra_ 264 LLKHRFVL 271 (309)
T ss_dssp HTTCHHHH
T ss_pred HHhCHHhc
Confidence 99985543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=418.72 Aligned_cols=257 Identities=22% Similarity=0.308 Sum_probs=212.0
Q ss_pred CCceeee-eecccCceEEEEEEE----CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 505 PSLSSCD-EAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 505 ~~y~i~~-~LG~G~fG~Vy~a~~----~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
++|.+.+ +||+|+||.||+|.+ ++..||||+.... ......+. |.+|+.+|++++|||||+++|++..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~----~~~E~~il~~l~HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEE----MMREAQIMHQLDNPYIVRLIGVCQA 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh---cCHHHHHH----HHHHHHHHHhCCCCCEeeEeeeecc
Confidence 4677888 499999999999986 2346888886422 22333344 4999999999999999999999864
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
+. .||||||+++|+|.+++.. ....+++..++.++.||+.||+|||++|||||||||+|||
T Consensus 81 ~~---------------~~lvmE~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nil 141 (285)
T d1u59a_ 81 EA---------------LMLVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL 141 (285)
T ss_dssp SS---------------EEEEEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred Ce---------------EEEEEEeCCCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhhee
Confidence 32 4999999999999999854 2357999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
|+.+ +.+||+|||+|+.+........ ......||+.|||||++.. ..++.++|||||||+||
T Consensus 142 l~~~-------~~~Kl~DFGla~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~----~~~~~ksDVwS~Gv~l~ 203 (285)
T d1u59a_ 142 LVNR-------HYAKISDFGLSKALGADDSYYT-------ARSAGKWPLKWYAPECINF----RKFSSRSDVWSYGVTMW 203 (285)
T ss_dssp EEET-------TEEEECCCTTCEECTTCSCEEC-------CCCSSCCCGGGCCHHHHHH----CEECHHHHHHHHHHHHH
T ss_pred eccC-------Cceeeccchhhhcccccccccc-------cccccccCccccChHHHhC----CCCCccchhhcchHHHH
Confidence 9977 5699999999987754332211 1233468999999999987 67899999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 740 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 740 ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
||+| |+.||.+.+..++...+..+.++.++.. +++.+.+||.+||+.||.+|
T Consensus 204 E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~---------------------------~~~~l~~li~~cl~~~p~~R 256 (285)
T d1u59a_ 204 EALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE---------------------------CPPELYALMSDCWIYKWEDR 256 (285)
T ss_dssp HHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTT---------------------------CCHHHHHHHHHTTCSSGGGS
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCc---------------------------CCHHHHHHHHHHcCCCHhHC
Confidence 9998 8999999988888888888876655432 24578999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 003185 819 PTAGDLYEMFVART 832 (840)
Q Consensus 819 PSa~ELLehLe~l~ 832 (840)
||+.+|++.|+..-
T Consensus 257 Ps~~~i~~~L~~~~ 270 (285)
T d1u59a_ 257 PDFLTVEQRMRACY 270 (285)
T ss_dssp CCHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHH
Confidence 99999998887643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=416.98 Aligned_cols=250 Identities=21% Similarity=0.328 Sum_probs=204.4
Q ss_pred eeecccCceEEEEEEEC----CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCC
Q 003185 511 DEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 586 (840)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~----~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~ 586 (840)
++||+|+||.||+|.+. +..||||++.... ..... .+.+.+|+.+|++++|||||+++|++..+.
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~----~~~~~~E~~il~~l~HpnIv~~~g~~~~~~----- 81 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPAL----KDELLAEANVMQQLDNPYIVRMIGICEAES----- 81 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHH----HHHHHHHHHHHHTCCCTTBCCEEEEEESSS-----
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh--CCHHH----HHHHHHHHHHHHhCCCCCCceEEEEeccCC-----
Confidence 47999999999999863 3568999864321 22222 234599999999999999999999986432
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEeccccc
Q 003185 587 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 666 (840)
Q Consensus 587 ~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~ 666 (840)
.+|||||+++|+|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+||||+.+
T Consensus 82 ----------~~lvmE~~~~g~L~~~l~~-----~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~--- 143 (277)
T d1xbba_ 82 ----------WMLVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ--- 143 (277)
T ss_dssp ----------EEEEEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET---
T ss_pred ----------EEEEEEcCCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccccc---
Confidence 4899999999999999986 4569999999999999999999999999999999999999987
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CC
Q 003185 667 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQ 745 (840)
Q Consensus 667 ~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT-G~ 745 (840)
+.+||+|||+|+.+........ ......||+.|||||++.+ ..++.++|||||||++|||+| |+
T Consensus 144 ----~~~kl~DFGla~~~~~~~~~~~-------~~~~~~gt~~y~APE~l~~----~~~~~~sDiwS~Gv~l~ellt~g~ 208 (277)
T d1xbba_ 144 ----HYAKISDFGLSKALRADENYYK-------AQTHGKWPVKWYAPECINY----YKFSSKSDVWSFGVLMWEAFSYGQ 208 (277)
T ss_dssp ----TEEEECCCTTCEECCTTCSEEE-------C----CCCGGGCCHHHHHH----CEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred ----Ccccccchhhhhhccccccccc-------cccccCCCceecCchhhcC----CCCCchhhhccchhhhhHHhhCCC
Confidence 5699999999987654322111 1123468999999999987 678999999999999999998 89
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 003185 746 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 825 (840)
Q Consensus 746 ~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELL 825 (840)
.||.+.+..++...+.++.++.++.. +++.+.+||.+||+.||.+|||+++|+
T Consensus 209 ~Pf~~~~~~~~~~~i~~~~~~~~p~~---------------------------~~~~~~~li~~cl~~dp~~RPs~~~i~ 261 (277)
T d1xbba_ 209 KPYRGMKGSEVTAMLEKGERMGCPAG---------------------------CPREMYDLMNLCWTYDVENRPGFAAVE 261 (277)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTT---------------------------CCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCcc---------------------------cCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 99999999999888888766655422 245789999999999999999999998
Q ss_pred HHHHhh
Q 003185 826 EMFVAR 831 (840)
Q Consensus 826 ehLe~l 831 (840)
+.|+..
T Consensus 262 ~~L~~~ 267 (277)
T d1xbba_ 262 LRLRNY 267 (277)
T ss_dssp HHHHHH
T ss_pred HHhhCH
Confidence 877653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-48 Score=430.34 Aligned_cols=257 Identities=22% Similarity=0.258 Sum_probs=214.3
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.+++|++.+.||+|+||.||+|++ .+..||+|++... .....+ .+.+|+.+|++|+|||||++++++.+.
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~----~~~~E~~il~~l~HpnIv~~~~~~~~~ 95 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKE----TVRKEIQTMSVLRHPTLVNLHDAFEDD 95 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHH----HHHHHHHHHHHTCCTTBCCEEEEEEET
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc----chhhHH----HHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 467999999999999999999998 5789999986432 222223 458999999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
+. .|||||||+||+|.+++.. ....+++..++.|+.||+.||.|||++|||||||||+||||
T Consensus 96 ~~--------------~~ivmE~~~gg~L~~~l~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll 157 (350)
T d1koaa2 96 NE--------------MVMIYEFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF 157 (350)
T ss_dssp TE--------------EEEEECCCCSCBHHHHHTC----TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CE--------------EEEEEEcCCCCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeee
Confidence 54 5999999999999999853 23569999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+. .+.+||+|||+|+.+..... .....||+.|||||++.+ ..++.++|||||||++||
T Consensus 158 ~~~~-----~~~vkL~DFG~a~~~~~~~~-----------~~~~~gT~~Y~aPEv~~~----~~~~~~~DiwSlGvilye 217 (350)
T d1koaa2 158 TTKR-----SNELKLIDFGLTAHLDPKQS-----------VKVTTGTAEFAAPEVAEG----KPVGYYTDMWSVGVLSYI 217 (350)
T ss_dssp SSTT-----SCCEEECCCTTCEECCTTSC-----------EEEECSCTTTCCHHHHHT----CCBCHHHHHHHHHHHHHH
T ss_pred ccCC-----CCeEEEeecchheecccccc-----------cceecCcccccCHHHHcC----CCCChhHhhhhhhHHHHH
Confidence 7552 25799999999987654322 123579999999999986 678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|++|+.||.+.+..+++..+.......... .....++.+.+||.+||..||.+|||
T Consensus 218 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~R~t 273 (350)
T d1koaa2 218 LLSGLSPFGGENDDETLRNVKSCDWNMDDS------------------------AFSGISEDGKDFIRKLLLADPNTRMT 273 (350)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCCSCCG------------------------GGGGCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCCcc------------------------cccCCCHHHHHHHHHHccCChhHCcC
Confidence 999999999999988888887664321111 11234568999999999999999999
Q ss_pred HHHHHHHHH
Q 003185 821 AGDLYEMFV 829 (840)
Q Consensus 821 a~ELLehLe 829 (840)
++||++|.+
T Consensus 274 ~~eil~hp~ 282 (350)
T d1koaa2 274 IHQALEHPW 282 (350)
T ss_dssp HHHHHHSTT
T ss_pred HHHHhcCcc
Confidence 999999944
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=421.53 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=207.4
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
-++|++.+.||+|+||+||+|.+ .+..||||++..... ......+.+.+|+.+|++++|||||++++++.+.+
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 81 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-----IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE 81 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc-----cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC
Confidence 35799999999999999999998 477899999753221 11122234589999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .||||||++||+|.+++.. ...+++..++.++.||+.||+|||++|||||||||+|||++
T Consensus 82 ~--------------~~ivmEy~~gg~L~~~~~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~ 142 (288)
T d1uu3a_ 82 K--------------LYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN 142 (288)
T ss_dssp E--------------EEEEECCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred E--------------EEEEEEccCCCCHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC
Confidence 4 4999999999999999886 35799999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||+|+.+...... ......+||+.|||||++.+ ..++.++|||||||+||||
T Consensus 143 ~~-------~~vkl~DFG~a~~~~~~~~~--------~~~~~~~GT~~Y~APE~~~~----~~~~~~~DiwSlGvilyel 203 (288)
T d1uu3a_ 143 ED-------MHIQITDFGTAKVLSPESKQ--------ARANSFVGTAQYVSPELLTE----KSACKSSDLWALGCIIYQL 203 (288)
T ss_dssp TT-------SCEEECCCTTCEECC------------------CCCCGGGCCHHHHHT----CCCCHHHHHHHHHHHHHHH
T ss_pred CC-------ceEEecccccceecccCCcc--------cccccccCCccccCceeecc----CCCCcccceehhhHHHHHH
Confidence 77 45999999999876432211 11234579999999999986 6789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
+||+.||.+.+..++...+.+... .++. ..++.+.+||.+||+.||.+|||+
T Consensus 204 l~g~~Pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~~li~~~L~~dP~~R~t~ 255 (288)
T d1uu3a_ 204 VAGLPPFRAGNEYLIFQKIIKLEY-DFPE---------------------------KFFPKARDLVEKLLVLDATKRLGC 255 (288)
T ss_dssp HHSSCSSCCSSHHHHHHHHHTTCC-CCCT---------------------------TCCHHHHHHHHTTSCSSGGGSTTS
T ss_pred hhCCCCCCCcCHHHHHHHHHcCCC-CCCc---------------------------cCCHHHHHHHHHHccCCHhHCcCH
Confidence 999999999999888888876532 2221 124578999999999999999999
Q ss_pred HHHHHH
Q 003185 822 GDLYEM 827 (840)
Q Consensus 822 ~ELLeh 827 (840)
+|++++
T Consensus 256 ~e~~~~ 261 (288)
T d1uu3a_ 256 EEMEGY 261 (288)
T ss_dssp GGGTCH
T ss_pred HHHcCC
Confidence 986443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.7e-49 Score=424.69 Aligned_cols=257 Identities=23% Similarity=0.215 Sum_probs=199.1
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
+.|++.+.||+|+||+||+|++ .+..||+|++...... .. ...+.+|+.+|++|+|||||++++++.+...
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 81 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE---GK----EGSMENEIAVLHKIKHPNIVALDDIYESGGH 81 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------------CHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh---hH----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4599999999999999999998 4778999997644321 11 1234899999999999999999999986654
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.|||||||+||+|.++|.. ...+++..+..++.||+.||+|||++|||||||||+|||+..
T Consensus 82 --------------~~lvmE~~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~ 142 (307)
T d1a06a_ 82 --------------LYLIMQLVSGGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYS 142 (307)
T ss_dssp --------------EEEEECCCCSCBHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESS
T ss_pred --------------EEEEEeccCCCcHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecc
Confidence 5999999999999999975 457999999999999999999999999999999999999975
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
.. ..+.+||+|||+|+....... ....+||+.|||||++.+ ..++.++|||||||+||||+
T Consensus 143 ~~----~~~~vkl~DFG~a~~~~~~~~-----------~~~~~GT~~y~APE~~~~----~~~~~~~DiwSlGvilyell 203 (307)
T d1a06a_ 143 LD----EDSKIMISDFGLSKMEDPGSV-----------LSTACGTPGYVAPEVLAQ----KPYSKAVDCWSIGVIAYILL 203 (307)
T ss_dssp SS----TTCCEEECCC-----------------------------CTTSCHHHHTT----CCCCTHHHHHHHHHHHHHHH
T ss_pred cC----CCceEEEeccceeEEccCCCe-----------eeeeeeCccccCcHHHcC----CCCCcHHHhhhhhHHHHHHH
Confidence 31 236799999999986543221 133579999999999986 67899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
+|+.||.+....++...+.+........ .....++.+.+||.+||+.||.+|||++
T Consensus 204 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~ 259 (307)
T d1a06a_ 204 CGYPPFYDENDAKLFEQILKAEYEFDSP------------------------YWDDISDSAKDFIRHLMEKDPEKRFTCE 259 (307)
T ss_dssp HSSCSCCCSSHHHHHHHHHTTCCCCCTT------------------------TTTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred hCCCCCCCCCHHHHHHHHhccCCCCCCc------------------------cccCCCHHHHHHHHHHccCCHhHCcCHH
Confidence 9999999998888888887764321111 1122356899999999999999999999
Q ss_pred HHHHHHHh
Q 003185 823 DLYEMFVA 830 (840)
Q Consensus 823 ELLehLe~ 830 (840)
|+++|.+-
T Consensus 260 eil~hp~~ 267 (307)
T d1a06a_ 260 QALQHPWI 267 (307)
T ss_dssp HHHHSTTT
T ss_pred HHhcCHhh
Confidence 99998543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=410.40 Aligned_cols=253 Identities=25% Similarity=0.340 Sum_probs=213.7
Q ss_pred CCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
++|++.++||+|+||+||+|+++ +..||||+..... .. .+. +.+|+.++++++|||||+++|++.....
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~--~~---~~~----~~~Ev~~~~~l~HpnIv~~~g~~~~~~~- 73 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MS---EDE----FIEEAKVMMNLSHEKLVQLYGVCTKQRP- 73 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS--SC---HHH----HHHHHHHHHTCCCTTBCCEEEEECCSSS-
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc--CC---HHH----HHHHHHHHHhcCCCceeeEEEEEeeCCc-
Confidence 57899999999999999999984 5689999865432 12 223 4899999999999999999999986553
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
.++||||+++|+|..++.. ....+++..++.|+.||++||+|||++||+||||||+|||++.+
T Consensus 74 -------------~~iv~Ey~~~g~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~ 136 (258)
T d1k2pa_ 74 -------------IFIITEYMANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ 136 (258)
T ss_dssp -------------EEEEEECCTTEEHHHHHHS----GGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTT
T ss_pred -------------eEEEEEccCCCcHHHhhhc----cccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCC
Confidence 4999999999999999864 23568899999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+.+||+|||+++.+...... ......||+.|+|||++.+ ..++.++|||||||++|||+|
T Consensus 137 -------~~~kl~DfG~a~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~----~~~~~ksDiwS~G~~l~el~t 196 (258)
T d1k2pa_ 137 -------GVVKVSDFGLSRYVLDDEYT---------SSVGSKFPVRWSPPEVLMY----SKFSSKSDIWAFGVLMWEIYS 196 (258)
T ss_dssp -------CCEEECCCSSCCBCSSSSCC---------CCCCSCCCGGGCCHHHHHH----CCCCHHHHHHHHHHHHHHHHT
T ss_pred -------CcEEECcchhheeccCCCce---------eecccCCCCCcCCcHHhcC----CCCCcceeecccchhhHhHHh
Confidence 56999999999866543221 1223468999999999987 678999999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 744 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 744 -G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
|+.||.+.+..++...+..+.++..+.. .++.+.+||.+||+.||.+|||++
T Consensus 197 ~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~---------------------------~~~~l~~li~~cl~~dP~~RPt~~ 249 (258)
T d1k2pa_ 197 LGKMPYERFTNSETAEHIAQGLRLYRPHL---------------------------ASEKVYTIMYSCWHEKADERPTFK 249 (258)
T ss_dssp TSCCTTTTSCHHHHHHHHHTTCCCCCCTT---------------------------CCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred cCCCCCCCCCHHHHHHHHHhCCCCCCccc---------------------------ccHHHHHHHHHHccCCHhHCcCHH
Confidence 8999999999999998888766544421 245789999999999999999999
Q ss_pred HHHHHHHhh
Q 003185 823 DLYEMFVAR 831 (840)
Q Consensus 823 ELLehLe~l 831 (840)
+|++||..+
T Consensus 250 eil~~L~di 258 (258)
T d1k2pa_ 250 ILLSNILDV 258 (258)
T ss_dssp HHHHHHHCC
T ss_pred HHHHHhhCC
Confidence 999999753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-49 Score=416.56 Aligned_cols=258 Identities=22% Similarity=0.377 Sum_probs=211.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
++.++|++.+.||+|+||.||+|.++ +..||||++... .. ..+. +.+|+.+|++++|||||+++|++...
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~--~~---~~~~----~~~E~~~l~~l~HpnIv~~~g~~~~~ 80 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG--SM---SPDA----FLAEANLMKQLQHQRLVRLYAVVTQE 80 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT--SS---CHHH----HHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC--cC---CHHH----HHHHHHHHHhCCCCCEeEEEeeeccC
Confidence 45678999999999999999999985 578999986432 11 1223 48999999999999999999987543
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
. .+|||||+++|+|.+++... ....+++..++.|+.||+.||.|||++||+||||||+||||
T Consensus 81 ~---------------~~iv~Ey~~~g~L~~~~~~~---~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll 142 (272)
T d1qpca_ 81 P---------------IYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV 142 (272)
T ss_dssp S---------------CEEEEECCTTCBHHHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred C---------------eEEEEEeCCCCcHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee
Confidence 2 38999999999999987542 12358999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||+|+.+...... ......||+.|||||++.. ..++.++|||||||+|||
T Consensus 143 ~~~-------~~~Kl~DFGla~~~~~~~~~---------~~~~~~gt~~y~APE~~~~----~~~~~~sDvwS~Gvvl~e 202 (272)
T d1qpca_ 143 SDT-------LSCKIADFGLARLIEDNEYT---------AREGAKFPIKWTAPEAINY----GTFTIKSDVWSFGILLTE 202 (272)
T ss_dssp CTT-------SCEEECCCTTCEECSSSCEE---------CCTTCCCCTTTSCHHHHHH----CEECHHHHHHHHHHHHHH
T ss_pred ecc-------cceeeccccceEEccCCccc---------cccccCCcccccChHHHhC----CCCCchhhhhhhHHHHHH
Confidence 977 56999999999876542211 1233468999999999986 568999999999999999
Q ss_pred HHhC-CCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLTG-~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|+|| .+||...+..++...+..+.++..+.. .++.+.+||.+||+.||.+||
T Consensus 203 llt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~---------------------------~~~~l~~li~~cl~~~P~~Rp 255 (272)
T d1qpca_ 203 IVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN---------------------------CPEELYQLMRLCWKERPEDRP 255 (272)
T ss_dssp HHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT---------------------------CCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhCCCCCCCCCCHHHHHHHHHhcCCCCCccc---------------------------ChHHHHHHHHHHcCCCHhHCc
Confidence 9995 566677788888888887766554421 245789999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 003185 820 TAGDLYEMFVARTS 833 (840)
Q Consensus 820 Sa~ELLehLe~l~~ 833 (840)
|+++|++.|+.+-.
T Consensus 256 t~~ei~~~L~~~ft 269 (272)
T d1qpca_ 256 TFDYLRSVLEDFFT 269 (272)
T ss_dssp CHHHHHHHHHHHHH
T ss_pred CHHHHHHHhhhhhh
Confidence 99999999987643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=411.22 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=201.6
Q ss_pred ceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCC
Q 003185 507 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 584 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p 584 (840)
|++.++||+|+||+||+|.+. +..||+|++.... ......+ .+.+|+++|++|+|||||++++++.....
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~--~~~~~~~----~~~~E~~il~~l~HpnIv~~~~~~~~~~~-- 82 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSERQ----RFKEEAEMLKGLQHPNIVRFYDSWESTVK-- 82 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHH----HHHHHHHHHTTCCCTTBCCEEEEEEEESS--
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh--CCHHHHH----HHHHHHHHHHhCCCCCeeeEEEEEeeccc--
Confidence 378889999999999999984 5678888765432 2333333 34899999999999999999999875321
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCCCcEEEec
Q 003185 585 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILIDL 662 (840)
Q Consensus 585 ~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~g--IVHRDLKPeNILLd~ 662 (840)
.....||||||+++|+|.+++.+ ...+++..++.|+.||+.||+|||+++ ||||||||+||||+.
T Consensus 83 --------~~~~~~ivmE~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~ 149 (270)
T d1t4ha_ 83 --------GKKCIVLVTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG 149 (270)
T ss_dssp --------SCEEEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS
T ss_pred --------cCCEEEEEEeCCCCCcHHHHHhc-----cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC
Confidence 12357999999999999999986 356999999999999999999999998 999999999999964
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ .+.+||+|||+|+...... ....+||+.|||||++.+ .++.++|||||||+||||+
T Consensus 150 ~------~~~~Kl~DFGla~~~~~~~------------~~~~~GT~~Y~aPE~~~~-----~~~~~~DIwSlGvilyel~ 206 (270)
T d1t4ha_ 150 P------TGSVKIGDLGLATLKRASF------------AKAVIGTPEFMAPEMYEE-----KYDESVDVYAFGMCMLEMA 206 (270)
T ss_dssp T------TSCEEECCTTGGGGCCTTS------------BEESCSSCCCCCGGGGGT-----CCCTHHHHHHHHHHHHHHH
T ss_pred C------CCCEEEeecCcceeccCCc------------cCCcccCccccCHHHhCC-----CCCCcCchhhHHHHHHHHH
Confidence 3 1469999999997543321 123579999999999864 4899999999999999999
Q ss_pred hCCCCCCCCC-HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 743 TLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 743 TG~~PF~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
+|+.||.+.. ..++...+..+..+... ....++++.+||.+||+.||++|||+
T Consensus 207 ~g~~Pf~~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~dp~~R~s~ 260 (270)
T d1t4ha_ 207 TSEYPYSECQNAAQIYRRVTSGVKPASF--------------------------DKVAIPEVKEIIEGCIRQNKDERYSI 260 (270)
T ss_dssp HSSCTTTTCSSHHHHHHHHTTTCCCGGG--------------------------GGCCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred HCCCCCCCcccHHHHHHHHHcCCCCccc--------------------------CccCCHHHHHHHHHHccCCHhHCcCH
Confidence 9999997654 55556666554332111 11124578999999999999999999
Q ss_pred HHHHHHHH
Q 003185 822 GDLYEMFV 829 (840)
Q Consensus 822 ~ELLehLe 829 (840)
+||++|.+
T Consensus 261 ~ell~Hp~ 268 (270)
T d1t4ha_ 261 KDLLNHAF 268 (270)
T ss_dssp HHHHTSGG
T ss_pred HHHhCCcc
Confidence 99999853
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=411.75 Aligned_cols=263 Identities=21% Similarity=0.326 Sum_probs=207.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC------eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGS------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 575 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g 575 (840)
+....|++.+.||+|+||.||+|.+.. ..||||++... ....... .|.+|+.+|++|+|||||+++|
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~---~~~~~~~----~~~~E~~il~~l~H~nIv~~~g 76 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRV----DFLGEAGIMGQFSHHNIIRLEG 76 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT---CCHHHHH----HHHHHHHHHHTCCCTTBCCEEE
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc---cChHHHH----HHHHHHHHHHhcCCCCEeeeeE
Confidence 344679999999999999999998732 35888875422 2223333 3489999999999999999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCC
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 655 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKP 655 (840)
++..... .++||||+.+++|.+++.. ....+++..++.++.||+.||+|||+++|+||||||
T Consensus 77 ~~~~~~~--------------~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp 138 (283)
T d1mqba_ 77 VISKYKP--------------MMIITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAA 138 (283)
T ss_dssp EECSSSS--------------EEEEEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred EEecCCc--------------eEEEEEecccCcchhhhhc----ccccccHHHHHHHHHHHHHhhhhccccccccCcccc
Confidence 9986554 4999999999999998876 335799999999999999999999999999999999
Q ss_pred CcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003185 656 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735 (840)
Q Consensus 656 eNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLG 735 (840)
+||||+.+ +.+||+|||+|+.+....... .......||+.|||||++.+ ..++.++||||||
T Consensus 139 ~NILl~~~-------~~~Kl~DFGla~~~~~~~~~~-------~~~~~~~gt~~Y~APE~l~~----~~~~~~sDI~S~G 200 (283)
T d1mqba_ 139 RNILVNSN-------LVCKVSDFGLSRVLEDDPEAT-------YTTSGGKIPIRWTAPEAISY----RKFTSASDVWSFG 200 (283)
T ss_dssp GGEEECTT-------CCEEECCCCC------------------------CCCGGGSCHHHHHS----CCCCHHHHHHHHH
T ss_pred ceEEECCC-------CeEEEcccchhhcccCCCccc-------eEeccCCCCccccCHHHHcc----CCCCCcccccccH
Confidence 99999977 569999999998765432111 11123458999999999986 6789999999999
Q ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003185 736 CLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 814 (840)
Q Consensus 736 vIL~ELLTG-~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~D 814 (840)
|+||||+++ .+||...+..++...+..+.++..+.. .+..+.+||.+||+.|
T Consensus 201 vil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~---------------------------~~~~l~~li~~cl~~~ 253 (283)
T d1mqba_ 201 IVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD---------------------------CPSAIYQLMMQCWQQE 253 (283)
T ss_dssp HHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT---------------------------CBHHHHHHHHHHTCSS
T ss_pred HHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchh---------------------------hHHHHHHHHHHHCcCC
Confidence 999999995 555666778888888887766554421 2457899999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCC
Q 003185 815 PTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 815 P~eRPSa~ELLehLe~l~~~ 834 (840)
|.+|||+.+|++.|+.+.++
T Consensus 254 p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 254 RARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp TTTSCCHHHHHHHHHHHHHS
T ss_pred HhHCcCHHHHHHHHHHHhhC
Confidence 99999999999999988764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-48 Score=409.81 Aligned_cols=261 Identities=21% Similarity=0.316 Sum_probs=204.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC---CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEe
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 578 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~---~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~ 578 (840)
++.++|++.+.||+|+||.||+|.+. +..++|+++.++... .....+ .+.+|+.+|++++|||||+++|++.
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~----~~~~E~~~l~~l~HpnIv~l~~~~~ 78 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVRE----KFLQEALTMRQFDHPHIVKLIGVIT 78 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHH----HHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHH----HHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 44578999999999999999999873 233455554444322 222333 4499999999999999999999985
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
. .. .||||||+++|+|..++.. ....+++..++.++.||+.||.|||++|||||||||+||
T Consensus 79 ~-~~--------------~~iv~E~~~~g~l~~~~~~----~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NI 139 (273)
T d1mp8a_ 79 E-NP--------------VWIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNV 139 (273)
T ss_dssp S-SS--------------CEEEEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred c-Ce--------------EEEEEEeccCCcHHhhhhc----cCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhhe
Confidence 3 22 3999999999999998875 345689999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
|++.+ +.+||+|||+|+........ ......||+.|+|||++.+ ..++.++|||||||+|
T Consensus 140 ll~~~-------~~~Kl~DfG~a~~~~~~~~~---------~~~~~~gt~~y~apE~l~~----~~~~~~~DiwSlGvil 199 (273)
T d1mp8a_ 140 LVSSN-------DCVKLGDFGLSRYMEDSTYY---------KASKGKLPIKWMAPESINF----RRFTSASDVWMFGVCM 199 (273)
T ss_dssp EEEET-------TEEEECC----------------------------CCGGGCCHHHHHH----CCCSHHHHHHHHHHHH
T ss_pred eecCC-------CcEEEccchhheeccCCcce---------eccceecCcccchhhHhcc----CCCCCccccccchHHH
Confidence 99987 56999999999876432211 1223468999999999987 6789999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 739 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 739 ~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
|||+| |.+||.+.+..++...+..+.++.++. .+++.+.+||.+||..||.+
T Consensus 200 ~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~~~li~~cl~~dp~~ 252 (273)
T d1mp8a_ 200 WEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------------------NCPPTLYSLMTKCWAYDPSR 252 (273)
T ss_dssp HHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCHhH
Confidence 99998 899999999999998888876654442 12457999999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 003185 818 RPTAGDLYEMFVARTS 833 (840)
Q Consensus 818 RPSa~ELLehLe~l~~ 833 (840)
|||+.||+++|+.+.+
T Consensus 253 Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 253 RPRFTELKAQLSTILE 268 (273)
T ss_dssp SCCHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHH
Confidence 9999999999998753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=425.18 Aligned_cols=277 Identities=23% Similarity=0.310 Sum_probs=202.1
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
-++|++.+.||+|+||+||+|++ ++..||+|++..+. .... ..++.+|+.+|++++|||||+++++|....
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 77 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAI----RNQIIRELQVLHECNSPYIVGFYGAFYSDG 77 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTH----HHHHHHHGGGGGGCCCTTBCCEEEEEECSS
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh---CHHH----HHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 46899999999999999999998 57889999976432 1112 234589999999999999999999998665
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCCCcEEE
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILI 660 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs-~gIVHRDLKPeNILL 660 (840)
. .||||||++||+|.+++.+ ...+++..++.++.||+.||.|||+ +||+||||||+||||
T Consensus 78 ~--------------~~iVmEy~~gg~L~~~l~~-----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl 138 (322)
T d1s9ja_ 78 E--------------ISICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 138 (322)
T ss_dssp E--------------EEEEEECCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE
T ss_pred E--------------EEEEEEcCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE
Confidence 3 5999999999999999986 2569999999999999999999997 599999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||+|+.+.... ....+||+.|||||++.+ ..|+.++|||||||++||
T Consensus 139 ~~~-------~~vkl~DFGla~~~~~~~------------~~~~~GT~~Y~APEvl~~----~~y~~~~DiWSlGvil~e 195 (322)
T d1s9ja_ 139 NSR-------GEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYSVQSDIWSMGLSLVE 195 (322)
T ss_dssp CTT-------CCEEECCCCCCHHHHHHT------------C---CCSSCCCCHHHHHC----SCCCTTHHHHHHHHHHHH
T ss_pred CCC-------CCEEEeeCCCccccCCCc------------cccccCCccccCchHHcC----CCCCcHHHHHHHHHHHHH
Confidence 877 469999999998764321 133579999999999987 678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHc---CCCCCcchHHhhhccCccccccccCC-------------CCCCchhhhhhHHHHH
Q 003185 741 LLTLQVPYMGLSELEIHDLIQM---GKRPRLTDELEALGSCHEHEVAQSGS-------------GFEKPEAELETLSFLV 804 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~---~~~p~l~~~l~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~s~~L~ 804 (840)
|++|+.||.+.+..+....... +.....+................... ...........+.++.
T Consensus 196 ll~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 275 (322)
T d1s9ja_ 196 MAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 275 (322)
T ss_dssp HHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHH
T ss_pred HHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHH
Confidence 9999999987654332111110 00000000000000000000000000 0000000112356899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHH
Q 003185 805 DVFRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 805 dLI~rCL~~DP~eRPSa~ELLehLe 829 (840)
+||.+||.+||.+|||++|+++|..
T Consensus 276 dli~~~L~~dP~~R~ta~e~L~Hpf 300 (322)
T d1s9ja_ 276 DFVNKCLIKNPAERADLKQLMVHAF 300 (322)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHHHHcCCChhHCcCHHHHhhCHh
Confidence 9999999999999999999999844
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.8e-48 Score=427.61 Aligned_cols=256 Identities=21% Similarity=0.290 Sum_probs=212.9
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
.++.|++++.||+|+||.||+|.+ ++..||+|++.... .... ..+.+|+.+|++|+|||||++++++...
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~----~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 98 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDK----YTVKNEISIMNQLHHPKLINLHDAFEDK 98 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHH----HHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc----hhHH----HHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 457899999999999999999997 57889999865331 2222 2458999999999999999999999866
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .|||||||+||+|.+++.. ....+++..++.|+.||+.||+|||++|||||||||+||||
T Consensus 99 ~~--------------~~ivmE~~~gg~L~~~~~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl 160 (352)
T d1koba_ 99 YE--------------MVLILEFLSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMC 160 (352)
T ss_dssp SE--------------EEEEEECCCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CE--------------EEEEEEcCCCChHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccc
Confidence 53 5999999999999987753 23569999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+... .+.+||+|||+|+.+..... .....||+.|||||++.+ ..++.++|||||||+|||
T Consensus 161 ~~~~-----~~~vkL~DFGla~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvilye 220 (352)
T d1koba_ 161 ETKK-----ASSVKIIDFGLATKLNPDEI-----------VKVTTATAEFAAPEIVDR----EPVGFYTDMWAIGVLGYV 220 (352)
T ss_dssp SSTT-----CCCEEECCCTTCEECCTTSC-----------EEEECSSGGGCCHHHHTT----CCBCHHHHHHHHHHHHHH
T ss_pred cccC-----CCeEEEeecccceecCCCCc-----------eeeccCcccccCHHHHcC----CCCCCccchHHHHHHHHH
Confidence 8542 26799999999987654321 123469999999999986 678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|+||+.||.+.+..+++..+.....+.... .....++.+.+||.+||+.||.+|||
T Consensus 221 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dp~~R~s 276 (352)
T d1koba_ 221 LLSGLSPFAGEDDLETLQNVKRCDWEFDED------------------------AFSSVSPEAKDFIKNLLQKEPRKRLT 276 (352)
T ss_dssp HHHSCCSSCCSSHHHHHHHHHHCCCCCCSS------------------------TTTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCCcc------------------------cccCCCHHHHHHHHHHccCChhHCcC
Confidence 999999999999998888887764321111 11223568999999999999999999
Q ss_pred HHHHHHHH
Q 003185 821 AGDLYEMF 828 (840)
Q Consensus 821 a~ELLehL 828 (840)
++|+++|.
T Consensus 277 ~~eil~Hp 284 (352)
T d1koba_ 277 VHDALEHP 284 (352)
T ss_dssp HHHHHTST
T ss_pred HHHHhcCH
Confidence 99999984
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=421.44 Aligned_cols=261 Identities=25% Similarity=0.340 Sum_probs=204.6
Q ss_pred CCCCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceee
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 574 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~ 574 (840)
+.++|++.+.||+|+||+||+|++.+ ..||+|+..... .... ...+.+|+.+|.++ +|||||+++
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~----~~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSE----REALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc---CHHH----HHHHHHHHHHHHHhcCCCcEeEEE
Confidence 44689999999999999999999732 247777653221 1112 23458999999998 799999999
Q ss_pred eEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc------------------cCCCCCCHHHHHHHHHHH
Q 003185 575 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE------------------TGEKHVSVKLALFIAQDV 636 (840)
Q Consensus 575 g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~------------------~~~~~ls~~~~~~Ia~QI 636 (840)
+++.....+ |||||||++|+|.++|..... .....+++..++.++.||
T Consensus 108 ~~~~~~~~~--------------~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 173 (325)
T d1rjba_ 108 GACTLSGPI--------------YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 173 (325)
T ss_dssp EEECSSSSC--------------EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred EEEeeCCeE--------------EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHH
Confidence 999876654 999999999999999975211 112358899999999999
Q ss_pred HHHHHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhh
Q 003185 637 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 716 (840)
Q Consensus 637 a~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL 716 (840)
+.||+|||++|||||||||+|||++.+ +.+||+|||+|+......... ......||+.|||||++
T Consensus 174 ~~gl~yLH~~~IiHRDlKp~Nill~~~-------~~~Kl~DFGla~~~~~~~~~~--------~~~~~~gt~~y~aPE~l 238 (325)
T d1rjba_ 174 AKGMEFLEFKSCVHRDLAARNVLVTHG-------KVVKICDFGLARDIMSDSNYV--------VRGNARLPVKWMAPESL 238 (325)
T ss_dssp HHHHHHHHHTTEEETTCSGGGEEEETT-------TEEEECCCGGGSCGGGCTTSE--------EETTEEECGGGCCHHHH
T ss_pred HHHHHHHHhCCeeeccCchhccccccC-------CeEEEeeccccccccCCCcee--------eeccccCCCccCChHHH
Confidence 999999999999999999999999977 569999999998765432211 01234689999999999
Q ss_pred hcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHHcCCCCCcchHHhhhccCccccccccCCCCCCch
Q 003185 717 RAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 794 (840)
Q Consensus 717 ~~~~~~~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~ 794 (840)
.+ ..++.++|||||||+||||+| |..||.+.+..+.+ ..+..+.++..+.
T Consensus 239 ~~----~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~------------------------ 290 (325)
T d1rjba_ 239 FE----GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPF------------------------ 290 (325)
T ss_dssp HH----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCT------------------------
T ss_pred cC----CCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCC------------------------
Confidence 87 678999999999999999998 89999887655444 4444444443332
Q ss_pred hhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003185 795 AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 795 ~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~ 830 (840)
..++.+.+||.+||+.||.+|||++||++||..
T Consensus 291 ---~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 291 ---YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 124579999999999999999999999999964
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.6e-47 Score=407.99 Aligned_cols=264 Identities=25% Similarity=0.374 Sum_probs=219.6
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCC-ChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEec
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 579 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~-~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~ 579 (840)
.++|++.+.||+|+||+||+|++ ++..+|||++....... .....+...+++.+|+.+|++|+ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 57899999999999999999997 67899999976654332 33444556667899999999997 9999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .||||||++||+|.++|.. ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 82 ~~~--------------~~ivmE~~~~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nil 142 (277)
T d1phka_ 82 NTF--------------FFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL 142 (277)
T ss_dssp SSE--------------EEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred Ccc--------------eEEEEEcCCCchHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEE
Confidence 664 4999999999999999976 356999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc--CCCCCCchhhHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~--~~~~~s~kSDVWSLGvI 737 (840)
++.+ +.+||+|||+++.+..... .....||+.|+|||++.+.. ....++.++||||+||+
T Consensus 143 l~~~-------~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvi 204 (277)
T d1phka_ 143 LDDD-------MNIKLTDFGFSCQLDPGEK-----------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 204 (277)
T ss_dssp ECTT-------CCEEECCCTTCEECCTTCC-----------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHH
T ss_pred EcCC-------CCeEEccchheeEccCCCc-----------eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchh
Confidence 9877 5699999999987654221 13356999999999997532 22457899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
||||++|+.||.+.+...+...+..+....... .....++++.+||.+||+.||.+
T Consensus 205 lyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~~p~~ 260 (277)
T d1phka_ 205 MYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP------------------------EWDDYSDTVKDLVSRFLVVQPQK 260 (277)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT------------------------TGGGSCHHHHHHHHHHCCSSGGG
T ss_pred hhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc------------------------ccccCCHHHHHHHHHHccCChhH
Confidence 999999999999999888888887663321111 11234568999999999999999
Q ss_pred CCCHHHHHHHH
Q 003185 818 RPTAGDLYEMF 828 (840)
Q Consensus 818 RPSa~ELLehL 828 (840)
|||++||++|-
T Consensus 261 R~s~~eil~h~ 271 (277)
T d1phka_ 261 RYTAEEALAHP 271 (277)
T ss_dssp SCCHHHHTTSG
T ss_pred CcCHHHHHcCH
Confidence 99999999984
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=415.92 Aligned_cols=282 Identities=22% Similarity=0.223 Sum_probs=206.0
Q ss_pred eeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCCCC
Q 003185 509 SCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 586 (840)
Q Consensus 509 i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p~~ 586 (840)
.++.||+|+||+||+|++ .++.||||++....... ....+.+.+.+|+.+|++++|||||++++++.....+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~--- 75 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE---AKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI--- 75 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC---
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhh---hhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCce---
Confidence 568999999999999997 57789999865443221 1122334569999999999999999999999877654
Q ss_pred CCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEeccccc
Q 003185 587 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 666 (840)
Q Consensus 587 ~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~~~~ 666 (840)
||||||+.++++..++. ....+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 76 -----------~ivmE~~~~~~~~~~~~-----~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~--- 136 (299)
T d1ua2a_ 76 -----------SLVFDFMETDLEVIIKD-----NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN--- 136 (299)
T ss_dssp -----------EEEEECCSEEHHHHHTT-----CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---
T ss_pred -----------eehhhhhcchHHhhhhh-----cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCC---
Confidence 99999999876655543 24678999999999999999999999999999999999999877
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 003185 667 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 746 (840)
Q Consensus 667 ~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLTG~~ 746 (840)
+.+||+|||+|+........ ....+||+.|||||++.. ...++.++|||||||+||||+||.+
T Consensus 137 ----~~~KL~DFG~a~~~~~~~~~----------~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlGvil~el~~g~~ 199 (299)
T d1ua2a_ 137 ----GVLKLADFGLAKSFGSPNRA----------YTHQVVTRWYRAPELLFG---ARMYGVGVDMWAVGCILAELLLRVP 199 (299)
T ss_dssp ----CCEEECCCGGGSTTTSCCCC----------CCCSCCCCTTCCHHHHTT---CSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ----CccccccCccccccCCCccc----------ccceecChhhccHHHHcc---CCCCChhhhhhhcchHHHHHHhCcC
Confidence 46999999999765442211 233579999999999875 3567999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003185 747 PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 826 (840)
Q Consensus 747 PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLe 826 (840)
||.+.+..+.+..|.+.........+...........................++.+.+||.+||+.||.+||||+|+++
T Consensus 200 pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 200 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 99999888887777654211111111111000000000000111111122344678999999999999999999999999
Q ss_pred HHHhhc
Q 003185 827 MFVART 832 (840)
Q Consensus 827 hLe~l~ 832 (840)
|-+-..
T Consensus 280 Hp~f~~ 285 (299)
T d1ua2a_ 280 MKYFSN 285 (299)
T ss_dssp SGGGTS
T ss_pred CHhhCC
Confidence 955433
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=420.23 Aligned_cols=255 Identities=24% Similarity=0.324 Sum_probs=214.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
+.+++|++++.||+|+||.||+|+. .+..||+|++..... ........+.+|+.+|++++|||||++++++.+
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~-----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-----IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhc-----cCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence 4678999999999999999999997 578999999753321 111122345899999999999999999999997
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... +||||||++||+|..++.. ...+++..++.++.||+.||+|||++|||||||||+|||
T Consensus 77 ~~~--------------~~iv~ey~~gg~L~~~~~~-----~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIL 137 (337)
T d1o6la_ 77 HDR--------------LCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137 (337)
T ss_dssp SSE--------------EEEEEECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred ccc--------------cccceeccCCCchhhhhhc-----ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeE
Confidence 764 4999999999999999986 357899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+ +.+||+|||+|+........ ....+||+.|||||++.+ ..|+.++|||||||+||
T Consensus 138 l~~~-------g~vkl~DFG~a~~~~~~~~~----------~~~~~GT~~Y~aPE~~~~----~~y~~~~DiwSlGvily 196 (337)
T d1o6la_ 138 LDKD-------GHIKITDFGLCKEGISDGAT----------MKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMY 196 (337)
T ss_dssp ECTT-------SCEEECCCTTCBCSCCTTCC----------BCCCEECGGGCCGGGGSS----SCBCTTHHHHHHHHHHH
T ss_pred ecCC-------CCEEEeecccccccccCCcc----------cccceeCHHHhhhhhccC----CCCChhhcccchhhHHH
Confidence 9887 46999999999865432211 234579999999999986 67899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
||++|++||.+.+..++...+..... .++. ..++.+.+||.+||++||.+||
T Consensus 197 eml~G~~pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~dli~~~L~~dP~~R~ 248 (337)
T d1o6la_ 197 EMMCGRLPFYNQDHERLFELILMEEI-RFPR---------------------------TLSPEAKSLLAGLLKKDPKQRL 248 (337)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCC-CCCT---------------------------TSCHHHHHHHHHHTCSSTTTST
T ss_pred HHHHCCCCCCCcCHHHHHHHHhcCCC-CCCc---------------------------cCCHHHHHHHHhhccCCchhhc
Confidence 99999999999999888888876642 2221 1245789999999999999999
Q ss_pred C-----HHHHHHHHH
Q 003185 820 T-----AGDLYEMFV 829 (840)
Q Consensus 820 S-----a~ELLehLe 829 (840)
+ ++||++|..
T Consensus 249 ~~~~~~~~eil~Hp~ 263 (337)
T d1o6la_ 249 GGGPSDAKEVMEHRF 263 (337)
T ss_dssp TCSTTTHHHHHTSGG
T ss_pred ccccccHHHHHcCcc
Confidence 4 999999843
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=416.26 Aligned_cols=256 Identities=21% Similarity=0.260 Sum_probs=214.2
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
-+++|++++.||+|+||+||+|.+ ++..||+|++..+. .... .+.+|+.+|+.++|||||++++++.+.
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~----~~~~Ei~il~~l~HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQV----LVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHH----HHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-----ccHH----HHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 478999999999999999999997 57789999975431 2222 348999999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. +|||||||+||+|.++|.. ....+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 74 ~~--------------~~lvmE~~~gg~L~~~i~~----~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll 135 (321)
T d1tkia_ 74 EE--------------LVMIFEFISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIY 135 (321)
T ss_dssp TE--------------EEEEECCCCCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CE--------------EEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceee
Confidence 64 5999999999999999964 23469999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.++ ...+||+|||+++........ ....||+.|+|||.+.+ ..++.++|||||||+||+
T Consensus 136 ~~~~-----~~~ikl~DFG~~~~~~~~~~~-----------~~~~~t~~y~ape~~~~----~~~~~~~DiWSlGvily~ 195 (321)
T d1tkia_ 136 QTRR-----SSTIKIIEFGQARQLKPGDNF-----------RLLFTAPEYYAPEVHQH----DVVSTATDMWSLGTLVYV 195 (321)
T ss_dssp SSSS-----CCCEEECCCTTCEECCTTCEE-----------EEEESCGGGSCHHHHTT----CEECHHHHHHHHHHHHHH
T ss_pred cCCC-----ceEEEEcccchhhccccCCcc-----------cccccccccccchhccC----CCCCchhhcccHHHHHHH
Confidence 8653 367999999999876432211 23468999999999986 678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|++|..||.+.+..++...|.+......... ....++.+.+||.+||..||.+|||
T Consensus 196 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~~dp~~R~s 251 (321)
T d1tkia_ 196 LLSGINPFLAETNQQIIENIMNAEYTFDEEA------------------------FKEISIEAMDFVDRLLVKERKSRMT 251 (321)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH------------------------HTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCChhh------------------------ccCCCHHHHHHHHHHccCChhHCcC
Confidence 9999999999999999888887643222211 1123567899999999999999999
Q ss_pred HHHHHHHHH
Q 003185 821 AGDLYEMFV 829 (840)
Q Consensus 821 a~ELLehLe 829 (840)
++|+++|.+
T Consensus 252 ~~eil~hp~ 260 (321)
T d1tkia_ 252 ASEALQHPW 260 (321)
T ss_dssp HHHHHHSHH
T ss_pred HHHHhcCHh
Confidence 999999854
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-47 Score=414.41 Aligned_cols=250 Identities=24% Similarity=0.335 Sum_probs=211.4
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
++++|++++.||+|+||+||+|++ ++..||+|++..... ......+.+.+|+.+|++++|||||++++++.+.
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 76 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-----VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA 76 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc-----cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC
Confidence 467899999999999999999997 478999999753321 1112234558999999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .|+||||+.||+|..++.. ...+++..++.++.||+.||+|||++|||||||||+||||
T Consensus 77 ~~--------------~~ivmE~~~gg~l~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl 137 (316)
T d1fota_ 77 QQ--------------IFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL 137 (316)
T ss_dssp SE--------------EEEEECCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred Ce--------------eeeEeeecCCccccccccc-----cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE
Confidence 54 5999999999999999986 4678899999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||+|+...... ....||+.|||||++.+ ..++.++|||||||+|||
T Consensus 138 ~~~-------g~vkL~DFG~a~~~~~~~-------------~~~~Gt~~Y~APE~l~~----~~y~~~~DiwSlGvilye 193 (316)
T d1fota_ 138 DKN-------GHIKITDFGFAKYVPDVT-------------YTLCGTPDYIAPEVVST----KPYNKSIDWWSFGILIYE 193 (316)
T ss_dssp CTT-------SCEEECCCSSCEECSSCB-------------CCCCSCTTTCCHHHHTT----CCBCTTHHHHHHHHHHHH
T ss_pred cCC-------CCEEEecCccceEecccc-------------ccccCcccccCHHHHcC----CCCCchhhccccchhHHH
Confidence 877 459999999998764321 23579999999999986 678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP- 819 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP- 819 (840)
|+||+.||.+.+..++...+.++..+ ++. ..++.+.+||.+||..||.+||
T Consensus 194 mltG~~Pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~~li~~~L~~dp~~R~~ 245 (316)
T d1fota_ 194 MLAGYTPFYDSNTMKTYEKILNAELR-FPP---------------------------FFNEDVKDLLSRLITRDLSQRLG 245 (316)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHHCCCC-CCT---------------------------TSCHHHHHHHHHHTCSCTTTCTT
T ss_pred HHhCCCCCCCcCHHHHHHHHHcCCCC-CCC---------------------------CCCHHHHHHHHHHhhhCHHhccc
Confidence 99999999999999988888776331 221 1245789999999999999996
Q ss_pred ----CHHHHHHHH
Q 003185 820 ----TAGDLYEMF 828 (840)
Q Consensus 820 ----Sa~ELLehL 828 (840)
|+++|++|.
T Consensus 246 ~~r~t~~~il~Hp 258 (316)
T d1fota_ 246 NLQNGTEDVKNHP 258 (316)
T ss_dssp SSTTTTHHHHTSG
T ss_pred cchhhHHHHHcCc
Confidence 999999984
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5e-47 Score=402.41 Aligned_cols=266 Identities=24% Similarity=0.281 Sum_probs=208.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||.||+|.+ .++.||+|++..... ...... ..+.+|+.+|+.++|||||++++++.....
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~----~~~~~E~~~l~~~~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA-RDPSFY----LRFRREAQNAAALNHPAIVAVYDTGEAETP 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT-TCHHHH----HHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc-cCHHHH----HHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence 5699999999999999999997 588999999754322 122222 345999999999999999999999986542
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.....||||||++|++|..++.. ...+++..++.|+.||+.||+|||++|||||||||+||||+.
T Consensus 82 ----------~~~~~~lvmE~~~g~~L~~~~~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~ 146 (277)
T d1o6ya_ 82 ----------AGPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 146 (277)
T ss_dssp ----------SSEEEEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET
T ss_pred ----------CCceEEEEEECCCCCEehhhhcc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCc
Confidence 12346999999999999999876 356999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.++|+|||.+......... .......+||+.|||||++.+ ..++.++|||||||+||||+
T Consensus 147 ~-------~~~~l~d~~~~~~~~~~~~~-------~~~~~~~~Gt~~Y~aPE~~~~----~~~~~~~DiwSlGvilyell 208 (277)
T d1o6ya_ 147 T-------NAVKVMDFGIARAIADSGNS-------VTQTAAVIGTAQYLSPEQARG----DSVDARSDVYSLGCVLYEVL 208 (277)
T ss_dssp T-------SCEEECCCTTCEECC-----------------------TTCCHHHHTT----CCCCHHHHHHHHHHHHHHHH
T ss_pred c-------ccceeehhhhhhhhcccccc-------ccccccccCcccccCHHHHcC----CCCCcceecccchHHHHHHH
Confidence 7 45999999998765432211 111234579999999999986 67899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-CH
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-TA 821 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP-Sa 821 (840)
||++||.+.+..++...+.......... .....++.+.+||.+||+.||.+|| |+
T Consensus 209 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~s~~l~~li~~~L~~dp~~R~~sa 264 (277)
T d1o6ya_ 209 TGEPPFTGDSPVSVAYQHVREDPIPPSA------------------------RHEGLSADLDAVVLKALAKNPENRYQTA 264 (277)
T ss_dssp HSSCSCCCSSHHHHHHHHHHCCCCCGGG------------------------TSSSCCHHHHHHHHHHTCSSGGGSCSSH
T ss_pred hCCCCCCCcCHHHHHHHHHhcCCCCCch------------------------hccCCCHHHHHHHHHHccCCHhHCHhHH
Confidence 9999999998888777666543221110 0112356899999999999999999 89
Q ss_pred HHHHHHHHhhc
Q 003185 822 GDLYEMFVART 832 (840)
Q Consensus 822 ~ELLehLe~l~ 832 (840)
+++++.|..+.
T Consensus 265 ~~l~~~l~r~~ 275 (277)
T d1o6ya_ 265 AEMRADLVRVH 275 (277)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHh
Confidence 99999998764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-48 Score=407.81 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=210.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+++++|++.+.||+|+||.||+|.+++..||||++..+ ...+. +.+|+.+|++++|||||+++|++....
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~------~~~~~----~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND------ATAQA----FLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC------C--HH----HHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcH------HHHHH----HHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 56789999999999999999999999999999985321 12233 489999999999999999999986432
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. ..||||||+++|+|.++|.... ...+++..++.|+.||+.||.|||+++|+||||||+|||++
T Consensus 74 ~-------------~~~lv~ey~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~ 137 (262)
T d1byga_ 74 G-------------GLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS 137 (262)
T ss_dssp --------------CCEEEECCCTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred C-------------cEEEEEeccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheec
Confidence 1 2499999999999999997621 23589999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||
T Consensus 138 ~~-------~~~kl~dfg~s~~~~~~~-------------~~~~~~~~y~aPE~l~~----~~~t~~sDIwSfG~il~el 193 (262)
T d1byga_ 138 ED-------NVAKVSDFGLTKEASSTQ-------------DTGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEI 193 (262)
T ss_dssp TT-------SCEEECCCCC-------------------------CCTTTSCHHHHHH----CCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CCEeecccccceecCCCC-------------ccccccccCCChHHHhC----CCCChHHHHHhHHHHHHHH
Confidence 87 569999999998654322 22358899999999987 6789999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 742 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 742 LT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
+| |.+||...+..++...+.++.++.++.. .++.+.+||.+||..||.+|||
T Consensus 194 ~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~---------------------------~~~~~~~li~~cl~~dP~~Rps 246 (262)
T d1byga_ 194 YSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG---------------------------CPPAVYEVMKNCWHLDAAMRPS 246 (262)
T ss_dssp HTTSCCSCTTSCGGGHHHHHTTTCCCCCCTT---------------------------CCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHCCCCCCCCCCHHHHHHHHHcCCCCCCCcc---------------------------CCHHHHHHHHHHcccCHhHCcC
Confidence 98 7999999888899989888777665532 2457899999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 003185 821 AGDLYEMFVARTS 833 (840)
Q Consensus 821 a~ELLehLe~l~~ 833 (840)
+.+|+++|+.+.+
T Consensus 247 ~~~l~~~L~~i~~ 259 (262)
T d1byga_ 247 FLQLREQLEHIKT 259 (262)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHh
Confidence 9999999998754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=410.78 Aligned_cols=257 Identities=19% Similarity=0.313 Sum_probs=208.3
Q ss_pred CCceeeeeecccCceEEEEEEEC--Ce----eEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEe
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKFG--SA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 578 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~--~~----~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~ 578 (840)
.+|++++.||+|+||+||+|.+. +. .||+|..... ..... .+.+.+|+.+|++++|||||+++|++.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~---~~~~~----~~~~~~E~~~l~~l~HpnIv~l~g~~~ 81 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKA----NKEILDEAYVMASVDNPHVCRLLGICL 81 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CT----HHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc---cCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 56999999999999999999873 22 4677664321 11112 234599999999999999999999997
Q ss_pred cCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcE
Q 003185 579 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 658 (840)
Q Consensus 579 ~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNI 658 (840)
+.. .+++|||+.+|+|.+++.. ....+++..++.|+.||+.||+|||++|||||||||+||
T Consensus 82 ~~~---------------~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NI 142 (317)
T d1xkka_ 82 TST---------------VQLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNV 142 (317)
T ss_dssp SSS---------------EEEEEECCTTCBHHHHHHH----TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred cCC---------------eeEEEEeccCCcccccccc----cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcc
Confidence 543 3899999999999998876 346799999999999999999999999999999999999
Q ss_pred EEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003185 659 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 738 (840)
Q Consensus 659 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL 738 (840)
||+.+ +.+||+|||+|+........ .......||+.|||||++.+ ..++.++|||||||+|
T Consensus 143 ll~~~-------~~~kl~DFGla~~~~~~~~~--------~~~~~~~gt~~y~APE~l~~----~~~~~~sDvwS~Gvil 203 (317)
T d1xkka_ 143 LVKTP-------QHVKITDFGLAKLLGAEEKE--------YHAEGGKVPIKWMALESILH----RIYTHQSDVWSYGVTV 203 (317)
T ss_dssp EEEET-------TEEEECCCSHHHHTTTTCC----------------CCTTTSCHHHHHH----CCCCHHHHHHHHHHHH
T ss_pred eeCCC-------CCeEeeccccceeccccccc--------ccccccccCccccChHHHhc----CCCChhhhhhhHHHHH
Confidence 99987 56999999999876542221 11123468999999999987 6789999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 739 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 739 ~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
|||+| |.+||.+.+..++...+..+.++..+.. +++.+.+||.+||..||.+
T Consensus 204 ~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~---------------------------~~~~~~~li~~cl~~dP~~ 256 (317)
T d1xkka_ 204 WELMTFGSKPYDGIPASEISSILEKGERLPQPPI---------------------------CTIDVYMIMVKCWMIDADS 256 (317)
T ss_dssp HHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTT---------------------------BCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcc---------------------------cCHHHHHHHHHhCCCChhh
Confidence 99998 8999999888888888888766554421 2457899999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 003185 818 RPTAGDLYEMFVARTS 833 (840)
Q Consensus 818 RPSa~ELLehLe~l~~ 833 (840)
|||+.+|+++|+.+..
T Consensus 257 RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 257 RPKFRELIIEFSKMAR 272 (317)
T ss_dssp SCCHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHh
Confidence 9999999999987743
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.7e-47 Score=407.19 Aligned_cols=263 Identities=24% Similarity=0.375 Sum_probs=215.3
Q ss_pred CCCCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 575 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g 575 (840)
+-++|++.+.||+|+||+||+|++.+ ..||||++... ...... +++.+|+.+|++++||||+++++
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~---~~~~~~----~~~~~E~~il~~l~h~niv~~~~ 83 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQ----ADFQREAALMAEFDNPNIVKLLG 83 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT---CCHHHH----HHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh---cChHHH----HHHHHHHHHHHhcCCCCccccee
Confidence 45689999999999999999999743 67899985322 222233 34599999999999999999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-------------------cCCCCCCHHHHHHHHHHH
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------------TGEKHVSVKLALFIAQDV 636 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-------------------~~~~~ls~~~~~~Ia~QI 636 (840)
++...... ++||||+++|+|.+++..... .....+++..++.|+.||
T Consensus 84 ~~~~~~~~--------------~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 149 (301)
T d1lufa_ 84 VCAVGKPM--------------CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 149 (301)
T ss_dssp EECSSSSC--------------EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred eeccCCce--------------EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHH
Confidence 99876644 999999999999999975211 122458899999999999
Q ss_pred HHHHHHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhh
Q 003185 637 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 716 (840)
Q Consensus 637 a~AL~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL 716 (840)
+.||+|||+++||||||||+||||+.+ +.+||+|||+|+......... ......||+.|||||.+
T Consensus 150 ~~gl~ylH~~~ivHrDlKp~NILld~~-------~~~Kl~DFGls~~~~~~~~~~--------~~~~~~~~~~y~aPE~~ 214 (301)
T d1lufa_ 150 AAGMAYLSERKFVHRDLATRNCLVGEN-------MVVKIADFGLSRNIYSADYYK--------ADGNDAIPIRWMPPESI 214 (301)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEECGG-------GCEEECCCSCHHHHTGGGCBC------------CCBCGGGCCHHHH
T ss_pred HHHhhhcccCCeEeeEEcccceEECCC-------CcEEEccchhheeccCCcccc--------ccCCCCcCcCcCCHHHH
Confidence 999999999999999999999999987 569999999998664432211 12334689999999999
Q ss_pred hcccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchh
Q 003185 717 RAMHKPNLYGLEVDIWSYGCLLLELLTLQ-VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 795 (840)
Q Consensus 717 ~~~~~~~~~s~kSDVWSLGvIL~ELLTG~-~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~ 795 (840)
.+ ..++.++|||||||+||||++|. +||.+.+..++...+..+.++.++..
T Consensus 215 ~~----~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~------------------------ 266 (301)
T d1lufa_ 215 FY----NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPEN------------------------ 266 (301)
T ss_dssp HH----CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTT------------------------
T ss_pred cc----CCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCcc------------------------
Confidence 87 67899999999999999999985 68999999999999888776655432
Q ss_pred hhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 003185 796 ELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 832 (840)
Q Consensus 796 ~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~ 832 (840)
+++.+.+||.+||+.||.+||||.||++.|+.+.
T Consensus 267 ---~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 267 ---CPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 2457899999999999999999999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=410.66 Aligned_cols=267 Identities=25% Similarity=0.414 Sum_probs=215.4
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEE
Q 003185 501 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 577 (840)
Q Consensus 501 p~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~ 577 (840)
.+++++|++.+.||+|+||.||+|.+ .+..++||++.++.... ....+ .+.+|+.+|+++ +|||||+++|++
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~----~~~~E~~~l~~l~~HpnIv~~~~~~ 80 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHR----DFAGELEVLCKLGHHPNIINLLGAC 80 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------C----HHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC-hHHHH----HHHHHHHHHHhccCCCCEeeEEEEE
Confidence 37889999999999999999999997 44555555554443222 22233 349999999999 699999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHh-----------ccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS-----------ETGEKHVSVKLALFIAQDVAAALVELHSK 646 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~-----------~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~ 646 (840)
...+. ++|||||+++|+|.++|.... ......+++..++.++.||+.||.|||++
T Consensus 81 ~~~~~--------------~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~ 146 (309)
T d1fvra_ 81 EHRGY--------------LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 146 (309)
T ss_dssp EETTE--------------EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ecCCe--------------eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC
Confidence 87653 599999999999999997421 12346799999999999999999999999
Q ss_pred CeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCC
Q 003185 647 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 726 (840)
Q Consensus 647 gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s 726 (840)
|||||||||+|||++.+ +.+||+|||+|+....... .....||+.|+|||.+.+ ..++
T Consensus 147 ~iiHrDlkp~NIL~~~~-------~~~kl~DfG~a~~~~~~~~-----------~~~~~gt~~y~aPE~l~~----~~~~ 204 (309)
T d1fvra_ 147 QFIHRDLAARNILVGEN-------YVAKIADFGLSRGQEVYVK-----------KTMGRLPVRWMAIESLNY----SVYT 204 (309)
T ss_dssp TEECSCCSGGGEEECGG-------GCEEECCTTCEESSCEECC-----------C----CCTTTCCHHHHHH----CEEC
T ss_pred CccccccccceEEEcCC-------CceEEcccccccccccccc-----------ccceecCCcccchHHhcc----CCCC
Confidence 99999999999999987 4699999999976543221 123458999999999987 6789
Q ss_pred chhhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHH
Q 003185 727 LEVDIWSYGCLLLELLTLQ-VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 805 (840)
Q Consensus 727 ~kSDVWSLGvIL~ELLTG~-~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~d 805 (840)
.++|||||||++|||++|. +||.+.+..++...+..+.++..+.. .++.+.+
T Consensus 205 ~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~~~---------------------------~~~~~~~ 257 (309)
T d1fvra_ 205 TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN---------------------------CDDEVYD 257 (309)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTT---------------------------BCHHHHH
T ss_pred ccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCcc---------------------------CCHHHHH
Confidence 9999999999999999965 67888999999888887766554422 2457999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 003185 806 VFRRCTEENPTERPTAGDLYEMFVARTSSS 835 (840)
Q Consensus 806 LI~rCL~~DP~eRPSa~ELLehLe~l~~~~ 835 (840)
||.+||+.||++|||+.+|+++|+.+.+..
T Consensus 258 li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 258 LMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 999999999999999999999999887543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.2e-47 Score=415.47 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=212.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
..+++|++++.||+|+||.||+|++ ++..||+|++..... ......+.+.+|+.+|+.++|||||++++++..
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 112 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-----VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc-----cCHHHHHHHHHHHHHHHHcCCCcEeeccccccc
Confidence 4578999999999999999999997 478999999753211 111122345899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... .++||||+.+|+|..++.. ...+++..++.|+.||+.||.|||++|||||||||+|||
T Consensus 113 ~~~--------------~~~v~e~~~~g~l~~~l~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NIL 173 (350)
T d1rdqe_ 113 NSN--------------LYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173 (350)
T ss_dssp SSE--------------EEEEEECCTTCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred ccc--------------cccccccccccchhhhHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcc
Confidence 653 5999999999999999976 246999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
|+.+ +.+||+|||+|+.+.... ....||+.|||||++.+ ..++.++|||||||+||
T Consensus 174 l~~~-------g~ikL~DFG~a~~~~~~~-------------~~~~Gt~~Y~APE~~~~----~~~~~~~DiwSlGvily 229 (350)
T d1rdqe_ 174 IDQQ-------GYIQVTDFGFAKRVKGRT-------------WTLCGTPEALAPEIILS----KGYNKAVDWWALGVLIY 229 (350)
T ss_dssp ECTT-------SCEEECCCTTCEECSSCB-------------CCCEECGGGCCHHHHTT----CCBCTHHHHHHHHHHHH
T ss_pred cCCC-------CCEEeeeceeeeeccccc-------------ccccCccccCCHHHHcC----CCCCccccccchhHHHH
Confidence 9877 469999999998764321 23469999999999986 67899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
||+||+.||.+.+...+...+...... ++. ..++.+.+||.+||..||.+|+
T Consensus 230 emltG~~Pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~~li~~~L~~dP~kR~ 281 (350)
T d1rdqe_ 230 EMAAGYPPFFADQPIQIYEKIVSGKVR-FPS---------------------------HFSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCC-CCT---------------------------TCCHHHHHHHHHHSCSCTTTCT
T ss_pred HHHhCCCCCCCcCHHHHHHHHhcCCCC-CCc---------------------------cCCHHHHHHHHHHhhhCHHhcc
Confidence 999999999999998888888776432 111 1245789999999999999994
Q ss_pred -----CHHHHHHHHH
Q 003185 820 -----TAGDLYEMFV 829 (840)
Q Consensus 820 -----Sa~ELLehLe 829 (840)
|+++|++|.+
T Consensus 282 ~~~r~t~~ell~Hp~ 296 (350)
T d1rdqe_ 282 GNLKNGVNDIKNHKW 296 (350)
T ss_dssp TSSTTTTHHHHTSGG
T ss_pred ccccccHHHHHcCcc
Confidence 9999999844
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-47 Score=404.05 Aligned_cols=260 Identities=25% Similarity=0.353 Sum_probs=208.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
++.++|++.+.||+|+||.||+|++. +..||||++... ... .+. |.+|+.+|++++|||||+++|++...
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~--~~~---~~~----~~~E~~~l~~l~h~nIv~~~g~~~~~ 84 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMS---PEA----FLQEAQVMKKLRHEKLVQLYAVVSEE 84 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT--SSC---HHH----HHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc--cCC---HHH----HHHHHHHHHhcccCCEeEEEEEEecC
Confidence 56789999999999999999999984 457999985422 221 223 48999999999999999999998543
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
. .++||||+++|+|..++... ....+++..++.++.||+.||+|||++||+||||||+||||
T Consensus 85 ~---------------~~lv~Ey~~~g~l~~~~~~~---~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll 146 (285)
T d1fmka3 85 P---------------IYIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 146 (285)
T ss_dssp S---------------CEEEECCCTTCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred C---------------eEEEEEecCCCchhhhhhhc---ccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE
Confidence 2 39999999999999998652 12459999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +++||+|||+|+........ ......||+.|+|||++.. ..++.++|||||||+|||
T Consensus 147 ~~~-------~~~kl~DfGla~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~ksDI~S~Giil~e 206 (285)
T d1fmka3 147 GEN-------LVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTE 206 (285)
T ss_dssp CGG-------GCEEECCCCTTC-----------------------CCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHH
T ss_pred CCC-------CcEEEcccchhhhccCCCce---------eeccccccccccChHHHhC----CCCCcHHhhhcchHHHHH
Confidence 877 56999999999876432211 1223468999999999987 678999999999999999
Q ss_pred HHhC-CCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 741 LLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 741 LLTG-~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
|+|| .+||.+....++...+..+.++.++.. +++.+.+||.+||+.||++||
T Consensus 207 l~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~---------------------------~~~~l~~li~~cl~~dP~~Rp 259 (285)
T d1fmka3 207 LTTKGRVPYPGMVNREVLDQVERGYRMPCPPE---------------------------CPESLHDLMCQCWRKEPEERP 259 (285)
T ss_dssp HHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT---------------------------SCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcc---------------------------cCHHHHHHHHHHcccCHhHCc
Confidence 9995 555677778888888877755444421 245799999999999999999
Q ss_pred CHHHHHHHHHhhcCCC
Q 003185 820 TAGDLYEMFVARTSSS 835 (840)
Q Consensus 820 Sa~ELLehLe~l~~~~ 835 (840)
|+++|++.|+......
T Consensus 260 s~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 260 TFEYLQAFLEDYFTST 275 (285)
T ss_dssp CHHHHHHHHHTTTSCS
T ss_pred CHHHHHHHHhhhhcCC
Confidence 9999999998876544
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=403.78 Aligned_cols=267 Identities=23% Similarity=0.360 Sum_probs=202.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCccee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 573 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l 573 (840)
++.++|++.+.||+|+||.||+|.+. ++.||||+.. .. ......+. +.+|+.++.++ +|+|||.+
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~--~~-~~~~~~~~----~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK--EG-ATHSEHRA----LMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHH----HHHHHHHHHHHCCCTTBCCE
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEc--cc-cCcHHHHH----HHHHHHHHHhhcCCCeEEEe
Confidence 44578999999999999999999972 2568888743 21 12233333 47888888877 58999999
Q ss_pred eeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHH
Q 003185 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 642 (840)
Q Consensus 574 ~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-----------~~~~ls~~~~~~Ia~QIa~AL~y 642 (840)
++++..... ..++|||||++|+|.++|...... ....+++..++.++.||+.||+|
T Consensus 83 ~~~~~~~~~-------------~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~y 149 (299)
T d1ywna1 83 LGACTKPGG-------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 149 (299)
T ss_dssp EEEECSTTS-------------CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHH
T ss_pred eeeeccCCC-------------eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHH
Confidence 998875432 259999999999999999763211 12458999999999999999999
Q ss_pred HHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC
Q 003185 643 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 722 (840)
Q Consensus 643 LHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~ 722 (840)
||++|||||||||+||||+.+ +.+||+|||+|+........ .......||+.|||||++.+
T Consensus 150 lH~~~ivHrDlKp~NILl~~~-------~~~Kl~DFGla~~~~~~~~~--------~~~~~~~gt~~y~APE~l~~---- 210 (299)
T d1ywna1 150 LASRKCIHRDLAARNILLSEK-------NVVKICDFGLARDIYKDPDY--------VRKGDARLPLKWMAPETIFD---- 210 (299)
T ss_dssp HHHTTCCCSCCCGGGEEECGG-------GCEEECC------CCSCTTS--------CCTTSCCCGGGGCCHHHHHH----
T ss_pred HHhCCCcCCcCCccceeECCC-------CcEEEccCcchhhccccccc--------cccCceeeCccccchhHhhc----
Confidence 999999999999999999877 46999999999865432211 11234579999999999987
Q ss_pred CCCCchhhHHHHHHHHHHHHhC-CCCCCCCCH-HHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhH
Q 003185 723 NLYGLEVDIWSYGCLLLELLTL-QVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 800 (840)
Q Consensus 723 ~~~s~kSDVWSLGvIL~ELLTG-~~PF~~~~~-~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s 800 (840)
..++.++|||||||++|||+|| .+||.+... ..+...+..+.++.+++. .+
T Consensus 211 ~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~ 263 (299)
T d1ywna1 211 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY---------------------------TT 263 (299)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTT---------------------------CC
T ss_pred CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCcc---------------------------CC
Confidence 6789999999999999999996 567877653 445556666655544421 24
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 003185 801 SFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 801 ~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~~ 834 (840)
+.+.+||.+||+.||.+|||++||++||+.+.++
T Consensus 264 ~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 264 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 5789999999999999999999999999988643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=403.94 Aligned_cols=285 Identities=20% Similarity=0.257 Sum_probs=210.6
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+++|++++.||+|+||+||+|.+ .++.||+|++..... . +...+.+.+|+.+|++++|||||++++++.+..
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~----~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~ 74 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--T----EGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 74 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--C----hHHHHHHHHHHHHHHhCCCCcEEEecccccccc
Confidence 47899999999999999999998 478999999754321 1 122334589999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .||||||+.+ ++..++.. .....+++..++.++.||+.||+|||++|||||||||+|||++
T Consensus 75 ~--------------~~iv~e~~~~-~~~~~~~~---~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~ 136 (298)
T d1gz8a_ 75 K--------------LYLVFEFLHQ-DLKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN 136 (298)
T ss_dssp E--------------EEEEEECCSE-EHHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred c--------------eeEEEeecCC-chhhhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeec
Confidence 3 5999999975 66666544 2345699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ ..+||+|||+|+........ .....||+.|+|||++.. ...++.++|||||||++|+|
T Consensus 137 ~~-------~~~kl~DFG~a~~~~~~~~~----------~~~~~gt~~y~apE~~~~---~~~~~~~~DiwSlGvily~m 196 (298)
T d1gz8a_ 137 TE-------GAIKLADFGLARAFGVPVRT----------YTHEVVTLWYRAPEILLG---CKYYSTAVDIWSLGCIFAEM 196 (298)
T ss_dssp TT-------SCEEECSTTHHHHHCCCSBC----------TTCCBCCCTTCCHHHHTT---CSSCCTHHHHHHHHHHHHHH
T ss_pred cc-------CcceeccCCcceeccCCccc----------ceeecccceeeehhhhcc---ccCCCccccccccchhhhHH
Confidence 77 46999999999866432221 233479999999999875 34568999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCC---CchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE---KPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
++|+.||.+.+..+....+.+.........+....... .......... ........+..+++||.+||..||.+|
T Consensus 197 ~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R 274 (298)
T d1gz8a_ 197 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP--DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKR 274 (298)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST--TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTS
T ss_pred hhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc--ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHC
Confidence 99999999988877766665431111111111100000 0000000010 111223445789999999999999999
Q ss_pred CCHHHHHHH--HHhhcCC
Q 003185 819 PTAGDLYEM--FVARTSS 834 (840)
Q Consensus 819 PSa~ELLeh--Le~l~~~ 834 (840)
||++||++| |+.+..+
T Consensus 275 ~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 275 ISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp CCHHHHHTSGGGTTCCCC
T ss_pred cCHHHHhCCHhhccCCCC
Confidence 999999999 5444443
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=400.59 Aligned_cols=261 Identities=23% Similarity=0.329 Sum_probs=202.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC---C--eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeE
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG---S--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 576 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~---~--~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~ 576 (840)
+..++|++.+.||+|+||.||+|++. + ..||||++..... ...... +.|.+|+.+|++++|||||+++|+
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~-~~~~~~----~~~~~Ei~~l~~l~H~nIv~~~g~ 79 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAM----DDFIREVNAMHSLDHRNLIRLYGV 79 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHH----HHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc-CCHHHH----HHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34567999999999999999999862 2 3577776532221 112222 345999999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCC
Q 003185 577 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 656 (840)
Q Consensus 577 ~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPe 656 (840)
+.+. . .++||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 80 ~~~~-~--------------~~lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~ 140 (273)
T d1u46a_ 80 VLTP-P--------------MKMVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAAR 140 (273)
T ss_dssp ECSS-S--------------CEEEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred Eeec-c--------------hheeeeeecCcchhhhhhcc----cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHH
Confidence 9643 2 38999999999999988752 246999999999999999999999999999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 736 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGv 736 (840)
||||+.+ +.+||+|||+++.+........ ......||..|+|||++.+ ..++.++|||||||
T Consensus 141 NIll~~~-------~~vkl~DfGl~~~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~----~~~~~~~Di~S~Gv 202 (273)
T d1u46a_ 141 NLLLATR-------DLVKIGDFGLMRALPQNDDHYV-------MQEHRKVPFAWCAPESLKT----RTFSHASDTWMFGV 202 (273)
T ss_dssp GEEEEET-------TEEEECCCTTCEECCC-CCEEE-------C-----CCGGGCCHHHHHH----CEEEHHHHHHHHHH
T ss_pred Hhccccc-------cceeeccchhhhhcccCCCcce-------ecCccccCcccCCHHHHhC----CCCCcchhhhhhHH
Confidence 9999987 5699999999987654332211 1233458889999999987 67899999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003185 737 LLLELLT-LQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 814 (840)
Q Consensus 737 IL~ELLT-G~~PF~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~D 814 (840)
++|||+| |..||.+.+..++...+.+. .+++.+. ..+..+.+||.+||..|
T Consensus 203 il~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~d 255 (273)
T d1u46a_ 203 TLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE---------------------------DCPQDIYNVMVQCWAHK 255 (273)
T ss_dssp HHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCT---------------------------TCCHHHHHHHHHHTCSS
T ss_pred HHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcc---------------------------cccHHHHHHHHHHcCCC
Confidence 9999998 89999999999988887655 3332221 22457999999999999
Q ss_pred CCCCCCHHHHHHHHHhh
Q 003185 815 PTERPTAGDLYEMFVAR 831 (840)
Q Consensus 815 P~eRPSa~ELLehLe~l 831 (840)
|.+|||+.+|++.|+..
T Consensus 256 p~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 256 PEDRPTFVALRDFLLEA 272 (273)
T ss_dssp GGGSCCHHHHHHHHHHH
T ss_pred hhHCcCHHHHHHHHHhc
Confidence 99999999999998864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.1e-47 Score=417.60 Aligned_cols=257 Identities=20% Similarity=0.255 Sum_probs=201.8
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 580 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~ 580 (840)
++++|++.+.||+|+||.||+|++ ++..||+|++...... .............|+.+++.++|||||++++++...
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~--~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK--MKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 79 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH--HHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcc--hhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC
Confidence 578999999999999999999998 5788999997532210 011111111223457778888899999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .||||||++||+|.++|.+ ...+++..++.++.||+.||.|||++|||||||||+||||
T Consensus 80 ~~--------------~~ivmE~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl 140 (364)
T d1omwa3 80 DK--------------LSFILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 140 (364)
T ss_dssp SE--------------EEEEECCCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CE--------------EEEEEEecCCCcHHHHHHh-----cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE
Confidence 54 5999999999999999986 3568999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||+|+.+.... .....||+.|||||++.. ...++.++|||||||+|||
T Consensus 141 ~~~-------g~iKl~DFGla~~~~~~~------------~~~~~GT~~y~APE~~~~---~~~~~~~~DiwSlGvilye 198 (364)
T d1omwa3 141 DEH-------GHVRISDLGLACDFSKKK------------PHASVGTHGYMAPEVLQK---GVAYDSSADWFSLGCMLFK 198 (364)
T ss_dssp CSS-------SCEEECCCTTCEECSSSC------------CCSCCSCGGGCCHHHHST---TCCCCTHHHHHHHHHHHHH
T ss_pred cCC-------CcEEEeeeceeeecCCCc------------ccccccccccchhHHhhc---CCCCCcccchhHHHHHHHH
Confidence 877 469999999998664321 233479999999999964 2568999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCC--CCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGK--RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~--~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
|+||+.||.+.+............ .+.++ ...++.+.+||.+||..||.+|
T Consensus 199 mltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~s~~~~~li~~~L~~dP~~R 251 (364)
T d1omwa3 199 LLRGHSPFRQHKTKDKHEIDRMTLTMAVELP---------------------------DSFSPELRSLLEGLLQRDVNRR 251 (364)
T ss_dssp HHHSSCSSCSSCSSCHHHHHHHSSSCCCCCC---------------------------SSSCHHHHHHHHHHTCSSTTTS
T ss_pred HHhCCCCCCCCCHHHHHHHHHhcccCCCCCC---------------------------CCCCHHHHHHHHHHcccCHHHh
Confidence 999999998765433333222221 11111 1235579999999999999999
Q ss_pred CC-----HHHHHHHHH
Q 003185 819 PT-----AGDLYEMFV 829 (840)
Q Consensus 819 PS-----a~ELLehLe 829 (840)
|| |+||++|.+
T Consensus 252 ~t~~~~~a~eil~Hp~ 267 (364)
T d1omwa3 252 LGCLGRGAQEVKESPF 267 (364)
T ss_dssp TTTSSSTHHHHHTSGG
T ss_pred CCCcccCHHHHHcCcc
Confidence 99 799999854
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=402.02 Aligned_cols=265 Identities=24% Similarity=0.373 Sum_probs=212.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC---------eeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcc
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIV 571 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV 571 (840)
++.++|++++.||+|+||.||+|+..+ ..||||+...+ ........ +.+|+..+.++ +|||||
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~----~~~e~~~l~~~~~HpnIv 82 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSD----LISEMEMMKMIGKHKNII 82 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT---CCHHHHHH----HHHHHHHHHHHCCCTTBC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc---cChHHHHH----HHHHHHHHHHhcCCCeEE
Confidence 456899999999999999999998622 35788875322 22233333 48899999888 799999
Q ss_pred eeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----------cCCCCCCHHHHHHHHHHHHHHH
Q 003185 572 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAAL 640 (840)
Q Consensus 572 ~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----------~~~~~ls~~~~~~Ia~QIa~AL 640 (840)
++++++..+..+ ++||||+++|+|.++|..... .....+++..++.++.||+.||
T Consensus 83 ~~~~~~~~~~~~--------------~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al 148 (299)
T d1fgka_ 83 NLLGACTQDGPL--------------YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 148 (299)
T ss_dssp CEEEEECSSSSC--------------EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHH
T ss_pred ecccccccCCeE--------------EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHH
Confidence 999999876544 999999999999999975211 1235689999999999999999
Q ss_pred HHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003185 641 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720 (840)
Q Consensus 641 ~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~ 720 (840)
+|||+++||||||||+|||++.+ +.+||+|||+++........ .......||+.|+|||.+.+
T Consensus 149 ~ylH~~~ivHrDiKp~NiLl~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~l~~-- 211 (299)
T d1fgka_ 149 EYLASKKCIHRDLAARNVLVTED-------NVMKIADFGLARDIHHIDYY--------KKTTNGRLPVKWMAPEALFD-- 211 (299)
T ss_dssp HHHHHTTCCCSCCSGGGEEECTT-------CCEEECSTTCCCCGGGCCTT--------CCCTTSCCGGGGSCHHHHHH--
T ss_pred HHhhhCCEEeeeecccceeecCC-------CCeEeccchhhccccccccc--------cccccCCCChhhhhhhHhcC--
Confidence 99999999999999999999987 46999999999877543221 11234568999999999987
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhh
Q 003185 721 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 799 (840)
Q Consensus 721 ~~~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 799 (840)
..++.++|||||||+||||++ |.+||.+.+..++...+..+.++..+.. .
T Consensus 212 --~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p~~---------------------------~ 262 (299)
T d1fgka_ 212 --RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSN---------------------------C 262 (299)
T ss_dssp --CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSS---------------------------C
T ss_pred --CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCCCCCcc---------------------------c
Confidence 679999999999999999998 7999999999888888887766554421 2
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003185 800 LSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 833 (840)
Q Consensus 800 s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~ 833 (840)
++.+.+||.+||+.||.+|||+.||++.|+.+.+
T Consensus 263 ~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 263 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 4579999999999999999999999999998864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=400.95 Aligned_cols=284 Identities=21% Similarity=0.202 Sum_probs=208.4
Q ss_pred CCCceeeeeecccCceEEEEEEEC---CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC---CCCCcceeeeEE
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHK 577 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~---~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L---~HpNIV~l~g~~ 577 (840)
-++|+++++||+|+||+||+|++. ++.||+|++........ .. ..+.+|+.+|+.| +|||||++++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~--~~----~~~~~E~~~l~~l~~~~HpnIv~~~~~~ 79 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MP----LSTIREVAVLRHLETFEHPNVVRLFDVC 79 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS--CB----CTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch--HH----HHHHHHHHHHHHHhhcCCCCcceeeeee
Confidence 468999999999999999999973 56789999765432211 11 1236777777666 799999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
...... .....+++|||+.++.+..... .....+++..++.++.||+.||+|||++|||||||||+|
T Consensus 80 ~~~~~~---------~~~~~~~~~e~~~~~~~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~N 146 (305)
T d1blxa_ 80 TVSRTD---------RETKLTLVFEHVDQDLTTYLDK----VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 146 (305)
T ss_dssp EEEECS---------SEEEEEEEEECCSCBHHHHHHH----SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred cccccc---------cCceEEEEEEeccCCchhhhhh----ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccE
Confidence 754321 2346799999998766554433 234678999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
||++.. +.+||+|||+++....... .....||+.|||||++.+ ..++.++|||||||+
T Consensus 147 ILi~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~gT~~Y~APE~~~~----~~y~~~~DiwSlG~i 204 (305)
T d1blxa_ 147 ILVTSS-------GQIKLADFGLARIYSFQMA-----------LTSVVVTLWYRAPEVLLQ----SSYATPVDLWSVGCI 204 (305)
T ss_dssp EEECTT-------CCEEECSCCSCCCCCGGGG-----------GCCCCCCCTTCCHHHHTT----CCCCTHHHHHHHHHH
T ss_pred EEEcCC-------CCeeecchhhhhhhccccc-----------CCCcccChhhcCcchhcC----CCCChhehhhchHHH
Confidence 999877 4599999999876543221 133579999999999986 678999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 817 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~e 817 (840)
||||+||++||.+.+..+....+...........+..........+ ...............++.+.+||.+||++||.+
T Consensus 205 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~ 283 (305)
T d1blxa_ 205 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF-HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 283 (305)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGS-CCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTT
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhh-ccccccchhhccccCCHHHHHHHHHHCcCChhH
Confidence 9999999999999988887777655322211211111110000000 000111111122334678999999999999999
Q ss_pred CCCHHHHHHHHH
Q 003185 818 RPTAGDLYEMFV 829 (840)
Q Consensus 818 RPSa~ELLehLe 829 (840)
|||++|+++|.+
T Consensus 284 R~sa~e~L~Hpf 295 (305)
T d1blxa_ 284 RISAYSALSHPY 295 (305)
T ss_dssp SCCHHHHHTSGG
T ss_pred CcCHHHHhcChh
Confidence 999999999944
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=409.45 Aligned_cols=251 Identities=26% Similarity=0.341 Sum_probs=207.3
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHH-hCCCCCcceeeeEEecC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLG-ALRHSCIVEMYGHKISS 580 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~-~L~HpNIV~l~g~~~~~ 580 (840)
+++|++++.||+|+||+||+|++ .++.||||++..... ..+...+.+.+|+.++. .++|||||++++++.+.
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~-----~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~ 75 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-----LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 75 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhc-----cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC
Confidence 47899999999999999999998 678999999753321 01111223367777665 68999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 660 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILL 660 (840)
.. .||||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 76 ~~--------------~yivmEy~~~g~L~~~i~~-----~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~ 136 (320)
T d1xjda_ 76 EN--------------LFFVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 136 (320)
T ss_dssp SE--------------EEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred Cc--------------eeEEEeecCCCcHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee
Confidence 64 4999999999999999986 3568999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003185 661 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 740 (840)
Q Consensus 661 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~E 740 (840)
+.+ +.+||+|||+|+........ .....||+.|||||++.+ ..++.++|||||||++||
T Consensus 137 ~~~-------~~~kl~DFG~a~~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvilye 195 (320)
T d1xjda_ 137 DKD-------GHIKIADFGMCKENMLGDAK----------TNTFCGTPDYIAPEILLG----QKYNHSVDWWSFGVLLYE 195 (320)
T ss_dssp CTT-------SCEEECCCTTCBCCCCTTCC----------BCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHH
T ss_pred cCC-------Cceeccccchhhhccccccc----------ccccCCCCCcCCHHHHcC----CCCCchhhhhhhhHHHHH
Confidence 977 45999999999865432211 233579999999999986 678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003185 741 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 820 (840)
Q Consensus 741 LLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPS 820 (840)
|+||+.||.+.+..++...+..... .++. ..++.+.+||.+||..||.+|||
T Consensus 196 mltG~~PF~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~dli~~~L~~dP~~R~s 247 (320)
T d1xjda_ 196 MLIGQSPFHGQDEEELFHSIRMDNP-FYPR---------------------------WLEKEAKDLLVKLFVREPEKRLG 247 (320)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHCCC-CCCT---------------------------TSCHHHHHHHHHHSCSSGGGSBT
T ss_pred HHhCCCCCCCCCHHHHHHHHHcCCC-CCCc---------------------------cCCHHHHHHHHHhcccCCCCCcC
Confidence 9999999999999998888876532 2221 12457899999999999999999
Q ss_pred HH-HHHHH
Q 003185 821 AG-DLYEM 827 (840)
Q Consensus 821 a~-ELLeh 827 (840)
+. +|++|
T Consensus 248 ~~~~l~~h 255 (320)
T d1xjda_ 248 VRGDIRQH 255 (320)
T ss_dssp TBSCGGGS
T ss_pred HHHHHHhC
Confidence 95 78876
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=397.39 Aligned_cols=266 Identities=21% Similarity=0.329 Sum_probs=219.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 574 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~ 574 (840)
++.++|++.+.||+|+||.||+|.+. +..||||++. .. ....... .+.+|+.++++++|||||+++
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~--~~-~~~~~~~----~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EA-ASMRERI----EFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECC--TT-SCHHHHH----HHHHHHHHGGGCCCTTBCCEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEEC--cc-cChHHHH----HHHHHHHHHHHcCCCCEeeee
Confidence 55689999999999999999999874 3678999753 22 2223333 348999999999999999999
Q ss_pred eEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Q 003185 575 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----TGEKHVSVKLALFIAQDVAAALVELHSKHIM 649 (840)
Q Consensus 575 g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIV 649 (840)
|++...... ++||||+++|+|.+++..... .....+++..+..++.||+.||.|||+++|+
T Consensus 90 ~~~~~~~~~--------------~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~iv 155 (308)
T d1p4oa_ 90 GVVSQGQPT--------------LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 155 (308)
T ss_dssp EEECSSSSC--------------EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred eEEecCCce--------------eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence 999866544 999999999999999975321 1224578999999999999999999999999
Q ss_pred cccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchh
Q 003185 650 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 729 (840)
Q Consensus 650 HRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kS 729 (840)
||||||+||||+.+ +++||+|||+|+.......... .....||+.|+|||.+.+ ..++.++
T Consensus 156 HrDlk~~NiLld~~-------~~~Kl~DFGla~~~~~~~~~~~--------~~~~~~t~~y~aPe~l~~----~~~~~~~ 216 (308)
T d1p4oa_ 156 HRDLAARNCMVAED-------FTVKIGDFGMTRDIYETDYYRK--------GGKGLLPVRWMSPESLKD----GVFTTYS 216 (308)
T ss_dssp CSCCSGGGEEECTT-------CCEEECCTTCCCGGGGGGCEEG--------GGSSEECGGGCCHHHHHH----CCCCHHH
T ss_pred eceEcCCceeecCC-------ceEEEeecccceeccCCcceee--------ccceecccccCCHHHHcc----CCCCccc
Confidence 99999999999877 5699999999987654332211 122368999999999987 6789999
Q ss_pred hHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHH
Q 003185 730 DIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 808 (840)
Q Consensus 730 DVWSLGvIL~ELLTG-~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~ 808 (840)
|||||||+||||+|| .+||.+.+..++...+.++.++..+.. +++.+.+||.
T Consensus 217 Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~~---------------------------~~~~l~~li~ 269 (308)
T d1p4oa_ 217 DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN---------------------------CPDMLFELMR 269 (308)
T ss_dssp HHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTT---------------------------CCHHHHHHHH
T ss_pred ccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCccc---------------------------chHHHHHHHH
Confidence 999999999999998 588999999999998888766554422 2457999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhcCC
Q 003185 809 RCTEENPTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 809 rCL~~DP~eRPSa~ELLehLe~l~~~ 834 (840)
+||+.||.+|||+.+|+++|+...++
T Consensus 270 ~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 270 MCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp HHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 99999999999999999999987654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.8e-46 Score=395.92 Aligned_cols=281 Identities=19% Similarity=0.208 Sum_probs=207.9
Q ss_pred CCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
+++|++.++||+|+||+||+|++ .+..||||++..... . +...+++.+|+.+|++++|||||++++++...+.
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~--~----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 74 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--D----EGIPSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG--G----GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred CCCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc--C----hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence 57999999999999999999998 468899999754421 1 1122345899999999999999999999997764
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
.+++|||+.++.+..+... ...+++..++.++.||+.||+|||++|||||||||+||||+.
T Consensus 75 --------------~~i~~e~~~~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~ 135 (286)
T d1ob3a_ 75 --------------LVLVFEHLDQDLKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR 135 (286)
T ss_dssp --------------EEEEEECCSEEHHHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred --------------eeEEEEeehhhhHHHHHhh-----cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcC
Confidence 4999999987655555432 467999999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||+|......... .....|++.|+|||.+.+ ...++.++|||||||++|||+
T Consensus 136 ~-------~~~kl~DfG~a~~~~~~~~~----------~~~~~~~~~y~~pE~~~~---~~~~~~~~DiwslGv~l~el~ 195 (286)
T d1ob3a_ 136 E-------GELKIADFGLARAFGIPVRK----------YTHEIVTLWYRAPDVLMG---SKKYSTTIDIWSVGCIFAEMV 195 (286)
T ss_dssp T-------SCEEECCTTHHHHHCC-------------------CCCTTCCHHHHTT---CCSCCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEecccccceecccCccc----------cceecccchhhhHHHHhC---CCCCCcceeehhcCcHHHHHH
Confidence 7 45999999999876443211 233468999999999975 356789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcccc-ccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE-VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
+|+.||.+.+..+....+...........+.......... .................++.+.+||.+||++||++|||+
T Consensus 196 ~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~ 275 (286)
T d1ob3a_ 196 NGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275 (286)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCH
Confidence 9999999988877776665431111111111111100000 000000111112223346789999999999999999999
Q ss_pred HHHHHHHH
Q 003185 822 GDLYEMFV 829 (840)
Q Consensus 822 ~ELLehLe 829 (840)
+|+++|.+
T Consensus 276 ~ell~Hp~ 283 (286)
T d1ob3a_ 276 KQALEHAY 283 (286)
T ss_dssp HHHHTSGG
T ss_pred HHHhcCcc
Confidence 99998853
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=408.16 Aligned_cols=263 Identities=22% Similarity=0.232 Sum_probs=202.1
Q ss_pred CCCCCceeee-eecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeEE
Q 003185 502 GSFPSLSSCD-EAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 577 (840)
Q Consensus 502 ~~~~~y~i~~-~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l~g~~ 577 (840)
..+++|.+.. .||+|+||+||+|++ ++..||+|++... . .+.+|+.++.++ +|||||+++++|
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~----~~~~E~~~~~~~~~hpnIv~l~~~~ 74 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------P----KARREVELHWRASQCPHIVRIVDVY 74 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------H----HHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---------H----HHHHHHHHHHHhcCCCCCCeEEEEE
Confidence 3478999875 599999999999997 5789999986421 1 237899987655 799999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCc
Q 003185 578 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 657 (840)
Q Consensus 578 ~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeN 657 (840)
.+... ....+|||||||+||+|.++|.+ .+...+++..++.|+.||+.||+|||++||+||||||+|
T Consensus 75 ~~~~~----------~~~~~~ivmEy~~gg~L~~~i~~---~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~N 141 (335)
T d2ozaa1 75 ENLYA----------GRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 141 (335)
T ss_dssp EEEET----------TEEEEEEEEECCCSEEHHHHHHS---CSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred eeccc----------CCCEEEEEEECCCCCcHHHHHHh---cCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccc
Confidence 75211 12357999999999999999975 233579999999999999999999999999999999999
Q ss_pred EEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003185 658 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 737 (840)
Q Consensus 658 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvI 737 (840)
||++... ..+.+||+|||+|+....... .....||+.|||||++.+ ..|+.++|||||||+
T Consensus 142 Ill~~~~----~~~~~Kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~y~~~~DiwSlGvi 202 (335)
T d2ozaa1 142 LLYTSKR----PNAILKLTDFGFAKETTSHNS-----------LTTPCYTPYYVAPEVLGP----EKYDKSCDMWSLGVI 202 (335)
T ss_dssp EEESCSS----TTCCEEECCCTTCEECCCCCC-----------CCCCSCCCSSCCCCCCCG----GGGSHHHHHHHHHHH
T ss_pred ccccccc----ccccccccccceeeeccCCCc-----------cccccCCcccCCcHHHcC----CCCCHHHHHHhhchh
Confidence 9998653 236799999999987644221 133579999999999986 568999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003185 738 LLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 816 (840)
Q Consensus 738 L~ELLTG~~PF~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~ 816 (840)
||+|+||++||.+.+.......+.... ..... + ........++.+.+||.+||+.||.
T Consensus 203 ly~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~--------------------~-~~~~~~~~s~~~~~li~~~L~~dP~ 261 (335)
T d2ozaa1 203 MYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE--------------------F-PNPEWSEVSEEVKMLIRNLLKTEPT 261 (335)
T ss_dssp HHHHTTSSCSCEETTCC--------CCCSCSSS--------------------C-CTTHHHHSCHHHHHHHHHHSCSSTT
T ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC--------------------C-CCcccccCCHHHHHHHHHHccCChh
Confidence 999999999998765544443332221 00000 0 0112234567899999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 003185 817 ERPTAGDLYEMFVA 830 (840)
Q Consensus 817 eRPSa~ELLehLe~ 830 (840)
+|||+.|+++|.+-
T Consensus 262 ~R~s~~eil~hp~~ 275 (335)
T d2ozaa1 262 QRMTITEFMNHPWI 275 (335)
T ss_dssp TSCCHHHHHHSHHH
T ss_pred HCcCHHHHHcCHHh
Confidence 99999999998543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-45 Score=393.69 Aligned_cols=262 Identities=23% Similarity=0.339 Sum_probs=204.6
Q ss_pred eeeeeecccCceEEEEEEECC---e--eEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 508 SSCDEAGKSVSSSLFRCKFGS---A--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 508 ~i~~~LG~G~fG~Vy~a~~~~---~--~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
.+.++||+|+||+||+|.+.. + .||||.+ +.. ......+.| .+|+.+|++++|||||+++|++.....
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~--~~~-~~~~~~~~~----~~E~~~l~~l~HpnIv~~~g~~~~~~~ 102 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRI-TDIGEVSQF----LTEGIIMKDFSHPNVLSLLGICLRSEG 102 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEE--CCC-CCHHHHHHH----HHHHHHHHTCCCTTBCCCCEEEEETTT
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEE--Ccc-cCHHHHHHH----HHHHHHHHhCCCCCEeEEeEEEEecCC
Confidence 346789999999999999732 2 4666664 322 233344444 999999999999999999999875331
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
..++|||||++|+|.+++.. ....+++..++.++.||+.||.|||+.+|+||||||+||||+.
T Consensus 103 -------------~~~lv~E~~~~g~l~~~~~~----~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~ 165 (311)
T d1r0pa_ 103 -------------SPLVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE 165 (311)
T ss_dssp -------------EEEEEEECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred -------------ceEEEEEEeecCchhhhhcc----ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECC
Confidence 35999999999999999874 3346778899999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||+++......... ........||+.|+|||.+.. ..++.++||||||++||||+
T Consensus 166 ~-------~~~kL~DFG~~~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDI~SfGivl~El~ 228 (311)
T d1r0pa_ 166 K-------FTVKVADFGLARDMYDKEFDS------VHNKTGAKLPVKWMALESLQT----QKFTTKSDVWSFGVLLWELM 228 (311)
T ss_dssp T-------CCEEECSSGGGCCTTTTTCCC------TTCTTCSSCCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEecccchhhcccccccc------ceecccccccccccChHHHhc----CCCCChhHhhhhHHHHHHHH
Confidence 6 569999999998765432211 111233568999999999987 67899999999999999999
Q ss_pred hCCCCCCC-CCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003185 743 TLQVPYMG-LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 821 (840)
Q Consensus 743 TG~~PF~~-~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa 821 (840)
||..||.. .+..++...+..+.++..+.. +++.+.+||.+||+.||.+||++
T Consensus 229 t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~---------------------------~~~~l~~li~~cl~~dP~~RPs~ 281 (311)
T d1r0pa_ 229 TRGAPPYPDVNTFDITVYLLQGRRLLQPEY---------------------------CPDPLYEVMLKCWHPKAEMRPSF 281 (311)
T ss_dssp TTSCCSCC------CHHHHHTTCCCCCCTT---------------------------CCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HCCCCCCCCCCHHHHHHHHHcCCCCCCccc---------------------------CcHHHHHHHHHHcCCCHhHCcCH
Confidence 97777654 455566677777766544421 24578999999999999999999
Q ss_pred HHHHHHHHhhcCCCCC
Q 003185 822 GDLYEMFVARTSSSIS 837 (840)
Q Consensus 822 ~ELLehLe~l~~~~~s 837 (840)
.||+++|+.+.++...
T Consensus 282 ~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 282 SELVSRISAIFSTFIG 297 (311)
T ss_dssp HHHHHHHHHHHHTCCS
T ss_pred HHHHHHHHHHHHhhhh
Confidence 9999999999876443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-45 Score=393.78 Aligned_cols=266 Identities=24% Similarity=0.368 Sum_probs=211.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCccee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 573 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L-~HpNIV~l 573 (840)
++.++|++.+.||+|+||.||+|++ .+..||||++... ....... .+.+|+.+++++ +|||||++
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~---~~~~~~~----~~~~E~~~~~~l~~HpnIv~~ 92 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS---AHLTERE----ALMSELKVLSYLGNHMNIVNL 92 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHH----HHHHHHHHHHHHCCCTTBCCE
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc---cCHHHHH----HHHHHHHHHHhccCCCCEEEE
Confidence 4557999999999999999999986 2357899886432 1223333 348999999999 59999999
Q ss_pred eeEEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhc-------------cCCCCCCHHHHHHHHHHHHHHH
Q 003185 574 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------TGEKHVSVKLALFIAQDVAAAL 640 (840)
Q Consensus 574 ~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-------------~~~~~ls~~~~~~Ia~QIa~AL 640 (840)
++++...... +||||||++|+|.+++..... .....+++..++.++.||+.||
T Consensus 93 ~g~~~~~~~~--------------~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl 158 (311)
T d1t46a_ 93 LGACTIGGPT--------------LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158 (311)
T ss_dssp EEEECSSSSC--------------EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHH
T ss_pred EEEEeeCCEE--------------EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHH
Confidence 9999876544 999999999999999986321 1234689999999999999999
Q ss_pred HHHHhCCeecccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003185 641 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 720 (840)
Q Consensus 641 ~yLHs~gIVHRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~ 720 (840)
+|||++|||||||||+|||++.+ +.+||+|||+++......... ......||+.|+|||++..
T Consensus 159 ~~LH~~~ivHrDLKp~NIl~~~~-------~~~ki~DfG~~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-- 221 (311)
T d1t46a_ 159 AFLASKNCIHRDLAARNILLTHG-------RITKICDFGLARDIKNDSNYV--------VKGNARLPVKWMAPESIFN-- 221 (311)
T ss_dssp HHHHHTTCCCSCCSGGGEEEETT-------TEEEECCCGGGSCTTSCTTSE--------ECSSSEECGGGCCHHHHHH--
T ss_pred HHHHhCCeeeccccccccccccc-------CcccccccchheeccCCCcce--------EeeecccChHHcCHHHhcC--
Confidence 99999999999999999999877 569999999998765432211 1234578999999999987
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH-HHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhh
Q 003185 721 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 798 (840)
Q Consensus 721 ~~~~~s~kSDVWSLGvIL~ELLT-G~~PF~~~~~~el-~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 798 (840)
..++.++|||||||+||||+| |.+||.+.+..+. ...+..+.++..+..
T Consensus 222 --~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~--------------------------- 272 (311)
T d1t46a_ 222 --CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEH--------------------------- 272 (311)
T ss_dssp --CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTT---------------------------
T ss_pred --CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCccc---------------------------
Confidence 678999999999999999999 6666766665444 444555554443321
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 003185 799 TLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 834 (840)
Q Consensus 799 ~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~~ 834 (840)
.+..+.+||.+||+.||.+|||+++|++.|+++.+.
T Consensus 273 ~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 273 APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 245799999999999999999999999999987654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-45 Score=391.25 Aligned_cols=301 Identities=17% Similarity=0.195 Sum_probs=210.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEec
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 579 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~ 579 (840)
.++++|++.++||+|+||+||+|++ .++.||||++...... . .+..++.+|+.+|++++||||+++++++..
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~----~~~~~~~~E~~il~~l~h~nii~~~~~~~~ 80 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--E----GFPITALREIKILQLLKHENVVNLIEICRT 80 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT--T----SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--h----HHHHHHHHHHHHHHHhcCCCccceEeeeec
Confidence 4579999999999999999999998 5789999986544321 1 222345899999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
.... ......+.|+||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 81 ~~~~------~~~~~~~~~iv~e~~~~~~~~~~~~-----~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NIL 149 (318)
T d3blha1 81 KASP------YNRCKGSIYLVFDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVL 149 (318)
T ss_dssp ----------------CEEEEEECCCEEHHHHHTC-----TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred cccc------ccccCceEEEEEeccCCCccchhhh-----cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchhee
Confidence 4321 0011235799999998765554332 3467899999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
|+.+ +.+||+|||+++.+....... .......+||+.|+|||++.+ ...++.++|||||||++|
T Consensus 150 l~~~-------~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~gT~~Y~aPE~~~~---~~~~~~k~DiwSlGvil~ 213 (318)
T d3blha1 150 ITRD-------GVLKLADFGLARAFSLAKNSQ------PNRYTNRVVTLWYRPPELLLG---ERDYGPPIDLWGAGCIMA 213 (318)
T ss_dssp ECTT-------SCEEECCCTTCEECCC-----------CCCCCSCCSCGGGCCHHHHTT---CSSCCTHHHHHHHHHHHH
T ss_pred ecCC-------CcEEeeecceeeecccccccc------cccccceecCHHHhhHHHHcC---CCCCCcHHHcccCCceee
Confidence 9977 469999999998765432211 112234579999999999975 246889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCc----hhhhhhHHHHHHHHHHhcccCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP----EAELETLSFLVDVFRRCTEENP 815 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~----~~~~~~s~~L~dLI~rCL~~DP 815 (840)
||++|+.||.+.+.......+........++....................... ......++.+++||.+||++||
T Consensus 214 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP 293 (318)
T d3blha1 214 EMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 293 (318)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSST
T ss_pred eHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCCh
Confidence 999999999998887777666553221111111111000000000000000000 0112234578899999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCC
Q 003185 816 TERPTAGDLYEMFVARTSSS 835 (840)
Q Consensus 816 ~eRPSa~ELLehLe~l~~~~ 835 (840)
++|||++|+++|.+-...+.
T Consensus 294 ~~R~sa~elL~Hpff~~~p~ 313 (318)
T d3blha1 294 AQRIDSDDALNHDFFWSDPM 313 (318)
T ss_dssp TTSCCHHHHHHSGGGSSSSC
T ss_pred hHCcCHHHHHcChhhccCCC
Confidence 99999999999977654433
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=395.23 Aligned_cols=280 Identities=19% Similarity=0.224 Sum_probs=205.6
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|+++++||+|+||+||+|.+ ++..||||++.. ........ +.+.+|+.+|++++|||||+++++|...+.
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~--~~~~~~~~----~~~~~Ei~il~~l~hpniv~l~~~~~~~~~ 91 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--PFQSELFA----KRAYRELRLLKHMRHENVIGLLDVFTPDET 91 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSS--TTSSHHHH----HHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEch--hhcChHHH----HHHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence 5899999999999999999997 478899999642 22233333 345899999999999999999999986653
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
. ....+.||||||+ +.+|..+++. ..+++..++.++.||+.||+|||++|||||||||+|||++.
T Consensus 92 ~--------~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~ 156 (346)
T d1cm8a_ 92 L--------DDFTDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE 156 (346)
T ss_dssp T--------TTCCCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred c--------cccceEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccc
Confidence 2 1233569999999 5688888765 56999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||+|+...... ....||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 157 ~-------~~~kl~Dfg~a~~~~~~~-------------~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlGvil~ell 213 (346)
T d1cm8a_ 157 D-------CELKILDFGLARQADSEM-------------TGYVVTRWYRAPEVILN---WMRYTQTVDIWSVGCIMAEMI 213 (346)
T ss_dssp T-------CCEEECCCTTCEECCSSC-------------CSSCSCGGGCCTHHHHT---TTCCCTTHHHHHHHHHHHHHH
T ss_pred c-------cccccccccceeccCCcc-------------ccccccccccCHHHHcC---CCCCCccchhhcchHHHHHHH
Confidence 7 459999999998664321 23469999999999975 245789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccC---CCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG---SGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|+.||.+.+.......+...........+............... ............++.+.+||.+||.+||.+||
T Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ 293 (346)
T d1cm8a_ 214 TGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293 (346)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC
T ss_pred HCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCc
Confidence 999999998887776666554222222211111000000000000 00111112233466889999999999999999
Q ss_pred CHHHHHHHH
Q 003185 820 TAGDLYEMF 828 (840)
Q Consensus 820 Sa~ELLehL 828 (840)
|++|||+|.
T Consensus 294 ta~eiL~Hp 302 (346)
T d1cm8a_ 294 TAGEALAHP 302 (346)
T ss_dssp CHHHHHHSG
T ss_pred CHHHHhcCh
Confidence 999999993
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=389.58 Aligned_cols=269 Identities=25% Similarity=0.278 Sum_probs=202.1
Q ss_pred CCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 584 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~p 584 (840)
.+|.+.+.||+|+||.||+|++++..||||++... ..+.+ ....|+..+..++|||||++++++.....
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~-------~~~~~--~~e~ei~~~~~~~HpnIv~~~~~~~~~~~-- 71 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-------EERSW--FREAEIYQTVMLRHENILGFIAADNKDNG-- 71 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGG-------GHHHH--HHHHHHHTSTTCCCTTBCCEEEEEEEECS--
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc-------chhHH--HHHHHHHHHhhCCCCcCcceEEEEEeCCC--
Confidence 36889999999999999999999999999986432 11222 11345566677899999999999986542
Q ss_pred CCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCeecccCCCC
Q 003185 585 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS--------KHIMHRDIKSE 656 (840)
Q Consensus 585 ~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs--------~gIVHRDLKPe 656 (840)
....+||||||+++|+|..+|++ ..+++..++.++.|++.||.|||. +|||||||||+
T Consensus 72 --------~~~~~~lv~Ey~~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~ 137 (303)
T d1vjya_ 72 --------TWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 137 (303)
T ss_dssp --------SSEEEEEEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGG
T ss_pred --------cceEEEEEEecccCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCcc
Confidence 23357999999999999999986 468999999999999999999996 59999999999
Q ss_pred cEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC--CCCCchhhHHHH
Q 003185 657 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP--NLYGLEVDIWSY 734 (840)
Q Consensus 657 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~--~~~s~kSDVWSL 734 (840)
||||+.+ +.+||+|||+++.......... .......||+.|||||++.+.... ..++.++|||||
T Consensus 138 NILl~~~-------~~~Kl~DFGl~~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~ 204 (303)
T d1vjya_ 138 NILVKKN-------GTCCIADLGLAVRHDSATDTID------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204 (303)
T ss_dssp GEEECTT-------SCEEECCCTTCEEEETTTTEEC------C----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred ceEEcCC-------CCeEEEecCccccccCCCccee------ccccceecccCcCChhhccccccccCCCcCcchhhhhh
Confidence 9999877 5699999999987755332211 112345799999999998752211 125789999999
Q ss_pred HHHHHHHHhCCCCCCCCC---------------HHHHHHHHHcC-CCCCcchHHhhhccCccccccccCCCCCCchhhhh
Q 003185 735 GCLLLELLTLQVPYMGLS---------------ELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 798 (840)
Q Consensus 735 GvIL~ELLTG~~PF~~~~---------------~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 798 (840)
||+||||+||..||.... ...+...+... .+|.++.. ....+
T Consensus 205 Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~----------------------~~~~~ 262 (303)
T d1vjya_ 205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR----------------------WQSCE 262 (303)
T ss_dssp HHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG----------------------GGGCH
T ss_pred HHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcc----------------------cCChH
Confidence 999999999988874321 11222222211 22222211 11233
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003185 799 TLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 833 (840)
Q Consensus 799 ~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe~l~~ 833 (840)
....+.+|+.+||+.||.+|||+.||+++|+.+..
T Consensus 263 ~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 263 ALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 45679999999999999999999999999998764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=390.60 Aligned_cols=249 Identities=22% Similarity=0.249 Sum_probs=196.8
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC--CCCcceeeeEEecC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISS 580 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~--HpNIV~l~g~~~~~ 580 (840)
++|++.+.||+|+||+||+|++ ++..||+|++.......... . ....++.+|+.+|++++ |||||++++++...
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~-~-~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-L-PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEE-C-TTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhh-h-hHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 4799999999999999999998 57899999876443221110 0 00122378999999997 89999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeccCC-CCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 581 KWLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 581 ~~~p~~~g~~~~~~~~~~LVmEy~~g-GSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
+. .|+||||+.+ ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 82 ~~--------------~~lv~e~~~~~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIl 142 (273)
T d1xwsa_ 82 DS--------------FVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENIL 142 (273)
T ss_dssp SE--------------EEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred Ce--------------EEEEEEeccCcchHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceE
Confidence 54 4999999976 688888876 357999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
++.+. +.+||+|||+|+...... .....||+.|||||++.+ ...++.++|||||||+||
T Consensus 143 l~~~~------~~vkl~DFG~a~~~~~~~------------~~~~~GT~~y~aPE~~~~---~~~~~~~~DiwSlGvily 201 (273)
T d1xwsa_ 143 IDLNR------GELKLIDFGSGALLKDTV------------YTDFDGTRVYSPPEWIRY---HRYHGRSAAVWSLGILLY 201 (273)
T ss_dssp EETTT------TEEEECCCTTCEECCSSC------------BCCCCSCGGGSCHHHHHH---SCBCHHHHHHHHHHHHHH
T ss_pred EecCC------CeEEECccccceeccccc------------ccccccCCCcCCHHHHcC---CCCCCcccccccceeeeh
Confidence 98552 469999999997654321 123579999999999986 234567899999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 740 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 740 ELLTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
||+||+.||.+.+ .+.+... .++ ...++++.+||.+||..||.+||
T Consensus 202 ell~g~~Pf~~~~------~i~~~~~-~~~---------------------------~~~s~~~~~li~~~L~~dp~~R~ 247 (273)
T d1xwsa_ 202 DMVCGDIPFEHDE------EIIRGQV-FFR---------------------------QRVSSECQHLIRWCLALRPSDRP 247 (273)
T ss_dssp HHHHSSCSCCSHH------HHHHCCC-CCS---------------------------SCCCHHHHHHHHHHTCSSGGGSC
T ss_pred hHhhCCCCCCCch------HHhhccc-CCC---------------------------CCCCHHHHHHHHHHccCCHhHCc
Confidence 9999999997532 1222211 111 11245799999999999999999
Q ss_pred CHHHHHHHHH
Q 003185 820 TAGDLYEMFV 829 (840)
Q Consensus 820 Sa~ELLehLe 829 (840)
|++|+++|.+
T Consensus 248 s~~eil~hp~ 257 (273)
T d1xwsa_ 248 TFEEIQNHPW 257 (273)
T ss_dssp CHHHHHTSGG
T ss_pred CHHHHhcCHh
Confidence 9999999854
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=395.08 Aligned_cols=281 Identities=22% Similarity=0.227 Sum_probs=206.9
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCCC
Q 003185 506 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 583 (840)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~~ 583 (840)
+|...++||+|+||+||+|++ .++.||||++..... .+ .+|+.+|++|+|||||+++++|......
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--------~~----~~Ei~il~~l~h~niv~~~~~~~~~~~~ 88 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FK----NRELQIMRKLDHCNIVRLRYFFYSSGEK 88 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--------SC----CHHHHHHHHCCCTTBCCEEEEEEEC--C
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--------HH----HHHHHHHHhcCCCCCCcEEEEEEecCcc
Confidence 699999999999999999998 578899999754321 11 5799999999999999999998754321
Q ss_pred CCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEecc
Q 003185 584 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 663 (840)
Q Consensus 584 p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~~ 663 (840)
....++||||||+++ ++...+.... .....+++..++.|+.||+.||+|||++||+||||||+||||+.+
T Consensus 89 --------~~~~~~~lv~Ey~~~-~~~~~l~~~~-~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~ 158 (350)
T d1q5ka_ 89 --------KDEVYLNLVLDYVPE-TVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD 158 (350)
T ss_dssp --------CSCCEEEEEEECCSE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT
T ss_pred --------CCceEEEEEEeccCC-ccHHHHHhhh-hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecC
Confidence 123457999999986 4555544322 234679999999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003185 664 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 743 (840)
Q Consensus 664 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELLT 743 (840)
+ ..+||+|||+++....... ....+||+.|+|||.+.+ ...++.++|||||||++|||++
T Consensus 159 ~------~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~---~~~~~~~~DIwSlG~il~el~~ 218 (350)
T d1q5ka_ 159 T------AVLKLCDFGSAKQLVRGEP-----------NVSYICSRYYRAPELIFG---ATDYTSSIDVWSAGCVLAELLL 218 (350)
T ss_dssp T------CCEEECCCTTCEECCTTSC-----------CCSCCSCTTSCCHHHHTT---CSSCCTHHHHHHHHHHHHHHHH
T ss_pred C------CceeEecccchhhccCCcc-----------cccccccccccChHHhhc---ccCCCcceeecccceEEEehhh
Confidence 3 3699999999986643221 233579999999999875 3568999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCc-cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 744 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH-EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 744 G~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
|..||...+..+.+..+.+.......+.+....... ...+................++.+.+||.+||.+||.+|||+.
T Consensus 219 g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~ 298 (350)
T d1q5ka_ 219 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298 (350)
T ss_dssp TSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHH
Confidence 999999988877777765542222223222211100 0000100000000011223466899999999999999999999
Q ss_pred HHHHHH
Q 003185 823 DLYEMF 828 (840)
Q Consensus 823 ELLehL 828 (840)
|+++|-
T Consensus 299 e~L~Hp 304 (350)
T d1q5ka_ 299 EACAHS 304 (350)
T ss_dssp HHHTSG
T ss_pred HHhcCH
Confidence 999983
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-44 Score=378.45 Aligned_cols=281 Identities=19% Similarity=0.210 Sum_probs=210.4
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+++|+++++||+|+||+||+|++ ++..||||+++.... ..... .++.+|+.+|+.++|||||++++++....
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~--~~~~~----~~~~~E~~il~~l~h~niv~~~~~~~~~~ 74 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVP----SSALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHH----HHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC--ChHHH----HHHHHHHHHHHhcCcCCEEeecccccccc
Confidence 57899999999999999999998 577899999765432 22222 34489999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .++||+++.+++|..++.. ...+++..++.++.|++.||+|||++|||||||||+|||++
T Consensus 75 ~--------------~~iv~~~~~~~~l~~~~~~-----~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~ 135 (292)
T d1unla_ 75 K--------------LTLVFEFCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 135 (292)
T ss_dssp E--------------EEEEEECCSEEHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred c--------------eeEEeeecccccccccccc-----ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc
Confidence 4 4999999999888887764 46789999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ ..+||+|||.|+........ .....+++.|+|||++.. ...++.++|||||||++|||
T Consensus 136 ~~-------~~~kl~DFG~a~~~~~~~~~----------~~~~~~~~~~~~pe~~~~---~~~~~~~~DiwSlG~il~el 195 (292)
T d1unla_ 136 RN-------GELKLANFGLARAFGIPVRC----------YSAEVVTLWYRPPDVLFG---AKLYSTSIDMWSAGCIFAEL 195 (292)
T ss_dssp TT-------CCEEECCCTTCEECCSCCSC----------CCSCCSCGGGCCHHHHTT---CSCCCTHHHHHHHHHHHHHH
T ss_pred cC-------CceeeeecchhhcccCCCcc----------ceeeccccchhhhhHhcc---CCCCCchhhccccchHHHHH
Confidence 77 45999999999876543221 223457899999999875 24578999999999999999
Q ss_pred HhCCCCC-CCCCHHHHHHHHHcCCCCCcchHHhhhccCccc-cccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 742 LTLQVPY-MGLSELEIHDLIQMGKRPRLTDELEALGSCHEH-EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 742 LTG~~PF-~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
++|+.|| .+.+..+....+.....+.....+......... ..................++.+.+||.+||+.||.+||
T Consensus 196 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ 275 (292)
T d1unla_ 196 ANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275 (292)
T ss_dssp TTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred hhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCc
Confidence 9999986 455566666555443222212111111111000 00001111112222334567899999999999999999
Q ss_pred CHHHHHHHHH
Q 003185 820 TAGDLYEMFV 829 (840)
Q Consensus 820 Sa~ELLehLe 829 (840)
||+|||+|.+
T Consensus 276 sa~e~L~Hp~ 285 (292)
T d1unla_ 276 SAEEALQHPY 285 (292)
T ss_dssp CHHHHTTSGG
T ss_pred CHHHHhcChh
Confidence 9999999853
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=385.52 Aligned_cols=284 Identities=18% Similarity=0.227 Sum_probs=203.6
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|+++++||+|+||+||+|.+ +++.||||++... ...... +++.+|+.+|++|+|||||++++++.....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~----~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF---EHQTYC----QRTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT---TCHHHH----HHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh---cChHHH----HHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence 4699999999999999999997 5889999986422 122222 345899999999999999999999876543
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
. .. ..+++|+|+.+|+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+||||+.
T Consensus 81 ~---------~~-~~~~l~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~ 144 (345)
T d1pmea_ 81 E---------QM-KDVYLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 144 (345)
T ss_dssp T---------TC-CCEEEEEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred c---------cc-ceEEEEEeecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECC
Confidence 2 11 22445556668999999975 46999999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+||+|||+|+......... ......+||+.|+|||++.. ...++.++||||+||++|+|+
T Consensus 145 ~-------~~~kl~DfG~a~~~~~~~~~~-------~~~~~~~gt~~y~aPE~l~~---~~~~~~~~DiwSlG~il~eml 207 (345)
T d1pmea_ 145 T-------CDLKICDFGLARVADPDHDHT-------GFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEML 207 (345)
T ss_dssp T-------CCEEECCCTTCEECCGGGCBC-------CTTCCCCSCGGGCCGGGTTT---BCSCSTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEcccCceeeccCCCccc-------eeeccccccceechHHHhhc---CCCCCchhhhhccCceehHHh
Confidence 7 469999999998765432211 11234579999999999864 256789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCcccc-ccccC--CCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE-VAQSG--SGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~-~~~~~--~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|+.||.+.+..+....+...................... ..... ............+..+++||.+||+.||.+||
T Consensus 208 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 287 (345)
T d1pmea_ 208 SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 287 (345)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred hCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCc
Confidence 9999999887766655554332111111111000000000 00000 00001111223456789999999999999999
Q ss_pred CHHHHHHHH
Q 003185 820 TAGDLYEMF 828 (840)
Q Consensus 820 Sa~ELLehL 828 (840)
|++|+++|.
T Consensus 288 ta~e~L~hp 296 (345)
T d1pmea_ 288 EVEQALAHP 296 (345)
T ss_dssp CHHHHHTSG
T ss_pred CHHHHhcCH
Confidence 999999984
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-43 Score=374.86 Aligned_cols=268 Identities=16% Similarity=0.167 Sum_probs=197.0
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++.+.||+|+||.||+|++ ++..||||+...+... . .+.+|+++++.++|+|+|..++.+.....
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~----~~~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------P----QLHIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS------C----CHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC------H----HHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence 4799999999999999999997 4789999987654211 1 23789999999998776666555443321
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
..++||||+. ++|...+.. ....+++..+..++.||+.||+|||++|||||||||+|||++.
T Consensus 77 -------------~~~ivme~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~ 138 (299)
T d1ckia_ 77 -------------YNVMVMELLG-PSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGL 138 (299)
T ss_dssp -------------EEEEEEECCC-CBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECC
T ss_pred -------------EEEEEEEEcC-Cchhhhhhh----ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccc
Confidence 3599999995 678777664 3457999999999999999999999999999999999999976
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
.+ ....+||+|||+|+.+....... ...........||+.|||||++.+ ..++.++|||||||++|||+
T Consensus 139 ~~----~~~~vkl~DFG~a~~~~~~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~~l~el~ 207 (299)
T d1ckia_ 139 GK----KGNLVYIIDFGLAKKYRDARTHQ---HIPYRENKNLTGTARYASINTHLG----IEQSRRDDLESLGYVLMYFN 207 (299)
T ss_dssp GG----GTTCEEECCCSSCEECBCTTTCC---BCCCCBCCSCCCCSSSCCHHHHTT----BCCCHHHHHHHHHHHHHHHH
T ss_pred cC----CCceeeeeccCcceecccccccc---ceeccccCCcCCCccccCHHHHhC----CCCCChhhEEecCHHHHHHH
Confidence 53 23579999999999875433221 111122345679999999999986 66899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 822 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ 822 (840)
||+.||...........+.......+... .+......++.+.+||.+||+.||.+||+++
T Consensus 208 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~ 267 (299)
T d1ckia_ 208 LGSLPWQGLKAATKRQKYERISEKKMSTP--------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYS 267 (299)
T ss_dssp HSSCTTCCCC-------HHHHHHHHHHSC--------------------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHH
T ss_pred hCCCcccccchHHHHHHHHHhhcccCCCC--------------------hhHhccCCCHHHHHHHHHHccCChhHCcCHH
Confidence 99999987665544333322100000000 0011123456899999999999999999999
Q ss_pred HHHHHHHhh
Q 003185 823 DLYEMFVAR 831 (840)
Q Consensus 823 ELLehLe~l 831 (840)
+|.+.|+.+
T Consensus 268 ~i~~~l~~~ 276 (299)
T d1ckia_ 268 YLRQLFRNL 276 (299)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 887776654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=386.75 Aligned_cols=281 Identities=20% Similarity=0.243 Sum_probs=206.6
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 582 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~~ 582 (840)
++|++++.||+|+||+||+|++ .+..||||++.. ........+. +.+|+.+|++|+|||||++++++.....
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~--~~~~~~~~~~----~~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--PFQSIIHAKR----TYRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSC--TTSSHHHHHH----HHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECc--hhcChHHHHH----HHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence 5799999999999999999997 588999998543 2233333333 4899999999999999999999875443
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEec
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 662 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd~ 662 (840)
. .....+++|+|+.+|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 92 ~---------~~~~~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~ 156 (348)
T d2gfsa1 92 L---------EEFNDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 156 (348)
T ss_dssp T---------TTCCCCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred c---------ccCceEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccc
Confidence 2 11123566777789999999853 46999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003185 663 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 742 (840)
Q Consensus 663 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ELL 742 (840)
+ +.+|++|||++....... ....||+.|+|||.+.+ ...++.++|||||||++|+|+
T Consensus 157 ~-------~~~kl~dfg~a~~~~~~~-------------~~~~g~~~y~apE~~~~---~~~~~~~~DiwSlGv~l~~ll 213 (348)
T d2gfsa1 157 D-------CELKILDFGLARHTDDEM-------------TGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAELL 213 (348)
T ss_dssp T-------CCEEECCC----CCTGGG-------------SSSCHHHHTSCHHHHTT---CSCCCTTHHHHHHHHHHHHHH
T ss_pred c-------ccccccccchhcccCccc-------------ccccccccccCchhhcC---CccCCcccchhhhhHHHHHHH
Confidence 7 459999999997654322 23468999999999875 245689999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccccccccC---CCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003185 743 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG---SGFEKPEAELETLSFLVDVFRRCTEENPTERP 819 (840)
Q Consensus 743 TG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eRP 819 (840)
+|+.||.+.+.......+.........+................. ............++.+++||.+||..||.+||
T Consensus 214 ~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ 293 (348)
T d2gfsa1 214 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293 (348)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCc
Confidence 999999999888877777654222222111110000000000000 00111112234567899999999999999999
Q ss_pred CHHHHHHHHH
Q 003185 820 TAGDLYEMFV 829 (840)
Q Consensus 820 Sa~ELLehLe 829 (840)
|++|+++|-+
T Consensus 294 ta~elL~Hp~ 303 (348)
T d2gfsa1 294 TAAQALAHAY 303 (348)
T ss_dssp CHHHHHTSGG
T ss_pred CHHHHhcCHh
Confidence 9999999854
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-43 Score=386.17 Aligned_cols=281 Identities=17% Similarity=0.223 Sum_probs=204.6
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeEEecCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 581 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g~~~~~~ 581 (840)
+++|+++++||+|+||+||+|.+ ++..||||++.... ....... ++.+|+.+|++++|||||+++++|....
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~--~~~~~~~----~~~~Ei~il~~l~hpnIv~~~~~f~~~~ 89 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAK----RAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT--SSHHHHH----HHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh--cCHHHHH----HHHHHHHHHHhcCCCCeeEEEEEEeccc
Confidence 47899999999999999999998 48899999975432 2333333 3489999999999999999999997654
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
.. ....++|+||||+.+ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 90 ~~--------~~~~~~~iv~Ey~~~-~l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~ 153 (355)
T d2b1pa1 90 TL--------EEFQDVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 153 (355)
T ss_dssp ST--------TTCCEEEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred cc--------ccCceeEEEEeccch-HHHHhhh-------cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccc
Confidence 32 123468999999976 5555442 4589999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.+ +.+|++|||+++....... .....||+.|+|||++.+ ..++.++||||+||++|+|
T Consensus 154 ~~-------~~~kl~df~~~~~~~~~~~-----------~~~~~~t~~y~aPE~l~~----~~~~~~~DiwSlG~~l~el 211 (355)
T d2b1pa1 154 SD-------CTLKILDFGLARTAGTSFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGEM 211 (355)
T ss_dssp TT-------CCEEECCCCC--------------------------CCTTCCHHHHTT----CCCCTTHHHHHHHHHHHHH
T ss_pred cc-------cceeeechhhhhccccccc-----------cccccccccccChhhhcC----CCCCCCcccccccchHHHH
Confidence 87 4599999999876544221 234569999999999986 6789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCcchHHhhhccCccc---------------cccccCCCCCCchhhhhhHHHHHHH
Q 003185 742 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH---------------EVAQSGSGFEKPEAELETLSFLVDV 806 (840)
Q Consensus 742 LTG~~PF~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~s~~L~dL 806 (840)
++|+.||.+.+.......+........++.+......... .+..... ..........+..+.+|
T Consensus 212 l~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dl 290 (355)
T d2b1pa1 212 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLF-PADSEHNKLKASQARDL 290 (355)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGS-CCSSHHHHHHHHHHHHH
T ss_pred hhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccc-cccccccccCCHHHHHH
Confidence 9999999998887777766554333333333221110000 0000000 11122344567889999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHH
Q 003185 807 FRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 807 I~rCL~~DP~eRPSa~ELLehLe 829 (840)
|.+||.+||++||||+|||+|.+
T Consensus 291 l~~mL~~dP~~R~ta~elL~Hpw 313 (355)
T d2b1pa1 291 LSKMLVIDPAKRISVDDALQHPY 313 (355)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSTT
T ss_pred HHHHCcCChhHCcCHHHHhcCcc
Confidence 99999999999999999999953
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.5e-43 Score=380.89 Aligned_cols=277 Identities=19% Similarity=0.203 Sum_probs=202.5
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEec
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 579 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~ 579 (840)
..++|+++++||+|+||+||+|++ ++..||+|++... ..+ ++.+|+.+|+.++ ||||+++++++..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-------~~~----~~~~Ei~il~~l~~hpnIv~~~~~~~~ 101 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKK----KIKREIKILENLRGGPNIITLADIVKD 101 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-------CHH----HHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-------HHH----HHHHHHHHHHhccCCCCCcEEEEEEEe
Confidence 457899999999999999999997 5789999986421 112 3489999999996 9999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEE
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 659 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNIL 659 (840)
... ...++||||+.+++|..+. ..+++..++.++.||+.||+|||++|||||||||+|||
T Consensus 102 ~~~------------~~~~~v~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NIL 161 (328)
T d3bqca1 102 PVS------------RTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 161 (328)
T ss_dssp TTT------------CSEEEEEECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred cCC------------CceeEEEeecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceE
Confidence 432 1469999999999987653 35999999999999999999999999999999999999
Q ss_pred EecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003185 660 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 739 (840)
Q Consensus 660 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~ 739 (840)
|+.++ ..+||+|||+|+....... .....||+.|+|||.+.+ ...++.++|||||||++|
T Consensus 162 i~~~~------~~vkl~DFG~a~~~~~~~~-----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~~l~ 221 (328)
T d3bqca1 162 IDHEH------RKLRLIDWGLAEFYHPGQE-----------YNVRVASRYFKGPELLVD---YQMYDYSLDMWSLGCMLA 221 (328)
T ss_dssp EETTT------TEEEECCGGGCEECCTTCC-----------CCSCCSCGGGCCHHHHTT---CCCCCTHHHHHHHHHHHH
T ss_pred EcCCC------CeeeecccccceeccCCCc-----------ccccccCccccCcccccC---CCCCCcccchhhhhhhhH
Confidence 98663 3699999999987644221 234568999999999876 245789999999999999
Q ss_pred HHHhCCCCCCCCC-HHHHHHHHHcCCCCCcchHHhhhccC-ccccccccC--------CCCCCchhhhhhHHHHHHHHHH
Q 003185 740 ELLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSC-HEHEVAQSG--------SGFEKPEAELETLSFLVDVFRR 809 (840)
Q Consensus 740 ELLTG~~PF~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~-~~~~~~~~~--------~~~~~~~~~~~~s~~L~dLI~r 809 (840)
||++|+.||.... ..+....+...........+...... ....+.... ............++++.+||.+
T Consensus 222 e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~ 301 (328)
T d3bqca1 222 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301 (328)
T ss_dssp HHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHH
T ss_pred HhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHH
Confidence 9999999996543 33333333221110000000000000 000000000 0011112233456789999999
Q ss_pred hcccCCCCCCCHHHHHHHHHh
Q 003185 810 CTEENPTERPTAGDLYEMFVA 830 (840)
Q Consensus 810 CL~~DP~eRPSa~ELLehLe~ 830 (840)
||.+||.+|||++|+|+|..-
T Consensus 302 mL~~dP~~R~ta~e~L~Hp~F 322 (328)
T d3bqca1 302 LLRYDHQSRLTAREAMEHPYF 322 (328)
T ss_dssp HSCSSGGGSCCHHHHHTSGGG
T ss_pred HccCChhHCcCHHHHhcCccc
Confidence 999999999999999998654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-44 Score=386.76 Aligned_cols=260 Identities=22% Similarity=0.270 Sum_probs=203.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC-CCcceeee
Q 003185 502 GSFPSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEMYG 575 (840)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~H-pNIV~l~g 575 (840)
+.+++|++++.||+|+||+||+|.. .+..||+|++............+ .+.+|+.+|++++| |||+++++
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~----~~~~E~~il~~l~h~pnIv~~~~ 96 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE----HTRTERQVLEHIRQSPFLVTLHY 96 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGG----GCCCHHHHHHHHHTCTTBCCEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHH----HHHHHHHHHHhccCCCeEEEeee
Confidence 4678999999999999999999986 36789999975433211111222 33889999999976 89999999
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCC
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 655 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKP 655 (840)
++..... .++||||+.+|+|..++.. ...+++..++.++.||+.||+|||++|||||||||
T Consensus 97 ~~~~~~~--------------~~~v~e~~~~~~L~~~i~~-----~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp 157 (322)
T d1vzoa_ 97 AFQTETK--------------LHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKL 157 (322)
T ss_dssp EEEETTE--------------EEEEECCCCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred eeccCCc--------------eeeeeecccccHHHHHHHh-----cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCc
Confidence 9987654 4999999999999999986 35678999999999999999999999999999999
Q ss_pred CcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003185 656 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 735 (840)
Q Consensus 656 eNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLG 735 (840)
+|||++.+ +.+||+|||+|+.+....... .....||+.|+|||.+.+ ....++.++||||||
T Consensus 158 ~Nill~~~-------~~vkL~DFG~a~~~~~~~~~~---------~~~~~g~~~~~~pe~~~~--~~~~~~~ksDIWSlG 219 (322)
T d1vzoa_ 158 ENILLDSN-------GHVVLTDFGLSKEFVADETER---------AYDFCGTIEYMAPDIVRG--GDSGHDKAVDWWSLG 219 (322)
T ss_dssp GGEEECTT-------SCEEESCSSEEEECCGGGGGG---------GCGGGSCCTTCCHHHHTT--CC---CTHHHHHHHH
T ss_pred cceeecCC-------CCEEEeeccchhhhccccccc---------ccccccccccchhHHhhc--CCcCCCchhhhHHHH
Confidence 99999987 469999999998765433221 133469999999999975 224578899999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcC---CCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 003185 736 CLLLELLTLQVPYMGLSELEIHDLIQMG---KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 812 (840)
Q Consensus 736 vIL~ELLTG~~PF~~~~~~el~~~I~~~---~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~ 812 (840)
|+||||++|+.||.+.+..+....+.+. ..+.++ ...++.+.+||.+||.
T Consensus 220 ~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~---------------------------~~~s~~~~~li~~~l~ 272 (322)
T d1vzoa_ 220 VLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP---------------------------QEMSALAKDLIQRLLM 272 (322)
T ss_dssp HHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC---------------------------TTSCHHHHHHHHHHTC
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc---------------------------ccCCHHHHHHHHHHcc
Confidence 9999999999999776544433333221 111111 1235689999999999
Q ss_pred cCCCCCC-----CHHHHHHHHH
Q 003185 813 ENPTERP-----TAGDLYEMFV 829 (840)
Q Consensus 813 ~DP~eRP-----Sa~ELLehLe 829 (840)
+||.+|| |++|+++|.+
T Consensus 273 ~dP~~R~s~~~~t~~eil~Hpf 294 (322)
T d1vzoa_ 273 KDPKKRLGCGPRDADEIKEHLF 294 (322)
T ss_dssp SSGGGSTTSSTTTHHHHHTSGG
T ss_pred cCHHHcCCCCcccHHHHHcCHh
Confidence 9999999 5899999743
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.5e-41 Score=361.93 Aligned_cols=267 Identities=16% Similarity=0.169 Sum_probs=205.1
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC-CCcceeeeEEecCC
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEMYGHKISSK 581 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~H-pNIV~l~g~~~~~~ 581 (840)
++|++++.||+|+||+||+|++ +++.||+|+...... .. .+.+|+++++.|+| +||+.+++++....
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~----~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 74 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------AP----QLRDEYRTYKLLAGCTGIPNVYYFGQEGL 74 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SC----CHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC------cH----HHHHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence 5799999999999999999997 578899998643321 11 23789999999985 89999999987655
Q ss_pred CCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCCCcEEEe
Q 003185 582 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 661 (840)
Q Consensus 582 ~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKPeNILLd 661 (840)
. .++||||+ +++|.+++.. ....++...+..++.|++.||+|||++|||||||||+||||+
T Consensus 75 ~--------------~~~vme~~-~~~l~~~~~~----~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~ 135 (293)
T d1csna_ 75 H--------------NVLVIDLL-GPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIG 135 (293)
T ss_dssp E--------------EEEEEECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC
T ss_pred c--------------cEEEEEec-CCCHHHHHHh----hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeec
Confidence 3 49999999 5799999875 235699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003185 662 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 741 (840)
Q Consensus 662 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kSDVWSLGvIL~EL 741 (840)
.... ...+.+||+|||+|+.+........ .........+||+.|||||++.+ ..++.++|||||||++|||
T Consensus 136 ~~~~--~~~~~vkl~DFG~a~~~~~~~~~~~---~~~~~~~~~~GT~~y~aPE~~~~----~~~~~~~DiwSlG~~l~el 206 (293)
T d1csna_ 136 RPNS--KNANMIYVVDFGMVKFYRDPVTKQH---IPYREKKNLSGTARYMSINTHLG----REQSRRDDLEALGHVFMYF 206 (293)
T ss_dssp CSSS--TTTTCEEECCCTTCEESBCTTTCCB---CCCCCCCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHHHHHH
T ss_pred Cccc--ccCCceEEcccceeEEcccCccccc---eeecccCceEEchhhcCHHHhcC----CCCChHHHHHHhhHHHHHH
Confidence 6421 1235699999999987754322211 11122345679999999999986 6789999999999999999
Q ss_pred HhCCCCCCCCC---HHHHHHHHHcCCCCCcchHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003185 742 LTLQVPYMGLS---ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 818 (840)
Q Consensus 742 LTG~~PF~~~~---~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~rCL~~DP~eR 818 (840)
+||..||.+.. .......+........... .....++++.+|+..|+..+|.+|
T Consensus 207 ltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~-----------------------l~~~~p~~l~~ii~~~~~~~~~~r 263 (293)
T d1csna_ 207 LRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE-----------------------LCAGFPEEFYKYMHYARNLAFDAT 263 (293)
T ss_dssp HHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH-----------------------HTTTSCHHHHHHHHHHHHCCTTCC
T ss_pred HhCCCcCCCccchhHHHHHHHHHhccCCCChHH-----------------------hcCCCCHHHHHHHHHHhcCCcccC
Confidence 99999997653 3333333332211111110 112235679999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 003185 819 PTAGDLYEMFVART 832 (840)
Q Consensus 819 PSa~ELLehLe~l~ 832 (840)
|+++.+.+.|+.+.
T Consensus 264 P~y~~l~~~l~~~~ 277 (293)
T d1csna_ 264 PDYDYLQGLFSKVL 277 (293)
T ss_dssp CCHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHH
Confidence 99999988887754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.3e-37 Score=335.63 Aligned_cols=282 Identities=19% Similarity=0.210 Sum_probs=190.9
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-----------CCCcc
Q 003185 505 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-----------HSCIV 571 (840)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-----------HpNIV 571 (840)
++|+++++||+|+||+||+|++ ++..||||+++.. ... .+.+.+|+.+++.+. |+|||
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-----~~~----~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv 83 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVY----TEAAEDEIKLLQRVNDADNTKEDSMGANHIL 83 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHH----HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-----ccc----hHHHHHHHHHHHHhcchhhhhhhhcCcCceE
Confidence 3699999999999999999997 5789999997532 111 223478888888775 57899
Q ss_pred eeeeEEecCCCCCCCCCCCccccceEEEEEeccCCCC-HHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCee
Q 003185 572 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS-VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIM 649 (840)
Q Consensus 572 ~l~g~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGS-L~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs-~gIV 649 (840)
++++++..... ...+++|+++..+. ....... .....+++..++.++.||+.||+|||+ .||+
T Consensus 84 ~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~i~~qil~al~~lh~~~~Iv 148 (362)
T d1q8ya_ 84 KLLDHFNHKGP------------NGVHVVMVFEVLGENLLALIKK---YEHRGIPLIYVKQISKQLLLGLDYMHRRCGII 148 (362)
T ss_dssp CCCEEEEEEET------------TEEEEEEEECCCCEEHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEE
T ss_pred EEEEEeeeccc------------cceeeeeeeccccccccccccc---ccccCCcHHHHHHHHHHHHHHHHHHhhhcCcc
Confidence 99998875432 13466666655443 3333332 334678999999999999999999998 8999
Q ss_pred cccCCCCcEEEecccccCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchh
Q 003185 650 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 729 (840)
Q Consensus 650 HRDLKPeNILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~kS 729 (840)
||||||+||||+.++. ......++|+|||.+....... ...+||+.|+|||++.+ ..++.++
T Consensus 149 HrDlKp~NIll~~~~~-~~~~~~~kl~dfg~s~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~ 210 (362)
T d1q8ya_ 149 HTDIKPENVLMEIVDS-PENLIQIKIADLGNACWYDEHY-------------TNSIQTREYRSPEVLLG----APWGCGA 210 (362)
T ss_dssp CSCCSGGGEEEEEEET-TTTEEEEEECCCTTCEETTBCC-------------CSCCSCGGGCCHHHHHT----CCCCTHH
T ss_pred cccCChhHeeeeccCc-ccccceeeEeeccccccccccc-------------ccccccccccChhhccc----cCCCccc
Confidence 9999999999987642 1122359999999997553321 23469999999999986 6689999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCCCcchHHhhhccCcccc-----ccccCCCCC-------
Q 003185 730 DIWSYGCLLLELLTLQVPYMGLSE------LEIHDLIQMGKRPRLTDELEALGSCHEHE-----VAQSGSGFE------- 791 (840)
Q Consensus 730 DVWSLGvIL~ELLTG~~PF~~~~~------~el~~~I~~~~~p~l~~~l~~~~~~~~~~-----~~~~~~~~~------- 791 (840)
||||+||++++|++|+.||..... ......+..... ..+..+.......... .........
T Consensus 211 DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (362)
T d1q8ya_ 211 DIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG-ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV 289 (362)
T ss_dssp HHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHC-SCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHH
T ss_pred cccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhC-CCCHHHhhcccccccccccchhhhccccccCCchhhh
Confidence 999999999999999999965432 111111111100 0111111110000000 000000000
Q ss_pred ---CchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003185 792 ---KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 829 (840)
Q Consensus 792 ---~~~~~~~~s~~L~dLI~rCL~~DP~eRPSa~ELLehLe 829 (840)
........++.+++||.+||.+||.+||||+|+|+|-.
T Consensus 290 ~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~ 330 (362)
T d1q8ya_ 290 LTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW 330 (362)
T ss_dssp HHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGG
T ss_pred cccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 01112445778999999999999999999999999954
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=7.6e-23 Score=203.83 Aligned_cols=141 Identities=18% Similarity=0.211 Sum_probs=106.9
Q ss_pred ceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCC----------hHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 003185 507 LSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSS----------ADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 575 (840)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~----------~~~~~~f~~~~~rEi~iL~~L~HpNIV~l~g 575 (840)
+.++++||+|+||+||+|.+ ++..||||+.+....... ............+|+..+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46899999999999999986 678999998654221100 0001112234467899999999999999886
Q ss_pred EEecCCCCCCCCCCCccccceEEEEEeccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCC
Q 003185 576 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 655 (840)
Q Consensus 576 ~~~~~~~~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~~~~Ia~QIa~AL~yLHs~gIVHRDLKP 655 (840)
+.. .+++|||+++..+. .++...+..++.||+.+|.|||++||+||||||
T Consensus 82 ~~~------------------~~lvme~~~~~~~~------------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP 131 (191)
T d1zara2 82 WEG------------------NAVLMELIDAKELY------------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQ 131 (191)
T ss_dssp EET------------------TEEEEECCCCEEGG------------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCST
T ss_pred ecC------------------CEEEEEeecccccc------------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCCh
Confidence 632 18999999875432 244556678999999999999999999999999
Q ss_pred CcEEEecccccCCCCCeEEEeecCCccccc
Q 003185 656 ENILIDLERKKADGKPVVKLCDFDRAVPLR 685 (840)
Q Consensus 656 eNILLd~~~~~~~~~~~vKL~DFGlA~~~~ 685 (840)
+|||++.+ .++|+|||+|+...
T Consensus 132 ~NILv~~~--------~~~liDFG~a~~~~ 153 (191)
T d1zara2 132 YNVLVSEE--------GIWIIDFPQSVEVG 153 (191)
T ss_dssp TSEEEETT--------EEEECCCTTCEETT
T ss_pred hheeeeCC--------CEEEEECCCcccCC
Confidence 99999855 38999999997653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.17 E-value=3.3e-06 Score=84.99 Aligned_cols=87 Identities=10% Similarity=0.084 Sum_probs=58.0
Q ss_pred CCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEecCCC
Q 003185 504 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 582 (840)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~~~~ 582 (840)
++.|++.+..+.++.+.||+....+..+++|+........ ...+.+|+.++..|. +--+.+++.+....+
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--------~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~- 83 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--------TYDVEREKDMMLWLEGKLPVPKVLHFERHDG- 83 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--------TTCHHHHHHHHHHHTTTSCCCCEEEEEEETT-
T ss_pred hhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc--------hhhHHHHHHHHHHHhccCCCCcEEEEEecCC-
Confidence 4567777766656667999998888888888764322111 112377888888775 433567777665443
Q ss_pred CCCCCCCCccccceEEEEEeccCCCCHHHH
Q 003185 583 LPSADGNPEHHLLQSAIFMEYVKGGSVKNY 612 (840)
Q Consensus 583 ~p~~~g~~~~~~~~~~LVmEy~~gGSL~~~ 612 (840)
..++||++++|.++.+.
T Consensus 84 -------------~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 84 -------------WSNLLMSEADGVLCSEE 100 (263)
T ss_dssp -------------EEEEEEECCSSEEHHHH
T ss_pred -------------ceEEEEEeccccccccc
Confidence 34999999998777543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.33 E-value=0.00021 Score=76.92 Aligned_cols=82 Identities=12% Similarity=-0.027 Sum_probs=46.0
Q ss_pred eeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-C--CCcceeeeEEecCCCCC
Q 003185 510 CDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-H--SCIVEMYGHKISSKWLP 584 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-H--pNIV~l~g~~~~~~~~p 584 (840)
.+.||.|....||++.. ++..+++|.-.......+. ....-..+...|++.|+.+. + ..+.+++.+... .
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~-~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~--~-- 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGE-SWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE--M-- 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--C-CCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT--T--
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCC-CCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC--C--
Confidence 55789999999999975 4567888865321111100 00000112256888777663 2 345666654321 1
Q ss_pred CCCCCCccccceEEEEEeccCCCC
Q 003185 585 SADGNPEHHLLQSAIFMEYVKGGS 608 (840)
Q Consensus 585 ~~~g~~~~~~~~~~LVmEy~~gGS 608 (840)
.++|||++.+..
T Consensus 106 ------------~~lvmE~L~~~~ 117 (392)
T d2pula1 106 ------------AVTVMEDLSHLK 117 (392)
T ss_dssp ------------TEEEECCCTTSE
T ss_pred ------------CEEEEeccCCcc
Confidence 289999997643
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.30 E-value=0.00021 Score=71.03 Aligned_cols=73 Identities=12% Similarity=0.073 Sum_probs=45.6
Q ss_pred eecccCc-eEEEEEEEC-CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC--CCcceeeeEEecCCCCCCCC
Q 003185 512 EAGKSVS-SSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SCIVEMYGHKISSKWLPSAD 587 (840)
Q Consensus 512 ~LG~G~f-G~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~H--pNIV~l~g~~~~~~~~p~~~ 587 (840)
.+..|.. +.||+.... +..+++|+..... .. .+..|+..|+.|.. -.+.+++.+....+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-------~~----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~------ 79 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-------LN----ELQDEAARLSWLATTGVPCAAVLDVVTEAG------ 79 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-------TS----CHHHHHHHHHHHHTTTCCBCCEEEEEECSS------
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-------Hh----HHHHHHHHHHHHHhcCCCCCceeeeccccc------
Confidence 4445544 689999874 5567888754221 11 23678888777752 33566777665433
Q ss_pred CCCccccceEEEEEeccCCCCH
Q 003185 588 GNPEHHLLQSAIFMEYVKGGSV 609 (840)
Q Consensus 588 g~~~~~~~~~~LVmEy~~gGSL 609 (840)
..++||+|++|.++
T Consensus 80 --------~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 80 --------RDWLLLGEVPGQDL 93 (255)
T ss_dssp --------CEEEEEECCSSEET
T ss_pred --------ceEEEEEeeecccc
Confidence 24999999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.65 E-value=0.011 Score=61.17 Aligned_cols=72 Identities=11% Similarity=0.010 Sum_probs=40.7
Q ss_pred ceEEEEEEE-CCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCc--ceeeeEEecCCCCCCCCCCCcccc
Q 003185 518 SSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI--VEMYGHKISSKWLPSADGNPEHHL 594 (840)
Q Consensus 518 fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~HpNI--V~l~g~~~~~~~~p~~~g~~~~~~ 594 (840)
--.||++.. ++..+++|+.+.. ..+. ++ +..|...|..|...+| +..+. .. ++......
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~--~~s~---~~----i~~E~~~l~~L~~~gipv~~p~~--~~-------g~~~~~~~ 96 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE--RWTA---DQ----ILEEHQFALQLVNDEVPVAAPVA--FN-------GQTLLNHQ 96 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT--TSCH---HH----HHHHHHHHHHHHHTTCSBCCCCC--BT-------TBSCEEET
T ss_pred cceeEEEEcCCCCEEEEEEeCCC--CCCH---HH----HHHHHHHHHHHHhcCCCCCCcee--cC-------CCeeeeee
Confidence 358999986 6778999997532 1121 22 3678888888753332 21111 11 11111233
Q ss_pred ceEEEEEeccCCC
Q 003185 595 LQSAIFMEYVKGG 607 (840)
Q Consensus 595 ~~~~LVmEy~~gG 607 (840)
...+.|++++.|.
T Consensus 97 ~~~~~l~~~~~G~ 109 (325)
T d1zyla1 97 GFYFAVFPSVGGR 109 (325)
T ss_dssp TEEEEEEECCCCE
T ss_pred eEEEEEEeecCCc
Confidence 4568899999763
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.47 E-value=0.021 Score=58.10 Aligned_cols=54 Identities=15% Similarity=0.070 Sum_probs=33.4
Q ss_pred CCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC
Q 003185 503 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR 566 (840)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~ 566 (840)
.++.+.-.+.|..|---+.|+...++..+++|++.... .. +. +..|+.+|..|.
T Consensus 16 ~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~---~~---~~----l~~~~~~l~~L~ 69 (316)
T d2ppqa1 16 DVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV---EK---ND----LPFFLGLMQHLA 69 (316)
T ss_dssp CCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC------C---CH----HHHHHHHHHHHH
T ss_pred CCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC---CH---HH----HHHHHHHHHhhh
Confidence 34555666778888889999999988889999974321 11 11 144667777764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.81 E-value=0.041 Score=58.20 Aligned_cols=71 Identities=15% Similarity=0.226 Sum_probs=46.1
Q ss_pred eeeecccCceEEEEEEEC---------CeeEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeEEec
Q 003185 510 CDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 579 (840)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~---------~~~vAVKI~~lk~~~~~~~~~~~f~~~~~rEi~iL~~L~-HpNIV~l~g~~~~ 579 (840)
++.|+.|-.-.+|++... ...+.+++.- . .... .. ..+|..+++.+. +.-..++++++.
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~--~~~~--id-----r~~E~~i~~~ls~~gl~Pkll~~~~- 115 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N--PETE--SH-----LVAESVIFTLLSERHLGPKLYGIFS- 115 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S--CCCH--HH-----HHHHHHHHHHHHHTTSSSCEEEEET-
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C--cchh--hH-----HHHHHHHHHHHHhCCCCCeEEEEcC-
Confidence 467888999999999863 2456666653 2 1111 11 157888888886 433457777653
Q ss_pred CCCCCCCCCCCccccceEEEEEeccCCCC
Q 003185 580 SKWLPSADGNPEHHLLQSAIFMEYVKGGS 608 (840)
Q Consensus 580 ~~~~p~~~g~~~~~~~~~~LVmEy~~gGS 608 (840)
+ ++||||++|.+
T Consensus 116 -~----------------g~I~efi~g~~ 127 (395)
T d1nw1a_ 116 -G----------------GRLEEYIPSRP 127 (395)
T ss_dssp -T----------------EEEECCCCEEE
T ss_pred -C----------------ceEEEEecccc
Confidence 1 78999998743
|